PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tan, KR; Yvon, C; Turiault, M; Mirzabekov, JJ; Doehner, J; Labouebe, G; Deisseroth, K; Tye, KM; Luscher, C				Tan, Kelly R.; Yvon, Cedric; Turiault, Marc; Mirzabekov, Julie J.; Doehner, Jana; Labouebe, Gwenael; Deisseroth, Karl; Tye, Kay M.; Luescher, Christian			GABA Neurons of the VTA Drive Conditioned Place Aversion	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE NEURONS; LATERAL HABENULA; NONDOPAMINERGIC NEURONS; SYNAPTIC PLASTICITY; CENTRAL AMYGDALA; REWARD; RAT; NUCLEUS; STIMULI	Salient but aversive stimuli inhibit the majority of dopamine (DA) neurons in the ventral tegmental area (VTA) and cause conditioned place aversion (CPA). The cellular mechanism underlying DA neuron inhibition has not been investigated and the causal link to behavior remains elusive. Here, we show that GABA neurons of the VTA inhibit DA neurons through neurotransmission at GABA(A) receptors. We also observe that GABA neurons increase their firing in response to a footshock and provide evidence that driving GABA neurons with optogenetic effectors is sufficient to affect behavior. Taken together, our data demonstrate that synaptic inhibition of DA neurons drives place aversion.	[Tan, Kelly R.; Yvon, Cedric; Turiault, Marc; Labouebe, Gwenael; Luescher, Christian] Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Mirzabekov, Julie J.; Deisseroth, Karl; Tye, Kay M.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Doehner, Jana] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Tye, Kay M.] MIT, Picower Inst Learning & Memory Brain & Cognit Sci, Cambridge, MA 02139 USA; [Luescher, Christian] Univ Hosp Geneva, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; Stanford University; University of Zurich; Massachusetts Institute of Technology (MIT); University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011; Tye, Kay/J-6158-2013; Core, Vector/CAF-4832-2022	Lüscher, Christian/0000-0001-7917-4596; Tye, Kay/0000-0002-2435-0182; 	National Center of Competences in Research; Swiss National Science Foundation; NRSA [F32 MH880102]; PILM (MIT); National Institutes of Health; Howard Hughes Medical Institute; Defense Advanced Research Projects Agency; Gatsby Charitable Foundation; Woo Foundation; Snyder Foundation; Yu Foundation; Wiegers Family Fund	National Center of Competences in Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PILM (MIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gatsby Charitable Foundation; Woo Foundation; Snyder Foundation; Yu Foundation; Wiegers Family Fund	We thank Matthew Brown for critical reading of the manuscript. We thank Eoin O'Connor for support in behavioral experiments. We also thank Gero Miesenbock for generously providing the GADcre mice. This study was supported by the National Center of Competences in Research. "SYNAPSY - The Synaptic Bases of Mental Diseases" financed by the Swiss National Science Foundation as well as a core grant to C.L. K.M.T. is supported by NRSA fellowship F32 MH880102 and PILM (MIT). K.D. is supported by the National Institutes of Health, the Howard Hughes Medical Institute, the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program, the Gatsby Charitable Foundation, the Woo, Snyder, and Yu Foundations, and the Wiegers Family Fund. All optogenetic tools and methods are distributed and supported freely (www.optogenetics.org). K.R.T. and C.L. designed the study and wrote the manuscript. K.R.T., C.Y., and G.L. performed the in vivo electrophysiological experiments and analyzed the data. K.R.T. performed the in vitro electrophysiological experiments and analyzed the data. M.T., K.M.T., and J.J.M. performed behavioral experiments in K.D.'s group, and K.D. also provided reagents. J.D. performed immunohistochemistry.	ACQUAS E, 1989, PSYCHOPHARMACOLOGY, V99, P151, DOI 10.1007/BF00442800; Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Anstrom KK, 2005, NEUROPSYCHOPHARMACOL, V30, P1832, DOI 10.1038/sj.npp.1300730; Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Cruz HG, 2008, J NEUROSCI, V28, P4069, DOI 10.1523/JNEUROSCI.0267-08.2008; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; Fadok JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012751; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gavello-Baudy S, 2008, PSYCHOPHARMACOLOGY, V201, P219, DOI 10.1007/s00213-008-1263-z; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Guarraci FA, 1999, ANN NY ACAD SCI, V877, P732, DOI 10.1111/j.1749-6632.1999.tb09312.x; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Lassen MB, 2007, BRAIN RES, V1156, P46, DOI 10.1016/j.brainres.2007.04.053; Lazaro-Munoz G, 2010, BIOL PSYCHIAT, V67, P1120, DOI 10.1016/j.biopsych.2009.12.002; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Rosenkranz JA, 2006, BIOL PSYCHIAT, V59, P801, DOI 10.1016/j.biopsych.2005.09.013; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sun WenLin, 2011, Curr Drug Abuse Rev, V4, P270; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; TEPPER JM, 1995, J NEUROSCI, V15, P3092; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2011, J NEUROSCI, V31, P4280, DOI 10.1523/JNEUROSCI.5310-10.2011; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; WILLIAMS GV, 1990, NEUROSCIENCE, V39, P1, DOI 10.1016/0306-4522(90)90217-R; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	53	390	397	3	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1173	1183		10.1016/j.neuron.2012.02.015	http://dx.doi.org/10.1016/j.neuron.2012.02.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445344	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000301998700014
J	Jaworski, A; Tessier-Lavigne, M				Jaworski, Alexander; Tessier-Lavigne, Marc			Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling	NATURE NEUROSCIENCE			English	Article							NEURONAL GROWTH CONES; GRASSHOPPER EMBRYOS; DROSOPHILA	Axons travel to their targets in bundles or fascicles, but the molecules regulating fasciculation remain incompletely characterized. We found that Slit2 and its Robo receptors are expressed by motor axons, and that inactivation of Slit2 or Robo1 and Robo2 in mice caused axons to defasciculate prematurely at muscle targets. In vitro, Slit2 secreted by motoneurons regulated fasciculation through Robo1 and Robo2. These results support the idea that Slit2 promotes axon fasciculation via an autocrine and/or juxtaparacrine mechanism.	[Jaworski, Alexander; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [Jaworski, Alexander; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10021 USA	Roche Holding; Genentech; Rockefeller University	Tessier-Lavigne, M (corresponding author), Genentech Inc, Div Res, San Francisco, CA 94080 USA.	marctl@mail.rockefeller.edu		Jaworski, Alexander/0000-0002-4596-5450	Genentech; The Rockefeller University	Genentech(Roche HoldingGenentech); The Rockefeller University	We thank N. Velarde for technical assistance, A. Koch and colleagues (Genentech) for expression and purification of Slit2, Robo1-Fc and Robo1-AP, S. Pfaff (Salk Institute) and J. Lewcock (Genentech) for sharing the HB9 antibody, and D. Simon for thoughtful comments on the manuscript. This work was supported by Genentech and The Rockefeller University.	Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Liu JM, 2003, MECH DEVELOP, V120, P1059, DOI 10.1016/S0925-4773(03)00161-8; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Shiau CE, 2009, DEVELOPMENT, V136, P4155, DOI 10.1242/dev.034355; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100	14	66	72	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					367	369		10.1038/nn.3037	http://dx.doi.org/10.1038/nn.3037			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22306607				2022-12-25	WOS:000300793100008
J	Poulet, JFA; Fernandez, LMJ; Crochet, S; Petersen, CCH				Poulet, James F. A.; Fernandez, Laura M. J.; Crochet, Sylvain; Petersen, Carl C. H.			Thalamic control of cortical states	NATURE NEUROSCIENCE			English	Article							BEHAVING MICE; BARREL CORTEX; RESPONSES; MODULATION; MECHANISMS; NETWORKS; DYNAMICS	We investigated the impact of thalamus on ongoing cortical activity in the awake, behaving mouse. We demonstrate that the desynchronized cortical state during active behavior is driven by a centrally generated increase in thalamic action potential firing, which can also be mimicked by optogenetic stimulation of the thalamus. The thalamus therefore is key in controlling cortical states.	[Poulet, James F. A.; Fernandez, Laura M. J.; Crochet, Sylvain; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Lausanne, Switzerland; [Poulet, James F. A.] Max Delbruck Ctr Mol Med MDC, Dept Neurosci, Berlin, Germany; [Poulet, James F. A.] Charite Univ Med Berlin, Neurosci Res Ctr, Berlin, Germany; [Poulet, James F. A.] Charite Univ Med Berlin, Cluster Excellence NeuroCure, Berlin, Germany; [Fernandez, Laura M. J.; Crochet, Sylvain] INSERM, U1028, F-69008 Lyon, France; [Fernandez, Laura M. J.; Crochet, Sylvain] Ctr Natl Rech Sci CNRS, UMR5292, Lyon, France; [Fernandez, Laura M. J.; Crochet, Sylvain] Integrat Physiol Brain Arousal Syst Team, Lyon Neurosci Res Ctr, Lyon, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Crochet, S (corresponding author), Ecole Polytech Fed Lausanne EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Lausanne, Switzerland.	sylvain.crochet@univ-lyon1.fr; carl.petersen@epfl.ch	Fernandez, Laura MJ/K-4717-2012; Petersen, Carl/M-5123-2017	Fernandez, Laura MJ/0000-0002-7942-3369; Petersen, Carl/0000-0003-3344-4495; Crochet, Sylvain/0000-0002-2965-8899; Poulet, James/0000-0003-0296-5415	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; Deutsche Forschungsgemeinschaft [Exc 257 NeuroCure]; European Research Council; Region Rhone-Alpes Exploradoc; Agence Nationale de la Recherche France [ANR-09-JCJC-0028-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Region Rhone-Alpes Exploradoc(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche France(French National Research Agency (ANR))	We would like to thank K. Svoboda (Howard Hughes Medical Institute Janelia Farm; Addgene plasmid 20071) and C. Luscher (University of Geneva; virus) for AAV-ChR2. This work was funded by grants from the Swiss National Science Foundation (C.C.H.P.), Human Frontiers in Science Program (J.F.A.P. and C. C. H. P.), SystemsX.ch (C. C. H. P.), Deutsche Forschungsgemeinschaft (Exc 257 NeuroCure) (J.F.A.P.), a European Research Council starting grant (J.F.A.P.), Region Rhone-Alpes Exploradoc (L.M.J.F.) and Agence Nationale de la Recherche France (project AWAKE CX, ANR-09-JCJC-0028-01) (S.C.).	Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9	15	203	204	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					370	372		10.1038/nn.3035	http://dx.doi.org/10.1038/nn.3035			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267163				2022-12-25	WOS:000300793100009
J	Jacob, V; Petreanu, L; Wright, N; Svoboda, K; Fox, K				Jacob, Vincent; Petreanu, Leopoldo; Wright, Nick; Svoboda, Karel; Fox, Kevin			Regular Spiking and Intrinsic Bursting Pyramidal Cells Show Orthogonal Forms of Experience-Dependent Plasticity in Layer V of Barrel Cortex	NEURON			English	Article							IN-VIVO; FIRING PATTERNS; ELECTROPHYSIOLOGICAL PROPERTIES; FUNCTIONAL-ORGANIZATION; SYNAPTIC PLASTICITY; SENSORY DEPRIVATION; CRITICAL PERIOD; VISUAL-CORTEX; SPINE GROWTH; NEURONS	Most functional plasticity studies in the cortex have focused on layers (L) II/III and IV, whereas relatively little is known of LV. Structural measurements of dendritic spines in vivo suggest some specialization among LV cell subtypes. We therefore studied experience-dependent plasticity in the barrel cortex using intracellular recordings to distinguish regular spiking (RS) and intrinsic bursting (IB) subtypes. Postsynaptic potentials and suprathreshold responses in vivo revealed a remarkable dichotomy in RS and IB cell plasticity; spared whisker potentiation occurred in IB but not RS cells while deprived whisker depression occurred in RS but not IB cells. Similar RS/IB differences were found in the LII/III to V connections in brain slices. Modeling studies showed that subthreshold changes predicted the suprathreshold changes. These studies demonstrate the major functional partition of plasticity within a single cortical layer and reveal the LII/III to LV connection as a major excitatory locus of cortical plasticity.	[Jacob, Vincent; Wright, Nick; Fox, Kevin] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, Wales; [Petreanu, Leopoldo; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Cardiff University; Howard Hughes Medical Institute	Fox, K (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, Wales.	foxkd@cardiff.ac.uk	Fox, Kevin/E-8836-2010	Fox, Kevin/0000-0002-2563-112X; Petreanu, Leopoldo/0000-0003-1434-4691; Jacob, Vincent/0000-0002-7055-213X	Silvio Conte Center (NIMH); MRC (UK); NIH; HHMI; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; Medical Research Council [G0901299] Funding Source: researchfish; MRC [G0901299] Funding Source: UKRI	Silvio Conte Center (NIMH); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We should like to thanks Vincenzo Crunelli for critically reading the manuscript, Gordon M.G. Shepherd for critical help during early stages of this work, and Alain Destexhe and Michelle Rudolph for help with the modeling. This work was supported by Silvio Conte Center (NIMH) and MRC (UK) grants to K.F. and by funding from NIH and HHMI to K.S.	AGMON A, 1992, J NEUROSCI, V12, P319; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1850, DOI 10.1152/jn.1993.69.6.1850; Beaver CJ, 2001, VISUAL NEUROSCI, V18, P811, DOI 10.1017/S0952523801185147; Briggs F, 2005, CEREB CORTEX, V15, P479, DOI 10.1093/cercor/bhh154; Bruno RM, 2009, J NEUROSCI, V29, P3172, DOI 10.1523/JNEUROSCI.5911-08.2009; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Colbert CA, 2001, RESTOR NEUROL NEUROS, V19, P199; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Degenetais E, 2002, CEREB CORTEX, V12, P1, DOI 10.1093/cercor/12.1.1; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Erchova IA, 2003, BRAIN RES BULL, V60, P373, DOI 10.1016/S0361-9230(03)00060-1; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; Gil Z, 1996, J NEUROSCI, V16, P6567; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Grewe BF, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00013; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hedrick T, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00001; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Jacob V, 2010, J NEUROSCI METH, V189, P65, DOI 10.1016/j.jneumeth.2010.03.020; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; LARKMAN AU, 1992, J COMP NEUROL, V323, P137, DOI 10.1002/cne.903230202; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MASON A, 1990, J NEUROSCI, V10, P1415; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; NUNEZ A, 1993, J NEUROPHYSIOL, V70, P418, DOI 10.1152/jn.1993.70.1.418; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Schierloh A, 2003, NEUROREPORT, V14, P1787, DOI 10.1097/00001756-200310060-00006; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Schwindt P, 1997, J NEUROPHYSIOL, V77, P2484, DOI 10.1152/jn.1997.77.5.2484; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; Wallace H, 1999, J NEUROBIOL, V41, P58, DOI 10.1002/(SICI)1097-4695(199910)41:1<58::AID-NEU8>3.0.CO;2-F; Wang XF, 2003, BRAIN RES, V989, P26, DOI 10.1016/S0006-8993(03)03321-3; WANG Z, 1993, J NEUROSCI, V13, P2199; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wimmer VC, 2010, J COMP NEUROL, V518, P4629, DOI 10.1002/cne.22483; Wright N, 2010, J NEUROPHYSIOL, V103, P709, DOI 10.1152/jn.00560.2009; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Zilberter M, 2009, CEREB CORTEX, V19, P2308, DOI 10.1093/cercor/bhn247	71	62	62	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					391	404		10.1016/j.neuron.2011.11.034	http://dx.doi.org/10.1016/j.neuron.2011.11.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284191	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000299761600018
J	Coate, TM; Raft, S; Zhao, XM; Ryan, AK; Crenshaw, EB; Kelley, MW				Coate, Thomas M.; Raft, Steven; Zhao, Xiumei; Ryan, Aimee K.; Crenshaw, E. Bryan, III; Kelley, Matthew W.			Otic Mesenchyme Cells Regulate Spiral Ganglion Axon Fasciculation through a Pou3f4/EphA4 Signaling Pathway	NEURON			English	Article							INNER-EAR; MAMMALIAN COCHLEA; AUDITORY NEURONS; EPH RECEPTORS; MOUSE; GUIDANCE; MOTOR; BRAIN; DROSOPHILA; MIGRATION	Peripheral axons from auditory spiral ganglion neurons (SGNs) form an elaborate series of radially and spirally oriented projections that interpret complex aspects of the auditory environment. However, the developmental processes that shape these axon tracts are largely unknown. Radial bundles are comprised of dense SGN fascicles that project through otic mesenchyme to form synapses within the cochlea. Here, we show that radial bundle fasciculation and synapse formation are disrupted when Pou3f4 (DFNX2) is deleted from otic mesenchyme. Further, we demonstrate that Pou3f4 binds to and directly regulates expression of Epha4, Epha4(-/-) mice present similar SGN defects, and exogenous EphA4 promotes SGN fasciculation in the absence of Pou3f4. Finally, Efnb2 deletion in SGNs leads to similar fasciculation defects, suggesting that ephrin-B2/EphA4 interactions are critical during this process. These results indicate a model whereby Pou3f4 in the otic mesenchyme establishes an Eph/ephrin-mediated fasciculation signal that promotes inner radial bundle formation.	[Coate, Thomas M.; Kelley, Matthew W.] Natl Inst Deafness & Other Commun Disorders, Lab Cochlear Dev, NIH, Bethesda, MD 20892 USA; [Raft, Steven] Natl Inst Deafness & Other Commun Disorders, Sensory Cell Regenerat & Dev Sect, NIH, Bethesda, MD 20892 USA; [Zhao, Xiumei] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Ryan, Aimee K.] McGill Univ, Res Inst, Ctr Hlth, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Crenshaw, E. Bryan, III] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Georgetown University; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Coate, TM (corresponding author), Natl Inst Deafness & Other Commun Disorders, Lab Cochlear Dev, NIH, Bethesda, MD 20892 USA.	coatet@nidcd.nih.gov			National Deafness and Other Communication Disorders Intramural Research Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000059] Funding Source: NIH RePORTER	National Deafness and Other Communication Disorders Intramural Research Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the members of the Kelley laboratory for their valuable discussions and technical assistance during this work. We thank Dr. Lisa Cunningham (NIH/National Institute on Deafness and other Communication Disorders [NIDCD]), Dr. Doris Wu (NIH/NIDCD), and Dr. Maria J. Donoghue (Georgetown University) for the critical reading of this manuscript. Epha4 null tissue was a kind gift from Dr. Maria J. Donoghue. Mr. Jonathan Stuckey was very helpful with the illustration in Figure 8. The National Deafness and Other Communication Disorders Intramural Research Program funded this work.	Ann KJ, 2009, GENESIS, V47, P137, DOI 10.1002/dvg.20454; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; Bianchi LM, 1998, HEARING RES, V117, P161, DOI 10.1016/S0378-5955(98)00010-0; Bossing T, 2002, DEVELOPMENT, V129, P4205; Breuskin I, 2010, J NEUROCHEM, V114, P1827, DOI 10.1111/j.1471-4159.2010.06897.x; Brors D, 2003, J COMP NEUROL, V462, P90, DOI 10.1002/cne.10707; CARNEY PR, 1983, J COMP NEUROL, V215, P359, DOI 10.1002/cne.902150402; Coate TM, 2009, J NEUROSCI, V29, P3404, DOI 10.1523/JNEUROSCI.5464-08.2009; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Driver EC, 2009, BIRTH DEFECTS RES C, V87, P212, DOI 10.1002/bdrc.20154; Driver EC, 2008, J NEUROSCI, V28, P7350, DOI 10.1523/JNEUROSCI.0312-08.2008; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Fritzsch B, 2005, HEARING RES, V206, P52, DOI 10.1016/j.heares.2004.11.025; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Hsieh CY, 2007, J COMP NEUROL, V504, P508, DOI 10.1002/cne.21465; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Huffman KJ, 2007, DEV NEUROBIOL, V67, P1655, DOI 10.1002/dneu.20535; Jhingory S, 2010, DEV BIOL, V344, P896, DOI 10.1016/j.ydbio.2010.06.006; Kandpal G, 1996, SOMAT CELL MOLEC GEN, V22, P511, DOI 10.1007/BF02369442; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Meier S, 2006, MECH DEVELOP, V123, P76, DOI 10.1016/j.mod.2005.09.004; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Miko IJ, 2008, HEARING RES, V235, P39, DOI 10.1016/j.heares.2007.09.003; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mukai S, 2011, ARCH TOXICOL, V85, P149, DOI 10.1007/s00204-010-0556-2; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; North HA, 2009, DEVELOPMENT, V136, P2467, DOI 10.1242/dev.034405; Okazawa H, 1996, P NATL ACAD SCI USA, V93, P11933, DOI 10.1073/pnas.93.21.11933; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Phippard D, 1998, HEARING RES, V120, P77, DOI 10.1016/S0378-5955(98)00059-8; Pickles JO, 2002, J COMP NEUROL, V449, P207, DOI 10.1002/cne.10231; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Puligilla C, 2009, CURR OPIN GENET DEV, V19, P368, DOI 10.1016/j.gde.2009.06.004; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Samadi DS, 2005, HEARING RES, V199, P11, DOI 10.1016/j.heares.2004.07.013; Simmons D, 2011, SPRINGER HANDB AUDIT, V38, P187, DOI 10.1007/978-1-4419-7070-1_7; SMITH C A, 1961, Trans Am Otol Soc, V49, P35; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Heumen WRA, 2000, HEARING RES, V139, P42, DOI 10.1016/S0378-5955(99)00158-6; Wang L, 2011, NEURON, V71, P263, DOI 10.1016/j.neuron.2011.06.021; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zhou CQ, 2011, LARYNGOSCOPE, V121, P1541, DOI 10.1002/lary.21861	60	65	66	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					49	63		10.1016/j.neuron.2011.10.029	http://dx.doi.org/10.1016/j.neuron.2011.10.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243746	Bronze, Green Accepted			2022-12-25	WOS:000299446800007
J	Mysore, SP; Knudsen, EI				Mysore, Shreesh P.; Knudsen, Eric I.			Reciprocal Inhibition of Inhibition: A Circuit Motif for Flexible Categorization in Stimulus Selection	NEURON			English	Article							NORMALIZATION MODEL; LATERAL INHIBITION; MUTUAL INHIBITION; MIDBRAIN NETWORK; RECEPTIVE-FIELD; NUCLEUS ISTHMI; ATTENTION; MECHANISMS; REPRESENTATION; INACTIVATION	As a precursor to the selection of a stimulus for gaze and attention, a midbrain network categorizes stimuli into "strongest" and "others." The categorization tracks flexibly, in real time, the absolute strength of the strongest stimulus. In this study, we take a first-principles approach to computations that are essential for such categorization. We demonstrate that classical feedforward lateral inhibition cannot produce flexible categorization. However, circuits in which the strength of lateral inhibition varies with the relative strength of competing stimuli categorize successfully. One particular implementation reciprocal inhibition of feedforward lateral inhibition is structurally the simplest, and it outperforms others in flexibly categorizing rapidly and reliably. Strong predictions of this anatomically supported circuit model are validated by neural responses measured in the owl midbrain. The results demonstrate the extraordinary power of a remarkably simple, neurally grounded circuit motif in producing flexible categorization, a computation fundamental to attention, perception, and decision making.	[Mysore, Shreesh P.; Knudsen, Eric I.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Mysore, SP (corresponding author), Stanford Univ, Dept Neurobiol, 299 W Campus Dr, Stanford, CA 94305 USA.	shreesh@stanford.edu		Mysore, Shreesh/0000-0002-7781-8252	National Institutes of Health [9R01 EY019179-30]; NATIONAL EYE INSTITUTE [R01EY019179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funding from the National Institutes of Health (9R01 EY019179-30, to E.I.K.). We thank Daniel Kimmel, Valerio Mante, and Alireza Soltani for critically reading the manuscript and for discussions. S.P.M. and E.I.K. designed the research and wrote the manuscript. S.P.M. performed the simulations, experiments, and analyses.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Asadollahi A, 2010, NAT NEUROSCI, V13, P889, DOI 10.1038/nn.2573; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Bolzon DM, 2009, J NEUROSCI, V29, P14143, DOI 10.1523/JNEUROSCI.2857-09.2009; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Deleuze C, 2006, J NEUROSCI, V26, P8633, DOI 10.1523/JNEUROSCI.2333-06.2006; EDWARDS DH, 1991, J NEUROSCI, V11, P1210; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Hahnloser R, 1999, NAT NEUROSCI, V2, P746, DOI 10.1038/11219; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; KOCH C, 1985, HUM NEUROBIOL, V4, P219; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lai DH, 2011, J NEUROPHYSIOL, V105, P793, DOI 10.1152/jn.00673.2010; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Mysore SP, 2011, CURR OPIN NEUROBIOL, V21, P653, DOI 10.1016/j.conb.2011.05.024; Mysore SP, 2011, J NEUROSCI, V31, P7745, DOI 10.1523/JNEUROSCI.5425-10.2011; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Nummela SU, 2010, J NEUROPHYSIOL, V104, P1538, DOI 10.1152/jn.00406.2010; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Pangratz-Fuehrer S, 2011, J NEUROSCI, V31, P10767, DOI 10.1523/JNEUROSCI.6655-10.2011; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; SERENO MI, 1987, J COMP NEUROL, V261, P319, DOI 10.1002/cne.902610302; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang Y, 2004, J COMP NEUROL, V469, P275, DOI 10.1002/cne.11007; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; YANG XL, 1991, P NATL ACAD SCI USA, V88, P3310, DOI 10.1073/pnas.88.8.3310	55	48	48	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					193	205		10.1016/j.neuron.2011.10.037	http://dx.doi.org/10.1016/j.neuron.2011.10.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243757	Bronze, Green Accepted			2022-12-25	WOS:000299446800018
J	de Sousa e Melo, F; Colak, S; Buikhuisen, J; Koster, J; Cameron, K; de Jong, JH; Tuynman, JB; Prasetyanti, PR; Fessler, E; van den Bergh, SP; Rodermond, H; Dekker, E; van der Loos, CM; Pals, ST; van de Vijver, MJ; Versteeg, R; Richel, DJ; Vermeulen, L; Medema, JP				de Sousa e Melo, Felipe; Colak, Selcuk; Buikhuisen, Joyce; Koster, Jan; Cameron, Kate; de Jong, Joan H.; Tuynman, Jurriaan B.; Prasetyanti, Pramudita R.; Fessler, Evelyn; van den Bergh, Saskia P.; Rodermond, Hans; Dekker, Evelien; van der Loos, Chris M.; Pals, Steven T.; van de Vijver, Marc J.; Versteeg, Rogier; Richel, Dick J.; Vermeulen, Louis; Medema, Jan Paul			Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients	CELL STEM CELL			English	Article							COLON-CANCER; EXPRESSION SIGNATURE; BREAST-CANCER; PHENOTYPE; SPECIMENS; APC	Gene signatures derived from cancer stem cells (CSCs) predict tumor recurrence for many forms of cancer. Here, we derived a gene signature for colorectal CSCs defined by high Wnt signaling activity, which in agreement with previous observations predicts poor prognosis. Surprisingly, however, we found that elevated expression of Wnt targets was actually associated with good prognosis, while patient tumors with low expression of Wnt target genes segregated with immature stem cell signatures. We discovered that several Wnt target genes, including ASCL2 and LGR5, become silenced by CpG island methylation during progression of tumorigenesis, and that their re-expression was associated with reduced tumor growth. Taken together, our data show that promoter methylation of Wnt target genes is a strong predictor for recurrence of colorectal cancer, and suggest that CSC gene signatures, rather than reflecting CSC numbers, may reflect differentiation status of the malignant tissue.	[de Sousa e Melo, Felipe; Colak, Selcuk; Buikhuisen, Joyce; Cameron, Kate; de Jong, Joan H.; Tuynman, Jurriaan B.; Prasetyanti, Pramudita R.; Fessler, Evelyn; van den Bergh, Saskia P.; Rodermond, Hans; Vermeulen, Louis; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol, Ctr Expt Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Dekker, Evelien] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [van der Loos, Chris M.; Pals, Steven T.; van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Richel, Dick J.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol, Ctr Expt Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.p.medema@amc.nl	Koster, Jan/C-5934-2008; Versteeg, Rogier/AAQ-1765-2020; Vermeulen, Louis/B-7488-2008; Pillay, Nischalan/F-9536-2012; Tuynman, J/X-2465-2019; Tuynman, JB/AAS-7745-2020	Koster, Jan/0000-0002-0890-7585; Vermeulen, Louis/0000-0002-6066-789X; Tuynman, JB/0000-0001-5952-8000; van de Vijver, Marc/0000-0002-0385-4787; Pals, Steven/0000-0002-1419-0939; Medema, Jan Paul/0000-0003-3045-2924; Dekker, Evelien/0000-0002-4363-0745; Buikhuisen, Joyce/0000-0002-1181-737X; Versteeg, Rogier/0000-0001-7172-0388	Netherlands Organisation for Scientific Research; Dutch Cancer Society [2009-4416]; Academisch Medisch Centrum (AMC)	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Academisch Medisch Centrum (AMC)	The authors would like to specially thank M. Oud for the tumor slides, and prof. T.M. van Gulik, prof. W.A. Bemelman, and Dr. P.J. Tanis for the primary tumor samples. Prof. S. Repping we would like to thank for critically reading the manuscript. This work was supported by a VICI grant from the Netherlands Organisation for Scientific Research and a Dutch Cancer Society grant (2009-4416) (to J.P.M.), and an Academisch Medisch Centrum (AMC) fellowship (to L.V. and F.d.S.E.M.). The TOP-GFP construct was a kind gift of Dr. L. Allies. The pMX-Axin2-ires-CD8 was kindly provided by Prof. H. Mano.	Al-Kofahi Y, 2011, HISTOPATHOLOGY, V59, P40, DOI 10.1111/j.1365-2559.2011.03878.x; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bertucci F, 2007, NEW ENGL J MED, V356, P1887; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Koinuma K, 2006, ONCOGENE, V25, P139, DOI 10.1038/sj.onc.1209009; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048	27	229	235	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					476	485		10.1016/j.stem.2011.10.008	http://dx.doi.org/10.1016/j.stem.2011.10.008			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056143	Bronze			2022-12-25	WOS:000297180200014
J	Ueno, T; Saito, S; Rogers, TT; Ralph, MAL				Ueno, Taiji; Saito, Satoru; Rogers, Timothy T.; Ralph, Matthew A. Lambon			Lichtheim 2: Synthesizing Aphasia and the Neural Basis of Language in a Neurocomputational Model of the Dual Dorsal-Ventral Language Pathways	NEURON			English	Article							ANTERIOR TEMPORAL-LOBE; SHORT-TERM-MEMORY; SEMANTIC DEMENTIA; SPEECH; REPRESENTATION; IMPAIRMENT; COMPREHENSION; ORGANIZATION; REPETITION; DYSLEXIA	Traditional neurological models of language were based on a single neural pathway (the dorsal pathway underpinned by the arcuate fasciculus). Contemporary neuroscience indicates that anterior temporal regions and the "ventral" language pathway also make a significant contribution, yet there is no computationally-implemented model of the dual pathway, nor any synthesis of normal and aphasic behavior. The "Lichtheim 2" model was implemented by developing a new variety of computational model which reproduces and explains normal and patient data but also incorporates neuroanatomical information into its architecture. By bridging the "mind-brain" gap in this way, the resultant "neurocomputational" model provides a unique opportunity to explore the relationship between lesion location and behavioral deficits, and to provide a platform for simulating functional neuroimaging data.	[Ueno, Taiji; Saito, Satoru; Ralph, Matthew A. Lambon] Univ Manchester, Neurosci & Aphasia Res Unit, Sch Psychol Sci, Manchester M13 9PL, Lancs, England; [Saito, Satoru] Kyoto Univ, Kyoto 6068501, Japan; [Rogers, Timothy T.] Univ Wisconsin, Madison, WI 53706 USA	University of Manchester; Kyoto University; University of Wisconsin System; University of Wisconsin Madison	Ralph, MAL (corresponding author), Univ Manchester, Neurosci & Aphasia Res Unit, Sch Psychol Sci, Manchester M13 9PL, Lancs, England.	matt.lambon-ralph@manchester.ac.uk	Ralph, Matthew A Lambon/A-1695-2009	Ralph, Matthew A Lambon/0000-0001-5907-2488; SAITO, Satoru/0000-0002-0403-3606	MRC [G0501632]; Royal Society; Experimental Psychology Society; Overseas Research Scholarship (UK); Nakajima Foundation (Japan); Medical Research Council [G0501632] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Experimental Psychology Society; Overseas Research Scholarship (UK); Nakajima Foundation (Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an MRC programme grant to M.A.L.R. (G0501632), a Royal Society travel grant to M.A.L.R. and S.S., and a Study Visit grant from the Experimental Psychology Society to T.U. T.U. was supported by an Overseas Research Scholarship (UK) and an Overseas Study Fellowship from the Nakajima Foundation (Japan).	Amano S., 1999, JAPANESE NTT DATABAS; Baldo JV, 2011, CORTEX, V47, P800, DOI 10.1016/j.cortex.2010.07.001; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Binder JR, 2011, NEUROIMAGE, V54, P1465, DOI 10.1016/j.neuroimage.2010.09.048; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Crisp J, 2006, J COGNITIVE NEUROSCI, V18, P348, DOI 10.1162/jocn.2006.18.3.348; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; Dhanjal NS, 2008, J NEUROSCI, V28, P9969, DOI 10.1523/JNEUROSCI.2607-08.2008; Dilkina K, 2008, COGN NEUROPSYCHOL, V25, P136, DOI 10.1080/02643290701723948; Dilkina K, 2010, BRAIN RES, V1365, P66, DOI 10.1016/j.brainres.2010.09.057; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Duffau H, 2009, J NEUROL, V256, P382, DOI 10.1007/s00415-009-0053-9; Eggert G.H., 1977, WERNICKES WORKS APHA; Fridriksson J, 2010, J NEUROSCI, V30, P11057, DOI 10.1523/JNEUROSCI.1120-10.2010; Galton CJ, 2001, NEUROLOGY, V57, P216, DOI 10.1212/WNL.57.2.216; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Griffiths TD, 2002, CURR OPIN NEUROL, V15, P31, DOI 10.1097/00019052-200202000-00006; Halle M., 1983, PROBLEM BOOK PHONOLO; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hillis AE, 2007, NEUROLOGY, V69, P200, DOI 10.1212/01.wnl.0000265600.69385.6f; HINTON GE, 1989, ARTIF INTELL, V40, P185, DOI 10.1016/0004-3702(89)90049-0; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Holland R, 2010, CEREB CORTEX, V20, P2771, DOI 10.1093/cercor/bhq020; Jefferies E, 2006, BRAIN, V129, P2132, DOI 10.1093/brain/awl153; Jefferies E, 2009, NEUROPSYCHOLOGY, V23, P492, DOI 10.1037/a0015452; Leff A, 2002, ANN NEUROL, V51, P553, DOI 10.1002/ana.10181; Lichtheim Ludwig, 1885, BRAIN, V7, P433, DOI DOI 10.1093/BRAIN/7.4.433; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; McClelland JL, 1989, LANG COGNITIVE PROC, V4, pSI287, DOI 10.1080/01690968908406371; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Nozari N, 2010, J MEM LANG, V63, P541, DOI 10.1016/j.jml.2010.08.001; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Plaut DC, 1999, CARN S COGN, P381; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Pobric G, 2007, P NATL ACAD SCI USA, V104, P20137, DOI 10.1073/pnas.0707383104; Price CJ, 1997, HUM BRAIN MAPP, V5, P264, DOI 10.1002/(SICI)1097-0193(1997)5:4<264::AID-HBM11>3.0.CO;2-E; Ralph MAL, 1998, NEUROPSYCHOLOGIA, V36, P775, DOI 10.1016/S0028-3932(97)00169-3; Ralph MAL, 2001, J COGNITIVE NEUROSCI, V13, P341, DOI 10.1162/08989290151137395; Ralph MAL, 2010, ANN NEUROL, V68, P570, DOI 10.1002/ana.22213; Ralph MAL, 2010, P NATL ACAD SCI USA, V107, P2717, DOI 10.1073/pnas.0907307107; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Rohde D.L.T., 1999, CMUCS99164; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; SHALLICE T, 1977, BRAIN LANG, V4, P479, DOI 10.1016/0093-934X(77)90040-2; Sharp DJ, 2010, ANN NEUROL, V68, P753, DOI 10.1002/ana.21866; Sharp DJ, 2004, ANN NEUROL, V56, P836, DOI 10.1002/ana.20294; Visser M, 2011, J COGNITIVE NEUROSCI, V23, P3121, DOI 10.1162/jocn_a_00007; Weiller C, 2011, BRAIN LANG, V118, P29, DOI 10.1016/j.bandl.2011.01.005; Welbourne SR, 2007, J COGNITIVE NEUROSCI, V19, P1125, DOI 10.1162/jocn.2007.19.7.1125; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1; Woollams AM, 2007, PSYCHOL REV, V114, P316, DOI 10.1037/0033-295X.114.2.316	64	179	181	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					385	396		10.1016/j.neuron.2011.09.013	http://dx.doi.org/10.1016/j.neuron.2011.09.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	837SR	22017995	Bronze, Green Submitted			2022-12-25	WOS:000296224000018
J	Sabharwal, P; Lee, C; Park, S; Rao, M; Sockanathan, S				Sabharwal, Priyanka; Lee, Changhee; Park, Sungjin; Rao, Meenakshi; Sockanathan, Shanthini			GDE2 Regulates Subtype-Specific Motor Neuron Generation through Inhibition of Notch Signaling	NEURON			English	Article							SPINAL-CORD; POOL IDENTITY; GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; NEUROMUSCULAR DEVELOPMENT; MUSCLE; EXPRESSION; GENE; DIFFERENTIATION; MOTONEURONS; DIVERSITY	The specification of spinal interneuron and motor neuron identities initiates within progenitor cells, while motor neuron subtype diversification is regulated by hierarchical transcriptional programs implemented postmitotically. Here we find that mice lacking GDE2, a six-transmembrane protein that triggers motor neuron generation, exhibit selective losses of distinct motor neuron subtypes, specifically in defined subsets of limb-innervating motor pools that correlate with the loss of force-generating alpha motor neurons. Mechanistically, GDE2 is expressed by postmitotic motor neurons but utilizes extracellular glycerophosphodiester phosphodiesterase activity to induce motor neuron generation by inhibiting Notch signaling in neighboring motor neuron progenitors. Thus, neuronal GDE2 controls motor neuron subtype diversity through a non-cell-autonomous feedback mechanism that directly regulates progenitor cell differentiation, implying that subtype specification initiates within motor neuron progenitor populations prior to their differentiation into postmitotic motor neurons.	[Sabharwal, Priyanka; Lee, Changhee; Park, Sungjin; Rao, Meenakshi; Sockanathan, Shanthini] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Sockanathan, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, PCTB1004,725 N Wolfe St, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu	Sabharwal, Priyanka/AAA-3303-2019	Sabharwal, Priyanka/0000-0002-2099-1994; Lee, ChangHee/0000-0002-9994-3142	Muscular Dystrophy Association; NIH (NINDS) [RO1NS046336]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046336] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIH (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Jeremy Dasen, Thomas Jessell, and Ben Novitch for antibodies, Zachary T. Bitzer for technical assistance, Goran Periz for antibody manufacture, members of the Sockanathan laboratory for discussions, and Alex Kolodkin and Ye Yan for comments on the manuscript. This work was funded by grants from the Muscular Dystrophy Association and from the NIH (NINDS RO1NS046336). All experiments involving animals were performed according to procedures approved by the Johns Hopkins IACUC review board.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Badea TC, 2003, J NEUROSCI, V23, P2314; BURKE RE, 1977, J NEUROPHYSIOL, V40, P667, DOI 10.1152/jn.1977.40.3.667; Buss RR, 2006, J NEUROSCI, V26, P13413, DOI 10.1523/JNEUROSCI.3528-06.2006; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Diez del Corral R, 2003, NEURON, V40, P65; FETCHO JR, 1992, BRAIN BEHAV EVOLUT, V40, P82, DOI 10.1159/000113905; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Hui K, 2008, CELL DEATH DIFFER, V15, P691, DOI 10.1038/sj.cdd.4402294; Ji SJ, 2009, DEVELOPMENT, V136, P231, DOI 10.1242/dev.028043; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Marklund U, 2010, DEVELOPMENT, V137, P437, DOI 10.1242/dev.036806; Matise MP, 1996, DEVELOPMENT, V122, P659; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shah V, 2004, DEV DYNAM, V231, P43, DOI 10.1002/dvdy.20103; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; WHITELAW V, 1983, J NEUROSCI, V3, P1199; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022	52	34	35	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1058	1070		10.1016/j.neuron.2011.07.028	http://dx.doi.org/10.1016/j.neuron.2011.07.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943603	Green Accepted, Bronze			2022-12-25	WOS:000295556500011
J	Williams, ME; Wilke, SA; Daggett, A; Davis, E; Otto, S; Ravi, D; Ripley, B; Bushong, EA; Ellisman, MH; Klein, G; Ghosh, A				Williams, Megan E.; Wilke, Scott A.; Daggett, Anthony; Davis, Elizabeth; Otto, Stefanie; Ravi, Deepak; Ripley, Beth; Bushong, Eric A.; Ellisman, Mark H.; Klein, Gerd; Ghosh, Anirvan			Cadherin-9 Regulates Synapse-Specific Differentiation in the Developing Hippocampus	NEURON			English	Article							LAMINA-SPECIFIC CONNECTIVITY; MOSSY FIBER BOUTONS; N-CADHERIN; CLASSIC CADHERINS; SPINE MORPHOGENESIS; TARGET RECOGNITION; DENTATE GYRUS; GRANULE CELLS; C-ELEGANS; IN-VIVO	Our understanding of mechanisms that regulate the differentiation of specific classes of synapses is limited. Here, we investigate the formation of synapses between hippocampal dentate gyrus (DG) neurons and their target CA3 neurons and find that DG neurons preferentially form synapses with CA3 rather than DG or CA1 neurons in culture, suggesting that specific interactions between DG and CA3 neurons drive synapse formation. Cadherin-9 is expressed selectively in DG and CA3 neurons, and downregulation of cadherin-9 in CA3 neurons leads to a selective decrease in the number and size of DG synapses onto CA3 neurons. In addition, loss of cadherin-9 from DG or CA3 neurons in vivo leads to striking defects in the formation and differentiation of the DG-CA3 mossy fiber synapse. These observations indicate that cadherin-9 bidirectionally regulates DG-CA3 synapse development and highlight the critical role of differentially expressed molecular cues in establishing specific connections in the mammalian brain.	[Williams, Megan E.; Wilke, Scott A.; Daggett, Anthony; Davis, Elizabeth; Otto, Stefanie; Ravi, Deepak; Ripley, Beth; Ghosh, Anirvan] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Klein, Gerd] Univ Med Clin, Med Res Ctr, Sect Transplantat Immunol & Immunohematol, D-72072 Tubingen, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ghosh, A (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	aghosh@ucsd.edu	Klein, Gerd/C-8499-2013	ripley, beth/0000-0001-7723-169X; Williams, Megan/0000-0002-5461-4126	Autism Speaks; NIH [R01 NS052772, R01 NS067216]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067216] Funding Source: NIH RePORTER	Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Webb for the PY antibody, H. Cline for the synaptophysin-GFP plasmid, P. Caroni for the membrane GFP plasmid, Y. Zou for confocal use, K. Tiglio, J. Fakhoury, and E. Kang for technical assistance, and A. Kolodkin, Y. Zou, Y. Jin, N. Spitzer, D. Berg, D. Trankner, and members of the Ghosh lab for comments and discussion. This work was supported by Autism Speaks (to M.E.W.) and NIH Grants R01 NS052772 (to A.G.) and R01 NS067216 (to A.G.).	Ackley BD, 2004, TRENDS NEUROSCI, V27, P540, DOI 10.1016/j.tins.2004.07.003; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bagri A, 2002, DEVELOPMENT, V129, P4249; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; Bekirov IH, 2002, NEUROSCIENCE, V115, P213, DOI 10.1016/S0306-4522(02)00375-5; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; CAMARDO J, 1983, J NEUROSCI, V3, P2614; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; GRABS D, 1994, EUR J NEUROSCI, V6, P1765, DOI 10.1111/j.1460-9568.1994.tb00569.x; Grosse G, 1998, J NEUROSCI RES, V51, P602, DOI 10.1002/(SICI)1097-4547(19980301)51:5<602::AID-JNR7>3.0.CO;2-J; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Poskanzer K, 2003, J NEUROSCI, V23, P2294; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Rose D, 2000, MICROSC RES TECHNIQ, V49, P3, DOI 10.1002/(SICI)1097-0029(20000401)49:1<3::AID-JEMT2>3.0.CO;2-E; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vogt AK, 2005, NEUROSCIENCE, V134, P783, DOI 10.1016/j.neuroscience.2005.04.039; VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	56	146	147	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 25	2011	71	4					640	655		10.1016/j.neuron.2011.06.019	http://dx.doi.org/10.1016/j.neuron.2011.06.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867881	Green Accepted, Bronze			2022-12-25	WOS:000294521600010
J	Mauceri, D; Freitag, HE; Oliveira, AMM; Bengtson, CP; Bading, H				Mauceri, Daniela; Freitag, H. Eckehard; Oliveira, Ana M. M.; Bengtson, C. Peter; Bading, Hilmar			Nuclear Calcium-VEGFD Signaling Controls Maintenance of Dendrite Arborization Necessary for Memory Formation	NEURON			English	Article							GROWTH-FACTOR-D; NMDA RECEPTORS; LATE-PHASE; KINASE-IV; TRANSCRIPTION; CBP; EXPRESSION; SURVIVAL; SYNAPSE; FAMILY	The role of neuronal dendrites is to receive and process synaptic inputs. The geometry of the dendritic arbor can undergo neuronal activity-dependent changes that may impact the cognitive abilities of the organism. Here we show that vascular endothelial growth factor D (VEGFD), commonly known as an angiogenic mitogen, controls the total length and complexity of dendrites both in cultured hippocampal neurons and in the adult mouse hippocampus. VEGFD expression is dependent upon basal neuronal activity and requires nuclear calcium-calmodulin-dependent protein kinase IV (CaMKIV) signaling. Suppression of VEGFD expression in the mouse hippocampus by RNA interference causes memory impairments. Thus, nuclear calcium-VEGFD signaling mediates the effect of neuronal activity on the maintenance of dendritic arbors in the adult hippocampus and is required for cognitive functioning. These results suggest that caution be employed in the clinical use of blockers of VEGFD signaling for antiangiogenic cancer therapy.	[Mauceri, Daniela; Freitag, H. Eckehard; Oliveira, Ana M. M.; Bengtson, C. Peter; Bading, Hilmar] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany.	hilmar.bading@uni-hd.de	Mauceri, Daniela/C-4969-2014; Oliveira, Ana M.M./AFF-2561-2022	Mauceri, Daniela/0000-0003-1225-4633; Oliveira, Ana M.M./0000-0002-2729-9036; Bengtson, C Peter/0000-0002-8245-3323	Alexander von Humboldt Foundation; European Research Council (ERC); Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 488, SFB 636]; European Network of Excellence NeuroNE; European Union; European Molecular Biology Organization (EMBO); Foundation for Science and Technology, Portugal	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Network of Excellence NeuroNE; European Union(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology)	We thank I. Bunzli-Ehret for her help with the preparation of hippocampal cultures; U. Weiss for western blot analysis; Drs. S. Oliviero, B.L. Sabatini, and A. Asano for providing plasmids; Drs. S.J. Zhang, D. Lau, and S. Romorini for discussions; and Dr. A.M. Hagenston for comments on the manuscript. All images of Golgi-impregnated tissues were taken at the Nikon Imaging Center at Heidelberg University. This work was supported by the Alexander von Humboldt Foundation (Wolfgang Paul Prize to H.B.), a European Research Council (ERC) Advanced Grant (to H.B.), the Sonderforschungsbereich (SFB) 488 and SFB 636 of the Deutsche Forschungsgemeinschaft (DFG), the European Network of Excellence NeuroNE, and the European Union Project Glutamate Receptor Interacting Proteins as Novel Neuroprotective Targets (EU Project GRIPANNT). H.B. is a member of the Excellence Cluster "CellNetworks" at Heidelberg University. D.M. is recipient of a European Molecular Biology Organization (EMBO) Long-Term Fellowship; AMMO. is recipient of a Postdoctoral Fellowship from the Foundation for Science and Technology, Portugal.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bliss TVP, 2007, HIPPOCAMPUS BOOK, P343; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; DELONG GR, 1993, AM J CLIN NUTR, V57, P286; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012; GOODMAN CS, 1978, J COMP NEUROL, V182, P681, DOI 10.1002/cne.901820408; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Licht T, 2010, DEVELOPMENT, V137, P261, DOI 10.1242/dev.039636; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Schafer G, 2008, CANCER RES, V68, P457, DOI 10.1158/0008-5472.CAN-07-5136; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHOLL DA, 1953, J ANAT, V87, P387; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Veeravagu A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E16; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Wiegert JS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-124; Wong SY, 2005, CANCER RES, V65, P9789, DOI 10.1158/0008-5472.CAN-05-0901; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	68	73	74	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 14	2011	71	1					117	130		10.1016/j.neuron.2011.04.022	http://dx.doi.org/10.1016/j.neuron.2011.04.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745642	Bronze			2022-12-25	WOS:000292806200011
J	Huang, H; Trussell, LO				Huang, Hai; Trussell, Laurence O.			KCNQ5 channels control resting properties and release probability of a synapse	NATURE NEUROSCIENCE			English	Article							AUDITORY BRAIN-STEM; PROTEIN-KINASE-C; POTASSIUM CHANNEL; TRANSMITTER RELEASE; MUSCARINIC MODULATION; K+ CHANNELS; INNER-EAR; ACTIVATION; SUBUNITS; OSCILLATIONS	Little is known about which ion channels determine the resting electrical properties of presynaptic membranes. In recordings made from the rat calyx of Held, a giant mammalian terminal, we found resting potential to be controlled by KCNQ (Kv7) K+ channels, most probably KCNQ5 (Kv7.5) homomers. Unlike most KCNQ channels, which are activated only by depolarizing stimuli, the presynaptic channels began to activate just below the resting potential. As a result, blockers and activators of KCNQ5 depolarized or hyperpolarized nerve terminals, respectively, markedly altering resting conductance. Moreover, the background conductance set by KCNQ5 channels, together with Na+ and hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels, determined the size and time course of the response to subthreshold stimuli. Signaling pathways known to directly affect exocytic machinery also regulated KCNQ5 channels, and increase or decrease of KCNQ5 channel activity controlled release probability through alterations in resting potential. Thus, ion channel determinants of presynaptic resting potential also control synaptic strength.	[Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Huang, H (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	huanghai@ohsu.edu	Huang, Hai/N-2330-2017; Huang, Hai/E-5588-2011	Huang, Hai/0000-0002-6928-3198; Huang, Hai/0000-0002-6928-3198	US National Institutes of Health [DC004450, NS028901]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901, R37NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004450] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank V. Balakrishnan and P. Brehm for comments, K. Bender and S. Kuo for technical advice and B. Kachar (National Institute on Deafness and Other Communication Disorders) for KCNQ4 antibody. L.O.T. is supported by US National Institutes of Health grants DC004450 and NS028901.	Alle H, 2008, CURR OPIN NEUROBIOL, V18, P314, DOI 10.1016/j.conb.2008.08.006; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Caminos E, 2007, J COMP NEUROL, V505, P363, DOI 10.1002/cne.21497; Chambard JM, 2005, PFLUG ARCH EUR J PHY, V450, P34, DOI 10.1007/s00424-004-1366-2; COCHET C, 1986, BIOCHEM J, V237, P25, DOI 10.1042/bj2370025; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Dodson PD, 2002, J NEUROSCI, V22, P6953; Elmedyb P, 2007, BASIC CLIN PHARMACOL, V100, P316, DOI 10.1111/j.1742-7843.2007.00048.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Garcia-Pino E, 2010, J COMP NEUROL, V518, P1301, DOI 10.1002/cne.22276; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Huang H, 2008, NEURON, V60, P975, DOI 10.1016/j.neuron.2008.10.052; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kim JH, 2007, NAT NEUROSCI, V10, P196, DOI 10.1038/nn1839; Leao RN, 2009, J NEUROSCI, V29, P13353, DOI 10.1523/JNEUROSCI.1463-09.2009; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Miceli F, 2009, CHANNELS, V3, P274; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Oliver D, 2003, J NEUROSCI, V23, P2141; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Roura-Ferrer M, 2009, CELL PHYSIOL BIOCHEM, V24, P325, DOI 10.1159/000257425; Saitoh N, 2001, P NATL ACAD SCI USA, V98, P14017, DOI 10.1073/pnas.241333598; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Soh H, 2010, MOL PHARMACOL, V78, P1088, DOI 10.1124/mol.110.066100; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Torborg CL, 2006, J NEUROSCI, V26, P7362, DOI 10.1523/JNEUROSCI.1257-06.2006; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200	50	59	60	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					840	U51		10.1038/nn.2830	http://dx.doi.org/10.1038/nn.2830			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666672	Green Accepted			2022-12-25	WOS:000292081700011
J	Dranovsky, A; Picchini, AM; Moadel, T; Sisti, AC; Yamada, A; Kimura, S; Leonardo, ED; Hen, R				Dranovsky, Alex; Picchini, Alyssa M.; Moadel, Tiffany; Sisti, Alexander C.; Yamada, Atsushi; Kimura, Shioko; Leonardo, E. David; Hen, Rene			Experience Dictates Stem Cell Fate in the Adult Hippocampus	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT DENTATE GYRUS; PROGENITOR CELLS; PATTERN SEPARATION; NEUROGENESIS; NEURONS; MICE; PROLIFERATION; DIVISION; MEMORY	Adult hippocampal neurogenesis has been implicated in cognitive and emotional processes, as well as in response to antidepressant treatment. However, little is known about how the adult stem cell lineage contributes to hippocampal structure and function and how this process is modulated by the animal's experience. Here we perform an indelible lineage analysis and report that neural stem cells can produce expanding and persisting populations of not only neurons, but also stem cells in the adult hippocampus. Furthermore, the ratio of stem cells to neurons depends on experiences of the animal or the location of the stem cell. Surprisingly, social isolation facilitated accumulation of stem cells, but not neurons. These results show that neural stem cells accumulate in the adult hippocampus and that the stem cell-lineage relationship is under control of anatomic and experiential niches. Our findings suggest that, in the hippocampus, fate specification may act as a form of cellular plasticity for adapting to environmental changes.	[Dranovsky, Alex; Picchini, Alyssa M.; Moadel, Tiffany; Sisti, Alexander C.; Leonardo, E. David; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Picchini, Alyssa M.; Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Dranovsky, Alex; Picchini, Alyssa M.; Moadel, Tiffany; Sisti, Alexander C.; Leonardo, E. David; Hen, Rene] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Yamada, Atsushi; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dranovsky, A (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	ad722@columbia.edu	Dranovsky, Alex/P-4357-2018; Leonardo, Eduardo/AAH-1525-2020	Dranovsky, Alex/0000-0001-7896-3243; Leonardo, Eduardo/0000-0001-7426-0217	NIH [K08MH079088, R01MH068542, NIH T32HD055165]; BRAINS [R01MH0911844]; NARSAD; NYSTEM; NCI CCR [P50 MH66171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC005522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH079088, R01MH091844, R01MH068542, R01MH091427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRAINS; NARSAD(NARSAD); NYSTEM; NCI CCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Matheus Araujo for technical assistance, Eric Kandel and Harshad Vishwasrao for sharing confocal resources, Richard Josephson for providing the pNerv-SXN construct, Linda Byrd for assistance with mice, and Frank Gonzalez. We are grateful to Chris Henderson, Fiona Doetsch, Ben Samuels, and Jesse Richardson-Jones for helpful discussions and critical reading of the manuscript. This work was supported by NIH K08MH079088, BRAINS R01MH0911844, and NARSAD Young Investigator Awards (A.D.); NIH R01MH068542 and NYSTEM (R.H.); NCI CCR Intramural Research Program (S.K.), P50 MH66171 (Molecular and Cellular Core) and the NYSTEM institutional development award; A.P. was supported by NIH T32HD055165. R.H. receives compensation as a consultant for Braincells, in relation to the generation of novel antidepressants. E.D.L. receives compensation as a consultant from PGxHealth.	Abusaad I, 1999, J COMP NEUROL, V408, P560, DOI 10.1002/(SICI)1096-9861(19990614)408:4<560::AID-CNE9>3.0.CO;2-P; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; GOULD E, 1992, J NEUROSCI, V12, P3642; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lu L, 2003, EXP NEUROL, V183, P600, DOI 10.1016/S0014-4886(03)00248-6; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	62	147	151	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 9	2011	70	5					908	923		10.1016/j.neuron.2011.05.022	http://dx.doi.org/10.1016/j.neuron.2011.05.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658584	Bronze, Green Accepted			2022-12-25	WOS:000291843500011
J	Sanders, SJ; Ercan-Sencicek, AG; Hus, V; Luo, R; Murtha, MT; Moreno-De-Luca, D; Chu, SH; Moreau, MP; Gupta, AR; Thomson, SA; Mason, CE; Bilguvar, K; Celestino-Soper, PBS; Choi, M; Crawford, EL; Davis, L; Wright, NRD; Dhodapkar, RM; DiCola, M; DiLullo, NM; Fernandez, TV; Fielding-Singh, V; Fishman, DO; Frahm, S; Garagaloyan, R; Goh, GS; Kammela, S; Klei, L; Lowe, JK; Lund, SC; McGrew, AD; Meyer, KA; Moffat, WJ; Murdoch, JD; O'Roak, BJ; Ober, GT; Pottenger, RS; Raubeson, MJ; Song, Y; Wang, Q; Yaspan, BL; Yu, TW; Yurkiewicz, LR; Beaudet, AL; Cantor, RM; Curland, M; Grice, DE; Gunel, M; Lifton, RP; Mane, SM; Martin, DM; Shaw, CA; Sheldon, M; Tischfield, JA; Walsh, CA; Morrow, EM; Ledbetter, DH; Fombonne, E; Lord, C; Martin, CL; Brooks, AI; Sutcliffe, JS; Cook, EH; Geschwind, D; Roeder, K; Devlin, B; State, MW				Sanders, Stephan J.; Ercan-Sencicek, A. Gulhan; Hus, Vanessa; Luo, Rui; Murtha, Michael T.; Moreno-De-Luca, Daniel; Chu, Su H.; Moreau, Michael P.; Gupta, Abha R.; Thomson, Susanne A.; Mason, Christopher E.; Bilguvar, Kaya; Celestino-Soper, Patricia B. S.; Choi, Murim; Crawford, Emily L.; Davis, Lea; Wright, Nicole R. Davis; Dhodapkar, Rahul M.; DiCola, Michael; DiLullo, Nicholas M.; Fernandez, Thomas V.; Fielding-Singh, Vikram; Fishman, Daniel O.; Frahm, Stephanie; Garagaloyan, Rouben; Goh, Gerald S.; Kammela, Sindhuja; Klei, Lambertus; Lowe, Jennifer K.; Lund, Sabata C.; McGrew, Anna D.; Meyer, Kyle A.; Moffat, William J.; Murdoch, John D.; O'Roak, Brian J.; Ober, Gordon T.; Pottenger, Rebecca S.; Raubeson, Melanie J.; Song, Youeun; Wang, Qi; Yaspan, Brian L.; Yu, Timothy W.; Yurkiewicz, Liana R.; Beaudet, Arthur L.; Cantor, Rita M.; Curland, Martin; Grice, Dorothy E.; Guenel, Murat; Lifton, Richard P.; Mane, Shrikant M.; Martin, Donna M.; Shaw, Chad A.; Sheldon, Michael; Tischfield, Jay A.; Walsh, Christopher A.; Morrow, Eric M.; Ledbetter, David H.; Fombonne, Eric; Lord, Catherine; Martin, Christa Lese; Brooks, Andrew I.; Sutcliffe, James S.; Cook, Edwin H., Jr.; Geschwind, Daniel; Roeder, Kathryn; Devlin, Bernie; State, Matthew W.			Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism	NEURON			English	Article							COPY NUMBER VARIATION; HIDDEN-MARKOV MODEL; EARLY-ONSET; 16P11.2; RISK; MICRODELETIONS; REARRANGEMENTS; DELETIONS; VARIANTS; GENES	We have undertaken a genome-wide analysis of rare copy-number variation (CNV) in 1124 autism spectrum disorder (ASD) families, each comprised of a single proband, unaffected parents, and, in most kindreds, an unaffected sibling. We find significant association of ASD with de novo duplications of 7q11.23, where the reciprocal deletion causes Williams-Beuren syndrome, characterized by a highly social personality. We identify rare recurrent de novo CNVs at five additional regions, including 16p13.2 (encompassing genes USP7 and C16orf72) and Cadherin 13, and implement a rigorous approach to evaluating the statistical significance of these observations. Overall, large de novo CNVs, particularly those encompassing multiple genes, confer substantial risks (OR = 5.6; CI = 2.6-12.0, p = 2.4 x 10(-7)). We estimate there are 130-234 ASD-related CNV regions in the human genome and present compelling evidence, based on cumulative data, for association of rare de novo events at 7q11.23, 15q11.2-13.1, 16p11.2, and Neurexin 1.	[Sanders, Stephan J.; Ercan-Sencicek, A. Gulhan; Murtha, Michael T.; Bilguvar, Kaya; Guenel, Murat; State, Matthew W.] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT 06520 USA; [Sanders, Stephan J.; Ercan-Sencicek, A. Gulhan; Murtha, Michael T.; Gupta, Abha R.; Wright, Nicole R. Davis; Dhodapkar, Rahul M.; DiLullo, Nicholas M.; Fernandez, Thomas V.; Kammela, Sindhuja; Moffat, William J.; Ober, Gordon T.; Song, Youeun; Yurkiewicz, Liana R.; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; [Sanders, Stephan J.; Ercan-Sencicek, A. Gulhan; Murtha, Michael T.; State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Sanders, Stephan J.; Ercan-Sencicek, A. Gulhan; Murtha, Michael T.; Bilguvar, Kaya; Choi, Murim; Goh, Gerald S.; Murdoch, John D.; Guenel, Murat; Lifton, Richard P.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Hus, Vanessa; Lund, Sabata C.; Lord, Catherine] Univ Michigan, Autism & Commun Disorders Ctr, Ann Arbor, MI 48109 USA; [Luo, Rui; Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Moreno-De-Luca, Daniel; Martin, Christa Lese] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Chu, Su H.; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Moreau, Michael P.; DiCola, Michael; Frahm, Stephanie; Wang, Qi; Brooks, Andrew I.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Thomson, Susanne A.; Crawford, Emily L.; McGrew, Anna D.; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol Biophys, New York, NY 10021 USA; [Mason, Christopher E.] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Bilguvar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Bilguvar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Celestino-Soper, Patricia B. S.; Beaudet, Arthur L.; Shaw, Chad A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Davis, Lea; Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60608 USA; [Fielding-Singh, Vikram] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Fishman, Daniel O.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Garagaloyan, Rouben; Curland, Martin] Microangelo Associates LLC, Pacific Palisades, CA 90272 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Lowe, Jennifer K.; Geschwind, Daniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA; [Meyer, Kyle A.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06510 USA; [O'Roak, Brian J.; Raubeson, Melanie J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pottenger, Rebecca S.] Princeton Univ, Princeton, NJ 08544 USA; [Yu, Timothy W.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Childrens Hosp Boston,Dept Neurol,Div Genet, Boston, MA 02115 USA; [Cantor, Rita M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Grice, Dorothy E.] Columbia Univ, Dept Psychiat, Div Child & Adolescent Psychiat, New York, NY 10032 USA; [Grice, Dorothy E.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Choi, Murim; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Mane, Shrikant M.] Yale Ctr Genome Anal, Orange, CT 06477 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; [Sheldon, Michael; Tischfield, Jay A.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Sheldon, Michael; Tischfield, Jay A.] Rutgers State Univ, Inst Human Genet, Piscataway, NJ 08854 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Ctr Life Sci, Howard Hughes Med Inst, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Ctr Life Sci, Div Genet,Childrens Hosp Boston, Boston, MA 02115 USA; [Morrow, Eric M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Morrow, Eric M.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Ledbetter, David H.] Geisinger Hlth Syst, Danville, PA 17822 USA; [Fombonne, Eric] McGill Univ, Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3Z 1P2, Canada; [Lord, Catherine] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Lord, Catherine] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Lord, Catherine] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Lord, Catherine] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA	Yale University; Yale University; Yale University; Yale University; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Emory University; Carnegie Mellon University; Rutgers State University New Brunswick; Yale University; Vanderbilt University; Cornell University; Cornell University; Yale University; Yale University; Baylor College of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; University of Washington; University of Washington Seattle; Princeton University; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; New York State Psychiatry Institute; Howard Hughes Medical Institute; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Brown University; Brown University; Geisinger Health System; McGill University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	State, MW (corresponding author), Yale Univ, Sch Med, Program Neurogenet, 230 S Frontage Rd, New Haven, CT 06520 USA.	matthew.state@yale.edu	Morrow, Eric/J-2767-2013; Bal, Vanessa Hus/AAN-2381-2020; Goh, Gerald/E-9158-2014; Fernandez, Thomas V/D-4295-2009; Goh, Gerald/N-1684-2015; Sanders, Stephan/S-8645-2019; Choi, Murim/AAP-9120-2021; Yu, Timothy W./AAF-5738-2019; State, Matthew/W-2256-2019; Mason, Christopher/HCH-3977-2022; Fombonne, Eric/M-4893-2018; Sutcliffe, James S/C-1348-2012; /AAD-2060-2020; Grice, Dorothy E/X-3372-2019	Morrow, Eric/0000-0003-3430-3520; Bal, Vanessa Hus/0000-0003-0750-823X; Goh, Gerald/0000-0002-3832-6466; Fernandez, Thomas V/0000-0003-0830-022X; Goh, Gerald/0000-0002-3832-6466; Yu, Timothy W./0000-0003-2988-7701; Fombonne, Eric/0000-0002-8605-3538; Sutcliffe, James S/0000-0001-5200-6007; /0000-0003-4651-0084; Grice, Dorothy E/0000-0002-8833-2549; Shaw, Chad/0000-0001-7267-5398; Sanders, Stephan/0000-0001-9112-5148; Dhodapkar, Rahul/0000-0002-2014-7515; Chu, Su/0000-0002-6345-008X; Lund, Sabata/0000-0002-6092-5131; Tischfield, Jay/0000-0003-3217-8287; O'Roak, Brian/0000-0002-4141-0095; Roeder, Kathryn/0000-0002-8869-6254; Martin, Donna/0000-0002-8070-2007; Yaspan, Brian/0000-0002-3787-2510; State, Matthew/0000-0003-1624-8302; Fielding-Singh, Vikram/0000-0002-9926-4975	Simons Foundation [SFARI 124827]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH080954, R25MH077823, T32MH065215, R01MH057881, K08MH087639] Funding Source: NIH RePORTER	Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are most grateful to all of the families at the participating Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (SSC) sites. This work was supported by a grant from the Simons Foundation (SFARI 124827). C.A. Walsh and R.P. Lifton are Investigators of the Howard Hughes Medical Institute. We wish to thank the SSC principal investigators A.L. Beaudet, R. Bernier, J. Constantino, E.H. Cook, Jr., E. Fombonne, D. Geschwind, D.E. Grice, A. Klin, D.H. Ledbetter, C. Lord, C.L. Martin, D.M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M.W. State, W. Stone, J.S. Sutcliffe, C.A. Walsh, and E. Wijsman; the coordinators and staff at the SSC sites; the SFARI staff (M. Greenup and S. Johnson); R. Smith and Z. Galfayan at Microangelo Associates for bioinformatics support; Prometheus Research; the Yale Center of Genomic Analysis staff, in particular S. Umlauf and C. Castaldi; T. Brooks-Boone and M. Wojciechowski for their help in administering the project at Yale; and J. Krystal, G.D. Fischbach, A. Packer, J. Spiro, and M. Benedetti for their suggestions throughout and very helpful comments during the preparation of this manuscript. Approved researchers can obtain the SSC population data set described in this study by applying at https://base.sfari.org. D.H. Ledbetter acts as a consultant for Roche Diagnostics and BioReference Laboratories; M.W. State, R.P. Lifton, and B.J. O'Roak hold a patent relating to the gene CNTNAP2.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Bugge M, 2000, J MED GENET, V37, P858, DOI 10.1136/jmg.37.11.858; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cook EH, 1997, AM J HUM GENET, V60, P928; Crossett A, 2010, STAT MED, V29, P2932, DOI 10.1002/sim.4057; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fu WQ, 2010, AM J HUM GENET, V87, P494, DOI 10.1016/j.ajhg.2010.09.006; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Gao MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010292; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Khoronenkova SV, 2011, NUCLEIC ACIDS RES, V39, P2604, DOI 10.1093/nar/gkq1210; Klauck SM, 1997, HUM GENET, V100, P224, DOI 10.1007/s004390050495; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S73; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Liang JS, 2009, J MED GENET, V46, P645, DOI 10.1136/jmg.2008.059220; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Makoff AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r114; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; SMALLEY SL, 1992, J AUTISM DEV DISORD, V22, P339, DOI 10.1007/BF01048239; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wassink TH, 2001, PSYCHIAT GENET, V11, P57, DOI 10.1097/00041444-200106000-00001; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	71	884	909	3	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					863	885		10.1016/j.neuron.2011.05.002	http://dx.doi.org/10.1016/j.neuron.2011.05.002			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658581	Bronze, Green Accepted			2022-12-25	WOS:000291843500008
J	Peng, A; Rotman, Z; Deng, PY; Klyachko, VA				Peng, Amy; Rotman, Ziv; Deng, Pan-Yue; Klyachko, Vitaly A.			Differential Motion Dynamics of Synaptic Vesicles Undergoing Spontaneous and Activity-Evoked Endocytosis	NEURON			English	Article							LIGHT-CHAIN KINASE; CA2+ SENSOR; MYOSIN-V; PRESYNAPTIC FUNCTION; SPONTANEOUS RELEASE; POOL; NEUROTRANSMISSION; INHIBITION; PLASTICITY; MOVEMENT	Synaptic vesicle exo- and endocytosis are usually driven by neuronal activity but can also occur spontaneously. The identity and differences between vesicles supporting evoked and spontaneous neuro-transmission remain highly debated. Here we combined nanometer-resolution imaging with a transient motion analysis approach to examine the dynamics of individual synaptic vesicles in hippocampal terminals under physiological conditions. We found that vesicles undergoing spontaneous and stimulated endocytosis differ in their dynamic behavior, particularly in the ability to engage in directed motion. Our data indicate that such motional differences depend on the myosin family of motor proteins, particularly myosin II. Analysis of synaptic transmission in the presence of myosin II inhibitor confirmed a specific role for myosin II in evoked, but not spontaneous, neurotransmission and also suggested a functional role of myosin II-mediated vesicle motion in supporting vesicle mobilization during neural activity.	[Peng, Amy; Rotman, Ziv; Deng, Pan-Yue; Klyachko, Vitaly A.] Washington Univ, Dept Cell Biol & Physiol, Dept Biomed Engn, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	Washington University (WUSTL)	Klyachko, VA (corresponding author), Washington Univ, Dept Cell Biol & Physiol, Dept Biomed Engn, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA.	klyachko@wustl.edu	Klyachko, Vitaly/E-9431-2012		Esther A. & Joseph Klingenstein Foundation; Edward Mallinckrodt, Jr. Foundation; Whitehall Foundation; Alzheimer's Association	Esther A. & Joseph Klingenstein Foundation; Edward Mallinckrodt, Jr. Foundation; Whitehall Foundation; Alzheimer's Association(Alzheimer's Association)	This work was supported in part by grants to V.A.K. from the Esther A. & Joseph Klingenstein Foundation, the Edward Mallinckrodt, Jr. Foundation, the Whitehall Foundation, and the Alzheimer's Association. We thank Dr. G. Danuzer and Dr. K. Jaqaman for kindly sharing their uTrack particle tracking software. We also thank Dr. S. Mennerick, Dr. V. Cavalli, and Dr. D. Owyoung for their constructive comments on the manuscript.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Gaffield MA, 2006, NEURON, V51, P317, DOI 10.1016/j.neuron.2006.06.031; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hua YF, 2010, NAT NEUROSCI, V13, P1451, DOI 10.1038/nn.2695; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Kamin D, 2010, BIOPHYS J, V99, P675, DOI 10.1016/j.bpj.2010.04.054; Leitz J, 2011, J NEUROSCI, V31, P16318, DOI 10.1523/JNEUROSCI.3358-11.2011; Lemke EA, 2005, J NEUROSCI, V25, P11034, DOI 10.1523/JNEUROSCI.2971-05.2005; Levitan ES, 2008, MOL NEUROBIOL, V37, P39, DOI 10.1007/s12035-008-8014-3; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Pang ZPP, 2011, NEURON, V70, P244, DOI 10.1016/j.neuron.2011.03.011; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Ryan TA, 1999, J NEUROSCI, V19, P1317; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Shakiryanova D, 2005, NAT NEUROSCI, V8, P173, DOI 10.1038/nn1377; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Takagishi Y, 2005, J PHYSIOL-LONDON, V569, P195, DOI 10.1113/jphysiol.2005.095943; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Tokuoka H, 2006, J NEUROSCI, V26, P11606, DOI 10.1523/JNEUROSCI.3400-06.2006; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wilhelm BG, 2010, NAT NEUROSCI, V13, P1454, DOI 10.1038/nn.2690; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	39	41	43	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1108	1115		10.1016/j.neuron.2012.01.023	http://dx.doi.org/10.1016/j.neuron.2012.01.023			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445339	Bronze			2022-12-25	WOS:000301998700009
J	Steinbeis, N; Bernhardt, BC; Singer, T				Steinbeis, Nikolaus; Bernhardt, Boris C.; Singer, Tania			Impulse Control and Underlying Functions of the Left DLPFC Mediate Age-Related and Age-Independent Individual Differences in Strategic Social Behavior	NEURON			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; CORTICAL THICKNESS; SELF-CONTROL; PREFRONTAL CORTEX; BRAIN-DEVELOPMENT; CHILDHOOD; CHILDREN; FAIRNESS; MYELINATION	Human social exchange is often characterized by conflicts of interest requiring strategic behavior for their resolution. To investigate the development of the cognitive and neural mechanisms underlying strategic behavior, we studied children's decisions while they played two types of economic exchange games with differing demands of strategic behavior. We show an increase of strategic behavior with age, which could not be explained by age-related changes in social preferences but instead by developmental differences in impulsivity and associated brain functions of the left dorsolateral prefrontal cortex (DLPFC). Furthermore, observed differences in cortical thickness of IDLPFC were predictive of differences in impulsivity and strategic behavior irrespective of age. We conclude that egoistic behavior in younger children is not caused by a lack of understanding right or wrong, but by the inability to implement behavioral control when tempted to act selfishly; a function relying on brain regions maturing only late in ontogeny.	[Steinbeis, Nikolaus; Bernhardt, Boris C.; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, D-04303 Leipzig, Germany; [Singer, Tania] Univ Zurich, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland	Max Planck Society; University of Zurich	Steinbeis, N (corresponding author), Max Planck Inst Human Cognit & Brain Sci, D-04303 Leipzig, Germany.	steinb@cbs.mpg.de	Bernhardt, Boris/AAF-2896-2021	Bernhardt, Boris/0000-0001-9256-6041	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This research was funded by the Swiss National Science Foundation ("Neuronal and developmental basis of empathy and emotion control: fMRI studies of adults and children aged 6 to 12 years"; to T.S.), and the University Research Priority Programs (URPP) of the University of Zurich.	Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brett M., 2009, NEUROIMAGE, V16, P2; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Burnett S., 2011, COGNITIVE DEV, V25, P183; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Chiron C, 1997, BRAIN, V120, P1057, DOI 10.1093/brain/120.6.1057; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85, DOI DOI 10.1037/0022-3514.44.1.113; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fornari E, 2007, NEUROIMAGE, V38, P511, DOI 10.1016/j.neuroimage.2007.07.010; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Guroglu B, 2011, NEUROIMAGE, V57, P634, DOI 10.1016/j.neuroimage.2011.04.032; Guroglu B, 2010, SOC COGN AFFECT NEUR, V5, P414, DOI 10.1093/scan/nsq013; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Harbaugh WT, 2003, BARGAINING CHILDREN; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Johnson MH, 2000, CHILD DEV, V71, P75, DOI 10.1111/1467-8624.00120; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kang HC, 2003, NEUROIMAGE, V19, P16, DOI 10.1016/S1053-8119(03)00038-7; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lenroot RK, 2009, HUM BRAIN MAPP, V30, P163, DOI 10.1002/hbm.20494; LitvackMiller W, 1997, GENET SOC GEN PSYCH, V123, P303; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Logan Gordon D., 1994, P189; Lu LH, 2009, CEREB CORTEX, V19, P2595, DOI 10.1093/cercor/bhp011; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murnighan JK, 1998, J ECON PSYCHOL, V19, P415, DOI 10.1016/S0167-4870(98)00017-8; Nimon K, 2008, BEHAV RES METHODS, V40, P457, DOI 10.3758/BRM.40.2.457; Poldrack RA, 2010, HUM BRAIN MAPP, V31, P872, DOI 10.1002/hbm.21039; Raven J., 2004, MANUAL RAVENS PROGR; Salami M, 2003, P NATL ACAD SCI USA, V100, P6174, DOI 10.1073/pnas.0937380100; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Thompson P., 2001, NAT NEUROSCI, V4, P1; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Worsley K., 2009, NEUROIMAGE, V47, pS102, DOI [10.1016/s1053-8119(09)70882-1, DOI 10.1016/S1053-8119(09)70882-1, 10.1016/S1053-8119(09)70882-1]; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6	64	196	202	4	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					1040	1051		10.1016/j.neuron.2011.12.027	http://dx.doi.org/10.1016/j.neuron.2011.12.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	909IQ	22405212	Bronze			2022-12-25	WOS:000301558600017
J	Iurilli, G; Ghezzi, D; Olcese, U; Lassi, G; Nazzaro, C; Tonini, R; Tucci, V; Benfenati, F; Medini, P				Iurilli, Giuliano; Ghezzi, Diego; Olcese, Umberto; Lassi, Glenda; Nazzaro, Cristiano; Tonini, Raffaella; Tucci, Valter; Benfenati, Fabio; Medini, Paolo			Sound-Driven Synaptic Inhibition in Primary Visual Cortex	NEURON			English	Article							NORMALIZATION MODEL; MULTISENSORY INTEGRATION; NEURONAL OSCILLATIONS; CORTICAL-NEURONS; BARREL CORTEX; RESPONSES; MODULATION; CELLS; INPUT; CAT	Multimodal objects and events activate many sensory cortical areas simultaneously. This is possibly reflected in reciprocal modulations of neuronal activity, even at the level of primary cortical areas. However, the synaptic character of these interareal interactions, and their impact on synaptic and behavioral sensory responses are unclear. Here, we found that activation of auditory cortex by a noise burst drove local GABAergic inhibition on supragranular pyramids of the mouse primary visual cortex, via cortico-cortical connections. This inhibition was generated by sound-driven excitation of a limited number of cells in infragranular visual cortical neurons. Consequently, visually driven synaptic and spike responses were reduced upon bimodal stimulation. Also, acoustic stimulation suppressed conditioned behavioral responses to a dim flash, an effect that was prevented by acute blockade of GABAergic transmission in visual cortex. Thus, auditory cortex activation by salient stimuli degrades potentially distracting sensory processing in visual cortex by recruiting local, translaminar, inhibitory circuits.	[Iurilli, Giuliano; Ghezzi, Diego; Olcese, Umberto; Lassi, Glenda; Nazzaro, Cristiano; Tonini, Raffaella; Tucci, Valter; Benfenati, Fabio; Medini, Paolo] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Medini, P (corresponding author), Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Via Morego 30, I-16163 Genoa, Italy.	paolo.medini@iit.it	Medini, Paolo/R-7504-2018; Ghezzi, Diego/B-7218-2012; Medini, Paolo/GWC-1936-2022; Tonini, Raffaella/J-2960-2012	Ghezzi, Diego/0000-0002-0554-7510; Olcese, Umberto/0000-0001-6968-2503; Iurilli, Giuliano/0000-0001-9037-2489; Lassi, Glenda/0000-0001-5102-3294; TONINI, Raffaella/0000-0003-1652-4709; Tucci, Valter/0000-0002-3796-3826	ISS; Compagnia di San Paolo of Torino; Telethon Italy [GGP09134]	ISS; Compagnia di San Paolo of Torino(Compagnia di San Paolo); Telethon Italy(Fondazione Telethon)	We thank Drs. Tommaso Pizzorusso, Matteo Caleo, and Prof. John Assad for critically reading the manuscript and Dr. Giacomo Pruzzo and Dr Alessandro Parodi for technical assistance. Grant support was from ISS Young Researchers (to P.M.), Compagnia di San Paolo of Torino (to P.M. and F.B.), Telethon Italy Grant GGP09134 (to F.B.).	AMZICA F, 1995, J NEUROSCI, V15, P4658; AVANZINI G, 1980, NEUROSCI LETT, V19, P27, DOI 10.1016/0304-3940(80)90250-5; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Banks MI, 2011, CEREB CORTEX, V21, P2620, DOI 10.1093/cercor/bhr048; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Berger TK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000473; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Butovas S, 2006, J NEUROPHYSIOL, V96, P1227, DOI 10.1152/jn.01170.2005; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Contreras D, 1997, J NEUROPHYSIOL, V78, P2742, DOI 10.1152/jn.1997.78.5.2742; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DEFELIPE J, 1986, J NEUROSCI, V6, P3749, DOI 10.1523/jneurosci.06-12-03749.1986; Dehner LR, 2004, CEREB CORTEX, V14, P387, DOI 10.1093/cercor/bhg135; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; FISHMAN MC, 1973, VISION RES, V13, P1415, DOI 10.1016/0042-6989(73)90002-3; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Higley MJ, 2005, J NEUROPHYSIOL, V93, P1920, DOI 10.1152/jn.00917.2004; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laramee ME, 2011, EUR J NEUROSCI, V34, P65, DOI 10.1111/j.1460-9568.2011.07732.x; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; MORRELL F, 1972, NATURE, V238, P44, DOI 10.1038/238044a0; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; PAPERNA T, 1991, J COMP NEUROL, V308, P432, DOI 10.1002/cne.903080310; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Sanchez-Vives MV, 2006, PROG BRAIN RES, V155, P287, DOI 10.1016/S0079-6123(06)55017-4; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009	63	214	215	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					814	828		10.1016/j.neuron.2011.12.026	http://dx.doi.org/10.1016/j.neuron.2011.12.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365553	Green Published, Bronze			2022-12-25	WOS:000300815400018
J	Oleson, EB; Beckert, MV; Morra, JT; Lansink, CS; Cachope, R; Abdullah, RA; Loriaux, AL; Schetters, D; Pattij, T; Roitman, MF; Lichtman, AH; Cheer, JF				Oleson, Erik B.; Beckert, Michael V.; Morra, Joshua T.; Lansink, Carien S.; Cachope, Roger; Abdullah, Rehab A.; Loriaux, Amy L.; Schetters, Dustin; Pattij, Tommy; Roitman, Mitchell F.; Lichtman, Aron H.; Cheer, Joseph F.			Endocannabinoids Shape Accumbal Encoding of Cue-Motivated Behavior via CB1 Receptor Activation in the Ventral Tegmentum	NEURON			English	Article							INTRACRANIAL SELF-STIMULATION; GOAL-DIRECTED BEHAVIOR; NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; SEEKING BEHAVIOR; IN-VIVO; REWARD; NEURONS; ANTAGONIST; MODULATION	Transient increases in nucleus accumbens (NAc) dopamine concentration are observed when animals are presented with motivationally salient stimuli and are theorized to energize reward seeking. They arise from high-frequency firing of dopamine neurons in the ventral tegmental area (VTA), which also results in the release of endocannabinoids from dopamine cell bodies. In this context, endocannabinoids are thought to regulate reward seeking by modulating dopamine signaling, although a direct link has never been demonstrated. To test this, we pharmacologically manipulated endocannabinoid neurotransmission in the VTA while measuring transient changes in dopamine concentration in the NAc during reward seeking. Disrupting endocannabinoid signaling dramatically reduced, whereas augmenting levels of the endocannabinoid 2-arachidonoylglycerol (2AG) increased, cue-evoked dopamine concentrations and reward seeking. These data suggest that 2AG in the VTA regulates reward seeking by sculpting ethologically relevant patterns of dopamine release during reward-directed behavior.	[Oleson, Erik B.; Beckert, Michael V.; Lansink, Carien S.; Cachope, Roger; Cheer, Joseph F.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Cheer, Joseph F.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Morra, Joshua T.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Abdullah, Rehab A.; Lichtman, Aron H.] Virginia Commonwealth Univ, Med Coll Virginia Campus, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Loriaux, Amy L.; Roitman, Mitchell F.] Univ Illinois, Dept Psychol, Chicago, IL 60607 USA; [Schetters, Dustin; Pattij, Tommy] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, NL-1081 HV Amsterdam, Netherlands	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Albany Medical College; Virginia Commonwealth University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Cheer, JF (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	jchee001@umaryland.edu	Cachope, Roger/K-2677-2012; Cheer, Joseph F/J-6102-2014	Cheer, Joseph F/0000-0001-5086-7559; Pattij, Tommy/0000-0002-0079-7385; Beckert, Michael/0000-0001-5440-966X	NIH [R01DA022340, R01DA025634, P01DA009789, F32DA032266, T32NS007375]; Rubicon Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA025890, R01DA022340, R01DA025634, F32DA032266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rubicon Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by NIH grants R01DA022340 (J.F.C.), R01DA025634 (M.F.R.), P01DA009789 (A.H.L.), F32DA032266 and T32NS007375 (E.B.O.), and a Rubicon Fellowship (C.S.L.). We also thank Geoff Schoenbaum, Peter Shizgal, Yolanda Mateo, and Joshua Jones for helpful comments in the preparation of this manuscript, John Peterson for instrumentation assistance and Merce Masana, Niels Vos, Ronny Gentry, and David Bernstein for technical assistance.	Alvarez-Jaimes L, 2008, NEUROPSYCHOPHARMACOL, V33, P2483, DOI 10.1038/sj.npp.1301630; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berry EM, 2002, PHARMACOL THERAPEUT, V95, P185, DOI 10.1016/S0163-7258(02)00257-7; BINDRA D, 1968, PSYCHOL REV, V75, P1, DOI 10.1037/h0025306; Brady AM, 2004, J NEUROSCI, V24, P1040, DOI 10.1523/JNEUROSCI.4178-03.2004; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; Cheer JF, 2007, J NEUROSCI, V27, P791, DOI 10.1523/JNEUROSCI.4152-06.2007; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Crystal JD, 2003, BEHAV BRAIN RES, V144, P57, DOI 10.1016/S0166-4328(03)00062-7; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Day JJ, 2010, BIOL PSYCHIAT, V68, P306, DOI 10.1016/j.biopsych.2010.03.026; De Vries TJ, 2005, TRENDS PHARMACOL SCI, V26, P420, DOI 10.1016/j.tips.2005.06.002; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2001, J NEUROSCI, V21, P2851, DOI 10.1523/JNEUROSCI.21-08-02851.2001; Foltin RW, 2007, PHARMACOL BIOCHEM BE, V86, P766, DOI 10.1016/j.pbb.2007.03.004; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gamaleddin I, 2011, BRIT J PHARMACOL, V164, P1652, DOI 10.1111/j.1476-5381.2011.01440.x; Garattini S., 1965, HASHISH ITS CHEMISTR, P70; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Gomez R, 2002, J NEUROSCI, V22, P9612; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Hillard CJ, 1997, J NEUROCHEM, V69, P631, DOI 10.1046/j.1471-4159.1997.69020631.x; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Julian MD, 2003, NEUROSCIENCE, V119, P309, DOI 10.1016/S0306-4522(03)00070-8; Justinova Z, 2008, NEUROPSYCHOPHARMACOL, V33, P2870, DOI 10.1038/npp.2008.21; Kelley AE, 1999, PSYCHOBIOLOGY, V27, P198; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Le Foll B, 2004, NEUROREPORT, V15, P2139, DOI 10.1097/00001756-200409150-00028; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lupica CR, 2005, NEUROPHARMACOLOGY, V48, P1105, DOI 10.1016/j.neuropharm.2005.03.016; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Matyas F, 2008, NEUROPHARMACOLOGY, V54, P95, DOI 10.1016/j.neuropharm.2007.05.028; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; MIRAS CJ, 1965, HASHISH ITS CHEMISTR, P37; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nesse RM, 1997, SCIENCE, V278, P63, DOI 10.1126/science.278.5335.63; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; NICOLAYSEN LC, 1988, BRAIN RES, V460, P50, DOI 10.1016/0006-8993(88)90428-3; Owesson-White CA, 2008, P NATL ACAD SCI USA, V105, P11957, DOI 10.1073/pnas.0803896105; Perra S, 2005, PSYCHOPHARMACOLOGY, V183, P368, DOI 10.1007/s00213-005-0195-0; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Scherma M., 2012, BR J PHARM IN PRESS, DOI [10.1111/j.1476-5381.2011.01467, DOI 10.1111/J.1476-5381.2011.01467]; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Solinas M, 2003, J PHARMACOL EXP THER, V306, P93, DOI 10.1124/jpet.102.047928; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Taylor KM, 2007, BEHAV PROCESS, V74, P168, DOI 10.1016/j.beproc.2006.11.005; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Van der Stelt M, 2006, CELL MOL LIFE SCI, V63, P1410, DOI 10.1007/s00018-006-6037-3; Ward SJ, 2007, NEUROPSYCHOPHARMACOL, V32, P2592, DOI 10.1038/sj.npp.1301384; Ward SJ, 2005, BEHAV PHARMACOL, V16, P381, DOI 10.1097/00008877-200509000-00010; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Xi ZX, 2008, NEUROPSYCHOPHARMACOL, V33, P1735, DOI 10.1038/sj.npp.1301552; Yavich L, 2000, NEUROSCI LETT, V293, P41, DOI 10.1016/S0304-3940(00)01484-1	69	119	119	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					360	373		10.1016/j.neuron.2011.11.018	http://dx.doi.org/10.1016/j.neuron.2011.11.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284189	Green Accepted, Bronze			2022-12-25	WOS:000299761600016
J	Fu, J; Bottegoni, G; Sasso, O; Bertorelli, R; Rocchia, W; Masetti, M; Guijarro, A; Lodola, A; Armirotti, A; Garau, G; Bandiera, T; Reggiani, A; Mor, M; Cavalli, A; Piomelli, D				Fu, Jin; Bottegoni, Giovanni; Sasso, Oscar; Bertorelli, Rosalia; Rocchia, Walter; Masetti, Matteo; Guijarro, Ana; Lodola, Alessio; Armirotti, Andrea; Garau, Gianpiero; Bandiera, Tiziano; Reggiani, Angelo; Mor, Marco; Cavalli, Andrea; Piomelli, Daniele			A catalytically silent FAAH-1 variant drives anandamide transport in neurons	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR; FORCE-FIELDS; INHIBITORS; INACTIVATION; ACCUMULATION; CELLS; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION; MODULATION	The endocannabinoid anandamide is removed from the synaptic space by a selective transport system, expressed in neurons and astrocytes, that remains molecularly uncharacterized. Here we describe a partly cytosolic variant of the intracellular anandamide-degrading enzyme fatty acid amide hydrolase-1 (FAAH-1), termed FAAH-like anandamide transporter (FLAT), that lacked amidase activity but bound anandamide with low micromolar affinity and facilitated its translocation into cells. Known anandamide transport inhibitors, such as AM404 and OMDM-1, blocked these effects. We also identified a competitive antagonist of the interaction of anandamide with FLAT, the phthalazine derivative ARN272, that prevented anandamide internalization in vitro, interrupted anandamide deactivation in vivo and exerted profound analgesic effects in rodent models of nociceptive and inflammatory pain, which were mediated by CB1 cannabinoid receptors. The results identify FLAT as a critical molecular component of anandamide transport in neural cells and a potential target for therapeutic drugs.	[Fu, Jin; Guijarro, Ana; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Bottegoni, Giovanni; Sasso, Oscar; Bertorelli, Rosalia; Rocchia, Walter; Masetti, Matteo; Armirotti, Andrea; Garau, Gianpiero; Bandiera, Tiziano; Reggiani, Angelo; Cavalli, Andrea; Piomelli, Daniele] Italian Inst Technol, Genoa, Italy; [Lodola, Alessio; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Cavalli, Andrea] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy	University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT; University of Parma; University of Bologna	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	piomelli@uci.edu	Garau, Gianpiero/A-2800-2012; Garau, Gianpiero/AAM-4234-2021; Mor, Marco/D-2394-2009; Armirotti, Andrea/AAB-3284-2019; Lodola, Alessio/H-9078-2013; Fu, Jin/A-3510-2012; Rocchia, Walter/H-3784-2012; bertorelli, rosalia/A-2989-2012	Garau, Gianpiero/0000-0001-9473-5814; Garau, Gianpiero/0000-0001-9473-5814; Mor, Marco/0000-0003-0199-1849; Lodola, Alessio/0000-0002-8675-1002; Rocchia, Walter/0000-0003-2480-7151; CAVALLI, ANDREA/0000-0002-6370-1176; Armirotti, Andrea/0000-0002-3766-8755; Masetti, Matteo/0000-0002-3757-7802; GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; Bottegoni, Giovanni/0000-0003-1251-583X; BERTORELLI, Rosalia/0000-0002-7913-3564	US National Institute on Drug Abuse; US National Institute on Alcohol Abuse and Alcoholism [DA-012413]; US National Institute on General Medicine [1R01GM093937-01]; Agilent/University of California Irvine Analytical Discovery Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US National Institute on General Medicine; Agilent/University of California Irvine Analytical Discovery Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Colombano, J. Kim, S. Mandrup-Bertozzi, D. Thongkham, G. Moreno-Sanz and R. Scarpelli for help with experiments and discussions about the project. This research was supported by grants from the US National Institute on Drug Abuse and the US National Institute on Alcohol Abuse and Alcoholism (DA-012413 to D. P.) and the US National Institute on General Medicine (1R01GM093937-01 to W. R.). The support provided by the Agilent/University of California Irvine Analytical Discovery Facility is gratefully acknowledged.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; Bojesen IN, 2003, J LIPID RES, V44, P1790, DOI 10.1194/jlr.M300170-JLR200; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hillard CJ, 2007, J MOL NEUROSCI, V33, P18, DOI 10.1007/s12031-007-0045-0; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Hillard CJ, 1997, J NEUROCHEM, V69, P631, DOI 10.1046/j.1471-4159.1997.69020631.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jacobsson SOP, 2001, BRIT J PHARMACOL, V132, P1743, DOI 10.1038/sj.bjp.0704029; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Li XQ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-11; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Maione S, 2008, BRIT J PHARMACOL, V155, P775, DOI 10.1038/bjp.2008.308; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; PEARSON GDN, 1982, P NATL ACAD SCI-BIOL, V79, P2976, DOI 10.1073/pnas.79.9.2976; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Reese-Wagoner A, 1999, BBA-MOL CELL BIOL L, V1441, P106, DOI 10.1016/S1388-1981(99)00154-7; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosso L, 2008, J COMPUT CHEM, V29, P24, DOI 10.1002/jcc.20675; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Seierstad M, 2008, J MED CHEM, V51, P7327, DOI 10.1021/jm800311k; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Yates ML, 2009, MOL PHARMACOL, V76, P11, DOI 10.1124/mol.109.055251	49	126	131	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					64	U82		10.1038/nn.2986	http://dx.doi.org/10.1038/nn.2986			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101642	Green Submitted, Green Accepted			2022-12-25	WOS:000298414400015
J	Hou, QM; Gilbert, J; Man, HY				Hou, Qingming; Gilbert, James; Man, Heng-Ye			Homeostatic Regulation of AMPA Receptor Trafficking and Degradation by Light-Controlled Single-Synaptic Activation	NEURON			English	Article							ACTIVITY-DEPENDENT UBIQUITINATION; CULTURED HIPPOCAMPAL-NEURONS; DENDRITIC PROTEIN-SYNTHESIS; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; NEURAL ACTIVITY; NMDA RECEPTORS; PLASTICITY; SUBUNIT; MECHANISMS	During homeostatic adjustment in response to alterations in neuronal activity, synaptic expression of AMPA receptors (AMPARs) is globally tuned up or down so that the neuronal activity is restored to a physiological range. Given that a central neuron receives multiple presynaptic inputs, whether and how AMPAR synaptic expression is homeostatically regulated at individual synapses remain unclear. In cultured hippocampal neurons we report that when activity of an individual presynaptic terminal is selectively elevated by light-controlled excitation, AMPAR abundance at the excited synapses is selectively downregulated in an NMDAR-dependent manner. The reduction in surface AMPARs is accompanied by enhanced receptor endocytosis and dependent on proteasomal activity. Synaptic activation also leads to a site-specific increase in the ubiquitin ligase Nedd4 and polyubiquitination levels, consistent with AMPAR ubiquitination and degradation in the spine. These results indicate that AMPAR accumulation at individual synapses is subject to autonomous homeostatic regulation in response to synaptic activity.	[Hou, Qingming; Gilbert, James; Man, Heng-Ye] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Man, HY (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	hman@bu.edu	hou, qingming/AAT-4381-2020	Man, Hengye/0000-0002-3530-3066	US National Institutes of Health [MH079407]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079407] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Dr. Ehud Isacoff for providing the LiGluR6/MAG system and comments on the manuscripts and Dr. Karl Deisseroth for providing the ChR-2 construct that was used in our initial exploration. We thank H.-Y.M. lab members for helpful discussions and Steve Amato and Amy Lin for critical reading of the manuscript. This work was supported by US National Institutes of Health Grant MH079407 (to H.-Y.M.).	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hou QM, 2008, MOL CELL NEUROSCI, V38, P213, DOI 10.1016/j.mcn.2008.02.010; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Maffei A, 2009, CURR OPIN NEUROBIOL, V19, P168, DOI 10.1016/j.conb.2009.05.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Rabinowitch I, 2008, TRENDS NEUROSCI, V31, P377, DOI 10.1016/j.tins.2008.05.005; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Roth-Alpermann C, 2006, P NATL ACAD SCI USA, V103, P11039, DOI 10.1073/pnas.0600894103; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Shen H, 2007, J NEUROSCI, V27, P8903, DOI 10.1523/JNEUROSCI.1571-07.2007; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turrigiano GG, 1998, NEURON, V21, P933, DOI 10.1016/S0896-6273(00)80607-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Yu LMY, 2009, CURR OPIN NEUROBIOL, V19, P327, DOI 10.1016/j.conb.2009.07.002; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009	76	76	76	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					806	818		10.1016/j.neuron.2011.10.011	http://dx.doi.org/10.1016/j.neuron.2011.10.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153376	Green Accepted, Bronze			2022-12-25	WOS:000297971100014
J	Chen, MJ; Li, Y; De Obaldia, ME; Yang, Q; Yzaguirre, AD; Yamada-Inagawa, T; Vink, CS; Bhandoola, A; Dzierzak, E; Speck, NA				Chen, Michael J.; Li, Yan; De Obaldia, Maria Elena; Yang, Qi; Yzaguirre, Amanda D.; Yamada-Inagawa, Tomoko; Vink, Chris S.; Bhandoola, Avinash; Dzierzak, Elaine; Speck, Nancy A.			Erythroid/Myeloid Progenitors and Hematopoietic Stem Cells Originate from Distinct Populations of Endothelial Cells	CELL STEM CELL			English	Article							CORE-BINDING-FACTOR; CBF-BETA; DEFINITIVE HEMATOPOIESIS; AORTIC ENDOTHELIUM; RUNX1 EXPRESSION; YOLK-SAC; AML1; IDENTIFICATION; GENERATION; TRANSGENE	Hematopoietic stem cells (HSCs) and an earlier wave of definitive erythroid/myeloid progenitors (EMPs) differentiate from hemogenic endothelial cells in the conceptus. EMPs can be generated in vitro from embryonic or induced pluripotent stem cells, but efforts to produce HSCs have largely failed. The formation of both EMPs and HSCs requires the transcription factor Runx1 and its non-DNA binding partner core binding factor beta (CBF beta). Here we show that the requirements for CBF beta in EMP and HSC formation in the conceptus are temporally and spatially distinct. Panendothelial expression of CBF beta in Tek-expressing cells was sufficient for EMP formation, but was not adequate for HSC formation. Expression of CBF beta in Ly6a-expressing cells, on the other hand, was sufficient for HSC, but not EMP, formation. The data indicate that EMPs and HSCs differentiate from distinct populations of hemogenic endothelial cells, with Ly6a expression specifically marking the HSC-generating hemogenic endothelium.	[Chen, Michael J.; Li, Yan; Yzaguirre, Amanda D.; Speck, Nancy A.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chen, Michael J.; Li, Yan; Yzaguirre, Amanda D.; Speck, Nancy A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [De Obaldia, Maria Elena; Yang, Qi; Bhandoola, Avinash] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Yamada-Inagawa, Tomoko; Vink, Chris S.; Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Erasmus University Rotterdam; Erasmus MC	Speck, NA (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	nancyas@exchange.upenn.edu		Vink, Chris S./0000-0002-3202-8361; De Obaldia, Maria/0000-0003-2488-3672	Netherlands Institute of Regenerative Medicine;  [R01HL091724]; NATIONAL CANCER INSTITUTE [R01CA058343, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077] Funding Source: NIH RePORTER	Netherlands Institute of Regenerative Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Tomomasa Yokomizo for teaching us how to perform the whole-mount immunohistochemistry. We are especially grateful to Andrea Stout for her help with confocal microscopy. This work was supported by R01HL091724 (N.A.S.) and Netherlands Institute of Regenerative Medicine (E.D.). Core services were supported by the Abramson Family Cancer Research Institute and the Abramson Cancer Center.	ADJA N, 1998, MOL CELL BIOL, V18, P7432; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bollerot K, 2005, GENE EXPR PATTERNS, V6, P29, DOI 10.1016/j.modgep.2005.05.003; CAI X, 2011, PLOS ONE IN PRESS; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lengerke C, 2010, BLOOD REV, V24, P27, DOI 10.1016/j.blre.2009.10.001; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Liakhovitskaia A, 2009, STEM CELLS, V27, P1616, DOI 10.1002/stem.71; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Ma XQ, 2002, BRIT J HAEMATOL, V116, P401, DOI 10.1046/j.1365-2141.2002.03250.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky AL, 1996, BLOOD, V87, P557, DOI 10.1182/blood.V87.2.557.bloodjournal872557; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; SINCLAIR AM, 1993, BLOOD, V82, P3052; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Talebian L, 2007, BLOOD, V109, P11, DOI 10.1182/blood-2006-05-021188; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; YOKOMIZO T, 2011, NAT PROTOC IN PRESS; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	55	172	176	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					541	552		10.1016/j.stem.2011.10.003	http://dx.doi.org/10.1016/j.stem.2011.10.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136929	Green Accepted, Bronze			2022-12-25	WOS:000297895000014
J	Baumgartner, T; Knoch, D; Hotz, P; Eisenegger, C; Fehr, E				Baumgartner, Thomas; Knoch, Daria; Hotz, Philine; Eisenegger, Christoph; Fehr, Ernst			Dorsolateral and ventromedial prefrontal cortex orchestrate normative choice	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DECISION-MAKING; ORBITOFRONTAL CORTEX; COGNITIVE CONTROL; SOCIAL COGNITION; NEURAL CIRCUITRY; SELF-CONTROL; NEUROBIOLOGY; PREFERENCES; MODULATION	Humans are noted for their capacity to over-ride self-interest in favor of normatively valued goals. We examined the neural circuitry that is causally involved in normative, fairness-related decisions by generating a temporarily diminished capacity for costly normative behavior, a 'deviant' case, through non-invasive brain stimulation (repetitive transcranial magnetic stimulation) and compared normal subjects' functional magnetic resonance imaging signals with those of the deviant subjects. When fairness and economic self-interest were in conflict, normal subjects (who make costly normative decisions at a much higher frequency) displayed significantly higher activity in, and connectivity between, the right dorsolateral prefrontal cortex (DLPFC) and the posterior ventromedial prefrontal cortex (pVMPFC). In contrast, when there was no conflict between fairness and economic self-interest, both types of subjects displayed identical neural patterns and behaved identically. These findings suggest that a parsimonious prefrontal network, the activation of right DLPFC and pVMPFC, and the connectivity between them, facilitates subjects' willingness to incur the cost of normative decisions.	[Baumgartner, Thomas; Hotz, Philine; Eisenegger, Christoph; Fehr, Ernst] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Baumgartner, Thomas; Knoch, Daria] Univ Basel, Dept Psychol, Lab Social & Affect Neurosci, Basel, Switzerland; [Eisenegger, Christoph] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Zurich; University of Basel; University of Cambridge	Baumgartner, T (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland.	t.baumgartner@unibas.ch; daria.knoch@unibas.ch; ernst.fehr@econ.uzh.ch	Knoch, Daria/H-7324-2012	Baumgartner, Thomas/0000-0001-5966-7377	Neurochoice Project of SystemsX; Swiss Initiative for Systems Biology; Swiss National Science Foundation [PP00P1-123381]	Neurochoice Project of SystemsX; Swiss Initiative for Systems Biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Ruff, K. E. Stephan and A. Rangel for their helpful comments. This study is a part of the project on the foundations of norm compliance in the National Center of Competence in Affective Sciences. E. F. also acknowledges support from the Neurochoice Project of SystemsX, the Swiss Initiative for Systems Biology. D. K. acknowledges support from the Swiss National Science Foundation (grant no. PP00P1-123381).	BAUMGARTNER T, 2011, HUM BRAIN MAPP  0513, DOI DOI 10.1002/HBM.21298; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Boyd R, 2005, ORIGIN EVOLUTION CUL; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Damasio A, 1995, DESCARTES ERROR EMOT; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Eisenegger C, 2008, NEUROIMAGE, V42, P379, DOI 10.1016/j.neuroimage.2008.04.172; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Griskova I, 2007, NEUROSCI LETT, V419, P162, DOI 10.1016/j.neulet.2007.04.030; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Herwig U, 2007, NEUROIMAGE, V37, P652, DOI 10.1016/j.neuroimage.2007.05.023; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Knoch D, 2009, P NATL ACAD SCI USA, V106, P20895, DOI 10.1073/pnas.0911619106; Koch G, 2005, NEUROIMAGE, V24, P34, DOI 10.1016/j.neuroimage.2004.09.042; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Miller BL, 1997, BRIT J PSYCHIAT, V170, P150, DOI 10.1192/bjp.170.2.150; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14	50	195	204	6	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1468	U149		10.1038/nn.2933	http://dx.doi.org/10.1038/nn.2933			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21964488	Green Accepted, Green Published			2022-12-25	WOS:000296518600024
J	Miharada, K; Karlsson, G; Rehn, M; Rorby, E; Siva, K; Cammenga, J; Karlsson, S				Miharada, Kenichi; Karlsson, Goran; Rehn, Matilda; Rorby, Emma; Siva, Kavitha; Cammenga, Jorg; Karlsson, Stefan			Cripto Regulates Hematopoietic Stem Cells as a Hypoxic-Niche-Related Factor through Cell Surface Receptor GRP78	CELL STEM CELL			English	Article							BONE-MARROW NICHE; SELF-RENEWAL; MOLECULAR CHARACTERIZATION; PROGENITOR CELLS; TGF-BETA; IN-VIVO; MAINTENANCE; PROTEINS; FAMILY; GROWTH	Hematopoietic stem cells (HSCs) are maintained in hypoxic niches in endosteal regions of bones. Here we demonstrate that Cripto and its receptor GRP78 are important regulators of HSCs in the niche. Flow cytometry analyses revealed two distinct subpopulations of CD34(-)KSL cells based on the expression of GRP78, and these populations showed different reconstitution potential in transplantation assays. GRP78(+)HSCs mainly reside in the endosteal area, are more hypoxic, and exhibit a lower mitochondrial potential, and their HSC capacity was maintained in vitro by Cripto through induction of higher glycolytic activity. Additionally, HIF-1 alpha KO mice have decreased numbers of GRP78(+)HSCs and reduced expression of Cripto in the endosteal niche. Furthermore, blocking GRP78 induced a movement of HSCs from the endosteal to the central marrow area. These data suggest that Cripto/GRP78 signaling is an important pathway that regulates HSC quiescence and maintains HSCs in hypoxia as an intermediary of HIF-1 alpha.	[Miharada, Kenichi; Karlsson, Goran; Rehn, Matilda; Rorby, Emma; Siva, Kavitha; Cammenga, Jorg; Karlsson, Stefan] Lund Univ, Lund Strateg Ctr Stem Cell Biol, Dept Mol Med & Gene Therapy, S-22184 Lund, Sweden	Lund University	Miharada, K (corresponding author), Lund Univ, Lund Strateg Ctr Stem Cell Biol, Dept Mol Med & Gene Therapy, S-22184 Lund, Sweden.	kenichi.miharada@med.lu.se; stefan.karlsson@med.lu.se	Miharada, Kenichi/C-1397-2014	Miharada, Kenichi/0000-0001-8073-4001; Karlsson, Goran/0000-0001-8197-754X; Siva, Kavitha/0000-0001-9480-4496; Rehn, Matilda/0000-0002-9436-9655	Swedish Research Council Linnaeus; Swedish Cancer Foundation (Cancerfonden); The Swedish Cancer Society; Swedish Children's Cancer Society; Swedish Medical Research Council; The Tobias Foundation; EU; PERSIST; Marie Curie actions; Center of Excellence; Swedish Foundation for Strategic Research	Swedish Research Council Linnaeus(Swedish Research Council); Swedish Cancer Foundation (Cancerfonden)(Swedish Cancer Society); The Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Society; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); The Tobias Foundation; EU(European Commission); PERSIST; Marie Curie actions(European Commission); Center of Excellence; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	We thank Leif Carlsson for providing Lhx2 cells; Susie Nilsson for sending a detailed protocol for analyzing eHSCs/cHSCs; Tariq Enver and Jonas Larsson for critical discussions; and Zhi Ma for excellent advice on flow cytometry analyses. This work was supported by the Hemato-Linne grant (Swedish Research Council Linnaeus), the Swedish Cancer Foundation (Cancerfonden), The Swedish Cancer Society (S.K.), the Swedish Children's Cancer Society (S.K.), the Swedish Medical Research Council (S.K.), The Tobias Prize awarded by The Royal Swedish Academy of Sciences financed by The Tobias Foundation (S.K.), and the EU project grants CONSERT, STEMEXPAND, and PERSIST. K.M. was funded by the EU-funded NOVEXPAND project in Marie Curie actions. The Lund Stem Cell Center was supported by a Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bianco C, 2010, AM J PATHOL, V177, P532, DOI 10.2353/ajpath.2010.100102; Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grassinger J, 2010, BLOOD, V116, P3185, DOI 10.1182/blood-2009-12-260703; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Hardy B, 2010, J MOL MED, V88, P1157, DOI 10.1007/s00109-010-0657-7; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Kahn J, 2004, BLOOD, V103, P2942, DOI 10.1182/blood-2003-07-2607; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Ogaeri T, 2009, STEM CELLS, V27, P1120, DOI 10.1002/stem.42; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ostergaard L, 2009, PROTEOMICS, V9, P4457, DOI 10.1002/pmic.200800130; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Richter K., 2002, BLOOD, V99, P3939; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	49	129	134	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					330	344		10.1016/j.stem.2011.07.016	http://dx.doi.org/10.1016/j.stem.2011.07.016			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982233	Bronze			2022-12-25	WOS:000296041200011
J	Cohen, S; Gabel, HW; Hemberg, M; Hutchinson, AN; Sadacca, LA; Ebert, DH; Harmin, DA; Greenberg, RS; Verdine, VK; Zhou, ZL; Wetsel, WC; West, AE; Greenberg, ME				Cohen, Sonia; Gabel, Harrison W.; Hemberg, Martin; Hutchinson, Ashley N.; Sadacca, L. Amanda; Ebert, Daniel H.; Harmin, David A.; Greenberg, Rachel S.; Verdine, Vanessa K.; Zhou, Zhaolan; Wetsel, William C.; West, Anne E.; Greenberg, Michael E.			Genome-Wide Activity-Dependent MeCP2 Phosphorylation Regulates Nervous System Development and Function	NEURON			English	Article							RETT-SYNDROME; MOUSE MODEL; BDNF TRANSCRIPTION; PYRAMIDAL NEURONS; DENDRITIC GROWTH; BINDING-SITES; HISTONE H1; CHROMATIN; PROTEIN; BRAIN	Autism spectrum disorders such as Rett syndrome (RTT) have been hypothesized to arise from defects in experience-dependent synapse maturation. FIT is caused by mutations in MECP2, a nuclear protein that becomes phosphorylated at S421 in response to neuronal activation. We show here that disruption of MeCP2 S421 phosphorylation in vivo results in defects in synapse development and behavior, implicating activity-dependent regulation of MeCP2 in brain development and RTT. We investigated the mechanism by which S421 phosphorylation regulates MeCP2 function and show by chromatin immunoprecipitation-sequencing that this modification occurs on MeCP2 bound across the genome. The phosphorylation of MeCP2 S421 appears not to regulate the expression of specific genes; rather, MeCP2 functions as a histone-like factor whose phosphorylation may facilitate a genome-wide response of chromatin to neuronal activity during nervous system development. We propose that RTT results in part from a loss of this experience-dependent chromatin remodeling.	[Cohen, Sonia; Gabel, Harrison W.; Sadacca, L. Amanda; Ebert, Daniel H.; Harmin, David A.; Greenberg, Rachel S.; Verdine, Vanessa K.; Zhou, Zhaolan; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hemberg, Martin] Childrens Hosp Boston, Dept Ophthalmol, Boston, MA 02115 USA; [Hutchinson, Ashley N.; Wetsel, William C.; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Duke University	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu			NIH [1R01NS048276, R01 DA022202, T32CA009361, K08MH90306, K99 NS058391, 1R21NS070250-01A1]; March of Dimes [1-FY07-482]; Medical Scientist Training Program; Department of Neurobiology; Damon Runyon Cancer Research Foundation [DRG-2048-10]; Dupont-Warren Fellowship in the Department of Psychiatry; NATIONAL CANCER INSTITUTE [T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS058391, K99NS058391, R21NS070250, R01NS048276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022202] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurobiology; Damon Runyon Cancer Research Foundation; Dupont-Warren Fellowship in the Department of Psychiatry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Griffith, P. Greer, S. Ross, N. Robinson, and Greenberg Lab members for critical reading of the manuscript; C. Chen, B. Bloodgood, E. Hong, R. Rodriguiz, J. Dodart, H. Ho, and the MRDDRC Gene Manipulation Core (M. Thompson, Y. Zhou, and H. Ye) for experimental assistance and advice. This work was supported by NIH grant 1R01NS048276 to M.E.G. A.E.W. was supported by NIH grant R01 DA022202 and March of Dimes grant 1-FY07-482; S.C. was supported by the Medical Scientist Training Program, Ruth L. Kirschstein NIH Training Grant T32CA009361, and the Department of Neurobiology Graduate Fellowship Fund at HMS; H.W.G. was supported by Damon Runyon Cancer Research Foundation Grant DRG-2048-10; D.H.E. was supported by NIH grant K08MH90306 and by the Dupont-Warren Fellowship in the Department of Psychiatry at HMS; Z.Z. was supported by NIH grant K99 NS058391. M.H. was supported by NIH grant 1R21NS070250-01A1.	Armstrong DD, 2002, MENT RETARD DEV D R, V8, P72, DOI 10.1002/mrdd.10027; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; GUY J, 2010, ANN REV CELL DE 1029; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Wittmann M, 2009, J NEUROSCI, V29, P14687, DOI 10.1523/JNEUROSCI.1160-09.2009; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	41	206	216	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					72	85		10.1016/j.neuron.2011.08.022	http://dx.doi.org/10.1016/j.neuron.2011.08.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982370	Bronze, Green Accepted			2022-12-25	WOS:000295856300009
J	Moore, BD; Kiley, CW; Sun, C; Usrey, WM				Moore, Bartlett D.; Kiley, Caitlin W.; Sun, Chao; Usrey, W. Martin			Rapid Plasticity of Visual Responses in the Adult Lateral Geniculate Nucleus	NEURON			English	Article							RECEPTIVE-FIELD ORGANIZATION; CORTICAL PLASTICITY; GANGLION-CELLS; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; RETINOGENICULATE SYNAPSE; AXON COLLATERALS; NMDA RECEPTORS; CAT RETINA; CORTEX; CONNECTIONS	Compared to the developing visual system, where neuronal plasticity has been well characterized at multiple levels, little is known about plasticity in the adult, particularly within subcortical structures. We made intraocular injections of 2-amino-4-phosphonobutyric acid (APB) in adult cats to block visual responses in On-center retinal ganglion cells and examined the consequences on visual responses in the lateral geniculate nucleus (LGN) of the thalamus. In contrast to current views of retinogeniculate organization, which hold that On-center LGN neurons should become silent with APB, we find that similar to 50% of On-center neurons rapidly develop Off-center responses. The time course of these emergent responses and the actions of APB in the retina indicate the plasticity occurs within the LGN. These results suggest there is greater divergence of retinogeniculate connections than previously recognized and that functionally silent, nonspecific retinal inputs can serve as a substrate for rapid plasticity in the adult.	[Moore, Bartlett D.; Kiley, Caitlin W.; Usrey, W. Martin] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Sun, Chao; Usrey, W. Martin] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95618 USA; [Usrey, W. Martin] Univ Calif Davis, Dept Neurol, Davis, CA 95618 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Usrey, WM (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA.	wmusrey@ucdavis.edu	Sun, Chao/B-3692-2008	Moore IV, Bartlett/0000-0002-3164-0452	National Institutes of Health [EY13588, EY16182, EY12576]; NATIONAL EYE INSTITUTE [R01EY016182, R01EY013588, P30EY012576, T32EY015387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY13588, EY16182, and EY12576. Katie Neverkovec, Kelly Henning, and Daniel Sperka provided expert technical assistance.	Allen EA, 2006, J NEUROSCI, V26, P11763, DOI 10.1523/JNEUROSCI.3297-06.2006; BERG DK, 1975, J PHYSIOL-LONDON, V244, P659, DOI 10.1113/jphysiol.1975.sp010818; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; BOLZ J, 1984, NEUROSCIENCE, V12, P875, DOI 10.1016/0306-4522(84)90176-3; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Cox CL, 2003, J NEUROSCI, V23, P7642; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; ESGUERRA M, 1992, VISUAL NEUROSCI, V8, P545, DOI 10.1017/S0952523800005642; Fox K, 2002, PHILOS T ROY SOC B, V357, P1709, DOI 10.1098/rstb.2002.1169; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HORTON JC, 1984, J NEUROSCI, V4, P374; KNAPP AG, 1983, J NEUROPHYSIOL, V50, P1236, DOI 10.1152/jn.1983.50.5.1236; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Liu XJ, 2008, J NEUROPHYSIOL, V99, P629, DOI 10.1152/jn.01171.2007; MASSEY SC, 1983, VISION RES, V23, P1607, DOI 10.1016/0042-6989(83)90174-8; MASTRONARDE DN, 1992, VISUAL NEUROSCI, V8, P407, DOI 10.1017/S0952523800004934; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; SCHILLER PH, 1982, NATURE, V297, P580, DOI 10.1038/297580a0; SCHILLER PH, 1984, VISION RES, V24, P923, DOI 10.1016/0042-6989(84)90067-1; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Sugihara H, 1997, NEUROSCI LETT, V233, P137, DOI 10.1016/S0304-3940(97)00656-3; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Wang X, 2011, NAT NEUROSCI, V14, P224, DOI 10.1038/nn.2707; WASSLE H, 1983, VISION RES, V23, P1151, DOI 10.1016/0042-6989(83)90029-9	35	23	23	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 8	2011	71	5					812	819		10.1016/j.neuron.2011.06.025	http://dx.doi.org/10.1016/j.neuron.2011.06.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903075	Bronze, Green Accepted			2022-12-25	WOS:000294877900007
J	Hayman, R; Verriotis, MA; Jovalekic, A; Fenton, AA; Jeffery, KJ				Hayman, Robin; Verriotis, Madeleine A.; Jovalekic, Aleksandar; Fenton, Andre A.; Jeffery, Kathryn J.			Anisotropic encoding of three-dimensional space by place cells and grid cells	NATURE NEUROSCIENCE			English	Article							ENTORHINAL CORTEX; PATH-INTEGRATION; REPRESENTATION; HIPPOCAMPUS; DIRECTION; FIELDS; INPUTS; MAP	The subjective sense of space may result in part from the combined activity of place cells in the hippocampus and grid cells in posterior cortical regions such as the entorhinal cortex and pre- and parasubiculum. In horizontal planar environments, place cells provide focal positional information, whereas grid cells supply odometric (distance measuring) information. How these cells operate in three dimensions is unknown, even though the real world is three-dimensional. We investigated this issue in rats exploring two different kinds of apparatus: a climbing wall (the 'pegboard') and a helix. Place and grid cell firing fields had normal horizontal characteristics but were elongated vertically, with grid fields forming stripes. It seems that grid cell odometry (and by implication path integration) is impaired or absent in the vertical domain, at least when the rat itself remains horizontal. These findings suggest that the mammalian encoding of three-dimensional space is anisotropic.	[Hayman, Robin; Verriotis, Madeleine A.; Jovalekic, Aleksandar; Jeffery, Kathryn J.] UCL, Inst Behav Neurosci, Dept Cognit Perceptual & Brain Sci, Div Psychol & Language Sci, London, England; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Fenton, Andre A.] SUNY, Dept Physiol & Pharmacol, Brooklyn, NY USA	University of London; University College London; New York University; State University of New York (SUNY) System; SUNY Maritime College	Jeffery, KJ (corresponding author), UCL, Inst Behav Neurosci, Dept Cognit Perceptual & Brain Sci, Div Psychol & Language Sci, London, England.	k.jeffery@ucl.ac.uk	Jeffery, Kathryn J/C-2409-2008	Jeffery, Kathryn J/0000-0002-9495-0378; Fenton, Andre/0000-0002-5063-1156; Verriotis, Madeleine/0000-0003-3019-0370; Hayman, Robin/0000-0003-1075-0430	Wellcome Trust; European Commission; Axona Ltd; National Science Foundation [IOS-0725001]	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Axona Ltd; National Science Foundation(National Science Foundation (NSF))	The work was supported by grants from the Wellcome Trust to K.J.J., the European Commission Framework 7 ('Spacebrain') to K.J.J. and Axona Ltd, and a National Science Foundation grant (no. IOS-0725001) to A.A.F. We thank E. Kelemen for help designing and M. Shkop for constructing the helical track, E. Leeper for building the pegboard arena, M. Witter for advice on histology and C. Barry and F. Cacucci for comments on the manuscript.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; JEFFERY K, ANIMAL THIN IN PRESS; Jeffery KJ, 2007, HIPPOCAMPUS, V17, P775, DOI 10.1002/hipo.20322; Jeffery KJ, 2006, EXP BRAIN RES, V169, P218, DOI 10.1007/s00221-005-0138-3; Knierim JJ, 2000, NAT NEUROSCI, V3, P209, DOI 10.1038/72910; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nitz DA, 2011, J NEUROPHYSIOL, V105, P1815, DOI 10.1152/jn.00573.2010; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Skaggs W. E., 1993, ADV NEURAL INF PROCE, V5, P1031; Stackman RW, 2000, J NEUROPHYSIOL, V83, P393, DOI 10.1152/jn.2000.83.1.393; TAFFORIN C, 1994, ADV SPACE RES, V14, P415, DOI 10.1016/0273-1177(94)90433-2	22	102	103	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1182	U244		10.1038/nn.2892	http://dx.doi.org/10.1038/nn.2892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21822271	Green Accepted			2022-12-25	WOS:000294284900019
J	Mizuseki, K; Diba, K; Pastalkova, E; Buzsaki, G				Mizuseki, Kenji; Diba, Kamran; Pastalkova, Eva; Buzsaki, Gyoergy			Hippocampal CA1 pyramidal cells form functionally distinct sublayers	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; ENTORHINAL CORTEX; CORTICAL-NEURONS; RAT HIPPOCAMPUS; BEHAVING RAT; FIELD CA1; OSCILLATIONS; MORPHOLOGY; NEOCORTEX; NETWORKS	Hippocampal CA1 pyramidal neurons have frequently been regarded as a homogeneous cell population in biophysical, pharmacological and modeling studies. We found robust differences between pyramidal neurons residing in the deep and superficial CA1 sublayers in rats. Compared with their superficial peers, deep pyramidal cells fired at higher rates, burst more frequently, were more likely to have place fields and were more strongly modulated by slow oscillations of sleep. Both deep and superficial pyramidal cells fired preferentially at the trough of theta oscillations during maze exploration, whereas deep pyramidal cells shifted their preferred phase of firing to the peak of theta during rapid eye movement (REM) sleep. Furthermore, although the majority of REM theta phase-shifting cells fired at the ascending phase of gamma oscillations during waking, nonshifting cells preferred the trough. Thus, CA1 pyramidal cells in adjacent sublayers can address their targets jointly or differentially, depending on brain states.	[Mizuseki, Kenji; Diba, Kamran; Pastalkova, Eva; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Mizuseki, Kenji/A-9214-2011	Mizuseki, Kenji/0000-0002-1456-2149; Diba, Kamran/0000-0001-5128-4478; Buzsaki, Gyorgy/0000-0002-3100-4800	US National Institutes of Health [NS034994, MH54671]; National Science Foundation; J.D. McDonnell Foundation; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Japan Society of Promotion for Sciences; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009947] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); J.D. McDonnell Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Japan Society of Promotion for Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank E. Cela, S. Fujisawa, P. M. Hiche, S. Ozen, A. Sirota, E. Stark and Y. Wang for comments on the manuscript, and D. Sullivan for valuable suggestions. This work was supported by the US National Institutes of Health (NS034994, MH54671), the National Science Foundation, the J.D. McDonnell Foundation, the Uehara Memorial Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Japan Society of Promotion for Sciences, and the Robert Leet and Clara Guthrie Patterson Trust.	Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; BAIMBRIDGE KG, 1991, SYNAPSE, V7, P269, DOI 10.1002/syn.890070404; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BILKEY DK, 1990, BRAIN RES, V514, P77, DOI 10.1016/0006-8993(90)90437-G; BRAGIN A, 1995, J NEUROSCI, V15, P47; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MASON A, 1990, J NEUROSCI, V10, P1415; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Molinari S, 1996, P NATL ACAD SCI USA, V93, P8028, DOI 10.1073/pnas.93.15.8028; MULLER RU, 1989, J NEUROSCI, V9, P4101; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; SORENSEN JC, 1993, ANAT EMBRYOL, V188, P107; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TAMAMAKI N, 1995, J COMP NEUROL, V353, P379, DOI 10.1002/cne.903530306; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, J NEUROSCI, V15, P30; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	50	227	231	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1174	U235		10.1038/nn.2894	http://dx.doi.org/10.1038/nn.2894			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21822270	Green Published, Green Accepted			2022-12-25	WOS:000294284900018
J	Sanuki, R; Onishi, A; Koike, C; Muramatsu, R; Watanabe, S; Muranishi, Y; Irie, S; Uneo, S; Koyasu, T; Matsui, R; Cherasse, Y; Urade, Y; Watanabe, D; Kondo, M; Yamashita, T; Furukawa, T				Sanuki, Rikako; Onishi, Akishi; Koike, Chieko; Muramatsu, Rieko; Watanabe, Satoshi; Muranishi, Yuki; Irie, Shoichi; Uneo, Shinji; Koyasu, Toshiyuki; Matsui, Ryosuke; Cherasse, Yoan; Urade, Yoshihiro; Watanabe, Dai; Kondo, Mineo; Yamashita, Toshihide; Furukawa, Takahisa			miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression	NATURE NEUROSCIENCE			English	Article							DEVELOPING MOUSE RETINA; HOMEOBOX GENE; CELL FATE; TRANSCRIPTION FACTORS; EARLY NEUROGENESIS; MICRORNA TARGETS; TRANSGENIC MICE; MESSENGER-RNAS; DIFFERENTIATION; EXPRESSION	MicroRNA-124a (miR-124a) is the most abundant microRNA expressed in the vertebrate CNS. Despite past investigations into the role of miR-124a, inconsistent results have left the in vivo function of miR-124a unclear. We examined the in vivo function of miR-124a by targeted disruption of Rncr3 (retinal non-coding RNA 3), the dominant source of miR-124a. Rncr3(-/-) mice exhibited abnormalities in the CNS, including small brain size, axonal mis-sprouting of dentate gyrus granule cells and retinal cone cell death. We found that Lhx2 is an in vivo target mRNA of miR-124a. We also observed that LHX2 downregulation by miR-124a is required for the prevention of apoptosis in the developing retina and proper axonal development of hippocampal neurons. These results suggest that miR-124a is essential for the maturation and survival of dentate gyrus neurons and retinal cones, as it represses Lhx2 translation.	[Sanuki, Rikako; Onishi, Akishi; Koike, Chieko; Watanabe, Satoshi; Muranishi, Yuki; Irie, Shoichi; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan; [Sanuki, Rikako; Onishi, Akishi; Watanabe, Satoshi; Irie, Shoichi; Furukawa, Takahisa] Japan Sci & Technol Agcy, Osaka Biosci Inst, Osaka, Japan; [Muramatsu, Rieko; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Uneo, Shinji; Koyasu, Toshiyuki; Kondo, Mineo] Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan; [Matsui, Ryosuke; Watanabe, Dai] Kyoto Univ, Dept Biol Sci, Fac Med, Grad Sch Biostudies,Sakyo Ku, Kyoto, Japan; [Cherasse, Yoan; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka, Japan	Japan Science & Technology Agency (JST); Osaka University; Nagoya University; Kyoto University	Furukawa, T (corresponding author), Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan.	furukawa@obi.or.jp	Sanuki, Rikako/AAV-7143-2021; Cherasse, Yoan/AAD-6442-2020	Sanuki, Rikako/0000-0001-9862-9840; Cherasse, Yoan/0000-0002-6139-8193; Yamashita, Toshihide/0000-0003-4559-7018; Watanabe, Satoshi/0000-0002-8129-6223	Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST); Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [23592603] Funding Source: KAKEN	Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Maniatis for RIPmiR-124a-2, M. Kilimann for Synapsin 1 promoter, Y. Omori, K. Terada, M. Ueno, N. Nagata, K. Aritake, Y. Oishi, T. Hamasaki, and H. Abe for critical comments and technical advice, and A. Tani, M. Kadowaki, Y. Kawakami, A. Ishimaru, H. Tsujii, T. Saioka, K. Sone, H. Abe, and S. Kennedy for technical assistance. This work was supported by Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Grant-in-Aid for Scientific Research (B), Grant-in-Aid for Young Scientists (B), a Grant for Molecular Brain Science from the Ministry of Education, Culture, Sports, Science and Technology, the Takeda Science Foundation, the Uehara Memorial Foundation, the Mochida Memorial Foundation, and the Naito Foundation.	BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Glancy M, 2009, EUR J HUM GENET, V17, P37, DOI 10.1038/ejhg.2008.133; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Holmes GL, 1999, J COMP NEUROL, V404, P537, DOI 10.1002/(SICI)1096-9861(19990222)404:4<537::AID-CNE9>3.0.CO;2-#; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Koyama R, 2004, CURR NEUROVASC RES, V1, P3, DOI 10.2174/1567202043480242; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; OKAZAKI MM, 1995, J COMP NEUROL, V352, P515, DOI 10.1002/cne.903520404; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Porter FD, 1997, DEVELOPMENT, V124, P2935; Qiu R, 2009, MECH DEVELOP, V126, P804, DOI 10.1016/j.mod.2009.08.002; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Sanuki R, 2010, FEBS LETT, V584, P753, DOI 10.1016/j.febslet.2009.12.030; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Xu XL, 2008, J NEUROSCI, V28, P11883, DOI 10.1523/JNEUROSCI.4114-08.2008; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	50	212	216	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1125	U177		10.1038/nn.2897	http://dx.doi.org/10.1038/nn.2897			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857657				2022-12-25	WOS:000294284900012
J	Sohn, JW; Xu, Y; Jones, JE; Wickman, K; Williams, KW; Elmquist, JK				Sohn, Jong-Woo; Xu, Yong; Jones, Juli E.; Wickman, Kevin; Williams, Kevin W.; Elmquist, Joel K.			Serotonin 2C Receptor Activates a Distinct Population of Arcuate Pro-opiomelanocortin Neurons via TRPC Channels	NEURON			English	Article							ENERGY HOMEOSTASIS REGULATION; GATED POTASSIUM CHANNELS; RECTIFYING K+ CHANNELS; MELANOCORTIN PATHWAYS; AGRP NEURONS; GLUCOSE-HOMEOSTASIS; D-FENFLURAMINE; POMC NEURONS; FOOD-INTAKE; I-KACH	Serotonin 2C receptors (5-HT(2C)Rs) expressed by pro-opiomelanocortin (POMC) neurons of hypothalamic arcuate nucleus regulate food intake, energy homeostasis and glucose metabolism. However, the cellular mechanisms underlying the effects of 5-HT to regulate POMC neuronal activity via 5-HT(2C)Rs have not yet been identified. In the present study, we found the putative transient receptor potential C (TRPC) channels mediate the activation of a subpopulation of POMC neurons by mCPP (a 5-HT(2C)R agonist). Interestingly, mCPP-activated POMC neurons were found to be a distinct population from those activated by leptin. Together, our data suggest that 5-HT(2C)R and leptin receptors are expressed by distinct subpopulations of arcuate POMC neurons and that both 5-HT and leptin exert their actions in POMC neurons via TRPC channels.	[Sohn, Jong-Woo; Xu, Yong; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Xu, Yong] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Jones, Juli E.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities	Williams, KW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	kevin.williams@utsouthwestern.edu; joel.elmquist@utsouthwestern.edu	Williams, Kevin W/ABD-5818-2021; Williams, Kevin W/AAA-4243-2020; Sohn, Jong Woo/D-6700-2014	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Xu, Yong/0000-0002-4908-1572; Wickman, Kevin/0000-0002-5179-9540	American Diabetes Association; Naman Family Fund for Basic Research; Curtis Hankamer Basic Research Fund;  [R00DK085330];  [P30DK079638-03];  [R01MH061933];  [P50DA011806];  [K01DK087780];  [R01DK53301];  [R01DK088423];  [RL1DK081185];  [PL1 DK081182];  [UL1RR024923]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085330, RL1DK081185, PL1DK081182, R37DK053301, P30DK079638, R01DK053301, K01DK087780, R01DK088423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583, R01MH061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Naman Family Fund for Basic Research; Curtis Hankamer Basic Research Fund; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Jefferey Friedman (Rockefeller University) for kindly providing us with the LepR-cre mice. This work was supported by grants to J.-W.S. (American Diabetes Association), Y.X. (R00DK085330, P30DK079638-03, American Diabetes Association, and the Naman Family Fund for Basic Research and the Curtis Hankamer Basic Research Fund), K.W. (R01MH061933, P50DA011806), K.W.W. (K01DK087780), and J.K.E. (R01DK53301, R01DK088423, and RL1DK081185). This work was also supported by PL1 DK081182 and UL1RR024923.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Astrup A, 2010, NEW ENGL J MED, V363, P288, DOI 10.1056/NEJMe1004076; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Davila V, 2003, J NEUROSCI, V23, P5693; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Giorgetti M, 2004, EUR J PHARMACOL, V488, P1, DOI 10.1016/j.ejphar.2004.01.036; Halford JCG, 2010, NAT REV ENDOCRINOL, V6, P255, DOI 10.1038/nrendo.2010.19; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Kennedy ME, 1996, NEUROPHARMACOLOGY, V35, P831, DOI 10.1016/0028-3908(96)00132-3; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perry CA, 2008, P NATL ACAD SCI USA, V105, P8148, DOI 10.1073/pnas.0803261105; Pollack A, 2010, NY TIMES        0627, pA1; POLLACK A, 2010, NY TIMES        1023, pA27; Qiu J, 2007, MOL PHARMACOL, V72, P885, DOI 10.1124/mol.107.038083; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Xu Y, 2010, J NEUROSCI, V30, P14630, DOI 10.1523/JNEUROSCI.5412-09.2010; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033	50	133	138	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 11	2011	71	3					488	497		10.1016/j.neuron.2011.06.012	http://dx.doi.org/10.1016/j.neuron.2011.06.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835345	Bronze, Green Accepted			2022-12-25	WOS:000293991700012
J	Shusterman, R; Smear, MC; Koulakov, AA; Rinberg, D				Shusterman, Roman; Smear, Matthew C.; Koulakov, Alexei A.; Rinberg, Dmitry			Precise olfactory responses tile the sniff cycle	NATURE NEUROSCIENCE			English	Article							BULB UNIT-ACTIVITY; ODOR REPRESENTATIONS; TEMPORAL PRECISION; SPIKE TRAINS; TUFTED CELLS; CORTEX; RAT; INFORMATION; INHIBITION; ACCURACY	In terrestrial vertebrates, sniffing controls odorant access to receptors, and therefore sets the timescale of olfactory stimuli. We found that odorants evoked precisely sniff-locked activity in mitral/tufted cells in the olfactory bulb of awake mouse. The trial-to-trial response jitter averaged 12 ms, a precision comparable to other sensory systems. Individual cells expressed odor-specific temporal patterns of activity and, across the population, onset times tiled the duration of the sniff cycle. Responses were more tightly time-locked to the sniff phase than to the time after inhalation onset. The spikes of single neurons carried sufficient information to discriminate odors. In addition, precise locking to sniff phase may facilitate ensemble coding by making synchrony relationships across neurons robust to variation in sniff rate. The temporal specificity of mitral/tufted cell output provides a potentially rich source of information for downstream olfactory areas.	[Shusterman, Roman; Smear, Matthew C.; Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA USA; [Smear, Matthew C.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Koulakov, Alexei A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Northwestern University; Cold Spring Harbor Laboratory	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	rinbergd@janelia.hhmi.org	Shusterman, Roman/B-9514-2008	Shusterman, Roman/0000-0002-1081-2884	Howard Hughes Medical Institute; US National Institutes of Health [R01 EY018068]; NATIONAL EYE INSTITUTE [R01EY018068] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Osborne and T. Tabachnik for design and fabrication of experimental equipment, S. Royer for help with electrophysiological setup, J. Nunez-Iglesias for help with statistical analysis, P. Ahammad, D.B. Chklovskii and S. Druckmann for discussions and A. Resulaj, J.T. Dudman, V. Jayaraman, E. Pastalkova and K. Svoboda for comments on the manuscript. R.S., M.C.S. and D.R. are supported by the Howard Hughes Medical Institute. A.A.K. was supported by US National Institutes of Health grant R01 EY018068.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Bishop C.M., 2006, PATTERN RECOGNITION; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Cang JH, 2003, J NEUROSCI, V23, P4108; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Fuentes RA, 2008, J NEUROPHYSIOL, V100, P422, DOI 10.1152/jn.00095.2008; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rieke F., 1997, SPIKES EXPLORING NEU; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	44	246	251	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1039	U136		10.1038/nn.2877	http://dx.doi.org/10.1038/nn.2877			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765422				2022-12-25	WOS:000293123700018
J	Sugi, T; Nishida, Y; Mori, I				Sugi, Takuma; Nishida, Yukuo; Mori, Ikue			Regulation of behavioral plasticity by systemic temperature signaling in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							HEAT-SHOCK-FACTOR; C-ELEGANS; LIFE-SPAN; MOLECULAR CHAPERONES; OLFACTORY NEURON; NERVOUS-SYSTEM; THERMOTAXIS; DROSOPHILA; ESTROGEN; PROTEIN	Animals cope with environmental changes by altering behavioral strategy. Environmental information is generally received by sensory neurons in the neural circuit that generates behavior. However, although environmental temperature inevitably influences an animal's entire body, the mechanism of systemic temperature perception remains largely unknown. We show here that systemic temperature signaling induces a change in a memory-based behavior in C. elegans. During behavioral conditioning, non-neuronal cells as well as neuronal cells respond to cultivation temperature through a heat-shock transcription factor that drives newly identified gene expression dynamics. This systemic temperature signaling regulates thermosensory neurons non-cell-autonomously through the estrogen signaling pathway, producing thermotactic behavior. We provide a link between systemic environmental recognition and behavioral plasticity in the nervous system.	[Sugi, Takuma; Nishida, Yukuo; Mori, Ikue] Nagoya Univ, Grp Mol Neurobiol, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Mori, Ikue] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Mori, Ikue] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Mori, I (corresponding author), Nagoya Univ, Grp Mol Neurobiol, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	m46920a@nucc.cc.nagoya-u.ac.jp	Sugi, Takuma/O-7429-2015		Japan Science and Technology (JST) agency	Japan Science and Technology (JST) agency(Japan Science & Technology Agency (JST))	We thank N. Hisamoto (Nagoya University), T. Mizuno (Nagoya University) and K. Matsumoto (Nagoya University) for sharing strains; A. Fire (Stanford University School of Medicine) for pPD plasmids; Y. Iino (University of Tokyo) for the gcy-5 and gcy-7 promoters; Caenorhabditis Genetic Center, C. elegans Knockout Consortium and S. Mitani at the National Bioresource Project, Japan, for strains; K. Terauchi and T. Kondo for kindly sharing the microarray apparatus; T. Inada for kindly sharing the quantitative PCR apparatus; C. Bargmann, S. Takagi, N. Hisamoto, A. Kuhara, P. Jurado, H. Sasakura, N. Ohnishi, T. Kimata, M. Nonomura and members of the Mori laboratory for comments on this manuscript and discussion. I.M. is a Scholar of the Institute for Advanced Research in Nagoya University, Japan. This work was supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology (JST) agency (to I.M.).	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bear M.F., 2007, NEUROSCIENCE, Vthird; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; CLOS J, 1993, NATURE, V364, P252, DOI 10.1038/364252a0; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Devaney E, 2006, INT J PARASITOL, V36, P641, DOI 10.1016/j.ijpara.2006.02.006; GOODSON ML, 1995, J BIOL CHEM, V270, P2447, DOI 10.1074/jbc.270.6.2447; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito H, 2006, J NEUROSCI METH, V154, P45, DOI 10.1016/j.jneumeth.2005.11.011; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mimoto A, 2007, BIOCHEM BIOPH RES CO, V364, P883, DOI 10.1016/j.bbrc.2007.10.089; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zariwala HA, 2003, J NEUROSCI, V23, P4369; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	41	52	56	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					984	U69		10.1038/nn.2854	http://dx.doi.org/10.1038/nn.2854			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706021				2022-12-25	WOS:000293123700011
J	Hong, SH; Pampalli, S; Lee, JB; McNicol, J; Collins, T; Draper, JS; Bhatia, M				Hong, Seok-Ho; Pampalli, Shravanti; Lee, Jung Bok; McNicol, Jamie; Collins, Tony; Draper, Jonathan S.; Bhatia, Mickie			Cell Fate Potential of Human Pluripotent Stem Cells Is Encoded by Histone Modifications	CELL STEM CELL			English	Article							DIFFERENTIATION; SUBPOPULATIONS; HETEROGENEITY; NICHE; STATE	Human embryonic stem cells (hESCs) expressing pluripotency markers are assumed to possess equipotent developmental potential. However, disparate responses to differentiation stimuli functionally illustrate that hESCs generate a spectrum of differentiated cell types, suggestive of lineage bias. Here, we reveal specific cell surface markers that allow sub-fractionation of hESCs expressing hallmark markers of pluripotency. By direct de novo isolation of these subsets, we demonstrate that propensities for lineage differentiation are balanced with reduced clonogenic self-renewal. Histone modification marks of gene loci associated with pluripotency versus lineage specificity predicted cell fate potential of these subfractions, thereby supporting the absence of uniform bivalency as a molecular paradigm to describe cell fate determination of pluripotent cells. Our study reveals that cell fate potential is encoded within cells comprising hESC cultures, highlighting them as a means to understand the mechanisms of lineage specification of pluripotent cells.	[Hong, Seok-Ho; Pampalli, Shravanti; Lee, Jung Bok; McNicol, Jamie; Collins, Tony; Draper, Jonathan S.; Bhatia, Mickie] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Michael G DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada; [Draper, Jonathan S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Draper, Jonathan S.; Bhatia, Mickie] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Bhatia, M (corresponding author), McMaster Univ, McMaster Stem Cell & Canc Res Inst, Michael G DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca		Rampalli, Shravanti/0000-0002-6391-6409; Draper, Jonathan/0000-0002-3241-7009	Canadian Institute of Health Research; Ontario Ministry of Research Innovation-(OCRiT GL2); Canadian Chair Program	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research Innovation-(OCRiT GL2)(Ministry of Research and Innovation, Ontario); Canadian Chair Program	This research was supported by the Canadian Institute of Health Research to M.B., Ontario Ministry of Research Innovation-(OCRiT GL2), and the Canadian Chair Program (CRC) to J.D. and M.B. We are grateful to Marilyne Levadoux-Martin for FACS expertise and Monica Graham for hESC culture. S.H and S.R designed the study, assisted in writing the manuscript, and performed most of the experiments. J.B. performed experiments. J.M. and T.C. performed Montage imaging and time lapse. J.D. provided intellectual input to the analysis of results and assisted in the initial drafts of the manuscript. M.B. supervised the experiments, provided intellectual support toward design and interpretation of the results, and wrote the final version of the manuscript.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bendall SC, 2008, REGEN MED, V3, P365, DOI 10.2217/17460751.3.3.365; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; CERDAN C, 2007, CURR PROTOC STEM CEL, V1, pCH1; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Stewart MH, 2008, J MOL MED, V86, P875, DOI 10.1007/s00109-008-0356-9; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vijayaragavan K, 2009, CELL STEM CELL, V4, P248, DOI 10.1016/j.stem.2008.12.011; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	38	69	72	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					24	36		10.1016/j.stem.2011.06.002	http://dx.doi.org/10.1016/j.stem.2011.06.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726831	Bronze			2022-12-25	WOS:000293157000007
J	Ultanir, SK; Hertz, NT; Li, GN; Ge, WP; Burlingame, AL; Pleasure, SJ; Shokat, KM; Jan, LY; Jan, YN				Ultanir, Sila K.; Hertz, Nicholas T.; Li, Guangnan; Ge, Woo-Ping; Burlingame, Alma L.; Pleasure, Samuel J.; Shokat, Kevan M.; Jan, Lily Yeh; Jan, Yuh-Nung			Chemical Genetic Identification of NDR1/2 Kinase Substrates AAK1 and Rabin8 Uncovers Their Roles in Dendrite Arborization and Spine Development	NEURON			English	Article							DROSOPHILA SENSORY NEURONS; CLATHRIN-MEDIATED ENDOCYTOSIS; ADAPTER-ASSOCIATED KINASE; PROTEIN-KINASE; SIGNALING PATHWAY; AMPA RECEPTORS; PHOSPHORYLATION; MORPHOGENESIS; TRAFFICKING; GROWTH	Dendrite arborization and synapse formation are essential for wiring the neural circuitry. The evolutionarily conserved NDR1/2 kinase pathway, important for polarized growth from yeast to mammals, controls dendrite growth and morphology in the worm and fly. The function of NDR1/2 in mammalian neurons and their downstream effectors were not known. Here we show that the expression of dominant negative (kinase-dead) NDR1/2 mutants or siRNA increase dendrite length and proximal branching of mammalian pyramidal neurons in cultures and in vivo, whereas the expression of constitutively active NDR1/2 has the opposite effect. Moreover, NDR1/2 contributes to dendritic spine development and excitatory synaptic function. We further employed chemical genetics and identified NDR1/2 substrates in the brain, including two proteins involved in intracellular vesicle trafficking: AAK1 (AP-2 associated kinase) and Rabin8, a GDP/GTP exchange factor (GEF) of Rab8 GTPase. We finally show that AAK1 contributes to dendrite growth regulation, and Rabin8 regulates spine development.	[Ultanir, Sila K.; Hertz, Nicholas T.; Ge, Woo-Ping; Shokat, Kevan M.; Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Ultanir, Sila K.; Ge, Woo-Ping; Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; [Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA; [Hertz, Nicholas T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Li, Guangnan; Pleasure, Samuel J.] Univ Calif San Francisco, Program Dev Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Li, Guangnan; Pleasure, Samuel J.] Univ Calif San Francisco, Program Neurosci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Li, Guangnan; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ultanir, SK (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	sila.ultanir@gmail.com; yuhnung.jan@ucsf.edu		Ultanir, Sila/0000-0001-5745-3957; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Hertz, Nicholas/0000-0002-6527-6898	National Institutes of Health (NIH) [NCRR RR015804, NCRR RR001614, NCRR01614, R37NS040929, 5R01MH084234, RO1EB001987]; Howard Hughes Medical Institute; National Alliance of Schizophrenia and Depression (NARSAD); Human Frontiers Science Programfellowship; Genentech; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR015804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077694, R01MH084234, R01MH066084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Alliance of Schizophrenia and Depression (NARSAD); Human Frontiers Science Programfellowship(Human Frontier Science Program); Genentech(Roche HoldingGenentech); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Mark Wessels, Peter Soba, and Hye-Young Lee for technical help and Chao Zhang for the valuable suggestion of kinase activation mutations. We thank Jon Trinidad for advice on phosphoproteomics and David Maltby for mass spectrometer instrumentation advice. We thank Jan and Shokat lab members for discussion and critical reading of the manuscript. Mass spectrometry was made possible by National Institutes of Health (NIH) grants (NCRR RR015804 and NCRR RR001614). Financial support for the purchase of the Linear Trap Quadrupole (LTQ)Velos Orbitrap mass spectrometer was provided by Howard Hughes Medical Institute and an NIH grant (NCRR01614 to A.L.B.). This work was supported by the National Alliance of Schizophrenia and Depression (NARSAD) Young Investigator Award (to S.K.U.), NARSAD Distinguished Investigator Award (to Y.N.J.), Human Frontiers Science Programfellowship (to W.P.G.), NIH grants (R37NS040929 and 5R01MH084234 to Y.N.J.;RO1EB001987 to K.M.S.), and Genentech predoctoral fellowship (to N.T.H.). K.M.S., L.Y.J., and Y.N.J. are investigators for the Howard Hughes Medical Institute.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cong JL, 2001, DEVELOPMENT, V128, P2793; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Fiala JC, 1998, J NEUROSCI, V18, P8900; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Geng W, 2000, GENETICS, V156, P1817; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Gupta-Rossi N, 2011, J BIOL CHEM, V286, P18720, DOI 10.1074/jbc.M110.190769; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jansen JM, 2009, CURR BIOL, V19, P2114, DOI 10.1016/j.cub.2009.10.071; Koike-Kumagai M, 2009, EMBO J, V28, P3879, DOI 10.1038/emboj.2009.312; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Kuai LT, 2011, CHEM BIOL, V18, P891, DOI 10.1016/j.chembiol.2011.03.017; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kurischko C, 2008, MOL BIOL CELL, V19, P5559, DOI 10.1091/mbc.E08-05-0455; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Stegert MR, 2004, J BIOL CHEM, V279, P23806, DOI 10.1074/jbc.M402472200; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stork O, 2004, J BIOL CHEM, V279, P45773, DOI 10.1074/jbc.M403552200; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Yang WK, 2011, NEURON, V72, P285, DOI 10.1016/j.neuron.2011.08.028; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	59	90	92	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1127	1142		10.1016/j.neuron.2012.01.019	http://dx.doi.org/10.1016/j.neuron.2012.01.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445341	Bronze, Green Accepted			2022-12-25	WOS:000301998700011
J	Zhou, J; Gennatas, ED; Kramer, JH; Miller, BL; Seeley, WW				Zhou, Juan; Gennatas, Efstathios D.; Kramer, Joel H.; Miller, Bruce L.; Seeley, William W.			Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome	NEURON			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PARKINSONS-DISEASE; BETA-AMYLOIDOSIS; TRANSMISSION; CONNECTIVITY; TRANSPORT; NEURONS; HUBS	Neurodegenerative diseases target large-scale neural networks. Four competing mechanistic hypotheses have been proposed to explain network-based disease patterning: nodal stress, transneuronal spread, trophic failure, and shared vulnerability. Here, we used task-free fMRI to derive the healthy intrinsic connectivity patterns seeded by brain regions vulnerable to any of five distinct neurodegenerative diseases. These data enabled us to investigate how intrinsic connectivity in health predicts region-by-region vulnerability to disease. For each illness, specific regions emerged as critical network "epicenters" whose normal connectivity profiles most resembled the disease-associated atrophy pattern. Graph theoretical analyses in healthy subjects revealed that regions with higher total connectional flow and, more consistently, shorter functional paths to the epicenters, showed greater disease-related vulnerability. These findings best fit a transneuronal spread model of network-based vulnerability. Molecular pathological approaches may help clarify what makes each epicenter vulnerable to its targeting disease and how toxic protein species travel between networked brain structures.	[Zhou, Juan; Gennatas, Efstathios D.; Kramer, Joel H.; Miller, Bruce L.; Seeley, William W.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Seeley, WW (corresponding author), Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA.	wseeley@memory.ucsf.edu		Zhou, Juan/0000-0002-0180-8648; Gennatas, Efstathios/0000-0001-9280-3609	National Institute of Aging (NIA) [AG19724, AG1657303]; Larry L. Hillblom Foundation; John Douglas French Alzheimer Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL INSTITUTE ON AGING [P01AG019724, P50AG016573, P50AG023501] Funding Source: NIH RePORTER	National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Larry L. Hillblom Foundation; John Douglas French Alzheimer Foundation; Consortium for Frontotemporal Dementia Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Aging (NIA grants AG19724 and AG1657303 to B.L.M. and W.W.S.), the Larry L. Hillblom Foundation (W.W.S. and J.H.K.), and the John Douglas French Alzheimer Foundation (W.W.S.), and the Consortium for Frontotemporal Dementia Research. We thank our research participants and their families for contributing to neurodegeneration research.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; BAKER HF, 1993, INT J EXP PATHOL, V74, P441; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kim EJ, 2005, BRAIN, V128, P1790, DOI 10.1093/brain/awh539; Kim EJ, 2012, CEREB CORTEX, V22, P251, DOI 10.1093/cercor/bhr004; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Mesulam M, 2012, NEUROIMAGE, V62, P2182, DOI 10.1016/j.neuroimage.2011.12.033; Miller B.L., 2009, BEHAV NEUROLOGY DEME; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1984, NEW ENGL J MED, V310, P661, DOI 10.1056/NEJM198403083101021; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SAPER CB, 1987, NEUROSCIENCE, V23, P389, DOI 10.1016/0306-4522(87)90063-7; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Scheinin NM, 2009, NEUROLOGY, V73, P1186, DOI 10.1212/WNL.0b013e3181bacf1b; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weintraub S., 1996, LA DEMENCE POURQUOI, P75; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	48	457	465	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 22	2012	73	6					1216	1227		10.1016/j.neuron.2012.03.004	http://dx.doi.org/10.1016/j.neuron.2012.03.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445348	Green Accepted, Bronze			2022-12-25	WOS:000301998700018
J	Ma, DK; Vozdek, R; Bhatla, N; Horvitz, HR				Ma, Dengke K.; Vozdek, Roman; Bhatla, Nikhil; Horvitz, H. Robert			CYSL-1 Interacts with the O-2-Sensing Hydroxylase EGL-9 to Promote H2S-Modulated Hypoxia-Induced Behavioral Plasticity in C. elegans	NEURON			English	Article							O-ACETYLSERINE SULFHYDRYLASE; CYSTATHIONINE BETA-SYNTHASE; CAENORHABDITIS-ELEGANS; HYDROGEN-SULFIDE; INDUCIBLE FACTOR; SERINE ACETYLTRANSFERASE; GUANYLATE CYCLASES; ACTIVE-SITE; OXYGEN; CYSTEINE	The C. elegans HIF-1 proline hydroxylase EGL-9 functions as an O-2 sensor in an evolutionarily conserved pathway for adaptation to hypoxia. H2S accumulates during hypoxia and promotes HIF-1 activity, but how H2S signals are perceived and transmitted to modulate HI F-1 and animal behavior is unknown. We report that the experience of hypoxia modifies a C. elegans locomotive behavioral response to O-2 through the EGL-9 pathway. From genetic screens to identify novel regulators of EGL-9-mediated behavioral plasticity, we isolated mutations of the gene cysl-1, which encodes a C. elegans homolog of sulfhydrylases/cysteine synthases. Hypoxia-dependent behavioral modulation and H2S-induced HIF-1 activation require the direct physical interaction of CYSL-1 with the EGL-9 C terminus. Sequestration of EGL-9 by CYSL-1 and inhibition of EGL-9-mediated hydroxylation by hypoxia together promote neuronal HIF-1 activation to modulate behavior. These findings demonstrate that CYSL-1 acts to transduce signals from H2S to EGL-9 to regulate O-2-dependent behavioral plasticity in C. elegans.	[Ma, Dengke K.; Bhatla, Nikhil; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Ma, Dengke K.; Bhatla, Nikhil; Horvitz, H. Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Vozdek, Roman] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12808 2, Czech Republic; [Vozdek, Roman] Gen Univ Hosp Prague, Prague 12808 2, Czech Republic	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Charles University Prague; General University Hospital Prague	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu		Vozdek, Roman/0000-0001-7691-152X	NIH [GM24663]; Grant Agency of Charles University, Prague, Czech Republic [21709]; Charles University [MSM0021620806]; National Science Foundation; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024663, R37GM024663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Agency of Charles University, Prague, Czech Republic(Czech Republic Government); Charles University; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jo Anne Powell-Coffman, Yuichi lino, Rene Garcia, Michael Hengartner, Mark Roth, Andy Fire, and Erik Jorgensen for reagents; the Caenorhabditis Genetics Center for strains; Na An, Rita Droste, and Tove Ljungars for technical assistance; Ales Hnizda, Jakub Knit, and Milan Kodicek for help with characterization of purified CYSL-1; Viktor Kozich for helpful discussion; and Shunji Nakano, Takashi Hirose, Nick Paquin, Howard Chang, and Shuo Luo for comments. This work was supported by grant GM24663 to H.R.H from the NIH. R.V. was supported by grant No. 21709 from Grant Agency of Charles University, Prague, Czech Republic and by the Research Project of Charles University No. MSM0021620806. H.R.H. is an Investigator of the Howard Hughes Medical Institute and the David H. Koch Professor of Biology at MIT. N.B is supported by a National Science Foundation Graduate Research Fellowship. D.K.M. is supported by a Helen Hay Whitney Foundation postdoctoral fellowship.	Aitken SM, 2011, BBA-PROTEINS PROTEOM, V1814, P1511, DOI 10.1016/j.bbapap.2011.03.006; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Budde MW, 2011, GENETICS, V189, P521, DOI 10.1534/genetics.111.129841; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Chang AJ, 2008, P NATL ACAD SCI USA, V105, P7321, DOI 10.1073/pnas.0802164105; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; JORGENSEN EM, 1997, C ELEGANS, V2, P769; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liu XH, 2010, BIOL PHARM BULL, V33, P1550, DOI 10.1248/bpb.33.1550; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mozzarelli A, 2011, BBA-PROTEINS PROTEOM, V1814, P1497, DOI 10.1016/j.bbapap.2011.04.011; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; ONO BI, 1994, YEAST, V10, P333, DOI 10.1002/yea.320100306; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; Quaegebeur A, 2010, CURR TOP MICROBIOL, V345, P71, DOI 10.1007/82_2010_83; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Ruvinsky I, 2007, DEV BIOL, V302, P617, DOI 10.1016/j.ydbio.2006.09.014; Salsi E, 2010, J BIOL CHEM, V285, P12813, DOI 10.1074/jbc.M109.075762; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shao ZY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001075; Shao ZY, 2009, GENETICS, V183, P821, DOI 10.1534/genetics.109.107284; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shen C, 2006, GENETICS, V174, P1205, DOI 10.1534/genetics.106.063594; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; TRENT C, 1983, GENETICS, V104, P619; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Wirtz M, 2005, PHOTOSYNTH RES, V86, P345, DOI 10.1007/s11120-005-8810-9; Wirtz M, 2010, AMINO ACIDS, V39, P1077, DOI 10.1007/s00726-010-0694-0; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	63	64	86	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 8	2012	73	5					925	940		10.1016/j.neuron.2011.12.037	http://dx.doi.org/10.1016/j.neuron.2011.12.037			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405203	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000301558600008
J	Hall, CJ; Flores, MV; Oehlers, SH; Sanderson, LE; Lam, EY; Crosier, KE; Crosier, PS				Hall, Christopher J.; Flores, Maria Vega; Oehlers, Stefan H.; Sanderson, Leslie E.; Lam, Enid Y.; Crosier, Kathryn E.; Crosier, Philip S.			Infection-Responsive Expansion of the Hematopoietic Stem and Progenitor Cell Compartment in Zebrafish Is Dependent upon Inducible Nitric Oxide	CELL STEM CELL			English	Article							C/EBP-BETA; EMERGENCY GRANULOPOIESIS; AORTIC ENDOTHELIUM; BLOOD PROGENITORS; BONE-MARROW; EXPRESSION; INFLAMMATION; MECHANISMS; LEUKOCYTES; BINDING	Hematopoietic stem cells (HSCs) are rare multipotent cells that contribute to all blood lineages. During inflammatory stress, hematopoietic stem and progenitor cells (HSPCs) can be stimulated to proliferate and differentiate into the required immune cell lineages. Manipulating signaling pathways that alter HSPC capacity holds great promise in the treatment of hematological malignancies. To date, signaling pathways that influence HSPC capacity, in response to hematopoietic stress, remain largely unknown. Using a zebrafish model of demand-driven granulopoiesis to explore the HSPC response to infection, we present data supporting a model where the zebrafish ortholog of the cytokine-inducible form of nitric oxide synthase (iNOS/NOS2) Nos2a acts downstream of the transcription factor C/ebp beta to control expansion of HSPCs following infection. These results provide new insights into the reactive capacity of HSPCs and how the blood system is "fine-tuned" in response to inflammatory stress.	[Hall, Christopher J.; Flores, Maria Vega; Oehlers, Stefan H.; Sanderson, Leslie E.; Lam, Enid Y.; Crosier, Kathryn E.; Crosier, Philip S.] Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Auckland 1, New Zealand	University of Auckland	Crosier, PS (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Private Bag 92019, Auckland 1, New Zealand.	ps.crosier@auckland.ac.nz	Sanderson, Leslie/GZG-9357-2022; Oehlers, Stefan/L-5341-2019	Sanderson, Leslie/0000-0002-8026-406X; Oehlers, Stefan/0000-0003-0260-672X; Lam, Enid Yi Ni/0000-0001-5843-7836; Hall, Chris/0000-0001-6473-7720	Ministry of Science & Innovation, New Zealand	Ministry of Science & Innovation, New Zealand	We thank Annie Chien, Sophie Wicker, Pauline Misa, Alisha Malik, and Alhad Mahagaonkar for excellent technical assistance. We also thank Nick Trede and Len Zon for supplying reporter lines and Graham Lieschke for supplying probe templates. Funding for this work was provided by a grant awarded to P.C. from the Ministry of Science & Innovation, New Zealand.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Clay H, 2005, ZEBRAFISH, V2, P105, DOI 10.1089/zeb.2005.2.105; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Guo Z, 2003, FASEB J, V17, P1718, DOI 10.1096/fj.02-1172fje; Guthrie SM, 2005, BLOOD, V105, P1916, DOI 10.1182/blood-2004-09-3415; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hall Chris, 2009, V546, P255, DOI 10.1007/978-1-60327-977-2_16; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KASTAN MB, 1989, BLOOD, V73, P1444; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Krasnov P, 2008, MOL MED, V14, P141, DOI 10.2119/2007-00011.Krasnov; Krstic A, 2009, GROWTH FACTORS, V27, P79, DOI 10.1080/08977190902757153; Lam EYN, 2010, BLOOD, V116, P909, DOI 10.1182/blood-2010-01-264382; Lam EYN, 2009, BLOOD, V113, P1241, DOI 10.1182/blood-2008-04-149898; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lepiller S, 2007, FREE RADICAL BIO MED, V43, P619, DOI 10.1016/j.freeradbiomed.2007.05.025; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Lyons SE, 2001, BLOOD, V97, P2611, DOI 10.1182/blood.V97.9.2611; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Michurina T, 2004, MOL THER, V10, P241, DOI 10.1016/j.ymthe.2004.05.030; Motoyoshi K, 1998, INT J HEMATOL, V67, P109; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Rezzoug F, 2008, J IMMUNOL, V180, P49, DOI 10.4049/jimmunol.180.1.49; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Teng XW, 2002, CIRC RES, V90, P125, DOI 10.1161/hh0202.103647; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Willett CE, 2001, DEV DYNAM, V222, P694, DOI 10.1002/dvdy.1223; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630	48	90	91	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					198	209		10.1016/j.stem.2012.01.007	http://dx.doi.org/10.1016/j.stem.2012.01.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305569	Bronze			2022-12-25	WOS:000300272100012
J	Li, KX; Lu, YM; Xu, ZH; Zhang, J; Zhu, JM; Zhang, JM; Cao, SX; Chen, XJ; Chen, Z; Luo, JH; Duan, SM; Li, XM				Li, Ke-Xin; Lu, Ying-Mei; Xu, Zheng-Hao; Zhang, Jing; Zhu, Jun-Ming; Zhang, Jian-Ming; Cao, Shu-Xia; Chen, Xiao-Juan; Chen, Zhong; Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming			Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy	NATURE NEUROSCIENCE			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; LONG-TERM POTENTIATION; PRIMARY VISUAL-CORTEX; GABAERGIC INTERNEURONS; POTASSIUM CHANNELS; NEURAL DEVELOPMENT; TYROSINE KINASE; NMDA RECEPTORS; K+ CHANNELS; ERBB4	Dysfunction of fast-spiking, parvalbumin-positive (FS-PV) interneurons is implicated in the pathogenesis of epilepsy. ErbB4, a key Neuregulin 1 (NRG1) receptor, is mainly expressed in this type of interneurons, and recent studies suggest that parvalbumin interneurons are a major target of NRG1-ErbB4 signaling in adult brain. Thus, we hypothesized that downregulation of NRG1-ErbB4 signaling in FS-PV interneurons is involved in epilepsy. We found that NRG1, through its receptor ErbB4, increased the intrinsic excitability of FS-PV interneurons. This effect was mediated by increasing the near-threshold responsiveness and decreasing the voltage threshold for action potentials through Kv1.1, a voltage-gated potassium channel. Furthermore, mice with specific deletion of ErbB4 in parvalbumin interneurons were more susceptible to pentylenetetrazole- and pilocarpine-induced models of epilepsy. Exogenous NRG1 delayed the onset of seizures and decreased their incidence and stage. Moreover, expression of ErbB4, but not ErbB2, was downregulated in human epileptogenic tissue. Together, our findings suggest that NRG1-ErbB4 signaling contributes to human epilepsy through regulating the excitability of FS-PV interneurons. ErbB4 may be a new target for anticonvulsant drugs in epilepsy.	[Li, Ke-Xin; Lu, Ying-Mei; Xu, Zheng-Hao; Zhang, Jing; Cao, Shu-Xia; Chen, Xiao-Juan; Chen, Zhong; Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Jun-Ming; Zhang, Jian-Ming] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, XM (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China.	lixm@zju.edu.cn	Luo, jian/HGE-7331-2022	Xu, Zhenghao/0000-0003-0033-525X; Li, Ke-Xin/0000-0003-3879-294X	National Natural Science Foundation of China [30970916, 31070926, 30725047]; state Ministry of Science and Technology of China [2010CB912004, 2010CB912002]; Zhejiang Provincial Natural Science Foundation of China [Z2090127]; Foundation for the Author of National Excellent Doctoral Dissertation of China [200937]; Science Foundation of Chinese Universities [JD09023]; Zhejiang Provincial Qianjiang Talent Plan [2010R10057]; Fundamental Research Funds for the Central Universities [2011XZZX002]; Zhejiang Province Key Technology Innovation Team [2010R50049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); state Ministry of Science and Technology of China(Ministry of Science and Technology, China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Science Foundation of Chinese Universities; Zhejiang Provincial Qianjiang Talent Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Province Key Technology Innovation Team	We thank L. Mei (Georgia Health Sciences University) for advice. We are grateful to T.M. Gao (Southern Medical University), Z.J. Huang (Cold Spring Harbor), X.H. Zhang (Institute of Neuroscience, Chinese Academy of Sciences) and L. Bao (Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences) for providing reagents and/or mice. We express our gratitude to the subjects and their families for their participation. We also thank T.M. Gao and I.C. Bruce for critical reading of this manuscript, and Q.L. Miao for technical assistance. This work was supported by grants from the National Natural Science Foundation of China (30970916, 31070926 and 30725047), the Major Research Program from the state Ministry of Science and Technology of China (2010CB912004, 2010CB912002), the Zhejiang Provincial Natural Science Foundation of China (Z2090127), the Foundation for the Author of National Excellent Doctoral Dissertation of China (200937), the Science Foundation of Chinese Universities (JD09023), the Zhejiang Provincial Qianjiang Talent Plan (2010R10057), the Fundamental Research Funds for the Central Universities (2011XZZX002) and Zhejiang Province Key Technology Innovation Team (2010R50049).	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cook KK, 2002, J BIOL CHEM, V277, P13268, DOI 10.1074/jbc.M108898200; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Dreyfus J, 1998, REMARKABLE MED HAS B; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lau D, 2000, J NEUROSCI, V20, P9071; Law AJ, 2004, NEUROSCIENCE, V127, P125, DOI 10.1016/j.neuroscience.2004.04.026; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Liguori R, 2001, MUSCLE NERVE, V24, P630, DOI 10.1002/mus.1048; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Perucca E, 2007, LANCET, V370, P313, DOI 10.1016/S0140-6736(07)61149-0; Pitcher GM, 2011, NAT MED, V17, P470, DOI 10.1038/nm.2315; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; WANG H, 1994, J NEUROSCI, V14, P4588; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	49	122	125	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					267	273		10.1038/nn.3006	http://dx.doi.org/10.1038/nn.3006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22158511				2022-12-25	WOS:000299603500018
J	Ahmad, M; Polepalli, JS; Goswami, D; Yang, XF; Kaeser-Woo, YJ; Sudhof, TC; Malenka, RC				Ahmad, Mohiuddin; Polepalli, Jai S.; Goswami, Debanjan; Yang, Xiaofei; Kaeser-Woo, Yea Jin; Suedhof, Thomas C.; Malenka, Robert C.			Postsynaptic Complexin Controls AMPA Receptor Exocytosis during LTP	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC VESICLE EXOCYTOSIS; CENTRAL-NERVOUS-SYSTEM; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; DEPENDENT EXOCYTOSIS; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; SYNAPTOTAGMIN-I; CA2+ SENSORS	Long-term potentiation (LTP) is a compelling synaptic correlate of learning and memory. LTP induction requires NMDA receptor (NMDAR) activation, which triggers SNARE-dependent exocytosis of AMPA receptors (AMPARs). However, the molecular mechanisms mediating AMPAR exocytosis induced by NMDAR activation remain largely unknown. Here, we show that complexin, a protein that regulates neurotransmitter release via binding to SNARE complexes, is essential for AMPAR exocytosis during LIP but not for the constitutive AMPAR exocytosis that maintains basal synaptic strength. The regulated postsynaptic AMPAR exocytosis during LIP requires binding of complexin to SNARE complexes. In hippocampal neurons, presynaptic complexin acts together with synaptotagmin-1 to mediate neurotransmitter release. However, postsynaptic synaptotagmin-1 is not required for complexin-dependent AMPAR exocytosis during LIP. These results suggest a complexin-dependent molecular mechanism for regulating AMPAR delivery to synapses, a mechanism that is surprisingly similar to presynaptic exocytosis but controlled by regulators other than synaptotagmin-1.	[Ahmad, Mohiuddin; Polepalli, Jai S.; Goswami, Debanjan; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Yang, Xiaofei; Kaeser-Woo, Yea Jin; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Ahmad, Mohiuddin/H-7295-2015	Ahmad, Mohiuddin/0000-0002-0976-9620; Ahmad, Mohiuddin/0000-0001-9123-0618; Polepalli, Jai/0000-0003-2004-2163	NIH [MH06334, P50 MH0864]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, P50MH086403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Daniela Iona Ion and Scarlett Fang for technical assistance, Sandra Jurado for contributing data, the Chen lab for providing neuronal cultures, and members of the Malenka and Sudhof labs for constructive comments and help during the course of the experiments. M.A. and J.S.P. performed electrophysiological recordings from acute slices and stereotaxic injections. D.G. performed AMPAR surface expression assays in hippocampal cultures. M.A. constructed plasmids, generated lentivirus, and performed western blot analyses and colocalization imaging assays. X.Y. performed electrophysiological assays in hippocampal cultures. Y.J.K.-W. designed shCpx2 and Venus-Cpx1. MA., J.S.P., TC.S., and R.C.M. wrote the manuscript. All authors reviewed the paper and edited it. R.C.M. and T.C.S. directed and coordinated the project. Supported by NIH grants MH06334 (to R.C.M.) and P50 MH0864 (R.C.M. and T.C.S.).	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Huang GZ, 2000, JPN J PHARMACOL, V84, P179, DOI 10.1254/jjp.84.179; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Takahashi S, 1999, EUR J NEUROSCI, V11, P2359, DOI 10.1046/j.1460-9568.1999.00652.x; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Yamada M, 1999, NEUROSCIENCE, V93, P7, DOI 10.1016/S0306-4522(99)00104-9; Yang XF, 2010, NEURON, V68, P907, DOI 10.1016/j.neuron.2010.11.001; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	48	90	93	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 26	2012	73	2					260	267		10.1016/j.neuron.2011.11.020	http://dx.doi.org/10.1016/j.neuron.2011.11.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284181	Bronze, Green Accepted			2022-12-25	WOS:000299761600008
J	Taniguchi, M; Carreira, MB; Smith, LN; Zirlin, BC; Neve, RL; Cowan, CW				Taniguchi, Makoto; Carreira, Maria B.; Smith, Laura N.; Zirlin, Benjamin C.; Neve, Rachael L.; Cowan, Christopher W.			Histone Deacetylase 5 Limits Cocaine Reward through cAMP-Induced Nuclear Import	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; BEHAVIORAL-RESPONSES; TRANSCRIPTION FACTOR; EMOTIONAL STIMULI; ACTIN POLYMERIZATION; GENE-EXPRESSION; PHOSPHORYLATION; EXPORT; INHIBITION; ACTIVATION	Chromatin remodeling by histone deacetylases (HDACs) is a key mechanism regulating behavioral adaptations to cocaine use. We report here that cocaine and cyclic adenosine monophosphate (cAMP) signaling induce the transient nuclear accumulation of HDAC5 in rodent striatum. We show that cAMP-stimulated nuclear import of HDAC5 requires a signaling mechanism that involves transient, protein phosphatase 2A (PP2A)-dependent dephosphorylation of a Cdk5 site (S279) found within the HDAC5 nuclear localization sequence. Dephosphorylation of HDAC5 increases its nuclear accumulation, by accelerating its nuclear import rate and reducing its nuclear export rate. Importantly, we show that dephosphorylation of HDAC5 S279 in the nucleus accumbens suppresses the development, but not expression, of cocaine reward behavior in vivo. Together, our findings reveal a molecular mechanism by which cocaine regulates HDAC5 function to antagonize the rewarding impact of cocaine, likely by putting a brake on drug-stimulated gene expression that supports drug-induced behavioral changes.	[Taniguchi, Makoto; Carreira, Maria B.; Smith, Laura N.; Zirlin, Benjamin C.; Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Taniguchi, Makoto; Carreira, Maria B.; Smith, Laura N.; Zirlin, Benjamin C.; Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT)	Cowan, CW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	christopher.cowan@utsouthwestern.edu	Cowan, Christopher W/I-2497-2014; Smith, Laura/W-2716-2018	Smith, Laura/0000-0003-3687-3148; Taniguchi, Makoto/0000-0001-6356-2463	NIDA [T32 DA07290, F32 DA027265, DA008277, DA027664]; FRAXA Foundation; Whitehall Foundation; Simons Foundation; NEI [EY018207]; NATIONAL EYE INSTITUTE [R01EY018207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027664, P01DA008227, F32DA027265, T32DA007290] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); FRAXA Foundation; Whitehall Foundation; Simons Foundation; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank Darya Fakhretdinova, Katie Schaukowitch, Lindsey Williams, and Marissa Baumgardner for technical assistance, Dr. Li Van in Protein Chemistry Technology Center lab for mass spectrometry analysis, Dr. Shari Birnbaum in UTSW Department of Psychiatry Behavioral Phenotyping Core for assistance with CPP data analysis, Dr. Timothy McKinsey for generously sharing the P-S259 class Ila HDAC antibody, and Dr. James Bibb (UTSW) for advice on in vitro Cdk5 assays. We also acknowledge Dr. Eric Olson (UTSW) for sharing HDAC5 KO mice and Yong-Chao Ma (CMRC/Northwestern) for critical reading of the manuscript. L.N.S. was supported by fellowships from NIDA (T32 DA07290 and F32 DA027265) and the FRAXA Foundation. C.W.C. acknowledges the generous support of the Whitehall Foundation, the Simons Foundation (SFARI grant), NIDA (DA008277 and DA027664), and NEI (EY018207 and a research supplement for underrepresented minorities to M.B.C.).	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dietrich JB, 2012, SYNAPSE, V66, P61, DOI 10.1002/syn.20988; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; Host L, 2011, J PSYCHOPHARMACOL, V25, P222, DOI 10.1177/0269881109348173; Hui B, 2010, SAUDI MED J, V31, P389; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Kalivas Peter W, 2004, Curr Psychiatry Rep, V6, P347, DOI 10.1007/s11920-004-0021-0; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Self DW, 1998, J NEUROSCI, V18, P1848; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Sucharov CC, 2006, AM J PHYSIOL-CELL PH, V291, pC1029, DOI 10.1152/ajpcell.00059.2006; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193	39	86	89	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 12	2012	73	1					108	120		10.1016/j.neuron.2011.10.032	http://dx.doi.org/10.1016/j.neuron.2011.10.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243750	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000299446800011
J	Livneh, Y; Mizrahi, A				Livneh, Yoav; Mizrahi, Adi			Experience-dependent plasticity of mature adult-born neurons	NATURE NEUROSCIENCE			English	Article							OLFACTORY-BULB; SYNAPTIC PLASTICITY; CRITICAL PERIOD; NEUROGENESIS; BRAIN; SYNAPTOGENESIS	The adult olfactory bulb and hippocampus are continuously supplied with newborn neurons that are thought to possess a capacity for plasticity only at a young neuronal age, mainly during the early stages of integration into the network. We find that the two main types of adult-born neurons in the mouse olfactory bulb undergo experience-dependent plasticity long after maturation and integration, as evidenced by stabilization of synaptic turnover rates. Thus, the potential time window for plasticity of adult-born neurons extends well into maturity.	[Livneh, Yoav; Mizrahi, Adi] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Mizrahi, Adi] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mizrahi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	mizrahia@cc.huji.ac.il	Livneh, Yoav/AAA-4007-2021	Livneh, Yoav/0000-0002-0434-4201	European Research Council [203994]; ERA-NET [0398216]; Israel Academy of Sciences and Humanities	European Research Council(European Research Council (ERC)European Commission); ERA-NET; Israel Academy of Sciences and Humanities	We thank H. Spors (Max Planck Institute of Biophysics, Frankfurt, Germany) for the analysis software for the intrinsic signals. We thank Y. Adam for assistance with surgical procedures. We thank members of the Mizrahi laboratory and D. Nachmani for discussions and for commenting on the manuscript. This work was supported by European Research Council (203994) and ERA-NET (0398216) grants to A. M. Y. L. is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kelsch W, 2009, J NEUROSCI, V29, P11852, DOI 10.1523/JNEUROSCI.2406-09.2009; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Livneh Y, 2009, J NEUROSCI, V29, P86, DOI 10.1523/JNEUROSCI.4105-08.2009; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Mizrahi A, 2007, NAT NEUROSCI, V10, P444, DOI 10.1038/nn1875; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	15	44	47	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					26	28		10.1038/nn.2980	http://dx.doi.org/10.1038/nn.2980			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22081159				2022-12-25	WOS:000298414400010
J	Keller, LC; Cheng, L; Locke, CJ; Muller, M; Fetter, RD; Davis, GW				Keller, Lani C.; Cheng, Ling; Locke, Cody J.; Mueller, Martin; Fetter, Richard D.; Davis, Graeme W.			Glial-Derived Prodegenerative Signaling in the Drosophila Neuromuscular System	NEURON			English	Article							AXONAL-TRANSPORT; CELL-DEATH; SPECTRIN MUTATIONS; ACTIVATION; RECEPTOR; MITOCHONDRIA; DISRUPTION; MECHANISMS; APOPTOSIS; MODEL	We provide evidence for a prodegenerative, glial-derived signaling framework in the Drosophila neuromuscular system that includes caspase and mitochondria-dependent signaling. We demonstrate that Drosophila TNF-alpha (eiger) is expressed in a subset of peripheral glia, and the TNF-a receptor (TNFR), Wengen, is expressed in motoneurons. NMJ degeneration caused by disruption of the spectrin/ankyrin skeleton is suppressed by an eiger mutation or by eiger knockdown within a subset of peripheral glia. Loss of wengen in motoneurons causes a similar suppression providing evidence for glial-derived prodegenerative INF-alpha signaling. Neither JNK nor NFK kappa beta is required for prodegenerative signaling. However, we provide evidence for the involvement of both an initiator and effector caspase, Dronc and Dcp-1, and mitochondrial-dependent signaling. Mutations that deplete the axon and nerve terminal of mitochondria suppress degeneration as do mutations in Drosophila Bcl-2 (debcl), a mitochondria-associated protein, and Apaf-1 (dark), which links mitochondrial signaling with caspase activity in other systems.	[Keller, Lani C.; Cheng, Ling; Locke, Cody J.; Mueller, Martin; Fetter, Richard D.; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St,Rock Hall,4th Floor N, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu			NIH [NS047342, K12GM081266]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047342, R01NS059867] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH Grant NS047342 to G.W.D. and K12GM081266 to L.C.K.	Aggarwal BB, 2000, ANN RHEUM DIS, V59, P6; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Ayaz D, 2008, J NEUROSCI, V28, P6010, DOI 10.1523/JNEUROSCI.0101-08.2008; Babcock DT, 2009, CURR BIOL, V19, P799, DOI 10.1016/j.cub.2009.03.062; Banerjee S, 2008, J NEUROSCI RES, V86, P1189, DOI 10.1002/jnr.21574; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Doumanis J, 2007, CELL DEATH DIFFER, V14, P907, DOI 10.1038/sj.cdd.4402082; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gowing G, 2006, J NEUROSCI, V26, P11397, DOI 10.1523/JNEUROSCI.0602-06.2006; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Laundrie B, 2003, GENETICS, V165, P1881; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Massaro CM, 2009, J CELL BIOL, V187, P101, DOI 10.1083/jcb.200903166; McDonald ER, 2001, J BIOL CHEM, V276, P14939, DOI 10.1074/jbc.M100399200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pielage J, 2011, NEURON, V69, P1114, DOI 10.1016/j.neuron.2011.02.007; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Qin YW, 2008, NEUROCHEM RES, V33, P1077, DOI 10.1007/s11064-007-9552-1; Reyes NA, 2010, J CLIN INVEST, V120, P3673, DOI 10.1172/JCI42986; Richardson H, 2002, J IMMUNOL METHODS, V265, P21, DOI 10.1016/S0022-1759(02)00068-6; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Sevrioukov EA, 2007, GENESIS, V45, P184, DOI 10.1002/dvg.20279; Shah SB, 2009, NEUROBIOL DIS, V36, P11, DOI 10.1016/j.nbd.2009.05.016; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Weber U, 2000, DEVELOPMENT, V127, P3619; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yang CS, 2010, EMBO J, V29, P3196, DOI 10.1038/emboj.2010.191	49	41	41	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					760	775		10.1016/j.neuron.2011.09.031	http://dx.doi.org/10.1016/j.neuron.2011.09.031			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153373	Bronze, Green Accepted			2022-12-25	WOS:000297971100011
J	Domingos, AI; Vaynshteyn, J; Voss, HU; Ren, XY; Gradinaru, V; Zang, F; Deisseroth, K; de Araujo, IE; Friedman, J				Domingos, Ana I.; Vaynshteyn, Jake; Voss, Henning U.; Ren, Xueying; Gradinaru, Viviana; Zang, Feng; Deisseroth, Karl; de Araujo, Ivan E.; Friedman, Jeffrey			Leptin regulates the reward value of nutrient	NATURE NEUROSCIENCE			English	Article							SWEET TASTE; ORBITOFRONTAL CORTEX; WANTING FOOD; WEIGHT-LOSS; DOPAMINE; NEURONS; BRAIN; SUCROSE; RESTRICTION; CIRCUITRY	We developed an assay for quantifying the reward value of nutrient and used it to analyze the effects of metabolic state and leptin. In this assay, mice chose between two sippers, one of which dispensed water and was coupled to optogenetic activation of dopaminergic (DA) neurons and the other of which dispensed natural or artificial sweeteners. This assay measured the reward value of sweeteners relative to lick-induced optogenetic activation of DA neurons. Mice preferred optogenetic stimulation of DA neurons to sucralose, but not to sucrose. However, the mice preferred sucralose plus optogenetic stimulation versus sucrose. We found that food restriction increased the value of sucrose relative to sucralose plus optogenetic stimulation, and that leptin decreased it. Our data suggest that leptin suppresses the ability of sucrose to drive taste-independent DA neuronal activation and provide new insights into the mechanism of leptin's effects on food intake.	[Domingos, Ana I.; Vaynshteyn, Jake; Friedman, Jeffrey] Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; [Voss, Henning U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Ren, Xueying; de Araujo, Ivan E.] Yale Univ, Sch Med, JB Pierce Lab, New Haven, CT USA; [Ren, Xueying] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Gradinaru, Viviana; Zang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Friedman, Jeffrey] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Cornell University; Yale University; The John B Pierce Laboratory, Inc; Yale University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Rockefeller University	Friedman, J (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu	Ren, Xueying/AAA-9464-2020; Ren, Xueying/ABF-8967-2021	Ren, Xueying/0000-0002-6503-0425; De Araujo, Ivan/0000-0003-3081-3339; Domingos, Ana/0000-0002-7938-4814	Klarman Family Foundation for Eating Disorders (KFFfED); Fundacao para a Ciencia e Tecnologia (Portugal); US National Institutes of Health [DC009997, MH075957]; Gatsby Foundation; Defense Advanced Research Projects Agency; Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R37MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009997] Funding Source: NIH RePORTER	Klarman Family Foundation for Eating Disorders (KFFfED); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank F. Pestilli for helping with the bootstrap analysis. We thank the Klarman Family Foundation for Eating Disorders (KFFfED) for supporting this work. A.I.D. was supported by Fundacao para a Ciencia e Tecnologia (Portugal) and KFFfED. J.V. was supported by KFFfED. X.R. and I.E.d.A. were supported by US National Institutes of Health grant DC009997 to I.E.d.A. F.Z., V.G. and K.D. were supported by the US National Institutes of Health (grant MH075957), the Gatsby Foundation and Defense Advanced Research Projects Agency. H.U.V. was partially supported by the Nancy M. and Samuel C. Fleming Research Scholar Award in Intercampus Collaborations.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500; Cameron JD, 2008, PHYSIOL BEHAV, V94, P474, DOI 10.1016/j.physbeh.2008.02.014; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; Eric Walters D., 1991, SWEETENERS DISCOVERY; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; Finlayson G, 2007, NEUROSCI BIOBEHAV R, V31, P987, DOI 10.1016/j.neubiorev.2007.03.004; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2004, BEHAV BRAIN RES, V155, P319, DOI 10.1016/j.bbr.2004.05.021; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Glencoe C, 2002, GLENCOE CHEM MATTER; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Haley S, 2005, SWEETENER CONSUMPTIO, P1; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lewis SR, 2006, PHYSIOL BEHAV, V87, P595, DOI 10.1016/j.physbeh.2005.12.002; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lydall ES, 2010, PSYCHOPHARMACOLOGY, V209, P153, DOI 10.1007/s00213-010-1779-x; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; ROZIN P, 1980, INT J OBESITY, V4, P356; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Servant G, 2010, P NATL ACAD SCI USA, V107, P4746, DOI 10.1073/pnas.0911670107; Shigemura N, 2003, ARCH HISTOL CYTOL, V66, P253, DOI 10.1679/aohc.66.253; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Umabiki M, 2010, TOHOKU J EXP MED, V220, P267, DOI 10.1620/tjem.220.267; Ventura E.E., 2010, OBESITY SILVER SPRIN, V19, P687; WEIJNEN JAWM, 1989, PHYSIOL BEHAV, V46, P923, DOI 10.1016/0031-9384(89)90192-3; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	45	171	176	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1562	U92		10.1038/nn.2977	http://dx.doi.org/10.1038/nn.2977			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081158	Green Accepted			2022-12-25	WOS:000297546300016
J	Puente, N; Cui, YH; Lassalle, O; Lafourcade, M; Georges, F; Venance, L; Grandes, P; Manzoni, OJ				Puente, Nagore; Cui, Yihui; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Venance, Laurent; Grandes, Pedro; Manzoni, Olivier J.			Polymodal activation of the endocannabinoid system in the extended amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; BED NUCLEUS; ENDOGENOUS CANNABINOIDS; TRPV1; LOCALIZATION; ANANDAMIDE; RECEPTORS; SYNAPSES; CHANNELS; 2-ARACHIDONOYL-GLYCEROL	The reason why neurons synthesize more than one endocannabinoid (eCB) and how this is involved in the regulation of synaptic plasticity in a single neuron is not known. We found that 2-arachidonoylglycerol (2-AG) and anandamide mediate different forms of plasticity in the extended amygdala of rats. Dendritic L-type Ca2+ channels and the subsequent release of 2-AG acting on presynaptic CB1 receptors triggered retrograde short-term depression. Long-term depression was mediated by postsynaptic mGluR5-dependent release of anandamide acting on postsynaptic TRPV1 receptors. In contrast, 2-AG/CB1R-mediated retrograde signaling mediated both forms of plasticity in the striatum. These data illustrate how the eCB system can function as a polymodal signal integrator to allow the diversification of synaptic plasticity in a single neuron.	[Cui, Yihui; Venance, Laurent] Coll France, Ctr Interdisciplinary Res Biol, CNRS, INSERM,U1050,UMR 7241, F-75231 Paris, France; [Puente, Nagore; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] INSERM, U862, Bordeaux, France; [Puente, Nagore; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] Univ Bordeaux, Bordeaux, France; [Puente, Nagore; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain; [Puente, Nagore; Lassalle, Olivier; Manzoni, Olivier J.] INSERM, U901, F-13258 Marseille, France; [Puente, Nagore; Lassalle, Olivier] Univ Mediterranee UMR S901, Marseille, France; [Puente, Nagore; Lassalle, Olivier; Manzoni, Olivier J.] INMED, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Venance, L (corresponding author), Coll France, Ctr Interdisciplinary Res Biol, CNRS, INSERM,U1050,UMR 7241, F-75231 Paris, France.	laurent.venance@college-de-france.fr; pedro.grandes@ehu.es; olivier.manzoni@inserm.fr	Manzoni, Olivier/M-7899-2016; Grandes, Pedro/H-7494-2015; Lafourcade, Mathieu/GQZ-7267-2022; Grandes, Pedro/AAA-1627-2019; Puente, Nagore/H-7054-2015; Cui, Yihui/AAB-9328-2022; Venance, Laurent/E-5840-2016	Manzoni, Olivier/0000-0002-5579-6208; Grandes, Pedro/0000-0003-3947-4230; Puente, Nagore/0000-0003-0866-5747; Cui, Yihui/0000-0002-7362-6237; Lafourcade, Mathieu/0000-0001-6117-1194; GEORGES, Francois/0000-0002-2628-2638; Venance, Laurent/0000-0003-0738-1662	INSERM; Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie) [ANR-06-NEURO-043-01]; Region Aquitaine; Basque Country University; Basque Country Government [ANR-06-NEURO-043-01, GIC07/70-IT-432-07]; Ministerio de Ciencia e Innovacion [SAF2009-07065]; Neuroscience School of Paris; Agence National pour la Recherche Neurosciences "Mobil,"; "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN [RD07/0001/2001]; College de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie)(French National Research Agency (ANR)); Region Aquitaine(Region Nouvelle-Aquitaine); Basque Country University; Basque Country Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Neuroscience School of Paris; Agence National pour la Recherche Neurosciences "Mobil,"(French National Research Agency (ANR)); "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); College de France	The authors thank N. Stella, M. Sepers and P. Chavis for critical reading of the manuscript, and R. Martinez for invaluable help in setting up the Manzoni laboratory. Work in the Manzoni laboratory was supported by INSERM, Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie ANR-06-NEURO-043-01) and Region Aquitaine. N. P. was supported by Basque Country Government Postdoctoral grant BFI05.185 and by a Basque Country University grant for PhD Researcher's Specialization. P.G. was supported by Basque Country Government grant GIC07/70-IT-432-07, by Ministerio de Ciencia e Innovacion (SAF2009-07065) and by "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN, grant RD07/0001/2001. Y.C. was supported by the Neuroscience School of Paris, Agence National pour la Recherche Neurosciences "Mobil," INSERM and College de France.	Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; Di Marzo V, 2001, TRENDS PHARMACOL SCI, V22, P346, DOI 10.1016/S0165-6147(00)01712-0; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P594, DOI 10.1016/j.tips.2008.09.004; Dumont EC, 2004, J NEUROSCI, V24, P8198, DOI 10.1523/JNEUROSCI.0425-04.2004; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Gaetani S, 2009, INT REV NEUROBIOL, V85, P57, DOI 10.1016/S0074-7742(09)85005-8; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Jalabert M, 2009, PROG NEURO-PSYCHOPH, V33, P1336, DOI 10.1016/j.pnpbp.2009.07.010; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Karbarz MJ, 2009, ANESTH ANALG, V108, P316, DOI 10.1213/ane.0b013e31818c7cbd; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Massi L, 2008, J NEUROSCI, V28, P10496, DOI 10.1523/JNEUROSCI.2291-08.2008; Mato S, 2008, NEUROPHARMACOLOGY, V54, P87, DOI 10.1016/j.neuropharm.2007.04.014; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Nyilas R, 2009, EUR J NEUROSCI, V29, P1964, DOI 10.1111/j.1460-9568.2009.06751.x; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puente N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008869; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2001, J NEUROSCI, V21, P109, DOI 10.1523/JNEUROSCI.21-01-00109.2001; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Rubino T, 2008, CEREB CORTEX, V18, P1292, DOI 10.1093/cercor/bhm161; Starowicz K, 2008, CURR PHARM DESIGN, V14, P42; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	125	125	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1542	U67		10.1038/nn.2974	http://dx.doi.org/10.1038/nn.2974			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057189				2022-12-25	WOS:000297546300013
J	Adhikari, A; Topiwala, MA; Gordon, JA				Adhikari, Avishek; Topiwala, Mihir A.; Gordon, Joshua A.			Single Units in the Medial Prefrontal Cortex with Anxiety-Related Firing Patterns Are Preferentially Influenced by Ventral Hippocampal Activity	NEURON			English	Article							ELEVATED-PLUS-MAZE; PROBE BURYING TESTS; SPATIAL MEMORY TASK; EXCITOTOXIC LESIONS; DOUBLE DISSOCIATION; SOCIAL-INTERACTION; FEAR EXPRESSION; ANIMAL-MODEL; RAT; RECEPTOR	The medial prefrontal cortex (mPFC) and ventral hippocampus (vHPC) functionally interact during innate anxiety tasks. To explore the consequences of this interaction, we examined task-related firing of single units from the mPFC of mice exploring standard and modified versions of the elevated plus maze (EPM), an innate anxiety paradigm. Hippocampal local field potentials (LFPs) were simultaneously monitored. The population of mPFC units distinguished between safe and aversive locations within the maze, regardless of the nature of the anxiogenic stimulus. Strikingly, mPFC units with stronger task-related activity were more strongly coupled to theta-frequency activity in the vHPC LFP. Lastly, task-related activity was inversely correlated with behavioral measures of anxiety. These results clarify the role of the vHPC-mPFC circuit in innate anxiety and underscore how specific inputs may be involved in the generation of behaviorally relevant neural activity within the mPFC.	[Topiwala, Mihir A.; Gordon, Joshua A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Adhikari, Avishek] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; [Gordon, Joshua A.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	jg343@columbia.edu	Adhikari, Avishek/N-1284-2015; Adhikari, Avishek/AAF-4444-2021; Adhikari, Avishek/A-3339-2012	Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211	NIMH [K08 MH098623, R01 MH081958]; Hope for Depression Research Foundation; IMHRO Rising Star Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081968] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation; IMHRO Rising Star Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E.B. Likhtik, P.T. O'Neill, R. Hen, and T. Sigurdsson for comments on the manuscript, as well as H. Moore and the members of the Gordon and Hen labs for helpful discussions of the experimental design and analysis. This work was supported by grants to J.A.G. from the NIMH (K08 MH098623 and R01 MH081958) and the Hope for Depression Research Foundation. J.A.G. is also the recipient of the IMHRO Rising Star Award. A.A. designed and performed the experiments, conducted the data analysis, and wrote the paper. M.A.T. assisted in performing the experiments and did the histology. J.A.G. designed the experiments, supervised the performance of the experiments and data analysis, and wrote the paper.	Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Birrell JM, 2000, J NEUROSCI, V20, P4320; Broersen LM, 1999, NEUROSCIENCE, V94, P47, DOI 10.1016/S0306-4522(99)00312-7; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Burton BG, 2009, BEHAV BRAIN RES, V199, P222, DOI 10.1016/j.bbr.2008.11.045; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Deacon RMJ, 2003, BEHAV BRAIN RES, V139, P139, DOI 10.1016/S0166-4328(02)00225-5; Farovik A, 2008, J NEUROSCI, V28, P13428, DOI 10.1523/JNEUROSCI.3662-08.2008; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gemmell C, 2002, BEHAV BRAIN RES, V133, P1; Gonzalez LE, 2000, BRAIN RES, V887, P7, DOI 10.1016/S0006-8993(00)02931-0; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; KESNER RP, 1987, NEUROPSYCHOLOGIA, V25, P653, DOI 10.1016/0028-3932(87)90056-X; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Klein J, 2010, BEHAV BRAIN RES, V213, P73, DOI 10.1016/j.bbr.2010.04.036; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; KOLB B, 1974, J COMP PHYSIOL PSYCH, V87, P772, DOI 10.1037/h0036970; Lacroix L, 2000, BEHAV NEUROSCI, V114, P1119, DOI 10.1037//0735-7044.114.6.1119; Lisboa SF, 2010, NEUROSCIENCE, V171, P760, DOI 10.1016/j.neuroscience.2010.09.048; Parent MA, 2010, CEREB CORTEX, V20, P393, DOI 10.1093/cercor/bhp108; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Peters YM, 2005, SYNAPSE, V56, P74, DOI 10.1002/syn.20129; Pratt WE, 2001, BEHAV BRAIN RES, V123, P165, DOI 10.1016/S0166-4328(01)00204-2; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Shah AA, 2004, BRAIN RES, V1028, P112, DOI 10.1016/j.brainres.2004.08.061; Shah AA, 2004, BRAIN RES, V996, P31, DOI 10.1016/j.brainres.2003.10.015; Shah AA, 2003, BRAIN RES, V969, P183, DOI 10.1016/S0006-8993(03)02299-6; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Stern CAJ, 2010, NEUROSCIENCE, V170, P214, DOI 10.1016/j.neuroscience.2010.06.080; Sullivan RM, 2002, BRAIN RES, V927, P69, DOI 10.1016/S0006-8993(01)03328-5; Swerdlow NR, 1995, PSYCHOPHARMACOLOGY, V122, P27, DOI 10.1007/BF02246438; Tait D, 2009, PSYCHOPHARMACOLOGY, V202, P295, DOI 10.1007/s00213-008-1364-8; Taxidis J, 2010, BIOL CYBERN, V102, P327, DOI 10.1007/s00422-010-0370-1; Verwer RWH, 1997, HIPPOCAMPUS, V7, P397, DOI 10.1002/(SICI)1098-1063(1997)7:4<397::AID-HIPO5>3.0.CO;2-G	47	167	168	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 8	2011	71	5					898	910		10.1016/j.neuron.2011.07.027	http://dx.doi.org/10.1016/j.neuron.2011.07.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903082	Green Accepted, Bronze			2022-12-25	WOS:000294877900014
J	Gonzales, KAU; Ng, HH				Gonzales, Kevin Andrew Uy; Ng, Huck-Hui			FoxO: A New Addition to the ESC Cartel	CELL STEM CELL			English	Editorial Material							PLURIPOTENCY FACTORS; CELL; LINEAGE		[Gonzales, Kevin Andrew Uy; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Gonzales, Kevin Andrew Uy; Ng, Huck-Hui] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117597, Singapore; [Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Ng, Huck Hui/A-1135-2009	Gonzales, Kevin Andrew/0000-0001-7418-965X				Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Gonzales KAU, 2011, BBA-GENE REGUL MECH, V1809, P337, DOI 10.1016/j.bbagrm.2011.06.009; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; van den Berg MCW, 2011, ANTIOXID REDOX SIGN, V14, P607, DOI 10.1089/ars.2010.3415; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	8	5	5	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					181	183		10.1016/j.stem.2011.08.003	http://dx.doi.org/10.1016/j.stem.2011.08.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885013	Bronze			2022-12-25	WOS:000295024200003
J	Paz, JT; Bryant, AS; Peng, K; Fenno, L; Yizhar, O; Frankel, WN; Deisseroth, K; Huguenard, JR				Paz, Jeanne T.; Bryant, Astra S.; Peng, Kathy; Fenno, Lief; Yizhar, Ofer; Frankel, Wayne N.; Deisseroth, Karl; Huguenard, John R.			A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy	NATURE NEUROSCIENCE			English	Article							SELECTIVE GLUTAMATE RECEPTORS; THALAMIC RETICULAR NUCLEUS; SOMATOSENSORY THALAMUS; IN-VITRO; SYNAPTIC DISTRIBUTION; CORTICAL-NEURONS; WAVE DISCHARGES; BARREL CORTEX; RELAY CELLS; RAT	Cortico-thalamo-cortical circuits mediate sensation and generate neural network oscillations associated with slow-wave sleep and various epilepsies. Cortical input to sensory thalamus is thought to mainly evoke feed-forward synaptic inhibition of thalamocortical (TC) cells via reticular thalamic nucleus (nRT) neurons, especially during oscillations. This relies on a stronger synaptic strength in the cortico-nRT pathway than in the cortico-TC pathway, allowing the feed-forward inhibition of TC cells to overcome direct cortico-TC excitation. We found a systemic and specific reduction in strength in GluA4-deficient (Gria4(-/-)) mice of one excitatory synapse of the rhythmogenic cortico-thalamo-cortical system, the cortico-nRT projection, and observed that the oscillations could still be initiated by cortical inputs via the cortico-TC-nRT-TC pathway. These results reveal a previously unknown mode of cortico-thalamo-cortical transmission, bypassing direct cortico-nRT excitation, and describe a mechanism for pathological oscillation generation. This mode could be active under other circumstances, representing a previously unknown channel of cortico-thalamo-cortical information processing.	[Paz, Jeanne T.; Bryant, Astra S.; Peng, Kathy; Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Fenno, Lief; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Frankel, Wayne N.] Jackson Lab, Bar Harbor, ME 04609 USA	Stanford University; Stanford University; Jackson Laboratory	Huguenard, JR (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	john.huguenard@stanford.edu	YIZHAR, OFER/AAV-8497-2021; Huguenard, John/I-5016-2012; Fenno, Lief/AAF-9638-2019; Huguenard, John/K-6429-2019; Fenno, Lief/AAK-2924-2020; Ritter, Stefanie L/D-9312-2012	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bryant, Astra/0000-0002-0887-2044; Yizhar, Ofer/0000-0003-4228-1448	US National Institutes of Health; National Institute of Neurological Disorders and Stroke [NS34774, NS06477, NS031348]; DARPA; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034774, R01NS034774, R01NS006477, R37NS031348, R01NS031348] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Parada for her expert histology technical support and A. Herbert and S. Jin for their help with animal husbandry. We also thank T. Davidson for insightful discussions on the optogenetic approach and C. Lee for a generous help during virus injections. This work was supported by grants from the US National Institutes of Health and the National Institute of Neurological Disorders and Stroke (NS34774, NS06477 and NS031348), the DARPA REPAIR program and the Epilepsy Foundation.	AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; Bal T, 2000, J NEUROSCI, V20, P7478; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; BERNARDO KL, 1987, J COMP NEUROL, V258, P542, DOI 10.1002/cne.902580406; Beyer B, 2008, HUM MOL GENET, V17, P1738, DOI 10.1093/hmg/ddn064; Blumenfeld H, 2000, J NEUROSCI, V20, P5153; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gentet LJ, 2003, J PHYSIOL-LONDON, V546, P801, DOI 10.1113/jphysiol.2002.032730; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; JONES EG, 1969, PROC R SOC SER B-BIO, V172, P173, DOI 10.1098/rspb.1969.0018; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; LIU XB, 1995, J COMP NEUROL, V352, P187, DOI 10.1002/cne.903520203; Liu XB, 1999, J COMP NEUROL, V414, P67; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Mineff EM, 2000, NEUROSCIENCE, V101, P969, DOI 10.1016/S0306-4522(00)00421-8; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OHARA PT, 1985, J NEUROCYTOL, V14, P365, DOI 10.1007/BF01217752; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573; PINAULT D, 1995, EUR J NEUROSCI, V7, P31, DOI 10.1111/j.1460-9568.1995.tb01017.x; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 1998, Adv Neurol, V77, P105; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; STERIADE M, 1995, J NEUROSCI, V15, P623; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WARREN RA, 1994, J NEUROPHYSIOL, V72, P1993, DOI 10.1152/jn.1994.72.4.1993; WONGRILEY MTT, 1976, BRAIN RES, V108, P257, DOI 10.1016/0006-8993(76)90185-2	50	129	129	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1167	U225		10.1038/nn.2896	http://dx.doi.org/10.1038/nn.2896			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857658	Green Accepted			2022-12-25	WOS:000294284900017
J	Li, HD; Zhong, XF; Chau, KF; Williams, EC; Chang, Q				Li, Hongda; Zhong, Xiaofen; Chau, Kevin Fongching; Williams, Emily Cunningham; Chang, Qiang			Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory	NATURE NEUROSCIENCE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; DNA METHYLATION; BDNF TRANSCRIPTION; NEURONAL MECP2; CHROMATIN; MUTATIONS	DNA methylation-dependent epigenetic mechanisms underlie the development and function of the mammalian brain. MeCP2 is highly expressed in neurons and functions as a molecular linker between DNA methylation, chromatin remodeling and transcription regulation. Previous in vitro studies have shown that neuronal activity-induced phosphorylation (NAIP) of methyl CpG-binding protein 2 (MeCP2) precedes its release from the Bdnf promoter and the ensuing Bdnf transcription. However, the in vivo function of this phosphorylation event remains elusive. We generated knock-in mice that lack NAIP of MeCP2 and found that they performed better in hippocampus-dependent memory tests, presented enhanced long-term potentiation at two synapses in the hippocampus and showed increased excitatory synaptogenesis. At the molecular level, the phospho-mutant MeCP2 protein bound more tightly to several MeCP2 target gene promoters and altered the expression of these genes. Our results suggest that NAIP of MeCP2 is required for modulating dynamic functions of the adult mouse brain.	[Li, Hongda; Williams, Emily Cunningham; Chang, Qiang] Univ Wisconsin, Genet Training Program, Madison, WI 53706 USA; [Li, Hongda; Zhong, Xiaofen; Chau, Kevin Fongching; Williams, Emily Cunningham; Chang, Qiang] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Chang, Qiang] Univ Wisconsin, Dept Genet & Neurol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chang, Q (corresponding author), Univ Wisconsin, Genet Training Program, Madison, WI 53706 USA.	qchang@waisman.wisc.edu	Li, Hongda/F-3034-2017	Li, Hongda/0000-0001-6754-5150; Chau, Kevin Fongching/0000-0002-7899-3247	Stem Cell and Regenerative Medicine Center at the University of Wisconsin, Madison; Friends of the Waisman Center [5T32GM07133]; National Alliance for Research on Schizophrenia and Depression; National Institute of Child Health and Human Development [R01 HD064743, R21 HD066560, P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064743, P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	Stem Cell and Regenerative Medicine Center at the University of Wisconsin, Madison; Friends of the Waisman Center; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	;We thank A. Messing, J. Svaren and J. Yin for critically reading the manuscript, S. Marwaha for assistance with mouse work, and M. Andrzejewski for assistance with statistical analysis. H.L. was supported by a pre-doctoral fellowship from the Stem Cell and Regenerative Medicine Center at the University of Wisconsin, Madison. E.C.W. was supported by a predoctoral training grant (5T32GM07133) and a graduate student fellowship from the Friends of the Waisman Center. Q.C. was supported by a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression. This work was partially supported by grants from the National Institute of Child Health and Human Development (R01 HD064743 and R21 HD066560 to Q.C., and P30 HD03352 to the Waisman Center).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	23	116	121	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1001	U89		10.1038/nn.2866	http://dx.doi.org/10.1038/nn.2866			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765426	Green Accepted			2022-12-25	WOS:000293123700013
J	Steinert, JR; Robinson, SW; Tong, HX; Haustein, MD; Kopp-Scheinpflug, C; Forsythe, ID				Steinert, Joern R.; Robinson, Susan W.; Tong, Huaxia; Haustein, Martin D.; Kopp-Scheinpflug, Cornelia; Forsythe, Ian D.			Nitric Oxide Is an Activity-Dependent Regulator of Target Neuron Intrinsic Excitability	NEURON			English	Article							KV3.1 POTASSIUM CHANNEL; CENTRAL AUDITORY SYNAPSE; CENTRAL-NERVOUS-SYSTEM; LONG-TERM DEPRESSION; RECTIFIER K+ CURRENT; DELAYED RECTIFIER; PYRAMIDAL NEURONS; NMDA RECEPTORS; TRAPEZOID BODY; MEDIAL NUCLEUS	Activity-dependent changes in synaptic strength are well established as mediating long-term plasticity underlying learning and memory, but modulation of target neuron excitability could complement changes in synaptic strength and regulate network activity. It is thought that homeostatic mechanisms match intrinsic excitability to the incoming synaptic drive, but evidence for involvement of voltage-gated conductances is sparse. Here, we show that glutamatergic synaptic activity modulates target neuron excitability and switches the basis of action potential repolarization from Kv3 to Kv2 potassium channel dominance, thereby adjusting neuronal signaling between low and high activity states, respectively. This nitric oxide-mediated signaling dramatically increases Kv2 currents in both the auditory brain stem and hippocampus (>3-fold) transforming synaptic integration and information transmission but with only modest changes in action potential waveform. We conclude that nitric oxide is a homeostatic regulator, tuning neuronal excitability to the recent history of excitatory synaptic inputs over intervals of minutes to hours.	[Steinert, Joern R.; Robinson, Susan W.; Tong, Huaxia; Haustein, Martin D.; Kopp-Scheinpflug, Cornelia; Forsythe, Ian D.] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	Forsythe, ID (corresponding author), Univ Leicester, MRC Toxicol Unit, Hodgkin Bldg, Leicester LE1 9HN, Leics, England.	idf@le.ac.uk	Steinert, Joern/ABB-4561-2020; Steinert, Joern/A-6678-2008; Steinert, Joern R/AAI-2742-2020	Steinert, Joern/0000-0003-1640-0845; Steinert, Joern R/0000-0003-1640-0845; Forsythe, Ian/0000-0001-8216-0419; Kopp-Scheinpflug, Conny/0000-0002-8083-6232	MRC; Deafness Research UK; Medical Research Council [MC_U132681855] Funding Source: researchfish; MRC [MC_U132681855] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deafness Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the MRC, Deafness Research UK (M.D.H., PhD scholarship), and The Wellcome Trust's Knockout Mouse Resource Committee for provision of the transgenic mouse lacking kcnb2 (LEX1551). Thanks to David Read for assistance with confocal imaging, and to Andy Randall, Timothy O'Leary, and David Wyllie for comments on a draft manuscript.	Artinian L, 2010, J NEUROSCI, V30, P1699, DOI 10.1523/JNEUROSCI.4511-09.2010; Boxall AR, 1996, EUR J NEUROSCI, V8, P2209, DOI 10.1111/j.1460-9568.1996.tb00743.x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brew HM, 1995, J NEUROSCI, V15, P8011; Brown JT, 2009, J PHYSIOL-LONDON, V587, P1265, DOI 10.1113/jphysiol.2008.167007; Brown JT, 2005, SYNAPSE, V55, P262, DOI 10.1002/syn.20115; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Devaux J, 2003, J NEUROSCI, V23, P4509; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Elezgarai I, 2003, NEUROSCIENCE, V118, P889, DOI 10.1016/S0306-4522(03)00068-X; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Fukushima F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003993; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hardingham N, 2006, J NEUROSCI, V26, P7395, DOI 10.1523/JNEUROSCI.0652-06.2006; Hennig MH, 2008, J PHYSIOL-LONDON, V586, P3129, DOI 10.1113/jphysiol.2008.152124; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Hernandez-Pineda R, 1999, J NEUROPHYSIOL, V82, P1512, DOI 10.1152/jn.1999.82.3.1512; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Johnston J, 2008, J PHYSIOL-LONDON, V586, P3493, DOI 10.1113/jphysiol.2008.153734; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Kopp-Scheinpflug C, 2011, HEARING RES, V279, P22, DOI 10.1016/j.heares.2011.02.007; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lien CC, 2003, J NEUROSCI, V23, P2058; Lu YF, 1999, J NEUROSCI, V19, P10250; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; Macica CM, 2001, J NEUROSCI, V21, P1160; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Moreno K, 2001, J PHYSIOL-LONDON, V530, P345, DOI 10.1111/j.1469-7793.2001.0345k.x; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Muennich EAL, 2004, J PHYSIOL-LONDON, V554, P673, DOI 10.1113/jphysiol.2003.056192; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Pal S, 2003, J NEUROSCI, V23, P4798; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; PERNEY TM, 1992, J NEUROPHYSIOL, V68, P756, DOI 10.1152/jn.1992.68.3.756; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Rivera-Arconada I, 2010, J NEUROSCI, V30, P5376, DOI 10.1523/JNEUROSCI.4359-09.2010; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shao LR, 2009, J PHYSIOL-LONDON, V587, P5907, DOI 10.1113/jphysiol.2009.179887; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Sneider JT, 2006, NEUROSCIENCE, V141, P1665, DOI 10.1016/j.neuroscience.2006.05.052; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Steinert JR, 2010, J PHYSIOL-LONDON, V588, P447, DOI 10.1113/jphysiol.2009.184317; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Tansey EP, 2002, HIPPOCAMPUS, V12, P137, DOI 10.1002/hipo.1104; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; van Welie I, 2006, J NEUROPHYSIOL, V95, P2007, DOI 10.1152/jn.00220.2005; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson GW, 2010, EUR J NEUROSCI, V31, P1935, DOI 10.1111/j.1460-9568.2010.07226.x; Youssoufian M, 2005, J NEUROPHYSIOL, V94, P3168, DOI 10.1152/jn.00342.2005	81	72	73	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					291	305		10.1016/j.neuron.2011.05.037	http://dx.doi.org/10.1016/j.neuron.2011.05.037			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791288	Green Published, hybrid			2022-12-25	WOS:000293433900013
J	Rudolph, S; Overstreet-Wadiche, L; Wadiche, JI				Rudolph, Stephanie; Overstreet-Wadiche, Linda; Wadiche, Jacques I.			Desynchronization of Multivesicular Release Enhances Purkinje Cell Output	NEURON			English	Article							EXCITATORY SYNAPTIC ACTION; PAIRED-PULSE DEPRESSION; LONG-TERM DEPRESSION; CLIMBING FIBER; TRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; COMPLEX SPIKE; NEURON SYNAPSE; MOSSY FIBER; K+ CHANNELS	The release of neurotransmitter-filled vesicles after action potentials occurs with discrete time courses: submillisecond phasic release that can be desynchronized by activity followed by "delayed release" that persists for tens of milliseconds. Delayed release has a well-established role in synaptic integration, but it is not clear whether desynchronization of phasic release has physiological consequences. At the climbing fiber to Purkinje cell synapse, the synchronous fusion of multiple vesicles is critical for generating complex spikes. Here we show that stimulation at physiological frequencies drives the temporal dispersion of vesicles undergoing multivesicular release, resulting in a slowing of the EPSC on the millisecond timescale. Remarkably, these changes in EPSC kinetics robustly alter the Purkinje cell complex spike in a manner that promotes axonal propagation of individual spikelets. Thus, desynchronization of multivesicular release enhances the precise and efficient information transfer by complex spikes.	[Rudolph, Stephanie; Overstreet-Wadiche, Linda; Wadiche, Jacques I.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Rudolph, Stephanie; Overstreet-Wadiche, Linda; Wadiche, Jacques I.] Univ Alabama Birmingham, Evelyn McKnight Brain Inst, Birmingham, AL 35294 USA; [Rudolph, Stephanie] Univ Freiburg, Dept Biol, D-79104 Freiburg, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Freiburg	Wadiche, JI (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	jwadiche@uab.edu		Wadiche, Linda/0000-0001-7367-5998; Wadiche, Jacques/0000-0001-8180-2061	National Institutes of Health (NIH) [NS065920]; Boehringer Ingelheim Fonds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065920, R01NS064025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) Grant NS065920 and Boehringer Ingelheim Fonds (S.R.). We would like to thank Craig E. Jahr, Peter Jonas, Anastassios V. Tzingounis, and members of the Wadiche labs for discussions and critical reading of the manuscript.	Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Atluri PP, 1998, J NEUROSCI, V18, P8214; Auger C, 1998, J NEUROSCI, V18, P4532; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Biro AA, 2006, J NEUROSCI, V26, P12487, DOI 10.1523/JNEUROSCI.3106-06.2006; Borst JGG, 2010, TRENDS NEUROSCI, V33, P259, DOI 10.1016/j.tins.2010.03.003; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Boudkkazi S, 2007, NEURON, V56, P1048, DOI 10.1016/j.neuron.2007.10.037; CAMPBELL NC, 1986, J PHYSIOL-LONDON, V377, P225, DOI 10.1113/jphysiol.1986.sp016183; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Crowley JJ, 2009, NEURON, V63, P843, DOI 10.1016/j.neuron.2009.09.004; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dittman JS, 1998, J NEUROSCI, V18, P6147; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Iremonger KJ, 2007, J NEUROSCI, V27, P6684, DOI 10.1523/JNEUROSCI.0934-07.2007; KATZ B, 1965, J PHYSIOL-LONDON, V181, P656, DOI 10.1113/jphysiol.1965.sp007790; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Khaliq ZM, 2005, J NEUROSCI, V25, P454, DOI 10.1523/JNEUROSCI.3045-04.2005; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maruta J, 2007, J NEUROSCI, V27, P11263, DOI 10.1523/JNEUROSCI.2559-07.2007; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Monsivais P, 2005, J NEUROSCI, V25, P464, DOI 10.1523/JNEUROSCI.3871-04.2005; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Piochon C, 2007, J NEUROSCI, V27, P10797, DOI 10.1523/JNEUROSCI.2422-07.2007; Prange O, 1999, J NEUROPHYSIOL, V81, P1810, DOI 10.1152/jn.1999.81.4.1810; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; SATO Y, 1992, J NEUROPHYSIOL, V68, P2051, DOI 10.1152/jn.1992.68.6.2051; Scheuss V, 2007, J PHYSIOL-LONDON, V585, P361, DOI 10.1113/jphysiol.2007.140988; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Swensen AM, 2003, J NEUROSCI, V23, P9650; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Telgkamp P, 2002, J NEUROSCI, V22, P8447; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Vyshedskiy A, 2000, J NEUROSCI, V20, P6326, DOI 10.1523/JNEUROSCI.20-17-06326.2000; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Weber JT, 2003, P NATL ACAD SCI USA, V100, P2878, DOI 10.1073/pnas.0536420100; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Zagha E, 2008, J NEUROSCI, V28, P1291, DOI 10.1523/JNEUROSCI.4358-07.2008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	63	32	32	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					991	1004		10.1016/j.neuron.2011.03.029	http://dx.doi.org/10.1016/j.neuron.2011.03.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658590	Green Accepted, Bronze			2022-12-25	WOS:000291843500017
J	Kuo, RI; Wu, GYK				Kuo, Richard I.; Wu, Guangying K.			The Generation of Direction Selectivity in the Auditory System	NEURON			English	Article							DORSAL COCHLEAR NUCLEUS; FREQUENCY-MODULATED SWEEPS; RAT INFERIOR COLLICULUS; VISUAL CORTICAL-NEURONS; MEDIAL GENICULATE-BODY; WHOLE-CELL RECORDINGS; ECHO-LOCATING BATS; BIG BROWN BAT; RESPONSE PROPERTIES; IN-VIVO	Both human speech and animal vocal signals contain frequency-modulated (FM) sounds. Although central auditory neurons that selectively respond to the direction of frequency modulation are known, the synaptic mechanisms underlying the generation of direction selectivity (DS) remain elusive. Here we show the emergence of DS neurons in the inferior colliculus by mapping the three major subcortical auditory nuclei. Cell-attached recordings reveal a highly reliable and precise firing of DS neurons to FM sweeps in a preferred direction. By using in vivo whole-cell current-clamp and voltage-clamp recordings, we found that the synaptic inputs to DS neurons are not direction selective, but temporally reversed excitatory and inhibitory synaptic inputs are evoked in response to opposing directions of FM sweeps. The construction of such temporal asymmetry, resulting DS, and its topography can be attributed to the spectral disparity of the excitatory and the inhibitory synaptic tonal receptive fields.	[Kuo, Richard I.; Wu, Guangying K.] CALTECH, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Kuo, Richard I.; Wu, Guangying K.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Wu, GYK (corresponding author), CALTECH, Broad Fellows Program Brain Circuitry, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	gwu@caltech.edu		Wu, Guangying/0000-0002-7243-5412	Broad Foundation; California Institute of Technology; Division of Biology of Caltech	Broad Foundation; California Institute of Technology; Division of Biology of Caltech	We thank M. Konishi, C.E. Carr, C. Koch, and S. Cassenaer for the discussion and comments to the manuscript and the study and AD. Steele and J. Lin for critical reading and style checking. We thank HA. Lester for the discussion of biophysical properties of neurons and space-clamping issues. This work was supported by grants to G.K.W. from the Broad Fellows Program in Brain Circuitry of the Broad Foundation and the California Institute of Technology. We also thank the Division of Biology of Caltech for generous support in providing us laboratory space.	AITKIN L, 1994, EXP BRAIN RES, V98, P53; AITKIN LM, 1975, J NEUROPHYSIOL, V38, P1196, DOI 10.1152/jn.1975.38.5.1196; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Atencio CA, 2007, J NEUROPHYSIOL, V98, P2182, DOI 10.1152/jn.00394.2007; BEYERL BD, 1978, BRAIN RES, V145, P209, DOI 10.1016/0006-8993(78)90858-2; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BOURK TR, 1981, HEARING RES, V4, P215, DOI 10.1016/0378-5955(81)90008-3; BRITT R, 1976, J NEUROPHYSIOL, V39, P179, DOI 10.1152/jn.1976.39.1.179; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; Casseday JH, 1997, J NEUROPHYSIOL, V77, P1595, DOI 10.1152/jn.1997.77.3.1595; CLOPTON BM, 1973, BRAIN RES, V56, P355, DOI 10.1016/0006-8993(73)90352-1; CLOPTON BM, 1974, EXP NEUROL, V42, P532, DOI 10.1016/0014-4886(74)90076-4; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; DRUGA R, 1984, PHYSIOL BOHEMOSLOV, V33, P31; ERULKAR SD, 1968, J NEUROPHYSIOL, V31, P537, DOI 10.1152/jn.1968.31.4.537; Felsheim C, 1996, HEARING RES, V98, P137, DOI 10.1016/0378-5955(96)00078-0; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Fuzessery ZM, 1996, J NEUROPHYSIOL, V76, P1059, DOI 10.1152/jn.1996.76.2.1059; Gittelman JX, 2009, J NEUROSCI, V29, P13030, DOI 10.1523/JNEUROSCI.2477-09.2009; GODFREY DA, 1978, J HISTOCHEM CYTOCHEM, V26, P118, DOI 10.1177/26.2.624832; Hage SR, 2003, EUR J NEUROSCI, V18, P2301, DOI 10.1046/j.1460-9568.2003.02945.x; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hickmott PW, 2002, J NEUROPHYSIOL, V88, P1288, DOI 10.1152/jn.00994.2001; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Ito T, 2009, J NEUROSCI, V29, P13860, DOI 10.1523/JNEUROSCI.3454-09.2009; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1990, J NEUROSCI, V10, P3178; Joshi S, 2006, J NEUROSCI METH, V156, P37, DOI 10.1016/j.jneumeth.2006.02.004; KALTENBACH JA, 1991, HEARING RES, V51, P149, DOI 10.1016/0378-5955(91)90013-Y; Koch U, 1998, J NEUROPHYSIOL, V80, P71, DOI 10.1152/jn.1998.80.1.71; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Lim HH, 2007, J NEUROSCI, V27, P8733, DOI 10.1523/JNEUROSCI.5127-06.2007; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Lui B, 2003, EXP BRAIN RES, V153, P550, DOI 10.1007/s00221-003-1618-y; Lumani A, 2010, BRAIN RES, V1351, P115, DOI 10.1016/j.brainres.2010.06.066; Malmierca MS, 2005, NEUROSCIENCE, V136, P883, DOI 10.1016/j.neuroscience.2005.04.040; Malmierca MS, 2002, J NEUROSCI, V22, P10891; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mauger SJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036004; MENDELSON JR, 1985, BRAIN RES, V327, P331, DOI 10.1016/0006-8993(85)91530-6; MERZENICH MM, 1974, BRAIN RES, V77, P397, DOI 10.1016/0006-8993(74)90630-1; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; MOLLER AR, 1974, J ACOUST SOC AM, V55, P631, DOI 10.1121/1.1914574; MOLLER AR, 1969, ACTA PHYSIOL SCAND, V76, P503, DOI 10.1111/j.1748-1716.1969.tb04497.x; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Nagtegaal AP, 2010, J NEUROPHYSIOL, V104, P940, DOI 10.1152/jn.00264.2010; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; NELSON PG, 1966, J NEUROPHYSIOL, V29, P834, DOI 10.1152/jn.1966.29.5.834; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Oliver DL, 1997, J COMP NEUROL, V382, P215, DOI 10.1002/(SICI)1096-9861(19970602)382:2<215::AID-CNE6>3.0.CO;2-6; Oliver DL, 2005, INFERIOR COLLICULUS, P69, DOI 10.1007/0-387-27083-3_2; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; POON PWF, 1992, EXP BRAIN RES, V91, P94; POON PWF, 1991, EXP BRAIN RES, V83, P598; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Ramachandran R, 1999, J NEUROPHYSIOL, V82, P152, DOI 10.1152/jn.1999.82.1.152; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; REES A, 1983, HEARING RES, V10, P301, DOI 10.1016/0378-5955(83)90095-3; Ricketts C, 1998, HEARING RES, V123, P27, DOI 10.1016/S0378-5955(98)00086-0; ROSE JE, 1960, NEURAL MECHANISMS AU, P116; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SINEX DG, 1981, HEARING RES, V4, P127, DOI 10.1016/0378-5955(81)90001-0; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; SUGA N, 1964, J PHYSIOL-LONDON, V175, P50, DOI 10.1113/jphysiol.1964.sp007503; SUGA N, 1968, J PHYSIOL-LONDON, V198, P51, DOI 10.1113/jphysiol.1968.sp008593; Syka J, 2000, EXP BRAIN RES, V133, P254, DOI 10.1007/s002210000426; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TOKUNAGA A, 1984, J HIRNFORSCH, V25, P461; VARTANIAN IA, 1974, ACUSTICA, V31, P305; Voytenko SV, 2007, J NEUROPHYSIOL, V97, P1368, DOI 10.1152/jn.00976.2006; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Winer J.A., 2005, INFERIOR COLLICULUS, DOI [10.1007/b138578, DOI 10.1007/B138578]; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Ye CQ, 2010, J NEUROSCI, V30, P1861, DOI 10.1523/JNEUROSCI.3088-09.2010; YOUNG ED, 1988, J NEUROPHYSIOL, V60, P1, DOI 10.1152/jn.1988.60.1.1; YOUNG ED, 1976, J NEUROPHYSIOL, V39, P282, DOI 10.1152/jn.1976.39.2.282; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	94	52	52	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					1016	1027		10.1016/j.neuron.2011.11.035	http://dx.doi.org/10.1016/j.neuron.2011.11.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405210	Bronze			2022-12-25	WOS:000301558600015
J	Park, D; Spencer, JA; Koh, BI; Kobayashi, T; Fujisaki, J; Clemens, TL; Lin, CP; Kronenberg, HM; Scadden, DT				Park, Dongsu; Spencer, Joel A.; Koh, Bong Ihn; Kobayashi, Tatsuya; Fujisaki, Joji; Clemens, Thomas L.; Lin, Charles P.; Kronenberg, Henry M.; Scadden, David T.			Endogenous Bone Marrow MSCs Are Dynamic, Fate-Restricted Participants in Bone Maintenance and Regeneration	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; HEMATOPOIETIC STEM; PROGENITOR CELLS; OSTEOBLAST; MICROENVIRONMENT; NICHE; DIFFERENTIATION; SPECIFICATION; POPULATION	Mesenchymal stem cells (MSCs) commonly defined by in vitro functions have entered clinical application despite little definition of their function in residence. Here, we report genetic pulse-chase experiments that define osteoblastic cells as short-lived and nonreplicative, requiring replenishment from bone-marrow-derived, Mx1(+) stromal cells with "MSC" features. These cells respond to tissue stress and migrate to sites of injury, supplying new osteoblasts during fracture healing. Single cell transplantation yielded progeny that both preserve progenitor function and differentiate into osteoblasts, producing new bone. They are capable of local and systemic translocation and serial transplantation. While these cells meet current definitions of MSCs in vitro, they are osteolineage restricted in vivo in growing and adult animals. Therefore, bone-marrow-derived MSCs may be a heterogeneous population with the Mx1(+) population, representing a highly dynamic and stress responsive stem/progenitor cell population of fate-restricted potential that feeds the high cell replacement demands of the adult skeleton.	[Park, Dongsu; Koh, Bong Ihn; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Spencer, Joel A.; Fujisaki, Joji; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Adv Microscopy Program, Boston, MA 02114 USA; [Spencer, Joel A.; Fujisaki, Joji; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Kobayashi, Tatsuya; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Park, Dongsu; Spencer, Joel A.; Koh, Bong Ihn; Fujisaki, Joji; Lin, Charles P.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Clemens, Thomas L.] Johns Hopkins Med, Ctr Musculoskeletal Res, Baltimore, MD 21287 USA; [Park, Dongsu; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	david_scadden@harvard.edu	Spencer, Joel/GLT-9687-2022; Spencer, Joel/A-4590-2013	Spencer, Joel/0000-0002-4013-8763; Kobayashi, Tatsuya/0000-0003-4264-5117; Park, Dongsu/0000-0002-2570-3250	Leukemia & Lymphoma Society; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR061434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Lo Celso, S. Mukherjee, J. Schoonmaker, S. Guo, R. Schlanger, and M. Kim for advice and technical assistance; N. Jeanson, A. Catic, J. Dietrich, and D. Sykes for reading the manuscript; the HSCl/MGH CRM Flow Core (L. Prickett, K. Folz-Donahue, and D. Dombkowski); and the Leukemia & Lymphoma Society (Fellowship Award to D.P.) and the National Institutes of Health (grants to T.L.C., C.P.L., H.M.K., and D.T.S.).	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lana-Elola E, 2007, DEV BIOL, V311, P335, DOI 10.1016/j.ydbio.2007.08.028; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; MCCULLOCH CAG, 1988, ANAT REC, V222, P128, DOI 10.1002/ar.1092220204; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; OWEN M, 1963, J CELL BIOL, V19, P19, DOI 10.1083/jcb.19.1.19; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014	33	446	472	1	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					259	272		10.1016/j.stem.2012.02.003	http://dx.doi.org/10.1016/j.stem.2012.02.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385654	Green Accepted, Bronze			2022-12-25	WOS:000301466500008
J	Ni, AM; Ray, S; Maunsell, JHR				Ni, Amy M.; Ray, Supratim; Maunsell, John H. R.			Tuned Normalization Explains the Size of Attention Modulations	NEURON			English	Article							PRIMARY VISUAL-CORTEX; MST NEURONAL-ACTIVITY; CAT STRIATE CORTEX; AREA V4; RECEPTIVE-FIELDS; GAIN-CONTROL; SHUNTING INHIBITION; PURSUIT INITIATION; SPATIAL SUMMATION; MULTIPLE STIMULI	The effect of attention on firing rates varies considerably within a single cortical area. The firing rate of some neurons is greatly modulated by attention while others are hardly affected. The reason for this variability across neurons is unknown. We found that the variability in attention modulation across neurons in area MT of macaques can be well explained by variability in the strength of tuned normalization across neurons. The presence of tuned normalization also explains a striking asymmetry in attention effects within neurons: when two stimuli are in a neuron's receptive field, directing attention to the preferred stimulus modulates firing rates more than directing attention to the nonpreferred stimulus. These findings show that much of the neuron-to-neuron variability in modulation of responses by attention depends on variability in the way the neurons process multiple stimuli, rather than differences in the influence of top-down signals related to attention.	[Ni, Amy M.; Maunsell, John H. R.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Ray, Supratim] Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India	Harvard University; Harvard Medical School; Indian Institute of Science (IISC) - Bangalore	Maunsell, JHR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	maunsell@hms.harvard.edu	Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439; Ray, Supratim/0000-0002-1968-1382	National Institutes of Health [R01EY005911]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY021550, R01EY005911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Marlene R. Cohen, Incheol Kang, and J. Patrick Mayo for helpful comments and discussions. We thank Anna Chambers, Steven J. Sleboda, Jon Hendry, and Vivian Y. lmamura for technical assistance. This work was supported by National Institutes of Health R01EY005911 and the Howard Hughes Medical Institute.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Britten KH, 1999, J NEUROSCI, V19, P5074; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Chaisanguanthum KS, 2011, J NEUROSCI, V31, P4868, DOI 10.1523/JNEUROSCI.6776-10.2011; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Ghose GM, 2008, J NEUROSCI, V28, P5115, DOI 10.1523/JNEUROSCI.0138-08.2008; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heimel JA, 2010, NAT NEUROSCI, V13, P642, DOI 10.1038/nn.2534; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee J, 2010, J NEUROSCI, V30, P3058, DOI 10.1523/JNEUROSCI.3766-09.2010; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Recanzone GH, 1999, J NEUROPHYSIOL, V82, P1710, DOI 10.1152/jn.1999.82.4.1710; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	62	60	60	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					803	813		10.1016/j.neuron.2012.01.006	http://dx.doi.org/10.1016/j.neuron.2012.01.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365552	Bronze, Green Accepted			2022-12-25	WOS:000300815400017
J	Badre, D; Doll, BB; Long, NM; Frank, MJ				Badre, David; Doll, Bradley B.; Long, Nicole M.; Frank, Michael J.			Rostrolateral Prefrontal Cortex and Individual Differences in Uncertainty-Driven Exploration	NEURON			English	Article							DECISION-MAKING; FRONTOPOLAR CORTEX; COGNITIVE CONTROL; TRADE-OFF; EXPLOITATION; INFORMATION; INTEGRATION; MECHANISMS; HIERARCHY; DOPAMINE	How do individuals decide to act based on a rewarding status quo versus an unexplored choice that might yield a better outcome? Recent evidence suggests that individuals may strategically explore as a function of the relative uncertainty about the expected value of options. However, the neural mechanisms supporting uncertainty-driven exploration remain underspecified. The present fMRI study scanned a reinforcement learning task in which participants stop a rotating clock hand in order to win points. Reward schedules were such that expected value could increase, decrease, or remain constant with respect to time. We fit several mathematical models to subject behavior to generate trial-by-trial estimates of exploration as a function of relative uncertainty. These estimates were used to analyze our fMRI data. Results indicate that rostrolateral prefrontal cortex tracks trial-by-trial changes in relative uncertainty, and this pattern distinguished individuals who rely on relative uncertainty for their exploratory decisions versus those who do not.	[Badre, David; Doll, Bradley B.; Long, Nicole M.; Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Brown Inst Brain Sci, Providence, RI 02912 USA	Brown University	Badre, D (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Brown Inst Brain Sci, Providence, RI 02912 USA.	david_badre@brown.edu; michael_frank@brown.edu			National Institute of Neurological Disease and Stroke [R01 NS065046]; National Institute of Mental Health [R01 MH080066-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065046] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The present work was supported by a National Institute of Neurological Disease and Stroke R01 NS065046 awarded to DB and a National Institute of Mental Health R01 MH080066-01 awarded to MJF.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Bunge SA, 2009, NEURON, V62, P609, DOI 10.1016/j.neuron.2009.05.020; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 1996, MACH LEARN, V25, P5, DOI 10.1023/A:1018357105171; Doll BB, 2009, HANDBOOK OF REWARD AND DECISION MAKING, P399, DOI 10.1016/B978-0-12-374620-7.00019-4; ELLSBERG, 1961, Q J ECON, V75, P643, DOI DOI 10.2307/1884324; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gittins J.C., 1974, STATISTICS, P241; Han S, 2009, J COGNITIVE NEUROSCI, V21, P922, DOI 10.1162/jocn.2009.21060; Jepma M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00170; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Krawczyk DC, 2011, CORTEX, V47, P588, DOI 10.1016/j.cortex.2010.04.008; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Speed A, 2010, COGN NEUROSCI-UK, V1, P126, DOI 10.1080/17588921003660728; Strauss GP, 2011, BIOL PSYCHIAT, V69, P424, DOI 10.1016/j.biopsych.2010.10.015; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Wallis JD, 2010, NAT NEUROSCI, V13, P7, DOI 10.1038/nn0110-7; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	40	139	141	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					595	607		10.1016/j.neuron.2011.12.025	http://dx.doi.org/10.1016/j.neuron.2011.12.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325209	Green Accepted, Bronze			2022-12-25	WOS:000300140600018
J	Mitra, A; Mitra, SS; Tsien, RW				Mitra, Ananya; Mitra, Siddhartha S.; Tsien, Richard W.			Heterogeneous reallocation of presynaptic efficacy in recurrent excitatory circuits adapting to inactivity	NATURE NEUROSCIENCE			English	Article							HOMEOSTATIC SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; NEURONS; CDK5; NETWORK; CULTURES; CORTEX; CA3; DEPRIVATION; ROSCOVITINE	Recurrent excitatory circuits face extreme challenges in balancing efficacy and stability. We recorded from CA3 pyramidal neuron pairs in rat hippocampal slice cultures to characterize synaptic and circuit-level changes in recurrent synapses resulting from long-term inactivity. Chronic tetrodotoxin treatment greatly reduced the percentage of connected CA3-CA3 neurons, but enhanced the strength of the remaining connections; presynaptic release probability sharply increased, whereas quantal size was unaltered. Connectivity was decreased in activity-deprived circuits by functional silencing of synapses, whereas three-dimensional anatomical analysis revealed no change in spine or bouton density or aggregate dendrite length. The silencing arose from enhanced Cdk5 activity and could be reverted by acute Cdk5 inhibition with roscovitine. Our results suggest that recurrent circuits adapt to chronic inactivity by reallocating presynaptic weights heterogeneously, strengthening certain connections while silencing others. This restricts synaptic output and input, preserving signaling efficacy among a subset of neuronal ensembles while protecting network stability.	[Mitra, Ananya; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Mitra, Siddhartha S.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Tsien, Richard W.] NYU, Inst Neurosci, New York, NY USA	Stanford University; Stanford University; New York University	Tsien, RW (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	rwtsien@stanford.edu			National Institute of Mental Health [5R37MH071739]; Mather Foundation Burnett Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH071739] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mather Foundation Burnett Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Pathak, Dhani and S. Owen for comments on the manuscript, A.Y. Olson for help with spine density analysis, I. Prada for advice on immunostaining techniques, and Stanford Neuroscience Microscope Core. We also thank members of the Tsien laboratory for helpful discussions throughout the project. This work was supported by National Institute of Mental Health grant 5R37MH071739 and grants from the Mather Foundation Burnett Family Foundation to R.W.T.	Aoki C, 2009, J COMP NEUROL, V517, P105, DOI 10.1002/cne.22137; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Butz M, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.010.2009; BUZSAKI G, 2006, RHYTHMS BRAIN, P464; Costa ACS, 2010, BEHAV BRAIN RES, V206, P52, DOI 10.1016/j.bbr.2009.08.034; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Hanson JE, 2007, J PHYSIOL-LONDON, V579, P53, DOI 10.1113/jphysiol.2006.114868; Hanson JE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-96; Hardingham NR, 2010, J NEUROSCI, V30, P1441, DOI 10.1523/JNEUROSCI.3244-09.2010; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Moulder KL, 2008, J NEUROSCI, V28, P5159, DOI 10.1523/JNEUROSCI.5317-07.2008; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Saviane Chiara, 2007, V403, P303, DOI 10.1007/978-1-59745-529-9_19; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tao L, 2006, P NATL ACAD SCI USA, V103, P12911, DOI 10.1073/pnas.0605415103; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761	50	57	57	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					250	257		10.1038/nn.3004	http://dx.doi.org/10.1038/nn.3004			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179109	Green Accepted			2022-12-25	WOS:000299603500016
J	Fetsch, CR; Pouget, A; DeAngelis, GC; Angelaki, DE				Fetsch, Christopher R.; Pouget, Alexandre; DeAngelis, Gregory C.; Angelaki, Dora E.			Neural correlates of reliability-based cue weighting during multisensory integration	NATURE NEUROSCIENCE			English	Article							STOCHASTIC MOTION SIGNALS; SUPERIOR TEMPORAL AREA; MACAQUE MONKEY; OPTIC FLOW; BAYESIAN INTEGRATION; HEADING PERCEPTION; POPULATION CODES; CORTICAL AREAS; SELF-MOTION; MST NEURONS	Integration of multiple sensory cues is essential for precise and accurate perception and behavioral performance, yet the reliability of sensory signals can vary across modalities and viewing conditions. Human observers typically employ the optimal strategy of weighting each cue in proportion to its reliability, but the neural basis of this computation remains poorly understood. We trained monkeys to perform a heading discrimination task from visual and vestibular cues, varying cue reliability randomly. The monkeys appropriately placed greater weight on the more reliable cue, and population decoding of neural responses in the dorsal medial superior temporal area closely predicted behavioral cue weighting, including modest deviations from optimality. We found that the mathematical combination of visual and vestibular inputs by single neurons is generally consistent with recent theories of optimal probabilistic computation in neural circuits. These results provide direct evidence for a neural mechanism mediating a simple and widespread form of statistical inference.	[Fetsch, Christopher R.; DeAngelis, Gregory C.; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Pouget, Alexandre; DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Pouget, Alexandre] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Angelaki, Dora E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Washington University (WUSTL); University of Rochester; University of Geneva; Baylor College of Medicine	Fetsch, CR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	crfetsch@u.washington.edu		DeAngelis, Gregory/0000-0002-1635-1273; Pouget, Alexandre/0000-0003-3054-6365	US National Institutes of Health [EY019087, EY016178]; US National Institutes of Health Institutional National Research Service [5-T32-EY13360-07]; National Science Foundation [BCS0446730]; Multidisciplinary University Research Initiative [N00014-07-1-0937]; James McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY016178, T32EY013360, R01EY019087] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Institutional National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Multidisciplinary University Research Initiative(MURI); James McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Turner, J. Arand, H. Schoknecht, B. Adeyemo and J. Lin for animal care and technical help, and V. Rao, S. Nelson and M. Jazayeri for discussions and comments on the manuscript. We are indebted to Y. Guan and S. Liu for generously contributing data to this project. This work was supported by grants from the US National Institutes of Health (EY019087 to D. E. A. and EY016178 to G. C. D.) and a US National Institutes of Health Institutional National Research Service Award (5-T32-EY13360-07 supporting C. R. F.). A. P. was supported by grants from the National Science Foundation (BCS0446730), Multidisciplinary University Research Initiative (N00014-07-1-0937) and the James McDonnell Foundation.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Clark J.J., 1990, DATA FUSION SENSORY; COCHRAN W. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P102; Dayan P., 2001, THEORETICAL NEUROSCI; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fetsch CR, 2010, J NEUROPHYSIOL, V104, P1506, DOI 10.1152/jn.91247.2008; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Fukushima K, 2008, NEURAL NETWORKS, V21, P774, DOI 10.1016/j.neunet.2007.12.049; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Heuer HW, 2007, J NEUROPHYSIOL, V98, P1115, DOI 10.1152/jn.00083.2007; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.5.i; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Landy M.S., 2011, SENSORY CUE INTEGRAT, P5, DOI [10.1093/acprof:oso/9780195387247.003.0001, DOI 10.1093/ACPROF:OSO/9780195387247.003.0001]; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lappe M, 1996, J NEUROSCI, V16, P6265; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Perrone JA, 1998, J NEUROSCI, V18, P5958; Rosas P, 2005, J OPT SOC AM A, V22, P801, DOI 10.1364/JOSAA.22.000801; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Stein BE., 1993, MERGING SENSES; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Xiao Q, 2006, VISUAL NEUROSCI, V23, P49, DOI 10.1017/S0952523806231055; YOUNG MJ, 1993, VISION RES, V33, P2685, DOI 10.1016/0042-6989(93)90228-O	50	250	252	1	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					146	U185		10.1038/nn.2983	http://dx.doi.org/10.1038/nn.2983			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101645	Green Accepted			2022-12-25	WOS:000298414400025
J	Maniar, TA; Kaplan, M; Wang, GJ; Shen, K; Wei, L; Shaw, JE; Koushika, SP; Bargmann, CI				Maniar, Tapan A.; Kaplan, Miriam; Wang, George J.; Shen, Kang; Wei, Li; Shaw, Jocelyn E.; Koushika, Sandhya P.; Bargmann, Cornelia I.			UNC-33 (CRMP) and ankyrin organize microtubules and localize kinesin to polarize axon-dendrite sorting	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; INITIAL SEGMENT; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; OLFACTORY CILIA; C-ELEGANS; TRANSPORT; TUBULIN; PROTEIN; VESICLES	The polarized distribution of neuronal proteins to axons and dendrites relies on microtubule-binding proteins such as CRMP, directed motors such as the kinesin UNC-104 (Kif1A) and diffusion barriers such as ankyrin. The causative relationships among these molecules are unknown. We show here that Caenorhabditis elegans CRMP (UNC-33) acts early in neuronal development, together with ankyrin (UNC-44), to organize microtubule asymmetry and axon-dendrite sorting. In unc-33 and unc-44 mutants, axonal proteins were mislocalized to dendrites and vice versa, suggesting bidirectional failures of axon-dendrite identity. unc-44 directed UNC-33 localization to axons, where it was enriched in a region that resembled the axon initial segment. unc-33 and unc-44 were both required to establish the asymmetric dynamics of axonal and dendritic microtubules; in their absence, microtubules were disorganized, the axonal kinesin UNC-104 invaded dendrites, and inappropriate UNC-104 activity randomized axonal protein sorting. We suggest that UNC-44 and UNC-33 direct polarized sorting through their global effects on neuronal microtubule organization.	[Maniar, Tapan A.; Kaplan, Miriam; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10021 USA; [Wang, George J.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Wei, Li; Shaw, Jocelyn E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Koushika, Sandhya P.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10021 USA.	cori@rockefeller.edu		Koushika, Sandhya/0000-0002-1742-7356; Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Ghenoiu, P. Nurse, Y. Saheki, S. Shaham, M. Tsunozaki, M. Heiman, A. Kelly, T. Starich and members of our labs for advice and comments on the manuscript, C. Janke (Institut Curie) and B. Edde (Universite Pierre et Marie Curie) for antibodies, and Y. Saheki (Rockefeller University) and the Caenorhabditis Genetics Center for strains. C. I. B. and K. S. are Investigators of the Howard Hughes Medical Institute. This work was supported by the Howard Hughes Medical Institute.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; BRENNER S, 1974, GENETICS, V77, P71; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; BURTON PR, 1985, J COMP NEUROL, V242, P147, DOI 10.1002/cne.902420202; BURTON PR, 1981, P NATL ACAD SCI-BIOL, V78, P3269, DOI 10.1073/pnas.78.5.3269; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; LI W, 1992, GENETICS, V132, P675; Mello C, 1995, METHOD CELL BIOL, V48, P451; MEYRAND P, 1992, J NEUROSCI, V12, P2803; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; OTSUKA AJ, 1995, J CELL BIOL, V129, P1081, DOI 10.1083/jcb.129.4.1081; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; SIDDIQUI SS, 1989, J NEUROSCI, V9, P2963; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; Tsuboi D, 2005, J NEUROCHEM, V95, P1629, DOI 10.1111/j.1471-4159.2005.03490.x; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	50	113	120	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					48	U66		10.1038/nn.2970	http://dx.doi.org/10.1038/nn.2970			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101643	Green Accepted			2022-12-25	WOS:000298414400013
J	Carey, BW; Markoulaki, S; Hanna, JH; Faddah, DA; Buganim, Y; Kim, J; Ganz, K; Steine, EJ; Cassady, JP; Creyghton, MP; Welstead, GG; Gao, Q; Jaenisch, R				Carey, Bryce W.; Markoulaki, Styliani; Hanna, Jacob H.; Faddah, Dina A.; Buganim, Yosef; Kim, Jongpil; Ganz, Kibibi; Steine, Eveline J.; Cassady, John P.; Creyghton, Menno P.; Welstead, G. Grant; Gao, Qing; Jaenisch, Rudolf			Reprogramming Factor Stoichiometry Influences the Epigenetic State and Biological Properties of Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							SOMATIC-CELLS; MEMORY; MICE; DIFFERENTIATION; ACTIVATION; GENES; ES	We compared two genetically highly defined transgenic systems to identify parameters affecting reprogramming of somatic cells to a pluripotent state. Our results demonstrate that the level and stoichiometry of reprogramming factors during the reprogramming process strongly influence the resulting pluripotency of iPS cells. High expression of Oct4 and Klf4 combined with lower expression of c-Myc and Sox2 produced iPS cells that efficiently generated "all-iPSC mice" by tetraploid (4n) complementation, maintained normal imprinting at the Dlk1-Dio3 locus, and did not create mice with tumors. Loss of imprinting (LOI) at the Dlk1-Dio3 locus did not strictly correlate with reduced pluripotency though the efficiency of generating "all-iPSC mice" was diminished. Our data indicate that stoichiometry of reprogramming factors can influence epigenetic and biological properties of iPS cells. This concept complicates efforts to define a "generic" epigenetic state of iPSCs and ESCs and should be considered when comparing different iPS and ES cell lines.	[Carey, Bryce W.; Markoulaki, Styliani; Faddah, Dina A.; Buganim, Yosef; Kim, Jongpil; Ganz, Kibibi; Steine, Eveline J.; Cassady, John P.; Welstead, G. Grant; Gao, Qing; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Carey, Bryce W.; Faddah, Dina A.; Cassady, John P.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Creyghton, Menno P.] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Weizmann Institute of Science; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974	NSF; NIH [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198, R01CA087869] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Flannery for help with mouse husbandry and D. Fu, K. Saha, A.W. Cheng, F. Soldner, and M. Dawlaty for excellent assistance and helpful comments. We also thank K. Hochedlinger and M. Stadtfeld for the Col1a1-OKSM mice and for iPSC DNA and for comments on the manuscript. D.A.F. was supported by a NSF graduate research fellowship (NSF GFRP). R.J. is supported by grants from the NIH: 5-RO1-HDO45022, 5-R37-CA084198, and 5-RO1-CA087869. R.J. is an adviser to Stemgent and cofounder of Fate Therapeutics.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Eggan K, 2003, METHOD ENZYMOL, V365, P25; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	28	245	249	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					588	598		10.1016/j.stem.2011.11.003	http://dx.doi.org/10.1016/j.stem.2011.11.003			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136932	Bronze, Green Published			2022-12-25	WOS:000297895000018
J	Tymianski, M				Tymianski, Michael			Emerging mechanisms of disrupted cellular signaling in brain ischemia	NATURE NEUROSCIENCE			English	Article							NMDA RECEPTOR ACTIVATION; HIPPOCAMPAL-NEURONS; TRPM7 CHANNELS; DEATH; PROTEIN; STROKE; CURRENTS; SUBUNITS; CALCIUM; PSD-95	Recent findings have provided insights into pathogenic mechanism(s) that may complement and add to the traditional glutamatergic mechanisms to which ischemic brain injury is ascribed. The discovery of mechanisms leading to ionic imbalance and signaling cascades that mediate cross-talk between redundant pathways of cell death, as well as mechanisms that operate downstream of, upstream of and in parallel with excitotoxicity, has spurred new research into therapeutics ranging from proof of concept in animals to human clinical trials. This Perspective presents an integrated consideration of new molecular pathogenic mechanisms underlying ischemic damage in the brain, and how our combined knowledge of these mechanisms and our existing knowledge of excitotoxicity may establish new targets for therapy, by allowing clearer boundaries on what might be expected of a given intervention, and may yield advances that will benefit patients.	[Tymianski, Michael] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Tymianski, Michael] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Tymianski, M (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	miketym2@rogers.com		Tymianski, Mike/0000-0002-6311-9565				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P179, DOI 10.1080/10799890600637522; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jia J, 2011, J CEREBR BLOOD F MET, V31, P2160, DOI 10.1038/jcbfm.2011.77; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MacDonald JF, 2006, TRENDS NEUROSCI, V29, P75, DOI 10.1016/j.tins.2005.12.001; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; McNulty S, 2005, PFLUG ARCH EUR J PHY, V451, P235, DOI 10.1007/s00424-005-1440-4; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Xie Yu-Feng, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P95; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	50	98	100	3	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1369	1373		10.1038/nn.2951	http://dx.doi.org/10.1038/nn.2951			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030547				2022-12-25	WOS:000296518600008
J	Kasri, NN; Nakano-Kobayashi, A; Van Aelst, L				Kasri, Nael Nadif; Nakano-Kobayashi, Akiko; Van Aelst, Linda			Rapid Synthesis of the X-Linked Mental Retardation Protein OPHN1 Mediates mGluR-Dependent LTD through Interaction with the Endocytic Machinery	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY; MOUSE MODEL; CEREBELLAR HYPOPLASIA; GLUTAMATE RECEPTORS; TRANSLATIONAL REGULATION; VENTRICULAR ENLARGEMENT; OLIGOPHRENIN-1 GENE; SIGNALING PATHWAY	Activation of group I metabotropic glutamate receptors leads to long-term depression (mGluR-LTD). Alterations in this form of plasticity have been linked to drug addiction and cognitive disorders. A key characteristic of mGluR-LTD is its dependence on rapid protein synthesis; however, the identities of the proteins mediating LTD remain elusive. Here, we identify the X-linked mental retardation protein OPHN1 as a molecule essential for mGluR-LTD in the hippocampus. mGluR-LTD induction elicits rapid dendritic OPHN1 synthesis, which is dependent on mGluR1 activation and independent of fragile X mental retardation protein (FMRP). This response is essential for nnGluR-LTD, as acute blockade of OPHN1 synthesis impedes LTD. mGluR-induced OPHN1 mediates LTD and associated persistent decreases in surface AMPARs via interactions with endophilin A2/3. Importantly, this role of OPHN1 is separable from its effects on basal synaptic strength, which require OPHN1's Rho-GAP activity and interaction with Homer1b/c. Thus, our data establish a role for rapid OPHN1 synthesis in mGluR-LTD.	[Kasri, Nael Nadif; Nakano-Kobayashi, Akiko; Van Aelst, Linda] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Van Aelst, L (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	vanaelst@cshl.edu	Nadif Kasri, Nael/E-2270-2012	Nadif Kasri, Nael/0000-0002-7448-9289	NAAR; NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808] Funding Source: NIH RePORTER	NAAR; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Li, J. Skowronski, E.-E. Govek, and members of the Van Aelst lab for discussions and/or critical reading of the manuscript. We are grateful to K. Svoboda and A. Zador for Fmr1 KO mice. This work was supported by NAAR and NIMH grants to L.V.A. N.N.K was a postdoctoral fellow from FWO Flanders and HFSF.	Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; des Portes V, 2004, AM J MED GENET A, V124A, P364, DOI 10.1002/ajmg.a.20422; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Nakano-Kobayashi A, 2009, CURR BIOL, V19, P1133, DOI 10.1016/j.cub.2009.05.022; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Zanni G, 2005, NEUROLOGY, V65, P1364, DOI 10.1212/01.wnl.0000182813.94713.ee; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008	46	42	42	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 20	2011	72	2					300	315		10.1016/j.neuron.2011.09.001	http://dx.doi.org/10.1016/j.neuron.2011.09.001			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017989	Green Accepted, Bronze			2022-12-25	WOS:000296224000012
J	Morrison, SE; Saez, A; Lau, B; Salzman, CD				Morrison, Sara E.; Saez, Alexandre; Lau, Brian; Salzman, C. Daniel			Different Time Courses for Learning-Related Changes in Amygdala and Orbitofrontal Cortex	NEURON			English	Article							CONDITIONAL OCULOMOTOR ASSOCIATIONS; SUPPLEMENTARY EYE FIELD; ORBITAL PREFRONTAL CORTEX; MACAQUE MONKEY AMYGDALA; NEURONAL-ACTIVITY; BASOLATERAL AMYGDALA; FRONTAL-CORTEX; REWARD CONTINGENCY; PRIMATE AMYGDALA; AVERSIVE STIMULI	The orbitofrontal cortex (OFC) and amygdala are thought to participate in reversal learning, a process in which cue-outcome associations are switched. However, current theories disagree on whether OFC directs reversal learning in the amygdala. Here, we show that during reversal of cues' associations with rewarding and aversive outcomes, neurons that respond preferentially to stimuli predicting aversive events update more quickly in amygdala than OFC; meanwhile, OFC neurons that respond preferentially to reward-predicting stimuli update more quickly than those in the amygdala. After learning, however, OFC consistently differentiates between impending reinforcements with a shorter latency than the amygdala. Finally, analysis of local field potentials (LFPs) reveals a disproportionate influence of OFC on amygdala that emerges after learning. We propose that reversal learning is supported by complex interactions between neural circuits spanning the amygdala and OFC, rather than directed by any single structure.	[Morrison, Sara E.; Saez, Alexandre; Lau, Brian; Salzman, C. Daniel] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Salzman, C. Daniel] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Salzman, C. Daniel] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Salzman, C. Daniel] Columbia Univ, Mahoney Ctr Brain & Behav, New York, NY 10032 USA; [Salzman, C. Daniel] Columbia Univ, WM Keck Ctr Brain Plast & Cognit, New York, NY 10032 USA; [Salzman, C. Daniel] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Salzman, CD (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	cds2005@columbia.edu	Lau, Brian/D-6991-2011	Lau, Brian/0000-0001-8615-8244; Morrison, Sara/0000-0003-0334-1284	NIMH; NIDA; NEI; James S. McDonnell foundation; Gatsby foundation; NSF; NIMH NRSA; Helen Hay Whitney Foundation; Kavli Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082017, F31MH081620, T32MH015144, RC1MH088458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020656] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); James S. McDonnell foundation; Gatsby foundation; NSF(National Science Foundation (NSF)); NIMH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helen Hay Whitney Foundation; Kavli Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Salzman lab and the Mahoney Center at Columbia for helpful comments and discussions; S. Dashnaw and J. Hirsch for MRI support; M. Belova and J. Paton for advice; and K. Marmon for invaluable technical assistance. This research was supported by grants from NIMH, NIDA, NEI, and the James S. McDonnell and Gatsby foundations to CDS. S.E.M. received support from an NSF graduate fellowship and from an individual NIMH NRSA. B.L. received support from NIMH institutional training grants and the Helen Hay Whitney Foundation. A.S. was supported by the Kavli Foundation. S.E.M. collected the data and analyzed the single unit data with advice from B.L. and C.D.S.; B.L. wrote the software to perform Granger analysis; A.S. analyzed the LFP data with assistance from B.L.; S.E.M. and C.D.S. designed the experiment and wrote the manuscript with input from B.L. and A.S. CDS supervised all aspects of the project.	Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Bermudez MA, 2010, J NEUROPHYSIOL, V103, P1158, DOI 10.1152/jn.00933.2009; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; Breitung J, 2006, J ECONOMETRICS, V132, P363, DOI 10.1016/j.jeconom.2005.02.004; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fudge JL, 2002, NEUROSCIENCE, V110, P257, DOI 10.1016/S0306-4522(01)00546-2; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; HABER SN, 1995, J NEUROSCI, V15, P4851; Hosokawa T, 2007, NEUROSCI RES, V57, P434, DOI 10.1016/j.neures.2006.12.003; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kazama A, 2009, J NEUROSCI, V29, P2794, DOI 10.1523/JNEUROSCI.4655-08.2009; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; LI WK, 1981, J ROY STAT SOC B MET, V43, P231; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MITZ AR, 1991, J NEUROSCI, V11, P1855; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Murray EA, 2007, ANN NY ACAD SCI, V1121, P273, DOI 10.1196/annals.1401.021; Murray EA, 2010, CURR OPIN NEUROBIOL, V20, P212, DOI 10.1016/j.conb.2010.02.001; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 2000, RHESUS MONKEY BRAIN; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS E T, 1992, P143; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Salzman CD, 2007, ANN NY ACAD SCI, V1121, P336, DOI 10.1196/annals.1401.034; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; SANGHERA MK, 1979, EXP NEUROL, V63, P610, DOI 10.1016/0014-4886(79)90175-4; Schlogl A, 2006, SIGNAL PROCESS, V86, P2426, DOI 10.1016/j.sigpro.2005.11.007; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014; Stefanacci L, 2000, J COMP NEUROL, V421, P52, DOI 10.1002/(SICI)1096-9861(20000522)421:1<52::AID-CNE4>3.0.CO;2-O; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; [No title captured]	63	96	99	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 22	2011	71	6					1127	1140		10.1016/j.neuron.2011.07.016	http://dx.doi.org/10.1016/j.neuron.2011.07.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943608	Bronze, Green Accepted			2022-12-25	WOS:000295556500016
J	Fitzgerald, JK; Freedman, DJ; Assad, JA				Fitzgerald, Jamie K.; Freedman, David J.; Assad, John A.			Generalized associative representations in parietal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; PRIMATE POSTERIOR PARIETAL; NEURONAL REPRESENTATIONS; PERCEPTUAL DECISION; PREFRONTAL CORTEX; NEURAL BASIS; MACAQUE; MEMORY; MONKEY; ORGANIZATION	Making associations between sensory stimuli is a critical aspect of behavior. We previously found that neurons in the lateral intraparietal area (LIP) of Macaca mulatta reflect learned associations between directions of moving visual stimuli. Individual LIP neurons might encode associations only for specific stimuli, such as motion directions; alternatively, they may encode more general associations whenever animals must decide between discrete alternatives. To test this, we asked whether LIP neurons encode learned associations between pairs of arbitrarily chosen static shapes and, in a separate task, whether the same neurons also encode associations between motion directions. Our experimental design dissociated the visual associations from the movements used to report those associations. We found robust encoding of the learned pair associations between shapes, and shape-pair-selective neurons tended to be selective for direction associations. These findings suggest that representing generic categorical outcomes may be a fundamental role of parietal neurons.	[Fitzgerald, Jamie K.; Freedman, David J.; Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Assad, John A.] Ctr Neurosci & Cognit Syst UniTn, Ist Italiano Tecnol, Rovereto, Italy	Harvard University; Harvard Medical School; University of Chicago; Istituto Italiano di Tecnologia - IIT	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	jassad@hms.harvard.edu			National Eye Institute [EY-12106, EY-12196]; National Institute of Mental Health Predoctoral National Research Service [F31 MH085439]; The Edward R. and Anne G. Lefler Center for the Study of Neurodegenerative Disorders; Charles H. Hood Postdoctoral Fellowship; NATIONAL EYE INSTITUTE [R01EY012106, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH085439] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health Predoctoral National Research Service; The Edward R. and Anne G. Lefler Center for the Study of Neurodegenerative Disorders; Charles H. Hood Postdoctoral Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Maunsell, M. Livingstone, R. Born, R. Wilson, D. Zaksas, D. Ruff, G. Kreiman, J. Ware and the Harvard Catalyst Program for comments and discussions, and K. Irwin, J. LeBlanc, T. Lafratta and C. Ponce for technical assistance. This work was supported by National Eye Institute grant EY-12106 (J.A.A.), Vision Core grant EY-12196, a National Institute of Mental Health Predoctoral National Research Service Award (F31 MH085439, J.K.F.), The Edward R. and Anne G. Lefler Center for the Study of Neurodegenerative Disorders Predoctoral Fellowship (J.K.F.) and a Charles H. Hood Postdoctoral Fellowship (D.J.F.).	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Fanini A, 2009, J NEUROPHYSIOL, V101, P289, DOI 10.1152/jn.00400.2007; Ferrera VP, 2006, NAT NEUROSCI, V9, P1207, DOI 10.1038/nn1006-1207; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; Herrington TM, 2009, J NEUROSCI, V29, P5793, DOI 10.1523/JNEUROSCI.4412-08.2009; Janssen P, 2008, J NEUROSCI, V28, P6679, DOI 10.1523/JNEUROSCI.0499-08.2008; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Naya Y, 2003, EUR J NEUROSCI, V18, P2915, DOI 10.1111/j.1460-9568.2003.03020.x; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Osada T, 2008, PHILOS T R SOC B, V363, P2187, DOI 10.1098/rstb.2008.2271; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 1999, J NEUROSCI, V19, P5493; Roitman JD, 2002, J NEUROSCI, V22, P9475; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Schlack A, 2007, NEURON, V53, P881, DOI 10.1016/j.neuron.2007.02.028; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Tudusciuc O, 2009, J NEUROPHYSIOL, V101, P2984, DOI 10.1152/jn.90713.2008; Vallentin D, 2010, EUR J NEUROSCI, V32, P1380, DOI 10.1111/j.1460-9568.2010.07427.x	35	60	60	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1075	U179		10.1038/nn.2878	http://dx.doi.org/10.1038/nn.2878			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765425	Green Accepted			2022-12-25	WOS:000293123700023
J	Caplan, AI; Correa, D				Caplan, Arnold I.; Correa, Diego			The MSC: An Injury Drugstore	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PROGENITOR CELLS; ADIPOSE-TISSUE; ADULT; CULTURES; THERAPY; DIFFERENTIATION; TRANSPLANTATION; MECHANISMS	Now that mesenchymal stem cells (MSCs) have been shown to be perivascular in vivo, the existing traditional view that focuses on the multipotent differentiation capacity of these cells should be expanded to include their equally interesting role as cellular modulators that brings them into a broader therapeutic scenario. We discuss existing evidence that leads us to propose that during local injury, MSCs are released from their perivascular location, become activated, and establish a regenerative microenvironment by secreting bioactive molecules and regulating the local immune response. These trophic and immunomodulatory activities suggest that MSCs may serve as site-regulated "drugstores" in vivo.	[Caplan, Arnold I.; Correa, Diego] Case Western Reserve Univ, Skeletal Res Ctr, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Caplan, AI (corresponding author), Case Western Reserve Univ, Skeletal Res Ctr, Dept Biol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	arnold.caplan@case.edu		Caplan, Arnold/0000-0002-8677-6621	E. Virginia and L. David Baldwin Research Fund; NIH [PO1-AR053622]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR053622] Funding Source: NIH RePORTER	E. Virginia and L. David Baldwin Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support for this article was provided by the E. Virginia and L. David Baldwin Research Fund and the NIH (PO1-AR053622).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2010, TISSUE ENG PT A, V16, P2415, DOI 10.1089/ten.TEA.2010.0216; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9; Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Itescu S, 2003, J MOL MED, V81, P288, DOI 10.1007/s00109-003-0432-0; Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI 10.1517/14712598.8.5.569 ; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Miller RH, 2010, DISCOV MED, V9, P236; Minguell JJ, 2006, EXP BIOL MED, V231, P39; Moretti P, 2010, ADV BIOCHEM ENG BIOT, V123, P29, DOI 10.1007/10_2009_15; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; OWEN M, 1988, CIBA F SYMP, V136, P42; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schuster MD, 2004, AM J PHYSIOL-HEART C, V287, pH525, DOI 10.1152/ajpheart.00058.2004; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009	53	1070	1110	3	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					11	15		10.1016/j.stem.2011.06.008	http://dx.doi.org/10.1016/j.stem.2011.06.008			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726829	Green Accepted, Bronze			2022-12-25	WOS:000293157000005
J	Chadick, JZ; Gazzaley, A				Chadick, James Z.; Gazzaley, Adam			Differential coupling of visual cortex with default or frontal-parietal network based on goals	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY PERFORMANCE; TOP-DOWN MODULATION; FUNCTIONAL INTERACTIONS; COGNITIVE TASK; HUMAN BRAIN; SUPPRESSION; ATTENTION	The relationship between top-down enhancement and suppression of sensory cortical activity and large-scale neural networks remains unclear. Functional connectivity analysis of human functional magnetic resonance imaging data revealed that visual cortical areas that selectively process relevant information are functionally connected with the frontal-parietal network, whereas those that process irrelevant information are simultaneously coupled with the default network. This indicates that sensory cortical regions are differentially and dynamically coupled with distinct networks on the basis of task goals.	[Chadick, James Z.; Gazzaley, Adam] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gazzaley, A (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA.	adam.gazzaley@ucsf.edu			US National Institutes of Health [5R01AG030395]; Larry L. Hillblom Center for the Biology of Aging; NATIONAL INSTITUTE ON AGING [R01AG030395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Center for the Biology of Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank A. Rutman, M. Ruben, J.A. Anguera, E. Morsella and T. Zanto for their assistance. This work was supported by the grants from the US National Institutes of Health, including 5R01AG030395 (A.G.), and Larry L. Hillblom Center for the Biology of Aging Graduate Fellowship (J.Z.C.).	Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009	15	158	161	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					830	832		10.1038/nn.2823	http://dx.doi.org/10.1038/nn.2823			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623362	Green Accepted			2022-12-25	WOS:000292081700009
J	Hua, YF; Sinha, R; Thiel, CS; Schmidt, R; Huve, J; Martens, H; Hell, SW; Egner, A; Klingauf, J				Hua, Yunfeng; Sinha, Raunak; Thiel, Cora S.; Schmidt, Roman; Hueve, Jana; Martens, Henrik; Hell, Stefan W.; Egner, Alexander; Klingauf, Jurgen			A readily retrievable pool of synaptic vesicles	NATURE NEUROSCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIVE ZONES; MEMBRANE; TRANSMITTER; EXOCYTOSIS; SYNAPSES; MODES; SYNAPTOBREVIN; LOCALIZATION; TRAFFICKING	Although clathrin-mediated endocytosis is thought to be the predominant mechanism of synaptic vesicle recycling, it seems to be too slow for fast recycling. Therefore, it was suggested that a presorted and preassembled pool of synaptic vesicle proteins on the presynaptic membrane might support a first wave of fast clathrin-mediated endocytosis. In this study we monitored the temporal dynamics of such a 'readily retrievable pool' of synaptic vesicle proteins in rat hippocampal neurons using a new type of probe. By applying cypHer5E, a new cyanine dye-based pH-sensitive exogenous marker, coupled to antibodies to luminal domains of synaptic vesicle proteins, we could reliably monitor synaptic vesicle recycling and demonstrate the preferential recruitment of a surface pool of synaptic vesicle proteins upon stimulated endocytosis. By using fluorescence nanoscopy of surface-labeled synaptotagmin 1, we could resolve the spatial distribution of the surface pool at the periactive zone in hippocampal boutons, which represent putative sites of endocytosis.	[Hua, Yunfeng; Sinha, Raunak; Thiel, Cora S.; Klingauf, Jurgen] Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany; [Hua, Yunfeng; Sinha, Raunak; Thiel, Cora S.; Hueve, Jana; Klingauf, Jurgen] Univ Munster, Inst Med Phys & Biophys, Dept Cellular Biophys, Munster, Germany; [Schmidt, Roman; Hell, Stefan W.; Egner, Alexander] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Hueve, Jana; Klingauf, Jurgen] Ctr Nanotechnol CeNTech, Fluorescence Microscopy Facil Muenster, Munster, Germany; [Martens, Henrik] Synapt Syst GmbH, Gottingen, Germany	Max Planck Society; University of Munster; Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany.	klingauf@uni-muenster.de		Hua, Yunfeng/0000-0003-0072-7122; Egner, Alexander/0000-0001-5248-3858	European Science Foundation/Deutsche Forschungsgemeinschaft (DFG) [CRP FP-020]; DFG [Kl 1334/1-1, SFB 944, CMPB, SFB755]; Max-Planck Foundation; International Max Planck Research School in Neurosciences at the University of Goettingen	European Science Foundation/Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)European Science Foundation (ESF)); DFG(German Research Foundation (DFG)); Max-Planck Foundation(Foundation CELLEX); International Max Planck Research School in Neurosciences at the University of Goettingen	We thank M. Pilot and I. Herfort for the preparation of primary cell cultures of hippocampal neurons and E. Neher and R. H. Chow for critical reading of the manuscript. We acknowledge D. Boening and M. Martineau for experimental support and we are grateful to K. Kolmakov and V. Belov (Max Planck Institute for Biophysical Chemistry, Goettingen) for providing us with the new fluorescent dye KK114. We thank G. Miesenbock (Oxford University) for providing superecliptic spH. We would also like to thank M. Hoon and N. Glyvuk for suggestions. This work was supported by grants from the European Science Foundation/Deutsche Forschungsgemeinschaft (DFG) (EUROMEMBRANE programme, EuroSynapse CRP FP-020 to J.K.) as well as from the DFG (Kl 1334/1-1 to C. S. T. and J.K., SFB 944 to J.K., CMPB to A. E. and S. W. H., and SFB755 to A. E. and S. W. H.). Y.H. is supported by a stipend from the Max-Planck Foundation and R. Sinha is supported by a stipend from the International Max Planck Research School in Neurosciences at the University of Goettingen.	Adie EJ, 2003, ASSAY DRUG DEV TECHN, V1, P251, DOI 10.1089/15406580360545062; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Brodin L, 2006, CELL TISSUE RES, V326, P301, DOI 10.1007/s00441-006-0216-2; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Goslin K., 1991, CULTURING NERVE CELL, P251; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hua YF, 2010, NAT NEUROSCI, V13, P1451, DOI 10.1038/nn.2695; Huve J, 2008, BIOPHYS J, V95, P877, DOI 10.1529/biophysj.107.127449; Kano H, 2002, ULTRAMICROSCOPY, V90, P207, DOI 10.1016/S0304-3991(01)00132-2; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Tabares L, 2007, J NEUROSCI, V27, P5422, DOI 10.1523/JNEUROSCI.0670-07.2007; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Teng HB, 1999, J NEUROSCI, V19, P4855; Teng HB, 2000, J NEUROSCI, V20, P7986; Vanden Berghe P, 2006, J PHYSIOL-LONDON, V572, P707, DOI 10.1113/jphysiol.2005.100842; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yao CK, 2009, CELL, V138, P947, DOI 10.1016/j.cell.2009.06.033; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	50	110	111	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					833	U42		10.1038/nn.2838	http://dx.doi.org/10.1038/nn.2838			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666673	Green Published			2022-12-25	WOS:000292081700010
J	Logan, MA; Hackett, R; Doherty, J; Sheehan, A; Speese, SD; Freeman, MR				Logan, Mary A.; Hackett, Rachel; Doherty, Johnna; Sheehan, Amy; Speese, Sean D.; Freeman, Marc R.			Negative regulation of glial engulfment activity by Draper terminates glial responses to axon injury	NATURE NEUROSCIENCE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INHIBITORY ITAMS; RECEPTOR DRAPER; NERVOUS-SYSTEM; NITRIC-OXIDE; TNF-ALPHA; DROSOPHILA; MICROGLIA; BRAIN; CELLS	Neuronal injury elicits potent cellular responses from glia, but molecular pathways modulating glial activation, phagocytic function and termination of reactive responses remain poorly defined. Here we show that positive or negative regulation of glial responses to axon injury is molecularly encoded by unique isoforms of the Drosophila melanogaster engulfment receptor Draper. Draper-I promotes engulfment of axonal debris through an immunoreceptor tyrosine based activation motif (ITAM). In contrast, Draper-II, an alternative splice variant, potently inhibits glial engulfment function. Draper-II suppresses Draper-I signaling through a previously undescribed immunoreceptor tyrosine based inhibitory motif (ITIM)-like domain and the tyrosine phosphatase Corkscrew (Csw). Intriguingly, loss of Draper-II Csw signaling prolongs expression of glial engulfment genes after axotomy and reduces the ability of glia to respond to secondary axotomy. Our work highlights a novel role for Draper-II in inhibiting glial responses to neurodegeneration, and indicates that a balance of opposing Draper-I and Draper-II signaling events is essential to maintain glial sensitivity to brain injury.	[Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Logan, MA (corresponding author), Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA.	loganm@ohsu.edu		Freeman, Marc/0000-0003-3481-3715; Speese, Sean/0000-0002-3965-9828	US National Institutes of Health (NIH) [1RO1NS053538]; NIH [P30NS069346 P30]; American Cancer Society [PF-07-258-01-CSM]; Medical Research Foundation of Oregon; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069346, R01NS053538] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Medical Research Foundation of Oregon; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Awasaki, M. Simon, E. Perkins, B. Dickson and the Vienna Drosophila RNAi Center (VDRC) for sharing fly lines and antibodies. We thank K. Kerr for technical advice and expertise. This work was supported by US National Institutes of Health (NIH) Grant 1RO1NS053538 (M.R.F.), NIH New Faculty Recruitment Grant P30NS069346 P30 (M.A.L.), an American Cancer Society Postdoctoral Fellowship (PF-07-258-01-CSM) (M.A.L.) and the Medical Research Foundation of Oregon (M.A.L.). M.R.F. is a Howard Hughes Medical Institute Early Career Scientist.	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Blasioli J, 1999, J BIOL CHEM, V274, P2303, DOI 10.1074/jbc.274.4.2303; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee SM, 2011, IMMUNOLOGY, V134, P224, DOI 10.1111/j.1365-2567.2011.03481.x; Logan MA, 2007, NEURON GLIA BIOL, V3, P63, DOI [10.1017/S1740925X0700049X, 10.1017/S1740925X07000646]; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Olcese L, 1996, J IMMUNOL, V156, P4531; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; PERRIMON N, 1985, GENETICS, V111, P23; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qin IY, 2005, FASEB J, V19, P550, DOI 10.1096/fj.04-2857com; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Singh TD, 2010, FEBS LETT, V584, P3936, DOI 10.1016/j.febslet.2010.08.050; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; Zhao J, 2006, GLIA, V53, P304, DOI 10.1002/glia.20283; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	46	56	59	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					722	730		10.1038/nn.3066	http://dx.doi.org/10.1038/nn.3066			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22426252	Green Accepted			2022-12-25	WOS:000303270200016
J	Smith, CJ; Watson, JD; VanHovene, MK; Colon-Ramos, DA; Miller, DM				Smith, Cody J.; Watson, Joseph D.; VanHovene, Miri K.; Colon-Ramos, Daniel A.; Miller, David M., III			Netrin (UNC-6) mediates dendritic self-avoidance	NATURE NEUROSCIENCE			English	Article							PIONEER AXON MIGRATIONS; CAENORHABDITIS-ELEGANS; GUIDES CELL; GUIDANCE; PROTEIN; MECHANISMS; OUTGROWTH; HOMOLOG; RECOGNITION; ATTRACTION	Dendrites from a single neuron may be highly branched but typically do not overlap. Self-avoidance behavior has been shown to depend on cell-specific membrane proteins that trigger mutual repulsion. Here we report the unexpected discovery that a diffusible cue, the axon guidance protein UNC-6 (Netrin), is required for self-avoidance of sister dendrites from the PVD nociceptive neuron in Caenorhabditis elegans. We used time-lapse imaging to show that dendrites fail to withdraw upon mutual contact in the absence of UNC-6 signaling. We propose a model in which the UNC-40 (Deleted in Colorectal Cancer; DCC) receptor captures UNC-6 at the tips of growing dendrites for interaction with UNC-5 on the apposing branch to induce mutual repulsion. UNC-40 also responds to dendritic contact through another pathway that is independent of UNC-6. Our findings offer a new model for how an evolutionarily conserved morphogenic cue and its cognate receptors can pattern a fundamental feature of dendritic architecture.	[Smith, Cody J.; Watson, Joseph D.; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Watson, Joseph D.; Miller, David M., III] Vanderbilt Univ, Neurosci Program, Nashville, TN USA; [Watson, Joseph D.; Miller, David M., III] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN USA; [VanHovene, Miri K.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Colon-Ramos, Daniel A.] Yale Univ, Dept Cell Biol, New Haven, CT USA; [Colon-Ramos, Daniel A.] Yale Univ, Program Cellular Neurosci & Neurodegenerat & Repa, New Haven, CT USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; California State University System; San Jose State University; Yale University; Yale University	Miller, DM (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA.	david.miller@vanderbilt.edu		VanHoven, Miri/0000-0001-7714-1555	US National Institutes of Health (NIH) National Center for Research Resources; NIH [R01 NS26115, R21 NS06882, F31 NS071801, R00 NS057931, MBRS SC3 GM089595]; Klingenstein Foundation; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM089595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026115, R00NS057931, R21NS066882, F31NS071801] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Bargmann (Rockefeller University) for unc-86::UNC-40::GFP, hspl6.2:: UNC-6::HA and the CX6488 strain; W. Wadsworth (Rutgers University) for the pIM97 unc-6 expression construct and unc-6(rh46); K. Shen (Stanford University) for constructs used to make pCJS01, F49H12.4::gateway::mcherry; P. Roy (University of Toronto) for the unc-40(e271) sequence; Y. Goshima (Yokohama City University) for ghls9; J. Culotti (Mount Sinai Hospital, Toronto) for the unc-5 rescue construct and for the modified UNC-5 protein strains used for structure function analysis and members of the D.M.M., R.B. and D.A.C.-R. laboratories for technical advice and for comments on the manuscript. Some of the strains used in this work were provided by the C. elegans Genetics Center, which is supported by the US National Institutes of Health (NIH) National Center for Research Resources. This work was supported by NIH R01 NS26115 (D.M.M.), NIH R21 NS06882 (D.M.M.), NIH F31 NS071801 (C.J.S.), NIH R00 NS057931 (D.A.C.-R.), the Klingenstein Foundation and an Alfred P. Sloan Foundation fellowship (D.A.C.-R.), and NIH MBRS SC3 GM089595 (M.K.V.).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Aguirre-Chen C, 2011, DEVELOPMENT, V138, P507, DOI 10.1242/dev.060939; Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Alexander M, 2009, DEVELOPMENT, V136, P911, DOI 10.1242/dev.030759; Asakura T, 2007, DEV BIOL, V304, P800, DOI 10.1016/j.ydbio.2007.01.028; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Eastman C, 1999, J NEUROSCI, V19, P6225; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Fleming T, 2010, DEV BIOL, V344, P94, DOI 10.1016/j.ydbio.2010.04.025; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hiramoto M, 2006, NAT NEUROSCI, V9, P58, DOI 10.1038/nn1612; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Killeen M, 2002, DEV BIOL, V251, P348, DOI 10.1006/dbio.2002.0825; Kuzina I, 2011, DEVELOPMENT, V138, P1839, DOI 10.1242/dev.062471; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; MacNeil LT, 2009, NAT NEUROSCI, V12, P150, DOI 10.1038/nn.2256; Matsubara D, 2011, GENE DEV, V25, P1982, DOI 10.1101/gad.16531611; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Merz DC, 2001, GENETICS, V158, P1071; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Park J, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-28; Quinn CC, 2008, CURR BIOL, V18, P808, DOI 10.1016/j.cub.2008.04.050; Schwarz V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-13; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Teichmann HM, 2011, NAT NEUROSCI, V14, P165, DOI 10.1038/nn.2717; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; Xu ZN, 2009, GENETICS, V183, P941, DOI 10.1534/genetics.109.108654; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	46	68	76	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					731	737		10.1038/nn.3065	http://dx.doi.org/10.1038/nn.3065			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22426253	Green Accepted			2022-12-25	WOS:000303270200017
J	Padgett, CL; Lalive, AL; Tan, KR; Terunuma, M; Munoz, MB; Pangalos, MN; Martinez-Hernandez, J; Watanabe, M; Moss, SJ; Lujan, R; Luscher, C; Slesinger, PA				Padgett, Claire L.; Lalive, Arnaud L.; Tan, Kelly R.; Terunuma, Miho; Munoz, Michaelanne B.; Pangalos, Menelas N.; Martinez-Hernandez, Jose; Watanabe, Masahiko; Moss, Stephen J.; Lujan, Rafael; Luescher, Christian; Slesinger, Paul A.			Methamphetamine-Evoked Depression of GABA(B) Receptor Signaling in GABA Neurons of the VTA	NEURON			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; MIDBRAIN DOPAMINE NEURONS; RECTIFYING POTASSIUM CHANNELS; PROTEIN-COUPLED RECEPTORS; KNOCK-OUT MICE; IN-VIVO; CHRONIC COCAINE; SYNAPTIC PLASTICITY; AMPHETAMINE TREATMENT	Psychostimulants induce neuroadaptations in excitatory and fast inhibitory transmission in the ventral tegmental area (VTA). Mechanisms underlying drug-evoked synaptic plasticity of slow inhibitory transmission mediated by GABA(B) receptors and G protein-gated inwardly rectifying potassium (GIRK/Kir(3)) channels, however, are poorly understood. Here, we show that 1 day after methamphetamine (METH) or cocaine exposure both synaptically evoked and baclofen-activated GABA(B)R-GIRK currents were significantly depressed in VTA GABA neurons and remained depressed for 7 days. Presynaptic inhibition mediated by GABA(B)Rs on GABA terminals was also weakened. Quantitative immunoelectron microscopy revealed internalization of GABA(B1) and GIRK2, which occurred coincident with dephosphorylation of serine 783 (S783) in GABA(B2), a site implicated in regulating GABA(B)R surface expression. Inhibition of protein phosphatases recovered GABABR-GIRK currents in VTA GABA neurons of METH-injected mice. This psychostimulant-evoked impairment in GABA(B)R signaling removes an intrinsic brake on GABA neuron spiking, which may augment GABA transmission in the mesocorticolimbic system.	[Lalive, Arnaud L.; Tan, Kelly R.; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Padgett, Claire L.; Munoz, Michaelanne B.; Slesinger, Paul A.] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Luescher, Christian] Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, CH-1211 Geneva, Switzerland; [Munoz, Michaelanne B.; Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Martinez-Hernandez, Jose; Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Inst Invest Discapacidades Neurol IDINE, Dept Ciencias Med, Albacete 02006, Spain; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Pangalos, Menelas N.] AstraZeneca, Innovat Med, Macclesfield SK10 4TG, Cheshire, England	University of Geneva; Salk Institute; University of Geneva; Tufts University; University of London; University College London; Universidad de Castilla-La Mancha; Hokkaido University; AstraZeneca	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, 1 Michel Servet, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch; slesinger@salk.edu	Martinez-Hernandez, Jose/A-6760-2012; WATANABE, Masahiko/A-4055-2012; Lujan, Rafael/G-2555-2015; Lüscher, Christian/A-2496-2011; Martinez-Hernandez, Jose/ABE-3991-2020; Watanabe, Masahiko/S-3614-2019	Martinez-Hernandez, Jose/0000-0002-5017-2877; WATANABE, Masahiko/0000-0001-5037-7138; Lüscher, Christian/0000-0001-7917-4596; Martinez-Hernandez, Jose/0000-0002-5017-2877; Watanabe, Masahiko/0000-0001-5037-7138; Terunuma, Miho/0000-0003-1876-9726; Lujan Miras, Rafael/0000-0003-2001-9545	Salk Institute's Catharina Foundation; Spanish Ministry of Education and Science [BFU-2009-08404]; Consolider [CSD2008-00005]; National Institute of Neurological Disorders and Stroke [NS048045, NS051195, NS056359, NS054900]; National Research Service [F31 DA029401]; National Institute on Drug Abuse [DA019022, DA025236]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081986, R01NS056359, R01NS048045, P01NS054900, R01NS051195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA029401, R21DA025236, R01DA019022] Funding Source: NIH RePORTER	Salk Institute's Catharina Foundation; Spanish Ministry of Education and Science(Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Research Service; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the Slesinger and Luscher laboratories, as well as G.O. Hjelmstad for comments on the manuscript. This work was supported by grants from the Salk Institute's Catharina Foundation (Postdoctoral Fellowship to C.L.P.), the Spanish Ministry of Education and Science (BFU-2009-08404 to R.L.) and Consolider (CSD2008-00005 to R.L.), the National Institute of Neurological Disorders and Stroke (NS048045, NS051195, NS056359, and NS054900 to S.J.M.), a Ruth L. Kirschstein National Research Service Award (F31 DA029401 to M.B.M) and the National Institute on Drug Abuse (DA019022 to P.A.S. and C.L.; DA025236 to P.A.S.).	Aguado C, 2008, J NEUROCHEM, V105, P497, DOI 10.1111/j.1471-4159.2007.05153.x; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Arora D, 2011, J NEUROSCI, V31, P12251, DOI 10.1523/JNEUROSCI.0494-11.2011; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bonci A, 1996, NEURON, V16, P631, DOI 10.1016/S0896-6273(00)80082-3; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Boyer SB, 2009, J NEUROSCI, V29, P15796, DOI 10.1523/JNEUROSCI.4103-09.2009; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; Clancy SM, 2007, J NEUROSCI, V27, P6388, DOI 10.1523/JNEUROSCI.1190-07.2007; Cooper DC, 2002, NEUROCHEM INT, V41, P333, DOI 10.1016/S0197-0186(02)00068-2; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Cruz HG, 2008, J NEUROSCI, V28, P4069, DOI 10.1523/JNEUROSCI.0267-08.2008; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Dobbs LK, 2008, NEUROSCIENCE, V156, P700, DOI 10.1016/j.neuroscience.2008.07.052; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; Erhardt S, 2002, N-S ARCH PHARMACOL, V365, P173, DOI 10.1007/s00210-001-0519-5; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Fukushima S, 2007, PSYCHOPHARMACOLOGY, V193, P55, DOI 10.1007/s00213-007-0749-4; Giorgetti M, 2002, NEUROSCIENCE, V109, P585, DOI 10.1016/S0306-4522(01)00510-3; Gonzalez-Maeso J, 2003, EUR J PHARMACOL, V481, P15, DOI 10.1016/j.ejphar.2003.09.002; GRACE AA, 1985, BRAIN RES, V333, P271, DOI 10.1016/0006-8993(85)91581-1; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; GUO H, 1993, J BIOL CHEM, V268, P11193; HENRY DJ, 1989, J PHARMACOL EXP THER, V251, P833; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kulik A, 2003, J NEUROSCI, V23, P11026; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lehrmann E, 2003, PHARMACOGENOMICS J, V3, P27, DOI 10.1038/sj.tpj.6500146; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Manzoni OJ, 1999, J NEUROSCI, V19, P6629; Morgan AD, 2003, NEUROPSYCHOPHARMACOL, V28, P932, DOI 10.1038/sj.npp.1300100; NESTLER EJ, 1990, J NEUROCHEM, V55, P1079, DOI 10.1111/j.1471-4159.1990.tb04602.x; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Pu L, 2006, NAT NEUROSCI, V9, P605, DOI 10.1038/nn1687; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; ROBERTS DCS, 1982, PHARMACOL BIOCHEM BE, V17, P901, DOI 10.1016/0091-3057(82)90469-5; Scibelli AC, 2011, PSYCHOPHARMACOLOGY, V214, P791, DOI 10.1007/s00213-010-2086-2; Shimosato K, 2001, N-S ARCH PHARMACOL, V364, P74, DOI 10.1007/s002100100433; Shoji S, 1997, J PHARMACOL EXP THER, V280, P129; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Taniyama K, 1991, Adv Exp Med Biol, V287, P413; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vardya I, 2010, EXP NEUROL, V225, P114, DOI 10.1016/j.expneurol.2010.05.022; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; WHITE FJ, 1984, BRAIN RES, V309, P283; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Xi ZX, 2003, J NEUROSCI, V23, P3498; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	75	95	99	2	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					978	989		10.1016/j.neuron.2011.12.031	http://dx.doi.org/10.1016/j.neuron.2011.12.031			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405207	Green Accepted, Bronze			2022-12-25	WOS:000301558600012
J	Nandy, AS; Tjan, BS				Nandy, Anirvan S.; Tjan, Bosco S.			Saccade-confounded image statistics explain visual crowding	NATURE NEUROSCIENCE			English	Article							HORIZONTAL CONNECTIONS; OBJECT RECOGNITION; PERCEPTION; RESOLUTION; EMERGENCE; ATTENTION; CONTEXT; CORTEX; V1; V4	Processing of shape information in human peripheral visual fields is impeded beyond what can be expected by poor spatial resolution. Visual crowding, the inability to identify objects in clutter, has been shown to be the primary factor limiting shape perception in peripheral vision. Despite the well-documented effects of crowding, its underlying causes remain poorly understood. Given that spatial attention both facilitates learning of image statistics and directs saccadic eye movements, we propose that the acquisition of image statistics in peripheral visual fields is confounded by eye-movement artifacts. Specifically, the image statistics acquired under a peripherally deployed spotlight of attention are systematically biased by saccade-induced image displacements. These erroneously represented image statistics lead to inappropriate contextual interactions in the periphery and cause crowding.	[Nandy, Anirvan S.; Tjan, Bosco S.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Tjan, Bosco S.] Univ So Calif, Neurosci Grad Program, Los Angeles, CA USA	University of Southern California; University of Southern California	Nandy, AS (corresponding author), Salk Inst Biol Studies, Syst Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nandy@salk.edu; btjan@usc.edu		Nandy, Anirvan/0000-0002-4225-5349	US National Institutes of Health [EY017707]; NATIONAL EYE INSTITUTE [R01EY017707] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to thank I. Biederman, A. Disney, J. Hirsch, M. Jadi, R. Millin and J. Reynolds for helpful comments on the manuscript. This research was supported by US National Institutes of Health grant EY017707 (B.S.T.).	Bahill A.T., 1975, INVEST OPHTH VIS SCI, V14, P68; Ben-Shahar O, 2004, NEURAL COMPUT, V16, P445, DOI 10.1162/089976604772744866; Bosking WH, 1997, J NEUROSCI, V17, P2112; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Bruce NDB, 2006, NEUROCOMPUTING, V69, P1301, DOI 10.1016/j.neucom.2005.12.096; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castet E, 2002, P NATL ACAD SCI USA, V99, P15159, DOI 10.1073/pnas.232377199; De Pisapia N, 2010, CURR BIOL, V20, P613, DOI 10.1016/j.cub.2010.01.056; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Garcia-Perez MA, 2001, J NEUROSCI, V21, P7313, DOI 10.1523/JNEUROSCI.21-18-07313.2001; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Gilbert C, 2000, VISION RES, V40, P1217, DOI 10.1016/S0042-6989(99)00234-5; Greenwood JA, 2010, CURR BIOL, V20, P496, DOI 10.1016/j.cub.2010.01.023; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lebedev S, 1996, INVEST OPHTH VIS SCI, V37, P2750; Levi DM, 2007, J VISION, V7, DOI 10.1167/7.2.21; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2009, CURR BIOL, V19, P1988, DOI 10.1016/j.cub.2009.09.056; Levi DM, 2002, J VISION, V2, P167, DOI 10.1167/2.2.3; Motter B. C., 2002, J VISION, V2, P274, DOI DOI 10.1167/2.7.274; Motter BC, 2007, J VISION, V7, DOI 10.1167/7.2.6; Motter BC, 2009, J NEUROSCI, V29, P5749, DOI 10.1523/JNEUROSCI.4496-08.2009; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Neri P, 2006, J NEUROPHYSIOL, V96, P142, DOI 10.1152/jn.01261.2005; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Petrov Y, 2007, J VISION, V7, DOI 10.1167/7.2.12; Pinon MC, 1998, CEREB CORTEX, V8, P685, DOI 10.1093/cercor/8.8.685; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; van den Berg R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000646; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; WILSON JR, 1976, J NEUROPHYSIOL, V39, P512, DOI 10.1152/jn.1976.39.3.512; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	49	80	83	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					463	U159		10.1038/nn.3021	http://dx.doi.org/10.1038/nn.3021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22231425	Green Accepted			2022-12-25	WOS:000300793100021
J	Retchless, BS; Gao, W; Johnson, JW				Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.			A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; K+ CHANNEL; EXTRACELLULAR VESTIBULE; SUBSTITUTED CYSTEINES; XENOPUS-OOCYTES; EXTERNAL MG2+; MUTANT CYCLES; ION CHANNELS; BLOCK	NMDA receptors (NMDARs) are glutamate-gated ion channels that are present at most excitatory mammalian synapses. The four GluN2 subunits (GluN2A-D) contribute to four diheteromeric NMDAR subtypes that have divergent physiological and pathological roles. Channel properties that are fundamental to NMDAR function vary among subtypes. We investigated the amino acid residues responsible for variations in channel properties by creating and examining NMDARs containing mutant GluN2 subunits. We found that the NMDAR subtype specificity of three crucial channel properties, Mg2+ block, selective permeability to Ca2+ and single-channel conductance, were all controlled primarily by the residue at a single GluN2 site in the M3 transmembrane region. Mutant cycle analysis guided by molecular modeling revealed that a GluN2-GluN1 subunit interaction mediates the site's effects. We conclude that a single GluN2 subunit residue couples with the pore-forming loop of the GluN1 subunit to create naturally occurring variations in NMDAR properties that are critical to synaptic plasticity and learning.	[Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Retchless, Beth Siegler; Gao, Wei; Johnson, Jon W.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JW (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	jjohnson@pitt.edu			US National Institutes of Health [R01 MH045817, F31 MH079755]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH079755, R01MH045817] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank A. Qian for valuable contributions to and advice on initial experiments, K. Bouch and C. Shiber for excellent technical assistance, M. Pellegrino for generous help with statistical analyses, M. Casio and A. Retchless for helpful discussions and comments on the manuscript, S. Meriney, M. Grabe, D. Wood and members of the Johnson laboratory for helpful discussions, and D. Colquhoun for making available the DC Analysis programs for single-channel analysis. This work was supported by US National Institutes of Health grants R01 MH045817 and associated S1 supplement (J.W.J.) and F31 MH079755 (B.S.R.).	Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; [Anonymous], 2004, STAT ANAL DATA DISPL; Antonov SM, 1999, P NATL ACAD SCI USA, V96, P14571, DOI 10.1073/pnas.96.25.14571; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chiu JC, 2002, MOL BIOL EVOL, V19, P1066, DOI 10.1093/oxfordjournals.molbev.a004165; Clarke RJ, 2006, J NEUROSCI, V26, P5825, DOI 10.1523/JNEUROSCI.0577-06.2006; Clinton SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1353, DOI 10.1038/sj.npp.1300451; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun David, 1995, P483; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHII T, 1993, J BIOL CHEM, V268, P2836; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuner T, 1996, J NEUROSCI, V16, P3549; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Madhusudhan M.S., 2007, CURR PROTOC PROTEIN, V2; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Qian A, 2005, J PHYSIOL-LONDON, V562, P319, DOI 10.1113/jphysiol.2004.076737; Qian AQ, 2006, J NEUROSCI, V26, P10899, DOI 10.1523/JNEUROSCI.3453-06.2006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schneggenburger R, 1996, BIOPHYS J, V70, P2165, DOI 10.1016/S0006-3495(96)79782-5; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprengel R, 2001, TRENDS PHARMACOL SCI, V22, P7, DOI 10.1016/S0165-6147(00)01588-1; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; Tikhonov DB, 2002, BIOPHYS J, V82, P1884, DOI 10.1016/S0006-3495(02)75538-0; Tikhonov DB, 2007, MOL MEMBR BIOL, V24, P135, DOI 10.1080/09687860601008806; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Williams K, 1998, MOL PHARMACOL, V53, P933; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Wrighton DC, 2008, J PHYSIOL-LONDON, V586, P211, DOI 10.1113/jphysiol.2007.143164; Wyllie DJA, 1996, P ROY SOC B-BIOL SCI, V263, P1079, DOI 10.1098/rspb.1996.0159; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009	50	62	63	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					406	U89		10.1038/nn.3025	http://dx.doi.org/10.1038/nn.3025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246434	Green Accepted			2022-12-25	WOS:000300793100014
J	Shinohara, R; Thumkeo, D; Kamijo, H; Kaneko, N; Sawamoto, K; Watanabe, K; Takebayashi, H; Kiyonari, H; Ishizaki, T; Furuyashiki, T; Narumiya, S				Shinohara, Ryota; Thumkeo, Dean; Kamijo, Hiroshi; Kaneko, Naoko; Sawamoto, Kazunobu; Watanabe, Keisuke; Takebayashi, Hirohide; Kiyonari, Hiroshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh			A role for mDia, a Rho-regulated actin nucleator, in tangential migration of interneuron precursors	NATURE NEUROSCIENCE			English	Article							NEURONAL MIGRATION; CENTROSOME SEPARATION; CEREBRAL-CORTEX; CELL-MIGRATION; ADULT BRAIN; NEUROGENESIS; MOVEMENT; CYTOSKELETON; PROTEIN; DIFFERENTIATION	In brain development, distinct types of migration, radial migration and tangential migration, are shown by excitatory and inhibitory neurons, respectively. Whether these two types of migration operate by similar cellular mechanisms remains unclear. We examined neuronal migration in mice deficient in mDia1 (also known as Diap1) and mDia3 (also known as Diap2), which encode the Rho-regulated actin nucleators mammalian diaphanous homolog 1 (mDia1) and mDia3. mDia deficiency impaired tangential migration of cortical and olfactory inhibitory interneurons, whereas radial migration and consequent layer formation of cortical excitatory neurons were unaffected. mDia-deficient neuroblasts exhibited reduced separation of the centrosome from the nucleus and retarded nuclear translocation. Concomitantly, anterograde F-actin movement and F-actin condensation at the rear, which occur during centrosomal and nuclear movement of wild-type cells, respectively, were impaired in mDia-deficient neuroblasts. Blockade of Rho-associated protein kinase (ROCK), which regulates myosin II, also impaired nuclear translocation. These results suggest that Rho signaling via mDia and ROCK critically regulates nuclear translocation through F-actin dynamics in tangential migration, whereas this mechanism is dispensable in radial migration.	[Shinohara, Ryota; Thumkeo, Dean; Kamijo, Hiroshi; Ishizaki, Toshimasa; Furuyashiki, Tomoyuki; Narumiya, Shuh] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto, Japan; [Kaneko, Naoko; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Inst Mol Med, Nagoya, Aichi, Japan; [Watanabe, Keisuke; Takebayashi, Hirohide] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Furuyashiki, Tomoyuki; Narumiya, Shuh] Core Res Evolut Sci & Technol, Tokyo, Japan	Kyoto University; Nagoya City University; Kumamoto University; RIKEN; Japan Science & Technology Agency (JST)	Narumiya, S (corresponding author), Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Takebayashi, Hirohide/AAO-1693-2020; Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014; Kaneko, Naoko/P-2054-2019; Shinohara, Ryota/AAN-1274-2021	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Shinohara, Ryota/0000-0001-5279-2642; Sawamoto, Kazunobu/0000-0003-1984-5129; Kaneko, Naoko/0000-0003-3121-7117	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23680041] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okabe for providing pCX-EGFP, F. Matsuzaki for providing pCAG-EGFP-C1 and pCAG-PACT-mKO1, Y. Yanagawa for providing GAD65 and GAD67 antisense probes, Y. Deguchi for providing mDia3 riboprobes, A. Mizutani for animal care, K. Tohyama for supporting genotyping and plasmid construction, T. Arai and A. Washimi for secretarial help, and K. Nonomura for technical assistance. R. S. thanks A. Kakizuka for providing the opportunity to work in Kyoto University Graduate School of Medicine. R. S. was supported by the Japan Society for the Promotion of Science Research Fellowship. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Core Research for Evolutional Science and Technology (CREST) grant from Japan Science and Technology Agency.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Baudoin JP, 2008, DEV NEUROSCI-BASEL, V30, P132, DOI 10.1159/000109858; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Vaughan S, 2011, TRENDS CELL BIOL, V21, P57, DOI 10.1016/j.tcb.2010.09.004; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452	50	91	94	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					373	U193		10.1038/nn.3020	http://dx.doi.org/10.1038/nn.3020			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246438	Green Submitted			2022-12-25	WOS:000300793100010
J	Choe, Y; Siegenthaler, JA; Pleasure, SJ				Choe, Youngshik; Siegenthaler, Julie A.; Pleasure, Samuel J.			A Cascade of Morphogenic Signaling Initiated by the Meninges Controls Corpus Callosum Formation	NEURON			English	Article							CALVARIAL BONE-DEVELOPMENT; CAJAL-RETZIUS CELLS; BETA-CATENIN GENE; AXON GUIDANCE; NEURAL CREST; SPINAL-CORD; COMMISSURAL PROJECTIONS; CEREBRAL-CORTEX; NERVOUS-SYSTEM; MOTOR-NEURONS	The corpus callosum is the most prominent commissural connection between the cortical hemispheres, and numerous neurodevelopmental disorders are associated with callosal agenesis. By using mice either with meningeal overgrowth or selective loss of meninges, we have identified a cascade of morphogenic signals initiated by the meninges that regulates corpus callosum development. The meninges produce BMP7, an inhibitor of callosal axon outgrowth. This activity is overcome by the induction of expression of Wnt3 by the callosal pathfinding neurons, which antagonize the inhibitory effects of BMP7. Wnt3 expression in the cingulate callosal pathfinding axons is developmentally regulated by another BMP family member, GDF5, which is produced by the adjacent Cajal-Retzius neurons and turns on before outgrowth of the callosal axons. The effects of GDF5 are in turn under the control of a soluble GDF5 inhibitor, Dan, made by the meninges. Thus, the meninges and medial neocortex use a cascade of signals to regulate corpus callosum development.	[Choe, Youngshik; Siegenthaler, Julie A.; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Pleasure, Samuel J.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Pleasure, Samuel J.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	sam.pleasure@ucsf.edu	abelmadani, abdel/D-7856-2012	, Julie/0000-0003-3700-6441	family of Glenn W. Johnson; National Institute of Neurological Disorders and Stroke [K99-R00, NS070920];  [R01 DA017627];  [R01 MH077694]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075188, R00NS070920, K99NS070920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017627] Funding Source: NIH RePORTER	family of Glenn W. Johnson; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Guangnan Li, Roeben Munji, and John Rubenstein for helpful discussions, Trung Huynh for technical assistance, and Kurt Thorn and the Nikon Imaging Center at UCSF for use of the confocal microscope. This work was supported by R01 DA017627 and R01 MH077694. S.J.P. is also supported by funds from the family of Glenn W. Johnson, Jr. J.S. is supported by a K99-R00 Pathway to Independence award from the National Institute of Neurological Disorders and Stroke (NS070920). The authors also thank Dr. Gail Martin, Dr. Makoto Taketo, and Dr. Tom Kume for sharing mouse reagents.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Aruga J, 2002, DEV BIOL, V244, P329, DOI 10.1006/dbio.2002.0598; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Brault V, 2001, DEVELOPMENT, V128, P1253; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dickson BJ, 2005, NAT NEUROSCI, V8, P1130, DOI 10.1038/nn0905-1130; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Etchevers HC, 1999, DEVELOPMENT, V126, P3533; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kim AS, 2003, DEV BRAIN RES, V145, P159, DOI 10.1016/S0165-3806(03)00213-X; Kim HJ, 1998, DEVELOPMENT, V125, P1241; KOESTER SE, 1994, J NEUROSCI, V14, P6608; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lavery DL, 2008, DEV DYNAM, V237, P768, DOI 10.1002/dvdy.21440; Law CO, 2008, DEVELOPMENT, V135, P2361, DOI 10.1242/dev.009019; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li GN, 2009, DEVELOPMENT, V136, P327, DOI 10.1242/dev.025742; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Maro GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004690; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mihrshahi R, 2006, J EXP ZOOL PART B, V306B, P8, DOI 10.1002/jez.b.21067; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Niederkofler V, 2010, DEVELOPMENT, V137, P427, DOI 10.1242/dev.042515; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Ozaki HS, 1998, J COMP NEUROL, V400, P197, DOI 10.1002/(SICI)1096-9861(19981019)400:2<197::AID-CNE3>3.0.CO;2-4; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Piper M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-43; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; Sanchez-Camacho C, 2011, DEV NEUROBIOL, V71, P337, DOI 10.1002/dneu.20865; Schmidt C, 2007, DEV DYNAM, V236, P2502, DOI 10.1002/dvdy.21260; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Shu TZ, 2003, J NEUROSCI, V23, P203; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Vivatbutsiri P, 2008, J ANAT, V212, P603, DOI 10.1111/j.1469-7580.2008.00893.x; Wang YS, 2002, J NEUROSCI, V22, P8563; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	62	58	58	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 23	2012	73	4					698	712		10.1016/j.neuron.2011.11.036	http://dx.doi.org/10.1016/j.neuron.2011.11.036			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365545	Bronze, Green Accepted			2022-12-25	WOS:000300815400010
J	Huang, SY; Trevino, M; He, KW; Ardiles, A; de Pasquale, R; Guo, YT; Palacios, A; Huganir, R; Kirkwood, A				Huang, ShiYong; Trevino, Mario; He, Kaiwen; Ardiles, Alvaro; de Pasquale, Roberto; Guo, Yatu; Palacios, Adrian; Huganir, Richard; Kirkwood, Alfredo			Pull-Push Neuromodulation of LTP and LTD Enables Bidirectional Experience-Induced Synaptic Scaling in Visual Cortex	NEURON			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; HIPPOCAMPAL CA1 REGION; CORTICAL PLASTICITY; INHIBITORY AUTOPHOSPHORYLATION; ADRENERGIC MODULATION; PREFRONTAL CORTEX; DEPRESSION; RECEPTORS; SYNAPSES	Neuromodulatory input, acting on G protein-coupled receptors, is essential for the induction of experience-dependent cortical plasticity. Here we report that G-coupled receptors in layer II/III of visual cortex control the polarity of synaptic plasticity through a pull-push regulation of LTP and LTD. In slices, receptors coupled to Gs promote LTP while suppressing LTD; conversely, receptors coupled to Gq11 promote LTD and suppress LTP. In vivo, the selective stimulation of Gs- or Gq11-coupled receptors brings the cortex into LIP-only or LTD-only states, which allows the potentiation or depression of targeted synapses with visual stimulation. The pull-push regulation of LTP/LTD occurs via direct control of the synaptic plasticity machinery and it is independent of changes in NMDAR activation or neuronal excitability. We propose these simple rules governing the pull-push control of LTP/LTD form a general metaplasticity mechanism that may contribute to neuromodulation of plasticity in other cortical circuits.	[Huang, ShiYong; Trevino, Mario; He, Kaiwen; Ardiles, Alvaro; de Pasquale, Roberto; Guo, Yatu; Kirkwood, Alfredo] Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA; [Ardiles, Alvaro; Palacios, Adrian] Univ Valparaiso, Ctr Interdisciplinario Neurociencias, Valparaiso, Chile; [Guo, Yatu] Tianjin Med Univ, Tianjin Eye Inst, Tianjin Eye Hosp, Tianjin, Peoples R China; [Huganir, Richard; Kirkwood, Alfredo] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Universidad de Valparaiso; Tianjin Medical University; Johns Hopkins University	Kirkwood, A (corresponding author), Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA.	kirkwood@jhu.edu	Ardiles, Alvaro/ABB-1565-2020; Palacios, Adrian G/E-9846-2015; DE PASQUALE, ROBERTO/AAE-2941-2019; Huang, Shiyong/D-5211-2009	Palacios, Adrian G/0000-0003-1532-7527; Ardiles, Alvaro/0000-0001-8295-2133; Huang, Shiyong/0000-0003-2976-5798; De Pasquale, Roberto/0000-0003-3383-7715	NIH; NATIONAL EYE INSTITUTE [R01EY012124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. H.K. Lee and Dr. S. Hendry for valuable comments. Supported by grants from the NIH.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Dudek SM, 1996, NEURON, V16, P1097, DOI 10.1016/S0896-6273(00)80136-1; Ego-Stengel V, 2002, NEUROSCIENCE, V111, P275, DOI 10.1016/S0306-4522(02)00011-8; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Fuenzalida M, 2007, J NEUROSCI, V27, P11940, DOI 10.1523/JNEUROSCI.0900-07.2007; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Hardingham N, 2008, NEURON, V60, P861, DOI 10.1016/j.neuron.2008.10.018; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Ji XH, 2008, CEREB CORTEX, V18, P1506, DOI 10.1093/cercor/bhm177; Jiang B, 2007, J NEUROSCI, V27, P9648, DOI 10.1523/JNEUROSCI.2655-07.2007; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Lee H. K., 2008, LEARNING MEMORY COMP; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu WH, 2006, P NATL ACAD SCI USA, V103, P18338, DOI 10.1073/pnas.0604560103; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Moore SJ, 2009, NEURON, V61, P287, DOI 10.1016/j.neuron.2008.12.013; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Philpot BD, 2003, J NEUROSCI, V23, P5583; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Scheiderer CL, 2004, J NEUROPHYSIOL, V91, P1071, DOI 10.1152/jn.00420.2003; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Zhabotinsky AM, 2006, J NEUROSCI, V26, P7337, DOI 10.1523/JNEUROSCI.0729-06.2006; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; Zhang L, 2005, J NEUROSCI, V25, P7697, DOI 10.1523/JNEUROSCI.2086-05.2005; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	47	78	79	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					497	510		10.1016/j.neuron.2011.11.023	http://dx.doi.org/10.1016/j.neuron.2011.11.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325202	Bronze, Green Accepted			2022-12-25	WOS:000300140600011
J	Lee, S; Ahmed, T; Lee, S; Kim, H; Choi, S; Kim, DS; Kim, SJ; Cho, J; Shin, HS				Lee, Sukchan; Ahmed, Touqeer; Lee, Soojung; Kim, Huisu; Choi, Sukwoo; Kim, Duk-Soo; Kim, Sang Jeong; Cho, Jeiwon; Shin, Hee-Sup			Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; CONDITIONED FEAR; THALAMOCORTICAL RELAY; NUCLEUS; AMYGDALA; LESIONS; MEMORY; RATS; ATTENTION	The mediodorsal thalamic nucleus has been implicated in the control of memory processes. However, the underlying neural mechanism remains unclear. Here we provide evidence for bidirectional modulation of fear extinction by the mediodorsal thalamic nucleus. Mice with a knockout or mediodorsal thalamic nucleus-specific knockdown of phospholipase C beta 4 exhibited impaired fear extinction. Mutant mediodorsal thalamic nucleus neurons in slices showed enhanced burst firing accompanied by increased T-type Ca2+ currents; blocking of T channels in vivo rescued the fear extinction. Tetrode recordings in freely moving mice revealed that, during extinction, the single-spike (tonic) frequency of mediodorsal thalamic nucleus neurons increased in wild-type mice, but was static in mutant mice. Furthermore, tonic-evoking microstimulations of the mediodorsal thalamic nucleus, contemporaneous with the extinction tones, rescued fear extinction in mutant mice and facilitated it in wild-type mice. In contrast, burst-evoking microstimulation suppressed extinction in wild-type mice, mimicking the mutation. These results suggest that the firing mode of the mediodorsal thalamic nucleus is critical for the modulation of fear extinction.	[Lee, Sukchan; Ahmed, Touqeer; Lee, Soojung; Kim, Huisu; Cho, Jeiwon; Shin, Hee-Sup] Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea; [Lee, Sukchan; Kim, Sang Jeong] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Kim, Huisu; Shin, Hee-Sup] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Choi, Sukwoo] Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul, South Korea; [Kim, Duk-Soo] Soonchunhyang Univ, Dept Anat, Coll Med, Cheonan Si, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Seoul National University (SNU); Soonchunhyang University	Shin, HS (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea.	shin@kist.re.kr	Ahmed, Touqeer/AAP-2195-2021; Kim, Sang Jeong/J-2740-2012	Kim, Sang Jeong/0000-0001-8931-3713; Ahmed, Touqeer/0000-0003-0322-8169	National Honor Scientist Program of Korea; Ministry of Education, Science and Technology, Korea	National Honor Scientist Program of Korea; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank J. Park for assistance with animal care and I. Hong for behavioral tests in the beginning of this work. This work was supported by a grant from the National Honor Scientist Program of Korea and a grant from the 21C Frontier Proteomics Program of the Ministry of Education, Science and Technology, Korea.	Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Cheong E, 2009, P NATL ACAD SCI USA, V106, P21912, DOI 10.1073/pnas.0912204106; Cheong EJ, 2008, J NEUROSCI, V28, P13331, DOI 10.1523/JNEUROSCI.3013-08.2008; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Garcia R, 2006, LEARN MEMORY, V13, P14, DOI 10.1101/lm.60406; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Hugues S, 2007, LEARN MEMORY, V14, P520, DOI 10.1101/lm.625407; Hunt PR, 1998, J NEUROSCI, V18, P10045; Inoue T, 2004, EUR J PHARMACOL, V497, P311, DOI 10.1016/j.ejphar.2004.06.061; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Jones E.G., 2012, THALAMUS; LABERGE D, 1990, J NEUROSCI, V10, P613; LaBerge D, 1997, CONSCIOUS COGN, V6, P149, DOI 10.1006/ccog.1997.0305; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Li XB, 2004, BRAIN RES, V1008, P261, DOI 10.1016/j.brainres.2004.02.038; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Liu XB, 1998, J COMP NEUROL, V395, P450, DOI 10.1002/(SICI)1096-9861(19980615)395:4<450::AID-CNE3>3.0.CO;2-0; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Mitchell AS, 2008, J NEUROSCI, V28, P258, DOI 10.1523/JNEUROSCI.4922-07.2008; Mitchell AS, 2005, EUR J NEUROSCI, V22, P973, DOI 10.1111/j.1460-9568.2005.04199.x; Miyata M, 2003, J NEUROSCI, V23, P8098; Nakamura M, 2004, EUR J NEUROSCI, V20, P2929, DOI 10.1111/j.1460-9568.2004.03768.x; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Portas CM, 1998, J NEUROSCI, V18, P8979; RAY JP, 1993, J COMP NEUROL, V337, P1, DOI 10.1002/cne.903370102; RAY JP, 1992, J COMP NEUROL, V323, P167, DOI 10.1002/cne.903230204; Riban V, 2004, EXP NEUROL, V188, P452, DOI 10.1016/j.expneurol.2004.04.020; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; VERGNES M, 1990, BRAIN RES, V523, P87, DOI 10.1016/0006-8993(90)91638-W; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; Zhang DX, 2002, J NEUROSCI, V22, P3277, DOI 10.1523/JNEUROSCI.22-08-03277.2002; Zoppelt D, 2003, NEUROPSYCHOLOGIA, V41, P1160, DOI 10.1016/S0028-3932(03)00019-8	43	54	54	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					308	314		10.1038/nn.2999	http://dx.doi.org/10.1038/nn.2999			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197828				2022-12-25	WOS:000299603500023
J	Subramaniam, S; Napolitano, F; Mealer, RG; Kim, S; Errico, F; Barrow, R; Shahani, N; Tyagi, R; Snyder, SH; Usiello, A				Subramaniam, Srinivasa; Napolitano, Francesco; Mealer, Robert G.; Kim, Seyun; Errico, Francesco; Barrow, Roxanne; Shahani, Neelam; Tyagi, Richa; Snyder, Solomon H.; Usiello, Alessandro			Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia	NATURE NEUROSCIENCE			English	Article							GTP-BINDING PROTEIN	L-DOPA-induced dyskinesia, the rate-limiting side effect in the therapy of Parkinson's disease, is mediated by activation of mammalian target of rapamycin (mTOR) signaling in the striatum. We found that Ras homolog enriched in striatum (Rhes), a striatal-specific protein, binds to and activates mTOR. Moreover, Rhes(-/-) mice showed reduced striatal mTOR signaling and diminished dyskinesia, but maintained motor improvement on L-DOPA treatment, suggesting a therapeutic benefit for Rhes-binding drugs.	[Subramaniam, Srinivasa; Mealer, Robert G.; Kim, Seyun; Barrow, Roxanne; Tyagi, Richa; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Napolitano, Francesco; Errico, Francesco; Usiello, Alessandro] Ceinge Biotecnol Avanzate, Lab Behav Neurosci, Naples, Italy; [Shahani, Neelam; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Usiello, Alessandro] Univ Naples 2, Dept Environm Sci, Naples, Italy	Johns Hopkins University; CEINGE Biotecnologie Avanzate; Johns Hopkins University; Johns Hopkins University; Universita della Campania Vanvitelli	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	ssnyder@jhmi.edu	tyagi, richa/A-7261-2015; usiello, alessandro/B-2368-2012; Napolitano, Francesco/F-8691-2012; Errico, Francesco/C-2787-2012; Kim, Seyun/B-3387-2012	Usiello, Alessandro/0000-0001-9203-853X; Napolitano, Francesco/0000-0003-0884-1851; ERRICO, Francesco/0000-0002-3636-7395	United States Public Health Service [MH18501]; Cure for Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cure for Huntington's Disease Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Romano, D. Vitucci, V. Marsili, P. Scherer and S. Korde for valuable technical assistance, and R. DiLauro (University of Naples) for providing the Rhes<SUP>-/-</SUP> mice. This work was supported by United States Public Health Service grant MH18501 (S.H.S.) and a grant of the Cure for Huntington's Disease Initiative (S.H.S.).	Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Quintero GC, 2008, NEUROREPORT, V19, P1563, DOI 10.1097/WNR.0b013e3283118434; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161	11	71	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					191	193		10.1038/nn.2994	http://dx.doi.org/10.1038/nn.2994			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179112	Green Accepted			2022-12-25	WOS:000299603500008
J	Swaminathan, SK; Freedman, DJ				Swaminathan, Sruthi K.; Freedman, David J.			Preferential encoding of visual categories in parietal cortex compared with prefrontal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SINGLE NEURONS; RHESUS-MONKEYS; MACAQUE MONKEY; DECISION; REPRESENTATIONS; INFORMATION; INTENTION; IMAGES; LOBE	The ability to recognize the behavioral relevance, or category membership, of sensory stimuli is critical for interpreting the meaning of events in our environment. Neurophysiological studies of visual categorization have found categorical representations of stimuli in prefrontal cortex (PFC), an area that is closely associated with cognitive and executive functions. Recent studies have also identified neuronal category signals in parietal areas that are typically associated with visual-spatial processing. It has been proposed that category-related signals in parietal cortex and other visual areas may result from 'top-down' feedback from PFC. We directly compared neuronal activity in the lateral intraparietal (LIP) area and PFC in monkeys performing a visual motion categorization task. We found that LIP showed stronger, more reliable and shorter latency category signals than PFC. These findings suggest that LIP is strongly involved in visual categorization and argue against the idea that parietal category signals arise as a result of feedback from PFC during this task.	[Swaminathan, Sruthi K.; Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago	Freedman, DJ (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	dfreedman@uchicago.edu			US National Institutes of Health [R01 EY019041, 5T32GM007839]; NATIONAL EYE INSTITUTE [R01EY019041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007839] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. McClellan for animal training and technical assistance, G. Huang, C. Rishel and S. Thomas for technical assistance, and the staff of The University of Chicago Animal Resources Center for expert veterinary assistance. We also thank J. Assad, J. Fitzgerald, T. Herrington, G. Ibos, J. McKee, E. Miller, C. Pack, M. Riesenhuber and A. Sarma for helpful discussions and/or comments on an earlier version of this manuscript. This work was supported by US National Institutes of Health grant R01 EY019041. Additional support was provided by a National Science Foundation Faculty Early Career Development Award, the Alfred P. Sloan Foundation, the Brain Research Foundation and US National Institutes of Health Training Grant 5T32GM007839.	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Ferrera VP, 2006, NAT NEUROSCI, V9, P1207, DOI 10.1038/nn1006-1207; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Fitzgerald JK, 2011, NAT NEUROSCI, V14, P1075, DOI 10.1038/nn.2878; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Merchant H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00069; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	31	124	124	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					315	320		10.1038/nn.3016	http://dx.doi.org/10.1038/nn.3016			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22246435	Green Accepted			2022-12-25	WOS:000299603500024
J	Hull, C; Regehr, WG				Hull, Court; Regehr, Wade G.			Identification of an Inhibitory Circuit that Regulates Cerebellar Golgi Cell Activity	NEURON			English	Article							FEEDFORWARD INHIBITION; GABAERGIC INTERNEURONS; SYNAPTIC INTEGRATION; GRANULAR LAYER; CHOLINERGIC INNERVATION; ELECTRICAL SYNAPSES; NEURAL CIRCUITRY; MOUSE CEREBELLUM; TRANSGENIC MICE; CORTEX	Here we provide evidence that revises the inhibitory circuit diagram of the cerebellar cortex. It was previously thought that Golgi cells, interneurons that are the sole source of inhibition onto granule cells, were exclusively coupled via gap junctions. Moreover, Golgi cells were believed to receive GABAergic inhibition from molecular layer interneurons (MLIs). Here we challenge these views by optogenetically activating the cerebellar circuitry to determine the timing and pharmacology of inhibition onto Golgi cells and by performing paired recordings to directly assess synaptic connectivity. In contrast to current thought, we find that Golgi cells, not MLIs, make inhibitory GABAergic synapses onto other Golgi cells. As a result, MLI feedback does not regulate the Golgi cell network, and Golgi cells are inhibited approximately 2 ms before Purkinje cells, following a mossy fiber input. Hence, Golgi cells and Purkinje cells receive unique sources of inhibition and can differentially process shared granule cell inputs.	[Hull, Court; Regehr, Wade G.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu		Hull, Court/0000-0002-0360-8367	National Institutes of Health [R37 NS032405, F32 NS060585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS060585, R37NS032405, R01NS032405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work was supported by National Institutes of Health grants R37 NS032405 to W.G.R. and F32 NS060585 to C.H.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; BARMACK NH, 1992, J COMP NEUROL, V317, P233, DOI 10.1002/cne.903170303; BARMACK NH, 1992, J COMP NEUROL, V317, P250, DOI 10.1002/cne.903170304; Beierlein M, 2007, NEURON, V54, P949, DOI 10.1016/j.neuron.2007.06.002; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Crowley JJ, 2009, NEURON, V63, P843, DOI 10.1016/j.neuron.2009.09.004; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; De Schutter E, 2000, PROG BRAIN RES, V124, P81; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Dieudonne S, 2000, J NEUROSCI, V20, P1837; Dugue GP, 2005, J NEUROSCI, V25, P6490, DOI 10.1523/JNEUROSCI.1500-05.2005; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; ECCLES J, 1964, NATURE, V204, P1265, DOI 10.1038/2041265a0; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Eccles JC, 1967, CEREBELLUM NEURONAL; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Galliano E, 2010, J PHYSIOL-LONDON, V588, P3639, DOI 10.1113/jphysiol.2010.189605; Geurts FJ, 2003, CEREBELLUM, V2, P290, DOI 10.1080/14734220310011948; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Isope P, 2002, ANN NY ACAD SCI, V978, P164, DOI 10.1111/j.1749-6632.2002.tb07564.x; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jaarsma D, 1997, PROG BRAIN RES, V114, P67; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; KERR CWH, 1991, J COMP NEUROL, V304, P502, DOI 10.1002/cne.903040313; Kistler WM, 2003, CEREBELLUM, V2, P44, DOI 10.1080/14734220309426; Maex R, 2000, J PHYSIOL-LONDON, V523, P175, DOI 10.1111/j.1469-7793.2000.t01-1-00175.x; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Mapelli L, 2009, J NEUROPHYSIOL, V101, P3089, DOI 10.1152/jn.91190.2008; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 2000, CURR BIOL, V10, pR522, DOI 10.1016/S0960-9822(00)00584-4; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; Palay S.L., 1974, CEREBELLAR CORTEX; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; SOTELO C, 1972, J CELL BIOL, V53, P271, DOI 10.1083/jcb.53.2.271; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Watanabe D, 2003, NEURON, V39, P821, DOI 10.1016/S0896-6273(03)00530-0; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	54	71	71	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					149	158		10.1016/j.neuron.2011.10.030	http://dx.doi.org/10.1016/j.neuron.2011.10.030			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243753	Bronze, Green Accepted			2022-12-25	WOS:000299446800014
J	Centanin, L; Hoeckendorf, B; Wittbrodt, J				Centanin, Lazaro; Hoeckendorf, Burkhard; Wittbrodt, Joachim			Fate Restriction and Multipotency in Retinal Stem Cells	CELL STEM CELL			English	Article							PIGMENT-CHIMERIC EYES; ADULT NEUROGENESIS; VERTEBRATE RETINA; LINEAGE ANALYSIS; NERVOUS-SYSTEM; XENOPUS-LAEVIS; OPTIC TECTUM; FROG RETINA; ZEBRAFISH; GROWTH	Stem cells have the capacity to both self-renew and generate postmitotic cells. Long-term tracking of individual clones in their natural environment constitutes the ultimate way to validate postembryonic stem cells. We identify retinal stem cells (RSCs) using the spatiotemporal organization of the fish retina and follow the complete offspring of a single cell during the postnatal life. RSCs generate two tissues of the adult fish retina, the neural retina (NR) and the retinal-pigmented epithelium (RPE). Despite their common embryonic origin and tight coordination during continuous organ growth, we prove that NR and RPE are maintained by dedicated RSCs that contribute in a fate-restricted manner to either one or the other tissue. We show that in the NR, RSCs are multipotent and generate all neuron types and glia. The clonal origin of these different cell types from a multipotent NSC has far-reaching implications for cell type and tissue homeostasis.	[Centanin, Lazaro; Hoeckendorf, Burkhard; Wittbrodt, Joachim] Univ Heidelberg, Ctr Organismal Studies COS Heidelberg, D-69120 Heidelberg, Germany; [Hoeckendorf, Burkhard] Univ Heidelberg, Hartmut Hoffman Berling Int Grad Sch, D-69120 Heidelberg, Germany; [Hoeckendorf, Burkhard] Karlsruhe Inst Technol, BioInterfaces Programme, BioInterfaces Int Grad Sch, D-76344 Eggenstein Leopoldshafen, Germany; [Wittbrodt, Joachim] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Centanin, L (corresponding author), Univ Heidelberg, Ctr Organismal Studies COS Heidelberg, Neuenheimer Feld 230, D-69120 Heidelberg, Germany.	lazaro.centanin@cos.uni-heidelberg.de; jochen.wittbrodt@cos.uni-heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377; Centanin, Lazaro/0000-0003-3889-4524	Marie Curie IIF fellowship; German Science Funding Agency [SFB 488, SFB 873]	Marie Curie IIF fellowship(European Commission); German Science Funding Agency	We thank T. Auer, D. Inoue, R. Reinhard, P. Haas, A. Schmidt, J.-R. Martinez-Morales, J.L. Mateo, and A. Mateos Gil for critical comments, discussions, and reading of the manuscript, P. Keller for initial recording and reconstruction of DSLM data, and A. Saraceno and E. Leist for fish husbandry. We very much appreciate the feedback during the review process on earlier versions of the manuscript. L.C. was supported by a Marie Curie IIF fellowship. This work was financially supported by the German Science Funding Agency through the SFB 488 and SFB 873 (J.W.).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Alunni A, 2010, DEV NEUROBIOL, V70, P693, DOI 10.1002/dneu.20799; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1992, EXP NEUROL, V115, P110, DOI 10.1016/0014-4886(92)90232-F; Amato MA, 2004, INT J DEV BIOL, V48, P993, DOI 10.1387/ijdb.041879ma; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brown KE, 2010, DEV BIOL, V339, P14, DOI 10.1016/j.ydbio.2009.12.003; Dowling J. E., 1987, RETINA APPROACHABLE; FEKETE DM, 1994, DEV BIOL, V166, P666, DOI 10.1006/dbio.1994.1346; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOLLYFIELD JG, 1968, DEV BIOL, V18, P163, DOI 10.1016/0012-1606(68)90041-9; HOLLYFIELD JG, 1971, DEV BIOL, V24, P264, DOI 10.1016/0012-1606(71)90098-4; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNT RK, 1988, P NATL ACAD SCI USA, V85, P3459, DOI 10.1073/pnas.85.10.3459; HUNT RK, 1987, P NATL ACAD SCI USA, V84, P3302, DOI 10.1073/pnas.84.10.3302; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Koster R, 1997, DEVELOPMENT, V124, P3147; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Moshiri A, 2004, INT J DEV BIOL, V48, P1003, DOI 10.1387/ijdb.041870am; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Nguyen V, 1999, J COMP NEUROL, V413, P385, DOI 10.1002/(SICI)1096-9861(19991025)413:3<385::AID-CNE3>3.0.CO;2-P; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.0.CO;2-C; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reh TA, 1998, J NEUROBIOL, V36, P206, DOI 10.1002/(SICI)1097-4695(199808)36:2<206::AID-NEU8>3.3.CO;2-4; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; STRAZNICKY K, 1971, J EMBRYOL EXP MORPH, V26, P67; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	51	66	67	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					553	562		10.1016/j.stem.2011.11.004	http://dx.doi.org/10.1016/j.stem.2011.11.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136930	Bronze			2022-12-25	WOS:000297895000015
J	Economides, JR; Sincich, LC; Adams, DL; Horton, JC				Economides, John R.; Sincich, Lawrence C.; Adams, Daniel L.; Horton, Jonathan C.			Orientation tuning of cytochrome oxidase patches in macaque primary visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; OCULAR-DOMINANCE; FUNCTIONAL-ORGANIZATION; RECORDING CAPABILITIES; CHROMATIC MECHANISMS; OWL MONKEY; COLOR; V1; V2; SELECTIVITY	The abundant concentration of cytochrome oxidase in patches or blobs of primate striate cortex has never been explained. Patches are thought to contain unoriented, color-opponent neurons. Lacking orientation selectivity, these cells might endow patches with high metabolic activity because they respond to all contours in visual scenes. To test this idea, we measured orientation tuning in layer 2/3 of macaque cortical area V1 using acutely implanted 100-electrode arrays. Each electrode recording site was identified and assigned to the patch or interpatch compartment. The mean orientation bandwidth of cells was 28.4 degrees in patches and 25.8 degrees in interpatches. Neurons in patches were indeed less orientation selective, but the difference was subtle, indicating that the processing of form and color is not strictly segregated in V1. The most conspicuous finding was that patch cells had a 49% greater overall firing rate. This global difference in neuronal responsiveness, rather than an absence of orientation tuning, may account for the rich mitochondrial enzyme activity that defines patches.	[Economides, John R.; Adams, Daniel L.; Horton, Jonathan C.] Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA; [Sincich, Lawrence C.] Univ Alabama, Dept Visual Sci, Birmingham, AL USA; [Adams, Daniel L.] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy	University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Trento	Horton, JC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA.	hortonj@vision.ucsf.edu	Economides, John/AAV-7631-2020; Adams, Daniel L/A-5229-2009	Economides, John/0000-0002-9236-2441; Adams, Daniel L/0000-0003-0376-4949; Horton, Jonathan/0000-0002-3952-435X	US National Eye Institute [EY10217, EY10217-16A1S1, EY13676, EY02162]; US National Institutes of Health [R00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162, R01EY010217, R56EY010217, F32EY013676] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY10217, EY10217-16A1S1 (J.C.H.), EY13676 (L.C.S.) and EY02162 (Beckman Vision Center) from the US National Eye Institute and by Research to Prevent Blindness. The California Regional Primate Research Center is supported by US National Institutes of Health Base Grant RR00169. C.M. Jocson provided technical assistance and M.K. Feusner assisted with computer programming.	BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; DEYOE EA, 1995, VISUAL NEUROSCI, V12, P629, DOI 10.1017/S0952523800008920; Eliades SJ, 2008, J NEUROSCI METH, V172, P201, DOI 10.1016/j.jneumeth.2008.04.029; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Farias MF, 1997, J COMP NEUROL, V386, P217, DOI 10.1002/(SICI)1096-9861(19970922)386:2<217::AID-CNE4>3.0.CO;2-4; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Heywood CA, 2003, NEUROL CLIN, V21, P483, DOI 10.1016/S0733-8619(02)00102-0; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; Horwitz GD, 2007, J NEUROPHYSIOL, V97, P3070, DOI 10.1152/jn.00965.2006; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; KENNEDY C, 1976, P NATL ACAD SCI USA, V73, P4230, DOI 10.1073/pnas.73.11.4230; Kim SJ, 2006, ANN BIOMED ENG, V34, P300, DOI 10.1007/s10439-005-9037-9; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3126, DOI 10.1152/jn.2002.87.6.3126; Landisman CE, 2002, J NEUROPHYSIOL, V87, P3138, DOI 10.1152/jn.00957.1999; LENNIE P, 1990, J NEUROSCI, V10, P649; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; MARTIN KAC, 1988, TRENDS NEUROSCI, V11, P380, DOI 10.1016/0166-2236(88)90072-0; McDonald JS, 2010, J VISION, V10, DOI 10.1167/10.12.34; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Nauhaus I, 2007, J NEUROPHYSIOL, V97, P3781, DOI 10.1152/jn.00120.2007; Nordhausen CT, 1996, BRAIN RES, V726, P129; NORDHAUSEN CT, 1994, BRAIN RES, V637, P27, DOI 10.1016/0006-8993(94)91213-0; O'Keefe LP, 1998, J NEUROPHYSIOL, V80, P594, DOI 10.1152/jn.1998.80.2.594; Polimeni JR, 2005, P NATL ACAD SCI USA, V102, P4158, DOI 10.1073/pnas.0500291102; PURVES D, 1993, J COMP NEUROL, V334, P169, DOI 10.1002/cne.903340202; Ringach DL, 2002, J NEUROSCI, V22, P5639; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1320; Seymour K, 2010, CEREB CORTEX, V20, P1946, DOI 10.1093/cercor/bhp265; Sincich LC, 2005, J NEUROSCI, V25, P10087, DOI 10.1523/JNEUROSCI.3313-05.2005; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Sincich LC, 2002, SCIENCE, V295, P1734, DOI 10.1126/science.1067902; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sumner P, 2008, NEUROIMAGE, V39, P814, DOI 10.1016/j.neuroimage.2007.09.013; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; TSO DY, 1988, J NEUROSCI, V8, P1712; WONGRILEY M, 1984, NATURE, V307, P262, DOI 10.1038/307262a0; Xu XM, 2004, J NEUROSCI, V24, P6237, DOI 10.1523/JNEUROSCI.1144-04.2004; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P71, DOI 10.1016/0166-4328(95)00184-0	50	28	29	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1574	U108		10.1038/nn.2958	http://dx.doi.org/10.1038/nn.2958			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057193	Green Submitted, Green Accepted			2022-12-25	WOS:000297546300018
J	Renton, AE; Majounie, E; Waite, A; Simon-Sanchez, J; Rollinson, S; Gibbs, JR; Schymick, JC; Laaksovirta, H; van Swieten, JC; Myllykangas, L; Kalimo, H; Paetau, A; Abramzon, Y; Remes, AM; Kaganovich, A; Scholz, SW; Duckworth, J; Ding, JH; Harmer, DW; Hernandez, DG; Johnson, JO; Mok, K; Ryten, M; Trabzuni, D; Guerreiro, RJ; Orrell, RW; Neal, J; Murray, A; Pearson, J; Jansen, IE; Sondervan, D; Seelaar, H; Blake, D; Young, K; Halliwell, N; Callister, JB; Toulson, G; Richardson, A; Gerhard, A; Snowden, J; Mann, D; Neary, D; Nalls, MA; Peuralinna, T; Jansson, L; Isoviita, VM; Kaivorinne, AL; Holtta-Vuori, M; Ikonen, E; Sulkava, R; Benatar, M; Wuu, J; Chio, A; Restagno, G; Borghero, G; Sabatelli, M; Heckerman, D; Rogaeva, E; Zinman, L; Rothstein, JD; Sendtner, M; Drepper, C; Eichler, EE; Alkan, C; Abdullaev, Z; Pack, SD; Dutra, A; Pak, E; Hardy, J; Singleton, A; Williams, NM; Heutink, P; Pickering-Brown, S; Morris, HR; Tienari, PJ; Traynor, BJ				Renton, Alan E.; Majounie, Elisa; Waite, Adrian; Simon-Sanchez, Javier; Rollinson, Sara; Gibbs, J. Raphael; Schymick, Jennifer C.; Laaksovirta, Hannu; van Swieten, John C.; Myllykangas, Liisa; Kalimo, Hannu; Paetau, Anders; Abramzon, Yevgeniya; Remes, Anne M.; Kaganovich, Alice; Scholz, Sonja W.; Duckworth, Jamie; Ding, Jinhui; Harmer, Daniel W.; Hernandez, Dena G.; Johnson, Janel O.; Mok, Kin; Ryten, Mina; Trabzuni, Danyah; Guerreiro, Rita J.; Orrell, Richard W.; Neal, James; Murray, Alex; Pearson, Justin; Jansen, Iris E.; Sondervan, David; Seelaar, Harro; Blake, Derek; Young, Kate; Halliwell, Nicola; Callister, Janis Bennion; Toulson, Greg; Richardson, Anna; Gerhard, Alex; Snowden, Julie; Mann, David; Neary, David; Nalls, Michael A.; Peuralinna, Terhi; Jansson, Lilja; Isoviita, Veli-Matti; Kaivorinne, Anna-Lotta; Holtta-Vuori, Maarit; Ikonen, Elina; Sulkava, Raimo; Benatar, Michael; Wuu, Joanne; Chio, Adriano; Restagno, Gabriella; Borghero, Giuseppe; Sabatelli, Mario; Heckerman, David; Rogaeva, Ekaterina; Zinman, Lorne; Rothstein, Jeffrey D.; Sendtner, Michael; Drepper, Carsten; Eichler, Evan E.; Alkan, Can; Abdullaev, Ziedulla; Pack, Svetlana D.; Dutra, Amalia; Pak, Evgenia; Hardy, John; Singleton, Andrew; Williams, Nigel M.; Heutink, Peter; Pickering-Brown, Stuart; Morris, Huw R.; Tienari, Pentti J.; Traynor, Bryan J.		ITALSGEN Consortium	A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMAN GENOME; MUTATIONS; TDP-43; DEMENTIA; SUSCEPTIBILITY; ASSOCIATION; POPULATION; COMMON	The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) locus contains one of the last major unidentified autosomal-dominant genes underlying these common neurodegenerative diseases. We have previously shown that a founder haplotype, covering the MOBKL2b, IFNK, and C9ORF72 genes, is present in the majority of cases linked to this region. Here we show that there is a large hexanucleotide (GGGGCC) repeat expansion in the first intron of C9ORF72 on the affected haplotype. This repeat expansion segregates perfectly with disease in the Finnish population, underlying 46.0% of familial ALS and 21.1% of sporadic ALS in that population. Taken together with the D90A SOD1 mutation, 87% of familial ALS in Finland is now explained by a simple monogenic cause. The repeat expansion is also present in one-third of familial ALS cases of outbred European descent, making it the most common genetic cause of these fatal neurodegenerative diseases identified to date.	[Renton, Alan E.; Schymick, Jennifer C.; Abramzon, Yevgeniya; Johnson, Janel O.; Traynor, Bryan J.] NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Majounie, Elisa; Scholz, Sonja W.; Hernandez, Dena G.; Nalls, Michael A.; Singleton, Andrew] NIA, Mol Genet Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Waite, Adrian; Pearson, Justin; Blake, Derek; Williams, Nigel M.; Morris, Huw R.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiatr Genet & Genom, Cardiff CF14 4XN, Wales; [Simon-Sanchez, Javier; van Swieten, John C.; Jansen, Iris E.; Sondervan, David; Heutink, Peter] Vrije Univ Amsterdam, Med Ctr, Depat Clin Genet, Sect Med Genom, NL-1081 HV Amsterdam, Netherlands; [Simon-Sanchez, Javier; van Swieten, John C.; Jansen, Iris E.; Sondervan, David; Heutink, Peter] Vrije Univ Amsterdam, Med Ctr, Alzheimer Dis Ctr, NL-1081 HV Amsterdam, Netherlands; [Simon-Sanchez, Javier; van Swieten, John C.; Seelaar, Harro] Erasmus MC Univ Med Ctr Rotterdam, Dept Neurol, NL-3015 CE Rotterdam, Netherlands; [Rollinson, Sara; Young, Kate; Halliwell, Nicola; Callister, Janis Bennion; Toulson, Greg; Pickering-Brown, Stuart] Univ Manchester, Fac Human & Med Sci, Manchester M13 9PT, Lancs, England; [Gibbs, J. Raphael; Hernandez, Dena G.; Johnson, Janel O.; Mok, Kin; Ryten, Mina; Trabzuni, Danyah; Guerreiro, Rita J.; Hardy, John] UCL, Dept Mol Neurosci, London WC1N 3BG, England; [Gibbs, J. Raphael; Hernandez, Dena G.; Johnson, Janel O.; Mok, Kin; Ryten, Mina; Trabzuni, Danyah; Guerreiro, Rita J.; Hardy, John] UCL, Reta Lila Weston Labs, Inst Neurol, London WC1N 3BG, England; [Laaksovirta, Hannu; Peuralinna, Terhi; Jansson, Lilja; Isoviita, Veli-Matti; Tienari, Pentti J.] Univ Helsinki, Dept Neurol, Cent Hosp, FIN-02900 Helsinki, Finland; [Laaksovirta, Hannu; Peuralinna, Terhi; Jansson, Lilja; Isoviita, Veli-Matti; Tienari, Pentti J.] Univ Helsinki, Mol Neurol Programme, Biomedicum, FIN-02900 Helsinki, Finland; [Myllykangas, Liisa; Kalimo, Hannu; Paetau, Anders] Univ Helsinki, Dept Pathol, Haartman Inst HUSLAB, FIN-02900 Helsinki, Finland; [Myllykangas, Liisa; Kalimo, Hannu; Paetau, Anders] Folkhalsan Res Ctr LM, FIN-02900 Helsinki, Finland; [Remes, Anne M.; Kaivorinne, Anna-Lotta] Univ Oulu, Inst Clin Med, FIN-90014 Oulu, Finland; [Remes, Anne M.; Kaivorinne, Anna-Lotta] Oulu Univ Hosp, Clin Res Ctr, FIN-90014 Oulu, Finland; [Kaganovich, Alice] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Scholz, Sonja W.] Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA; [Scholz, Sonja W.; Rothstein, Jeffrey D.; Traynor, Bryan J.] Johns Hopkins Univ, Dept Neurol, Brain Sci Inst, Baltimore, MD 21287 USA; [Harmer, Daniel W.] Illumina Inc, Hayward, CA 94545 USA; [Orrell, Richard W.] UCL, Dept Clin Neurosci, Inst Neurol, London NW3 2PG, England; [Neal, James] Cardiff Univ, Sch Med, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales; [Murray, Alex] Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Richardson, Anna; Gerhard, Alex; Snowden, Julie; Mann, David; Neary, David] Univ Manchester, Neurodegenerat & Mental Hlth Res Grp, Cerebral Funct Unit, Sch Community Based Med, Manchester M6 8HD, Lancs, England; [Holtta-Vuori, Maarit; Ikonen, Elina] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland; [Sulkava, Raimo] Univ Eastern Finland, Sect Geriatr, Inst Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland; [Benatar, Michael] Univ Miami, Miller Sch Med, Neuromuscular Div, Dept Neurol, Miami, FL 33136 USA; [Wuu, Joanne] Univ Miami, Miller Sch Med, Clin Translat Res Div, Dept Neurol, Miami, FL 33136 USA; [Chio, Adriano] Univ Turin, Dept Neurosci, I-10126 Turin, Italy; [Restagno, Gabriella] ASOOIRM S Anna, Mol Genet Unit, Dept Clin Pathol, I-10126 Turin, Italy; [Borghero, Giuseppe] Azienda Univ Osped Cagliari, Dept Neurol, I-09042 Cagliari, Italy; [Borghero, Giuseppe] Univ Cagliari, I-09042 Cagliari, Italy; [Sabatelli, Mario] Catholic Univ, Neurol Inst, I-10100 Rome, Italy; [Sabatelli, Mario] ICOMM Assoc ALS Res, I-10100 Rome, Italy; [Heckerman, David] Microsoft Res, Los Angeles, CA 90024 USA; [Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Rogaeva, Ekaterina] Univ Toronto, Toronto Western Hosp, Div Neurol, Dept Med, Toronto, ON M5S 3H2, Canada; [Zinman, Lorne] Univ Toronto, Div Neurol, Dept Internal Med, Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Sendtner, Michael; Drepper, Carsten] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Eichler, Evan E.; Alkan, Can] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Eichler, Evan E.; Alkan, Can] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Abdullaev, Ziedulla; Pack, Svetlana D.] NCI, Chromosome Pathol Unit, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Dutra, Amalia; Pak, Evgenia] NHGRI, NIH, Bethesda, MD 20892 USA; [Morris, Huw R.] Aneurin Bevan Local Hlth Board, Dept Neurol, Royal Gwent Hosp, Newport NP20 2UB, Gwent, Wales	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cardiff University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Manchester; University of London; University College London; University of London; University College London; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Oulu; University of Oulu; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Georgetown University; Johns Hopkins University; Illumina; University of London; University College London; Cardiff University; Cardiff University; University of Manchester; University of Helsinki; University of Eastern Finland; University of Miami; University of Miami; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Microsoft; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Wurzburg; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Royal Gwent Hospital	Traynor, BJ (corresponding author), NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	traynorb@mail.nih.gov	Hölttä, Maarit/AAX-4013-2020; Sendtner, Michael/J-1542-2012; Mok, Kin/U-6893-2019; Spataro, Rossella/B-3656-2016; Ricci, Claudia/I-8202-2018; Gibbs, J. Raphael/A-3984-2010; Mandrioli, Jessica/K-7235-2016; Traynor, Bryan J/G-5690-2010; Guerreiro, Rita J L/A-1327-2011; Alkan, Can/D-2982-2009; Resource Center, NINDS Human Genetics/AGF-2474-2022; Morris, Huw R/B-8527-2008; Chio, Adriano/K-3425-2016; Scholz, Sonja/AAN-6601-2021; Trabzuni, Daniah/AAI-2037-2021; Myllykangas, Liisa/X-9512-2019; Singleton, Andrew B/C-3010-2009; LOGROSCINO, GIANCARLO/K-5148-2016; Mok, Kin Ying/F-5860-2012; Drepper, Carsten/GSN-2009-2022; Tienari, Pentti J/A-4893-2012; Ryten, Mina/Q-8419-2016; Mandich, Paola/CAG-1105-2022; Orrell, Richard/L-2123-2013; Trabzuni, Daniah M/C-4034-2012; Lunetta, Christian/K-9214-2016; Colletti, Tiziana/K-2195-2018; Pack, Svetlana D./C-2020-2014; Marinou Aktipi, Kalliopi/AAB-8246-2020; Sendtner, Michael/M-8137-2014; Luigetti, Marco ML/J-2782-2018; Battistini, Stefania/N-2596-2015; Scholz, Sonja W./R-5524-2017; rothstein, jeffrey d/C-9470-2013; Hardy, John/C-2451-2009; Sander-Effron, Samuel/AAX-2231-2020; Pickering-Brown, Stuart/D-4008-2009; Benatar, Michael/AAF-6605-2019; Ganesh, Dunna Sai/AGX-5170-2022; Conforti, Francesca Luisa/K-8877-2016	Hölttä, Maarit/0000-0002-0488-4486; Sendtner, Michael/0000-0002-4737-2974; Mok, Kin/0000-0003-3145-880X; Spataro, Rossella/0000-0002-8910-3131; Ricci, Claudia/0000-0002-2431-0308; Gibbs, J. Raphael/0000-0002-6985-0658; Mandrioli, Jessica/0000-0002-9244-9782; Alkan, Can/0000-0002-5443-0706; Morris, Huw R/0000-0002-5473-3774; Chio, Adriano/0000-0001-9579-5341; Scholz, Sonja/0000-0002-6623-0429; Trabzuni, Daniah/0000-0003-4826-9570; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Mok, Kin Ying/0000-0003-3145-880X; Mandich, Paola/0000-0003-3123-3512; Trabzuni, Daniah M/0000-0003-4826-9570; Lunetta, Christian/0000-0002-4788-1875; Pack, Svetlana D./0000-0003-3256-6626; Marinou Aktipi, Kalliopi/0000-0003-3384-0367; Sendtner, Michael/0000-0002-4737-2974; Luigetti, Marco ML/0000-0001-7539-505X; Battistini, Stefania/0000-0003-2887-7624; Scholz, Sonja W./0000-0002-6623-0429; Hardy, John/0000-0002-3122-0423; Pickering-Brown, Stuart/0000-0003-1561-6054; Benatar, Michael/0000-0003-4241-5135; FLORIS, Gianluca/0000-0001-8821-123X; Guerreiro, Rita/0000-0001-5879-3486; Gerhard, Alexander/0000-0002-8071-6062; Isoviita, Veli-Matti/0000-0001-7329-8934; Renton, Alan E./0000-0001-6702-8268; Newton-Bishop, Julia/0000-0001-9147-6802; Ikonen, Elina/0000-0001-8382-1135; Heutink, Peter/0000-0001-5218-1737; Sabatelli, Mario/0000-0001-6635-4985; Simon Sanchez, Javier/0000-0001-5141-5829; Conforti, Francesca Luisa/0000-0001-8364-1783; Simone, Isabella Laura/0000-0002-7429-3091; Myllykangas, Liisa/0000-0002-2237-5466; Drepper, Carsten/0000-0002-7883-6479; Callister, Janis/0000-0003-4407-3095; Traynor, Bryan/0000-0003-0527-2446; Snowden, Julie/0000-0002-3976-4310	NIH, National Institute on Aging [Z01-AG000949-02]; NINDS; Packard Center for ALS Research at Hopkins; ALS Association; Microsoft Research; Ontario Research Fund; Hersenstichting Nederland Fellowship [B08.03]; Neuroscience Campus Amsterdam; Nuts Ohra Fonds; Stichting Dioraphte [09020300]; UK MND Association [6057]; The Medical Research Council UK; Wellcome Trust; Helsinki University Central Hospital; Finnish Academy; Finnish Medical Society Duodecim, Kuopio University; Italian Health Ministry (Ricerca Sanitaria Finalizzata); Fondazione Vialli e Mauro ONLUS; Federazione Italians Giuoco Calcio; Compagnia di San Paolo; European Community [259867]; Deutsche Forschungsgemeinschaft [SFB 581, TP4]; Muscular Dystrophy Association; Emory Woodruff Health Sciences Center; Oulu University Hospital; Finnish Medical Foundation; Alzheimers Research UK [ART-PPG2011A-14, ART-PG2010-1] Funding Source: researchfish; Medical Research Council [G0700943, G0701441, G0801418B, MC_G0901330, G0802462, MC_G1000735, MC_PC_09003, G0701075, MC_G1000734] Funding Source: researchfish; MRC [MC_G1000735, G0802462, MC_G1000734, MC_PC_09003, G0700943, G0701441, G0701075, MC_G0901330] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIDBC011349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000934, ZIAAG000951, U24AG021886, Z01AG000949, ZIAAG000933] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Packard Center for ALS Research at Hopkins; ALS Association; Microsoft Research(Microsoft); Ontario Research Fund; Hersenstichting Nederland Fellowship; Neuroscience Campus Amsterdam; Nuts Ohra Fonds; Stichting Dioraphte; UK MND Association; The Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Helsinki University Central Hospital; Finnish Academy(Academy of Finland); Finnish Medical Society Duodecim, Kuopio University; Italian Health Ministry (Ricerca Sanitaria Finalizzata)(Ministry of Health, Italy); Fondazione Vialli e Mauro ONLUS; Federazione Italians Giuoco Calcio; Compagnia di San Paolo(Compagnia di San Paolo); European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Muscular Dystrophy Association(Muscular Dystrophy Association); Emory Woodruff Health Sciences Center; Oulu University Hospital; Finnish Medical Foundation; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Intramural Research Programs of the NIH, National Institute on Aging (Z01-AG000949-02), and NINDS. The work was also supported by the Packard Center for ALS Research at Hopkins (B.J.T.), the ALS Association (B.J.T., A.C.), Microsoft Research (B.J.T.. P.J.T.), Ontario Research Fund (E.R.), Hersenstichting Nederland Fellowship project B08.03 and the Neuroscience Campus Amsterdam (J.S-S.), Nuts Ohra Fonds (J.v.S.), Stichting Dioraphte (J.v.S. - Grant 09020300), the UK MND Association (H.M. - MNDA Grant 6057, J.H., R.W.O.), The Medical Research Council UK (J.H., S.P.B.), the Wellcome Trust (J.H.), the Helsinki University Central Hospital, the Finnish Academy (P.J.T.), the Finnish Medical Society Duodecim, Kuopio University, the Italian Health Ministry (Ricerca Sanitaria Finalizzata 2007, to A.C.), Fondazione Vialli e Mauro ONLUS (A.C.). Federazione Italians Giuoco Calcio (A.C., M.S., B.J.T.) and Compagnia di San Paolo (A.C., G.R.). the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreements 259867 (A.G.) and 259867 (M.S., C.D.), Deutsche Forschungsgemeinschaft (M.S. - Grant SFB 581, TP4), the Muscular Dystrophy Association (M.B., J.W.), the Emory Woodruff Health Sciences Center (M.B., J.W.), EVO grants from Oulu University Hospital (A.M.R.) and the Finnish Medical Foundation (A.M.R.). DNA samples for this study were obtained in part from the NINDS repository at the Coriell Cell Repositories (http://www.coriell.org/), and the National Cell Repository for Alzheimer's Disease (http://ncrad.iu.edu). We thank the DNA extraction and storage facility of the National Institute for Health and Welfare/FIMM, Helsinki, Finland and Dr Tuomo Polvikoski, Institute for Ageing and Health. Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK for their help in extraction of DNA from ALS patients. We also thank Nayia Nicolaou for her assistance. J.R. is Director of the Packard Center for ALS Research at Hopkins, D. Harmer is an employee of Illumina. E.E.E. is on the scientific advisory board of Pacific Biosciences, and D. Heckerman is an employee of Microsoft Research. We thank the patients and research subjects who contributed samples for this study.	Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; Cann HM, 2002, SCIENCE, V296, P261; Chio A, 2008, NEUROLOGY, V70, P533, DOI 10.1212/01.wnl.0000299187.90432.3f; DEJESUSHERNANDE.M, 2011, NEURON IN PRESS, V72, DOI DOI 10.1016/J.NEURON.2011.09.011; Haaf T, 1996, NAT GENET, V12, P183, DOI 10.1038/ng0296-183; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liehr T, 2009, FLUORESCENCE IN SITU; Lillo P, 2009, J CLIN NEUROSCI, V16, P1131, DOI 10.1016/j.jocn.2009.03.005; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mok K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.005; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pearson JP, 2011, J NEUROL, V258, P647, DOI 10.1007/s00415-010-5815-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Warner JP, 1996, J MED GENET, V33, P1022, DOI 10.1136/jmg.33.12.1022; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299	34	2906	2971	4	244	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 20	2011	72	2					257	268		10.1016/j.neuron.2011.09.010	http://dx.doi.org/10.1016/j.neuron.2011.09.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	21944779	Bronze, Green Accepted			2022-12-25	WOS:000296224000009
J	Wilson, SM; Galantucci, S; Tartaglia, MC; Rising, K; Patterson, DK; Henry, ML; Ogar, JM; DeLeon, J; Miller, BL; Gorno-Tempini, ML				Wilson, Stephen M.; Galantucci, Sebastiano; Tartaglia, Maria Carmela; Rising, Kindle; Patterson, Dianne K.; Henry, Maya L.; Ogar, Jennifer M.; DeLeon, Jessica; Miller, Bruce L.; Gorno-Tempini, Maria Luisa			Syntactic Processing Depends on Dorsal Language Tracts	NEURON			English	Article							SENTENCE COMPREHENSION; 3 VARIANTS; DIFFUSION; PATHWAYS; CONNECTIVITY; PARCELLATION; TRACTOGRAPHY; NETWORKS	Frontal and temporal language areas involved in syntactic processing are connected by several dorsal and ventral tracts, but the functional roles of the different tracts are not well understood. To identify which white matter tract(s) are important for syntactic processing, we examined the relationship between white matter damage and syntactic deficits in patients with primary progressive aphasia, using multimodal neuroimaging and neurolinguistic assessment. Diffusion tensor imaging showed that microstructural damage to left hemisphere dorsal tracts-the superior longitudinal fasciculus including its arcuate component-was strongly associated with deficits in comprehension and production of syntax. Damage to these dorsal tracts predicted syntactic deficits after gray matter atrophy was taken into account, and fMRI confirmed that these tracts connect regions modulated by syntactic processing. In contrast, damage to ventral tracts-the extreme capsule fiber system or the uncinate fasciculus-was not associated with syntactic deficits. Our findings show that syntactic processing depends primarily on dorsal language tracts.	[Wilson, Stephen M.; Rising, Kindle; Patterson, Dianne K.] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA; [Wilson, Stephen M.] Univ Arizona, Dept Neurol, Tucson, AZ 85721 USA; [Galantucci, Sebastiano; Tartaglia, Maria Carmela; Henry, Maya L.; Ogar, Jennifer M.; DeLeon, Jessica; Miller, Bruce L.; Gorno-Tempini, Maria Luisa] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Galantucci, Sebastiano] Ist Sci San Raffaele, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy; [Galantucci, Sebastiano] Univ Hosp San Raffaele, Milan, Italy	University of Arizona; University of Arizona; University of California System; University of California San Francisco; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Wilson, SM (corresponding author), Univ Arizona, Dept Speech Language & Hearing Sci, 1131 E 2nd St, Tucson, AZ 85721 USA.	smwilson@u.arizona.edu	Galantucci, Sebastiano/K-3379-2018; Gorno-Tempini, Maria Luisa/E-7203-2012; Henry, Maya L./U-1748-2019	Galantucci, Sebastiano/0000-0002-2583-607X; Patterson, Dianne/0000-0001-7518-3110; Henry, Maya/0000-0002-8745-6451; Deleon, Jessica/0000-0002-9779-0541; Wilson, Stephen/0000-0001-9884-2852	NIH [NIDCD R03 DC010878, NINDS R01 NS050915, NIA P01 AG019724, NIA P50 AG023501]; Fonds de la recherche en sante du Quebec (FRSQ); State of California [DHS 04-35516]; Alzheimer's Disease Research Center of California [03-75271 DHS/ADP/ARCC]; Larry L. Hillblom Foundation; John Douglas French Alzheimer's Foundation; Koret Family Foundation; McBean Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, P01AG019724, T32AG023481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010878] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); State of California; Alzheimer's Disease Research Center of California; Larry L. Hillblom Foundation; John Douglas French Alzheimer's Foundation; Koret Family Foundation; McBean Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Growdon, J. Jang and B. Khan for administrative support, N. Dronkers and F. Agosta for helpful discussions, the staff of the UCSF Memory and Aging Center, and the patients, caregivers, and volunteers who participated in the research. Supported by NIH (NIDCD R03 DC010878, NINDS R01 NS050915, NIA P01 AG019724, NIA P50 AG023501); Fonds de la recherche en sante du Quebec (FRSQ); State of California (DHS 04-35516); Alzheimer's Disease Research Center of California (03-75271 DHS/ADP/ARCC); Larry L. Hillblom Foundation; John Douglas French Alzheimer's Foundation; Koret Family Foundation; McBean Family Foundation.	Agosta F, 2010, BRAIN, V133, P286, DOI 10.1093/brain/awp233; Amici S, 2007, J NEUROSCI, V27, P6282, DOI 10.1523/JNEUROSCI.1331-07.2007; Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Delis DC, 2001, D KEFS EXAMINERS MAN, DOI DOI 10.1037/T15082-000; Dunn L. M., 1997, BRIT PICTURE VOCABUL, V3rd; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Goodglass H, 1972, Cortex, V8, P191; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Grossman M, 2005, CORTEX, V41, P764, DOI 10.1016/S0010-9452(08)70295-8; Grossman M, 2005, J NEUROL NEUROSUR PS, V76, P644, DOI 10.1136/jnnp.2004.039966; Hodges J R, 1996, J Int Neuropsychol Soc, V2, P511; Kaplan E, 1983, BOSTON DIAGNOSTIC AP; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makris N, 2009, BRAIN STRUCT FUNCT, V213, P343, DOI 10.1007/s00429-008-0199-8; Ogar J, 2006, BRAIN LANG, V97, P343, DOI 10.1016/j.bandl.2006.01.008; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Sonty SP, 2007, J NEUROSCI, V27, P1334, DOI 10.1523/JNEUROSCI.4127-06.2007; Thompson CK, 1997, APHASIOLOGY, V11, P297, DOI 10.1080/02687039708248473; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weiller C, 2009, TRENDS COGN SCI, V13, P369, DOI 10.1016/j.tics.2009.06.007; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Wertz R., 1984, APRAXIA SPEECH ADULT; Whitwell JL, 2010, NEUROLOGY, V74, P1279, DOI 10.1212/WNL.0b013e3181d9edde; Wilson SM, 2010, J NEUROSCI, V30, P16845, DOI 10.1523/JNEUROSCI.2547-10.2010; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129	42	185	189	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					397	403		10.1016/j.neuron.2011.09.014	http://dx.doi.org/10.1016/j.neuron.2011.09.014			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017996	Bronze, Green Accepted			2022-12-25	WOS:000296224000019
J	Marro, S; Pang, ZPP; Yang, N; Tsai, MC; Qu, K; Chang, HY; Sudhof, TC; Wernig, M				Marro, Samuele; Pang, Zhiping P.; Yang, Nan; Tsai, Miao-Chih; Qu, Kun; Chang, Howard Y.; Suedhof, Thomas C.; Wernig, Marius			Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; TRANSCRIPTION FACTORS; DOPAMINERGIC-NEURONS; EPIGENETIC MEMORY; MOUSE HEPATOCYTES; GENE-EXPRESSION; CRE RECOMBINASE; BETA-CELLS; LIVER	Several recent studies have showed that mouse and human fibroblasts can be directly reprogrammed into induced neuronal (iN) cells, bypassing a pluripotent intermediate state. However, fibroblasts represent heterogeneous mesenchymal progenitor cells that potentially contain neural crest lineages, and the cell of origin remained undefined. This raises the fundamental question of whether lineage reprogramming is possible between cell types derived from different germ layers. Here, we demonstrate that terminally differentiated hepatocytes can be directly converted into functional iN cells. Importantly, single-cell and genome-wide expression analyses showed that fibroblast- and hepatocyte-derived iN cells not only induced a neuronal transcriptional program, but also silenced their donor transcriptome. The remaining donor signature decreased over time and could not support functional hepatocyte properties. Thus, the reprogramming factors lead to a binary lineage switch decision rather than an induction of hybrid phenotypes, but iN cells retain a small but detectable epigenetic memory of their donor cells.	[Marro, Samuele; Yang, Nan; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Marro, Samuele; Yang, Nan; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Chang, Howard Y.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Tsai, Miao-Chih; Qu, Kun; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, 265 Campus Dr, Stanford, CA 94305 USA.	wernig@stanford.edu	Qu, Kun/G-3359-2012; Yang, Nan/H-3174-2012; Marro, Samuele G./I-4493-2014; Pang, Zhiping/AAF-5757-2020	Marro, Samuele G./0000-0002-9326-6945; Pang, Zhiping/0000-0002-6183-1233; Tsai, Miao-Chih/0000-0003-4471-4825; Yang, Nan/0000-0003-3663-1288	Stanford School of Medicine; NARSAD; Stinehart-Reed Foundation; Ellison Medical Foundation; Howard Hughes Medical Institute; NIH [RC4NS073015-01, R01MH092931-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	Stanford School of Medicine; NARSAD(NARSAD); Stinehart-Reed Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank T. Vierbuchen for providing MEF cultures, TTF cultures, NPC cultures, and critical comments on the manuscript; A. Lanctot for help with mouse genotyping; P. Lovelace for support with FACS; and C. Kuo and I. Graef for mice. M.W. is a New York Stem Cell Foundation-Robertson Investigator. In addition, this work was supported by the Dean's Postdoctoral Fellowship at the Stanford School of Medicine (S.M.), a NARSAD Young Investigator Award (Z.P.P.), the Stinehart-Reed Foundation, (MW.) the Ellison Medical Foundation (MW.), the Howard Hughes Medical Institute (H.Y.C. and T.C.S.), and the NIH grants RC4NS073015-01 (MW. and H.Y.C.) and R01MH092931-01 (MW. and T.C.S.).	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Li WC, 2007, INT J BIOCHEM CELL B, V39, P541, DOI 10.1016/j.biocel.2006.10.017; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	25	247	264	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					374	382		10.1016/j.stem.2011.09.002	http://dx.doi.org/10.1016/j.stem.2011.09.002			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21962918	Green Accepted, Bronze			2022-12-25	WOS:000296041200015
J	Franks, KM; Russo, MJ; Sosulski, DL; Mulligan, AA; Siegelbaum, SA; Axel, R				Franks, Kevin M.; Russo, Marco J.; Sosulski, Dara L.; Mulligan, Abigail A.; Siegelbaum, Steven A.; Axel, Richard			Recurrent Circuitry Dynamically Shapes the Activation of Piriform Cortex	NEURON			English	Article							MAMMALIAN OLFACTORY-BULB; ASSOCIATIVE MEMORY; PYRAMIDAL NEURONS; NEURAL ACTIVITY; SINGLE NEURONS; RAT; INHIBITION; ODOR; REPRESENTATIONS; ORGANIZATION	In the piriform cortex, individual odorants activate a unique ensemble of neurons that are distributed without discernable spatial order. Piriform neurons receive convergent excitatory inputs from random collections of olfactory bulb glomeruli. Pyramidal cells also make extensive recurrent connections with other excitatory and inhibitory neurons. We introduced channelrhodopsin into the piriform cortex to characterize these intrinsic circuits and to examine their contribution to activity driven by afferent bulbar inputs. We demonstrated that individual pyramidal cells are sparsely interconnected by thousands of excitatory synaptic connections that extend, largely undiminished, across the piriform cortex, forming a large excitatory network that can dominate the bulbar input. Pyramidal cells also activate inhibitory interneurons that mediate strong, local feedback inhibition that scales with excitation. This recurrent network can enhance or suppress bulbar input, depending on whether the input arrives before or after the cortex is activated. This circuitry may shape the ensembles of piriform cells that encode odorant identity.	[Franks, Kevin M.; Russo, Marco J.; Sosulski, Dara L.; Siegelbaum, Steven A.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Mulligan, Abigail A.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Franks, Kevin M.; Russo, Marco J.; Sosulski, Dara L.; Mulligan, Abigail A.; Siegelbaum, Steven A.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		Russo, Marco/0000-0001-8064-6685; Axel, Richard/0000-0002-3141-4076	Robert Leet and Clara Guthrie Patterson Trust; National Institute on Deafness and Other Communication Disorders (NIDCD); National Institutes of Health; Howard Hughes Medical Institute; Mathers Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009839] Funding Source: NIH RePORTER	Robert Leet and Clara Guthrie Patterson Trust; National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mathers Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Karl Deisseroth, Ian Wickersham, and Ed Callaway for generously providing reagents, Larry Abbott for helpful discussions, and Phyllis Kisloff for assistance with manuscript preparation. This work was supported by The Robert Leet and Clara Guthrie Patterson Trust and a National Institute on Deafness and Other Communication Disorders (NIDCD) K99 grant (K.M.F.), a Ruth L. Kirschstein National Research Service Award predoctoral fellowship from the National Institutes of Health (D.L.S.), the Howard Hughes Medical Institute (S.A.S. and R.A.), and a grant from the Mathers Foundation (R.A.).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BARKAI E, 1994, J NEUROPHYSIOL, V72, P659, DOI 10.1152/jn.1994.72.2.659; Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Braitenberg V, 1998, CORTEX STAT GEOMETRY; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cang JH, 2003, J NEUROSCI, V23, P4108; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Datiche F, 1996, J COMP NEUROL, V376, P265; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; KETCHUM KL, 1993, J NEUROPHYSIOL, V69, P248, DOI 10.1152/jn.1993.69.1.248; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Linster C, 2001, CHEM SENSES, V26, P585, DOI 10.1093/chemse/26.5.585; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; LUSKIN MB, 1983, J COMP NEUROL, V216, P292, DOI 10.1002/cne.902160306; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McGinley MJ, 2011, J NEUROPHYSIOL, V105, P1444, DOI 10.1152/jn.00715.2010; Meister M, 2001, J NEUROSCI, V21, P1351; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poo C, 2011, NEURON, V72, P41, DOI 10.1016/j.neuron.2011.08.015; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Saar D, 2002, J NEUROPHYSIOL, V87, P2358, DOI 10.1152/jn.2002.87.5.2358; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; STEVENS CF, 1969, J NEUROPHYSIOL, V32, P184, DOI 10.1152/jn.1969.32.2.184; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; WILSON M, 1992, J NEUROPHYSIOL, V67, P981, DOI 10.1152/jn.1992.67.4.981; Yang JL, 2004, J COMP NEUROL, V473, P30, DOI 10.1002/cne.20104	59	121	122	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					49	56		10.1016/j.neuron.2011.08.020	http://dx.doi.org/10.1016/j.neuron.2011.08.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982368	Bronze, Green Accepted			2022-12-25	WOS:000295856300007
J	Kirilly, D; Wong, JJL; Lim, EKH; Wang, Y; Zhang, H; Wang, C; Liao, QM; Wang, HF; Liou, YC; Wang, HY; Yu, FW				Kirilly, Daniel; Wong, Jack Jing Lin; Lim, Edwin Kok Hao; Wang, Yan; Zhang, Heng; Wang, Cheng; Liao, Qiuming; Wang, Haifeng; Liou, Yih-Cherng; Wang, Hongyan; Yu, Fengwei			Intrinsic Epigenetic Factors Cooperate with the Steroid Hormone Ecdysone to Govern Dendrite Pruning in Drosophila	NEURON			English	Article							CHROMATIN REMODELING COMPLEXES; RUBINSTEIN-TAYBI-SYNDROME; CREB-BINDING-PROTEIN; HISTONE H3; UBIQUITIN-PROTEASOME; GENE-EXPRESSION; SENSORY NEURONS; METAMORPHOSIS; MECHANISMS; DEGENERATION	Pruning that selectively removes unnecessary axons/dendrites is crucial for sculpting neural circuits during development. During Drosophila metamorphosis, dendritic arborization sensory neurons, ddaCs, selectively prune their larval dendrites in response to the steroid hormone ecdysone. However, it is unknown whether epigenetic factors are involved in dendrite pruning. Here, we analyzed 81 epigenetic factors, from which a Brahma (Brm)-containing chromatin remodeler and a histone acetyltransferase CREB-binding protein (CBP) were identified for their critical roles in initiating dendrite pruning. Brm and CBP specifically activate a key ecdysone response gene, sox14, but not EcR-B1. Furthermore, the HAT activity of CBP is important for sox14 expression and dendrite pruning. EcR-B1 associates with CBP in the presence of ecdysone, which is facilitated by Brm, resulting in local enrichment of an active chromatin mark H3K27Ac at the sox14 locus. Thus, specific intrinsic epigenetic factors cooperate with steroid hormones to activate selective transcriptional programs, thereby initiating neuronal remodeling.	[Kirilly, Daniel; Wong, Jack Jing Lin; Lim, Edwin Kok Hao; Wang, Yan; Zhang, Heng; Liao, Qiuming; Wang, Haifeng; Liou, Yih-Cherng; Yu, Fengwei] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Kirilly, Daniel; Wong, Jack Jing Lin; Lim, Edwin Kok Hao; Wang, Yan; Zhang, Heng; Liao, Qiuming; Wang, Haifeng; Liou, Yih-Cherng; Yu, Fengwei] Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; [Wong, Jack Jing Lin; Liou, Yih-Cherng; Wang, Hongyan; Yu, Fengwei] Ctr Life Sci, NUS Grad Sch Integrated Sci & Engn, Singapore 117456, Singapore; [Wang, Cheng; Wang, Hongyan; Yu, Fengwei] Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorder Program, Singapore 169857, Singapore; [Wang, Hongyan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Yu, Fengwei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Yu, FW (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore.	fengwei@tll.org.sg	Wang, Hongyan/AAB-3030-2019	Wang, Hongyan/0000-0003-4623-1878; Yu, Fengwei/0000-0003-0268-199X	Singapore Millennium Foundation; Duke-NUS [MOE2008-T2-1-048, NRF-RF2009-02]; Temasek Life Sciences Laboratory, and Singapore	Singapore Millennium Foundation; Duke-NUS; Temasek Life Sciences Laboratory, and Singapore	We thank R. Barrio, B. Calvi, Y.N. Jan, W.A. Johnson, A. Lusser, J. Kadonaga, A.L. Kolodkin, J. Kumar, M. Mannervik, M. Meister, J. Muller, T. Min, M. Prestel, F. Sauer, M. Scott, J.A. Simon, J.W. Tamkun, J.P. Taylor, L.M. Thompson, J.E. Treisman, the Bloomington Stock Center, the Kyoto Stock Center, Developmental Studies Hybridoma Bank (University of Iowa), and VDRC for generously providing antibodies and fly stocks. We thank members of the Yu and Wang laboratories for discussions, H. Yu, H.H. Ng, S. Roy, A. Kolodkin, and S. Aw for reading of the manuscript, and V. Jishy, S. Li, C. Liu, and B. Sun for technical advice. This work was supported by Singapore Millennium Foundation (D.K), Duke-NUS funding, MOE2008-T2-1-048 and NRF-RF2009-02 (H.W.), Temasek Life Sciences Laboratory, and Singapore (F.Y.).	Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bantignies F, 2000, MOL CELL BIOL, V20, P9317, DOI 10.1128/MCB.20.24.9317-9330.2000; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Boulanger A, 2011, NAT NEUROSCI, V14, P37, DOI 10.1038/nn.2700; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Collins RT, 2000, GENE DEV, V14, P3140, DOI 10.1101/gad.854300; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Elfring LK, 1998, GENETICS, V148, P251; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kumar JP, 2004, GENETICS, V168, P877, DOI 10.1534/genetics.104.029850; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zraly CB, 2006, J BIOL CHEM, V281, P35305, DOI 10.1074/jbc.M607806200	60	51	52	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2011	72	1					86	100		10.1016/j.neuron.2011.08.003	http://dx.doi.org/10.1016/j.neuron.2011.08.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982371	Bronze			2022-12-25	WOS:000295856300010
J	Ala-Laurila, P; Greschner, M; Chichilnisky, EJ; Rieke, F				Ala-Laurila, Petri; Greschner, Martin; Chichilnisky, E. J.; Rieke, Fred			Cone photoreceptor contributions to noise and correlations in the retinal output	NATURE NEUROSCIENCE			English	Article							MIDGET GANGLION-CELLS; PRIMATE RETINA; ABSOLUTE THRESHOLD; Y-CELL; X-CELL; RESPONSES; LIGHT; SENSITIVITY; POPULATION; PARASOL	Transduction and synaptic noise generated in retinal cone photoreceptors determine the fidelity with which light inputs are encoded, and the readout of cone signals by downstream circuits determines whether this fidelity is used for vision. We examined the effect of cone noise on visual signals by measuring its contribution to correlated noise in primate retinal ganglion cells. Correlated noise was strong in the responses of dissimilar cell types with shared cone inputs. The dynamics of cone noise could account for rapid correlations in ganglion cell activity, and the extent of shared cone input could explain correlation strength. Furthermore, correlated noise limited the fidelity with which visual signals were encoded by populations of ganglion cells. Thus, a simple picture emerges: cone noise, traversing the retina through diverse pathways, accounts for most of the noise and correlations in the retinal output and constrains how higher centers exploit signals carried by parallel visual pathways.	[Ala-Laurila, Petri; Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ala-Laurila, Petri; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Greschner, Martin; Chichilnisky, E. J.] Salk Inst Biol Studies, La Jolla, CA USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Salk Institute	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	rieke@u.washington.edu	Ala-Laurila, Petri/AAE-1203-2019	Ala-Laurila, Petri/0000-0002-6139-6825; Chichilnisky, E.J./0000-0002-5613-0248	Howard Hughes Medical Institute; US National Institutes of Health [EY-11850, EY-13150]; Academy of Finland [123231]; McKnight Foundation; Pioneer Postdoctoral Fellowship Award; NATIONAL EYE INSTITUTE [R01EY013150, R01EY017992, R01EY011850, P30EY001730] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); McKnight Foundation; Pioneer Postdoctoral Fellowship Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank G. Horwitz, G. Murphy, L. Paninski and M. Vidne for detailed comments on the manuscript and helpful discussions, D. Carleton, E. Martinson and P. Newman for excellent technical assistance, G. D. Field, J.L. Gauthier, J. Shlens and A. Sher for experimental assistance, A. M. Litke, M. I. Grivich, D. Petrusca, W. Dabrowski, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development, and J. Crook, D. Dacey, T. Haun, M. Manookin, O. Packer, B. Peterson, H. Fox, K. Osborn and the Tissue Distribution Program of the Regional Primate Research Center at the University of Washington for providing primate tissue. This work was supported by the Howard Hughes Medical Institute (F. R.), the US National Institutes of Health (EY-11850 to F. R. and EY-13150 to E. J. C.), the Academy of Finland (grant 123231 to P. A.-L.), the McKnight Foundation (E. J. C.) and a Pioneer Postdoctoral Fellowship Award (M.G.).	AHO AC, 1987, J OPT SOC AM A, V4, P2321, DOI 10.1364/JOSAA.4.002321; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BAYLOR DA, 1977, J PHYSIOL-LONDON, V271, P425, DOI 10.1113/jphysiol.1977.sp012007; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borghuis BG, 2009, J NEUROSCI, V29, P3045, DOI 10.1523/JNEUROSCI.5071-08.2009; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Choi SY, 2005, NEURON, V48, P555, DOI 10.1016/j.neuron.2005.09.011; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; DACEY DM, 1992, VISUAL NEUROSCI, V9, P279, DOI 10.1017/S0952523800010695; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DONNER K, 1992, VISION RES, V32, P853, DOI 10.1016/0042-6989(92)90028-H; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Gauthier JL, 2009, J NEUROSCI, V29, P4675, DOI 10.1523/JNEUROSCI.5294-08.2009; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; Hamer RD, 2003, J GEN PHYSIOL, V122, P419, DOI 10.1085/jgp.200308832; Hidaka S, 2004, J NEUROSCI, V24, P10553, DOI 10.1523/JNEUROSCI.3319-04.2004; Hu EH, 2003, J NEUROSCI, V23, P6768; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; LAMB TD, 1977, J PHYSIOL-LONDON, V272, P435, DOI 10.1113/jphysiol.1977.sp012053; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; MOLLON JD, 1992, VISION RES, V32, P745, DOI 10.1016/0042-6989(92)90189-P; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Rieke F., 1997, SPIKES EXPLORING NEU; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shlens J, 2008, CURR OPIN NEUROBIOL, V18, P396, DOI 10.1016/j.conb.2008.09.010; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Westheimer G., 1981, PROGR SENSORY PHYSL, P1, DOI DOI 10.1007/978-3-642-66744-2; Xu Y, 2008, J COMP NEUROL, V507, P1871, DOI 10.1002/cne.21644; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	49	64	64	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1309	U127		10.1038/nn.2927	http://dx.doi.org/10.1038/nn.2927			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21926983	Green Accepted			2022-12-25	WOS:000295254200020
J	Kastner, DB; Baccus, SA				Kastner, David B.; Baccus, Stephen A.			Coordinated dynamic encoding in the retina using opposing forms of plasticity	NATURE NEUROSCIENCE			English	Article							SLOW CONTRAST ADAPTATION; GANGLION-CELLS; VARIANCE ADAPTATION; SALAMANDER RETINA; VISUAL-ADAPTATION; TEMPORAL CONTRAST; NATURAL IMAGES; SPATIAL SCALE; BIPOLAR CELLS; INFORMATION	The range of natural inputs encoded by a neuron often exceeds its dynamic range. To overcome this limitation, neural populations divide their inputs among different cell classes, as with rod and cone photoreceptors, and adapt by shifting their dynamic range. We report that the dynamic behavior of retinal ganglion cells in salamanders, mice and rabbits is divided into two opposing forms of short-term plasticity in different cell classes. One population of cells exhibited sensitization-a persistent elevated sensitivity following a strong stimulus. This newly observed dynamic behavior compensates for the information loss caused by the known process of adaptation occurring in a separate cell population. The two populations divide the dynamic range of inputs, with sensitizing cells encoding weak signals and adapting cells encoding strong signals. In the two populations, the linear, threshold and adaptive properties are linked to preserve responsiveness when stimulus statistics change, with one population maintaining the ability to respond when the other fails.	[Baccus, Stephen A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Kastner, David B.] Stanford Univ, Neurosci Program, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Baccus, SA (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	baccus@stanford.edu		Kastner, David/0000-0001-9681-425X	US National Eye Institute; Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Karl Kirchgessner Foundation; Alfred P. Sloan Foundation; Stanford Medical Scientist Training Program; US National Science Foundation; NATIONAL EYE INSTITUTE [R01EY022933, R01EY016842] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Karl Kirchgessner Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Stanford Medical Scientist Training Program; US National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Knudsen and W. T. Newsome for comments on the manuscript; D. Baylor, R. W. Tsien, B. Wandell, P. Jadzinsky, A. L. Fairhall, F. Rieke, D. S. Fisher and K. D. Miller for discussions; and Y. Ozuysal and A. Huberman for technical assistance. This work was supported by grants from the US National Eye Institute, Pew Charitable Trusts, McKnight Endowment Fund for Neuroscience, Karl Kirchgessner Foundation and Alfred P. Sloan Foundation (S. A. B.); and by the Stanford Medical Scientist Training Program and a US National Science Foundation Integrative Graduate Education and Research Traineeship (D. B. K.). Rabbit experiments were performed in the laboratory of M. Meister at Harvard University.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Baccus SA, 2007, ANNU REV PHYSIOL, V69, P271, DOI 10.1146/annurev.physiol.69.120205.124451; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; DAYAN P, 2009, THEORETICAL NEUROSCI, V460; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Li GL, 2007, J NEUROSCI, V27, P7377, DOI 10.1523/JNEUROSCI.0410-07.2007; MAGUIRE G, 1989, P NATL ACAD SCI USA, V86, P10144, DOI 10.1073/pnas.86.24.10144; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Snippe HP, 2003, J OPT SOC AM A, V20, P1321, DOI 10.1364/JOSAA.20.001321; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Wessel R, 1996, J NEUROPHYSIOL, V75, P2280, DOI 10.1152/jn.1996.75.6.2280	38	61	62	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1317	U135		10.1038/nn.2906	http://dx.doi.org/10.1038/nn.2906			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909086	Green Accepted			2022-12-25	WOS:000295254200021
J	Mellios, N; Sugihara, H; Castro, J; Banerjee, A; Le, C; Kumar, A; Crawford, B; Strathmann, J; Tropea, D; Levine, SS; Edbauer, D; Sur, M				Mellios, Nikolaos; Sugihara, Hiroki; Castro, Jorge; Banerjee, Abhishek; Le, Chuong; Kumar, Arooshi; Crawford, Benjamin; Strathmann, Julia; Tropea, Daniela; Levine, Stuart S.; Edbauer, Dieter; Sur, Mriganka			miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity	NATURE NEUROSCIENCE			English	Article							MONOCULAR DEPRIVATION; MORPHOGENESIS	Using quantitative analyses, we identified microRNAs (miRNAs) that were abundantly expressed in visual cortex and that responded to dark rearing and/or monocular deprivation. The most substantially altered miRNA, miR-132, was rapidly upregulated after eye opening and was delayed by dark rearing. In vivo inhibition of miR-132 in mice prevented ocular dominance plasticity in identified neurons following monocular deprivation and affected the maturation of dendritic spines, demonstrating its critical role in the plasticity of visual cortex circuits.	[Mellios, Nikolaos; Sugihara, Hiroki; Castro, Jorge; Banerjee, Abhishek; Le, Chuong; Kumar, Arooshi; Crawford, Benjamin; Tropea, Daniela; Sur, Mriganka] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Strathmann, Julia; Edbauer, Dieter] DZNE German Ctr Neurodegenerat Dis, Munich, Germany; [Levine, Stuart S.] MIT, Biomicro Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	msur@mit.edu	Edbauer, Dieter/M-9906-2019; Tropea, Daniela/AAX-8147-2020	Edbauer, Dieter/0000-0002-7186-4653; Levine, Stuart/0000-0001-7363-562X; Tropea, Daniela/0000-0001-9730-6636; Sugihara, Hiroki/0000-0002-0637-3700	US National Eye Institute [1F32EY020066-01]; Helmholtz Young Investigator program [HZ-NG-607]; Simons Foundation; US National Institutes of Health [EY017098, EY007023]; NATIONAL EYE INSTITUTE [R01EY007023, R01EY017098, F32EY020066] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Helmholtz Young Investigator program; Simons Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Sharma and C. Runyan for feedback, G. Kreiman for assistance with data analysis, M. Constantine-Paton and her laboratory for sharing equipment and B. Karki for technical assistance. Supported by US National Eye Institute Ruth L. Kirschstein Postdoctoral Fellowship 1F32EY020066-01 (N.M.), Helmholtz Young Investigator program HZ-NG-607 (D. E.), a Simons Foundation postdoctoral fellowship (A. B.) and US National Institutes of Health EY017098 and EY007023 to M.S.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105	15	141	148	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1240	1242		10.1038/nn.2909	http://dx.doi.org/10.1038/nn.2909			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21892155	Green Accepted, Green Submitted			2022-12-25	WOS:000295254200008
J	Rao-Ruiz, P; Rotaru, DC; van der Loo, RJ; Mansvelder, HD; Stiedl, O; Smit, AB; Spijker, S				Rao-Ruiz, Priyanka; Rotaru, Diana C.; van der Loo, Rolinka J.; Mansvelder, Huibert D.; Stiedl, Oliver; Smit, August B.; Spijker, Sabine			Retrieval-specific endocytosis of GluA2-AMPARs underlies adaptive reconsolidation of contextual fear	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM DEPRESSION; MEMORY RECONSOLIDATION; SYNAPTIC PLASTICITY; EXTINCTION; CONSOLIDATION; MECHANISMS; ERASURE; POTENTIATION; REACTIVATION	Upon retrieval, fear memories are rendered labile and prone to modification, necessitating a restabilization process of reconsolidation to persist further. This process is also crucial for modulating both strength and content of an existing memory and forms a promising therapeutic target for fear-related disorders. However, the molecular and cellular mechanism of adaptive reconsolidation still remains obscure. Here we show that retrieval of fear memory induces a biphasic temporal change in GluA2-containing AMPA-type glutamate receptor (AMPAR) membrane expression and synaptic strength in the mouse dorsal hippocampus. Blockade of retrieval-induced, regulated, GluA2-dependent endocytosis enhanced subsequent expression of fear. In addition, this blockade prevented the loss of fear response after reconsolidation-update of fear memory content in the long-term. Thus, endocytosis of GluA2-containing AMPARs allows plastic changes at the synaptic level that exerts an inhibitory constraint on memory strengthening and underlies the loss of fear response by reinterpretation of memory content during adaptive reconsolidation.	[Rao-Ruiz, Priyanka; Rotaru, Diana C.; van der Loo, Rolinka J.; Stiedl, Oliver; Smit, August B.; Spijker, Sabine] VU Univ Vrije Univ, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Rotaru, Diana C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Stiedl, Oliver] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), VU Univ Vrije Univ, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	sabine.spijker@cncr.vu.nl	Spijker, Sabine/F-2300-2011; Mansvelder, Huibert/N-6138-2018; Rotaru, Diana/AAZ-9058-2020; Stiedl, Oliver/AAB-5004-2021	Mansvelder, Huibert/0000-0003-1365-5340; Stiedl, Oliver/0000-0002-4427-9221; Rao-Ruiz, Priyanka/0000-0001-9504-1427; Spijker, Sabine/0000-0002-6814-2019; Rotaru, Diana/0000-0002-0724-3596	Neuromics Marie Curie Early Stage Training grant [MEST-CT-2005-020919]	Neuromics Marie Curie Early Stage Training grant	The authors thank J. Peters, M. van den Oever, R. van Kesteren and S. A. Kushner for critical reading of previous versions of this manuscript, and K. W. Li for technical advice in relation to biotinylation experiments. P.R.-R. was supported by a Neuromics Marie Curie Early Stage Training grant (MEST-CT-2005-020919).	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Counotte DS, 2011, NAT NEUROSCI, V14, P417, DOI 10.1038/nn.2770; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; GORDON WC, 1973, PHYSIOL BEHAV, V10, P1071, DOI 10.1016/0031-9384(73)90190-X; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lee JLC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00168; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Robertson SD, 2010, J NEUROSCI, V30, P11305, DOI 10.1523/JNEUROSCI.0126-10.2010; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350	50	152	154	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1302	U117		10.1038/nn.2907	http://dx.doi.org/10.1038/nn.2907			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909089				2022-12-25	WOS:000295254200019
J	Taniguchi, H; He, M; Wu, P; Kim, S; Paik, R; Sugino, K; Kvitsani, D; Fu, Y; Lu, JT; Lin, Y; Miyoshi, G; Shima, Y; Fishell, G; Nelson, SB; Huang, ZJ				Taniguchi, Hiroki; He, Miao; Wu, Priscilla; Kim, Sangyong; Paik, Raehum; Sugino, Ken; Kvitsani, Duda; Fu, Yu; Lu, Jiangteng; Lin, Ying; Miyoshi, Goichi; Shima, Yasuyuki; Fishell, Gord; Nelson, Sacha B.; Huang, Z. Josh			A Resource of Cre Driver Lines for Genetic Targeting of GABAergic Neurons in Cerebral Cortex	NEURON			English	Article							INTERNEURON DIVERSITY SERIES; CENTRAL-NERVOUS-SYSTEM; CORTICAL INTERNEURONS; HIPPOCAMPAL INTERNEURONS; IN-VIVO; SOMATOSENSORY CORTEX; RAT; EXPRESSION; CELLS; TRANSCRIPTION	A key obstacle to understanding neural circuits in the cerebral cortex is that of unraveling the diversity of GABAergic interneurons. This diversity poses general questions for neural circuit analysis: how are these interneuron cell types generated and assembled into stereotyped local circuits and how do they differentially contribute to circuit operations that underlie cortical functions ranging from perception to cognition? Using genetic engineering in mice, we have generated and characterized approximately 20 Cre and inducible CreER knockin driver lines that reliably target major classes and lineages of GABAergic neurons. More select populations are captured by intersection of Cre and Flp drivers. Genetic targeting allows reliable identification, monitoring, and manipulation of cortical GABAergic neurons, thereby enabling a systematic and comprehensive analysis from cell fate specification, migration, and connectivity, to their functions in network dynamics and behavior. As such, this approach will accelerate the study of GABAergic circuits throughout the mammalian brain.	[Taniguchi, Hiroki; He, Miao; Wu, Priscilla; Kim, Sangyong; Paik, Raehum; Kvitsani, Duda; Fu, Yu; Lu, Jiangteng; Lin, Ying; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sugino, Ken; Shima, Yasuyuki; Nelson, Sacha B.] Brandeis Univ, Dept Biol, Waltham, MA 02154 USA; [Sugino, Ken; Shima, Yasuyuki; Nelson, Sacha B.] Brandeis Univ, Ctr Behav Gen, Waltham, MA 02154 USA; [Miyoshi, Goichi; Fishell, Gord] NYU, Dept Cell Biol, Med Ctr, Smilow Neurosci Program, New York, NY 10016 USA	Cold Spring Harbor Laboratory; Brandeis University; Brandeis University; New York University	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu	He, Miao/AAQ-1044-2020; Miyoshi, Goichi/H-4759-2012; Miyoshi, Goichi/O-2029-2019	He, Miao/0000-0003-0731-6801; Huang, Z. Josh/0000-0003-0592-028X; Nelson, Sacha/0000-0002-0108-8599; Kvitsiani, Duda/0000-0003-3175-1774; Fishell, Gordon/0000-0002-9640-9278; Kim, Sang Yong/0000-0001-7326-7505	NIH [U01 MH078844-01, U01 MH078844-02, U01 MH078844-03]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We apologize for not being able to cite more authors due to space limitation. We thank Drs. Hongkui Zeng for generously providing the Ai9 reporter line, Florin Albeanu for help with in vivo 2-photon imaging. This work was supported by NIH grants U01 MH078844-01 and U01 MH078844-02 to Z.J.H. and subaward U01 MH078844-03 to S.B.N. H.T. was supported by a NARSAD Postdoctoral Fellowship. Z.J.H. was a McKnight Scholar and a Simons Investigator.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2001, NEUROCHEM RES, V26, P899, DOI 10.1023/A:1012324231897; Cajal R., 1899, TEXTURA SISTEMA NERV; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; de Lecea L, 2008, MOL CELL ENDOCRINOL, V286, P88, DOI 10.1016/j.mce.2007.12.014; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Higo S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.025.2009; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huang ZJ, 2010, IMAGING DEV BIOL LAB, P199; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katona I, 1999, J NEUROSCI, V19, P4544; Kilduff TS, 2011, TRENDS NEUROSCI, V34, P10, DOI 10.1016/j.tins.2010.09.005; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Korosi A, 2008, EUR J PHARMACOL, V583, P204, DOI 10.1016/j.ejphar.2007.11.066; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Long J.E., 2009, CEREB CORTEX, V19, pi96, DOI [10.1093/cercor/bhp045, DOI 10.1093/CERCOR/BHP045]; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MACOSKO EZ, 2009, NAT NEUROSCI, V13, P133; Magno L, 2009, BRAIN RES, V1304, P164, DOI 10.1016/j.brainres.2009.09.050; Major DE, 2000, J COMP NEUROL, V423, P243; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McLean DL, 2008, DEV NEUROBIOL, V68, P817, DOI 10.1002/dneu.20617; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; SIK A, 1995, J NEUROSCI, V15, P6651; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Somogyi P, 2003, EUR J NEUROSCI, V17, P2503, DOI 10.1046/j.1460-9568.2003.02697.x; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004	73	1103	1105	6	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					995	1013		10.1016/j.neuron.2011.07.026	http://dx.doi.org/10.1016/j.neuron.2011.07.026			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943598	Bronze, Green Accepted			2022-12-25	WOS:000295556500006
J	Wunderlich, K; Symmonds, M; Bossaerts, P; Dolan, RJ				Wunderlich, Klaus; Symmonds, Mkael; Bossaerts, Peter; Dolan, Raymond J.			Hedging Your Bets by Learning Reward Correlations in the Human Brain	NEURON			English	Article							DECISION-MAKING; ORBITOFRONTAL CORTEX; PREDICTION ERRORS; PREFRONTAL CORTEX; ECONOMIC VALUE; RISK-TAKING; REPRESENTATION; INFERENCE; INSULA; VALUES	Human subjects are proficient at tracking the mean and variance of rewards and updating these via prediction errors. Here, we addressed whether humans can also learn about higher-order relationships between distinct environmental outcomes, a defining ecological feature of contexts where multiple sources of rewards are available. By manipulating the degree to which distinct outcomes are correlated, we show that subjects implemented an explicit model-based strategy to learn the associated outcome correlations and were adept in using that information to dynamically adjust their choices in a task that required a minimization of outcome variance. Importantly, the experimentally generated outcome correlations were explicitly represented neuronally in right midinsula with a learning prediction error signal expressed in rostral anterior cingulate cortex. Thus, our data show that the human brain represents higher-order correlation structures between rewards, a core adaptive ability whose immediate benefit is optimized sampling.	[Wunderlich, Klaus; Symmonds, Mkael; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Bossaerts, Peter] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Bossaerts, Peter] Ecole Polytech Fed Lausanne, Swiss Finance Inst, CH-1015 Lausanne, Switzerland	University of London; University College London; California Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Finance Institute (SFI)	Wunderlich, K (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.	k.wunderlich@ucl.ac.uk	Bossaerts, Peter/AAZ-9851-2020; Bossaerts, Peter/O-9964-2015	Bossaerts, Peter/0000-0003-2308-2603; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust; Max Planck Award	Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Award(Max Planck Society)	This study was supported by a Wellcome Trust Program Grant and Max Planck Award.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Andrade A, 1999, NEUROIMAGE, V10, P483, DOI 10.1006/nimg.1999.0479; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Benartzi S, 2001, AM ECON REV, V91, P79, DOI 10.1257/aer.91.1.79; Bossaerts P, 2010, BRAIN STRUCT FUNCT, V214, P645, DOI 10.1007/s00429-010-0253-1; Bunzeck N, 2010, HUM BRAIN MAPP, V31, P1380, DOI 10.1002/hbm.20939; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Danforth BN, 1999, P ROY SOC B-BIOL SCI, V266, P1985, DOI 10.1098/rspb.1999.0876; Daniel K, 2002, J MONETARY ECON, V49, P139, DOI 10.1016/S0304-3932(01)00091-5; DODSON L, 1989, J ACCOUNTANCY, V167, P131; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Fox CW, 2003, EVOL ECOL RES, V5, P273; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Gentle J. E., 1998, CHOLESKY FACTORIZATI, P93; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; JORION P, 2009, FINANCIAL RISK MANAG; Kacelnik A, 1996, AM ZOOL, V36, P402; Kagel J., 1997, HDB EXPT EC; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seymour B, 2008, CURR OPIN NEUROBIOL, V18, P173, DOI 10.1016/j.conb.2008.07.010; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Symmonds M, 2010, J NEUROSCI, V30, P14380, DOI 10.1523/JNEUROSCI.1459-10.2010; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106; YOSHIMURA J, 1991, EVOL ECOL, V5, P173, DOI 10.1007/BF02270833	63	27	27	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 22	2011	71	6					1141	1152		10.1016/j.neuron.2011.07.025	http://dx.doi.org/10.1016/j.neuron.2011.07.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943609	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000295556500017
J	Rauschecker, AM; Bowen, RF; Perry, LM; Kevan, AM; Dougherty, RF; Wandell, BA				Rauschecker, Andreas M.; Bowen, Reno F.; Perry, Lee M.; Kevan, Alison M.; Dougherty, Robert F.; Wandell, Brian A.			Visual Feature-Tolerance in the Reading Network	NEURON			English	Article							WORD FORM AREA; FUNCTIONAL SPECIALIZATION; MOTION DISCRIMINATION; MAGNOCELLULAR DEFECT; FUSIFORM GYRUS; OBJECT; CORTEX; SENSITIVITY; MT; PERCEPTION	A century of neurology and neuroscience shows that seeing words depends on ventral occipital-temporal (VOT) circuitry. Typically, reading is learned using high-contrast line-contour words. We explored whether a specific VOT region, the visual word form area (VWFA), learns to see only these words or recognizes words independent of the specific shape-defining visual features. Word forms were created using atypical features (motion-dots, luminance-dots) whose statistical properties control word-visibility. We measured fMRI responses as word form visibility varied, and we used TMS to interfere with neural processing in specific cortical circuits, while subjects performed a lexical decision task. For all features, VWFA responses increased with word-visibility and correlated with performance. TMS applied to motion-specialized area hMT+ disrupted reading performance for motion-dots, but not line-contours or luminance-dots. A quantitative model describes feature-convergence in the VWFA and relates VWFA responses to behavioral performance. These findings suggest how visual feature-tolerance in the reading network arises through signal convergence from feature-specialized cortical areas.	[Rauschecker, Andreas M.] Stanford Univ, Stanford Sch Med, Neurosci Program, Stanford, CA 94305 USA; [Rauschecker, Andreas M.] Stanford Univ, Stanford Sch Med, Med Scientist Training Program, Stanford, CA 94305 USA; [Rauschecker, Andreas M.; Bowen, Reno F.; Perry, Lee M.; Kevan, Alison M.; Dougherty, Robert F.; Wandell, Brian A.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Rauschecker, AM (corresponding author), Stanford Univ, Stanford Sch Med, Neurosci Program, Stanford, CA 94305 USA.	andreasr@stanford.edu		Rauschecker, Andreas/0000-0003-0633-9876	Medical Scientist Training Program; Bio-X Graduate Student Fellowship Program; NIH [EY015000]; NATIONAL EYE INSTITUTE [R01EY015000] Funding Source: NIH RePORTER	Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bio-X Graduate Student Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Michal Ben-Shachar and Jason Yeatman for their advice. This work was supported by the Medical Scientist Training Program, the Bio-X Graduate Student Fellowship Program, and NIH RO1 Grant EY015000.	Ben-Shachar M, 2007, NEUROIMAGE, V37, P1396, DOI 10.1016/j.neuroimage.2007.05.060; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; Ben-Shachar M, 2007, CURR OPIN NEUROBIOL, V17, P258, DOI 10.1016/j.conb.2007.03.006; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Blanke O, 2007, NEUROPSYCHOLOGIA, V45, P644, DOI 10.1016/j.neuropsychologia.2006.07.019; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brem S, 2006, NEUROIMAGE, V29, P822, DOI 10.1016/j.neuroimage.2005.09.023; BRITTEN KH, 1992, EXP BRAIN RES, V88, P292, DOI 10.1007/BF02259104; BROCA P, 1861, B SOC ANAT PARIS, V6, P398; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; Demb JB, 1998, J NEUROSCI, V18, P6939; Demb JB, 1997, P NATL ACAD SCI USA, V94, P13363, DOI 10.1073/pnas.94.24.13363; Devlin JT, 2006, J COGNITIVE NEUROSCI, V18, P911, DOI 10.1162/jocn.2006.18.6.911; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Ferber S, 2003, CEREB CORTEX, V13, P716, DOI 10.1093/cercor/13.7.716; GALABURDA A, 1993, ANN NY ACAD SCI, V682, P70, DOI 10.1111/j.1749-6632.1993.tb22960.x; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; GRAHAM N, 1978, VISION RES, V18, P815, DOI 10.1016/0042-6989(78)90122-0; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Laycock R, 2009, EXP BRAIN RES, V197, P69, DOI 10.1007/s00221-009-1894-2; Liederman J, 2003, BRAIN LANG, V85, P140, DOI 10.1016/S0093-934X(02)00550-3; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; LOGOTHETIS N, 1990, INVEST OPHTHALMOL  S, P30; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Marcar VL, 1997, NEUROPSYCHOLOGIA, V35, P1459, DOI 10.1016/S0028-3932(97)00057-2; MARCAR VL, 1992, EUR J NEUROSCI, V4, P1228, DOI 10.1111/j.1460-9568.1992.tb00148.x; MARTIN F, 1987, PERCEPTION, V16, P215, DOI 10.1068/p160215; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; McCloskey M, 2000, J MEM LANG, V43, P157, DOI 10.1006/jmla.2000.2724; Medler D.A., 2005, MCWORD ONLINE ORTHOG; Mysore SG, 2006, J NEUROPHYSIOL, V95, P1864, DOI 10.1152/jn.00627.2005; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Prieto EA, 2007, NEUROIMAGE, V37, P1384, DOI 10.1016/j.neuroimage.2007.03.080; Qiao E, 2010, NEUROIMAGE, V49, P1786, DOI 10.1016/j.neuroimage.2009.09.034; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; REGAN D, 1992, J NEUROSCI, V12, P2198; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Richardson FM, 2011, J NEUROSCI, V31, P8239, DOI 10.1523/JNEUROSCI.6519-10.2011; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Sack AT, 2006, NEUROIMAGE, V29, P1326, DOI 10.1016/j.neuroimage.2005.08.027; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; Stein J, 2003, NEUROPSYCHOLOGIA, V41, P1785, DOI 10.1016/S0028-3932(03)00179-9; Szwed M, 2011, NEUROIMAGE, V56, P330, DOI 10.1016/j.neuroimage.2011.01.073; Szwed M, 2009, VISION RES, V49, P718, DOI 10.1016/j.visres.2009.01.003; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VAINA LM, 1990, VISUAL NEUROSCI, V5, P353, DOI 10.1017/S0952523800000444; VAINA LM, 1989, BIOL CYBERN, V61, P347, DOI 10.1007/BF00200800; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; WANDELL BA, 2010, ANN REV PSY IN PRESS, DOI DOI 10.1146/ANNUREV-PSYCH-120710-100434; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; WARRINGTON EK, 1980, BRAIN, V103, P99, DOI 10.1093/brain/103.1.99; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	78	37	38	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 8	2011	71	5					941	953		10.1016/j.neuron.2011.06.036	http://dx.doi.org/10.1016/j.neuron.2011.06.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903085	Green Accepted, Bronze			2022-12-25	WOS:000294877900017
J	Becker, MW; Jordan, CT				Becker, Michael W.; Jordan, Craig T.			Leukemia Sternness Signatures Step toward the Clinic	CELL STEM CELL			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; CELLS		[Becker, Michael W.; Jordan, Craig T.] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	University of Rochester	Jordan, CT (corresponding author), Univ Rochester, James P Wilmot Canc Ctr, 601 Elmwood Ave,Box 704, Rochester, NY 14642 USA.	craig_jordan@urmc.rochester.edu	; jordan, craig/D-7666-2014	Becker, Michael/0000-0001-9890-8815; jordan, craig/0000-0003-0869-3465				Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	10	8	8	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					185	186		10.1016/j.stem.2011.08.006	http://dx.doi.org/10.1016/j.stem.2011.08.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885015	Bronze			2022-12-25	WOS:000295024200005
J	Sul, JH; Jo, S; Lee, D; Jung, MW				Sul, Jung Hoon; Jo, Suhyun; Lee, Daeyeol; Jung, Min Whan			Role of rodent secondary motor cortex in value-based action selection	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; DECISION-MAKING; AFFERENT CONNECTIONS; MATCHING BEHAVIOR; NEURONAL-ACTIVITY; AGRANULAR CORTEX; EYE FIELDS; REWARD; RAT	Despite widespread neural activity related to reward values, signals related to upcoming choice have not been clearly identified in the rodent brain. Here we examined neuronal activity in the lateral (AGl) and medial (AGm) agranular cortex, corresponding to the primary and secondary motor cortex, respectively, in rats performing a dynamic foraging task. Choice signals, before behavioral manifestation of the rat's choice, arose in the AGm earlier than in any other areas of the rat brain previously studied under free-choice conditions. The AGm also conveyed neural signals for decision value and chosen value. By contrast, upcoming choice signals arose later, and value signals were weaker, in the AGl. We also found that AGm lesions made the rats' choices less dependent on dynamically updated values. These results suggest that rodent secondary motor cortex might be uniquely involved in both representing and reading out value signals for flexible action selection.	[Sul, Jung Hoon; Jo, Suhyun; Jung, Min Whan] Ajou Univ, Neurosci Lab, Inst Med Sci, Sch Med, Suwon 441749, South Korea; [Jo, Suhyun; Jung, Min Whan] Ajou Univ, Grad Program Neurosci, Sch Med, Suwon 441749, South Korea; [Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Ajou University; Ajou University; Yale University	Jung, MW (corresponding author), Ajou Univ, Neurosci Lab, Inst Med Sci, Sch Med, Suwon 441749, South Korea.	min@ajou.ac.kr	Lee, Daeyeol/A-6794-2008; Jung, Min Whan/GXF-5216-2022	Lee, Daeyeol/0000-0003-3474-019X; Jo, Suhyun/0000-0002-6538-8240	Brain Research Center; Korea National Research Foundation [2011-0015618]; Cognitive Neuroscience Program; Ministry of Education, Science and Technology, Korea [2011-0019209]; US National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	Brain Research Center; Korea National Research Foundation(National Research Foundation of Korea); Cognitive Neuroscience Program; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Lee for discussion, P. Nachev for commenting on the manuscript, J.W. Ghim for helping with analysis and E. Seuter for proofreading the manuscript. This work was supported by a grant from the Brain Research Center of the 21st Century Frontier Research Program, a Korea National Research Foundation grant (2011-0015618), the Cognitive Neuroscience Program, and the Original Technology Research Program for Brain Science (2011-0019209) funded by the Ministry of Education, Science and Technology, Korea (to M.W.J.), and the US National Institutes of Health (to D.L.).	AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Huh N, 2009, LEARN MEMORY, V16, P315, DOI 10.1101/lm.1295509; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kargo WJ, 2007, J NEUROSCI, V27, P3548, DOI 10.1523/JNEUROSCI.3604-06.2007; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kim YB, 2007, J NEUROPHYSIOL, V98, P3548, DOI 10.1152/jn.00310.2007; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; MILLER MW, 1987, EXP BRAIN RES, V67, P339; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; PASSINGHAM RE, 1988, BEHAV NEUROSCI, V102, P101, DOI 10.1037/0735-7044.102.1.101; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; REEP RL, 1984, NEUROSCI LETT, V44, P247, DOI 10.1016/0304-3940(84)90030-2; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SANDERSON KJ, 1984, BRAIN RES, V292, P251, DOI 10.1016/0006-8993(84)90761-3; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Sohn JW, 2007, J NEUROSCI, V27, P13655, DOI 10.1523/JNEUROSCI.2982-07.2007; STADDON JER, 1981, J EXP ANAL BEHAV, V35, P397, DOI 10.1901/jeab.1981.35-397; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; Thevarajah D, 2009, J NEUROSCI, V29, P1998, DOI 10.1523/JNEUROSCI.4764-08.2009; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31, DOI [DOI 10.1016/j.bbr.2003.09.028, DOI 10.1016/j.pscychresns.2017.01.006]; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7	50	133	133	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1202	U139		10.1038/nn.2881	http://dx.doi.org/10.1038/nn.2881			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841777	Green Accepted			2022-12-25	WOS:000294284900022
J	Summerfield, C; Behrens, TE; Koechlin, E				Summerfield, Christopher; Behrens, Timothy E.; Koechlin, Etienne			Perceptual Classification in a Rapidly Changing Environment	NEURON			English	Article							HUMAN PREFRONTAL CORTEX; DECISION-MAKING; COGNITIVE CONTROL; CINGULATE CORTEX; NEURAL MECHANISMS; UNCERTAINTY; REWARD; RISK; CATEGORIZATION; CHOICE	Humans and monkeys can learn to classify perceptual information in a statistically optimal fashion if the functional groupings remain stable over many hundreds of trials, but little is known about categorization when the environment changes rapidly. Here, we used a combination of computational modeling and functional neuroimaging to understand how humans classify visual stimuli drawn from categories whose mean and variance jumped unpredictably. Models based on optimal learning (Bayesian model) and a cognitive strategy (working memory model) both explained unique variance in choice, reaction time, and brain activity. However, the working memory model was the best predictor of performance in volatile environments, whereas statistically optimal performance emerged in periods of relative stability. Bayesian and working memory models predicted decision-related activity in distinct regions of the prefrontal cortex and midbrain. These findings suggest that perceptual category judgments, like value-guided choices, may be guided by multiple controllers.	[Summerfield, Christopher] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Behrens, Timothy E.] John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB, Oxford OX3 9DU, England; [Behrens, Timothy E.] UCL, Wellcome Ctr Cognit Neuroimaging, London WC1N 3BG, England; [Koechlin, Etienne] Ecole Normale Super, INSERM, Dept Etud Cognit, F-75005 Paris, France; [Koechlin, Etienne] Univ Paris 06, Grp Hosp Pitie Salpetriere, Ctr NeuroImaging Res, F-75005 Paris, France	University of Oxford; University of Oxford; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Summerfield, C (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	christopher.summerfield@psy.ox.ac.uk	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Behrens, Timothy/0000-0003-0048-1177	European Young Investigator award	European Young Investigator award	We thank Eric Bardinet, Kevin Nigaud, Romain Valabregue, and Eric Bertasi for technical assistance. This work was supported by a European Young Investigator award to E.K. C.S. and E.K. designed the study, C.S. collected the data, C.S and T.E.B analyzed the data, and all three authors contributed to the writing of the paper.	ANDERSON JR, 1991, PSYCHOL REV, V98, P409, DOI 10.1037/0033-295X.98.3.409; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; ASHBY FG, 1988, J EXP PSYCHOL LEARN, V14, P33, DOI 10.1037/0278-7393.14.1.33; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Blair M, 2003, MEM COGNITION, V31, P1293, DOI 10.3758/BF03195812; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Bunzeck N, 2010, HUM BRAIN MAPP, V31, P1380, DOI 10.1002/hbm.20939; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Freedman DJ, 2008, NEUROSCI BIOBEHAV R, V32, P311, DOI 10.1016/j.neubiorev.2007.07.011; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green CS, 2010, P NATL ACAD SCI USA, V107, P16401, DOI 10.1073/pnas.1001709107; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Kahneman D., 1982, JUDGMENT UNCERTAINTY; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Michna ML, 2008, J VISION, V8, DOI 10.1167/8.5.10; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nachev P, 2009, NAT REV NEUROSCI, V10, P829, DOI 10.1038/nrn2667-c1; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; NISBETT RE, 1983, PSYCHOL REV, V90, P339, DOI 10.1037/0033-295X.90.4.339; Pearson JM, 2009, CURR BIOL, V19, P1532, DOI 10.1016/j.cub.2009.07.048; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2009, CURR OPIN NEUROBIOL, V19, P75, DOI 10.1016/j.conb.2009.02.005; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; SUMMERFIELD C, 2009, COGNITIVE NEUROSCIEN, P1019; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Swets J. A., 1964, SIGNAL DETECT RECOG, P3; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Toni I, 2001, NEUROIMAGE, V14, P1048, DOI 10.1006/nimg.2001.0894; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	54	51	51	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					725	736		10.1016/j.neuron.2011.06.022	http://dx.doi.org/10.1016/j.neuron.2011.06.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	815JJ	21867887	Green Accepted, Bronze			2022-12-25	WOS:000294521600016
J	Bernardo, AS; Faial, T; Gardner, L; Niakan, KK; Ortmann, D; Senner, CE; Callery, EM; Trotter, MW; Hemberger, M; Smith, JC; Bardwell, L; Moffett, A; Pedersen, RA				Bernardo, Andreia S.; Faial, Tiago; Gardner, Lucy; Niakan, Kathy K.; Ortmann, Daniel; Senner, Claire E.; Callery, Elizabeth M.; Trotter, Matthew W.; Hemberger, Myriam; Smith, James C.; Bardwell, Lee; Moffett, Ashley; Pedersen, Roger A.			BRACHYURY and CDX2 Mediate BMP-Induced Differentiation of Human and Mouse Pluripotent Stem Cells into Embryonic and Extraembryonic Lineages	CELL STEM CELL			English	Article							PRIMITIVE STREAK; MORPHOGENETIC MOVEMENT; TARGETED DISRUPTION; DEFINITIVE ENDODERM; HUMAN-PLACENTA; GERM LAYER; FATE; TROPHOBLAST; MESODERM; EXPRESSION	BMP is thought to induce hESC differentiation toward multiple lineages including mesoderm and trophoblast. The BMP-induced trophoblast phenotype is a long-standing paradox in stem cell biology. Here we readdressed BMP function in hESCs and mouse epiblast-derived cells. We found that BMP4 cooperates with FGF2 (via ERK) to induce mesoderm and to inhibit endoderm differentiation. These conditions induced cells with high levels of BRACHYURY (BRA) that coexpressed CDX2. BRA was necessary for and preceded CDX2 expression; both genes were essential for expression not only of mesodermal genes but also of trophoblast-associated genes. Maximal expression of the latter was seen in the absence of FGF but these cells coexpressed mesodermal genes and moreover they differed in cell surface and epigenetic properties from placental trophoblast. We conclude that BMP induces human and mouse pluripotent stem cells primarily to form mesoderm, rather than trophoblast, acting through BRA and CDX2.	[Bernardo, Andreia S.; Faial, Tiago; Niakan, Kathy K.; Ortmann, Daniel; Callery, Elizabeth M.; Trotter, Matthew W.; Pedersen, Roger A.] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Gardner, Lucy; Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Senner, Claire E.; Hemberger, Myriam] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Faial, Tiago; Callery, Elizabeth M.; Smith, James C.] MRC Natl Inst Med Res, London NW7 1AA, England; [Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Gardner, Lucy; Niakan, Kathy K.; Senner, Claire E.; Hemberger, Myriam; Moffett, Ashley; Pedersen, Roger A.] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Faial, Tiago] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Niakan, Kathy K.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Bernardo, Andreia S.; Ortmann, Daniel; Trotter, Matthew W.; Pedersen, Roger A.] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC National Institute for Medical Research; University of California System; University of California Irvine; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Bernardo, AS (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England.	asb63@cam.ac.uk; ralp2@cam.ac.uk	Moffett, Ashley/J-9754-2013; Bardwell, Lee/I-8284-2019	Bardwell, Lee/0000-0002-2393-8363; Bernardo, Andreia Sofia/0000-0002-5355-6657; Trotter, Matthew/0000-0003-3702-915X; Senner, Claire/0000-0001-5237-3165; Hemberger, Myriam/0000-0003-3332-6958; Smith, Jim/0000-0003-2413-9392; Faial, Tiago/0000-0003-0864-1200; Niakan, Kathy/0000-0003-1646-4734	EU [HEALTH-F4-2009-223485/PluriSys]; MRC; Evelyn Trust; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Fundacao para a Ciencia e a Tecnologia, Portugal; British Heart Foundation; Centre for Trophoblast Research; Welcome Trust; MRC [G1000847, MC_U117597140, G0600275, G0800784] Funding Source: UKRI; British Heart Foundation [FS/10/022/28262] Funding Source: researchfish; Medical Research Council [G0800784B, G0600275, MC_U117597140, G1000847, G0800784] Funding Source: researchfish	EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Evelyn Trust; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); British Heart Foundation(British Heart Foundation); Centre for Trophoblast Research; Welcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Gabrielle Brons for supporting EpiSC and epiblast culture; Morgan Alexander for assisting with hESC culture; Nigel Miller for performing the flow sorts; Andrew Sharkey for discussions; Jamie Trott for validating KRT7 staining; R&D Systems for the SOX17-APC antibody; Doug Melton for the HuES9 cell line; and members of the Pedersen laboratory for comments. This work was supported by EU FP7 grant HEALTH-F4-2009-223485/PluriSys (mouse work only), MRC Programme grant, The Evelyn Trust, and Cambridge Hospitals National Institute for Health Research Biomedical Research Centre funding (RAP.); Fundacao para a Ciencia e a Tecnologia, Portugal (T.F.); British Heart Foundation (DO.); Centre for Trophoblast Research (K.K.N.); and Welcome Trust (J.C.S.).	Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; LAWSON KA, 1991, DEVELOPMENT, V113, P891; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; PARAMESWARAN M, 1995, DEV GENET, V17, P16, DOI 10.1002/dvg.1020170104; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Roper S, 2009, CELL CYCLE, V8, P1515, DOI 10.4161/cc.8.10.8381; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; SINGER KH, 1989, J INVEST DERMATOL, V92, P166, DOI 10.1111/1523-1747.ep12276685; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tarkowski AK, 2010, DEV BIOL, V348, P190, DOI 10.1016/j.ydbio.2010.09.022; TAVARE JM, 1989, CELL SIGNAL, V1, P55, DOI 10.1016/0898-6568(89)90020-X; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu Z, 2008, J BIOL CHEM, V283, P24991, DOI 10.1074/jbc.M803893200; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yook JY, 2011, STEM CELLS DEV, V20, P1479, DOI 10.1089/scd.2010.0392; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	49	243	251	1	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					144	155		10.1016/j.stem.2011.06.015	http://dx.doi.org/10.1016/j.stem.2011.06.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816365	Green Published, hybrid			2022-12-25	WOS:000293990900011
J	Awasaki, T; Huang, YL; O'Connor, MB; Lee, T				Awasaki, Takeshi; Huang, Yaling; O'Connor, Michael B.; Lee, Tzumin			Glia instruct developmental neuronal remodeling through TGF-beta signaling	NATURE NEUROSCIENCE			English	Article							DROSOPHILA METAMORPHOSIS; RECEPTOR; REQUIREMENT; MYOGLIANIN; EXPRESSION; SYSTEM; BRAIN	We found that glia secrete myoglianin, a TGF-beta ligand, to instruct developmental neural remodeling in Drosophila. Glial myoglianin upregulated neuronal expression of an ecdysone nuclear receptor that triggered neurite remodeling following the late-larval ecdysone peak. Thus glia orchestrate developmental neural remodeling not only by engulfment of unwanted neurites but also by enabling neuron remodeling.	[Awasaki, Takeshi; Huang, Yaling; Lee, Tzumin] Univ Massachusetts, Dept Neurobiol, Worcester, MA 01605 USA; [Awasaki, Takeshi; Huang, Yaling; Lee, Tzumin] Howard Hughes Med Inst, Ashburn, VA USA; [O'Connor, Michael B.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN USA; [O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Awasaki, T (corresponding author), Univ Massachusetts, Dept Neurobiol, Worcester, MA 01605 USA.	awasakit@janelia.hhmi.org; leet@janelia.hhmi.org	O'Connor, Michael B/C-9977-2014; AWASAKI, Takeshi/AAO-7579-2021	O'Connor, Michael B/0000-0002-3067-5506; AWASAKI, Takeshi/0000-0003-2662-6389	US National Institutes of Health [NS42049, MH83607]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Nakanishi, C. Hama, K. Ito, M. R. Freeman, the Bloomington Stock Center, the Vienna Drosophila RNAi Center, the Exelixis stock collection at Harvard Medical School and the Developmental Studies Hybridoma Bank for fly stocks and antibodies, M. A. Logan and C.-F. Kao for critical reading of the manuscript and members of the Lee laboratory for fruitful discussion. This work was supported by the US National Institutes of Health (NS42049 and MH83607 to T. L.).	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Awasaki T, 2011, NAT NEUROSCI, V14, P6, DOI 10.1038/nn0111-6; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee-Hoeflich ST, 2005, FEBS LETT, V579, P4615, DOI 10.1016/j.febslet.2005.06.088; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	15	88	88	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					821	823		10.1038/nn.2833	http://dx.doi.org/10.1038/nn.2833			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685919	Green Accepted			2022-12-25	WOS:000292081700006
J	Girshick, AR; Landy, MS; Simoncelli, EP				Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.			Cardinal rules: visual orientation perception reflects knowledge of environmental statistics	NATURE NEUROSCIENCE			English	Article							ANISOTROPY; DISCRIMINATION; INFORMATION; SELECTIVITY; INTEGRATION; MODELS	Humans are good at performing visual tasks, but experimental measurements have revealed substantial biases in the perception of basic visual attributes. An appealing hypothesis is that these biases arise through a process of statistical inference, in which information from noisy measurements is fused with a probabilistic model of the environment. However, such inference is optimal only if the observer's internal model matches the environment. We found this to be the case. We measured performance in an orientation-estimation task and found that orientation judgments were more accurate at cardinal (horizontal and vertical) orientations. Judgments made under conditions of uncertainty were strongly biased toward cardinal orientations. We estimated observers' internal models for orientation and found that they matched the local orientation distribution measured in photographs. In addition, we determined how a neural population could embed probabilistic information responsible for such biases.	[Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.] NYU, Dept Psychol, New York, NY 10003 USA; [Girshick, Ahna R.; Landy, Michael S.; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University; New York University	Girshick, AR (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	ahna.girshick@gmail.com		Simoncelli, Eero/0000-0002-1206-527X; Landy, Michael/0000-0002-2079-4552	US National Institutes of Health [EY019451, EY16165]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY016165, F32EY019451] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We wish to thank D. Ganguli for helpful discussions on image statistics and population coding, T. Saarela for the monitor calibration and N. Solomon for assisting with the experiments. This work was funded by US National Institutes of Health grants EY019451 (A.R.G.) and EY16165 (M.S.L.), and the Howard Hughes Medical Institute (E.P.S.).	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; BIRCH EE, 1983, VISION RES, V23, P1019, DOI 10.1016/0042-6989(83)90012-3; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Brainard DH, 2006, J VISION, V6, P1267, DOI 10.1167/6.11.10; Burge J, 2010, J NEUROSCI, V30, P7269, DOI 10.1523/JNEUROSCI.5551-09.2010; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Cohen EH, 2007, J NEUROSCI, V27, P12540, DOI 10.1523/JNEUROSCI.4496-07.2007; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Dakin SC, 2001, J OPT SOC AM A, V18, P1016, DOI 10.1364/JOSAA.18.001016; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; El-Bizri N., 2005, ARAB SCI PHILOS, V15, P189, DOI 10.1017/S0957423905000172; Farid H, 2004, IEEE T IMAGE PROCESS, V13, P496, DOI 10.1109/TIP.2004.823819; FISCHER BJ, 2010, INT JT C NEUR NETW, P1; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Ganguli D., 2010, ADV NEURAL INFORM PR, V23; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Granlund Gosta H., 1995, SIGNAL PROCESSING CO; Green DM, 1966, SIGNAL DETECTION THE; Griffiths TL, 2008, CAMB HANDB PSYCHOL, P59; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Ho YX, 2007, J VISION, V7, DOI 10.1167/7.1.1; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maloney LT, 2009, VISUAL NEUROSCI, V26, P147, DOI 10.1017/S0952523808080905; Mamassian P, 2001, COGNITION, V81, pB1, DOI 10.1016/S0010-0277(01)00116-0; MAYER MJ, 1977, VISION RES, V17, P703, DOI 10.1016/S0042-6989(77)80006-0; MITCHELL DE, 1973, VISION RES, V13, P535, DOI 10.1016/0042-6989(73)90023-0; ORBAN GA, 1984, VISION RES, V24, P121, DOI 10.1016/0042-6989(84)90097-X; Ringach DL, 2002, J NEUROSCI, V22, P5639; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simoncelli E, 1993, THESIS MIT; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Stocker AA, 2009, J VISION, V9, DOI 10.1167/9.9.9; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TIMNEY BN, 1976, SCIENCE, V193, P699, DOI 10.1126/science.948748; Tomassini A, 2010, VISION RES, V50, P541, DOI 10.1016/j.visres.2009.12.005; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	50	312	312	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					926	U156		10.1038/nn.2831	http://dx.doi.org/10.1038/nn.2831			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642976	Green Accepted			2022-12-25	WOS:000292081700022
J	Johnson, SL; Beurg, M; Marcotti, W; Fettiplace, R				Johnson, Stuart L.; Beurg, Maryline; Marcotti, Walter; Fettiplace, Robert			Prestin-Driven Cochlear Amplification Is Not Limited by the Outer Hair Cell Membrane Time Constant	NEURON			English	Article							GUINEA-PIG COCHLEA; MECHANOELECTRICAL TRANSDUCER CHANNELS; RAT COCHLEA; MECHANOTRANSDUCER CHANNEL; DEVELOPMENTAL-CHANGES; POSTNATAL-DEVELOPMENT; POTASSIUM CURRENTS; VOLTAGE-DEPENDENCE; CALCIUM-CHANNELS; MOUSE COCHLEA	Outer hair cells (OHCs) provide amplification in the mammalian cochlea using somatic force generation underpinned by voltage-dependent conformational changes of the motor protein prestin. However, prestin must be gated by changes in membrane potential on a cycle-by-cycle basis and the periodic component of the receptor potential may be greatly attenuated by low-pass filtering due to the OHC time constant (tau(m)), questioning the functional relevance of this mechanism. Here, we measured tau(m) from OHCs with a range of characteristic frequencies (CF) and found that, at physiological endolymphatic calcium concentrations, approximately half of the mechanotransducer (MT) channels are opened at rest, depolarizing the membrane potential to near -40 mV. The depolarized resting potential activates a voltage-dependent K+ conductance, thus minimizing tau(m) and expanding the membrane filter so there is little receptor potential attenuation at the cell's CF. These data suggest that minimal tau(m) filtering in vivo ensures optimal activation of prestin.	[Johnson, Stuart L.; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Beurg, Maryline] Univ Bordeaux Segalen, CHU Pellegrin, INSERM, U587, F-33076 Bordeaux, France; [Fettiplace, Robert] Univ Wisconsin, Sch Med, Dept Neurosci, Madison, WI 53706 USA	University of Sheffield; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Wisconsin System; University of Wisconsin Madison	Marcotti, W (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	w.marcotti@sheffield.ac.uk; fettiplace@wisc.edu		Beurg, Maryline/0000-0003-3069-267X	National Institutes on Deafness and other Communication Disorders [RO1 DC01362]; Wellcome Trust [088719]; RNID [G41]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER	National Institutes on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Wellcome Trust(Wellcome TrustEuropean Commission); RNID; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes on Deafness and other Communication Disorders Grant RO1 DC01362 to R.F. and grants from the Wellcome Trust (088719) and RNID (G41) to W.M. W.M. is a Royal Society University Research Fellow. We thank Tony Ricci and Jong-Hoon Nam for advice on the manuscript.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; BOSHER SK, 1978, NATURE, V273, P377, DOI 10.1038/273377a0; BOSHER SK, 1971, J PHYSIOL-LONDON, V212, P739, DOI 10.1113/jphysiol.1971.sp009354; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; DALLOS P, 1986, HEARING RES, V22, P185, DOI 10.1016/0378-5955(86)90095-X; DALLOS P, 1985, J NEUROSCI, V5, P1591; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1995, SCIENCE, V268, P1420, DOI 10.1126/science.7770765; DALLOS P, 1983, HEARING RES, V12, P89, DOI 10.1016/0378-5955(83)90120-X; DALLOS P, 1985, J NEUROSCI, V5, P1609; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Frolenkov GI, 2000, J NEUROSCI, V20, P5940, DOI 10.1523/JNEUROSCI.20-16-05940.2000; Grant L, 2008, J NEUROPHYSIOL, V99, P2183, DOI 10.1152/jn.01174.2007; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Jia SP, 2007, J NEUROSCI, V27, P1006, DOI 10.1523/JNEUROSCI.5452-06.2007; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kimitsuki T, 2003, HEARING RES, V180, P85, DOI 10.1016/S0378-5955(03)00109-6; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mahendrasingam S, 2010, EUR J NEUROSCI, V31, P1595, DOI 10.1111/j.1460-9568.2010.07182.x; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Mistrik P, 2009, J R SOC INTERFACE, V6, P279, DOI 10.1098/rsif.2008.0201; MULLER M, 1991, HEARING RES, V56, P1, DOI 10.1016/0378-5955(91)90147-2; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; PREYER S, 1994, HEARING RES, V77, P116, DOI 10.1016/0378-5955(94)90259-3; Preyer S, 1996, AUDIT NEUROSCI, V2, P145; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V247, P97, DOI 10.1098/rspb.1992.0014; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; SALT AN, 1989, AM J OTOLARYNG, V10, P371, DOI 10.1016/0196-0709(89)90030-6; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Yang D, 2004, J NEUROBIOL, V58, P479, DOI 10.1002/neu.10289; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	60	193	194	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 23	2011	70	6					1143	1154		10.1016/j.neuron.2011.04.024	http://dx.doi.org/10.1016/j.neuron.2011.04.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689600	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000292410700012
J	Flandin, P; Zhao, YG; Vogt, D; Jeong, J; Long, J; Potter, G; Westphal, H; Rubensteint, JLR				Flandin, Pierre; Zhao, Yangu; Vogt, Daniel; Jeong, Juhee; Long, Jason; Potter, Gregory; Westphal, Heiner; Rubensteint, John L. R.			Lhx6 and Lhx8 Coordinately Induce Neuronal Expression of Shh that Controls the Generation of Interneuron Progenitors	NEURON			English	Article							MEDIAL GANGLIONIC EMINENCE; LIM-HOMEOBOX GENE; SONIC HEDGEHOG; CORTICAL INTERNEURONS; STRIATAL INTERNEURONS; VENTRAL TELENCEPHALON; CHOLINERGIC NEURONS; SPECIFICATION; FOREBRAIN; MIGRATION	Lhx6 and Lhx8 transcription factor coexpression in early-born MGE neurons is required to induce neuronal Shh expression. We provide evidence that these transcription factors regulate expression of a Shh enhancer in MGE neurons. Lhx6 and Lhx8 are also required to prevent Nkx2-1 expression in a subset of pallial interneurons. Shh function in early-born MGE neurons was determined by genetically eliminating Shh expression in the MGE mantle zone (MZ). This mutant had reduced SHH signaling in the overlying progenitor zone, which led to reduced Lhx6, Lhx8, and Nkx2-1 expression in the rostrodorsal MGE and a preferential reduction of late-born somatostatin(+) and parvalbumin(+) cortical interneurons. Thus, Lhx6 and Lhx8 regulate MGE development through autonomous and nonautonomous mechanisms, the latter by promoting Shh expression in MGE neurons, which in turn feeds forward to promote the developmental program of the rostrodorsal MGE.	[Flandin, Pierre; Vogt, Daniel; Jeong, Juhee; Long, Jason; Potter, Gregory; Rubensteint, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Flandin, Pierre; Vogt, Daniel; Jeong, Juhee; Long, Jason; Potter, Gregory; Rubensteint, John L. R.] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Zhao, Yangu; Westphal, Heiner] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Mammalian Genes & Dev, Program Genom Differentiat, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rubensteint, JLR (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	john.rubenstein@ucsf.edu		Potter, Gregory/0000-0002-0585-6575; Vogt, Daniel/0000-0003-1876-5936	Nina Ireland; Larry L. Hillblom Foundation; March of Dimes; Weston Havens Foundation; NIMH [R37 MH049428, R01 MH081880]; NIDCR [K99 DE019486-01]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE019486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH081880] Funding Source: NIH RePORTER	Nina Ireland; Larry L. Hillblom Foundation; March of Dimes(March of Dimes); Weston Havens Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the research grants to J.L.R.R. from Nina Ireland, Larry L. Hillblom Foundation, March of Dimes, Weston Havens Foundation, NIMH R37 MH049428 and R01 MH081880; to J.J. from NIDCR K99 DE019486-01; and to H.W. and Y.Z. from the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH.	Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Garcia-Lopez M, 2008, J COMP NEUROL, V506, P46, DOI 10.1002/cne.21524; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Gulacsi A, 2006, CEREB CORTEX, V16, pI89, DOI 10.1093/cercor/bhk018; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Manuel M, 2010, DEVELOPMENT, V137, P487, DOI 10.1242/dev.039800; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2005, DEVELOPMENT, V132, P4987, DOI 10.1242/dev.02090; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yu WY, 2009, DEV BIOL, V334, P264, DOI 10.1016/j.ydbio.2009.07.026; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002	38	101	104	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 9	2011	70	5					939	950		10.1016/j.neuron.2011.04.020	http://dx.doi.org/10.1016/j.neuron.2011.04.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658586	Green Accepted, Bronze			2022-12-25	WOS:000291843500013
J	Kim, H; Lee, G; Ganat, Y; Papapetrou, EP; Lipchina, I; Socci, ND; Sadelain, M; Studer, L				Kim, Hyesoo; Lee, Gabsang; Ganat, Yosif; Papapetrou, Eirini P.; Lipchina, Inna; Socci, Nicholas D.; Sadelain, Michel; Studer, Lorenz			miR-371-3 Expression Predicts Neural Differentiation Propensity in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							DOPAMINE NEURONS; SELF-RENEWAL; PARKINSONS-DISEASE; DERIVATION; EPIBLAST; LINES; INHIBITION; INDUCTION; CULTURE; SINGLE	The use of pluripotent stem cells in regenerative medicine and disease modeling is complicated by the variation in differentiation properties between lines. In this study, we characterized 13 human embryonic stem cell (hESC) and 26 human induced pluripotent stem cell (hiPSC) lines to identify markers that predict neural differentiation behavior. At a general level, markers previously known to distinguish mouse ESCs from epiblast stem cells (EPI-SCs) correlated with neural differentiation behavior. More specifically, quantitative analysis of miR-371-3 expression prospectively identified hESC and hiPSC lines with differential neurogenic differentiation propensity and in vivo dopamine neuron engraftment potential. Transient KLF4 transduction increased miR-371-3 expression and altered neurogenic behavior and pluripotency marker expression. Conversely, suppression of miR-371-3 expression in KLF4-transduced cells rescued neural differentiation propensity. miR-371-3 expression level therefore appears to have both a predictive and a functional role in determining human pluripotent stem cell neurogenic differentiation behavior.	[Kim, Hyesoo; Lee, Gabsang; Ganat, Yosif; Lipchina, Inna; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Papapetrou, Eirini P.; Sadelain, Michel; Studer, Lorenz] Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA; [Socci, Nicholas D.] Sloan Kettering Inst, Computat Biol Ctr, New York, NY 10065 USA; [Sadelain, Michel] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	studerl@mskcc.org	Pillay, Nischalan/F-9536-2012; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	Kinetics Foundation; Starr Foundation; NYSTEM; European Commission; NYSCF	Kinetics Foundation; Starr Foundation; NYSTEM; European Commission(European CommissionEuropean Commission Joint Research Centre); NYSCF	We would like to thank J. Hendrikx (SKI Flow Cytometry Core lab), A. Viale (SKI Genomics Core lab), and M. Leversha (Molecular Cytogenetics core) for excellent technical support. We also thank M. Tomishima for critical review of the manuscript, P. Tesar for providing mouse EPI-SCs, and C. Rohena for help with teratoma data. The work was supported by grants from the Kinetics Foundation, the Starr Foundation, NYSTEM, and the European Commission project NeuroStemCell. G.L. was supported by a NYSCF, Druckenmiller fellowship.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Sanchez-Pernaute R, 2008, BRAIN, V131, P2127, DOI 10.1093/brain/awn144; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	35	103	110	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					695	706		10.1016/j.stem.2011.04.002	http://dx.doi.org/10.1016/j.stem.2011.04.002			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624813	Bronze			2022-12-25	WOS:000291844100017
J	Singh, AM; Reynolds, D; Cliff, T; Ohtsuka, S; Mattheyses, AL; Sun, YH; Menendez, L; Kulik, M; Dalton, S				Singh, Amar M.; Reynolds, David; Cliff, Timothy; Ohtsuka, Satoshi; Mattheyses, Alexa L.; Sun, Yuhua; Menendez, Laura; Kulik, Michael; Dalton, Stephen			Signaling Network Crosstalk in Human Pluripotent Cells: A Smad2/3-Regulated Switch that Controls the Balance between Self-Renewal and Differentiation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; FIBROBLAST-GROWTH-FACTOR; DEFINITIVE ENDODERM; BETA-CATENIN; EFFICIENT DIFFERENTIATION; MAINTAINS PLURIPOTENCY; HEMATOPOIETIC-CELLS; DEFINED CONDITIONS; WNT/BETA-CATENIN; NANOG EXPRESSION	A general mechanism for how intracellular signaling pathways in human pluripotent cells are coordinated and how they maintain self-renewal remain to be elucidated. In this report, we describe a signaling mechanism where PI3K/Akt activity maintains self-renewal by restraining prodifferentiation signaling through suppression of the Raf/Mek/Erk and canonical Wnt signaling pathways. When active, PI3K/Akt establishes conditions where Activin A/Smad2,3 performs a pro-self-renewal function by activating target genes, including Nanog. When PI3K/Akt signaling is low, Wnt effectors are activated and function in conjunction with Smad2,3 to promote differentiation. The switch in Smad2,3 activity after inactivation of PI3K/Akt requires the activation of canonical Wnt signaling by Erk, which targets Gsk313. In sum, we define a signaling framework that converges on Smad2,3 and determines its ability to regulate the balance between alternative cell states. This signaling paradigm has far-reaching implications for cell fate decisions during early embryonic development.	[Singh, Amar M.; Reynolds, David; Cliff, Timothy; Ohtsuka, Satoshi; Sun, Yuhua; Menendez, Laura; Kulik, Michael; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA; [Mattheyses, Alexa L.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; Emory University	Dalton, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, 500 DW Brooks Dr, Athens, GA 30602 USA.	sdalton@uga.edu	孙, 玉华/AAS-2506-2020; Sun, Yuhua/J-7547-2013	孙, 玉华/0000-0001-7902-9022; Mattheyses, Alexa L/0000-0002-5119-7750; Dalton, Stephen/0000-0002-3450-1263	National Institute of Child Health and Human Development [HD049647]; National Institute for General Medical Sciences [GM75334]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to S.D. from the National Institute of Child Health and Human Development (HD049647) and the National Institute for General Medical Sciences (GM75334). We would like to thank George Daley for providing hiPSCs and Julie Nelson for assistance with FACS.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Blalock WL, 2000, ONCOGENE, V19, P526, DOI 10.1038/sj.onc.1203337; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Funaba M, 2000, MOL ENDOCRINOL, V14, P1583, DOI 10.1210/me.14.10.1583; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; LABONNE C, 1994, DEVELOPMENT, V120, P463; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li WL, 2012, STEM CELLS, V30, P61, DOI 10.1002/stem.768; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; McCubrey JA, 1998, LEUKEMIA, V12, P1903, DOI 10.1038/sj.leu.2401215; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsutsui H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1165; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Villa-Diaz LG, 2009, STEM CELLS DEV, V18, P641, DOI 10.1089/scd.2008.0010; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Weisberg E, 1998, MECH DEVELOP, V79, P17, DOI 10.1016/S0925-4773(98)00160-9; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu P., 2011, CELL STEM CELL, V8, P326; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	58	248	260	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					312	326		10.1016/j.stem.2012.01.014	http://dx.doi.org/10.1016/j.stem.2012.01.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385658	Green Accepted, Bronze			2022-12-25	WOS:000301466500012
J	Hu, Y; Park, KK; Yang, L; Wei, X; Yang, Q; Cho, KS; Thielen, P; Lee, AH; Cartoni, R; Glimcher, LH; Chen, DF; He, ZG				Hu, Yang; Park, Kevin K.; Yang, Liu; Wei, Xin; Yang, Qiang; Cho, Kin-Sang; Thielen, Peter; Lee, Ann-Hwee; Cartoni, Romain; Glimcher, Laurie H.; Chen, Dong Feng; He, Zhigang			Differential Effects of Unfolded Protein Response Pathways on Axon Injury-Induced Death of Retinal Ganglion Cells	NEURON			English	Article							OPEN-ANGLE GLAUCOMA; TRANSCRIPTION FACTOR XBP-1; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER STRESS; RETINITIS-PIGMENTOSA; OCULAR HYPERTENSION; OXIDATIVE STRESS; MOUSE MODELS; OPTIC-NERVE	Loss of retinal ganglion cells (RGCs) accounts for visual function deficits after optic nerve injury, but how axonal insults lead to neuronal death remains elusive. By using an optic nerve crush model that results in the death of the majority of RGCs, we demonstrate that axotomy induces differential activation of distinct pathways of the unfolded protein response in axotomized RGCs. Optic nerve injury provokes a sustained CCAAT/enhancer binding homologous protein (CHOP) upregulation, and deletion of CHOP promotes RGC survival. In contrast, IRE/XBP-1 is only transiently activated, and forced XBP-1 activation dramatically protects RGCs from axon injury-induced death. Importantly, such differential activations of CHOP and XBP-1 and their distinct effects on neuronal cell death are also observed in RGCs with other types of axonal insults, such as vincristine treatment and intraocular pressure elevation, suggesting a new protective strategy for neurodegeneration associated with axonal damage.	[Hu, Yang; Park, Kevin K.; Yang, Liu; Cartoni, Romain; He, Zhigang] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, Boston, MA 02115 USA; [Hu, Yang; Park, Kevin K.; Yang, Liu; Cartoni, Romain; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Wei, Xin; Yang, Qiang; Cho, Kin-Sang; Chen, Dong Feng] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA 02114 USA; [Thielen, Peter; Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Thielen, Peter; Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hu, Yang] Temple Univ, Sch Med, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19140 USA; [Park, Kevin K.] Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Chen, Dong Feng] Boston Healthcare Syst, Ctr Innovat Visual Rehabil, Vet Affairs, Boston, MA 02130 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Hu, Y (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	yanghu@temple.edu; dongfeng.chen@schepens.harvard.edu; zhigang.he@childrens.harvard.edu	Chen, Dong/AAJ-2444-2020	Chen, Dong/0000-0001-6283-8843; Hu, Yang/0000-0002-7980-1649; Thielen, Peter/0000-0003-1807-2785; Cho, Kin-Sang/0000-0003-4285-615X	National Eye Institute; Miami Project to Cure Paralysis; Department of Veterans Affairs; National Institutes of Health (NIH) [AI32412]; NIH National Research Service; NATIONAL EYE INSTITUTE [R01EY021342, R01EY021526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Miami Project to Cure Paralysis; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Xu and L. Connolly for technical support. Our work was supported by grants from the National Eye Institute (Z.H.), Miami Project to Cure Paralysis (K.K.P.), Department of Veterans Affairs (D.F.C.), National Institutes of Health (NIH) grant AI32412, and a grant from an anonymous foundation (L.H.G.). Y.H. was supported by an NIH National Research Service Award Postdoctoral Fellowship. Y.H., K.K.P., L.Y., Q.Y., X.W., P.T., and A.H.L. performed the experiments and analyzed the data. Y.H., L.H.G., D.F.C., and Z.H. designed experiments and prepared the manuscript.	Aoki S, 2002, J NEUROSCI, V22, P10751; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen H., 2010, INVEST OPHTH VIS SCI, V52, P36; COHENCORY S, 1994, NEURON, V12, P747, DOI 10.1016/0896-6273(94)90328-X; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Doh SH, 2010, BRAIN RES, V1308, P158, DOI 10.1016/j.brainres.2009.10.025; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Levin L A, 1997, Curr Opin Ophthalmol, V8, P9, DOI 10.1097/00055735-199712000-00003; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin KRG, 2002, METHODS, V28, P267, DOI 10.1016/S1046-2023(02)00232-3; McKernan DP, 2007, J NEUROCHEM, V102, P922, DOI 10.1111/j.1471-4159.2007.04573.x; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Selles-Navarro I, 2001, EXP NEUROL, V167, P282, DOI 10.1006/exnr.2000.7573; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Silva A, 2006, J PERIPHER NERV SYST, V11, P211, DOI 10.1111/j.1529-8027.2006.0090.x; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Urano F, 2000, J CELL SCI, V113, P3697; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	47	142	148	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					445	452		10.1016/j.neuron.2011.11.026	http://dx.doi.org/10.1016/j.neuron.2011.11.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325198	Bronze, Green Accepted			2022-12-25	WOS:000300140600007
J	English, DF; Ibanez-Sandoval, O; Stark, E; Tecuapetla, F; Buzsaki, G; Deisseroth, K; Tepper, JM; Koos, T				English, Daniel F.; Ibanez-Sandoval, Osvaldo; Stark, Eran; Tecuapetla, Fatuel; Buzsaki, Gyoergy; Deisseroth, Karl; Tepper, James M.; Koos, Tibor			GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons	NATURE NEUROSCIENCE			English	Article							TONICALLY ACTIVE NEURONS; FAST-SPIKING INTERNEURONS; NICOTINIC ACH RECEPTORS; MIDBRAIN DOPAMINE; PRIMATES STRIATUM; GABA(A) RECEPTORS; TOURETTE-SYNDROME; RESPONSES; REWARD; DESENSITIZATION	Neostriatal cholinergic interneurons are believed to be important for reinforcement-mediated learning and response selection by signaling the occurrence and motivational value of behaviorally relevant stimuli through precisely timed multiphasic population responses. An important problem is to understand how these signals regulate the functioning of the neostriatum. Here we describe the synaptic organization of a previously unknown circuit that involves direct nicotinic excitation of several classes of GABAergic interneurons, including neuroptide Y-expressing neurogilaform neurons, and enables cholinergic interneurons to exert rapid inhibitory control of the activity of projection neurons. We also found that, in vivo, the dominant effect of an optogenetically reproduced pause-excitation population response of cholinergic interneurons was powerful and rapid inhibition of the firing of projection neurons that is coincident with synchronous cholinergic activation. These results reveal a previously unknown circuit mechanism that transmits reinforcement-related information of ChAT interneurons in the mouse neostriatal network.	[English, Daniel F.; Ibanez-Sandoval, Osvaldo; Stark, Eran; Tecuapetla, Fatuel; Buzsaki, Gyoergy; Tepper, James M.; Koos, Tibor] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Stanford University	Koos, T (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	tibkoos@yahoo.com	Tepper, James/AAA-3828-2019	Tepper, James/0000-0002-8643-4082; Stark, Eran/0000-0002-2446-9140; Buzsaki, Gyorgy/0000-0002-3100-4800; English, Daniel/0000-0003-2284-870X; Tecuapetla, Fatuel/0000-0002-9191-6553	US National Institutes of Health [NS072950, NS034865]; Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072950, R01NS034865, R56NS034865] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Berlin for confocal microscopy, L. Zaborszky for providing ChAT-EGFP mice, R. Yanez-Munoz for providing integration deficient pCMV-dR8.74-D64V plasmid DNA and for advice regarding virus production, N. Altan-Bonnet, W. Friedman and Haesun Kim for generously providing access to an ultracentrifuge facility and other equipment in their laboratories, C. T. Unal and A. Kreitzer for valuable discussion, A. Berenyi, S. Fujisawa and M. Vandecasteele for advice regarding in vivo recording methods, H. Xenias for help with confocal imaging, F. Shah for help with immunocytochemical procedures and other technical assistance, and I. Tadros for virus injections. The research was supported by US National Institutes of Health grant NS072950 and a Busch Biomedical Research Grant of Rutgers University to T. K., US National Institutes of Health grant NS034865 to J. M. T. and Rutgers University funds.	AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1998, J NEUROPHYSIOL, V80, P3341, DOI 10.1152/jn.1998.80.6.3341; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Banks MI, 1998, J NEUROSCI, V18, P1305; Banks MI, 2000, J NEUROSCI, V20, P937, DOI 10.1523/JNEUROSCI.20-03-00937.2000; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; De Rover M, 2005, SYNAPSE, V55, P17, DOI 10.1002/syn.20087; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; HILL JA, 1993, J NEUROSCI, V13, P1551; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ibanez-Sandoval O, 2011, J NEUROSCI, V31, P16757, DOI 10.1523/JNEUROSCI.2628-11.2011; Ibanez-Sandoval O, 2010, J NEUROSCI, V30, P6999, DOI 10.1523/JNEUROSCI.5996-09.2010; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Karayannis T, 2010, J NEUROSCI, V30, P9898, DOI 10.1523/JNEUROSCI.5883-09.2010; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; KUBOTA Y, 1993, NEUROREPORT, V5, P205, DOI 10.1097/00001756-199312000-00004; Leckman JF, 2006, J CHILD PSYCHOL PSYC, V47, P537, DOI 10.1111/j.1469-7610.2006.01620.x; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Overstreet LS, 2000, J NEUROSCI, V20, P7914; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tecuapetla F, 2009, J NEUROSCI, V29, P8977, DOI 10.1523/JNEUROSCI.6145-08.2009; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	50	203	205	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					123	U155		10.1038/nn.2984	http://dx.doi.org/10.1038/nn.2984			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158514	Green Accepted			2022-12-25	WOS:000298414400022
J	Bhogal, B; Jepson, JE; Savva, YA; Pepper, ASR; Reenan, RA; Jongens, TA				Bhogal, Balpreet; Jepson, James E.; Savva, Yiannis A.; Pepper, Anita S-R; Reenan, Robert A.; Jongens, Thomas A.			Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein	NATURE NEUROSCIENCE			English	Article							TANDEM AFFINITY PURIFICATION; MESSENGER-RNA; SYNAPTIC STRUCTURE; FMRP; POLYRIBOSOMES; EXPRESSION; NEURONS; DFMR1; ADAR; LOCALIZATION	Loss of FMR1 gene function results in fragile X syndrome, the most common heritable form of intellectual disability. The protein encoded by this locus (FMRP) is an RNA-binding protein that is thought to primarily act as a translational regulator; however, recent studies have implicated FMRP in other mechanisms of gene regulation. We found that the Drosophila fragile X homolog (dFMR1) biochemically interacted with the adenosine-to-inosine RNA-editing enzyme dADAR. Adar and Fmr1 mutant larvae exhibited distinct morphological neuromuscular junction (NMJ) defects. Epistasis experiments based on these phenotypic differences revealed that Adar acts downstream of Fmr1 and that dFMR1 modulates dADAR activity. Furthermore, sequence analyses revealed that a loss or overexpression of dFMR1 affects editing efficiency on certain dADAR targets with defined roles in synaptic transmission. These results link dFMR1 with the RNA-editing pathway and suggest that proper NMJ synaptic architecture requires modulation of dADAR activity by dFMR1.	[Bhogal, Balpreet; Pepper, Anita S-R; Jongens, Thomas A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Jepson, James E.; Savva, Yiannis A.; Reenan, Robert A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	University of Pennsylvania; Pennsylvania Medicine; Brown University	Jongens, TA (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	jongens@mail.med.upenn.edu	Pepper, Anita/GWC-7680-2022	Bhogal, Balpreet/0000-0002-3997-7316; jepson, james/0000-0002-3357-2801	National Institute of Mental Health [MH086705]; National Institute of General Medical Science [GM086902]; Ellison Medical Foundation;  [5T32GM008216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216, R01GM086902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086705] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ellison Medical Foundation(Lawrence Ellison Foundation); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank current and former members of the Jongens laboratory for helpful discussions and technical support, especially R. Beerman for preliminary studies with the LMB experiments, and S. Cruz and C. Dubowy. We also thank M. Sundaram and D. Hancks for critical reading of the manuscript. We are grateful to R. Carstens, G. Bashaw, T. Dockendorff, C. Hughes, K. Kaestner, S. Artavanis-Tsakonas, the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly strains and reagents. We also thank C.-X. Yuan and The Perelman School of Medicine at the University of Pennsylvania Proteomics Facility for help with the mass spectrometry results. This work was supported by a Predoctoral Training grant in Genetics (5T32GM008216 to B.B.), a National Institute of Mental Health grant (MH086705 to T.A.J.), a National Institute of General Medical Science grant (GM086902 to T.A.J.) and an Ellison Medical Foundation Senior Scholar award to R.A.R.	Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Banerjee P, 2007, GENETICS, V175, P1241, DOI 10.1534/genetics.106.068908; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Estes PS, 2008, MOL CELL NEUROSCI, V39, P170, DOI 10.1016/j.mcn.2008.06.012; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gatto CL, 2008, DEVELOPMENT, V135, P2637, DOI 10.1242/dev.022244; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jepson JEC, 2011, J BIOL CHEM, V286, P8325, DOI 10.1074/jbc.M110.186817; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Pepper ASR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007618; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Xu XL, 2008, J NEUROSCI, V28, P11883, DOI 10.1523/JNEUROSCI.4114-08.2008; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zeng F, 2006, NAT PROTOC, V1, P920, DOI 10.1038/nprot.2006.81; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	50	63	63	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1517	U40		10.1038/nn.2950	http://dx.doi.org/10.1038/nn.2950			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037499	Green Accepted			2022-12-25	WOS:000297546300010
J	Lonardo, E; Hermann, PC; Mueller, MT; Huber, S; Balic, A; Miranda-Lorenzo, I; Zagorac, S; Alcala, S; Roderiguez-Arabaolaza, I; Ramirez, JC; Torres-Ruiz, R; Garcia, E; Hidalgo, M; Cebrian, DA; Heuchel, R; Lohr, M; Berger, F; Bartenstein, P; Aicher, A; Heeschen, C				Lonardo, Enza; Hermann, Patrick C.; Mueller, Maria-Theresa; Huber, Stephan; Balic, Anamaria; Miranda-Lorenzo, Irene; Zagorac, Sladjana; Alcala, Sonia; Roderiguez-Arabaolaza, Iker; Carlos Ramirez, Juan; Torres-Ruiz, Raul; Garcia, Elena; Hidalgo, Manuel; Alvaro Cebrian, David; Heuchel, Rainer; Lohr, Matthias; Berger, Frank; Bartenstein, Peter; Aicher, Alexandra; Heeschen, Christopher			Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy	CELL STEM CELL			English	Article							ACTIVIN-A; STELLATE-CELLS; TGF-BETA; HEDGEHOG PROMOTES; GROWTH-FACTOR; PATHWAYS; AGGRESSIVENESS; INHIBITION; PHENOTYPE; FIBROSIS	Nodal and Activin belong to the TGF-beta superfamily and are important regulators of embryonic stem cell fate. Here we investigated whether Nodal and Activin regulate self-renewal of pancreatic cancer stem cells. Nodal and Activin were hardly detectable in more differentiated pancreatic cancer cells, while cancer stem cells and stroma-derived pancreatic stellate cells markedly overexpressed Nodal and Activin, but not TGF-beta. Knockdown or pharmacological inhibition of the Nodal/Activin receptor Alk4/7 in cancer stem cells virtually abrogated their self-renewal capacity and in vivo tumorigenicity, and reversed the resistance of orthotopically engrafted cancer stem cells to gemcitabine. However, engrafted primary human pancreatic cancer tissue with a substantial stroma showed no response due to limited drug delivery. The addition of a stroma-targeting hedgehog pathway inhibitor enhanced delivery of the Nodal/Activin inhibitor and translated into long-term, progression-free survival. Therefore, inhibition of the Alk4/7 pathway, if combined with hedgehog pathway inhibition and gemcitabine, provides atherapeutic strategy for targeting cancer stem cells.	[Lonardo, Enza; Hermann, Patrick C.; Balic, Anamaria; Miranda-Lorenzo, Irene; Zagorac, Sladjana; Alcala, Sonia; Roderiguez-Arabaolaza, Iker; Aicher, Alexandra; Heeschen, Christopher] Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Clin Res Programme, Madrid 28029, Spain; [Garcia, Elena; Hidalgo, Manuel] Spanish Natl Canc Res Ctr CNIO, Gastrointestinal Canc Clin Res Unit, Madrid 28029, Spain; [Alvaro Cebrian, David] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid 28029, Spain; [Mueller, Maria-Theresa] Heidelberg Univ, Dept Surg, D-69120 Heidelberg, Germany; [Huber, Stephan] Univ Munich, Dept Surg, D-81377 Munich, Germany; [Berger, Frank] Univ Munich, Dept Radiol, D-81377 Munich, Germany; [Bartenstein, Peter] Univ Munich, Dept Nucl Med, D-81377 Munich, Germany; [Carlos Ramirez, Juan; Torres-Ruiz, Raul] Spanish Natl Cardiovasc Res Ctr CNIC, Viral Vector Unit, Madrid, Spain; [Heuchel, Rainer; Lohr, Matthias] Karolinska Inst, S-17165 Solna, Sweden	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Ruprecht Karls University Heidelberg; University of Munich; University of Munich; University of Munich; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Karolinska Institutet	Heeschen, C (corresponding author), Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Clin Res Programme, Madrid 28029, Spain.	christopher.heeschen@cnio.es	Arabaolaza, Iker Rodríguez/AAC-3773-2020; Löhr, Matthias/A-3692-2012; Hermann, Patrick/Y-6254-2019; Aicher, Alexandra/GZK-8031-2022; lonardo, enza/AAI-5726-2020; HIDALGO, MANUEL/I-4995-2015; Ruiz, Raul Torres/J-1649-2018; Zagorac, Sladana/R-4897-2019; Ramírez, Juan Carlos/B-7979-2015; Heuchel, Rainer/P-7875-2019; Guba, Markus/M-4309-2019	Löhr, Matthias/0000-0002-7647-198X; Hermann, Patrick/0000-0003-0418-0478; HIDALGO, MANUEL/0000-0002-3765-3318; Ruiz, Raul Torres/0000-0001-9606-0398; Zagorac, Sladana/0000-0001-6389-1830; Heuchel, Rainer/0000-0002-2782-585X; Balic, Anamaria/0000-0001-6796-1197; Heeschen, Christopher/0000-0002-1158-8554; Alcala, Sonia/0000-0002-7644-4973; Aicher, Alexandra/0000-0002-8920-9577; Lonardo, Enza/0000-0001-6654-1043	Dr. Mildred Scheel Foundation [108168]; ERC [Pa-CSC 233460]; Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo de Investigacion Sanitaria [PS09/02129]; Ministerio de Ciencia e Innovacion, Spain [PLE2009-0105]; Roche	Dr. Mildred Scheel Foundation(Deutsche Krebshilfe); ERC(European Research Council (ERC)European Commission); Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Roche(Roche Holding)	We are indebted to Mercedes Alonso for excellent technical assistance and Francisco X. Real for providing primary tissue samples (both from the Spanish National Cancer Research Centre). This work was supported by the Dr. Mildred Scheel Foundation (108168), the ERC Advanced Investigator Grant (Pa-CSC 233460), the Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PS09/02129), and the Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (PLE2009-0105; both Ministerio de Ciencia e Innovacion, Spain). E.L. is supported by the Roche Postdoctoral Fellowship Program. Ludwig-Maximilian-University and the Spanish National Cancer Research Centre have filed a patent application for the use of the described treatment modality for epithelial cancer. The authors (E.L., M.T.M., P.C.H., S.H., and C.H.) are inventors of these patents, and may receive royalties from licensees.	Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; FRIESS H, 1994, INT J CANCER, V56, P668, DOI 10.1002/ijc.2910560511; Gallmeier E, 2011, STEM CELLS, V29, P418, DOI 10.1002/stem.595; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kleeff J, 1998, INT J CANCER, V77, P860, DOI 10.1002/(SICI)1097-0215(19980911)77:6<860::AID-IJC11>3.0.CO;2-5; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ohnishi N, 2003, GUT, V52, P1487, DOI 10.1136/gut.52.10.1487; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Schneider Gunter, 2003, Mol Cancer, V2, P15, DOI 10.1186/1476-4598-2-15; Shimizu K, 2008, J GASTROENTEROL, V43, P823, DOI 10.1007/s00535-008-2249-7; Shinozaki S, 2008, J CELL PHYSIOL, V216, P38, DOI 10.1002/jcp.21372; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Torres R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019794; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	37	297	310	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					433	446		10.1016/j.stem.2011.10.001	http://dx.doi.org/10.1016/j.stem.2011.10.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056140	Bronze			2022-12-25	WOS:000297180200011
J	Farovik, A; Place, RJ; Miller, DR; Eichenbaum, H				Farovik, Anja; Place, Ryan James; Miller, Danielle Renee; Eichenbaum, Howard			Amygdala lesions selectively impair familiarity in recognition memory	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; EMOTIONAL MEMORY; RECOLLECTION; HIPPOCAMPAL; STIMULI; RATS	A major controversy in the study of memory concerns whether there are distinct medial temporal lobe (MTL) substrates of recollection and familiarity. Studies using receiver operating characteristics analyses of recognition memory indicate that the hippocampus is essential for recollection, but not for familiarity. We found the converse pattern in the amygdala, wherein damage impaired familiarity while sparing recollection. Combined with previous findings, these results dissociate recollection and familiarity by selective MTL damage.	[Farovik, Anja; Place, Ryan James; Miller, Danielle Renee; Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	hbe@bu.edu		Sullivan, Danielle R./0000-0002-0141-5887	National Institute of Mental Health [MH52090]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052090] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Yonelinas and M. Sauvage for their thoughtful comments on data analysis, and National Institute on Drug Abuse (NIDA) for valuable inspiration. This work was supported by National Institute of Mental Health Project Grant MH52090.	Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; AGGLETON JP, 1989, BEHAV NEUROSCI, V103, P962, DOI 10.1037/0735-7044.103.5.962; Babiloni C, 2009, HUM BRAIN MAPP, V30, P2077, DOI 10.1002/hbm.20648; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Bowles B, 2010, NEUROPSYCHOLOGIA, V48, P2640, DOI 10.1016/j.neuropsychologia.2010.05.010; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	15	30	31	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1416	1417		10.1038/nn.2919	http://dx.doi.org/10.1038/nn.2919			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21946327	Green Accepted			2022-12-25	WOS:000296518600016
J	Brooks, ES; Greer, CL; Romero-Calderon, R; Serway, CN; Grygoruk, A; Haimovitz, JM; Nguyen, BT; Najibi, R; Tabone, CJ; de Belle, JS; Krantz, DE				Brooks, Elizabeth S.; Greer, Christina L.; Romero-Calderon, Rafael; Serway, Christine N.; Grygoruk, Anna; Haimovitz, Jasmine M.; Bac T. Nguyen; Najibi, Rod; Tabone, Christopher J.; de Belle, J. Steven; Krantz, David E.			A Putative Vesicular Transporter Expressed in Drosophila Mushroom Bodies that Mediates Sexual Behavior May Define a Neurotransmitter System	NEURON			English	Article							MONOAMINE TRANSPORTER; SUBSTRATE RECOGNITION; GENETIC DISSECTION; CENTRAL COMPLEX; MOTOR-ACTIVITY; INSECT BRAIN; TAURINE-LIKE; MELANOGASTER; MUTANTS; BODY	Vesicular transporters are required for the storage of all classical and amino acid neurotransmitters in synaptic vesicles. Some neurons lack known vesicular transporters, suggesting additional neurotransmitter systems remain unidentified. Insect mushroom bodies (MBs) are critical for several behaviors, including learning, but the neurotransmitters released by the intrinsic Kenyon cells (KCs) remain unknown. Likewise, KCs do not express a known vesicular transporter. We report the identification of a novel Drosophila gene portabella (prt) that is structurally similar to known vesicular transporters. Both larval and adult brains express PRT in the KCs of the MBs. Additional PRT cells project to the central complex and optic ganglia. prt mutation causes an olfactory learning deficit and an unusual defect in the male's position during copulation that is rescued by expression in KCs. Because prt is expressed in neurons that lack other known vesicular transporters or neurotransmitters, it may define a previously unknown neurotransmitter system responsible for sexual behavior and a component of olfactory learning.	[Brooks, Elizabeth S.; Greer, Christina L.; Romero-Calderon, Rafael; Serway, Christine N.; Grygoruk, Anna; Haimovitz, Jasmine M.; Bac T. Nguyen; Najibi, Rod; Krantz, David E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Hatos Ctr Neuropharmacol,Gonda Goldschmied Ctr Ge, Los Angeles, CA 90095 USA; [Brooks, Elizabeth S.; Greer, Christina L.; Romero-Calderon, Rafael; Serway, Christine N.; Grygoruk, Anna; Haimovitz, Jasmine M.; Bac T. Nguyen; Najibi, Rod; Krantz, David E.] Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Gonda Goldschmied Ctr Genet & Neurosci Res, Los Angeles, CA 90095 USA; [Tabone, Christopher J.; de Belle, J. Steven] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Krantz, DE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Hatos Ctr Neuropharmacol,Gonda Goldschmied Ctr Ge, Room 3357C,695 Charles Young Dr, Los Angeles, CA 90095 USA.	dkrantz@ucla.edu		Greer, Christina/0000-0001-6863-5975; Tabone, Christopher/0000-0001-8746-0680	National Institutes of Health [MH01709]; EJLB, Jr. Foundation; Edward Mallinckrodt, Jr. Foundation; Stephan & Shirley Hates Neuroscience Research Foundation; National Institute of Neurological Diseases and Stroke [T32NS048004]; National Science Foundation [IBN-0237395]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076900, K08MH001709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EJLB, Jr. Foundation; Edward Mallinckrodt, Jr. Foundation; Stephan & Shirley Hates Neuroscience Research Foundation; National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Volker Hartenstein for his critical reading of the manuscript and acknowledge David Patton (deceased) for his important contributions to early phases of this work. We would also like to thank Marianne Cilluffo and colleagues at the UCLA Microscopic Techniques Laboratory for their help with paraffin embedding, sectioning, and mounting of histological samples, Alicia Thompson at the USC Center for Electron Microscopy and Microanalysis for her help in performing scanning electron microscopy, and the anonymous reviewers for their excellent suggestions. This work was funded by the National Institutes of Health (MH01709) and the EJLB and Edward Mallinckrodt, Jr. Foundations (D.E.K.), with support from the Stephan & Shirley Hates Neuroscience Research Foundation (E.S.B., R.R.-C., A.G.), a National Institute of Neurological Diseases and Stroke training grant (T32NS048004) in Neurobehavioral Genetics (E.S.B.), and an National Science Foundation grant (IBN-0237395, J.S.d.B.).	Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; ACKERMAN SL, 1986, J NEUROGENET, V3, P111, DOI 10.3109/01677068609106898; Ahuja A, 2008, GENETICS, V179, P503, DOI 10.1534/genetics.107.086363; Baier A, 2002, J EXP BIOL, V205, P1233; Bao XX, 2010, CELL TISSUE RES, V340, P51, DOI 10.1007/s00441-010-0932-5; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BUDNIK V, 1989, J NEUROSCI, V9, P2866; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Carhan A, 2005, GENES BRAIN BEHAV, V4, P449, DOI 10.1111/j.1601-183X.2004.00117.x; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chaudhry FA, 2008, ANNU REV PHARMACOL, V48, P277, DOI 10.1146/annurev.pharmtox.46.120604.141146; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Fei H, 2010, J EXP BIOL, V213, P1717, DOI 10.1242/jeb.036053; FERVEUR JF, 1993, NATURWISSENSCHAFTEN, V80, P474, DOI 10.1007/BF01136042; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; GAILEY DA, 1984, GENETICS, V106, P613; GORCZYCA MG, 1987, J NEUROSCI, V7, P1361; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; HALL JC, 1979, ANNU REV GENET, V13, P127, DOI 10.1146/annurev.ge.13.120179.001015; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim MH, 1999, J BIOL CHEM, V274, P673, DOI 10.1074/jbc.274.2.673; Kitamoto T, 1998, J BIOL CHEM, V273, P2706, DOI 10.1074/jbc.273.5.2706; KONRAD KD, 1987, DEV BIOL, V122, P172, DOI 10.1016/0012-1606(87)90343-5; Kuniyoshi H, 2002, GENETICS, V162, P1775; Lawal HO, 2010, NEUROBIOL DIS, V40, P102, DOI 10.1016/j.nbd.2010.05.008; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Ng CS, 2008, BEHAV GENET, V38, P195, DOI 10.1007/s10519-008-9190-7; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; Noveen A, 2000, DEVELOPMENT, V127, P3475; ODELL KMC, 1995, NEURON, V15, P55, DOI 10.1016/0896-6273(95)90064-0; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Popov A V, 2003, Neurosci Behav Physiol, V33, P53, DOI 10.1023/A:1021179331583; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Romero-Calderon R, 2007, DEV NEUROBIOL, V67, P550, DOI 10.1002/dneu.20342; Sakai T, 2006, J NEUROBIOL, V66, P821, DOI 10.1002/neu.20262; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHAFER S, 1988, J COMP NEUROL, V268, P60, DOI 10.1002/cne.902680107; Schurmann FW, 2000, ACTA BIOL HUNG, V51, P355; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Sinakevitch I, 2001, J COMP NEUROL, V439, P352, DOI 10.1002/cne.1355; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TOKUNAGA C, 1961, GENETICS, V46, P157; Villella A, 1997, GENETICS, V147, P1107; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wessnitzer J, 2006, BIOINSPIR BIOMIM, V1, P63, DOI 10.1088/1748-3182/1/3/001; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	71	17	17	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					316	329		10.1016/j.neuron.2011.08.032	http://dx.doi.org/10.1016/j.neuron.2011.08.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017990	Bronze, Green Accepted			2022-12-25	WOS:000296224000013
J	Postiglione, MP; Juschke, C; Xie, YL; Haas, GA; Charalambous, C; Knoblich, JA				Postiglione, Maria Pia; Jueschke, Christoph; Xie, Yunli; Haas, Gerald A.; Charalambous, Christoforos; Knoblich, Juergen A.			Mouse Inscuteable Induces Apical-Basal Spindle Orientation to Facilitate Intermediate Progenitor Generation in the Developing Neocortex	NEURON			English	Article							ASYMMETRIC CELL DIVISIONS; NEURAL STEM-CELLS; OUTER SUBVENTRICULAR ZONE; RADIAL GLIAL-CELLS; DROSOPHILA NEUROBLASTS; MITOTIC SPINDLE; CEREBRAL-CORTEX; SELF-RENEWAL; DEVELOPING TELENCEPHALON; MAMMALIAN NEUROGENESIS	Neurons in the mammalian neocortex arise from asymmetric divisions of progenitors residing in the ventricular zone. While in most progenitor divisions, the mitotic spindle is parallel to the ventricular surface, some progenitors reorient the spindle and divide in oblique orientations. Here, we use conditional deletion and overexpression of mouse Inscuteable (mInsc) to analyze the relevance of spindle reorientation in cortical progenitors. Mutating mInsc almost abolishes oblique and vertical mitotic spindles, while mInsc overexpression has the opposite effect. Our data suggest that oblique divisions are essential for generating the correct numbers of neurons in all cortical layers. Using clonal analysis, we demonstrate that spindle orientation affects the rate of indirect neurogenesis, a process where progenitors give rise to basal progenitors, which in turn divide symmetrically into two differentiating neurons. Our results indicate that the orientation of progenitor cell divisions is important for correct lineage specification in the developing mammalian brain.	[Postiglione, Maria Pia; Jueschke, Christoph; Xie, Yunli; Haas, Gerald A.; Charalambous, Christoforos; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Xie, Yunli/J-4638-2019	Knoblich, Juergen A/0000-0002-6751-3404; Juschke, Christoph/0000-0001-5842-4824; Xie, Yunli/0000-0002-7126-0972	Austrian Academy of Sciences; EU; Austrian Science Fund (FWF); European Research Council (ERC); Austrian Science Fund (FWF) [Z 153] Funding Source: researchfish	Austrian Academy of Sciences; EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We wish to thank Karin Paiha and Pawel Pasierbek for excellent bio-optics support and image analysis, Meinrad Busslinger and Abdallah Souabni for help with knockout generation, Frederik Wirtz-Peitz for generating transgenic flies, Elke Kleiner for technical assistance, all members of the J.A.K. lab for discussions, Thom Kauffman for antibodies, and Nina Corsini and Frederik Wirtz-Peitz for comments on the manuscript. Work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, the EU seventh framework program network EuroSyStem, the Austrian Science Fund (FWF), and an advanced grant of the European Research Council (ERC).	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fujimori K, 2002, J COMP NEUROL, V449, P330, DOI 10.1002/cne.10286; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Katoh M, 2003, INT J MOL MED, V11, P111; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Pierani A, 2009, DEV GROWTH DIFFER, V51, P325, DOI 10.1111/j.1440-169X.2009.01095.x; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Sun QY, 2006, FRONT BIOSCI-LANDMRK, V11, P1137, DOI 10.2741/1868; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; YACHNIS AT, 1993, J COMP NEUROL, V334, P356, DOI 10.1002/cne.903340303; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Zhang JZ, 2003, GENETICS, V165, P2063; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	78	127	129	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 20	2011	72	2					269	284		10.1016/j.neuron.2011.09.022	http://dx.doi.org/10.1016/j.neuron.2011.09.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017987	Green Published, hybrid			2022-12-25	WOS:000296224000010
J	Herrmann, R; Heflin, SJ; Hammond, T; Lee, B; Wang, J; Gainetdinov, RR; Caron, MG; Eggers, ED; Frishman, LJ; McCall, MA; Arshavsky, VY				Herrmann, Rolf; Heflin, Stephanie J.; Hammond, Timothy; Lee, Bowa; Wang, Jing; Gainetdinov, Raul R.; Caron, Marc G.; Eggers, Erika D.; Frishman, Laura J.; McCall, Maureen A.; Arshavsky, Vadim Y.			Rod Vision Is Controlled by Dopamine-Dependent Sensitization of Rod Bipolar Cells by GABA	NEURON			English	Article							RETINAL HORIZONTAL CELLS; GAMMA-AMINOBUTYRIC-ACID; MOUSE RETINA; MAMMALIAN RETINA; RAT RETINA; LATERAL INHIBITION; RECEPTORS; FEEDBACK; TRANSMISSION; MODULATION	Dark and light adaptation of retinal neurons allow our vision to operate over an enormous light intensity range. Here we report a mechanism that controls the light sensitivity and operational range of rod-driven bipolar cells that mediate dim-light vision. Our data indicate that the light responses of these cells are enhanced by sustained chloride currents via GABA(C) receptor channels. This sensitizing GABAergic input is controlled by dopamine D1 receptors, with horizontal cells serving as a plausible source of GABA release. Our findings expand the role of dopamine in vision from its well-established function of suppressing rod-driven signals in bright light to enhancing the same signals under dim illumination. They further reveal a role for GABA in sensitizing the circuitry for dim-light vision, thereby complementing GABA's traditional role in providing dynamic feedforward and feedback inhibition in the retina.	[Wang, Jing; Frishman, Laura J.] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Herrmann, Rolf; Hammond, Timothy; Lee, Bowa; Arshavsky, Vadim Y.] Duke Univ, Albert Eye Res Inst, Durham, NC 27710 USA; [Gainetdinov, Raul R.; Caron, Marc G.] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Heflin, Stephanie J.; McCall, Maureen A.] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Gainetdinov, Raul R.] Italian Inst Technol, I-16163 Genoa, Italy; [Eggers, Erika D.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; [Eggers, Erika D.] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85724 USA	University of Houston System; University of Houston; Duke University; Duke University; University of Louisville; Istituto Italiano di Tecnologia - IIT; University of Arizona; University of Arizona	Frishman, LJ (corresponding author), Univ Houston, Coll Optometry, Houston, TX 77204 USA.	lfrishman@uh.edu; mo.mccall@louisville.edu; vadim.arshavsky@duke.edu	Gainetdinov, Raul R/G-5875-2011	Gainetdinov, Raul R/0000-0003-2951-6038; McCall, Maureen/0000-0002-9781-315X; Eggers, Erika/0000-0003-1465-7284	NIH [EY10336, MH073853, EY06671, EY014701, EY5722]; RPB; NATIONAL EYE INSTITUTE [R01EY006671, P30EY005722, R01EY014701, P30EY007551, R01EY010336, R00EY018131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853, R01MH073853] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M.E. Burns for critically reading an earlier version of the manuscript. This work was supported by the NIH grants EY10336 (V.Y.A.), MH073853 (M.G.), EY06671 (L.J.F.), EY014701 (M.A.M.), EY5722 (to Duke University), and RPB (M.A.M.).	AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; Babai N, 2009, J PHYSIOL-LONDON, V587, P2353, DOI 10.1113/jphysiol.2009.169656; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Chavez AE, 2010, J NEUROSCI, V30, P2330, DOI 10.1523/JNEUROSCI.5574-09.2010; Deniz S, 2011, J NEUROCHEM, V116, P350, DOI 10.1111/j.1471-4159.2010.07114.x; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Eggers ED, 2007, J PHYSIOL-LONDON, V582, P569, DOI 10.1113/jphysiol.2007.131763; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Guo CY, 2010, J COMP NEUROL, V518, P1647, DOI 10.1002/cne.22294; HANKINS M, 1994, DOC OPHTHALMOL, V86, P325, DOI 10.1007/BF01203555; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; Hull C, 2006, J NEUROSCI, V26, P6979, DOI 10.1523/JNEUROSCI.1386-06.2006; Jones SM, 2009, J NEUROPHYSIOL, V102, P691, DOI 10.1152/jn.00285.2009; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; KNAPP AG, 1990, P NATL ACAD SCI USA, V87, P767, DOI 10.1073/pnas.87.2.767; Li BQ, 2008, VISUAL NEUROSCI, V25, P109, DOI 10.1017/S0952523808080164; Li L, 2000, J NEUROSCI, V20, P1893; Lukasiewicz PD, 1998, SEMIN CELL DEV BIOL, V9, P293, DOI 10.1006/scdb.1998.0238; MANGEL SC, 1985, SCIENCE, V229, P1107, DOI 10.1126/science.4035351; McCall MA, 2002, J NEUROSCI, V22, P4163, DOI 10.1523/JNEUROSCI.22-10-04163.2002; Mills SL, 2007, VISUAL NEUROSCI, V24, P593, DOI 10.1017/S0952523807070575; NAARENDORP F, 1991, VISION RES, V31, P1, DOI 10.1016/0042-6989(91)90068-G; Nir I, 2000, BRAIN RES, V870, P118, DOI 10.1016/S0006-8993(00)02409-4; Robson JG, 2004, VISION RES, V44, P3253, DOI 10.1016/j.visres.2004.09.002; Robson JG, 1998, DOC OPHTHALMOL, V95, P187, DOI 10.1023/A:1001891904176; Rodieck R.W., 1998, 1 STEPS SEEING; Roska B, 2000, J NEUROSCI, V20, P1941; Satoh H, 2001, NEUROSCI LETT, V310, P161, DOI 10.1016/S0304-3940(01)02120-6; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; Shapley R., 1984, PROGR RETINAL RES, V3, P263; Shields CR, 2000, J NEUROSCI, V20, P2673; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; TESSIERLAVIGNE M, 1988, J GEN PHYSIOL, V91, P49, DOI 10.1085/jgp.91.1.49; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P79, DOI 10.1113/jphysiol.1978.sp012294; VARDI N, 1994, VISUAL NEUROSCI, V11, P135, DOI 10.1017/S0952523800011172; Vardi N, 2000, J NEUROSCI, V20, P7657; Veruki ML, 1996, EUR J NEUROSCI, V8, P2286, DOI 10.1111/j.1460-9568.1996.tb01192.x; Vu TQ, 2000, J NEUROSCI, V20, P1414; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1989, J COMP NEUROL, V279, P43, DOI 10.1002/cne.902790105; Weiler R, 2000, BRAIN RES REV, V32, P121, DOI 10.1016/S0165-0173(99)00071-5; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; YANG XL, 1988, J NEUROSCI, V8, P2269; YANG XL, 1991, P NATL ACAD SCI USA, V88, P3310, DOI 10.1073/pnas.88.8.3310; Zhang LL, 2007, J NEUROPHYSIOL, V98, P266, DOI 10.1152/jn.00288.2007	51	76	77	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					101	110		10.1016/j.neuron.2011.07.030	http://dx.doi.org/10.1016/j.neuron.2011.07.030			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982372	Bronze, Green Accepted			2022-12-25	WOS:000295856300011
J	Sun, W; Maffie, JK; Lin, L; Petralia, RS; Rudy, B; Hoffman, DA				Sun, Wei; Maffie, Jon K.; Lin, Lin; Petralia, Ronald S.; Rudy, Bernardo; Hoffman, Dax A.			DPP6 Establishes the A-Type K+ Current Gradient Critical for the Regulation of Dendritic Excitability in CA1 Hippocampal Neurons	NEURON			English	Article							PYRAMIDAL NEURONS; POTASSIUM CHANNELS; ACTION-POTENTIALS; APICAL DENDRITES; DOWN-REGULATION; ALPHA-SUBUNITS; KV4.2 CHANNELS; PROTEIN DPPX; RAT-BRAIN; MODULATION	Subthreshold-activating A-type K+ currents are essential for the proper functioning of the brain, where they act to delay excitation and regulate firing frequency. In CA1 hippocampal pyramidal neuron dendrites, the density of A-type K+ current increases with distance from the soma, playing an important role in synaptic integration and plasticity. The mechanism underlying this gradient has, however, remained elusive. Here, dendritic recordings from mice lacking the Kv4 transmembrane auxiliary subunit DPP6 revealed that this protein is critical for generating the A-current gradient. Loss of DPP6 led to a decrease in A-type current, specifically in distal dendrites. Decreased current density was accompanied by a depolarizing shift in the voltage dependence of channel activation. Together these changes resulted in hyperexcitable dendrites with enhanced dendritic AP back-propagation, calcium electrogenesis, and induction of synaptic long-term potentiation. Despite enhanced dendritic excitability, firing behavior evoked by somatic current injection was mainly unaffected in DPP6-KO recordings, indicating compartmentalized regulation of neuronal excitability.	[Sun, Wei; Lin, Lin; Hoffman, Dax A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurophysiol & Biophys Unit, NIH, Bethesda, MD 20892 USA; [Sun, Wei] Peking Univ, Hlth Sci Ctr, Neurosci Res Inst, Beijing 01082801114, Peoples R China; [Sun, Wei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Beijing 01082801114, Peoples R China; [Maffie, Jon K.; Rudy, Bernardo] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; [Maffie, Jon K.; Rudy, Bernardo] NYU, Sch Med, Smilow Neurosci Program, New York, NY 10016 USA; [Petralia, Ronald S.] Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Peking University; Peking University; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Hoffman, DA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurophysiol & Biophys Unit, NIH, Bethesda, MD 20892 USA.	hoffmand@mail.nih.gov	Hoffman, Dax A/E-5155-2011	Hoffman, Dax A/0000-0001-6999-2157; Rudy, Bernardo/0000-0001-5748-6900	NICHD; NIDCD; NINDS [NS045217]; NIH [5F30NS071660]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS071660, R01NS045217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, ZICDC000081] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the NICHD and NIDCD Intramural Research Programs and by NINDS grant NS045217 (B.R.) and NIH 5F30NS071660 (J.K.M.). We thank Dr. Ya-Xian Wang for help with the immunogold study and Begum Choudhury for excellent technical assistance.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; CLARK SD, 2008, FRONT MOL NEUROSCI, V1, P8; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Colbert CM, 1997, J NEUROSCI, V17, P6512; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; HANSKI C, 1988, EXP CELL RES, V178, P64, DOI 10.1016/0014-4827(88)90378-3; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jung HY, 1997, J NEUROSCI, V17, P6639; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim J, 2008, J NEUROPHYSIOL, V100, P1835, DOI 10.1152/jn.90261.2008; Kim J, 2008, NEUROSCIENTIST, V14, P276, DOI 10.1177/1073858408315041; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Menegola M, 2008, NEUROSCIENCE, V154, P953, DOI 10.1016/j.neuroscience.2008.04.022; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Remy S, 2009, NEURON, V61, P906, DOI 10.1016/j.neuron.2009.01.032; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zagha E, 2008, J NEUROSCI, V28, P1291, DOI 10.1523/JNEUROSCI.4358-07.2008; Zhao CP, 2011, HIPPOCAMPUS, V21, P288, DOI 10.1002/hipo.20748	49	80	82	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 22	2011	71	6					1102	1115		10.1016/j.neuron.2011.08.008	http://dx.doi.org/10.1016/j.neuron.2011.08.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943606	Green Accepted, Bronze			2022-12-25	WOS:000295556500014
J	Foo, LC; Allen, NJ; Bushong, EA; Ventura, PB; Chung, WS; Zhou, L; Cahoy, JD; Daneman, R; Zong, H; Ellisman, MH; Barres, BA				Foo, Lynette C.; Allen, Nicola J.; Bushong, Eric A.; Ventura, P. Britten; Chung, Won-Suk; Zhou, Lu; Cahoy, John D.; Daneman, Richard; Zong, Hui; Ellisman, Mark H.; Barres, Ben A.			Development of a Method for the Purification and Culture of Rodent Astrocytes	NEURON			English	Article							INTRACELLULAR CALCIUM; RAT-BRAIN; IN-SITU; HIPPOCAMPAL-NEURONS; CNS SYNAPTOGENESIS; NERVOUS-SYSTEM; GLUTAMATE; CELLS; OSCILLATIONS; GLIA	The inability to purify and culture astrocytes has long hindered studies of their function. Whereas astrocyte progenitor cells can be cultured from neonatal brain, culture of mature astrocytes from postnatal brain has not been possible. Here, we report a new method to prospectively purify astrocytes by immunopanning. These astrocytes undergo apoptosis in culture, but vascular cells and HBEGF promote their survival in serum-free culture. We found that some developing astrocytes normally undergo apoptosis in vivo and that the vast majority of astrocytes contact blood vessels, suggesting that astrocytes are matched to blood vessels by competing for vascular-derived trophic factors such as HBEGF. Compared to traditional astrocyte cultures, the gene profiles of the cultured purified postnatal astrocytes much more closely resemble those of in vivo astrocytes. Although these astrocytes strongly promote synapse formation and function, they do not secrete glutamate in response to stimulation.	[Foo, Lynette C.; Allen, Nicola J.; Chung, Won-Suk; Zhou, Lu; Cahoy, John D.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscope & Imaging Res, La Jolla, CA 92093 USA; [Ventura, P. Britten; Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of Oregon	Foo, LC (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	lfoo@stanford.edu	Chung, Won-Suk/B-9011-2016	Chung, Won-Suk/0000-0003-1060-9007	NIH [R01 NS059893]; Agency for Science, Technology and Research, Singapore; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Fabian and A. Ibrahim for technical support, M. van der Hart of Brains On-Line, LLC for the mass spectrometry analysis of the glutamate samples and, Prof. F. Zeng for the anti-rat HBEGF antibody. This work was supported by grants from NIH R01 NS059893 (B.A.B.) and the Agency for Science, Technology and Research, Singapore (L.C.F). We thank Vincent and Stella Coates for their generous support.	Aguado F, 2002, J NEUROSCI, V22, P9430; AlAli SY, 1996, J ANAT, V188, P257; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; FARBER SA, 1995, J NEUROSCI, V15, P7442; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; HAAS RJ, 1970, J ANAT, V107, P421; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hildebrand B, 1997, NEUROSCIENCE, V78, P957, DOI 10.1016/S0306-4522(96)00676-8; Hughes TA, 1996, EXP CELL RES, V222, P275, DOI 10.1006/excr.1996.0035; JENSEN AM, 1991, J NEUROSCI, V11, P1674; Kimelberg HK, 1997, J NEUROCHEM, V68, P1088; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; KRUEGER BK, 1995, J NEUROSCI, V15, P3366; Kuga N, 2011, J NEUROSCI, V31, P2607, DOI 10.1523/JNEUROSCI.5319-10.2011; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Paluzzi S, 2007, J NEUROCHEM, V103, P1196, DOI 10.1111/j.1471-4159.2007.04826.x; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2003, NEUROSCIENCE, V120, P979, DOI 10.1016/S0306-4522(03)00379-8; Pasti L, 1997, J NEUROSCI, V17, P7817; Pilitsis JG, 1998, BRAIN RES, V798, P294, DOI 10.1016/S0006-8993(98)00430-2; SKOFF RP, 1991, GLIA, V4, P165, DOI 10.1002/glia.440040208; SORIANO E, 1993, J HISTOCHEM CYTOCHEM, V41, P819, DOI 10.1177/41.6.8315274; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	40	251	258	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 8	2011	71	5					799	811		10.1016/j.neuron.2011.07.022	http://dx.doi.org/10.1016/j.neuron.2011.07.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903074	Bronze, Green Accepted			2022-12-25	WOS:000294877900006
J	Kuhlman, SJ; Tring, E; Trachtenberg, JT				Kuhlman, Sandra J.; Tring, Elaine; Trachtenberg, Joshua T.			Fast-spiking interneurons have an initial orientation bias that is lost with vision	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD PLASTICITY; VISUAL-CORTEX; NEURONS; SELECTIVITY; EXPERIENCE; DIVERSITY; RESPONSES; CIRCUITS; MOUSE	We found that in mice, following eye opening, fast-spiking, parvalbumin-positive GABAergic interneurons had well-defined orientation tuning preferences and that subsequent visual experience broadened this tuning. Broad inhibitory tuning was not required for the developmental sharpening of excitatory tuning but did precede binocular matching of excitatory orientation tuning. We propose that experience-dependent broadening of inhibition is a candidate for initiating the critical period of excitatory binocular plasticity in developing visual cortex.	[Kuhlman, Sandra J.; Tring, Elaine; Trachtenberg, Joshua T.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Trachtenberg, JT (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	jtrachtenberg@mednet.ucla.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282	US National Eye Institute [EY016052, EY016052S2]; NATIONAL EYE INSTITUTE [R01EY016052] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Silva for use of equipment and space, P. Golshani and D. Chow for technical training and discussion, D. Ringach and R. Gruver for help with data analysis, and T. Otis, S. Smith, M. Stryker and D. Ringach for comments on earlier versions of the manuscript. This work was supported by the US National Eye Institute (grants EY016052 and EY016052S2).	Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hull C, 2007, NAT NEUROSCI, V10, P400, DOI 10.1038/nn0407-400; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Ringach DL, 2002, J NEUROSCI, V22, P5639; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162	15	75	75	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1121	1123		10.1038/nn.2890	http://dx.doi.org/10.1038/nn.2890			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21750548	Green Accepted			2022-12-25	WOS:000294284900011
J	Dreosti, E; Esposti, F; Baden, T; Lagnado, L				Dreosti, Elena; Esposti, Federico; Baden, Tom; Lagnado, Leon			In vivo evidence that retinal bipolar cells generate spikes modulated by light	NATURE NEUROSCIENCE			English	Article							EXOCYTOSIS; CHANNELS; CURRENTS; INFLUX	Retinal bipolar cells have been assumed to generate purely graded responses to light. To test this idea we imaged the presynaptic calcium transient in live zebrafish. We found that ON, OFF, transient and sustained bipolar cells are all capable of generating fast 'all-or-none' calcium transients modulated by visual stimulation.	[Dreosti, Elena; Esposti, Federico; Baden, Tom; Lagnado, Leon] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ll1@mrc-lmb.cam.ac.uk		Esposti, Federico/0000-0002-0033-3118; Dreosti, Elena/0000-0002-6738-7057; Baden, Tom/0000-0003-2808-4210	Wellcome Trust [083220]; MRC [MC_U105178794] Funding Source: UKRI; Medical Research Council [MC_U105178794] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank all of the members of the Lagnado laboratory for discussions that contributed to this work. We also thank the Wellcome Trust for funding (grant 083220).	Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Cui JJ, 2008, VISUAL NEUROSCI, V25, P635, DOI 10.1017/S0952523808080851; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Palmer MJ, 2006, J PHYSIOL-LONDON, V572, P747, DOI 10.1113/jphysiol.2006.105205; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001	11	47	49	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					951	952		10.1038/nn.2841	http://dx.doi.org/10.1038/nn.2841			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706020	Green Accepted			2022-12-25	WOS:000293123700006
J	Fischer, BJ; Pena, JL				Fischer, Brian J.; Pena, Jose Luis			Owl's behavior and neural representation predicted by Bayesian inference	NATURE NEUROSCIENCE			English	Article							BARN-OWL; SOUND LOCALIZATION; INTERAURAL TIME; AUDITORY SPACE; OPTIC TECTUM; TYTO-ALBA; RESPONSES; MAPS	The owl captures prey using sound localization. In the classical model, the owl infers sound direction from the position of greatest activity in a brain map of auditory space. However, this model fails to describe the actual behavior. Although owls accurately localize sources near the center of gaze, they systematically underestimate peripheral source directions. We found that this behavior is predicted by statistical inference, formulated as a Bayesian model that emphasizes central directions. We propose that there is a bias in the neural coding of auditory space, which, at the expense of inducing errors in the periphery, achieves high behavioral accuracy at the ethologically relevant range. We found that the owl's map of auditory space decoded by a population vector is consistent with the behavioral model. Thus, a probabilistic model describes both how the map of auditory space supports behavior and why this representation is optimal.	[Fischer, Brian J.] Ecole Normale Super, Group Neural Theory, Dept Etud Cognit, F-75231 Paris, France; [Fischer, Brian J.] INSERM, Lab Neurosci Cognit, U960, Paris, France; [Pena, Jose Luis] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Yeshiva University; Albert Einstein College of Medicine	Fischer, BJ (corresponding author), Ecole Normale Super, Group Neural Theory, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	bfischer.su@gmail.com		Pena, Jose/0000-0001-6773-5640	US National Institutes of Health [DC007690]; Marie Curie Team of Excellence [BIND MECT-CT-20095-02481]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007690] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Team of Excellence(European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Hausmann and H. Wagner for providing the behavioral data and C. Keller and T. Takahashi for providing the head-related transfer functions. We thank S. Edut, D. Eilam, E. Knudsen, M. Konishi and K. Saberi, whose work substantially contributed to testing our hypothesis. We thank S. Deneve, M. Konishi, A. Margolis, A. Oster, O. Schwartz and A. Wohrer for advice and comments on the manuscript. This study was supported by US National Institutes of Health grant DC007690 (J.L.P.) and the Marie Curie Team of Excellence grant BIND MECT-CT-20095-02481 (B.J.F.).	Bergan JF, 2005, J NEUROSCI, V25, P9816, DOI 10.1523/JNEUROSCI.2533-05.2005; Blauert J., 1983, SPATIAL HEARING PSYC; CARR CE, 1990, J NEUROSCI, V10, P3227; Christianson GB, 2006, J NEUROSCI, V26, P5948, DOI 10.1523/JNEUROSCI.0220-06.2006; Edut S, 2004, BEHAV BRAIN RES, V155, P207, DOI 10.1016/j.bbr.2004.04.018; Fischer BJ, 2008, J NEUROSCI, V28, P8107, DOI 10.1523/JNEUROSCI.1969-08.2008; Ganguli D., 2010, ADV NEURAL INFORM PR, V23; Georgopoulos A. P., 1984, DYNAMIC ASPECTS NEOC, P501; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hausmann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007721; JAY MF, 1990, COMP PERCEPTION, P351; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Kover H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010497; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; Nix J, 2006, J ACOUST SOC AM, V119, P463, DOI 10.1121/1.2139619; Nodal FR, 2008, NEUROSCIENCE, V154, P397, DOI 10.1016/j.neuroscience.2007.12.022; OLSEN JF, 1989, J NEUROSCI, V9, P2591; Pecka M, 2010, J NEUROPHYSIOL, V103, P38, DOI 10.1152/jn.00628.2009; Perez ML, 2009, J NEUROPHYSIOL, V102, P1472, DOI 10.1152/jn.00400.2009; Populin LC, 1998, J NEUROSCI, V18, P2147; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SEUNG HS, 1993, P NATL ACAD SCI USA, V93, P339; SHI L, 2009, ADV NEURAL INFORM PR, V22; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Stern R. M., 1996, BINAURAL SPATIAL HEA, P499; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; van Hemmen JL, 2008, BIOL CYBERN, V98, P509, DOI 10.1007/s00422-008-0215-3; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; ZAHN JR, 1978, SENS PROCESS, V2, P32	38	79	79	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1061	U163		10.1038/nn.2872	http://dx.doi.org/10.1038/nn.2872			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725311	Green Accepted			2022-12-25	WOS:000293123700021
J	Babu, K; Hu, ZT; Chien, SC; Garriga, G; Kaplan, JM				Babu, Kavita; Hu, Zhitao; Chien, Shih-Chieh; Garriga, Gian; Kaplan, Joshua M.			The Immunoglobulin Super Family Protein RIG-3 Prevents Synaptic Potentiation and Regulates Wnt Signaling	NEURON			English	Article							DROSOPHILA EGF RECEPTOR; CAENORHABDITIS-ELEGANS; C-ELEGANS; ADHESION MOLECULE; NEURONAL POLARITY; REQUIRES RETROMER; AMPA RECEPTORS; SUPERFAMILY; BETA; TRANSMISSION	Cell surface Ig superfamily proteins (IgSF) have been implicated in several aspects of neuron development and function. Here, we describe the function of a Caenorhabditis elegans IgSF protein, RIG-3. Mutants lacking RIG-3 have an exaggerated paralytic response to a cholinesterase inhibitor, aldicarb. Although RIG-3 is expressed in motor neurons, heightened drug responsiveness was caused by an aldicarb-induced increase in muscle ACR-16 acetylcholine receptor (AChR) abundance, and a corresponding potentiation of postsynaptic responses at neuromuscular junctions. Mutants lacking RIG-3 also had defects in the anteroposterior polarity of the ALM mechanosensory neurons. The effects of RIG-3 on synaptic transmission and ALM polarity were both mediated by changes in Wnt signaling, and in particular by inhibiting CAM-1, a Ror-type receptor tyrosine kinase that binds Wnt ligands. These results identify RIG-3 as a regulator of Wnt signaling, and suggest that RIG-3 has an anti-plasticity function that prevents activity-induced changes in postsynaptic receptor fields.	[Babu, Kavita; Hu, Zhitao; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Babu, Kavita; Hu, Zhitao; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Chien, Shih-Chieh; Garriga, Gian] Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA; [Garriga, Gian] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	Babu, Kavita/O-1913-2017; hu, zhitao/H-5626-2011	Babu, Kavita/0000-0002-7527-3666; Hu, Zhitao/0000-0002-2948-3339	NIH [NS32196, NS32057]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196, R37NS032196, R01NS032057] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (NS32196 to J.M.K. and NS32057 to G.G.). We thank the following for strains, reagents, and advice: C. elegans Genetic Stock Center, Villu Maricq, Jihong Bai, Ed Pym, and Eyleen O'Rourke. We also thank members of the Kaplan laboratory for suggestions and comments on this manuscript.	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRENNER S, 1974, GENETICS, V77, P71; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cox EA, 2004, J CELL SCI, V117, P1867, DOI 10.1242/jcs.01177; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Fleming T, 2010, DEV BIOL, V344, P94, DOI 10.1016/j.ydbio.2010.04.025; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Goda Y, 2002, NEURON, V35, P1, DOI 10.1016/S0896-6273(02)00765-1; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hu ZT, 2011, NEURON, V71, P92, DOI 10.1016/j.neuron.2011.04.021; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Myers TR, 2007, P NATL ACAD SCI USA, V104, P20368, DOI 10.1073/pnas.0709989104; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schwarz V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-13; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; Sun C, 2003, GENOMICS, V82, P130, DOI 10.1016/S0888-7543(03)00110-1; Takeda Yasuo, 2001, Keio Journal of Medicine, V50, P240; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Uyemura K, 1996, Essays Biochem, V31, P37; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	76	28	32	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 14	2011	71	1					103	116		10.1016/j.neuron.2011.05.034	http://dx.doi.org/10.1016/j.neuron.2011.05.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745641	Green Accepted, Bronze			2022-12-25	WOS:000292806200010
J	Yuen, EY; Wei, J; Liu, WH; Zhong, P; Li, XN; Yan, Z				Yuen, Eunice Y.; Wei, Jing; Liu, Wenhua; Zhong, Ping; Li, Xiangning; Yan, Zhen			Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex	NEURON			English	Article							DENDRITIC MORPHOLOGY; SYNAPTIC PLASTICITY; HIPPOCAMPAL; UBIQUITIN; CORTICOSTERONE; MEMORY; BRAIN; NEUROBIOLOGY; TRANSMISSION; DYSFUNCTION	Chronic stress could trigger maladaptive changes associated with stress-related mental disorders; however, the underlying mechanisms remain elusive. In this study, we found that exposing juvenile male rats to repeated stress significantly impaired the temporal order recognition memory, a cognitive process controlled by the prefrontal cortex (PFC). Concomitantly, significantly reduced AMPAR- and NMDAR-mediated synaptic transmission and glutamate receptor expression were found in PFC pyramidal neurons from repeatedly stressed animals. All these effects relied on activation of glucocorticold receptors and the subsequent enhancement of ubiquitin/proteasome-mediated degradation of GluR1 and NR1 subunits, which was controlled by the E3 ubiquitin ligase Nedd4-1 and Fbx2, respectively. Inhibition of proteasomes or knockdown of Nedd4-1 and Fbx2 in PFC prevented the loss of glutamatergic responses and recognition memory in stressed animals. Our results suggest that repeated stress dampens PFC glutamatergic transmission by facilitating glutamate receptor turnover, which causes the detrimental effect on PFC-dependent cognitive processes.	[Yuen, Eunice Y.; Wei, Jing; Liu, Wenhua; Zhong, Ping; Li, Xiangning; Yan, Zhen] SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu	Li, Xiangning/AGH-1884-2022	Liu, Wenhua/0000-0003-0903-8497; Yan, Zhen/0000-0002-3519-9596; Li, Xiangning/0000-0002-3747-2824	National Institutes of Health [MH85774, MH84233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823, R01MH084233, R01MH085774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Xiaoqing Chen for her excellent technical support. This work was supported by National Institutes of Health grants MH85774 and MH84233 (to Z.Y.).	Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Beylin AV, 2003, HORM BEHAV, V43, P124, DOI 10.1016/S0018-506X(02)00025-9; Brody A L, 2001, Semin Clin Neuropsychiatry, V6, P102, DOI 10.1053/scnp.2001.21837; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Gu ZL, 2007, MOL PHARMACOL, V71, P1030, DOI 10.1124/mol.106.032490; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Karst H, 2003, J NEUROPHYSIOL, V89, P625, DOI 10.1152/jn.00691.2002; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu WH, 2011, NEUROBIOL AGING, V32, P1818, DOI 10.1016/j.neurobiolaging.2009.10.017; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Moghaddam B, 2004, NEUROTOX RES, V6, P73, DOI 10.1007/BF03033299; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Newport DJ, 2000, CURR OPIN NEUROBIOL, V10, P211, DOI 10.1016/S0959-4388(00)00080-5; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Stuss D.T., 2002, PRINCIPLES FRONTAL L; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Van Praag HM, 2005, WORLD J BIOL PSYCHIA, V6, P5, DOI [10.1080/15622970510030018, 10.1016/j.pnpbp.2004.05.031]; Vyas A, 2002, J NEUROSCI, V22, P6810; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	63	365	379	5	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					962	977		10.1016/j.neuron.2011.12.033	http://dx.doi.org/10.1016/j.neuron.2011.12.033			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405206	Green Accepted, Bronze			2022-12-25	WOS:000301558600011
J	Liebe, S; Hoerzer, GM; Logothetis, NK; Rainer, G				Liebe, Stefanie; Hoerzer, Gregor M.; Logothetis, Nikos K.; Rainer, Gregor			Theta coupling between V4 and prefrontal cortex predicts visual short-term memory performance	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; PHASE-LOCKING; NEURONAL SYNCHRONIZATION; PARIETAL CORTEX; SPATIAL MEMORY; NEURAL BASIS; OSCILLATIONS; TASK; BRAIN; REPRESENTATION	Short-term memory requires communication between multiple brain regions that collectively mediate the encoding and maintenance of sensory information. It has been suggested that oscillatory synchronization underlies intercortical communication. Yet, whether and how distant cortical areas cooperate during visual memory remains elusive. We examined neural interactions between visual area V4 and the lateral prefrontal cortex using simultaneous local field potential (LFP) recordings and single-unit activity (SUA) in monkeys performing a visual short-term memory task. During the memory period, we observed enhanced between-area phase synchronization in theta frequencies (3-9 Hz) of LFPs together with elevated phase locking of SUA to theta oscillations across regions. In addition, we found that the strength of intercortical locking was predictive of the animals' behavioral performance. This suggests that theta-band synchronization coordinates action potential communication between V4 and prefrontal cortex that may contribute to the maintenance of visual short-term memories.	[Liebe, Stefanie; Logothetis, Nikos K.; Rainer, Gregor] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Tubingen, Germany; [Hoerzer, Gregor M.] Graz Univ Technol, Inst Theoret Comp Sci, A-8010 Graz, Austria; [Logothetis, Nikos K.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Rainer, Gregor] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	Max Planck Society; Graz University of Technology; University of Manchester; University of Fribourg	Liebe, S (corresponding author), UCL, Dept Physiol Pharmacol & Neurosci, London, England.	s.liebe@ucl.ac.uk; gregor.rainer@unifr.ch	Logothetis, Nikos/U-9282-2019; Rainer, Gregor/B-5876-2012	Rainer, Gregor/0000-0002-5805-2220	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 550]; Max Planck Society; European Union [FP7-231267, FP7-506778]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	We would like to thank J. Macke for discussions regarding analyses, and T. Mrsic-Flogel and J. Macke for useful comments on the manuscript. We also thank A.-L. Keller for help with histology. S. L. was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 550 and a doctoral Fellowship of the Max Planck Society. G. M. H. was supported by projects FP7-231267 ("Self-Organized Recurrent Neural Learning for Language Processing", ORGANIC) and FP7-506778 (Pattern Analysis, Statistical Modeling and Computational Learning, PASCAL2) of the European Union. G.R. is a European Science Foundation European Young Investigator.	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Fell J, 2008, NEUROIMAGE, V43, P410, DOI 10.1016/j.neuroimage.2008.07.021; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Guderian S, 2005, HIPPOCAMPUS, V15, P901, DOI 10.1002/hipo.20125; Hoerzer GM, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00014; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liebe S, 2011, J NEUROSCI, V31, P10215, DOI 10.1523/JNEUROSCI.1791-10.2011; Liebe S, 2009, J VISION, V9, DOI 10.1167/9.5.14; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Pasupathy A, 2006, PROG BRAIN RES, V154, P293, DOI 10.1016/S0079-6121(06)54016-6; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; TOWE AL, 1970, EXP NEUROL, V29, P366, DOI 10.1016/0014-4886(70)90065-8; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; Weiss S, 2000, NEUROREPORT, V11, P2357, DOI 10.1097/00001756-200008030-00005; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	49	198	201	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					456	U150		10.1038/nn.3038	http://dx.doi.org/10.1038/nn.3038			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286175	Green Submitted			2022-12-25	WOS:000300793100020
J	Goddard, CA; Sridharan, D; Huguenard, JR; Knudsen, EI				Goddard, C. Alex; Sridharan, Devarajan; Huguenard, John R.; Knudsen, Eric I.			Gamma Oscillations Are Generated Locally in an Attention-Related Midbrain Network	NEURON			English	Article							OPTIC TECTUM; SUPERIOR COLLICULUS; NUCLEUS ISTHMI; HIGH-FREQUENCY; SYNCHRONIZATION; RHYTHMS; SYSTEM; CELLS; PROJECTIONS; COMPETITION	Gamma-band (25-140 Hz) oscillations are a hallmark of sensory processing in the forebrain. The optic tectum (OT), a midbrain structure implicated in sensorimotor processing and attention, also exhibits gamma oscillations. However, the origin and mechanisms of these oscillations remain unknown. We discovered that in acute slices of the avian OT, persistent (> 100 ms) epochs of large amplitude gamma oscillations can be evoked that closely resemble those recorded in vivo. We found that cholinergic, glutamatergic, and GABAergic mechanisms differentially regulate the structure of the oscillations at various timescales. These persistent oscillations originate in the multisensory layers of the OT and are broadcast to visual layers via the cholinergic nucleus Ipc, providing a potential mechanism for enhancing the processing of visual information within the OT. The finding that the midbrain contains an intrinsic gamma-generating circuit suggests that the OT could use its own oscillatory code to route signals to forebrain networks.	[Goddard, C. Alex; Sridharan, Devarajan; Knudsen, Eric I.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Huguenard, John R.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA	Stanford University; Stanford University	Sridharan, D (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	cgoddard@stanford.edu; dsridhar@stanford.edu	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Devarajan, Sridharan/0000-0003-1998-9018	Stanford Dean's Postdoctoral Fellowship; NEI [F32 EY018787-01, EY019179-31]; NINDS [NS34774]; NATIONAL EYE INSTITUTE [R01EY019179, F32EY018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034774, R01NS006477, R01NS034774, P01NS012151] Funding Source: NIH RePORTER	Stanford Dean's Postdoctoral Fellowship; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Stanford Dean's Postdoctoral Fellowship (C.A.G.), NEI F32 EY018787-01 (C.A.G.), NINDS NS34774 (J.R.H.), and NEI EY019179-31 (E.I.K.). Special thanks to Stefan Heller, Tom Clandinin, Kwabena Boahen, Shreesh Mysore, Astra Bryant, and members of the Knudsen and Huguenard labs for assistance and useful discussions.	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Arai I, 2004, J NEUROPHYSIOL, V92, P715, DOI 10.1152/jn.00159.2004; Asadollahi A, 2010, NAT NEUROSCI, V13, P889, DOI 10.1038/nn.2573; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Brecht M, 2004, J NEUROPHYSIOL, V92, P424, DOI 10.1152/jn.00639.2003; Brecht M, 1999, J NEUROSCI, V19, P3567; BRESSLER SL, 1980, ELECTROEN CLIN NEURO, V50, P19, DOI 10.1016/0013-4694(80)90319-3; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M., 2011, MOL PSYCHIA IN PRESS, DOI [10.1038/journal.mp.2011.31, DOI 10.1038/JOURNAL.MP.2011.31]; Dudkin EA, 2003, BRAIN RES, V969, P44, DOI 10.1016/S0006-8993(03)02274-1; Endo T, 2005, J NEUROPHYSIOL, V94, P3893, DOI 10.1152/jn.00211.2005; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gandal MJ, 2012, NEUROPHARMACOLOGY, V62, P1504, DOI 10.1016/j.neuropharm.2011.02.007; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; GRAYBIEL AM, 1978, BRAIN RES, V145, P365, DOI 10.1016/0006-8993(78)90870-3; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gruberg E, 2006, J NEUROSCI, V26, P10368, DOI 10.1523/JNEUROSCI.3288-06.2006; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HUNT SP, 1976, J COMP NEUROL, V170, P173, DOI 10.1002/cne.901700204; ISA T, 2009, J NEUROPHYSIOL; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Islam MR, 2008, J COMP NEUROL, V511, P658, DOI 10.1002/cne.21871; KING WM, 1991, NEUROSCIENCE, V40, P701, DOI 10.1016/0306-4522(91)90006-A; KING WM, 1990, BRAIN RES, V527, P150; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lee PH, 2001, J NEUROSCI, V21, P8145, DOI 10.1523/JNEUROSCI.21-20-08145.2001; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; Middleton SJ, 2008, NEURON, V58, P763, DOI 10.1016/j.neuron.2008.03.030; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Neuenschwander S, 1996, VISUAL NEUROSCI, V13, P575, DOI 10.1017/S0952523800008257; Phongphanphanee P, 2011, J NEUROSCI, V31, P1949, DOI 10.1523/JNEUROSCI.2305-10.2011; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Ramcharitar JU, 2006, J NEUROPHYSIOL, V96, P2319, DOI 10.1152/jn.00311.2006; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Roopun AK, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00008; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SORENSON EM, 1989, J COMP NEUROL, V281, P641, DOI 10.1002/cne.902810412; Sridharan D, 2011, J NEUROPHYSIOL, V105, P2005, DOI 10.1152/jn.00965.2010; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Vokoun CR, 2010, J NEUROSCI, V30, P10667, DOI 10.1523/JNEUROSCI.1387-10.2010; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang Y, 2006, J COMP NEUROL, V494, P7, DOI 10.1002/cne.20821	57	38	41	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					567	580		10.1016/j.neuron.2011.11.028	http://dx.doi.org/10.1016/j.neuron.2011.11.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325207	Green Accepted, Bronze			2022-12-25	WOS:000300140600016
J	Hilliard, AT; Miller, JE; Fraley, ER; Horvath, S; White, SA				Hilliard, Austin T.; Miller, Julie E.; Fraley, Elizabeth R.; Horvath, Steve; White, Stephanie A.			Molecular Microcircuitry Underlies Functional Specification in a Basal Ganglia Circuit Dedicated to Vocal Learning	NEURON			English	Article							COEXPRESSION NETWORK ANALYSIS; GENE-EXPRESSION; HUMAN BRAIN; SYNAPTIC PLASTICITY; FOXP2 EXPRESSION; SONGBIRD; STRIATUM; NEURONS; LANGUAGE; PROTEIN	Similarities between speech and birdsong make songbirds advantageous for investigating the neurogenetics of learned vocal communication-a complex phenotype probably supported by ensembles of interacting genes in cortico-basal ganglia pathways of both species. To date, only FoxP2 has been identified as critical to both speech and birdsong. We performed weighted gene coexpression network analysis on microarray data from singing zebra finches to discover gene ensembles regulated during vocal behavior. We found similar to 2,000 singing-regulated genes comprising three coexpression groups unique to area X, the basal ganglia subregion dedicated to learned vocalizations. These contained known targets of human FOXP2 and potential avian targets. We validated biological pathways not previously implicated in vocalization. Higher-order gene coexpression patterns, rather than expression levels, molecularly distinguish area X from the ventral striato-pallidum during singing. The previously unknown structure of singing-driven networks enables prioritization of molecular interactors that probably bear on human motor disorders, especially those affecting speech.	[Hilliard, Austin T.; Miller, Julie E.; Fraley, Elizabeth R.; White, Stephanie A.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Hilliard, Austin T.; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [Fraley, Elizabeth R.; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Mol Cellular & Integrat Physiol, Los Angeles, CA USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	White, SA (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	sawhite@ucla.edu	Hilliard, Austin/AAM-1752-2020; Hilliard, Austin/AAT-7316-2020; White, Stephanie Ann/AAE-7683-2019	Hilliard, Austin/0000-0002-1289-4377; White, Stephanie Ann/0000-0002-3490-2294; Miller, Julie/0000-0003-0371-0342	NIH [F31 MH082533, R01 MH070712]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH082533, R01MH070712] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Peter Langfelder and Michael Oldham for advice on microarray preprocessing and network analysis; Jason Howard and Erich Jarvis for the arrays through a partnership with Agilent Technologies; Patty Phelps, Sarah Bottjer, and Erica Sloan for material support; Felix Schweizer and Grace Xiao for statistical advice; and four anonymous reviewers for insightful commentary. This work was supported by NIH grants F31 MH082533 (ATH) and R01 MH070712 (SAW). Author contributions: J.E.M.. A.T.H., and S.A.W. designed the experiments; J.E.M. collected the animals and tissue punches, analyzed the song, and, together with E.F., performed the biological validation; A.T.H. performed the RNA isolation, array preprocessing, song analysis, and WGCNA, with guidance from S.H.; A.T.H., J.E.M., E.F., S.H., and S.A.W. wrote and/or edited the manuscript.	Balthazart J, 2008, NEUROSCIENCE, V153, P944, DOI 10.1016/j.neuroscience.2008.02.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Farries MA, 2002, J NEUROSCI, V22, P3776; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hessler NA, 1999, J NEUROSCI, V19, P10461; Hosono K, 2010, GENOMICS, V96, P102, DOI 10.1016/j.ygeno.2010.05.003; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Kaestner KH, 2000, GENE DEV, V14, P142; Kim YH, 2004, J COMP NEUROL, V469, P535, DOI 10.1002/cne.11033; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li XC, 2007, P NATL ACAD SCI USA, V104, P6834, DOI 10.1073/pnas.0701619104; LIEBERMAN P, 2006, EVOLUTIONARY BIOL LA; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Miller JE, 2008, J NEUROPHYSIOL, V100, P2015, DOI 10.1152/jn.90415.2008; Miller JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008592; Musella A, 2009, MOL CELL NEUROSCI, V40, P89, DOI 10.1016/j.mcn.2008.09.001; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Poopatanapong A, 2006, J NEUROBIOL, V66, P1613, DOI 10.1002/neu.20329; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Soderstrom K, 2004, DEV BRAIN RES, V153, P225, DOI 10.1016/j.devbrainres.2004.09.002; Soderstrom K, 2010, DEV NEUROBIOL, V70, P195, DOI 10.1002/dneu.20772; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Teramitsu I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008548; Thompson JA, 2011, J NEUROPHYSIOL, V105, P1159, DOI 10.1152/jn.00676.2010; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; White SA, 2010, BRAIN LANG, V115, P21, DOI 10.1016/j.bandl.2009.10.002; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	51	79	79	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					537	552		10.1016/j.neuron.2012.01.005	http://dx.doi.org/10.1016/j.neuron.2012.01.005			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325205	Green Accepted, hybrid			2022-12-25	WOS:000300140600014
J	Endo, K; Karim, MR; Taniguchi, H; Krejci, A; Kinameri, E; Siebert, M; Ito, K; Bray, SJ; Moore, AW				Endo, Keita; Karim, M. Rezaul; Taniguchi, Hiroaki; Krejci, Alena; Kinameri, Emi; Siebert, Matthias; Ito, Kei; Bray, Sarah J.; Moore, Adrian W.			Chromatin modification of Notch targets in olfactory receptor neuron diversification	NATURE NEUROSCIENCE			English	Article							EXTERNAL SENSORY ORGANS; CELL FATE DECISIONS; TRANSCRIPTIONAL CONTROL; GENE CHOICE; STEM-CELLS; DROSOPHILA; EXPRESSION; METHYLATION; ENHANCER; COMPLEX	Neuronal-class diversification is central during neurogenesis. This requirement is exemplified in the olfactory system, which utilizes a large array of olfactory receptor neuron (ORN) classes. We discovered an epigenetic mechanism in which neuron diversity is maximized via locus-specific chromatin modifications that generate context-dependent responses from a single, generally used intracellular signal. Each ORN in Drosophila acquires one of three basic identities defined by the compound outcome of three iterated Notch signaling events during neurogenesis. Hamlet, the Drosophila Evil and Prdm16 proto-oncogene homolog, modifies cellular responses to these iteratively used Notch signals in a context-dependent manner, and controls odorant receptor gene choice and ORN axon targeting specificity. In nascent ORNs, Hamlet erases the Notch state inherited from the parental cell, enabling a modified response in a subsequent round of Notch signaling. Hamlet directs locus-specific modifications of histone methylation and histone density and controls accessibility of the DNA-binding protein Suppressor of Hairless at the Notch target promoter.	[Karim, M. Rezaul; Taniguchi, Hiroaki; Kinameri, Emi; Siebert, Matthias; Moore, Adrian W.] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Endo, Keita; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Krejci, Alena; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Krejci, Alena] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Krejci, Alena] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	RIKEN; University of Tokyo; University of Cambridge; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Moore, AW (corresponding author), RIKEN Brain Sci Inst, Wako, Saitama, Japan.	adrianm@brain.riken.jp	Taniguchi, Hiroaki/H-6329-2016; Siebert, Matthias/K-8494-2014; Moore, Adrian W/A-3339-2013; Moore, Adrian Walton/AAN-5656-2021; Krejci, Alena/H-2623-2014	Siebert, Matthias/0000-0002-1739-5825; Moore, Adrian W/0000-0002-8242-301X; Moore, Adrian Walton/0000-0002-8242-301X; Krejci, Alena/0000-0001-7589-4035; Karim, M. Rezaul/0000-0001-5440-0315; Bray, Sarah/0000-0002-1642-599X; Taniguchi, Hiroaki/0000-0001-7270-390X	Japan Society for the Promotion of Science; RIKEN; Medical Research Council; RIKEN Brain Science Institute; MRC [G0800034] Funding Source: UKRI; Medical Research Council [G0800034] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RIKEN Brain Science Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Luo, T. Hummel, Y. Hiromi, Y.N. Jan, F. Matsuzaki, S. Parkhurst, the Bloomington Drosophila Stock Center, Bloomington Drosophila Genomics Resource Center, the Iowa Developmental Studies Hybridoma Bank and Flybase for Drosophila stocks, DNA clones, antibodies and indispensable database information, and C. Yokoyama and members of the Moore laboratory for advice on the manuscript. Funding was provided by Japan Society for the Promotion of Science Grants-in-Aid Young Scientists (B) to H.T. and Scientific Research (C) to K.E., a RIKEN-Deutscher Akademischer Austauschdienst Research Internship Scholarship to M.S., a Medical Research Council program grant to S.J.B., and a RIKEN Brain Science Institute core award to A.W.M.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Andrews HK, 2009, EMBO REP, V10, P636, DOI 10.1038/embor.2009.66; Bai L, 2009, J NEUROSCI, V29, P12940, DOI 10.1523/JNEUROSCI.3525-09.2009; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chou YH, 2010, CELL, V142, P954, DOI 10.1016/j.cell.2010.08.015; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Moore AW, 2004, GENE DEV, V18, P623, DOI 10.1101/gad.1170904; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang SW, 1997, DEVELOPMENT, V124, P4435	46	60	60	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					224	233		10.1038/nn.2998	http://dx.doi.org/10.1038/nn.2998			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197833				2022-12-25	WOS:000299603500013
J	Ramirez, DMO; Khvotchev, M; Trauterman, B; Kavalali, ET				Ramirez, Denise M. O.; Khvotchev, Mikhail; Trauterman, Brent; Kavalali, Ege T.			Vti1a Identifies a Vesicle Pool that Preferentially Recycles at Rest and Maintains Spontaneous Neurotransmission	NEURON			English	Article							SYNAPTIC VESICLES; SPONTANEOUS RELEASE; SNARE COMPLEX; HIPPOCAMPAL SYNAPSES; FLUORESCENT PROTEINS; EVOKED RELEASE; CA2+ SENSOR; FUSION; TRANSMISSION; EXOCYTOSIS	Recent studies suggest that synaptic vesicles (SVs) giving rise to spontaneous neurotransmission are distinct from those that carry out evoked release. However, the molecular basis of this dichotomy remains unclear. Here, we focused on two noncenonical SNARE molecules, Vps10p-tail-interactor-1a (vti1a) and VAMP7, previously shown to reside on SVs. Using simultaneous multicolor imaging at individual synapses, we could show that compared to the more abundant vesicular SNARE synaptobre-vin2, both vti1a and VAMP7 were reluctantly mobilized during activity. Vti1a, but not VAMP7, showed robust trafficking under resting conditions that could be partly matched by synaptobrevin2. Furthermore, loss of vti1a function selectively reduced high-frequency spontaneous neurotransmitter release detected postsynaptically. Expression of a truncated version of vti1a augmented spontaneous release more than full-length vti1a, suggesting that an auto-inhibitory process regulates vti1a function. Taken together, these results support the premise that in its native form vti1a selectively maintains spontaneous neurotransmitter release.	[Ramirez, Denise M. O.; Khvotchev, Mikhail; Trauterman, Brent; Kavalali, Ege T.] UT SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; [Kavalali, Ege T.] UT SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kavalali, ET (corresponding author), UT SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA.	ege.kavalali@utsouthwestern.edu	Khvotchev, Mikhail/G-5411-2013	Khvotchev, Mikhail/0000-0001-9328-8549; Ramirez, Denise/0000-0003-4090-033X	NIMH [R01MH066198, F32MH093109]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066198, F32MH093109] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by grants from the NIMH (R01MH066198) to E.T.K. and (F32MH093109) to D.M.O.R. We thank Dr. Thomas C. Sudhof for his encouragement and support at the initial stages of this work. We thank Drs. Megumi Adachi and Pei Liu for assistance with syb2 knockout mice. We also thank Dr. Thierry Galli for the initial VAMP7 expression construct and Drs. Matthew Kennedy and Michael Ehlers for the TfR-pHluorin construct. We greatly appreciate Dr. Christopher Gilpin's help with immuno-EM analysis and Dr. Manjot Bal sharing syntaxin6-expressing neurons. We gratefully acknowledge Dr. Lisa M. Monteggia for discussions and her critical insight during this project.	Abenavoli A, 2002, J NEUROSCI, V22, P6336; Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Deak F, 2009, J NEUROSCI, V29, P8639, DOI 10.1523/JNEUROSCI.0898-09.2009; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Drose S, 1997, J EXP BIOL, V200, P1; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Hua SY, 1998, J NEUROPHYSIOL, V80, P3233, DOI 10.1152/jn.1998.80.6.3233; Hua YF, 2010, NAT NEUROSCI, V13, P1451, DOI 10.1038/nn.2695; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Kunwar AJ, 2011, P NATL ACAD SCI USA, V108, P2575, DOI 10.1073/pnas.1013891108; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Mathew SS, 2008, J NEUROSCI, V28, P725, DOI 10.1523/JNEUROSCI.3625-07.2008; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Muzerelle A, 2003, NEUROSCIENCE, V122, P59, DOI 10.1016/S0306-4522(03)00567-0; Nosyreva E, 2010, J NEUROSCI, V30, P7358, DOI 10.1523/JNEUROSCI.5358-09.2010; Pang ZPP, 2011, NEURON, V70, P244, DOI 10.1016/j.neuron.2011.03.011; Prange O, 1999, J NEUROSCI, V19, P6427; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Ramirez DMO, 2011, CURR OPIN NEUROBIOL, V21, P275, DOI 10.1016/j.conb.2011.01.007; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sara Y, 2011, J NEUROSCI, V31, P5378, DOI 10.1523/JNEUROSCI.5234-10.2011; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Virmani T, 2005, J NEUROSCI, V25, P10922, DOI 10.1523/JNEUROSCI.3766-05.2005; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; von Mollard GF, 1998, J BIOL CHEM, V273, P2624, DOI 10.1074/jbc.273.5.2624; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Wilhelm BG, 2010, NAT NEUROSCI, V13, P1454, DOI 10.1038/nn.2690; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Zenisek D, 2008, P NATL ACAD SCI USA, V105, P4922, DOI 10.1073/pnas.0709067105	66	121	123	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 12	2012	73	1					121	134		10.1016/j.neuron.2011.10.034	http://dx.doi.org/10.1016/j.neuron.2011.10.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243751	Green Accepted, Bronze			2022-12-25	WOS:000299446800012
J	Lee, H; Choi, MK; Lee, D; Kim, HS; Hwang, H; Kim, H; Park, S; Paik, YK; Lee, J				Lee, Harksun; Choi, Myung-kyu; Lee, Daehan; Kim, Hye-sung; Hwang, Hyejin; Kim, Heekyeong; Park, Sungsu; Paik, Young-ki; Lee, Junho			Nictation, a dispersal behavior of the nematode Caenorhabditis elegans, is regulated by IL2 neurons	NATURE NEUROSCIENCE			English	Article							DAUER-INDUCING PHEROMONE; C-ELEGANS; DEFICIENT MUTANTS; GENETIC-ANALYSIS; EXCITABLE CELLS; CHANNELRHODOPSIN-2; NEUROTRANSMISSION; TRANSMISSION; LOCOMOTION; RESPONSES	Many nematodes show a stage-specific behavior called nictation in which a worm stands on its tail and waves its head in three dimensions. Here we show that nictation is a dispersal behavior regulated by a specific set of neurons, the IL2 cells, in C. elegans. We established assays for nictation and showed that cholinergic transmission was required for nictation. Cell type-specific rescue experiments and genetic ablation experiments revealed that the IL2 ciliated head neurons were essential for nictation. Intact cilia in IL2 neurons, but not in other ciliated head neurons, were essential, as the restoration of the corresponding wild-type gene activity in IL2 neurons alone in cilia-defective mutants was sufficient to restore nictation. Optogenetic activation of IL2 neurons induced nictation, suggesting that signals from IL2 neurons are sufficient for nictation. Finally, we demonstrated that nictation is required for transmission of C. elegans to a new niche using flies as artificial carriers, suggesting a role of nictation as a dispersal and survival strategy under harsh conditions.	[Lee, Harksun; Choi, Myung-kyu; Lee, Daehan; Kim, Hye-sung; Lee, Junho] Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Funct Cellul, Seoul, South Korea; [Hwang, Hyejin; Park, Sungsu] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Kim, Heekyeong; Paik, Young-ki] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Lee, Junho] Seoul Natl Univ, World Class Univ, Dept Biophys & Chem Biol, Seoul, South Korea	Seoul National University (SNU); Ewha Womans University; Yonsei University; Seoul National University (SNU)	Lee, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Funct Cellul, Seoul, South Korea.	elegans@snu.ac.kr	Lee, Junho/AAO-4706-2021; Park, Sungsu/L-1920-2013; Park, Sungsu/AAF-4792-2020; Lee, Daehan/AAZ-6469-2021	Park, Sungsu/0000-0003-3062-1302; Lee, Daehan/0000-0002-0546-8484	Brain Research Center; World Class University program; Research Center for Functional Cellulomics; Seoul Scholarship Foundation	Brain Research Center; World Class University program; Research Center for Functional Cellulomics; Seoul Scholarship Foundation	This work was initiated when J.L. was at his sabbatical leave in M. Han's laboratory (University of Colorado at Boulder). The authors thank Y. Kohara (National Institute of Genetics, Japan) for cDNA clones, A. Fire (Stanford University) for vectors, the J. Yim laboratory and the C. K. Chung laboratory (Seoul National University) for providing flies for our experiment, A. Gottschalk (Goethe University) for the ChR2 plasmid, P. Sengupta (Brandeis University) for the daf-10 cDNA plasmid and the Caenorhabditis Genetics Center for C. elegans strains. This work was supported by Brain Research Center of the 21st Century Frontier Research Program, the World Class University program and Research Center for Functional Cellulomics. M. C. was supported by Hi Seoul Science Fellowship from the Seoul Scholarship Foundation.	ALBERT PS, 1983, J COMP NEUROL, V219, P461, DOI 10.1002/cne.902190407; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere Antoine, 2005, P1; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CAMPBELL JF, 1993, BEHAVIOUR, V126, P155, DOI 10.1163/156853993X00092; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chen J, 2006, EXP GERONTOL, V41, P1059, DOI 10.1016/j.exger.2006.07.005; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Croll NA., 1977, BIOL NEMATODES, P152; Darwin C., 1877, DIFFERENT FORMS FLOW; Evans A. A. F., 1976, The organization of nematodes., P383; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MILLER MW, 1992, J NEUROPHYSIOL, V68, P2174, DOI 10.1152/jn.1992.68.6.2174; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nonet ML, 1997, J NEUROSCI, V17, P8061; Ouellet J, 2008, DEVELOPMENT, V135, P2583, DOI 10.1242/dev.012435; Palikhova TA, 2006, B EXP BIOL MED+, V142, P275, DOI 10.1007/s10517-006-0345-3; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Peden EM, 2005, CURR BIOL, V15, P394, DOI 10.1016/j.cub.2004.12.073; Praitis V, 2001, GENETICS, V157, P1217; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; RAND JB, 1984, GENETICS, V106, P227; RAND JB, 1989, GENETICS, V122, P73; REED EM, 1965, NATURE, V206, P210, DOI 10.1038/206210a0; Sivasundar A, 2003, GENETICS, V163, P147; SUDHAUS W, 1989, NEMATOLOGICA, V35, P305, DOI 10.1163/002825989X00412; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; VOWELS JJ, 1992, GENETICS, V130, P105; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yono O, 2008, ZOOL SCI, V25, P517, DOI 10.2108/zsj.25.517; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	45	96	96	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					107	U134		10.1038/nn.2975	http://dx.doi.org/10.1038/nn.2975			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22081161				2022-12-25	WOS:000298414400020
J	Simons, SB; Caruana, DA; Zhao, ML; Dudek, SM				Simons, Stephen B.; Caruana, Douglas A.; Zhao, Meilan; Dudek, Serena M.			Caffeine-induced synaptic potentiation in hippocampal CA2 neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ADENOSINE; RECEPTOR; PLASTICITY; TRANSMISSION; ANTAGONISTS; MEMORY; RATS	Caffeine enhances cognition, but even high non-physiological doses have modest effects on synapses. A(1) adenosine receptors (A(1)Rs) are antagonized by caffeine and are most highly enriched in hippocampal CA2, which has not been studied in this context. We found that physiological doses of caffeine in vivo or A(1)R antagonists in vitro induced robust, long-lasting potentiation of synaptic transmission in rat CA2 without affecting other regions of the hippocampus.	[Simons, Stephen B.; Caruana, Douglas A.; Zhao, Meilan; Dudek, Serena M.] Natl Inst Environm Hlth Sci, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dudek, SM (corresponding author), Natl Inst Environm Hlth Sci, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA.	dudek@niehs.nih.gov	Dudek, Serena/C-6561-2009	Dudek, Serena/0000-0003-4094-8368; Caruana, Douglas/0000-0002-8687-0263	US National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES 100221]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100221, ZIAES100221] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank D. Armstrong and members of the Dudek laboratory for their input on the manuscript. This research was supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES 100221).	ARAI A, 1992, BRAIN RES, V598, P173, DOI 10.1016/0006-8993(92)90181-8; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; CHOI OH, 1988, LIFE SCI, V43, P387, DOI 10.1016/0024-3205(88)90517-6; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; FORGHANI R, 1995, HIPPOCAMPUS, V5, P71, DOI 10.1002/hipo.450050109; GARASCHUK O, 1992, NEUROSCI LETT, V135, P10, DOI 10.1016/0304-3940(92)90124-P; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; LUCAS PB, 1990, BIOL PSYCHIAT, V28, P35, DOI 10.1016/0006-3223(90)90429-6; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Ochiishi T, 1999, NEUROSCIENCE, V93, P955, DOI 10.1016/S0306-4522(99)00179-7; Prediger RDS, 2005, NEUROSCI LETT, V376, P160, DOI 10.1016/j.neulet.2004.11.049; Simons SB, 2009, P NATL ACAD SCI USA, V106, P14080, DOI 10.1073/pnas.0904775106; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Zhao M, 2007, J NEUROSCI, V27, P12025, DOI 10.1523/JNEUROSCI.4094-07.2007	15	55	56	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					23	25		10.1038/nn.2962	http://dx.doi.org/10.1038/nn.2962			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101644	Green Accepted			2022-12-25	WOS:000298414400009
J	Viventi, J; Kim, DH; Vigeland, L; Frechette, ES; Blanco, JA; Kim, YS; Avrin, AE; Tiruvadi, VR; Hwang, SW; Vanleer, AC; Wulsin, DF; Davis, K; Gelber, CE; Palmer, L; Van der Spiegel, J; Wu, J; Xiao, JL; Huang, YG; Contreras, D; Rogers, JA; Litt, B				Viventi, Jonathan; Kim, Dae-Hyeong; Vigeland, Leif; Frechette, Eric S.; Blanco, Justin A.; Kim, Yun-Soung; Avrin, Andrew E.; Tiruvadi, Vineet R.; Hwang, Suk-Won; Vanleer, Ann C.; Wulsin, Drausin F.; Davis, Kathryn; Gelber, Casey E.; Palmer, Larry; Van der Spiegel, Jan; Wu, Jian; Xiao, Jianliang; Huang, Yonggang; Contreras, Diego; Rogers, John A.; Litt, Brian			Flexible, foldable, actively multiplexed, high-density electrode array for mapping brain activity in vivo	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ELECTRICAL-ACTIVITY; MOTOR CORTEX; NEOCORTEX; EPILEPSY; SILICON; WAVES; ELECTROCORTICOGRAMS; ARRANGEMENTS; VARIABILITY	Arrays of electrodes for recording and stimulating the brain are used throughout clinical medicine and basic neuroscience research, yet are unable to sample large areas of the brain while maintaining high spatial resolution because of the need to individually wire each passive sensor at the electrode-tissue interface. To overcome this constraint, we developed new devices that integrate ultrathin and flexible silicon nanomembrane transistors into the electrode array, enabling new dense arrays of thousands of amplified and multiplexed sensors that are connected using fewer wires. We used this system to record spatial properties of cat brain activity in vivo, including sleep spindles, single-trial visual evoked responses and electrographic seizures. We found that seizures may manifest as recurrent spiral waves that propagate in the neocortex. The developments reported here herald a new generation of diagnostic and therapeutic brain-machine interface devices.	[Frechette, Eric S.; Davis, Kathryn; Litt, Brian] Hosp Univ Penn, Dept Neurol, Penn Epilepsy Ctr, Philadelphia, PA 19104 USA; [Viventi, Jonathan] NYU, Polytech Inst, Dept Elect & Comp Engn, Brooklyn, NY USA; [Viventi, Jonathan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Kim, Dae-Hyeong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Vigeland, Leif; Palmer, Larry; Contreras, Diego] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Blanco, Justin A.] USN Acad, Dept Elect & Comp Engn, Annapolis, MD 21402 USA; [Kim, Yun-Soung; Hwang, Suk-Won; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Urbana, IL USA; [Kim, Yun-Soung; Hwang, Suk-Won; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL USA; [Avrin, Andrew E.; Van der Spiegel, Jan] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Tiruvadi, Vineet R.; Vanleer, Ann C.; Wulsin, Drausin F.; Gelber, Casey E.; Litt, Brian] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Wu, Jian] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China; [Xiao, Jianliang] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA; [Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	University of Pennsylvania; Pennsylvania Medicine; New York University; New York University Tandon School of Engineering; New York University; Seoul National University (SNU); University of Pennsylvania; United States Department of Defense; United States Navy; United States Naval Academy; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania; University of Pennsylvania; Tsinghua University; University of Colorado System; University of Colorado Boulder; Northwestern University; Northwestern University	Litt, B (corresponding author), Hosp Univ Penn, Dept Neurol, Penn Epilepsy Ctr, 3400 Spruce St, Philadelphia, PA 19104 USA.	jrogers@uiuc.edu; littb@mail.med.upenn.edu	Huang, Yonggang/B-6998-2009; huang, yonggang/O-6236-2019; Xiao, Jianliang/B-4535-2008; Wu, Jian/I-3466-2012; Rogers, John/L-2798-2016; HWANG, SUKWON/Q-8329-2018	Wu, Jian/0000-0003-2295-6815; HWANG, SUKWON/0000-0002-6883-201X; Kim, Dae-Hyeong/0000-0002-4722-1893	National Science Foundation [DMI0328162]; US Department of Energy, Division of Materials Sciences through the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471, DE-FG02-07ER46453]; US National Institutes of Health (National Institute of Neurological Disorders and Stroke) [RO1-NS041811, RO1-NS48598]; Citizens United for Research in Epilepsy; Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research; Ruth L. Kirschstein National Research Service from the US National Institutes of Health, National Heart, Lung and Blood Institute [2T32HL007954]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031724] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007035, R01EY020765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041811, R01NS048598] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Division of Materials Sciences through the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign(United States Department of Energy (DOE)); US National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Citizens United for Research in Epilepsy; Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research; Ruth L. Kirschstein National Research Service from the US National Institutes of Health, National Heart, Lung and Blood Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science Foundation (grant DMI0328162) and the US Department of Energy, Division of Materials Sciences (Award No. DE-FG02-07ER46471), through the Materials Research Laboratory and Center for Microanalysis of Materials (DE-FG02-07ER46453) at the University of Illinois at Urbana-Champaign. J.A.R. acknowledges a National Security Science and Engineering Faculty Fellowship. Work at the University of Pennsylvania was supported by grants from the US National Institutes of Health (National Institute of Neurological Disorders and Stroke RO1-NS041811 and RO1-NS48598), the Julie's Hope Award from the Citizens United for Research in Epilepsy, and the Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research. J.V. received a Ruth L. Kirschstein National Research Service Award (2T32HL007954) from the US National Institutes of Health, National Heart, Lung and Blood Institute.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Anderson WS, 2007, BIOL CYBERN, V97, P173, DOI 10.1007/s00422-007-0166-0; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Blanco JA, 2010, J NEUROPHYSIOL, V104, P2900, DOI 10.1152/jn.01082.2009; Branco DM, 2003, J CLIN NEUROPHYSIOL, V20, P17, DOI 10.1097/00004691-200302000-00002; Brunner P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00005; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; Freeman WJ, 2000, J NEUROSCI METH, V95, P111, DOI 10.1016/S0165-0270(99)00160-0; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gais S, 2002, J NEUROSCI, V22, P6830; Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Kellis SS, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0974; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kitzmiller JP, 2007, J NEUROSCI METH, V162, P155, DOI 10.1016/j.jneumeth.2007.01.004; Larochelle H., 2007, P 24 INT C MACH LEAR, P473, DOI DOI 10.1145/1273496.1273556; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Margalit E, 2003, J NEUROSCI METH, V123, P129, DOI 10.1016/S0165-0270(02)00345-X; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Padnick LB, 1999, VISION RES, V39, P2833, DOI 10.1016/S0042-6989(99)00016-4; PAULLET JE, 1994, SIAM J APPL MATH, V54, P1720, DOI 10.1137/S0036139993250683; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Ryu SI, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0987; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106; Sekitani T, 2007, NAT MATER, V6, P413, DOI 10.1038/nmat1903; Stead M, 2010, BRAIN, V133, P2789, DOI 10.1093/brain/awq190; Stieglitz T, 2002, SENSOR ACTUAT B-CHEM, V83, P8, DOI 10.1016/S0925-4005(01)01021-8; Stieglitz T, 2001, SENSOR ACTUAT A-PHYS, V90, P203, DOI 10.1016/S0924-4247(01)00520-9; Streetman B. G., 1981, SOLID STATE ELECT DE; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Thompson SE, 2004, IEEE T ELECTRON DEV, V51, P1790, DOI 10.1109/TED.2004.836648; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069; Yeager JD, 2008, J NEUROSCI METH, V173, P279, DOI 10.1016/j.jneumeth.2008.06.024	50	756	793	31	522	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1599	U138		10.1038/nn.2973	http://dx.doi.org/10.1038/nn.2973			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081157	Green Accepted, Green Submitted			2022-12-25	WOS:000297546300021
J	Magri, L; Cambiaghi, M; Cominelli, M; Alfaro-Cervello, C; Cursi, M; Pala, M; Bulfone, A; Garcia-Verdugo, JM; Leocani, L; Minicucci, F; Poliani, PL; Galli, R				Magri, Laura; Cambiaghi, Marco; Cominelli, Manuela; Alfaro-Cervello, Clara; Cursi, Marco; Pala, Mauro; Bulfone, Alessandro; Manuel Garcia-Verdugo, Jose; Leocani, Letizia; Minicucci, Fabio; Poliani, Pietro Luigi; Galli, Rossella			Sustained Activation of mTOR Pathway in Embryonic Neural Stem Cells Leads to Development of Tuberous Sclerosis Complex-Associated Lesions	CELL STEM CELL			English	Article							BRAIN PATHOLOGY; SELF-RENEWAL; IN-VIVO; C-MYC; EXPRESSION; TSC2; DIFFERENTIATION; NEURONS; MOUSE; MODEL	Tuberous Sclerosis Complex (TSC) is a multisystem genetic disorder characterized by hamartomatous neurological lesions that exhibit abnormal cell proliferation and differentiation. Hyperactivation of mTOR pathway by mutations in either the Tsc1 or Tsc2 gene underlies TSC pathogenesis, but involvement of specific neural cell populations in the formation of TSC-associated neurological lesions remains unclear. We deleted Tsc1 in Emx1-expressing embryonic telencephalic neural stem cells (NSCs) and found that mutant mice faithfully recapitulated TSC neuropathological lesions, such as cortical lamination defects and subependymal nodules (SENs). These alterations were caused by enhanced generation of SVZ neural progeny, followed by their premature differentiation and impaired maturation during both embryonic and postnatal development. Notably, mTORC1-dependent Akt inhibition and STAT3 activation were involved in the reduced self-renewal and earlier neuronal and astroglial differentiation of mutant NSCs. Thus, finely tuned mTOR activation in embryonic NSCs may be critical to prevent development of TSC-associated brain lesions.	[Magri, Laura; Galli, Rossella] Ist Sci San Raffaele, Neural Stem Cell Biol Unit, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Cambiaghi, Marco; Leocani, Letizia] Ist Sci San Raffaele, Expt Neurophysiol Unit, Inst Expt Neurol, I-20132 Milan, Italy; [Cursi, Marco; Minicucci, Fabio] Ist Sci San Raffaele, Dept Neurol, Epilepsy Ctr, I-20132 Milan, Italy; [Magri, Laura] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Cominelli, Manuela; Poliani, Pietro Luigi] Univ Brescia, Dept Pathol, Spedali Civili Brescia, I-25124 Brescia, Italy; [Alfaro-Cervello, Clara; Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Lab Neurobiol Comparada, Valencia 46012, Spain; [Alfaro-Cervello, Clara; Manuel Garcia-Verdugo, Jose] CIBERNED, Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia, Spain; [Pala, Mauro; Bulfone, Alessandro] BioFlag Ltd, I-09010 Cagliari, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Brescia; University of Valencia; CIBERNED; Prince Felipe Research Center	Galli, R (corresponding author), Ist Sci San Raffaele, Neural Stem Cell Biol Unit, Div Regenerat Med Stem Cells & Gene Therapy, Via Olgettina 58, I-20132 Milan, Italy.	galli.rossella@hsr.it	Leocani, Letizia/ABH-4703-2020; Pala, Mauro/AAY-4774-2020; Cambiaghi, Marco/AAJ-3331-2020; Poliani, Pietro Luigi/E-8145-2010; Cambiaghi, Marco/AAB-8739-2019; García-Verdugo, José Manuel/L-8421-2017; Alfaro-Cervello, Clara/D-1900-2015; Galli, Rossella/AAI-8028-2020; Cominelli, Manuela/J-9988-2016; Minicucci, Fabio/AAO-3629-2020	Poliani, Pietro Luigi/0000-0002-5662-8978; Cambiaghi, Marco/0000-0002-0109-012X; García-Verdugo, José Manuel/0000-0001-9872-6499; Galli, Rossella/0000-0001-9023-7033; Cominelli, Manuela/0000-0002-4520-6104; Leocani, Letizia/0000-0001-9326-6753; CURSI, Marco/0000-0002-7928-0417; Alfaro-Cervello, Clara/0000-0002-3737-4028; Pala, Mauro/0000-0002-3165-5291	Associazione Sclerosi Tuberosa (AST)	Associazione Sclerosi Tuberosa (AST)	This work was supported by Associazione Sclerosi Tuberosa (AST) to R.G. We thank Paolo Caferra for help and assistance with molecular analysis and Luca Muzio for critical reading of the manuscript.	Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Crino PB, 2010, NEUROLOGY, V74, P1716, DOI 10.1212/WNL.0b013e3181e04325; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dasgupta B, 2005, J NEUROSCI, V25, P5584, DOI 10.1523/JNEUROSCI.4693-04.2005; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ess KC, 2004, GLIA, V46, P28, DOI 10.1002/glia.10324; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Holmes GL, 2007, EPILEPSIA, V48, P617, DOI 10.1111/j.1528-1167.2007.01035.x; Jozwiak J, 2008, LANCET ONCOL, V9, P73, DOI 10.1016/S1470-2045(07)70411-4; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Orlova KA, 2010, J NEUROPATH EXP NEUR, V69, P850, DOI 10.1097/NEN.0b013e3181eac1f5; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Ridler K, 2004, J CHILD NEUROL, V19, P658, DOI 10.1177/08830738040190090501; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Uhlmann EJ, 2002, ONCOGENE, V21, P4050, DOI 10.1038/sj.onc.1205435; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	31	179	180	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					447	462		10.1016/j.stem.2011.09.008	http://dx.doi.org/10.1016/j.stem.2011.09.008			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056141	Bronze			2022-12-25	WOS:000297180200012
J	Rosin, B; Slovik, M; Mitelman, R; Rivlin-Etzion, M; Haber, SN; Israel, Z; Vaadia, E; Bergman, H				Rosin, Boris; Slovik, Maya; Mitelman, Rea; Rivlin-Etzion, Michal; Haber, Suzanne N.; Israel, Zvi; Vaadia, Eilon; Bergman, Hagai			Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism	NEURON			English	Article							1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE PRIMATE MODEL; PRIMARY MOTOR CORTEX; BASAL GANGLIA; SUBTHALAMIC NUCLEUS; GLOBUS-PALLIDUS; OSCILLATORY ACTIVITY; PATHOLOGICAL SYNCHRONIZATION; MOVEMENT-DISORDERS; NEURONAL-ACTIVITY; FIRING PATTERNS	Continuous high-frequency deep brain stimulation (DBS) is a widely used therapy for advanced Parkinson's disease (PD) management. However, the mechanisms underlying DBS effects remain enigmatic and are the subject of an ongoing debate. Here, we present and test a closed-loop stimulation strategy for PD in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of PD. Application of pallidal closed-loop stimulation leads to dissociation between changes in basal ganglia (BG) discharge rates and patterns, providing insights into PD pathophysiology. Furthermore, cortico-pallidal closed-loop stimulation has a significantly greater effect on akinesia and on cortical and pallidal discharge patterns than standard open-loop DBS and matched control stimulation paradigms. Thus, closed-loop DBS paradigms, by modulating pathological oscillatory activity rather than the discharge rate of the BG-cortical networks, may afford more effective management of advanced PD. Such strategies have the potential to be effective in additional brain disorders in which a pathological neuronal discharge pattern can be recognized.	[Rosin, Boris; Slovik, Maya; Mitelman, Rea; Rivlin-Etzion, Michal; Vaadia, Eilon; Bergman, Hagai] Hebrew Univ Jerusalem, Hadassah Med Assoc, Sch Med,Dept Med Neurobiol Physiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Rosin, Boris; Slovik, Maya; Mitelman, Rea; Rivlin-Etzion, Michal; Israel, Zvi; Vaadia, Eilon; Bergman, Hagai] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; [Mitelman, Rea; Rivlin-Etzion, Michal; Vaadia, Eilon; Bergman, Hagai] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; [Haber, Suzanne N.] Univ Rochester, Dept Pharmacol & Physiol, Sch Med & Dent, Rochester, NY 14642 USA; [Israel, Zvi] Hebrew Univ Jerusalem, Hadassah Med Assoc, Sch Med, Ctr Funct & Restorat Neurosurg, IL-91120 Jerusalem, Israel; [Vaadia, Eilon; Bergman, Hagai] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Rochester; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rosin, B (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Assoc, Sch Med,Dept Med Neurobiol Physiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	boris.rosin@mail.huji.ac.il	Israel, Zvi/S-5814-2016; Bergman, Hagai/AAI-4683-2021	Israel, Zvi/0000-0002-0060-5769; Bergman, Hagai/0000-0002-2402-6673; Rivlin, Michal/0000-0002-1310-3370; Mitelman, Rea/0000-0003-1271-7757	Netherlands friends of the Hebrew University (HUNA) "Fighting against Parkinson,"; Vorst family; Dekker foundation	Netherlands friends of the Hebrew University (HUNA) "Fighting against Parkinson,"; Vorst family; Dekker foundation	We thank Abraham Solomon (Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel), Gene la Morris (Department of Neurobiology, University of Haifa, Israel), Ahmed Moustafa (Center for Molecular and Behavioral Neuroscience, Rutgers University, NJ), Harry Xenias (Center for Molecular and Behavioral Neuroscience, Rutgers University, NJ), Eden Chlamtac (School of Computer Science, Tel Aviv University, Israel), and Timothy Denison (Medtronic Technology, MN) for reviewing early versions of this manuscript; Mati Joshua (Department of Clinical Neurobiology, The Hebrew University School of Medicine, Jerusalem, Israel) for suggestions in experimental design; Alpha-Omega Engineering (Nazareth, Israel) for providing the DSP used in the experiments; Tuvia Kurz for the primate illustrations in Figure 1; and Esther Singer for English editing. This study was supported by the Netherlands friends of the Hebrew University (HUNA) "Fighting against Parkinson," the Vorst family, and Dekker foundation grants. Authors' contributions: B.R. assembled the experimental setup and wrote the necessary software; B.R. and H.B. designed the experimental paradigm; E.V. performed the primate surgeries, together with M.R.-E (first primate) and Z.I. (second primate); H.B. and B.R. served as anesthesiologist and an assistant in the surgeries, respectively; B.R., M.S., R.M., and M.R.-E performed the experiments; S.N.H. performed the histological analysis; and B.R. and H.B. conducted the analysis and wrote the manuscript. All authors discussed the results, reviewed the manuscript, and made their comments.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baker KB, 2011, EXP NEUROL, V231, P309, DOI 10.1016/j.expneurol.2011.06.012; Bar-Gad I, 2004, J NEUROSCI, V24, P7410, DOI 10.1523/JNEUROSCI.1691-04.2004; Bar-Gad Izhar, 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P305; Batista CAS, 2010, NEURAL NETWORKS, V23, P114, DOI 10.1016/j.neunet.2009.08.005; Benabid AL, 2009, PROG BRAIN RES, V175, P379, DOI 10.1016/S0079-6123(09)17525-8; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Brown P, 2006, J NEURAL TRANSM-SUPP, P27, DOI 10.1007/978-3-211-45295-0_6; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Carlson JD, 2010, J NEUROPHYSIOL, V103, P962, DOI 10.1152/jn.00363.2009; Cassim F, 2002, EPILEPTIC DISORD, V4, pS31; Chan V, 2011, NEUROBIOL DIS, V41, P2, DOI 10.1016/j.nbd.2010.08.012; de Solages C, 2010, EXP NEUROL, V221, P260, DOI 10.1016/j.expneurol.2009.11.012; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Deuschl G, 2006, MOVEMENT DISORD, V21, pS219, DOI 10.1002/mds.20957; Dorval AD, 2010, J NEUROPHYSIOL, V104, P911, DOI 10.1152/jn.00103.2010; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Eusebio A, 2007, PARKINSONISM RELAT D, V13, pS434, DOI 10.1016/S1353-8020(08)70044-0; Eusebio A, 2009, EXP NEUROL, V217, P1, DOI 10.1016/j.expneurol.2009.02.003; Feng X, 2007, J NEURAL ENG, V4, pL14, DOI 10.1088/1741-2560/4/2/L03; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frankemolle AMM, 2010, BRAIN, V133, P746, DOI 10.1093/brain/awp315; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; Gubellini P, 2009, PROG NEUROBIOL, V89, P79, DOI 10.1016/j.pneurobio.2009.06.003; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Heimer G, 2006, J NEURAL TRANSM-SUPP, P17; Heimer G, 2002, J NEUROSCI, V22, P7850; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hurtado JA, 2005, J NEUROPHYSIOL, V93, P1569, DOI 10.1152/jn.00829.2004; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Johnson MD, 2008, J NEUROPHYSIOL, V100, P2549, DOI 10.1152/jn.90372.2008; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Lafreniere-Roula M, 2010, EXP BRAIN RES, V205, P251, DOI 10.1007/s00221-010-2362-8; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; LANGSTON J W, 1984, Neurology, V34, P268; Lathi B. P., 2004, LINEAR SYSTEMS SIGNA, V2nd; Leblois A, 2007, EUR J NEUROSCI, V26, P1701, DOI 10.1111/j.1460-9568.2007.05777.x; Lee JY, 2010, CLIN NEUROL NEUROSUR, V112, P47, DOI 10.1016/j.clineuro.2009.10.008; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Lozano Andres M, 2004, Suppl Clin Neurophysiol, V57, P733; Magill PJ, 2004, J NEUROPHYSIOL, V92, P2122, DOI 10.1152/jn.00333.2004; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; McCairn KW, 2009, J NEUROPHYSIOL, V101, P1941, DOI 10.1152/jn.91092.2008; McIntyre CC, 2009, IEEE ENG MED BIO, P4228, DOI 10.1109/IEMBS.2009.5334592; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Mikos A, 2011, NEUROIMAGE, V54, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Moran A, 2010, J NEUROSCI METH, V186, P116, DOI 10.1016/j.jneumeth.2009.10.024; Moro E, 2006, ARCH NEUROL-CHICAGO, V63, pE1, DOI 10.1001/archneur.63.9.noc60069; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nise N.S., 2007, CONTROL SYSTEMS ENG, P636; Parush N, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00022; Popovych OV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164102; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; REDMOND D E JR, 1985, Society for Neuroscience Abstracts, V11, P166; Rouse AG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036018; Stanslaski S, 2009, IEEE ENG MED BIO, P5494, DOI 10.1109/IEMBS.2009.5334562; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Tass P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016009; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; Vitek Jerrold L, 2008, Cleve Clin J Med, V75 Suppl 2, pS59; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Volkmann J, 2006, MOVEMENT DISORD, V21, pS284, DOI 10.1002/mds.20961; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Weinberger M, 2009, EXP NEUROL, V219, P58, DOI 10.1016/j.expneurol.2009.05.014; Wichmann T, 2006, J NEURAL TRANSM-SUPP, P21; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67	80	510	517	4	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					370	384		10.1016/j.neuron.2011.08.023	http://dx.doi.org/10.1016/j.neuron.2011.08.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017994	Bronze			2022-12-25	WOS:000296224000017
J	Alvarez-Fischer, D; Fuchs, J; Castagner, F; Stettler, O; Massiani-Beaudoin, O; Moya, KL; Bouillot, C; Oertel, WH; Lombes, A; Faigle, W; Joshi, RL; Hartmann, A; Prochiantz, A				Alvarez-Fischer, Daniel; Fuchs, Julia; Castagner, Francois; Stettler, Olivier; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Oertel, Wolfgang H.; Lombes, Anne; Faigle, Wolfgang; Joshi, Rajiv L.; Hartmann, Andreas; Prochiantz, Alain			Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults	NATURE NEUROSCIENCE			English	Article							FACTOR 4E EIF4E; PARKINSONS-DISEASE; TRANSCRIPTION FACTOR; RETINAL AXONS; MICE; TRANSLATION; MECHANISMS; SURVIVAL; MODEL; VULNERABILITY	Mice heterozygous for the homeobox gene Engrailed-1 (En1) display progressive loss of mesencephalic dopaminergic (mDA) neurons. We report that exogenous Engrailed-1 and Engrailed-2 (collectively Engrailed) protect mDA neurons from 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP), a mitochondrial complex I toxin used to model Parkinson's disease in animals. Engrailed enhances the translation of nuclearly encoded mRNAs for two key complex I subunits, Ndufs1 and Ndufs3, and increases complex I activity. Accordingly, in vivo protection against MPTP by Engrailed is antagonized by Ndufs1 small interfering RNA. An association between Engrailed and complex I is further confirmed by the reduced expression of Ndufs1 and Ndufs3 in the substantia nigra pars compacta of En1 heterozygous mice. Engrailed also confers in vivo protection against 6-hydroxydopamine and alpha-synuclein-A30P. Finally, the unilateral infusion of Engrailed into the midbrain increases striatal dopamine content, resulting in contralateral amphetamine-induced turning. Therefore, Engrailed is both a survival factor for adult mDA neurons and a regulator of their physiological activity.	[Alvarez-Fischer, Daniel; Fuchs, Julia; Castagner, Francois; Stettler, Olivier; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Joshi, Rajiv L.; Prochiantz, Alain] Coll France, INSERM, Ctr Interdisciplinary Res Biol, CNRS,Unite Mixte Rech 7241,U1050, F-75231 Paris, France; [Alvarez-Fischer, Daniel; Hartmann, Andreas] Univ Paris 06, INSERM, Ctr Rech, Inst Cerveau & Moelle Epiniere,INSERM,Unite Mixte, Paris, France; [Alvarez-Fischer, Daniel; Hartmann, Andreas] Grp Hosp Pitie Salpetriere, F-75634 Paris, France; [Alvarez-Fischer, Daniel; Oertel, Wolfgang H.] Univ Marburg, Dept Neurol, Marburg, Germany; [Fuchs, Julia; Castagner, Francois; Stettler, Olivier; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Joshi, Rajiv L.; Prochiantz, Alain] Paris Sci Lettres Res Univ, Paris, France; [Fuchs, Julia; Castagner, Francois; Massiani-Beaudoin, Olivia; Moya, Kenneth L.; Bouillot, Colette; Joshi, Rajiv L.; Prochiantz, Alain] Univ Paris 06, Ecole Doctorale 158, Paris, France; [Stettler, Olivier] Univ Paris 05, Paris, France; [Lombes, Anne] Hop La Pitie Salpetriere, INSERM, U975, Paris, France; [Faigle, Wolfgang] Inst Curie, Lab Spectrometrie Masse, Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Philipps University Marburg; UDICE-French Research Universities; PSL Research University Paris; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Prochiantz, A (corresponding author), Coll France, INSERM, Ctr Interdisciplinary Res Biol, CNRS,Unite Mixte Rech 7241,U1050, U114, F-75231 Paris, France.	rajiv.joshi@college-de-france.fr; andreas.hartmann@psl.aphp.fr; alain.prochiantz@college-de-france.fr	Alvarez-Fischer, Daniel/AAJ-7572-2021; Lombes, Anne/G-4684-2014; Fuchs, Julia/M-7529-2017	Alvarez-Fischer, Daniel/0000-0001-7655-9589; Lombes, Anne/0000-0002-9064-0399; Fuchs, Julia/0000-0002-3045-0470; Castagner, Francois/0000-0002-9830-0057; Faigle, Wolfgang/0000-0002-7664-8722	Agence Nationale pour la Recherche [ANR-06-013-01]; Michael. J. Fox Foundation (MJFF); Fondation de France; European Community [222999]; University Medical Center Giessen and Marburg (UKGM); German Academic Exchange Service (DAAD); German Research Foundation (DFG); FRM; NERF (Neuropole de Recherche Francilien)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Michael. J. Fox Foundation (MJFF); Fondation de France(Fondation de France); European Community(European Commission); University Medical Center Giessen and Marburg (UKGM); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); FRM(Fondation pour la Recherche Medicale); NERF (Neuropole de Recherche Francilien)	This work was supported by Agence Nationale pour la Recherche (ANR-06-013-01), the Michael. J. Fox Foundation (MJFF), Fondation de France (Physiopathology of Parkinson disease) and the European Community (FP7 222999, mdDANeurodev project). D.A.-F. was funded by the MJFF, the University Medical Center Giessen and Marburg (UKGM) and the German Academic Exchange Service (DAAD). The CIRB group is part of a Global Research Laboratory (KAIST, South Korea) and a Foundation for Medical Research (FRM) team. J. F. was funded by the German Research Foundation (DFG), the MJFF, FRM and NERF (Neuropole de Recherche Francilien). A. H. was temporarily supported by INSERM. We thank E. Ipendey for technical help. Confocal imaging and quantification were performed by V. Mignon and B. Saubamea. We thank the Laboratory of Mass Spectrometry and Proteomics, Institut Curie for assistance. We are indebted to A. Prigent, E. Hirsch, P. Michel and M. Volovitch for intellectual input.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Chung CY, 2010, BRAIN, V133, P2022, DOI 10.1093/brain/awq142; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Toni A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-13; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Di Nardo AA, 2007, MOL CELL NEUROSCI, V35, P230, DOI 10.1016/j.mcn.2007.02.015; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Douhou A, 2001, J NEUROCHEM, V78, P163, DOI 10.1046/j.1471-4159.2001.00401.x; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Fuchs J, 2009, NEUROBIOL AGING, V30, P731, DOI 10.1016/j.neurobiolaging.2007.08.014; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Haubenberger D, 2011, NEUROBIOL AGING, V32, P302, DOI 10.1016/j.neurobiolaging.2009.02.015; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hoglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Ibad RT, 2011, J NEUROSCI, V31, P5495, DOI 10.1523/JNEUROSCI.0187-11.2011; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joshi RL, 2011, FEBS LETT, V585, P1573, DOI 10.1016/j.febslet.2011.05.006; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Nedelec S, 2004, P NATL ACAD SCI USA, V101, P10815, DOI 10.1073/pnas.0403824101; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; Recchia A, 2008, NEUROBIOL DIS, V30, P8, DOI 10.1016/j.nbd.2007.11.002; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Sonnier L, 2007, J NEUROSCI, V27, P1063, DOI 10.1523/JNEUROSCI.4583-06.2007; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Topisirovic I, 2005, HISTOL HISTOPATHOL, V20, P1275, DOI 10.14670/HH-20.1275; Topisirovic I, 2005, MOL CELL BIOL, V25, P1100, DOI 10.1128/MCB.25.3.1100-1112.2005; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018	50	98	100	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1260	U182		10.1038/nn.2916	http://dx.doi.org/10.1038/nn.2916			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21892157	Green Submitted			2022-12-25	WOS:000295254200014
J	Zacharek, SJ; Fillmore, CM; Lau, AN; Gludish, DW; Chou, A; Ho, JWK; Zamponi, R; Gazit, R; Bock, C; Jager, N; Smith, ZD; Kim, TM; Saunders, AH; Wong, J; Lee, JH; Roach, RR; Rossi, DJ; Meissner, A; Gimelbrant, AA; Park, PJ; Kim, CF				Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Ho, Joshua W. K.; Zamponi, Raffaella; Gazit, Roi; Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Kim, Tae-min; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Rossi, Derrick J.; Meissner, Alex; Gimelbrant, Alexander A.; Park, Peter J.; Kim, Carla F.			Lung Stem Cell Self-Renewal Relies on BMI1-Dependent Control of Expression at Imprinted Loci	CELL STEM CELL			English	Article							P57(KIP2)	BMI1 is required for the self-renewal of stem cells in many tissues including the lung epithelial stem cells, Bronchioalveolar Stem Cells (BASCs). Imprinted genes, which exhibit expression from only the maternally or paternally inherited allele, are known to regulate developmental processes, but what their role is in adult cells remains a fundamental question. Many imprinted genes were derepressed in Bmi1 knockout mice, and knockdown of Cdkn1c (p57) and other imprinted genes partially rescued the self-renewal defect of Bmi1 mutant lung cells. Expression of p57 and other imprinted genes was required for lung cell self-renewal in culture and correlated with repair of lung epithelial cell injury in vivo. Our data suggest that BM11-dependent regulation of expressed alleles at imprinted loci, distinct from imprinting per se, is required for control of lung stem cells. We anticipate that the regulation and function of imprinted genes is crucial for self-renewal in diverse adult tissue-specific stem cells.	[Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Zamponi, Raffaella; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Kim, Carla F.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Gazit, Roi; Rossi, Derrick J.] Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Zamponi, Raffaella; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Gimelbrant, Alexander A.; Kim, Carla F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ho, Joshua W. K.; Kim, Tae-min; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Zacharek, Sima J.; Fillmore, Christine M.; Lau, Allison N.; Gludish, David W.; Chou, Alan; Zamponi, Raffaella; Gazit, Roi; Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Saunders, Arven H.; Wong, Janice; Lee, Joo-Hyeon; Roach, Rebecca R.; Rossi, Derrick J.; Meissner, Alex; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ho, Joshua W. K.; Park, Peter J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Meissner, Alex] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Jaeger, Natalie; Smith, Zachary D.; Rossi, Derrick J.; Meissner, Alex] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Gimelbrant, Alexander A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; Harvard University; Dana-Farber Cancer Institute	Kim, CF (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	carla.kim@childrens.harvard.edu	Bock, Christoph/AAE-7618-2019; Brainson, Christine/AAG-4688-2020; Ho, Joshua W. K./AAK-7759-2020; Gazit, Roi/J-3352-2017; Zamponi, Raffaella/V-5683-2018; Lee, Joo-Hyeon/AAM-2777-2020	Bock, Christoph/0000-0001-6091-3088; Brainson, Christine/0000-0002-0854-5043; Ho, Joshua W. K./0000-0003-2331-7011; Lee, Joo-Hyeon/0000-0002-7364-6422; Zamponi, Raffaella/0000-0002-3313-1387; Gludish, David/0000-0002-3537-4585; Park, Peter/0000-0001-9378-960X; Gazit, Roi/0000-0002-0548-2147; Gimelbrant, Alexander/0000-0001-6986-0285; Jaeger, Natalie/0000-0002-9589-7580	Ladies Auxiliary to the Veterans of Foreign Wars; National Defense Science Engineering [RO1 HL090136, U01 HL100402]; American Cancer Society [RSG-08-082-01-MGO]; V Foundation for Cancer Research; Basil O'Conner March of Dimes Starter Award; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL090136] Funding Source: NIH RePORTER	Ladies Auxiliary to the Veterans of Foreign Wars; National Defense Science Engineering; American Cancer Society(American Cancer Society); V Foundation for Cancer Research; Basil O'Conner March of Dimes Starter Award; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Kim Lab members for discussions; S. Temple, C. Dulac, C. Gregg, D. Tenen, C. Hetherington, S. Eliedge, J. Luo, N. Solimini, M. Hemann, C. Meacham, and B. Wilson for reagents and discussions; DFCI and CHB HemOnc FACS facilities; CHB Molecular Genetics Core facility; R. Bronson for histology; L. Zon, S. Orkin, and G. Daley for critical reading; and M. Goodell for sharing unpublished data. This work was supported by the Ladies Auxiliary to the Veterans of Foreign Wars (C.M.F.), the National Defense Science & Engineering Graduate Fellowship (A.N.L.), RO1 HL090136, U01 HL100402, American Cancer Society Research Scholar Grant #RSG-08-082-01-MGO, the V Foundation for Cancer Research, a Basil O'Conner March of Dimes Starter Award, and the Harvard Stem Cell Institute (C.F.K.).	Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhogal B, 2004, GENOMICS, V84, P961, DOI 10.1016/j.ygeno.2004.08.004; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007	5	93	96	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					272	280		10.1016/j.stem.2011.07.007	http://dx.doi.org/10.1016/j.stem.2011.07.007			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885022	Green Accepted, Bronze			2022-12-25	WOS:000295024200013
J	Matsuoka, RL; Chivatakarn, O; Badea, TC; Samuels, IS; Cahill, H; Katayama, KI; Kumar, SR; Suto, F; Chedotal, A; Peachey, NS; Nathans, J; Yoshida, Y; Giger, RJ; Kolodkin, AL				Matsuoka, Ryota L.; Chivatakarn, Onanong; Badea, Tudor C.; Samuels, Ivy S.; Cahill, Hugh; Katayama, Kei-ichi; Kumar, Sumit R.; Suto, Fumikazu; Chedotal, Alain; Peachey, Neal S.; Nathans, Jeremy; Yoshida, Yutaka; Giger, Roman J.; Kolodkin, Alex L.			Class 5 Transmembrane Semaphorins Control Selective Mammalian Retinal Lamination and Function	NEURON			English	Article							OSCILLATORY POTENTIALS; GANGLION-CELLS; BIPOLAR CELLS; B-WAVE; MOUSE; PATHWAY; RESPONSES; SEMA5A; DSCAM; MICE	In the vertebrate retina, neurites from distinct neuronal cell types are constrained within the plexiform layers, allowing for establishment of retinal lamination. However, the mechanisms by which retinal neurites are segregated within the inner or outer plexiform layers are not known. We find that the transmembrane semaphorins Sema5A and Sema5B constrain neurites from multiple retinal neuron subtypes within the inner plexiform layer (IPL). In Serna5A(-/-); Serna5B(-/-) mice, retinal ganglion cells (RGCs) and annacrine and bipolar cells exhibit severe defects leading to neurite mistargeting into the outer portions of the retina. These targeting abnormalities are more prominent in the outer (OFF) layers of the IPL and result in functional defects in select RGC response properties. Sema5A and Sema5B inhibit retinal neurite outgrowth through PlexinA1 and PlexinA3 receptors both in vitro and in vivo. These findings define a set of ligands and receptors required for the establishment of inner retinal lamination and function.	[Chivatakarn, Onanong; Giger, Roman J.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Matsuoka, Ryota L.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Badea, Tudor C.; Cahill, Hugh; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Matsuoka, Ryota L.; Badea, Tudor C.; Cahill, Hugh; Nathans, Jeremy; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Samuels, Ivy S.; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [Katayama, Kei-ichi; Yoshida, Yutaka] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Kumar, Sumit R.] NEI, Retinal Circuit Dev & Genet Unit, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA; [Suto, Fumikazu] Natl Ctr Neurol & Psychiat, Dept Ultrastruct Res, Kodaira, Tokyo 1878502, Japan; [Chedotal, Alain] INSERM, UMR S968, F-75012 Paris, France; [Chedotal, Alain] Univ Paris 06, UMR S968, F-75012 Paris, France; [Chedotal, Alain] CNRS, Inst Vis, UMR 7210, F-75012 Paris, France; [Samuels, Ivy S.; Peachey, Neal S.] Cleveland VA Med Ctr, Res Serv, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Center for Neurology & Psychiatry - Japan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Giger, RJ (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	rgiger@umich.edu; kolodkin@jhmi.edu	Matsuoka, Ryota L./K-5439-2019; Peachey, Neal/G-5533-2010; Badea, Tudor Constantin/B-1654-2018; Chedotal, Alain/F-2750-2017; Katayama, Kei-ichi/J-4699-2013	Matsuoka, Ryota L./0000-0001-6214-2889; Peachey, Neal/0000-0002-4419-7226; Badea, Tudor Constantin/0000-0003-3086-6713; Chedotal, Alain/0000-0001-7577-3794; Katayama, Kei-ichi/0000-0003-0527-4644; Nathans, Jeremy/0000-0001-8106-5460	Nakajima Foundation [R01 NS35165]; NRSA [F31NS056558-01A1]; Veterans Administration; Foundation Fighting Blindness; Foundation pour la Rechereche Medicale;  [R01 NS065048];  [R01 NS047333]; NATIONAL EYE INSTITUTE [ZIAEY000504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165, R37NS035165, R01NS047333, F31NS056558, R01NS065048] Funding Source: NIH RePORTER	Nakajima Foundation; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Foundation Fighting Blindness(European Commission); Foundation pour la Rechereche Medicale; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K.-W. Yau and T. Xue for the Opn4<SUP>Tau-LacZ/Tau-LacZ</SUP> mice, M. Tessier-Lavigne for the PlexA3<SUP>-/-</SUP> mice, B. Howell for the Dab-1 antibody, and F. Haeseleer for the CaBP5 antibody. We also thank D. Kantor, S. Kozlov, C. Hawkins, and K. Takamiya for their assistance with the generation of the Sema5A<SUP>-/-</SUP> and Sema5B<SUP>-/-</SUP> mice. We thank M. Riccomagno, K. Mandai, S.-H. Wang, Y. Duan, and T. Tran for helpful suggestions and discussions throughout this project, D. Johnson for assistance with mouse experiments, and members of the Kolodkin laboratory for assistance. This work was supported by R01 NS35165 (to A.L.K.), a predoctoral fellowship from the Nakajima Foundation (to R.L.M.), NRSA F31NS056558-01A1 (to O.C.), the Veterans Administration (to I.S.S. and N.S.P.), the Foundation Fighting Blindness (to N.S.P.), R01 NS065048 (to Y.Y.), the Foundation pour la Rechereche Medicale (Programme equipe FRM) (to A.C.), and R01 NS047333 (to R.J.G.). A.L.K. and J.N. are investigators of the Howard Hughes Medical Institute.	Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Byerly MS, 2009, WIRES SYST BIOL MED, V1, P380, DOI 10.1002/wsbm.22; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Dong CJ, 2002, VISION RES, V42, P1081, DOI 10.1016/S0042-6989(02)00032-9; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiore R, 2005, MOL CELL BIOL, V25, P2310, DOI 10.1128/MCB.25.6.2310-2319.2005; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Goldberg JL, 2004, J NEUROSCI, V24, P4989, DOI 10.1523/JNEUROSCI.4390-03.2004; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Hilario JD, 2009, DEV BIOL, V326, P190, DOI 10.1016/j.ydbio.2008.11.007; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Lett RLM, 2009, CEREB CORTEX, V19, P1408, DOI 10.1093/cercor/bhn179; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Maxeiner S, 2005, J NEUROSCI, V25, P566, DOI 10.1523/JNEUROSCI.3232-04.2005; McCall MA, 2002, J NEUROSCI, V22, P4163, DOI 10.1523/JNEUROSCI.22-10-04163.2002; McCall MA, 2008, J PHYSIOL-LONDON, V586, P4385, DOI 10.1113/jphysiol.2008.159327; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; NAARENDORP F, 1993, J NEUROPHYSIOL, V70, P1681, DOI 10.1152/jn.1993.70.4.1681; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Oster SF, 2003, DEVELOPMENT, V130, P775, DOI 10.1242/dev.00299; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Samuels IS, 2010, J NEUROPHYSIOL, V104, P391, DOI 10.1152/jn.00088.2010; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; WACHTMEISTER L, 1978, INVEST OPHTH VIS SCI, V17, P1176; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	55	112	113	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 11	2011	71	3					460	473		10.1016/j.neuron.2011.06.009	http://dx.doi.org/10.1016/j.neuron.2011.06.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835343	Green Accepted, Bronze			2022-12-25	WOS:000293991700010
J	Rochefort, NL; Narushima, M; Grienberger, C; Marandi, N; Hill, DN; Konnerth, A				Rochefort, Nathalie L.; Narushima, Madoka; Grienberger, Christine; Marandi, Nima; Hill, Daniel N.; Konnerth, Arthur			Development of Direction Selectivity in Mouse Cortical Neurons	NEURON			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; MONKEY STRIATE CORTEX; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; RESPONSE PROPERTIES; OCULAR-DOMINANCE; CAT	Previous studies of the ferret visual cortex indicate that the development of direction selectivity requires visual experience. Here, we used two-photon calcium imaging to study the development of direction selectivity in layer 2/3 neurons of the mouse visual cortex in vivo. Surprisingly, just after eye opening nearly all orientation-selective neurons were also direction selective. During later development, the number of neurons responding to drifting gratings increased in parallel with the fraction of neurons that were orientation, but not direction, selective. Our experiments demonstrate that direction selectivity develops normally in dark-reared mice, indicating that the early development of direction selectivity is independent of visual experience. Furthermore, remarkable functional similarities exist between the development of direction selectivity in cortical neurons and the previously reported development of direction selectivity in the mouse retina. Together, these findings provide strong evidence that the development of orientation and direction selectivity in the mouse brain is distinctly different from that in ferrets.	[Rochefort, Nathalie L.; Narushima, Madoka; Grienberger, Christine; Marandi, Nima; Hill, Daniel N.; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Rochefort, Nathalie L.; Narushima, Madoka; Grienberger, Christine; Marandi, Nima; Hill, Daniel N.; Konnerth, Arthur] Tech Univ Munich, Ctr Integrated Prot Sci, D-80802 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, Biedersteinerstr 29, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de		Rochefort, Nathalie/0000-0002-3498-6221; Grienberger, Christine/0000-0002-7774-4062; Narushima, Madoka/0000-0003-3308-248X	Deutsche Forschungsgemeinschaft [IRTG 1373]; Friedrich Schiedel Foundation; Japan Society for the Promotion of Science	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich Schiedel Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Jia Lou for excellent technical assistance. This study was supported by grants of the Deutsche Forschungsgemeinschaft to A.K. and by the Friedrich Schiedel Foundation. A.K. is a Carl von Linde Senior Fellow of the Institute for Advanced Study of the Technische Universitat Munchen. N.L.R. was supported by the DFG (IRTG 1373). M.N. was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad.	BENEVENTO LA, 1992, BRAIN RES, V572, P198, DOI 10.1016/0006-8993(92)90470-T; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Elstrott J, 2009, CURR OPIN NEUROBIOL, V19, P293, DOI 10.1016/j.conb.2009.03.004; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fortin S, 1999, DEV BRAIN RES, V112, P55, DOI 10.1016/S0165-3806(98)00157-6; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Iwai Y, 2003, J NEUROSCI, V23, P6695; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; LEVICK WR, 1980, NATURE, V286, P389, DOI 10.1038/286389a0; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; METIN C, 1988, EXP BRAIN RES, V69, P594; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Sanderson MJ, 2003, METHOD ENZYMOL, V360, P447; SHOU TD, 1995, J NEUROPHYSIOL, V73, P1414, DOI 10.1152/jn.1995.73.4.1414; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; THOMPSON KG, 1994, VISUAL NEUROSCI, V11, P927, DOI 10.1017/S0952523800003886; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; VIDYASAGAR TR, 1982, EXP BRAIN RES, V46, P157; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Xu XM, 2002, VISUAL NEUROSCI, V19, P97, DOI 10.1017/S0952523802191097; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162	47	121	124	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 11	2011	71	3					425	432		10.1016/j.neuron.2011.06.013	http://dx.doi.org/10.1016/j.neuron.2011.06.013			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835340	Green Submitted, Bronze			2022-12-25	WOS:000293991700007
J	Shelly, M; Cancedda, L; Lim, BK; Popescu, AT; Cheng, PL; Gao, HF; Poo, MM				Shelly, Maya; Cancedda, Laura; Lim, Byung Kook; Popescu, Andrei T.; Cheng, Pei-lin; Gao, Hongfeng; Poo, Mu-ming			Semaphorin3A Regulates Neuronal Polarization by Suppressing Axon Formation and Promoting Dendrite Growth	NEURON			English	Article							HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; TARGETED DISRUPTION; RECEPTOR GENE; SAD KINASES; C-ELEGANS; POLARITY; MECHANISMS; CAMP; PHOSPHORYLATION	Semaphorin 3A (Sema3A) is a secreted factor known to guide axon/dendrite growth and neuronal migration. We found that it also acts as a polarizing factor for axon/dendrite development in cultured hippocampal neurons. Exposure of the undifferentiated neurite to localized Sema3A suppressed its differentiation into axon and promoted dendrite formation, resulting in axon formation away from the Sema3A source, and bath application of Sema3A to polarized neurons promoted dendrite growth but suppressed axon growth. Fluorescence resonance energy transfer (FRET) imaging showed that Sema3A elevated the cGMP but reduced cAMP and protein kinase A (PKA) activity, and its axon suppression is attributed to the downregulation of PKA-dependent phosphorylation of axon determinants LKB1 and GSK-3 beta. Downregulating Sema3A signaling in rat embryonic cortical progenitors via in utero electroporation of siRNAs against the Sema3A receptor neuropilin-1 also resulted in polarization defects in vivo. Thus, Sema3A regulates the earliest step of neuronal morphogenesis by polarizing axon/dendrite formation.	[Shelly, Maya] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Cancedda, Laura] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Lim, Byung Kook; Popescu, Andrei T.; Cheng, Pei-lin; Gao, Hongfeng; Poo, Mu-ming] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Istituto Italiano di Tecnologia - IIT; University of California System; University of California Berkeley	Shelly, M (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	maya.shelly@stonybrook.edu	Cheng, Pei-Lin/ABB-2255-2021	Cheng, Pei-Lin/0000-0002-0090-8153; Cancedda, Laura/0000-0003-0566-057X; Lim, Byungkook/0000-0002-3766-5415; shelly, maya/0000-0002-2211-1751	USNIH; NATIONAL EYE INSTITUTE [R01EY014979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	USNIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Thakar, S. Li, M. Nasir, and D. Liepmann (University of California, Berkeley, CA) for help with PDMS microfluidic molds, J. Zhang (Johns Hopkins University, Baltimore, MD) for the ICUE and AKAR FRET probes, M. J. Lohse (University of Wurzburg, Germany) for the cGES-DE5 FRET probe, and M. Feller (University of California, Berkeley, CA) for advice on FRET imaging. This work was supported by a grant from USNIH.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Gao Y, 2003, J NEUROSCI, V23, P11770; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Ikegami R, 2004, DEV CELL, V6, P383, DOI 10.1016/S1534-5807(04)00057-7; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kettunen P, 2005, DEVELOPMENT, V132, P323, DOI 10.1242/dev.01541; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	42	154	159	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 11	2011	71	3					433	446		10.1016/j.neuron.2011.06.041	http://dx.doi.org/10.1016/j.neuron.2011.06.041			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835341	Bronze, Green Accepted			2022-12-25	WOS:000293991700008
J	Straub, C; Hunt, DL; Yamasaki, M; Kim, KS; Watanabe, M; Castillo, PE; Tomita, S				Straub, Christoph; Hunt, David L.; Yamasaki, Miwako; Kim, Kwang S.; Watanabe, Masahiko; Castillo, Pablo E.; Tomita, Susumu			Distinct functions of kainate receptors in the brain are determined by the auxiliary subunit Neto1	NATURE NEUROSCIENCE			English	Article							MOSSY-FIBER SYNAPSES; MEDIATED SYNAPTIC-TRANSMISSION; THALAMOCORTICAL SYNAPSES; HIPPOCAMPAL INTERNEURONS; GLUTAMATE RECEPTORS; ACTIVATION; DESENSITIZATION; GLUR6; EXPRESSION; AMPA	Ionotropic glutamate receptors principally mediate fast excitatory transmission in the brain. Among the three classes of ionotropic glutamate receptors, kainate receptors (KARs) have a unique brain distribution, which has been historically defined by H-3-radiolabeled kainate binding. Compared with recombinant KARs expressed in heterologous cells, synaptic KARs exhibit characteristically slow rise-time and decay kinetics. However, the mechanisms responsible for these distinct KAR properties remain unclear. We found that both the high-affinity binding pattern in the mouse brain and the channel properties of native KARs are determined by the KAR auxiliary subunit Neto1. Through modulation of agonist binding affinity and off-kinetics of KARs, but not trafficking of KARs, Neto1 determined both the KAR high-affinity binding pattern and the distinctively slow kinetics of postsynaptic KARs. By regulating KAR excitatory postsynaptic current kinetics, Neto1 can control synaptic temporal summation, spike generation and fidelity.	[Straub, Christoph; Kim, Kwang S.; Tomita, Susumu] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Straub, Christoph; Kim, Kwang S.; Tomita, Susumu] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Hunt, David L.; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Straub, Christoph; Hunt, David L.] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan	Yale University; Yale University; Yeshiva University; Albert Einstein College of Medicine; Hokkaido University	Tomita, S (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA.	pablo.castillo@einstein.yu.edu; susumu.tomita@yale.edu	Watanabe, Masahiko/S-3614-2019; Yamasaki, Miwako/I-8053-2014; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; Yamasaki, Miwako/0000-0003-4974-9349; WATANABE, Masahiko/0000-0001-5037-7138; Hunt, David/0000-0002-7567-5649; Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health/National Institute of Mental Health [R01 MH085080, R01 MH081935]; Boehringer-Ingelheim PhD fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan [19100005]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935, R01MH085080] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Boehringer-Ingelheim PhD fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Tomita and Castillo laboratories for helpful discussions. We thank M. T. W. Ho for technical advice on slice preparation, G. Somers for maintaining mouse colonies, S. F. Heinemann (Salk Institute) for generating GluK2 knockout mice and the KOMP for creating Neto1 KO mice. S. T. and P. E. C. are supported by grants from the US National Institutes of Health/National Institute of Mental Health (R01 MH085080 and R01 MH081935, respectively). C. S. is supported by a Boehringer-Ingelheim PhD fellowship. M. W. is supported by Grants-in-Aid for Scientific Research (19100005) provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; BERGER M, 1983, NEUROSCI LETT, V39, P237, DOI 10.1016/0304-3940(83)90306-3; Bowie D, 2003, J PHYSIOL-LONDON, V547, P373, DOI 10.1113/jphysiol.2002.033076; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Cui CH, 1999, J NEUROSCI, V19, P8281; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fernandes HB, 2009, NEURON, V63, P818, DOI 10.1016/j.neuron.2009.08.010; FOSTER AC, 1981, NATURE, V289, P73, DOI 10.1038/289073a0; Frerking M, 2002, J NEUROSCI, V22, P7434; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2001, J NEUROPHYSIOL, V86, P1139, DOI 10.1152/jn.2001.86.3.1139; Kwon HB, 2008, NEURON, V60, P1082, DOI 10.1016/j.neuron.2008.10.045; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Michishita M, 2004, DEV BRAIN RES, V153, P135, DOI 10.1016/j.devbrainres.2004.06.012; Michishita M, 2003, BIOCHEM BIOPH RES CO, V306, P680, DOI 10.1016/S0006-291X(03)01035-0; Mott DD, 2010, J PHYSIOL-LONDON, V588, P683, DOI 10.1113/jphysiol.2009.185207; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Paternain AV, 1998, NEUROPHARMACOLOGY, V37, P1249, DOI 10.1016/S0028-3908(98)00098-7; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Sachidhanandam S, 2009, J NEUROSCI, V29, P5000, DOI 10.1523/JNEUROSCI.5807-08.2009; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Swanson GT, 2002, NEURON, V34, P589, DOI 10.1016/S0896-6273(02)00676-1; Swanson GT, 1998, J PHYSIOL-LONDON, V513, P639, DOI 10.1111/j.1469-7793.1998.639ba.x; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wondolowski J, 2009, J NEUROSCI, V29, P563, DOI 10.1523/JNEUROSCI.4788-08.2009; Wu LJ, 2005, J NEUROPHYSIOL, V94, P1805, DOI 10.1152/jn.00091.2005; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	49	93	95	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					866	U83		10.1038/nn.2837	http://dx.doi.org/10.1038/nn.2837			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623363	Green Accepted			2022-12-25	WOS:000292081700014
J	Clark, DA; Bursztyn, L; Horowitz, MA; Schnitzer, MJ; Clandinin, TR				Clark, Damon A.; Bursztyn, Limor; Horowitz, Mark A.; Schnitzer, Mark J.; Clandinin, Thomas R.			Defining the Computational Structure of the Motion Detector in Drosophila	NEURON			English	Article							MONKEY STRIATE CORTEX; WHITE-NOISE ANALYSIS; REVERSE-PHI MOTION; RECEPTIVE-FIELDS; VISUAL-SYSTEM; LOBULA PLATE; OPTOMOTOR RESPONSES; BLOWFLY CALLIPHORA; MOVEMENT DETECTORS; NERVOUS-SYSTEM	Many animals rely on visual motion detection for survival. Motion information is extracted from spatiotemporal intensity patterns on the retina, a paradigmatic neural computation. A phenomenological model, the Hassenstein-Reichardt correlator (HRC), relates visual inputs to neural activity and behavioral responses to motion, but the circuits that implement this computation remain unknown. By using cell-type specific genetic silencing, minimal motion stimuli, and in vivo calcium imaging, we examine two critical HRC inputs. These two pathways respond preferentially to light and dark moving edges. We demonstrate that these pathways perform overlapping but complementary subsets of the computations underlying the HRC. A numerical model implementing differential weighting of these operations displays the observed edge preferences. Intriguingly, these pathways are distinguished by their sensitivities to a stimulus correlation that corresponds to an illusory percept, "reverse phi," that affects many species. Thus, this computational architecture may be widely used to achieve edge selectivity in motion detection.	[Clark, Damon A.; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Bursztyn, Limor; Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu		Freifeld, Limor/0000-0002-0739-6947; Clark, Damon/0000-0001-8487-700X	Jane Coffin Childs Postdoctoral fellowship; Fulbright Science and Technology Fellowship; Stanford Bio-X SIGF Bruce and Elizabeth Dunlevie Fellowship; W.M. Keck Foundation; NIH [DP10D003560, DP0035350]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	Jane Coffin Childs Postdoctoral fellowship; Fulbright Science and Technology Fellowship; Stanford Bio-X SIGF Bruce and Elizabeth Dunlevie Fellowship; W.M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Axel Borst, Chi-Hon Lee, Daryl Gohl, Mathias Wernet, and Marion Si lies for fly stocks and Bob Schneeveis for assistance in constructing the behavioral rig. The authors would also like to thank James Fitzgerald and Tony Movshon for helpful discussions; Liqun Luo, Miriam Goodman, Saskia de Vries, Daryl Gohl, and Marion Si lies for comments on the manuscript; and Sheetal Bhalerao for aid with dissections. This work was supported by a Jane Coffin Childs Postdoctoral fellowship (D.A.C.), a Fulbright Science and Technology Fellowship and a Stanford Bio-X SIGF Bruce and Elizabeth Dunlevie Fellowship (L.B.), the W.M. Keck Foundation (M.H., M.J.S., and T.R.C.), and NIH Director's Pioneer Awards to M.J.S. (DP10D003560) and T.R.C. (DP0035350).	ANSTIS SM, 1970, VISION RES, V10, P1411, DOI 10.1016/0042-6989(70)90092-1; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; Bours R.J., 2007, J VIS, V7, P81; Bours RJE, 2009, VISION RES, V49, P1, DOI 10.1016/j.visres.2008.09.014; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Duistermars BJ, 2007, J EXP BIOL, V210, P3218, DOI 10.1242/jeb.007807; ECKERT H, 1981, J COMP PHYSIOL, V143, P511, DOI 10.1007/BF00609918; EGELHAAF M, 1989, J OPT SOC AM A, V6, P116, DOI 10.1364/JOSAA.6.000116; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GOTZ KG, 1973, J COMP PHYSIOL, V85, P235, DOI 10.1007/BF00694232; Haag J, 1997, J NEUROSCI, V17, P4809; Harris RA, 1999, VISION RES, V39, P2603, DOI 10.1016/S0042-6989(98)00297-1; HASSENSTEIN B, 1951, Z VERGL PHYSIOL, V33, P301; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HAUSEN K, 1989, J NEUROSCI, V9, P3828; HAUSEN K, 1976, Z NATURFORSCH C, V31, P629; Hecht S, 1934, J GEN PHYSIOL, V17, P517, DOI 10.1085/jgp.17.4.517; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KALMUS H, 1949, PHYS COMP OECOL, V1, P127; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Krekelberg B, 2005, J NEUROPHYSIOL, V93, P2908, DOI 10.1152/jn.00473.2004; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MARMARELIS PZ, 1973, KYBERNETIK, V12, P74, DOI 10.1007/BF00272463; Mo CH, 2003, NEURAL COMPUT, V15, P735, DOI 10.1162/08997660360581886; Nordstrom K, 2009, TRENDS NEUROSCI, V32, P383, DOI 10.1016/j.tins.2009.03.004; Reichardt W., 1961, S PRINC SENS COMM, P303; Reichardt W., 1976, Q REV BIOPHYS, V9, p[311, 428]; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; RODRIGUES V, 1984, BRAIN RES, V324, P374, DOI 10.1016/0006-8993(84)90053-2; SAKAI HM, 1988, VISUAL NEUROSCI, V1, P287, DOI 10.1017/S0952523800001942; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Tammero LF, 2004, J EXP BIOL, V207, P113, DOI 10.1242/jeb.00724; Theobald JC, 2010, J EXP BIOL, V213, P1366, DOI 10.1242/jeb.037945; van Hateren JH, 2005, J NEUROSCI, V25, P4343, DOI 10.1523/JNEUROSCI.0616-05.2005; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; Wiederman SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002784; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	55	169	169	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 23	2011	70	6					1165	1177		10.1016/j.neuron.2011.05.023	http://dx.doi.org/10.1016/j.neuron.2011.05.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689602	Bronze, Green Accepted			2022-12-25	WOS:000292410700014
J	Allen, D; Bond, CT; Lujan, R; Ballesteros-Merino, C; Lin, MT; Wang, K; Klett, N; Watanabe, M; Shigemoto, R; Stackman, RW; Maylie, J; Adelman, JP				Allen, Duane; Bond, Chris T.; Lujan, Rafael; Ballesteros-Merino, Carmen; Lin, Mike T.; Wang, Kang; Klett, Nathan; Watanabe, Masahiko; Shigemoto, Ryuichi; Stackman, Robert W., Jr.; Maylie, James; Adelman, John P.			The SK2-long isoform directs synaptic localization and function of SK2-containing channels	NATURE NEUROSCIENCE			English	Article							SMALL-CONDUCTANCE; AMPA RECEPTORS; GLUTAMATE RECEPTORS; SK2 CHANNELS; TRAFFICKING; MEMORY; PLASTICITY; SYNAPSES; SUBUNITS; LOOP	SK2-containing channels are expressed in the postsynaptic density (PSD) of dendritic spines on mouse hippocampal area CA1 pyramidal neurons and influence synaptic responses, plasticity and learning. The Sk2 gene (also known as Kcnn2) encodes two isoforms that differ only in the length of their N-terminal domains. SK2-long (SK2-L) and SK2-short (SK2-S) are coexpressed in CA1 pyramidal neurons and likely form heteromeric channels. In mice lacking SK2-L (SK2-S only mice), SK2-S-containing channels were expressed in the extrasynaptic membrane, but were excluded from the PSD. The SK channel contribution to excitatory postsynaptic potentials was absent in SK2-S only mice and was restored by SK2-L re-expression. Blocking SK channels increased the amount of long-term potentiation induced in area CA1 in slices from wild-type mice but had no effect in slices from SK2-S only mice. Furthermore, SK2-S only mice outperformed wild-type mice in the novel object recognition task. These results indicate that SK2-L directs synaptic SK2-containing channel expression and is important for normal synaptic signaling, plasticity and learning.	[Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Allen, Duane; Bond, Chris T.; Lin, Mike T.; Wang, Kang; Klett, Nathan; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Lujan, Rafael; Ballesteros-Merino, Carmen] Univ Castilla La Mancha, Fac Med, Inst Invest Discapacidades Neurol, Dept Ciencias Med, Albacete, Spain; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan; [Stackman, Robert W., Jr.] Florida Atlantic Univ, Dept Psychol, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Stackman, Robert W., Jr.] Florida Atlantic Univ, FAU Max Planck Florida Inst Integrat Biol, Boca Raton, FL 33431 USA; [Stackman, Robert W., Jr.] Florida Atlantic Univ, Neurosci Program, Boca Raton, FL 33431 USA	Oregon Health & Science University; Oregon Health & Science University; Universidad de Castilla-La Mancha; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.	mayliej@ohsu.edu; adelman@ohsu.edu	Shigemoto, Ryuichi/E-3628-2013; Wang, Kang/AAE-1168-2019; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019; Stackman, Robert W./E-8685-2019; Lujan, Rafael/G-2555-2015	Shigemoto, Ryuichi/0000-0001-8761-9444; Wang, Kang/0000-0002-4563-7385; WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545; Stackman Jr, Robert/0000-0002-5950-046X	US National Institutes of Health [NS038880, MH081860-01, F32MH080480, MH0876591-01]; National Science Foundation [IBN 0630522]; Spanish Ministry of Education and Science [CSD2008-00005, BFU-2009-08404/BFI]; Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha [PPII11-0284-9301]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH080480, R01MH081860, R01MH076752, R01MH086591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Education and Science(Spanish Government); Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Vick, C. Christakis and K. Smith (all from FAU) for their expert assistance with the behavioral testing. This work was supported by US National Institutes of Health grants NS038880 (J.P.A.), MH081860-01 (J.M.), F32MH080480 (M.T.L.) and MH0876591-01 (R.W.S.), National Science Foundation grant IBN 0630522 (R.W.S.), and grants from the Spanish Ministry of Education and Science (CONSOLIDER CSD2008-00005) and Consejeria de Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha (PPII11-0284-9301) and Spanish Ministry of Education and Science (BFU-2009-08404/BFI) to R.L.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kye MJ, 2007, MOL CELL BIOCHEM, V300, P9, DOI 10.1007/s11010-006-9320-6; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Stackman RW, 2008, LEARN MEMORY, V15, P208, DOI 10.1101/lm.906808; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Vick KA, 2010, NEUROPHARMACOLOGY, V58, P650, DOI 10.1016/j.neuropharm.2009.11.008	28	48	50	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					744	U344		10.1038/nn.2832	http://dx.doi.org/10.1038/nn.2832			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21602822	Green Accepted			2022-12-25	WOS:000290958000017
J	Spike, BT; Engle, DD; Lin, JC; Cheung, SK; La, J; Wahl, GM				Spike, Benjamin T.; Engle, Dannielle D.; Lin, Jennifer C.; Cheung, Samantha K.; La, Justin; Wahl, Geoffrey M.			A Mammary Stem Cell Population Identified and Characterized in Late Embryogenesis Reveals Similarities to Human Breast Cancer	CELL STEM CELL			English	Article							GENE-EXPRESSION SIGNATURE; TRANSCRIPTOME ANALYSIS; MESENCHYMAL TRANSITION; DUCTAL MORPHOGENESIS; VIMENTIN EXPRESSION; KINASE INHIBITOR; FAT PADS; GLAND; MOUSE; MODELS	Gene expression signatures relating mammary stem cell populations to breast cancers have focused on adult tissue. Here, we identify, isolate, and characterize the fetal mammary stem cell (fMaSC) state since the invasive and proliferative processes of mammogenesis resemble phases of cancer progression. fMaSC frequency peaks late in embryogenesis, enabling more extensive stem cell purification than achieved with adult tissue. fMaSCs are self-renewing, multipotent, and coexpress multiple mammary lineage markers. Gene expression, transplantation, and in vitro analyses reveal putative autocrine and paracrine regulatory mechanisms, including ErbB and FGF signaling pathways impinging on fMaSC growth. Expression profiles from fMaSCs and associated stroma exhibit significant similarities to basal-like and Her2(+) intrinsic breast cancer subtypes. Our results reveal links between development and cancer and provide resources to identify new candidates for diagnosis, prognosis, and therapy.	[Spike, Benjamin T.; Engle, Dannielle D.; Lin, Jennifer C.; Cheung, Samantha K.; La, Justin; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Spike, Benjamin T.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Engle, Dannielle D.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Wahl, GM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu	La, Justin/AAU-7141-2021	Engle, Dannielle/0000-0003-1876-7675; La, Justin/0000-0003-1596-6193	G. Harold and Leila Y. Mathers Charitable Foundation [CA009523, GM07240, CA009370]; California Breast Cancer Research Program [15GB-0015]; National Cancer Institute [5P30CA014195]; NATIONAL CANCER INSTITUTE [T32CA009523, T32CA009370, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; California Breast Cancer Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to Evelyn Lauder, visionary founder and inspirational leader of the Breast Cancer Research Foundation, and Corinne Mentzelopoulos for generously supporting the Salk Institute. We thank J.C. Izpisua Belmonte, T. Bonnefoix, G. Cunha, C. Eaves, P. Eirew, L. Ellies, P. Gray, J. Green, S. Kinkel, A. Legler, D. Medina, C.M. Perou, A. Prat, A. Rodrigues, B. Vonderhaar, and Wahl Lab members for invaluable advice; Pfizer for neratinib; and BCRF, DOD-BCRP, Susan G. Komen for the Cure, the G. Harold and Leila Y. Mathers Charitable Foundation, T32 training grants CA009523 (B.T.S.), GM07240 (D.D.E.), CA009370 (J.C.L.), and California Breast Cancer Research Program 15GB-0015 (D.D.E.) for funding; and National Cancer Institute 5P30CA014195 for core resource support.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anbazhagan R, 1998, J PATHOL, V184, P197, DOI 10.1002/(SICI)1096-9896(199802)184:2&lt;197::AID-PATH992&gt;3.0.CO;2-J; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Brewer BG, 2009, EXP MOL PATHOL, V86, P192, DOI 10.1016/j.yexmp.2008.12.002; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cunha GR, 1996, J MAMMARY GLAND BIOL, V1, P21, DOI 10.1007/BF02096300; DEOME KB, 1959, CANCER RES, V19, P515; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jackson-Fisher AJ, 2004, P NATL ACAD SCI USA, V101, P17138, DOI 10.1073/pnas.0407057101; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Jacobs TW, 1999, J CLIN ONCOL, V17, P1983, DOI 10.1200/JCO.1999.17.7.1983; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Livasy CA, 2006, GYNECOL ONCOL, V100, P101, DOI 10.1016/j.ygyno.2005.07.124; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; MORK C, 1990, DIFFERENTIATION, V43, P146; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Powers S, 2008, CELL CYCLE, V7, P200, DOI 10.4161/cc.7.2.5284; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rusnak DW, 2001, MOL CANCER THER, V1, P85; SAKAKURA T, 1979, J NATL CANCER I, V63, P733, DOI 10.1093/jnci/63.3.733; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strizzi L, 2009, CANCER RES, V69, P7131, DOI 10.1158/0008-5472.CAN-09-1199; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wansbury O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2928; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	74	157	160	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					183	197		10.1016/j.stem.2011.12.018	http://dx.doi.org/10.1016/j.stem.2011.12.018			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305568	Green Accepted, Bronze			2022-12-25	WOS:000300272100011
J	Chia, PH; Patel, MR; Shen, K				Chia, Poh Hui; Patel, Maulik R.; Shen, Kang			NAB-1 instructs synapse assembly by linking adhesion molecules and F-actin to active zone proteins	NATURE NEUROSCIENCE			English	Article							FILAMENT-BINDING PROTEIN; LIPRIN-ALPHA; VESICLE EXOCYTOSIS; CELL-ADHESION; C. ELEGANS; DROSOPHILA; NEURABIN; MORPHOGENESIS; CYTOSKELETON; MATURATION	During synaptogenesis, macromolecular protein complexes assemble at the pre- and postsynaptic membrane. Extensive literature identifies many transmembrane molecules sufficient to induce synapse formation and several intracellular scaffolding molecules responsible for assembling active zones and recruiting synaptic vesicles. However, little is known about the molecular mechanisms coupling membrane receptors to active zone molecules during development. Using Caenorhabditis elegans, we identify an F-actin network present at nascent presynaptic terminals and required for presynaptic assembly. We unravel a sequence of events whereby specificity-determining adhesion molecules define the location of developing synapses and locally assemble F-actin. Next, the adaptor protein NAB-1 (neurabin) binds to F-actin and recruits active zone proteins SYD-1 and SYD-2 (liprin-alpha) by forming a tripartite complex. NAB-1 localizes transiently to synapses during development and is required for presynaptic assembly. Altogether, we identify a role for the actin cytoskeleton during presynaptic development and characterize a molecular pathway whereby NAB-1 links synaptic partner recognition to active zone assembly.	[Chia, Poh Hui; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Chia, Poh Hui] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu			Howard Hughes Medical Institute; US National Institutes of Health [R01 NS048392]; Agency for Science, Technology, and Research (Singapore); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology, and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Caenorhabditis Genetics Center and Japanese National Bioresource Project for strains. We also thank C. Gao and Y. Fu for technical assistance and T. Clandinin, K. Zito, K. Mizumoto, C.Y. Ou and Shen laboratory members for manuscript comments. This work was funded by the Howard Hughes Medical Institute and US National Institutes of Health grant R01 NS048392. P.H.C. is supported by the Agency for Science, Technology, and Research (Singapore).	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Keep NH, 2000, NEUROL SCI, V21, pS929, DOI 10.1007/s100720070006; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Tallafuss A, 2010, EUR J NEUROSCI, V32, P198, DOI 10.1111/j.1460-9568.2010.07340.x; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	44	57	60	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					234	242		10.1038/nn.2991	http://dx.doi.org/10.1038/nn.2991			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22231427	Green Accepted			2022-12-25	WOS:000299603500014
J	Kauer, TM; Figueiredo, JL; Hingtgen, S; Shah, K				Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid			Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas	NATURE NEUROSCIENCE			English	Article							GLIOBLASTOMA-MULTIFORME CELLS; RADIOTHERAPY PLUS CONCOMITANT; IN-VIVO; S-TRAIL; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; BRAIN-TUMORS; APOPTOSIS; DELIVERY; CANCER	Therapeutically engineered stem cells have shown promise for glioblastoma multiforme (GBM) therapy; however, key preclinical studies are urgently needed for their clinical translation. In this study, we investigated a new approach to GBM treatment using therapeutic stem cells encapsulated in biodegradable, synthetic extracellular matrix (sECM) in mouse models of human GBM resection. Using multimodal imaging, we first showed quantitative surgical debulking of human GBM tumors in mice, which resulted in increased survival. Next, sECM encapsulation of engineered stem cells increased their retention in the tumor resection cavity, permitted tumor-selective migration and release of diagnostic and therapeutic proteins in vivo. Simulating the clinical scenario of GBM treatment, the release of tumor-selective S-TRAIL (secretable tumor necrosis factor apoptosis inducing ligand) from sECM-encapsulated stem cells in the resection cavity eradicated residual tumor cells by inducing caspase-mediated apoptosis, delayed tumor regrowth and significantly increased survival of mice. This study demonstrates the efficacy of encapsulated therapeutic stem cells in mouse models of GBM resection and may have implications for developing effective therapies for GBM.	[Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA; [Kauer, Timo M.; Figueiredo, Jose-Luiz; Hingtgen, Shawn; Shah, Khalid] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shah, Khalid] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Shah, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Neurotherapy & Imaging Lab, Boston, MA 02114 USA.	kshah@helix.mgh.harvard.edu			Alliance for Cancer Cell and Gene Therapy; American Cancer Society; James McDonald Foundation; NATIONAL CANCER INSTITUTE [R01CA138922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071197] Funding Source: NIH RePORTER	Alliance for Cancer Cell and Gene Therapy; American Cancer Society(American Cancer Society); James McDonald Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Prestwich (University of Utah) and T. Zarembinski (Biotime Inc.) for providing us with sECMs, H. Wakimoto (Massachusetts General Hospital) for providing the primary GBM lines and D. Bhere for critical reading of the manuscript. This work was supported by the Alliance for Cancer Cell and Gene Therapy (K.S.), American Cancer Society (K.S.) and James McDonald Foundation (K.S.).	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Affronti ML, 2009, CANCER, V115, P3501, DOI 10.1002/cncr.24398; Akbar U, 2009, J NEURO-ONCOL, V94, P203, DOI 10.1007/s11060-009-9857-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Asthagiri AR, 2007, NEUROL CLIN, V25, P975, DOI 10.1016/j.ncl.2007.07.006; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Balyasnikova IV, 2011, CANCER LETT, V310, P148, DOI 10.1016/j.canlet.2011.06.029; Chen JA, 2010, TUMOR BIOL, V31, P613, DOI 10.1007/s13277-010-0077-x; Choi SA, 2012, EUR J CANCER, V48, P129, DOI 10.1016/j.ejca.2011.04.033; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; de Oliveira MS, 2009, J NEURO-ONCOL, V93, P191, DOI 10.1007/s11060-008-9775-2; Ehtesham M, 2002, CANCER RES, V62, P7170; Erpolat OP, 2009, TUMORI J, V95, P191; Germano IM, 2006, J NEUROSURG, V105, P88, DOI 10.3171/jns.2006.105.1.88; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Hingtgen S, 2008, MOL CANCER THER, V7, P3575, DOI 10.1158/1535-7163.MCT-08-0640; Hingtgen SD, 2010, STEM CELLS, V28, P832, DOI 10.1002/stem.313; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Kahana S, 2011, CELL SIGNAL, V23, P1348, DOI 10.1016/j.cellsig.2011.03.017; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim SM, 2010, STEM CELLS, V28, P2217, DOI 10.1002/stem.543; Kock N, 2007, NEOPLASIA, V9, P435, DOI 10.1593/neo.07223; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Minniti G, 2008, J NEURO-ONCOL, V88, P97, DOI 10.1007/s11060-008-9538-0; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721; Ren B, 2009, CANCER RES, V69, P3856, DOI 10.1158/0008-5472.CAN-08-2940; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Sarin H, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-77; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; Siegelin MD, 2009, NEUROSCI LETT, V454, P223, DOI 10.1016/j.neulet.2009.03.031; Snyder EY, 2011, EXP NEUROL, V230, P75, DOI 10.1016/j.expneurol.2011.03.012; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; van Eekelen M, 2010, ONCOGENE, V29, P3185, DOI 10.1038/onc.2010.75; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu XY, 2009, PROSTAG OTH LIPID M, V89, P140, DOI 10.1016/j.prostaglandins.2009.07.006	50	156	162	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					197	204		10.1038/nn.3019	http://dx.doi.org/10.1038/nn.3019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197831	Green Accepted			2022-12-25	WOS:000299603500010
J	Elling, U; Taubenschmid, J; Wirnsberger, G; O'Malley, R; Demers, SP; Vanhaelen, Q; Shukalyuk, AI; Schmauss, G; Schramek, D; Schnuetgen, F; von Melchner, H; Ecker, JR; Stanford, WL; Zuber, J; Stark, A; Penninger, JM				Elling, Ulrich; Taubenschmid, Jasmin; Wirnsberger, Gerald; O'Malley, Ronan; Demers, Simon-Pierre; Vanhaelen, Quentin; Shukalyuk, Andrey I.; Schmauss, Gerald; Schramek, Daniel; Schnuetgen, Frank; von Melchner, Harald; Ecker, Joseph R.; Stanford, William L.; Zuber, Johannes; Stark, Alexander; Penninger, Josef M.			Forward and Reverse Genetics through Derivation of Haploid Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL NETWORKS; EXPRESSION; DIFFERENTIATION; PLURIPOTENCY; COMMITMENT; SCREENS; NUMBER; GENES; LINE	All somatic mammalian cells carry two copies of chromosomes (diploidy), whereas organisms with a single copy of their genome, such as yeast, provide a basis for recessive genetics. Here we report the generation of haploid mouse ESC lines from parthenogenetic embryos. These cells carry 20 chromosomes, express stem cell markers, and develop into all germ layers in vitro and in vivo. We also developed a reversible mutagenesis protocol that allows saturated genetic recessive screens and results in homozygous alleles. This system allowed us to generate a knockout cell line for the microRNA processing enzyme Drosha. In a forward genetic screen, we identified Gpr107 as a molecule essential for killing by ricin, a toxin being used as a bioweapon. Our results open the possibility of combining the power of a haploid genome with pluripotency of embryonic stem cells to uncover fundamental biological processes in defined cell types at a genomic scale.	[Elling, Ulrich; Taubenschmid, Jasmin; Wirnsberger, Gerald; Schmauss, Gerald; Schramek, Daniel; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [O'Malley, Ronan; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Demers, Simon-Pierre; Vanhaelen, Quentin; Stanford, William L.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Shukalyuk, Andrey I.; Stanford, William L.] Univ Toronto, Toronto, ON M5G 1L5, Canada; [Schnuetgen, Frank; von Melchner, Harald] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany; [Stanford, William L.] Inst Syst Biol, Seattle, WA USA; [Ecker, Joseph R.] Howard Hughes Med Inst, Seattle, WA USA; [Zuber, Johannes; Stark, Alexander] Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Salk Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Goethe University Frankfurt; Institute for Systems Biology (ISB); Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Schnütgen, Frank/ABD-8637-2020; Stark, Alexander/D-1473-2012; Penninger, Josef M/I-6860-2013; Zuber, Johannes/E-7517-2011; Schramek, Daniel/J-5792-2014; Schramek, Daniel/AAL-1470-2020; VANHAELEN, QUENTIN/W-3160-2019; Taubenschmid-Stowers, Jasmin/C-3137-2018; Ecker, Joseph R/B-9144-2008	Schnütgen, Frank/0000-0002-2426-6685; Stark, Alexander/0000-0003-2611-0841; Penninger, Josef M/0000-0002-8194-3777; Zuber, Johannes/0000-0001-8810-6835; Schramek, Daniel/0000-0001-9977-2104; VANHAELEN, QUENTIN/0000-0002-4611-2046; Taubenschmid-Stowers, Jasmin/0000-0003-3377-2026; Ecker, Joseph R/0000-0001-5799-5895; Stanford, William/0000-0002-5813-8016; omalley, ronan/0000-0002-4907-0339	Canadian Institutes for Health Research [MOP-89910]; Canada Research Chair in Integrative Stem Cell Biology; FWF [1434-B13]; European Community [FP7/2007-2013, 223151 - INFLA-CARE, 242922]; European Research Council (ERC); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (Austro-Mouse); EU ERC; Howard Hughes Medical Institute; Gordon and Betty Moore foundation; Austrian Science Fund (FWF) [I 434] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Integrative Stem Cell Biology; FWF(Austrian Science Fund (FWF)); European Community(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (Austro-Mouse); EU ERC(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore foundation(Gordon and Betty Moore Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank all members of our laboratories, in particular Dr. Wing Chang, for helpful discussions. Funding was provided by the Canadian Institutes for Health Research (MOP-89910) to W.L.S. W.L.S. is funded by a Canada Research Chair in Integrative Stem Cell Biology. U.E. was supported by a grant from the FWF (Project 1434-B13). G.W. and D.S. were funded from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 223151 - INFLA-CARE. AS. is supported by a European Research Council (ERC) Starting Grant from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 242922. J.M.P. is supported by grants from IMBA, the Austrian Ministry of Sciences, and the Austrian Academy of Sciences, GEN-AU (Austro-Mouse), and by an EU ERC Advanced Grant. This work was supported, in part, by the Howard Hughes Medical Institute and a grant from the Gordon and Betty Moore foundation to J.R.E. J.R.E. is an HHMI-GBMP Investigator. We thank B. Zuber for helpful discussions and pathologic examination of teratomas. We are grateful to Thijn Brummelkamp for valuable discussions to establish retrovirus-based genome-wide mutagenesis. We thank all IMBA service units, especially Biooptics, the VBC Genomics unit, and the Transgenic Service, for technical support with this project. The ricin hits are currently being evaluated for patent protection.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Otto SP, 2001, SCIENCE, V292, P2441, DOI 10.1126/science.1062890; Papaloucas M, 2008, Pak J Biol Sci, V11, P2370, DOI 10.3923/pjbs.2008.2370.2371; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Schnuetgen F, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn603; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THOMSON JA, 1988, GENE DEV, V2, P1344, DOI 10.1101/gad.2.10.1344; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	34	174	202	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					563	574		10.1016/j.stem.2011.10.012	http://dx.doi.org/10.1016/j.stem.2011.10.012			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136931	Green Accepted, Bronze			2022-12-25	WOS:000297895000016
J	Yang, WK; Peng, YH; Li, H; Lin, HC; Lin, YC; Lai, TT; Suo, H; Wang, CH; Lin, WH; Ou, CY; Zhou, X; Pi, HW; Chang, HC; Chien, CT				Yang, Wei-Kang; Peng, Yu-Huei; Li, Hsun; Lin, Hsiu-Chen; Lin, Yu-Ching; Lai, Tzu-Ting; Suo, Hsien; Wang, Chien-Hsiang; Lin, Wei-Hsiang; Ou, Chan-Yen; Zhou, Xin; Pi, Haiwei; Chang, Henry C.; Chien, Cheng-Ting			Nak Regulates Localization of Clathrin Sites in Higher-Order Dendrites to Promote Local Dendrite Growth	NEURON			English	Article							DROSOPHILA SENSORY NEURONS; RECEPTOR-MEDIATED ENDOCYTOSIS; ADHESION MOLECULE L1; DEPENDENT ENDOCYTOSIS; ACTIN CYTOSKELETON; SIGNALING PATHWAY; PROTEIN; GENE; PHOSPHORYLATION; MORPHOGENESIS	During development, dendrites arborize in a field several hundred folds of their soma size, a process regulated by intrinsic transcription program and cell adhesion molecule (CAM)-mediated interaction. However, underlying cellular machineries that govern distal higher-order dendrite extension remain largely unknown. Here, we show that Nak, a clathrin adaptor-associated kinase, promotes higher-order dendrite growth through endocytosis. In nak mutants, both the number and length of higher-order dendrites are reduced, which are phenocopied by disruptions of clathrin-mediated endocytosis. Nak interacts genetically with components of the endocytic pathway, colocalizes with clathrin puncta, and is required for dendritic localization of clathrin puncta. More importantly, these Nak-containing clathrin structures preferentially localize to branching points and dendritic tips that are undergoing active growth. We present evidence that the Drosophila L1-CAM homolog Neuroglian is a relevant cargo of Nak-dependent internalization, suggesting that localized clathrin-mediated endocytosis of CAMs facilitates the extension of nearby higher-order dendrites.	[Yang, Wei-Kang; Peng, Yu-Huei; Li, Hsun; Lin, Hsiu-Chen; Lin, Yu-Ching; Lai, Tzu-Ting; Suo, Hsien; Wang, Chien-Hsiang; Lin, Wei-Hsiang; Ou, Chan-Yen; Chien, Cheng-Ting] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Yang, Wei-Kang; Chien, Cheng-Ting] Natl Taiwan Univ, Inst Mol Med, Taipei 106, Taiwan; [Zhou, Xin; Chang, Henry C.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Pi, Haiwei] Chang Gang Univ, Dept Biomed Sci, Tao Yuan 333, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chang Gung University	Chien, CT (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	ctchien@gate.sinica.edu.tw	Chien, Cheng-Ting/AAA-5200-2021; Yang, Wei-Kang/ABE-6938-2021	Chien, Cheng-Ting/0000-0002-7906-7173; OU, CHAN-YEN/0000-0002-6627-5088; Meir, Yaa-Jyuhn/0000-0001-6084-3446	Taiwan National Science Council [NSC96-3112-B-001-018]; American Heart Association; American Cancer Society; National Science Council; Academia Sinica of Taiwan	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica of Taiwan(Academia Sinica - Taiwan)	We thank J.A. Knoblich, T. Uemura, Y.N. Jan, M. Gonzalez-Gaitan, S.L. Schmid, T.D. Murphy, R.W. Carthew, N.J. Bellen, Bloomington Drosophila Stock Center, DGRC, Vienna Drosophila RNAi Center, and DSHB for providing reagents. Protein identification by mass spectrometry analysis was performed at the NRPGM Core Facilities for Proteomics Research funded by the Taiwan National Science Council (NSC96-3112-B-001-018). H.C.C. is supported by American Heart Association Scientist Development and American Cancer Society Research Scholar grants. C.T.-C. is supported by grants from National Science Council and Academia Sinica of Taiwan.	BAZINET C, 1993, GENETICS, V134, P1119; Beronja S, 2005, J CELL BIOL, V169, P635, DOI 10.1083/jcb.200410081; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; CHOVNICK A, 1958, P NATL ACAD SCI USA, V44, P333, DOI 10.1073/pnas.44.4.333; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2003, TRAFFIC, V4, P885, DOI 10.1046/j.1398-9219.2003.0142.x; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Huet F, 2002, P NATL ACAD SCI USA, V99, P9948, DOI 10.1073/pnas.142310099; Islam R, 2003, DEVELOPMENT, V130, P2051, DOI 10.1242/dev.00415; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Kamiguchi H, 2003, MOL NEUROBIOL, V28, P219, DOI 10.1385/MN:28:3:219; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee DW, 2005, J CELL SCI, V118, P4311, DOI 10.1242/jcs.02548; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; McAllister AK, 2002, NEURON, V33, P2, DOI 10.1016/S0896-6273(01)00577-3; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Medina PMB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003054; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Ovecka M, 2005, PROTOPLASMA, V226, P39, DOI 10.1007/s00709-005-0103-9; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Peng YH, 2009, BIOCHEM BIOPH RES CO, V382, P108, DOI 10.1016/j.bbrc.2009.02.139; Pruyne D, 2000, J CELL SCI, V113, P571; Raghu P, 2009, J CELL BIOL, V185, P129, DOI 10.1083/jcb.200807027; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Smythe E, 2003, EMBO REP, V4, P246, DOI 10.1038/sj.embor.embor776; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; WRIGHT TRF, 1976, GENETICS, V84, P267; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	55	21	21	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 20	2011	72	2					285	299		10.1016/j.neuron.2011.08.028	http://dx.doi.org/10.1016/j.neuron.2011.08.028			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017988	Bronze			2022-12-25	WOS:000296224000011
J	Zou, P; Yoshihara, H; Hosokawa, K; Tai, I; Shinmyozu, K; Tsukahara, F; Maru, Y; Nakayama, K; Nakayama, KI; Suda, T				Zou, Peng; Yoshihara, Hiroki; Hosokawa, Kentaro; Tai, Ikue; Shinmyozu, Kaori; Tsukahara, Fujiko; Maru, Yoshiro; Nakayama, Keiko; Nakayama, Keiichi I.; Suda, Toshio			p57(KiP2) and p27(Kip1) Cooperate to Maintain Hematopoietic Stem Cell Quiescence through Interactions with Hsc70	CELL STEM CELL			English	Article							SHOCK COGNATE PROTEIN-70; BONE-MARROW NICHE; CYCLIN D1; NUCLEAR-LOCALIZATION; UP-REGULATION; EXPRESSION; LEUKEMIA; FAMILY; GROWTH; ROLES	Cell cycle regulators play critical roles in the balance between hematopoietic stem cell (HSC) dormancy and proliferation. In this study, we report that cell cycle entry proceeded normally in HSCs null for cyclin-dependent kinase (CDK) inhibitor p57 due to compensatory upregulation of p27. HSCs null for both p57 and p27, however, were more proliferative and had reduced capacity to engraft in transplantation. We found that heat shock cognate protein 70 (Hsc70) interacts with both p57 and p27 and that the subcellular localization of Hsc70 was critical to maintain HSC cell cycle kinetics. Combined deficiency of p57 and p27 in HSCs resulted in nuclear import of an Hsc70/cyclin D1 complex, concomitant with Rb phosphorylation, and elicited severe defects in maintaining HSC quiescence. Taken together, these data suggest that regulation of cytoplasmic localization of Hsc70/cyclin D1 complex by p57 and p27 is a key intracellular mechanism in controlling HSC dormancy.	[Zou, Peng; Yoshihara, Hiroki; Hosokawa, Kentaro; Tai, Ikue; Suda, Toshio] Keio Univ Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat, Shinjuku Ku, Tokyo 1608582, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Prote Support Unit, Kobe, Hyogo 6500047, Japan; [Tsukahara, Fujiko; Maru, Yoshiro] Tokyo Womens Med Univ Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Dept Dev Genet, Sendai, Miyagi 9808575, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan	Keio University; RIKEN; Tohoku University; Kyushu University	Zou, P (corresponding author), Keio Univ Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat, Shinjuku Ku, Tokyo 1608582, Japan.	zoupeng@sc.itc.heio.ac.jp; sudato@sc.itc.keio.ac.jp	Suda, Toshio/H-6761-2013	Suda, Toshio/0000-0001-7540-1771; Yoshihara, Hiroki/0000-0001-5128-4515	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Keio University; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23590309, 22130004, 22790920] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Cancer Stem Cells" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, the Global COE program "Education and Research Center for Stem Cell Medicine" of Keio University, and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baharvand H, 2007, STEM CELLS, V25, P1888, DOI 10.1634/stemcells.2007-0107; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Diehl JA, 2003, MOL CELL BIOL, V23, P1764, DOI 10.1128/MCB.23.5.1764-1774.2003; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Imamura Y, 2009, J BIOL CHEM, V284, P14316, DOI 10.1074/jbc.M807278200; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Jose-Eneriz ES, 2008, BRIT J HAEMATOL, V142, P571, DOI 10.1111/j.1365-2141.2008.07221.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Pocaly M, 2008, PROTEOMICS, V8, P2394, DOI 10.1002/pmic.200701035; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Yamamoto M, 2006, MOL CARCINOGEN, V45, P901, DOI 10.1002/mc.20204; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Ye ZJ, 2005, P NATL ACAD SCI USA, V102, P18461, DOI 10.1073/pnas.0509314102; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162	38	198	200	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					247	261		10.1016/j.stem.2011.07.003	http://dx.doi.org/10.1016/j.stem.2011.07.003			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885020	Bronze			2022-12-25	WOS:000295024200011
J	Tong, C; Ohyama, T; Tien, AC; Rajan, A; Haueter, CM; Bellen, HJ				Tong, Chao; Ohyama, Tomoko; Tien, An-Chi; Rajan, Akhila; Haueter, Claire M.; Bellen, Hugo J.			Rich Regulates Target Specificity of Photoreceptor Cells and N-Cadherin Trafficking in the Drosophila Visual System via Rab6	NEURON			English	Article							ENDOPLASMIC-RETICULUM; ADHESION MOLECULES; GOLGI-APPARATUS; LIPRIN-ALPHA; AXON-AXON; TRANSPORT; MELANOGASTER; COMPLEX; SELECTION; NEURONS	Neurons establish specific synaptic connections with their targets, a process that is highly regulated. Numerous cell adhesion molecules have been implicated in target recognition, but how these proteins are precisely trafficked and targeted is poorly understood. To identify components that affect synaptic specificity, we carried out a forward genetic screen in the Drosophila eye. We identified a gene, named rid l homologue (rich), whose loss leads to synaptic specificity defects. Loss of rich leads to reduction of N-Cadherin in the photoreceptor cell synapses but not of other proteins implicated in target recognition, including Sec15, DLAR, Jelly belly, and PTP69D. The Rich protein binds to Rab6, and Rab6 mutants display very similar phenotypes as the rich mutants. The active form of Rab6 strongly suppresses the rich synaptic specificity defect, indicating that Rab6 is regulated by Rich. We propose that Rich activates Rab6 to regulate N-Cadherin trafficking and affects synaptic specificity.	[Tong, Chao; Ohyama, Tomoko; Rajan, Akhila; Haueter, Claire M.; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tien, An-Chi; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Haueter, Claire M.; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu		Bellen, Hugo/0000-0001-5992-5989; Ohyama, Tomoko/0000-0003-1697-1138; Tong, Chao/0000-0001-6521-5465	National Institute of Neurological Disorders [T32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124] Funding Source: NIH RePORTER	National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to S.L. Zipursky, C.H. Lee, T.R. Clandinin, I. Salecker, P.R. Hiesinger, A. Ephrussi, R.H. Palmer, T. Hummel, the Bloomington Drosophila Stock Center, and the Developmental Studies Hybridoma Bank for providing reagents. We thank Yuchun He and Hong-Lin Pan for injections to generate transgenic flies. We thank P.R. Hiesinger, N. Giagtzoglou, and V. Bayat, for comments. H.J.B. is an investigator of the Howard Hughes Medical Institute. C.T. is supported by a T32 from the National Institute of Neurological Disorders. Confocal microscopy was supported by the Mental Retardation and Developmental Disabilities Research Center at Baylor College of Medicine.	Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Choe KM, 2006, P NATL ACAD SCI USA, V103, P11601, DOI 10.1073/pnas.0601185103; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Coutelis JB, 2007, DEVELOPMENT, V134, P1419, DOI 10.1242/dev.02821; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Hofmeyer K, 2006, P NATL ACAD SCI USA, V103, P11595, DOI 10.1073/pnas.0604766103; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Kondylis V, 2001, MOL BIOL CELL, V12, P2308, DOI 10.1091/mbc.12.8.2308; Kunes Samuel, 1993, Current Opinion in Neurobiology, V3, P53, DOI 10.1016/0959-4388(93)90035-W; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Matthews BJ, 2008, NEURON, V58, P1, DOI 10.1016/j.neuron.2008.03.024; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Meinertzhagen Ian A., 1993, P1363; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Opdam FJM, 2000, J CELL SCI, V113, P2725; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; RATNAKUMAR K, 2003, RH GAL4 RH GFP INSER; RATNAKUMAR K, 2004, P RH1 GAL4 P RH4 GAL; RATNAKUMAR K, 2004, P NINAE EGFP P P PAN; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Senti KA, 2000, DEVELOPMENT, V127, P2291; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Tong Chao, 2007, V397, P215; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	74	23	25	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 11	2011	71	3					447	459		10.1016/j.neuron.2011.06.040	http://dx.doi.org/10.1016/j.neuron.2011.06.040			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835342	Bronze, Green Accepted			2022-12-25	WOS:000293991700009
J	Saha, RN; Wissink, EM; Bailey, ER; Zhao, ML; Fargo, DC; Hwang, JY; Daigle, KR; Fenn, JD; Adelman, K; Dudek, SM				Saha, Ramendra N.; Wissink, Erin M.; Bailey, Emma R.; Zhao, Meilan; Fargo, David C.; Hwang, Ji-Yeon; Daigle, Kelly R.; Fenn, J. Daniel; Adelman, Karen; Dudek, Serena M.			Rapid activity-induced transcription of Arc and other IEGs relies on poised RNA polymerase II	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; BREAST-CANCER CELLS; LATE-PHASE; HIPPOCAMPAL-NEURONS; DROSOPHILA-MELANOGASTER; PROTEIN EXPRESSION; HSP70 GENE; IN-VIVO; P-TEFB	Transcription of immediate early genes (IEGs) in neurons is highly sensitive to neuronal activity, but the mechanism underlying these early transcription events is largely unknown. We found that several IEGs, such as Arc (also known as Arg3.1), are poised for near-instantaneous transcription by the stalling of RNA polymerase II (Pol II) just downstream of the transcription start site in rat neurons. Depletion through RNA interference of negative elongation factor, a mediator of Pol II stalling, reduced the Pol II occupancy of the Arc promoter and compromised the rapid induction of Arc and other IEGs. In contrast, reduction of Pol II stalling did not prevent transcription of IEGs that were expressed later and largely lacked promoter-proximal Pol II stalling. Together, our data strongly indicate that the rapid induction of neuronal IEGs requires poised Pol II and suggest a role for this mechanism in a wide variety of transcription-dependent processes, including learning and memory.	[Saha, Ramendra N.; Wissink, Erin M.; Bailey, Emma R.; Zhao, Meilan; Hwang, Ji-Yeon; Daigle, Kelly R.; Fenn, J. Daniel; Dudek, Serena M.] Natl Inst Environm Hlth Sci, Neurobiol Lab, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] Natl Inst Environm Hlth Sci, Lib & Informat Serv, US Natl Inst Hlth, Res Triangle Pk, NC USA; [Adelman, Karen] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, US Natl Inst Hlth, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dudek, SM (corresponding author), Natl Inst Environm Hlth Sci, Neurobiol Lab, US Natl Inst Hlth, Res Triangle Pk, NC 27709 USA.	dudek@niehs.nih.gov	Saha, Ramendra/C-7000-2014; Dudek, Serena/C-6561-2009	Saha, Ramendra/0000-0002-5494-2584; Dudek, Serena/0000-0003-4094-8368; Wissink, Erin/0000-0003-1054-4899; Adelman, Karen/0000-0001-5364-334X	US National Institutes of Health, NIEHS [Z01 ES100221, Z01 ES101987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZICES102506, Z01ES100221, ZIAES100221, ZIAES101987, Z01ES101987] Funding Source: NIH RePORTER	US National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank D. Armstrong, P. Wade and members of the Dudek laboratory for critical review of the manuscript, the National Institute of Environmental Health Sciences (NIEHS) Viral Vector Core for lentivirus preparations, the NIEHS Microarray Core for generating, processing and analyzing microarray data, the US National Institutes of Health Intramural Sequencing Center for ChIP-seq sample preparations and sequencing, and the NIEHS Imaging Center for assistance with confocal imaging. This research was supported by the Intramural Research Program of the US National Institutes of Health, NIEHS (Z01 ES100221 to S. M. D. and Z01 ES101987 to K.A.).	Adams JP, 2005, NAT REV NEUROSCI, V6, P737, DOI 10.1038/nrn1749; Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, ONCOGENE, V26, P2543, DOI 10.1038/sj.onc.1210047; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Coulon V, 1999, J BIOL CHEM, V274, P30439, DOI 10.1074/jbc.274.43.30439; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saha RN, 2008, EXP BIOL MED, V233, P385, DOI 10.3181/0709-MR-241; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	46	114	115	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					848	U62		10.1038/nn.2839	http://dx.doi.org/10.1038/nn.2839			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623364	Green Accepted			2022-12-25	WOS:000292081700012
J	Bodmer, D; Ascano, M; Kuruvilla, R				Bodmer, Daniel; Ascano, Maria; Kuruvilla, Rejji			Isoform-Specific Dephosphorylation of Dynamin1 by Calcineurin Couples Neurotrophin Receptor Endocytosis to Axonal Growth	NEURON			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; IN-VIVO; SYMPATHETIC NEURONS; TARGET INNERVATION; SIGNAL-TRANSDUCTION; CYCLOSPORINE-A; DOWNS-SYNDROME; TRK RECEPTORS; MOUSE MODEL; NGF	Endocytic events are critical for neuronal survival in response to target-derived neurotrophic cues, but whether local axon growth is mediated by endocytosis-dependent signaling mechanisms remains unclear. Here, we report that Nerve Growth Factor (NGF) promotes endocytosis of its TrkA receptors and axon growth by calcineurin-mediated dephosphorylation of the endocytic GTPase dynamin1. Conditional deletion of calcineurin in sympathetic neurons disrupts NGF-dependent innervation of peripheral target tissues. Calcineurin signaling is required locally in sympathetic axons to support NGF-mediated growth in a manner independent of transcription. We show that calcineurin associates with dynamin1 via a PxIxIT interaction motif found only in specific dynamin1 splice variants. PxIxIT-containing dynamin1 isoforms colocalize with surface TrkA receptors, and their phosphoregulation is selectively required for NGF-dependent TrkA internalization and axon growth in sympathetic neurons. Thus, NGF-dependent phosphoregulation of dynamin1 is a critical event coordinating neurotrophin receptor endocytosis and axonal growth.	[Bodmer, Daniel; Ascano, Maria; Kuruvilla, Rejji] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Kuruvilla, R (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	rkuruvilla@jhu.edu		Kuruvilla, Rejji/0000-0002-2851-675X	US National Institutes of Health [R01 MH080738]; Whitehall Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080738] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Antonella Riccio, Samer Hattar, and Haiqing Zhao for insightful comments on this manuscript. We thank Mark McNiven for providing dynamin1 constructs, Moses Chao for the P-TrkA (Y794) antibody, and Lois Greene for the adenovirus-Cre. This work was supported by US National Institutes of Health (grant R01 MH080738) and a Whitehall Foundation award to R.K.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Ascano M, 2009, J NEUROSCI, V29, P11674, DOI 10.1523/JNEUROSCI.1542-09.2009; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gallo G, 1997, J NEUROSCI, V17, P5445; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Ghasemlou N, 2004, J PINEAL RES, V37, P230, DOI 10.1111/j.1600-079X.2004.00160.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; LOEB DM, 1994, J BIOL CHEM, V269, P8901; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lu B, 2004, PROG BRAIN RES, V146, P137, DOI 10.1016/S0079-6123(03)46010-X; Orike N, 2001, J NEUROBIOL, V47, P295, DOI 10.1002/neu.1036; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; RUBIN E, 1985, J NEUROSCI, V5, P673; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	45	57	60	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1085	1099		10.1016/j.neuron.2011.04.025	http://dx.doi.org/10.1016/j.neuron.2011.04.025			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689596	Green Accepted, Bronze			2022-12-25	WOS:000292410700008
J	Liu, TM; Kong, D; Shah, BP; Ye, CP; Koda, S; Saunders, A; Ding, JB; Yang, ZF; Sabatini, BL; Lowell, BB				Liu, Tiemin; Kong, Dong; Shah, Bhavik P.; Ye, Chianping; Koda, Shuichi; Saunders, Arpiar; Ding, Jun B.; Yang, Zongfang; Sabatini, Bernardo L.; Lowell, Bradford B.			Fasting Activation of AgRP Neurons Requires NMDA Receptors and Involves Spinogenesis and Increased Excitatory Tone	NEURON			English	Article							TERM SYNAPTIC PLASTICITY; ARCUATE NUCLEUS; ENERGY-EXPENDITURE; HYPOTHALAMIC NEURONS; GLUCOSE-HOMEOSTASIS; WEIGHT HOMEOSTASIS; NEUROPEPTIDE-Y; POMC NEURONS; SK CHANNELS; OBESITY	AgRP neuron activity drives feeding and weight gain whereas that of nearby POMC neurons does the opposite. However, the role of excitatory glutamatergic input in controlling these neurons is unknown. To address this question, we generated mice lacking NMDA receptors (NMDARs) on either AgRP or POMC neurons. Deletion of NMDARs from AgRP neurons markedly reduced weight, body fat and food intake whereas deletion from POMC neurons had no effect. Activation of AgRP neurons by fasting, as assessed by c-Fos, Agrp and Npy mRNA expression, AMPA receptor-mediated EPSCs, depolarization and firing rates, required NMDARs. Furthermore, AgRP but not POMC neurons have dendritic spines and increased glutamatergic input onto AgRP neurons caused by fasting was paralleled by an increase in spines, suggesting fasting induced synaptogenesis and spinogenesis. Thus glutamatergic synaptic transmission and its modulation by NMDARs play key roles in controlling AgRP neurons and determining the cellular and behavioral response to fasting.	[Liu, Tiemin; Kong, Dong; Shah, Bhavik P.; Ye, Chianping; Koda, Shuichi; Yang, Zongfang; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA; [Liu, Tiemin; Kong, Dong; Shah, Bhavik P.; Ye, Chianping; Koda, Shuichi; Yang, Zongfang; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Koda, Shuichi] Asubio Pharma Co Ltd, Kobe, Hyogo 6500047, Japan; [Saunders, Arpiar; Ding, Jun B.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Asubio Pharma Co., Ltd.; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA.	blowell@bidmc.harvard.edu	Ding, Jun/B-2513-2009; ç, æ /AAU-6965-2020; Core, Vector/CAF-4832-2022	Ding, Jun/0000-0003-0690-1312; 	National Institutes of Health [R01 DK089044, R01 DK071051, R37 DK053477, R01 DK075632, BNORC Transgenic Core-P30 DK046200, BADERC Transgenic Core-P30 DK057521, BADERC-P30 DK057521, F31 NS074842, K99 NS075136, NS046579]; American Diabetes Association; Shapiro predoctoral fellowship; Parkinson's Disease Foundation [PDF-FBS-1106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053477, R01DK071051, P30DK046200, R01DK075632, P30DK057521, R01DK096010, R01DK089044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579, T32NS007484, K99NS075136, F31NS074842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Shapiro predoctoral fellowship; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank M. Krashes, L. Vong, C. Bjorbaek, and J. Lu for helpful discussions; and B. Choi, X. Hu, S. Ma, and J. Yu for excellent technical support. This work was supported by grants from the National Institutes of Health (to B.B.L.: R01 DK089044, R01 DK071051, R37 DK053477, R01 DK075632, BNORC Transgenic Core-P30 DK046200 and BADERC Transgenic Core-P30 DK057521; to D.K.: a P&F from BADERC-P30 DK057521; to A.S.: F31 NS074842; to J.B.D.: K99 NS075136; to B.L.S.: NS046579) and the American Diabetes Association (to B.B.L.: Mentor-Based Postdoctoral Fellowship). A.S. is a recipient of a Shapiro predoctoral fellowship and J.B.D. is a recipient of a Parkinson's Disease Foundation postdoctoral fellowship (PDF-FBS-1106).	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Bito H, 2010, NAT CHEM BIOL, V6, P560, DOI 10.1038/nchembio.408; Broberger C, 1998, J COMP NEUROL, V402, P460; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Csakvari E, 2007, NEUROSCIENCE, V144, P1288, DOI 10.1016/j.neuroscience.2006.11.008; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FRANKFURT M, 1990, NEUROENDOCRINOLOGY, V51, P530, DOI 10.1159/000125387; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Smart JL, 2006, J CLIN INVEST, V116, P495, DOI 10.1172/JCI25243; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yuste R, 2010, DENDRITIC SPINES	54	191	194	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					511	522		10.1016/j.neuron.2011.11.027	http://dx.doi.org/10.1016/j.neuron.2011.11.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325203	Green Accepted, Bronze			2022-12-25	WOS:000300140600012
J	Kratsios, P; Stolfi, A; Levine, M; Hobert, O				Kratsios, Paschalis; Stolfi, Alberto; Levine, Michael; Hobert, Oliver			Coordinated regulation of cholinergic motor neuron traits through a conserved terminal selector gene	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HOMEOBOX GENES; IDENTIFICATION; EXPRESSION; FAMILY; SPECIFICATION; REPRESSION; DIFFERENTIATION; DIVERSITY; CHORDATE	Cholinergic motor neurons are defined by the coexpression of a battery of genes encoding proteins that act sequentially to synthesize, package and degrade acetylcholine and reuptake its breakdown product, choline. How expression of these critical motor neuron identity determinants is controlled and coordinated is not understood. We show here that, in the nematode Caenorhabditis elegans, all members of the cholinergic gene battery, as well as many other markers of terminal motor neuron fate, are co-regulated by a shared cis-regulatory signature and a common trans-acting factor, the phylogenetically conserved COE (Collier, Olf, EBF)-type transcription factor UNC-3. UNC-3 initiated and maintained expression of cholinergic fate markers and was sufficient to induce cholinergic fate in other neuron types. UNC-3 furthermore operated in negative feedforward loops to induce the expression of transcription factors that repress individual UNC-3-induced terminal fate markers, resulting in diversification of motor neuron differentiation programs in specific motor neuron subtypes. A chordate ortholog of UNC-3, Ciona intestinalis COE, was also both required and sufficient for inducing a cholinergic fate. Thus, UNC-3 is a terminal selector for cholinergic motor neuron differentiation whose function is conserved across phylogeny.	[Kratsios, Paschalis; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA; [Stolfi, Alberto; Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Div Genet Genom & Dev, Berkeley, CA 94720 USA	Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Kratsios, P (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	pk2357@columbia.edu; or38@columbia.edu	Stolfi, Alberto/AAS-8031-2021	Hobert, Oliver/0000-0002-7634-2854; Kratsios, Paschalis/0000-0002-1363-9271; Levine, Michael/0000-0001-7629-0081	Muscle Dystrophy Association; US National Institutes of Health [R01NS039996, R01NS050266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039996, R01NS050266] Funding Source: NIH RePORTER	Muscle Dystrophy Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for expert assistance in generating transgenic strains; P. Sengupta (Brandeis University) for providing plasmids; many colleagues in the C. elegans community, particularly D. Miller (Vanderbilt University), for providing reporter strains; D. Wu and G. Minevich for bioinformatic analysis; and I. Rand and members of the Hobert laboratory for comments on the manuscript. We are grateful to Caenorhabditis Genetics Center (University of Minnesota) for providing strains. This work was funded by the Muscle Dystrophy Association and the US National Institutes of Health (R01NS039996; R01NS050266). O.H. is an Investigator of the Howard Hughes Medical Institute.	ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Alon U., 2006, INTRO SYSTEMS BIOL D; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bigelow HR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-27; Combes D, 2003, EUR J NEUROSCI, V18, P497, DOI 10.1046/j.1460-9568.2003.02749.x; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Esmaeili B, 2002, DEVELOPMENT, V129, P853; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Hallam S, 2000, DEVELOPMENT, V127, P4239; Hobert O, 2010, TRENDS NEUROSCI, V33, P435, DOI 10.1016/j.tins.2010.05.006; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Naciff JM, 1999, J NEUROCHEM, V72, P17, DOI 10.1046/j.1471-4159.1999.0720017.x; O'Meara MM, 2009, GENETICS, V181, P1679, DOI 10.1534/genetics.108.097832; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Prasad B, 2008, DEV BIOL, V323, P207, DOI 10.1016/j.ydbio.2008.08.029; Rand James B, 2007, WormBook, P1; Russo MT, 2004, DEV BIOL, V267, P517, DOI 10.1016/j.ydbio.2003.11.005; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Von Stetina SE, 2005, INT REV NEUROBIOL, V69, P125, DOI 10.1016/S0074-7742(05)69005-8; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Von Stetina SE, 2007, GENE DEV, V21, P332, DOI 10.1101/gad.1502107; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Yoshida R, 2004, GENESIS, V39, P130, DOI 10.1002/gene.20032	44	102	103	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					205	214		10.1038/nn.2989	http://dx.doi.org/10.1038/nn.2989			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22119902	Green Accepted			2022-12-25	WOS:000299603500011
J	Eggermann, E; Jonas, P				Eggermann, Emmanuel; Jonas, Peter			How the 'slow' Ca2+ buffer parvalbumin affects transmitter release in nanodomain-coupling regimes	NATURE NEUROSCIENCE			English	Article							TERM SYNAPTIC PLASTICITY; FACILITATION; CELL; NEURONS	Parvalbumin is thought to act in a manner similar to EGTA, but how a slow Ca2+ buffer affects nanodomain-coupling regimes at GABAergic synapses is unclear. Direct measurements of parvalbumin concentration and paired recordings in rodent hippocampus and cerebellum revealed that parvalbumin affects synaptic dynamics only when expressed at high levels. Modeling suggests that, in high concentrations, parvalbumin may exert BAPTA-like effects, modulating nanodomain coupling via competition with local saturation of endogenous fixed buffers.	[Jonas, Peter] IST Austria, Klosterneuburg, Austria; [Eggermann, Emmanuel; Jonas, Peter] Univ Freiburg, Inst Physiol 1, D-79106 Freiburg, Germany	Institute of Science & Technology - Austria; University of Freiburg	Jonas, P (corresponding author), IST Austria, Klosterneuburg, Austria.	peter.jonas@ist.ac.at		Jonas, Peter/0000-0001-5001-4804	European Research Council [268548] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Atluri PP, 1996, J NEUROSCI, V16, P5661; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Matveev V, 2004, BIOPHYS J, V86, P2691, DOI 10.1016/S0006-3495(04)74324-6; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sakaba T, 2008, NEURON, V57, P406, DOI 10.1016/j.neuron.2007.11.029; Schmidt H, 2003, BIOPHYS J, V84, P2599, DOI 10.1016/S0006-3495(03)75065-6; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Vreugdenhil M, 2003, J NEUROPHYSIOL, V89, P1414, DOI 10.1152/jn.00576.2002; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	15	90	94	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					20	22		10.1038/nn.3002	http://dx.doi.org/10.1038/nn.3002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138646	Green Accepted			2022-12-25	WOS:000298414400008
J	Ip, JPK; Shi, L; Chen, Y; Itoh, Y; Fu, WY; Betz, A; Yung, WH; Gotoh, Y; Fu, AKY; Ip, NY				Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Itoh, Yasuhiro; Fu, Wing-Yu; Betz, Andrea; Yung, Wing-Ho; Gotoh, Yukiko; Fu, Amy K. Y.; Ip, Nancy Y.			alpha 2-chimaerin controls neuronal migration and functioning of the cerebral cortex through CRMP-2	NATURE NEUROSCIENCE			English	Article							RADIAL MIGRATION; CORTICAL-NEURONS; REGULATOR; MODEL; EPHA4; BRAIN; CDK5; RETRACTION; DIVISION; EPILEPSY	Disrupted cortical neuronal migration is associated with epileptic seizures and developmental delay. However, the molecular mechanism by which disruptions of early cortical development result in neurological symptoms is poorly understood. Here we report alpha 2-chimaerin as a key regulator of cortical neuronal migration and function. In utero suppression of alpha 2-chimaerin arrested neuronal migration at the multipolar stage, leading to accumulation of ectopic neurons in the subcortical region. Mice with such migration defects showed an imbalance between excitation and inhibition in local cortical circuitry and greater susceptibility to convulsant-induced seizures. We further show that alpha 2-chimaerin regulates bipolar transition and neuronal migration through modulating the activity of CRMP-2, a microtubule-associated protein. These findings establish a new alpha 2-chimaerin-dependent mechanism underlying neuronal migration and proper functioning of the cerebral cortex and provide insights into the pathogenesis of seizure-related neurodevelopmental disorders.	[Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China; [Ip, Jacque P. K.; Shi, Lei; Chen, Yu; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Itoh, Yasuhiro; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Betz, Andrea] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Yung, Wing-Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Tokyo; University of Otago; Chinese University of Hong Kong	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	Ip, Jacque Pak Kan/AAH-1744-2020; Yung, Ho/R-6161-2018	Ip, Jacque Pak Kan/0000-0003-4545-8261; Yung, Ho/0000-0002-5542-8173; Shi, Lei/0000-0001-8695-3432; Ito, Yasuhiro/0000-0001-8590-9122; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Fu, Kit Yu/0000-0003-4085-6201	Research Grants Council of Hong Kong [HKUST 661007, 660808, 660610, 660110]; University Grants Committee [AoE/B-15/01]; Hong Kong Jockey Club; Croucher Foundation	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee; Hong Kong Jockey Club; Croucher Foundation	We are grateful to C. Hall (University College London) for alpha 2-chimaerin constructs, antibody and CRMP-2 constructs; K. Kaibuchi (Nagoya University Graduate School of Medicine) for pCRMP-2 (Thr514) antibody; and T. Matsuda and C. L. Cepko (Harvard Medical School) for pCAG vectors. We thank N. Brose and T. Marquardt (Max Planck Institute) for providing Chn1<SUP>-/-</SUP> mice. We thank K.-O. Lai and Z. Cheung for critical reading of the manuscript and members of the Ip laboratory for discussions. We also thank C. Kwong, H. W. Tsang, Y. Dai, B. Butt, T. Ye and K. Ho for technical assistance. This study was supported in part by the Research Grants Council of Hong Kong (HKUST 661007, 660808, 660610 and 660110), the Area of Excellence Scheme of the University Grants Committee (AoE/B-15/01) and the Hong Kong Jockey Club. J.P.K.I. and N. Y. I. are recipients of a Croucher Foundation Research Studentship and Croucher Foundation Senior Research Fellowship, respectively.	Ackman JB, 2009, J NEUROSCI, V29, P313, DOI 10.1523/JNEUROSCI.4093-08.2009; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bar I, 2000, EUR J MORPHOL, V38, P321, DOI 10.1076/ejom.38.5.321.7361; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; CHANG BS, 2006, PRINCIPLES MOL MED, V13, P1073; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Davidsson J, 2008, EPILEPSY RES, V81, P69, DOI 10.1016/j.eplepsyres.2008.04.018; Deutsch SI, 2010, EUR NEUROPSYCHOPHARM, V20, P281, DOI 10.1016/j.euroneuro.2010.02.005; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fukumitsu H, 2006, J NEUROSCI, V26, P13218, DOI 10.1523/JNEUROSCI.4251-06.2006; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Guerrini R, 2003, EPILEPTIC DISORD, V5, pS9; Hall C, 2005, TRENDS BIOCHEM SCI, V30, P169, DOI 10.1016/j.tibs.2005.02.003; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Lapray D, 2010, CEREB CORTEX, V20, P2694, DOI 10.1093/cercor/bhq014; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Lo KY, 2005, J BIOL CHEM, V280, P41744, DOI 10.1074/jbc.M506554200; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; North HA, 2009, DEVELOPMENT, V136, P2467, DOI 10.1242/dev.034405; Ohmiya M, 2002, NEUROSCI LETT, V317, P21, DOI 10.1016/S0304-3940(01)02412-0; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Tabata H, 2003, J NEUROSCI, V23, P9996; Thomas EA, 2003, MOL PSYCHIATR, V8, P983, DOI 10.1038/sj.mp.4001425; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	50	68	69	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					39	U55		10.1038/nn.2972	http://dx.doi.org/10.1038/nn.2972			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138645				2022-12-25	WOS:000298414400012
J	Chong, JJH; Chandrakanthan, V; Xaymardan, M; Asli, NS; Li, J; Ahmed, I; Heffernan, C; Menon, MK; Scarlett, CJ; Rashidianfar, A; Biben, C; Zoellner, H; Colvin, EK; Pimanda, JE; Biankin, AV; Zhou, B; Pu, WT; Prall, OWJ; Harvey, RP				Chong, James J. H.; Chandrakanthan, Vashe; Xaymardan, Munira; Asli, Naisana S.; Li, Joan; Ahmed, Ishtiaq; Heffernan, Corey; Menon, Mary K.; Scarlett, Christopher J.; Rashidianfar, Amirsalar; Biben, Christine; Zoellner, Hans; Colvin, Emily K.; Pimanda, John E.; Biankin, Andrew V.; Zhou, Bin; Pu, William T.; Prall, Owen W. J.; Harvey, Richard P.			Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial Origin	CELL STEM CELL			English	Article							NEURAL CREST CELLS; BONE-MARROW; PROGENITOR CELLS; C-KIT; PERIPHERAL-BLOOD; IN-VITRO; CFU-F; HEART; EPICARDIUM; MULTIPOTENT	Colony-forming units fibroblast (CFU-Fs), analogous to those giving rise to bone marrow (BM) mesenchymal stem cells (MSCs), are present in many organs, although the relationship between BM and organ-specific CFU-Fs in homeostasis and tissue repair is unknown. Here we describe a population of adult cardiac-resident CFU-Fs (cCFU-Fs) that occupy a perk vascular, adventitial niche and show broad trans-germ layer potency in vitro and in vivo. CRE lineage tracing and embryo analysis demonstrated a proepicardial origin for cCFU-Fs. Furthermore, in BM transplantation chimeras, we found no interchange between BM and cCFU-Fs after aging, myocardial infarction, or BM stem cell mobilization. BM and cardiac and aortic CFU-Fs had distinct CRE lineage signatures, indicating that they arise from different progenitor beds during development. These diverse origins for CFU-Fs suggest an underlying basis for differentiation biases seen in different CFU-F populations, and could also influence their capacity for participating in tissue repair.	[Chong, James J. H.; Chandrakanthan, Vashe; Xaymardan, Munira; Asli, Naisana S.; Li, Joan; Ahmed, Ishtiaq; Heffernan, Corey; Menon, Mary K.; Rashidianfar, Amirsalar; Biben, Christine; Prall, Owen W. J.; Harvey, Richard P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Chandrakanthan, Vashe; Pimanda, John E.] Univ New S Wales, Lowy Canc Res Ctr, Prince Wales Clin Sch, Kensington, NSW 2052, Australia; [Li, Joan; Harvey, Richard P.] Univ New S Wales, St Vincents Clin Sch, Fac Med, Kensington, NSW 2052, Australia; [Xaymardan, Munira; Harvey, Richard P.] Univ Sydney, Australian Res Council Special Res Initiat Stem C, Sydney, NSW 2006, Australia; [Xaymardan, Munira; Zoellner, Hans] Univ Sydney, Cellular & Mol Pathol Res Unit, Dept Oral Pathol & Oral Med, Fac Dent, Sydney, NSW 2006, Australia; [Scarlett, Christopher J.; Colvin, Emily K.; Biankin, Andrew V.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Scarlett, Christopher J.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW 2258, Australia; [Biben, Christine; Prall, Owen W. J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Zhou, Bin; Pu, William T.] Childrens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zhou, Bin] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Newcastle; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Harvey, RP (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia.	r.harvey@victorchang.edu.au	Pu, William/AAJ-8301-2020; Chong, James/E-2924-2018; Zoellner, Hans/GWQ-7168-2022; Li, Joan/E-6319-2012	Pu, William/0000-0002-4551-8079; Chong, James/0000-0002-5201-4856; Li, Joan/0000-0003-4037-3592; Xaymardan, Munira/0000-0003-0078-0863; Biankin, Andrew/0000-0002-0362-5597; Scarlett, Christopher/0000-0002-4140-7785; Zhou, Bin/0000-0001-5278-5522; Zoellner, Hans/0000-0003-4804-2464; Colvin, Emily/0000-0002-5435-5902; Harvey, Richard/0000-0002-9950-9792; Seyedasli, Naisana/0000-0001-9012-3984	Victorian State Government; Australian Stem Cell Centre [PO82, S4M1]; National Health and Medical Research Counsel Australia [354400, 573705, 573707, 535903]; Australia-India Strategic Research Fund [BF020084]; Johnson and Johnson; Atlantic Philanthropies [19131]; Cancer Institute New South Wales [09/CDF/2-40, 10/CRF/1-01]; Australian Cancer Research Foundation; Royal Australian College of Surgeons; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust; National Heart Foundation of Australia (NHF); NHF [CR 08S3958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683, U01HL100401] Funding Source: NIH RePORTER	Victorian State Government; Australian Stem Cell Centre; National Health and Medical Research Counsel Australia; Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Atlantic Philanthropies; Cancer Institute New South Wales; Australian Cancer Research Foundation; Royal Australian College of Surgeons; Avner Nahmani Pancreatic Cancer Foundation; R. T. Hall Trust; National Heart Foundation of Australia (NHF)(National Heart Foundation of Australia); NHF(National Heart Foundation of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Ku, K. Evans, and M. Pinese for technical assistance, and Y. Saga, K. Chien, P. Soriano, P. Ruiz-Lozano, and C. Lobe for mice. Research was supported by the Victorian State Government Operational Infrastructure Support scheme and grants from the Australian Stem Cell Centre (PO82; S4M1), National Health and Medical Research Counsel Australia (IRIISS; 354400; 573705; 573707; and 535903), Australia-India Strategic Research Fund (BF020084), Johnson and Johnson (Focused Giving Program), Atlantic Philanthropies (Flagship Scheme; 19131), Cancer Institute New South Wales (09/CDF/2-40 and 10/CRF/1-01), Australian Cancer Research Foundation, Royal Australian College of Surgeons, The Avner Nahmani Pancreatic Cancer Foundation, and the R. T. Hall Trust. J.C. held a National Heart Foundation of Australia (NHF) scholarship, and O.W.J.P., an NHF Career Development Award (CR 08S3958).	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Carmona R, 2010, J CELL MOL MED, V14, P2066, DOI 10.1111/j.1582-4934.2010.01088.x; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Ebihara Y, 2006, EXP HEMATOL, V34, P219, DOI 10.1016/j.exphem.2005.10.008; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fazel SS, 2008, FASEB J, V22, P930, DOI 10.1096/fj.07-8636com; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Galvez BG, 2008, CELL DEATH DIFFER, V15, P1417, DOI 10.1038/cdd.2008.75; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Iwasaki M, 2011, EUR HEART J, V32, P627, DOI 10.1093/eurheartj/ehq442; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Lie-Venema H, 2008, DIFFERENTIATION, V76, P809, DOI 10.1111/j.1432-0436.2007.00262.x; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Lund TC, 2008, HAEMATOLOGICA, V93, P908, DOI 10.3324/haematol.12384; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Shenje LT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001929; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xaymardan M, 2009, STEM CELLS, V27, P1911, DOI 10.1002/stem.106; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104; Zhang N, 2006, STEM CELLS DEV, V15, P17, DOI 10.1089/scd.2006.15.17; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhou B, 2008, BIOCHEM BIOPH RES CO, V375, P450, DOI 10.1016/j.bbrc.2008.08.044; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2010, DEV BIOL, V338, P251, DOI 10.1016/j.ydbio.2009.12.007	54	288	296	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					527	540		10.1016/j.stem.2011.10.002	http://dx.doi.org/10.1016/j.stem.2011.10.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136928	Bronze, Green Published, Green Accepted			2022-12-25	WOS:000297895000013
J	Fujisawa, S; Buzsaki, G				Fujisawa, Shigeyoshi; Buzsaki, Gyoergy			A 4 Hz Oscillation Adaptively Synchronizes Prefrontal, VTA, and Hippocampal Activities	NEURON			English	Article							VENTRAL TEGMENTAL AREA; WORKING-MEMORY TASK; GENETIC MOUSE MODEL; NEURONS IN-VIVO; THETA-OSCILLATIONS; DOPAMINE NEURONS; SPONTANEOUS-ALTERNATION; GAMMA OSCILLATIONS; PHASE-LOCKING; TERM-MEMORY	Network oscillations support transient communication across brain structures. We show here, in rats, that task-related neuronal activity in the medial prefrontal cortex (PFC), the hippocampus, and the ventral tegmental area (VTA), regions critical for working memory, is coordinated by a 4 Hz oscillation. A prominent increase of power and coherence of the 4 Hz oscillation in the PFC and the VTA and its phase modulation of gamma power in both structures was present in the working memory part of the task. Subsets of both PFC and hippocampal neurons predicted the turn choices of the rat. The goal-predicting PFC pyramidal neurons were more strongly phase locked to both 4 Hz and hippocampal theta oscillations than nonpredicting cells. The 4 Hz and theta oscillations were phase coupled and jointly modulated both gamma waves and neuronal spikes in the PFC, the VTA, and the hippocampus. Thus, multi-plexed timing mechanisms in the PFC-VTA-hippo-campus axis may support processing of information, including working memory.	[Fujisawa, Shigeyoshi; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Fujisawa, Shigeyoshi/N-6439-2015	Fujisawa, Shigeyoshi/0000-0003-3963-4281; Buzsaki, Gyorgy/0000-0002-3100-4800	NIH [NS34994, MH54671]; James S. McDonnell Foundation; National Science Foundation Temporal Dynamics Learning Center; Uehara Memorial Foundation; Naito Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Science Foundation Temporal Dynamics Learning Center; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Amarasingham for help with data analysis and M. Belluscio, K. Diba, K. Mizuseki, J. Patel, A. Peyrache, E. Stark, and D. Sullivan for comments on the manuscript. Supported by grants from the NIH (NS34994, MH54671), James S. McDonnell Foundation, National Science Foundation Temporal Dynamics Learning Center, the Uehara Memorial Foundation, the Naito Foundation, and the Japan Society for the Promotion of Science (S.F.).	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BAPREROGLU C, 1992, J PSYCHOPHYSIOL, V13, P161; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; DIVAC I, 1975, PHYSIOL PSYCHOL, V3, P39; Dzirasa K, 2010, J NEUROSCI, V30, P16314, DOI 10.1523/JNEUROSCI.4289-10.2010; Fitch TE, 2006, J NEUROPHYSIOL, V95, P2808, DOI 10.1152/jn.01210.2005; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Fuster J.M., 2001, PREFRONTAL CORTEX; Gaykema RP, 1996, J COMP NEUROL, V374, P555; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Koos T, 2011, CURR OPIN NEUROBIOL, V21, P393, DOI 10.1016/j.conb.2011.05.010; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lavin A, 2005, J NEUROSCI, V25, P5013, DOI 10.1523/JNEUROSCI.0557-05.2005; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Mizuki Y., 1987, American Journal of EEG Technology, V27, P91; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Paladini CA, 1999, SYNAPSE, V32, P165, DOI 10.1002/(SICI)1098-2396(19990601)32:3<165::AID-SYN3>3.0.CO;2-N; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STEVENS R, 1973, BRAIN RES, V52, P203, DOI 10.1016/0006-8993(73)90659-8; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	62	308	311	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					153	165		10.1016/j.neuron.2011.08.018	http://dx.doi.org/10.1016/j.neuron.2011.08.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982376	Bronze, Green Accepted			2022-12-25	WOS:000295856300015
J	Lien, WH; Guo, XY; Polak, L; Lawton, LN; Young, RA; Zheng, DY; Fuchs, E				Lien, Wen-Hui; Guo, Xingyi; Polak, Lisa; Lawton, Lee N.; Young, Richard A.; Zheng, Deyou; Fuchs, Elaine			Genome-wide Maps of Histone Modifications Unwind In Vivo Chromatin States of the Hair Follicle Lineage	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REGULATORY CIRCUITRY; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; SKIN; METHYLATION; POLYCOMB; BULGE; MARKS; DIFFERENTIATION	Using mouse skin, where bountiful reservoirs of synchronized hair follicle stem cells (HF-SCs) fuel cycles of regeneration, we explore how adult SCs remodel chromatin in response to activating cues. By profiling global mRNA and chromatin changes in quiescent and activated HF-SCs and their committed, transit-amplifying (TA) progeny, we show that polycomb-group (PcG)-mediated H3K27-trimethylation features prominently in HF-lineage progression by mechanisms distinct from embryonic-SCs. In HF-SCs, PcG represses nonskin lineages and HF differentiation. In TA progeny, nonskin regulators remain PcG-repressed, HF-SC regulators acquire H3K27me3-marks, and HF-lineage regulators lose them. Interestingly, genes poised in embryonic stem cells, active in HF-SCs, and PcG-repressed in TA progeny encode not only key transcription factors, but also signaling regulators. We document their importance in balancing HF-SC quiescence, underscoring the power of chromatin mapping in dissecting SC behavior. Our findings explain how HF-SCs cycle through quiescent and activated states without losing stemness and define roles for PcG-mediated repression in governing a fate switch irreversibly.	[Lien, Wen-Hui; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Lawton, Lee N.; Young, Richard A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Zheng, Deyou/0000-0003-4354-5337; Lien, Wen-Hui/0000-0002-2282-3169	Harvey L. Karp Postdoctoral Fellowship; NIH/NIAMS [R01AR31737]; NIH/NIMH [R21MH087840]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087840] Funding Source: NIH RePORTER	Harvey L. Karp Postdoctoral Fellowship; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Dewell for assistance in high-throughput sequencing and analysis (RU Genomics Resource Center); A. Viale, D. You, and J. Zhao for microarray (MSKCC microarray facility); S. Mazel, L. Li, A. Lloyd, and S. Tadesse for FACS sorting (RU FACS facility); and K.-M. Noh (Allis lab, RU) for providing ESC cDNAs. We also thank Fuchs' lab members N. Stokes and D. Oristian for assistance in mouse research (Fuchs lab); E. Ezhkova for Ezh1/2 dKO cDNA samples; Y.-C. Hsu for unpublished microarray information; and A. Folgueras, E. Ezhkova, L Zhang, S. Beronja, B. Keyes, M. Kadaja, Y.-C. Hsu, and T. Chen for discussions and comments on the manuscript. W.-H.L. was supported by a Harvey L. Karp Postdoctoral Fellowship and is currently a Jane Coffin Child Postdoctoral Fellow. E.F. is an HHMI Investigator. This work was supported by a grant (to E.F.) from the NIH/NIAMS (R01AR31737) and partially by NIH/NIMH (R21MH087840, D.Z.).	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Bardot B, 2004, INT J DEV BIOL, V48, P149, DOI 10.1387/ijdb.15272379; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakamura M, 2003, FASEB J, V17, P497, DOI 10.1096/fj.02-0247fje; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qiu WL, 2011, J INVEST DERMATOL, V131, P1067, DOI 10.1038/jid.2010.400; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	44	158	160	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					219	232		10.1016/j.stem.2011.07.015	http://dx.doi.org/10.1016/j.stem.2011.07.015			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885018	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000295024200009
J	MacDonald, CJ; Lepage, KQ; Eden, UT; Eichenbaum, H				MacDonald, Christopher J.; Lepage, Kyle Q.; Eden, Uri T.; Eichenbaum, Howard			Hippocampal "Time Cells" Bridge the Gap in Memory for Discontiguous Events	NEURON			English	Article							SPATIAL FIRING PATTERNS; COMPLEX-SPIKE CELLS; PLACE CELLS; PYRAMIDAL CELLS; UNIT-ACTIVITY; RETRIEVAL; SEQUENCES; REPLAY; INFORMATION; NEURONS	The hippocampus is critical to remembering the flow of events in distinct experiences and, in doing so, bridges temporal gaps between discontiguous events. Here, we report a robust hippocampal representation of sequence memories, highlighted by "time cells" that encode successive moments during an empty temporal gap between the key events, while also encoding location and ongoing behavior. Furthermore, just as most place cells "remap" when a salient spatial cue is altered, most time cells form qualitatively different representations ("retime") when the main temporal parameter is altered. Hippocampal neurons also differentially encode the key events and disambiguate different event sequences to compose unique, temporally organized representations of specific experiences. These findings suggest that hippocampal neural ensembles segment temporally organized memories much the same as they represent locations of important events in spatially defined environments.	[MacDonald, Christopher J.; Lepage, Kyle Q.; Eden, Uri T.; Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	hbe@bu.edu			NIMH [MH71702, MH095297]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095297, P50MH071702] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH grants MH71702 and MH095297. We would like to thank Charlotte Wincott, Stephen Carrow, and Steve Ramirez for their enthusiastic assistance.	Agster KL, 2002, J NEUROSCI, V22, P5760; [Anonymous], 1983, CANADIAN PSYCHOL; BREESE CR, 1989, J NEUROSCI, V9, P1097; Brown EN, 2004, MATH COMP BIOL SER, P253; Brown TI, 2010, J NEUROSCI, V30, P7414, DOI 10.1523/JNEUROSCI.6021-09.2010; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Daley D., 2003, INTRO THEORY POINT P, V1; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Farovik A, 2010, LEARN MEMORY, V17, P801, DOI 10.1101/lm.1616209; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Hales JB, 2010, NEUROPSYCHOLOGIA, V48, P3351, DOI 10.1016/j.neuropsychologia.2010.07.025; Hales JB, 2009, J COGNITIVE NEUROSCI, V21, P1244, DOI 10.1162/jocn.2009.21096; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kesner RP, 2005, BEHAV NEUROSCI, V119, P781, DOI 10.1037/0735-7044.119.3.781; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Kumaran D, 2006, NEURON, V49, P617, DOI 10.1016/j.neuron.2005.12.024; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2000, NEUROSCIENCE, V100, P11, DOI 10.1016/S0306-4522(00)00258-X; Levy W. B., 1989, COMPUTATIONAL MODELS, P243, DOI DOI 10.1016/S0079-7421(08)60113-9; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McCullagh P, 1989, GEN LINEAR MODELS; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MECK WH, 1984, BEHAV NEUROSCI, V98, P3, DOI 10.1037/0735-7044.98.1.3; Mitra P., 2007, OBSERVED BRAIN DYNAM; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1994, J NEUROSCI, V14, P7235; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Paz R, 2010, P NATL ACAD SCI USA, V107, P6046, DOI 10.1073/pnas.0910834107; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Ross RS, 2009, HIPPOCAMPUS, V19, P790, DOI 10.1002/hipo.20558; Shapiro ML, 2006, CURR OPIN NEUROBIOL, V16, P701, DOI 10.1016/j.conb.2006.08.017; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; SHARP PE, 1995, J NEUROSCI, V15, P173; Skaggs WE, 1998, J NEUROSCI, V18, P8455; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Staddon JER, 1999, J EXP ANAL BEHAV, V71, P215, DOI 10.1901/jeab.1999.71-215; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	69	612	619	3	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					737	749		10.1016/j.neuron.2011.07.012	http://dx.doi.org/10.1016/j.neuron.2011.07.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867888	Green Accepted, Bronze			2022-12-25	WOS:000294521600017
J	Paez-Gonzalez, P; Abdi, K; Luciano, D; Liu, Y; Soriano-Navarro, M; Rawlins, E; Bennett, V; Garcia-Verdugo, JM; Kuo, CT				Paez-Gonzalez, Patricia; Abdi, Khadar; Luciano, Dominic; Liu, Yan; Soriano-Navarro, Mario; Rawlins, Emma; Bennett, Vann; Manuel Garcia-Verdugo, Jose; Kuo, Chay T.			Ank3-Dependent SVZ Niche Assembly Is Required for the Continued Production of New Neurons	NEURON			English	Article							NEURAL STEM-CELLS; TRANSCRIPTION FACTORS; EPENDYMAL CELLS; VASCULAR NICHE; RADIAL GLIA; EPITHELIAL-CELLS; ADULT; ASTROCYTES; REPAIR; GENE	The rodent subventricular/subependymal zone (SVZ/SEZ) houses neural stem cells (NSCs) that generate olfactory bulb interneurons. It is unclear how the SVZ environment sustains neuronal production into adulthood. We discovered that the adapter molecule Ankyrin-3 (Ank3) is specifically upregulated in ventricular progenitors destined to become ependymal cells, but not in NSCs, and is required for SVZ niche assembly through progenitor lateral adhesion. Furthermore, we found that Ank3 expression is controlled by Foxj1, a transcriptional regulator of multicilia formation, and genetic deletion of this pathway led to complete loss of SVZ niche structure. Interestingly, radial glia continued to transition into postnatal NSCs without this niche. However, inducible deletion of Foxj1-Ank3 from mature SVZ ependyma resulted in dramatic depletion of neurogenesis. Targeting a pathway regulating ependymal organization/assembly and showing its requirement for new neuron production, our results have important implications for environmental control of adult neurogenesis and harvesting NSCs for replacement therapy.	[Paez-Gonzalez, Patricia; Abdi, Khadar; Liu, Yan; Rawlins, Emma; Bennett, Vann; Kuo, Chay T.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Paez-Gonzalez, Patricia; Abdi, Khadar; Kuo, Chay T.] Duke Univ, Med Ctr, Dept Pediat, Brumley Neonatal Perinatal Res Inst, Durham, NC 27710 USA; [Luciano, Dominic; Kuo, Chay T.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Soriano-Navarro, Mario; Manuel Garcia-Verdugo, Jose] CIBERNED, Unidad Mixta CIPF UVEG, Lab Morfol Celular, Valencia, Spain; [Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Inst Brain Sci, Durham, NC 27708 USA	Duke University; Duke University; Duke University; CIBERNED; Prince Felipe Research Center; Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Kuo, CT (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	chay.kuo@duke.edu	García-Verdugo, José Manuel/L-8421-2017; Paez-Gonzalez, Patricia/E-5069-2018	García-Verdugo, José Manuel/0000-0001-9872-6499; Paez-Gonzalez, Patricia/0000-0002-6786-3869; Rawlins, Emma Louise/0000-0001-7426-3792; Soriano Navarro, Mario/0000-0002-7245-2095	Jean and George Brumley Jr. Endowment; Ruth K. Broad Foundation; Sontag Foundation; David & Lucile Packard Foundation; March of Dimes [5-FY09-34]; N.I.H. [1 DP2 OD004453-01]; Medical Research Council [G0900424] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078192] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004453] Funding Source: NIH RePORTER; MRC [G0900424] Funding Source: UKRI	Jean and George Brumley Jr. Endowment; Ruth K. Broad Foundation; Sontag Foundation; David & Lucile Packard Foundation(The David & Lucile Packard Foundation); March of Dimes(March of Dimes); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Bejerano and A. Wenger (Stanford) for help with ank3 sequence analysis; F. Merkle (Harvard), Z. Mirzadeh (Barrow Neuro. Inst.), T. Ghashghaei (N.C. State), G. Michelotti, T. Oliver, and S. Johnson for helpful discussions; L. Ostrowski (U.N.C. Chapel Hill) for Foxj1-GFP reporter and S. Brody (Washington U.) for Foxj1-null mice; F. Wang for tdTomato reporter mice; N. Pershing, A. Gaines, D. Fromme, and E. Weston for project assistance; and M. Bagnat, A. Buckley, C. Eroglu, B. Hogan, T. Lechler, and A. West for helpful comments on manuscript. This work was supported by Jean and George Brumley Jr. Endowment (to P.P.-G., K.M.A., and C.T.K.); Ruth K. Broad Foundation (to P.P.-G.); and Sontag Foundation, David & Lucile Packard Foundation, Basil O'Connor Starter Scholar Research Award 5-FY09-34 from the March of Dimes, and N.I.H. Director's New Innovator Award 1 DP2 OD004453-01 (to C.T.K.).	Abdi KM, 2008, MOL BIOL CELL, V19, P536, DOI 10.1091/mbc.E07-08-0818; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bejerano G, 2005, NAT METHODS, V2, P535, DOI 10.1038/nmeth0705-535; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Karolchik Donna, 2007, V395, P17; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1; Prothmann C, 2001, BRAIN RES, V920, P74, DOI 10.1016/S0006-8993(01)03021-9; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhang Y, 2007, AM J RESP CELL MOL, V36, P515, DOI 10.1165/rcmb.2006-0475RC; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	45	89	97	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 14	2011	71	1					61	75		10.1016/j.neuron.2011.05.029	http://dx.doi.org/10.1016/j.neuron.2011.05.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745638	Green Accepted, Bronze			2022-12-25	WOS:000292806200007
J	Dickendesher, TL; Baldwin, KT; Mironova, YA; Koriyama, Y; Raiker, SJ; Askew, KL; Wood, A; Geoffroy, CG; Zheng, BH; Liepmann, CD; Katagiri, Y; Benowitz, LI; Geller, HM; Giger, RJ				Dickendesher, Travis L.; Baldwin, Katherine T.; Mironova, Yevgeniya A.; Koriyama, Yoshiki; Raiker, Stephen J.; Askew, Kim L.; Wood, Andrew; Geoffroy, Cedric G.; Zheng, Binhai; Liepmann, Claire D.; Katagiri, Yasuhiro; Benowitz, Larry I.; Geller, Herbert M.; Giger, Roman J.			NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; CORTICOSPINAL TRACT REGENERATION; SPINAL-CORD-INJURY; AXON REGENERATION; NOGO-66 RECEPTOR; NEURITE GROWTH; OPTIC-NERVE; FUNCTIONAL RECEPTOR; RECOVERY	In the adult mammalian CNS, chondroitin sulfate proteoglycans (CSPGs) and myelin-associated inhibitors (MAIs) stabilize neuronal structure and restrict compensatory sprouting following injury. The Nogo receptor family members NgR1 and NgR2 bind to MAIs and have been implicated in neuronal inhibition. We found that NgR1 and NgR3 bind with high affinity to the glycosaminoglycan moiety of proteoglycans and participate in CSPG inhibition in cultured neurons. Nogo receptor triple mutants (Ngr1(-/-); Ngr2(-/-); Ngr3(-/-); which are also known as Rtn4r, Rtn4rI2 and Rtn4rI1, respectively), but not single mutants, showed enhanced axonal regeneration following retro-orbital optic nerve crush injury. The combined loss of Ngr1 and Ngr3 (Ngr1(-/-); Ngr3(-/-)), but not Ngr1 and Ngr2 (Ngr1(-/-); Ngr2(-/-)), was sufficient to mimic the triple mutant regeneration phenotype. Regeneration in Ngr1(-/-); Ngr3(-/-) mice was further enhanced by simultaneous ablation of Rptp sigma (also known as Ptprs), a known CSPG receptor. Collectively, our results identify NgR1 and NgR3 as CSPG receptors, suggest that there is functional redundancy among CSPG receptors, and provide evidence for shared mechanisms of MAI and CSPG inhibition.	[Dickendesher, Travis L.; Giger, Roman J.] Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA; [Dickendesher, Travis L.; Baldwin, Katherine T.; Mironova, Yevgeniya A.; Raiker, Stephen J.; Giger, Roman J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Baldwin, Katherine T.; Mironova, Yevgeniya A.; Giger, Roman J.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Childrens Hosp, Sch Med, Lab Neurosci Res Neurosurg, Boston, MA 02115 USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Raiker, Stephen J.] Univ Rochester, Sch Med & Dent, Dept Biomed Genet, Rochester, NY USA; [Askew, Kim L.; Wood, Andrew] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT USA; [Geoffroy, Cedric G.; Zheng, Binhai] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Liepmann, Claire D.; Katagiri, Yasuhiro; Geller, Herbert M.] NHLBI, Dev Neurobiol Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Giger, Roman J.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Rochester; Pfizer; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Giger, RJ (corresponding author), Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA.	rgiger@umich.edu	geoffroy, cedric/AAK-5855-2020; Koriyama, Yoshiki/AAA-1830-2022	Benowitz, Larry/0000-0002-0277-7222; Baldwin, Katherine/0000-0002-4423-5712; Koriyama, Yoshiki/0000-0001-8777-329X; Geller, Herbert/0000-0002-7048-6144	Neuroscience Training Grant [T32EY017878]; University of Michigan; Cellular and Molecular Biology Training Grant [T32GM007315]; National Research Service Award Ruth Kirschstein Fellowship [F31NS061589]; New York State Spinal Cord Injury Research Program; Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation; US Department of Veterans Affairs [1I0IRX000229-01]; National Institute of Neurological Disorders and Stroke [R56NSO47333]; National Eye Institute; NATIONAL EYE INSTITUTE [T32EY017878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054734, R56NS047333, F31NS061589, R01NS047333, T32NS076401, T32NS007489] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000229] Funding Source: NIH RePORTER	Neuroscience Training Grant; University of Michigan(University of Michigan System); Cellular and Molecular Biology Training Grant; National Research Service Award Ruth Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Spinal Cord Injury Research Program; Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation; US Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank M. Tremblay for Rptp sigma<SUP>-/-</SUP> mice, M. Greenberg for Ngr3<SUP>-/-</SUP> mice, B. Pierchala for p75<SUP>NTR-/-</SUP> mice, B. Bates, D. Howland and M.L. Mercado for their assistance in the generation and initial analysis of Ngr1<SUP>-/-</SUP>; Ngr2<SUP>-/-</SUP>; Ngr3<SUP>-/-</SUP> mice, U. Rutishauser for Endo-N, D. Figge and Y. Yasui for assistance in ELISA binding assays, Y. Yin for training in optic nerve surgery, Y. Duan for generation of the RPTP sigma(Igl-3)-Fc construct,). Barbieri for technical assistance and M.M. Zaleska for project administration. This work was supported by Neuroscience Training Grant T32EY017878 and the University of Michigan Rackham Merit Fellowship (T.L.D.), Cellular and Molecular Biology Training Grant T32GM007315 (K.T.B. and Y.A.M.), National Research Service Award Ruth Kirschstein Fellowship F31NS061589 (S.J.R.), the New York State Spinal Cord Injury Research Program, the Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation, the US Department of Veterans Affairs (1I0IRX000229-01), the National Institute of Neurological Disorders and Stroke (R56NSO47333, R.J.G.) and the National Eye Institute (L.I.B.).	Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P1; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Powell EM, 2001, GLIA, V33, P288, DOI 10.1002/1098-1136(20010315)33:4<288::AID-GLIA1027>3.0.CO;2-R; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shypitsyna A, 2011, MOL BIOL EVOL, V28, P1363, DOI 10.1093/molbev/msq313; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Williams G, 2008, J BIOL CHEM, V283, P16641, DOI 10.1074/jbc.M802067200; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zhang L, 2011, J GENET GENOMICS, V38, P515, DOI 10.1016/j.jgg.2011.10.001; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	48	324	333	5	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					703	712		10.1038/nn.3070	http://dx.doi.org/10.1038/nn.3070			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406547	Green Submitted, Green Accepted			2022-12-25	WOS:000303270200014
J	Zheng, S; Gray, EE; Chawla, G; Porse, BT; O'Dell, TJ; Black, DL				Zheng, Sika; Gray, Erin E.; Chawla, Geetanjali; Porse, Bo Torben; O'Dell, Thomas J.; Black, Douglas L.			PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2	NATURE NEUROSCIENCE			English	Article							TRACT BINDING-PROTEIN; NONSENSE-MEDIATED DECAY; LONG-TERM POTENTIATION; AMPA RECEPTOR FUNCTION; MESSENGER-RNA DECAY; EXCITATORY SYNAPSES; EXPRESSION; SWITCH; CELLS; MOUSE	Postsynaptic density protein 95 (PSD-95) is essential for synaptic maturation and plasticity. Although its synaptic regulation has been widely studied, the control of PSD-95 cellular expression is not understood. We found that Psd-95 was controlled post-transcriptionally during neural development. Psd-95 was transcribed early in mouse embryonic brain, but most of its product transcripts were degraded. The polypyrimidine tract binding proteins PTBP1 and PTBP2 repressed Psd-95 (also known as Dlg4) exon 18 splicing, leading to premature translation termination and nonsense-mediated mRNA decay. The loss of first PTBP1 and then of PTBP2 during embryonic development allowed splicing of exon 18 and expression of PSD-95 late in neuronal maturation. Re-expression of PTBP1 or PTBP2 in differentiated neurons inhibited PSD-95 expression and impaired the development of glutamatergic synapses. Thus, expression of PSD-95 during early neural development is controlled at the RNA level by two PTB proteins whose sequential downregulation is necessary for synapse maturation.	[Zheng, Sika; Chawla, Geetanjali; Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Gray, Erin E.] Univ Calif Los Angeles, Interdept PhD Program Neurosci, Los Angeles, CA 90024 USA; [Porse, Bo Torben] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Porse, Bo Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Porse, Bo Torben] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [O'Dell, Thomas J.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA.	dougb@microbio.ucla.edu	Chawla, Geetanjali/AAH-9493-2021; Zheng, Sika/ABB-9203-2020	Chawla, Geetanjali/0000-0003-0354-3716; Zheng, Sika/0000-0002-0573-4981; Porse, Bo/0000-0001-6043-0844	US National Institutes of Health [RO1 GM 49662, R01 MH60919, NIH F32 MH84562]; Lundbeck Foundation [R5-2006-99] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060919, F31MH085462] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Baraban and E. Anderson for thoughtful suggestions on the manuscript, and K. Martin, L. Zipursky, W. Yang and members of the Black laboratory for helpful discussion. We thank S. Sharma for the His-tagged PTBP1 recombinant proteins, and A. Han and S. Sharma for help with the EMSA experiments. We thank Q. Lin for help with Imaris software. This work was supported in part by grants from the US National Institutes of Health (RO1 GM 49662 to D.L.B., R01 MH60919 to T.J.O. and NIH F32 MH84562 to E.E.G.). D.L.B. is an Investigator of the Howard Hughes Medical Institute.	Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Ashiya M, 1997, RNA, V3, P996; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Black DL, 2008, NEURON, V58, P297, DOI 10.1016/j.neuron.2008.04.019; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2010, NUCLEIC ACIDS RES, V38, P1086, DOI 10.1093/nar/gkp1136; Chen L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002806; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hyvonen MT, 2006, RNA, V12, P1569, DOI 10.1261/rna.39806; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Liu HY, 2002, RNA, V8, P137, DOI 10.1017/S1355838202015029; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wyneken U, 2001, NEUROSCIENCE, V102, P65, DOI 10.1016/S0306-4522(00)00469-3; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zheng S, 2010, J CLIN INVEST, V120, P2446, DOI 10.1172/JCI33144	50	147	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					381	U202		10.1038/nn.3026	http://dx.doi.org/10.1038/nn.3026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246437	Green Accepted, Green Submitted			2022-12-25	WOS:000300793100011
J	Saygin, ZM; Osher, DE; Koldewyn, K; Reynolds, G; Gabrieli, JDE; Saxe, RR				Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Reynolds, Gretchen; Gabrieli, John D. E.; Saxe, Rebecca R.			Anatomical connectivity patterns predict face selectivity in the fusiform gyrus	NATURE NEUROSCIENCE			English	Article							RHESUS-MONKEY; FUNCTIONAL LOCALIZATION; CORTICAL REGION; CORTEX; AREA; PERCEPTION; PROSOPAGNOSIA; MACAQUE; BRAIN; PROJECTIONS	A fundamental assumption in neuroscience is that brain structure determines function. Accordingly, functionally distinct regions of cortex should be structurally distinct in their connections to other areas. We tested this hypothesis in relation to face selectivity in the fusiform gyrus. By using only structural connectivity, as measured through diffusion-weighted imaging, we were able to predict functional activation to faces in the fusiform gyrus. These predictions outperformed two control models and a standard group-average benchmark. The structure function relationship discovered from the initial participants was highly robust in predicting activation in a second group of participants, despite differences in acquisition parameters and stimuli. This approach can thus reliably estimate activation in participants who cannot perform functional imaging tasks and is an alternative to group-activation maps. Additionally, we identified cortical regions whose connectivity was highly influential in predicting face selectivity within the fusiform, suggesting a possible mechanistic architecture underlying face processing in humans.	[Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Reynolds, Gretchen; Gabrieli, John D. E.; Saxe, Rebecca R.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Saygin, Zeynep M.; Osher, David E.; Koldewyn, Kami; Gabrieli, John D. E.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Saygin, ZM (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	zsaygin@mit.edu; dosher@mit.edu	Gabrieli, John/AAJ-2869-2020; Koldewyn, Kami/Q-6108-2019; Saygin, Zeynep M./AAV-4951-2020; Koldewyn, Kami/B-6434-2013	Koldewyn, Kami/0000-0003-3588-6449; /0000-0003-2377-1791	US Public Health Service [DA023427]; US National Institute of Mental Health [F32 MH084488]; US National Eye Institute [T32 EY013935]; Poitras Center for Affective Disorders Research; Simons Foundation; Ellison Medical Foundation; NATIONAL EYE INSTITUTE [T32EY013935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH084488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA023427] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Poitras Center for Affective Disorders Research; Simons Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Kanwisher, S. Ghosh, F. Polli and the Athinoula A. Martinos Imaging Center at McGovern Institute for Brain Research, Massachusetts Institute of Technology. This work was supported by US Public Health Service DA023427, US National Institute of Mental Health F32 MH084488, US National Eye Institute T32 EY013935, the Poitras Center for Affective Disorders Research, the Simons Foundation and the Ellison Medical Foundation.	Annese J, 2005, CEREB CORTEX, V15, P1044, DOI 10.1093/cercor/bhh205; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508; GLICKSTEIN M, 1994, J COMP NEUROL, V349, P51, DOI 10.1002/cne.903490105; Gloor P., 1997, TEMPORAL LOBE LIMBIC; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Hastie T., 2009, UNSUPERVISED LEARNIN; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; LANDIS T, 1986, CORTEX, V22, P243, DOI 10.1016/S0010-9452(86)80048-X; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Peled S., 2005, P I SOC MAGN RESON M, V13, P1323; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; SCHMAHMANN JD, 1993, J COMP NEUROL, V337, P94, DOI 10.1002/cne.903370107; SCHMAHMANN JD, 1992, J COMP NEUROL, V326, P159, DOI 10.1002/cne.903260202; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; Sewards TV, 2011, NEUROPSYCHOLOGIA, V49, P277, DOI 10.1016/j.neuropsychologia.2010.11.018; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983	41	194	199	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					321	327		10.1038/nn.3001	http://dx.doi.org/10.1038/nn.3001			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197830	Green Accepted, Green Submitted			2022-12-25	WOS:000299603500025
J	Nicolas, CS; Peineau, S; Amici, M; Csaba, Z; Fafouri, A; Javalet, C; Collett, VJ; Hildebrandt, L; Seaton, G; Choi, SL; Sim, SE; Bradley, C; Lee, K; Zhuo, M; Kaang, BK; Gressens, P; Dournaud, P; Fitzjohn, SM; Bortolotto, ZA; Cho, K; Collingridge, GL				Nicolas, Celine S.; Peineau, Stephane; Amici, Mascia; Csaba, Zsolt; Fafouri, Assia; Javalet, Charlotte; Collett, Valerie J.; Hildebrandt, Lars; Seaton, Gillian; Choi, Sun-Lim; Sim, Su-Eon; Bradley, Clarrisa; Lee, Kyungmin; Zhuo, Min; Kaang, Bong-Kiun; Gressens, Pierre; Dournaud, Pascal; Fitzjohn, Stephen M.; Bortolotto, Zuner A.; Cho, Kwangwook; Collingridge, Graham L.			The JAK/STAT Pathway Is Involved in Synaptic Plasticity	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR ENDOCYTOSIS; HIPPOCAMPAL-NEURONS; JAK-STAT; TYROSINE PHOSPHORYLATION; DEPENDENT ACTIVATION; KINASE INHIBITORS; JAK2/STAT3 AXIS; JANUS KINASES; IFN-GAMMA	The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is involved in many cellular processes, including cell growth and differentiation, immune functions and cancer. It is activated by various cytokines, growth factors, and protein tyrosine kinases (PTKs) and regulates the transcription of many genes. Of the four JAK isoforms and seven STAT isoforms known, JAK2 and STAT3 are highly expressed in the brain where they are present in the postsynaptic density (PSD). Here, we demonstrate a new neuronal function for the JAK/STAT pathway. Using a variety of complementary approaches, we show that the JAK/STAT pathway plays an essential role in the induction of NMDA-receptor dependent long-term depression (NMDAR-LTD) in the hippocampus. Therefore, in addition to established roles in cytokine signaling, the JAK/STAT pathway is involved in synaptic plasticity in the brain.	[Nicolas, Celine S.; Peineau, Stephane; Amici, Mascia; Javalet, Charlotte; Collett, Valerie J.; Fitzjohn, Stephen M.; Bortolotto, Zuner A.; Collingridge, Graham L.] MRC Ctr Synapt Plast, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Peineau, Stephane; Csaba, Zsolt; Fafouri, Assia; Gressens, Pierre; Dournaud, Pascal] Robert Debre Hosp, INSERM, U676, F-75019 Paris, France; [Peineau, Stephane; Csaba, Zsolt; Fafouri, Assia; Gressens, Pierre; Dournaud, Pascal] Univ Paris 07, Fac Med Denis Diderot, F-75019 Paris, France; [Hildebrandt, Lars; Seaton, Gillian; Cho, Kwangwook; Collingridge, Graham L.] Sch Clin Sci, MRC Ctr Synapt Plast, Henry Wellcome LINE, Bristol BS1 3NY, Avon, England; [Choi, Sun-Lim; Sim, Su-Eon; Bradley, Clarrisa; Zhuo, Min; Kaang, Bong-Kiun; Collingridge, Graham L.] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea; [Choi, Sun-Lim; Kaang, Bong-Kiun] Seoul Natl Univ, Dept Biol Sci, Coll Nat Sci, Natl Creat Res Initiat Ctr Memory, Seoul 151747, South Korea; [Lee, Kyungmin] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea	University of Bristol; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Bristol; Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University	Collingridge, GL (corresponding author), MRC Ctr Synapt Plast, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	g.l.collingridge@bristol.ac.uk	Lee, Kyungmin/AAH-9165-2020; gressens, pierre/M-7557-2017; Zhuo, Min/A-2072-2008; Amici, Mascia/L-3842-2019; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020; Lee, Kyungmin/ABC-5624-2020	gressens, pierre/0000-0002-0909-4221; Zhuo, Min/0000-0001-9062-3241; Amici, Mascia/0000-0001-8548-4179; Collingridge, Graham L/0000-0002-9572-5359; Lee, Kyungmin/0000-0002-5425-4212; Fitzjohn, Stephen/0000-0002-3859-7530; Nicolas, Celine/0000-0002-5285-5946; Peineau, Stephane/0000-0002-4721-6795; Csaba, Zsolt/0000-0002-3392-2605; Seaton, Gillian/0000-0002-2768-7514; Cho, Kwangwook/0000-0001-6724-7073	MRC; BBSRC; Inserm; Universite Paris Diderot; PremUP; Fondation Roger de Spoelberch; Fondation Grace de Monaco; Leducq Foundation; WCU through the KOSEF; MEST [R31-10089]; Korean Ministry of Science and Technology; BK21 fellowship; Universite Denis Diderot-Paris 7; Assistance publique-Hopitaux de Paris (AP-HP) (Contrat d'Interface); Association pour la Recherche sur le Cancer (ARC); Federation pour la Recherche sur le Cerveau (FRC); Biotechnology and Biological Sciences Research Council [BB/G003963/1, BB/H006451/1] Funding Source: researchfish; Medical Research Council [G0601813, G0601841B, MC_G1000734] Funding Source: researchfish; BBSRC [BB/G003963/1, BB/H006451/1] Funding Source: UKRI; MRC [MC_G1000734, G0601813] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot; PremUP; Fondation Roger de Spoelberch; Fondation Grace de Monaco; Leducq Foundation(Leducq Foundation); WCU through the KOSEF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); BK21 fellowship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Universite Denis Diderot-Paris 7; Assistance publique-Hopitaux de Paris (AP-HP) (Contrat d'Interface); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Federation pour la Recherche sur le Cerveau (FRC); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the MRC and BBSRC, Inserm, Universite Paris Diderot, PremUP, Fondation Roger de Spoelberch, Fondation Grace de Monaco and Leducq Foundation. G.L.C. and M.Z. are WCU International Scholars and supported by WCU program through the KOSEF funded by the MEST (R31-10089). S.-L.C. and B.-K.K. are supported by the Creative Research Initiatives Program of the Korean Ministry of Science and Technology. S.-L.C. and S.-E.S. are supported by BK21 fellowship. P.D. is supported by Universite Denis Diderot-Paris 7, Assistance publique-Hopitaux de Paris (AP-HP) (Contrat d'Interface), Association pour la Recherche sur le Cancer (ARC), and Federation pour la Recherche sur le Cerveau (FRC).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Amici M, 2009, BIOCHEM SOC T, V37, P1359, DOI 10.1042/BST0371359; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Beales ILP, 2009, J MOL ENDOCRINOL, V42, P305, DOI 10.1677/JME-08-0096; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto Zuner A, 2011, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0613s54; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Cattaneo E, 1999, TRENDS NEUROSCI, V22, P365, DOI 10.1016/S0166-2236(98)01378-2; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Chung HJ, 2000, J NEUROSCI, V20, P7258; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; De-Fraja C, 1998, J NEUROSCI RES, V54, P320, DOI 10.1002/(SICI)1097-4547(19981101)54:3<320::AID-JNR3>3.0.CO;2-R; Delhhommeau F, 2010, INT J HEMATOL, V91, P165, DOI 10.1007/s12185-010-0530-z; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Frank GD, 2002, MOL ENDOCRINOL, V16, P367, DOI 10.1210/me.16.2.367; GAO SP, 2006, SCI STKE, pPE30; Han K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000187; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Hrabetova S, 1996, J NEUROSCI, V16, P5324; Hsin H, 2010, J NEUROSCI, V30, P11983, DOI 10.1523/JNEUROSCI.1029-10.2010; Jo J, 2010, NAT NEUROSCI, V13, P1216, DOI 10.1038/nn.2636; Kai JI, 2010, J CELL BIOCHEM, V111, P1522, DOI 10.1002/jcb.22881; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SK, 2010, LIFE SCI, V86, P863, DOI 10.1016/j.lfs.2010.03.022; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Mahmoud GS, 2006, J NEUROPHYSIOL, V95, P2962, DOI 10.1152/jn.00947.2005; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murata S, 2000, MOL BRAIN RES, V78, P80, DOI 10.1016/S0169-328X(00)00077-2; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ng DCH, 2010, BIOCHEM J, V425, P95, DOI 10.1042/BJ20091213; Orellana DI, 2005, NEUROTOX RES, V8, P295, DOI 10.1007/BF03033983; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; Reyes M, 1996, J NEUROSCI, V16, P5951; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; Tups A, 2009, J NEUROENDOCRINOL, V21, P961, DOI 10.1111/j.1365-2826.2009.01916.x; Wilks AF, 2008, SEMIN CELL DEV BIOL, V19, P319, DOI 10.1016/j.semcdb.2008.07.020; Xu L, 2008, J CLIN INVEST, V118, P272, DOI 10.1172/JCI33009; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	69	153	159	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 26	2012	73	2					374	390		10.1016/j.neuron.2011.11.024	http://dx.doi.org/10.1016/j.neuron.2011.11.024			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284190	Green Published, hybrid			2022-12-25	WOS:000299761600017
J	O'Loghlen, A; Munoz-Cabello, AM; Gaspar-Maia, A; Wu, HA; Banito, A; Kunowska, N; Racek, T; Pemberton, HN; Beolchi, P; Lavial, F; Masui, O; Vermeulen, M; Carroll, T; Graumann, J; Heard, E; Dillon, N; Azuara, V; Snijders, AP; Peters, G; Bernstein, E; Gil, J				O'Loghlen, Ana; Munoz-Cabello, Ana M.; Gaspar-Maia, Alexandre; Wu, Hsan-Au; Banito, Ana; Kunowska, Natalia; Racek, Tomas; Pemberton, Helen N.; Beolchi, Patrizia; Lavial, Fabrice; Masui, Osamu; Vermeulen, Michiel; Carroll, Thomas; Graumann, Johannes; Heard, Edith; Dillon, Niall; Azuara, Veronique; Snijders, Ambrosius P.; Peters, Gordon; Bernstein, Emily; Gil, Jesus			MicroRNA Regulation of Cbx7 Mediates a Switch of Polycomb Orthologs during ESC Differentiation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; METHYLATED HISTONE H3; DEVELOPMENTAL REGULATORS; SKELETAL-MUSCLE; GENES; PLURIPOTENT; SENESCENCE; CIRCUITRY; PROTEINS; INK4A	The Polycomb Group (PcG) of chromatin modifiers regulates pluripotency and differentiation. Mammalian genomes encode multiple homologs of the Polycomb repressive complex 1 (PRC1) components, including five orthologs of the Drosophila Polycomb protein (Cbx2, Cbx4, Cbx6, Cbx7, and Cbx8). We have identified Cbx7 as the primary Polycomb ortholog of PRC1 complexes in embryonic stem cells (ESCs). The expression of Cbx7 is downregulated during ESC differentiation, preceding the upregulation of Cbx2, Cbx4, and Cbx8, which are directly repressed by Cbx7. Ectopic expression of Cbx7 inhibits differentiation and X chromosome inactivation and enhances ESC self-renewal. Conversely, Cbx7 knockdown induces differentiation and derepresses lineage-specific markers. In a functional screen, we identified the miR-125 and miR-181 families as regulators of Cbx7 that are induced during ESC differentiation. Ectopic expression of these miRNAs accelerates ESC differentiation via regulation of Cbx7. These observations establish a critical role for Cbx7 and its regulatory miRNAs in determining pluripotency.	[O'Loghlen, Ana; Munoz-Cabello, Ana M.; Banito, Ana; Beolchi, Patrizia; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England; [O'Loghlen, Ana; Munoz-Cabello, Ana M.; Banito, Ana; Kunowska, Natalia; Beolchi, Patrizia; Carroll, Thomas; Dillon, Niall; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Epigenet Sect, London W12 0NN, England; [Kunowska, Natalia; Dillon, Niall] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London W12 0NN, England; [Snijders, Ambrosius P.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Biomol Mass Spectrometry & Prote Lab, London W12 0NN, England; [Gaspar-Maia, Alexandre; Wu, Hsan-Au; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Racek, Tomas; Pemberton, Helen N.; Peters, Gordon] CRUK London Res Inst, Mol Oncol Lab, London WC2A 3PX, England; [Lavial, Fabrice; Azuara, Veronique] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England; [Masui, Osamu; Heard, Edith] Inst Curie, F-75248 Paris, France; [Vermeulen, Michiel; Graumann, Johannes] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [Graumann, Johannes] Qatar Fdn, Weill Cornell Med Coll Qatar, Doha, Qatar	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Icahn School of Medicine at Mount Sinai; Cancer Research UK; Imperial College London; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Max Planck Society; Utrecht University; Utrecht University Medical Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Gil, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Proliferat Grp, Hammersmith Campus, London W12 0NN, England.	jesus.gil@csc.mrc.ac.uk	Xie, Huangming/B-2260-2012; Heard, Edith/D-7197-2017; O'Loghlen, Ana/K-9965-2014; Masui, Osamu/AAH-4111-2019; Gil, Jesus/C-7739-2012; Graumann, Johannes/C-5241-2008; Gaspar-Maia, Alexandre/AAY-5416-2020; Banito, Ana/P-6168-2017; Cabello, Ana Maria Muñoz/E-5292-2016; Vermeulen, Michiel/C-8883-2013	Heard, Edith/0000-0001-8052-7117; Gil, Jesus/0000-0002-4303-6260; Graumann, Johannes/0000-0002-3015-5850; Gaspar-Maia, Alexandre/0000-0001-8528-5575; Cabello, Ana Maria Muñoz/0000-0002-8047-768X; Vermeulen, Michiel/0000-0003-0836-6894; Lavial, Fabrice/0000-0001-9752-4393; Azuara, Veronique/0000-0003-4608-3713; Banito, Ana/0000-0003-2188-0003; Snijders, Bram/0000-0002-5416-8592; O'Loghlen, Ana/0000-0002-8141-1965	NYSTEM IDEA [C024285]; ANR; ERC; MRC; MRC Technology; CRUK; EMBO; BBSRC [BB/G011117/1] Funding Source: UKRI; MRC [MC_U120036884, MC_U120085810] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011117/1] Funding Source: researchfish; Medical Research Council [MC_U120085810, MC_U120036884] Funding Source: researchfish	NYSTEM IDEA; ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Technology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Mathias Mann for his support; Elizabeth Duncan and David Allis for sharing the LF2 Cbx7 ESCs; and Yen-Sin Ang, Kajan Ratnakumar, Haruhiko Koseki, Adrian Bracken, Meng Li, Tristan Rodriguez, Cynthia Fisher, and Sam Wormwald for advice and reagents. This work was supported by an NYSTEM IDEA Award C024285 to E.B. E.H. and O.M. received support from the ANR and ERC Advanced Investigator award. Core support from the MRC and grants from MRC Technology, CRUK, and AICR went to fund J.G.'s research. A.M. was funded by Fundacion Ramon Areces, and A.B., by the Portuguese FCT. J.G. is also supported by the EMBO Young Investigator Programme.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Glud M, 2011, MELANOMA RES, V21, P253, DOI 10.1097/CMR.0b013e328345333b; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Melton C, 2010, ADV EXP MED BIOL, V695, P105, DOI 10.1007/978-1-4419-7037-4_8; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	33	159	164	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					33	46		10.1016/j.stem.2011.12.004	http://dx.doi.org/10.1016/j.stem.2011.12.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226354	Green Published, hybrid			2022-12-25	WOS:000299449500009
J	Miskiewicz, K; Jose, LE; Bento-Abreu, A; Fislage, M; Taes, I; Kasprowicz, J; Swerts, J; Sigrist, S; Versees, W; Robberecht, W; Verstreken, P				Miskiewicz, Katarzyna; Jose, Liya E.; Bento-Abreu, Andre; Fislage, Marcus; Taes, Ines; Kasprowicz, Jaroslaw; Swerts, Jef; Sigrist, Stephan; Versees, Wim; Robberecht, Wim; Verstreken, Patrik			ELP3 Controls Active Zone Morphology by Acetylating the ELKS Family Member Bruchpilot	NEURON			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; IN-VIVO; SYNAPTIC-TRANSMISSION; HISTONE ACETYLATION; CALCIUM INDICATORS; NEURAL ACTIVITY; QUANTAL CONTENT; RELEASE SITES; PLASTICITY; ACETYLTRANSFERASE	Elongator protein 3 (ELP3) acetylates histones in the nucleus but also plays a role in the cytoplasm. Here, we report that in Drosophila neurons, ELP3 is necessary and sufficient to acetylate the ELKS family member Bruchpilot, an integral component of the presynaptic density where neurotransmitters are released. We find that in elp3 mutants, presynaptic densities assemble normally, but they show morphological defects such that their cytoplasmic extensions cover a larger area, resulting in increased vesicle tethering as well as a more proficient neurotransmitter release. We propose a model where ELP3-dependent acetylation of Bruchpilot at synapses regulates the structure of individual presynaptic densities and neurotransmitter release efficiency.	[Miskiewicz, Katarzyna; Jose, Liya E.; Kasprowicz, Jaroslaw; Swerts, Jef; Verstreken, Patrik] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Miskiewicz, Katarzyna; Jose, Liya E.; Kasprowicz, Jaroslaw; Swerts, Jef; Verstreken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Bento-Abreu, Andre; Taes, Ines; Robberecht, Wim] VIB, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Bento-Abreu, Andre; Taes, Ines; Robberecht, Wim] Katholieke Univ Leuven, Neurobiol Lab, B-3000 Louvain, Belgium; [Fislage, Marcus; Versees, Wim] Katholieke Univ Leuven, VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Fislage, Marcus; Versees, Wim] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Sigrist, Stephan] Free Univ Berlin, Dept Genet, Inst Biol, D-14195 Berlin, Germany	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Vrije Universiteit Brussel; Free University of Berlin	Verstreken, P (corresponding author), VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium.	patrik.verstreken@cme.vib-kuleuven.be	Verstreken, Patrik/AAC-7591-2022; Versées, Wim/H-5518-2015	Verstreken, Patrik/0000-0002-5073-5393; Fislage, Marcus/0000-0002-2527-2657; Versees, Wim/0000-0002-4695-696X	Marie Curie Excellence [MEXT-CT-2006-042267]; ERC [260678]; FWO [G094011, G095511, G074709, G025909]; Research Fund KU Leuven: BOF-OT; GOA [11/014]; Belgian Federal Science Policy Office; Motor Neuron Disease Association UK [6046]; European Community [FP7/2007-2013, 259867]; Flemish Government; Francqui Foundation; Hercules Foundation [AKUL/09/037]; IWT	Marie Curie Excellence(European Commission); ERC(European Research Council (ERC)European Commission); FWO(FWO); Research Fund KU Leuven: BOF-OT; GOA; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Motor Neuron Disease Association UK; European Community(European Commission); Flemish Government(European Commission); Francqui Foundation; Hercules Foundation; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We thank the Vienna Drosophila RNAi Center, the Bloomington and Harvard Drosophila stock centers, and the Developmental Studies Hybridoma bank as well as Hugo Bellen and Aaron DiAntonio for reagents. We especially thank Ron Habets as well as Sebastian Munck, Pieter Baatsen, and Jan Slabbaert, and other members of the P.V., W.R., and W.V. labs for help and comments. Support was provided by a Marie Curie Excellence grant (MEXT-CT-2006-042267), an ERC Starting Grant (260678), FWO Grants G094011, G095511, G074709, and G025909, the Research Fund KU Leuven: BOF-OT and GOA 11/014, lnteruniversity attraction Poles (lUAP) program P6/43 of the Belgian Federal Science Policy Office, the Motor Neuron Disease Association UK (6046), The European Community's Health Seventh Framework Programme (FP7/2007-2013; 259867), a Methusalem grant of the Flemish Government, the Francqui Foundation, the Hercules Foundation (project AKUL/09/037), and VIB. W.V. is supported by an FWO postdoctoral grant, M.F. by an IWT postdoctoral grant, L.E.J. by a predoctoral VIB fellowship, and W.R. by a E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen LF, 2005, METHODS, V36, P368, DOI 10.1016/j.ymeth.2005.03.011; Choi JK, 2010, HUM MOL GENET, V19, P4474, DOI 10.1093/hmg/ddq379; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Hallermann S, 2010, HFSP J, V4, P72, DOI 10.2976/1.3338710; Han QJ, 2008, BIOCHEM J, V409, P779, DOI 10.1042/BJ20070578; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiao W, 2010, J STRUCT BIOL, V172, P389, DOI 10.1016/j.jsb.2010.07.007; Johnson EL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000193; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nieratschker V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000700; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Vandenberghe W, 1998, BRAIN RES, V807, P1, DOI 10.1016/S0006-8993(98)00569-1; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Versees W, 2010, MOL MICROBIOL, V76, P1065, DOI 10.1111/j.1365-2958.2010.07162.x; Walia H, 1998, J BIOL CHEM, V273, P14516, DOI 10.1074/jbc.273.23.14516; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; WESTERFIELD M, 2003, ZEBRAFISH BOOK; Weyhersmuller A, 2011, J NEUROSCI, V31, P6041, DOI 10.1523/JNEUROSCI.6698-10.2011; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	54	75	77	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					776	788		10.1016/j.neuron.2011.10.010	http://dx.doi.org/10.1016/j.neuron.2011.10.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153374	Bronze, Green Accepted			2022-12-25	WOS:000297971100012
J	Sweeney, LB; Chou, YH; Wu, ZH; Joo, W; Komiyama, T; Potter, CJ; Kolodkin, AL; Garcia, KC; Luo, LQ				Sweeney, Lora B.; Chou, Ya-Hui; Wu, Zhuhao; Joo, William; Komiyama, Takaki; Potter, Christopher J.; Kolodkin, Alex L.; Garcia, K. Christopher; Luo, Liqun			Secreted Semaphorins from Degenerating Larval ORN Axons Direct Adult Projection Neuron Dendrite Targeting	NEURON			English	Article							DROSOPHILA OLFACTORY CIRCUIT; STRUCTURAL BASIS; WIRING SPECIFICITY; MOSAIC ANALYSIS; MAP TOPOGRAPHY; RECEPTOR; PLEXIN; GUIDANCE; EXPRESSION; SYSTEM	During assembly of the Drosophila olfactory circuit, projection neuron (PN) dendrites prepattern the developing antennal lobe before the arrival of axons from their presynaptic partners, the adult olfactory receptor neurons (ORNs). We previously found that levels of transmembrane Semaphorin-1a, which acts as a receptor, instruct PN dendrite targeting along the dorsolateral-ventromedial axis. Here we show that two secreted semaphorins, Sema-2a and Sema-2b, provide spatial cues for PN dendrite targeting. Sema-2a and Sema-2b proteins are distributed in gradients opposing the Sema-1a protein gradient, and Sema-1a binds to Sema-2a-expressing cells. In Sema-2a and Sema-2b double mutants, PN dendrites that normally target dorsolaterally in the antennal lobe mistarget ventromedially, phenocopying cell-autonomous Sema-1a removal from these PNs. Cell ablation, cell-specific knockdown, and rescue experiments indicate that secreted semaphorins from degenerating larval ORN axons direct dendrite targeting. Thus, a degenerating brain structure instructs the wiring of a developing circuit through the repulsive action of secreted semaphorins.	[Sweeney, Lora B.; Chou, Ya-Hui; Wu, Zhuhao; Joo, William; Komiyama, Takaki; Potter, Christopher J.; Kolodkin, Alex L.; Garcia, K. Christopher; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Sweeney, Lora B.; Chou, Ya-Hui; Joo, William; Komiyama, Takaki; Potter, Christopher J.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sweeney, Lora B.; Joo, William; Komiyama, Takaki; Luo, Liqun] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Wu, Zhuhao; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Johns Hopkins University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Wu, Zhuhao/I-5852-2018; Chou, Ya-Hui/F-3775-2014; Potter, Christopher John/H-5884-2019	Chou, Ya-Hui/0000-0001-6552-8728; Potter, Christopher John/0000-0002-5223-8112; Komiyama, Takaki/0000-0001-9609-4600; Wu, Zhuhao/0000-0002-2471-0555; Luo, Liqun/0000-0001-5467-9264; Sweeney, Lora/0000-0001-9242-5601	NIH [R01-DC005982, R01-NS35165]; Howard Hughes Medical Institute; Developmental and Neonatal Training Program [T32 HD007249]; Lieberman Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Developmental and Neonatal Training Program; Lieberman Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH (R01-DC005982 to L.L., R01-NS35165 to A.L.K.) and the Howard Hughes Medical Institute (to A.L.K., K.C.G., and L.L.). L.B.S. was supported by the Developmental and Neonatal Training Program (T32 HD007249) and a Lieberman Fellowship. We thank N. Goriatcheva and D. Luginbuhl for technical assistance, U. Heberlein and E.C. Mahn for an unpublished GAL4 line, and W. Hong for critical comments.	Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; DRESCHER U, 1995, CELL, V82, P369; Han DD, 2000, DEVELOPMENT, V127, P573; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; STJOHNSTON D, 1992, CELL, V68, P201; Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	39	50	51	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					734	747		10.1016/j.neuron.2011.09.026	http://dx.doi.org/10.1016/j.neuron.2011.09.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153371	Green Accepted, Bronze			2022-12-25	WOS:000297971100009
J	Pollarolo, G; Schulz, JG; Munck, S; Dotti, CG				Pollarolo, Giulia; Schulz, Joachim G.; Munck, Sebastian; Dotti, Carlos G.			Cytokinesis remnants define first neuronal asymmetry in vivo	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; ADHERENS JUNCTIONS; CLEAVAGE FURROW; DROSOPHILA; POLARITY; LOCALIZATION; RHO; MODULATION; MIGRATION; CADHERINS	Giulia Pollarolo(1,2,4), Joachim G Schulz(1,2,4), Sebastian Munck(1,2) & Carlos G Dotti(1-3) Polarization of a neuron begins with the appearance of the first neurite, thus defining the ultimate growth axis. Unlike late occurring polarity events (such as axonal growth), very little is known about this fundamental process. We show here that, in Drosophila melanogaster neurons in vivo, the first membrane deformation occurred 3.6 min after precursor division. Clustering of adhesion complex components (Bazooka (Par-3), cadherin-catenin) marked this place by 2.8 min after division; the upstream phosphatidylinositol 4,5-bisphosphate, by 0.7 min after division; and the furrow components RhoA and Aurora kinase, from the time of cytokinesis. Local DE-cadherin inactivation prevented sprout formation, whereas perturbation of division orientation did not alter polarization from the cytokinesis pole. This is, to our knowledge, the first molecular study of initial neuronal polarization in vivo. The mechanisms of polarization seem to be defined at the precursor stage.	[Pollarolo, Giulia; Schulz, Joachim G.; Munck, Sebastian; Dotti, Carlos G.] Vlaams Inst Biotechnol, Dept Mol & Dev Genet, Louvain, Belgium; [Pollarolo, Giulia; Schulz, Joachim G.; Munck, Sebastian; Dotti, Carlos G.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Dotti, Carlos G.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Schulz, JG (corresponding author), Vlaams Inst Biotechnol, Dept Mol & Dev Genet, Campus Gasthuisberg, Louvain, Belgium.	joachim.schulz@med.kuleuven.be; carlos.dotti@cme.vib-kuleuven.be	Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Munck, Sebastian/0000-0002-5182-5358; Pollarolo, Giulia/0000-0002-7140-8981	Boehringer Ingelheim Foundation; Katholieke Universiteit Leuven; Fonds Wetenschappelijk Onderzook-Vlaanderen	Boehringer Ingelheim Foundation(Boehringer Ingelheim); Katholieke Universiteit Leuven(KU Leuven); Fonds Wetenschappelijk Onderzook-Vlaanderen	We would like to thank C. Gonzalez, F. Calderon de Anda, A. Gartner and F. Feiguin for discussions; M. Morgan for technical help and discussions; T. Lecuit and R. Levayer for sharing their adapted CALI protocol; and Y. Bellaiche (Curie Institute), H. Bellen (Baylor College of Medicine), C. Gonzalez (Institut de Recerca Biomedica, Barcelona), T.J.C. Harris (University of Toronto), S. Hayashi (RIKEN Center for Developmental Biology), Y. Hong (University of Pittsburgh), J. Knoblich (Institute of Molecular Biotechnology, Wien), H. Oda (JT Biohistory Research Hall, Takatsuki), M. Rolls (Pennsylvania State University), the Bloomington Drosophila Stock Center and the Developmental Studies Hybridoma Bank for providing us with stocks and reagents. G.P. was supported by a Boehringer Ingelheim Foundation scholarship. This work was supported by Katholieke Universiteit Leuven and Fonds Wetenschappelijk Onderzook-Vlaanderen.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2008, J CELL SCI, V121, P178, DOI 10.1242/jcs.023143; Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Gao L, 2009, MOL BIOL CELL, V20, P2540, DOI 10.1091/mbc.E09-03-0194; Gervais L, 2008, DEVELOPMENT, V135, P3829, DOI 10.1242/dev.029009; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Khazaei MR, 2009, J BIOL CHEM, V284, P33571, DOI 10.1074/jbc.M109.055897; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Menchon SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024190; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	50	59	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1525	U50		10.1038/nn.2976	http://dx.doi.org/10.1038/nn.2976			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081156				2022-12-25	WOS:000297546300011
J	Wisotsky, Z; Medina, A; Freeman, E; Dahanukar, A				Wisotsky, Zev; Medina, Adriana; Freeman, Erica; Dahanukar, Anupama			Evolutionary differences in food preference rely on Gr64e, a receptor for glycerol	NATURE NEUROSCIENCE			English	Article							LABELLAR SUGAR RECEPTOR; DROSOPHILA-MELANOGASTER; CHEMOSENSORY RECEPTORS; GUSTATORY RECEPTORS; CELLULAR BASIS; BITTER TASTE; SWEET; PERCEPTION; RESPONSES; NEURONS	Very little is known about how stimuli that are typically not rich in sugars, such as beer, trigger attractive gustatory responses in Drosophila. We identified a member of the gustatory receptor family, Gr64e, as a receptor that is required for feeding preference for beer and other sources that have fermenting yeast. We found that Gr64e is required for neuronal and behavioral responses to glycerol, an abundant component of growing yeast and fermentation products. Ectopic expression of Gr64e in an olfactory neuron conferred responsiveness to glycerol. We also found that Drosophila species that are predicted to carry pseudogenes of Gr64e had reduced glycerol sensitivity. Our results provide insight into the molecular mechanisms of feeding acceptance of yeast products and raise the possibility that Gr64e contributes to specific evolutionary variations in appetitive selectivity across Drosophila species.	[Wisotsky, Zev; Dahanukar, Anupama] Univ Calif Riverside, Interdept Neurosci Program, Riverside, CA 92521 USA; [Medina, Adriana; Dahanukar, Anupama] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Freeman, Erica; Dahanukar, Anupama] Univ Calif Riverside, Bioengn Interdept Grad Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Dahanukar, A (corresponding author), Univ Calif Riverside, Interdept Neurosci Program, Riverside, CA 92521 USA.	anupama.dahanukar@ucr.edu		Dahanukar, Anupama/0000-0003-0534-7700	Whitehall Foundation [2010-12-42]; National Science Foundation Integrated Graduate Education Research and Training Program in Video Bioinformatics [DGE0903667]	Whitehall Foundation; National Science Foundation Integrated Graduate Education Research and Training Program in Video Bioinformatics	We thank W. Tom and A. Ray for help with olfactory single-sensillum recordings, K. Risser for initial behavioral analysis, members of the Dahanukar and Ray laboratories for helpful discussions, and A. Ray, S. Charlu and S. Siemens for comments on the manuscript. This research was supported in part by a Whitehall Foundation Research grant (2010-12-42, to A.D.) and a fellowship from the National Science Foundation Integrated Graduate Education Research and Training Program in Video Bioinformatics (DGE0903667 to E.F.)	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; ANDRE L, 1991, FEBS LETT, V286, P13, DOI 10.1016/0014-5793(91)80930-2; Bamforth CW, 2005, J I BREWING, V111, P259, DOI 10.1002/j.2050-0416.2005.tb00681.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Brandolini V, 2002, WORLD J MICROB BIOT, V18, P481, DOI 10.1023/A:1015574117335; COOPER DM, 1960, EVOLUTION, V14, P41, DOI 10.2307/2405921; DACUNHA AB, 1951, EVOLUTION, V5, P97, DOI 10.1111/j.1558-5646.1951.tb02766.x; DACUNHA AB, 1957, ECOLOGY, V38, P98, DOI 10.2307/1932131; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DETHIER VG, 1955, Q REV BIOL, V30, P348, DOI 10.1086/401030; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOBZHANSKY T, 1956, ECOLOGY, V37, P544, DOI 10.2307/1930178; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Gordesky-Gold B, 2008, CHEM SENSES, V33, P301, DOI 10.1093/chemse/bjm088; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Intelmann D, 2009, CHEMOSENS PERCEPT, V2, P118, DOI 10.1007/s12078-009-9049-1; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Keller A, 2007, CURR BIOL, V17, pR77, DOI 10.1016/j.cub.2006.12.031; Kent LB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-41; KLOPPER WJ, 1986, J I BREWING, V92, P225, DOI 10.1002/j.2050-0416.1986.tb04405.x; Koseki T, 2005, CHEM SENSES, V30, pI277, DOI 10.1093/chemse/bjh222; Koseki T, 2004, CHEM SENSES, V29, P703, DOI 10.1093/chemse/bjh075; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MATTICK LR, 1970, AM J ENOL VITICULT, V21, P213; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson Hugh M., 2009, Journal of Insect Science (Tucson), V9, P1; Romano P, 1997, J APPL MICROBIOL, V82, P615, DOI 10.1111/j.1365-2672.1997.tb03592.x; ROSINI G, 1982, MICROBIAL ECOL, V8, P83, DOI 10.1007/BF02011464; Scanes K. T., 1998, South African Journal for Enology and Viticulture, V19, P17; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	50	58	60	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1534	U161		10.1038/nn.2944	http://dx.doi.org/10.1038/nn.2944			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057190				2022-12-25	WOS:000297546300012
J	Kim, JI; Lee, HR; Sim, SE; Baek, J; Yu, NK; Choi, JH; Ko, HG; Lee, YS; Park, SW; Kwak, C; Ahn, SJ; Choi, SY; Kim, H; Kim, KH; Backx, PH; Bradley, CA; Kim, E; Jang, DJ; Lee, K; Kim, SJ; Zhuo, M; Collingridge, GL; Kaang, BK				Kim, Jae-Ick; Lee, Hye-Ryeon; Sim, Su-eon; Baek, Jinhee; Yu, Nam-Kyung; Choi, Jun-Hyeok; Ko, Hyoung-Gon; Lee, Yong-Seok; Park, Soo-Won; Kwak, Chuljung; Ahn, Sung-Ji; Choi, So Yoen; Kim, Hyun; Kim, Kyoung-Han; Backx, Peter H.; Bradley, Clarrisa A.; Kim, Eunjoon; Jang, Deok-Jin; Lee, Kyungmin; Kim, Sang Jeong; Zhuo, Min; Collingridge, Graham L.; Kaang, Bong-Kiun			PI3K gamma is required for NMDA receptor-dependent long-term depression and behavioral flexibility	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; SYNAPTIC PLASTICITY; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; NOVELTY ACQUISITION; SIGNALING PATHWAY; IN-VITRO; KINASE; MEMORY; POTENTIATION	Phosphatidylinositol 3-kinase (PI3K) has been implicated in synaptic plasticity and other neural functions in the brain. However, the role of individual PI3K isoforms in the brain is unclear. We investigated the role of PI3K gamma in hippocampal-dependent synaptic plasticity and cognitive functions. We found that PI3K gamma has a crucial and specific role in NMDA receptor (NMDAR)-mediated synaptic plasticity at mouse Schaffer collateral-commissural synapses. Both genetic deletion and pharmacological inhibition of PI3K gamma disrupted NMDAR long-term depression (LTD) while leaving other forms of synaptic plasticity intact. Accompanying this physiological deficit, the impairment of NMDAR LTD by PI3K gamma blockade was specifically correlated with deficits in behavioral flexibility. These findings suggest that a specific PI3K isoform, PI3K gamma, is critical for NMDAR LTD and some forms of cognitive function. Thus, individual isoforms of PI3Ks may have distinct roles in different types of synaptic plasticity and may therefore influence various kinds of behavior.	[Kim, Jae-Ick; Lee, Hye-Ryeon; Sim, Su-eon; Baek, Jinhee; Yu, Nam-Kyung; Choi, Jun-Hyeok; Ko, Hyoung-Gon; Lee, Yong-Seok; Park, Soo-Won; Kwak, Chuljung; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Natl Creat Res Initiat Ctr Memory, Dept Biol Sci, Seoul 151742, South Korea; [Sim, Su-eon; Bradley, Clarrisa A.; Kim, Sang Jeong; Zhuo, Min; Collingridge, Graham L.; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea; [Ahn, Sung-Ji; Kim, Sang Jeong] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Choi, So Yoen; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Kyoung-Han; Backx, Peter H.; Zhuo, Min] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; [Jang, Deok-Jin] Kyungpook Natl Univ, Coll Ecol & Environm, Dept Appl Biol, Sangju Si, Kyeongbuk, South Korea; [Lee, Kyungmin] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea; [Collingridge, Graham L.] Sch Physiol & Pharmacol, MRC Ctr Synapt Plast, Bristol, Avon, England	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); University of Toronto; Korea Advanced Institute of Science & Technology (KAIST); Kyungpook National University; Kyungpook National University; University of Bristol	Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Natl Creat Res Initiat Ctr Memory, Dept Biol Sci, Seoul 151742, South Korea.	kaang@snu.ac.kr	collingridge, graham/AAI-8362-2020; Kim, Eunjoon/C-1566-2011; Kim, Sang Jeong/J-2740-2012; Kim, Jae-Ick/AAY-6005-2020; Kim, Jae-Ick/R-4007-2017; Zhuo, Min/A-2072-2008; Lee, Yong Seok/J-5587-2012; Collingridge, Graham L/C-4605-2015; Lee, Kyungmin/ABC-5624-2020; Lee, Kyungmin/AAH-9165-2020; Choi, So Yoen/AAV-1947-2020; Kim, Kyoung-Han/AAZ-4908-2021	Kim, Jae-Ick/0000-0001-9705-0394; Zhuo, Min/0000-0001-9062-3241; Collingridge, Graham L/0000-0002-9572-5359; Lee, Kyungmin/0000-0002-5425-4212; Ahn, Sung Ji/0000-0001-8836-8069; Baek, Jinhee/0000-0002-0998-0047; Kim, Kyoung-Han/0000-0002-0433-656X; Kim, Sang Jeong/0000-0001-8931-3713; Kim, Hyun/0000-0002-7210-5798; Ko, Hyoung-Gon/0000-0002-7730-6986; Park, Soowon/0000-0002-3348-940X	Korean Ministry of Science and Technology; World Class University; BK21 fellowship; Seoul Science fellowship; Canadian Institutes of Health Research [62954]; MRC [G0601813] Funding Source: UKRI; Medical Research Council [G0601813] Funding Source: researchfish	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); World Class University; BK21 fellowship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul Science fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Creative Research Initiatives Program of the Korean Ministry of Science and Technology and World Class University project. J.-I.K. and H.-R.L. are supported by a BK21 fellowship and Seoul Science fellowship. S.-E. S. and J.B. are supported by a BK21 fellowship. P. H. B. is a Career Investigator of the Heart and Stroke Foundation of Ontario and has support from a Canadian Institutes of Health Research grant (62954). B.-K.K. is a Yonam Foundation Scholar. G. L. C. and M.Z. are WCU International Scholars.	Barros DM, 2001, BEHAV PHARMACOL, V12, P629, DOI 10.1097/00008877-200112000-00007; Bartlett SE, 1999, J NEUROSCI RES, V56, P44, DOI 10.1002/(SICI)1097-4547(19990401)56:1<44::AID-JNR6>3.0.CO;2-6; Bernstein HG, 1998, CELL MOL BIOL, V44, P973; Bondev A, 1999, BIOL CHEM, V380, P1337, DOI 10.1515/BC.1999.171; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hayer S, 2009, FASEB J, V23, P4288, DOI 10.1096/fj.09-135160; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jin YJ, 2007, NEURON, V55, P277, DOI 10.1016/j.neuron.2007.06.035; Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kerfant EG, 2006, TRENDS CARDIOVAS MED, V16, P250, DOI 10.1016/j.tcm.2006.04.006; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Morishita W, 1997, J NEUROSCI, V17, P941; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Opazo P, 2003, J NEUROSCI, V23, P3679; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Ran I, 2009, J NEUROSCI, V29, P5605, DOI 10.1523/JNEUROSCI.5355-08.2009; Sanna PP, 2002, J NEUROSCI, V22, P3359; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SELBACH O, 2009, ACTA PHYSL OXF, V198, P277; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Yamboliev IA, 2000, AM J PHYSIOL-CELL PH, V279, pC352, DOI 10.1152/ajpcell.2000.279.2.C352; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; Zhuo M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-4	50	108	109	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1447	U123		10.1038/nn.2937	http://dx.doi.org/10.1038/nn.2937			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22019731				2022-12-25	WOS:000296518600021
J	Venken, KJT; Simpson, JH; Bellen, HJ				Venken, Koen J. T.; Simpson, Julie H.; Bellen, Hugo J.			Genetic Manipulation of Genes and Cells in the Nervous System of the Fruit Fly	NEURON			English	Editorial Material							SITE-SPECIFIC RECOMBINATION; GREEN FLUORESCENT PROTEIN; MALE COURTSHIP BEHAVIOR; ENCODED OPTICAL SENSOR; SHAW POTASSIUM CHANNEL; GENOME-WIDE ANALYSIS; DEFINED END-POINTS; NEURAL STEM-CELLS; TOXIN LIGHT-CHAIN; DROSOPHILA-MELANOGASTER	Research in the fruit fly Drosophila melanogaster has led to insights in neural development, axon guidance, ion channel function, synaptic transmission, learning and memory, diurnal rhythmicity, and neural disease that have had broad implications for neuroscience. Drosophila is currently the eukaryotic model organism that permits the most sophisticated in vivo manipulations to address the function of neurons and neuronally expressed genes. Here, we summarize many of the techniques that help assess the role of specific neurons by labeling, removing, or altering their activity. We also survey genetic manipulations to identify and characterize neural genes by mutation, overexpression, and protein labeling. Here, we attempt to acquaint the reader with available options and contexts to apply these methods.	[Simpson, Julie H.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Venken, Koen J. T.; Bellen, Hugo J.] Baylor Coll Med, Neurol Res Inst, Depat Mol & Human Genet, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Dept Neurosci, Program Dev Biol, Houston, TX 77030 USA	Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Simpson, JH (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	simpsonj@janelia.hhmi.org; hbellen@bcm.tmc.edu	Venken, Koen/B-9909-2013	Venken, Koen/0000-0003-0741-4698; Simpson, Julie/0000-0002-6793-7100; Bellen, Hugo/0000-0001-5992-5989	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [RC4 GM096355-01, T32 GM007526, R01 GM067858, RC4 GM096355, T32 GM007526-34, R01 GM067858-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096355, T32GM007526, R01GM067858] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; ALDERSON T, 1965, NATURE, V207, P164, DOI 10.1038/207164a0; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Allen MJ, 2002, GENESIS, V34, P132, DOI 10.1002/gene.10129; Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Apitz H, 2004, DEV GENES EVOL, V214, P453, DOI 10.1007/s00427-004-0423-3; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BELLEN HJ, 1992, DEVELOPMENT, V114, P787; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Bello B, 1998, DEVELOPMENT, V125, P2193; Benton R, 2011, NEURON, V69, P399, DOI 10.1016/j.neuron.2011.01.021; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bieschke ET, 1998, MOL GEN GENET, V258, P571, DOI 10.1007/s004380050770; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Blumenstiel JP, 2009, GENETICS, V182, P25, DOI 10.1534/genetics.109.101998; Boekel Christian, 2008, V420, P119, DOI 10.1007/978-1-59745-583-1_7; Bohm RA, 2010, P NATL ACAD SCI USA, V107, P16378, DOI 10.1073/pnas.1004669107; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Bullock T. H., 1978, NEUROBIOLOGY MAUTHNE, P1; Busch S, 2010, J COMP NEUROL, V518, P2355, DOI 10.1002/cne.22337; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cachero S, 2011, NAT METHODS, V8, P217, DOI 10.1038/nmeth0311-217; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chen D, 2008, NAT METHODS, V5, P323, DOI [10.1038/NMETH.1191, 10.1038/nmeth.1191]; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Choi CM, 2009, SCIENCE, V324, P54, DOI 10.1126/science.1168275; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Clyne PJ, 2003, GENETICS, V165, P1433; Cobb Matthew, 2009, SEB Experimental Biology Series, V63, P1; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Cook KR, 2010, FLY, V4, P88, DOI 10.4161/fly.4.1.11230; Cook RK, 2010, GENETICS, V186, P1095, DOI 10.1534/genetics.110.123265; COOLEY L, 1990, P NATL ACAD SCI USA, V87, P3170, DOI 10.1073/pnas.87.8.3170; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Diegelmann S, 2008, FLY, V2, P236, DOI 10.4161/fly.6817; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dornan AJ, 2005, GENESIS, V42, P236, DOI 10.1002/gene.20143; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Edwards Alexis C, 2009, BMC Biol, V7, P29, DOI 10.1186/1741-7007-7-29; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fischbach KF, 2008, ADV EXP MED BIOL, V628, P115, DOI 10.1007/978-0-387-78261-4_8; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Fotowat H, 2009, J NEUROPHYSIOL, V102, P875, DOI 10.1152/jn.00073.2009; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gao G, 2008, P NATL ACAD SCI USA, V105, P13999, DOI 10.1073/pnas.0805843105; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Gonzalez-Bellido PT, 2009, J NEUROSCI, V29, P14199, DOI 10.1523/JNEUROSCI.2873-09.2009; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grant D, 1998, GENETICS, V149, P1019; Griffin R, 2009, NAT METHODS, V6, P600, DOI 10.1038/nmeth.1349; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guerrero G, 2002, BIOPHYS J, V83, P3607, DOI 10.1016/S0006-3495(02)75361-7; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Halfon MS, 2002, GENESIS, V34, P135, DOI 10.1002/gene.10136; HALL JC, 1979, GENETICS, V92, P437; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; Han DD, 2000, DEVELOPMENT, V127, P573; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1; Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hodge JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002274; Hodge JJL, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.013.2009; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Holmes TC, 2007, COLD SPRING HARB MON, V49, P19; Horn C, 2003, GENETICS, V163, P647; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Huang J, 2011, GENETICS, V189, P391, DOI 10.1534/genetics.111.129247; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Huet F, 2002, P NATL ACAD SCI USA, V99, P9948, DOI 10.1073/pnas.142310099; Hui EKW, 1998, CELL MOL LIFE SCI, V54, P1403, DOI 10.1007/s000180050262; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Jayaraman V, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/003.2007, 10.3389/neuro.04.003.2007]; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jenett A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-544; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kasuya J, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.011.2009; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Knowles-Barley S, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq005; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kondo S, 2009, GENETICS, V183, P1165, DOI 10.1534/genetics.109.106567; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kong EC, 2010, ALCOHOL CLIN EXP RES, V34, P302, DOI 10.1111/j.1530-0277.2009.01093.x; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kulkarni NH, 2002, GENETICS, V161, P1507; KUNES S, 1991, GENE DEV, V5, P970, DOI 10.1101/gad.5.6.970; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; lampietro C., 2010, PLOS GENET, V6; Langer CCH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008928; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Le T, 2007, BIOTECHNIQUES, V42, P162, DOI 10.2144/000112386; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Liebl FLW, 2006, J NEUROBIOL, V66, P332, DOI 10.1002/neu.20229; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; LIN DM, 1995, NEURON, V14, P707, DOI 10.1016/0896-6273(95)90215-5; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529; Luan H, 2007, CURR OPIN NEUROBIOL, V17, P572, DOI 10.1016/j.conb.2007.10.001; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martin JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000275; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Mathieu J, 2007, GENETICS, V176, P1579, DOI 10.1534/genetics.107.071282; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; McNabb SL, 2008, J EXP BIOL, V211, P2263, DOI 10.1242/jeb.015818; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; Meinertzhagen IA, 2010, ACTA ZOOL-STOCKHOLM, V91, P64, DOI 10.1111/j.1463-6395.2009.00425.x; Meinertzhagen IA, 2009, J NEUROGENET, V23, P68, DOI 10.1080/01677060802610604; Meissner GW, 2011, GENETICS, V189, P195, DOI 10.1534/genetics.111.129940; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyazaki T, 2010, J COMP NEUROL, V518, P4147, DOI 10.1002/cne.22433; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; Mohr SE, 2002, GENETICS, V162, P165; Moline MM, 1999, DEVELOPMENT, V126, P4375; Mondal K, 2007, J MOL BIOL, V370, P939, DOI 10.1016/j.jmb.2007.05.035; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Myrick KV, 2009, GENETICS, V182, P653, DOI 10.1534/genetics.109.103762; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Kane CJ, 2011, CURR TOP BEHAV NEURO, V7, P37, DOI 10.1007/7854_2010_110; O'Keefe LV, 2007, TRENDS GENET, V23, P238, DOI 10.1016/j.tig.2007.03.007; Oh SW, 2003, GENETICS, V163, P195; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Pare AC, 2009, GENETICS, V181, P53, DOI 10.1534/genetics.108.094193; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Peng HC, 2011, NAT METHODS, V8, P493, DOI [10.1038/NMETH.1602, 10.1038/nmeth.1602]; Pepple KL, 2008, DEVELOPMENT, V135, P4071, DOI 10.1242/dev.028951; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Peter A, 2002, EMBO REP, V3, P34, DOI 10.1093/embo-reports/kvf012; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Ping Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016043; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Potter CJ, 2011, NAT PROTOC, V6, P1105, DOI 10.1038/nprot.2011.347; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Raghu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019472; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Rollmann SM, 2005, J NEUROBIOL, V63, P146, DOI 10.1002/neu.20123; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Roman G, 2002, GENESIS, V34, P127, DOI 10.1002/gene.10133; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Rong Y.S., 2002, GENE DEV, V16, P1566; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Roy S, 2010, FLY, V4, P12, DOI 10.4161/fly.4.1.10995; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schulz JG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp450; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Sepp KJ, 1999, GENETICS, V151, P1093; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Siegal ML, 1996, GENETICS, V144, P715; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Simpson JH, 2009, ADV GENET, V65, P79, DOI 10.1016/S0065-2660(09)65003-3; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Smith HK, 1996, DEV GENES EVOL, V206, P14, DOI 10.1007/s004270050026; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Stebbins MJ, 2001, GENE, V270, P103, DOI 10.1016/S0378-1119(01)00447-4; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stowers R.S., 2011, FLY AUSTIN, V5; Stowers RS, 1999, GENETICS, V152, P1631; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Sun BH, 2001, COMP BIOCHEM PHYS B, V130, P521, DOI 10.1016/S1096-4959(01)00470-5; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; SUZUKI DT, 1971, P NATL ACAD SCI USA, V68, P890, DOI 10.1073/pnas.68.5.890; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Szuts D, 2000, P NATL ACAD SCI USA, V97, P5351, DOI 10.1073/pnas.97.10.5351; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Ting CY, 2011, GENETICS, V188, P229, DOI 10.1534/genetics.110.126193; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; Umezaki Y, 2011, J INSECT PHYSIOL, V57, P1290, DOI 10.1016/j.jinsphys.2011.06.004; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Venken KJT, 2010, GENETICS, V186, P1111, DOI 10.1534/genetics.110.121285; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang H, 2010, GENOME RES, V20, P981, DOI 10.1101/gr.102921.109; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Weng RF, 2009, GENETICS, V183, P399, DOI 10.1534/genetics.109.105213; Wesolowska N, 2010, FLY, V4, P53, DOI 10.4161/fly.4.1.10993; White B, 2001, CURR BIOL, V11, pR1041, DOI 10.1016/S0960-9822(01)00621-2; White BH, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.020.2009; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wing JP, 1998, CELL DEATH DIFFER, V5, P930, DOI 10.1038/sj.cdd.4400423; Witsell A, 2009, GENETICS, V183, P1187, DOI 10.1534/genetics.109.108472; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273; XU T, 1993, DEVELOPMENT, V117, P1223; Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107; Yamamoto-Hino M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001254; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Yasunaga K, 2006, MECH DEVELOP, V123, P893, DOI 10.1016/j.mod.2006.08.008; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Yu DH, 2003, J NEUROSCI, V23, P64; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345; Yu HH, 2009, J NEUROSCI, V29, P1904, DOI 10.1523/JNEUROSCI.5743-08.2009; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang W, 2007, EUR J NEUROSCI, V26, P2405, DOI 10.1111/j.1460-9568.2007.05862.x; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131; Zimmermann G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005100; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	370	274	277	2	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					202	230		10.1016/j.neuron.2011.09.021	http://dx.doi.org/10.1016/j.neuron.2011.09.021			29	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017985	Green Accepted, Bronze			2022-12-25	WOS:000296224000006
J	Bromberg-Martin, ES; Hikosaka, O				Bromberg-Martin, Ethan S.; Hikosaka, Okihide			Lateral habenula neurons signal errors in the prediction of reward information	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINE NEURONS; OBSERVING RESPONSES; STIMULATION; UNCERTAINTY; ACQUISITION; ENCODE; DECISIONS; CORTEX	Humans and animals have the ability to predict future events, which they cultivate by continuously searching their environment for sources of predictive information. However, little is known about the neural systems that motivate this behavior. We hypothesized that information-seeking is assigned value by the same circuits that support reward-seeking, such that neural signals encoding reward prediction errors (RPEs) include analogous information prediction errors (IPEs). To test this, we recorded from neurons in the lateral habenula, a nucleus that encodes RPEs, while monkeys chose between cues that provided different chances to view information about upcoming rewards. We found that a subpopulation of lateral habenula neurons transmitted signals resembling IPEs, responding when reward information was unexpectedly cued, delivered or denied. These signals evaluated information sources reliably, even when the monkey's decisions did not. These neurons could provide a common instructive signal for reward-seeking and information-seeking behavior.	[Bromberg-Martin, Ethan S.; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Bromberg-Martin, ES (corresponding author), NEI, Sensorimotor Res Lab, US Natl Inst Hlth, Bldg 10, Bethesda, MD 20892 USA.	bromberge@mail.nih.gov			National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Matsumoto, S. Hong, I. Monosov, M. Yasuda, S. Yamamoto, Y. Tachibana, H. Kim and D. Lee for valuable discussions. This work was supported by the intramural research program at the National Eye Institute.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beierholm U.R., 2010, PLOS COMPUT BIOL, V6, P9; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Butko NJ, 2010, IEEE T AUTON MENT DE, V2, P91, DOI 10.1109/TAMD.2010.2051029; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; CHEW SH, 1994, J RISK UNCERTAINTY, V8, P267, DOI 10.1007/BF01064045; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; DALY HB, 1992, LEARNING AND MEMORY : THE BEHAVIORAL AND BIOLOGICAL SUBSTRATES, P81; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DINSMOOR JA, 1983, BEHAV BRAIN SCI, V6, P693, DOI 10.1017/S0140525X00017969; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eliaz K, 2007, AM ECON REV, V97, P166, DOI 10.1257/aer.97.2.166; Fantino E., 1977, HDB OPERANT BEHAV; Friedman A, 2011, NEUROPHARMACOLOGY, V60, P381, DOI 10.1016/j.neuropharm.2010.10.006; Hayden BY, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00166; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; Houk JC, 1995, MODELS INFORMATION P, P249; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; KREPS DM, 1978, ECONOMETRICA, V46, P185, DOI 10.2307/1913656; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oyama K, 2010, J NEUROSCI, V30, P11447, DOI 10.1523/JNEUROSCI.1719-10.2010; PROKASY WF, 1956, J COMP PHYSIOL PSYCH, V49, P131, DOI 10.1037/h0046740; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; SUTHERLAND RJ, 1981, J COMP PHYSIOL PSYCH, V95, P781, DOI 10.1037/h0077833; WARD EF, 1971, PSYCHON SCI, V24, P139, DOI 10.3758/BF03331790; WYCKOFF LB, 1952, PSYCHOL REV, V59, P431, DOI 10.1037/h0053932; WYCKOFF LB, 1959, PSYCHOL REV, V66, P68, DOI 10.1037/h0046882	50	159	159	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1209	U149		10.1038/nn.2902	http://dx.doi.org/10.1038/nn.2902			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857659	Green Accepted			2022-12-25	WOS:000294284900023
J	Antzoulatos, EG; Miller, EK				Antzoulatos, Evan G.; Miller, Earl K.			Differences between Neural Activity in Prefrontal Cortex and Striatum during Learning of Novel Abstract Categories	NEURON			English	Article							BASAL GANGLIA; REPRESENTATION; PATTERNS; MONKEYS	Learning to classify diverse experiences into meaningful groups, like categories, is fundamental to normal cognition. To understand its neural basis, we simultaneously recorded from multiple electrodes in lateral prefrontal cortex and dorsal striatum, two interconnected brain structures critical for learning. Each day, monkeys learned to associate novel abstract, dot-based categories with a right versus left saccade. Early on, when they could acquire specific stimulus-response associations, striatum activity was an earlier predictor of the corresponding saccade. However, as the number of exemplars increased and monkeys had to learn to classify them, PFC activity began to predict the saccade associated with each category before the striatum. While monkeys were categorizing novel exemplars at a high rate, PFC activity was a strong predictor of their corresponding saccade early in the trial before the striate! neurons. These results suggest that striatum plays a greater role in stimulus-response association and PFC in abstraction of categories.	[Antzoulatos, Evan G.; Miller, Earl K.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Miller, EK (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ekmiller@mit.edu	Antzoulatos, Evan/D-3204-2012; Miller, Earl K./AAE-8187-2019; Antzoulatos, Evan/Q-9726-2016	Antzoulatos, Evan/0000-0002-7366-2078; Miller, Earl K./0000-0002-0582-6958; Antzoulatos, Evan/0000-0002-7366-2078	National Institutes of Mental Health [5RC1MH088316-02]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088316, R01MH065252] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank S. Brincat, T. Buschman, J. Cromer, C. Diogo, D. Floravante, V. Puig, J. Rose, J. Roy, M. Siegel, and M. Wicherski for helpful discussions and comments on the manuscript. They also thank K. MacCully and D. Ouellette for technical assistance and J. Liu and M. Machon for help in animal training. This work was funded by the National Institutes of Mental Health (5RC1MH088316-02), the Simons Foundation, and Richard and Linda Hardy.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Ashby FG, 2011, ANN NY ACAD SCI, V1224, P147, DOI 10.1111/j.1749-6632.2010.05874.x; BLOUGH DS, 1985, J EXP PSYCHOL ANIM B, V11, P261, DOI 10.1037/0097-7403.11.2.261; Cromer JA, 2011, J COGNITIVE NEUROSCI, V23, P1823, DOI 10.1162/jocn.2010.21555; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; Dayan P., 2001, THEORETICAL NEUROSCI; Everling S, 2006, EUR J NEUROSCI, V23, P2197, DOI 10.1111/j.1460-9568.2006.04736.x; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Grandin Temple, 2006, THINKING PICTURES MY, V2nd; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Miller E.K., 2008, NEUROSCIENCE RULE GU; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; POSNER MI, 1967, J EXP PSYCHOL, V73, P28, DOI 10.1037/h0024135; Reber PJ, 1998, P NATL ACAD SCI USA, V95, P747, DOI 10.1073/pnas.95.2.747; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Seger CA, 2000, NEUROPSYCHOLOGIA, V38, P1316, DOI 10.1016/S0028-3932(00)00014-2; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Smith JD, 2008, J EXP PSYCHOL GEN, V137, P390, DOI 10.1037/0096-3445.137.2.390; Squire LR, 1995, P NATL ACAD SCI USA, V92, P12470, DOI 10.1073/pnas.92.26.12470; Sripati AP, 2009, J NEUROSCI, V29, P7788, DOI 10.1523/JNEUROSCI.5766-08.2009; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 2002, NEUROIMAGE, V16, P401, DOI 10.1006/nimg.2002.1109; Zaki SR, 2003, J INT NEUROPSYCH SOC, V9, P394, DOI 10.1017/S1355617703930050	30	84	87	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					243	249		10.1016/j.neuron.2011.05.040	http://dx.doi.org/10.1016/j.neuron.2011.05.040			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	801JF	21791284	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000293433900009
J	Kuo, SP; Trussell, LO				Kuo, Sidney P.; Trussell, Laurence O.			Spontaneous Spiking and Synaptic Depression Underlie Noradrenergic Control of Feed-Forward Inhibition	NEURON			English	Article							DORSAL COCHLEAR NUCLEUS; LOCUS-COERULEUS NEURONS; GREEN FLUORESCENT PROTEIN; SHORT-TERM DEPRESSION; CARTWHEEL CELLS; PURKINJE-CELLS; THALAMOCORTICAL SYNAPSES; TRANSGENIC MICE; STELLATE CELLS; BARREL CORTEX	Inhibitory interneurons across diverse brain regions commonly exhibit spontaneous spiking activity, even in the absence of external stimuli. It is not well understood how stimulus-evoked inhibition can be distinguished from background inhibition arising from spontaneous firing. We found that noradrenaline simultaneously reduced spontaneous inhibitory inputs and enhanced evoked inhibitory currents recorded from principal neurons of the mouse dorsal cochlear nucleus (DCN). Together, these effects produced a large increase in signal-to-noise ratio for stimulus-evoked inhibition. Surprisingly, the opposing effects on background and evoked currents could both be attributed to noradrenergic silencing of spontaneous spiking in glycinergic interneurons. During spontaneous firing, glycine release was decreased due to strong short-term depression. Elimination of background spiking relieved inhibitory synapses from depression and thereby enhanced stimulus-evoked inhibition. Our findings illustrate a simple yet powerful neuromodulatory mechanism to shift the balance between background and stimulus-evoked signals.	[Kuo, Sidney P.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97239 USA; [Kuo, Sidney P.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; [Kuo, Sidney P.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Trussell, LO (corresponding author), Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97239 USA.	trussell@ohsu.edu			NIH [RO1DC004450, F31DC010120]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004450, F31DC010120] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to Pierre Apostolides and Drs. Hai Huang, Haining Zhong, and Craig Jahr for helpful discussions and to Elizabeth Brodeen-Kuo and Drs. Kevin Bender and John Williams for advice and suggestions on the manuscript. We thank Dr. Sascha du Lac for providing GIN and GlyT2-EGFP mice. This work was supported by NIH grants RO1DC004450 (LOT.) and F31DC010120 (S.P.K.).	ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Arima J, 1998, J PHYSIOL-LONDON, V508, P57, DOI 10.1111/j.1469-7793.1998.057br.x; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Bender KJ, 2010, NEURON, V68, P500, DOI 10.1016/j.neuron.2010.09.026; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Carr DB, 2007, J PHYSIOL-LONDON, V584, P437, DOI 10.1113/jphysiol.2007.141671; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Davis KA, 1997, J NEUROSCI, V17, P6798; Davis KA, 1996, J NEUROPHYSIOL, V76, P3012, DOI 10.1152/jn.1996.76.5.3012; deNo R Lorente, 1981, PRIMARY ACOUSTIC NUC; DODT HU, 2002, SCI STKE, pPL2; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; FREEDMAN R, 1976, BRIT J PHARMACOL, V57, P603, DOI 10.1111/j.1476-5381.1976.tb10391.x; Frerking M, 2006, J NEUROPHYSIOL, V96, P2139, DOI 10.1152/jn.00243.2006; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Golding NL, 1997, J NEUROPHYSIOL, V78, P248, DOI 10.1152/jn.1997.78.1.248; Groh A, 2008, J NEUROSCI, V28, P9652, DOI 10.1523/JNEUROSCI.1554-08.2008; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Hirata A, 2006, J NEUROSCI, V26, P4426, DOI 10.1523/JNEUROSCI.5298-05.2006; Hirono M, 2006, J NEUROPHYSIOL, V95, P700, DOI 10.1152/jn.00711.2005; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; JONES BE, 1983, J COMP NEUROL, V215, P382, DOI 10.1002/cne.902150404; Kim Y, 2007, J NEUROPHYSIOL, V97, P1705, DOI 10.1152/jn.00536.2006; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; KLEPPER A, 1991, BRAIN RES, V557, P190, DOI 10.1016/0006-8993(91)90134-H; Kondo S, 1997, J PHYSIOL-LONDON, V498, P165, DOI 10.1113/jphysiol.1997.sp021849; KOSSL M, 1989, J NEUROSCI, V9, P4169; KOSSL M, 1988, J COMP NEUROL, V269, P523, DOI 10.1002/cne.902690405; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; KROMER LF, 1976, BRAIN RES, V118, P531, DOI 10.1016/0006-8993(76)90327-9; Leao RM, 2002, J NEUROPHYSIOL, V87, P2297, DOI 10.1152/jn.2002.87.5.2297; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Mancilla JG, 2009, J NEUROPHYSIOL, V102, P1287, DOI 10.1152/jn.91272.2008; MANIS PB, 1994, J COMP NEUROL, V348, P261, DOI 10.1002/cne.903480208; May BJ, 2000, HEARING RES, V148, P74, DOI 10.1016/S0378-5955(00)00142-8; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Portfors CV, 2007, J NEUROPHYSIOL, V98, P744, DOI 10.1152/jn.01356.2006; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Roberts MT, 2008, J NEUROSCI, V28, P9440, DOI 10.1523/JNEUROSCI.2226-08.2008; Roberts MT, 2010, J NEUROPHYSIOL, V104, P2462, DOI 10.1152/jn.00312.2010; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Solis MM, 2006, J NEUROPHYSIOL, V95, P2265, DOI 10.1152/jn.00836.2005; Sutherland DP, 1998, HEARING RES, V120, P86, DOI 10.1016/S0378-5955(98)00056-2; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Telgkamp P, 2002, J NEUROSCI, V22, P8447; Thompson AM, 2003, J COMP NEUROL, V457, P374, DOI 10.1002/cne.10540; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; WATERHOUSE BD, 1980, EXP NEUROL, V67, P11, DOI 10.1016/0014-4886(80)90159-4; WILLIAMS JT, 1985, NEUROSCIENCE, V14, P95, DOI 10.1016/0306-4522(85)90166-6; WILLIAMS JT, 1985, NEUROSCIENCE, V14, P103, DOI 10.1016/0306-4522(85)90167-8; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; ZHANG S, 1993, J NEUROPHYSIOL, V69, P1384, DOI 10.1152/jn.1993.69.5.1384; ZHANG S, 1994, J NEUROPHYSIOL, V71, P914, DOI 10.1152/jn.1994.71.3.914; Zhao YJ, 2011, J NEUROSCI, V31, P3158, DOI 10.1523/JNEUROSCI.5303-10.2011; Zhao YJ, 2009, J NEUROPHYSIOL, V101, P2434, DOI 10.1152/jn.00047.2009	69	37	37	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 28	2011	71	2					306	318		10.1016/j.neuron.2011.05.039	http://dx.doi.org/10.1016/j.neuron.2011.05.039			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791289	Bronze, Green Accepted			2022-12-25	WOS:000293433900014
J	Zhou, HH; Desimone, R				Zhou, Huihui; Desimone, Robert			Feature-Based Attention in the Frontal Eye Field and Area V4 during Visual Search	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; NEURAL MECHANISMS; TOP-DOWN; PREFRONTAL CORTEX; VENTRAL STREAM; SALIENCE MAP; MACAQUE; NEURONS; SELECTIVITY; RESPONSES	When we search for a target in a crowded visual scene, we often use the distinguishing features of the target, such as color or shape, to guide our attention and eye movements. To investigate the neural mechanisms of feature-based attention, we simultaneously recorded neural responses in the frontal eye field (FEF) and area V4 while monkeys performed a visual search task. The responses of cells in both areas were modulated by feature attention, independent of spatial attention, and the magnitude of response enhancement was inversely correlated with the number of saccades needed to find the target. However, an analysis of the latency of sensory and attentional influences on responses suggested that V4 provides bottom-up sensory information about stimulus features, whereas the FEF provides a top-down attentional bias toward target features that modulates sensory processing in V4 and that could be used to guide the eyes to a searched-for target.	[Zhou, Huihui; Desimone, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zhou, HH (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhouhuih@mit.edu	Desimone, Robert/G-1121-2018	Desimone, Robert/0000-0002-5938-4227	NIH [EY017921, 5P30EY2621-33]; NATIONAL EYE INSTITUTE [P30EY002621, R01EY017921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors were supported by EY017921 and 5P30EY2621-33 (NIH). We thank Matt Heard, Jonathan Winkle, and Grant Pielli for technical help and Narcisse Bichot, Daniel Baldauf, and Ying Zhang for comments on the manuscript.	Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Buffalo EA, 2010, P NATL ACAD SCI USA, V107, P361, DOI 10.1073/pnas.0907658106; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Egner T, 2008, J NEUROSCI, V28, P6141, DOI 10.1523/JNEUROSCI.1262-08.2008; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Hayden BY, 2005, NEURON, V47, P637, DOI 10.1016/j.neuron.2005.07.020; Ipata AE, 2009, EXP BRAIN RES, V192, P479, DOI 10.1007/s00221-008-1557-8; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Monosov IE, 2010, P NATL ACAD SCI USA, V107, P13105, DOI 10.1073/pnas.1002870107; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Peng XM, 2008, J NEUROPHYSIOL, V100, P796, DOI 10.1152/jn.01188.2007; Phillips AN, 2010, J NEUROPHYSIOL, V103, P1238, DOI 10.1152/jn.00776.2009; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Ungerleider LG, 2008, CEREB CORTEX, V18, P477, DOI 10.1093/cercor/bhm061; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	46	151	155	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1205	1217		10.1016/j.neuron.2011.04.032	http://dx.doi.org/10.1016/j.neuron.2011.04.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689605	Green Published, Bronze, Green Accepted			2022-12-25	WOS:000292410700017
J	Chakrabarty, P; Ceballos-Diaz, C; Lin, WL; Beccard, A; Jansen-West, K; McFarland, NR; Janus, C; Dickson, D; Das, P; Golde, TE				Chakrabarty, Paramita; Ceballos-Diaz, Carolina; Lin, Wen-Lang; Beccard, Amanda; Jansen-West, Karen; McFarland, Nikolaus R.; Janus, Christopher; Dickson, Dennis; Das, Pritam; Golde, Todd E.			Interferon-gamma induces progressive nigrostriatal degeneration and basal ganglia calcification	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MICE; CALCINOSIS; EXPRESSION	We found that CNS-directed expression of interferon-gamma (IFN-gamma) resulted in basal ganglia calcification, reminiscent of human idiopathic basal ganglia calcification (IBGC), and nigrostriatal degeneration. Our results indicate that IFN-gamma mediates age-progressive nigrostriatal degeneration in the absence of exogenous stressors. Further study of this model may provide insight into selective nigrostriatal degeneration in human IBGC and other Parkinson syndromes.	[Chakrabarty, Paramita; Ceballos-Diaz, Carolina; Beccard, Amanda; Janus, Christopher; Golde, Todd E.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Lin, Wen-Lang; Jansen-West, Karen; Dickson, Dennis; Das, Pritam] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [McFarland, Nikolaus R.] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Mayo Clinic; State University System of Florida; University of Florida	Golde, TE (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	tgolde@mbi.ufl.edu	McFarland, Nikolaus R/I-4209-2017	McFarland, Nikolaus R/0000-0002-8699-8857; Dickson, Dennis W/0000-0001-7189-7917	US National Institutes of Health/National Institute on Aging; Ellison Medical Foundation; American Health Assistance Foundation; NATIONAL INSTITUTE ON AGING [R01AG029886, R01AG018454, P01AG025531] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health/National Institute on Aging (T.E.G.), the Ellison Medical Foundation (T.E.G.) and American Health Assistance Foundation (P.D.).	Baba Y, 2005, MAYO CLIN PROC, V80, P641, DOI 10.4065/80.5.641; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Devos D, 2010, FUND CLIN PHARMACOL, V24, P407, DOI 10.1111/j.1472-8206.2009.00798.x; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Horwitz MS, 1997, NAT MED, V3, P1037, DOI 10.1038/nm0997-1037; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Manyam BV, 2001, MOVEMENT DISORD, V16, P258, DOI 10.1002/mds.1049; Morishima T, 2002, EUR J NEUROL, V9, P521, DOI 10.1046/j.1468-1331.2002.00449.x; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Paschali A, 2009, CLIN NUCL MED, V34, P421, DOI 10.1097/RLU.0b013e3181a7d195; Savoldi F, 1980, Acta Neurol (Napoli), V2, P231; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shelton GD, 1999, MUSCLE NERVE, V22, P156, DOI 10.1002/(SICI)1097-4598(199902)22:2<156::AID-MUS3>3.0.CO;2-U	15	53	55	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					694	696		10.1038/nn.2829	http://dx.doi.org/10.1038/nn.2829			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21572432	Green Accepted			2022-12-25	WOS:000290958000010
J	O'Sullivan, ML; de Wit, J; Savas, JN; Comoletti, D; Otto-Hitt, S; Yates, JR; Ghosh, A				O'Sullivan, Matthew L.; de Wit, Joris; Savas, Jeffrey N.; Comoletti, Davide; Otto-Hitt, Stefanie; Yates, John R., III; Ghosh, Anirvan			FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development	NEURON			English	Article							ALPHA-LATROTOXIN RECEPTOR; RICH REPEAT PROTEINS; COUPLED RECEPTORS; NEURAL CIRCUITS; CELL-ADHESION; FAMILY; EXOCYTOSIS; DIFFERENTIATION; SUSCEPTIBILITY; INTERACTS	Latrophilins (LPHNs) are a small family of G protein-coupled receptors known to mediate the massive synaptic exocytosis caused by the black widow spider venom alpha-latrotoxin, but their endogenous ligands and function remain unclear. Mutations in LPHN3 are strongly associated with attention deficit hyperactivity disorder, suggesting a role for latrophilins in human cognitive function. Using affinity chromatography and mass spectrometry, we identify the FLAT family of leucine-rich repeat transmembrane proteins as endogenous postsynaptic ligands for latrophilins. We demonstrate that the FLRT3 and LPHN3 ectodomains interact with high affinity in trans and that interference with this interaction using soluble recombinant LPHN3, LPHN3 shRNA, or FLRT3 shRNA reduces excitatory synapse density in cultured neurons. In addition, reducing FLRT3 levels with shRNA in vivo decreases afferent input strength and dendritic spine number in dentate granule cells. These observations indicate that LPHN3 and its ligand FLRT3 play an important role in glutamatergic synapse development.	[O'Sullivan, Matthew L.; de Wit, Joris; Otto-Hitt, Stefanie; Ghosh, Anirvan] Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Comoletti, Davide] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Comoletti, Davide] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, New Brunswick, NJ 08901 USA; [Ghosh, Anirvan] CNS Discovery, CH-4070 Basel, Switzerland	University of California System; University of California San Diego; Scripps Research Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA.	aghosh@ucsd.edu		O'Sullivan, Matthew/0000-0003-2201-0106; de Wit, Joris/0000-0003-1120-1089	Brain and Behavior Research Foundation (formerly NARSAD); Autism Speaks grant [2617]; NIH [F32AG039127, NS067216, NS064124, P41 RR011823, R01 MH067880]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064124, R01NS067216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER	Brain and Behavior Research Foundation (formerly NARSAD); Autism Speaks grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Katie Tiglio, Joseph Antonios, Christine Wu, and Tim Young for assistance with virus injections, virus and recombinant protein production, and antibody testing. This work was supported by the Brain and Behavior Research Foundation (formerly NARSAD) (J.d.W.), Autism Speaks grant 2617 (D.C.), NIH fellowship F32AG039127 (J.N.S.), and NIH grants NS067216 (A.G.), NS064124 (A.G.), P41 RR011823 (J.R.Y.), and R01 MH067880 (J.R.Y.).	Allen Institute for Brain Science, 2009, ALL MOUS BRAIN ATL; Arcos-Burgos M, 2010, MOL PSYCHIATR, V15, P1053, DOI 10.1038/mp.2010.6; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Chen XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008411; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Domene S, 2011, AM J MED GENET B, V156B, P11, DOI 10.1002/ajmg.b.31141; Ichtchenko K, 1999, J BIOL CHEM, V274, P5491, DOI 10.1074/jbc.274.9.5491; Ichtchenko K, 1998, EMBO J, V17, P6188, DOI 10.1093/emboj/17.21.6188; Jain M, 2012, MOL PSYCHIATR, V17, P741, DOI 10.1038/mp.2011.59; Karaulanov E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005742; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Martinez AF, 2011, AM J MED GENET B, V156B, P1, DOI 10.1002/ajmg.b.31137; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Ribases M, 2011, GENES BRAIN BEHAV, V10, P149, DOI 10.1111/j.1601-183X.2010.00649.x; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Silva JP, 2009, J BIOL CHEM, V284, P6495, DOI 10.1074/jbc.M806979200; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wheldon LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010264; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189	35	169	182	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					903	910		10.1016/j.neuron.2012.01.018	http://dx.doi.org/10.1016/j.neuron.2012.01.018			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405201	Green Accepted, Bronze			2022-12-25	WOS:000301558600006
J	Wagner, DE; Ho, JJ; Reddien, PW				Wagner, Daniel E.; Ho, Jaclyn J.; Reddien, Peter W.			Genetic Regulators of a Pluripotent Adult Stem Cell System in Planarians Identified by RNAi and Clonal Analysis	CELL STEM CELL			English	Article							SCHMIDTEA-MEDITERRANEA; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; REGENERATION; EXPRESSION; GERMLINE; POLYCOMB; DROSOPHILA; MAINTENANCE	Pluripotency is a central, well-studied feature of embryonic development, but the role of pluripotent cell regulation in somatic tissue regeneration remains poorly understood. In planarians, regeneration of entire animals from tissue fragments is promoted by the activity of adult pluripotent stem cells (cNeoblasts). We utilized transcriptional profiling to identify planarian genes expressed in adult proliferating, regenerative cells (neoblasts). We also developed quantitative clonal analysis methods for expansion and differentiation of cNeoblast descendants that, together with RNAi, revealed gene roles in stem cell biology. Genes encoding two zinc finger proteins, Vasa, a LIM domain protein, Sox and Jun-like transcription factors, two candidate RNA-binding proteins, a Setd8-like protein, and PRC2 (Polycomb) were required for proliferative expansion and/or differentiation of cNeoblast-derived clones. These findings suggest that planarian stem cells utilize molecular mechanisms found in germ cells and other pluripotent cell types and identify genetic regulators of the planarian stem cell system.	[Wagner, Daniel E.; Ho, Jaclyn J.; Reddien, Peter W.] MIT Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Reddien, PW (corresponding author), MIT Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	reddien@wi.mit.edu		/0000-0002-5569-333X; Wagner, Daniel/0000-0002-2983-635X; Ho, Jaclyn/0000-0001-9166-5953	NIH [R01GM080639]; Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Bell for microarray assistance; J. van Wolfswinkel for cDNA sequence assembly; D. Wenemoser and K. Li for fgfr cloning; and P. Hsu, R. Young, D. Kim, S. Lapan, and all P.W.R. lab members for comments and discussion. P.W.R. is an early career scientist of the Howard Hughes Medical Institute and an associate member of the Broad Institute of Harvard and MIT. We acknowledge support from the NIH (R01GM080639) and the Keck Foundation.	Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bardeen CR, 1904, J EXP ZOOL, V1, P191, DOI 10.1002/jez.1400010107; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; DENELL RE, 1978, GENETICS, V90, P277; Dubois F, 1949, B BIOL FR BELG, V83, P213; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Garvin C, 1998, GENETICS, V148, P167; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hayashi T, 2010, DEV GROWTH DIFFER, V52, P131, DOI 10.1111/j.1440-169X.2009.01157.x; Higuchi S, 2007, DEV GROWTH DIFFER, V49, P571, DOI 10.1111/j.1440-169X.2007.00947.x; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ogawa K, 2002, DEV GROWTH DIFFER, V44, P191; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Rouhana L, 2010, DEV BIOL, V341, P429, DOI 10.1016/j.ydbio.2010.02.037; Salvetti A, 2005, DEVELOPMENT, V132, P1863, DOI 10.1242/dev.01785; Salvetti A, 2009, DEV BIOL, V328, P305, DOI 10.1016/j.ydbio.2009.01.029; Scimone ML, 2011, DEVELOPMENT, V138, P4387, DOI 10.1242/dev.068098; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Solana J, 2009, DEV BIOL, V328, P410, DOI 10.1016/j.ydbio.2009.01.043; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Styhler S, 1998, DEVELOPMENT, V125, P1569; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiura T, 2007, EXP CELL RES, V313, P782, DOI 10.1016/j.yexcr.2006.11.014; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang L, 2002, MOL BIOL REP, V29, P369, DOI 10.1023/A:1021246109101; Yamazaki T., 2010, MOL BIOL CELL, V21, P2953; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102	62	129	132	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					299	311		10.1016/j.stem.2012.01.016	http://dx.doi.org/10.1016/j.stem.2012.01.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385657	Green Accepted, Bronze			2022-12-25	WOS:000301466500011
J	Huang, H; Tan, BZ; Shen, YR; Tao, J; Jiang, FL; Sung, YY; Ng, CK; Raida, M; Kohr, G; Higuchi, M; Fatemi-Shariatpanahi, H; Harden, B; Yue, DT; Soong, TW				Huang, Hua; Tan, Bao Zhen; Shen, Yiru; Tao, Jin; Jiang, Fengli; Sung, Ying Ying; Ng, Choon Keow; Raida, Manfred; Koehr, Georg; Higuchi, Miyoko; Fatemi-Shariatpanahi, Hadi; Harden, Bradley; Yue, David T.; Soong, Tuck Wah			RNA Editing of the IQ Domain in Ca(v)1.3 Channels Modulates Their Ca2+-Dependent Inactivation	NEURON			English	Article							SEROTONIN 2C RECEPTORS; PANCREATIC BETA-CELL; SUPRACHIASMATIC NUCLEUS; CALCIUM-CHANNELS; SPLICE VARIANTS; MESSENGER-RNA; CA2+-SENSITIVE INACTIVATION; POTASSIUM CHANNELS; SODIUM-CHANNELS; CA2+ CHANNELS	Adenosine-to-inosine RNA editing is crucial for generating molecular diversity, and serves to regulate protein function through recoding of genomic information. Here, we discover editing within Ca(v)1.3 Ca2+ channels, renown for low-voltage Ca2+-influx and neuronal pacemaking. Significantly, editing occurs within the channel's IQ domain, a calmodulin-binding site mediating inhibitory Ca2+-feedback (CM) on channels. The editing turns out to require RNA adenosine deaminase ADAR2, whose variable activity could underlie a spatially diverse pattern of Ca(v)1.3 editing seen across the brain. Edited Ca(v)1.3 protein is detected both in brain tissue and within the surface membrane of primary neurons. Functionally, edited Ca(v)1.3 channels exhibit strong reduction of CDI; in particular, neurons within the suprachiasmatic nucleus show diminished CM, with higher frequencies of repetitive action-potential and calcium-spike activity, in wild-type versus ADAR2 knockout mice. Our study reveals a mechanism for fine-tuning Ca(v)1.3 channel properties in CNS, which likely impacts a broad spectrum of neurobiological functions.	[Huang, Hua; Tan, Bao Zhen; Shen, Yiru; Tao, Jin; Jiang, Fengli; Sung, Ying Ying; Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Huang, Hua; Tan, Bao Zhen; Soong, Tuck Wah] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Ng, Choon Keow; Raida, Manfred] Ctr Expt Therapeut, Singapore, Singapore; [Koehr, Georg; Higuchi, Miyoko] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Fatemi-Shariatpanahi, Hadi; Harden, Bradley; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; [Fatemi-Shariatpanahi, Hadi; Harden, Bradley; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Soong, Tuck Wah] Natl Neurosci Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Max Planck Society; Johns Hopkins University; Johns Hopkins University; National Neuroscience Institute (NNI)	Soong, TW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.	phsstw@nus.edu.sg	Harden, Bradley/A-1583-2019	Harden, Bradley/0000-0002-3884-1636; Huang, Hua/0000-0002-7421-3696; Tao, Jin/0000-0002-8481-3732	Singapore Biomedical Research Council; NIH [RO1 DC00276, RO1 MH065531, R37 HL076795]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000276, P30DC005211] Funding Source: NIH RePORTER	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	T.W.S. is supported by the Singapore Biomedical Research Council and the NIH (RO1 DC00276). D.T.Y. is supported by the NIH (RO1 MH065531, R37 HL076795, and RO1 DC00276). H.H., B.Z.T., Y.S., J.F.J., Y.Y.S., B.H., and H.F.S. carried out experiments and analysis; M.H bred and genotyped the wild type GluR-B<SUP>R/R</SUP> and knockout ADAR2<SUP>-/-</SUP>/GluR-B<SUP>R/R</SUP> for the molecular and brain slice work; G.K advised on the brain slice work; D.T.Y and T.W.S. supervised the research, analyzed data, made figures, and wrote the article.	Aghajanian G.K., 2002, NEUROPSYCHOPHARMACOL, P15; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cloues RK, 2003, J NEUROSCI, V23, P1593; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Espinosa F, 2008, J NEUROSCI, V28, P5570, DOI 10.1523/JNEUROSCI.0747-08.2008; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fenoglio-Simeone KA, 2009, EPILEPSIA, V50, P2027, DOI 10.1111/j.1528-1167.2009.02163.x; Gan ZJ, 2006, J BIOL CHEM, V281, P33386, DOI 10.1074/jbc.M604484200; Gillespie CF, 1997, BRAIN RES, V759, P181, DOI 10.1016/S0006-8993(97)00235-7; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Itri JN, 2010, J NEUROPHYSIOL, V103, P632, DOI 10.1152/jn.00670.2009; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kawasaki F, 2002, J NEUROSCI, V22, P5856; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liu GH, 2004, MOL PHARMACOL, V65, P1269, DOI 10.1124/mol.65.5.1269; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Mintz EM, 2002, NEUROSCIENCE, V109, P773, DOI 10.1016/S0306-4522(01)00519-X; OHARA BF, 1995, MOL BRAIN RES, V28, P239, DOI 10.1016/0169-328X(94)00212-W; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Paxinos G., 2001, STEREOTAXIC COORDINA; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Raman IM, 1999, J NEUROSCI, V19, P1663; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Schmauss C, 2003, NEUROSCIENTIST, V9, P237, DOI 10.1177/1073858403253669; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sergeeva OA, 2007, CELL MOL NEUROBIOL, V27, P669, DOI 10.1007/s10571-007-9153-1; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Sim CK, 2007, J BIOL RHYTHM, V22, P445, DOI 10.1177/0748730407306041; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Smith L A, 1998, J Neurogenet, V12, P227; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Soong TW, 2002, J NEUROSCI, V22, P10142; Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Taylor JT, 2005, AM J PHYSIOL-ENDOC M, V289, pE900, DOI 10.1152/ajpendo.00101.2005; Tsunemi T, 2002, J BIOL CHEM, V277, P7214, DOI 10.1074/jbc.M108222200; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200	70	90	91	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					304	316		10.1016/j.neuron.2011.11.022	http://dx.doi.org/10.1016/j.neuron.2011.11.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284185	Bronze, Green Accepted			2022-12-25	WOS:000299761600012
J	Atallah, BV; Bruns, W; Carandini, M; Scanziani, M				Atallah, Bassam V.; Bruns, William; Carandini, Matteo; Scanziani, Massimo			Parvalbumin-Expressing Interneurons Linearly Transform Cortical Responses to Visual Stimuli	NEURON			English	Article							INHIBITORY NEURONS; GABAERGIC NEURONS; STRIATE CORTEX; ORIENTATION; SELECTIVITY; CELLS; CAT; MECHANISMS; ATTENTION; SUBTYPES	The response of cortical neurons to a sensory stimulus is shaped by the network in which they are embedded. Here we establish a role of parvalbumin (PV)-expressing cells, a large class of inhibitory neurons that target the soma and perisomatic compartments of pyramidal cells, in controlling cortical responses. By bidirectionally manipulating PV cell activity in visual cortex we show that these neurons strongly modulate layer 2/3 pyramidal cell spiking responses to visual stimuli while only modestly affecting their tuning properties. PV cells' impact on pyramidal cells is captured by a linear transformation, both additive and multiplicative, with a threshold. These results indicate that PV cells are ideally suited to modulate cortical gain and establish a causal relationship between a select neuron type and specific computations performed by the cortex during sensory processing.	[Atallah, Bassam V.] Univ Calif San Diego, Computat Neurosci Grad Program, La Jolla, CA 92093 USA; [Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Bruns, William; Scanziani, Massimo] Univ Calif San Diego, Neurobiol Sect, Div Biol, La Jolla, CA 92093 USA; [Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of London; University College London	Atallah, BV (corresponding author), Univ Calif San Diego, Computat Neurosci Grad Program, La Jolla, CA 92093 USA.	bassam.atallah@gmail.com; mscanziani@ucsd.edu	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682; Atallah, Bassam/0000-0003-2315-7126	NIH [NS061521]; Gatsby Charitable Foundation; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS061521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C. Niell and M. Stryker for providing expertise and sharing code at the initial stages of this project; H. Adesnik for his help implementing optogenetic approaches; S.R. Olsen for his insights and help in developing the visual recording configuration; and J. Evora, A.N. Linder, and P. Abelkop for histology and mouse husbandry. M.C. holds the GlaxoSmithKline / Fight for Sight Chair in Visual Neuroscience. B.V.A. was supported by NIH NS061521. This work was supported by the Gatsby Charitable Foundation and HHMI.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Callaway EM, 2002, J NEUROCYTOL, V31, P231, DOI 10.1023/A:1024165824469; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carandini M, 2007, NEURON, V54, P11, DOI 10.1016/j.neuron.2007.03.019; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CONNORS BW, 1986, J NEUROSCI, V6, P164; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; PRINCE DA, 1978, ANNU REV NEUROSCI, V1, P395, DOI 10.1146/annurev.ne.01.030178.002143; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162	52	390	391	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					159	170		10.1016/j.neuron.2011.12.013	http://dx.doi.org/10.1016/j.neuron.2011.12.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243754	Green Accepted, Bronze			2022-12-25	WOS:000299446800015
J	Kim, J; Su, SC; Wang, HY; Cheng, AW; Cassady, JP; Lodato, MA; Lengner, CJ; Chung, CY; Dawlaty, MM; Tsai, LH; Jaenisch, R				Kim, Jongpil; Su, Susan C.; Wang, Haoyi; Cheng, Albert W.; Cassady, John P.; Lodato, Michael A.; Lengner, Christopher J.; Chung, Chee-Yeun; Dawlaty, Meelad M.; Tsai, Li-Huei; Jaenisch, Rudolf			Functional Integration of Dopaminergic Neurons Directly Converted from Mouse Fibroblasts	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; PARKINSONS-DISEASE; DIRECT CONVERSION; DEFINED FACTORS; ANIMAL-MODEL; MIDBRAIN; GENERATION; PROTEIN; FETAL	Recent advances in somatic cell reprogramming have highlighted the plasticity of the somatic epigenome, particularly through demonstrations of direct lineage reprogramming of one somatic cell type to another by defined factors. However, it is not clear to what extent this type of reprogramming is able to generate fully functional differentiated cells. In addition, the activity of the reprogrammed cells in cell transplantation assays, such as those envisaged for cell-based therapy of Parkinson's disease (PD), remains to be determined. Here we show that ectopic expression of defined transcription factors in mouse tail tip fibroblasts is sufficient to induce Pitx3+ neurons that closely resemble midbrain dopaminergic (DA) neurons. In addition, transplantation of these induced DA (iDA) neurons alleviates symptoms in a mouse model of PD. Thus, iDA neurons generated from abundant somatic fibroblasts by direct lineage reprogramming hold promise for modeling neurodegenerative disease and for cell-based therapies of PD.	[Kim, Jongpil; Wang, Haoyi; Cheng, Albert W.; Cassady, John P.; Lodato, Michael A.; Lengner, Christopher J.; Chung, Chee-Yeun; Dawlaty, Meelad M.; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.; Cassady, John P.; Lodato, Michael A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Su, Susan C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Su, Susan C.; Tsai, Li-Huei] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Lodato, Michael/AAX-9211-2021	Cheng, Albert/0000-0003-2653-5743; Lengner, Christopher/0000-0002-0574-5189; Lodato, Michael/0000-0003-4175-1073	National Institutes of Health (NIH) [R37 HD045022 (6-9)]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to Dr. M. Li for the Pitx3-eGFP targeting construct. We thank Dr. M. Wernig, for kindly providing Ascl1, Brn2, and Myth1 lentiviral constructs, and Dr. T. Petryshen for technical supports. We also thank R. Flannery for veterinary assistance, D. Fu for technical assistance, and B. Carey, D. Hockemeyer, Y. Li, G. Welstead, and C. Garrett-Engele for comments. This work was supported by grants from the National Institutes of Health (NIH R37 HD045022 (6-9)/RJ) and the Howard Hughes Medical Institute. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics.	Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hedlund E, 2007, STEM CELLS, V25, P1126, DOI 10.1634/stemcells.2006-0540; Huse DM, 2005, MOVEMENT DISORD, V20, P1449, DOI 10.1002/mds.20609; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Olanow C.W., 1996, P NATL ACAD SCI USA, V19, p[102, 10343]; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	20	198	207	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					413	419		10.1016/j.stem.2011.09.011	http://dx.doi.org/10.1016/j.stem.2011.09.011			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22019014	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000297180200009
J	Matsumoto, A; Takeishi, S; Kanie, T; Susaki, E; Onoyama, I; Tateishi, Y; Nakayama, K; Nakayama, KI				Matsumoto, Akinobu; Takeishi, Shoichiro; Kanie, Tomoharu; Susaki, Etsuo; Onoyama, Ichiro; Tateishi, Yuki; Nakayama, Keiko; Nakayama, Keiichi I.			p57 Is Required for Quiescence and Maintenance of Adult Hematopoietic Stem Cells	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR; CDK INHIBITOR; MICE LACKING; IN-VIVO; MOUSE DEVELOPMENT; P57(KIP2); P27(KIP1); DIFFERENTIATION; P21(CIP1/WAF1); APOPTOSIS	Quiescence is required for the maintenance of hematopoietic stem cells (HSCs). Members of the Cip/Kip family of cyclin-dependent kinase (CDK) inhibitors (p21, p27, p57) have been implicated in HSC quiescence, but loss of p21 or p27 in mice affects HSC quiescence or functionality only under conditions of stress. Although p57 is the most abundant family member in quiescent HSCs, its role has remained un-characterized. Here we show a severe defect in the self-renewal capacity of p57-deficient HSCs and a reduction of the proportion of the cells in G(0) phase. Additional ablation of p21 in a p57-null background resulted in a further decrease in the colony-forming activity of HSCs. Moreover, the HSC abnormalities of p57-deficient mice were corrected by knocking in the p27 gene at the p57 locus. Our results therefore suggest that, among Cip/Kip family CDK inhibitors, p57 plays a predominant role in the quiescence and maintenance of adult HSCs.	[Matsumoto, Akinobu; Takeishi, Shoichiro; Kanie, Tomoharu; Susaki, Etsuo; Onoyama, Ichiro; Tateishi, Yuki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Matsumoto, Akinobu; Takeishi, Shoichiro; Kanie, Tomoharu; Susaki, Etsuo; Onoyama, Ichiro; Tateishi, Yuki; Nakayama, Keiko; Nakayama, Keiichi I.] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Dept Dev Genet,Aoba Ku, Sendai, Miyagi 9808575, Japan	Kyushu University; Japan Science & Technology Agency (JST); Tohoku University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Kanie, Tomoharu/AAI-5682-2020; Matsumoto, Akinobu/GPF-4945-2022	Kanie, Tomoharu/0000-0002-2084-1451; Takeishi, Shoichiro/0000-0003-1640-909X; Susaki, Etsuo/0000-0001-5621-7311; Matsumoto, Akinobu/0000-0002-4077-3935	Grants-in-Aid for Scientific Research [19057011] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Halaban R, 2005, CANCER METAST REV, V24, P339, DOI 10.1007/s10555-005-1582-z; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moshinsky DJ, 2003, BIOCHEM BIOPH RES CO, V310, P1026, DOI 10.1016/j.bbrc.2003.09.114; Nagahama H, 2001, ANAT EMBRYOL, V203, P77, DOI 10.1007/s004290000146; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Rosu-Myles M, 2007, EXP HEMATOL, V35, P394, DOI 10.1016/j.exphem.2006.11.005; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Susaki E, 2009, P NATL ACAD SCI USA, V106, P5192, DOI 10.1073/pnas.0811712106; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	30	220	224	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					262	271		10.1016/j.stem.2011.06.014	http://dx.doi.org/10.1016/j.stem.2011.06.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885021	Bronze			2022-12-25	WOS:000295024200012
J	Son, EY; Ichida, JK; Wainger, BJ; Toma, JS; Rafuse, VF; Woolf, CJ; Eggan, K				Son, Esther Y.; Ichida, Justin K.; Wainger, Brian J.; Toma, Jeremy S.; Rafuse, Victor F.; Woolf, Clifford J.; Eggan, Kevin			Conversion of Mouse and Human Fibroblasts into Functional Spinal Motor Neurons	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; MOTONEURONS; DIFFERENTIATION; NESTIN	The mammalian nervous system comprises many distinct neuronal subtypes, each with its own phenotype and differential sensitivity to degenerative disease. Although specific neuronal types can be isolated from rodent embryos or engineered from stem cells for translational studies, transcription factor-mediated reprogramming might provide a more direct route to their generation. Here we report that the forced expression of select transcription factors is sufficient to convert mouse and human fibroblasts into induced motor neurons (iMNs). iMNs displayed a morphology, gene expression signature, electrophysiology, synaptic functionality, in vivo engraftment capacity, and sensitivity to degenerative stimuli similar to those of embryo-derived motor neurons. We show that the converting fibroblasts do not transit through a proliferative neural progenitor state, and thus form bona fide motor neurons via a route distinct from embryonic development. Our findings demonstrate that fibroblasts can be converted directly into a specific differentiated and functional neural subtype, the spinal motor neuron.	[Son, Esther Y.; Ichida, Justin K.; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Son, Esther Y.; Ichida, Justin K.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Son, Esther Y.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Toma, Jeremy S.; Rafuse, Victor F.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 1X5, Canada	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dalhousie University	Eggan, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu	Woolf, Clifford/A-9784-2010; Eggan, Kevin/P-7119-2018; Wainger, Brian/L-7553-2017		Howard Hughes Medical Institute; Harvard Stem Cell Institute; P<SUP>2</SUP>ALS; New York Stem Cell Foundation; NIH [1RC2 NS069395-01, R01 HD045732-03, 5T32GM007592]; Novartis Institutes for BioMedical Research; Stan and Fiona Druckenmiller/New York Stem Cell Foundation; Natural Sciences and Engineering Research Council of Canada; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, K99NS077435, RC2NS069395, R00NS077435] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; P<SUP>2</SUP>ALS; New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for BioMedical Research; Stan and Fiona Druckenmiller/New York Stem Cell Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to A.C. Carter for help with lineage tracing experiments and E. Kiskinis, S. de Boer, G. Boulting, and J. Rivera-Feliciano for providing reagents and helpful discussions. We would also like to thank B. Tilton for assistance with FAGS, K. Harrison for providing the mouse Hb9 cDNA, N. Atwater for assistance with glia preparation, J. Sandoe and K. Sandor for help with molecular cloning, K. Koszka for help with mouse husbandry, and M.Y. Son for help with the diagram in Figure 1. This work was made possible by support provided by the Howard Hughes Medical Institute, the Harvard Stem Cell Institute, P<SUP>2</SUP>ALS, the New York Stem Cell Foundation, NIH GO grant 1RC2 NS069395-01, and NIH grant R01 HD045732-03 to K.E. J.K.I. is supported by the Novartis Institutes for BioMedical Research and a Stan and Fiona Druckenmiller/New York Stem Cell Foundation postdoctoral fellowship. B.J.W. is supported by NIH Training Grant 5T32GM007592. C.J.W. used facilities provided by the Children's Hospital Boston Intellectual and Developmental Disabilities Research Center and the NIH. J.S.T. was funded by a Natural Sciences and Engineering Research Council of Canada graduate student scholarship award. V.F.R is supported by the Natural Sciences and Engineering Research Council of Canada. The authors are filing a patent based on the results reported in this paper. K.E. is a member of the iPierian scientific advisory board.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Alessandri-Haber N, 1999, J PHYSIOL-LONDON, V518, P203, DOI 10.1111/j.1469-7793.1999.0203r.x; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; CAIAZZO M, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10284; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; DAHM LM, 1988, DEV BIOL, V130, P621, DOI 10.1016/0012-1606(88)90357-0; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; LUPA MT, 1989, J NEUROSCI, V9, P3937; Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; PANG ZP, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10202; Peljto M, 2011, CURR OPIN NEUROBIOL, V21, P43, DOI 10.1016/j.conb.2010.09.012; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Soundararajan P, 2007, STEM CELLS, V25, P1697, DOI 10.1634/stemcells.2006-0654; Soundararajan P, 2010, J NEUROSCI, V30, P6595, DOI 10.1523/JNEUROSCI.4932-09.2010; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	29	480	514	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					205	218		10.1016/j.stem.2011.07.014	http://dx.doi.org/10.1016/j.stem.2011.07.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21852222	Green Submitted, Green Accepted, Bronze			2022-12-25	WOS:000295024200008
J	Bruchas, MR; Schindler, AG; Shankar, H; Messinger, DI; Miyatake, M; Land, BB; Lemos, JC; Hagan, CE; Neumaier, JF; Quintana, A; Palmiter, RD; Chavkin, C				Bruchas, Michael R.; Schindler, Abigail G.; Shankar, Haripriya; Messinger, Daniel I.; Miyatake, Mayurni; Land, Benjamin B.; Lemos, Julia C.; Hagan, Catherine E.; Neumaier, John F.; Quintana, Albert; Palmiter, Richard D.; Chavkin, Charles			Selective p38 alpha MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and Addiction	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; KAPPA-OPIOID RECEPTOR; ELECTRODE VOLTAMMETRIC MEASUREMENTS; P38 MAPK; SOCIAL DEFEAT; TRYPTOPHAN-HYDROXYLASE; TRANSPORTER KINETICS; DEVELOPMENTAL ROLE; DOPAMINE NEURONS; REWARD	Maladaptive responses to stress adversely affect human behavior, yet the signaling mechanisms underlying stress-responsive behaviors remain poorly understood. Using a conditional gene knockout approach, the alpha isoform of p38 mitogen-activated protein kinase (MAPK) was selectively inactivated by AAV1-Cre-recombinase infection in specific brain regions or by promoter-driven excision of p38 alpha MAPK in serotonergic neurons (by Slc6a4-Cre or ePet1-Cre) or astrocytes (by Gfap-CreERT2). Social defeat stress produced social avoidance (a model of depression-like behaviors) and reinstatement of cocaine preference (a measure of addiction risk) in wild-type mice, but not in mice having p38 alpha MAPK selectively deleted in serotonin-producing neurons of the dorsal raphe nucleus. Stress-induced activation of p38 alpha MAPK translocated the serotonin transporter to the plasma membrane and increased the rate of transmitter uptake at serotonergic nerve terminals. These findings suggest that stress initiates a cascade of molecular and cellular events in which p38 alpha MAPK induces a hyposerotonergic state underlying depression-like and drug-seeking behaviors.	[Bruchas, Michael R.; Schindler, Abigail G.; Shankar, Haripriya; Messinger, Daniel I.; Miyatake, Mayurni; Land, Benjamin B.; Lemos, Julia C.; Neumaier, John F.; Chavkin, Charles] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Land, Benjamin B.; Lemos, Julia C.; Neumaier, John F.; Chavkin, Charles] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Hagan, Catherine E.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Neumaier, John F.] Univ Washington, Dept Psychiat & Behav Neurosci, Seattle, WA 98195 USA; [Quintana, Albert; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Quintana, Albert; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bruchas, MR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	bruchasm@wustl.edu; cchavkin@uw.edu	Quintana, Albert/N-5544-2015; Bruchas, Michael/G-7616-2012	Quintana, Albert/0000-0003-1674-7160; Lemos, Julia/0000-0002-5442-8876	National Institute on Drug Abuse [RO1-DA030074, R21-DA025970, RO1-DA016898, T32-DA07278, KO5-DA020570, K99-DA025182]; Hope for Depression Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030074, T32DA007278, K05DA020570, R21DA025970, R01DA016898, K99DA025182] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Hope for Depression Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank Drs. Larry Zweifel and Ali Guler (University of Washington) for helpful discussion. The floxed p38 alpha (p38 alpha<SUP>lox</SUP>) transgenic mice were provided by Dr. K. Otsu (Osaka University) though the RIKEN Bioresearch Center. The SERT-Cre mice were provided by Dr. Xiaoxi Zhuang (University of Chicago). The GFAP-CreERT2 mice were provided by Dr. Hans Kirchoff (University of Leipzig). Dr. Evan Deneris (Case Western Reserve University) provided the ePET1-Cre driver line. Support was provided by USPHS grants from the National Institute on Drug Abuse RO1-DA030074, R21-DA025970, RO1-DA016898, T32-DA07278, KO5-DA020570 (C.C.), K99-DA025182 (M.R.B.), and the Hope for Depression Research Foundation (C.C.).	Ahmed BY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-4; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Avgustinovich D F, 2005, Neurosci Behav Physiol, V35, P959, DOI 10.1007/s11055-005-0152-8; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bari A, 2010, NEUROPSYCHOPHARMACOL, V35, P1290, DOI 10.1038/npp.2009.233; Beidel DC, 2010, BEHAV RES THER, V48, P992, DOI 10.1016/j.brat.2010.06.005; Bel N, 1997, EUR J NEUROSCI, V9, P1728, DOI 10.1111/j.1460-9568.1997.tb01530.x; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bruchas MR, 2010, BRAIN RES, V1314, P44, DOI 10.1016/j.brainres.2009.08.062; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Burnette WB, 1996, ANAL CHEM, V68, P2932, DOI 10.1021/ac960022x; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Daws LC, 2009, PHARMACOL THERAPEUT, V121, P89, DOI 10.1016/j.pharmthera.2008.10.004; Earles C, 1998, ANAL BIOCHEM, V264, P191, DOI 10.1006/abio.1998.2850; Eriksson TM, 2012, MOL PSYCHIATR, V17, P173, DOI 10.1038/mp.2010.131; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Gong KZ, 2008, J BIOL CHEM, V283, P29028, DOI 10.1074/jbc.M801313200; Haenisch B, 2011, PHARMACOL THERAPEUT, V129, P352, DOI 10.1016/j.pharmthera.2010.12.002; Hagan CE, 2010, J NEUROSCI METH, V193, P29, DOI 10.1016/j.jneumeth.2010.08.009; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hensler JG, 2006, NEUROSCI BIOBEHAV R, V30, P203, DOI 10.1016/j.neubiorev.2005.06.007; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hirst WD, 1998, NEUROCHEM INT, V33, P11, DOI 10.1016/S0197-0186(05)80003-8; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Kirby LG, 2008, J NEUROSCI, V28, P12927, DOI 10.1523/JNEUROSCI.2887-08.2008; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Lee SH, 2000, J NEUROSCI RES, V60, P623, DOI 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4; Lemos JC, 2011, NEUROPSYCHOPHARMACOL, V36, P721, DOI 10.1038/npp.2010.200; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; MacGillivray L, 2010, NEUROSCIENCE, V171, P407, DOI 10.1016/j.neuroscience.2010.08.055; MCELVAIN JS, 1992, ANN NY ACAD SCI, V654, P480, DOI 10.1111/j.1749-6632.1992.tb26006.x; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nakamura K, 2007, MOL NEUROBIOL, V35, P45, DOI 10.1007/BF02700623; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Paul ED, 2011, PHYSIOL BEHAV, V104, P272, DOI 10.1016/j.physbeh.2011.01.006; Pickel VM, 1999, J NEUROSCI, V19, P7356, DOI 10.1523/JNEUROSCI.19-17-07356.1999; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ramamoorthy S, 2007, J BIOL CHEM, V282, P11639, DOI 10.1074/jbc.M611353200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravna AW, 2003, J PHARMACOL EXP THER, V307, P34, DOI 10.1124/jpet.103.054593; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Roche M, 2003, J NEUROSCI, V23, P970; Sajikumar S, 2011, P NATL ACAD SCI USA, V108, P2551, DOI 10.1073/pnas.1016849108; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Shippenberg T S, 1986, NIDA Res Monogr, V75, P563; SIEGFRIED K, 1985, J AFFECT DISORDERS, pS33; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tan M, 2009, J BIOL CHEM, V284, P6270, DOI 10.1074/jbc.M806742200; Tao R, 2000, J PSYCHOPHARMACOL, V14, P100, DOI 10.1177/026988110001400201; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104; Zhen XC, 2001, J NEUROSCI, V21, P5513, DOI 10.1523/JNEUROSCI.21-15-05513.2001; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028	79	185	190	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 11	2011	71	3					498	511		10.1016/j.neuron.2011.06.011	http://dx.doi.org/10.1016/j.neuron.2011.06.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835346	Bronze, Green Accepted			2022-12-25	WOS:000293991700013
J	Crosby, KM; Inoue, W; Pittman, QJ; Bains, JS				Crosby, Karen M.; Inoue, Wataru; Pittman, Quentin J.; Bains, Jaideep S.			Endocannabinoids Gate State-Dependent Plasticity of Synaptic Inhibition in Feeding Circuits	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; LONG-TERM DEPRESSION; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; GABA TRANSMISSION; MEDIATED CONTROL; RECEPTOR; ACTIVATION; RELEASE	Changes in food availability alter the output of hypothalamic nuclei that underlie energy homeostasis. Here, we asked whether food deprivation impacts the ability of GABA synapses in the dorsomedial hypothalamus (DMH), an important integrator of satiety signals, to undergo activity-dependent changes. GABA synapses in DMH slices from satiated rats exhibit endocannabinoid-mediated long-term depression (LTDGABA) in response to high-frequency stimulation of afferents. When CB1 Rs are blocked, however, the same stimulation elicits long-term potentiation (LTPGABA), which manifests presynaptically and requires heterosynaptic recruitment of NMDARs and nitric oxide (NO). Interestingly, NO signaling is required for eCB-mediated LTDGABA. Twenty-four hour food deprivation results in a CORT-mediated loss of CB1R signaling and, consequently, GABA synapses only exhibit LTPGABA. These observations indicate that CB1R signaling promotes LTDGABA and gates LTPGABA. Furthermore, the satiety state of an animal, through regulation of eCB signaling, determines the polarity of activity-dependent plasticity at GABA synapses in the DMH.	[Crosby, Karen M.; Inoue, Wataru; Pittman, Quentin J.; Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Crosby, Karen M.; Inoue, Wataru; Pittman, Quentin J.; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.	jsbains@ucalgary.ca	Inoue, Wataru/M-2163-2015	Inoue, Wataru/0000-0002-2438-5123; Bains, Jaideep/0000-0002-3634-6463; Pittman, Quentin/0000-0003-0984-7665	NSERC Canada; AI-HS; Hotchkiss Brain Institute Obesity Initiative; Canadian Institutes for Health Research	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); AI-HS; Hotchkiss Brain Institute Obesity Initiative; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank Mio Tsutsui and Cheryl Sank for technical support. We also thank Dr. K. Sharkey for providing the CB1R<SUP>-/-</SUP> mice. We are grateful to members of our labs for comments on earlier drafts of the manuscript. K.M.C. is supported by an NSERC Canada Graduate Scholarship, an AI-HS Studentship, and a Hotchkiss Brain Institute Obesity Initiative Scholarship. W.I. is supported by an AI-HS Fellowship. Q.J.P. is an AI-HS Scientist and J.S.B. is an AI-HS Senior Scholar. This work was funded by operating grants to Q.J.P. and J.S.B. from the Canadian Institutes for Health Research.	ALGER BE, 2005, SCI STKE, pPE51; Alger BE, 2009, CURR TOP BEHAV NEURO, V1, P141, DOI 10.1007/978-3-540-88955-7_6; AROLA L, 1984, ARCH INT PHYSIOL BIO, V92, P297, DOI 10.3109/13813458409071170; Bains JS, 1997, J PHYSIOL-LONDON, V499, P733, DOI 10.1113/jphysiol.1997.sp021965; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; BLIGH ME, 1990, PHYSIOL BEHAV, V48, P373, DOI 10.1016/0031-9384(90)90331-W; Boudaba C, 1997, J NEUROPHYSIOL, V77, P3396, DOI 10.1152/jn.1997.77.6.3396; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Chepkova AN, 2009, PFLUG ARCH EUR J PHY, V459, P131, DOI 10.1007/s00424-009-0714-7; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Dallman MF, 1999, ENDOCRINOLOGY, V140, P4015, DOI 10.1210/en.140.9.4015; DANIEL H, 1993, EUR J NEUROSCI, V5, P1079, DOI 10.1111/j.1460-9568.1993.tb00961.x; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di S, 2005, ENDOCRINOLOGY, V146, P4292, DOI 10.1210/en.2005-0610; Di S, 2003, J NEUROSCI, V23, P4850; Di S, 2009, J NEUROSCI, V29, P393, DOI 10.1523/JNEUROSCI.4546-08.2009; DiMicco JA, 2002, PHARMACOL BIOCHEM BE, V71, P469, DOI 10.1016/S0091-3057(01)00689-X; El-Husseini AED, 1999, J CHEM NEUROANAT, V17, P45, DOI 10.1016/S0891-0618(99)00023-X; Feil Robert, 2008, V184, P529; Gaetani S, 2008, Eat Weight Disord, V13, pe42; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Hill MN, 2008, HIPPOCAMPUS, V18, P221, DOI 10.1002/hipo.20386; Hill MN, 2005, EUR J PHARMACOL, V528, P99, DOI 10.1016/j.ejphar.2005.10.058; Hirasawa M, 2004, J PHYSIOL-LONDON, V559, P611, DOI 10.1113/jphysiol.2004.066159; HORN T, 1994, AM J PHYSIOL, V266, pR306, DOI 10.1152/ajpregu.1994.266.1.R306; Huang H, 2007, J NEUROSCI, V27, P4870, DOI 10.1523/JNEUROSCI.0732-07.2007; Jahng JW, 2005, BRAIN RES, V1048, P185, DOI 10.1016/j.brainres.2005.04.072; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kokkola T, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-21; Kyriakatos A, 2007, J NEUROSCI, V27, P12664, DOI 10.1523/JNEUROSCI.3174-07.2007; MAILLEUX P, 1993, NEUROSCI LETT, V156, P51, DOI 10.1016/0304-3940(93)90437-P; Makara JK, 2007, J NEUROSCI, V27, P10211, DOI 10.1523/JNEUROSCI.2104-07.2007; Malcher-Lopes R, 2006, J NEUROSCI, V26, P6643, DOI 10.1523/JNEUROSCI.5126-05.2006; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Nugent FS, 2009, NEUROPSYCHOPHARMACOL, V34, P1829, DOI 10.1038/npp.2009.5; Oliet SHR, 2007, J NEUROSCI, V27, P1325, DOI 10.1523/JNEUROSCI.2676-06.2007; Renner E, 2010, EUR J NEUROSCI, V31, P302, DOI 10.1111/j.1460-9568.2009.07053.x; Romeo RD, 2006, HORM BEHAV, V50, P463, DOI 10.1016/j.yhbeh.2006.06.002; Rossi S, 2008, J NEUROSCI, V28, P7284, DOI 10.1523/JNEUROSCI.5346-07.2008; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SQUADRITO F, 1994, NEUROPHARMACOLOGY, V33, P83, DOI 10.1016/0028-3908(94)90100-7; Stern JE, 2001, AM J PHYSIOL-REG I, V280, pR1815, DOI 10.1152/ajpregu.2001.280.6.R1815; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Thompson RH, 1998, BRAIN RES REV, V27, P89, DOI 10.1016/S0165-0173(98)00010-1; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; Ulrich-Lai YM, 2011, J COMP NEUROL, V519, P1301, DOI 10.1002/cne.22571; Wamsteeker JI, 2010, J NEUROSCI, V30, P11188, DOI 10.1523/JNEUROSCI.1046-10.2010; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Yamada K, 1996, J CHEM NEUROANAT, V10, P295, DOI 10.1016/0891-0618(96)00133-0	63	43	43	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 11	2011	71	3					529	541		10.1016/j.neuron.2011.06.006	http://dx.doi.org/10.1016/j.neuron.2011.06.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835348	Green Accepted, Bronze			2022-12-25	WOS:000293991700015
J	Hoch, M; Fischer, P; Stapel, B; Missol-Kolka, E; Sekkali, B; Scherr, M; Favret, F; Braun, T; Eder, M; Schuster-Gossler, K; Gossler, A; Hilfiker, A; Balligand, JL; Drexler, H; Hilfiker-Kleiner, D				Hoch, Melanie; Fischer, Philipp; Stapel, Britta; Missol-Kolka, Ewa; Sekkali, Belaid; Scherr, Michaela; Favret, Fabrice; Braun, Thomas; Eder, Matthias; Schuster-Gossler, Karin; Gossler, Achim; Hilfiker, Andres; Balligand, Jean-Luc; Drexler, Helmut; Hilfiker-Kleiner, Denise			Erythropoietin Preserves the Endothelial Differentiation Capacity of Cardiac Progenitor Cells and Reduces Heart Failure during Anticancer Therapies	CELL STEM CELL			English	Article							STEM-CELLS; SIGNAL TRANSDUCER; PROTECTIVE ROLE; INFLAMMATION; ACTIVATOR; SYSTEM; GROWTH; PLAYS; MODEL	Anticancer therapies, such as targeting of STAT3 or the use of anthracyclins (doxorubicin), can induce cardiomyopathy. In mice prone to developing heart failure as a result of reduced cardiac STAT3 expression (cardiomyocyte-restricted deficiency of STAT3) or treatment with doxorubicin, we observed impaired endothelial differentiation capacity of Sca-1(+) cardiac progenitor cells (CPCs) in conjunction with attenuated CCL2/CCR2 activation. Mice in both models also displayed reduced erythropoietin (EPO) levels in the cardiac microenvironment. EPO binds to CPCs and seems to be responsible for maintaining an active CCL2/CCR2 system. Supplementation with the EPO derivative CERA in a hematocrit-inactive low dose was sufficient to upregulate CCL2, restore endothelial differentiation of CPCs, and preserve the cardiac microvasculature and cardiac function in both mouse models. Thus, low-dose EPO treatment could potentially be exploited as a therapeutic strategy to reduce the risk of heart failure in certain treatment regimens.	[Hoch, Melanie; Fischer, Philipp; Stapel, Britta; Missol-Kolka, Ewa; Drexler, Helmut; Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany; [Scherr, Michaela; Eder, Matthias] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, D-30625 Hannover, Germany; [Schuster-Gossler, Karin; Gossler, Achim] Hannover Med Sch, Dept Mol Biol, D-30625 Hannover, Germany; [Hilfiker, Andres] Hannover Med Sch, Dept HTTG, D-30625 Hannover, Germany; [Sekkali, Belaid; Balligand, Jean-Luc] Univ Louvain, Sch Med, Expt & Clin Res Inst, B-1200 Brussels, Belgium; [Favret, Fabrice] Univ Paris 13, EA Reponses Cellulaires & Fonct Hypoxie 2363, F-93017 Paris, France; [Braun, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Paris 13; Max Planck Society	Hilfiker-Kleiner, D (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany.	hilfiker.denise@mh-hannover.de	Balligand, Jean-Luc J/D-7543-2012; Braun, Thomas/B-2310-2008	Favret, Fabrice/0000-0002-2827-9758; Braun, Thomas/0000-0002-6165-4804; BALLIGAND, Jean-Luc/0000-0002-0522-4156	DFG [HI 842/3-2]; Foundation Leducq	DFG(German Research Foundation (DFG)); Foundation Leducq(Leducq Foundation)	We thank the cell sorting core facility and the core facility for laser microscopy of the Hannover Medical School (Braukmann-Wittenberg-Herz-Stiftung and DFG), Martina Kasten, Tibor Horvath, Silvia Gutzke, Sergej Erschow, Inga Sorensen, and Birgit Brandt for excellent technical assistance. This work was supported by the DFG (HI 842/3-2 and REBIRTH) and the Foundation Leducq.	Asaumi Y, 2007, CIRCULATION, V115, P2022, DOI 10.1161/CIRCULATIONAHA.106.659037; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bergmann MW, 2011, EUR J HEART FAIL, V13, P560, DOI 10.1093/eurjhf/hfr002; Chen X, 2007, CARDIOVASC DRUG THER, V21, P367, DOI 10.1007/s10557-007-6052-0; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Deng JX, 2007, CURR CANCER DRUG TAR, V7, P91, DOI 10.2174/156800907780006922; El Hasnaoui-Saadani R, 2009, AM J PHYSIOL-REG I, V296, pR801, DOI 10.1152/ajpregu.00119.2008; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Gewirtz DA, 2006, CLIN CANCER RES, V12, P2232, DOI 10.1158/1078-0432.CCR-05-2287; Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Iwakura T, 2011, J MOL CELL CARDIOL, V51, P207, DOI 10.1016/j.yjmcc.2011.04.013; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lin JS, 2008, J PHYSIOL-LONDON, V586, P5757, DOI 10.1113/jphysiol.2008.160887; Madonna R, 2009, EXP CELL RES, V315, P2921, DOI 10.1016/j.yexcr.2009.07.016; Miller Cindy L, 2005, Methods Mol Biol, V290, P71; Mohri T, 2009, ARTERIOSCL THROM VAS, V29, P754, DOI 10.1161/ATVBAHA.108.174870; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Nakagami H, 2006, HYPERTENSION, V48, P112, DOI 10.1161/01.HYP.0000225426.12101.15; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tamura Y, 2011, ARTERIOSCL THROM VAS, V31, P582, DOI 10.1161/ATVBAHA.110.214726; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Ueba H, 2010, P NATL ACAD SCI USA, V107, P14357, DOI 10.1073/pnas.1003019107; Vogiatzi G, 2010, EXPERT OPIN BIOL TH, V10, P251, DOI 10.1517/14712590903547819; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105	37	57	58	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					131	143		10.1016/j.stem.2011.07.001	http://dx.doi.org/10.1016/j.stem.2011.07.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816364	Bronze			2022-12-25	WOS:000293990900010
J	Rosenberg, A; Issa, NP				Rosenberg, Ari; Issa, Naoum P.			The Y Cell Visual Pathway Implements a Demodulating Nonlinearity	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; 2ND-ORDER MOTION; RECEPTIVE-FIELD; X-CELLS; CONTRAST SENSITIVITY; TEMPORAL PROPERTIES; SPATIAL PROPERTIES; BIPOLAR CELLS; AREA 17	Neural encoding of sensory signals involves both linear and nonlinear processes. Determining which nonlinear operations are implemented by neural systems is crucial to understanding sensory processing. Here, we ask if demodulation, the process used to decode AM radio signals, describes how Y cells in the cat LGN nonlinearly encode the visual scene. In response to visual AM signals across a wide range of carrier frequencies, Y cells were found to transmit a demodulated signal, with the firing rate of single-units fluctuating at the envelope frequency but not the carrier frequency. A comparison of temporal frequency tuning properties between LGN Y cells and neurons in two primary cortical areas suggests that Y cells initiate a distinct pathway that carries a demodulated representation of the visual scene to cortex. The nonlinear signal processing carried out by the Y cell pathway simplifies the neural representation of complex visual features and allows high spatiotemporal frequencies to drive cortical responses.	[Rosenberg, Ari] Univ Chicago, Comm Computat Neurosci, Chicago, IL 60615 USA; [Issa, Naoum P.] Univ Chicago, Dept Neurobiol, Chicago, IL 60615 USA	University of Chicago; University of Chicago	Rosenberg, A (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	rosenberg@pcg.wustl.edu; naoumpissa@gmail.com		Issa, Naoum Pierre/0000-0001-9247-1341; Rosenberg, Ari/0000-0002-8606-2987	Department of Homeland Security [DE-AC05-00OR22750, DE-AC05-06OR23100]; Brain Research Foundation; Mallinckrodt Foundation	Department of Homeland Security(United States Department of Homeland Security (DHS)); Brain Research Foundation; Mallinckrodt Foundation	We thank T. Robert Husson, Atul K. Mallik, and Jing Zhang for assistance during experimental sessions. This work was supported by Department of Homeland Security Fellowship DE-AC05-00OR22750 and Dissertation Grant DE-AC05-06OR23100 (A.R.) and grants from the Brain Research Foundation and Mallinckrodt Foundation (N.P.I.).	Baker CL, 2001, PROG BRAIN RES, V134, P171; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Crook JD, 2008, J NEUROSCI, V28, P11277, DOI 10.1523/JNEUROSCI.2982-08.2008; D'Antona AD, 2009, J VISION, V9, DOI 10.1167/9.3.12; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; DAUGMAN JG, 1995, J OPT SOC AM A, V12, P641, DOI 10.1364/JOSAA.12.000641; Demb JB, 2001, NEURON, V32, P711, DOI 10.1016/S0896-6273(01)00484-6; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Derrington A, 1998, VISION RES, V38, P3531, DOI 10.1016/S0042-6989(98)00050-9; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; FLEET DJ, 1994, VISION RES, V34, P3057, DOI 10.1016/0042-6989(94)90278-X; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Hegde J, 2004, J VISION, V4, P838, DOI 10.1167/4.10.1; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUMPHREY AL, 1985, J COMP NEUROL, V233, P190, DOI 10.1002/cne.902330204; IKEDA H, 1975, EXP BRAIN RES, V22, P363; Issa NP, 2008, J NEUROPHYSIOL, V99, P2745, DOI 10.1152/jn.90211.2008; JARAMILLO F, 1993, NATURE, V364, P527, DOI 10.1038/364527a0; Johnson AP, 2004, J OPT SOC AM A, V21, P913, DOI 10.1364/JOSAA.21.000913; KLEIN SA, 1986, J OPT SOC AM A, V3, P868, DOI 10.1364/JOSAA.3.000868; Mareschal I, 1998, J NEUROPHYSIOL, V80, P2811, DOI 10.1152/jn.1998.80.6.2811; Mareschal I, 1998, NAT NEUROSCI, V1, P150, DOI 10.1038/401; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; PRICE DJ, 1994, J NEUROSCI, V14, P2732; QIAN N, 1994, J NEUROSCI, V14, P7367; Rivest J, 1996, VISION RES, V36, P53, DOI 10.1016/0042-6989(95)00056-6; Rosenberg A, 2008, VISUAL NEUROSCI, V25, P187, DOI 10.1017/S0952523808080528; Rosenberg A, 2010, J NEUROSCI, V30, P1985, DOI 10.1523/JNEUROSCI.3258-09.2010; Savard M, 2011, NEUROSCIENCE, V172, P270, DOI 10.1016/j.neuroscience.2010.10.061; Schofield AJ, 2000, PERCEPTION, V29, P1071, DOI 10.1068/p2913; Shofner WP, 1996, J ACOUST SOC AM, V99, P3592, DOI 10.1121/1.414957; Smith AT, 1998, VISION RES, V38, P403, DOI 10.1016/S0042-6989(97)00134-X; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; SO YT, 1979, EXP BRAIN RES, V36, P533; Song YN, 2007, VISUAL NEUROSCI, V24, P65, DOI 10.1017/S0952523807070113; Stockman A, 1998, VISION RES, V38, P3703, DOI 10.1016/S0042-6989(98)00049-2; STONE J, 1973, J NEUROPHYSIOL, V36, P551, DOI 10.1152/jn.1973.36.3.551; TRETTER F, 1975, J NEUROPHYSIOL, V38, P1099, DOI 10.1152/jn.1975.38.5.1099; VICTOR JD, 1977, P NATL ACAD SCI USA, V74, P3068, DOI 10.1073/pnas.74.7.3068; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; WOLLMAN DE, 1995, J NEUROSCI METH, V60, P107, DOI 10.1016/0165-0270(94)00226-7; Zhang JX, 2007, J NEUROSCI, V27, P9310, DOI 10.1523/JNEUROSCI.0500-07.2007; Zhou YX, 1996, J NEUROPHYSIOL, V75, P1038, DOI 10.1152/jn.1996.75.3.1038	47	29	29	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					348	361		10.1016/j.neuron.2011.05.044	http://dx.doi.org/10.1016/j.neuron.2011.05.044			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791292	Bronze			2022-12-25	WOS:000293433900017
J	Matsumoto, I; Ohmoto, M; Narukawa, M; Yoshihara, Y; Abe, K				Matsumoto, Ichiro; Ohmoto, Makoto; Narukawa, Masataka; Yoshihara, Yoshihiro; Abe, Keiko			Skn-1a (Pou2f3) specifies taste receptor cell lineage	NATURE NEUROSCIENCE			English	Article							CODES; SPECIFICATION	Functional diversification of taste cells is crucial for proper discrimination of taste qualities. We found the homeodomain protein Skn-1a (Pou2f3) to be expressed in sweet, umami and bitter taste cells. Skn-1a-deficient mice lacked electrophysiological and behavioral responses to sweet, umami and bitter tastes, as a result of a complete absence of sweet, umami and bitter cells and the concomitant expansion of sour cells. Skn-1a is critical for generating and balancing the diverse composition of taste cells.	[Matsumoto, Ichiro; Ohmoto, Makoto; Narukawa, Masataka; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Yoshihara, Yoshihiro] RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Saitama, Japan	University of Tokyo; RIKEN	Matsumoto, I (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	imatsumoto@monell.org; aka7308@mail.ecc.u-tokyo.ac.jp	Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166	Ministry of Education, Culture, Sports, Science and Technology of Japan [16688006, 18688020, 21780121, 16108004, 20380183]; Research and Development Program for New Bioindustry Initiatives; Ajinomoto Amino Acid Research Program; US National Institute on Deafness and Other Communication Disorders [R03 DC011143]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011143] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research and Development Program for New Bioindustry Initiatives; Ajinomoto Amino Acid Research Program; US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Y. Sato for assistance with the BAC library screening, the staff of the Research Resource Center, RIKEN, for assistance with generating chimeric and transgenic mice, and T. Kondo for useful comments on the manuscript. This work was supported in part by a Grant-in-Aid for Scientific Research (16688006 and 18688020 to I.M., 21780121 to M.O., and 16108004 and 20380183 to K.A.) and Innovative Areas (Systems Molecular Ethology, Y.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Research and Development Program for New Bioindustry Initiatives (K.A.), an Ajinomoto Amino Acid Research Program research grant (I.M.), and US National Institute on Deafness and Other Communication Disorders research grant R03 DC011143 (I.M.).	ANDERSEN B, 1993, SCIENCE, V260, P78, DOI 10.1126/science.7682011; Andersen B, 1997, GENE DEV, V11, P1873, DOI 10.1101/gad.11.14.1873; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Ohmoto M, 2006, CHEM SENSES, V31, P739, DOI 10.1093/chemse/bjl016; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916	11	110	112	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					685	687		10.1038/nn.2820	http://dx.doi.org/10.1038/nn.2820			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21572433	Green Accepted			2022-12-25	WOS:000290958000007
J	Raj, A; Kuceyeski, A; Weiner, M				Raj, Ashish; Kuceyeski, Amy; Weiner, Michael			A Network Diffusion Model of Disease Progression in Dementia	NEURON			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; NEURODEGENERATIVE DISEASES; FIBER ORIENTATIONS; CORTICAL NETWORKS; OLDEST-OLD; PREVALENCE; ATROPHY; PATTERNS; VULNERABILITY	Patterns of dementia are known to fall into dissociated but dispersed brain networks, suggesting that the disease is transmitted along neuronal pathways rather than by proximity. This view is supported by neuropathological evidence for "prion-like" transsynaptic transmission of disease agents like misfolded tau and beta amyloid. We mathematically model this transmission by a diffusive mechanism mediated by the brain's connectivity network obtained from tractography of 14 healthy-brain MRIs. Subsequent graph theoretic analysis provides a fully quantitative, testable, predictive model of dementia. Specifically, we predict spatially distinct "persistent modes," which, we found, recapitulate known patterns of dementia and match recent reports of selectively vulnerable dissociated brain networks. Model predictions also closely match T1-weighted MRI volumetrics of 18 Alzheimer's and 18 frontotemporal dementia subjects. Prevalence rates predicted by the model strongly agree with published data. This work has many important implications, including dimensionality reduction, differential diagnosis, and especially prediction of future atrophy using baseline MRI morphometrics.	[Raj, Ashish; Kuceyeski, Amy] Cornell Univ, Dept Radiol, Weill Med Coll, New York, NY 10044 USA; [Weiner, Michael] Univ Calif San Francisco, Dept Radiol, Ctr Imaging Neurodegenerat Dis CIND, SF Vet Adm Hosp 114M, San Francisco, CA 94121 USA	Cornell University; University of California System; University of California San Francisco	Raj, A (corresponding author), Cornell Univ, Dept Radiol, Weill Med Coll, 515 E 71 St,Suite S123, New York, NY 10044 USA.	ashish@med.cornell.edu			National Institutes of Health [R01 NS075425, F32 EB012404-01, P41 RR023953-02, P41 RR023953-02S1, R21 EB008138-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008138, F32EB012404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by the following grants from the National Institutes of Health: R01 NS075425, F32 EB012404-01, P41 RR023953-02, P41 RR023953-02S1, and R21 EB008138-02. Author Contributions: A.R. conceptualized this study and developed the mathematical model, performed all correlations and statistical tests, and wrote the manuscript. He is responsible for the classification results as well as the disease prevalence results and the corresponding model predictions. A.K. performed volumetric analysis of AD/bvFTD/aged patients and extracted the healthy-brain structural network. She also helped fine-tune the manuscript. M.W. provided guidance, clinical input, and interpretation, MRI data for volumetric analysis, and improvement of the manuscript. A.R. would like to thank Dr. Norman Relkin for valuable advice.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Aleman-Gomez Y, 2005, 12 ANN M ORG HUM BRA; Almond DP, 2011, SPRINGER PROC MATH, V3, P3, DOI 10.1007/978-3-642-16876-5_1; Apostolova LG, 2007, ARCH NEUROL-CHICAGO, V64, P1489, DOI 10.1001/archneur.64.10.1489; Barreda JL, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-5; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bhalla US, 2003, PROG BIOPHYS MOL BIO, V81, P45, DOI 10.1016/S0079-6107(02)00046-9; Boxer AL, 2006, ARCH NEUROL-CHICAGO, V63, P81, DOI 10.1001/archneur.63.1.81; Boxer AL, 2005, ALZ DIS ASSOC DIS, V19, pS3, DOI 10.1097/01.wad.0000183086.99691.91; Braak H, 2000, ANN NY ACAD SCI, V924, P53; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Di Carlo A, 2002, J AM GERIATR SOC, V50, P41, DOI 10.1046/j.1532-5415.2002.50006.x; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Klauschen F, 2009, HUM BRAIN MAPP, V30, P1310, DOI 10.1002/hbm.20599; Kobayashi Mie, 2009, Brain and Nerve (Tokyo), V61, P972; Kondor R. I., 2002, PROC 19 INT C MACH L, P315; Kuczynski B, 2010, ALZHEIMERS DEMENT, V6, P54, DOI 10.1016/j.jalz.2009.04.1228; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lomasko T, 2009, J THEOR BIOL, V256, P104, DOI 10.1016/j.jtbi.2008.08.025; Martinez S, 2007, IEEE CONTR SYST MAG, V27, P75, DOI 10.1109/MCS.2007.384124; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morrison PJ, 2010, LANCET NEUROL, V9, P1147, DOI 10.1016/S1474-4422(10)70287-8; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 1996, BRAIN COGNITION, V31, P176, DOI 10.1006/brcg.1996.0041; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pereira JMS, 2009, NEUROLOGY, V72, P1653, DOI 10.1212/WNL.0b013e3181a55fa2; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Rabinovici GD, 2009, BEHAV NEUROL, V21, P117, DOI [10.3233/BEN-2009-0232, 10.1155/2009/609839]; Rabinovici GD, 2010, BRAIN, V133, P512, DOI 10.1093/brain/awp326; Raj A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014832; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Santos SF, 2010, REV NEUROSCIENCE, V21, P153; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shalizi C. R., 2001, THESIS U WISCONSIN M; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thompson PM, 2003, J NEUROSCI, V23, P994; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Whitwell JL, 2009, NEURODEGENER DIS, V6, P106, DOI 10.1159/000209507; Whitwell JL, 2005, ARCH NEUROL-CHICAGO, V62, P1402, DOI 10.1001/archneur.62.9.1402; Wu MJ, 2007, NEUROIMAGE, V34, P1612, DOI 10.1016/j.neuroimage.2006.07.050; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	63	418	424	9	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 22	2012	73	6					1204	1215		10.1016/j.neuron.2011.12.040	http://dx.doi.org/10.1016/j.neuron.2011.12.040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445347	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000301998700017
J	Knobloch, HS; Charlet, A; Hoffmann, LC; Eliava, M; Khrulev, S; Cetin, AH; Osten, P; Schwarz, MK; Seeburg, PH; Stoop, R; Grinevicht, V				Knobloch, H. Sophie; Charlet, Alexandre; Hoffmann, Lena C.; Eliava, Marina; Khrulev, Sergey; Cetin, Ali H.; Osten, Pavel; Schwarz, Martin K.; Seeburg, Peter H.; Stoop, Ron; Grinevicht, Valery			Evoked Axonal Oxytocin Release in the Central Amygdala Attenuates Fear Response	NEURON			English	Article							CENTRAL NUCLEUS; CONDITIONED FEAR; BRAIN OXYTOCIN; VASOPRESSIN; NEURONS; STRESS; EXPRESSION; SYSTEM; IMMUNOREACTIVITY; ORGANIZATION	The hypothalamic neuropeptide oxytocin (OT), which controls childbirth and lactation, receives increasing attention for its effects on social behaviors, but how it reaches central brain regions is still unclear. Here we gained by recombinant viruses selective genetic access to hypothalamic OT neurons to study their connectivity and control their activity by optogenetic means. We found axons of hypothalamic OT neurons in the majority of forebrain regions, including the central amygdala (CeA), a structure critically involved in OT-mediated fear suppression. In vitro, exposure to blue light of channelrhodopsin-2-expressing OT axons activated a local GABAergic circuit that inhibited neurons in the output region of the CeA. Remarkably, in vivo, local blue-light-induced endogenous OT release robustly decreased freezing responses in fear-conditioned rats. Our results thus show widespread central projections of hypothalamic OT neurons and demonstrate that OT release from local axonal endings can specifically control region-associated behaviors.	[Charlet, Alexandre; Stoop, Ron] Univ Hosp Ctr Lausanne, Dept Psychiat, Ctr Psychiat Neurosci, CH-1008 Prilly, Switzerland; [Knobloch, H. Sophie; Hoffmann, Lena C.; Eliava, Marina; Khrulev, Sergey; Cetin, Ali H.; Osten, Pavel; Schwarz, Martin K.; Seeburg, Peter H.; Grinevicht, Valery] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Eliava, Marina] German Canc Res Inst, Dept Clin Neurobiol, D-69120 Heidelberg, Germany	Max Planck Society	Stoop, R (corresponding author), Univ Hosp Ctr Lausanne, Dept Psychiat, Ctr Psychiat Neurosci, CH-1008 Prilly, Switzerland.	rstoop@unil.ch; valery.grinevich@mpimf-heidelberg.mpg.de	Charlet, Alexandre/D-5179-2016	Charlet, Alexandre/0000-0003-4837-3706; Grinevich, Valery/0000-0002-6337-8866	Max Planck Society [SFB488]; German Research Foundation [GR 3619/2-1, GR 3619/3-1]; Chica and Heinz Schaller Research Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Chica and Heinz Schaller Research Foundation	We thank Anna Illarionova and Natalie Landeck for the cloning of several viral vectors, Miriam Kernert for her help with injection of viruses into rat brains, Guenther Giese and Annemarie Scherbach for assistance with confocal microscopy, Sophie Koszinowski for help with experiments in peripartum rats, Rolf Sprengel for input into OT-promoter selection, Georg Koehr and Claudia Rauner for initial electrophysiological recordings, Edward Callaway and Karl K. Conzelmann for TVA and RG plasmids, Scott Sternson for the ChR2-mCherry rAAV vector, Matthias Klugmann for the GFAP-GFP rAAV vector, Daniel Huber, Marios Abatis, and Jerome Wahis for advice or help with optogenetic experiments, Hannah Monyer for supporting the electron microscopic study, and Harold Gainer for antibodies against OT and VP. Supported by the Max Planck Society, grant SFB488 to P.H.S., grants GR 3619/2-1 and GR 3619/3-1 by the German Research Foundation to V.G., and the Chica and Heinz Schaller Research Foundation to V.G.	BENBARAK Y, 1985, J NEUROSCI, V5, P81; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; BUIJS RM, 1983, PHARMACOL THERAPEUT, V22, P127, DOI 10.1016/0163-7258(83)90056-6; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; CALDWELL JD, 1987, NEUROENDOCRINOLOGY, V46, P39, DOI 10.1159/000124794; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M., 2000, AMYGDALA, P213; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eliava M, 2003, HISTOCHEM CELL BIOL, V120, P183, DOI 10.1007/s00418-003-0557-9; FERRIS CF, 1992, ANN NY ACAD SCI, V652, P456, DOI 10.1111/j.1749-6632.1992.tb34382.x; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Griffin GD, 2010, J COMP NEUROL, V518, P4531, DOI 10.1002/cne.22470; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; HITCHCOCK JM, 1991, BEHAV NEUROSCI, V105, P826, DOI 10.1037/0735-7044.105.6.826; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; KAPP BS, 1979, PHYSIOL BEHAV, V23, P1109, DOI 10.1016/0031-9384(79)90304-4; Kawasaki A, 2005, EUR J NEUROSCI, V22, P672, DOI 10.1111/j.1460-9568.2005.04240.x; Krause EG, 2011, J NEUROSCI, V31, P5470, DOI 10.1523/JNEUROSCI.6078-10.2011; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; LIPOSITS Z, 1986, HISTOCHEMISTRY, V85, P95, DOI 10.1007/BF00491754; Lubin DA, 2003, BEHAV NEUROSCI, V117, P195, DOI 10.1037/0735-7044.117.2.195; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; McEwen Barbara B, 2004, Adv Pharmacol, V50, P531; MEEKER RB, 1991, BRAIN RES, V564, P181, DOI 10.1016/0006-8993(91)91454-9; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NAVONE F, 1989, J CELL BIOL, V109, P3425, DOI 10.1083/jcb.109.6.3425; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Neumann ID, 2007, BIOCHEM SOC T, V35, P1252, DOI 10.1042/BST0351252; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters JH, 2008, J NEUROSCI, V28, P11731, DOI 10.1523/JNEUROSCI.3419-08.2008; Pilpel N, 2009, J NEUROSCI METH, V182, P55, DOI 10.1016/j.jneumeth.2009.05.020; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; ROOZENDAAL B, 1992, ANN NY ACAD SCI, V652, P460, DOI 10.1111/j.1749-6632.1992.tb34384.x; ROOZENDAAL B, 1992, BRAIN RES, V596, P35, DOI 10.1016/0006-8993(92)91529-N; ROOZENDAAL B, 1993, BRAIN RES BULL, V32, P573, DOI 10.1016/0361-9230(93)90157-7; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; SAWCHENKO PE, 1983, PROG BRAIN RES, V60, P19; Simeon D, 2011, PSYCHONEUROENDOCRINO, V36, P1418, DOI 10.1016/j.psyneuen.2011.03.013; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; SOFRONIEW MV, 1983, PROG BRAIN RES, V60, P101; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; THEODOSIS DT, 1985, NATURE, V313, P682, DOI 10.1038/313682a0; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Wotjak CT, 1998, NEUROSCIENCE, V85, P1209, DOI 10.1016/S0306-4522(97)00683-0; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; ZINGG HH, 1988, MOL BRAIN RES, V4, P1, DOI 10.1016/0169-328X(88)90011-3	61	657	670	7	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					553	566		10.1016/j.neuron.2011.11.030	http://dx.doi.org/10.1016/j.neuron.2011.11.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325206	Bronze			2022-12-25	WOS:000300140600015
J	Li, ZW; Fei, T; Zhang, JP; Zhu, GY; Wang, L; Lu, DY; Chi, XC; Teng, Y; Hou, N; Yang, X; Zhang, HQ; Han, JDJ; Chen, YG				Li, Zhongwei; Fei, Teng; Zhang, Jianping; Zhu, Gaoyang; Wang, Lu; Lu, Danyu; Chi, Xiaochun; Teng, Yan; Hou, Ning; Yang, Xiao; Zhang, Hongquan; Han, Jing-Dong J.; Chen, Ye-Guang			BMP4 Signaling Acts via Dual-Specificity Phosphatase 9 to Control ERK Activity in Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							ACTIVATED PROTEIN-KINASE; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; MAP KINASE; DIFFERENTIATION; PLURIPOTENCY; MAINTENANCE; INVOLVEMENT; SMAD4/DPC4; REGULATORS	Extrinsic BMP and LIF signaling collaboratively maintain mouse embryonic stem cell (ESC) pluripotency, whereas appropriate ERK activity is essential for ESC fate commitment. However, how the extrinsic signals restrain appropriate ERK activity remains elusive. Here, we show that, whereas LIF sustains relatively high ERK activity, BMP4 can steadily attenuate ERK activity by upregulating ERK-specific dual-specificity phosphatase 9 (DUSP9). This upregulation requires Smad1/5 and Smad4 and specifically occurs to DUSP9, but not other DUSPs, and only in ESCs. Through DUSP9-mediated inhibition of ERK activity, BMP signaling reinforces the self-renewal status of mouse ESCs together with LIF. Upon LIF withdrawal, ESCs spontaneously undergo neural differentiation, during which process DUSP9 can partially mediate BMP inhibition on neural commitment. Collectively, our findings identify DUSP9 as a critical mediator of BMP signaling to control appropriate ERK activity critical for ESC fate determination.	[Li, Zhongwei; Fei, Teng; Zhang, Jianping; Zhu, Gaoyang; Wang, Lu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Lu, Danyu; Chi, Xiaochun; Zhang, Hongquan] Peking Univ, Sch Basic Med Sci, Lab Stem Cells Dev & Reprod Med, Beijing 100191, Peoples R China; [Teng, Yan; Hou, Ning; Yang, Xiao] Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing 100071, Peoples R China; [Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Partner Inst Computat Biol, Shanghai 200031, Peoples R China	Tsinghua University; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Fei, Teng/G-5324-2015; XIAO, YANG/GPW-5529-2022	Fei, Teng/0000-0001-5707-0673; Yang, Xiao/0000-0002-0298-9831; FEI, TENG/0000-0001-9620-0450	Ministry of Sciences and Technology of China [2011CBA01104, 2011CB943803, 2010CB833706]; National Natural Science Foundation of China [30921004, 91019003, 30930050]; Tsinghua University [2010THZ0]	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	The authors wish to thank Dr. Stephen M. Keyse for DUSP9 antibodies and plasmids, Dr. Kehkooi Kee for lentiviral expression plasmids, Shanshan Zhu and Wei Zhang for bioinformatics analysis, and Jun Du and Benyu Ma for technical assistance. This work was supported by grants from Ministry of Sciences and Technology of China (2011CBA01104, 2011CB943803, 2010CB833706), National Natural Science Foundation of China (30921004, 91019003, 30930050), and Tsinghua University Initiative Scientific Research Program (2010THZ0) to Y.-G.C.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Datto M, 2000, CYTOKINE GROWTH F R, V11, P37, DOI 10.1016/S1359-6101(99)00027-1; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Fei T, 2010, SCI CHINA LIFE SCI, V53, P497, DOI 10.1007/s11427-010-0096-2; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seuntjens E, 2009, CYTOKINE GROWTH F R, V20, P449, DOI 10.1016/j.cytogfr.2009.10.005; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Theodosiou A, 2002, GENOME BIOL, V3; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	46	104	110	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					171	182		10.1016/j.stem.2011.12.016	http://dx.doi.org/10.1016/j.stem.2011.12.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305567	Bronze			2022-12-25	WOS:000300272100010
J	Bolinger, D; Gollisch, T				Boelinger, Daniel; Gollisch, Tim			Closed-Loop Measurements of Iso-Response Stimuli Reveal Dynamic Nonlinear Stimulus Integration in the Retina	NEURON			English	Article							THALAMOCORTICAL FEEDFORWARD INHIBITION; TIGER SALAMANDER RETINA; GANGLION-CELLS; BIPOLAR CELLS; SYNAPTIC DEPRESSION; SPATIAL SUMMATION; RECEPTIVE-FIELD; BARREL CORTEX; Y-CELLS; CAT	Neurons often integrate information from multiple parallel signaling streams. How a neuron combines these inputs largely determines its computational role in signal processing. Experimental assessment of neuronal signal integration, however, is often confounded by cell-intrinsic nonlinear processes that arise after signal integration has taken place. To overcome this problem and determine how ganglion cells in the salamander retina integrate visual contrast over space, we used automated online analysis of recorded spike trains and closed-loop control of the visual stimuli to identify different stimulus patterns that give the same neuronal response. These iso-response stimuli revealed a threshold-quadratic transformation as a fundamental nonlinearity within the receptive field center. Moreover, for a subset of ganglion cells, the method revealed an additional dynamic nonlinearity that renders these cells particularly sensitive to spatially homogeneous stimuli. This function is shown to arise from a local inhibition-mediated dynamic gain control mechanism.	[Boelinger, Daniel; Gollisch, Tim] Max Planck Inst Neurobiol, Visual Coding Grp, D-82152 Martinsried, Germany; [Boelinger, Daniel; Gollisch, Tim] Bernstein Ctr Computat Neurosci Munich, D-82152 Martinsried, Germany; [Gollisch, Tim] Univ Med Ctr Gottingen, Dept Ophthalmol, D-37073 Gottingen, Germany; [Gollisch, Tim] Bernstein Ctr Computat Neurosci Gottingen, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Gollisch, T (corresponding author), Max Planck Inst Neurobiol, Visual Coding Grp, D-82152 Martinsried, Germany.	tim.gollisch@med.uni-goettingen.de	889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138; Gollisch, Tim/0000-0003-3998-533X	German Ministry for Education and Research through the Bernstein Center for Computational Neuroscience Munich; Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center [889]; Max Planck Society; German Initiative of Excellence; International Human Frontier Science Program Organization	German Ministry for Education and Research through the Bernstein Center for Computational Neuroscience Munich; Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); German Initiative of Excellence; International Human Frontier Science Program Organization(Human Frontier Science Program)	We thank A. Borst for comments on the manuscript and the members of the Gollisch Lab for helpful discussions. This work was supported by the Max Planck Society, the German Initiative of Excellence, the International Human Frontier Science Program Organization, the German Ministry for Education and Research through the Bernstein Center for Computational Neuroscience Munich, and the Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center 889.	Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; Bellavance MA, 2010, J NEUROSCI, V30, P1057, DOI 10.1523/JNEUROSCI.4805-09.2010; Benda J, 2007, CURR OPIN NEUROBIOL, V17, P430, DOI 10.1016/j.conb.2007.07.009; Burkhardt DA, 1998, VISUAL NEUROSCI, V15, P219, DOI 10.1017/S0952523898152021; Burkhardt DA, 1998, J NEUROPHYSIOL, V80, P1070, DOI 10.1152/jn.1998.80.3.1070; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Chen X, 2010, J NEUROPHYSIOL, V103, P2618, DOI 10.1152/jn.01109.2009; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Crook JD, 2008, J NEUROSCI, V28, P11277, DOI 10.1523/JNEUROSCI.2982-08.2008; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Gollisch T, 2005, PLOS BIOL, V3, P144, DOI 10.1371/journal.pbio.0030008; Gollisch T, 2002, J NEUROSCI, V22, P10434; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Ishikane H, 1999, VISUAL NEUROSCI, V16, P1001, DOI 10.1017/S0952523899166033; Jarsky T, 2011, J NEUROSCI, V31, P11003, DOI 10.1523/JNEUROSCI.2631-11.2011; MARIANI AP, 1986, PROC R SOC SER B-BIO, V227, P483, DOI 10.1098/rspb.1986.0035; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Molnar A, 2009, J COMPUT NEUROSCI, V27, P569, DOI 10.1007/s10827-009-0170-6; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; SESTOKAS AK, 1987, VISION RES, V27, P1399, DOI 10.1016/0042-6989(87)90150-7; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; Sherry DM, 1998, VISUAL NEUROSCI, V15, P1175, DOI 10.1017/S0952523898156201; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Strowbridge BW, 2009, ANN NY ACAD SCI, V1170, P270, DOI 10.1111/j.1749-6632.2009.04018.x; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; TOWE AL, 1970, EXP NEUROL, V29, P366, DOI 10.1016/0014-4886(70)90065-8; VICTOR JD, 1988, J PHYSIOL-LONDON, V405, P289, DOI 10.1113/jphysiol.1988.sp017334; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000	48	55	55	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					333	346		10.1016/j.neuron.2011.10.039	http://dx.doi.org/10.1016/j.neuron.2011.10.039			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284187	Bronze			2022-12-25	WOS:000299761600014
J	Alfonso, J; Le Magueresse, C; Zuccotti, A; Khodosevich, K; Monyer, H				Alfonso, Julieta; Le Magueresse, Corentin; Zuccotti, Annalisa; Khodosevich, Konstantin; Monyer, Hannah			Diazepam Binding Inhibitor Promotes Progenitor Proliferation in the Postnatal SVZ by Reducing GABA Signaling	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE; CELL-CYCLE; OLFACTORY-BULB; BENZODIAZEPINE-RECEPTOR; ADULT NEUROGENESIS; RAT-BRAIN; NEURONS; LOCALIZATION; EXPRESSION; MIGRATION	The subventricular zone (SVZ) of the lateral ventricles is the largest neurogenic niche of the postnatal brain. New SVZ-generated neurons migrate via the rostral migratory stream to the olfactory bulb (OB) where they functionally integrate into preexisting neuronal circuits. Nonsynaptic GABA signaling was previously shown to inhibit SVZ-derived neurogenesis. Here we identify the endogenous protein diazepam binding inhibitor (DBI) as a positive modulator of SVZ postnatal neurogenesis by regulating GABA activity in transit-amplifying cells. We performed DBI loss- and gain-of-function experiments in vivo at the peak of postnatal OB neuron generation in mice and demonstrate that DBI enhances proliferation by preventing SVZ progenitors to exit the cell cycle. Furthermore, we provide evidence that DBI exerts its effect on SVZ progenitors via its octadecaneuropeptide proteolytic product (ODN) by inhibiting GABA-induced currents. Together our data reveal a regulatory mechanism by which DBI counteracts the inhibitory effect of nonsynaptic GABA signaling on subventricular neuronal proliferation.	[Alfonso, Julieta; Le Magueresse, Corentin; Zuccotti, Annalisa; Khodosevich, Konstantin; Monyer, Hannah] German Canc Res Ctr, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; [Alfonso, Julieta; Le Magueresse, Corentin] Heidelberg Univ, Fac Med, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Monyer, H (corresponding author), German Canc Res Ctr, Dept Clin Neurobiol, D-69120 Heidelberg, Germany.	h.monyer@dkfz-heidelberg.de		Le Magueresse, Corentin/0000-0001-8418-4991; Monyer, Hannah/0000-0002-9332-5749; Khodosevich, Konstantin/0000-0001-7232-5558	Christiane Nuesslein-Volhard fellowship; Medical Faculty Heidelberg; Schilling Foundation; DFG [SFB 488, SG 643]	Christiane Nuesslein-Volhard fellowship; Medical Faculty Heidelberg; Schilling Foundation; DFG(German Research Foundation (DFG))	We thank R. Hintz-Herkommer, I. Preugschat-Gumprecht, and T. Weber for excellent technical assistance and N. Nilsson for helping with knockdown experiments. We also thank Prof. S. Mandrup and A. Marcher (University of Southern Denmark) for kindly providing brains from knockout mice to test the specificity of the DBI antibody. J.A. was supported in part by a Christiane Nuesslein-Volhard fellowship, C.L.M. was supported by a Postdoctoral Grant from Medical Faculty Heidelberg, and H.M. was supported by the Schilling Foundation and DFG (SFB 488 and SG 643).	Abrahamsen H, 2010, CURR BIOL, V20, pR415, DOI 10.1016/j.cub.2010.03.011; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALHO H, 1995, CELL GROWTH DIFFER, V6, P309; ALHO H, 1988, P NATL ACAD SCI USA, V85, P7018, DOI 10.1073/pnas.85.18.7018; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BORMANN J, 1991, NEUROPHARMACOLOGY, V30, P1387, DOI 10.1016/S0028-3908(11)80006-7; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Codina C, 2000, NEUROSCI LETT, V287, P53, DOI 10.1016/S0304-3940(00)01134-4; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; D'Hulst C, 2009, DRUG DISCOV TODAY, V14, P866, DOI 10.1016/j.drudis.2009.06.009; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fukumitsu H, 2006, J NEUROSCI, V26, P13218, DOI 10.1523/JNEUROSCI.4251-06.2006; Gandolfo P, 2000, J NEUROCHEM, V75, P701, DOI 10.1046/j.1471-4159.2000.0750701.x; Gandolfo P, 1999, NEUROPHARMACOLOGY, V38, P725, DOI 10.1016/S0028-3908(98)00231-7; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Lacar B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00043; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MIETTINEN H, 1995, CANCER RES, V55, P2691; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mitsuhashi T, 2009, BRAIN DEV-JPN, V31, P553, DOI 10.1016/j.braindev.2009.05.002; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Neess D, 2011, J BIOL CHEM, V286, P3460, DOI 10.1074/jbc.M110.161109; Nguyen LD, 2003, AEROSPACE ENG, V23, P23; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Rogelius N, 2005, J NEUROSCI METH, V142, P285, DOI 10.1016/j.jneumeth.2004.09.008; SLOBODYANSKY E, 1989, J NEUROCHEM, V53, P1276, DOI 10.1111/j.1471-4159.1989.tb07425.x; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Stefovska VG, 2008, ANN NEUROL, V64, P434, DOI 10.1002/ana.21463; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi T, 1996, J NEUROSCI, V16, P6183; Teissier A, 2011, CEREB CORTE IN PRESS; TONG Y, 1991, NEUROPEPTIDES, V20, P33, DOI 10.1016/0143-4179(91)90037-J; TONON MC, 1990, NEUROPEPTIDES, V15, P17, DOI 10.1016/0143-4179(90)90155-R; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Yanase H, 2002, ARCH HISTOL CYTOL, V65, P27, DOI 10.1679/aohc.65.27; Zhang RL, 2008, J CEREBR BLOOD F MET, V28, P602, DOI 10.1038/sj.jcbfm.9600556	58	82	83	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					76	87		10.1016/j.stem.2011.11.011	http://dx.doi.org/10.1016/j.stem.2011.11.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226357	Bronze			2022-12-25	WOS:000299449500012
J	Ping, Y; Tsunoda, S				Ping, Yong; Tsunoda, Susan			Inactivity-induced increase in nAChRs upregulates Shal K+ channels to stabilize synaptic potentials	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; HIPPOCAMPAL PYRAMIDAL NEURONS; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA-MELANOGASTER; POTASSIUM CURRENTS; DELAYED RECTIFIER; CO-ASSEMBLE; EXCITABILITY; PLASTICITY; KV4.2	Long-term synaptic changes, which are essential for learning and memory, are dependent on homeostatic mechanisms that stabilize neural activity. Homeostatic responses have also been implicated in pathological conditions, including nicotine addiction. Although multiple homeostatic pathways have been described, little is known about how compensatory responses are tuned to prevent them from overshooting their optimal range of activity. We found that prolonged inhibition of nicotinic acetylcholine receptors (nAChRs), the major excitatory receptors in the Drosophila CNS, resulted in a homeostatic increase in the Drosophila alpha 7 (D alpha 7)-nAChR. This response then induced an increase in the transient A-type K+ current carried by Shaker cognate L (Shal; also known as voltage-gated K+ channel 4, Kv4) channels. Although increasing D alpha 7-nAChRs boosted miniature excitatory postsynaptic currents, the ensuing increase in Shal channels served to stabilize postsynaptic potentials. These data identify a previously unknown mechanism for fine tuning the homeostatic response.	[Ping, Yong; Tsunoda, Susan] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Tsunoda, S (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	susan.tsunoda@colostate.edu		Ping, Yong/0000-0003-1066-5471	US National Institutes of Health [R01 GM083335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083335] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Waro for genetic crosses and technical assistance. We thank H. Bellen (Baylor College of Medicine) for the antibody to D alpha 7 and the D alpha 7-deficient mutant line, S. Sigrist (Institute for Biology/Genetics) for the UAS-nAcR alpha-18C-EGFP fly line, M. Fujioka (Thomas Jefferson University) for the RRa-GAL4, RN2-GAL4 and EL-GAL4 fly lines, S. Singh (State University of New York, Buffalo) for the Shab[3] line, and E. Gundelfinger and U. Thomas (Leibniz Institute for Neurobiology) for the antibodies to Drosophila nAChRs. We also thank C. Yeung for carrying out genetic mapping and crosses for the transgenic HA-Shal line. S. T. is supported by a grant from the US National Institutes of Health (R01 GM083335).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chamaon K, 2000, FEBS LETT, V482, P189, DOI 10.1016/S0014-5793(00)02057-3; Chamaon K, 2002, J NEUROCHEM, V80, P149, DOI 10.1046/j.0022-3042.2001.00685.x; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Diao FQ, 2009, MOL CELL NEUROSCI, V42, P33, DOI 10.1016/j.mcn.2009.05.003; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fenster CP, 1999, J NEUROSCI, V19, P4804; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grauso M, 2002, GENETICS, V160, P1519; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Hegde P, 1999, J BIOL CHEM, V274, P22109, DOI 10.1074/jbc.274.31.22109; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; JONAS PE, 1994, J NEUROBIOL, V25, P1494, DOI 10.1002/neu.480251203; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Lee D, 1999, J NEUROSCI, V19, P5311; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Misonou H, 2010, NEUROSCIENTIST, V16, P51, DOI 10.1177/1073858409341085; Nataraj K, 2010, NEURON, V68, P750, DOI 10.1016/j.neuron.2010.09.033; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Ping Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016043; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schulz R, 2000, J NEUROCHEM, V74, P2537, DOI 10.1046/j.1471-4159.2000.0742537.x; Small DH, 2008, TRENDS MOL MED, V14, P103, DOI 10.1016/j.molmed.2007.12.006; Su HL, 2003, J NEUROSCI, V23, P9246; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004	50	28	28	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					90	U115		10.1038/nn.2969	http://dx.doi.org/10.1038/nn.2969			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22081160	Green Accepted			2022-12-25	WOS:000298414400018
J	Stephan, AB; Tobochnik, S; Dibattista, M; Wall, CM; Reisert, J; Zhao, HQ				Stephan, Aaron B.; Tobochnik, Steven; Dibattista, Michele; Wall, Crystal M.; Reisert, Johannes; Zhao, Haiqing			The Na+/Ca2+ exchanger NCKX4 governs termination and adaptation of the mammalian olfactory response	NATURE NEUROSCIENCE			English	Article							SODIUM-CALCIUM EXCHANGE; ROD OUTER SEGMENTS; SENSORY NEURONS; RECEPTOR-CELLS; SODIUM/CALCIUM EXCHANGER; MOLECULAR-CLONING; ADENYLYL-CYCLASE; ODOR ADAPTATION; CHANNEL; MOUSE	Sensory perception requires accurate encoding of stimulus information by sensory receptor cells. We identified NCKX4, a potassium-dependent Na+/Ca2+ exchanger, as being necessary for rapid response termination and proper adaptation of vertebrate olfactory sensory neurons (OSNs). Nckx4(-/-) (also known as Slc24a4) mouse OSNs displayed substantially prolonged responses and stronger adaptation. Single-cell electrophysiological analyses revealed that the majority of Na+-dependent Ca2+ exchange in OSNs relevant to sensory transduction is a result of NCKX4 and that Nckx4(-/-) mouse OSNs are deficient in encoding action potentials on repeated stimulation. Olfactory-specific Nckx4(-/-) mice had lower body weights and a reduced ability to locate an odorous source. These results establish the role of NCKX4 in shaping olfactory responses and suggest that rapid response termination and proper adaptation of peripheral sensory receptor cells tune the sensory system for optimal perception.	[Stephan, Aaron B.; Tobochnik, Steven; Wall, Crystal M.; Zhao, Haiqing] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Dibattista, Michele; Reisert, Johannes] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Johns Hopkins University; Monell Chemical Senses Center	Zhao, HQ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	hzhao@jhu.edu	DIBATTISTA, Michele/AAC-7621-2022	DIBATTISTA, Michele/0000-0002-3955-4663; Wall, Crystal/0000-0002-2169-7156; Tobochnik, Steven/0000-0001-9071-8398	US National Institutes of Health [DC007395]; Morley Kare Fellowship; Monell Chemical Senses Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morley Kare Fellowship; Monell Chemical Senses Center; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Bozza for providing the OMP-Cre mouse line. We thank K. Cunningham, K. Cygnar, D. Fambrough, S. Hattar, R. Kuruvilla, D. Luo and F. Margolis for suggestions and discussions. We also thank members of the Hattar-Kuruvilla-Zhao mouse tri-laboratory of the Johns Hopkins Department of Biology for discussions. This research was supported by US National Institutes of Health grant DC007395, a Morley Kare Fellowship (to J.R.) and the Monell Chemical Senses Center. A. B. S. is currently a Department of Energy Biosciences Fellow of the Life Sciences Research Foundation.	Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; Cygnar KD, 2010, JOVE-J VIS EXP, V37, pe1850; Danaceau JP, 2000, J GEN PHYSIOL, V115, P759, DOI 10.1085/jgp.115.6.759; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MENCO BPM, 1984, CELL TISSUE RES, V235, P225; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V535, P637, DOI 10.1111/j.1469-7793.2001.00637.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SCHNETKAMP PPM, 1995, CELL CALCIUM, V18, P322, DOI 10.1016/0143-4160(95)90028-4; SCHNETKAMP PPM, 1991, ANN NY ACAD SCI, V639, P10, DOI 10.1111/j.1749-6632.1991.tb17285.x; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Song Y, 2008, NEURON, V58, P374, DOI 10.1016/j.neuron.2008.02.029; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; YAN C, 1995, P NATL ACAD SCI USA, V92, P9677, DOI 10.1073/pnas.92.21.9677; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	50	84	87	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					131	U164		10.1038/nn.2943	http://dx.doi.org/10.1038/nn.2943			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22057188	Green Submitted, Green Accepted			2022-12-25	WOS:000298414400023
J	Linden, H; Tetzlaff, T; Potjans, TC; Pettersen, KH; Grun, S; Diesmann, M; Einevoll, GT				Linden, Henrik; Tetzlaff, Tom; Potjans, Tobias C.; Pettersen, Klas H.; Gruen, Sonja; Diesmann, Markus; Einevoll, Gaute T.			Modeling the Spatial Reach of the LFP	NEURON			English	Article							LOCAL-FIELD POTENTIALS; SOURCE-DENSITY METHOD; CAT CEREBRAL-CORTEX; NEURONAL-ACTIVITY; FIRING RATES; GAMMA-BAND; FREQUENCY; SELECTIVITY; DISCHARGES; ACTIVATION	The local field potential (LFP) reflects activity of many neurons in the vicinity of the recording electrode and is therefore useful for studying local network dynamics. Much of the nature of the LFP is, however, still unknown. There are, for instance, contradicting reports on the spatial extent of the region generating the LFP. Here, we use a detailed biophysical modeling approach to investigate the size of the contributing region by simulating the LFP from a large number of neurons around the electrode. We find that the size of the generating region depends on the neuron morphology, the synapse distribution, and the correlation in synaptic activity. For uncorrelated activity, the LFP represents cells in a small region (within a radius of a few hundred micrometers). If the LFP contributions from different cells are correlated, the size of the generating region is determined by the spatial extent of the correlated activity.	[Linden, Henrik; Tetzlaff, Tom; Pettersen, Klas H.; Einevoll, Gaute T.] Norwegian Univ Life Sci, Dept Math Sci & Technol, N-1432 As, Norway; [Linden, Henrik] Royal Inst Technol KTH, Dept Computat Biol, Sch Comp Sci & Commun, S-10044 Stockholm, Sweden; [Tetzlaff, Tom; Potjans, Tobias C.; Gruen, Sonja; Diesmann, Markus] Forschungszentrum Julich, Inst Neurosci & Med INM6, D-52425 Julich, Germany; [Potjans, Tobias C.; Diesmann, Markus] RIKEN, Computat Sci Res Program, Brain & Neural Syst Team, Wako, Saitama 3510198, Japan; [Potjans, Tobias C.] Univ Freiburg, Fac Biol 3, D-79104 Freiburg, Germany; [Pettersen, Klas H.; Einevoll, Gaute T.] Norwegian Univ Life Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Gruen, Sonja] Rhein Westfal TH Aachen, D-52062 Aachen, Germany; [Gruen, Sonja; Diesmann, Markus] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Diesmann, Markus] RTWH Aachen Univ, Fac Med, D-52074 Aachen, Germany	Norwegian University of Life Sciences; Royal Institute of Technology; Helmholtz Association; Research Center Julich; RIKEN; University of Freiburg; Norwegian University of Life Sciences; RWTH Aachen University; RIKEN; RWTH Aachen University	Einevoll, GT (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, N-1432 As, Norway.	gaute.einevoll@umb.no	Diesmann, Markus/H-3722-2013; Grün, Sonja/I-6321-2013; Tetzlaff, Tom/B-4587-2012	Diesmann, Markus/0000-0002-2308-5727; Grün, Sonja/0000-0003-2829-2220; Tetzlaff, Tom/0000-0001-5794-5425; Linden, Henrik/0000-0001-5630-4095	Research Council of Norway (eVita [eNEURO], NOTUR); EU [15879 (FACETS), 269921 (BrainScaleS)]; BMBF [01GQ0420]; MEXT, Japan; Helmholtz Alliance on Systems Biology	Research Council of Norway (eVita [eNEURO], NOTUR)(Research Council of Norway); EU(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Helmholtz Alliance on Systems Biology	We thank the anonymous reviewers for their very useful suggestions. This work was partially funded by the Research Council of Norway (eVita [eNEURO], NOTUR), EU Grant 15879 (FACETS), EU Grant 269921 (BrainScaleS), BMBF Grant 01GQ0420 to BCCN Freiburg, Next-Generation Supercomputer Project of MEXT, Japan, and the Helmholtz Alliance on Systems Biology.	Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berens P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.002.2008; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Carnevale NT, 2006, NEURON BOOK; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Denker M, 2011, CEREB CORTEX, V21, P2681, DOI 10.1093/cercor/bhr040; Denker M, 2010, J COMPUT NEUROSCI, V29, P599, DOI 10.1007/s10827-010-0241-8; DENO RL, 1947, J CELL COMPAR PHYSL, V29, P207, DOI 10.1002/jcp.1030290303; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; DI S, 1990, J NEUROPHYSIOL, V63, P832, DOI 10.1152/jn.1990.63.4.832; Einevoll GT, 2007, J NEUROPHYSIOL, V97, P2174, DOI 10.1152/jn.00845.2006; Gewaltig MO, 2007, SCHOLARPEDIA, V2, P1430, DOI [DOI 10.4249/SCH0LARPEDIA.1430, 10.4249/scholarpedia.1430, DOI 10.4249/SCHOLARPEDIA.1430]; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hines Michael L, 2009, Front Neuroinform, V3, P1, DOI 10.3389/neuro.11.001.2009; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Holt GR, 1998, THESIS CALTECH PASAD; Johnston D., 1995, FDN CELLULAR NEUROPH; Kandel A, 1997, J NEUROSCI, V17, P6783; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kelly RC, 2010, J COMPUT NEUROSCI, V29, P567, DOI 10.1007/s10827-009-0208-9; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Leski S, 2011, NEUROINFORMATICS, V9, P401, DOI 10.1007/s12021-011-9111-4; Linden H, 2010, J COMPUT NEUROSCI, V29, P423, DOI 10.1007/s10827-010-0245-4; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pettersen KH, 2008, J COMPUT NEUROSCI, V24, P291, DOI 10.1007/s10827-007-0056-4; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Potjans T.C., 2011, CELL TYPE SPECIFIC C; RALL WILFRID, 1962, BIOPHYS JOUR, V2, P145; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Roux S, 2006, BEHAV BRAIN RES, V169, P335, DOI 10.1016/j.bbr.2006.02.004; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tetzlaff T, 2008, NEURAL COMPUT, V20, P2133, DOI 10.1162/neco.2008.05-07-525; Wagatsuma Nobuhiko, 2011, Front Comput Neurosci, V5, P31, DOI 10.3389/fncom.2011.00031; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009	56	259	259	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					859	872		10.1016/j.neuron.2011.11.006	http://dx.doi.org/10.1016/j.neuron.2011.11.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153380	Bronze			2022-12-25	WOS:000297971100018
J	Quinlan, AR; Boland, MJ; Leibowitz, ML; Shumilina, S; Pehrson, SM; Baldwin, KK; Hall, IM				Quinlan, Aaron R.; Boland, Michael J.; Leibowitz, Mitchell L.; Shumilina, Svetlana; Pehrson, Sidney M.; Baldwin, Kristin K.; Hall, Ira M.			Genome Sequencing of Mouse Induced Pluripotent Stem Cells Reveals Retroelement Stability and Infrequent DNA Rearrangement during Reprogramming	CELL STEM CELL			English	Article							COPY NUMBER VARIATION; L1 RETROTRANSPOSITION; LINE-1 RETROTRANSPOSITION; IDENTIFICATION; EVOLUTION; INSIGHTS; ELEMENTS; MICE	The biomedical utility of induced pluripotent stem cells (iPSCs) will be diminished if most iPSC lines harbor deleterious genetic mutations. Recent micro-array studies have shown that human iPSCs carry elevated levels of DNA copy number variation compared with those in embryonic stem cells, suggesting that these and other classes of genomic structural variation (SV), including inversions, smaller duplications and deletions, complex rearrangements, and retroelement transpositions, may frequently arise as a consequence of reprogramming. Here we employ whole-genome paired-end DNA sequencing and sensitive mapping algorithms to identify all classes of SV in three fully pluripotent mouse iPSC lines. Despite the improved scope and resolution of this study, we find few spontaneous mutations per line (one or two) and no evidence for endogenous retroelement transposition. These results show that genome stability can persist throughout reprogramming, and argue that it is possible to generate iPSCs lacking gene-disrupting mutations using current reprogramming methods.	[Boland, Michael J.; Pehrson, Sidney M.; Baldwin, Kristin K.] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Quinlan, Aaron R.; Leibowitz, Mitchell L.; Shumilina, Svetlana; Hall, Ira M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Quinlan, Aaron R.; Hall, Ira M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Scripps Research Institute; University of Virginia; University of Virginia	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	kbaldwin@scripps.edu; irahall@virginia.edu		Quinlan, Aaron/0000-0003-1756-0859; Baldwin, Kristin/0000-0002-6137-030X; Boland, Michael/0000-0001-5649-9603; Leibowitz, Mitchell/0000-0003-1874-5441	NRSA [1F32HG005197-01]; California Institute for Regenerative Medicine; Pew Scholar Award; Esther B.O'Keeffe Family Foundation; Shapiro Family Foundation; Burroughs Wellcome; NIH [DP2OD006493-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG005197] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006493] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Pew Scholar Award; Esther B.O'Keeffe Family Foundation; Shapiro Family Foundation; Burroughs Wellcome(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Lindberg for algorithm development and R. Clark for computational support, and A. Prorock and Y. Bao (UVA Sequencing Core) for DNA sequencing. We acknowledge S. Kupriyanov and G. Martin (TSRI Mouse Genetics Facility) for assistance with ESC derivation, and K. Nazor for assistance with cell culture. Support to A.R.Q. was from an NRSA postdoctoral fellowship (1F32HG005197-01); to K.K.B. and M.J.B., from the California Institute for Regenerative Medicine, a Pew Scholar Award, the Esther B.O'Keeffe Family Foundation, and the Shapiro Family Foundation; and to I.M.H., from a Burroughs Wellcome Fund Career Award and the NIH Director's New Innovator Award (DP2OD006493-01). The authors declare no competing financial interests.	Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Deng WB, 2009, TRENDS GENET, V25, P425, DOI 10.1016/j.tig.2009.09.004; Fan JS, 2011, MUTAT RES-FUND MOL M, V713, P8, DOI 10.1016/j.mrfmmm.2011.05.018; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Momcilovic O, 2011, RESULTS PROBL CELL D, V53, P415, DOI 10.1007/978-3-642-19065-0_18; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Oyamada Y, 2005, RESP PHYSIOL NEUROBI, V145, P143, DOI 10.1016/j.resp.2004.11.003; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	35	86	90	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					366	373		10.1016/j.stem.2011.07.018	http://dx.doi.org/10.1016/j.stem.2011.07.018			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982236	Green Accepted, Bronze			2022-12-25	WOS:000296041200014
J	Poo, C; Isaacson, JS				Poo, Cindy; Isaacson, Jeffry S.			A Major Role for Intracortical Circuits in the Strength and Tuning of Odor-Evoked Excitation in Olfactory Cortex	NEURON			English	Article							RAT PIRIFORM CORTEX; PYRAMIDAL CELLS; CRITICAL PERIOD; BULB; REPRESENTATIONS; NEURONS; INPUT; ASSOCIATION; SUPPRESSION; INHIBITION	In primary sensory cortices, there are two main sources of excitation: afferent sensory input relayed from the periphery and recurrent intracortical input. Untangling the functional roles of these two excitatory pathways is fundamental for understanding how cortical neurons process sensory stimuli. Odor representations in the primary olfactory (piriform) cortex depend on excitatory sensory afferents from the olfactory bulb. However, piriform cortex pyramidal cells also receive dense intracortical excitatory connections, and the relative contribution of these two pathways to odor responses is unclear. Using a combination of in vivo whole-cell voltage-clamp recording and selective synaptic silencing, we show that the recruitment of intracortical input, rather than olfactory bulb input, largely determines the strength of odor-evoked excitatory synaptic transmission in rat piriform cortical neurons. Furthermore, we find that intracortical synapses dominate odor-evoked excitatory transmission in broadly tuned neurons, whereas bulbar synapses dominate excitatory synaptic responses in more narrowly tuned neurons.	[Poo, Cindy; Isaacson, Jeffry S.] Univ Calif San Diego, Sch Med, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, Ctr Neural Circuits & Behav, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jisaacson@ucsd.edu		Poo, Cindy/0000-0003-1698-8394	 [R01DC04682];  [5F31DC009366]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004682, F31DC009366] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to M. Scanziani for helpful comments and P. Abelkop for technical assistance. Supported by R01DC04682 (J.S.I.) and 5F31DC009366 (C.P.).	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; BOWER JM, 1986, P NATL ACAD SCI USA, V83, P1115, DOI 10.1073/pnas.83.4.1115; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; DOI N, 1990, CELL MOL NEUROBIOL, V10, P559, DOI 10.1007/BF00712849; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Poo C, 2007, J NEUROSCI, V27, P7553, DOI 10.1523/JNEUROSCI.1786-07.2007; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2006, J NEUROSCI, V26, P11938, DOI 10.1523/JNEUROSCI.3473-06.2006; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; TANG AC, 1994, BRAIN RES, V659, P75, DOI 10.1016/0006-8993(94)90865-6; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Zhan C, 2010, J NEUROSCI, V30, P16662, DOI 10.1523/JNEUROSCI.4400-10.2010	34	88	88	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					41	48		10.1016/j.neuron.2011.08.015	http://dx.doi.org/10.1016/j.neuron.2011.08.015			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982367	Bronze, Green Accepted			2022-12-25	WOS:000295856300006
J	Volpicelli-Daley, LA; Luk, KC; Patel, TP; Tanik, SA; Riddle, DM; Stieber, A; Meaney, DF; Trojanowski, JQ; Lee, VMY				Volpicelli-Daley, Laura A.; Luk, Kelvin C.; Patel, Tapan P.; Tanik, Selcuk A.; Riddle, Dawn M.; Stieber, Anna; Meaney, David F.; Trojanowski, John Q.; Lee, Virginia M. -Y.			Exogenous alpha-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death	NEURON			English	Article							PARKINSONS-DISEASE; IN-VIVO; INCLUSIONS; BODIES; TRANSMISSION; PATHOGENESIS; AGGREGATION; DEMENTIA; PROTEIN; TARGET	Inclusions composed of alpha-synuclein (alpha-syn), i.e., Lewy bodies (LBs) and Lewy neurites (LNs), define synucleinopathies including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Here, we demonstrate that preformed fibrils generated from full-length and truncated recombinant alpha-syn enter primary neurons, probably by adsorptive-mediated endocytosis, and promote recruitment of soluble endogenous alpha-syn into insoluble PD-like LBs and LNs. Remarkably, endogenous alpha-syn was sufficient for formation of these aggregates, and overexpression of wild-type or mutant alpha-syn was not required. LN-like pathology first developed in axons and propagated to form LB-like inclusions in perikarya. Accumulation of pathologic alpha-syn led to selective decreases in synaptic proteins, progressive impairments in neuronal excitability and connectivity, and, eventually, neuron death. Thus, our data contribute important insights into the etiology and pathogenesis of PD-like alpha-syn inclusions and their impact on neuronal functions, and they provide a model for discovering therapeutics targeting pathologic alpha-syn-mediated neurodegeneration.	[Volpicelli-Daley, Laura A.; Luk, Kelvin C.; Tanik, Selcuk A.; Riddle, Dawn M.; Stieber, Anna; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Volpicelli-Daley, Laura A.; Luk, Kelvin C.; Tanik, Selcuk A.; Riddle, Dawn M.; Stieber, Anna; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Patel, Tapan P.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, VMY (corresponding author), Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	vmylee@upenn.edu	Luk, Kelvin/AAZ-4202-2020	Luk, Kelvin/0000-0002-6591-6269; Hempsall, Ann-Maree/0000-0001-8610-0106; Meaney, David/0000-0002-0954-4122; Patel, Tapan/0000-0001-8959-6645	National Institutes of Health [NS053488, NS015202]; Picower Foundation; Benaroya Foundation; RJG Foundation; Jeff and Anne Keefer fund for Parkinson's Research; Parkinson Council; Stein-Bellet Family Fund; Army Research Office [W911F-10-1-0526]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; Benaroya Foundation; RJG Foundation; Jeff and Anne Keefer fund for Parkinson's Research; Parkinson Council; Stein-Bellet Family Fund; Army Research Office; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Kurt Brunden, James Soper, Linda Kwong, Eddie Lee, and Jing Guo are thanked for reading the manuscript and for helpful discussions, and Patrick O'Brien, Christine Schultheiss, Victoria Kehm, Christina Haas, and Jeffrey Yeh for technical assistance. This work was supported by National Institutes of Health Grants NS053488, the Picower Foundation, the Benaroya Foundation, the RJG Foundation, the Jeff and Anne Keefer fund for Parkinson's Research, the Parkinson Council, the Stein-Bellet Family Fund, and National Institutes of Health Grant NS015202 and Army Research Office W911F-10-1-0526.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Baba M, 1998, AM J PATHOL, V152, P879; Banks WA, 1998, J CELL SCI, V111, P533; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; BROADWELL RD, 1988, P NATL ACAD SCI USA, V85, P632, DOI 10.1073/pnas.85.2.632; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Fortin DL, 2010, MOVEMENT DISORD, V25, pS21, DOI 10.1002/mds.22722; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; GONATAS NK, 1973, J CELL BIOL, V59, P436, DOI 10.1083/jcb.59.2.436; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	45	931	945	3	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2011	72	1					57	71		10.1016/j.neuron.2011.08.033	http://dx.doi.org/10.1016/j.neuron.2011.08.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982369	Bronze, Green Accepted			2022-12-25	WOS:000295856300008
J	Sreenivasan, S; Fiete, I				Sreenivasan, Sameet; Fiete, Ila			Grid cells generate an analog error-correcting code for singularly precise neural computation	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; FISHER INFORMATION; UNIT-ACTIVITY; SPATIAL MAP; DIRECTION; CA1; HIPPOCAMPUS; INTEGRATION; MODEL; REPRESENTATION	Entorhinal grid cells in mammals fire as a function of animal location, with spatially periodic response patterns. This nonlocal periodic representation of location, a local variable, is unlike other neural codes. There is no theoretical explanation for why such a code should exist. We examined how accurately the grid code with noisy neurons allows an ideal observer to estimate location and found this code to be a previously unknown type of population code with unprecedented robustness to noise. In particular, the representational accuracy attained by grid cells over the coding range was in a qualitatively different class from what is possible with observed sensory and motor population codes. We found that a simple neural network can effectively correct the grid code. To the best of our knowledge, these results are the first demonstration that the brain contains, and may exploit, powerful error-correcting codes for analog variables.	[Sreenivasan, Sameet; Fiete, Ila] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Sreenivasan, Sameet] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA	University of Texas System; University of Texas Austin; Rensselaer Polytechnic Institute	Fiete, I (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	ilafiete@mail.clm.utexas.edu		Fiete, Ila/0000-0003-4738-2539	Office of Naval Research through the Multidisciplinary University Research Initiative	Office of Naval Research through the Multidisciplinary University Research Initiative	We are grateful to Y. Burak, S. Seung, A. Kepecs, P. Latham, A. Pouget and P. Dayan for thought-provoking questions and comments, S. H. Lee for helpful conversations, T. Lam for advice on a volume computation, D. Johnston, A. Huk, N. Priebe, A. Tan and members of our laboratory for comments on the manuscript, and A. Preston for useful pointers to the literature. I. F. is a Sloan Foundation Fellow, a Searle Scholar and a McKnight Scholar, and receives funding from the Office of Naval Research through the Multidisciplinary University Research Initiative.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; [Anonymous], 1988, EYE BRAIN VISION; Bethge M, 2002, NEURAL COMPUT, V14, P2317, DOI 10.1162/08997660260293247; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; GOBLICK TJ, 1965, IEEE T INFORM THEORY, V11, P558, DOI 10.1109/TIT.1965.1053821; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; HANZO L, 2002, TURBO CODING TURBO E; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jin DHZ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051922; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; McDonald D., 2004, PRACTICAL HAZOPS TRI; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Ristic B, 2004, KALMAN FILTER PARTIC; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shamir M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000286; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Sudan M, 2001, ANN IEEE SYMP FOUND, P36; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; TAUBE JS, 1990, J NEUROSCI, V10, P420; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Xie XH, 2002, PHYS REV E, V66, DOI 10.1003/PhysRevE.66.041902; Zhang K, 1996, J NEUROSCI, V16, P2112; Zhang KC, 1999, NEURAL COMPUT, V11, P75, DOI 10.1162/089976699300016809	51	111	111	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1330	U154		10.1038/nn.2901	http://dx.doi.org/10.1038/nn.2901			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909090				2022-12-25	WOS:000295254200023
J	Halassa, MM; Siegle, JH; Ritt, JT; Ting, JT; Feng, GP; Moore, CI				Halassa, Michael M.; Siegle, Joshua H.; Ritt, Jason T.; Ting, Jonathan T.; Feng, Guoping; Moore, Christopher I.			Selective optical drive of thalamic reticular nucleus generates thalamic bursts and cortical spindles	NATURE NEUROSCIENCE			English	Article							SLEEP; OSCILLATIONS; PATTERNS; CORTEX; SLOW	The thalamic reticular nucleus (TRN) is hypothesized to regulate neocortical rhythms and behavioral states. Using optogenetics and multi-electrode recording in behaving mice, we found that brief selective drive of TRN switched the thalamocortical firing mode from tonic to bursting and generated state-dependent neocortical spindles. These findings provide causal support for the involvement of the TRN in state regulation in vivo and introduce a new model for addressing the role of this structure in behavior.	[Halassa, Michael M.; Siegle, Joshua H.; Ting, Jonathan T.; Feng, Guoping] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Halassa, Michael M.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ritt, Jason T.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Moore, Christopher I.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Boston University; Brown University	Feng, GP (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	fengg@mit.edu; cim@mit.edu	Feng, Guoping/Y-2827-2019	Ting, Jonathan/0000-0001-8266-0392; Moore, Christopher/0000-0003-4534-1602	US National Institutes of Health [R01 NS045130-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by a US National Institutes of Health award (R01 NS045130-05) to C.I.M.	Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Contreras D, 1997, J NEUROSCI, V17, P1179; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Espinosa F, 2008, J NEUROSCI, V28, P5570, DOI 10.1523/JNEUROSCI.0747-08.2008; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; Li B, 1999, J PHYSIOL-LONDON, V514, P857, DOI 10.1111/j.1469-7793.1999.857ad.x; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sohal VS, 2006, J NEUROSCI, V26, P4247, DOI 10.1523/JNEUROSCI.3812-05.2006; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Steriade M, 2001, NAT NEUROSCI, V4, P671, DOI 10.1038/89434	15	188	194	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1118	1120		10.1038/nn.2880	http://dx.doi.org/10.1038/nn.2880			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785436	Green Accepted			2022-12-25	WOS:000294284900010
J	Puram, SV; Kim, AH; Ikeuchi, Y; Wilson-Grady, JT; Merdes, A; Gygi, SP; Bonni, A				Puram, Sidharth V.; Kim, Albert H.; Ikeuchi, Yoshiho; Wilson-Grady, Joshua T.; Merdes, Andreas; Gygi, Steven P.; Bonni, Azad			A CaMKII beta signaling pathway at the centrosome regulates dendrite patterning in the brain	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; DEVELOPING CEREBELLUM; NEURONAL DEVELOPMENT; ASSOCIATION DOMAIN; MENTAL-RETARDATION; RAT-BRAIN; MORPHOGENESIS; MECHANISMS; NEUROBIOLOGY; SEPARATION	The protein kinase calcium/calmodulin-dependent kinase II (CaMKII) predominantly consists of the alpha and beta isoforms in the brain. Although CaMKII alpha functions have been elucidated, the isoform-specific catalytic functions of CaMKII beta have remained unknown. Using knockdown analyses in primary rat neurons and in the rat cerebellar cortex in vivo, we report that CaMKII beta operates at the centrosome in a CaMKII alpha-independent manner to drive dendrite retraction and pruning. We also find that the targeting protein PCM1 (pericentriolar material 1) localizes CaMKII beta to the centrosome. Finally, we uncover the E3 ubiquitin ligase Cdc20-APC (cell division cycle 20-anaphase promoting complex) as a centrosomal substrate of CaMKII beta. CaMKII beta phosphorylates Cdc20 at Ser51, which induces Cdc20 dispersion from the centrosome, thereby inhibiting centrosomal Cdc20-APC activity and triggering the transition from growth to retraction of dendrites. Our findings define a new, isoform-specific function for CaMKII beta that regulates ubiquitin signaling at the centrosome and thereby orchestrates dendrite patterning, with important implications for neuronal connectivity in the brain.	[Puram, Sidharth V.; Kim, Albert H.; Ikeuchi, Yoshiho; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Puram, Sidharth V.; Wilson-Grady, Joshua T.; Bonni, Azad] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Puram, Sidharth V.] Harvard Univ, Sch Med, MD PhD Program, Boston, MA USA; [Kim, Albert H.] Childrens Hosp, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Wilson-Grady, Joshua T.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Merdes, Andreas] Ctr Natl Rech Sci Pierre Fabre, Ctr Rech Pharmacol Sante, Unite Mixte Rech 2587, Toulouse, France	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	ikeuchi, yoshiho/C-1713-2014; Ikeuchi, Yoshiho/N-1057-2019; Kim, Albert H./HGF-0057-2022	ikeuchi, yoshiho/0000-0002-2829-3840; Puram, Sidharth/0000-0003-3543-889X	US National Institutes of Health [NS051255]; Ruth L. Kirschstein National Research Service (National Cancer Institute); Brain Science Foundation; Human Frontier Science Program Long-term Fellowship; NATIONAL CANCER INSTITUTE [F32CA124028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brain Science Foundation; Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ericsson for assistance with electron microscopy experiments and J. Blenis, G. Corfas and members of the Bonni laboratory for discussions and critical reading of the manuscript. This work was supported by US National Institutes of Health grant NS051255 (A.B.), a Ruth L. Kirschstein National Research Service Award (National Cancer Institute), a Brain Science Foundation grant (A.H.K.) and a Human Frontier Science Program Long-term Fellowship (Y.I.).	Altman J, 1997, DEV CEREBELLAR SYSTE; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; BROCKE L, 1995, J NEUROSCI, V15, P6797; CAJAL SRY, 1995, HISTOLOGY NERVOUS SY, V2, P3; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gillingham AK, 2000, EMBO REP, V1, P524; GOSLIN K, 1998, RAT HIPPOCAMPAL NEUR; Griffith LC, 2004, J NEUROSCI, V24, P8391, DOI 10.1523/JNEUROSCI.2888-04.2004; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MILLER SG, 1985, J BIOL CHEM, V260, P9039; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2007, J NEUROSCI, V27, P10037, DOI 10.1523/JNEUROSCI.0361-07.2007; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; VALLANO ML, 1989, J NEUROSCI METH, V30, P1, DOI 10.1016/0165-0270(89)90067-8; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	49	64	65	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					973	U58		10.1038/nn.2857	http://dx.doi.org/10.1038/nn.2857			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725312	Green Accepted			2022-12-25	WOS:000293123700010
J	Koch, SM; Dela Cruz, CG; Hnasko, TS; Edwards, RH; Huberman, AD; Ullian, EM				Koch, Selina M.; Dela Cruz, Cassandra G.; Hnasko, Thomas S.; Edwards, Robert H.; Huberman, Andrew D.; Ullian, Erik M.			Pathway-Specific Genetic Attenuation of Glutamate Release Alters Select Features of Competition-Based Visual Circuit Refinement	NEURON			English	Article							EYE-SPECIFIC SEGREGATION; RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; RETINOGENICULATE SYNAPSE; MOUSE; PROJECTIONS; SYSTEM; EXPRESSION; WAVES; SEROTONIN	A hallmark of mammalian neural circuit development is the refinement of initially imprecise connections by competitive activity-dependent processes. In the developing visual system retinal ganglion cell (RGC) axons from the two eyes undergo activity-dependent competition for territory in the dorsal lateral geniculate nucleus (dLGN). The direct contributions of synaptic transmission to this process, however, remain unclear. We used a genetic approach to reduce glutamate release selectively from ipsilateral-projecting RGCs and found that their release-deficient axons failed to exclude competing axons from the ipsilateral eye territory in the dLGN. Nevertheless, the release-deficient axons consolidated and maintained their normal amount of dLGN territory, even in the face of fully active competing axons. These results show that during visual circuit refinement glutamatergic transmission plays a direct role in excluding competing axons from inappropriate target regions, but they argue that consolidation and maintenance of axonal territory are largely insensitive to alterations in synaptic activity levels.	[Dela Cruz, Cassandra G.; Ullian, Erik M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Koch, Selina M.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Hnasko, Thomas S.; Edwards, Robert H.; Ullian, Erik M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Huberman, Andrew D.] Univ Calif San Diego, Div Biol Sci, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Huberman, Andrew D.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Ullian, EM (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	ulliane@vision.ucsf.edu		Hnasko, Thomas/0000-0001-6176-8513	NIMH [MH50712]; The E. Matilda Zigler Foundation for the Blind; Research to Prevent Blindness and March of Dimes; NEI [EY002162]; Research to Prevent Blindness;  [T32-EY07120]; NATIONAL EYE INSTITUTE [P30EY002162, T32EY007120, R01EY022157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712, R37MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); The E. Matilda Zigler Foundation for the Blind; Research to Prevent Blindness and March of Dimes; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Phong Nguyen for expert technical assistance. This work was supported by NIMH-MH50712 (R.H.E.), The E. Matilda Zigler Foundation for the Blind (A.D.H.), T32-EY07120 (S.M.K.), Research to Prevent Blindness and March of Dimes (E.M.U.), NEI-EY002162, and a Research to Prevent Blindness Unrestricted Grant.	Bansal A, 2000, J NEUROSCI, V20, P7672; Bickford ME, 2010, J COMP NEUROL, V518, P622, DOI 10.1002/cne.22223; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Fujiyama F, 2003, J COMP NEUROL, V465, P234, DOI 10.1002/cne.10848; Garcia-Frigola C, 2010, EMBO J, V29, P3170, DOI 10.1038/emboj.2010.172; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koch SM, 2010, J NEUROSCI, V30, P5404, DOI 10.1523/JNEUROSCI.4893-09.2010; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rebsam A, 2009, J NEUROSCI, V29, P14855, DOI 10.1523/JNEUROSCI.3462-09.2009; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SHATZ CJ, 1986, ANNU REV NEUROSCI, V9, P171, DOI 10.1146/annurev.ne.09.030186.001131; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; Ziburkus J, 2009, J NEUROPHYSIOL, V102, P3082, DOI 10.1152/jn.90618.2008	44	36	36	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 28	2011	71	2					235	242		10.1016/j.neuron.2011.05.045	http://dx.doi.org/10.1016/j.neuron.2011.05.045			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791283	Bronze, Green Accepted			2022-12-25	WOS:000293433900008
J	Lee, TKW; Castilho, A; Cheung, VCH; Tang, KH; Ma, S; Irene, OLN				Lee, Terence Kin Wah; Castilho, Antonia; Cheung, Vincent Chi Ho; Tang, Kwan Ho; Ma, Stephanie; Irene Oi Lin Ng			CD24(+) Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation	CELL STEM CELL			English	Article							CANCER STEM-CELLS; HEPATOCELLULAR-CARCINOMA; PROSPECTIVE IDENTIFICATION; TGF-BETA; EXPRESSION; GENE; RECURRENCE; MODELS	Tumor-initiating cells (T-ICs) are a subpopulation of chemoresistant tumor cells that have been shown to cause tumor recurrence upon chemotherapy. Identification of T-ICs and their related pathways are therefore priorities for the development of new therapeutic paradigms. We established chemoresistant hepatocellular carcinoma (HCC) xenograft tumors in immunocompromised mice in which an enriched T-IC population was capable of tumor initiation and self-renewal. With this model, we found CD24 to be upregulated in residual chemoresistant tumors when compared with bulk tumor upon cisplatin treatment. CD24(+) HCC cells were found to be critical for the maintenance, self-renewal, differentiation, and metastasis of tumors and to significantly impact patients' clinical outcome. With a lentiviral-based knockdown approach, CD24 was found to be a functional liver T-IC marker that drives T-IC genesis through STAT3-mediated NANOG regulation. Our findings point to a CD24 cascade in liver T-ICs that may provide an attractive therapeutic target for HCC patients.	[Lee, Terence Kin Wah; Castilho, Antonia; Cheung, Vincent Chi Ho; Ma, Stephanie; Irene Oi Lin Ng] Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China; [Lee, Terence Kin Wah; Castilho, Antonia; Cheung, Vincent Chi Ho; Tang, Kwan Ho; Ma, Stephanie; Irene Oi Lin Ng] Univ Hong Kong, Liver Canc & Hepatitis Res Lab, Dept Pathol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Irene, OLN (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China.	iolng@hku.hk	; Ma, Stephanie Kwai Yee/C-4766-2009	Tang, Kwan Ho/0000-0001-7729-5159; Ma, Stephanie Kwai Yee/0000-0002-2029-7943; Ng, Irene Oi-lin/0000-0001-7532-2029; Lee, Kin Wah/0000-0003-0682-322X	Hong Kong Research Grants Council [HKU 1/06C, HKU 7/CRF/09]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The authors would like to thank LKS Faculty of Medicine at The University of Hong Kong for the Faculty Core Facility. The study was supported by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRF/09). I.O.L.N. is Loke Yew Professor in Pathology.	Aguayo A, 2001, SEMIN ONCOL, V28, P503, DOI 10.1053/sonc.2001.26953; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; ARII S, 1992, CANCER, V69, P913, DOI 10.1002/1097-0142(19920215)69:4<913::AID-CNCR2820690413>3.0.CO;2-T; Averbook BJ, 2002, SURGERY, V132, P611; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Byers LA, 2009, CLIN CANCER RES, V15, P6852, DOI 10.1158/1078-0432.CCR-09-0767; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cram DS, 1999, DIFFERENTIATION, V64, P237, DOI 10.1046/j.1432-0436.1999.6440237.x; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Friel AM, 2008, CELL CYCLE, V7, P242, DOI 10.4161/cc.7.2.5207; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; HEDVAT M, 2003, CANCER CELL, V16, P487; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HUANG LR, 1995, CANCER RES, V55, P4717; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kassahun Woubet T, 2006, Exp Clin Transplant, V4, P549; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Kuvshinoff BW, 2002, SURGERY, V132, P605, DOI 10.1067/msy.2002.127545; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Marquardt JU, 2010, SEMIN LIVER DIS, V30, P26, DOI 10.1055/s-0030-1247130; Mattison J, 2010, CANCER RES, V70, P883, DOI 10.1158/0008-5472.CAN-09-1737; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; PIRRUCCELLO SJ, 1986, J IMMUNOL, V136, P3779; Sammar M, 1997, BIOCHEM BIOPH RES CO, V234, P330, DOI 10.1006/bbrc.1997.6639; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh SK, 2003, CANCER RES, V63, P5821; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; Wang M, 2011, INT J CANCER, V128, P72, DOI 10.1002/ijc.25317; Woo HG, 2008, CLIN CANCER RES, V14, P2056, DOI 10.1158/1078-0432.CCR-07-1473; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	51	463	491	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					50	63		10.1016/j.stem.2011.06.005	http://dx.doi.org/10.1016/j.stem.2011.06.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726833	Green Submitted, Bronze			2022-12-25	WOS:000293157000009
J	Shang, YH; Haynes, P; Pirez, N; Harrington, KI; Guo, F; Pollack, J; Hong, PY; Griffith, LC; Rosbash, M				Shang, Yuhua; Haynes, Paula; Pirez, Nicolas; Harrington, Kyle I.; Guo, Fang; Pollack, Jordan; Hong, Pengyu; Griffith, Leslie C.; Rosbash, Michael			Imaging analysis of clock neurons reveals light buffers the wake-promoting effect of dopamine	NATURE NEUROSCIENCE			English	Article							DROSOPHILA-MELANOGASTER; CIRCADIAN CLOCK; ADENYLYL-CYCLASE; LATERAL NEURONS; REGULATES SLEEP; PDF CELLS; RECEPTOR; OCTOPAMINE; CIRCUIT; AROUSAL	How animals maintain proper amounts of sleep yet remain flexible to changes in environmental conditions remains unknown. We found that environmental light suppressed the wake-promoting effects of dopamine in fly brains. The ten large lateral-ventral neurons (l-LNvs), a subset of clock neurons, are wake-promoting and respond to dopamine, octopamine and light. Behavioral and imaging analyses suggested that dopamine is a stronger arousal signal than octopamine. Notably, light exposure not only suppressed l-LNv responses, but also synchronized responses of neighboring l-LNvs. This regulation occurred by distinct mechanisms: light-mediated suppression of octopamine responses was regulated by the circadian clock, whereas light regulation of dopamine responses occurred by upregulation of inhibitory dopamine receptors. Plasticity therefore alters the relative importance of diverse cues on the basis of the environmental mix of stimuli. The regulatory mechanisms described here may contribute to the control of sleep stability while still allowing behavioral flexibility.	[Shang, Yuhua; Guo, Fang; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Waltham, MA 02254 USA; [Shang, Yuhua; Haynes, Paula; Pirez, Nicolas; Guo, Fang; Griffith, Leslie C.; Rosbash, Michael] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Harrington, Kyle I.; Pollack, Jordan; Hong, Pengyu] Brandeis Univ, Dept Comp Sci, Waltham, MA USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	rosbash@brandeis.edu	Guo, Fang/H-4067-2014; Hong, Pengyu/AAE-6736-2020	Guo, Fang/0000-0003-2219-2886; Harrington, Kyle/0000-0002-7237-1973; Griffith, Leslie/0000-0003-3164-9876; Hong, Pengyu/0000-0002-3177-2754; Pirez, Nicolas/0000-0002-0463-0080	US National Institutes of Health [PO1 NS044232-06, R01 MH067284, NIH R01 EB007042]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM033205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713, P01NS044232] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Taghert for kindly providing pdfGal4 (X) and UAS-EPAC flies. We obtained UAS-D2R-RNAi lines from the Vienna Drosophila RNAi center. We are grateful to O. Shafer for technical help with cAMP imaging. We also thank E. Dougherty for assistance in confocal microscopy, K. Palm and S. Pescatore for administrative assistance and C. Vecsey for comments on the manuscript. The work was supported in part by grants from the US National Institutes of Health (PO1 NS044232-06 to M. R., R01 MH067284 to L. C. G. and NIH R01 EB007042 to P. Hong).	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; Cayre M, 1999, J NEUROPHYSIOL, V81, P1, DOI 10.1152/jn.1999.81.1.1; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hall JC, 2005, METHOD ENZYMOL, V393, P61, DOI 10.1016/S0076-6879(05)93004-8; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shakiryanova D, 2008, P NATL ACAD SCI USA, V105, P13610, DOI 10.1073/pnas.0802131105; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Soille P., 2013, MORPHOLOGICAL IMAGE; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039	36	77	79	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					889	U110		10.1038/nn.2860	http://dx.doi.org/10.1038/nn.2860			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685918	Green Accepted			2022-12-25	WOS:000292081700017
J	Ding, JB; Oh, WJ; Sabatini, BL; Gu, CH				Ding, Jun B.; Oh, Won-Jong; Sabatini, Bernardo L.; Gu, Chenghua			Semaphorin 3E-Plexin-D1 signaling controls pathway-specific synapse formation in the striatum	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; CM-PF COMPLEX; BASAL GANGLIA; NEURAL CIRCUITS; RECOGNITION; CONNECTIONS; MECHANISMS; EXPRESSION; MOLECULES; PROTEINS	The proper formation of synaptic connectivity in the mammalian brain is critical for complex behavior. In the striatum, balanced excitatory synaptic transmission from multiple sources onto two classes of principal neurons is required for coordinated and voluntary motor control. Here we show that the interaction between the secreted semaphorin 3E (Sema3E) and its receptor Plexin-D1 is a critical determinant of synaptic specificity in cortico-thalamo-striatal circuits in mice. We find that Sema3e (encoding Sema3E) is highly expressed in thalamostriatal projection neurons, whereas in the striatum Plxnd1 (encoding Plexin-D1) is selectively expressed in direct-pathway medium spiny neurons (MSNs). Despite physical intermingling of the MSNs, genetic ablation of Plxnd1 or Sema3e results in functional and anatomical rearrangement of thalamostriatal synapses specifically in direct-pathway MSNs without effects on corticostriatal synapses. Thus, our results demonstrate that Sema3E and Plexin-D1 specify the degree of glutamatergic connectivity between a specific source and target in the complex circuitry of the basal ganglia.	[Ding, Jun B.; Oh, Won-Jong; Sabatini, Bernardo L.; Gu, Chenghua] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Ding, Jun B.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu; chenghua_gu@hms.harvard.edu	Ding, Jun/B-2513-2009	Ding, Jun/0000-0003-0690-1312	Lefler postdoctoral fellowship; Whitehall and Klingenstein foundations; Parkinson's Disease Foundation [PDF-FBS-1106]; US National Institute of Neurological Disorders and Stroke [K99-NS075136, NS046579, NS064583]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS075136, T32NS007484, R37NS046579, R01NS046579, R00NS075136, R01NS064583] Funding Source: NIH RePORTER	Lefler postdoctoral fellowship; Whitehall and Klingenstein foundations(Klingenstein Philanthropies); Parkinson's Disease Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank L. Ding (Harvard NeuroDiscovery Center) for assistance in image analysis, T. lessen (Columbia University) and Y. Yoshida (Cincinnati Children's Hospital Medical Center) for providing Plexin-D1 conditional mice, C. Henderson (Columbia University) and F. Mann (Universite de la Mediterranee) for Sema3E mice, A. Kautzman, B. Stevens and E. Benecchi for assistance with array tomography and J. Hjorth for assistance with Scholl analysis. We thank members of Sabatini and Gu laboratories for discussions. This work was funded by a Lefler postdoctoral fellowship (W.-J.O.), the Whitehall and Klingenstein foundations (C.G.), the Parkinson's Disease Foundation (PDF-FBS-1106, J.B.D.) and the US National Institute of Neurological Disorders and Stroke (K99-NS075136, J.B.D.; NS046579, B.L.S.; NS064583, C.G.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Johnson-Venkatesh EM, 2010, EUR J NEUROSCI, V32, P181, DOI 10.1111/j.1460-9568.2010.07338.x; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Raju DV, 2006, J COMP NEUROL, V499, P231, DOI 10.1002/cne.21099; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Watakabe A, 2006, J COMP NEUROL, V499, P258, DOI 10.1002/cne.21106; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2010, J NEUROSCI, V30, P3579, DOI 10.1523/JNEUROSCI.6319-09.2010	40	72	77	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					215	223		10.1038/nn.3003	http://dx.doi.org/10.1038/nn.3003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179111	Green Accepted			2022-12-25	WOS:000299603500012
J	Zhang, XL; Zhaoping, L; Zhou, TG; Fang, F				Zhang, Xilin; Zhaoping, Li; Zhou, Tiangang; Fang, Fang			Neural Activities in V1 Create a Bottom-Up Saliency Map	NEURON			English	Article							SELECTIVE VISUAL-ATTENTION; FRONTAL EYE FIELD; CORTICAL AREAS; EXTRASTRIATE; COMPONENTS; CONNECTIONS; RESPONSES; PARIETAL; PRIORITY; STRIATE	The bottom-up contribution to the allocation of exogenous attention is a saliency map, whose neural substrate is hard to identify because of possible contamination by top-down signals. We obviated this possibility using stimuli that observers could not perceive, but that nevertheless, through orientation contrast between foreground and background regions, attracted attention to improve a localized visual discrimination. When orientation contrast increased, so did the degree of attraction, and two physiological measures: the amplitude of the earliest (C1) component of the ERP, which is associated with primary visual cortex, and fMRI BOLD signals in areas V1-V4 (but not the intraparietal sulcus). Significantly, across observers, the degree of attraction correlated with the C1 amplitude and just the V1 BOLD signal. These findings strongly support the proposal that a bottom-up saliency map is created in V1, challenging the dominant view that the saliency map is generated in the parietal cortex.	[Zhang, Xilin; Fang, Fang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Zhang, Xilin; Fang, Fang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Fang, Fang] Peking Univ, Ctr Life Sci, Beijing 100871, Peoples R China; [Fang, Fang] Peking Univ, IDG, McGovern Inst Brain Res, Beijing 100871, Peoples R China; [Zhaoping, Li] UCL, Dept Comp Sci, London WC1E 6BT, England; [Zhou, Tiangang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	Peking University; Peking University; Peking University; Peking University; University of London; University College London; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fang, F (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	ffang@pku.edu.cn		ZHANG, XILIN/0000-0003-0449-934X	Ministry of Science and Technology of China [2011CBA00405, 2010CB833903]; National Natural Science Foundation of China [30925014, 30870762, 90920012, 30921064, 90820307]; Fundamenta Research Funds for the Central Universities; Gatsby Charitable Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamenta Research Funds for the Central Universities; Gatsby Charitable Foundation	We are grateful to Peter Dayan for reading the manuscript with helpful comments and Yan Song for help with dipole source localization. This work was supported by the Ministry of Science and Technology of China (2011CBA00405 and 2010CB833903), the National Natural Science Foundation of China (Project 30925014, 30870762, 90920012, 30921064, and 90820307), the Fundamenta Research Funds for the Central Universities, and the Gatsby Charitable Foundation.	Ales JM, 2010, NEUROIMAGE, V52, P1401, DOI 10.1016/j.neuroimage.2010.05.016; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Bao M, 2010, J NEUROSCI, V30, P15080, DOI 10.1523/JNEUROSCI.5703-09.2010; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; Burrows BE, 2009, J NEUROSCI, V29, P15169, DOI 10.1523/JNEUROSCI.3710-09.2009; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Frey HP, 2010, J NEUROSCI, V30, P4547, DOI 10.1523/JNEUROSCI.5217-09.2010; Friston K.J., 1995, HUM BRAIN MAPP, V2, P211; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P1584, DOI 10.1162/jocn.2009.21103; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hegde J, 2003, J NEUROSCI, V23, P9968; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JEFFREYS DA, 1972, EXP BRAIN RES, V16, P1; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Koene A, 2007, J VISION, V7, DOI 10.1167/7.11.14; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; LYNCH JC, 1987, EXP BRAIN RES, V68, P437; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Schiller PH, 1998, COGNITIVE NEUROSCIENCE OF ATTENTION, P3; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; WOLFE JM, 1988, PERCEPT PSYCHOPHYS, V44, P81, DOI 10.3758/BF03207480; WOLFE JM, 1994, VISION RES, V34, P1187, DOI 10.1016/0042-6989(94)90300-X; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; Zhaoping L, 2007, PLOS COMPUT BIOL, V3, P616, DOI 10.1371/journal.pcbi.0030062; Zhaoping L, 2008, J VISION, V8, DOI 10.1167/8.5.1	62	127	138	6	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					183	192		10.1016/j.neuron.2011.10.035	http://dx.doi.org/10.1016/j.neuron.2011.10.035			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243756	Bronze			2022-12-25	WOS:000299446800017
J	Bagley, EE; Hacker, J; Chefer, VI; Mallet, C; McNally, GP; Chieng, BCH; Perroud, J; Shippenberg, TS; Christie, MJ				Bagley, Elena E.; Hacker, Jennifer; Chefer, Vladimir I.; Mallet, Christophe; McNally, Gavan P.; Chieng, Billy C. H.; Perroud, Julie; Shippenberg, Toni S.; Christie, MacDonald J.			Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors	NATURE NEUROSCIENCE			English	Article							PERIAQUEDUCTAL GRAY; MORPHINE-WITHDRAWAL; MIDBRAIN NEURONS; RECEPTORS; TIAGABINE; OPIATE; INHIBITION; MODULATION; ACTIVATION; EXPRESSION	directly via transporter currents. A physiological or pathophysiological role for transporter currents has not been described. We found that GABA transporter 1 (GAT-1) cation currents directly increased GABAergic neuronal excitability and synaptic GABA release in the periaqueductal gray (PAG) during opioid withdrawal in rodents. In contrast, GAT-1 did not indirectly alter GABA receptor responses via modulation of extracellular GABA concentrations. Notably, we found that GAT-1-induced increases in GABAergic activity contributed to many PAG-mediated signs of opioid withdrawal. Together, these data support the hypothesis that GAT-1 activity directly produces opioid withdrawal signs through direct hyperexcitation of GABAergic PAG neurons and nerve terminals, which presumably enhances GABAergic inhibition of PAG output neurons. These data provide, to the best of our knowledge, the first evidence that dysregulation of a neurotransmitter transporter current is important for the maladaptive plasticity that underlies opiate withdrawal.	[Bagley, Elena E.; Christie, MacDonald J.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Bagley, Elena E.; Hacker, Jennifer; Mallet, Christophe; Chieng, Billy C. H.; Perroud, Julie; Christie, MacDonald J.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Chefer, Vladimir I.; Shippenberg, Toni S.] NIDA, Integrat Neurosci Sect, Baltimore, MD USA; [McNally, Gavan P.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of Sydney; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of New South Wales Sydney	Christie, MJ (corresponding author), Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia.	mac.christie@sydney.edu.au	Christie, MacDonald J/F-4724-2013; Mallet, Christophe/K-2918-2015	Christie, MacDonald J/0000-0002-0622-609X; Chieng, Billy/0000-0003-0222-8001; McNally, Gavan/0000-0001-9061-6463; Bagley, Elena/0000-0002-3167-0707; Mallet, Christophe/0000-0002-0873-6763	National Health and Medical Research Council of Australia; National Institute on Drug Abuse of the US National Institutes of Health	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute on Drug Abuse of the US National Institutes of Health	We thank Y. Azriel for preparing the image shown in Figure 1a, and T. Kaneko (Kyoto University) for donating Gad67-GFP mice. This work was supported by the National Health and Medical Research Council of Australia and the National Institute on Drug Abuse Intramural Research Program of the US National Institutes of Health.	Bagley EE, 2005, NEURON, V45, P433, DOI 10.1016/j.neuron.2004.12.049; Barbaresi P, 2001, J COMP NEUROL, V429, P337, DOI 10.1002/1096-9861(20000108)429:2<337::AID-CNE12>3.0.CO;2-Z; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bonci A, 1997, J NEUROSCI, V17, P796; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; Chefer VI, 2009, EUR J NEUROSCI, V30, P272, DOI 10.1111/j.1460-9568.2009.06827.x; Cherubini E, 2001, TRENDS NEUROSCI, V24, P155, DOI 10.1016/S0166-2236(00)01724-0; Chieng B, 1998, J NEUROSCI, V18, P7033; Chieng B, 1996, J NEUROSCI, V16, P7128; Chieng BCH, 2005, NEUROREPORT, V16, P1279, DOI 10.1097/01.wnr.0000175246.35837.5c; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; CUSHMAN P, 1973, JAMA-J AM MED ASSOC, V226, P747, DOI 10.1001/jama.226.7.747; DISTEFANO PS, 1985, J PHARMACOL EXP THER, V233, P339; Gonzalez G, 2007, DRUG ALCOHOL DEPEN, V87, P1, DOI 10.1016/j.drugalcdep.2006.07.003; Hack SP, 2003, NEUROPHARMACOLOGY, V45, P575, DOI 10.1016/S0028-3908(03)00205-3; Hacker J, 2006, NEUROSCIENCE, V137, P1389, DOI 10.1016/j.neuroscience.2005.10.052; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Ingram SL, 1998, J NEUROSCI, V18, P10269; Itouji A, 1996, MOL BRAIN RES, V37, P309; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; LASCHKA E, 1976, PSYCHOPHARMACOLOGIA, V46, P141, DOI 10.1007/BF00421383; Luer MS, 1998, ANN PHARMACOTHER, V32, P1173, DOI 10.1345/aph.18053; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; McNally GP, 2004, J NEUROSCI, V24, P6912, DOI 10.1523/JNEUROSCI.1828-04.2004; Minozzi S., 2008, COCHRANE DB SYST REV, V16; Myrick H, 2005, J PSYCHOACTIVE DRUGS, V37, P409, DOI 10.1080/02791072.2005.10399814; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Overstreet LS, 2003, J NEUROSCI, V23, P2618; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Sofuoglu M, 2005, PSYCHOPHARMACOLOGY, V181, P504, DOI 10.1007/s00213-005-0010-y; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tzavara ET, 2002, EUR J NEUROSCI, V16, P149, DOI 10.1046/j.1460-9568.2002.02061.x; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Yang K, 2003, BIOCHEM BIOPH RES CO, V302, P233, DOI 10.1016/S0006-291X(03)00156-6	40	41	43	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1548	U76		10.1038/nn.2940	http://dx.doi.org/10.1038/nn.2940			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037500				2022-12-25	WOS:000297546300014
J	Kubin, T; Poling, J; Kostin, S; Gajawada, P; Hein, S; Rees, W; Wietelmann, A; Tanaka, M; Lorchner, H; Schimanski, S; Szibor, M; Warnecke, H; Braun, T				Kubin, Thomas; Poeling, Jochen; Kostin, Sawa; Gajawada, Praveen; Hein, Stefan; Rees, Wolfgang; Wietelmann, Astrid; Tanaka, Minoru; Loerchner, Holger; Schimanski, Silvia; Szibor, Marten; Warnecke, Henning; Braun, Thomas			Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling	CELL STEM CELL			English	Article							ADULT CARDIAC MYOCYTES; HEART-FAILURE; STEM-CELLS; GENE-EXPRESSION; TISSUE-REPAIR; GROWTH-FACTOR; REGENERATION; CYTOKINE; MUSCLE; GP130	Cardiomyocyte remodeling, which includes partial dedifferentiation of cardiomyocytes, is a process that occurs during both acute and chronic disease processes. Here, we demonstrate that oncostatin M (OSM) is a major mediator of cardiomyocyte dedifferentiation and remodeling during acute myocardial infarction (MI) and in chronic dilated cardiomyopathy (DCM). Patients suffering from DCM show a strong and lasting increase of OSM expression and signaling. OSM treatment induces dedifferentiation of cardiomyocytes and upregulation of stem cell markers and improves cardiac function after MI. Conversely, inhibition of OSM signaling suppresses cardiomyocyte remodeling after MI and in a mouse model of DCM, resulting in deterioration of heart function after MI but improvement of cardiac performance in DCM. We postulate that dedifferentiation of cardiomyocytes initially protects stressed hearts but fails to support cardiac structure and function upon continued activation. Manipulation of OSM signaling provides a means to control the differentiation state of cardiomyocytes and cellular plasticity.	[Kubin, Thomas; Poeling, Jochen; Kostin, Sawa; Gajawada, Praveen; Wietelmann, Astrid; Loerchner, Holger; Schimanski, Silvia; Szibor, Marten; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, D-61321 Bad Nauheim, Germany; [Poeling, Jochen; Rees, Wolfgang; Warnecke, Henning] Schuchtermann Clin, Dept Cardiac Surg, D-49214 Bad Rothenfelde, Germany; [Hein, Stefan] Kerckhoff Hosp, Dept Cardiac Surg, D-61231 Bad Nauheim, Germany; [Tanaka, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Max Planck Society; Kerckhoff Clinic; University of Tokyo	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Ludwigstr 43, D-61321 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804	Max Planck Society; Excellence Initiative "Cardiopulmonary System" at the University of Giessen-Marburg Lung Center (UGMLC); HMWK	Max Planck Society(Max Planck Society); Excellence Initiative "Cardiopulmonary System" at the University of Giessen-Marburg Lung Center (UGMLC); HMWK	The authors thank Kerstin Richter, Brigitte Matzke, Ute Schuchmann, and Sylvia Jeratsch for excellent technical assistance and Gerhard Stammler for statistical analyses. This work was supported by the Max Planck Society and the Excellence Initiative "Cardiopulmonary System" at the University of Giessen-Marburg Lung Center (UGMLC), and the Cell and Gene Therapy Center (CGT) supported by the HMWK.	Apostolakis S, 2010, CARDIOVASC RES, V85, P649, DOI 10.1093/cvr/cvp327; Ausma J, 1998, MOL CELL BIOCHEM, V186, P159, DOI 10.1023/A:1006887803970; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Braun T, 2007, TRENDS BIOTECHNOL, V25, P441, DOI 10.1016/j.tibtech.2007.08.004; Dispersyn GD, 2002, EUR HEART J, V23, P849, DOI 10.1053/euhj.2001.2963; Driesen RB, 2009, J CELL MOL MED, V13, P896, DOI 10.1111/j.1582-4934.2008.00523.x; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Gibson RM, 2000, J BIOL CHEM, V275, P22574, DOI 10.1074/jbc.M907658199; Gwechenberger M, 2004, CROAT MED J, V45, P149; Hein S, 2009, EXP CLIN CARDIOL, V14, pE68; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hohensinner PJ, 2009, FASEB J, V23, P774, DOI 10.1096/fj.08-108035; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kodama H, 1997, CIRC RES, V81, P656; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Kubin T, 1999, AM J PHYSIOL-HEART C, V276, pH2179, DOI 10.1152/ajpheart.1999.276.6.H2179; Laube F, 2006, J CELL SCI, V119, P4719, DOI 10.1242/jcs.03252; Neuhaus P, 2003, MOL CELL BIOL, V23, P6037, DOI 10.1128/MCB.23.17.6037-6048.2003; Osorio KM, 2011, J CELL BIOL, V193, P235, DOI 10.1083/jcb.201006068; Rucker-Martin C, 2002, CARDIOVASC RES, V55, P38, DOI 10.1016/S0008-6363(02)00338-3; Ruoslahti E, 1997, SCIENCE, V276, P1345, DOI 10.1126/science.276.5317.1345; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sharov VG, 1997, INT J CARDIOL, V60, P273, DOI 10.1016/S0167-5273(97)00117-4; Shioi T, 1996, CIRCULATION, V94, P2930, DOI 10.1161/01.CIR.94.11.2930; Song HY, 2007, INT J BIOCHEM CELL B, V39, P439, DOI 10.1016/j.biocel.2006.07.014; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weiss TW, 2005, J MOL CELL CARDIOL, V39, P545, DOI 10.1016/j.yjmcc.2005.03.015; Weiss TW, 2003, CARDIOVASC RES, V59, P628, DOI 10.1016/S0008-6363(03)00463-2; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	38	211	218	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					420	432		10.1016/j.stem.2011.08.013	http://dx.doi.org/10.1016/j.stem.2011.08.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056139	Bronze			2022-12-25	WOS:000297180200010
J	Lapid, H; Shushan, S; Plotkin, A; Voet, H; Roth, Y; Hummel, T; Schneidman, E; Sobel, N				Lapid, Hadas; Shushan, Sagit; Plotkin, Anton; Voet, Hillary; Roth, Yehudah; Hummel, Thomas; Schneidman, Elad; Sobel, Noam			Neural activity at the human olfactory epithelium reflects olfactory perception	NATURE NEUROSCIENCE			English	Article							ODORANT STRUCTURE; NASAL CAVITY; RAT; RESPONSES; PATTERNS; MUCOSA; BULB; PLEASANTNESS; STIMULATION; DYNAMICS	Organization of receptive surfaces reflects primary axes of perception. In vision, retinal coordinates reflect spatial coordinates. In audition, cochlear coordinates reflect tonal coordinates. However, the rules underlying the organization of the olfactory receptive surface are unknown. To test the hypothesis that organization of the olfactory epithelium reflects olfactory perception, we inserted an electrode into the human olfactory epithelium to directly measure odorant-induced evoked responses. We found that pairwise differences in odorant pleasantness predicted pairwise differences in response magnitude; that is, a location that responded maximally to a pleasant odorant was likely to respond strongly to other pleasant odorants, and a location that responded maximally to an unpleasant odorant was likely to respond strongly to other unpleasant odorants. Moreover, the extent of an individual's perceptual span predicted their span in evoked response. This suggests that, similarly to receptor surfaces for vision and audition, organization of the olfactory receptor surface reflects key axes of perception.	[Lapid, Hadas; Shushan, Sagit; Plotkin, Anton; Schneidman, Elad; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Lapid, Hadas] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shushan, Sagit; Roth, Yehudah] Tel Aviv Univ, Sackler Sch Med, Edith Wolfson Med Ctr, Dept Otolaryngol Head & Neck Surg, Holon, Israel; [Voet, Hillary] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Hummel, Thomas] Univ Dresden, Sch Med, Smell & Taste Clin, Dresden, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Technische Universitat Dresden	Lapid, H (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	hadas.lapid@gmail.com; noam.sobel@weizmann.ac.il		Sobel, Noam/0000-0002-3232-9391; schneidman, elad/0000-0001-8653-9848	ERC [200850]; James S. McDonnell Foundation	ERC(European Research Council (ERC)European Commission); James S. McDonnell Foundation	This work was supported by ERC-FP7 Ideas grant #200850 and by the James S. McDonnell Foundation.	Ayci F, 2005, FLAVOUR FRAG J, V20, P481, DOI 10.1002/ffj.1487; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; EDWARDS DA, 1988, EXPERIENTIA, V44, P208, DOI 10.1007/BF01941707; EZEH PI, 1995, J NEUROPHYSIOL, V73, P2207, DOI 10.1152/jn.1995.73.6.2207; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Garcia GJM, 2009, J AEROSOL MED PULM D, V22, P139, DOI 10.1089/jamp.2008.0713; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; HORNUNG DE, 1977, BRAIN RES, V128, P158, DOI 10.1016/0006-8993(77)90244-X; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1234, DOI 10.1073/pnas.0409314102; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; Iwema CL, 2004, J NEUROSCI, V24, P356, DOI 10.1523/JNEUROSCI.1219-03.2004; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Knecht A, 2004, PHYSIOL BEHAV, V83, P13, DOI 10.1016/j.physbeh.2004.07.024; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Lapid H, 2009, J NEUROPHYSIOL, V102, P2121, DOI 10.1152/jn.91321.2008; Leopold DA, 2000, LARYNGOSCOPE, V110, P417, DOI 10.1097/00005537-200003000-00016; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; MORAN DT, 1982, J NEUROCYTOL, V11, P721, DOI 10.1007/BF01153516; MOZELL MM, 1973, SCIENCE, V181, P1247, DOI 10.1126/science.181.4106.1247; Purves D, 2001, PHILOS T ROY SOC B, V356, P285, DOI 10.1098/rstb.2000.0772; RICHARDSON JTE, 1989, PSYCHOL BULL, V105, P352, DOI 10.1037/0033-2909.105.3.352; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; Scott JW, 2007, J NEUROPHYSIOL, V97, P1941, DOI 10.1152/jn.01305.2006; Scott JW, 1997, J NEUROPHYSIOL, V77, P1950, DOI 10.1152/jn.1997.77.4.1950; Vater M, 2011, HEARING RES, V273, P89, DOI 10.1016/j.heares.2010.05.018; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; Wise PM, 2009, ANN NY ACAD SCI, V1170, P206, DOI 10.1111/j.1749-6632.2009.03912.x; Yang GC, 2007, CHEM SENSES, V32, P215, DOI 10.1093/chemse/bjl047; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Zarzo M, 2008, J SENS STUD, V23, P354, DOI 10.1111/j.1745-459X.2008.00160.x; [No title captured]	50	67	67	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1455	U132		10.1038/nn.2926	http://dx.doi.org/10.1038/nn.2926			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21946326				2022-12-25	WOS:000296518600022
J	Vickery, TJ; Chun, MM; Lee, D				Vickery, Timothy J.; Chun, Marvin M.; Lee, Daeyeol			Ubiquity and Specificity of Reinforcement Signals throughout the Human Brain	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; MIXED-STRATEGY GAME; DORSOLATERAL PREFRONTAL CORTEX; HUMAN ORBITOFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; DECISION-MAKING; PARIETAL CORTEX; PREDICTION ERRORS; REWARD SIGNALS; VISUAL-CORTEX	Reinforcements and punishments facilitate adaptive behavior in diverse domains ranging from perception to social interactions. A conventional approach to understanding the corresponding neural substrates focuses on the basal ganglia and its dopaminergic projections. Here, we show that reinforcement and punishment signals are surprisingly ubiquitous in the gray matter of nearly every subdivision of the human brain. Humans played either matching-pennies or rock-paper-scissors games against computerized opponents while being scanned using fMRI. Multivoxel pattern analysis was used to decode previous choices and their outcomes, and to predict upcoming choices. Whereas choices were decodable from a confined set of brain structures, their outcomes were decodable from nearly all cortical and subcortical structures. In addition, signals related to both reinforcements and punishments were recovered reliably in many areas and displayed patterns not consistent with salience-based explanations. Thus, reinforcement and punishment might play global modulatory roles in the entire brain.	[Vickery, Timothy J.; Chun, Marvin M.; Lee, Daeyeol] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Chun, Marvin M.; Lee, Daeyeol] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Vickery, TJ (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	tim.vickery@gmail.com	Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X; Chun, Marvin/0000-0003-1070-7993	Department of Neurobiology and Kavli Institute for Neuroscience, Yale University School of Medicine	Department of Neurobiology and Kavli Institute for Neuroscience, Yale University School of Medicine	This study was supported by the Department of Neurobiology and Kavli Institute for Neuroscience, Yale University School of Medicine. We thank Matt Kleinman, Zhihao Zhang, and Sam Cartmell for assistance with data collection, and Brice Kuhl for useful discussions.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kim S, 2009, NEURAL NETWORKS, V22, P294, DOI 10.1016/j.neunet.2009.03.010; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lee D, 2005, COGNITIVE BRAIN RES, V25, P416, DOI 10.1016/j.cogbrainres.2005.07.003; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Vickery TJ, 2009, CEREB CORTEX, V19, P916, DOI 10.1093/cercor/bhn140; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Wrase J, 2007, NEUROIMAGE, V36, P1253, DOI 10.1016/j.neuroimage.2007.04.001	61	134	138	2	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					166	177		10.1016/j.neuron.2011.08.011	http://dx.doi.org/10.1016/j.neuron.2011.08.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	833BH	21982377	Bronze			2022-12-25	WOS:000295856300016
J	Ben-David, U; Mayshar, Y; Benvenisty, N				Ben-David, Uri; Mayshar, Yoav; Benvenisty, Nissim			Large-Scale Analysis Reveals Acquisition of Lineage-Specific Chromosomal Aberrations in Human Adult Stem Cells	CELL STEM CELL			English	Editorial Material							CULTURE ADAPTATION; COPY NUMBER; IN-VITRO; PLURIPOTENCY; CLASSIFICATION; TRANSFORMATION; ABNORMALITIES; INSTABILITY; MALIGNANCY; MUTATIONS	In this study, we assessed the genetic integrity of over 400 samples of human multipotent stem cells using gene expression data sets. Our analysis reveals that neural and mesenchymal stem cells acquire characteristic large chromosomal aberrations at a similar, or somewhat lower, frequency to that seen in pluripotent stem cells, sometimes within a few passages in culture. Some of the identified chromosomal abnormalities can also be detected in human tumors of the respective tissues.	[Ben-David, Uri; Mayshar, Yoav; Benvenisty, Nissim] Hebrew Univ Jerusalem, Stem Cell Unit, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Mayshar, Y (corresponding author), Hebrew Univ Jerusalem, Stem Cell Unit, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	myoavi@cc.huji.ac.il; nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378; Mayshar, Yoav/0000-0002-5553-2472				Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Ben-David U, 2010, CELL CYCLE, V9, P4603, DOI 10.4161/cc.9.23.14094; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Buyanovskaya OA, 2009, B EXP BIOL MED+, V148, P109, DOI 10.1007/s10517-009-0647-3; Casalbore P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004434; Dahlen A, 2003, INT J CANCER, V103, P616, DOI 10.1002/ijc.10864; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x; Mitelman F., 2022, MITELMAN DATABASE CH; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Schorle H, 2007, INT J ANDROL, V30, P281; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takeuchi M, 2009, IN VITRO CELL DEV-AN, V45, P290, DOI 10.1007/s11626-008-9174-1; Ueyama H, 2012, J CELL MOL MED, V16, P72, DOI 10.1111/j.1582-4934.2011.01303.x; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamaguchi T, 1996, ANTICANCER RES, V16, P2009; Zhang ZX, 2007, CELL BIOL INT, V31, P645, DOI 10.1016/j.cellbi.2006.11.025	30	179	188	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					97	102		10.1016/j.stem.2011.06.013	http://dx.doi.org/10.1016/j.stem.2011.06.013			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816361	Bronze			2022-12-25	WOS:000293990900006
J	Hishida, T; Nozaki, Y; Nakachi, Y; Mizuno, Y; Okazaki, Y; Ema, M; Takahashi, S; Nishimoto, M; Okuda, A				Hishida, Tomoaki; Nozaki, Yuriko; Nakachi, Yutaka; Mizuno, Yosuke; Okazaki, Yasushi; Ema, Masatsugu; Takahashi, Satoru; Nishimoto, Masazumi; Okuda, Akihiko			Indefinite Self-Renewal of ESCs through Myc/Max Transcriptional Complex-Independent Mechanisms	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; C-MYC; RAT BLASTOCYSTS; PLURIPOTENCY; MAX; DIFFERENTIATION; EXPRESSION; PATHWAYS; PHOSPHORYLATION; SURVIVAL	Embryonic stem cells (ESCs) can self-renew indefinitely under the governance of ESC-specific transcriptional circuitries in which each transcriptional factor regulates distinct or overlapping sets of genes with other factors. c-Myc is a key player that is crucially involved in maintaining the undifferentiated state and the self-renewal of ESCs. However, the mechanism by which c-Myc helps preserve the ESC status is still poorly understood. Here we addressed this question by performing loss-of-function studies with the Max gene, which encodes the best-characterized partner protein for all Myc family proteins. Although Myc/Max complexes are widely regarded as crucial regulators of the ESC status, our data revealed that ESCs do not absolutely require these complexes in certain contexts and that this requirement is restricted to empirical ESC culture conditions without a MAPK inhibitor.	[Hishida, Tomoaki; Nozaki, Yuriko; Okuda, Akihiko] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Saitama 3501241, Japan; [Nakachi, Yutaka; Mizuno, Yosuke; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, Saitama 3501241, Japan; [Nishimoto, Masazumi] Saitama Med Univ, Res Ctr Genom Med, Radioisotope Expt Lab, Saitama 3501241, Japan; [Hishida, Tomoaki; Nozaki, Yuriko; Okazaki, Yasushi; Takahashi, Satoru; Okuda, Akihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Ema, Masatsugu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama 3320012, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tsukuba	Okuda, A (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Saitama 3501241, Japan.	akiokuda@saitama-med.ac.jp	Nakachi, Yutaka/M-2446-2013	Nakachi, Yutaka/0000-0003-1964-2495; Okazaki, Yasushi/0000-0003-3241-5502; Ema, Masatsugu/0000-0003-0645-6183	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Strategic Research Center in Private Universities; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Center in Private Universities; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We thank Dr. Hitoshi Niwa for helpful discussions and providing the EBRTcH3 ESCs and Tbx3 cDNA and Dr. Bruno Amati for c-Myc and Max cDNAs and their EG and RX derivatives. We also thank Keiko Amagai and Yukiko Yatsuka for technical assistance. This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and primarily by a Grant-in-Aid for Support Project of Strategic Research Center in Private Universities to the Saitama Medical University Research Center for Genomic Medicine. This study was performed as a part of the Core Research for Evolutional Science and Technology (CREST) project supported by the Japan Science and Technology Agency.	AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hong SL, 2000, GENE DEV, V14, P17; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Steiger D, 2008, NAT GENET, V40, P1084, DOI 10.1038/ng.178; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Wert M, 2001, ONCOGENE, V20, P3746, DOI 10.1038/sj.onc.1204466; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	37	51	52	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					37	49		10.1016/j.stem.2011.04.020	http://dx.doi.org/10.1016/j.stem.2011.04.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726832	Bronze			2022-12-25	WOS:000293157000008
J	Eichner, H; Joesch, M; Schnell, B; Reiff, DF; Borst, A				Eichner, Hubert; Joesch, Maximilian; Schnell, Bettina; Reiff, Dierk F.; Borst, Alexander			Internal Structure of the Fly Elementary Motion Detector	NEURON			English	Article							DROSOPHILA-MELANOGASTER; DIRECTION SELECTIVITY; RESPONSE PROPERTIES; VISUAL-SYSTEM; BLOWFLY CALLIPHORA; MOVEMENT DETECTORS; LOBULA PLATE; NEURAL CODE; OPTIC FLOW; VISION	Recent experiments have shown that motion detection in Drosophila starts with splitting the visual input into two parallel channels encoding brightness increments (ON) or decrements (OFF). This suggests the existence of either two (ON-ON, OFF-OFF) or four (for all pairwise interactions) separate motion detectors. To decide between these possibilities, we stimulated flies using sequences of ON and OFF brightness pulses while recording from motion-sensitive tangential cells. We found direction-selective responses to sequences of same sign (ON-ON, OFF-OFF), but not of opposite sign (ON-OFF, OFF-ON), refuting the existence of four separate detectors. Based on further measurements, we propose a model that reproduces a, variety of additional experimental data sets, including ones that were previously interpreted as support for four separate detectors. Our experiments and the derived model mark an important step in guiding further dissection of the fly motion detection circuit.	[Eichner, Hubert; Joesch, Maximilian; Schnell, Bettina; Reiff, Dierk F.; Borst, Alexander] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Borst, A (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, D-82152 Martinsried, Germany.	borst@neuro.mpg.de		Joesch, Maximilian/0000-0002-3937-1330; Schnell, Bettina/0000-0001-7700-2600				ANSTIS SM, 1970, VISION RES, V10, P1411, DOI 10.1016/0042-6989(70)90092-1; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Dror RO, 2001, J OPT SOC AM A, V18, P241, DOI 10.1364/JOSAA.18.000241; EGELHAAF M, 1987, BIOL CYBERN, V56, P69, DOI 10.1007/BF00317982; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Enciso G, 2010, J COMPUT NEUROSCI, V28, P567, DOI 10.1007/s10827-010-0238-3; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Franceschini N., 1989, P360; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GRZYWACZ NM, 1987, SYNAPSE, V1, P417, DOI 10.1002/syn.890010506; GUO A, 1987, NATURWISSENSCHAFTEN, V74, P91, DOI 10.1007/BF00366085; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Harris RA, 2002, VISION RES, V42, P1701, DOI 10.1016/S0042-6989(02)00100-1; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P179, DOI 10.1007/BF00619212; Ibbotson MR, 2001, J NEUROPHYSIOL, V86, P997, DOI 10.1152/jn.2001.86.2.997; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; Lindemann JP, 2005, J NEUROSCI, V25, P6435, DOI 10.1523/JNEUROSCI.1132-05.2005; MADDESS T, 1986, PROC R SOC SER B-BIO, V228, P433, DOI 10.1098/rspb.1986.0062; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; POGGIO T, 1973, KYBERNETIK, V13, P223, DOI 10.1007/BF00274887; RAMACHANDRAN VS, 1986, SCI AM, V254, P102, DOI 10.1038/scientificamerican0686-102; Reichardt W, 1961, SENS COMMUN, P303; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Reisenman C, 2003, VISION RES, V43, P1291, DOI 10.1016/S0042-6989(03)00091-9; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Spavieri DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000860; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	47	119	120	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 23	2011	70	6					1155	1164		10.1016/j.neuron.2011.03.028	http://dx.doi.org/10.1016/j.neuron.2011.03.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689601	Green Submitted, Bronze			2022-12-25	WOS:000292410700013
J	Xu, SJ; Jiang, WC; Poo, MM; Dan, Y				Xu, Shengjin; Jiang, Wanchen; Poo, Mu-ming; Dan, Yang			Activity recall in a visual cortical ensemble	NATURE NEUROSCIENCE			English	Article							BARREL CORTEX; SYNAPTIC MODIFICATION; CORRELATED ACTIVITY; PREFRONTAL CORTEX; HUMAN HIPPOCAMPUS; AUDITORY-CORTEX; SINGLE NEURONS; OWL MONKEYS; PLASTICITY; SEQUENCES	Cue-triggered recall of learned temporal sequences is an important cognitive function that has been attributed to higher brain areas. Here recordings in both anesthetized and awake rats demonstrate that after repeated stimulation with a moving spot that evoked sequential firing of an ensemble of primary visual cortex (V1) neurons, just a brief flash at the starting point of the motion path was sufficient to evoke a sequential firing pattern that reproduced the activation order evoked by the moving spot. The speed of recalled spike sequences may reflect the internal dynamics of the network rather than the motion speed. In awake rats, such recall was observed during a synchronized ('quiet wakeful') brain state having large-amplitude, low-frequency local field potential (LFP) but not in a desynchronized ('active') state having low-amplitude, high-frequency LFP. Such conditioning-enhanced, cue-evoked sequential spiking of a V1 ensemble may contribute to experience-based perceptual inference in a brain state-dependent manner.	[Xu, Shengjin; Jiang, Wanchen; Poo, Mu-ming] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Xu, Shengjin; Jiang, Wanchen] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Poo, Mu-ming; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA; [Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Poo, MM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	mpoo@berkeley.edu	Xu, Shengjin/G-2594-2016	Dan, Yang/0000-0002-3818-877X	973 Program [2011CBA00400]; SSSTC [GJHZ0902]; Chinese Academy of Sciences [KSCX2-YW-R-29]; Howard Hughes Medical Institute; US National Institutes of Health [NS036999]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); SSSTC; Chinese Academy of Sciences(Chinese Academy of Sciences); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Buzsaki, H. D. Lv and H. S. Yao for comments and suggestions. This work was supported by 973 Program (2011CBA00400), SSSTC Program GJHZ0902 and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-29). Y.D. was supported in part by the Howard Hughes Medical Institute and M.-m.P. by a grant from the US National Institutes of Health (NS036999).	Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Hebb Donald O., 1949, ORG BEHAV; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rao RPN, 2000, ADV NEUR IN, V12, P164; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	98	98	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					449	U141		10.1038/nn.3036	http://dx.doi.org/10.1038/nn.3036			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267160	Green Accepted, Green Submitted			2022-12-25	WOS:000300793100019
J	Napoli, I; Noon, LA; Ribeiro, S; Kerai, AP; Parrinello, S; Rosenberg, LH; Collins, MJ; Harrisingh, MC; White, IJ; Woodhoo, A; Lloyd, AC				Napoli, Ilaria; Noon, Luke A.; Ribeiro, Sara; Kerai, Ajay P.; Parrinello, Simona; Rosenberg, Laura H.; Collins, Melissa J.; Harrisingh, Marie C.; White, Ian J.; Woodhoo, Ashwin; Lloyd, Alison C.			A Central Role for the ERK-Signaling Pathway in Controlling Schwann Cell Plasticity and Peripheral Nerve Regeneration In Vivo	NEURON			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SCIATIC-NERVE; HUMAN CONNEXIN32; MOUSE MODEL; NF1 LOSS; INJURY; DEMYELINATION; NEUREGULIN-1; MYELINATION; ENSHEATHMENT	Following damage to peripheral nerves, a remarkable process of clearance and regeneration takes place. Axons downstream of the injury degenerate, while the nerve is remodeled to direct axonal regrowth. Schwann cells are important for this regenerative process. "Sensing" damaged axons, they dedifferentiate to a progenitor-like state, in which they aid nerve regeneration. Here, we demonstrate that activation of an inducible Raf-kinase transgene in myelinated Schwann cells is sufficient to control this plasticity by inducing severe demyelination in the absence of axonal damage, with the period of demyelination/ataxia determined by the duration of Raf activation. Remarkably, activation of Raf-kinase also induces much of the inflammatory response important for nerve repair, including breakdown of the blood-nerve barrier and the influx of inflammatory cells. This reversible in vivo model identifies a central role for ERK signaling in Schwann cells in orchestrating nerve repair and is a powerful system for studying peripheral neuropathies and cancer.	[Napoli, Ilaria; Noon, Luke A.; Ribeiro, Sara; Kerai, Ajay P.; Parrinello, Simona; Rosenberg, Laura H.; Collins, Melissa J.; Harrisingh, Marie C.; White, Ian J.; Lloyd, Alison C.] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Napoli, Ilaria; Noon, Luke A.; Ribeiro, Sara; Kerai, Ajay P.; Parrinello, Simona; Rosenberg, Laura H.; Collins, Melissa J.; Harrisingh, Marie C.; White, Ian J.; Lloyd, Alison C.] UCL, UCL Canc Inst, London WC1E 6BT, England; [Woodhoo, Ashwin] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of London; University College London	Lloyd, AC (corresponding author), UCL, MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	alison.lloyd@ucl.ac.uk	Ribeiro, Sara/I-1615-2013; Noon, Luke A/H-4141-2014; woodhoo, ashwin/A-4904-2015	Ribeiro, Sara/0000-0002-6500-8412; Noon, Luke A/0000-0002-0502-4322; woodhoo, ashwin/0000-0002-8395-2837; Collins, Melissa/0000-0003-1641-848X; Napoli, Ilaria/0000-0002-0649-1950	AICR; CRUK; Wellcome Trust; EMBO; Cancer Research UK [11244] Funding Source: researchfish; Worldwide Cancer Research [12-0041] Funding Source: researchfish	AICR; CRUK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by a project grant from the AICR and by a programme grant from CRUK. A.W. was supported by a Programme Grant to K.R. Jessen and R. Mirsky from the Wellcome Trust. I.N. was partly supported by an EMBO fellowship. We would like to thank Steven Scherer and John Bermingham, Jr. for the P0 vector construct, the CRUK transgenic facility for the generation of the transgenic animals, UCL Biological Services for the maintenance of the animals and for useful advice, and Tomas Adejumo for help with the FAGS analysis. We thank Martin Raff, David Parkinson, Rhona Mirsky, and Kristian Jessen for critical reading of the manuscript.	Bradley JL, 1998, J ANAT, V192, P529, DOI 10.1046/j.1469-7580.1998.19240529.x; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Fischer S, 2008, GLIA, V56, P836, DOI 10.1002/glia.20657; Groh J, 2010, HUM MOL GENET, V19, P3530, DOI 10.1093/hmg/ddq269; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2005, J NEUROSCI, V25, P7111, DOI 10.1523/JNEUROSCI.1319-05.2005; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kohl B, 2010, AM J PATHOL, V176, P1390, DOI 10.2353/ajpath.2010.090694; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; McClatchey AI, 2007, ANNU REV PATHOL-MECH, V2, P191, DOI 10.1146/annurev.pathol.2.010506.091940; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MORRIS JH, 1972, Z ZELLFORSCH MIK ANA, V124, P165, DOI 10.1007/BF00335678; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Parrinello S, 2009, TRENDS CELL BIOL, V19, P395, DOI 10.1016/j.tcb.2009.05.003; Parrinello S, 2008, GENE DEV, V22, P3335, DOI 10.1101/gad.490608; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Scherer SS, 2005, J NEUROSCI, V25, P1550, DOI 10.1523/JNEUROSCI.3082-04.2005; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Staser K, 2010, BLOOD, V116, P157, DOI 10.1182/blood-2009-09-242875; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Toews AD, 1998, J NEUROSCI RES, V53, P260, DOI 10.1002/(SICI)1097-4547(19980715)53:2<260::AID-JNR15>3.0.CO;2-A; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; WEERASURIYA A, 1988, BRAIN RES, V445, P181, DOI 10.1016/0006-8993(88)91091-8; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zochodne DW, 2008, NEUROBIOLOGY OF PERIPHERAL NERVE REGENERATION, P1, DOI 10.1017/CBO9780511541759	49	267	276	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					729	742		10.1016/j.neuron.2011.11.031	http://dx.doi.org/10.1016/j.neuron.2011.11.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365547	Bronze			2022-12-25	WOS:000300815400012
J	Srihasam, K; Mandeville, JB; Morocz, IA; Sullivan, KJ; Livingstone, MS				Srihasam, Krishna; Mandeville, Joseph B.; Morocz, Istvan A.; Sullivan, Kevin J.; Livingstone, Margaret S.			Behavioral and Anatomical Consequences of Early versus Late Symbol Training in Macaques	NEURON			English	Article							SURFACE-BASED ANALYSIS; FACE-LIKE STIMULI; CONTRAST AGENT; VISUAL-FIELD; CORTEX; MONKEYS; AREAS; HUMANS; AWAKE; SHAPE	Distinct brain regions, reproducible from one person to the next, are specialized for processing different kinds of human expertise, such as face recognition and reading. Here, we explore the relationship between age of learning, learning ability, and specialized brain structures. Specifically, we ask whether the existence of reproducible cortical domains necessarily means that certain abilities are innate, or innately easily learned, or whether reproducible domains can be formed, or refined, by interactions between genetic programs and common early experience. Functional MRI showed that intensive early, but not late, experience caused the formation of category-selective regions in macaque temporal lobe for stimuli never naturally encountered by monkeys. And behaviorally, early training produced more fluent processing of these stimuli than the same training in adults. One explanation for these results is that in higher cortical areas, as in early sensory areas, experience drives functional clustering and functional clustering determines how that information is processed.	[Srihasam, Krishna; Sullivan, Kevin J.; Livingstone, Margaret S.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mandeville, Joseph B.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Morocz, Istvan A.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Livingstone, MS (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	mlivingstone@hms.harvard.edu		Livingstone, Margaret/0000-0002-1950-0123	NIH [EY16187]; NATIONAL EYE INSTITUTE [R01EY016187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY16187. We thank Wim Vanduffel for much help developing scanning technology, Tristram Savage for monkey training, and Winrich Freiwald, Doris Tsao, and Heather Sternshein for advice and comments.	Anstis S, 2005, PERCEPTION, V34, P237, DOI 10.1068/p5412; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Bell AH, 2009, J NEUROPHYSIOL, V101, P688, DOI 10.1152/jn.90657.2008; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Castro-Caldas A, 2009, J NEUROPSYCHOL, V3, P17, DOI 10.1348/174866408X289953; Changizi MA, 2006, AM NAT, V167, pE117, DOI 10.1086/502806; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Desimone R, 1989, HDB NEUROPSYCHOLOGY; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Farah MJ, 1996, BEHAV BRAIN RES, V76, P181, DOI 10.1016/0166-4328(95)00198-0; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fize D, 2003, J NEUROSCI, V23, P7395; Fukushima K., 1988, COMPUTER SOC PRESS T, P136; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; GOREN CC, 1975, PEDIATRICS, V56, P544; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HUBEL DH, 1977, BRAIN RES, V122, P336, DOI 10.1016/0006-8993(77)90299-2; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kolster H, 2009, J NEUROSCI, V29, P7031, DOI 10.1523/JNEUROSCI.0518-09.2009; Kourtzi Z, 2006, CURR OPIN NEUROBIOL, V16, P152, DOI 10.1016/j.conb.2006.03.012; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Livingstone MS, 2010, ANIM COGN, V13, P711, DOI 10.1007/s10071-010-0321-1; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Op de Beeck HP, 2008, CEREB CORTEX, V18, P1676, DOI 10.1093/cercor/bhm196; Polk TA, 1995, P NATL ACAD SCI USA, V92, P12370, DOI 10.1073/pnas.92.26.12370; Price CJ, 1997, HUM BRAIN MAPP, V5, P264, DOI 10.1002/(SICI)1097-0193(1997)5:4<264::AID-HBM11>3.0.CO;2-E; ROLLS ET, 1995, EXP BRAIN RES, V103, P409; Saleem KS, 2007, COMBINED MRI HISTOLO; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sohal VS, 2000, NETWORK-COMP NEURAL, V11, P169, DOI 10.1088/0954-898X/11/3/301; Srihasam K, 2010, NEUROIMAGE, V51, P267, DOI 10.1016/j.neuroimage.2010.01.082; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TOOTELL RBH, 1983, SCIENCE, V220, P737, DOI 10.1126/science.6301017; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	65	62	62	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					608	619		10.1016/j.neuron.2011.12.022	http://dx.doi.org/10.1016/j.neuron.2011.12.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325210	Bronze, Green Accepted			2022-12-25	WOS:000300140600019
J	Csaszar, E; Kirouac, DC; Yu, M; Wang, WJ; Qiao, WL; Cooke, MP; Boitano, AE; Ito, C; Zandstra, PW				Csaszar, Elizabeth; Kirouac, Daniel C.; Yu, Mei; Wang, WeiJia; Qiao, Wenlian; Cooke, Michael P.; Boitano, Anthony E.; Ito, Caryn; Zandstra, Peter W.			Rapid Expansion of Human Hematopoietic Stem Cells by Automated Control of Inhibitory Feedback Signaling	CELL STEM CELL			English	Article							EX-VIVO EXPANSION; CORD-BLOOD; IN-VITRO; INTERACTION NETWORKS; PROGENITOR CELLS; TNF-ALPHA; TGF-BETA; TRANSPLANTATION; PROLIFERATION; MIP-1-ALPHA	Clinical hematopoietic transplantation outcomes are strongly correlated with the numbers of cells infused. Anticipated novel therapeutic implementations of hematopoietic stem cells (HSCs) and their derivatives further increase interest in strategies to expand HSCs ex vivo. A fundamental limitation in all HSC-driven culture systems is the rapid generation of differentiating cells and their secreted inhibitory feedback signals. Herein we describe an integrated computational and experimental strategy that enables a tunable reduction in the global levels and impact of paracrine signaling factors in an automated closed-system process by employing a controlled fed-batch media dilution approach. Application of this system to human cord blood cells yielded a rapid (12-day) 11-fold increase of HSCs with self-renewing, multilineage repopulating ability. These results highlight the marked improvements that control of feedback signaling can offer primary stem cell culture and demonstrate a clinically relevant rapid and relatively low culture volume strategy for ex vivo HSC expansion.	[Csaszar, Elizabeth; Kirouac, Daniel C.; Yu, Mei; Wang, WeiJia; Qiao, Wenlian; Ito, Caryn; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Csaszar, Elizabeth; Zandstra, Peter W.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E1, Canada; [Zandstra, Peter W.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Cooke, Michael P.; Boitano, Anthony E.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zandstra, Peter W.] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1L7, Canada; [Zandstra, Peter W.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; Novartis; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zandstra, PW (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada.	peter.zandstra@utoronto.ca	Wang, Weijia/O-6061-2017	Wang, Weijia/0000-0002-0270-8366	Leukemia and Lymphoma Society of Canada; Canadian Stem Cell Network; Canadian Institutes for Health Research [MOP-57885]; Ontario Ministry of Research and Innovation; NSERC	Leukemia and Lymphoma Society of Canada; Canadian Stem Cell Network; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank the donors and the Research Centre for Women's and Infants' Health BioBank of Mount Sinai Hospital for the human specimens used in this study. The authors thank Dr. Connie Eaves and members of the P.W.Z. laboratory for their helpful discussion. This work was funded by the Leukemia and Lymphoma Society of Canada, the Canadian Stem Cell Network, the Canadian Institutes for Health Research (MOP-57885), and the Ontario Ministry of Research and Innovation. E.C. and D.C.K. were supported by NSERC Graduate Scholarships. P.W.Z. is the Canada Research Chair in Stem Cell Bioengineering.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BONNET D, 1995, EXP HEMATOL, V23, P551; BROXMEYER HE, 1995, ANN HEMATOL, V71, P235, DOI 10.1007/s002770050112; Broxmeyer HE, 1999, EXP HEMATOL, V27, P1113, DOI 10.1016/S0301-472X(99)00045-4; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Collins PC, 1997, BIOTECHNOL BIOENG, V55, P693, DOI 10.1002/(SICI)1097-0290(19970820)55:4<693::AID-BIT11>3.0.CO;2-D; Csaszar E, 2009, BIOTECHNOL BIOENG, V103, P402, DOI 10.1002/bit.22297; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Farid SS, 2006, ADV BIOCHEM ENG BIOT, V101, P1, DOI 10.1007/10_014; Fortunel NO, 2000, BLOOD, V96, P2022; Gluckman E, 2009, BONE MARROW TRANSPL, V44, P621, DOI 10.1038/bmt.2009.280; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ito CY, 2010, BLOOD, V115, P257, DOI 10.1182/blood-2009-07-228106; Jackson M., 2011, STEM CELLS IN PRESS; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; Klostranec JM, 2007, NANO LETT, V7, P2812, DOI 10.1021/nl071415m; Koller MR, 1998, BONE MARROW TRANSPL, V21, P653, DOI 10.1038/sj.bmt.1701157; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Patel SD, 2000, BIOTECHNOL PROGR, V16, P885, DOI 10.1021/bp000080a; Rizo A, 2006, HUM MOL GENET, V15, pR210, DOI 10.1093/hmg/ddl175; Sautois B, 1997, EXP HEMATOL, V25, P103; Wagner JE, 2010, SEMIN HEMATOL, V47, P3, DOI 10.1053/j.seminhematol.2009.10.011; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; ZHANG Y, 1995, BLOOD, V86, P2930; Zhong YM, 2010, BIOCHEM BIOPH RES CO, V398, P377, DOI 10.1016/j.bbrc.2010.06.075	34	184	193	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					218	229		10.1016/j.stem.2012.01.003	http://dx.doi.org/10.1016/j.stem.2012.01.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305571	Bronze			2022-12-25	WOS:000300272100014
J	Cho, JH; Bayazitov, IT; Meloni, EG; Myers, KM; Carlezon, WA; Zakharenko, SS; Bolshakov, VY				Cho, Jun-Hyeong; Bayazitov, Ildar T.; Meloni, Edward G.; Myers, Karyn M.; Carlezon, William A., Jr.; Zakharenko, Stanislav S.; Bolshakov, Vadim Y.			Coactivation of thalamic and cortical pathways induces input timing-dependent plasticity in amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; FEAR CONDITIONING PATHWAYS; MEDIAL GENICULATE-BODY; LATERAL AMYGDALA; AUDITORY-CORTEX; SYNAPTIC PLASTICITY; EXTRACELLULAR RECORDINGS; GLUTAMATE UPTAKE; MEMORY FORMATION; TEMPORAL CORTEX	Long-term synaptic enhancements in cortical and thalamic auditory inputs to the lateral nucleus of the amygdala (LAn) mediate encoding of conditioned fear memory. It is not known, however, whether the convergent auditory conditioned stimulus (CSa) pathways interact with each other to produce changes in their synaptic function. We found that continuous paired stimulation of thalamic and cortical auditory inputs to the LAn with the interstimulus delay approximately mimicking a temporal pattern of their activation in behaving animals during auditory fear conditioning resulted in persistent potentiation of synaptic transmission in the cortico-amygdala pathway in rat brain slices. This form of input timing-dependent plasticity (ITDP) in cortical input depends on inositol 1,4,5-trisphosphate (InsP(3))-sensitive Ca2+ release from internal stores and postsynaptic Ca2+ influx through calcium-permeable kainate receptors during its induction. ITDP in the auditory projections to the LAn, determined by characteristics of presynaptic activity patterns, may contribute to the encoding of the complex CSa.	[Cho, Jun-Hyeong; Meloni, Edward G.; Myers, Karyn M.; Carlezon, William A., Jr.; Bolshakov, Vadim Y.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Bayazitov, Ildar T.; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	Harvard University; McLean Hospital; St Jude Children's Research Hospital	Bolshakov, VY (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA.	vadimb@mclean.harvard.edu	Zakharenko, Stanislav/D-3287-2013; Cho, Jun-Hyeong/GXM-7966-2022	Zakharenko, Stanislav/0000-0001-8115-202X; Cho, Jun-Hyeong/0000-0002-6844-3583; /0000-0002-4162-3947	US National Institutes of Health [MH083011, MH090464, MH079079]; National Alliance for Research on Schizophrenia and Depression; Whitehall Foundation; US Army [W81XWH-08-2-0126]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083011, R01MH090464, R01MH079079] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); Whitehall Foundation; US Army(United States Department of DefenseUnited States Army); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Y. Li and K. Tully for constructive discussions. This study was supported by US National Institutes of Health grants MH083011, MH090464 (V. Y. B.) and MH079079 (S.S.Z.), the National Alliance for Research on Schizophrenia and Depression (V. Y. B.), Whitehall Foundation (V. Y. B.), and US Army Medical Research Acquisition Activity grant #W81XWH-08-2-0126 (V. Y. B.).	Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; CLUGNET MC, 1990, J NEUROSCI, V10, P2818; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Johnson LR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.003.2008; Ko S, 2005, J NEUROSCI, V25, P977, DOI 10.1523/JNEUROSCI.4059-04.2005; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MASCAGNI F, 1993, NEUROSCIENCE, V57, P697, DOI 10.1016/0306-4522(93)90016-9; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Pare D, 2000, J NEUROSCI, V20, P2701; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shin RM, 2010, P NATL ACAD SCI USA, V107, P19073, DOI 10.1073/pnas.1009803107; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; Wilding TJ, 2005, J NEUROSCI, V25, P9470, DOI 10.1523/JNEUROSCI.2826-05.2005	50	46	46	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					113	U145		10.1038/nn.2993	http://dx.doi.org/10.1038/nn.2993			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158512	Green Submitted, Green Accepted			2022-12-25	WOS:000298414400021
J	Ranganath, C; Flegal, KE; Kelly, LL				Ranganath, Charan; Flegal, Kristin E.; Kelly, Laura L.			Can Cognitive Training Improve Episodic Memory?	NEURON			English	Editorial Material							HEALTHY OLDER-ADULTS; BRAIN PLASTICITY; WORKING-MEMORY; RECOLLECTION; PERFORMANCE; PROGRAM; IMPACT	Neuroscience-inspired approaches to train cognitive abilities are bringing about a paradigm shift in the way scientists view the treatment of memory dysfunction, but it can be challenging to prove whether such approaches have significant effects.	[Ranganath, Charan; Flegal, Kristin E.; Kelly, Laura L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA	University of California System; University of California Davis	Ranganath, C (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA.	cranganath@ucdavis.edu		Flegal, Kristin/0000-0001-9773-9554	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH096469, R01MH068721] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH096469, R01 MH068721, R01MH068721] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bissig D, 2007, PSYCHOL SCI, V18, P720, DOI 10.1111/j.1467-9280.2007.01966.x; BRIGHAM MC, 1988, PSYCHOL AGING, V3, P249, DOI 10.1037/0882-7974.3.3.249; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Carter CS, 2007, SCHIZOPHRENIA BULL, V33, P1131, DOI 10.1093/schbul/sbm081; de la Fuente-Fernandez R, 2002, LANCET NEUROL, V1, P85, DOI 10.1016/S1474-4422(02)00038-8; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Jennings JM, 2005, AGING NEUROPSYCHOL C, V12, P278, DOI 10.1080/138255890968312; Jennings JM, 2003, NEUROPSYCHOL REHABIL, V13, P417, DOI 10.1080/09602010244000390; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Lustig C, 2008, PSYCHOL AGING, V23, P754, DOI 10.1037/a0014295; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Murphy DR, 2000, PSYCHOL AGING, V15, P323, DOI [10.1037/0882-7974.15.2.323, 10.1037//0882-7974.15.2.323]; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Paxton JL, 2006, PSYCHOL AGING, V21, P499, DOI 10.1037/0882-7974.21.3.499; Ranganath C., 2008, LEARNING MEMORY COMP, V2008, P261; Rebok GW, 2007, J GERONTOL B-PSYCHOL, V62, P53, DOI 10.1093/geronb/62.special_issue_1.53; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x	20	24	25	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					688	691		10.1016/j.neuron.2011.10.022	http://dx.doi.org/10.1016/j.neuron.2011.10.022			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	860TR	22153366	Bronze, Green Accepted			2022-12-25	WOS:000297971100004
J	Bellone, C; Mameli, M; Luscher, C				Bellone, Camilla; Mameli, Manuel; Luescher, Christian			In utero exposure to cocaine delays postnatal synaptic maturation of glutamatergic transmission in the VTA	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM DEPRESSION; TRANSPORTER KNOCKOUT MICE; PRENATAL COCAINE; NMDA RECEPTORS; DOPAMINE-TRANSPORTER; AMPA RECEPTORS; SUBUNIT COMPOSITION; MATERNAL TOXICITY; WORKING-MEMORY	Maternal exposure to cocaine may perturb fetal development and affect synaptic maturation in the offspring. However, the molecular mechanism underlying such changes remains elusive. We focused on the postnatal maturation of glutamatergic transmission onto ventral tegmental area dopamine neurons in the mouse. We found that, during the first postnatal week, transmission was dominated by calcium-permeable AMPA receptors and GluN2B-containing NMDA receptors. Subsequently, mGluR1 receptors drove synaptic insertion of calcium-impermeable AMPA receptors and GluN2A-containing NMDAR. When pregnant mice were exposed to cocaine, this glutamate receptor switch was delayed in offspring as a result of a direct effect of cocaine on the fetal dopamine transporter and impaired mGluR1 function. Finally, positive modulation of mGluR1 in vivo was sufficient to rescue maturation. These data identify the molecular target through which in utero cocaine delays postnatal synaptic maturation, reveal the underlying expression mechanism of this impairment and propose a potential rescue strategy.	[Bellone, Camilla; Mameli, Manuel; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, Geneva, Switzerland	University of Geneva; University of Geneva	Bellone, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	camilla.bellone@unige.ch; christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Mameli, Manuel/0000-0002-0570-6964; bellone, camilla/0000-0002-6774-6275	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank members of the Luscher laboratory M. Serafin and A. Holtmaat for critical reading of the manuscript. We thank H. H. Gu, who provided the DAT knock-in mouse line, and K. Huber, who provided the breeding pairs for the mGluR1 mutant mouse line. C. B. is an Ambizione fellow. This work was supported by the Swiss National Science Foundation.	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Brill J, 2008, J NEUROSCI, V28, P13918, DOI 10.1523/JNEUROSCI.3229-08.2008; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Crozatier C, 2003, DEV BRAIN RES, V147, P97, DOI 10.1016/j.devbrainres.2003.10.006; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; Friedman E, 1998, ANN NY ACAD SCI, V846, P238, DOI 10.1111/j.1749-6632.1998.tb09741.x; Gendle MH, 2004, NEUROTOXICOL TERATOL, V26, P319, DOI 10.1016/j.ntt.2003.12.001; GOLDEN GS, 1973, DEV BIOL, V33, P300, DOI 10.1016/0012-1606(73)90139-5; Guerriero RM, 2005, DEV NEUROSCI-BASEL, V27, P235, DOI 10.1159/000085997; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Hecht GS, 1998, BEHAV NEUROSCI, V112, P410, DOI 10.1037/0735-7044.112.2.410; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Hu ZL, 2004, J COMP NEUROL, V476, P301, DOI 10.1002/cne.20230; HUTCHINGS DE, 1989, NEUROTOXICOL TERATOL, V11, P65, DOI 10.1016/0892-0362(89)90087-1; Keller RW, 1996, NEUROSCI LETT, V205, P153, DOI 10.1016/0304-3940(96)12409-5; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Khan ZU, 2000, NEUROSCIENCE, V100, P689, DOI 10.1016/S0306-4522(00)00274-8; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Linares TJ, 2006, J PEDIATR PSYCHOL, V31, P85, DOI 10.1093/jpepsy/jsj020; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; Mayes L, 2007, CHILD NEUROPSYCHOL, V13, P205, DOI 10.1080/09297040600888753; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Rocha BA, 2002, PSYCHOPHARMACOLOGY, V163, P221, DOI 10.1007/s00213-002-1140-0; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; SCALZO FM, 1990, PHARMACOL BIOCHEM BE, V37, P371, DOI 10.1016/0091-3057(90)90350-Q; Schilstrom B, 2006, J NEUROSCI, V26, P8549, DOI 10.1523/JNEUROSCI.5179-05.2006; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SOBRIAN SK, 1995, MOL NEUROBIOL, V11, P121, DOI 10.1007/BF02740690; Stanwood GD, 2001, CEREB CORTEX, V11, P430, DOI 10.1093/cercor/11.5.430; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SERIES; Substance Abuse and Mental Health Services Administration, 2010, HHS PUBL, VSMA 09- 4425; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Thompson BL, 2005, BEHAV BRAIN RES, V164, P107, DOI 10.1016/j.bbr.2005.06.010; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Tilley MR, 2009, NEUROREPORT, V20, P9, DOI 10.1097/WNR.0b013e32831b9ce4; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Trksak GH, 2007, NEUROTOXICOL TERATOL, V29, P570, DOI 10.1016/j.ntt.2007.06.003; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	51	60	60	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1439	U113		10.1038/nn.2930	http://dx.doi.org/10.1038/nn.2930			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21964489				2022-12-25	WOS:000296518600020
J	Kohl, MM; Shipton, OA; Deacon, RM; Rawlins, JNP; Deisseroth, K; Paulsen, O				Kohl, Michael M.; Shipton, Olivia A.; Deacon, Robert M.; Rawlins, J. Nicholas P.; Deisseroth, Karl; Paulsen, Ole			Hemisphere-specific optogenetic stimulation reveals left-right asymmetry of hippocampal plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RECEPTOR SUBUNIT EXPRESSION; SYNAPTIC PLASTICITY; SYNAPSES; ALLOCATION; NEURONS; CORTEX; RAT	Postsynaptic spines at CA3-CA1 synapses differ in glutamate receptor composition according to the hemispheric origin of CA3 afferents. To study the functional consequences of this asymmetry, we used optogenetic tools to selectively stimulate axons of CA3 pyramidal cells originating in either left or right mouse hippocampus. We found that left CA3 input produced more long-term potentiation at CA1 synapses than right CA3 input as a result of differential expression of GluN2B subunit-containing NMDA receptors.	[Kohl, Michael M.; Shipton, Olivia A.; Paulsen, Ole] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Kohl, Michael M.; Shipton, Olivia A.; Paulsen, Ole] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Deacon, Robert M.; Rawlins, J. Nicholas P.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of Cambridge; University of Oxford; University of Oxford; Stanford University	Paulsen, O (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	op210@cam.ac.uk	Paulsen, Ole/ABB-4843-2020; Kohl, Michael/AAE-4767-2021	Paulsen, Ole/0000-0002-2258-5455; Kohl, Michael/0000-0002-2566-5426	Biotechnology and Biological Sciences Research Council; Wellcome Trust (OXION Initiative); EPA Cephalosporin Fund; BBSRC [BB/H002383/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002383/2] Funding Source: researchfish; Medical Research Council [G0001354, G0001354B, G1000183B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust (OXION Initiative)(Wellcome Trust); EPA Cephalosporin Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank D. Paterson for providing surgery facilities, and D. Katzel and L. Upton for help with immunohistochemistry. This research was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust (OXION Initiative). An equipment grant from the EPA Cephalosporin Fund is gratefully acknowledged.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BLISS TVP, 1983, J PHYSIOL-LONDON, V341, P617, DOI 10.1113/jphysiol.1983.sp014828; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; WHEAL HV, 1983, BRAIN RES, V272, P247, DOI 10.1016/0006-8993(83)90570-X; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	15	85	86	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1413	1415		10.1038/nn.2915	http://dx.doi.org/10.1038/nn.2915			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21946328	Green Accepted			2022-12-25	WOS:000296518600015
J	Cohen, L; Rothschild, G; Mizrahi, A				Cohen, Lior; Rothschild, Gideon; Mizrahi, Adi			Multisensory Integration of Natural Odors and Sounds in the Auditory Cortex	NEURON			English	Article							NEURONAL OSCILLATIONS; CORTICAL DETECTION; MATERNAL-BEHAVIOR; RECEPTIVE-FIELDS; BARREL CORTEX; LOW-LEVEL; PLASTICITY; MOUSE; COMMUNICATION; EXPERIENCE	Motherhood is associated with different forms of physiological alterations including transient hormonal changes and brain plasticity. The underlying impact of these changes on the emergence of maternal behaviors and sensory processing within the mother's brain are largely unknown. By using in vivo cell-attached recordings in the primary auditory cortex of female mice, we discovered that exposure to pups' body odor reshapes neuronal responses to pure tones and natural auditory stimuli. This olfactory-auditory interaction appeared naturally in lactating mothers shortly after parturition and was long lasting. Naive virgins that had experience with the pups also showed an appearance of olfactory-auditory integration in A1, suggesting that multisensory integration may be experience dependent. Neurons from lactating mothers were more sensitive to sounds as compared to those from experienced mice, independent of the odor effects. These uni- and multisensory cortical changes may facilitate the detection and discrimination of pup distress calls and strengthen the bond between mothers and their neonates.	[Cohen, Lior; Rothschild, Gideon; Mizrahi, Adi] Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel; [Cohen, Lior; Rothschild, Gideon; Mizrahi, Adi] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mizrahi, A (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel.	mizrahia@cc.huji.ac.il			Edmond and Lily Safra Center for Brain Sciences; European Research Council [203994]	Edmond and Lily Safra Center for Brain Sciences; European Research Council(European Research Council (ERC)European Commission)	We thank I. Nelken, Y. Yarom, T. Zador, L. Luo, S. Shea, Y. Gutfreund, and A. Amedi for critically commenting on early versions of this manuscript. We thank I. Nelken for invaluable advice on statistical analyses and all the members of the A.M. lab for their helpful comments and discussions. We thank H. Kopel for help with the design of the olfactory stimulation. L.C. and A.M. designed and conceived the experiments. L.C. performed the experiments and analyzed the data. G.R. wrote the sounds delivery software and helped with the technical design of the experiments. L.C. and A.M. wrote the paper. L.C. is supported by a fellowship from the Edmond and Lily Safra Center for Brain Sciences. This work was supported by a European Research Council grant to A.M. (grant #203994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram R, 2010, J NEUROENDOCRINOL, V22, P778, DOI 10.1111/j.1365-2826.2010.02012.x; Besle J, 2008, J NEUROSCI, V28, P14301, DOI 10.1523/JNEUROSCI.2875-08.2008; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; DeWeese MR, 2003, J NEUROSCI, V23, P7940; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EHRET G, 1975, BEHAVIOUR, V52, P38; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1987, NATURWISSENSCHAFTEN, V74, P47, DOI 10.1007/BF00367047; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Haack B., 1983, SOUND COMMUNICATION; Halene TB, 2009, NEUROREPORT, V20, P1260, DOI 10.1097/WNR.0b013e3283300cde; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Harris KD, 2011, HEARING RES, V271, P37, DOI 10.1016/j.heares.2010.06.006; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hromadka T, 2009, CURR OPIN NEUROBIOL, V19, P430, DOI 10.1016/j.conb.2009.07.009; Kanwal JS, 2002, NEUROREPORT, V13, P2193, DOI 10.1097/00001756-200212030-00006; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Kayser C, 2009, HEARING RES, V258, P80, DOI 10.1016/j.heares.2009.02.011; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Leuner B, 2010, TRENDS NEUROSCI, V33, P465, DOI 10.1016/j.tins.2010.07.003; Levy F, 2004, HORM BEHAV, V46, P284, DOI 10.1016/j.yhbeh.2004.02.005; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; Mann P E, 2001, Prog Brain Res, V133, P251; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miranda JA, 2009, HEARING RES, V252, P21, DOI 10.1016/j.heares.2009.04.014; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Musacchia G, 2009, HEARING RES, V258, P72, DOI 10.1016/j.heares.2009.06.018; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Nelken I, 2008, FRONT NEUROSCI-SWITZ, V2, P107, DOI 10.3389/neuro.01.009.2008; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; NOIROT E, 1966, ANIM BEHAV, V14, P459, DOI 10.1016/S0003-3472(66)80045-3; O'Connell MN, 2011, NEURON, V69, P805, DOI 10.1016/j.neuron.2011.01.012; Rao PDP, 2004, BRAIN BEHAV EVOLUT, V63, P151, DOI 10.1159/000076241; Romanski LM, 2009, ANNU REV NEUROSCI, V32, P315, DOI 10.1146/annurev.neuro.051508.135431; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroger E, 1998, PSYCHOPHYSIOLOGY, V35, P755, DOI 10.1111/1469-8986.3560755; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Seo HS, 2011, CHEM SENSES, V36, P301, DOI 10.1093/chemse/bjq129; SEWELL GD, 1970, NATURE, V227, P410, DOI 10.1038/227410a0; Shughrue PJ, 2002, PROG BRAIN RES, V139, P15; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE., 1993, MERGING SENSES; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 2006, J NEUROSCI, V26, P11844, DOI 10.1523/JNEUROSCI.3295-06.2006; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Wesson DW, 2010, J NEUROSCI, V30, P3013, DOI 10.1523/JNEUROSCI.6003-09.2010; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yu LP, 2010, J NEUROSCI, V30, P4904, DOI 10.1523/JNEUROSCI.5575-09.2010	70	113	113	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					357	369		10.1016/j.neuron.2011.08.019	http://dx.doi.org/10.1016/j.neuron.2011.08.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017993	Bronze			2022-12-25	WOS:000296224000016
J	Goh, GY; Huang, H; Ullman, J; Borre, L; Hnasko, TS; Trussell, LO; Edwards, RH				Goh, Germaine Y.; Huang, Hai; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Trussell, Laurence O.; Edwards, Robert H.			Presynaptic regulation of quantal size: K+/H+ exchange stimulates vesicular glutamate transport	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLES; CHROMAFFIN GHOSTS; ACTIVE-TRANSPORT; CLC PROTEINS; CHLORIDE; TRANSMITTER; RELEASE; PROTON; PH; TRAFFICKING	The amount of neurotransmitter stored in a single synaptic vesicle can determine the size of the postsynaptic response, but the factors that regulate vesicle filling are poorly understood. A proton electrochemical gradient (Delta mu(H+)) generated by the vacuolar H+-ATPase drives the accumulation of classical transmitters into synaptic vesicles. The chemical component of Delta mu(H+) (Delta pH) has received particular attention for its role in the vesicular transport of cationic transmitters as well as in protein sorting and degradation. Thus, considerable work has addressed the factors that promote Delta pH. However, synaptic vesicle uptake of the principal excitatory transmitter glutamate depends on the electrical component of Delta mu(H+) (Delta psi). We found that rat brain synaptic vesicles express monovalent cation/H+ exchange activity that converts Delta pH into Delta psi, and that this promotes synaptic vesicle filling with glutamate. Manipulating presynaptic K+ at a glutamatergic synapse influenced quantal size, indicating that synaptic vesicle K+/H+ exchange regulates glutamate release and synaptic transmission.	[Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Grad Program Neurosci, San Francisco, CA 94143 USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Grad Program Cell Biol, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Grad Program Bioengn, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Grad Program Neurosci, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Grad Program Cell Biol, San Francisco, CA USA; [Goh, Germaine Y.; Ullman, Julie; Borre, Lars; Hnasko, Thomas S.; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Grad Program Bioengn, San Francisco, CA USA; [Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Huang, Hai; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Ullman, Julie] Univ Calif Berkeley, Grad Program Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Berkeley	Edwards, RH (corresponding author), Univ Calif San Francisco, Dept Physiol, Grad Program Neurosci, Box 0444, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu	Huang, Hai/N-2330-2017	Huang, Hai/0000-0002-6928-3198; Hnasko, Thomas/0000-0001-6176-8513; Ullman, Julie/0000-0003-1325-0650	A*STAR; American Heart Association; National Institute on Deafness and Other Communication Disorders; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Drug Abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504, P01DA010154] Funding Source: NIH RePORTER	A*STAR(Agency for Science Technology & Research (A*STAR)); American Heart Association(American Heart Association); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Orlowski, S. Schuldiner and members of the Edwards laboratory for many thoughtful discussions, S. Manandhar and F. Farrimond for technical assistance, and R. P. Seal for critical reading of the manuscript. This work was supported by fellowships from A*STAR (to G.Y.G.) and the American Heart Association (to L. B.), and by grants from the National Institute on Deafness and Other Communication Disorders and the National Institute of Neurological Disorders and Stroke (to L.O.T.), and from the National Institute of Mental Health and the National Institute on Drug Abuse (to R.H.E.).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Chaudhry Farrukh A., 2008, V184, P77; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HELL JW, 1994, PREPARATION SYNAPTIC; Hill JK, 2006, J NEUROSCI, V26, P9944, DOI 10.1523/JNEUROSCI.2990-06.2006; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Huang H, 2008, NEURON, V60, P975, DOI 10.1016/j.neuron.2008.10.052; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; JOHNSON RG, 1981, J BIOL CHEM, V256, P5773; JOHNSON RG, 1979, J BIOL CHEM, V254, P963; Karunanithi S, 2002, J NEUROSCI, V22, P10267; KNOTH J, 1981, BIOCHEMISTRY-US, V20, P6625, DOI 10.1021/bi00526a016; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Price GD, 2006, J NEUROSCI, V26, P11432, DOI 10.1523/JNEUROSCI.1660-06.2006; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Steinert JR, 2006, NEURON, V50, P723, DOI 10.1016/j.neuron.2006.04.025; TABB JS, 1992, J BIOL CHEM, V267, P15412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; VANDYKE RW, 1988, J BIOL CHEM, V263, P2603; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wolosker H, 1996, J BIOL CHEM, V271, P11726, DOI 10.1074/jbc.271.20.11726; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007	49	52	54	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1285	U97		10.1038/nn.2898	http://dx.doi.org/10.1038/nn.2898			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874016	Green Accepted			2022-12-25	WOS:000295254200017
J	MacEvoy, SP; Epstein, RA				MacEvoy, Sean P.; Epstein, Russell A.			Constructing scenes from objects in human occipitotemporal cortex	NATURE NEUROSCIENCE			English	Article							TOPOGRAPHICAL DISORIENTATION; NEURAL MECHANISMS; NATURAL IMAGES; PARAHIPPOCAMPAL; REPRESENTATIONS; INFORMATION; CATEGORY; NORMALIZATION; COMPETITION; ATTENTION	We used functional magnetic resonance imaging (fMRI) to demonstrate the existence of a mechanism in the human lateral occipital (LO) cortex that supports recognition of real-world visual scenes through parallel analysis of within-scene objects. Neural activity was recorded while subjects viewed four categories of scenes and eight categories of 'signature' objects strongly associated with the scenes in three experiments. Multivoxel patterns evoked by scenes in the LO cortex were well predicted by the average of the patterns elicited by their signature objects. By contrast, there was no relationship between scene and object patterns in the parahippocampal place area (PPA), even though this region responds strongly to scenes and is believed to be crucial for scene identification. By combining information about multiple objects within a scene, the LO cortex may support an object-based channel for scene recognition that complements the processing of global scene properties in the PPA.	[MacEvoy, Sean P.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA; [MacEvoy, Sean P.; Epstein, Russell A.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Boston College; University of Pennsylvania	MacEvoy, SP (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	sean.macevoy.1@bc.edu	Epstein, Russell/G-4517-2013; MA, Lei/I-4597-2014		US National Eye Institute [EY-016464]; NATIONAL EYE INSTITUTE [R01EY016464] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors wish to thank E. Ward, A. Stigliani and Z. Yang for assistance with data collection. This work was supported by US National Eye Institute grant EY-016464 to R.A.E.	Aguirre GK, 2007, NEUROIMAGE, V35, P1480, DOI 10.1016/j.neuroimage.2007.02.005; Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Andresen DR, 2009, NEUROIMAGE, V45, P522, DOI 10.1016/j.neuroimage.2008.11.009; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Beck DM, 2007, J VISION, V7, DOI 10.1167/7.2.19; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; BIEDERMAN I, 1974, J EXP PSYCHOL, V103, P597, DOI 10.1037/h0037158; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diana RA, 2008, HIPPOCAMPUS, V18, P536, DOI 10.1002/hipo.20433; Drucker DM, 2009, CEREB CORTEX, V19, P2269, DOI 10.1093/cercor/bhn244; Eger E, 2008, J NEUROPHYSIOL, V100, P2038, DOI 10.1152/jn.90305.2008; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, CEREB CORTEX, V17, P1680, DOI 10.1093/cercor/bhl079; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; HABIB M, 1987, CORTEX, V23, P73, DOI 10.1016/S0010-9452(87)80020-5; Haushofer J, 2008, PLOS BIOL, V6, P1459, DOI 10.1371/journal.pbio.0060187; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; MacEvoy SP, 2009, CURR BIOL, V19, P943, DOI 10.1016/j.cub.2009.04.020; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Potter MC, 2004, J EXP PSYCHOL HUMAN, V30, P478, DOI 10.1037/0096-1523.30.3.478; Reddy L, 2009, P NATL ACAD SCI USA, V106, P21447, DOI 10.1073/pnas.0907330106; Renninger LW, 2004, VISION RES, V44, P2301, DOI 10.1016/j.visres.2004.04.006; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROGOSA D, 1980, PSYCHOL BULL, V88, P307, DOI 10.1037/0033-2909.88.2.307; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005	45	110	114	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1323	U144		10.1038/nn.2903	http://dx.doi.org/10.1038/nn.2903			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21892156	Green Accepted			2022-12-25	WOS:000295254200022
J	Helmstaedter, M; Briggman, KL; Denk, W				Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried			High-accuracy neurite reconstruction for high-throughput neuroanatomy	NATURE NEUROSCIENCE			English	Article							ELECTRON-MICROSCOPY; VALIDATION	Neuroanatomic analysis depends on the reconstruction of complete cell shapes. High-throughput reconstruction of neural circuits, or connectomics, using volume electron microscopy requires dense staining of all cells, which leads even experts to make annotation errors. Currently, reconstruction speed rather than acquisition speed limits the determination of neural wiring diagrams. We developed a method for fast and reliable reconstruction of densely labeled data sets. Our approach, based on manually skeletonizing each neurite redundantly (multiple times) with a visualization-annotation software tool called KNOSSOS, is similar to 50-fold faster than volume labeling. Errors are detected and eliminated by a redundant-skeleton consensus procedure (RESCOP), which uses a statistical model of how true neurite connectivity is transformed into annotation decisions. RESCOP also estimates the reliability of consensus skeletons. Focused reannotation of difficult locations promises a rather steep increase of reliability as a function of the average skeleton redundancy and thus the nearly error-free analysis of large neuroanatomical datasets.	[Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried] Max Planck Inst Med Res, Heidelberg, Germany	Max Planck Society	Helmstaedter, M (corresponding author), Max Planck Inst Med Res, Heidelberg, Germany.	moritz.helmstaedter@mpimf-heidelberg.mpg.de	denk, winfried/I-6627-2012		Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank B. Andres, F. Hamprecht, U. Kothe, V. Jain, S. Seung and S. Turaga for many fruitful discussions and comments on the manuscript, J. Bollmann and A. Schaefer for helpful comments on the manuscript, C. Roome for information technology support, J. Kornfeld and F. Svara for programming KNOSSOS, and J. Hanne, H. Jakobi and H. Wissler for help with annotator training. We thank N. Abazova, E. Abs, A. Antunes, P. Bastians, J. Bauer, M. Beez, M. Beining, S. Bender, S. Best, L. Brosi, M. Bucher, E. Buckler, J. Buhmann, C. Burkhardt, F. Drawitsch, L. Ehm, S. Ehm, C. Fianke, R. Foltin, S. Freiss, M. Funk, A. Gebhardt, M. Gruen, K. Haase, J. Hammerich, J. Hanne, B. Hauber, M. Hensen, L. Hofmann, P. Hofmann, M. Hulser, F. Isensee, H. Jakobi, M. Jonczyk, A. Joschko, A. Juenger, S. Kaspar, K. Kessler, A. Khan, M. Kiapes, A. Klein, C. Klein, S. Laiouar, T. Lang, L. Lebelt, H. Lesch, C. Lieven, D. Luft, E. Moeller, A. Muellner, M. Mueller, D. Ollech, A. Oppold, T. Otolski, S. Oumohand, S. Pfarr, M. Pohrath, A. Poos, S. Putzke, J. Reinhardt, A. Rommerskirchen, M. Roth, J. Sambel, K. Schramm, C. Sellmann, J. Sieber, I. Sonntag, M. Stahlberg, T. Stratmann, J. Trendel, F. Trogisch, M. Uhrig, A. Vogel, J. Volz, C. Weber, P. Weber, K. Weiss, L. Weisshaar, E. Wiegand, T. Wiegand, M. Wiese, R. Wiggers, C. Willburger and A. Zegarra for neurite skeletonizations. This work was funded by the Max Planck Society.	Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; BRIGGMAN KL, 2011, NATURE IN PRESS; CAJAL SRY, 1999, TEXTURA SISTEMA NERV; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Crook S, 2007, NEUROINFORMATICS, V5, P96, DOI 10.1007/s12021-007-0003-6; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Golgi, 1873, GAZ MED ITAL LOMBARD, V33, P244, DOI DOI 10.1056/NEJMOA1602253; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Jeong WK, 2010, IEEE COMPUT GRAPH, V30, P58, DOI 10.1109/MCG.2010.56; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; STRETTON AO, 1968, SCIENCE, V162, P132, DOI 10.1126/science.162.3849.132; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Wang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P1; WANG W, 2009, IEEE INT S BIOM IM N, P342; Warfield SK, 2008, PHILOS T R SOC A, V366, P2361, DOI 10.1098/rsta.2008.0040; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033	32	171	174	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1081	U189		10.1038/nn.2868	http://dx.doi.org/10.1038/nn.2868			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743472				2022-12-25	WOS:000293123700024
J	Ihrie, RA; Shah, JK; Harwell, CC; Levine, JH; Guinto, CD; Lezameta, M; Kriegstein, AR; Alvarez-Buylla, A				Ihrie, Rebecca A.; Shah, Jugal K.; Harwell, Corey C.; Levine, Jacob H.; Guinto, Cristina D.; Lezameta, Melissa; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo			Persistent Sonic Hedgehog Signaling in Adult Brain Determines Neural Stem Cell Positional Identity	NEURON			English	Article							SUBVENTRICULAR ZONE; OLFACTORY-BULB; NEURONAL MIGRATION; VASCULAR NICHE; EXPRESSION; BINDING; REVEALS; PROLIFERATION; INTERNEURONS; MAINTENANCE	Neural stem cells (NSCs) persist in the subventricular zone (SVZ) of the adult brain. Location within this germinal region determines the type of neuronal progeny NSCs generate, but the mechanism of adult NSC positional specification remains unknown. We show that sonic hedgehog (Shh) signaling, resulting in high gli levels, occurs in the ventral SVZ and is associated with the genesis of specific neuronal progeny. Shh is selectively produced by a small group of ventral forebrain neurons. Ablation of Shh decreases production of ventrally derived neuron types, while ectopic activation of this pathway in dorsal NSCs respecifies their progeny to deep granule interneurons and calbindin-positive periglomerular cells. These results show that Shh is necessary and sufficient for the specification of adult ventral NSCs.	[Ihrie, Rebecca A.; Shah, Jugal K.; Harwell, Corey C.; Levine, Jacob H.; Guinto, Cristina D.; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ihrie, Rebecca A.; Shah, Jugal K.; Levine, Jacob H.; Guinto, Cristina D.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Harwell, Corey C.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Lezameta, Melissa] Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46980, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Valencia	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu		Harwell, Corey/0000-0002-8043-5869; Shah, Jugal/0000-0003-0429-5021; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Ihrie, Rebecca/0000-0003-0439-0141	Damon Runyon Cancer Research Foundation [DRG1935-07]; AACR/NBTS; Ford Foundation; UNCF; US National Institutes of Health [NS28478, HD32116]; John G. Bowes Research Fund; Goldhirsh Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R37NS028478, R01NS028478] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; AACR/NBTS; Ford Foundation; UNCF; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John G. Bowes Research Fund; Goldhirsh Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Alexandra Joyner for sharing the Gli1CreER<SUP>T2</SUP> mouse line prior to publication, David Rowitch and the members of the Rowitch and Alvarez-Buylla labs for many useful conversations, and T. Nguyen for assistance with qRT-PCR preparations. R.A.I. was supported by postdoctoral fellowships from the Damon Runyon Cancer Research Foundation (DRG1935-07) and the AACR/NBTS. C.C.H. was supported by a Ford Foundation Postdoctoral Fellowship and a UNCF Merck Postdoctoral Science Research Fellowship. This work was supported by grants from the US National Institutes of Health (NS28478 and HD32116), the John G. Bowes Research Fund, and a grant from the Goldhirsh Foundation to A.A.-B. A.A.-B. is the Heather and Melanie Muss Endowed Chair of Neurological Surgery at UCSF.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Bai CB, 2002, DEVELOPMENT, V129, P4753; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Ho KS, 2002, CURR OPIN NEUROBIOL, V12, P57, DOI 10.1016/S0959-4388(02)00290-8; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Kosaka K, 2007, BRAIN RES, V1167, P42, DOI 10.1016/j.brainres.2007.04.087; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Liem KF, 2000, DEVELOPMENT, V127, P4855; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Long FX, 2001, DEVELOPMENT, V128, P5099; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Traiffort E, 2001, EUR J NEUROSCI, V14, P839, DOI 10.1046/j.0953-816x.2001.01708.x; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yang YS, 2001, BIOTECHNIQUES, V31, P1036, DOI 10.2144/01315st03; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	66	177	190	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					250	262		10.1016/j.neuron.2011.05.018	http://dx.doi.org/10.1016/j.neuron.2011.05.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791285	Green Accepted, Bronze			2022-12-25	WOS:000293433900010
J	Ribas-Fernandes, JJF; Solway, A; Diuk, C; McGuire, JT; Barto, AG; Niv, Y; Botvinick, MM				Ribas-Fernandes, Jose J. F.; Solway, Alec; Diuk, Carlos; McGuire, Joseph T.; Barto, Andrew G.; Niv, Yael; Botvinick, Matthew M.			A Neural Signature of Hierarchical Reinforcement Learning	NEURON			English	Article							TEMPORAL DIFFERENCE MODELS; COGNITIVE CONTROL; REWARD PREDICTION; LATERAL HABENULA; RESPONSES; DOPAMINE; ERRORS; BRAIN; CONFLICT; FEEDBACK	Human behavior displays hierarchical structure: simple actions cohere into subtask sequences, which work together to accomplish overall task goals. Although the neural substrates of such hierarchy have been the target of increasing research, they remain poorly understood. We propose that the computations supporting hierarchical behavior may relate to those in hierarchical reinforcement learning (HRL), a machine-learning framework that extends reinforcement-learning mechanisms into hierarchical domains. To test this, we leveraged a distinctive prediction arising from HRL. In ordinary reinforcement learning, reward prediction errors are computed when there is an unanticipated change in the prospects for accomplishing overall task goals. HRL entails that prediction errors should also occur in relation to task subgoals. In three neuroimaging studies we observed neural responses consistent with such subgoal-related reward prediction errors, within structures previously implicated in reinforcement learning. The results reported support the relevance of HRL to the neural processes underlying hierarchical behavior.	[Ribas-Fernandes, Jose J. F.; Solway, Alec; Diuk, Carlos; Niv, Yael; Botvinick, Matthew M.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA; [Ribas-Fernandes, Jose J. F.] Champalimaud Fdn, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [McGuire, Joseph T.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Barto, Andrew G.] Univ Massachusetts, Dept Comp Sci, Amherst, MA 01002 USA; [Niv, Yael; Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA	Princeton University; Fundacao Champalimaud; University of Pennsylvania; University of Massachusetts System; University of Massachusetts Amherst; Princeton University	Botvinick, MM (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA.	matthewb@princeton.edu		McGuire, Joseph/0000-0001-6259-0809; Ribas Fernandes, Jose/0000-0003-0675-2783	Fundacao para a Ciencia e Tecnologia [SFRH/BD/33273/2007]; INRSA Training Grant in Quantitative Neuroscience [2 T32 MH065214]; AFOSR [FA9550-08-1-041]; Sloan Research Fellowship; National Institute of Mental Health [P50 MH062196]; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); INRSA Training Grant in Quantitative Neuroscience; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Sloan Research Fellowship(Alfred P. Sloan Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Francisco Pereira for useful suggestions, and Steven lbara, Wouter Kool, Janani Prabhakar, and Natalia Cordova for help with running participants. J.J.F.R.-F. was supported by the Fundacao para a Ciencia e Tecnologia, scholarship SFRH/BD/33273/2007, A.S. by an INRSA Training Grant in Quantitative Neuroscience 2 T32 MH065214, A.G.B. by AFOSR Grant FA9550-08-1-041, Y.N. by a Sloan Research Fellowship, and M.M.B. by the National Institute of Mental Health Grant P50 MH062196 and a Collaborative Activity Award from the James S. McDonnell Foundation.	BADRE D, 2011, CEREB CORTE IN PRESS; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Baker TE, 2011, BIOL PSYCHOL, V87, P25, DOI 10.1016/j.biopsycho.2011.01.010; Barto AG, 2003, DISCRETE EVENT DYN S, V13, P343; Beiser, 1995, MODELS INFORM PROCES, P215; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Chentanez, 2005, ADV NEURAL INFORM PR, P1281, DOI DOI 10.21236/ADA440280; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daw ND, 2009, COGNITION, V113, P259, DOI 10.1016/j.cognition.2009.09.005; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; DIETTERICH TG, 1998, P 15 INT C MACH LEAR, P118; Grafman J., 2002, HDB NEUROPSYCHOLOGY; Grent-'T-Jong T, 2007, PLOS BIOL, V5, P114, DOI 10.1371/journal.pbio.0050012; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Hestvik A, 2007, BRAIN LANG, V100, P301, DOI 10.1016/j.bandl.2006.07.007; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Krigolson OE, 2006, NEUROSCIENCE, V137, P13, DOI 10.1016/j.neuroscience.2005.10.064; LASHLEY KS, 1951, BEHAV HIXON S, P112; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Parr R, 1998, ADV NEUR IN, V10, P1043; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Reynolds JR, 2009, COGNITION, V113, P281, DOI 10.1016/j.cognition.2009.05.015; Salas R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00036; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1999, ARTIF INTELL, V112, P181, DOI 10.1016/S0004-3702(99)00052-1; Talairach J., 1988, COPLANAR STEREOTAXIC; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; YAMAGUCHI S, 1995, ELECTROEN CLIN NEURO, V94, P450, DOI 10.1016/0013-4694(94)00315-C; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	60	115	115	4	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					370	379		10.1016/j.neuron.2011.05.042	http://dx.doi.org/10.1016/j.neuron.2011.05.042			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	801JF	21791294	Green Accepted, Bronze			2022-12-25	WOS:000293433900019
J	Armbruster, M; Ryan, TA				Armbruster, Moritz; Ryan, Timothy A.			Synaptic vesicle retrieval time is a cell-wide rather than individual-synapse property	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; ENDOCYTOSIS; RELEASE	Although individual nerve terminals from the same neuron often differ in neurotransmitter release characteristics, the extent to which endocytic retrieval of synaptic vesicle components differs is unknown. We used high-fidelity optical recordings to undertake a large-scale analysis of endocytosis kinetics of individual boutons in hippocampal rat neurons. Our data indicate that endocytosis kinetics do not differ substantially across boutons from the same cell but instead appear to be controlled at a cell-wide level.	[Armbruster, Moritz; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Armbruster, Moritz] Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10021 USA	Cornell University; Rockefeller University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Armbruster, Moritz/0000-0003-2341-513X; Ryan, Timothy/0000-0003-2533-9548	US National Institutes of Health; David Rockefeller Graduate School of the Rockefeller University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Rockefeller Graduate School of the Rockefeller University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Ryan laboratory and J. Dittman for useful discussions and R. Kwan for excellent technical assistance. vGlut-pHluorin was kindly provided by S. Voglmaier and R. Edwards (University of California, San Francisco) and the synaptophysin-pHluorin construct was kindly provided by Y. Zhu (Salk Institute). This work was supported by grants from the US National Institutes of Health (T. A. R.) and the David Rockefeller Graduate School of the Rockefeller University.	Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Elston RC, 2008, BASIC BIOSTATISTICS; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; KOENIG JH, 1983, J NEUROBIOL, V14, P411, DOI 10.1002/neu.480140602; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vangel MG, 1996, AM STAT, V50, P21, DOI 10.2307/2685039	14	20	20	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					824	826		10.1038/nn.2828	http://dx.doi.org/10.1038/nn.2828			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623361	Green Accepted			2022-12-25	WOS:000292081700007
J	Rabinowitz, NC; Willmore, BDB; Schnupp, JWH; King, AJ				Rabinowitz, Neil C.; Willmore, Ben D. B.; Schnupp, Jan W. H.; King, Andrew J.			Contrast Gain Control in Auditory Cortex	NEURON			English	Article							RECEPTIVE-FIELDS; PERCEPTUAL COMPENSATION; ADAPTATION; RESPONSES; REPRESENTATION; NORMALIZATION; REVERBERATION; SUPPRESSION; STATISTICS; MODULATION	The auditory system must represent sounds with a wide range of statistical properties. One important property is the spectrotemporal contrast in the acoustic environment: the variation in sound pressure in each frequency band, relative to the mean pressure. We show that neurons in ferret auditory cortex rescale their gain to partially compensate for the spectrotemporal contrast of recent stimulation. When contrast is low, neurons increase their gain, becoming more sensitive to small changes in the stimulus, although the effectiveness of contrast gain control is reduced at low mean levels. Gain is primarily determined by contrast near each neuron's preferred frequency, but there is also a contribution from contrast in more distant frequency bands. Neural responses are modulated by contrast over timescales of similar to 100 ms. By using contrast gain control to expand or compress the representation of its inputs, the auditory system may be seeking an efficient coding of natural sounds.	[Rabinowitz, Neil C.; Willmore, Ben D. B.; Schnupp, Jan W. H.; King, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Rabinowitz, NC (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	neil.rabinowitz@merton.ox.ac.uk; andrew.king@dpag.ox.ac.uk	; King, Andrew/M-6708-2013	Willmore, Ben/0000-0002-2969-7572; schnupp, jan w h/0000-0002-2604-0057; King, Andrew/0000-0001-5180-7179; Rabinowitz, Neil/0000-0002-4030-1567	Wellcome Trust [WT076508AIA]; Merton College, Oxford	Wellcome Trust(Wellcome TrustEuropean Commission); Merton College, Oxford	This work was supported by the Wellcome Trust through a Principal Research Fellowship to A.J.K. (WT076508AIA) and by Merton College, Oxford through a Domus A three-year studentship to N.C.R. We are grateful to Sandra Tolnai, Jennifer Bizley, and Kerry Walker for assistance with data collection. We also would like to thank Fernando Nodal, Douglas Hartley, Amal Isaiah, and Bashir Ahmed for their helpful contributions to the surgical preparations.	Abbott LF, 2005, PROG BRAIN RES, V149, P147, DOI 10.1016/S0079-6123(05)49011-1; Abolafia JM, 2011, CEREB CORTEX, V21, P977, DOI 10.1093/cercor/bhq163; Ahrens MB, 2008, J NEUROSCI, V28, P1929, DOI 10.1523/JNEUROSCI.3377-07.2008; Attias H, 1997, ADV NEUR IN, V9, P27; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bizley JK, 2010, J NEUROSCI, V30, P5078, DOI 10.1523/JNEUROSCI.5475-09.2010; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Escabi MA, 2003, J NEUROSCI, V23, P11489; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Gourevitch B, 2009, CEREB CORTEX, V19, P1448, DOI 10.1093/cercor/bhn184; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Miller RL, 1999, J ACOUST SOC AM, V106, P2693, DOI 10.1121/1.428135; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Reiss LAJ, 2007, J NEUROPHYSIOL, V98, P2133, DOI 10.1152/jn.01239.2006; Sahani M, 2003, ADV NEURAL INFORM PR, P125; Sahani M, 2002, ADV NEURAL INFORM PR, V15, P317; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; STEENEKEN HJM, 1980, J ACOUST SOC AM, V67, P318, DOI 10.1121/1.384464; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; VANVEEN TM, 1985, J ACOUST SOC AM, V77, P628, DOI 10.1121/1.391880; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Watkins AJ, 2005, J ACOUST SOC AM, V118, P249, DOI 10.1121/1.1923369; Watkins AJ, 2007, ACTA ACUST UNITED AC, V93, P403; Watkins PV, 2008, NAT NEUROSCI, V11, P1259, DOI 10.1038/nn.2201; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009	53	152	153	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 23	2011	70	6					1178	1191		10.1016/j.neuron.2011.04.030	http://dx.doi.org/10.1016/j.neuron.2011.04.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689603	hybrid, Green Published			2022-12-25	WOS:000292410700015
J	Kwon, SE; Chapman, ER				Kwon, Sung E.; Chapman, Edwin R.			Synaptophysin Regulates the Kinetics of Synaptic Vesicle Endocytosis in Central Neurons	NEURON			English	Article							TYROSINE PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; CHANNEL PROTEIN; SYNAPTOTAGMIN-I; MEMBRANE; SYNAPSES; IDENTIFICATION; SYNAPTOBREVIN; BIOGENESIS; MECHANISM	Despite being the most abundant synaptic vesicle membrane protein, the function of synaptophysin remains enigmatic. For example, synaptic transmission was reported to be completely normal in synaptophysin knockout mice; however, direct experiments to monitor the synaptic vesicle cycle have not been carried out. Here, using optical imaging and electrophysiological experiments, we demonstrate that synaptophysin is required for kinetically efficient endocytosis of synaptic vesicles in cultured hippocampal neurons. Truncation analysis revealed that distinct structural elements of synaptophysin differentially regulate vesicle retrieval during and after stimulation. Thus, synaptophysin regulates at least two phases of endocytosis to ensure vesicle availability during and after sustained neuronal activity.	[Kwon, Sung E.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Kwon, Sung E.; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	chapman@physiology.wisc.edu		Chapman, Edwin/0000-0001-9787-8140	NIH [MH061876]; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Jackson and X. Lou for their comments on this manuscript. We also thank M. Dong and M. Dunning for help with cDNA constructs used to carry out this work. This study was supported by a grant from the NIH (MH061876). S.E.K was supported by Epilepsy Foundation predoctoral fellowship. E.R.C is an Investigator of the Howard Hughes Medical Institute.	Arthur CP, 2007, STRUCTURE, V15, P707, DOI 10.1016/j.str.2007.04.011; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Evans GJO, 2005, BIOCHEM SOC T, V33, P1350, DOI 10.1042/BST0331350; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; LEUBE RE, 1995, J CELL SCI, V108, P883; LEUBE RE, 1989, CELL, V59, P433, DOI 10.1016/0092-8674(89)90028-7; LINSTEDT AD, 1991, J PHYSIOL-PARIS, V85, P90; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Neher Erwin, 2010, Front Synaptic Neurosci, V2, P144, DOI 10.3389/fnsyn.2010.00144; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	42	280	301	3	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 9	2011	70	5					847	854		10.1016/j.neuron.2011.04.001	http://dx.doi.org/10.1016/j.neuron.2011.04.001			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658579	Green Accepted, Bronze			2022-12-25	WOS:000291843500006
J	Klaes, C; Westendorff, S; Chakrabarti, S; Gail, A				Klaes, Christian; Westendorff, Stephanie; Chakrabarti, Shubhodeep; Gail, Alexander			Choosing Goals, Not Rules: Deciding among Rule-Based Action Plans	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; DORSAL PREMOTOR CORTEX; DECISION-MAKING; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; MATCHING BEHAVIOR; MONKEY PARIETAL; MOTOR; REPRESENTATION; TRANSFORMATION	In natural situations, movements are often directed toward locations different from that of the evoking sensory stimulus. Movement goals must then be inferred from the sensory cue based on rules. When there is uncertainty about the rule that applies for a given cue, planning a movement involves both 'Choosing the relevant rule and computing the movement goal based on that rule. Under these conditions, it is not clear whether primates compute multiple movement goals based on all possible rules before choosing an action, or whether they first choose a rule and then only represent the movement goal associated with that rule. Supporting the former hypothesis, we show that neurons in the frontoparietal reach areas of monkeys simultaneously represent two different rule-based movement goals, which are biased by the monkeys' choice preferences. Apparently, primates choose between multiple behavioral options by weighing against each other the movement goals associated with each option.	[Klaes, Christian; Westendorff, Stephanie; Gail, Alexander] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Klaes, Christian; Westendorff, Stephanie; Chakrabarti, Shubhodeep; Gail, Alexander] German Primate Ctr, D-37077 Gottingen, Germany	Deutsches Primatenzentrum (DPZ)	Gail, A (corresponding author), Bernstein Ctr Computat Neurosci, Gottingen, Germany.	agail@gwdg.de	Chakrabarti, Shubhodeep/R-9778-2018; 889, CRC/L-1607-2018; Klaes, Christian/AAJ-5843-2021	Chakrabarti, Shubhodeep/0000-0002-2759-019X; 889, CRC/0000-0002-6678-3138; 	Federal Ministry for Education and Research (BMBF, Germany) [01GQ0433, 01GQ0814, 01GQ1005C]; Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre 889; Alexander von Humboldt Foundation	Federal Ministry for Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre 889(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank Sina Plumer and Ludwig Ehrenreich for their help in data collection. This work was supported by the Federal Ministry for Education and Research (BMBF, Germany, grants 01GQ0433, 01GQ0814, 01GQ1005C), the Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Centre 889 "Cellular Mechanisms of Sensory Processing," and the Alexander von Humboldt Foundation.	Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Baldauf D, 2008, J NEUROSCI, V28, P10081, DOI 10.1523/JNEUROSCI.3423-08.2008; Basso MA, 1998, J NEUROSCI, V18, P7519; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; Gail A, 2009, J NEUROSCI, V29, P9490, DOI 10.1523/JNEUROSCI.1095-09.2009; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Iyer A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000444; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kim B, 2010, J NEUROSCI, V30, P2340, DOI 10.1523/JNEUROSCI.1730-09.2010; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Medendorp WP, 2006, J NEUROPHYSIOL, V95, P1645, DOI 10.1152/jn.00905.2005; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; WEINRICH M, 1982, J NEUROSCI, V2, P1329; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106; Yanai Y, 2008, J NEUROSCI, V28, P1728, DOI 10.1523/JNEUROSCI.4662-07.2008; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zhang MS, 2004, J NEUROPHYSIOL, V91, P1424, DOI 10.1152/jn.00504.2003	47	100	100	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					536	548		10.1016/j.neuron.2011.02.053	http://dx.doi.org/10.1016/j.neuron.2011.02.053			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555078	Bronze			2022-12-25	WOS:000290926100014
J	Tschida, KA; Mooney, R				Tschida, Katherine A.; Mooney, Richard			Deafening Drives Cell-Type-Specific Changes to Dendritic Spines in a Sensorimotor Nucleus Important to Learned Vocalizations	NEURON			English	Article							GANGLIA-FOREBRAIN CIRCUIT; PRIMATE AUDITORY-CORTEX; IDENTIFIED HVC NEURONS; LONG-TERM POTENTIATION; ADULT ZEBRA FINCHES; BASAL GANGLIA; SONG SYSTEM; SYNAPTIC PLASTICITY; HEARING-LOSS; NEURAL ACTIVITY	Hearing loss prevents vocal learning and causes learned vocalizations to deteriorate, but how vocalization-related auditory feedback acts on neural circuits that control vocalization remains poorly understood. We deafened adult zebra finches, which rely on auditory feedback to maintain their learned songs, to test the hypothesis that deafening modifies synapses on neurons in a sensorimotor nucleus important to song production. Longitudinal in vivo imaging revealed that deafening selectively decreased the size and stability of dendritic spines on neurons that provide input to a striatothalamic pathway important to audition-dependent vocal plasticity, and changes in spine size preceded and predicted subsequent vocal degradation. Moreover, electrophysiological recordings from these neurons showed that structural changes were accompanied by functional weakening of both excitatory and inhibitory synapses, increased intrinsic excitability, and changes in spontaneous action potential output. These findings shed light on where and how auditory feedback acts within sensorimotor circuits to shape learned vocalizations.	[Tschida, Katherine A.; Mooney, Richard] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Mooney, R (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu		Mooney, Richard/0000-0002-3308-1367; Tschida, Katherine/0000-0002-8171-1722	NSF; NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank I. Davison, F. Wang, M. Sommer, and T. Roberts for their helpful comments on the manuscript. K.A.T. was supported by a predoctoral award from NSF, and R.M. was supported by grants from NIDCD and NSF.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Cardin JA, 2004, J NEUROPHYSIOL, V91, P2148, DOI 10.1152/jn.00918.2003; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; DAMASIO AR, 1982, ARCH NEUROL-CHICAGO, V39, P15, DOI 10.1001/archneur.1982.00510130017003; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; DEROBERTIS EDP, 1955, J BIOPHYS BIOCHEM CY, V1, P47, DOI 10.1083/jcb.1.1.47; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fujimoto H, 2011, J NEUROSCI, V31, P10023, DOI 10.1523/JNEUROSCI.1606-11.2011; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horita H, 2008, EUR J NEUROSCI, V28, P2519, DOI 10.1111/j.1460-9568.2008.06535.x; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kim DJ, 2009, NEUROREPORT, V20, P1032, DOI 10.1097/WNR.0b013e32832e0cdd; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Kotak VC, 2008, CEREB CORTEX, V18, P2098, DOI 10.1093/cercor/bhm233; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Lei HM, 2010, NEURON, V65, P122, DOI 10.1016/j.neuron.2009.12.008; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; PETITTO LA, 1993, NATO ADV SCI INST SE, V69, P365; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Roy A, 2009, J NEUROPHYSIOL, V102, P979, DOI 10.1152/jn.00293.2009; Sakata JT, 2008, J NEUROSCI, V28, P11378, DOI 10.1523/JNEUROSCI.3254-08.2008; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shibata DK, 2007, AM J NEURORADIOL, V28, P243; Smith KM, 2011, CEREB CORTEX, V21, P991, DOI 10.1093/cercor/bhq164; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; WALDSTEIN RS, 1990, J ACOUST SOC AM, V88, P2099, DOI 10.1121/1.400107; Walmsley B, 2006, J PHYSIOL-LONDON, V572, P313, DOI 10.1113/jphysiol.2006.104851; WILLIAMS H, 1992, BEHAV NEURAL BIOL, V57, P67, DOI 10.1016/0163-1047(92)90768-Y; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	67	40	40	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 8	2012	73	5					1028	1039		10.1016/j.neuron.2011.12.038	http://dx.doi.org/10.1016/j.neuron.2011.12.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405211	Green Accepted, Bronze			2022-12-25	WOS:000301558600016
J	Kao, CF; Yu, HH; He, YS; Kao, JC; Lee, T				Kao, Chih-Fei; Yu, Hung-Hsiang; He, Yisheng; Kao, Jui-Chun; Lee, Tzumin			Hierarchical Deployment of Factors Regulating Temporal Fate in a Diverse Neuronal Lineage of the Drosophila Central Brain	NEURON			English	Article							OLFACTORY MAP; REPRESENTATION; SPECIFICATION; IDENTITY	The anterodorsal projection neuron lineage of Drosophila melanogaster produces 40 neuronal types in a stereotypic order. Here we take advantage of this complete lineage sequence to examine the role of known temporal fating factors, including Chinmo and the Hb/Kr/Pdm/Cas transcriptional cascade, within this diverse central brain lineage. Kr mutation affects the temporal fate of the neuroblast (NB) itself, causing a single fate to be skipped, whereas Chinmo null only elicits fate transformation of NB progeny without altering cell counts. Notably, Chinmo operates in two separate windows to prevent fate transformation (into the subsequent Chinmo-indenpendent fate) within each window. By contrast, Hb/Pdm/Cas play no detectable role, indicating that Kr either acts outside of the cascade identified in the ventral nerve cord or that redundancy exists at the level of fating factors. Therefore, hierarchical fating mechanisms operate within the lineage to generate neuronal diversity in an unprecedented fashion.	[Kao, Chih-Fei; He, Yisheng; Kao, Jui-Chun; Lee, Tzumin] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Yu, Hung-Hsiang; Lee, Tzumin] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Lee, T (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	leetz@janelia.hhmi.org	Yu, Hung-Hsiang/AGP-0497-2022	Yu, Hung-Hsiang/0000-0002-2430-9251	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Schroeder for critical reading of the manuscript and members of the Lee laboratory for helpful discussion. We are especially grateful to Dr. G.M. Rubin for sharing. GR-GAL4s prior to publication. We also thank the Janelia Farm Fly Light project team for generating images of GR-GAL4s that we reviewed to identify specific lines. The cas<SUP>24</SUP> allele and UAS-Kr line are kindly provided by Dr. A.P. Gould and Dr. C.Q. Doe, respectively. Other fly stocks are from the Bloomington Stock Center and the Transgenic RNAi Project at Harvard Medical School. This work was supported by the National Institutes of Health and Howard Hughes Medical Institute.	Baek M, 2009, J NEUROSCI, V29, P6904, DOI 10.1523/JNEUROSCI.1585-09.2009; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kao CF, 2010, CURR OPIN NEUROBIOL, V20, P14, DOI 10.1016/j.conb.2009.10.017; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	24	33	33	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					677	684		10.1016/j.neuron.2011.12.018	http://dx.doi.org/10.1016/j.neuron.2011.12.018			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365543	Bronze, Green Accepted			2022-12-25	WOS:000300815400008
J	Levitin, DJ				Levitin, Daniel J.			What Does It Mean to Be Musical?	NEURON			English	Editorial Material							GENETICS	Music can be seen as a model system for understanding gene x environment interactions and how these can influence neurocognitive development. The concept of musicality, however, is underspecified and not well understood. Here, I propose a framework for defining musicality to provide a foundation for studying the contributions of biological and environmental factors.	[Levitin, Daniel J.] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; [Levitin, Daniel J.] McGill Univ, Interdisciplinary Program Neurosci, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Levitin, DJ (corresponding author), McGill Univ, Dept Psychol, 1205 Ave Dr Penfield, Montreal, PQ H3A 1B1, Canada.	dlevitin@psych.mcgill.ca						Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Ericsson K.A., 1991, GEN THEORY EXPERTISE; Howe MJA, 1998, BEHAV BRAIN SCI, V21, P399, DOI 10.1017/S0140525X9800123X; Huron D.B., 2006, SWEET ANTICIPATION M; Hyde LW, 2011, TRENDS COGN SCI, V15, P417, DOI 10.1016/j.tics.2011.07.001; Kalbfleisch M Layne, 2004, Anat Rec B New Anat, V277, P21, DOI 10.1002/ar.b.20010; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Levitin DJ, 2009, ANN NY ACAD SCI, V1156, P211, DOI 10.1111/j.1749-6632.2009.04417.x; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Levitin DJ., 2006, THIS IS YOUR BRAIN M; MARIN OSM, 1999, NEUROLOGICAL ASPECTS, P653; McPherson G.E., 1995, PSYCHOL MUSIC, V23, P142, DOI [10.1177/0305735695232003, DOI 10.1177/0305735695232003]; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Posner MI, 2012, DEV PSYCHOL, V48, P827, DOI 10.1037/a0025530; Robbins TW, 2011, TRENDS COGN SCI, V15, P375, DOI 10.1016/j.tics.2011.07.006; Seashore CE., 1919, SEASHORE MEASUREMENT; Sloboda J, 2008, NATURE, V454, P32, DOI 10.1038/454032a; Ukkola-Vuoti L, 2011, J HUM GENET, V56, P324, DOI 10.1038/jhg.2011.13	20	57	58	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					633	637		10.1016/j.neuron.2012.01.017	http://dx.doi.org/10.1016/j.neuron.2012.01.017			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	899KS	22365540	Bronze, Green Submitted			2022-12-25	WOS:000300815400005
J	Kendler, KS; Chen, XN; Dick, D; Maes, H; Gillespie, N; Neale, MC; Riley, B				Kendler, Kenneth S.; Chen, Xiangning; Dick, Danielle; Maes, Hermine; Gillespie, Nathan; Neale, Michael C.; Riley, Brien			Recent advances in the genetic epidemiology and molecular genetics of substance use disorders	NATURE NEUROSCIENCE			English	Review							ENVIRONMENTAL RISK-FACTORS; GENOME-WIDE ASSOCIATION; STRESSFUL LIFE EVENTS; LUNG-CANCER; NICOTINE DEPENDENCE; ALCOHOL DEPENDENCE; CHROMOSOME 15Q25.1; SUSCEPTIBILITY LOCUS; CANNABIS INITIATION; DRUG-DEPENDENCE	This article reviews current advances in the genetics of substance use disorders (SUDs). Both genetic and environmental sources of risk are required to develop a complete picture of SUD etiology. Genetic sources of risk for SUDs are not highly substance specific in their effects. Genetic and environmental risks for SUDs typically do not only add together but also interact with each other over development. Risk gene identification for SUDs has been difficult, with one recent success in identifying nicotinic receptor variants that affect risk for nicotine dependence. The impact of genetic variants on SUD risk will individually be small. Although genetic epidemiologic methods are giving us an increasingly accurate map of broad causal pathways to SUDs, gene discovery will be needed to identify the specific biological systems. Identifying these risk genes and understanding their action will require large clinical samples, and interaction between these studies and work in model organisms.	[Kendler, Kenneth S.; Chen, Xiangning; Dick, Danielle; Maes, Hermine; Gillespie, Nathan; Neale, Michael C.; Riley, Brien] Virginia Commonwealth Univ, Med Coll Virginia, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Kendler, Kenneth S.; Chen, Xiangning; Dick, Danielle; Maes, Hermine; Gillespie, Nathan; Neale, Michael C.; Riley, Brien] Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychiat, Richmond, VA 23298 USA; [Kendler, Kenneth S.; Chen, Xiangning; Maes, Hermine; Neale, Michael C.; Riley, Brien] Virginia Commonwealth Univ, Med Coll Virginia, Dept Human & Mol Genet, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Kendler, KS (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA.	kendler@vcu.edu	Kendler, Kenneth/AAF-2876-2019; Gillespie, Nathan/D-6029-2013; Neale, Michael/AAD-5056-2020		US National Institutes of Health [DA18673, AA011408, AA017828, DA030005, AA018755, AA15416, DA023549, DA025109, DA022989, DA024413, DA027070, MH084952, DA019498]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011408, R01AA011408, P20AA017828, K02AA018755, R01AA015416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018673, K99DA023549, U01DA024413, R37DA018673, R01DA030005, R00DA023549, K01DA019498, R01DA024413, R21DA027070, R01DA025109] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by US National Institutes of Health grants DA18673 (M.C.N., H.M.), AA011408, AA017828, DA030005 (K.S.K., B.R.), AA018755, AA15416 (D.D.), DA023549 (N.G.), DA025109, DA022989, DA024413, DA027070, MH084952 (H.M.) and DA019498 (X.C.).	Agrawal A, 2005, ADDICT BEHAV, V30, P1043, DOI 10.1016/j.addbeh.2004.09.007; Agrawal A, 2006, BEHAV GENET, V36, P640, DOI 10.1007/s10519-006-9069-4; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Blomeyer D, 2008, BIOL PSYCHIAT, V63, P146, DOI 10.1016/j.biopsych.2007.04.026; Boardman JD, 2008, BEHAV GENET, V38, P234, DOI 10.1007/s10519-008-9197-0; Boardman JD, 2010, J HEALTH SOC BEHAV, V51, P108, DOI 10.1177/0022146509361195; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Conway KP, 2010, DRUG ALCOHOL DEPEN, V111, P4, DOI 10.1016/j.drugalcdep.2010.03.011; Covault J, 2004, AM J MED GENET B, V129B, P104, DOI 10.1002/ajmg.b.30091; Covault J, 2007, BIOL PSYCHIAT, V61, P609, DOI 10.1016/j.biopsych.2006.05.018; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; Dick DM, 2011, MOL PSYCHIATR, V16, P800, DOI 10.1038/mp.2010.73; Dick DM, 2007, J ABNORM PSYCHOL, V116, P213, DOI 10.1037/0021-843X.116.1.213; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; Dick DM, 2009, ARCH GEN PSYCHIAT, V66, P649, DOI 10.1001/archgenpsychiatry.2009.48; Dick DM, 2006, J STUD ALCOHOL, V67, P185, DOI 10.15288/jsa.2006.67.185; Dick DM, 2001, J ABNORM PSYCHOL, V110, P625, DOI 10.1037//0021-843X.110.4.625; Dickson PA, 2006, ALCOHOL CLIN EXP RES, V30, P1093, DOI 10.1111/j.1530-0277.2006.00128.x; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Enoch MA, 2006, AM J MED GENET B, V141B, P599, DOI 10.1002/ajmg.b.30336; Erlich PM, 2010, HUM GENET, V128, P491, DOI 10.1007/s00439-010-0876-6; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gillespie NA, 2007, ADDICTION, V102, P920, DOI 10.1111/j.1360-0443.2007.01804.x; Gillespie NA, 2011, DRUG ALCOHOL DEPEN, V118, P166, DOI 10.1016/j.drugalcdep.2011.03.014; Gillespie NA, 2009, ADDICTION, V104, P430, DOI 10.1111/j.1360-0443.2008.02456.x; GOEDDE HW, 1992, HUM GENET, V88, P344; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Grobin AC, 1998, PSYCHOPHARMACOLOGY, V139, P2, DOI 10.1007/s002130050685; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Gruss M, 2001, EUR J NEUROSCI, V14, P1246, DOI 10.1046/j.0953-816x.2001.01754.x; Hansen HM, 2010, HUM MOL GENET, V19, P3652, DOI 10.1093/hmg/ddq268; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2009, ARCH GEN PSYCHIAT, V66, P640, DOI 10.1001/archgenpsychiatry.2008.554; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Joslyn G, 2008, P NATL ACAD SCI USA, V105, P20368, DOI 10.1073/pnas.0810970105; Kaufman J, 2007, BIOL PSYCHIAT, V61, P1228, DOI 10.1016/j.biopsych.2006.06.039; Kendler K.S., 2006, GENES ENV PSYCHOPATH, V1st ed.; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674; Kendler KS, 2007, ARCH GEN PSYCHIAT, V64, P958, DOI 10.1001/archpsyc.64.8.958; Kendler KS, 2007, ARCH GEN PSYCHIAT, V64, P1313, DOI 10.1001/archpsyc.64.11.1313; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Kendler KS, 2011, AM J PSYCHIAT, V168, P29, DOI 10.1176/appi.ajp.2010.10030340; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; KENDLER KS, 1986, AM J PSYCHIAT, V143, P279; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koopmans JR, 1999, BEHAV GENET, V29, P445, DOI 10.1023/A:1021679005623; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Lappalainen J, 2005, ALCOHOL CLIN EXP RES, V29, P493, DOI 10.1097/01.ALC.0000158938.97464.90; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Lubke G, 2008, MULTIVAR BEHAV RES, V43, P592, DOI 10.1080/00273170802490673; Maes H.H., 2009, NCI TOBACCO CONTROL, V20; Maes HH, 2011, BEHAV GENET, V41, P680, DOI 10.1007/s10519-011-9476-z; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; Munafo M.R, J NATL CANC IN PRESS; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1097/00000374-200006000-00020; Neale MC, 1999, BEHAV GENET, V29, P233, DOI 10.1023/A:1021638122693; Neale MC, 2006, ADDICT BEHAV, V31, P1010, DOI 10.1016/j.addbeh.2006.03.047; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schuckit MA, 1997, ADDICTION, V92, P979, DOI 10.1046/j.1360-0443.1997.9289797.x; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Timberlake DS, 2006, NICOTINE TOB RES, V8, P123, DOI 10.1080/14622200500432054; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Vanyukov MM, 2009, BEHAV GENET, V39, P233, DOI 10.1007/s10519-009-9269-9; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0	89	110	112	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					181	189		10.1038/nn.3018	http://dx.doi.org/10.1038/nn.3018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22281715	Green Accepted			2022-12-25	WOS:000299603500007
J	Verhoef, BE; Vogels, R; Janssen, P				Verhoef, Bram-Ernst; Vogels, Rufin; Janssen, Peter			Inferotemporal Cortex Subserves Three-Dimensional Structure Categorization	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; STEREOSCOPIC DEPTH-PERCEPTION; AREA MT; ELECTRICAL MICROSTIMULATION; CORTICAL MICROSTIMULATION; DISCRIMINATION TASK; OBJECT RECOGNITION; HEADING PERCEPTION; RELATIVE DISPARITY; HUMAN BRAIN	We perceive real-world objects as three-dimensional (3D), yet it is unknown which brain area underlies our ability to perceive objects in this way. The macaque inferotemporal (IT) cortex contains neurons that respond selectively to 3D structures defined by binocular disparity. To examine the causal role of IT in the categorization of 3D structures, we electrically stimulated clusters of IT neurons with a similar 3D-structure preference while monkeys performed a 3D-structure categorization task. Microstimulation of 3D-structure-selective IT clusters caused monkeys to choose the preferred structure of the 3D-structure-selective neurons considerably more often. Microstimulation in IT also accelerated the monkeys' choice for the preferred structure, while delaying choices corresponding to the nonpreferred structure of a given site. These findings reveal that 3D-structure-selective neurons in IT contribute to the categorization of 3D objects.	[Verhoef, Bram-Ernst; Vogels, Rufin; Janssen, Peter] Neuro & Psychofysiol Lab, BE-3000 Louvain, Belgium		Janssen, P (corresponding author), Neuro & Psychofysiol Lab, Campus Gasthuisberg,O&N2,Herestr 49,Bus 1021, BE-3000 Louvain, Belgium.	peter.janssen@med.kuleuven.be		Verhoef, Bram-Ernst/0000-0003-3535-9008	Fonds Wetenschappelijk Onderzoek [G.0495.05N, G.0713.09]; Geneeskundige Stichting Koningin Elisabeth; Interuniversitaire Attractiepolen; Geconcerteerde OnderzoeksActies [2005/18, 2010/19]; Excellentiefinanciering [05/014]; Programmafinanciering [10/008]; KU Leuven [PDMK/10/217]	Fonds Wetenschappelijk Onderzoek(FWO); Geneeskundige Stichting Koningin Elisabeth; Interuniversitaire Attractiepolen; Geconcerteerde OnderzoeksActies; Excellentiefinanciering(KU Leuven); Programmafinanciering; KU Leuven(KU Leuven)	We thank Inez Puttemans, Piet Kayenbergh, Gerrit Meulemans, Stijn Verstraeten, Marjan Docx, Wouter Depuydt, Marc De Paep, and Karin Winnepenninckx for assistance. We thank Steve Raiguel for comments on a previous version of this manuscript. B.-E.V. received a postdoctoral fellowship at KU Leuven (Research Fund K.U. Leuven; PDMK/10/217). This work was supported by Fonds Wetenschappelijk Onderzoek grant G.0495.05N and G.0713.09, Geneeskundige Stichting Koningin Elisabeth, Interuniversitaire Attractiepolen, Geconcerteerde OnderzoeksActies 2005/18 and 2010/19, Excellentiefinanciering 05/014 and Programmafinanciering 10/008.	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Anzai A, 2010, CURR OPIN NEUROBIOL, V20, P367, DOI 10.1016/j.conb.2010.04.006; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; COWEY A, 1979, PROC R SOC SER B-BIO, V204, P399, DOI 10.1098/rspb.1979.0035; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Howard IP, 1995, BINOCULAR VISION STE; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Joly O, 2009, NEUROIMAGE, V47, P262, DOI 10.1016/j.neuroimage.2009.04.043; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Phillips F, 1996, J EXP PSYCHOL HUMAN, V22, P930; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Srivastava S, 2009, J NEUROSCI, V29, P10613, DOI 10.1523/JNEUROSCI.6016-08.2009; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Thomas E, 2001, J COGNITIVE NEUROSCI, V13, P190, DOI 10.1162/089892901564252; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Umeda K, 2007, J NEUROPHYSIOL, V98, P241, DOI 10.1152/jn.01336.2006; Verhoef BE, 2010, CURR BIOL, V20, P909, DOI 10.1016/j.cub.2010.03.058; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; Zhang T, 2011, J NEUROSCI, V31, P2569, DOI 10.1523/JNEUROSCI.5520-10.2011	48	45	45	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 12	2012	73	1					171	182		10.1016/j.neuron.2011.10.031	http://dx.doi.org/10.1016/j.neuron.2011.10.031			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243755	Bronze			2022-12-25	WOS:000299446800016
J	Chapuis, J; Wilson, DA				Chapuis, Julie; Wilson, Donald A.			Bidirectional plasticity of cortical pattern recognition and behavioral sensory acuity	NATURE NEUROSCIENCE			English	Article							PIRIFORM CORTEX; ALZHEIMERS-DISEASE; OLFACTORY CORTEX; ODOR; DISCRIMINATION; NETWORK; NEURONS; MEMORY; RATS; HIPPOCAMPUS	Learning to adapt to a complex and fluctuating environment requires the ability to adjust neural representations of sensory stimuli. Through pattern completion processes, cortical networks can reconstruct familiar patterns from degraded input patterns, whereas pattern separation processes allow discrimination of even highly overlapping inputs. Here we show that the balance between pattern separation and completion is experience dependent. Rats given extensive training with overlapping complex odorant mixtures showed improved behavioral discrimination ability and enhanced piriform cortical ensemble pattern separation. In contrast, behavioral training to disregard normally detectable differences between overlapping mixtures resulted in impaired piriform cortical ensemble pattern separation (enhanced pattern completion) and impaired discrimination. This bidirectional effect was not found in the olfactory bulb; it may be due to plasticity within olfactory cortex itself. Thus pattern recognition, and the balance between pattern separation and completion, is highly malleable on the basis of task demands and occurs in concert with changes in perceptual performance.	[Chapuis, Julie; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Chapuis, Julie; Wilson, Donald A.] NYU, Langone Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Chapuis, J (corresponding author), Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA.	jchapuis@nki.rfmh.org; donald.wilson@nyumc.org		Wilson, Donald/0000-0001-8918-2151	US National Institutes of Health [DC003906, DC008982]; Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC008982] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by US National Institutes of Health grants DC003906 and DC008982 to D.A.W. and a Fyssen Foundation post-doctoral grant to J.C.	BAKIN JS, 1992, BRAIN RES, V577, P226, DOI 10.1016/0006-8993(92)90278-H; Barnes CA, 1997, NATURE, V388, P272, DOI 10.1038/40859; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Chapuis J, 2009, J NEUROSCI, V29, P10287, DOI 10.1523/JNEUROSCI.0505-09.2009; Chen CFF, 2011, J NEUROPHYSIOL, V106, P3136, DOI 10.1152/jn.00721.2011; Cohen-Matsliah SI, 2009, EUR J NEUROSCI, V30, P1339, DOI 10.1111/j.1460-9568.2009.06894.x; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Fletcher ML, 2005, J NEUROSCI, V25, P792, DOI 10.1523/JNEUROSCI.4673-04.2005; Fletcher ML, 2003, J NEUROSCI, V23, P6946; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1230, DOI 10.1152/jn.1992.67.5.1230; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Kay LM, 2010, J NEUROPHYSIOL, V104, P829, DOI 10.1152/jn.00166.2010; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Li F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015401; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; Martin C, 2007, J NEUROPHYSIOL, V98, P2196, DOI 10.1152/jn.00524.2007; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Preacher K. J., 2002, CALCULATION TEST DIF; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Restrepo D, 2009, TRENDS NEUROSCI, V32, P525, DOI 10.1016/j.tins.2009.06.001; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Saar D, 1999, J NEUROSCI, V19, P8616; Seckinger RA, 2004, SCHIZOPHR RES, V69, P55, DOI 10.1016/S0920-9964(03)00124-5; SMITH DV, 1979, CHEM SENS FLAV, V4, P215, DOI 10.1093/chemse/4.3.215; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Tanila H, 1997, J NEUROSCI, V17, P5167; Tanila H, 1997, J NEUROSCI, V17, P5155; Tristan C, 2009, EUR J NEUROSCI, V29, P921, DOI 10.1111/j.1460-9568.2009.06651.x; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010	50	135	135	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					155	U194		10.1038/nn.2966	http://dx.doi.org/10.1038/nn.2966			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101640	Green Accepted			2022-12-25	WOS:000298414400026
J	Graybeal, C; Feyder, M; Schulman, E; Saksida, LM; Bussey, TJ; Brigman, JL; Holmes, A				Graybeal, Carolyn; Feyder, Michael; Schulman, Emily; Saksida, Lisa M.; Bussey, Timothy J.; Brigman, Jonathan L.; Holmes, Andrew			Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF	NATURE NEUROSCIENCE			English	Article							FEAR EXTINCTION; MICE; REORGANIZATION; EXPOSURE; CORTEX	Stress affects various forms of cognition. We found that moderate stress enhanced late reversal learning in a mouse touchscreen-based choice task. Ventromedial prefrontal cortex (vmPFC) lesions mimicked the effect of stress, whereas orbitofrontal and dorsolateral striatal lesions impaired reversal. Stress facilitation of reversal was prevented by BDNF infusion into the vmPFC. These findings suggest a mechanism by which stress-induced vmPFC dysfunction disinhibits learning by alternate (for example, striatal) systems.	[Graybeal, Carolyn; Feyder, Michael; Schulman, Emily; Brigman, Jonathan L.; Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Med Res Council, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Holmes, A (corresponding author), NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD USA.	andrew.holmes@mail.nih.gov	Saksida, Lisa M/M-2753-2016; Bussey, Timothy J/M-2758-2016	Saksida, Lisa M/0000-0002-8416-8171; Bussey, Timothy J/0000-0001-7518-4041	National Institute on Alcohol Abuse; Alcoholism Intramural Research Program [Z01-AA000411]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000411, ZIAAA000411, K22AA020303] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Alcoholism Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Shaham, G. Quirk and G. Schoenbaum for valuable discussions. This work was supported by the National Institute on Alcohol Abuse and Alcoholism Intramural Research Program (Z01-AA000411).	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BALLEINE B, 1992, Q J EXP PSYCHOL-B, V45, P285; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Shors TJ, 2006, ANNU REV PSYCHOL, V57, P55, DOI 10.1146/annurev.psych.57.102904.190205; Stalnaker TA, 2009, NEUROPHARMACOLOGY, V56, P63, DOI 10.1016/j.neuropharm.2008.07.019	15	124	125	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1507	1509		10.1038/nn.2954	http://dx.doi.org/10.1038/nn.2954			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	855EJ	22057192	Green Accepted, Green Submitted			2022-12-25	WOS:000297546300007
J	Zonouzi, M; Renzi, M; Farrant, M; Cull-Candy, SG				Zonouzi, Marzieh; Renzi, Massimiliano; Farrant, Mark; Cull-Candy, Stuart G.			Bidirectional plasticity of calcium-permeable AMPA receptors in oligodendrocyte lineage cells	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; GENE-EXPRESSION; WHITE-MATTER; ACTIVATION; RELEASE; NEURONS; PHOSPHORYLATION; EXCITOTOXICITY	Oligodendrocyte precursor cells (OPCs), a major glial cell type that gives rise to myelinating oligodendrocytes in the CNS, express calcium-permeable AMPA receptors (CP-AMPARs). Although CP-AMPARs are important for OPC proliferation and neuron-glia signaling, they render OPCs susceptible to ischemic damage in early development. We identified factors controlling the dynamic regulation of AMPAR subtypes in OPCs from rat optic nerve and mouse cerebellar cortex. We found that activation of group 1 mGluRs drove an increase in the proportion of CP-AMPARs, reflected by an increase in single-channel conductance and inward rectification. This plasticity required the elevation of intracellular calcium and used PI3K, PICK-1 and the JNK pathway. In white matter, neurons and astrocytes release both ATP and glutamate. Unexpectedly, activation of purinergic receptors in OPCs decreased CP-AMPAR expression, suggesting a capacity for homeostatic regulation. Finally, we found that stargazin-related transmembrane AMPAR regulatory proteins, which are critical for AMPAR surface expression in neurons, regulate CP-AMPAR plasticity in OPCs.	[Zonouzi, Marzieh; Renzi, Massimiliano; Farrant, Mark; Cull-Candy, Stuart G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Cull-Candy, SG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	m.farrant@ucl.ac.uk; s.cull-candy@ucl.ac.uk		Farrant, Mark/0000-0002-9918-0376; Cull-Candy, Stuart G/0000-0002-0831-8326; RENZI, MASSIMILIANO/0000-0001-6973-3569; Funk, Marzieh/0000-0001-7371-9823; Zonouzi, Marzieh/0000-0002-7087-1202	Wellcome Trust; Medical Research Council (Laboratory for Molecular Cell Biology, University College London)	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (Laboratory for Molecular Cell Biology, University College London)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank I. Coombs, C. Bats, C. Shelley, D. Soto and D. Studniarczyk for invaluable help and discussion. We are grateful to E. Molnar (Bristol University) for CG4-OPC cells, D. Attwell and C. Reynell (University College London) for providing NG2-DsRed mice, R. Nicoll (University of California, San Francisco) for TARP cDNA (rat, gamma-2), J. Wood (University College London) for GFP-PICK-1 inhibitor peptide, M. Watanabe (Hokkaido University) for antibody to TARP gamma-2, B. Clark (University College London) for antibody to calbindin, and D. Cutler and M. Marsh (Laboratory for Molecular Cell Biology, University College London) for generous help and access to equipment. This work was supported by a Wellcome Trust Programme grant (S. G. C.-C. and M. F.). M.Z. was in receipt of a Medical Research Council (Laboratory for Molecular Cell Biology, University College London) studentship.	Ahn SM, 2010, J NEUROSCI RES, V88, P992, DOI 10.1002/jnr.22275; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Clem RL, 2010, J NEUROSCI, V30, P6360, DOI 10.1523/JNEUROSCI.6276-09.2010; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Deng WB, 2004, P NATL ACAD SCI USA, V101, P7751, DOI 10.1073/pnas.0307850101; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Follett PL, 2000, J NEUROSCI, V20, P9235; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Haberlandt C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017575; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; James G, 2001, CELL CALCIUM, V30, P251, DOI 10.1054/ceca.2001.0232; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Li XM, 2007, EUR J NEUROSCI, V25, P391, DOI 10.1111/j.1460-9568.2006.05300.x; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luyt K, 2003, J NEUROCHEM, V84, P1452, DOI 10.1046/j.1471-4159.2003.01661.x; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Pankratov YV, 2002, J NEUROSCI, V22, P8363; PENDE M, 1994, P NATL ACAD SCI USA, V91, P3215, DOI 10.1073/pnas.91.8.3215; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Santos AE, 2006, CELL DEATH DIFFER, V13, P652, DOI 10.1038/sj.cdd.4401785; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vieira M, 2010, NEUROBIOL DIS, V40, P645, DOI 10.1016/j.nbd.2010.08.008; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	50	81	84	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1430	U103		10.1038/nn.2942	http://dx.doi.org/10.1038/nn.2942			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21983683	Green Accepted			2022-12-25	WOS:000296518600019
J	Hill, DN; Curtis, JC; Moore, JD; Kleinfeld, D				Hill, Daniel N.; Curtis, John C.; Moore, Jeffrey D.; Kleinfeld, David			Primary Motor Cortex Reports Efferent Control of Vibrissa Motion on Multiple Timescales	NEURON			English	Article							SCANNING SENSORIMOTOR SYSTEM; TRIGEMINAL GANGLION NEURONS; CENTRAL PATTERN GENERATOR; AIR WHISKING BEHAVIOR; BARREL CORTEX; RHYTHMIC WHISKING; OBJECT LOCALIZATION; ELECTRICAL-ACTIVITY; NATURAL WHISKING; EXPLORATORY WHISKING	Exploratory whisking in rat is an example of self-generated movement on multiple timescales, from slow variations in the envelope of whisking to the rapid sequence of muscle contractions during a single whisk cycle. We find that, as a population, spike trains of single units in primary vibrissa motor cortex report the absolute angle of vibrissa position. This representation persists after sensory nerve transection, indicating an efferent source. About two-thirds of the units are modulated by slow variations in the envelope of whisking, while relatively few units report rapid changes in position within the whisk cycle. The combined results from this study and past measurements, which show that primary sensory cortex codes the whisking envelope as a motor copy signal, imply that signals present in both sensory and motor cortices are necessary to compute angular coordinates based on vibrissa touch.	[Hill, Daniel N.; Moore, Jeffrey D.; Kleinfeld, David] Univ Calif San Diego, Computat Neurosci Grad Program, San Diego, CA 92093 USA; [Hill, Daniel N.; Moore, Jeffrey D.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, Div Phys Sci, San Diego, CA 92093 USA; [Hill, Daniel N.] Tech Univ Munich, Inst Neurosci, D-80333 Munich, Germany; [Curtis, John C.] Salk Inst Biol Studies, San Diego, CA 92037 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Technical University of Munich; Salk Institute; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Computat Neurosci Grad Program, San Diego, CA 92093 USA.	dk@physics.ucsd.edu			NIH [NS051177, FNS054393A, 5F31NS066664]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058668, F31NS066664, F31NS054393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Adrienne L. Fairhall and Haim Sompolinsky for discussions on spike coding and statistics and comments on a draft of the manuscript, Jing W. Wang for discussions on population responses, Douglas Rubino for discussions on data analysis, Ehud Ahissar, Carlos D. Brody, Beth Friedman, David Golomb, and Michael J. Pesavento for comments on the manuscript, G. Allen White for assistance with the electronics, and the NIH for financial support (NS051177 to D.K., FNS054393A to D.N.H., and 5F31NS066664 to J.D.M.).	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; ARVIDSSON J, 1991, J COMP NEUROL, V309, P1, DOI 10.1002/cne.903090102; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Black H. S., 1953, MODULATION THEORY; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; CARVELL GE, 1991, SOMATOSENS MOT RES, V8, P159, DOI 10.3109/08990229109144740; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Castro-Alamancos MA, 2006, J NEUROPHYSIOL, V96, P1691, DOI 10.1152/jn.00454.2006; Chakrabarti S, 2008, J NEUROPHYSIOL, V100, P50, DOI 10.1152/jn.90327.2008; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Dayan P., 2001, THEORETICAL NEUROSCI; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Eden UT, 2010, J NEUROSCI METH, V190, P149, DOI 10.1016/j.jneumeth.2010.04.012; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Fee MS, 1996, J NEUROPHYSIOL, V76, P3823, DOI 10.1152/jn.1996.76.6.3823; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Friedman WA, 2006, J NEUROPHYSIOL, V95, P1274, DOI 10.1152/jn.00945.2005; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; Gao PH, 2003, SOMATOSENS MOT RES, V20, P191, DOI 10.1080/08990220310001622924; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Golub G. H., 1965, CALCULATING SINGULAR; GRANNAN ER, 1993, NEURAL COMPUT, V5, P550, DOI 10.1162/neco.1993.5.4.550; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Hemelt ME, 2008, J NEUROPHYSIOL, V100, P1245, DOI 10.1152/jn.90478.2008; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hoffer ZS, 2005, J COMP NEUROL, V488, P82, DOI 10.1002/cne.20579; Hoffer ZS, 2003, J COMP NEUROL, V466, P525, DOI 10.1002/cne.10895; Kim U, 1999, J COMP NEUROL, V408, P489; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Lang EJ, 2006, J PHYSIOL-LONDON, V571, P101, DOI 10.1113/jphysiol.2005.102764; Leigh RJ, 1997, ANN NY ACAD SCI, V835, P353, DOI 10.1111/j.1749-6632.1997.tb48641.x; Leiser SC, 2007, NEURON, V53, P117, DOI 10.1016/j.neuron.2006.10.036; Lundstrom BN, 2010, J NEUROSCI, V30, P5071, DOI 10.1523/JNEUROSCI.2193-09.2010; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Moxon KA, 2008, J NEUROPHYSIOL, V100, P551, DOI 10.1152/jn.90386.2008; Nelson ME, 2006, J COMP PHYSIOL A, V192, P573, DOI 10.1007/s00359-006-0099-4; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor SM, 2002, J NEUROPHYSIOL, V87, P2137, DOI 10.1152/jn.00229.2001; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; PREMACK D, 1968, NATURE, V217, P288, DOI 10.1038/217288a0; SCHWARTZ AB, 1988, J NEUROSCI METH, V8, P2918; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Simony E, 2010, J NEUROSCI, V30, P8935, DOI 10.1523/JNEUROSCI.0172-10.2010; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Towal RB, 2008, J NEUROPHYSIOL, V100, P740, DOI 10.1152/jn.01295.2007; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Travers Joseph B., 1995, P239; Urbain N, 2007, NEURON, V56, P714, DOI 10.1016/j.neuron.2007.10.023; Venkatachalam S, 1999, J NEUROSCI METH, V90, P37, DOI 10.1016/S0165-0270(99)00065-5; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wiener N., 1964, EXTRAPOLATION INTERP	75	112	112	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 20	2011	72	2					344	356		10.1016/j.neuron.2011.09.020	http://dx.doi.org/10.1016/j.neuron.2011.09.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017992	Green Accepted, Bronze			2022-12-25	WOS:000296224000015
J	Barkat, TR; Polley, DB; Hensch, TK				Barkat, Tania Rinaldi; Polley, Daniel B.; Hensch, Takao K.			A critical period for auditory thalamocortical connectivity	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CORTEX; PLASTICITY; EXPERIENCE; REPRESENTATION; ORGANIZATION; INPUTS; MOUSE; SELECTIVITY; PERCEPTION	Neural circuits are shaped by experience during periods of heightened brain plasticity in early postnatal life. Exposure to acoustic features produces age-dependent changes through largely unresolved cellular mechanisms and sites of origin. We isolated the refinement of auditory thalamocortical connectivity by in vivo recordings and day-by-day voltage-sensitive dye imaging in an acute brain slice preparation. Passive tone-rearing modified response strength and topography in mouse primary auditory cortex (A1) during a brief, 3-d window, but did not alter tonotopic maps in the thalamus. Gene-targeted deletion of a forebrain-specific cell-adhesion molecule (Icam5) accelerated plasticity in this critical period. Consistent with its normal role of slowing spinogenesis, loss of Icam5 induced precocious stubby spine maturation on pyramidal cell dendrites in neocortical layer 4 (L4), identifying a primary locus of change for the tonotopic plasticity. The evolving postnatal connectivity between thalamus and cortex in the days following hearing onset may therefore determine a critical period for auditory processing.	[Barkat, Tania Rinaldi; Hensch, Takao K.] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Polley, Daniel B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Eaton Peabody Lab,Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Hensch, TK (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	hensch@mcb.harvard.edu	Hensch, Takao/L-4182-2019	Rinaldi Barkat, Tania/0000-0001-8650-0986; Polley, Daniel/0000-0002-5120-2409	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Human Frontiers Science Program; National Institute on Deafness and Other Communication Disorders [009836]; Harvard Society of Fellows; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009836] Funding Source: NIH RePORTER	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Human Frontiers Science Program(Human Frontier Science Program); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Harvard Society of Fellows; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Icam5<SUP>-/-</SUP> mice and antibody were kindly provided by M. Mishina (University of Tokyo) and Y. Yoshihara (RIKEN BSI), respectively. We thank M. Nakamura, A. Takesian, N. Gogolla, E.-J. Yang, K. Quast, M. Marcotrigiano, M. Kelly, R. Pavlyuk, B. Jones O'Brien and V. Khatri for technical assistance and comments. This work was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (T. K. H.), the Human Frontiers Science Program (T. K. H.), the National Institute on Deafness and Other Communication Disorders (grant 009836, D. B. P.) and the Harvard Society of Fellows (T.R.B.).	ALFORD BR, 1963, ANN OTO RHINOL LARYN, V72, P237, DOI 10.1177/000348946307200119; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Geissler DB, 2004, EUR J NEUROSCI, V19, P1027, DOI 10.1111/j.1460-9568.2004.03205.x; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Harris JA, 2006, HEARING RES, V216, P127, DOI 10.1016/j.heares.2006.03.016; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kim H, 2009, J NEUROSCI, V29, P5163, DOI 10.1523/JNEUROSCI.0365-09.2009; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; MOGDANS J, 1994, J NEUROPHYSIOL, V72, P2875, DOI 10.1152/jn.1994.72.6.2875; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Popescu MV, 2010, NEURON, V65, P718, DOI 10.1016/j.neuron.2010.02.019; Razak KA, 2008, P NATL ACAD SCI USA, V105, P4465, DOI 10.1073/pnas.0709504105; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; Seidl AH, 2005, J NEUROPHYSIOL, V94, P1028, DOI 10.1152/jn.01143.2004; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhao CP, 2009, J NEUROSCI, V29, P15479, DOI 10.1523/JNEUROSCI.4471-09.2009; Zhou X, 2008, NEUROSCIENCE, V154, P390, DOI 10.1016/j.neuroscience.2008.01.026	50	160	163	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1189	U252		10.1038/nn.2882	http://dx.doi.org/10.1038/nn.2882			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21804538	Green Accepted			2022-12-25	WOS:000294284900020
J	Xi, ZX; Peng, XQ; Li, X; Song, R; Zhang, HY; Liu, QR; Yang, HJ; Bi, GH; Li, J; Gardner, EL				Xi, Zheng-Xiong; Peng, Xiao-Qing; Li, Xia; Song, Rui; Zhang, Hai-Ying; Liu, Qing-Rong; Yang, Hong-Ju; Bi, Guo-Hua; Li, Jie; Gardner, Eliot L.			Brain cannabinoid CB2 receptors modulate cocaine's actions in mice	NATURE NEUROSCIENCE			English	Article							DORSAL-HORN NEURONS; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR CHARACTERIZATION; CHRONIC PAIN; RAT; EXPRESSION; DOPAMINE; AGONISTS; RESPONSES; IDENTIFICATION	The presence and function of cannabinoid CB2 receptors in the brain have been the subjects of much debate. We found that systemic, intranasal or intra-accumbens local administration of JWH133, a selective CB2 receptor agonist, dose-dependently inhibited intravenous cocaine self-administration, cocaine-enhanced locomotion, and cocaine-enhanced accumbens extracellular dopamine in wild-type and CB1 receptor knockout (CB1-/-, also known as Cnr1(-/-)) mice, but not in CB2-/-(Cnr2(-/-)) mice. This inhibition was mimicked by GW405833, another CB2 receptor agonist with a different chemical structure, and was blocked by AM630, a selective CB2 receptor antagonist. Intra-accumbens administration of JWH133 alone dose-dependently decreased, whereas intra-accumbens administration of AM630 elevated, extracellular dopamine and locomotion in wild-type and CB1-/- mice, but not in CB2-/- mice. Intra-accumbens administration of AM630 also blocked the reduction in cocaine self-administration and extracellular dopamine produced by systemic administration of JWH133. These findings suggest that brain CB2 receptors modulate cocaine's rewarding and locomotor-stimulating effects, likely by a dopamine-dependent mechanism.	[Xi, Zheng-Xiong; Peng, Xiao-Qing; Li, Xia; Song, Rui; Zhang, Hai-Ying; Liu, Qing-Rong; Yang, Hong-Ju; Bi, Guo-Hua; Li, Jie; Gardner, Eliot L.] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Song, Rui] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Academy of Military Medical Sciences - China	Xi, ZX (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA.	zxi@intra.nida.nih.gov	Liu, Qing-Rong/A-3059-2012	Liu, Qing-Rong/0000-0001-8477-6452; Zhang, Haiying/0000-0003-0593-5940; PENG, XIAOQING/0000-0002-7272-5428	National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000478, ZIADA000513] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Y. Shaham and E.A. Stein of the Intramural Research Program of the National Institute on Drug Abuse, and K. Mackie of Indiana University for their helpful comments on this manuscript. This research was supported by the Intramural Research Program of the National Institute on Drug Abuse.	Anand U, 2008, PAIN, V138, P667, DOI 10.1016/j.pain.2008.06.007; Ashton JC, 2008, CURR MED CHEM, V15, P1428, DOI 10.2174/092986708784567716; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baek J-H, 2008, ACTA OTO-LARYNGOL, V128, P1; Bardo MT, 1998, CRIT REV NEUROBIOL, V12, P37, DOI 10.1615/CritRevNeurobiol.v12.i1-2.30; BAYEWITCH M, 1995, FEBS LETT, V375, P143, DOI 10.1016/0014-5793(95)01207-U; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Bingham B, 2007, BRIT J PHARMACOL, V151, P1061, DOI 10.1038/sj.bjp.0707303; Brown SM, 2002, BBA-GENE STRUCT EXPR, V1576, P255, DOI 10.1016/S0167-4781(02)00341-X; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Chin CL, 2008, BRIT J PHARMACOL, V153, P367, DOI 10.1038/sj.bjp.0707506; Costantino HR, 2007, INT J PHARMACEUT, V337, P1, DOI 10.1016/j.ijpharm.2007.03.025; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Haydon PG, 2009, NEUROPHARMACOLOGY, V56, P83, DOI 10.1016/j.neuropharm.2008.06.050; Huffman JW, 2005, MINI-REV MED CHEM, V5, P641, DOI 10.2174/1389557054368844; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Jhaveri MD, 2008, EUR J NEUROSCI, V27, P1722, DOI 10.1111/j.1460-9568.2008.06162.x; Lanciego JL, 2011, J PSYCHOPHARMACOL, V25, P97, DOI 10.1177/0269881110367732; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; Liu QR, 2009, GENES BRAIN BEHAV, V8, P519, DOI 10.1111/j.1601-183X.2009.00498.x; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Malan TP, 2003, CURR OPIN PHARMACOL, V3, P62, DOI 10.1016/S1471-4892(02)00004-8; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Mukherjee S, 2004, EUR J PHARMACOL, V505, P1, DOI 10.1016/j.ejphar.2004.09.058; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Parolaro D, 2008, DRUG NEWS PERSPECT, V21, P149, DOI 10.1358/dnp.2008.21.3.1203411; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Ross RA, 2001, NEUROPHARMACOLOGY, V40, P221, DOI 10.1016/S0028-3908(00)00135-0; Sagar DR, 2005, EUR J NEUROSCI, V22, P371, DOI 10.1111/j.1460-9568.2005.04206.x; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Schwarting RKW, 1997, NEUROTOXICOLOGY, V18, P689; Soria G, 2005, NEUROPSYCHOPHARMACOL, V30, P1670, DOI 10.1038/sj.npp.1300707; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Thakur GA, 2005, MINI-REV MED CHEM, V5, P631, DOI 10.2174/1389557054368772; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xi ZX, 2008, NEUROPSYCHOPHARMACOL, V33, P1735, DOI 10.1038/sj.npp.1301552; Yao BB, 2006, BRIT J PHARMACOL, V149, P145, DOI 10.1038/sj.bjp.0706838; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	50	280	286	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1160	U216		10.1038/nn.2874	http://dx.doi.org/10.1038/nn.2874			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785434	Green Accepted			2022-12-25	WOS:000294284900016
J	Kole, MHP				Kole, Maarten H. P.			First Node of Ranvier Facilitates High-Frequency Burst Encoding	NEURON			English	Article							ACTION-POTENTIAL INITIATION; NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE NEURONS; PRIMARY SOMATOSENSORY CORTEX; MECHANISMS UNDERLYING BURST; PERSISTENT SODIUM CURRENT; WAVE-FORM; AXON; CHANNELS; SEGMENT	In central neurons the first node of Ranvier is located at the first axonal branchpoint, similar to 100 mu m from the axon initial segment where synaptic inputs are integrated and converted into action potentials (APs). Whether the first node contributes to this signal transformation is not well understood. Here it was found that in neocortical layer 5 axons, the first branchpoint is required for intrinsic high-frequency (>= 100 Hz) AP bursts. Furthermore, block of nodal Na(+) channels or axotomy of the first node in intrinsically bursting neurons depolarized the somatic AP voltage threshold (similar to 5 mV) and eliminated APs selectively within a high-frequency cluster in response to steady currents or simulated synaptic inputs. These results indicate that nodal persistent Na+ current exerts an anterograde influence on AP initiation in the axon initial segment, revealing a computational role of the first node of Ranvier beyond conduction of the propagating AP.	[Kole, Maarten H. P.] Australian Natl Univ, Dept Neurosci, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Kole, MHP (corresponding author), NIN, NL-1105 BA Amsterdam, Netherlands.	m.kole@nin.knaw.nl		Kole, Maarten/0000-0002-3883-5682	Australian National Health & Medical Research Council (NHMRC) [525437]	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health & Medical Research Council (NHMRC Project Grant #525437). Special thanks go to Jason Gavrilis, Stefan Hallermann, and Greg Stuart for insightful discussions and comments to earlier versions of the manuscript. The author is furthermore grateful for the support of Scott Jones and Vincent Daria with the two-photon imaging.	Baccus SA, 1998, P NATL ACAD SCI USA, V95, P8345, DOI 10.1073/pnas.95.14.8345; Bekkers JM, 2007, P NATL ACAD SCI USA, V104, P11447, DOI 10.1073/pnas.0701586104; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; DEZEEUW CI, 1990, J COMP NEUROL, V300, P495, DOI 10.1002/cne.903000405; DUBOIS JM, 1975, PFLUG ARCH EUR J PHY, V357, P145, DOI 10.1007/BF00584552; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Foust A, 2010, J NEUROSCI, V30, P6891, DOI 10.1523/JNEUROSCI.0552-10.2010; FRANCESCHETTI S, 1995, BRAIN RES, V696, P127, DOI 10.1016/0006-8993(95)00807-3; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Golomb D, 2006, J NEUROPHYSIOL, V96, P1912, DOI 10.1152/jn.00205.2006; HUXLEY AF, 1949, J PHYSIOL-LONDON, V108, P315, DOI 10.1113/jphysiol.1949.sp004335; Kepecs A, 2002, J NEUROSCI, V22, P9053; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; KHATTAB FAHMY I., 1968, BRAIN RES, V9, P149, DOI 10.1016/0006-8993(68)90265-5; Kim JH, 2010, J NEUROSCI, V30, P15479, DOI 10.1523/JNEUROSCI.3982-10.2010; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Mantegazza M, 1998, J PHYSIOL-LONDON, V507, P105, DOI 10.1111/j.1469-7793.1998.105bu.x; MASON A, 1990, J NEUROSCI, V10, P1415; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; Mejia-Gervacio S, 2007, NEURON, V53, P843, DOI 10.1016/j.neuron.2007.02.023; Monsivais P, 2005, J NEUROSCI, V25, P464, DOI 10.1523/JNEUROSCI.3871-04.2005; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Palmer LM, 2010, J PHYSIOL-LONDON, V588, P1709, DOI 10.1113/jphysiol.2010.188300; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Ranvier L.J., 1871, CR HEBD ACAD SCI, V73, P1168; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Schmidt-Hieber C, 2010, J NEUROSCI, V30, P10233, DOI 10.1523/JNEUROSCI.6335-09.2010; Schwindt P, 1999, J NEUROPHYSIOL, V81, P1341, DOI 10.1152/jn.1999.81.3.1341; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P173, DOI 10.1098/rstb.1979.0004; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; STYS PK, 1993, P NATL ACAD SCI USA, V90, P6976, DOI 10.1073/pnas.90.15.6976; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; WAXMAN SG, 1985, SCIENCE, V228, P1502, DOI 10.1126/science.2409596; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005	53	73	75	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 25	2011	71	4					671	682		10.1016/j.neuron.2011.06.024	http://dx.doi.org/10.1016/j.neuron.2011.06.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867883	Bronze			2022-12-25	WOS:000294521600012
J	Hitoshi, S; Ishino, Y; Kumar, A; Jasmine, S; Tanaka, KF; Kondo, T; Kato, S; Hosoya, T; Hotta, Y; Ikenaka, K				Hitoshi, Seiji; Ishino, Yugo; Kumar, Akhilesh; Jasmine, Salma; Tanaka, Kenji F.; Kondo, Takeshi; Kato, Shigeaki; Hosoya, Toshihiko; Hotta, Yoshiki; Ikenaka, Kazuhiro			Mammalian Gcm genes induce Hes5 expression by active DNA demethylation and induce neural stem cells	NATURE NEUROSCIENCE			English	Article							NERVOUS-SYSTEM; MICE LACKING; DROSOPHILA; NEUROGENESIS; BINDING; DIFFERENTIATION; EMBRYOGENESIS; TRANSCRIPTION; GLYCOSYLASE; GLIOGENESIS	Signaling mediated by Notch receptors is crucial for the development of many organs and the maintenance of various stem cell populations. The activation of Notch signaling is first detectable by the expression of an effector gene, Hes5, in the neuroepithelium of mouse embryos at embryonic day (E) 8.0-8.5, and this activation is indispensable for the generation of neural stem cells. However, the molecular mechanism by which Hes5 expression is initiated in stem-producing cells remains unknown. We found that mammalian Gcm1 and Gcm2 (glial cells missing 1 and 2) are involved in the epigenetic regulation of Hes5 transcription by DNA demethylation independently of DNA replication. Loss of both Gcm genes and subsequent lack of Hes5 upregulation in the neuroepithelium of E7.5-8.5 Gcm1(-/-); Gcm2(-/-) mice resulted in the impaired induction of neural stem cells. Our data suggest that Hes5 expression is serially activated first by Gcms and later by the canonical Notch pathway.	[Hitoshi, Seiji; Ishino, Yugo; Kumar, Akhilesh; Jasmine, Salma; Tanaka, Kenji F.; Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan; [Hitoshi, Seiji; Ishino, Yugo; Kumar, Akhilesh; Jasmine, Salma; Tanaka, Kenji F.; Ikenaka, Kazuhiro] Grad Univ Adv Studies, Dept Physiol Sci, Sch Life Sci, Okazaki, Aichi, Japan; [Kondo, Takeshi; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Hosoya, Toshihiko] RIKEN, Hosoya Res Unit, Brain Sci Inst, Wako, Saitama, Japan; [Hotta, Yoshiki] Res Org Informat & Syst, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; University of Tokyo; RIKEN; Research Organization of Information & Systems (ROIS)	Hitoshi, S (corresponding author), Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan.	shitoshi-tky@umin.ac.jp	Kumar, Akhilesh/G-9413-2013; Hosoya, Toshihiko/Q-2514-2018	Hosoya, Toshihiko/0000-0001-8559-8344; Tanaka, Kenji/0000-0003-2511-0057	Ministry of Education, Culture, Sports, Science and Technology of Japan [19650096]; Grants-in-Aid for Scientific Research [23680042, 22115004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. Kageyama, J.S. Nye, T. Miyazaki and T. Honjo for plasmids, T.-e.U and Y. Imai for MBD4 mutant mice, and R. Kageyama, D. van der Kooy and K. Nakashima for comments. This work was supported by a Grant-in-Aid for Exploratory Research (19650096) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (K.I.S.H.).	Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Cau E, 2000, DEVELOPMENT, V127, P2323; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Egger B, 2002, DEVELOPMENT, V129, P3295; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Iwasaki Y, 2003, DEVELOPMENT, V130, P6027, DOI 10.1242/dev.00822; Jones BW, 2005, DEV BIOL, V278, P265, DOI 10.1016/j.ydbio.2004.11.022; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; Nakahira E, 2006, DEV BIOL, V291, P123, DOI 10.1016/j.ydbio.2005.12.010; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; OKA C, 1995, DEVELOPMENT, V121, P3291; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Schreiber J, 1998, NUCLEIC ACIDS RES, V26, P2337, DOI 10.1093/nar/26.10.2337; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	41	48	50	4	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					957	U35		10.1038/nn.2875	http://dx.doi.org/10.1038/nn.2875			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765423				2022-12-25	WOS:000293123700008
J	Sejourne, J; Placais, PY; Aso, Y; Siwanowicz, I; Trannoy, S; Thoma, V; Tedjakumala, SR; Rubin, GM; Tchenio, P; Ito, K; Isabel, G; Tanimoto, H; Preat, T				Sejourne, Julien; Placais, Pierre-Yves; Aso, Yoshinori; Siwanowicz, Igor; Trannoy, Severine; Thoma, Vladimiros; Tedjakumala, Stevanus R.; Rubin, Gerald M.; Tchenio, Paul; Ito, Kei; Isabel, Guillaume; Tanimoto, Hiromu; Preat, Thomas			Mushroom body efferent neurons responsible for aversive olfactory memory retrieval in Drosophila	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; TIMING-DEPENDENT PLASTICITY; EXTRINSIC NEURONS; CONSOLIDATED MEMORY; PROTEIN; BODIES; INTEGRATION; DOPAMINE; DYNAMICS; BEHAVIOR	Aversive olfactory memory is formed in the mushroom bodies in Drosophila melanogaster. Memory retrieval requires mushroom body output, but the manner in which a memory trace in the mushroom body drives conditioned avoidance of a learned odor remains unknown. To identify neurons that are involved in olfactory memory retrieval, we performed an anatomical and functional screen of defined sets of mushroom body output neurons. We found that MB-V2 neurons were essential for retrieval of both short- and long-lasting memory, but not for memory formation or memory consolidation. MB-V2 neurons are cholinergic efferent neurons that project from the mushroom body vertical lobes to the middle superiormedial protocerebrum and the lateral horn. Notably, the odor response of MB-V2 neurons was modified after conditioning. As the lateral horn has been implicated in innate responses to repellent odorants, we propose that MB-V2 neurons recruit the olfactory pathway involved in innate odor avoidance during memory retrieval.	[Sejourne, Julien; Placais, Pierre-Yves; Trannoy, Severine; Tchenio, Paul; Isabel, Guillaume; Preat, Thomas] Ecole Super Phys & Chim Ind Ville Paris, CNRS, Neurobiol Unit, Paris, France; [Aso, Yoshinori; Siwanowicz, Igor; Thoma, Vladimiros; Tedjakumala, Stevanus R.; Tanimoto, Hiromu] Max Planck Inst Neurobiol, Martinsried, Germany; [Aso, Yoshinori; Rubin, Gerald M.] Howard Hughes Med Inst, Ashburn, VA USA; [Tchenio, Paul] Univ Paris 11, CNRS, UPR 3321, F-91405 Orsay, France; [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Max Planck Society; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Tokyo	Preat, T (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, Neurobiol Unit, Paris, France.	hiromut@neuro.mpg.de; thomas.preat@espci.fr	Tanimoto, Hiromu/J-6810-2016; Aso, Yoshinori/ACJ-9439-2022; Trannoy, Severine/D-1530-2015	Trannoy, Severine/0000-0002-5059-9846; Thoma, Vladimiros/0000-0002-2688-4639; Rubin, Gerald/0000-0001-8762-8703; Preat, Thomas/0000-0001-9976-1763	Japan Society for the Promotion of Science; Agence Nationale pour la Recherche; Fondation Bettencourt-Schueler; Fondation pour la Recherche Medicale; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Max-Planck-Gesellschaft; Region Ile-de-France; Deutscher Akademischer Austausch Dienst	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Bettencourt-Schueler; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max-Planck-Gesellschaft(Max Planck Society); Region Ile-de-France(Region Ile-de-France); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	We thank J. Urban and G. M. Technau for the MZ160 line, the members of the NP consortium for the NP2492 line, J.-M. Dura for the y<SUP>1</SUP>w<SUP>1118</SUP>; GAL80[y<SUP>+</SUP>], Sb line and for discussions, L. L. Looger for the UAS-GCaMP3 line, T. Kitamoto for the GAD1-GAL80 and Cha<SUP>3.3kb</SUP>-GAL80 lines, and V. Hakim, I. Rivals and members of our laboratories for discussions. This work was supported by grants from the Japan Society for the Promotion of Science (K. I.), the Agence Nationale pour la Recherche (T. P.), the Fondation Bettencourt-Schueler (T. P.), the Fondation pour la Recherche Medicale (T. P.), the Emmy-Noether Program from Deutsche Forschungsgemeinschaft (H. T.), the Bernstein Focus Learning from Bundesministerium fur Bildung und Forschung (H. T.) and the Max-Planck-Gesellschaft (H. T.). J. S. and G. I. were supported by the Fondation pour la Recherche Medicale, P.-Y.P. was supported by a grant from Region Ile-de-France and Y.A. was supported by Deutscher Akademischer Austausch Dienst.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Bashir ZI, 2003, NEUROSCI RES, V45, P363, DOI 10.1016/S0168-0102(03)00002-6; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; FIALA A, 2003, SCI STKE, pPL6; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1998, LEARN MEMORY, V5, P52; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sepp KJ, 1999, GENETICS, V151, P1093; Takagawa K, 1996, NEUROSCI RES, V24, P237, DOI 10.1016/0168-0102(95)00999-X; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	50	150	151	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					903	U129		10.1038/nn.2846	http://dx.doi.org/10.1038/nn.2846			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685917	Green Submitted			2022-12-25	WOS:000292081700019
J	Cohen, MR; Maunsell, JHR				Cohen, Marlene R.; Maunsell, John H. R.			Using Neuronal Populations to Study the Mechanisms Underlying Spatial and Feature Attention	NEURON			English	Article							SELECTIVE VISUAL-ATTENTION; MACAQUE AREA V4; EFFECTIVE CONNECTIVITY; NORMALIZATION MODEL; PARIETAL CORTEX; NEURAL ACTIVITY; FRONTAL-CORTEX; BEHAVING MICE; MODULATION; RESPONSES	Visual attention affects both perception and neuronal responses. Whether the same neuronal mechanisms mediate spatial attention, which improves perception of attended locations, and nonspatial forms of attention has been a subject of considerable debate. Spatial and feature attention have similar effects on individual neurons. Because visual cortex is retinotopically organized, however, spatial attention can comodulate local neuronal populations, whereas feature attention generally requires more selective modulation. We compared the effects of feature and spatial attention on local and spatially separated populations by recording simultaneously from dozens of neurons in both hemispheres of V4. Feature and spatial attention affect the activity of local populations similarly, modulating both firing rates and correlations between pairs of nearby neurons. However, whereas spatial attention appears to act on local populations, feature attention is coordinated across hemispheres. Our results are consistent with a unified attentional mechanism that can modulate the responses of arbitrary subgroups of neurons.	[Cohen, Marlene R.; Maunsell, John H. R.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Cohen, Marlene R.; Maunsell, John H. R.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cohen, MR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cohenm@pitt.edu	Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439	NIH [K99EY020844-01, R01EY005911]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY005911, K99EY020844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to Mark Histed, Adam Kohn, Amy Ni, and Douglas Ruff for helpful discussions and comments on an earlier version of the manuscript. This work was supported by NIH grants K99EY020844-01 (M.R.C.) and R01EY005911 (J.H.R.M.) and the Howard Hughes Medical Institute.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cavanaugh J, 2006, J NEUROSCI, V26, P11347, DOI 10.1523/JNEUROSCI.2376-06.2006; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Coull JT, 1998, J NEUROSCI, V18, P7426; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Cutrell EB, 2002, EXP BRAIN RES, V144, P103, DOI 10.1007/s00221-002-1032-x; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; ESPINOSA IE, 1988, BRAIN RES, V450, P39, DOI 10.1016/0006-8993(88)91542-9; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gregoriou GG, 2009, PROG BRAIN RES, V176, P35, DOI 10.1016/S0079-6123(09)17603-3; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hayden BY, 2009, VISION RES, V49, P1182, DOI 10.1016/j.visres.2008.06.011; Herrington TM, 2009, J NEUROSCI, V29, P14160, DOI 10.1523/JNEUROSCI.1916-09.2009; Herrington TM, 2009, J NEUROSCI, V29, P5793, DOI 10.1523/JNEUROSCI.4412-08.2009; Houtkamp R, 2003, PERCEPT PSYCHOPHYS, V65, P1136, DOI 10.3758/BF03194840; KEREN G, 1976, J EXP PSYCHOL GEN, V105, P349, DOI 10.1037/0096-3445.105.4.349; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; KWAK HW, 1992, PERCEPT PSYCHOPHYS, V51, P455, DOI 10.3758/BF03211641; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Liu TS, 2011, VISION RES, V51, P26, DOI 10.1016/j.visres.2010.09.023; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; NISSEN MJ, 1985, J GERONTOL, V40, P185, DOI 10.1093/geronj/40.2.185; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROSSI AF, 1995, VISION RES, V35, P621, DOI 10.1016/0042-6989(94)00156-G; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; Sally SL, 2009, SPATIAL VISION, V22, P529, DOI 10.1163/156856809789822970; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; VONWRIGH.JM, 1970, ACTA PSYCHOL, V33, P280, DOI 10.1016/0001-6918(70)90140-X; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 2004, VISION RES, V44, P1411, DOI 10.1016/j.visres.2003.11.024; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	78	147	148	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1192	1204		10.1016/j.neuron.2011.04.029	http://dx.doi.org/10.1016/j.neuron.2011.04.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689604	Bronze, Green Accepted			2022-12-25	WOS:000292410700016
J	Kahnt, T; Grueschow, M; Speck, O; Haynes, JD				Kahnt, Thorsten; Grueschow, Marcus; Speck, Oliver; Haynes, John-Dylan			Perceptual Learning and Decision-Making in Human Medial Frontal Cortex	NEURON			English	Article							PRIMARY VISUAL-CORTEX; ANTERIOR CINGULATE CORTEX; SUBJECTIVE SENSORY EXPERIENCE; HUMAN BRAIN; PREDICTION ERRORS; PREFRONTAL CORTEX; NEURAL CODES; ORIENTATION; DISCRIMINATION; DOPAMINE	The dominant view that perceptual learning is accompanied by changes in early sensory representations has recently been challenged. Here we tested the idea that perceptual learning can be accounted for by reinforcement learning involving changes in higher decision-making areas. We trained subjects on an orientation discrimination task involving feedback over 4 days, acquiring fMRI data on the first and last day. Behavioral improvements were well explained by a reinforcement learning model in which learning leads to enhanced readout of sensory information, thereby establishing noise-robust representations of decision variables. We find stimulus orientation encoded in early visual and higher cortical regions such as lateral parietal cortex and anterior cingulate cortex (ACC). However, only activity patterns in the ACC tracked changes in decision variables during learning. These results provide strong evidence for perceptual learning-related changes in higher order areas and suggest that perceptual and reward learning are based on a common neurobiological mechanism.	[Kahnt, Thorsten; Grueschow, Marcus; Haynes, John-Dylan] Charite, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Kahnt, Thorsten; Haynes, John-Dylan] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Grueschow, Marcus; Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, D-04303 Leipzig, Germany; [Grueschow, Marcus; Haynes, John-Dylan] Otto Von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany; [Speck, Oliver] Otto Von Guericke Univ, Inst Expt Phys, Fac Nat Sci, D-39120 Magdeburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Max Planck Society; Otto von Guericke University; Otto von Guericke University	Kahnt, T (corresponding author), Charite, Bernstein Ctr Computat Neurosci, Philippstr 13,House 6, D-10115 Berlin, Germany.	thorsten.kahnt@bccn-berlin.de; haynes@bccn-berlin.de	Speck, Oliver/F-1406-2013; Haynes, John-Dylan/Q-1148-2016	Speck, Oliver/0000-0002-6019-5597; Haynes, John-Dylan/0000-0003-1786-6954; Kahnt, Thorsten/0000-0002-3575-2670	Sonderforschungsbereich of the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG] [SFB 779 A3]; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung [BMBF]) [01GQ0411]; Excellence Initiative of the German Federal Ministry of Education and Research (DFG) [GSC86/1-2009]; Max Planck Society	Sonderforschungsbereich of the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG](German Research Foundation (DFG)); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung [BMBF])(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal Ministry of Education and Research (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank R. Korbs for technical assistance. This work was funded by the Sonderforschungsbereich (SFB 779 A3) of the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG]), the Bernstein Computational Neuroscience Program of the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung [BMBF] Grant 01GQ0411), the Excellence Initiative of the German Federal Ministry of Education and Research (DFG Grant GSC86/1-2009), and the Max Planck Society.	Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kahnt T, 2011, NEUROIMAGE, V56, P709, DOI 10.1016/j.neuroimage.2010.05.058; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kahnt T, 2009, J COGNITIVE NEUROSCI, V21, P1332, DOI 10.1162/jocn.2009.21092; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Lemus L, 2010, NEURON, V67, P335, DOI 10.1016/j.neuron.2010.06.015; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Mannion DJ, 2010, J NEUROPHYSIOL, V103, P3465, DOI 10.1152/jn.00190.2010; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2009, CURR OPIN NEUROBIOL, V19, P75, DOI 10.1016/j.conb.2009.02.005; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Seymour K, 2009, CURR BIOL, V19, P177, DOI 10.1016/j.cub.2008.12.050; Shmuel A, 2010, NEUROIMAGE, V49, P1957, DOI 10.1016/j.neuroimage.2009.08.040; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Zhang E, 2010, P NATL ACAD SCI USA, V107, P15969, DOI 10.1073/pnas.1003547107; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; Zhang T, 2010, VISION RES, V50, P368, DOI 10.1016/j.visres.2009.08.024	61	119	122	3	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					549	559		10.1016/j.neuron.2011.02.054	http://dx.doi.org/10.1016/j.neuron.2011.02.054			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	768HZ	21555079	Bronze			2022-12-25	WOS:000290926100015
J	Madisen, L; Mao, TY; Koch, H; Zhuo, JM; Berenyi, A; Fujisawa, S; Hsu, YWA; Garcia, AJ; Gu, X; Zanella, S; Kidney, J; Gu, H; Mao, YM; Hooks, BM; Boyden, ES; Buzsaki, G; Ramirez, JM; Jones, AR; Svoboda, K; Han, X; Turner, EE; Zeng, HK				Madisen, Linda; Mao, Tianyi; Koch, Henner; Zhuo, Jia-min; Berenyi, Antal; Fujisawa, Shigeyoshi; Hsu, Yun-Wei A.; Garcia, Alfredo J., III; Gu, Xuan; Zanella, Sebastien; Kidney, Jolene; Gu, Hong; Mao, Yimei; Hooks, Bryan M.; Boyden, Edward S.; Buzsaki, Gyoergy; Ramirez, Jan Marino; Jones, Allan R.; Svoboda, Karel; Han, Xue; Turner, Eric E.; Zeng, Hongkui			A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing	NATURE NEUROSCIENCE			English	Article							NEURAL CIRCUITRY; IN-VIVO; MILLISECOND-TIMESCALE; GABAERGIC NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; OPTICAL CONTROL; CHANNELRHODOPSIN-2; BRAIN; ORGANIZATION	Cell type specific expression of optogenetic molecules allows temporally precise manipulation of targeted neuronal activity. Here we present a toolbox of four knock-in mouse lines engineered for strong, Cre-dependent expression of channelrhodopsins ChR2-tdTomato and ChR2-EYFP, halorhodopsin eNpHR3.0 and archaerhodopsin Arch-ER2. All four transgenes mediated Cre-dependent, robust activation or silencing of cortical pyramidal neurons in vitro and in vivo upon light stimulation, with ChR2-EYFP and Arch-ER2 demonstrating light sensitivity approaching that of in utero or virally transduced neurons. We further show specific photoactivation of parvalbumin-positive interneurons in behaving ChR2-EYFP reporter mice. The robust, consistent and inducible nature of our ChR2 mice represents a significant advance over previous lines, and the Arch-ER2 and eNpHR3.0 mice are to our knowledge the first demonstration of successful conditional transgenic optogenetic silencing. When combined with the hundreds of available Cre driver lines, this optimized toolbox of reporter mice will enable widespread investigations of neural circuit function with unprecedented reliability and accuracy.	[Madisen, Linda; Kidney, Jolene; Gu, Hong; Jones, Allan R.; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Mao, Tianyi; Hooks, Bryan M.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA; [Koch, Henner; Hsu, Yun-Wei A.; Garcia, Alfredo J., III; Zanella, Sebastien; Ramirez, Jan Marino; Turner, Eric E.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Zhuo, Jia-min; Gu, Xuan; Mao, Yimei; Han, Xue] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Berenyi, Antal; Fujisawa, Shigeyoshi; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA	Allen Institute for Brain Science; Howard Hughes Medical Institute; Seattle Children's Hospital; Boston University; Rutgers State University Newark; Rutgers State University New Brunswick; Massachusetts Institute of Technology (MIT)	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	hongkuiz@alleninstitute.org	Berényi, Antal/A-9174-2013; Zhuo, Jia-Min/M-7546-2014; Fujisawa, Shigeyoshi/N-6439-2015; Chee, Melissa/G-4150-2014; Turner, Eric e/K-3556-2015	Berényi, Antal/0000-0003-0084-8530; Zhuo, Jia-Min/0000-0001-9199-5485; Fujisawa, Shigeyoshi/0000-0003-3963-4281; Chee, Melissa/0000-0003-3815-9095; Turner, Eric e/0000-0001-5499-6788; Mao, Tianyi/0000-0002-3532-8319; Buzsaki, Gyorgy/0000-0002-3100-4800; Ramirez, Jan-Marino/0000-0002-5626-3999; Hsu, Yun-Wei/0000-0001-7851-2733	Allen Institute for Brain Science; Howard Hughes Medical Institute; US National Institutes of Health (NIH) [DA028298, MH085944, NS034994, MH54671]; Alfred P. Sloan Foundation; US National Science Foundation; Marie Curie Fellowship; EU [2009 IOF 254780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671, R00MH085944, R01MH093667, R21MH090478, K99MH085944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028298] Funding Source: NIH RePORTER	Allen Institute for Brain Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Science Foundation(National Science Foundation (NSF)); Marie Curie Fellowship(European Commission); EU(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the technical support of the Atlas Production Team, led by P. Wohnoutka, and the Technology Team, led by C. Dang, at the Allen Institute. We thank A. Nagy (Mount Sinai Hospital in Toronto) for providing the G4 ES cell line and K. Deisseroth (Stanford University) for providing the eNpHR3.0 construct. The authors wish to thank the Allen Institute founders, PG. Allen and J. Allen, for their vision, encouragement and support. This work was funded by the Allen Institute for Brain Science and the Howard Hughes Medical Institute, US National Institutes of Health (NIH) grant DA028298 to H.Z., NIH grants MH90478 and MH093667 to E.E.T., NIH grant MH085944 and an Alfred P. Sloan Foundation grant to X.H., NIH grants NS034994 and MH54671 and a US National Science Foundation grant to GB., and a Marie Curie Fellowship (EU FP7 PEOPLE 2009 IOF 254780) to A.B.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lewis TL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001021; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Liu XB, 2011, J COMP NEUROL, V519, P1181, DOI 10.1002/cne.22567; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	43	786	795	5	158	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					793	802		10.1038/nn.3078	http://dx.doi.org/10.1038/nn.3078			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446880	Green Accepted, Green Submitted			2022-12-25	WOS:000303270200025
J	Thier, M; Worsdorfer, P; Lakes, YB; Gorris, R; Herms, S; Opitz, T; Seiferling, D; Quandel, T; Hoffmann, P; Nothen, MM; Brustle, O; Edenhofer, F				Thier, Marc; Woersdoerfer, Philipp; Lakes, Yenal B.; Gorris, Raphaela; Herms, Stefan; Opitz, Thoralf; Seiferling, Dominic; Quandel, Tamara; Hoffmann, Per; Noethen, Markus M.; Bruestle, Oliver; Edenhofer, Frank			Direct Conversion of Fibroblasts into Stably Expandable Neural Stem Cells	CELL STEM CELL			English	Article							MOUSE FIBROBLASTS; GENERATION; DIFFERENTIATION; CARDIOMYOCYTES; PLURIPOTENCY; NEURONS; OCT4	Recent advances have suggested that direct induction of neural stem cells (NSCs) could provide an alternative to derivation from somatic tissues or pluripotent cells. Here we show direct derivation of stably expandable NSCs from mouse fibroblasts through a curtailed version of reprogramming to pluripotency. By constitutively inducing Sox2, Klf4, and c-Myc while strictly limiting Oct4 activity to the initial phase of reprogramming, we generated neurosphere-like colonies that could be expanded for more than 50 passages and do not depend on sustained expression of the reprogramming factors. These induced neural stem cells (iNSCs) uniformly display morphological and molecular features of NSCs, such as the expression of Nestin, Pax6, and Olig2, and have a genome-wide transcriptional profile similar to that of brain-derived NSCs. Moreover, iNSCs can differentiate into neurons, astrocytes, and oligodendrocytes. Our results demonstrate that functional NSCs can be generated from somatic cells by factor-driven induction.	[Thier, Marc; Woersdoerfer, Philipp; Lakes, Yenal B.; Seiferling, Dominic; Edenhofer, Frank] Univ Bonn, Inst Reconstruct Neurobiol, Stem Cell Engn Grp, D-53105 Bonn, Germany; [Thier, Marc; Woersdoerfer, Philipp; Lakes, Yenal B.; Gorris, Raphaela; Seiferling, Dominic; Quandel, Tamara; Bruestle, Oliver; Edenhofer, Frank] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, Hertie Fdn, D-53105 Bonn, Germany; [Herms, Stefan; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Opitz, Thoralf] Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders DZNE, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Edenhofer, F (corresponding author), Univ Bonn, Inst Reconstruct Neurobiol, Stem Cell Engn Grp, Sigmund Freud Str 25, D-53105 Bonn, Germany.	f.edenhofer@uni-bonn.de	Herms, Stefan/J-1949-2014; Hoffmann, Per/A-5149-2010; Edenhofer, Frank/ABG-9458-2020	Herms, Stefan/0000-0002-2786-8200; Hoffmann, Per/0000-0002-6573-983X; Edenhofer, Frank/0000-0002-6489-714X; Nothen, Markus/0000-0002-8770-2464; Worsdorfer, Philipp/0000-0003-3398-3229	Deutsche Forschungsgemeinschaft DFG [ED79/1-2]; German Ministry of Education and Research, BMBF [01GN1009B]; European Commission; Merck KGaA, Darmstadt, Germany	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Merck KGaA, Darmstadt, Germany	We thank Austin Smith (Cambridge University, UK) for providing us with the Oct4-GiP reporter and NS5 cell line and Rudolf Jaenisch (Whitehead Institute, USA) for the kind gift of FUW-vectors. We are indebted to Ian Duncan (University of Wisconsin, USA) for providing us with md rats, Didier Trono (EPFL Lausanne, Switzerland) for providing the helper plasmids psPAX2 and pMD2.G, and Shinya Yamanaka for providing the plasmids pMXs-Sox2, pMXs-Klf4, and pMXs-c-myc. We thank Sandra Meyer and Rajkumar Thummer for critical reading of the manuscript; and Benedikt Berninger (Ludwig-Maximilians University Munich, Germany), Magdalena Getz (Institute for Stem Cell Research Munich, Germany), Veit Hornung (University of Bonn, Germany), and all members of the Stem Cell Engineering Group for helpful discussions. We thank Nicole Russ, Kathrin Vogt, Stephanie Mielke, and Anke Leinhaas for excellent technical support. This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (ED79/1-2), the German Ministry of Education and Research, BMBF (NewNeurons; 01GN1009B), the European Commission, and Merck KGaA, Darmstadt, Germany.	Bosnali M, 2008, BIOL CHEM, V389, P851, DOI 10.1515/BC.2008.106; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Sheng C, 2012, CELL RES, V22, P208, DOI 10.1038/cr.2011.175; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2010, INT J DEV BIOL, V54, P1713, DOI 10.1387/ijdb.103193mt; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	28	382	401	0	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					473	479		10.1016/j.stem.2012.03.003	http://dx.doi.org/10.1016/j.stem.2012.03.003			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22445518	Bronze			2022-12-25	WOS:000303079400015
J	Bassani, S; Cingolani, LA; Valnegri, P; Folci, A; Zapata, J; Gianfelice, A; Sala, C; Goda, Y; Passafaro, M				Bassani, Silvia; Cingolani, Lorenzo A.; Valnegri, Pamela; Folci, Alessandra; Zapata, Jonathan; Gianfelice, Antonella; Sala, Carlo; Goda, Yukiko; Passafaro, Maria			The X-Linked Intellectual Disability Protein TSPAN7 Regulates Excitatory Synapse Development and AMPAR Trafficking	NEURON			English	Article							KINASE-C-ALPHA; ACTIVITY-DEPENDENT REGULATION; TRANSMEMBRANE 4 SUPERFAMILY; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; MENTAL-RETARDATION; RECEPTOR TRAFFICKING; TETRASPANIN PROTEINS; GLUTAMATE RECEPTORS; PICK1	Mutations in TSPAN7-a member of the tetraspanin protein superfamily are implicated in some forms of X-linked intellectual disability. Here we show that TSPAN7 overexpression promotes the formation of filopodia and dendritic spines in cultured hippocampal neurons from embryonic rats, whereas TSPAN7 silencing reduces head size and stability of spines and AMPA receptor currents. Via its C terminus, TSPAN7 interacts with the PDZ domain of protein interacting with C kinase 1 (PICK1), to regulate PICK1 and GluR2/3 association and AMPA receptor trafficking. These findings indicate that, in hippocampal neurons, TSPAN7 regulates AMPA receptor trafficking by limiting PICK1 accessibility to AMPA receptors and suggest an additional mechanism for the functional maturation of glutamatergic synapses, whose impairment is implicated in intellectual disability.	[Bassani, Silvia; Valnegri, Pamela; Folci, Alessandra; Zapata, Jonathan; Gianfelice, Antonella; Sala, Carlo; Passafaro, Maria] Univ Milan, CNR Inst Neurosci, Dept Med Pharmacol, I-20129 Milan, Italy; [Bassani, Silvia; Valnegri, Pamela; Folci, Alessandra; Passafaro, Maria] Inst Neurosci, Dulbecco Telethon Inst, CNR, I-20129 Milan, Italy; [Cingolani, Lorenzo A.; Goda, Yukiko] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Cingolani, Lorenzo A.; Goda, Yukiko] UCL, Cell Biol Unit, London WC1E 6BT, England; [Cingolani, Lorenzo A.] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Sala, Carlo] Neurol Inst, I-20133 Milan, Italy; [Sala, Carlo] Fdn Carlo Besta, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; Istituto Italiano di Tecnologia - IIT; IRCCS Istituto Neurologico Besta	Passafaro, M (corresponding author), Univ Milan, CNR Inst Neurosci, Dept Med Pharmacol, I-20129 Milan, Italy.	m.passafaro@in.cnr.it	Sala, Carlo/A-2493-2009; Cingolani, Lorenzo/J-1530-2012; Cingolani, Lorenzo A/ABH-1364-2021; Folci, Alessandra/AAB-7843-2019; Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016; Bassani, Silvia/A-7241-2012; Folci, Alessandra/ABF-8954-2021	Sala, Carlo/0000-0003-0662-9523; Cingolani, Lorenzo A/0000-0001-9538-1659; Folci, Alessandra/0000-0002-8158-118X; Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Bassani, Silvia/0000-0003-0553-7168; 	Telethon Italy [S01014TELU]; Fondazione Cariplo [2008-2318, 2009.264]; Fondazione Mariani; Telethon-Italy [GGP09196]; Italian Institute of Technology; Ministry of Health; Terdismental [16983-SAL-50]; Medical Research Council; Marie Curie Actions 7degrees Framework Programme	Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Fondazione Mariani; Telethon-Italy(Fondazione Telethon); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Ministry of Health; Terdismental; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Actions 7degrees Framework Programme	The authors thank Annalisa Gaimarri and Cecilia Gotti for the GluA2/3 column and Don Ward for help with the English. M.P. was supported by Telethon Italy (S01014TELU), Fondazione Cariplo (2008-2318), and Fondazione Mariani. C.S. was supported by Telethon-Italy Grant GGP09196, Fondazione CARIPLO Project number 2009.264, Italian Institute of Technology Seed Grant and Ministry of Health in the frame of ERA-NET NEURON. M.P. and C.S. were also supported by Terdismental 16983-SAL-50. L.A.C. and Y.G. received support from the Medical Research Council. J.Z. is supported by Marie Curie Actions 7 degrees Framework Programme: SyMBad Marie Curie (Synapse: from molecules to brain diseases) International Research and Training program 2002-2007.	Abidi FE, 2002, J MED GENET, V39, P430, DOI 10.1136/jmg.39.6.430; Arellano JI, 2007, NEUROSCIENCE, V145, P464, DOI 10.1016/j.neuroscience.2006.12.015; Arstikaitis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016998; Berditchevski F, 2001, J CELL SCI, V114, P4143; Boda B, 2002, NEUROSCIENCE, V114, P13, DOI 10.1016/S0306-4522(02)00218-X; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Boucheix C., 2001, EXPERT REV MOL MED, V2001, P1; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hanley JG, 2008, CELL ADHES MIGR, V2, P276, DOI 10.4161/cam.2.4.6510; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hosokawa Y, 1999, NEUROSCI RES, V35, P281, DOI 10.1016/S0168-0102(99)00093-0; Humeau Y, 2009, J NEUROCHEM, V109, P1, DOI 10.1111/j.1471-4159.2009.05881.x; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	49	65	67	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 22	2012	73	6					1143	1158		10.1016/j.neuron.2012.01.021	http://dx.doi.org/10.1016/j.neuron.2012.01.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445342	Green Published, Bronze			2022-12-25	WOS:000301998700012
J	Boutet, SC; Cheung, TH; Quach, NL; Liu, L; Prescott, SL; Edalati, A; Iori, K; Rando, TA				Boutet, Stephane C.; Cheung, Tom H.; Quach, Navaline L.; Liu, Ling; Prescott, Sara L.; Edalati, Abdolhossein; Iori, Kevin; Rando, Thomas A.			Alternative Polyadenylation Mediates MicroRNA Regulation of Muscle Stem Cell Function	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR PAX3; 3' UNTRANSLATED REGIONS; SATELLITE CELLS; PROGENITOR CELLS; MESSENGER-RNAS; MET RECEPTOR; EXPRESSION; DIFFERENTIATION; PROLIFERATION; MAINTENANCE	Pax3, a key myogenic regulator, is transiently expressed during activation of adult muscle stem cells, or satellite cells (SCs), and is also expressed in a subset of quiescent SCs (QSCs), but only in specific muscles. The mechanisms regulating these variations in expression are not well understood. Here we show that Pax3 levels are regulated by miR-206, a miRNA with a previously demonstrated role in myogenic differentiation. In most QSCs and activated SCs, miR-206 expression suppresses Pax3 expression. Paradoxically, QSCs that express high levels of Pax3 also express high levels of miR-206. In these QSCs, Pax3 transcripts are subject to alternative polyadenylation, resulting in transcripts with shorter 3' untranslated regions (3'UTRs) that render them resistant to regulation by miR-206. Similar alternate polyadenylation of the Pax3 transcript also occurs in myogenic progenitors during development. Our findings may reflect a general role of alternative polyadenylation in circumventing miRNA-mediated regulation of stem cell function.	[Boutet, Stephane C.; Cheung, Tom H.; Quach, Navaline L.; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Boutet, Stephane C.; Cheung, Tom H.; Quach, Navaline L.; Liu, Ling; Prescott, Sara L.; Edalati, Abdolhossein; Iori, Kevin; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.] VA Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] VA Palo Alto Hlth Care Syst, RR&D Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu		Prescott, Sara/0000-0003-4348-9021; Rando, Thomas/0000-0001-5843-8564	Muscular Dystrophy Association; Glenn Foundation for Medical Research; NIH [P01 AG036695, R01 AG023806, R01 AR056849, R01 AR062185, DP1 OD000392]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056849, R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R01AG023806, R37AG023806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000392] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Glenn Foundation for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. B. Olwin for generously providing the chicken anti-Syndecan4 antibody. This work was supported by a Muscular Dystrophy Association Development Grant to S.C.B., and by grants from the Glenn Foundation for Medical Research, the NIH (P01 AG036695, R01 AG023806 [R37 MERIT Award], R01 AR056849, R01 AR062185, and DP1 OD000392 [an NIH Director's Pioneer Award]), and the Department of Veterans Affairs (Merit Review) to T.A.R.	Barber TD, 1999, GENE, V237, P311, DOI 10.1016/S0378-1119(99)00339-X; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOBER E, 1994, DEVELOPMENT, V120, P603; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Boutet SC, 2010, MOL CELL, V40, P749, DOI 10.1016/j.molcel.2010.09.029; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Goljanek-Whysall K, 2011, P NATL ACAD SCI USA, V108, P11936, DOI 10.1073/pnas.1105362108; GOULDING M, 1994, DEVELOPMENT, V120, P957; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Parker CJ, 2004, INT J CANCER, V108, P314, DOI 10.1002/ijc.11527; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pritchard C, 2003, GENE, V305, P61, DOI 10.1016/S0378-1119(02)01186-1; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tian HJ, 2005, MOL BRAIN RES, V137, P174, DOI 10.1016/j.molbrainres.2005.03.001; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Wang QY, 2006, CANCER RES, V66, P8574, DOI 10.1158/0008-5472.CAN-06-0947; Winter J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-105; Yang XM, 1996, DEVELOPMENT, V122, P2163; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	45	110	116	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					327	336		10.1016/j.stem.2012.01.017	http://dx.doi.org/10.1016/j.stem.2012.01.017			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385659	Green Accepted, Bronze			2022-12-25	WOS:000301466500013
J	Kumamoto, N; Gu, Y; Wang, J; Janoschka, S; Takemaru, KI; Levine, J; Ge, SY				Kumamoto, Natsuko; Gu, Yan; Wang, Jia; Janoschka, Stephen; Takemaru, Ken-Ichi; Levine, Joel; Ge, Shaoyu			A role for primary cilia in glutamatergic synaptic integration of adult-born neurons	NATURE NEUROSCIENCE			English	Article							NEWLY GENERATED NEURONS; BETA-CATENIN; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; PROGENITOR POOL; BRAIN; MORPHOGENESIS; DISEASE; MALFORMATION; MECHANISMS	The sequential synaptic integration of adult-born neurons has been widely examined in rodents, but the mechanisms regulating the integration remain largely unknown. The primary cilium, a microtubule-based signaling center, is essential for vertebrate development, including the development of the CNS. We examined the assembly and function of the primary cilium in the synaptic integration of adult-born mouse hippocampal neurons. Primary cilia were absent in young adult-born neurons, but assembled precisely at the stage when newborn neurons approach their final destination, further extend dendrites and form synapses with entorhinal cortical projections. Conditional deletion of cilia from adult-born neurons induced severe defects in dendritic refinement and synapse formation. Deletion of primary cilia led to enhanced Wnt and beta-catenin signaling, which may account for these developmental defects. Taken together, our findings identify the assembly of primary cilia as a critical regulatory event in the dendritic refinement and synaptic integration of adult-born neurons.	[Kumamoto, Natsuko; Gu, Yan; Wang, Jia; Janoschka, Stephen; Levine, Joel; Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Janoschka, Stephen] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Takemaru, Ken-Ichi] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ge, SY (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	sge@notes.cc.sunysb.edu	Core, Vector/CAF-4832-2022; Gu, Yan/K-4702-2017	Gu, Yan/0000-0001-5562-6279	US National Institutes of Health [NS065915, HL107493]; American Heart Association [0930067N]; State University of New York Research Excellence in Academic Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493, R56HL107493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); State University of New York Research Excellence in Academic Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Halegoua, M. Kernan, G. Matthews, L. Role and H. Song for critical comments, and F.-Q. Li, J. Rodriguez and Q. Xiong for technical support. This work was supported by grants from the US National Institutes of Health (NS065915 to S. G. and HL107493 to K.-I.T.), the American Heart Association (0930067N to S.G.) and the State University of New York Research Excellence in Academic Health (to S.G.).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brault V, 2001, DEVELOPMENT, V128, P1253; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Li FQ, 2010, MOL BIOL CELL, V21, P311, DOI 10.1091/mbc.E09-05-0437; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Masdeu C, 2007, NEUROREPORT, V18, P395, DOI 10.1097/WNR.0b013e32801421ce; McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ocbina PJR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006839; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	118	124	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					399	U79		10.1038/nn.3042	http://dx.doi.org/10.1038/nn.3042			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22306608	Green Accepted, Green Published			2022-12-25	WOS:000300793100013
J	Wills, ZP; Mandel-Brehm, C; Mardinly, AR; McCord, AE; Giger, RJ; Greenberg, ME				Wills, Zachary P.; Mandel-Brehm, Caleigh; Mardinly, Alan R.; McCord, Alejandra E.; Giger, Roman J.; Greenberg, Michael E.			The Nogo Receptor Family Restricts Synapse Number in the Developing Hippocampus	NEURON			English	Article							DENDRITIC SPINE; NMDA RECEPTOR; MYELIN; INHIBITION; PLASTICITY; RHO; TRANSCRIPTION; GLYCOPROTEIN; REGENERATION	Neuronal development is characterized by a period of exuberant synaptic growth that is well studied. However, the mechanisms that restrict this process are less clear. Here we demonstrate that glycosylphosphatidylinositol-anchored cell-surface receptors of the Nogo Receptor family (NgR1, NgR2, and NgR3) restrict excitatory synapse formation. Loss of any one of the NgRs results in an increase in synapse number in vitro, whereas loss of all three is necessary for abnormally elevated synaptogenesis in vivo. We show that NgR1 inhibits the formation of new synapses in the postsynaptic neuron by signaling through the coreceptor TROY and RhoA. The NgR family is downregulated by neuronal activity, a response that may limit NgR function and facilitate activity-dependent synapse development. These findings suggest that NgR1, a receptor previously shown to restrict axon growth in the adult, also functions in the dendrite as a barrier that limits excitatory synapse number during brain development.	[Wills, Zachary P.; Mandel-Brehm, Caleigh; Mardinly, Alan R.; McCord, Alejandra E.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wills, Zachary P.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Giger, Roman J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Giger, Roman J.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu		mandel-brehm, caleigh/0000-0001-7764-6529; Wills, Zachary/0000-0001-9822-6742; Mardinly, Alan/0000-0001-9891-6719	National Institute of Neurological Disorders and Stroke [RO1 5R01NS045500]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Mark Wessels and Christina G. Kane for general technical assistance; Sonia Cohen and Paul Greer for preparation of seizure and enriched environment samples, respectively; Athar Malik for reconstructing the shCON RNAi construct targeting firefly luciferase; Marc Tessier-Lavigne for the NgR1<SUP>-/-</SUP> mice; Zhigang He for WTNgR1, DNNgR1, and WTTROY expression constructs; M. Gee and P. Zhang for assistance with mouse colony management; Sara Vasquez for assistance with neuronal cell cultures; Jesse Gray, T.K. Kim, and David Harmin for RNAseq data (Kim et al., 2010); the MRDDRC Imaging Core (L. Bu); the HMS EM facility (Maria Ericsson); Eric Griffith and Ivo Spiegel for help editing the manuscript; and Sarah Ross for assistance in the writing of this manuscript. This work was supported by National Institute of Neurological Disorders and Stroke grant RO1 5R01NS045500 to M.E.G.	Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Niederost B, 2002, J NEUROSCI, V22, P10368; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Pradhan AD, 2010, DEV NEUROSCI-BASEL, V32, P313, DOI 10.1159/000309135; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; SHOLL DA, 1953, J ANAT, V87, P387; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Wang XX, 2002, J NEUROSCI, V22, P5505; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	34	97	106	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					466	481		10.1016/j.neuron.2011.11.029	http://dx.doi.org/10.1016/j.neuron.2011.11.029			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325200	Green Accepted, Bronze			2022-12-25	WOS:000300140600009
J	Zhang, JY; Ackman, JB; Xu, HP; Crair, MC				Zhang, Jiayi; Ackman, James B.; Xu, Hong-Ping; Crair, Michael C.			Visual map development depends on the temporal pattern of binocular activity in mice	NATURE NEUROSCIENCE			English	Article							EYE-SPECIFIC SEGREGATION; RETINAL GANGLION-CELLS; DEVELOPING RETINOTECTAL SYSTEM; OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELDS; INSTRUCTIVE ROLE; NEURONAL-ACTIVITY; WAVES; RETINOGENICULATE; CORTEX	Binocular competition is thought to drive eye-specific segregation in the developing visual system, potentially through Hebbian synaptic learning rules that are sensitive to correlations in afferent activity. Altering retinal activity can disrupt eye-specific segregation, but little is known about the temporal features of binocular activity that modulate visual map development. We used optogenetic techniques to directly manipulate retinal activity in vivo and identified a critical period before eye opening in mice when specific binocular features of retinal activity drive visual map development. Synchronous activation of both eyes disrupted segregation, whereas asynchronous stimulation enhanced segregation. The optogenetic stimulus applied was spatially homogenous; accordingly, retinotopy of ipsilateral projections was markedly perturbed, but contralateral retinotopy was unaffected or even improved. These results provide direct evidence that the synchrony and precise temporal pattern of binocular retinal activity during a critical period in development regulates eye-specific segregation and retinotopy in the developing visual system.	[Zhang, Jiayi; Ackman, James B.; Xu, Hong-Ping; Crair, Michael C.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Crair, Michael C.] Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT USA	Yale University; Yale University	Crair, MC (corresponding author), Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA.	michael.crair@yale.edu		Ackman, James/0000-0003-0802-6080; Zhang, Jiayi/0000-0002-1575-0723	US National Institutes of Health [P30 EY000785, R01 EY015788, R01 EY015788S]; Research to Prevent Blindness; Brown-Coxe Fellowship; NATIONAL EYE INSTITUTE [R01EY001578, R01EY015788, P30EY000785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Brown-Coxe Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Crair laboratory for comments on the manuscript, J. Cardin and M. Higley for experimental guidance and Y. Zhang for technical help. This work was supported by US National Institutes of Health grants P30 EY000785, R01 EY015788 and R01 EY015788S to M.C.C. and by a Research to Prevent Blindness Challenge Grant to the Department of Ophthalmology & Visual Sciences. J.Z. was supported by a Brown-Coxe Fellowship. M.C.C. also thanks the family of W. Ziegler III for their support.	ALTMANN L, 1987, J NEUROPHYSIOL, V58, P965, DOI 10.1152/jn.1987.58.5.965; [Anonymous], [No title captured]; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Butts Daniel A, 2010, Front Synaptic Neurosci, V2, P30, DOI 10.3389/fnsyn.2010.00030; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Demas JA, 2012, DEV NEUROBIOL, V72, P537, DOI 10.1002/dneu.20880; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Faguet J, 2009, J NEUROPHYSIOL, V101, P855, DOI 10.1152/jn.90893.2008; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Hayakawa I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011001; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kastanenka KV, 2010, J NEUROSCI, V30, P10575, DOI 10.1523/JNEUROSCI.2773-10.2010; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Koch SM, 2011, NEURON, V71, P235, DOI 10.1016/j.neuron.2011.05.045; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; SHATZ CJ, 1983, J NEUROSCI, V3, P482; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Xu HP, 2010, NEURON, V65, P503, DOI 10.1016/j.neuron.2010.01.035	49	95	96	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					298	307		10.1038/nn.3007	http://dx.doi.org/10.1038/nn.3007			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179110	Green Accepted			2022-12-25	WOS:000299603500022
J	Brickley, SG; Mody, I				Brickley, Stephen G.; Mody, Istvan			Extrasynaptic GABA(A) Receptors: Their Function in the CNS and Implications for Disease	NEURON			English	Review							CEREBELLAR GRANULE CELLS; HIPPOCAMPAL PYRAMIDAL NEURONS; GABAERGIC SYNAPTIC-TRANSMISSION; AMINOBUTYRIC ACID(A) RECEPTORS; SUBUNIT-CONTAINING RECEPTORS; MEDIATED TONIC INHIBITION; RAT SOMATOSENSORY CORTEX; THALAMIC RELAY NEURONS; SLOW-WAVE SLEEP; DELTA-SUBUNIT	Over the past two decades, research has identified extrasynaptic GABA(A) receptor populations that enable neurons to sense the low ambient GABA concentrations present in the extracellular space in order to generate a form of tonic inhibition not previously considered in studies of neuronal excitability. The importance of this tonic inhibition in regulating states of consciousness is highlighted by the fact that extrasynaptic GABA(A) receptors (GABA(A)Rs) are believed to be key targets for anesthetics, sleep-promoting drugs, neurosteroids, and alcohol. The neurosteroid sensitivity of these extrasynaptic GABA(A)Rs may explain their importance in stress-, ovarian cycle-, and pregnancy-related mood disorders. Moreover, disruptions in network dynamics associated with schizophrenia, epilepsy, and Parkinson's disease may well involve alterations in the tonic GABA(A)R-mediated conductance. Extrasynaptic GABA(A)Rs may therefore present a therapeutic target for treatment of these diseases, with the potential to enhance cognition and aid post-stroke functional recovery.	[Brickley, Stephen G.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	Imperial College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brickley, SG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, S Kensington Campus, London SW7 2AZ, England.	s.brickley@imperial.ac.uk		Brickley, Stephen/0000-0002-0930-7346	Wellcome Trust [WT094211MA]; MRC [G0501584]; NIH [NS030549, MH076994]; Coelho Endowment; MRC [G0901892, G0800506] Funding Source: UKRI; Medical Research Council [G0800506, G0501584, G0901892] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS030549] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coelho Endowment; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S.G.B.'s research in this area is currently funded by the Wellcome Trust (WT094211MA) and the MRC (G0501584). I.M.'s research is supported by the NIH (NS030549 and MH076994) and the Coelho Endowment.	Ade KK, 2008, J NEUROSCI, V28, P1185, DOI 10.1523/JNEUROSCI.3908-07.2008; Agnati LF, 2010, BRAIN RES REV, V64, P137, DOI 10.1016/j.brainresrev.2010.03.003; Anton RF, 2011, AM J PSYCHIAT, V168, P709, DOI 10.1176/appi.ajp.2011.10101436; Atack JR, 2010, PHARMACOL THERAPEUT, V125, P11, DOI 10.1016/j.pharmthera.2009.09.001; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Ballard TM, 2009, PSYCHOPHARMACOLOGY, V202, P207, DOI 10.1007/s00213-008-1357-7; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Beghi E., 2010, ADV NEUROL DISORD, V3, P85; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Belelli D, 2003, J NEUROSCI, V23, P10013; BENARI Y, 1994, PROG BRAIN RES, V102, P261; Biagini G, 2010, CURR OPIN NEUROL, V23, P170, DOI 10.1097/WCO.0b013e32833735cf; Birnir B, 2000, J MEMBRANE BIOL, V174, P21, DOI 10.1007/s002320001028; BLISS TV, 1970, J PHYSL, V207, P61; Boehm SL, 2006, EUR J PHARMACOL, V541, P158, DOI 10.1016/j.ejphar.2006.02.054; Borghese CM, 2006, J PHARMACOL EXP THER, V319, P208, DOI 10.1124/jpet.106.104406; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Bright DP, 2011, J NEUROSCI, V31, P753, DOI 10.1523/JNEUROSCI.2996-10.2011; BROWN DA, 1979, J PHYSIOL-PARIS, V75, P667; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chambers MS, 2004, J MED CHEM, V47, P5829, DOI 10.1021/jm040863t; Chaudhuri KR, 2008, J NEUROL, V255, P33, DOI 10.1007/s00415-008-5006-1; Chiron C, 2011, NAT REV NEUROL, V7, P189, DOI 10.1038/nrneurol.2011.25; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Collinson N, 2002, J NEUROSCI, V22, P5572; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Dawson GR, 2006, J PHARMACOL EXP THER, V316, P1335, DOI 10.1124/jpet.105.092320; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Drasbek KR, 2007, J NEUROPHYSIOL, V97, P2293, DOI 10.1152/jn.00651.2006; Drasbek KR, 2006, CEREB CORTEX, V16, P1134, DOI 10.1093/cercor/bhj055; Ehrenberg B, 2000, NEUROLOGY, V54, pS33; Errington AC, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/790590; FARIELLO RG, 1987, NEUROPHARMACOLOGY, V26, P161, DOI 10.1016/0028-3908(87)90204-8; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Faulhaber J, 1997, PSYCHOPHARMACOLOGY, V130, P285, DOI 10.1007/s002130050241; Feng Y, 2010, GENES BRAIN BEHAV, V9, P668, DOI 10.1111/j.1601-183X.2010.00598.x; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Hadley SH, 2007, J PHYSIOL-LONDON, V581, P1001, DOI 10.1113/jphysiol.2007.132886; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; HARRISON NL, 1984, BRAIN RES, V323, P287, DOI 10.1016/0006-8993(84)90299-3; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Jia F, 2008, J PHARMACOL EXP THER, V326, P475, DOI 10.1124/jpet.108.139303; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x; Katayama S, 2007, ANESTH ANALG, V104, P1422, DOI 10.1213/01.ane.0000261519.04083.3e; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kekesi KA, 1997, NEUROREPORT, V8, P1183, DOI 10.1097/00001756-199703240-00025; Kirmse K, 2008, J PHYSIOL-LONDON, V586, P5665, DOI 10.1113/jphysiol.2008.161943; KISH SJ, 1986, ANN NEUROL, V20, P26, DOI 10.1002/ana.410200106; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Knust H, 2009, BIOORG MED CHEM LETT, V19, P5940, DOI 10.1016/j.bmcl.2009.08.053; Korpi ER, 2007, ALCOHOL, V41, P163, DOI 10.1016/j.alcohol.2007.03.007; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Levy LM, 2002, ANN NEUROL, V52, P755, DOI 10.1002/ana.10372; Liang J, 2007, J NEUROSCI, V27, P12367, DOI 10.1523/JNEUROSCI.2786-07.2007; Linden AM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00003; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Maldonado-Aviles JG, 2009, AM J PSYCHIAT, V166, P450, DOI 10.1176/appi.ajp.2008.08101484; Maneuf YP, 2003, CELL MOL LIFE SCI, V60, P742, DOI 10.1007/s00018-003-2108-x; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Markwardt SJ, 2011, NAT NEUROSCI, V14, P1407, DOI 10.1038/nn.2935; Martin LJ, 2009, BIOCHEM SOC T, V37, P1334, DOI 10.1042/BST0371334; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Mulley JC, 2005, HUM MOL GENET, V14, pR243, DOI 10.1093/hmg/ddi355; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Navarro JF, 2002, PROG NEURO-PSYCHOPH, V26, P1389, DOI 10.1016/S0278-5846(02)00305-6; Nie H, 2011, P NATL ACAD SCI USA, V108, P4459, DOI 10.1073/pnas.1016156108; NUSSER Z, 1995, J NEUROSCI, V15, P2948; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Nutt DJ, 2007, NEUROPHARMACOLOGY, V53, P810, DOI 10.1016/j.neuropharm.2007.08.008; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; Owens DF, 1999, J NEUROPHYSIOL, V82, P570, DOI 10.1152/jn.1999.82.2.570; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Perucca E, 1998, EPILEPSIA, V39, P5, DOI 10.1111/j.1528-1157.1998.tb01268.x; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P1401, DOI 10.4088/JCP.v66n1109; Porcello DM, 2003, J NEUROPHYSIOL, V89, P1378, DOI 10.1152/jn.00899.2002; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; Prut L, 2010, GENES BRAIN BEHAV, V9, P478, DOI 10.1111/j.1601-183X.2010.00575.x; Rau V, 2009, ANESTH ANALG, V109, P1816, DOI 10.1213/ANE.0b013e3181bf6ae6; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; Rewal M, 2009, J NEUROSCI, V29, P543, DOI 10.1523/JNEUROSCI.3199-08.2009; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Sanna E, 2004, J NEUROSCI, V24, P6521, DOI 10.1523/JNEUROSCI.0075-04.2004; Santhakumar V, 2010, NEUROSCIENCE, V167, P644, DOI 10.1016/j.neuroscience.2010.02.048; Santhakumar V, 2007, ALCOHOL, V41, P211, DOI 10.1016/j.alcohol.2007.04.011; Saul S., 2007, NY TIMES        0329; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Serra M, 2006, J NEUROCHEM, V98, P122, DOI 10.1111/j.1471-4159.2006.03850.x; Shen H, 2007, NAT NEUROSCI, V10, P469, DOI 10.1038/nn1868; Shen H, 2010, SCIENCE, V327, P1515, DOI 10.1126/science.1184245; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; SOLTESZ I, 1990, EUR J NEUROSCI, V2, P414, DOI 10.1111/j.1460-9568.1990.tb00434.x; Spigelman I, 2002, EPILEPSIA, V43, P3, DOI 10.1046/j.1528-1157.43.s.5.8.x; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; STERIADE M, 1993, J NEUROSCI, V13, P3284; STEWART GO, 1983, ANAESTH INTENS CARE, V11, P107, DOI 10.1177/0310057X8301100203; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tassone DM, 2007, CLIN THER, V29, P26, DOI 10.1016/j.clinthera.2007.01.013; Tokuda K, 2011, J NEUROSCI, V31, P9905, DOI 10.1523/JNEUROSCI.1660-11.2011; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; Tolman JA, 2009, EXPERT OPIN PHARMACO, V10, P3077, DOI 10.1517/14656560903451690; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VALEYEV AY, 1993, NEUROSCI LETT, V155, P199, DOI 10.1016/0304-3940(93)90707-R; Vargas-Caballero M, 2010, NEUROPHARMACOLOGY, V58, P668, DOI 10.1016/j.neuropharm.2009.11.005; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; Wafford KA, 2006, CURR OPIN PHARMACOL, V6, P30, DOI 10.1016/j.coph.2005.10.004; Wafford KA, 2008, NAT REV DRUG DISCOV, V7, P530, DOI 10.1038/nrd2464; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Winsky-Sommerer R, 2007, EUR J NEUROSCI, V25, P1893, DOI 10.1111/j.1460-9568.2007.05455.x; Winter L, 2003, ANESTH ANALG, V97, P798, DOI 10.1213/01.ANE.0000075835.73967.F3; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yamada J, 2007, CEREB CORTEX, V17, P1782, DOI 10.1093/cercor/bhl087; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; Yee BK, 2004, EUR J NEUROSCI, V20, P1928, DOI 10.1111/j.1460-9568.2004.03642.x; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zarnowska ED, 2009, J NEUROPHYSIOL, V101, P1179, DOI 10.1152/jn.91203.2008; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	163	429	439	11	186	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					23	34		10.1016/j.neuron.2011.12.012	http://dx.doi.org/10.1016/j.neuron.2011.12.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243744	Bronze, Green Accepted			2022-12-25	WOS:000299446800005
J	Burridge, PW; Keller, G; Gold, JD; Wu, JC				Burridge, Paul W.; Keller, Gordon; Gold, Joseph D.; Wu, Joseph C.			Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming	CELL STEM CELL			English	Review							PROMOTES CARDIAC DIFFERENTIATION; FUNCTIONAL-PROPERTIES; HEART REGENERATION; MOUSE FIBROBLASTS; MASTER REGULATOR; SMOOTH-MUSCLE; PROLIFERATION; MESODERM; MESP1; PROGENITORS	Cardiovascular disease is a leading cause of death worldwide. The limited capability of heart tissue to regenerate has prompted methodological developments for creating de novo cardiomyocytes, both in vitro and in vivo. Beyond uses in cell replacement therapy, patient-specific cardiomyocytes may find applications in drug testing, drug discovery, and disease modeling. Recently, approaches for generating cardiomyocytes have expanded to encompass three major sources of starting cells: human pluripotent stem cells (hPSCs), adult heart-derived cardiac progenitor cells (CPCs), and reprogrammed fibroblasts. We discuss state-of-the-art methods for generating de novo cardiomyocytes from hPSCs and reprogrammed fibroblasts, highlighting potential applications and future challenges.	[Burridge, Paul W.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Burridge, Paul W.; Wu, Joseph C.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Keller, Gordon] MaRS Ctr, Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON MG5 1L7, Canada; [Gold, Joseph D.] Geron Corp, Neurobiol & Cell Therapies Res, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Geron Corporation	Wu, JC (corresponding author), Stanford Univ, Sch Med, Dept Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	joewu@stanford.edu	Burridge, Paul Wesley/AAI-2717-2021; Wu, Joseph/H-1067-2013	Keller, Gordon/0000-0001-9309-9297; Wu, Joseph/0000-0002-6068-8041	NIH [DP2OD004437, RC1AG036142, R33HL089027]; California Institute of Regenerative Medicine [RB3-05219]; Burroughs Wellcome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036142] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge funding support from the NIH New Innovator Award DP2OD004437, RC1AG036142, R33HL089027, the California Institute of Regenerative Medicine RB3-05219, and the Burroughs Wellcome Foundation Career Award for Medical Scientists (J.C.W.). Due to space limitations, we are unable to include all of the important papers relevant to induced pluripotent stem cell derivation and application; we apologize to those investigators whose work was omitted here. Joseph Gold is an employee of Geron Corporation.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2011, NAT PROTOC, V6, P572, DOI 10.1038/nprot.2011.325; Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Boudoulas KD, 2009, DIS MODEL MECH, V2, P344, DOI 10.1242/dmm.000240; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cao F, 2009, CANCER RES, V69, P2709, DOI 10.1158/0008-5472.CAN-08-4122; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Chung HCY, 2012, STEM CELLS DEV, V21, P206, DOI 10.1089/scd.2010.0440; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; Davis RP, 2011, TRENDS MOL MED, V17, P475, DOI 10.1016/j.molmed.2011.05.001; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Denning C., 2008, DRUG DISCOV TODAY TH, V5, P223, DOI [10.1016/j.ddstr.2008.08.002, DOI 10.1016/J.DDSTR.2008.08.002]; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Gaur M, 2010, CYTOTHERAPY, V12, P807, DOI 10.3109/14653249.2010.491821; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Hudson J, 2012, STEM CELLS DEV, V21, P1513, DOI 10.1089/scd.2011.0254; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Itzhaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018037; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jang J, 2008, STEM CELLS, V26, P2782, DOI 10.1634/stemcells.2007-1053; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Josowitz R, 2011, CURR OPIN CARDIOL, V26, P223, DOI 10.1097/HCO.0b013e32834598ad; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lee YK, 2010, MOL ENDOCRINOL, V24, P1728, DOI 10.1210/me.2010-0032; Li W, 2012, HUM MOL GENET, V21, P32, DOI 10.1093/hmg/ddr435; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Martinez-Fernandez A, 2011, J CARDIOVASC TRANSL, V4, P131, DOI 10.1007/s12265-010-9250-2; Martinez-Fernandez A, 2010, J CARDIOVASC TRANSL, V3, P13, DOI 10.1007/s12265-009-9150-5; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; McDevitt TC, 2005, J MOL CELL CARDIOL, V39, P865, DOI 10.1016/j.yjmcc.2005.09.007; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nguyen PK, 2011, CIRC RES, V109, P962, DOI 10.1161/CIRCRESAHA.111.242909; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Perino MG, 2008, J MOL CELL CARDIOL, V45, P475, DOI 10.1016/j.yjmcc.2008.05.002; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Ramirez JM, 2011, STEM CELLS, V29, P1469, DOI 10.1002/stem.681; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Ren YM, 2011, J MOL CELL CARDIOL, V51, P280, DOI 10.1016/j.yjmcc.2011.04.012; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Van Hoof D, 2010, J PROTEOME RES, V9, P1610, DOI 10.1021/pr901138a; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Willems E, 2011, CIRC RES, V109, P360, DOI 10.1161/CIRCRESAHA.111.249540; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yamanaka S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003896; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	128	465	483	3	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					16	28		10.1016/j.stem.2011.12.013	http://dx.doi.org/10.1016/j.stem.2011.12.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226352	Green Accepted, Bronze			2022-12-25	WOS:000299449500008
J	Kajikawa, Y; Schroeder, CE				Kajikawa, Yoshinao; Schroeder, Charles E.			How Local Is the Local Field Potential?	NEURON			English	Article							PRIMARY AUDITORY-CORTEX; SOURCE-DENSITY ANALYSIS; RECORDED FLASH-VEP; VISUAL-CORTEX; EVOKED-POTENTIALS; CORTICAL FIELDS; EEG; RESPONSES; CAT; MONKEY	Local field potentials (LFPs) are of growing importance in neurophysiological investigations. LFPs supplement action potential recordings by indexing activity relevant to EEG, magnetoencephalographic, and hemodynamic (fMRI) signals. Recent reports suggest that LFPs reflect activity within very small domains of several hundred micrometers. We examined this conclusion by comparing LFP, current source density (CSD), and multiunit activity (MUA) signals in macaque auditory cortex. Estimated by frequency tuning bandwidths, these signals' "listening areas" differ systematically with an order of MUA < CSD < LFP. Computational analyses confirm that observed LFPs receive local contributions. Direct measurements indicate passive spread of LFPs to sites more than a centimeter from their origins. These findings appear to be independent of the frequency content of the LFP. Our results challenge the idea that LFP recordings typically integrate over extremely circumscribed local domains. Rather, LFPs appear as a mixture of local potentials with "volume conducted" potentials from distant sites.	[Kajikawa, Yoshinao; Schroeder, Charles E.] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; [Schroeder, Charles E.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Nathan Kline Institute for Psychiatric Research; Columbia University	Kajikawa, Y (corresponding author), Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA.	ykajikawa@nki.rfmh.org			National Institute of Health [K01MH082415, R01MH060358, R01DC011490]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060358, K01MH082415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011490] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants from the National Institute of Health (K01MH082415, R01MH060358, and R01DC011490).	AREZZO J, 1975, BRAIN RES, V90, P57, DOI 10.1016/0006-8993(75)90682-4; Avitan L, 2009, J NEUROPHYSIOL, V102, P3046, DOI 10.1152/jn.91143.2008; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BULLOCK TH, 1945, YALE J BIOL MED, V17, P657; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; COLE KS, 1968, MEMBRANES IONS IMPUL; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P1, DOI 10.1016/0013-4694(66)90136-2; De Ribaupierre F., 1972, NEURON, V48, P185; ECCLES JC, 1951, ELECTROEN CLIN NEURO, V3, P449, DOI 10.1016/0013-4694(51)90033-8; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2743, DOI 10.1152/jn.1998.80.5.2743; Eggermont JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020046; Freeman JZ, 1969, NEUROBIOLOGY CEREBEL, P421; Galambos R, 1941, SCIENCE, V93, P215, DOI 10.1126/science.93.2409.215; Geselowitz DB, 1998, IEEE ENG MED BIOL, V17, P128, DOI 10.1109/51.646230; GIVRE SJ, 1994, VISION RES, V34, P415, DOI 10.1016/0042-6989(94)90156-2; GIVRE SJ, 1995, VISUAL NEUROSCI, V12, P229, DOI 10.1017/S0952523800007914; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Heitz RP, 2010, J NEUROPHYSIOL, V104, P2433, DOI 10.1152/jn.00604.2010; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Ince NF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014384; Ingber L, 2011, MATH BIOSCI, V229, P160, DOI 10.1016/j.mbs.2010.12.003; Kandel A, 1997, J NEUROSCI, V17, P6783; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; KLEE MR, 1965, SCIENCE, V147, P519, DOI 10.1126/science.147.3657.519; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Kosaki H, 1997, J COMP NEUROL, V386, P304; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Kusmierek P, 2009, J NEUROPHYSIOL, V102, P1606, DOI 10.1152/jn.00167.2009; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Ledberg A, 2007, CEREB CORTEX, V17, P44, DOI 10.1093/cercor/bhj123; LEGATT AD, 1986, ELECTROEN CLIN NEURO, V64, P53, DOI 10.1016/0013-4694(86)90043-X; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LORENTE de NO R, 1947, Stud Rockefeller Inst Med Res Repr, V132, P384; Luck S.J., 2005, INTRO EVENT RELATED; Maier A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00031; Maier A, 2011, J NEUROSCI, V31, P1971, DOI 10.1523/JNEUROSCI.5300-09.2011; Marshall WH, 1937, SCIENCE, V85, P388, DOI 10.1126/science.85.2207.388; MARTIN AR, 1976, J THEOR BIOL, V59, P179, DOI 10.1016/S0022-5193(76)80031-8; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MITZDORF U, 1978, EXP BRAIN RES, V33, P371; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MITZDORF U, 1979, J COMP NEUROL, V187, P71, DOI 10.1002/cne.901870105; Mitzdorf U., 1986, EVOKED POTENTIAL, P141; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nelson MJ, 2010, J NEUROPHYSIOL, V103, P2315, DOI 10.1152/jn.00157.2010; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Norena A, 2002, HEARING RES, V166, P202, DOI 10.1016/S0378-5955(02)00329-5; NUNEZ P L, 1991, Brain Topography, V4, P151, DOI 10.1007/BF01132772; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; O'Connell MN, 2011, NEURON, V69, P805, DOI 10.1016/j.neuron.2011.01.012; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; PETERSON NN, 1995, EVOKED POTENTIAL, V96, P248, DOI 10.1016/0168-5597(95)00006-E; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; RANCK JB, 1963, EXP NEUROL, V7, P144, DOI 10.1016/S0014-4886(63)80005-9; Rasch M, 2009, J NEUROSCI, V29, P13785, DOI 10.1523/JNEUROSCI.2390-09.2009; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Schneider TR, 2011, J NEUROSCI, V31, P2502, DOI 10.1523/JNEUROSCI.6447-09.2011; SCHROEDER CE, 1992, ELECTROEN CLIN NEURO, V84, P219, DOI 10.1016/0168-5597(92)90003-T; Schroeder CE, 1995, EEG CL N SU, P55; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Srinivasan R, 2006, PROG BRAIN RES, V159, P29, DOI 10.1016/S0079-6123(06)59003-X; STEINSCHNEIDER M, 1995, BRAIN LANG, V48, P326, DOI 10.1006/brln.1995.1015; STEINSCHNEIDER M, 1992, ELECTROEN CLIN NEURO, V84, P196, DOI 10.1016/0168-5597(92)90026-8; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TENKE CE, 1993, EXP BRAIN RES, V94, P183; Ulbert T, 2004, EPILEPSIA, V45, P48, DOI 10.1111/j.0013-9580.2004.04011.x; Vaughan Jr HG, 1988, HUMAN EVENT RELATED, V3, P45; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Wang CM, 2005, J NEUROSCI, V25, P604, DOI 10.1523/JNEUROSCI.4151-04.2005; Winter WR, 2007, STAT MED, V26, P3946, DOI 10.1002/sim.2978; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	88	328	330	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					847	858		10.1016/j.neuron.2011.09.029	http://dx.doi.org/10.1016/j.neuron.2011.09.029			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153379	Bronze, Green Accepted			2022-12-25	WOS:000297971100017
J	Pestilli, F; Carrasco, M; Heeger, DJ; Gardner, JL				Pestilli, Franco; Carrasco, Marisa; Heeger, David J.; Gardner, Justin L.			Attentional Enhancement via Selection and Pooling of Early Sensory Responses in Human Visual Cortex	NEURON			English	Article							EXTRASTRIATE AREA V4; SPATIAL ATTENTION; NEURONAL-ACTIVITY; CONTRAST DISCRIMINATION; STIMULUS CONTRAST; NEURAL MECHANISMS; COVERT ATTENTION; WORKING-MEMORY; STRIATE CORTEX; TELL US	The computational processes by which attention improves behavioral performance were characterized by measuring visual cortical activity with functional magnetic resonance imaging as humans performed a contrast-discrimination task with focal and distributed attention. Focal attention yielded robust improvements in behavioral performance accompanied by increases in cortical responses. Quantitative analysis revealed that if performance were limited only by the sensitivity of the measured sensory signals, the improvements in behavioral performance would have corresponded to an unrealistically large reduction in response variability. Instead, behavioral performance was well characterized by a pooling and selection process for which the largest sensory responses, those most strongly modulated by attention, dominated the perceptual decision. This characterization predicts that highcontrast distracters that evoke large responses should negatively impact behavioral performance. We tested and confirmed this prediction. We conclude that attention enhanced behavioral performance predominantly by enabling efficient selection of the behaviorally relevant sensory signals.	[Pestilli, Franco; Carrasco, Marisa; Heeger, David J.; Gardner, Justin L.] NYU, Dept Psychol, New York, NY 10003 USA; [Pestilli, Franco; Carrasco, Marisa; Heeger, David J.; Gardner, Justin L.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Pestilli, Franco] Columbia Univ, Dept Neurosci, Mahoney Keck Ctr Brain & Behav Res, Unit 87, New York, NY 10032 USA; [Pestilli, Franco; Gardner, Justin L.] RIKEN, Brain Sci Inst, Gardner Res Unit, Wako, Saitama 3150198, Japan	New York University; New York University; Columbia University; RIKEN	Pestilli, F (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	fp2190@brain.riken.jp; justin@brain.riken.jp		Pestilli, Franco/0000-0002-2469-0494; Gardner, Justin/0000-0003-2220-5050	Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; National Eye Institute [F32-EY016260, T32-EY1393309]; National Institutes of Health [R01-MH069880, R01-EY016200, R01-EY019693]; Gardner Research Unit, RIKEN Brain Science Institute; Italian Academy for Advanced Studies in America; National Institute of Mental Health [T32-MH05174]; NATIONAL EYE INSTITUTE [F32EY016260, T32EY013933, R01EY019693, R01EY016200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069880] Funding Source: NIH RePORTER	Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gardner Research Unit, RIKEN Brain Science Institute; Italian Academy for Advanced Studies in America; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund and a National Research Service Award (NRSA) from the National Eye Institute (F32-EY016260) to J.L.G., and National Institutes of Health Grants R01-MH069880 (to D.J.H.), R01-EY016200 (to M.C.), and R01-EY019693 (to D.J.H. and M.C.). F.P. was supported by Gardner Research Unit, RIKEN Brain Science Institute, The Italian Academy for Advanced Studies in America, and training grants from the National Institute of Mental Health (T32-MH05174) and National Eye Institute (T32-EY1393309). We thank the Center for Brain Imaging at New York University for technical assistance, Aniruddha Das, Adam Kohn, and J. Anthony Movshon for helpful comments on previous versions of the manuscript, and Vince Ferrera and Brian A. Wandell for generous support and advice.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRAUN J, 1994, J NEUROSCI, V14, P554; Buracas GT, 2007, J NEUROSCI, V27, P93, DOI 10.1523/JNEUROSCI.3162-06.2007; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Foley JM, 1998, J OPT SOC AM A, V15, P1036, DOI 10.1364/JOSAA.15.001036; Gardner JL, 2005, NEURON, V47, P607, DOI 10.1016/j.neuron.2005.07.016; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Gorea A, 2001, NAT NEUROSCI, V4, P1146, DOI 10.1038/nn741; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Herrmann K, 2010, NAT NEUROSCI, V13, P1554, DOI 10.1038/nn.2669; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee J, 2010, J NEUROPHYSIOL, V104, P960, DOI 10.1152/jn.01019.2009; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Li X, 2008, P NATL ACAD SCI USA, V105, P6202, DOI 10.1073/pnas.0801390105; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Murray S.O., 2008, J VIS, V8, P21; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Palmer J, 2009, VISION RES, V49, P1045, DOI 10.1016/j.visres.2008.02.022; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pestilli F, 2009, VISION RES, V49, P1144, DOI 10.1016/j.visres.2008.09.018; Pooresmaeili A, 2010, J NEUROSCI, V30, P12701, DOI 10.1523/JNEUROSCI.1388-10.2010; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; Sergent C, 2011, J COGNITIVE NEUROSCI, V23, P1921, DOI 10.1162/jocn.2010.21553; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Thiele A, 2009, CEREB CORTEX, V19, P2970, DOI 10.1093/cercor/bhp070; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Yigit-Elliott S, 2011, PSYCHOL SCI, V22, P771, DOI 10.1177/0956797611407927; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884	58	127	127	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					832	846		10.1016/j.neuron.2011.09.025	http://dx.doi.org/10.1016/j.neuron.2011.09.025			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153378	Bronze, Green Accepted			2022-12-25	WOS:000297971100016
J	Wang, CC; Held, RG; Chang, SC; Yang, LL; Delpire, E; Ghosh, A; Hall, BJ				Wang, Chih-Chieh; Held, Richard G.; Chang, Shiao-Chi; Yang, Lingling; Delpire, Eric; Ghosh, Anirvan; Hall, Benjamin J.			A Critical Role for GluN2B-Containing NMDA Receptors in Cortical Development and Function	NEURON			English	Article							D-ASPARTATE RECEPTOR; PROTEIN-KINASE-II; GTPASE-ACTIVATING PROTEIN; NR2B SUBUNIT; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; SPINE DENSITY; MICE LACKING; HIPPOCAMPAL; SYNAPSES	The subunit composition of N-methyl D-aspartate receptors (NMDARs) is tightly regulated during cortical development. NMDARs are initially dominated by GluN2B (NR2B), whereas GluN2A (NR2A) incorporation increases after birth. The function of GluN2B-containing NMDARs during development, however, is incompletely understood. We generated a mouse in which we genetically replaced GluN2B with GluN2A (2B -> 2A). Although this manipulation restored NMDAR-mediated currents at glutamatergic synapses, it did not rescue GluN2B loss of function. Protein translation-dependent homeostatic synaptic plasticity is occluded in the absence of GluN2B, and AMPA receptor contribution is enriched at excitatory cortical synapses. Our experiments indicate that specificity of GluN2B-mediated signaling is due to its unique interaction with the protein effector alpha calcium-calmodulin kinase II and the regulation of the mTOR pathway. Homozygous 2B -> 2A mice exhibited high rates of lethality, suppressed feeding, and depressed social exploratory behavior. These experiments indicate that GluN2B-containing NMDARs activate unique cellular processes that cannot be rescued by replacement with GluN2A.	[Wang, Chih-Chieh; Held, Richard G.; Hall, Benjamin J.] Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA; [Yang, Lingling; Hall, Benjamin J.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Chang, Shiao-Chi] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Delpire, Eric] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; [Ghosh, Anirvan] Univ Calif San Diego, Neurobiol Program, La Jolla, CA 92093 USA	Tulane University; Tulane University; Tulane University; Vanderbilt University; University of California System; University of California San Diego	Hall, BJ (corresponding author), Tulane Univ, Neurosci Program, 2013 Percival Stern Hall,6400 Freret St, New Orleans, LA 70118 USA.	benhall@tulane.edu		Held, Richard/0000-0001-8231-0341	Integrated Neuroscience Initiative on Alcoholism [AA13514]; National Alliance for Research on Schizophrenia and Depression; National Science Foundation (NSF CAREER) [065374]; Tulane School of Science and Engineering;  [T286D];  [T286A]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013514] Funding Source: NIH RePORTER	Integrated Neuroscience Initiative on Alcoholism; National Alliance for Research on Schizophrenia and Depression(NARSAD); National Science Foundation (NSF CAREER)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Tulane School of Science and Engineering; ; ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank R. Huganir (Johns Hopkins University) for GluN2A cDNA, A. Barris (University of Washington) for CaMKII RSQD cDNA, G. Rumbaugh (Scripps Research Institute Florida) for SynGAP cDNA, G. Patrick (University of California, San Diego) for T286D and T286A CaMKII cDNAs, and G. Westbrook (Oregon Health and Science University Vollum Institute) for GluN2B KO mice. The GluN2B conditional KO mice were generated by the Integrated Neuroscience Initiative on Alcoholism (INIA-Stress award AA13514 to E.D.). This work was supported by the National Alliance for Research on Schizophrenia and Depression (Independent Investigator Award to A.G.), the National Science Foundation (NSF CAREER award 065374 to B.J.H.), and the Tulane School of Science and Engineering.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Almeida SS, 2001, PHYSIOL BEHAV, V74, P45, DOI 10.1016/S0031-9384(01)00554-6; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Belsham B, 2001, HUM PSYCHOPHARM CLIN, V16, P139, DOI 10.1002/hup.279; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; FONG YL, 1989, J BIOL CHEM, V264, P16759; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Speed HE, 2009, HIPPOCAMPUS, V19, P187, DOI 10.1002/hipo.20496; Stefani MR, 2005, BIOL PSYCHIAT, V57, P433, DOI 10.1016/j.biopsych.2004.11.031; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tovar KR, 2000, J NEUROPHYSIOL, V83, P616, DOI 10.1152/jn.2000.83.1.616; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985	60	125	130	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					789	805		10.1016/j.neuron.2011.09.023	http://dx.doi.org/10.1016/j.neuron.2011.09.023			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153375	Bronze			2022-12-25	WOS:000297971100013
J	Wang, T; Chen, KS; Zeng, XM; Yang, JG; Wu, Y; Shi, X; Qin, BM; Zeng, LW; Esteban, MA; Pan, GJ; Pei, DQ				Wang, Tao; Chen, Keshi; Zeng, Xiaoming; Yang, Jianguo; Wu, Yun; Shi, Xi; Qin, Baoming; Zeng, Lingwen; Esteban, Miguel Angel; Pan, Guangjin; Pei, Duanqing			The Histone Demethylases Jhdm1a/1b Enhance Somatic Cell Reprogramming in a Vitamin-C-Dependent Manner	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; MOUSE FIBROBLASTS; SELF-RENEWAL; INDUCTION; WIDESPREAD; GENERATION; OCT4; GENE; EXPRESSION	Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) resets the epigenome to an embryonic-like state. Vitamin C enhances the reprogramming process, but the underlying mechanisms are unclear. Here we show that the histone demethylases Jhdm1a/1b are key effectors of somatic cell reprogramming downstream of vitamin C. We first observed that vitamin C induces H3K36me2/3 demethylation in mouse embryonic fibroblasts in culture and during reprogramming. We then identified Jhdm1a/1b, two known vitamin-C-dependent H3K36 demethylases, as potent regulators of reprogramming through gain- and loss-of-function approaches. Furthermore, we found that Jhdm1b accelerates cell cycle progression and suppresses cell senescence during reprogramming by repressing the Ink4/Arf locus. Jhdm1b also cooperates with Oct4 to activate the microRNA cluster 302/367, an integral component of the pluripotency machinery. Our results therefore reveal a role for H3K36me2/3 in cell fate determination and establish a link between histone demethylases and vitamin-C-induced reprogramming.	[Wang, Tao; Chen, Keshi; Zeng, Xiaoming; Yang, Jianguo; Wu, Yun; Shi, Xi; Qin, Baoming; Zeng, Lingwen; Esteban, Miguel Angel; Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Tao; Chen, Keshi; Zeng, Xiaoming; Yang, Jianguo; Wu, Yun; Shi, Xi; Qin, Baoming; Zeng, Lingwen; Esteban, Miguel Angel; Pan, Guangjin; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Hlth, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences	Pei, DQ (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Qin, Baoming/G-1553-2015; wang, tom/M-6808-2014; Chen, Keshi/AAE-4600-2020	Qin, Baoming/0000-0001-7652-161X; Chen, Keshi/0000-0003-0402-4555	Ministry of Science and Technology [2009CB941102, 2011CB965200, 2011CBA01106]; Chinese Academy of Sciences [XDA01020401, XDA01020106, XDA01020202, XDA01020404]; National Natural Science Foundation of China [90813033]; National S&T Major Special Project on Major New Drug Innovation [2011ZX09102-010]; Bureau of Science and Technology of Guangzhou Municipality [2010U1-E00521]; Chinese Academy of Sciences/SAFEA	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project on Major New Drug Innovation; Bureau of Science and Technology of Guangzhou Municipality; Chinese Academy of Sciences/SAFEA(Chinese Academy of Sciences)	We thank Eryun Zhong, Baojian Liao, Yanting Xue, and Chunlan Chen, along with other members of our laboratory for their support. This work was funded in part by grants from the Ministry of Science and Technology 973 program (2009CB941102, 2011CB965200, and 2011CBA01106), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant No. XDA01020401, XDA01020106, XDA01020202, and XDA01020404); the National Natural Science Foundation of China (90813033), the Ministry of Science and Technology International Technology Cooperation Program (2010DFB30430), the National S&T Major Special Project on Major New Drug Innovation (Grant No.2011ZX09102-010), the Bureau of Science and Technology of Guangzhou Municipality (2010U1-E00521), and the Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams (to D.P.). We thank Dr. Degui Chen of Shanghai Institute of Biochemistry and Cell Biology for discussions and help in the early phase of this work.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Knowles HJ, 2003, CANCER RES, V63, P1764; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; PETERKOFSKY B, 1991, AM J CLIN NUTR, V54, pS1135, DOI 10.1093/ajcn/54.6.1135s; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; ROBERTSON WV, 1953, J BIOL CHEM, V201, P689; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILSON CWM, 1973, LANCET, V1, P1058; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SQ, 2011, HUM MOL GENET, V20, P3176, DOI 10.1093/hmg/ddr223; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	52	328	362	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					575	587		10.1016/j.stem.2011.10.005	http://dx.doi.org/10.1016/j.stem.2011.10.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22100412	Bronze			2022-12-25	WOS:000297895000017
J	Makuch, L; Volk, L; Anggono, V; Johnson, RC; Yu, YL; Duning, K; Kremerskothen, J; Xia, J; Takamiya, K; Huganir, RL				Makuch, Lauren; Volk, Lenora; Anggono, Victor; Johnson, Richard C.; Yu, Yilin; Duning, Kerstin; Kremerskothen, Joachim; Xia, Jun; Takamiya, Kogo; Huganir, Richard L.			Regulation of AMPA Receptor Function by the Human Memory-Associated Gene KIBRA	NEURON			English	Article							DOMAIN-CONTAINING PROTEIN; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; EPISODIC MEMORY; KINASE-C; PICK1; TRAFFICKING; EXPRESSION; DROSOPHILA; GLUR2	KIBRA has recently been identified as a gene associated with human memory performance. Despite the elucidation of the role of KIBRA in several diverse processes in nonneuronal cells, the molecular function of KIBRA in neurons is unknown. We found that KIBRA directly binds to the protein interacting with C-kinase 1 (PICK1) and forms a complex with alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors (AMPARs), the major excitatory neurotransmitter receptors in the brain. KIBRA knockdown accelerates the rate of AM PAR recycling following N-methyl-D-aspartate receptor-induced internalization. Genetic deletion of KIBRA in mice impairs both long-term depression and long-term potentiation at hippocampal Schaffer collateral-CA1 synapses. Moreover, KIBRA knockout mice have severe deficits in contextual fear learning and memory. These results indicate that KIBRA regulates higher brain function by regulating AMPAR trafficking and synaptic plasticity.	[Makuch, Lauren; Volk, Lenora; Anggono, Victor; Johnson, Richard C.; Yu, Yilin; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Duning, Kerstin; Kremerskothen, Joachim] Univ Hosp Munster, Dept Mol Nephrol, D-48149 Munster, Germany; [Xia, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Takamiya, Kogo] Miyazaki Univ, Fac Med, Dept Integrat Physiol, Miyazaki 8891692, Japan	Howard Hughes Medical Institute; Johns Hopkins University; University of Munster; Hong Kong University of Science & Technology; University of Miyazaki	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu	Anggono, Victor/J-2750-2013; Xia, Jun/C-7234-2009	Anggono, Victor/0000-0002-4062-4884; Xia, Jun/0000-0001-9308-2188; Takamiya, Kogo/0000-0001-7240-6307; Volk, Lenora/0000-0002-9074-4091	National Institute of Health [MH64856, NS36715, T32MH15330]; Howard Hughes Medical Institute; International Human Frontier Science Program [LT00399/2008-L]; Australian National Health and Medical Research Council [477108]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015330, R01MH064856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); International Human Frontier Science Program(Human Frontier Science Program); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Health (MH64856 and NS36715) and the Howard Hughes Medical Institute (to R.L.H.). V.A. is supported by fellowships from the International Human Frontier Science Program (LT00399/2008-L) and the Australian National Health and Medical Research Council (ID. 477108). L.V. is supported by a training grant from the National Institute of Health (T32MH15330). We thank Min Dai and Monica Coulter for technical support. Under a licensing agreement between Millipore Corporation and The Johns Hopkins University, R.L.H. is entitled to a share of royalties received by the University on sales of products described in this article. R.L.H. is a paid consultant to Millipore Corporation. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict-of-interest policies.	Almeida OP, 2008, J CELL MOL MED, V12, P1672, DOI 10.1111/j.1582-4934.2008.00229.x; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Clem RL, 2010, J NEUROSCI, V30, P6360, DOI 10.1523/JNEUROSCI.6276-09.2010; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Johannsen S, 2008, NEUROSCIENCE, V155, P1165, DOI 10.1016/j.neuroscience.2008.06.054; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mao LF, 2010, P NATL ACAD SCI USA, V107, P19038, DOI 10.1073/pnas.1013494107; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Smith DR, 2007, LEARN MEMORY, V14, P597, DOI 10.1101/lm.614807; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Takamiya K, 2008, J NEUROSCI, V28, P5752, DOI 10.1523/JNEUROSCI.0654-08.2008; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012	39	91	93	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1022	1029		10.1016/j.neuron.2011.08.017	http://dx.doi.org/10.1016/j.neuron.2011.08.017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943600	Green Accepted, Bronze			2022-12-25	WOS:000295556500008
J	Keck, T; Scheuss, V; Jacobsen, RI; Wierenga, CJ; Eysel, UT; Bonhoeffer, T; Hubener, M				Keck, Tara; Scheuss, Volker; Jacobsen, R. Irene; Wierenga, Corette J.; Eysel, Ulf T.; Bonhoeffer, Tobias; Huebener, Mark			Loss of Sensory Input Causes Rapid Structural Changes of Inhibitory Neurons in Adult Mouse Visual Cortex	NEURON			English	Article							ACTIVITY-DEPENDENT REGULATION; CAT STRIATE CORTEX; LONG-TERM; FUNCTIONAL REORGANIZATION; HIPPOCAMPAL-NEURONS; IN-VIVO; RETINAL LESIONS; RAT HIPPOCAMPUS; SPINE GROWTH; AREA 17	A fundamental property of neuronal circuits is the ability to adapt to altered sensory inputs. It is well established that the functional synaptic changes underlying this adaptation are reflected by structural modifications in excitatory neurons. In contrast, the degree to which structural plasticity in inhibitory neurons accompanies functional changes is less clear. Here, we use two-photon imaging to monitor the fine structure of inhibitory neurons in mouse visual cortex after deprivation induced by retinal lesions. We find that a subset of inhibitory neurons carry dendritic spines, which form glutamatergic synapses. Removal of visual input correlates with a rapid and lasting reduction in the number of inhibitory cell spines. Similar to the effects seen for dendritic spines, the number of inhibitory neuron boutons dropped sharply after retinal lesions. Together, these data suggest that structural changes in inhibitory neurons may precede structural changes in excitatory circuitry, which ultimately result in functional adaptation following sensory deprivation.	[Keck, Tara; Scheuss, Volker; Jacobsen, R. Irene; Wierenga, Corette J.; Bonhoeffer, Tobias; Huebener, Mark] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Eysel, Ulf T.] Ruhr Univ Bochum, Dept Expt Neurophysiol, D-44780 Bochum, Germany	Max Planck Society; Ruhr University Bochum	Hubener, M (corresponding author), Max Planck Inst Neurobiol, Am Klopferspitz 18, D-82152 Martinsried, Germany.	mark@neuro.mpg.de	Volker, Scheuss/G-7846-2015; Jacobsen, Ragnhild Irene/ABE-4300-2020; Wierenga, Corette J./H-2749-2019; Bonhoeffer, Tobias/B-9481-2009	Jacobsen, Ragnhild Irene/0000-0001-9521-5044; Wierenga, Corette J./0000-0001-9073-4099; Keck, Tara/0000-0001-6623-1037; Scheuss, Volker/0000-0002-0659-3228; Eysel, Ulf/0000-0001-6087-957X; Bonhoeffer, Tobias/0000-0001-7897-6634	Max Planck Society; Amgen Foundation; Marie Curie grant IEF [40528]; Marie Curie grant ERG [256284]; International Human Frontier Science Program Organization; German Research Foundation [SFB 874, SFB 870]; European Community [223326]; Medical Research Council [G0901899B, G0900499] Funding Source: researchfish; MRC [G0900499] Funding Source: UKRI	Max Planck Society(Max Planck SocietyFoundation CELLEX); Amgen Foundation(Amgen); Marie Curie grant IEF; Marie Curie grant ERG; International Human Frontier Science Program Organization(Human Frontier Science Program); German Research Foundation(German Research Foundation (DFG)); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Max Planck Society (T.K., VS., R.I.J., C.J.W., TB., and M.H.), the Amgen Foundation (R.I.J.), Marie Curie grants IEF #40528 and ERG #256284 (C.J.W.), the International Human Frontier Science Program Organization (V.S.), and the German Research Foundation (U.T.E.: SFB 874; M.H.: SFB 870). The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP2007-2013] under grant agreement no 223326 (M.H.). The transgenic mice were kindly provided by Gabor Szabo (Budapest, Hungary). We would like to thank Valentin Stein and Alexander J. Krupp for assistance with electrophysiology data analysis, and Volker Staiger and Claudia Huber for technical assistance.	Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Calford MB, 2003, J NEUROSCI, V23, P6434; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EYSEL UT, 1982, NATURE, V299, P442, DOI 10.1038/299442a0; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hu TT, 2009, CEREB CORTEX, V19, P2982, DOI 10.1093/cercor/bhp069; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kirkwood Alfredo, 1995, Biological Research, V28, P73; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Kreczko A, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/415135; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Martinez A, 1999, J COMP NEUROL, V404, P438, DOI 10.1002/(SICI)1096-9861(19990222)404:4<438::AID-CNE2>3.0.CO;2-K; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; PETERS A, 1981, J COMP NEUROL, V203, P685, DOI 10.1002/cne.902030408; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; ROSIER AM, 1995, J COMP NEUROL, V359, P476, DOI 10.1002/cne.903590309; Schuett S, 2002, J NEUROSCI, V22, P6549; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Wierenga CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015915; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; YASUDA R, 2004, SCI STKE, pP15; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	60	154	154	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 8	2011	71	5					869	882		10.1016/j.neuron.2011.06.034	http://dx.doi.org/10.1016/j.neuron.2011.06.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903080	hybrid			2022-12-25	WOS:000294877900012
J	Luis, NM; Morey, L; Mejetta, S; Pascual, G; Janich, P; Kuebler, B; Roma, G; Nascimento, E; Frye, M; Di Croce, L; Benitah, SA				Luis, Nuno Miguel; Morey, Lluis; Mejetta, Stefania; Pascual, Gloria; Janich, Peggy; Kuebler, Bernd; Roma, Guglielmo; Nascimento, Elisabete; Frye, Michaela; Di Croce, Luciano; Benitah, Salvador Aznar			Regulation of Human Epidermal Stem Cell Proliferation and Senescence Requires Polycomb-Dependent and -Independent Functions of Cbx4	CELL STEM CELL			English	Article							TRANSIT-AMPLIFYING CELLS; GROUP PROTEINS; METHYLTRANSFERASE ACTIVITY; REPRESSIVE COMPLEX; GENE-EXPRESSION; X-INACTIVATION; HISTONE H2A; DIFFERENTIATION; KERATINOCYTE; RING1B	Human epidermal stem cells transit from a slow cycling to an actively proliferating state to contribute to homeostasis. Both stem cell states differ in their cell cycle profiles but must remain guarded from differentiation and senescence. Here we show that Cbx4, a Polycomb Repressive Complex 1 (PRC1)-associated protein, maintains human epidermal stem cells as slow-cycling and undifferentiated, while protecting them from senescence. Interestingly, abrogating the polycomb activity of Cbx4 impairs its antisenescent function without affecting stem cell differentiation, indicating that differentiation and senescence are independent processes in human epidermis. Conversely, Cbx4 inhibits stem cell activation and differentiation through its SUMO ligase activity. Global transcriptome and chromatin occupancy analyses indicate that Cbx4 regulates modulators of epidermal homeostasis and represses factors such as Ezh2, Dnmt1, and Bmi1 to prevent the active stem cell state. Our results suggest that distinct Polycomb complexes balance epidermal stem cell dormancy and activation, while continually preventing senescence and differentiation.	[Luis, Nuno Miguel; Morey, Lluis; Mejetta, Stefania; Pascual, Gloria; Janich, Peggy; Kuebler, Bernd; Roma, Guglielmo; Di Croce, Luciano; Benitah, Salvador Aznar] CRG, Barcelona 08003, Spain; [Luis, Nuno Miguel; Morey, Lluis; Mejetta, Stefania; Pascual, Gloria; Janich, Peggy; Kuebler, Bernd; Roma, Guglielmo; Di Croce, Luciano; Benitah, Salvador Aznar] UPF, Barcelona 08003, Spain; [Nascimento, Elisabete; Frye, Michaela] Wellcome Trust Cambridge Stem Cell Inst, Cambridge CB2 1QR, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Cambridge	Benitah, SA (corresponding author), CRG, Barcelona 08003, Spain.	salvador.aznar-benitah@crg.es	Di Croce, Luciano/E-7759-2015; Luis, Nuno Miguel/ABD-9784-2020; Luis, Nuno/F-2405-2012; Cozzuto, Luca/K-5385-2015; Angulo, Gloria Pascual/AAA-7668-2019; Kuebler, Bernd/K-2823-2017; Aznar-Benitah, Salvador/F-4761-2016	Di Croce, Luciano/0000-0003-3488-6228; Luis, Nuno Miguel/0000-0001-5438-9638; Luis, Nuno/0000-0001-5438-9638; Cozzuto, Luca/0000-0003-3194-8892; Angulo, Gloria Pascual/0000-0003-3810-6647; Kuebler, Bernd/0000-0002-4472-871X; Aznar-Benitah, Salvador/0000-0002-9059-5049; Morey, Lluis/0000-0001-9851-4066; Janich, Peggy/0000-0003-1045-7365; Frye, Michaela/0000-0002-5636-6840	Fondo de Investigacion Sanitario (FIS, Spanish Ministerio de Sanidad, MICINN); AGAUR (Government of Cataluna); Spanish "Ministerio de Educacion y Ciencia" [BFU2010-18692]; Fundacao pars a Ciencia e Tecnologia (Portugal); Spanish Ministerio de Sanidad; CRG-Novartis; La Caixa International Ph.D. Fellowship; MRC [G0801904] Funding Source: UKRI; Medical Research Council [G0801904] Funding Source: researchfish	Fondo de Investigacion Sanitario (FIS, Spanish Ministerio de Sanidad, MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); AGAUR (Government of Cataluna)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); Fundacao pars a Ciencia e Tecnologia (Portugal); Spanish Ministerio de Sanidad(Spanish Government); CRG-Novartis; La Caixa International Ph.D. Fellowship(La Caixa Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Fondo de Investigacion Sanitario (FIS, Spanish Ministerio de Sanidad, MICINN) and AGAUR (Government of Cataluna) to S.A.B., and by the Spanish "Ministerio de Educacion y Ciencia" (BFU2010-18692) and Consolider to L.D.C. N.M.L. is funded by a fellowship from Fundacao pars a Ciencia e Tecnologia (Portugal). G.P. is the recipient of a FIS fellowship (Spanish Ministerio de Sanidad). L.M. is funded by CRG-Novartis Fellowship; S.M. is funded by La Caixa International Ph.D. Fellowship. We would like to thank David Wotton for providing us with the SUMO mutant versions of Cbx4, and Agusti Toll and Ramon Pujol from the Hospital del Mar (Barcelona) for kindly providing the human skin biopsies. Special thanks to all the CRG core facilities and Animal Unit for technical support, and to Veronica Raker for manuscript proofreading and helpful discussions.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gangatirkar P, 2007, NAT PROTOC, V2, P178, DOI 10.1038/nprot.2006.448; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gosselet FP, 2007, CELL SIGNAL, V19, P731, DOI 10.1016/j.cellsig.2006.09.006; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kim SH, 2008, INT J BIOCHEM CELL B, V40, P2462, DOI 10.1016/j.biocel.2008.04.018; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klein AM, 2011, J R SOC INTERFACE, V8, P1815, DOI 10.1098/rsif.2011.0240; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Webb A, 2004, DIFFERENTIATION, V72, P387, DOI 10.1111/j.1432-0436.2004.07208005.x; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Yang SH, 2010, MOL CELL BIOL, V30, P2193, DOI 10.1128/MCB.01510-09; Zhou W, 2009, BMB REP, V42, P154, DOI 10.5483/BMBRep.2009.42.3.154	64	109	118	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 2	2011	9	3					233	246		10.1016/j.stem.2011.07.013	http://dx.doi.org/10.1016/j.stem.2011.07.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	822DN	21885019	Bronze			2022-12-25	WOS:000295024200010
J	Snellman, J; Mehta, B; Babai, N; Bartoletti, TM; Akmentin, W; Francis, A; Matthews, G; Thoreson, W; Zenisek, D				Snellman, Josefin; Mehta, Bhupesh; Babai, Norbert; Bartoletti, Theodore M.; Akmentin, Wendy; Francis, Adam; Matthews, Gary; Thoreson, Wallace; Zenisek, David			Acute destruction of the synaptic ribbon reveals a role for the ribbon in vesicle priming	NATURE NEUROSCIENCE			English	Article							INNER PLEXIFORM LAYER; EXOCYTOSED PROTONS; ACTIVE ZONES; BASSOON; POOL; ORGANIZATION; DEPRESSION; RECEPTORS; TRANSIENT; TRANSPORT	In vision, balance and hearing, sensory receptor cells translate sensory stimuli into electrical signals whose amplitude is graded with stimulus intensity. The output synapses of these sensory neurons must provide fast signaling to follow rapidly changing stimuli while also transmitting graded information covering a wide range of stimulus intensity and must be able to sustain this signaling for long time periods. To meet these demands, specialized machinery for transmitter release, the synaptic ribbon, has evolved at the synaptic outputs of these neurons. We found that acute disruption of synaptic ribbons by photodamage to the ribbon markedly reduced both sustained and transient components of neurotransmitter release in mouse bipolar cells and salamander cones without affecting the ultrastructure of the ribbon or its ability to localize synaptic vesicles to the active zone. Our results indicate that ribbons mediate both slow and fast signaling at sensory synapses and support an additional role for the synaptic ribbon in priming vesicles for exocytosis at active zones.	[Snellman, Josefin; Mehta, Bhupesh; Francis, Adam; Zenisek, David] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Babai, Norbert; Bartoletti, Theodore M.; Thoreson, Wallace] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA; [Akmentin, Wendy; Matthews, Gary] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Zenisek, David] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Zenisek, David] Yale Univ, Sch Med, Ctr Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA	Yale University; University of Nebraska System; University of Nebraska Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University; Yale University	Zenisek, D (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	david.zenisek@yale.edu	Thoreson, Wallace B./F-6172-2010; Babai, Norbert/T-2952-2019; Zenisek, David/C-6555-2011	Thoreson, Wallace B./0000-0001-7104-042X; 	US National Institutes of Health [R01 EY003821, EY018111, EY10542]; Yale University [EY000785]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY003821, R29EY010542, R01EY010542, R21EY018111, P30EY000785, R55EY010542, R01EY014990] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to thank S. Mentone for electron microscopy. This work was funded by US National Institutes of Health grants R01 EY003821 (G. M.), EY018111 (D.Z.) and EY10542 (W. T.), Yale University Vision Core grant EY000785 (M. Crair) and Research to Prevent Blindness (W.T.).	Bartoletti TM, 2010, J NEUROPHYSIOL, V103, P419, DOI 10.1152/jn.00718.2009; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Chol SY, 2008, VISUAL NEUROSCI, V25, P693, DOI 10.1017/S0952523808080814; Coggins MR, 2007, J PHYSIOL-LONDON, V584, P853, DOI 10.1113/jphysiol.2007.140848; Cowan WM, 2001, SYNAPSES, P1; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Grunert U, 2002, J COMP NEUROL, V447, P138, DOI 10.1002/cne.10220; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; Hoffman-Kim D, 2007, METHOD CELL BIOL, V82, P335, DOI 10.1016/S0091-679(06)82011-X; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Jarsky T, 2010, J NEUROSCI, V30, P11885, DOI 10.1523/JNEUROSCI.1415-10.2010; Johnson SL, 2002, PFLUG ARCH EUR J PHY, V443, P653, DOI 10.1007/s00424-001-0763-z; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LoGiudice L, 2008, J NEUROSCI, V28, P3150, DOI 10.1523/JNEUROSCI.5753-07.2008; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; Midorikawa M, 2007, NAT NEUROSCI, V10, P1268, DOI 10.1038/nn1963; Miller R F, 2001, Prog Brain Res, V131, P241; Molloy DP, 1998, J BIOL CHEM, V273, P20867, DOI 10.1074/jbc.273.33.20867; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; Paillart C, 2003, J NEUROSCI, V23, P4092; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; Snellman J, 2009, J PHYSIOL-LONDON, V587, P2443, DOI 10.1113/jphysiol.2008.165241; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WONGRILE.MT, 1974, J NEUROCYTOL, V3, P1, DOI 10.1007/BF01111929; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004; Zenisek D, 2008, P NATL ACAD SCI USA, V105, P4922, DOI 10.1073/pnas.0709067105	47	95	95	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1135	U262		10.1038/nn.2870	http://dx.doi.org/10.1038/nn.2870			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21785435	Green Accepted			2022-12-25	WOS:000294284900013
J	Nozaki, C; Vergnano, AM; Filliol, D; Ouagazzal, AM; Le Goff, A; Carvalho, S; Reiss, D; Gaveriaux-Ruff, C; Neyton, J; Paoletti, P; Kieffer, BL				Nozaki, Chihiro; Vergnano, Angela Maria; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Le Goff, Anne; Carvalho, Stephanie; Reiss, David; Gaveriaux-Ruff, Claire; Neyton, Jacques; Paoletti, Pierre; Kieffer, Brigitte L.			Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTICALLY RELEASED ZINC; SPINAL-CORD; MOLECULAR-MECHANISMS; ZN2+; DOMAIN; MICE; LOCALIZATION; HYPERALGESIA; ANTAGONISTS	Zinc is abundant in the central nervous system and regulates pain, but the underlying mechanisms are unknown. In vitro studies have shown that extracellular zinc modulates a plethora of signaling membrane proteins, including NMDA receptors containing the NR2A subunit, which display exquisite zinc sensitivity. We created NR2A-H128S knock-in mice to investigate whether Zn2+-NR2A interaction influences pain control. In these mice, high-affinity (nanomolar) zinc inhibition of NMDA currents was lost in the hippocampus and spinal cord. Knock-in mice showed hypersensitivity to radiant heat and capsaicin, and developed enhanced allodynia in inflammatory and neuropathic pain models. Furthermore, zinc-induced analgesia was completely abolished under both acute and chronic pain conditions. Our data establish that zinc is an endogenous modulator of excitatory neurotransmission in vivo and identify a new mechanism in pain processing that relies on NR2A NMDA receptors. The study also potentially provides a molecular basis for the pain-relieving effects of dietary zinc supplementation.	[Vergnano, Angela Maria; Le Goff, Anne; Carvalho, Stephanie; Neyton, Jacques; Paoletti, Pierre] Ecole Normale Super, Inst Biol, F-75231 Paris, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] CNRS, UMR7104, Illkirch Graffenstaden, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] INSERM, U964, Illkirch Graffenstaden, France; [Nozaki, Chihiro; Filliol, Dominique; Ouagazzal, Abdel-Mouttalib; Reiss, David; Gaveriaux-Ruff, Claire; Kieffer, Brigitte L.] Univ Strasbourg, Illkirch Graffenstaden, France; [Vergnano, Angela Maria; Le Goff, Anne; Carvalho, Stephanie; Neyton, Jacques; Paoletti, Pierre] CNRS, UMR8197, Paris, France; [Vergnano, Angela Maria; Le Goff, Anne; Carvalho, Stephanie; Neyton, Jacques; Paoletti, Pierre] INSERM, U1024, Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Paoletti, P (corresponding author), Ecole Normale Super, Inst Biol, 24 Rue Lhomond, F-75231 Paris, France.	pierre.paoletti@ens.fr	GAVERIAUX-RUFF, Claire/A-9671-2017; Paoletti, Pierre/L-7358-2013	GAVERIAUX-RUFF, Claire/0000-0002-3523-8102; Paoletti, Pierre/0000-0002-3681-4845	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg; Agence Nationale de la Recherche (France); US National Institutes of Health, National Institue on Drug Abuse [DA05010]; Equipe Fondation pour la Recherche Medicale (FRM); Region Ile-de-France; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg; Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); US National Institutes of Health, National Institue on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Equipe Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region Ile-de-France(Region Ile-de-France); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Puvion, A. Matifas and R. Weibel for technical assistance and E. Krejci for help with the targeting vector. We thank B. Barbour, J. Becker and E. Schwartz for comments on the manuscript. We also thank Victor Faundez (Emory University) for the gift of the ZnT3 antibody. This research was supported by the Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite de Strasbourg, the Agence Nationale de la Recherche (France) grant SynapticZinc (P.P. and B.K.), the US National Institutes of Health, National Institue on Drug Abuse grant DA05010 (B.K.) and an Equipe Fondation pour la Recherche Medicale (FRM) grant (P.P.). C.N. was supported by the FRM and A.M.V. by the Region Ile-de-France.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hambidge KM, 2007, J NUTR, V137, P1101, DOI 10.1093/jn/137.4.1101; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Head KA, 2006, ALTERN MED REV, V11, P294; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jo SM, 2008, BIOMETALS, V21, P151, DOI 10.1007/s10534-007-9103-x; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Larson AA, 1997, J PHARMACOL EXP THER, V282, P1319; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Le Bars D, 2001, PHARMACOL REV, V53, P597; Liu T, 1999, NEUROREPORT, V10, P1619, DOI 10.1097/00001756-199905140-00042; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Ma JY, 2001, BRAIN RES BULL, V56, P575, DOI 10.1016/S0361-9230(01)00728-6; Ma QP, 2000, NEUROSCIENCE, V101, P699, DOI 10.1016/S0306-4522(00)00419-X; Matsumoto M, 2010, J NEUROCHEM, V112, P521, DOI 10.1111/j.1471-4159.2009.06473.x; Miledi R, 2002, P NATL ACAD SCI USA, V99, P13238, DOI 10.1073/pnas.192445299; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; SafiehGarabedian B, 1996, NEUROPHARMACOLOGY, V35, P599, DOI 10.1016/0028-3908(96)84630-2; SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Sendur OF, 2008, RHEUMATOL INT, V28, P1117, DOI 10.1007/s00296-008-0593-9; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Svensson CI, 2003, NEUROREPORT, V14, P1153, DOI 10.1097/00001756-200306110-00010; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Vardeh D, 2009, J CLIN INVEST, V119, P287, DOI 10.1172/JCI37098; Velazquez RA, 1999, J NEUROSCI, V19, P2288; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4; Yoshida H, 2010, BRIT J ORAL MAX SURG, V48, P469, DOI 10.1016/j.bjoms.2009.08.001	49	85	90	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1017	U108		10.1038/nn.2844	http://dx.doi.org/10.1038/nn.2844			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725314	Green Accepted, Green Submitted			2022-12-25	WOS:000293123700015
J	Wang, L; Klein, R; Zheng, BH; Marquardt, T				Wang, Liang; Klein, Ruediger; Zheng, Binhai; Marquardt, Till			Anatomical Coupling of Sensory and Motor Nerve Trajectory via Axon Tracking	NEURON			English	Article							EMBRYONIC CHICK HINDLIMB; INNERVATION PATTERNS; DORSAL; SPECIFICATION; EXPRESSION; OUTGROWTH; NEURONS	It is a long-standing question how developing motor and sensory neuron projections cooperatively form a common principal grid of peripheral nerve pathways relaying behavioral outputs and somatosensory inputs. Here, we explored this issue through targeted cell lineage and gene manipulation in mouse, combined with in vitro live axon imaging. In the absence of motor projections, dorsal (epaxial) and ventral (hypaxial) sensory projections form in a randomized manner, while removal of EphA3/4 receptor tyrosine kinases expressed by epaxial motor axons triggers selective failure to form epaxial sensory projections. EphA3/4 act non-cell-autonomously by inducing sensory axons to track along preformed epaxial motor projections. This involves cognate ephrin-A proteins on sensory axons but is independent from EphA3/4 signaling in motor axons proper. Assembly of peripheral nerve pathways thus involves motor axon subtype-specific signals that couple sensory projections to discrete motor pathways.	[Wang, Liang; Marquardt, Till] European Neurosci Inst ENI G, Dev Neurobiol Lab, D-37077 Gottingen, Germany; [Klein, Ruediger] Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Munich, Germany; [Zheng, Binhai] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Max Planck Society; University of California System; University of California San Diego	Marquardt, T (corresponding author), European Neurosci Inst ENI G, Dev Neurobiol Lab, Grisebachstr 5, D-37077 Gottingen, Germany.	t.marquardt@eni-g.de	Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163	Deutsche Forschungsgemeinschaft (DFG); DFG Research Center for Molecular Physiology of the brain (CMPB); NIH/NINDS [R01NS054734]; Roman Reed Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054734] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Research Center for Molecular Physiology of the brain (CMPB)(German Research Foundation (DFG)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Roman Reed Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Klusowski and E. Ling for technical assistance and D. Muller and A. Kania for comments on the manuscript. We are indebted to B. Novitch and T.M. Jessell for providing Olig2<SUP>Cre</SUP> mice and to D. Feldheim for Efna2/5<SUP>null</SUP> mice. We further thank G. Lemke and A. Brown for Epha3<SUP>null</SUP> mice, E. Turner for Brn3a<SUP>tau:lacZ</SUP> mice, L.F. Reichardt for anti-TrkC, and S.L. Pfaff for Isl1/2, Lhx3 antibodies, as well as S. Eimer and D.W. Richter for support obtaining the Cell<SUP>boolean AND</SUP>M system and Olympus-Germany for providing the DSU. This work was supported by the Emmy Noether Program of the Deutsche Forschungsgemeinschaft (DFG), as well as the DFG Research Center for Molecular Physiology of the brain (CMPB). B.Z. was funded by NIH/NINDS (R01NS054734) and a Roman Reed Fund. The ENI-G is a cooperation of the University of Gottingen Medical School (UMG) and the Max-Planck Gesellschaft.	Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FRANK E, 1982, J PHYSIOL-LONDON, V324, P495, DOI 10.1113/jphysiol.1982.sp014126; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; HAMBURGER V, 1929, ROUX ARCH DEVEL BIOL, V119, P47; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Herrmann JE, 2010, GENESIS, V48, P101, DOI 10.1002/dvg.20587; Honig MG, 1998, DEVELOPMENT, V125, P995; HONIG MG, 1986, DEV BIOL, V118, P532, DOI 10.1016/0012-1606(86)90024-2; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; LANDMESSER L, 1986, DEV BIOL, V118, P511, DOI 10.1016/0012-1606(86)90023-0; Landmesser L T, 1983, Prog Clin Biol Res, V110 Pt A, P207; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; SCOTT SA, 1986, J NEUROBIOL, V17, P649, DOI 10.1002/neu.480170609; SCOTT SA, 1988, DEV BIOL, V126, P362, DOI 10.1016/0012-1606(88)90146-7; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; SWANSON GJ, 1986, J EMBRYOL EXP MORPH, V95, P37; Taylor AC, 1944, J EXP ZOOL, V96, P159, DOI 10.1002/jez.1400960204; TOSNEY KW, 1989, J EXP ZOOL, V251, P232, DOI 10.1002/jez.1402510211; Vaidya A, 2003, MOL CELL BIOL, V23, P8092, DOI 10.1128/MCB.23.22.8092-8098.2003; Wang G, 1999, DEV BIOL, V208, P324, DOI 10.1006/dbio.1999.9212; Wenner P, 1995, J NEUROSCI, V15, P8191; Xue Y, 1999, J COMP NEUROL, V408, P299, DOI 10.1002/(SICI)1096-9861(19990607)408:3<299::AID-CNE1>3.0.CO;2-N	37	40	40	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					263	277		10.1016/j.neuron.2011.06.021	http://dx.doi.org/10.1016/j.neuron.2011.06.021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791286	Bronze			2022-12-25	WOS:000293433900011
J	Vong, L; Ye, CP; Yang, ZF; Choi, B; Chua, S; Lowell, BB				Vong, Linh; Ye, Chianping; Yang, Zongfang; Choi, Brian; Chua, Streamson, Jr.; Lowell, Bradford B.			Leptin Action on GABAergic Neurons Prevents Obesity and Reduces Inhibitory Tone to POMC Neurons	NEURON			English	Article							HYPOTHALAMIC ARCUATE NUCLEUS; AGOUTI-RELATED PROTEIN; GREEN FLUORESCENT PROTEIN; NEUROPEPTIDE-Y NEURONS; RECEPTOR MESSENGER-RNA; ENERGY-BALANCE; AGRP NEURONS; FOOD-INTAKE; PROOPIOMELANOCORTIN NEURONS; MEDIOBASAL HYPOTHALAMUS	Leptin acts in the brain to prevent obesity. The underlying neurocircuitry responsible for this is poorly understood, in part because of incomplete knowledge regarding first-order, leptin-responsive neurons. To address this, we and others have been removing leptin receptors from candidate first-order neurons. While functionally relevant neurons have been identified, the observed effects have been small, suggesting that most first-order neurons remain unidentified. Here we take an alternative approach and test whether first-order neurons are inhibitory (GABAergic, VGAT(+)) or excitatory (glutamatergic, VGLUT2(+)). Remarkably, the vast majority of leptin's antiobesity effects are mediated by GABAergic neurons; glutamatergic neurons play only a minor role. Leptin, working directly on presynaptic GABAergic neurons, many of which appear not to express AgRP, reduces inhibitory tone to postsynaptic POMC neurons. As POMC neurons prevent obesity, their disinhibition by leptin action on presynaptic GABAergic neurons probably mediates, at least in part, leptin's antiobesity effects.	[Vong, Linh; Ye, Chianping; Yang, Zongfang; Choi, Brian; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; [Vong, Linh; Ye, Chianping; Yang, Zongfang; Choi, Brian; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Chua, Streamson, Jr.] Albert Einstein Coll Med, Dept Med, New York, NY 10461 USA; [Chua, Streamson, Jr.] Albert Einstein Coll Med, Dept Neurosci, New York, NY 10461 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Yeshiva University; Yeshiva University	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, 330 Brookline Ave,EC CLS717, Boston, MA 02215 USA.	blowell@bidmc.harvard.edu			National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK089044, R01 DK075632, P30 DK046200, P30 DK057521, PO1DK26687, U54HD058155, F32 DK078478]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD058155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK075632, F32DK078478, P30DK057521, P30DK026687, R01DK089044] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank members of the Lowell laboratory for helpful discussions; C.B. Saper, C. Bjorbaek, and B.P. Bean for advice; J.K. Elmquist and D.P. Olson for comments on the manuscript; and M. Herman for help with statistics. This work was supported by grants from the National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK089044, R01 DK075632, P30 DK046200, and P30 DK057521 to B.B.L; PO1DK26687 and U54HD058155 to S.C.; F32 DK078478 to L.V.).	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Bagnol D, 1999, J NEUROSCI, V19; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baskin DG, 1999, HORM METAB RES, V31, P345, DOI 10.1055/s-2007-978751; Baskin DG, 1999, DIABETES, V48, P828, DOI 10.2337/diabetes.48.4.828; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elias CF, 2000, J COMP NEUROL, V423, P261; Faouzi M, 2007, ENDOCRINOLOGY, V148, P5414, DOI 10.1210/en.2007-0655; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Leinninger GM, 2008, ACTA PHYSIOL, V192, P49, DOI 10.1111/j.1748-1716.2007.01784.x; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Leshan RL, 2009, J NEUROSCI, V29, P3138, DOI 10.1523/JNEUROSCI.0155-09.2009; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; MATSUMOTO A, 1978, EXP NEUROL, V59, P404, DOI 10.1016/0014-4886(78)90232-7; Mercer JG, 1998, ENDOCRINOLOGY, V139, P29, DOI 10.1210/en.139.1.29; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Munzberg H, 2008, PHYSIOL BEHAV, V94, P664, DOI 10.1016/j.physbeh.2008.04.020; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Munzberg H, 2007, J NEUROSCI, V27, P69, DOI 10.1523/JNEUROSCI.3168-06.2007; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ovesjo ML, 2001, J NEUROENDOCRINOL, V13, P505, DOI 10.1046/j.1365-2826.2001.00662.x; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Smart JL, 2006, J CLIN INVEST, V116, P495, DOI 10.1172/JCI25243; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; VANDENPOL AN, 1982, J COMP NEUROL, V204, P65, DOI 10.1002/cne.902040108; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yee CL, 2009, J COMP NEUROL, V517, P37, DOI 10.1002/cne.22132; Zhao LP, 2004, MOL CELL ENDOCRINOL, V215, P89, DOI 10.1016/j.mce.2003.11.009	72	687	696	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 14	2011	71	1					142	154		10.1016/j.neuron.2011.05.028	http://dx.doi.org/10.1016/j.neuron.2011.05.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745644	Green Accepted, Bronze			2022-12-25	WOS:000292806200013
J	Klockener, T; Hess, S; Belgardt, BF; Paeger, L; Verhagen, LAW; Husch, A; Sohn, JW; Hampel, B; Dhillon, H; Zigman, JM; Lowell, BB; Williams, KW; Elmquist, JK; Horvath, TL; Kloppenburg, P; Bruning, JC				Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Sohn, Jong-Woo; Hampel, Brigitte; Dhillon, Harveen; Zigman, Jeffrey M.; Lowell, Bradford B.; Williams, Kevin W.; Elmquist, Joel K.; Horvath, Tamas L.; Kloppenburg, Peter; Bruening, Jens C.			High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL HYPOTHALAMIC NUCLEUS; STEROIDOGENIC FACTOR-I; PROOPIOMELANOCORTIN NEURONS; BODY-WEIGHT; EXPRESSING NEURONS; ARCUATE NUCLEUS; POMC NEURONS; FOOD-INTAKE; GLUCOSE; LEPTIN	Steroidogenic factor 1 (SF-1)-expressing neurons of the ventromedial hypothalamus (VMH) control energy homeostasis, but the role of insulin action in these cells remains undefined. We show that insulin activates phosphatidylinositol-3-OH kinase (PI3K) signaling in SF-1 neurons and reduces firing frequency in these cells through activation of K-ATP channels. These effects were abrogated in mice with insulin receptor deficiency restricted to SF-1 neurons (SF-1(Delta IR) mice). Whereas body weight and glucose homeostasis remained the same in SF-1(Delta IR) mice as in controls under a normal chow diet, they were protected from diet-induced leptin resistance, weight gain, adiposity and impaired glucose tolerance. High-fat feeding activated PI3K signaling in SF-1 neurons of control mice, and this response was attenuated in the VMH of SF-1(Delta IR) mice. Mimicking diet-induced overactivation of PI3K signaling by disruption of the phosphatidylinositol-3,4,5-trisphosphate phosphatase PTEN led to increased body weight and hyperphagia under a normal chow diet. Collectively, our experiments reveal that high-fat diet-induced, insulin-dependent PI3K activation in VMH neurons contributes to obesity development.	[Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, D-5000 Cologne, Germany; [Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Cologne, Germany; [Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Hampel, Brigitte; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, CMMC, Cologne, Germany; [Kloeckener, Tim; Hess, Simon; Belgardt, Bengt F.; Paeger, Lars; Verhagen, Linda A. W.; Husch, Andreas; Hampel, Brigitte; Kloppenburg, Peter; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Kloeckener, Tim; Belgardt, Bengt F.; Verhagen, Linda A. W.; Hampel, Brigitte; Bruening, Jens C.] Max Planck Inst Neurol Res, Cologne, Germany; [Hess, Simon; Paeger, Lars; Husch, Andreas; Kloppenburg, Peter] Univ Cologne, Inst Zool, Bioctr, D-5000 Cologne, Germany; [Sohn, Jong-Woo; Zigman, Jeffrey M.; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Hypothalam Res, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dhillon, Harveen; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02215 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; University of Cologne; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Yale University	Bruning, JC (corresponding author), Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Weyertal 121, D-5000 Cologne, Germany.	jens.bruening@uni-koeln.de	Sohn, Jong Woo/D-6700-2014; Williams, Kevin W/AAA-4243-2020; Williams, Kevin W/ABD-5818-2021	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Belgardt, Bengt-Frederik/0000-0003-4537-9002; Paeger, Lars/0000-0001-8716-3483; Zigman, Jeffrey/0000-0003-3477-1295	Federal Ministry of Education and Research [KL 762/2-2, FP7-HEALTH-2009-241592, FP7-KBBE-2010-4-266408, FKZ 01GI0845]; Deutsche Forschungsgemeinschaft [Br. 1492/7-1]; US National Institute of Health [R01DK53301, RL1DK081185, K01DK087780, R01 DK071051, P30 DK046200, P30 DK057521, OD006850, DK080000, PL1 DK081182, UL1RR024923, K08 DK068069-01A2]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053301, R01DK080000, RL1DK081185, K01DK087780, P30DK057521, P30DK046200, K08DK068069, R01DK071051, PL1DK081182] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Schmall and T. Rayle for secretarial assistance and S. Irlenbusch and H. Wratil for technical assistance. We thank M. Low (Oregon Health & Science University) for providing POMC<SUP>GFP</SUP> mice. Recombinant mouse leptin was obtained from A. F. Parlow, the National Hormone and Peptide Program (NHPP), National Institute of Diabetes and Digestive and Kidney Diseases. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KL 762/2-2 to P. K.); Cologne Center for Molecular Medicine (CMMC); under FP7-HEALTH-2009-241592 (European Union) EurOCHIP; under FP7-KBBE-2010-4-266408 (European Union) Full4Health and through the Kompetenznetz Adipositas (Competence Network for Adipositas) funded by the Federal Ministry of Education and Research (FKZ 01GI0845) to J.C.B.; and also through funds from the Deutsche Forschungsgemeinschaft (Br. 1492/7-1 to J.C.B.). This work was supported by US National Institute of Health grants R01DK53301 and RL1DK081185 (to J.K.E.); K01DK087780 (to K. W. W.); R01 DK071051, P30 DK046200 and P30 DK057521 (to B. B. L.); OD006850 and DK080000 (to T. L. H.); and PL1 DK081182, UL1RR024923 and K08 DK068069-01A2 (to J.M.Z.).	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Choudhury AI, 2005, J CLIN INVEST, V115, P940; CLARK JT, 1987, REGUL PEPTIDES, V17, P31, DOI 10.1016/0167-0115(87)90030-9; Cotero VE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1101, DOI 10.1152/ajpendo.90932.2008; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Davidowa H, 2001, NEUROREPORT, V12, P3201, DOI 10.1097/00001756-200110290-00012; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Janoschek R, 2006, P NATL ACAD SCI USA, V103, P10707, DOI 10.1073/pnas.0600425103; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kloppenburg P, 2007, J NEUROPHYSIOL, V98, P2910, DOI 10.1152/jn.00660.2007; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Li G, 2003, DIABETES, V52, P1951, DOI 10.2337/diabetes.52.8.1951; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; MAYER J, 1956, NATURE, V178, P1399, DOI 10.1038/1781399a0; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Xu Y, 2010, CELL METAB, V12, P88, DOI 10.1016/j.cmet.2010.05.002; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006	50	173	176	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					911	U139		10.1038/nn.2847	http://dx.doi.org/10.1038/nn.2847			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642975	Green Accepted			2022-12-25	WOS:000292081700020
J	Hobbs, RM; Fagoonee, S; Papa, A; Webster, K; Altruda, F; Nishinakamura, R; Chai, L; Pandolfi, PP				Hobbs, Robin M.; Fagoonee, Sharmila; Papa, Antonella; Webster, Kaitlyn; Altruda, Fiorella; Nishinakamura, Ryuichi; Chai, Li; Pandolfi, Pier Paolo			Functional Antagonism between Sall4 and Plzf Defines Germline Progenitors	CELL STEM CELL			English	Article							SPERMATOGONIAL STEM-CELLS; TOWNES-BROCKS-SYNDROME; LEUKEMIA ZINC-FINGER; SELF-RENEWAL; PROMYELOCYTIC LEUKEMIA; OKIHIRO-SYNDROME; RETINOIC ACID; MOUSE TESTIS; GENE-EXPRESSION; TRANSGENIC MICE	Transcription factors required for formation of embryonic tissues often maintain their expression in adult stem cell populations, but whether their function remains equivalent is not clear. Here we demonstrate critical and distinct roles for Sall4 in development of embryonic germ cells and differentiation of postnatal spermatogonial progenitor cells (SPCs). In differentiating SPCs, Sall4 levels transiently increase and Sall4 physically interacts with Plzf, a transcription factor exclusively required for adult stem cell maintenance. Mechanistically, Sall4 sequesters Plzf to noncognate chromatin domains to induce expression of Kit, a target of Plzf-mediated repression required for differentiation. Plzf in turn antagonizes Sall4 function by displacing Sall4 from cognate chromatin to induce Sall4 expression. Taken together, these data suggest that transcription factors required for embryonic tissue development postnatally take on distinct roles through interaction with opposing factors, which hence define properties of the adult stem cell compartment.	[Hobbs, Robin M.; Papa, Antonella; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med,Dept Med, Boston, MA 02115 USA; [Hobbs, Robin M.; Papa, Antonella; Webster, Kaitlyn; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med,Dept Pathol, Boston, MA 02115 USA; [Chai, Li] Harvard Univ, Brigham & Womans Hosp, Sch Med, Dept Pathol,Joint Program Transfus Med, Boston, MA 02115 USA; [Fagoonee, Sharmila; Altruda, Fiorella] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Turin; Kumamoto University	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med,Dept Med, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Fagoonee, Sharmila/L-1940-2019; Hobbs, Robin/I-2577-2014	Fagoonee, Sharmila/0000-0001-6070-6716; Pandolfi, Pier Paolo/0000-0002-5352-5295; Webster, Kaitlyn/0000-0001-9902-0500; Chai, Li/0000-0003-1937-4750; Papa, Antonella/0000-0001-8653-7121; Hobbs, Robin/0000-0002-3853-2614	NIH [RO1HL092437]; NATIONAL CANCER INSTITUTE [R01CA071692] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are particularly indebted to Marco Seandel for initial comments regarding this work. We would also like to thank Shahin Raft, Bing Lim, Dan Tenen, and members of the Pandolfi lab for helpful discussions. This work was supported by NIH grants to P.P.P. and by RO1HL092437 to L.C.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cao DF, 2009, AM J SURG PATHOL, V33, P1065, DOI 10.1097/PAS.0b013e3181a13eef; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; De Rooij DG, 2000, J ANDROL, V21, P776; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Ebata KT, 2007, BIOL REPROD, V76, P841, DOI 10.1095/biolreprod.106.058305; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Kawakami Y, 2009, DEVELOPMENT, V136, P585, DOI 10.1242/dev.027748; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Kohlhase J, 2000, HUM MUTAT, V16, P460, DOI 10.1002/1098-1004(200012)16:6<460::AID-HUMU2>3.0.CO;2-4; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; McLean DJ, 2003, BIOL REPROD, V69, P2085, DOI 10.1095/biolreprod.103.017020; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Mithraprabhu S, 2009, REPRODUCTION, V138, P743, DOI 10.1530/REP-08-0537; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ohta H, 2003, BIOL REPROD, V69, P1815, DOI 10.1095/biolreprod.103.019323; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Payne CJ, 2010, STEM CELLS, V28, P1424, DOI 10.1002/stem.464; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Toyoda S, 2009, DEV BIOL, V325, P238, DOI 10.1016/j.ydbio.2008.10.019; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Yamashita K, 2007, GENES CELLS, V12, P171, DOI 10.1111/j.1365-2443.2007.01042.x; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795	49	124	130	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					284	298		10.1016/j.stem.2012.02.004	http://dx.doi.org/10.1016/j.stem.2012.02.004			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385656	Green Accepted, Bronze			2022-12-25	WOS:000301466500010
J	Odermatt, B; Nikolaev, A; Lagnado, L				Odermatt, Benjamin; Nikolaev, Anton; Lagnado, Leon			Encoding of Luminance and Contrast by Linear and Nonlinear Synapses in the Retina	NEURON			English	Article							BIPOLAR CELLS; FUNCTIONAL CIRCUITRY; SYNAPTIC ACTIVITY; NATURAL IMAGES; TUNING CURVES; S-POTENTIALS; LIGHT; ROD; EXOCYTOSIS; RESPONSES	Understanding how neural circuits transmit information is technically challenging because the neural code is contained in the activity of large numbers of neurons and synapses. Here, we use genetically encoded reporters to image synaptic transmission across a population of sensory neurons-bipolar cells in the retina of live zebrafish. We demonstrate that the luminance sensitivities of these synapses varies over 10(4) with a log-normal distribution. About half the synapses made by ON and OFF cells alter their polarity of transmission as a function of luminance to generate a triphasic tuning curve with distinct maxima and minima. These nonlinear synapses signal temporal contrast with greater sensitivity than linear ones. Triphasic tuning curves increase the dynamic range over which bipolar cells signal light and improve the efficiency with which luminance information is transmitted. The most efficient synapses signaled luminance using just 1 synaptic vesicle per second per distinguishable gray level.	[Odermatt, Benjamin; Nikolaev, Anton; Lagnado, Leon] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	ll1@mrc-lmb.cam.ac.uk			Medical Research Council; Wellcome Trust; E.U; Medical Research Council [MC_U105178794] Funding Source: researchfish; MRC [MC_U105178794] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); E.U(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Aude Derevier for help with immunofluorescence and Mario Dorostkar for support with the SARFIA software. Ellen Schmitt and John Dowling provided us with EM pictures of zebrafish bipolar cells. Support for this work was provided by the Medical Research Council, the Wellcome Trust, and an E.U. Marie Curie fellowship to B.O.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Arai I, 2010, J NEUROSCI, V30, P9260, DOI 10.1523/JNEUROSCI.1590-10.2010; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; Attwell D, 2005, NAT REV NEUROSCI, V6, P841, DOI 10.1038/nrn1784; Baccus SA, 2007, ANNU REV PHYSIOL, V69, P271, DOI 10.1146/annurev.physiol.69.120205.124451; Baden T, 2011, CURR BIOL, V21, P1859, DOI 10.1016/j.cub.2011.09.042; BARLOW HB, 1987, J OPT SOC AM A, V4, P2366, DOI 10.1364/JOSAA.4.002366; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; Brady N, 2000, PERCEPTION, V29, P1041, DOI 10.1068/p2996; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Choi SY, 2005, NEURON, V48, P555, DOI 10.1016/j.neuron.2005.09.011; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Connaughton VP, 2004, J COMP NEUROL, V477, P371, DOI 10.1002/cne.20261; Dayan P., 2005, THEORETICAL NEUROSCI; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; Dreosti E, 2011, NAT NEUROSCI, V14, P951, DOI 10.1038/nn.2841; Dreosti E, 2011, EXP PHYSIOL, V96, P4, DOI 10.1113/expphysiol.2009.051953; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Freed MA, 2000, J NEUROSCI, V20, P3956; Freed MA, 2000, J NEUROPHYSIOL, V83, P2956, DOI 10.1152/jn.2000.83.5.2956; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Geisler WS, 2011, VISION RES, V51, P771, DOI 10.1016/j.visres.2010.09.027; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Hamilton R, 2007, VISION RES, V47, P2968, DOI 10.1016/j.visres.2007.04.020; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Laughlin S, 1989, COMPUTING NEURON; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Masland RH, 2005, CURR BIOL, V15, pR808, DOI 10.1016/j.cub.2005.09.023; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; Nusslein-Volhard C, 2002, ZEBRAFISH; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pouget A, 1999, NEURAL COMPUT, V11, P85, DOI 10.1162/089976699300016818; Pouli T., 2010, P ACM S APPL PERC GR, P9; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Ren JQ, 2002, VISION RES, V42, P293, DOI 10.1016/S0042-6989(01)00284-X; RICHARDS WA, 1982, APPL OPTICS, V21, P2569, DOI 10.1364/AO.21.002569; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Smith RG, 2009, PROG RETIN EYE RES, V28, P263, DOI 10.1016/j.preteyeres.2009.05.001; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Ueno S, 2004, INVEST OPHTH VIS SCI, V45, P1033, DOI 10.1167/iovs.03-0657; VICTOR JD, 1977, P NATL ACAD SCI USA, V74, P3068, DOI 10.1073/pnas.74.7.3068; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Zaghloul KA, 2007, J NEUROPHYSIOL, V97, P4327, DOI 10.1152/jn.01091.2006	70	64	65	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					758	773		10.1016/j.neuron.2011.12.023	http://dx.doi.org/10.1016/j.neuron.2011.12.023			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365549	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000300815400014
J	DiCarlo, JJ; Zoccolan, D; Rust, NC				DiCarlo, James J.; Zoccolan, Davide; Rust, Nicole C.			How Does the Brain Solve Visual Object Recognition?	NEURON			English	Review							INFERIOR TEMPORAL CORTEX; RECEPTIVE-FIELD PROPERTIES; INFEROTEMPORAL CORTEX; SHAPE SELECTIVITY; INDIVIDUAL NEURONS; FAMILIAR OBJECTS; SINGLE NEURONS; NEURAL CIRCUIT; CORTICAL AREAS; NATURAL IMAGES	Mounting evidence suggests that 'core object recognition,' the ability to rapidly recognize objects despite substantial appearance variation, is solved in the brain via a cascade of reflexive, largely feedforward computations that culminate in a powerful neuronal representation in the inferior temporal cortex. However, the algorithm that produces this solution remains poorly understood. Here we review evidence ranging from individual neurons and neuronal populations to behavior and computational models. We propose that understanding this algorithm will require using neuronal and psychophysical data to sift through many computational models, each based on building blocks of small, canonical subnetworks with a common functional goal.	[DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [DiCarlo, James J.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Zoccolan, Davide] Int Sch Adv Studies SISSA, Cognit Neurosci Sect, I-34136 Trieste, Italy; [Rust, Nicole C.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Zoccolan, Davide] Int Sch Adv Studies SISSA, Neurobiol Sect, I-34136 Trieste, Italy	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); International School for Advanced Studies (SISSA); University of Pennsylvania; International School for Advanced Studies (SISSA)	DiCarlo, JJ (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	dicarlo@mit.edu	Zoccolan, Davide/AAO-5571-2020	Zoccolan, Davide/0000-0001-7221-4188	U.S. National Eye Institute [NIH NEI R01EY014970-01]; Defense Advanced Research Projects Agency (DARPA); National Science Foundation (NSF); Accademia Nazionale dei Lincei-Compagnia di San Paolo; Compagnia di San Paolo; Marie Curie International Reintegration Grant; NIH NEI; Alfred P. Sloan Foundation; NATIONAL EYE INSTITUTE [R01EY014970] Funding Source: NIH RePORTER	U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation (NSF)(National Science Foundation (NSF)); Accademia Nazionale dei Lincei-Compagnia di San Paolo(Compagnia di San Paolo); Compagnia di San Paolo(Compagnia di San Paolo); Marie Curie International Reintegration Grant(European Commission); NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	J.J.D. was supported by the U.S. National Eye Institute (NIH NEI R01EY014970-01), The Defense Advanced Research Projects Agency (DARPA), and the National Science Foundation (NSF). D.Z. was supported by an Accademia Nazionale dei Lincei-Compagnia di San Paolo Grant, a Programma Neuroscienze grant from the Compagnia di San Paolo, and a Marie Curie International Reintegration Grant. N.R. was supported by the NIH NEI and a fellowship from the Alfred P. Sloan Foundation.	Abbott LF, 1996, CEREB CORTEX, V6, P498, DOI 10.1093/cercor/6.3.498; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Afraz SR, 2008, VISION RES, V48, P42, DOI 10.1016/j.visres.2007.10.028; Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Aggelopoulos NC, 2005, EUR J NEUROSCI, V22, P2903, DOI 10.1111/j.1460-9568.2005.04487.x; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BENGIO Y, 1995, NEURAL COMPUT, V7, P1289, DOI 10.1162/neco.1995.7.6.1289; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brewer AA, 2002, J NEUROSCI, V22, P10416; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cardoso-Leite P, 2010, SEEING PERCEIVING, V23, P89, DOI 10.1163/187847510X503588; Collins CE, 2010, P NATL ACAD SCI USA, V107, P15927, DOI 10.1073/pnas.1010356107; Cox DD, 2005, NAT NEUROSCI, V8, P1145, DOI 10.1038/nn1519; David SV, 2006, J NEUROPHYSIOL, V96, P3492, DOI 10.1152/jn.00575.2006; De Baene W, 2007, J NEUROPHYSIOL, V97, P2900, DOI 10.1152/jn.00741.2006; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; DiCarlo JJ, 1998, J NEUROSCI, V18, P2626; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Edelman S., 1999, REPRESENTATION RECOG; Engel TA, 2011, J NEUROSCI, V31, P6982, DOI 10.1523/JNEUROSCI.6150-10.2011; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Fazl A, 2009, COGNITIVE PSYCHOL, V58, P1, DOI 10.1016/j.cogpsych.2008.05.001; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; GROSS CG, 1994, CEREB CORTEX, V4, P455, DOI 10.1093/cercor/4.5.455; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; HOLMES EJ, 1984, J NEUROSCI, V4, P3063; Horel JA, 1996, BEHAV BRAIN RES, V76, P199, DOI 10.1016/0166-4328(95)00196-4; Hoyer PO, 2002, VISION RES, V42, P1593, DOI 10.1016/S0042-6989(02)00017-2; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Hurri J, 2003, NEURAL COMPUT, V15, P663, DOI 10.1162/089976603321192121; Huxlin KR, 2000, CEREB CORTEX, V10, P671, DOI 10.1093/cercor/10.7.671; Ikkai A, 2011, J COGNITIVE NEUROSCI, V23, P1494, DOI 10.1162/jocn.2010.21499; INTRAUB H, 1980, J EXP PSYCHOL-HUM L, V6, P1, DOI 10.1037/0278-7393.6.1.1; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Jarrett K, 2009, P INT C COMP VIS ICC; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Karlinsky L, 2008, LECT NOTES COMPUT SC, V5303, P321, DOI 10.1007/978-3-540-88688-4_24; Kayaert G, 2005, CEREB CORTEX, V15, P1308, DOI 10.1093/cercor/bhi014; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kingdom FAA, 2007, J VISION, V7, DOI 10.1167/7.14.11; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Kravitz DJ, 2008, TRENDS COGN SCI, V12, P114, DOI 10.1016/j.tics.2007.12.006; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Lawson R, 1999, ACTA PSYCHOL, V102, P221, DOI 10.1016/S0001-6918(98)00052-3; Lecun Y., 2004, P CVPR 04 IEEE; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; Lennie P, 2005, J OPT SOC AM A, V22, P2013, DOI 10.1364/JOSAA.22.002013; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; Li N, 2008, SCIENCE, V321, P1502, DOI 10.1126/science.1160028; Li N, 2010, NEURON, V67, P1062, DOI 10.1016/j.neuron.2010.08.029; Li N, 2009, J NEUROPHYSIOL, V102, P360, DOI 10.1152/jn.90745.2008; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Majaj N., 2012, COMPUTATIONAL SYSTEM; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Marr D., 1982, VISION COMPUTATIONAL; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Missal M, 1997, CEREB CORTEX, V7, P758, DOI 10.1093/cercor/7.8.758; Missal M, 1999, J NEUROPHYSIOL, V82, P131, DOI 10.1152/jn.1999.82.1.131; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; NOWAK LG, 1997, CEREBRAL CORTEX EXTR, P870; OKUSKY J, 1982, J COMP NEUROL, V210, P278, DOI 10.1002/cne.902100307; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Op de Beeck HP, 2010, TRENDS COGN SCI, V14, P236, DOI 10.1016/j.tics.2010.03.010; Op de Beeck HP, 2008, J NEUROSCI, V28, P11796, DOI 10.1523/JNEUROSCI.3799-08.2008; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Perry G, 2010, EXP BRAIN RES, V204, P255, DOI 10.1007/s00221-010-2309-0; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Pinto N., 2008, WHY IS REAL WORLD OB; Pinto N, 2011, IEEE WORKSH APPL COM; Pinto N., 2009, IEEE COMP VIS PATT R; Pinto N., 2010, FRONT NEUROSCI, DOI [10.3389/conf.fnins.2010.03.00283, DOI 10.3389/CONF.FNINS.2010.03.00283]; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Roelfsema PR, 2011, ATTEN PERCEPT PSYCHO, V73, P2542, DOI 10.3758/s13414-011-0200-0; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; RUBIN GS, 1992, VISION RES, V32, P895, DOI 10.1016/0042-6989(92)90032-E; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Rust NC, 2010, CURR OPIN NEUROBIOL, V20, P382, DOI 10.1016/j.conb.2010.04.013; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SALEEM KS, 1993, CEREB CORTEX, V3, P454, DOI 10.1093/cercor/3.5.454; Saleem KS, 2000, J NEUROSCI, V20, P5083; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stevens CF, 2001, NATURE, V411, P193, DOI 10.1038/35075572; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; STRYKER MP, 1992, NATURE, V360, P301, DOI 10.1038/360301a0; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Suzuki W, 2000, J COMP NEUROL, V422, P206, DOI 10.1002/(SICI)1096-9861(20000626)422:2<206::AID-CNE5>3.0.CO;2-0; Suzuki W, 2006, J NEUROSCI, V26, P10524, DOI 10.1523/JNEUROSCI.1532-06.2006; Tafazoli S, 2012, J NEUROSCI, V32, P21, DOI 10.1523/JNEUROSCI.3932-11.2012; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TOVEE MJ, 1994, J NEUROPHYSIOL, V72, P1049, DOI 10.1152/jn.1994.72.3.1049; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Ullman S, 2004, NEURAL NETWORKS, V17, P833, DOI 10.1016/j.neunet.2004.01.006; Ullman S., 1996, HIGH LEVEL VISION; Ullman S., 2009, CLASSIFICATION OBJEC; Valyear KF, 2006, NEUROPSYCHOLOGIA, V44, P218, DOI 10.1016/j.neuropsychologia.2005.05.004; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 2002, CEREB CORTEX, V12, P756, DOI 10.1093/cercor/12.7.756; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; von Bonin G., 1947, NEOCORTEX MACACA MUL; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; WEISKRANTZ L, 1984, BRAIN, V107, P1033, DOI 10.1093/brain/107.4.1033; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; YAGINUMA S, 1982, NEUROPSYCHOLOGIA, V20, P21, DOI 10.1016/0028-3932(82)90084-7; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; Yasuda M, 2010, CEREB CORTEX, V20, P1630, DOI 10.1093/cercor/bhp227; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005; Zoccolan D, 2007, J NEUROSCI, V27, P12292, DOI 10.1523/JNEUROSCI.1897-07.2007; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	189	830	838	12	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					415	434		10.1016/j.neuron.2012.01.010	http://dx.doi.org/10.1016/j.neuron.2012.01.010			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325196	Green Accepted, Bronze, Green Published			2022-12-25	WOS:000300140600005
J	Thomas, GM; Hayashi, T; Chiu, SL; Chen, CM; Huganir, RL				Thomas, Gareth M.; Hayashi, Takashi; Chiu, Shu-Ling; Chen, Chih-Ming; Huganir, Richard L.			Palmitoylation by DHHC5/8 Targets GRIP1 to Dendritic Endosomes to Regulate AMPA-R Trafficking	NEURON			English	Article							TRANSLATIONAL PROFILING APPROACH; DOMAIN-CONTAINING PROTEINS; NMDA RECEPTOR TRAFFICKING; CNS CELL-TYPES; POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; DIFFERENTIAL PALMITOYLATION; NEURONAL DEVELOPMENT; MENTAL-RETARDATION; IN-VIVO	Palmitoylation, a key regulatory mechanism controlling protein targeting, is catalyzed by DHHC-family palmitoyl acyltransferases (PATs). Impaired PAT activity is linked to neurodevelopmental and neuropsychiatric disorders, suggesting critical roles for palmitoylation in neuronal function. However, few substrates for specific PATs are known, and functional consequences of palmitoylation events are frequently uncharacterized. Here, we identify the closely related PATs DHHC5 and DHHC8 as specific regulators of the PDZ domain protein GRIP1b. Binding, palmitoylation, and dendritic targeting of GRIP1b require a PDZ ligand unique to DHHC5/8. Palmitoylated GRIP1b is targeted to trafficking endosomes and may link endosomes to kinesin motors. Consistent with this trafficking role, GRIP1b's palmitoylation turnover rate approaches the highest of all reported proteins, and palmitoylation increases GRIP1b's ability to accelerate AMPA-R recycling. To our knowledge, these findings identify the first neuronal DHHC5/8 substrate, define novel mechanisms controlling palmitoylation specificity, and suggest further links between dysregulated palmitoylation and neuropathological conditions.	[Thomas, Gareth M.; Hayashi, Takashi; Chiu, Shu-Ling; Chen, Chih-Ming; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Thomas, Gareth M.; Hayashi, Takashi; Chiu, Shu-Ling; Chen, Chih-Ming; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Hunterian 1001,725 N Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu	Chiu, Shu-Ling/F-3613-2014; Chiu, Shu-Ling/AAC-9478-2022	Chiu, Shu-Ling/0000-0003-4429-7830; Hayashi, Takashi/0000-0003-3591-2109	Howard Hughes Medical Institute; NIH [R01 MH64856]; University on sales of products; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University on sales of products; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge Drs. Masaki and Yuko Fukata (National Institutes of Natural Sciences, Okazaki, Japan) for mouse DHHC cDNAs, and Dr. Y. Igarashi (Hokkaido University, Japan) for human DHHC5 and DHHC8 cDNA. We thank Mrs. Min Dai for neuronal "Banker" cultures, Mr. R. Johnson for the myc-FUW vector and KBD construct, Mrs. L. Hamm for expert technical assistance, Dr. C.-Y. Su (Yale University) for comments on the manuscript, and Dr. V. Anggono and all other R.L.H. lab members for helpful discussions. This work was supported by funding from the Howard Hughes Medical Institute and the NIH (R01 MH64856). Under a licensing agreement between Millipore Corporation and The Johns Hopkins University, R.L.H. is entitled to a share of royalties received by the University on sales of products described in this article. R.L.H. is a paid consultant to Millipore Corporation. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict-of-interest policies.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Draper JM, 2010, MOL MEMBR BIOL, V27, P123, DOI 10.3109/09687681003616854; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fallin MD, 2004, AM J HUM GENET, V75, P204, DOI 10.1086/422474; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; GOSLIN K, 1998, CULTURING NERVE CELL; Gratacos M, 2009, AM J MED GENET B, V150B, P808, DOI 10.1002/ajmg.b.30902; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hanley LJ, 2010, NEUROSCI LETT, V485, P167, DOI 10.1016/j.neulet.2010.09.003; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Li Y, 2010, J BIOL CHEM, V285, P13022, DOI 10.1074/jbc.M109.079426; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Mao LF, 2010, P NATL ACAD SCI USA, V107, P19038, DOI 10.1073/pnas.1013494107; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; Mejias R, 2011, P NATL ACAD SCI USA, V108, P4920, DOI 10.1073/pnas.1102233108; Misra C, 2010, MOL CELL NEUROSCI, V43, P341, DOI 10.1016/j.mcn.2010.01.001; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Takamiya K, 2008, J NEUROSCI, V28, P5752, DOI 10.1523/JNEUROSCI.0654-08.2008; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamazaki M, 2001, NEUROSCI LETT, V304, P81, DOI 10.1016/S0304-3940(01)01766-9; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	69	118	119	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					482	496		10.1016/j.neuron.2011.11.021	http://dx.doi.org/10.1016/j.neuron.2011.11.021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325201	Green Accepted, Bronze			2022-12-25	WOS:000300140600010
J	Taverna, E; Haffner, C; Pepperkok, R; Huttner, WB				Taverna, Elena; Haffner, Christiane; Pepperkok, Rainer; Huttner, Wieland B.			A new approach to manipulate the fate of single neural stem cells in tissue	NATURE NEUROSCIENCE			English	Article							RADIAL GLIA; IN-VIVO; NEUROEPITHELIAL CELLS; DEVELOPING NEOCORTEX; BASAL PROGENITORS; CEREBRAL-CORTEX; SELF-RENEWAL; NEURONS; NEUROGENESIS; EXPANSION	A challenge in the field of neural stem cell biology is the mechanistic dissection of single stem cell behavior in tissue. Although such behavior can be tracked by sophisticated imaging techniques, current methods of genetic manipulation do not allow researchers to change the level of a defined gene product on a truly acute time scale and are limited to very few genes at a time. To overcome these limitations, we established microinjection of neuroepithelial/radial glial cells (apical progenitors) in organotypic slice culture of embryonic mouse brain. Microinjected apical progenitors showed cell cycle parameters that were indistinguishable to apical progenitors in utero, underwent self-renewing divisions and generated neurons. Microinjection of single genes, recombinant proteins or complex mixtures of RNA was found to elicit acute and defined changes in apical progenitor behavior and progeny fate. Thus, apical progenitor microinjection provides a new approach to acutely manipulating single neural stem and progenitor cells in tissue.	[Taverna, Elena; Haffner, Christiane; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	Huttner, Wieland B./P-4080-2018; Taverna, Elena/AFW-4935-2022; taverna, elena/O-8180-2014	taverna, elena/0000-0002-2430-4725; Pepperkok, Rainer/0000-0002-9762-3583	Max Planck Institute of Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG) [SFB 655, TRR 83]; European Research Council [250197]; Fonds der Chemischen Industrie	Max Planck Institute of Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We are grateful to R.F. Hevner for kindly providing the Tbr2-GFP mouse line, T. Miyata for pCS2-Ngn2, E. Tanaka for pCAGGS-Cherry and C. Eckmann for OAT and helpful discussion. We thank J. Helppi and other members of the animal facility, as well as H. Wolf of the workshop, of the Max Planck Institute of Molecular Cell Biology and Genetics for excellent support, A. Ettinger for advice with NS-5 cells, K. Saito for advice with retina slice culture, J.F. Fei and Y.J. Chang for experimental advice, Y. Arai and). Pulvers for discussion, and A.-M. Marzesco, F. Mora-Bermudez, E. Paluch and F.K. Wong for helpful comments on the manuscript. W.B.H. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB 655, A2; TRR 83, Tp6) and the European Research Council (250197), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie.	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Alfei L, 1999, EUR J HISTOCHEM, V43, P29; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwon GS, 2007, GENESIS, V45, P208, DOI 10.1002/dvg.20293; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Ludtke JJ, 2002, MOL THER, V5, P579, DOI 10.1006/mthe.2002.0581; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Osumi N, 2001, METHODS, V24, P35, DOI 10.1006/meth.2001.1154; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; PEPPERKOK R, 1988, P NATL ACAD SCI USA, V85, P6748, DOI 10.1073/pnas.85.18.6748; Pepperkok R., 1994, CELL BIOL LAB HDB, P22; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; ROSA P, 1989, J CELL BIOL, V109, P17, DOI 10.1083/jcb.109.1.17; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Sul JY, 2009, P NATL ACAD SCI USA, V106, P7624, DOI 10.1073/pnas.0902161106; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294	44	25	25	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					329	337		10.1038/nn.3008	http://dx.doi.org/10.1038/nn.3008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22179113				2022-12-25	WOS:000299603500026
J	Banghart, MR; Sabatini, BL				Banghart, Matthew R.; Sabatini, Bernardo L.			Photoactivatable Neuropeptides for Spatiotemporally Precise Delivery of Opioids in Neural Tissue	NEURON			English	Article							LOCUS-CERULEUS; POTASSIUM CHANNELS; RECEPTOR; ENKEPHALIN; INHIBITION; DENDRITES; RELEASE; DISSOCIATION; EXPRESSION; DYNORPHIN	Neuropeptides activate G protein-coupled receptors to acutely modulate cellular excitability and synaptic transmission. However, due to the lack of reagents for precise delivery of peptides within dense brain tissue, the spatiotemporal scale over which neuropeptides act is unknown. To achieve rapid and spatially delimited delivery of neuropeptides in mammalian brain tissue, we developed photoactivatable analogs of two opioids: [Leu(5)]-enkephalin (LE) and the 8 amino acid form of Dynorphin A (Dyn-8). These peptides are functionally inactive prior to photolysis, and exposure to ultraviolet (UV) light causes clean release of LE and Dyn-8. Recordings from acute slices of rat locus coeruleus (LC) demonstrated that photorelease of LE activates mu opioid receptor-coupled K+ channels with kinetics that approach the limits imposed by G protein-mediated signaling. Temporally precise and spatially delimited photorelease revealed the kinetics and ionic nature of the mu opioid response and the mechanisms that determine the spatial profile of enkephalinergic volume transmission in LC.	[Banghart, Matthew R.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu		Banghart, Matthew/0000-0001-7248-2932	National Institute of Mental Health [MH085498]; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085498] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank members of the Sabatini laboratory and G. Pekkumaz for helpful comments during the preparation of the manuscript. We thank S.D. Liberles, L.B. Buck, and J. Lemon for assistance with the SEAP assays and for the gift of reagents; J.L. Whistler for the mu opioid receptor plasmid DNA; J.B. Cohen and D.C. Chiara for HPLC access; J.T. Williams for insightful discussions; R. Shah for technical support; and the ICCB-Longwood screening facility for access to plate readers. The work was funded by a grant from the Helen Hay Whitney Foundation (postdoctoral fellowship) to M.R.B. and a grant from the National Institute of Mental Health (MH085498) to B.L.S. M.R.B. conducted the experiments and data analysis. M.R.B. and B.L.S. designed the experiments and wrote the manuscript.	Adamantidis A, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.031.2009; ALREJA M, 1994, BRAIN RES, V639, P320, DOI 10.1016/0006-8993(94)91746-9; ALREJA M, 1993, J NEUROSCI, V13, P3525; BEDDELL CR, 1977, PROC R SOC SER B-BIO, V198, P249, DOI 10.1098/rspb.1977.0096; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Chalifoux JR, 2011, J NEUROSCI, V31, P4221, DOI 10.1523/JNEUROSCI.4561-10.2011; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Curtis AL, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-13-j0001.2001; DROLET G, 1992, J NEUROSCI, V12, P3162, DOI 10.1523/JNEUROSCI.12-08-03162.1992; Duggan AW, 2000, PROG BRAIN RES, V125, P369; DUGGAN AW, 1983, PHARMACOL REV, V35, P219; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Gerrits MAFM, 2003, EUR NEUROPSYCHOPHARM, V13, P424, DOI 10.1016/j.euroneuro.2003.08.003; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Ingram S, 1997, MOL PHARMACOL, V52, P136, DOI 10.1124/mol.52.1.136; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Ishimatsu M, 1996, J NEUROSCI, V16, P5196; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KHACHATURIAN H, 1985, TRENDS NEUROSCI, V8, P111, DOI 10.1016/0166-2236(85)90048-7; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; LUPICA CR, 1992, BRAIN RES, V593, P226, DOI 10.1016/0006-8993(92)91312-3; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; MORLEY JS, 1980, ANNU REV PHARMACOL, V20, P81, DOI 10.1146/annurev.pa.20.040180.000501; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Osborne PB, 1996, J NEUROPHYSIOL, V76, P1559, DOI 10.1152/jn.1996.76.3.1559; PEPPER CM, 1980, SCIENCE, V209, P394, DOI 10.1126/science.7384811; Sarkisov Dmitry V., 2007, V38, P149; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Shipley MT, 1996, J COMP NEUROL, V365, P56, DOI 10.1002/(SICI)1096-9861(19960129)365:1<56::AID-CNE5>3.0.CO;2-I; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Sreekumar R, 1998, Methods Enzymol, V291, P78; Strand FL, 1999, NEUROPEPTIDES REGULA; Svoboda KR, 1999, J NEUROSCI, V19, P85, DOI 10.1523/JNEUROSCI.19-01-00085.1999; Tallent Melanie K., 2008, V44, P177, DOI 10.1007/400_2007_037; Tatsu Y, 1996, BIOCHEM BIOPH RES CO, V227, P688, DOI 10.1006/bbrc.1996.1570; TERENIUS L, 1976, BIOCHEM BIOPH RES CO, V71, P175, DOI 10.1016/0006-291X(76)90265-5; Toll L, 1998, NIDA Res Monogr, V178, P440; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Travagli RA, 1996, J NEUROPHYSIOL, V75, P2029, DOI 10.1152/jn.1996.75.5.2029; TRAVAGLI RA, 1995, J NEUROPHYSIOL, V74, P519, DOI 10.1152/jn.1995.74.2.519; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VanBockstaele EJ, 1996, J COMP NEUROL, V376, P65, DOI 10.1002/(SICI)1096-9861(19961202)376:1<65::AID-CNE4>3.0.CO;2-M; VanBockstaele EJ, 1996, J NEUROSCI, V16, P5037; Wagner J.J., 1995, PSYCHOPHARMACOLOGY 4; WILLIAMS JT, 1982, NATURE, V299, P74, DOI 10.1038/299074a0; WILLIAMS JT, 1987, J PHARMACOL EXP THER, V243, P397; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137	51	51	51	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					249	259		10.1016/j.neuron.2011.11.016	http://dx.doi.org/10.1016/j.neuron.2011.11.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284180	Bronze, Green Accepted			2022-12-25	WOS:000299761600007
J	Salero, E; Blenkinsop, TA; Corneo, B; Harris, A; Rabin, D; Stern, JH; Temple, S				Salero, Enrique; Blenkinsop, Timothy A.; Corneo, Barbara; Harris, Ashley; Rabin, David; Stern, Jeffrey H.; Temple, Sally			Adult Human RPE Can Be Activated into a Multipotent Stem Cell that Produces Mesenchymal Derivatives	CELL STEM CELL			English	Article							RETINAL-PIGMENT EPITHELIUM; SELF-RENEWAL; OSSEOUS METAPLASIA; MAMMALIAN EYE; IN-VITRO; DIFFERENTIATION; REGENERATION; TISSUE; EXPRESSION	The retinal pigment epithelium (RPE) is a monolayer of cells underlying and supporting the neural retina. It begins as a plastic tissue, capable, in some species, of generating lens and retina, but differentiates early in development and remains normally nonproliferative throughout life. Here we show that a subpopulation of adult human APE cells can be activated in vitro to a self-renewing cell, the retinal pigment epithelial stem cell (RPESC) that loses RPE markers, proliferates extensively, and can redifferentiate into stable cobblestone RPE monolayers. Clonal studies demonstrate that RPESCs are multipotent and in defined conditions can generate both neural and mesenchymal progeny. This plasticity may explain human pathologies in which mesenchymal fates are seen in the eye, for example in proliferative vitroretinopathy (PVR) and phthisis bulbi. This study establishes the RPESC as an accessible, human CNS-derived multipotent stem cell, useful for the study of fate choice, replacement therapy, and disease modeling.	[Salero, Enrique; Blenkinsop, Timothy A.; Corneo, Barbara; Rabin, David; Stern, Jeffrey H.; Temple, Sally] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Harris, Ashley] Univ Michigan, Ann Arbor, MI 48109 USA; [Rabin, David; Temple, Sally] Albany Med Coll, Albany, NY 12208 USA	University of Michigan System; University of Michigan; Albany Medical College	Temple, S (corresponding author), Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org		Corneo, Barbara/0000-0001-5189-6749	NYSTEM DOH [C024399, C024414]; American Health Assistance Foundation [M200037]; Steinbach Foundation; Regenerative Research Foundation	NYSTEM DOH; American Health Assistance Foundation(BrightFocus Foundation); Steinbach Foundation; Regenerative Research Foundation	This work was supported by NYSTEM DOH (grants C024399 to E.S. and C024414 to S.T.), American Health Assistance Foundation (M200037 to S.T.), the Steinbach Foundation, and the Regenerative Research Foundation. We acknowledge with deep gratitude the support and encouragement of Dr. Heinrich Medicus. We thank Soma De for early help in establishing the culture system, Meredithe Applebury and Michael Radosevich for helpful discussions, Sheldon Miller and Arvydas Maminishkis for fetal RPE cultures and invaluable insight, and Carol Charniga and Patricia Lederman for technical assistance. We are indebted to the eye donors and their families.	Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Amemiya K, 2004, BIOCHEM BIOPH RES CO, V316, P1, DOI 10.1016/j.bbrc.2004.01.172; APPLE DJ, 1982, AM J OPHTHALMOL, V94, P344, DOI 10.1016/0002-9394(82)90360-9; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blenkinsop T.A., 2011, METHOD MOL IN PRESS; Burke JM, 1996, EXP EYE RES, V62, P63, DOI 10.1006/exer.1996.0008; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Haruta M, 2001, NAT NEUROSCI, V4, P1163, DOI 10.1038/nn762; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Ikegami Y, 2002, J NEUROBIOL, V50, P209, DOI 10.1002/neu.10031; KAMPIK A, 1981, ARCH OPHTHALMOL-CHIC, V99, P1445, DOI 10.1001/archopht.1981.03930020319025; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Loeffler KU, 1996, GRAEF ARCH CLIN EXP, V234, pS70, DOI 10.1007/BF02343051; Loewenstein JI, 1997, ARCH OPHTHALMOL-CHIC, V115, P117, DOI 10.1001/archopht.1997.01100150119023; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Mann I, 1964, ARCH OPHTHALMOL-CHIC, V99, P873; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; PEER J, 1988, AM J OPHTHALMOL, V106, P742, DOI 10.1016/0002-9394(88)90714-3; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Rapaport DH, 1995, J COMP NEUROL, V363, P359, DOI 10.1002/cne.903630303; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Shields CL, 2006, RETINA-J RET VIT DIS, V26, P328, DOI 10.1097/00006982-200603000-00012; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Spence JR, 2007, DEV DYNAM, V236, P1161, DOI 10.1002/dvdy.21115; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Toyran S, 2005, BRIT J OPHTHALMOL, V89, P885, DOI 10.1136/bjo.2004.056374; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Vemuganti Geeta K., 2002, Indian Journal of Ophthalmology, V50, P183	32	182	193	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					88	95		10.1016/j.stem.2011.11.018	http://dx.doi.org/10.1016/j.stem.2011.11.018			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226358	Bronze			2022-12-25	WOS:000299449500013
J	Mogil, JS; Sorge, RE; LaCroix-Fralish, ML; Smith, SB; Fortin, A; Sotocinal, SG; Ritchie, J; Austin, JS; Schorscher-Petcu, A; Melmed, K; Czerminski, J; Bittong, RA; Mokris, JB; Neubert, JK; Campbell, CM; Edwards, RR; Campbell, JN; Crawley, JN; Lariviere, WR; Wallace, MR; Sternberg, WF; Balaban, CD; Belfer, I; Fillingim, RB				Mogil, Jeffrey S.; Sorge, Robert E.; LaCroix-Fralish, Michael L.; Smith, Shad B.; Fortin, Anny; Sotocinal, Susana G.; Ritchie, Jennifer; Austin, Jean-Sebastien; Schorscher-Petcu, Ara; Melmed, Kara; Czerminski, Jan; Bittong, Rosalie A.; Mokris, J. Brad; Neubert, John K.; Campbell, Claudia M.; Edwards, Robert R.; Campbell, James N.; Crawley, Jacqueline N.; Lariviere, William R.; Wallace, Margaret R.; Sternberg, Wendy F.; Balaban, Carey D.; Belfer, Inna; Fillingim, Roger B.			Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction	NATURE NEUROSCIENCE			English	Article							INBRED MOUSE STRAINS; STRESS-INDUCED ANALGESIA; NOCICEPTION; RESPONSES; RECEPTOR; OXYTOCIN; MICE; HERITABILITY; MECHANISMS; CAPSAICIN	Quantitative trait locus mapping of chemical/inflammatory pain in the mouse identified the Avpr1a gene, which encodes the vasopressin-1A receptor (V1AR), as being responsible for strain-dependent pain sensitivity to formalin and capsaicin. A genetic association study in humans revealed the influence of a single nucleotide polymorphism (rs10877969) in AVPR1A on capsaicin pain levels, but only in male subjects reporting stress at the time of testing. The analgesic efficacy of the vasopressin analog desmopressin revealed a similar interaction between the drug and acute stress, as desmopressin inhibition of capsaicin pain was only observed in nonstressed subjects. Additional experiments in mice confirmed the male-specific interaction of V1AR and stress, leading to the conclusion that vasopressin activates endogenous analgesia mechanisms unless they have already been activated by stress. These findings represent, to the best of our knowledge, the first explicit demonstration of analgesic efficacy depending on the emotional state of the recipient, and illustrate the heuristic power of a bench-to-bedside-to-bench translational strategy.	[Mogil, Jeffrey S.; Sorge, Robert E.; LaCroix-Fralish, Michael L.; Smith, Shad B.; Sotocinal, Susana G.; Ritchie, Jennifer; Austin, Jean-Sebastien; Schorscher-Petcu, Ara; Melmed, Kara; Czerminski, Jan] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Mogil, Jeffrey S.; Sorge, Robert E.; LaCroix-Fralish, Michael L.; Smith, Shad B.; Sotocinal, Susana G.; Ritchie, Jennifer; Austin, Jean-Sebastien; Schorscher-Petcu, Ara; Melmed, Kara; Czerminski, Jan] McGill Univ, Ctr Res Pain, Montreal, PQ, Canada; [Fortin, Anny] Emerillon Therapeut, Montreal, PQ, Canada; [Bittong, Rosalie A.; Mokris, J. Brad; Neubert, John K.; Fillingim, Roger B.] Univ Florida, Coll Dent, Gainesville, FL USA; [Campbell, Claudia M.; Edwards, Robert R.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Campbell, James N.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA; [Crawley, Jacqueline N.] NIMH, Bethesda, MD 20892 USA; [Lariviere, William R.; Belfer, Inna] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Wallace, Margaret R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sternberg, Wendy F.] Haverford Coll, Dept Psychol, Haverford, PA 19041 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	McGill University; McGill University; State University System of Florida; University of Florida; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Haverford College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mogil, JS (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	jeffrey.mogil@mcgill.ca	Balaban, Carey/O-6586-2019; Smith, Shad/AAO-8760-2020; Mogil, Jeffrey/AAA-9611-2019; Balaban, Carey/I-3467-2017; Fillingim, Roger/K-3569-2019; Melmed, Kara/AAS-3287-2020	Balaban, Carey/0000-0002-3570-3844; Mogil, Jeffrey/0000-0003-1359-5720; Balaban, Carey/0000-0002-3570-3844; Melmed, Kara/0000-0003-4084-8586; Fillingim, Roger/0000-0002-7699-8183; Czerminski, Jan/0000-0002-2576-4192; LaCroix-Fralish, Michael/0000-0002-8850-5972; Ritchie, Jennifer/0000-0003-2092-1387; Schorscher-Petcu, Ara/0000-0001-5808-5172	US National Institutes of Health [NS41670]; CTSA [RR02980]; Louise and Alan Edwards Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021198, R01DA015191] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Louise and Alan Edwards Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by US National Institutes of Health grant NS41670 (R.B.F. and J.S.M.), CTSA grant RR02980 and the Louise and Alan Edwards Foundation (J.S.M.). We thank Pfeiffer of America for providing metered spray pumps.	ABBOTT FV, 1986, EUR J PHARMACOL, V126, P141, DOI 10.1016/0014-2999(86)90750-8; Balaban CD, 2005, J PAIN, V6, P315, DOI 10.1016/j.jpain.2005.01.346; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; FANSELOW MS, 1986, J EXP PSYCHOL ANIM B, V12, P301, DOI 10.1037/0097-7403.12.3.301; Fillingim RB, 2005, J PAIN, V6, P116, DOI 10.1016/j.jpain.2004.11.005; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; GAMBLE GD, 1989, NEUROSCI LETT, V96, P312, DOI 10.1016/0304-3940(89)90397-2; Honda K, 2009, J PHARMACOL SCI, V109, P38, DOI 10.1254/jphs.08R30FM; Hu SB, 2003, J NEUROIMMUNOL, V135, P72, DOI 10.1016/S0165-5728(02)00442-3; KEMPPAINEN P, 1987, PHARMACOL TOXICOL, V61, P16, DOI 10.1111/j.1600-0773.1987.tb01765.x; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Lariviere WR, 2005, J PAIN, V6, P777, DOI 10.1016/j.jpain.2005.06.007; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; Mogil Jefrey S., 1996, Physiology and Behavior, V59, P123, DOI 10.1016/0031-9384(95)02073-X; Mogil JS, 1997, PHARMACOL BIOCHEM BE, V56, P61, DOI 10.1016/S0091-3057(96)00157-8; Mogil JS, 1998, PAIN, V76, P115, DOI 10.1016/S0304-3959(98)00032-3; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Nair HK, 2011, PAIN, V152, P599, DOI 10.1016/j.pain.2010.11.029; Nissenbaum J, 2010, GENOME RES, V20, P1180, DOI 10.1101/gr.104976.110; Pohl J, 1996, PEPTIDES, V17, P641, DOI 10.1016/0196-9781(96)00034-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schmelz M, 2009, EXP BRAIN RES, V196, P173, DOI 10.1007/s00221-009-1809-2; Schorscher-Petcu A, 2010, J NEUROSCI, V30, P8274, DOI 10.1523/JNEUROSCI.1594-10.2010; Shi MM, 1999, J CLIN PATHOL-MOL PA, V52, P295, DOI 10.1136/mp.52.5.295; Stern R. A., 1997, VISUAL ANALOG MOOD S; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; Tribollet E, 1998, PROG BRAIN RES, V119, P45; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wilson SG, 2002, PAIN, V96, P385, DOI 10.1016/S0304-3959(01)00489-4; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905; Yang J, 2006, BRAIN RES, V1069, P127, DOI 10.1016/j.brainres.2005.11.045; Yang J, 2006, REGUL PEPTIDES, V137, P156, DOI 10.1016/j.regpep.2006.07.004; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	40	79	86	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1569	U99		10.1038/nn.2941	http://dx.doi.org/10.1038/nn.2941			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22019732	Green Accepted			2022-12-25	WOS:000297546300017
J	Szulwach, KE; Li, XK; Li, YJ; Song, CX; Wu, H; Dai, Q; Irier, H; Upadhyay, AK; Gearing, M; Levey, AI; Vasanthakumar, A; Godley, LA; Chang, Q; Cheng, XD; He, C; Jin, P				Szulwach, Keith E.; Li, Xuekun; Li, Yujing; Song, Chun-Xiao; Wu, Hao; Dai, Qing; Irier, Hasan; Upadhyay, Anup K.; Gearing, Marla; Levey, Allan I.; Vasanthakumar, Aparna; Godley, Lucy A.; Chang, Qiang; Cheng, Xiaodong; He, Chuan; Jin, Peng			5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging	NATURE NEUROSCIENCE			English	Article							EMBRYONIC STEM-CELLS; CPG-BINDING PROTEIN-2; DNA METHYLATION; L1 RETROTRANSPOSITION; RETT-SYNDROME; ADULT NEUROGENESIS; BDNF TRANSCRIPTION; MEMORY FORMATION; MECP2; 5-HYDROXYMETHYLCYTOSINE	DNA methylation dynamics influence brain function and are altered in neurological disorders. 5-hydroxymethylcytosine (5-hmC), a DNA base that is derived from 5-methylcytosine, accounts for similar to 40% of modified cytosine in the brain and has been implicated in DNA methylation-related plasticity. We mapped 5-hmC genome-wide in mouse hippocampus and cerebellum at three different ages, which allowed us to assess its stability and dynamic regulation during postnatal neurodevelopment through adulthood. We found developmentally programmed acquisition of 5-hmC in neuronal cells. Epigenomic localization of 5-hmC-regulated regions revealed stable and dynamically modified loci during neurodevelopment and aging. By profiling 5-hmC in human cerebellum, we found conserved genomic features of 5-hmC. Finally, we found that 5-hmC levels were inversely correlated with methyl-CpG-binding protein 2 dosage, a protein encoded by a gene in which mutations cause Rett syndrome. These data suggest that 5-hmC-mediated epigenetic modification is critical in neurodevelopment and diseases.	[Szulwach, Keith E.; Li, Xuekun; Li, Yujing; Irier, Hasan; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Song, Chun-Xiao; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Song, Chun-Xiao; Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Upadhyay, Anup K.; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Gearing, Marla; Levey, Allan I.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Vasanthakumar, Aparna; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Chang, Qiang] Univ Wisconsin, Waisman Ctr, Dept Genet & Neurol, Madison, WI 53705 USA	Emory University; University of Chicago; University of Chicago; Emory University; Rollins School Public Health; Emory University; Emory University; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	peng.jin@emory.edu	Wu, Hao/H-3899-2017; Li, Yujing/AAJ-1411-2020; Levey, Allan/F-2104-2011; Jin, Peng/B-5977-2012; Dai, Qing/ABD-8444-2021; Li, yujing/GQA-4109-2022	Wu, Hao/0000-0003-1269-7354; Li, Yujing/0000-0002-4363-2484; Levey, Allan/0000-0002-3153-502X; Jin, Peng/0000-0001-6137-6659; Song, Chun-Xiao/0000-0002-7781-6521	US National Institutes of Health (NIH) [T32MH087977]; NIH [CA129831, CA129831-03S1, GM071440, GM049245, NS051630, MH076090, P50AG025688]; Emory Alzheimer's Disease Center [P50AG025688]; Simons Foundation Autism Research Initiative; Beckman Young Investigator Award; Basil O'Connor Scholar Research Award; Emory Genetics Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064743, P30HD003352] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA129831] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245, R01GM071440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087977, R56MH076090, R01MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051630, R21NS067461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Alzheimer's Disease Center; Simons Foundation Autism Research Initiative; Beckman Young Investigator Award; Basil O'Connor Scholar Research Award(March of Dimes); Emory Genetics Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank the members of the Jin laboratory for their assistance, and S.T. Warren and C. Strauss for critical reading of the manuscript. H.I. is supported by the Training Program in Human Disease Genetics funded by the US National Institutes of Health (NIH, T32MH087977). L.A.G. is supported by NIH grants CA129831 and CA129831-03S1. C.H. was partially supported by NIH grant GM071440. X.C. was supported by NIH grant GM049245 and is a Georgia Research Alliance Eminent Scholar. M.G. and A.I.L. are partially supported by Emory Alzheimer's Disease Center (P50AG025688). P.J. is supported by NIH grants (NS051630, MH076090 and P50AG025688) and Simons Foundation Autism Research Initiative. P.J. is also the recipient of a Beckman Young Investigator Award, Basil O'Connor Scholar Research Award and Alfred P. Sloan Research Fellow in Neuroscience. This work was supported, in part, by the Emory Genetics Discovery Fund.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kuemerle B, 1997, J NEUROSCI, V17, P7881; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Song DL, 1996, DEVELOPMENT, V122, P627; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	579	602	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1607	U150		10.1038/nn.2959	http://dx.doi.org/10.1038/nn.2959			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037496	Green Accepted			2022-12-25	WOS:000297546300022
J	Takashima, S; Kanatsu-Shinohara, M; Tanaka, T; Takehashi, M; Morimoto, H; Shinohara, T				Takashima, Seiji; Kanatsu-Shinohara, Mito; Tanaka, Takashi; Takehashi, Masanori; Morimoto, Hiroko; Shinohara, Takashi			Rac Mediates Mouse Spermatogonial Stem Cell Homing to Germline Niches by Regulating Transmigration through the Blood-Testis Barrier	CELL STEM CELL			English	Article							TIGHT JUNCTION STRANDS; SELF-RENEWAL; MICE; SPERMATOGENESIS; TRANSPLANTATION; PROLIFERATION; TRANSMISSION; ACTIVATION; GENERATION; MIGRATION	The homing ability of spermatogonial stem cells (SSCs) allows them to migrate into niches after being transplantated into infertile testes. Transplanted SSCs attach to Sertoli cells and transmigrate through the blood-testis barrier (BTB), formed by inter-Sertoli tight junctions, toward niches on the basement membrane. The most critical step is the passage through the BTB, which limits the homing efficiency to <10%. Here we demonstrated the involvement of Rac1 in SSC transmigration. Rac1-deficient SSCs did not colonize the adult testes, but they reinitiated spermatogenesis when transplanted into pup testes without a BTB. Moreover, a dominant-negative Rac1 construct not only reduced the expression of several claudin proteins, which comprise the BTB, but also increased SSC proliferation both in vitro and in vivo. Short hairpin RNA (shRNA) -mediated suppression of claudin3, which was downregulated by Rac inhibition, reduced the SSC homing efficiency. Thus, Rac1 is a critical regulator of SSC homing and proliferation.	[Takashima, Seiji; Kanatsu-Shinohara, Mito; Tanaka, Takashi; Takehashi, Masanori; Morimoto, Hiroko; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Shinohara, Takashi] CREST, Japan Sci & Technol Agcy, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kanatsu-Shinohara, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	mshinoha@virus.kyoto-u.ac.jp; tshinoha@virus.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019	Takashima, Seiji/0000-0002-9176-3139	Japan Science and Technology Agency (CREST); Program for Promotion of Basic and Applied Researches for Innovation in Bio-Oriented Industry; Senri Life Science Foundation; Ministry of Health, Labour, and Welfare; Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Researches for Innovation in Bio-Oriented Industry; Senri Life Science Foundation; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Government of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors declare they have no financial conflicts of interest. We thank Ms. Y. Ogata for technical assistance and Dr. S. Tsukita for the generous gifts of KO mice and antibodies against claudins. This research was supported by Japan Science and Technology Agency (CREST); Program for Promotion of Basic and Applied Researches for Innovation in Bio-Oriented Industry; Senri Life Science Foundation; the Ministry of Health, Labour, and Welfare; Government of Japan through its "Funding Program for Next Generation World-Leading Researchers:" and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cancelas JA, 2006, EXP HEMATOL, V34, P976, DOI 10.1016/j.exphem.2006.03.016; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; De Rooij DG, 2000, J ANDROL, V21, P776; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kanatsu-Shinohara M, 2010, P NATL ACAD SCI USA, V107, P6210, DOI 10.1073/pnas.0914448107; Kitajiri SI, 2004, J CELL SCI, V117, P5087, DOI 10.1242/jcs.01393; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Morrow CMK, 2009, BIOL REPROD, V81, P871, DOI 10.1095/biolreprod.109.077040; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohta H, 2004, BIOL REPROD, V70, P1286, DOI 10.1095/biolreprod.103.024612; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; Russell LD, 1996, J ANDROL, V17, P603; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	40	43	44	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 4	2011	9	5					463	475		10.1016/j.stem.2011.08.011	http://dx.doi.org/10.1016/j.stem.2011.08.011			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	850FJ	22056142	Bronze			2022-12-25	WOS:000297180200013
J	Erlich, JC; Bialek, M; Brody, CD				Erlich, Jeffrey C.; Bialek, Max; Brody, Carlos D.			A Cortical Substrate for Memory-Guided Orienting in the Rat	NEURON			English	Article							FRONTAL EYE FIELD; POSTERIOR PARIETAL CORTEX; MEDIAL AGRANULAR CORTEX; MOTOR CORTEX; PREFRONTAL CORTEX; SUPERIOR COLLICULUS; ELECTRICAL-STIMULATION; AFFERENT CONNECTIONS; EFFERENT CONNECTIONS; PREPARATION SIGNALS	Anatomical, stimulation, and lesion data have suggested a homology between the rat frontal orienting fields (FOE) (centered at +2 AP, +/- 1.3 ML mm from Bregma) and primate frontal cortices such as the frontal or supplementary eye fields. We investigated the functional role of the FOF using rats trained to perform a memory-guided orienting task, in which there was a delay period between the end of a sensory stimulus instructing orienting direction and the time of the allowed motor response. Unilateral inactivation of the FOF resulted in impaired contralateral responses. Extracellular recordings of single units revealed that 37% of FOF neurons had delay period firing rates that predicted the direction of the rats' later orienting motion. Our data provide the first electrophysiological and pharmacological evidence supporting the existence in the rat, as in the primate, of a frontal cortical area involved in the preparation and/or planning of orienting responses.	[Erlich, Jeffrey C.; Bialek, Max; Brody, Carlos D.] Princeton Univ, Howard Hughes Med Inst, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Erlich, Jeffrey C.; Bialek, Max; Brody, Carlos D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University	Brody, CD (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	brody@princeton.edu	Bialek, Max/AAT-1360-2021; Erlich, Jeffrey C./G-3717-2011	Erlich, Jeffrey C./0000-0001-9073-7986; Bialek, Max/0000-0003-1590-0063	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank B.W. Brunton and J.K. Jun for contributions to software to obtain head direction data, D.W. Tank and J.P. Rickgauer for suggestions to improve whisker tracking, B.W. Brunton, J.K. Jun, C.D. Kopec. and T. Hanks for discussion and comments on the manuscript, A. Keller and D. Kleinfeld for discussions related to the role of the FOE in whisker control, and L. Osorio and G. Brown for technical assistance. This work was supported by the Howard Hughes Medical Institute.	Arbib MA, 1997, PHILOS T R SOC B, V352, P1429, DOI 10.1098/rstb.1997.0129; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407; Corwin JV, 1998, PSYCHOBIOLOGY, V26, P87; COWEY A, 1974, BRAIN RES, V72, P53, DOI 10.1016/0006-8993(74)90649-0; CROWNE DP, 1986, BEHAV BRAIN RES, V22, P227, DOI 10.1016/0166-4328(86)90067-7; CROWNE DP, 1982, BEHAV BRAIN RES, V6, P25, DOI 10.1016/0166-4328(82)90079-1; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Dorris MC, 1998, J NEUROSCI, V18, P7015; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Ferrier D, 1875, P ROY SOC LOND B BIO, V23, P409, DOI DOI 10.1098/RSPL.1874.0058; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Goldman-Rakic P S, 1992, Curr Opin Neurobiol, V2, P830, DOI 10.1016/0959-4388(92)90141-7; Green D. M., 1974, SIGNAL DETECTION THE; Guandalini P, 1998, BRAIN RES BULL, V47, P377, DOI 10.1016/S0361-9230(98)00122-1; Hebb DO, 1940, ARCH NEURO PSYCHIATR, V44, P421, DOI 10.1001/archneurpsyc.1940.02280080181011; Hull CL, 1932, PSYCHOL REV, V39, P25, DOI 10.1037/h0072640; Kargo WJ, 2007, J NEUROSCI, V27, P3548, DOI 10.1523/JNEUROSCI.3604-06.2007; Keller EL, 2008, J NEUROPHYSIOL, V100, P2726, DOI 10.1152/jn.90673.2008; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; KUNZLE H, 1976, BRAIN RES, V117, P487, DOI 10.1016/0006-8993(76)90754-X; Lawrence BM, 2005, J NEUROPHYSIOL, V94, P1498, DOI 10.1152/jn.00214.2005; LEICHNETZ GR, 1987, J COMP NEUROL, V263, P387, DOI 10.1002/cne.902630306; LEONARD CM, 1969, BRAIN RES, V12, P321, DOI 10.1016/0006-8993(69)90003-1; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MISHKIN M, 1955, J COMP PHYSIOL PSYCH, V48, P492, DOI 10.1037/h0040318; Mizumori S.J., 2005, HEAD DIRECTION CELLS, P203; Monteon JA, 2010, J NEUROPHYSIOL, V104, P3462, DOI 10.1152/jn.01032.2009; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; Nakamura K, 1999, J NEUROPHYSIOL, V82, P2503, DOI 10.1152/jn.1999.82.5.2503; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Paxinos G., 2004, RAT BRAIN STEREOTAXI; REEP RL, 1984, NEUROSCI LETT, V44, P247, DOI 10.1016/0304-3940(84)90030-2; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Reep RL, 2009, NEUROBIOL LEARN MEM, V91, P104, DOI 10.1016/j.nlm.2008.08.010; RIEHLE A, 1993, BEHAV BRAIN RES, V53, P35, DOI 10.1016/S0166-4328(05)80264-5; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schiller PH, 2005, PROG BRAIN RES, V149, P157, DOI 10.1016/S0079-6123(05)49012-3; SINNAMON HM, 1984, PHYSIOL BEHAV, V33, P185, DOI 10.1016/0031-9384(84)90098-2; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Steinmetz NA, 2010, J NEUROPHYSIOL, V103, P1171, DOI 10.1152/jn.00689.2009; STUESSE SL, 1990, EXP BRAIN RES, V80, P532; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Tolman EC, 1938, PSYCHOL REV, V45, P1, DOI 10.1037/h0062733; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Zilles K., 1985, CORTEX RAT STEREOTAX	66	172	173	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					330	343		10.1016/j.neuron.2011.07.010	http://dx.doi.org/10.1016/j.neuron.2011.07.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017991	Bronze, Green Accepted			2022-12-25	WOS:000296224000014
J	Guo, JJU; Ma, DKK; Mo, H; Ball, MP; Jang, MH; Bonaguidi, MA; Balazer, JA; Eaves, HL; Xie, B; Ford, E; Zhang, K; Ming, GL; Gao, Y; Song, HJ				Guo, Junjie U.; Ma, Dengke K.; Mo, Huan; Ball, Madeleine P.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Balazer, Jacob A.; Eaves, Hugh L.; Xie, Bin; Ford, Eric; Zhang, Kun; Ming, Guo-li; Gao, Yuan; Song, Hongjun			Neuronal activity modifies the DNA methylation landscape in the adult brain	NATURE NEUROSCIENCE			English	Article							REGULATES MEMORY FORMATION; EPIGENETIC REGULATION; GENE-REGULATION; DEMETHYLATION; CELLS; TRANSCRIPTION; PLASTICITY; GENOME; NEUROGENESIS; CANCER	DNA methylation has been traditionally viewed as a highly stable epigenetic mark in postmitotic cells. However, postnatal brains appear to show stimulus-induced methylation changes, at least in a few identified CpG dinucleotides. How extensively the neuronal DNA methylome is regulated by neuronal activity is unknown. Using a next-generation sequencing-based method for genome-wide analysis at single-nucleotide resolution, we quantitatively compared the CpG methylation landscape of adult mouse dentate granule neurons in vivo before and after synchronous neuronal activation. About 1.4% of 219,991 CpGs measured showed rapid active demethylation or de novo methylation. Some modifications remained stable for at least 24 h. These activity-modified CpGs showed a broad genomic distribution with significant enrichment in low-CpG density regions, and were associated with brain-specific genes related to neuronal plasticity. Our study implicates modification of the neuronal DNA methylome as a previously underappreciated mechanism for activity-dependent epigenetic regulation in the adult nervous system.	[Guo, Junjie U.; Ma, Dengke K.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Ming, Guo-li; Gao, Yuan; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Ma, Dengke K.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mo, Huan; Eaves, Hugh L.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Ball, Madeleine P.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02138 USA; [Balazer, Jacob A.] Proofpoint Inc, Sunnyvale, CA USA; [Xie, Bin; Gao, Yuan] Lieber Inst Brain Dev, Div Genom Epigenom & Bioinformat, Baltimore, MD USA; [Ford, Eric] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Virginia Commonwealth University; Harvard University; Johns Hopkins University; University of California System; University of California San Diego	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	garygao@gmail.com; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013; Gao, Yuan/E-1706-2011; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; Mo, Huan/0000-0001-6029-458X; Ball, Mad/0000-0003-0544-5925	US National Institutes of Health (NIH) [AG024984, NS047344]; McKnight Scholar Award; NARSAD; NIH [HD069184, NS048271]; Johns Hopkins Brain Science Institute; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Lieber Institute; US National Institute of Mental Health [MH090115]; Maryland Stem Cell Research Fund (MSCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH090115, R00MH090115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R37NS047344, R01NS047344, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Brain Science Institute(Johns Hopkins University); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Lieber Institute; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Maryland Stem Cell Research Fund (MSCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Church, S. Baylin, D. Ginty and K. Christian for comments and suggestions; G. Sun for help with FACS; and W. Y. Kim (Johns Hopkins University) for breeding Gadd45b knockout mice. This work was supported by US National Institutes of Health (NIH; AG024984, NS047344), McKnight Scholar Award and NARSAD (Brain and Behavior Research Fund) to H. S.; by NIH (HD069184, NS048271), Johns Hopkins Brain Science Institute, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and NARSAD grants to G.-l. M.; and Lieber Institute start-up funds to Y. G. J.U.G. was a FARMS (Foundation for Advanced Research in Medical Sciences) fellow. M.H.J. was supported by a US National Institute of Mental Health K99 award (MH090115). M. A. B. was partially supported by a fellowship from Maryland Stem Cell Research Fund (MSCRF); M. P. B. was supported by grants from the NIH to G. Church.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Ford EC, 2011, RADIAT RES, V175, P774, DOI 10.1667/RR2214.1; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; NASS MMK, 1973, J MOL BIOL, V80, P155, DOI 10.1016/0022-2836(73)90239-8; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	50	459	467	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1345	U172		10.1038/nn.2900	http://dx.doi.org/10.1038/nn.2900			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874013	Green Accepted			2022-12-25	WOS:000295254200025
J	Morgan, JL; Soto, F; Wong, ROL; Kerschensteiner, D				Morgan, Joshua L.; Soto, Florentina; Wong, Rachel O. L.; Kerschensteiner, Daniel			Development of Cell Type-Specific Connectivity Patterns of Converging Excitatory Axons in the Retina	NEURON			English	Article							BIPOLAR CELLS; MOUSE RETINA; GANGLION-CELLS; PRIMATE RETINA; SYNAPTIC CONNECTIVITY; CORTICAL CIRCUITS; MAMMALIAN RETINA; CAT RETINA; IN-VIVO; SYNAPSES	To integrate information from different presynaptic cell types, dendrites receive distinct patterns of synapses from converging axons. How different afferents in vivo establish specific connectivity patterns with the same dendrite is poorly understood. Here, we examine the synaptic development of three glutamatergic bipolar cell types converging onto a common postsynaptic retinal ganglion cell. We find that after axons and dendrites target appropriate synaptic layers, patterns of connections among these neurons diverge through selective changes in the conversion of axo-dendritic appositions to synapses. This process is differentially regulated by neurotransmission, which is required for the shift from single to multisynaptic appositions of one bipolar cell type but not for maintenance and elimination, respectively, of connections from the other two types. Thus, synaptic specificity among converging excitatory inputs in the retina emerges via differential synaptic maturation of axo-dendritic appositions and is shaped by neurotransmission in a cell type-dependent manner.	[Morgan, Joshua L.; Wong, Rachel O. L.; Kerschensteiner, Daniel] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; [Soto, Florentina; Kerschensteiner, Daniel] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL)	Kerschensteiner, D (corresponding author), Univ Washington, Sch Med, Dept Biol Struct, 1959 NE Pacific St, Seattle, WA 98195 USA.	dkerschensteiner@wustl.edu			NEI [EY 07031]; NIH [EY10699, EY17101]; J.S. McDonnell Foundation; Alfred P. Sloan Foundation; Whitehall Foundation; Hope for Vision Foundation; Edward Mallinckrodt Jr. Foundation; NATIONAL EYE INSTITUTE [R01EY017101, F32EY007031, R01EY021855, P30EY001730, T32EY007031, R01EY010699] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; Hope for Vision Foundation; Edward Mallinckrodt Jr. Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Wong and Kerschensteiner laboratories for comments on the manuscript. This work was supported by an NEI Training grant EY 07031 (University of Washington, J.L.M.), NIH grants EY10699, EY17101, and J.S. McDonnell Foundation (R.O.L.W.), the Alfred P. Sloan Foundation, the Whitehall Foundation, the Hope for Vision Foundation, and the Edward Mallinckrodt Jr. Foundation (D.K.).	Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Breuninger T, 2011, J NEUROSCI, V31, P6504, DOI 10.1523/JNEUROSCI.0616-11.2011; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Freed MA, 2000, J NEUROSCI, V20, P3956; FREED MA, 1988, J NEUROSCI, V8, P2303; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Haverkamp S, 2001, J NEUROSCI, V21, P2488, DOI 10.1523/JNEUROSCI.21-07-02488.2001; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; MORGAN JL, 2011, IMAGING DEV BIOL, P177; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	56	62	62	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 22	2011	71	6					1014	1021		10.1016/j.neuron.2011.08.025	http://dx.doi.org/10.1016/j.neuron.2011.08.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943599	Green Accepted, Bronze			2022-12-25	WOS:000295556500007
J	Gittis, AH; Hang, GB; LaDow, ES; Shoenfeld, LR; Atallah, BV; Finkbeiner, S; Kreitzer, AC				Gittis, Aryn H.; Hang, Giao B.; LaDow, Eva S.; Shoenfeld, Liza R.; Atallah, Bassam V.; Finkbeiner, Steven; Kreitzer, Anatol C.			Rapid Target-Specific Remodeling of Fast-Spiking Inhibitory Circuits after Loss of Dopamine	NEURON			English	Article							MEDIUM SPINY NEURONS; HIPPOCAMPAL INTERNEURON NETWORKS; SYNCHRONIZED GAMMA-OSCILLATIONS; EXTERNAL GLOBUS-PALLIDUS; BASAL GANGLIA OUTPUT; BAC TRANSGENIC MICE; PARKINSONS-DISEASE; GABAERGIC INTERNEURONS; SUBTHALAMIC NUCLEUS; STRIATAL NEURONS	In Parkinson's disease (PD), dopamine depletion alters neuronal activity in the direct and indirect pathways and leads to increased synchrony in the basal ganglia network. However, the origins of these changes remain elusive. Because GABAergic interneurons regulate activity of projection neurons and promote neuronal synchrony, we recorded from pairs of striatal fast-spiking (FS) interneurons and direct- or indirect-pathway MSNs after dopamine depletion with 6-OHDA. Synaptic properties of FS-MSN connections remained similar, yet within 3 days of dopamine depletion, individual FS cells doubled their connectivity to indirect-pathway MSNs, whereas connections to direct-pathway MSNs remained unchanged. A model of the striatal microcircuit revealed that such increases in FS innervation were effective at enhancing synchrony within targeted cell populations. These data suggest that after dopamine depletion, rapid target-specific microcircuit organization in the striatum may lead to increased synchrony of indirect-pathway MSNs that contributes to pathological network oscillations and motor symptoms of PD.	[Gittis, Aryn H.; Hang, Giao B.; LaDow, Eva S.; Shoenfeld, Liza R.; Finkbeiner, Steven; Kreitzer, Anatol C.] Univ Calif San Diego, Gladstone Inst Neurol Dis, La Jolla, CA 92093 USA; [LaDow, Eva S.] Univ Calif San Diego, Pharmacogen & Pharmaceut Sci Program, La Jolla, CA 92093 USA; [Atallah, Bassam V.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Atallah, Bassam V.] Univ Calif San Diego, Neurobiol Sect, Div Biol, La Jolla, CA 92093 USA; [Finkbeiner, Steven; Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Finkbeiner, Steven; Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Univ Calif San Diego, Gladstone Inst Neurol Dis, La Jolla, CA 92093 USA.	akreitzer@gladstone.ucsf.edu	Gittis, Aryn/I-6128-2016	Gittis, Aryn/0000-0002-3591-5775; Atallah, Bassam/0000-0003-2315-7126	Tourette Syndrome Association; NIH [F32 NS065641, R01 NS064984]; Pew Biomedical Scholars Program; W.M. Keck Foundation; McKnight Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984, F32NS065641] Funding Source: NIH RePORTER	Tourette Syndrome Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Biomedical Scholars Program; W.M. Keck Foundation(W.M. Keck Foundation); McKnight Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to K. Bender, J. Fish, and P. Ohara for assistance with cell fills and neuron reconstructions. Thank you to R. Johnson in the Vanderbilt Neurochemistry Core for performing HPLC analyses and K. Thorn and A. Thwin in the UCSF Nikon Imaging Center for assistance with microscopy. Mini analysis and data acquisition routines for Igor Pro were written by M.A. Xu-Friedman. This work was supported by grants to A.H.G. from the Tourette Syndrome Association and NIH Grant F32 NS065641, and to A.C.K. by NIH Grant R01 NS064984, the Pew Biomedical Scholars Program, the W.M. Keck Foundation, and the McKnight Foundation.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Azdad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006908; Bacci A, 2003, J NEUROSCI, V23, P9664; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bausch SB, 2005, EPILEPSY BEHAV, V7, P390, DOI 10.1016/j.yebeh.2005.07.019; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bevan MD, 1998, J NEUROSCI, V18, P9438; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Branchi I, 2010, BEHAV BRAIN RES, V208, P137, DOI 10.1016/j.bbr.2009.11.020; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Burkhardt JM, 2007, EUR J NEUROSCI, V26, P1912, DOI 10.1111/j.1460-9568.2007.05813.x; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Centonze D, 2003, J NEUROSCI, V23, P6245; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Courtemanche R, 2003, J NEUROSCI, V23, P11741; DAVENPORT CJ, 1990, EXP NEUROL, V109, P180, DOI 10.1016/0014-4886(90)90072-Z; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Dehorter N, 2009, J NEUROSCI, V29, P7776, DOI 10.1523/JNEUROSCI.1527-09.2009; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Fino E, 2007, NEUROSCI RES, V58, P305, DOI 10.1016/j.neures.2007.04.002; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Galvan A, 2007, PROG BRAIN RES, V160, P287, DOI 10.1016/S0079-6123(06)60017-4; Gernert M, 2002, J NEUROSCI, V22, P7244; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Jaidar O, 2010, J NEUROSCI, V30, P11326, DOI 10.1523/JNEUROSCI.1380-10.2010; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Klaassen A, 2006, P NATL ACAD SCI USA, V103, P19152, DOI 10.1073/pnas.0608215103; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kuhn AA, 2008, EXP NEUROL, V214, P140, DOI 10.1016/j.expneurol.2008.07.023; Kuhn AA, 2004, BRAIN, V127, P735, DOI 10.1093/brain/awh106; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Smith Y, 1998, NEUROSCIENCE, V86, P353; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; VALDES F, 1982, P NATL ACAD SCI-BIOL, V79, P193, DOI 10.1073/pnas.79.1.193; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Walters JR, 2007, NEUROSCIENCE, V144, P762, DOI 10.1016/j.neuroscience.2006.10.006; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Zhou JW, 1996, DEV BRAIN RES, V97, P297, DOI 10.1016/S0165-3806(96)00159-9	91	122	125	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 8	2011	71	5					858	868		10.1016/j.neuron.2011.06.035	http://dx.doi.org/10.1016/j.neuron.2011.06.035			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903079	Green Accepted, Bronze			2022-12-25	WOS:000294877900011
J	McDermott, JH; Simoncelli, EP				McDermott, Josh H.; Simoncelli, Eero P.			Sound Texture Perception via Statistics of the Auditory Periphery: Evidence from Sound Synthesis	NEURON			English	Article							COCKTAIL PARTY; AMPLITUDE-MODULATION; RECEPTIVE-FIELDS; DISCRIMINATION; SPEECH; MECHANISMS; FREQUENCY; RESPONSES; MASKING; CONTEXT	Rainstorms, insect swarms, and galloping horses produce "sound textures"-the collective result of many similar acoustic events. Sound textures are distinguished by temporal homogeneity, suggesting they could be recognized with time-averaged statistics. To test this hypothesis, we processed real-world textures with an auditory model containing filters tuned for sound frequencies and their modulations, and measured statistics of the resulting decomposition. We then assessed the realism and recognizability of novel sounds synthesized to have matching statistics. Statistics of individual frequency channels, capturing spectral power and sparsity, generally failed to produce compelling synthetic textures; however, combining them with correlations between channels produced identifiable and natural-sounding textures. Synthesis quality declined if statistics were computed from biologically implausible auditory models. The results suggest that sound texture perception is mediated by relatively simple statistics of early auditory representations, presumably computed by downstream neural populations. The synthesis methodology offers a powerful tool for their further investigation.	[McDermott, Josh H.; Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY 10003 USA; [McDermott, Josh H.; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University; New York University	McDermott, JH (corresponding author), NYU, Howard Hughes Med Inst, 550 1St Ave, New York, NY 10003 USA.	jhm@cns.nyu.edu		Simoncelli, Eero/0000-0002-1206-527X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Asari H, 2006, J NEUROSCI, V26, P7477, DOI 10.1523/JNEUROSCI.1563-06.2006; ATHINEOS M, 2003, P ICASSP 03 HONG KON, DOI DOI 10.1109/ASPAA.2003.1285816; Attias H, 1998, ADV NEUR IN, V10, P103; BACON SP, 1989, J ACOUST SOC AM, V85, P2575, DOI 10.1121/1.397751; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Baumann S, 2011, NAT NEUROSCI, V14, P423, DOI 10.1038/nn.2771; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bell AJ, 1996, NETWORK-COMP NEURAL, V7, P261, DOI 10.1088/0954-898X/7/2/005; CROCHIERE RE, 1976, AT&T TECH J, V55, P1069, DOI 10.1002/j.1538-7305.1976.tb02929.x; Cusack R, 2003, J EXP PSYCHOL HUMAN, V29, P713, DOI 10.1037/0096-1523.29.3.713; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; DECHEVEIGNE A, 2004, PITCH PERCEPTION MOD; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; Dubnov S, 2002, IEEE COMPUT GRAPH, V22, P38, DOI 10.1109/MCG.2002.1016697; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Gardner W. G., 1998, APPL DIGITAL SIGNAL; Ghitza O, 2001, J ACOUST SOC AM, V110, P1628, DOI 10.1121/1.1396325; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Gygi B, 2004, J ACOUST SOC AM, V115, P1252, DOI 10.1121/1.1635840; Heeger D.J., 1995, P 22 ANN C COMP GRAP, P229, DOI DOI 10.1145/218380.218446; Irino T, 1996, J ACOUST SOC AM, V99, P2316, DOI 10.1121/1.415419; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Julesz B., 1962, IRE T INFORM THEOR, V8, P84, DOI [10.1109/TIT.1962.1057698, DOI 10.1109/TIT.1962.1057698]; Kayser C, 2005, CURR BIOL, V15, P1943, DOI 10.1016/j.cub.2005.09.040; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001655; Lorenzi C, 1999, J ACOUST SOC AM, V105, P2987, DOI 10.1121/1.426911; Lorenzi C, 2001, J ACOUST SOC AM, V110, P2470, DOI 10.1121/1.1406160; McDermott Josh H., 2009, 2009 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA), P297, DOI 10.1109/ASPAA.2009.5346467; McDermott JH, 2008, P NATL ACAD SCI USA, V105, P5939, DOI 10.1073/pnas.0711291105; McDermott JH, 2011, P NATL ACAD SCI USA, V108, P1188, DOI 10.1073/pnas.1004765108; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; Mesgarani N, 2009, J NEUROPHYSIOL, V102, P3329, DOI 10.1152/jn.91128.2008; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Overath T, 2008, J NEUROSCI, V28, P13268, DOI 10.1523/JNEUROSCI.4596-08.2008; Popat K, 1995, P AJCAI WORKSH COMP, P293; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rodriguez FA, 2010, J NEUROSCI, V30, P15969, DOI 10.1523/JNEUROSCI.0966-10.2010; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; Schonwiesner M, 2009, P NATL ACAD SCI USA, V106, P14611, DOI 10.1073/pnas.0907682106; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; SLANEY M, 1995, ADV NEURAL INFORM PR, V7; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Strickland EA, 1996, J ACOUST SOC AM, V99, P3638, DOI 10.1121/1.414962; Verron Charles, 2009, 2009 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA), P321, DOI 10.1109/ASPAA.2009.5346504; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zhu SC, 1997, NEURAL COMPUT, V9, P1627, DOI 10.1162/neco.1997.9.8.1627; Zhu X., 2004, P 7 INT C DIG AUD EF, P345	62	190	191	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 8	2011	71	5					926	940		10.1016/j.neuron.2011.06.032	http://dx.doi.org/10.1016/j.neuron.2011.06.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903084	Green Accepted, Bronze			2022-12-25	WOS:000294877900016
J	Miri, A; Daie, K; Arrenberg, AB; Baier, H; Aksay, E; Tank, DW				Miri, Andrew; Daie, Kayvon; Arrenberg, Aristides B.; Baier, Herwig; Aksay, Emre; Tank, David W.			Spatial gradients and multidimensional dynamics in a neural integrator circuit	NATURE NEUROSCIENCE			English	Article							FRACTIONAL-ORDER DYNAMICS; EYE-POSITION; PERSISTENT ACTIVITY; VESTIBULOOCULAR REFLEX; OCULOMOTOR INTEGRATOR; PREPOSITUS-HYPOGLOSSI; TEMPORAL INTEGRATION; WORKING-MEMORY; MODEL NEURON; ALERT CAT	In a neural integrator, the variability and topographical organization of neuronal firing-rate persistence can provide information about the circuit's functional architecture. We used optical recording to measure the time constant of decay of persistent firing (persistence time) across a population of neurons comprising the larval zebrafish oculomotor velocity-to-position neural integrator. We found extensive persistence time variation (tenfold; coefficients of variation = 0.58-1.20) across cells in individual larvae. We also found that the similarity in firing between two neurons decreased as the distance between them increased and that a gradient in persistence time was mapped along the rostrocaudal and dorsoventral axes. This topography is consistent with the emergence of persistence time heterogeneity from a circuit architecture in which nearby neurons are more strongly interconnected than distant ones. Integrator circuit models characterized by multiple dimensions of slow firing-rate dynamics can account for our results.	[Miri, Andrew; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Miri, Andrew; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Daie, Kayvon; Aksay, Emre] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Daie, Kayvon; Aksay, Emre] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Daie, Kayvon] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA USA; [Arrenberg, Aristides B.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA USA	Princeton University; Princeton University; Cornell University; Cornell University; Cornell University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	ema2004@med.cornell.edu; dwtank@princeton.edu		Aksay, Emre/0000-0002-4561-4175; Arrenberg, Aristides/0000-0001-8262-7381	National Science Foundation; US National Institutes of Health [EY007138-16, R01 MH060651, R01 NS053358]; Krevans fellowship; Burroughs Wellcome Career Award at the Scientific Interface; Frueauff Foundation; Human Frontier Science Program; NATIONAL EYE INSTITUTE [T32EY007138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krevans fellowship; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); Frueauff Foundation; Human Frontier Science Program(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Dombeck for technical advice, F. Collman for motion-correction software, and M. Goldman, A. Kinkhabwala and P. Bradley for helpful discussions. This work was supported by a National Science Foundation predoctoral fellowship (A. M.), a US National Institutes of Health Training grant (EY007138-16, K. D.), a Krevans fellowship (A. B. A.), a Burroughs Wellcome Career Award at the Scientific Interface, a Searle Scholar award, the Frueauff Foundation (E. A.), the Human Frontier Science Program (H. B.), and US National Institutes of Health grants (R01 MH060651 to D. W. T. and R01 NS053358 to H.B.).	Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2003, J NEUROSCI, V23, P10852; Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; ANASTASIO TJ, 1994, BIOL CYBERN, V72, P69, DOI 10.1007/BF00206239; Anastasio TJ, 1998, BIOL CYBERN, V79, P377, DOI 10.1007/s004220050487; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Beck JC, 2006, J NEUROPHYSIOL, V96, P1370, DOI 10.1152/jn.00335.2006; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; COHEN B, 1972, EXP NEUROL, V36, P101, DOI 10.1016/0014-4886(72)90139-2; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Debowy O, 2011, J NEUROPHYSIOL, V105, P896, DOI 10.1152/jn.00313.2010; ESCUDERO M, 1992, J PHYSIOL-LONDON, V458, P539, DOI 10.1113/jphysiol.1992.sp019433; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; HUANG Z, 2009, THESIS PRINCETON U; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; Ma LH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005944; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Major G, 2004, P NATL ACAD SCI USA, V101, P7745, DOI 10.1073/pnas.0401992101; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; MILES FA, 1980, J NEUROPHYSIOL, V43, P1426, DOI 10.1152/jn.1980.43.5.1426; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Oestreich J, 2006, NEURON, V49, P577, DOI 10.1016/j.neuron.2006.01.027; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SHINODA Y, 1974, J NEUROPHYSIOL, V37, P653, DOI 10.1152/jn.1974.37.4.653; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; SKAVENSKI AA, 1973, J NEUROPHYSIOL, V36, P724, DOI 10.1152/jn.1973.36.4.724; Sklavos S, 2005, VISION RES, V45, P1525, DOI 10.1016/j.visres.2005.01.005; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; Teramae JN, 2005, J COMPUT NEUROSCI, V18, P105, DOI 10.1007/s10827-005-5474-6; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049	50	81	82	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1150	U207		10.1038/nn.2888	http://dx.doi.org/10.1038/nn.2888			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857656	Green Accepted			2022-12-25	WOS:000294284900015
J	Bello, EP; Mateo, Y; Gelman, DM; Noain, D; Shin, JH; Low, MJ; Alvarez, VA; Lovinger, DM; Rubinstein, M				Bello, Estefania P.; Mateo, Yolanda; Gelman, Diego M.; Noain, Daniela; Shin, Jung H.; Low, Malcolm J.; Alvarez, Veronica A.; Lovinger, David M.; Rubinstein, Marcelo			Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D-2 autoreceptors	NATURE NEUROSCIENCE			English	Article							RECEPTOR-DEFICIENT MICE; CONDITIONED PLACE PREFERENCE; D2 RECEPTORS; FEEDBACK MECHANISM; LOCOMOTOR-ACTIVITY; MUTANT MICE; RELEASE; MOUSE; TRANSPORTER; ABSENCE	Dopamine (DA) D-2 receptors expressed in DA neurons (D-2 autoreceptors) exert a negative feedback regulation that reduces DA neuron firing, DA synthesis and DA release. As D-2 receptors are mostly expressed in postsynaptic neurons, pharmacological and genetic approaches have been unable to definitively address the in vivo contribution of D-2 autoreceptors to DA-mediated behaviors. We found that midbrain DA neurons from mice deficient in D-2 autoreceptors (Drd2(loxP/loxP); Dat(+/IRES-cre), referred to as autoDrd2KO mice) lacked DA-mediated somatodendritic synaptic responses and inhibition of DA release. AutoDrd2KO mice displayed elevated DA synthesis and release, hyperlocomotion and supersensitivity to the psychomotor effects of cocaine. The mice also exhibited increased place preference for cocaine and enhanced motivation for food reward. Our results highlight the importance of D-2 autoreceptors in the regulation of DA neurotransmission and demonstrate that D-2 autoreceptors are important for normal motor function, food-seeking behavior, and sensitivity to the locomotor and rewarding properties of cocaine.	[Bello, Estefania P.; Gelman, Diego M.; Noain, Daniela; Rubinstein, Marcelo] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol, Buenos Aires, DF, Argentina; [Mateo, Yolanda; Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Shin, Jung H.; Alvarez, Veronica A.] NIAAA, Sect Neuronal Struct, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Low, Malcolm J.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Rubinstein, Marcelo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Michigan System; University of Michigan; University of Buenos Aires	Rubinstein, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol, Buenos Aires, DF, Argentina.	mrubins@dna.uba.ar	Alvarez, Veronica A/E-9745-2015	Alvarez, Veronica A/0000-0003-2611-8675; Noain, Daniela/0000-0001-5482-7933; Low, Malcolm/0000-0002-9900-3708	Howard Hughes Medical Institute; Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica; National Science Foundation [INT-9901278]; US National Institutes of Health [R01-MH61326]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000421, ZIAAA000416] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank J. Sztein, G. Levin, C. Backman, V. Rodriguez, R. Lorenzo, S. Nemirovsky, M. Peper, S. Merani, C. Carbone, F. Maschi and M. Baetscher for their scientific and technical assistance. This work was supported in part by an International Research Scholar Grant of the Howard Hughes Medical Institute (M.R.), Universidad de Buenos Aires (M.R.) and Agencia Nacional de Promocion Cientifica y Tecnologica (M.R.), National Science Foundation grant INT-9901278 (M.J.L. and M.R.) and US National Institutes of Health grant R01-MH61326 (M.J.L.). E.P.B., D.N. and D.M.G. received doctoral fellowships from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. Y.M., J.H.S., V.A.A. and D.M.L. were supported by the Division of Intramural Clinical and Biological Research of the National Institute on Alcohol Abuse and Alcoholism. J.H.S. and V.A.A. received support from the Intramural Program of the National Institute of Neurological Disorders and Stroke.	Avale ME, 2004, MOL PSYCHIATR, V9, P718, DOI 10.1038/sj.mp.4001474; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; BUNNEY BS, 1973, NATURE-NEW BIOL, V245, P123, DOI 10.1038/newbio245123a0; Chausmer AL, 2002, PSYCHOPHARMACOLOGY, V163, P54, DOI 10.1007/s00213-002-1142-y; CUBEDDU LX, 1982, J PHARMACOL EXP THER, V223, P497; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Falzone TL, 2002, EUR J NEUROSCI, V15, P158, DOI 10.1046/j.0953-816x.2001.01842.x; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Pellizzari EH, 2008, LIFE SCI, V83, P413, DOI 10.1016/j.lfs.2008.07.004; Hidalgo-Sanchez M, 2005, J COMP NEUROL, V483, P17, DOI 10.1002/cne.20402; John CE, 2006, J NEUROCHEM, V96, P267, DOI 10.1111/j.1471-4159.2005.03557.x; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; Kelly MA, 1998, J NEUROSCI, V18, P3470; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Koeltzow TE, 1998, J NEUROSCI, V18, P2231; Maina FK, 2010, ACS CHEM NEUROSCI, V1, P450, DOI 10.1021/cn100003u; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Nemirovsky SI, 2009, SYNAPSE, V63, P991, DOI 10.1002/syn.20680; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Phillips PEM, 2002, SYNAPSE, V44, P15, DOI 10.1002/syn.10049; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Sano H, 2003, J NEUROSCI, V23, P9078; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Thanos PK, 2001, J NEUROCHEM, V78, P1094, DOI 10.1046/j.1471-4159.2001.00492.x; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	50	254	258	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1033	U128		10.1038/nn.2862	http://dx.doi.org/10.1038/nn.2862			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743470	Green Published, Green Accepted			2022-12-25	WOS:000293123700017
J	Kumar, J; Schuck, P; Mayer, ML				Kumar, Janesh; Schuck, Peter; Mayer, Mark L.			Structure and Assembly Mechanism for Heteromeric Kainate Receptors	NEURON			English	Article							N-TERMINAL DOMAIN; LIGAND-BINDING; CRYSTAL-STRUCTURE; NMDA RECEPTORS; AMPA RECEPTORS; SUBUNIT; EXPRESSION; TRAFFICKING; MODULATION; CHANNELS	Native glutamate receptor ion channels are tetrameric assemblies containing two or more different subunits. NMDA receptors are obligate heteromers formed by coassembly of two or three divergent gene families. While some AMPA and kainate receptors can form functional homomeric ion channels, the KA1 and KA2 subunits are obligate heteromers which function only in combination with GluR5-7. The mechanisms controlling glutamate receptor assembly involve an initial step in which the amino terminal domains (ATD) assemble as dimers. Here, we establish by sedimentation velocity that the ATDs of GluR6 and KA2 coassemble as a heterodimer of K-d 11 nM, 32,000-fold lower than the K-d for homodimer formation by KA2; we solve crystal structures for the GluR6/KA2 ATD heterodimer and heterotetramer assemblies. Using these structures as a guide, we perform a mutant cycle analysis to probe the energetics of assembly and show that high-affinity ATD interactions are required for biosynthesis of functional heteromeric receptors.	[Kumar, Janesh; Mayer, Mark L.] NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,DHHS, Bethesda, MD 20892 USA; [Schuck, Peter] NIBIB, Lab Cellular Imaging & Macromol Biophys, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Mayer, ML (corresponding author), NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,DHHS, Bethesda, MD 20892 USA.	mayerm@mail.nih.gov	Mayer, Mark/AAE-7356-2019; Schuck, Peter/AAA-6888-2020; Mayer, Mark L/H-5500-2013; Kumar, Janesh/AAG-3002-2019	Mayer, Mark/0000-0003-4378-8451; Schuck, Peter/0000-0002-8859-6966; Kumar, Janesh/0000-0003-0767-3788	National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NICHD; NIBIB, NIH, DHHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000008] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIBIB, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Carla Glasser and Andrea Balbo for technical assistance and Drs. Peter Kwong and Yongping Yang for advice with suspension cell cultures. Nucleic acid sequencing was performed by the NINDS DNA sequencing facility. Synchrotron diffraction data was collected at the GM/CA CAT 23 ID-B beamline. GM/CA CAT has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. This work was supported by the intramural research programs of NICHD and NIBIB, NIH, DHHS (M.L.M. and P.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BROSE N, 1994, J BIOL CHEM, V269, P16780; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2010, J MOL BIOL, V404, P680, DOI 10.1016/j.jmb.2010.10.006; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ren Z, 2003, J NEUROSCI, V23, P6608; Ripley B, 2011, P NATL ACAD SCI USA, V108, P367, DOI 10.1073/pnas.1015163108; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Swanson GT, 1998, MOL PHARMACOL, V53, P942; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009	62	94	97	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					319	331		10.1016/j.neuron.2011.05.038	http://dx.doi.org/10.1016/j.neuron.2011.05.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791290	Bronze, Green Accepted			2022-12-25	WOS:000293433900015
J	Zhang, HB; Constantine, R; Vorobiev, S; Chen, Y; Seetharaman, J; Huang, YJ; Xiao, R; Montelione, GT; Gerstner, CD; Davis, MW; Inana, G; Whitby, FG; Jorgensen, EM; Hill, CP; Tong, L; Baehr, W				Zhang, Houbin; Constantine, Ryan; Vorobiev, Sergey; Chen, Yang; Seetharaman, Jayaraman; Huang, Yuanpeng Janet; Xiao, Rong; Montelione, Gaetano T.; Gerstner, Cecilia D.; Davis, M. Wayne; Inana, George; Whitby, Frank G.; Jorgensen, Erik M.; Hill, Christopher P.; Tong, Liang; Baehr, Wolfgang			UNC119 is required for G protein trafficking in sensory neurons	NATURE NEUROSCIENCE			English	Article							LIGHT-DRIVEN TRANSLOCATION; CAENORHABDITIS-ELEGANS; PHOTORECEPTOR PROTEIN; RETINAL DEGENERATION; BINDING PROTEIN; PDE-DELTA; C-ELEGANS; TRANSDUCIN; UNC-119; COMPLEX	UNC119 is widely expressed among vertebrates and other phyla. We found that UNC119 recognized the acylated N terminus of the rod photoreceptor transducin alpha (T alpha) subunit and Caenorhabditis elegans G proteins ODR-3 and GPA-13. The crystal structure of human UNC119 at 1.95-angstrom resolution revealed an immunoglobulin-like beta-sandwich fold. Pulldowns and isothermal titration calorimetry revealed a tight interaction between UNC119 and acylated G alpha peptides. The structure of co-crystals of UNC119 with an acylated T alpha N-terminal peptide at 2.0 angstrom revealed that the lipid chain is buried deeply into UNC119's hydrophobic cavity. UNC119 bound T alpha-GTP, inhibiting its GTPase activity, thereby providing a stable UNC119-T alpha-GTP complex capable of diffusing from the inner segment back to the outer segment after light-induced translocation. UNC119 deletion in both mouse and C. elegans led to G protein mislocalization. Thus, UNC119 is a Ga subunit cofactor essential for G protein trafficking in sensory cilia.	[Zhang, Houbin; Constantine, Ryan; Gerstner, Cecilia D.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Constantine, Ryan] Univ Utah, Hlth Sci Ctr, Grad Program Neurosci, Salt Lake City, UT USA; [Vorobiev, Sergey; Chen, Yang; Seetharaman, Jayaraman; Tong, Liang] Columbia Univ, Dept Biol Sci, NE Struct Genom Consortium, New York, NY 10027 USA; [Huang, Yuanpeng Janet; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, NE Struct Genom Consortium, Piscataway, NJ 08855 USA; [Davis, M. Wayne; Jorgensen, Erik M.; Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Inana, George] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Whitby, Frank G.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Columbia University; Rutgers State University New Brunswick; Utah System of Higher Education; University of Utah; Bascom Palmer Eye Institute; University of Miami; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.	wbaehr@hsc.utah.edu	Zhang, Houbin/A-8887-2012	Davis, Mikel/0000-0003-1867-1593; Montelione, Gaetano/0000-0002-9440-3059; Zhang, Houbin/0000-0002-2968-7454; Tong, Liang/0000-0002-0563-6468	US National Institutes of Health [EY08123, EY019298, EY014800-039003, EY10848, NS034307]; Howard Hughes Medical Institute; Protein Structure Initiative of the US National Institutes of Health; University of Utah Macromolecule Crystallography Core Facility; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY014800, R01EY010848, R01EY008123, R01EY019298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307, R01NS034307] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Protein Structure Initiative of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Utah Macromolecule Crystallography Core Facility; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Abramowitz and J. Schwanof for access to the X4A beamline at the National Synchrotron Light Source and G. DeTitta of Hauptman Woodward Research Institute for crystallization screening. This work was supported by US National Institutes of Health grants EY08123 (W. B.), EY019298 (W. B.), EY014800-039003 (National Eye Institute core grant), EY10848 (G. I.) and NS034307 (E. M. J.), by the Howard Hughes Medical Institute (E. M. J.), by a grant from the Protein Structure Initiative of the US National Institutes of Health (U54 GM074958), by the University of Utah Macromolecule Crystallography Core Facility, by a Center Grant of the Foundation Fighting Blindness to the University of Utah, and unrestricted grants to the Departments of Ophthalmology at the University of Utah from Research to Prevent Blindness. W. B. is a recipient of a Research to Prevent Blindness Senior Investigator Award.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alpadi K, 2008, J BIOL CHEM, V283, P26461, DOI 10.1074/jbc.M801625200; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Chung S, 2007, GENE, V389, P45, DOI 10.1016/j.gene.2006.09.032; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elias R, 2004, MOL VIS, V10, P672; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gorska MM, 2006, J BIOL CHEM, V281, P14429, DOI 10.1074/jbc.M512718200; Haeseleer F, 2008, INVEST OPHTH VIS SCI, V49, P2366, DOI 10.1167/iovs.07-1166; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Higashide T, 1998, INVEST OPHTH VIS SCI, V39, P690; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ishiba Y, 2007, EXP EYE RES, V84, P473, DOI 10.1016/j.exer.2006.10.016; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Knobel KM, 2001, DEVELOPMENT, V128, P4079; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MADURO M, 1995, GENETICS, V141, P977; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Vepachedu R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005211; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200	50	117	124	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					874	+		10.1038/nn.2835	http://dx.doi.org/10.1038/nn.2835			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642972	Green Accepted			2022-12-25	WOS:000292081700015
J	Royer, S; Zemelman, BV; Losonczy, A; Kim, J; Chance, F; Magee, JC; Buzsaki, G				Royer, Sebastien; Zemelman, Boris V.; Losonczy, Attila; Kim, Jinhyun; Chance, Frances; Magee, Jeffrey C.; Buzsaki, Gyoergy			Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; PHASE-PRECESSION; THETA OSCILLATIONS; IN-VIVO; SYNAPTIC PLASTICITY; INTERNEURONS; DYNAMICS; MECHANISMS; SEQUENCES; CORTEX	A consortium of inhibitory neurons control the firing patterns of pyramidal cells, but their specific roles in the behaving animal are largely unknown. We performed simultaneous physiological recordings and optogenetic silencing of either perisomatic (parvalbumin (PV) expressing) or dendrite-targeting (somatostatin (SOM) expressing) interneurons in hippocampal area CA1 of head-fixed mice actively moving a treadmill belt rich with visual-tactile stimuli. Silencing of either PV or SOM interneurons increased the firing rates of pyramidal cells selectively in their place fields, with PV and SOM interneurons having their largest effect during the rising and decaying parts of the place field, respectively. SOM interneuron silencing powerfully increased burst firing without altering the theta phase of spikes. In contrast, PV interneuron silencing had no effect on burst firing, but instead shifted the spikes' theta phase toward the trough of theta. These findings indicate that perisomatic and dendritic inhibition have distinct roles in controlling the rate, burst and timing of hippocampal pyramidal cells.	[Royer, Sebastien; Zemelman, Boris V.; Losonczy, Attila; Kim, Jinhyun; Chance, Frances; Magee, Jeffrey C.; Buzsaki, Gyoergy] Howard Hughes Med Inst, Ashburn, VA USA; [Royer, Sebastien; Kim, Jinhyun] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY USA; [Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Howard Hughes Medical Institute; Korea Institute of Science & Technology (KIST); Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	mageej@janelia.hhmi.org; gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800; Zemelman, Boris/0000-0003-2463-4887; Chance, Frances/0000-0003-1420-4664	Howard Hughes Medical Institute; US National Institutes of Health [NS34994, MH54671]; James S. McDonnell Foundation; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (NRF) [WCI 2009-003]; Kavli and Searle Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea (NRF)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Kavli and Searle Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G.F. Turi, T. Adelman and T. Tabachnik for technical contributions, and D. Huber for useful advice. This work was supported by the Howard Hughes Medical Institute, the US National Institutes of Health (NS34994, MH54671), the James S. McDonnell Foundation and the World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea (NRF grant number: WCI 2009-003). A.L. was supported by the Kavli and Searle Foundations.	Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; O'Keefe J, 2006, NEUROSCIENCE, P475; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	48	390	392	6	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					769	775		10.1038/nn.3077	http://dx.doi.org/10.1038/nn.3077			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446878	Green Accepted			2022-12-25	WOS:000303270200022
J	Bernard, A; Lubbers, LS; Tanis, KQ; Luo, R; Podtelezhnikov, AA; Finney, EM; McWhorter, MME; Serikawa, K; Lemon, T; Morgan, R; Copeland, C; Smith, K; Cullen, V; Davis-Turak, J; Lee, CK; Sunkin, SM; Loboda, AP; Levine, DM; Stone, DJ; Hawrylycz, MJ; Roberts, CJ; Jones, AR; Geschwind, DH; Lein, ES				Bernard, Amy; Lubbers, Laura S.; Tanis, Keith Q.; Luo, Rui; Podtelezhnikov, Alexei A.; Finney, Eva M.; McWhorter, Mollie M. E.; Serikawa, Kyle; Lemon, Tracy; Morgan, Rebecca; Copeland, Catherine; Smith, Kimberly; Cullen, Vivian; Davis-Turak, Jeremy; Lee, Chang-Kyu; Sunkin, Susan M.; Loboda, Andrey P.; Levine, David M.; Stone, David J.; Hawrylycz, Michael J.; Roberts, Christopher J.; Jones, Allan R.; Geschwind, Daniel H.; Lein, Ed S.			Transcriptional Architecture of the Primate Neocortex	NEURON			English	Article							MONKEY VISUAL-CORTEX; CEREBRAL-CORTEX; GENE-EXPRESSION; HUMAN BRAIN; NEURONAL CLASSES; SMALL-WORLD; ORGANIZATION; PATTERNS; RNA; SPECIFICATION	Genome-wide transcriptional profiling was used to characterize the molecular underpinnings of neocortical organization in rhesus macaque, including cortical areal specialization and laminar cell-type diversity. Microarray analysis of individual cortical layers across sensorimotor and association cortices identified robust and specific molecular signatures for individual cortical layers and areas, prominently involving genes associated with specialized neuronal function. Overall, transcriptome-based relationships were related to spatial proximity, being strongest between neighboring cortical areas and between proximal layers. Primary visual cortex OM displayed the most distinctive gene expression compared to other cortical regions in rhesus and human, both in the specialized layer 4 as well as other layers. Laminar patterns were more similar between macaque and human compared to mouse, as was the unique V1 profile that was not observed in mouse. These data provide a unique resource detailing neocortical transcription patterns in a nonhuman primate with great similarity in gene expression to human.	[Bernard, Amy; Lemon, Tracy; Morgan, Rebecca; Copeland, Catherine; Smith, Kimberly; Lee, Chang-Kyu; Sunkin, Susan M.; Hawrylycz, Michael J.; Jones, Allan R.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Lubbers, Laura S.] Merck Res Labs, Dept Neurosci, West Point, PA 19486 USA; [Tanis, Keith Q.; Podtelezhnikov, Alexei A.; Finney, Eva M.; Loboda, Andrey P.; Stone, David J.; Roberts, Christopher J.] Merck Res Labs, Dept Informat & Anal, West Point, PA 19486 USA; [McWhorter, Mollie M. E.; Serikawa, Kyle; Cullen, Vivian; Levine, David M.] Rosetta Inpharmat, Seattle, WA 98109 USA; [Davis-Turak, Jeremy; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Luo, Rui; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Allen Institute for Brain Science; Merck & Company; Merck & Company; Merck & Company; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lein, ES (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	edl@alleninstitute.org	Davis-Turak, Jeremy/B-8000-2014	Davis-Turak, Jeremy/0000-0002-4462-5171; Tanis, Keith/0000-0001-6744-1183; Bernard, Amy/0000-0003-2540-1153	Merck Research Labs; Allen Institute for Brain Science; NIH [5R37 MH060233-11]; Allen Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233] Funding Source: NIH RePORTER	Merck Research Labs; Allen Institute for Brain Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was sponsored by Merck Research Labs, the Allen Institute for Brain Science and NIH Grant 5R37 MH060233-11 (D.H.G., R.L.). The authors wish to thank the Allen Institute founders, Paul G. Allen and Jody Patton, for their vision, encouragement, and support. We thank Mike Citron for specimen identification, Ken Lodge for providing pilot tissue and sample collection methods, and Dr. Jane Fontenot, Dana Hasselschwert, and Marcus Louis for assistance with tissue collection. Thanks to Crissa Wolkey for sample processing and Rachel Dalley and Sheila Shapouri for LMD images. We wish to acknowledge Paul Wohnoutka, Amanda Ebbed, and Lon Luong for supporting data production, Chinh Dang for supporting database needs, Kelly Overly for contracting assistance, David Haynor for discussions on project design, and Christof Koch for critical reading of the manuscript. Finally, thanks to Affymetrix for preferred pricing on rhesus microarrays.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bishop KM, 2002, J NEUROSCI, V22, P7627; Brodmann K., 1909, VERGELICHENDE LOKALI; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hoerder-Suabedissen A, 2009, CEREB CORTEX, V19, P1738, DOI 10.1093/cercor/bhn195; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamoto K, 2009, RNA BIOL, V6, P248, DOI 10.4161/rna.6.3.8370; Jacobs AJ, 1996, J COMP NEUROL, V364, P383; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Krubitzer L, 2009, ANN NY ACAD SCI, V1156, P44, DOI 10.1111/j.1749-6632.2009.04421.x; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mukamel Z, 2011, J NEUROSCI, V31, P11437, DOI 10.1523/JNEUROSCI.0181-11.2011; O'Leary DDM, 2008, CURR OPIN NEUROBIOL, V18, P90, DOI 10.1016/j.conb.2008.05.011; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Paxinos G., 2000, RHESUS MONKEY BRAIN; Preuss TM, 2002, CEREB CORTEX, V12, P671, DOI 10.1093/cercor/12.7.671; Quevedo C, 2010, MOL BIOL CELL, V21, P1125, DOI 10.1091/mbc.E09-04-0292; Raj A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014832; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Takahata T, 2009, CEREB CORTEX, V19, P1937, DOI 10.1093/cercor/bhn220; Wang WZ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-69; Watakabe A, 2009, CEREB CORTEX, V19, P1915, DOI 10.1093/cercor/bhn219; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Winrow CJ, 2009, BRAIN RES, V1271, P1, DOI 10.1016/j.brainres.2009.02.083; Yamamori T, 2006, NEUROSCI RES, V55, P11, DOI 10.1016/j.neures.2006.02.006; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zilles K, 2004, J ANAT, V205, P417, DOI 10.1111/j.0021-8782.2004.00357.x; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	50	165	187	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1083	1099		10.1016/j.neuron.2012.03.002	http://dx.doi.org/10.1016/j.neuron.2012.03.002			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445337	Green Accepted, Bronze			2022-12-25	WOS:000301998700007
J	Siegert, S; Cabuy, E; Scherf, BG; Kohler, H; Panda, S; Le, YZ; Fehling, HJ; Gaidatzis, D; Stadler, MB; Roska, B				Siegert, Sandra; Cabuy, Erik; Scherf, Brigitte Gross; Kohler, Hubertus; Panda, Satchidananda; Le, Yun-Zheng; Fehling, Hans Joerg; Gaidatzis, Dimos; Stadler, Michael B.; Roska, Botond			Transcriptional code and disease map for adult retinal cell types	NATURE NEUROSCIENCE			English	Article							MACULAR DEGENERATION; GENE-EXPRESSION; IN-VIVO; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; HUMAN FIBROBLASTS; COMMON VARIANTS; AMACRINE CELLS; MOUSE; PHOTOTRANSDUCTION	Brain circuits are assembled from a large variety of morphologically and functionally diverse cell types. It is not known how the intermingled cell types of an individual adult brain region differ in their expressed genomes. Here we describe an atlas of cell type transcriptomes in one brain region, the mouse retina. We found that each adult cell type expressed a specific set of genes, including a unique set of transcription factors, forming a 'barcode' for cell identity. Cell type transcriptomes carried enough information to categorize cells into morphological classes and types. Several genes that were specifically expressed in particular retinal circuit elements, such as inhibitory neuron types, are associated with eye diseases. The resource described here allows gene expression to be compared across adult retinal cell types, experimenting with specific transcription factors to differentiate stem or somatic cells to retinal cell types, and predicting cellular targets of newly discovered disease-associated genes.	[Siegert, Sandra; Cabuy, Erik; Scherf, Brigitte Gross; Kohler, Hubertus; Gaidatzis, Dimos; Stadler, Michael B.; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK USA; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany; [Gaidatzis, Dimos; Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Salk Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Ulm University; Swiss Institute of Bioinformatics	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Panda, Satchidananda/J-6891-2012; Siegert, Sandra/GWC-4507-2022; Roska, Botond/AAD-7268-2021	Siegert, Sandra/0000-0001-8635-0877; 	Friedrich Miescher Institute; Alcon award; National Center of Competence in Research; European Research Council; Swiss-Hungarian grant; European Union; NATIONAL EYE INSTITUTE [R01EY020900] Funding Source: NIH RePORTER	Friedrich Miescher Institute; Alcon award; National Center of Competence in Research(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Swiss-Hungarian grant; European Union(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Djaffer, J. Juttner, J. Hall and Y. Shimada for technical assistance, E. Oakeley for comments on the experimental design, D. Balya for providing help with programming, and K. Farrow, S. Rompani, K. Yonehara, V. Busskamp, S. Oakeley, P. King, A. Matus, S. Arber and F. Rijli for comments on the manuscript. We thank Z. Raics for making the webpage, and L. Kus and S. Gong (Rockefeller University) for help and for BACs from the GENSAT project. We thank I. Provencio (University of Virginia) for providing the melanopsin antibody. The study was supported by Friedrich Miescher Institute funds, Alcon award, a National Center of Competence in Research Genetics grant, a European Research Council grant, a Swiss-Hungarian grant, and RETICIRC, TREATRUSH, SEEBETTER and OPTONEURO grants from the European Union to B.R.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Arendt D, 2003, INT J DEV BIOL, V47, P563; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chen J, 2007, J CLIN INVEST, V117, P2758, DOI 10.1172/JCI33513; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Morrow EM, 1998, J NEUROSCI, V18, P3738; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tarpey P, 2006, NAT GENET, V38, P1242, DOI 10.1038/ng1893; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	50	194	204	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					487	U191		10.1038/nn.3032	http://dx.doi.org/10.1038/nn.3032			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267162				2022-12-25	WOS:000300793100024
J	Gregoriou, GG; Gotts, SJ; Desimone, R				Gregoriou, Georgia G.; Gotts, Stephen J.; Desimone, Robert			Cell-Type-Specific Synchronization of Neural Activity in FEF with V4 during Attention	NEURON			English	Article							FRONTAL EYE FIELD; SACCADE TARGET SELECTION; HUMAN CORTICOSPINAL SYSTEM; COVERT SPATIAL ATTENTION; MACAQUE AREA V4; VISUAL-ATTENTION; SUPERIOR COLLICULUS; NEURONAL SYNCHRONIZATION; PREFRONTAL CORTEX; MOTOR CORTEX	Shifts of gaze and shifts of attention are closely linked and it is debated whether they result from the same neural mechanisms. Both processes involve the frontal eye fields (FEF), an area which is also a source of top-down feedback to area V4 during covert attention. To test the relative contributions of oculomotor and attention-related FEF signals to such feedback, we recorded simultaneously from both areas in a covert attention task and in a saccade task. In the attention task, only visual and visuomovement FEF neurons showed enhanced responses, whereas movement cells were unchanged. Importantly, visual, but not movement or visuomovement cells, showed enhanced gamma frequency synchronization with activity in V4 during attention. Within FEF, beta synchronization was increased for movement cells during attention but was suppressed in the saccade task. These findings support the idea that the attentional modulation of visual processing is not mediated by movement neurons.	[Gregoriou, Georgia G.] Univ Crete, Dept Basic Sci, Fac Med, Iraklion 71003, Crete, Greece; [Gregoriou, Georgia G.] Fdn Res & Technol, Inst Appl & Computat Math, Iraklion 70013, Crete, Greece; [Gotts, Stephen J.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; [Desimone, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	University of Crete; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT)	Gregoriou, GG (corresponding author), Univ Crete, Dept Basic Sci, Fac Med, Iraklion 71003, Crete, Greece.	gregoriou@med.uoc.gr	Desimone, Robert/G-1121-2018; Gregoriou, Georgia/AAD-3925-2019; Gregoriou, Georgia/F-7759-2011; Gotts, Stephen/J-4842-2012	Gregoriou, Georgia/0000-0002-4002-6657; Gregoriou, Georgia/0000-0002-4002-6657; Desimone, Robert/0000-0002-5938-4227	European Community [PIRG05-GA-2009-246761]; General Secretariat for Research and Technology [9FR27]; University of Crete [3004]; National Institutes of Health (USA) [MH64445]; National Institute of Mental Health, Division of Intramural Research;  [5R01EY017921]; NATIONAL EYE INSTITUTE [R01EY017921, R01EY017292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH064445] Funding Source: NIH RePORTER	European Community(European Commission); General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); University of Crete; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health, Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Grant Pielli, Donovan Stock and Courtney Alfes for help with the animal training and Steve Stefanou and George Spiropoulos for help with preliminary analysis. The authors were supported by a 5R01EY017921 Grant to R.D., by the European Community's Seventh Framework Programme (Grant PIRG05-GA-2009-246761), the General Secretariat for Research and Technology (Grant 9FR27), and the Special Account of Research Funds, University of Crete (Grant 3004) to G.G.G. S.J.G. was supported initially by MH64445 from the National Institutes of Health (USA) and later by the National Institute of Mental Health, Division of Intramural Research.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Androulidakis AG, 2007, EUR J NEUROSCI, V25, P3758, DOI 10.1111/j.1460-9568.2007.05620.x; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BOCH RA, 1989, J NEUROPHYSIOL, V61, P1064, DOI 10.1152/jn.1989.61.5.1064; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; FISCHER B, 1981, EXP BRAIN RES, V44, P129; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; FRIES W, 1984, J COMP NEUROL, V230, P55, DOI 10.1002/cne.902300106; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Gregoriou GG, 2009, PROG BRAIN RES, V176, P35, DOI 10.1016/S0079-6123(09)17603-3; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Hunt AR, 2003, COGNITIVE BRAIN RES, V18, P102, DOI 10.1016/j.cogbrainres.2003.08.006; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Juan CH, 2004, P NATL ACAD SCI USA, V101, P15541, DOI 10.1073/pnas.0403507101; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Klein R. M., 1980, ATTENTION PERFORM, P259, DOI DOI 10.1037/E665402011-424; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget P, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.002.2009; Ray S, 2009, J NEUROPHYSIOL, V102, P3091, DOI 10.1152/jn.00270.2009; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rizzolatti G., 1983, ADV VERTEBRATE NEURO, P261, DOI [10.1007/978-1-4684-4412-4_12, DOI 10.1007/978-1-4684-4412-4_12]; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; Schafer RJ, 2011, SCIENCE, V332, P1568, DOI 10.1126/science.1199892; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	75	143	144	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 9	2012	73	3					581	594		10.1016/j.neuron.2011.12.019	http://dx.doi.org/10.1016/j.neuron.2011.12.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325208	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000300140600017
J	Dann, A; Poeck, H; Croxford, AL; Gaupp, S; Kierdorf, K; Knust, M; Pfeifer, D; Maihoefer, C; Endres, S; Kalinke, U; Meuth, SG; Wiendl, H; Knobeloch, KP; Akira, S; Waisman, A; Hartmann, G; Prinz, M				Dann, Angela; Poeck, Hendrik; Croxford, Andrew L.; Gaupp, Stefanie; Kierdorf, Katrin; Knust, Markus; Pfeifer, Dietmar; Maihoefer, Cornelius; Endres, Stefan; Kalinke, Ulrich; Meuth, Sven G.; Wiendl, Heinz; Knobeloch, Klaus-Peter; Akira, Shizuo; Waisman, Ari; Hartmann, Gunther; Prinz, Marco			Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-HELPER-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; PATHOGEN RECOGNITION; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; INTERFERON-BETA; INNATE IMMUNITY	The action of cytosolic RIG-I-like helicases (RLHs) in the CNS during autoimmunity is largely unknown. Using a mouse model of multiple sclerosis, we found that mice lacking the RLH adaptor IPS-1 developed exacerbated disease that was accompanied by markedly higher inflammation, increased axonal damage and elevated demyelination with increased encephalitogenic immune responses. Furthermore, activation of RLH ligands such as 5'-triphosphate RNA oligonucleotides decreased CNS inflammation and improved clinical signs of disease. RLH stimulation repressed the maintenance and expansion of committed T(H)1 and T(H)17 cells, whereas T-cell differentiation was not altered. Notably, T(H)1 and T(H)17 suppression required type I interferon receptor engagement on dendritic cells, but not on macrophages or microglia. These results identify RLHs as negative regulators of T(H)1 and T(H)17 responses in the CNS, demonstrate a protective role of the RLH pathway for brain inflammation, and establish oligonucleotide ligands of RLHs as potential therapeutics for the treatment of multiple sclerosis.	[Dann, Angela; Gaupp, Stefanie; Kierdorf, Katrin; Knust, Markus; Knobeloch, Klaus-Peter; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Dann, Angela; Kierdorf, Katrin; Knust, Markus] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Poeck, Hendrik; Endres, Stefan; Hartmann, Gunther] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Poeck, Hendrik] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-8000 Munich, Germany; [Croxford, Andrew L.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany; [Maihoefer, Cornelius] Univ Munich, Dept Radiat Oncol, Munich, Germany; [Endres, Stefan] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Endres, Stefan] Univ Munich, Div Clin Pharmacol, Dept Internal Med, Munich, Germany; [Kalinke, Ulrich] Helmholtz Ctr Infect Res, TWINCORE, Ctr Expt & Clin Infect Res, Inst Expt Infect Res, Braunschweig, Germany; [Kalinke, Ulrich] Hannover Med Sch, D-3000 Hannover, Germany; [Meuth, Sven G.; Wiendl, Heinz] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Bonn; Technical University of Munich; Johannes Gutenberg University of Mainz; University of Freiburg; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; University of Munster; Osaka University; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Dept Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Kierdorf, Katrin/AAO-6288-2021; Hartmann, Gunther/P-7492-2017; Meuth, Sven G/HHM-8941-2022; Akira, Shizuo/C-3134-2009; Waisman, Ari/C-7383-2015; Wiendl, Heinz/AAX-6041-2021	Hartmann, Gunther/0000-0003-1021-2018; Meuth, Sven G/0000-0003-2571-3501; Waisman, Ari/0000-0003-4304-8234; Kierdorf, Katrin/0000-0002-9272-4780; Wiendl, Heinz/0000-0003-4310-3432; Kalinke, Ulrich/0000-0003-0503-9564; Maihofer, Cornelius/0000-0002-0506-4519	German Research Council (DFG) [KFO177, SFB670, SFB704]; Bundesministerium fur Bildung und Forschung (BMBF); DFG [Graduiertenkolleg 1202, SFB 620, FOR133, PR 577/8-1]; Center of Integrated Protein Science Munich; Competence Network of Neurodegenerative Disorders; Center of Chronic Immunodeficiency (CCI); Gemeinnutzige Hertie-Foundation	German Research Council (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Center of Integrated Protein Science Munich; Competence Network of Neurodegenerative Disorders; Center of Chronic Immunodeficiency (CCI); Gemeinnutzige Hertie-Foundation	This work was supported by KFO177, SFB670 and SFB704 of the German Research Council (DFG), and a Biofuture and a Go-Bio grant of the Bundesministerium fur Bildung und Forschung (BMBF) to G. H., a DFG Graduiertenkolleg 1202 fellowship to C. M., the Center of Integrated Protein Science Munich, a research professorship and a "BayImmunet" grant to S. E. M. P. was supported by the BMBF-funded Competence Network of Multiple Sclerosis, the Competence Network of Neurodegenerative Disorders, the Center of Chronic Immunodeficiency (CCI), the DFG (SFB 620, FOR1336 and PR 577/8-1) and the Gemeinnutzige Hertie-Foundation.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; FIERZ W, 1985, J IMMUNOL, V134, P3785; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mitsdoerffer M, 2009, ANN NEUROL, V65, P487, DOI 10.1002/ana.21722; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2010, TRENDS MOL MED, V16, P379, DOI 10.1016/j.molmed.2010.06.001; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	50	54	56	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					98	U126		10.1038/nn.2964	http://dx.doi.org/10.1038/nn.2964			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138643				2022-12-25	WOS:000298414400019
J	Vitureira, N; Letellier, M; White, IJ; Goda, Y				Vitureira, Nathalia; Letellier, Mathieu; White, Ian J.; Goda, Yukiko			Differential control of presynaptic efficacy by postsynaptic N-cadherin and beta-catenin	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; CELL-ADHESION MOLECULES; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; HIPPOCAMPAL SYNAPSES; RELEASE PROBABILITY; HOMEOSTATIC PLASTICITY; DENDRITIC SPINES; GLUR2	N-cadherin is a homophilic adhesion protein that remains expressed at mature excitatory synapses beyond its developmental role in synapse formation. We investigated the trans-synaptic activity of N-cadherin in regulating synapse function in rodent cultured hippocampal neurons using optical methods and electrophysiology. Interfering with N-cadherin in postsynaptic neurons reduced basal release probability (p(r)) at inputs to the neuron, and this trans-synaptic impairment of release accompanied impaired vesicle endocytosis. Moreover, loss of the GluA2 AMPA-type glutamate receptor subunit, which decreased p(r) by itself, occluded the interference with postsynaptic N-cadherin. The loss of postsynaptic N-cadherin activity, however, did not affect the compensatory upregulation of p(r) induced by chronic activity silencing, whereas postsynaptic beta-catenin deletion blocked this presynaptic homeostatic adaptation. Our findings suggest that postsynaptic N-cadherin helps link basal pre- and postsynaptic strengths to control the p(r) offset, whereas the p(r) gain adjustment requires a distinct trans-synaptic pathway involving beta-catenin.	[Vitureira, Nathalia; Letellier, Mathieu; White, Ian J.; Goda, Yukiko] UCL, Mol Cell Biol Lab, MRC, London, England; [Vitureira, Nathalia; Letellier, Mathieu; White, Ian J.; Goda, Yukiko] UCL, Cell Biol Unit, London, England; [Goda, Yukiko] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	University of London; University College London; University of London; University College London; RIKEN	Goda, Y (corresponding author), UCL, Mol Cell Biol Lab, MRC, London, England.	goda@brain.riken.jp	Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016; Mathieu, Letellier/R-9031-2019	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Mathieu, Letellier/0000-0003-4008-298X; Vitureira, Nathalia/0000-0003-1196-4094	UK Medical Research Council; European Union; RIKEN Brain Science Institute; Medical Research Council [MC_U122669937] Funding Source: researchfish; MRC [MC_U122669937] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); RIKEN Brain Science Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Kemler (Max Planck Institute of Immunology) for beta-catenin floxed mice, T. Okuda (Keio University) and M. Passafaro (University of Milan) for sharing plasmids, D. Elliott for expert technical assistance and the members of the Goda laboratory for discussions. This work was supported by the UK Medical Research Council, the European Union 7th Framework Program EUROSPIN project and the RIKEN Brain Science Institute.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Brault V, 2001, DEVELOPMENT, V128, P1253; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Han EB, 2009, P NATL ACAD SCI USA, V106, P10817, DOI 10.1073/pnas.0903603106; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Ripley B, 2011, P NATL ACAD SCI USA, V108, P367, DOI 10.1073/pnas.1015163108; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	51	51	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					81	U106		10.1038/nn.2995	http://dx.doi.org/10.1038/nn.2995			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138644	Green Accepted			2022-12-25	WOS:000298414400017
J	Graf, T				Graf, Thomas			Historical Origins of Transdifferentiation and Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; DEPENDENT DNA-POLYMERASE; CHICKEN ERYTHROID-CELLS; E26 LEUKEMIA-VIRUS; LINEAGE COMMITMENT; T-CELLS; B-CELLS; HEMATOPOIETIC-CELLS; DIRECT CONVERSION; MYELOID-LEUKEMIA	Transcription factor-induced reprogramming of specialized cells into other cell types and to pluripotency has revolutionized our thinking about cell plasticity, differentiation, and stem cells. The recent advances in this area were enabled by the confluence of a number of experimental breakthroughs that took place over the past 60 years. In this article, I give a historical and personal perspective of the events that set the stage for our current understanding of cellular reprogramming.	[Graf, Thomas] Ctr Genom Regulat, Barcelona 08003, Spain; [Graf, Thomas] Pompeu Fabra Univ, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Graf, T (corresponding author), Ctr Genom Regulat, Barcelona 08003, Spain.	thomas.graf@crg.es	Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117	Ministerio de Ciencia e Inovacion [SAF2007-63058]	Ministerio de Ciencia e Inovacion(Spanish Government)	This review is dedicated to Hartmut Beug (1945-2011). I would also like to thank Konrad Hochedlinger, Mark Ptashne, Matthias Stadtfeld, Helen Blau, Stephen Tapscott, Timm Schroeder, Andrew Lassar, Meinrad Busslinger, Rudolf Jaenisch, Tariq Enver, Denis Thieffry, Pura Munoz, Pia Cosma, Salvador Aznar Benitah, and my coworkers for comments, anecdotes, and materials. This work was supported by the Ministerio de Ciencia e Inovacion, SAF2007-63058.	Arber N, 1997, CANCER RES, V57, P1569; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BEUG H, 1984, CELL, V39, P579, DOI 10.1016/0092-8674(84)90465-3; BEUG H, 1987, GENE DEV, V1, P277, DOI 10.1101/gad.1.3.277; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Frykberg L, 1988, Oncogene Res, V3, P313; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GRAF T, 1992, CELL, V70, P201, DOI 10.1016/0092-8674(92)90096-U; GRAF T, 1978, NATURE, V275, P496, DOI 10.1038/275496a0; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; HADORN E, 1968, SCI AM, V219, P110, DOI 10.1038/scientificamerican1168-110; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; HARRIS H, 1965, NATURE, V205, P640, DOI 10.1038/205640a0; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones P, 2011, NAT CELL BIOL, V13, P2, DOI 10.1038/ncb0111-2; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KING TJ, 1955, P NATL ACAD SCI USA, V41, P321, DOI 10.1073/pnas.41.5.321; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; METZ T, 1991, GENE DEV, V5, P369, DOI 10.1101/gad.5.3.369; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAGY A, 1990, DEVELOPMENT, V110, P815; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; NESS SA, 1987, CELL, V51, P41, DOI 10.1016/0092-8674(87)90008-0; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; Piccolo FM, 2011, PHILOS T R SOC B, V366, P2260, DOI 10.1098/rstb.2011.0004; PTASHNE M, 1967, NATURE, V214, P232, DOI 10.1038/214232a0; Ptashne M, 2011, NAT CHEM BIOL, V7, P484, DOI 10.1038/nchembio.611; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; URSPRUNG H, 1962, DEV BIOL, V4, P40, DOI 10.1016/0012-1606(62)90032-5; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; WEINTRAUB H, 1982, CELL, V28, P931, DOI 10.1016/0092-8674(82)90072-1; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	132	135	145	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 2	2011	9	6					504	516		10.1016/j.stem.2011.11.012	http://dx.doi.org/10.1016/j.stem.2011.11.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	859SB	22136926	Bronze			2022-12-25	WOS:000297895000011
J	Takahashi, YK; Roesch, MR; Wilson, RC; Toreson, K; O'Donnell, P; Niv, Y; Schoenbaum, G				Takahashi, Yuji K.; Roesch, Matthew R.; Wilson, Robert C.; Toreson, Kathy; O'Donnell, Patricio; Niv, Yael; Schoenbaum, Geoffrey			Expectancy-related changes in firing of dopamine neurons depend on orbitofrontal cortex	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ORBITAL PREFRONTAL CORTEX; ENCODES RESPONSE; DECISION-MAKING; FRONTAL-CORTEX; REWARD VALUE; MODEL-FREE; RAT; PREDICTION; STRIATUM	The orbitofrontal cortex has been hypothesized to carry information regarding the value of expected rewards. Such information is essential for associative learning, which relies on comparisons between expected and obtained reward for generating instructive error signals. These error signals are thought to be conveyed by dopamine neurons. To test whether orbitofrontal cortex contributes to these error signals, we recorded from dopamine neurons in orbitofrontal-lesioned rats performing a reward learning task. Lesions caused marked changes in dopaminergic error signaling. However, the effect of lesions was not consistent with a simple loss of information regarding expected value. Instead, without orbitofrontal input, dopaminergic error signals failed to reflect internal information about the impending response that distinguished externally similar states leading to differently valued future rewards. These results are consistent with current conceptualizations of orbitofrontal cortex as supporting model-based behavior and suggest an unexpected role for this information in dopaminergic error signaling.	[Takahashi, Yuji K.; Toreson, Kathy; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Roesch, Matthew R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Roesch, Matthew R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Wilson, Robert C.; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Wilson, Robert C.; Niv, Yael] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [O'Donnell, Patricio; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] NIDA, Intramural Res Program, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Princeton University; Princeton University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Takahashi, YK (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ytaka001@umaryland.edu; schoenbg@schoenbaumlab.org		O'Donnell, Patricio/0000-0001-7788-624X	US National Institute on Drug Abuse; US National Institute on Mental Health; Binational United States-Israel Science Foundation; Sloan Research Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH083940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, K01DA021609, R01DA015718, R01DA031695] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Mental Health; Binational United States-Israel Science Foundation; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the US National Institute on Drug Abuse to G.S. and M.R. and from the US National Institute on Mental Health to Y.K.T., a Sloan Research Fellowship to Y.N. and a Binational United States-Israel Science Foundation grant to Y.N. and R.C.W.	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAW ND, NEURON IN PRESS; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Gershman SJ, 2010, CURR OPIN NEUROBIOL, V20, P251, DOI 10.1016/j.conb.2010.02.008; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRACE AA, 1984, J NEUROSCI, V4, P2877; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Lodge DJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1227, DOI 10.1038/npp.2011.7; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Niv Y, 2006, NAT NEUROSCI, V9, P987, DOI 10.1038/nn0806-987; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pickens CL, 2003, J NEUROSCI, V23, P11078; Ramus SJ, 2000, J NEUROSCI, V20, P8199, DOI 10.1523/jneurosci.20-21-08199.2000; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SIMON DA, J NEUROSCI IN PRESS; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; van Duuren E, 2008, J NEUROSCI, V28, P8590, DOI 10.1523/JNEUROSCI.5549-07.2008; van Duuren E, 2009, J NEUROSCI, V29, P8965, DOI 10.1523/JNEUROSCI.0005-09.2009; Vazquez-Borsetti P, 2009, CEREB CORTEX, V19, P1678, DOI 10.1093/cercor/bhn204; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Young JJ, 2011, J NEUROSCI, V31, P5989, DOI 10.1523/JNEUROSCI.5436-10.2011	50	176	178	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1590	U129		10.1038/nn.2957	http://dx.doi.org/10.1038/nn.2957			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037501	Green Accepted			2022-12-25	WOS:000297546300020
J	Sharot, T; Korn, CW; Dolan, RJ				Sharot, Tali; Korn, Christoph W.; Dolan, Raymond J.			How unrealistic optimism is maintained in the face of reality	NATURE NEUROSCIENCE			English	Article							FUTURE LIFE EVENTS; PREFRONTAL CORTEX; NEURAL MECHANISMS; DECISION-MAKING; REWARD; PERCEPTIONS; CHOICE; HEALTH	Unrealistic optimism is a pervasive human trait that influences domains ranging from personal relationships to politics and finance. How people maintain unrealistic optimism, despite frequently encountering information that challenges those biased beliefs, is unknown. We examined this question and found a marked asymmetry in belief updating. Participants updated their beliefs more in response to information that was better than expected than to information that was worse. This selectivity was mediated by a relative failure to code for errors that should reduce optimism. Distinct regions of the prefrontal cortex tracked estimation errors when those called for positive update, both in individuals who scored high and low on trait optimism. However, highly optimistic individuals exhibited reduced tracking of estimation errors that called for negative update in right inferior prefrontal gyrus. These findings indicate that optimism is tied to a selective update failure and diminished neural coding of undesirable information regarding the future.	[Sharot, Tali; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Korn, Christoph W.] Free Univ Berlin, Dept Educ & Psychol, D-1000 Berlin, Germany; [Korn, Christoph W.] Humboldt Univ, Sch Mind & Brain, Berlin, Germany	University of London; University College London; Free University of Berlin; Humboldt University of Berlin	Sharot, T (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	t.sharot@ucl.ac.uk		Korn, Christoph/0000-0002-8228-2624; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust; British Academy; German Academic Exchange Service (DAAD)	Wellcome Trust(Wellcome TrustEuropean Commission); British Academy; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We thank S. Fleming for assistance with analysis, P. Dayan for discussion, and T. Behrens, D. Schiller, Q. Huys, J. Winston, B. De Martino, S. Fleming, S. Bengtsson, K. Wunderlich, H. Heekeren, S. Kennerley and M. Guitart-Masip for comments on a previous version of this manuscript. This study was supported by a Wellcome Trust Program grant to R. J. D., a British Academy Postdoctoral Fellowship to T. S., and a German Academic Exchange Service (DAAD) scholarship to C. W. K.	Armor D.A., 2012, HEURISTICS BIASES PS, P334, DOI [DOI 10.1017/CBO9780511808098.021, 10.1017/cbo9780511808098.021]; BAKER LA, 1993, LAW HUMAN BEHAV, V17, P439, DOI 10.1007/BF01044377; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Calderon TG, 1993, MIDATLANTIC J BUS, V29, P41, DOI DOI 10.1016/0001-4575(89)90024-9; CHANG EC, 2000, OPTIMISM PESSIMISM I; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Ekman, 1983, QUESTIONS EMOTIONS, P39; Gerrard Meg, 1999, Journal of the National Cancer Institute Monographs, P94; Greening SG, 2011, NEUROIMAGE, V54, P1432, DOI 10.1016/j.neuroimage.2010.09.017; Mitchell DGV, 2009, J NEUROSCI, V29, P10827, DOI 10.1523/JNEUROSCI.0963-09.2009; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Puri M, 2007, J FINANC ECON, V86, P71, DOI 10.1016/j.jfineco.2006.09.003; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sharot T., 2011, OPTIMISM BIAS; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shefrin H., 2010, ROUTLEDGE COMPANION; Strunk DR, 2006, BEHAV RES THER, V44, P861, DOI 10.1016/j.brat.2005.07.001; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; UBEL P, 2009, FORBES          0222; Varki A, 2009, NATURE, V460, P684, DOI 10.1038/460684c; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; WEINSTEIN ND, 1995, HEALTH PSYCHOL, V14, P132, DOI 10.1037/0278-6133.14.2.132; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153	29	316	321	5	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1475	U156		10.1038/nn.2949	http://dx.doi.org/10.1038/nn.2949			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	841NI	21983684	Green Published, Green Accepted			2022-12-25	WOS:000296518600025
J	Tognini, P; Putignano, E; Coatti, A; Pizzorusso, T				Tognini, Paola; Putignano, Elena; Coatti, Alessandro; Pizzorusso, Tommaso			Experience-dependent expression of miR-132 regulates ocular dominance plasticity	NATURE NEUROSCIENCE			English	Article								miR-132 is a CREB-induced microRNA that is involved in dendritic spine plasticity. We found that visual experience regulated histone post-translational modifications at a CRE locus that is important for miR-212 and miR-132 cluster transcription, and regulated miR-132 expression in the visual cortex of juvenile mice. Monocular deprivation reduced miR-132 expression in the cortex contralateral to the deprived eye. Counteracting this miR-132 reduction with an infusion of chemically modified miR-132 mimic oligonucleotides completely blocked ocular dominance plasticity.	[Tognini, Paola; Putignano, Elena; Coatti, Alessandro; Pizzorusso, Tommaso] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Tognini, Paola; Putignano, Elena; Coatti, Alessandro] Scuola Normale Super Pisa, Pisa, Italy; [Pizzorusso, Tommaso] Univ Florence, Dipartimento Psicol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; University of Florence	Pizzorusso, T (corresponding author), CNR, Ist Neurosci, I-56100 Pisa, Italy.	tommaso@in.cnr.it	Pizzorusso, Tommaso/D-1399-2013	Pizzorusso, Tommaso/0000-0001-5614-0668; Putignano, Elena/0000-0002-4313-408X	European Union [223326, 223524]; EXTRAPLAST IIT project; Telethon project [GGP09196]; MIUR	European Union(European Commission); EXTRAPLAST IIT project; Telethon project(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR))	We thank L. Dolfi and F. Cremisi for help with ISH. This work was supported by European Union 7th Framework Program (FP2007-2013) grant agreements 223326 and 223524, EXTRAPLAST IIT project, Telethon project GGP09196 and MIUR EpiGen.	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kuhn DE, 2010, J BIOL CHEM, V285, P1529, DOI 10.1074/jbc.M109.033407; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Spolidoro M, 2012, CEREB CORTEX, V22, P725, DOI 10.1093/cercor/bhr158; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105	14	102	102	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1237	1239		10.1038/nn.2920	http://dx.doi.org/10.1038/nn.2920			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21892154	Green Accepted, Green Submitted			2022-12-25	WOS:000295254200007
J	Geffeney, SL; Cueva, JG; Glauser, DA; Doll, JC; Lee, THC; Montoya, M; Karania, S; Garakani, AM; Pruitt, BL; Goodman, MB				Geffeney, Shana L.; Cueva, Juan G.; Glauser, Dominique A.; Doll, Joseph C.; Lee, Tim Hau-Chen; Montoya, Misty; Karania, Snetu; Garakani, Arman M.; Pruitt, Beth L.; Goodman, Miriam B.			DEG/ENaC but Not TRP Channels Are the Major Mechanoelectrical Transduction Channels in a C. elegans Nociceptor	NEURON			English	Article							MECHANOSENSORY TRANSDUCTION; SENSORY FUNCTIONS; NEURAL CIRCUITS; ION CHANNELS; TOUCH; NEURONS; FAMILY; GENE; MECHANISMS; PROTEINS	Many nociceptors detect mechanical cues, but the ion channels responsible for mechanotransduction in these sensory neurons remain obscure. Using in vivo recordings and genetic dissection, we identified the DEG/ENaC protein, DEG-1, as the major mechanotransduction channel in ASH, a polymodal nociceptor in Caenorhabditis elegans. But DEG-1 is not the only mechanotransduction channel in ASH: loss of deg-1 revealed a minor current whose properties differ from those expected of DEG/ENaC channels. This current was independent of two TRPV channels expressed in ASH. Although loss of these TRPV channels inhibits behavioral responses to noxious stimuli, we found that both mechanoreceptor currents and potentials were essentially wild-type in TRPV mutants. We propose that ASH nociceptors rely on two genetically distinct mechanotransduction channels and that TRPV channels contribute to encoding and transmitting information. Because mammalian and insect nociceptors also coexpress DEG/ENaCs and TRPVs, the cellular functions elaborated here for these ion channels may be conserved.	[Geffeney, Shana L.; Cueva, Juan G.; Glauser, Dominique A.; Lee, Tim Hau-Chen; Montoya, Misty; Karania, Snetu; Goodman, Miriam B.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Doll, Joseph C.; Pruitt, Beth L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Garakani, Arman M.] Reify Corp, Saratoga, CA 95070 USA	Stanford University; Stanford University	Goodman, MB (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	mbgoodman@stanford.edu	Glauser, Dominique/B-3918-2012; Goodman, Miriam B./H-3036-2019	Glauser, Dominique/0000-0002-3228-7304; Goodman, Miriam B./0000-0002-5810-1272; Geffeney, Shana/0000-0003-0504-2077; Pruitt, Beth L./0000-0002-4861-2124	NIH National Center for Research Resources (NCRR); NIH [NS047715, EB006745]; McKnight Foundation; Donald B. and Delia E. Baxter Foundation; Helen Hay Whitney Foundation; Swiss National Science Foundation; NSF; Stanford Medical School; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715] Funding Source: NIH RePORTER	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Donald B. and Delia E. Baxter Foundation; Helen Hay Whitney Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF(National Science Foundation (NSF)); Stanford Medical School; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Bargmann, M. Chalfie, A. Hart, M. Koelle, S. Mitani, the C. elegans Knockout Consortium, and the Caenorhabditis Genetic Center, which is funded by the NIH National Center for Research Resources (NCRR), for strains; Wormbase; T. Ozaki and A. Naim for help with initial data analysis; S. Husson, A. Gottschalk, S. Lechner, G. Lewin for sharing data prior to publication; and three anonymous reviewers. This work was supported by NIH (NS047715, EB006745), the McKnight Foundation, the Donald B. and Delia E. Baxter Foundation, and fellowships from the Helen Hay Whitney Foundation (S.L.G.), the Swiss National Science Foundation (D.A.G.), NSF (J.C.D.), and the Stanford Medical School Dean's Fellowships (S.L.G., D.A.G.). A.M.G. is a developer at Reify Corporation, maker of Visible software.	ARNADOTTIR J, 2011, J NEUROSCI IN PRESS; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chatzigeorgiou M, 2011, NEURON, V70, P299, DOI 10.1016/j.neuron.2011.02.046; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Colbert HA, 1997, J NEUROSCI, V17, P8259; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cueva JG, 2007, J NEUROSCI, V27, P14089, DOI 10.1523/JNEUROSCI.4179-07.2007; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; GARCIAANOVEROS J, 1995, THESIS COLOMBIA U NE; Glauser DA, 2011, GENETICS, V188, P91, DOI 10.1534/genetics.111.127100; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hall DH, 1997, J NEUROSCI, V17, P1033; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; Hardie RC, 2001, J EXP BIOL, V204, P3403; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; JUUSOLA M, 1994, J NEUROPHYSIOL, V72, P3026, DOI 10.1152/jn.1994.72.6.3026; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Lee J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011012; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Liang X, 2011, CYTOSKELETON, V68, P1, DOI 10.1002/cm.20493; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Lumpkin EA, 2010, J CELL BIOL, V191, P237, DOI 10.1083/jcb.201006074; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; NISE N, 1998, CONTROL SYSTEMS ENG; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Park SJ, 2007, P NATL ACAD SCI USA, V104, P17376, DOI 10.1073/pnas.0702138104; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Poole K, 2011, HANDBOOK OF TOUCH: NEUROSCIENCE, BEHAVIORAL, AND HEALTH PERSPECTIVES, P59; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Rosenhead L., 1963, LAMINAR BOUNDARY LAY; Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang Y, 2008, EMBO J, V27, P2388, DOI 10.1038/emboj.2008.161; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	67	88	89	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 8	2011	71	5					845	857		10.1016/j.neuron.2011.06.038	http://dx.doi.org/10.1016/j.neuron.2011.06.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903078	Green Accepted, Bronze			2022-12-25	WOS:000294877900010
J	Ajami, B; Bennett, JL; Krieger, C; McNagny, KM; Rossi, FMV				Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; McNagny, Kelly M.; Rossi, Fabio M. V.			Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; PERIVASCULAR CELLS; CNS; MACROPHAGES; MIGRATION; PATHOGENESIS	In multiple sclerosis and the experimental autoimmune encephalitis (EAE) mouse model, two pools of morphologically indistinguishable phagocytic cells, microglia and inflammatory macrophages, accrue from proliferating resident precursors and recruitment of blood-borne progenitors, respectively. Whether these cell types are functionally equivalent is hotly debated, but is challenging to address experimentally. Using a combination of parabiosis and myeloablation to replace circulating progenitors without affecting CNS-resident microglia, we found a strong correlation between monocyte infiltration and progression to the paralytic stage of EAE. Inhibition of chemokine receptor-dependent recruitment of monocytes to the CNS blocked EAE progression, suggesting that these infiltrating cells are essential for pathogenesis. Finally, we found that, although microglia can enter the cell cycle and return to quiescence following remission, recruited monocytes vanish, and therefore do not ultimately contribute to the resident microglial pool. In conclusion, we identified two distinct subsets of myelomonocytic cells with distinct roles in neuroinflammation and disease progression.	[Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; McNagny, Kelly M.; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013; Ajami, Bahareh/AAA-7262-2019; McNagny, Kelly/P-5239-2014	Rossi, Fabio MV/0000-0002-0368-2620; McNagny, Kelly/0000-0003-4737-3499	Canadian Institute for Health Research (CIHR) [MOP 81382]; Multiple Sclerosis Society of Canada; Amyotrophic Lateral Sclerosis Society of Canada; Muscular Dystrophy Canada [JNM-69682]; Natural Science and Engineering Research Council of Canada [CHRP 299119]; Michael Smith Foundation for Health Research Senior Scholar; Michael Smith Foundation; Canadian Research Chairs program	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Amyotrophic Lateral Sclerosis Society of Canada; Muscular Dystrophy Canada(Muscular Dystrophy Association); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research Senior Scholar(Michael Smith Foundation for Health Research); Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Research Chairs program(Canada Research Chairs)	We thank B. Chua, T. Godbey, K. Ranta, M. Cowan, L. Rollins and the Biomedical Research Center animal unit personnel for advice and help on animal welfare. We thank A. Johnson, C. K. Chang, J. Kang and D. Mahdaviani for their technical help. This work was supported by Canadian Institute for Health Research (CIHR, MOP 81382) grants and a grant from the Multiple Sclerosis Society of Canada to F.M. V.R., a Neuromuscular Research Partnership grant from the CIHR, a grant from the Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy Canada to C.K. and F.M.V.R. (JNM-69682), a Collaborative Health Research grant from the CIHR and the Natural Science and Engineering Research Council of Canada to C.K. and F.M.V.R. (CHRP 299119), and a research grant from the Multiple Sclerosis Society of Canada to K.M.M. K.M.M. is a Michael Smith Foundation for Health Research Senior Scholar. B. A is supported by a Michael Smith Foundation Senior Graduate Studentship and a CIHR-Amyotrophic Lateral Sclerosis Doctoral Research Award. J.L.B. is supported by a Multiple Sclerosis Society of Canada Postdoctoral Research Fellowship. This research was undertaken, in part, thanks to funding from the Canadian Research Chairs program to F.M.V.R.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Bauer J, 1995, GLIA, V15, P437, DOI 10.1002/glia.440150407; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; BROSNAN CF, 1981, J IMMUNOL, V126, P614; BUKILICA M, 1991, INT J NEUROSCI, V59, P167, DOI 10.3109/00207459108985460; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; KRALL WJ, 1994, BLOOD, V83, P2737; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; MASON D, 1991, IMMUNOL TODAY, V12, P57, DOI 10.1016/0167-5699(91)90158-P; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Streit WJ, 2002, E SCHERING RES FDN W, V39, P11; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	50	736	749	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1142	U263		10.1038/nn.2887	http://dx.doi.org/10.1038/nn.2887			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21804537				2022-12-25	WOS:000294284900014
J	Paik, SB; Ringach, DL				Paik, Se-Bum; Ringach, Dario L.			Retinal origin of orientation maps in visual cortex	NATURE NEUROSCIENCE			English	Article							CELL RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; PREFERENCE MAPS; GANGLION-CELLS; ON-CENTER; SELECTIVITY; COLUMNS; ORGANIZATION; DOMAINS; SPECIFICITY	The orientation map is a hallmark of primary visual cortex in higher mammals. It is not yet known how orientation maps develop, what function they have in visual processing and why some species lack them. Here we advance the notion that quasi-periodic orientation maps are established by moire interference of regularly spaced ON- and OFF-center retinal ganglion cell mosaics. A key prediction of the theory is that the centers of iso-orientation domains must be arranged in a hexagonal lattice on the cortical surface. Here we show that such a pattern is observed in individuals of four different species: monkeys, cats, tree shrews and ferrets. The proposed mechanism explains how orientation maps can develop without requiring precise patterns of spontaneous activity or molecular guidance. Further, it offers a possible account for the emergence of orientation tuning in single neurons despite the absence of orderly orientation maps in rodents species.	[Paik, Se-Bum; Ringach, Dario L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Ringach, Dario L.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Ringach, DL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	dario@ucla.edu	Paik, Se-Bum/B-8277-2013	Paik, Se-Bum/0000-0002-4078-305X	 [EY017396];  [EY018322]; NATIONAL EYE INSTITUTE [R01EY018322] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to A. Benucci and M. Carandini (University College London) for sharing their imaging data of cat primary visual cortex, supported by research grant EY017396 to M. Carandini. We also thank D. Fitzpatrick (Max Planck Florida Institute), L. White (Duke University), W. Bosking (University Texas at Austin) and Y. Li (UC Berkeley) for sharing existing ferret and tree shrew maps. We thank M. Carandini, D. Fitzpatrick, R. Shapley, J.-M. Alonso and E. Callaway for providing comments on earlier versions of this manuscript. This work was supported by research grant EY018322 (D.L.R.).	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; AMIDROR I, 2000, THEORY MOIRE PHENOME; Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BRAASTAD BO, 1985, J NEUROPHYSIOL, V53, P1158, DOI 10.1152/jn.1985.53.5.1158; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Eglen SJ, 2005, VISUAL NEUROSCI, V22, P859, DOI 10.1017/S0952523805226147; Gauthier JL, 2009, J NEUROSCI, V29, P4675, DOI 10.1523/JNEUROSCI.5294-08.2009; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; LIVINGSTONE MS, 1995, VISION RES, V35, P345, DOI 10.1016/0042-6989(94)00133-7; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; Muir DR, 2011, CEREB CORTEX, V21, P2244, DOI 10.1093/cercor/bhq290; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohshiro T, 2006, NAT NEUROSCI, V9, P1541, DOI 10.1038/nn1799; POGGIO GF, 1975, BRAIN RES, V100, P25, DOI 10.1016/0006-8993(75)90240-1; PURVES D, 1992, TRENDS NEUROSCI, V15, P362, DOI 10.1016/0166-2236(92)90180-G; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; SHERK H, 1976, J NEUROPHYSIOL, V39, P63, DOI 10.1152/jn.1976.39.1.63; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Van Hooser SD, 2007, NEUROSCIENTIST, V13, P639, DOI 10.1177/1073858407306597; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568	50	88	88	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					919	U147		10.1038/nn.2824	http://dx.doi.org/10.1038/nn.2824			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21623365	Green Accepted			2022-12-25	WOS:000292081700021
J	Fioravante, D; Chu, YX; Myoga, MH; Leitges, M; Regehr, WG				Fioravante, Diasynou; Chu, YunXiang; Myoga, Michael H.; Leitges, Michael; Regehr, Wade G.			Calcium-Dependent Isoforms of Protein Kinase C Mediate Posttetanic Potentiation at the Calyx of Held	NEURON			English	Article							TERM SYNAPTIC PLASTICITY; SPONTANEOUS TRANSMITTER RELEASE; FROG NEUROMUSCULAR-JUNCTION; POST-TETANIC POTENTIATION; PHORBOL ESTERS; PRESYNAPTIC PLASTICITY; VESICLE FUSION; CA2+ SENSOR; RAT CALYX; NEUROTRANSMITTER RELEASE	High-frequency stimulation leads to a transient increase in the amplitude of evoked synaptic transmission that is known as posttetanic potentiation (PTP). Here we examine the roles of the calcium-dependent protein kinase C isoforms PKC alpha and PKC beta in PTP at the calyx of Held synapse. In PKC alpha/beta double knockouts, 80% of PTP is eliminated, whereas basal synaptic properties are unaffected. PKC alpha and PKC beta produce PTP by increasing the size of the readily releasable pool of vesicles evoked by high-frequency stimulation and by increasing the fraction of this pool released by the first stimulus. PKC alpha and PKC beta do not facilitate presynaptic calcium currents. The small PTP remaining in double knockouts is mediated partly by an increase in miniature excitatory postsynaptic current amplitude and partly by a mechanism involving myosin light chain kinase. These experiments establish that PKC alpha and PKC beta are crucial for PTP and suggest that long-lasting presynaptic calcium increases produced by tetanic stimulation may activate these isoforms to produce PTP.	[Fioravante, Diasynou; Chu, YunXiang; Myoga, Michael H.; Regehr, Wade G.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Chu, YunXiang] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; University of Oslo; Harvard University	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	NIH [R37 NS032405]; EF [182157]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405, R37NS032405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EF; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Evangelos Antzoulatos, Miklos Antal, Aaron Best, John Crowley, Lindsey Glickfeld, Court Hull, Michael Myoga, Todd Pressler, and Monica Thanawala for comments on a previous version of the manuscript. We thank Kimberly McDaniels for help with genotyping and Jeannie Chin and Helen Bateup for immunohistochemistry protocols. This work was supported by NIH grant R37 NS032405 to W.G.R. and EF grant 182157 to Y.X.C.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Bao JX, 1997, SCIENCE, V275, P969, DOI 10.1126/science.275.5302.969; Beierlein M, 2004, J NEUROPHYSIOL, V92, P591, DOI 10.1152/jn.00057.2004; Beierlein M, 2007, NEURON, V54, P949, DOI 10.1016/j.neuron.2007.06.002; Brager DH, 2003, NAT NEUROSCI, V6, P551, DOI 10.1038/nn1067; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; CASTILLO JD, 1954, J PHYSIOL, V124, P574; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Corbalan-Garcia S, 1999, BIOCHEM J, V337, P513, DOI 10.1042/0264-6021:3370513; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELANEY KR, 1994, J NEUROSCI, V14, P5885; ELIOT LS, 1994, J NEUROSCI, V14, P3280; Feng T.P., 1941, CHINESE J PHYSIOL, V16, P341; Fiumara F, 2007, J CELL SCI, V120, P3228, DOI 10.1242/jcs.012005; GRIFFITH WH, 1990, J NEUROPHYSIOL, V63, P491, DOI 10.1152/jn.1990.63.3.491; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Habets RLP, 2007, J PHYSIOL-LONDON, V581, P467, DOI 10.1113/jphysiol.2006.127365; Habets RLP, 2006, J NEUROPHYSIOL, V96, P2868, DOI 10.1152/jn.00427.2006; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Khoutorsky A, 2009, LEARN MEMORY, V16, P129, DOI 10.1101/lm.1275709; Kohout SC, 2002, BIOCHEMISTRY-US, V41, P11411, DOI 10.1021/bi026041k; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Korogod N, 2007, P NATL ACAD SCI USA, V104, P15923, DOI 10.1073/pnas.0704603104; Lee JS, 2008, J NEUROSCI, V28, P7945, DOI 10.1523/JNEUROSCI.2165-08.2008; Lee JS, 2010, J GEN PHYSIOL, V136, P259, DOI 10.1085/jgp.201010437; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; LEVTOV A, 1980, J PHYSIOL-LONDON, V309, P247, DOI 10.1113/jphysiol.1980.sp013507; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Magleby K L, 1979, Prog Brain Res, V49, P175; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V245, P183, DOI 10.1113/jphysiol.1975.sp010840; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NUSSINOVITCH I, 1988, J PHYSIOL-LONDON, V396, P435, DOI 10.1113/jphysiol.1988.sp016971; Oleskevich S, 2000, J PHYSIOL-LONDON, V526, P349, DOI 10.1111/j.1469-7793.2000.t01-1-00349.x; Pang ZPP, 2011, NEURON, V70, P244, DOI 10.1016/j.neuron.2011.03.011; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; REGEHR WG, 1994, J NEUROSCI, V14, P523; REYMANN KG, 1988, BRAIN RES, V440, P305, DOI 10.1016/0006-8993(88)91000-1; REYMANN KG, 1988, BRAIN RES, V461, P388, DOI 10.1016/0006-8993(88)90274-0; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Saitoh N, 2001, P NATL ACAD SCI USA, V98, P14017, DOI 10.1073/pnas.241333598; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Virmani T, 2005, J NEUROSCI, V25, P10922, DOI 10.1523/JNEUROSCI.3766-05.2005; Wang DL, 1998, P NATL ACAD SCI USA, V95, P7133, DOI 10.1073/pnas.95.12.7133; Weeber EJ, 2000, J NEUROSCI, V20, P5906, DOI 10.1523/JNEUROSCI.20-16-05906.2000; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; ZUCKER RS, 1983, J GEN PHYSIOL, V81, P355, DOI 10.1085/jgp.81.3.355	67	37	37	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					1005	1019		10.1016/j.neuron.2011.04.019	http://dx.doi.org/10.1016/j.neuron.2011.04.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658591	Bronze, Green Accepted			2022-12-25	WOS:000291843500018
J	Guo, WX; Zhang, L; Christopher, DM; Teng, ZQ; Fausett, SR; Liu, CM; George, OL; Klingensmith, J; Jin, P; Zhao, XY				Guo, Weixiang; Zhang, Li; Christopher, Devin M.; Teng, Zhao-Qian; Fausett, Sarah R.; Liu, Changmei; George, Olivia L.; Klingensmith, John; Jin, Peng; Zhao, Xinyu			RNA-Binding Protein FXR2 Regulates Adult Hippocampal Neurogenesis by Reducing Noggin Expression	NEURON			English	Article							NEURAL STEM-CELLS; X MENTAL-RETARDATION; LONG-TERM DEPRESSION; DENTATE GYRUS; MOUSE MODEL; EPIGENETIC REGULATION; PROGENITOR CELLS; ENRICHED ENVIRONMENT; SYNAPTIC PLASTICITY; SUBVENTRICULAR ZONE	In adult mammalian brains, neurogenesis persists in the subventricular zone of the lateral ventricles (SVZ) and the dentate gyrus (DG) of the hippocampus. Although evidence suggest that adult neurogenesis in these two regions is subjected to differential regulation, the underlying mechanism is unclear. Here, we show that the RNA-binding protein FXR2 specifically regulates DG neurogenesis by reducing the stability of Noggin mRNA. FXR2 deficiency leads to increased Noggin expression and subsequently reduced BMP signaling, which results in increased proliferation and altered fate specification of neural stem/progenitor cells in DG. In contrast, Noggin is not regulated by FXR2 in the SVZ, because Noggin expression is restricted to the ependymal cells of the lateral ventricles, where FXR2 is not expressed. Differential regulation of SVZ and DG stem cells by FXR2 may be a key component of the mechanism that governs the different neurogenic processes in these two adult germinal zones.	[Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Fausett, Sarah R.; Klingensmith, John] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Guo, Weixiang; Zhang, Li; Christopher, Devin M.; Teng, Zhao-Qian; Liu, Changmei; George, Olivia L.; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	Emory University; Duke University; University of New Mexico	Zhao, XY (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI 53705 USA.	xzhao@waisman.wisc.edu	Liu, Changmei/H-9600-2012; Teng, Zhao-Qian/AAD-1033-2021; Jin, Peng/B-5977-2012; Teng, Zhao-Qian/J-6260-2015	Teng, Zhao-Qian/0000-0002-7232-3381; Jin, Peng/0000-0001-6137-6659; Teng, Zhao-Qian/0000-0002-7232-3381; Fausett, Sarah/0000-0003-2046-0226	International Rett Syndrome Foundation; National Institutes of Health (NIH) [MH080434, MH078972, NS068932]; NIH/National Institute of Mental Health [MH19101]; NIH ARACDA/ASERT; University of New Mexico Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH080434, T34MH019101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068932] Funding Source: NIH RePORTER	International Rett Syndrome Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH ARACDA/ASERT; University of New Mexico Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ms. Cheryl. T. Strauss for editing the manuscript, Nora Perrone-Bizzozero for teaching us the biotinylated-RNA pull-down assay, Eric G. Schaller and Adeline C. Murthy for critical reading of the manuscript, and Sergei J. von Hoyningen-Huene and Adeline Murthy for technical assistance. This work was supported by grants from the International Rett Syndrome Foundation and the National Institutes of Health (NIH) (grants MH080434 and MH078972 to X.Z. and grant NS068932 to J.K.). D.M.C. was supported by an NIH/National Institute of Mental Health Career Opportunity for Research (COR) training grant (MH19101). O.L.G. was supported by NIH ARACDA/ASERT program. Images in this paper were generated in the University of New Mexico Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed on http://hsc.unm.edu/crtc/microscopy/acknowledgement.shtml.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Agulhon C, 1999, J NEUROPATH EXP NEUR, V58, P867, DOI 10.1097/00005072-199908000-00009; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Bhattacharyya A, 2008, STEM CELLS DEV, V17, P107, DOI 10.1089/scd.2007.0073; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brennan FX, 2006, GENES BRAIN BEHAV, V5, P467, DOI 10.1111/j.1601-183X.2005.00183.x; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Callan MA, 2010, HUM MOL GENET, V19, P3068, DOI 10.1093/hmg/ddq213; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chaturvedi G, 2009, CELL PROLIFERAT, V42, P425, DOI 10.1111/j.1365-2184.2009.00616.x; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Coffee RL, 2010, DIS MODEL MECH, V3, P471, DOI 10.1242/dmm.004598; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; Deschenes-Furry J, 2007, J NEUROSCI, V27, P665, DOI 10.1523/JNEUROSCI.4626-06.2007; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kirkpatrick LL, 2001, GENOMICS, V78, P169, DOI 10.1006/geno.2001.6667; Klingensmith J, 2010, AM J MED GENET C, V154C, P43, DOI 10.1002/ajmg.c.30256; Kohyama J, 2010, J CELL BIOL, V189, P159, DOI 10.1083/jcb.200908048; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li XK, 2008, STEM CELLS DEV, V17, P1043, DOI 10.1089/scd.2008.0036; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu RR, 2007, BIOCHEM BIOPH RES CO, V364, P528, DOI 10.1016/j.bbrc.2007.10.036; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tervonen TA, 2009, NEUROBIOL DIS, V33, P250, DOI 10.1016/j.nbd.2008.10.010; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Yang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000444; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	65	60	63	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 9	2011	70	5					924	938		10.1016/j.neuron.2011.03.027	http://dx.doi.org/10.1016/j.neuron.2011.03.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658585	Green Accepted, Bronze			2022-12-25	WOS:000291843500012
J	Panman, L; Andersson, E; Alekseenko, Z; Hedlund, E; Kee, N; Mong, J; Uhde, CW; Deng, QL; Sandberg, R; Stanton, LW; Ericson, J; Perlmann, T				Panman, Lia; Andersson, Elisabet; Alekseenko, Zhanna; Hedlund, Eva; Kee, Nigel; Mong, Jamie; Uhde, Christopher W.; Deng, Qiaolin; Sandberg, Rickard; Stanton, Lawrence W.; Ericson, Johan; Perlmann, Thomas			Transcription Factor-Induced Lineage Selection of Stem-Cell-Derived Neural Progenitor Cells	CELL STEM CELL			English	Article							DOPAMINERGIC-NEURONS; SONIC HEDGEHOG; MOTOR-NEURON; DIRECTED DIFFERENTIATION; VENTRAL MESENCEPHALON; PARKINSONS-DISEASE; DEFINED FACTORS; SPINAL-CORD; IN-VITRO; IDENTITY	The generation of specific types of neurons from stem cells offers important opportunities in regenerative medicine. However, future applications and proper verification of cell identities will require stringent ways to generate homogeneous neuronal cultures. Here we show that transcription factors like Lmx1a, Phox2b, Nkx2.2, and Olig2 can induce desired neuronal lineages from most expressing neural progenitor cells by a mechanism resembling developmental binary cell-fate switching. Such efficient selection of cell fate resulted in remarkable cellular enrichment that enabled global gene-expression validation of generated neurons and identification of previously unrecognized features in the studied cell lineages. Several sources of stem cells have a limited competence to differentiate into specific neuronal cell types; e.g., dopamine neurons. However, we show that the combination of factors that normally promote either regional or dedicated neuronal specification can overcome limitations in cellular competence and also promote efficient reprogramming in more remote neural contexts, including human neural progenitor cells.	[Andersson, Elisabet; Alekseenko, Zhanna; Kee, Nigel; Mong, Jamie; Uhde, Christopher W.; Deng, Qiaolin; Sandberg, Rickard; Ericson, Johan; Perlmann, Thomas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Panman, Lia; Hedlund, Eva; Kee, Nigel; Mong, Jamie; Sandberg, Rickard; Perlmann, Thomas] Ludwig Inst Canc Res, S-17177 Stockholm, Sweden; [Mong, Jamie; Stanton, Lawrence W.] Genome Inst Singapore, Singapore 138672, Singapore	Karolinska Institutet; Ludwig Institute for Cancer Research; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ericson, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	johan.ericson@ki.se; thomas.perlmann@licr.ki.se	Deng, Qiaolin/AAD-6905-2020; Mong, Jamie/AFU-5649-2022	Deng, Qiaolin/0000-0001-5934-7816; Sandberg, Rickard/0000-0001-6473-1740; Hedlund, Eva/0000-0001-6347-0075; Alekseenko, Zhanna/0000-0002-6560-9699; andersson, elisabet/0000-0003-3095-465X; Ericson, Johan/0000-0002-8019-7127; Mong, Jamie/0000-0003-0312-4482; Kee, Nigel/0000-0002-7095-0760	Wennergren stiftelsen; European Union [222943, 222999]; Knut och Alice Wallenberg Foundation; Michael J. Fox Foundation for Parkinson's Research; Vetenskapsradet; Goran Gustafssons Stiftelse; Swedish Foundation for Strategic Research	Wennergren stiftelsen; European Union(European Commission); Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Michael J. Fox Foundation for Parkinson's Research; Vetenskapsradet(Swedish Research Council); Goran Gustafssons Stiftelse; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	We are grateful to S. Friling and C.Y. Leung for valuable experimental help and discussions and members of the Ericson and Perlmann laboratories for discussions. This work was supported by funding from the Wennergren stiftelsen (L.P.); European Union, seventh framework programme under the grant agreements NEuroStemCell (grant 222943 to T.P. and J.E.) and mdDANeurodev (grant 222999 to T.P.); Knut och Alice Wallenberg Foundation (J.E. and T.P.); the Michael J. Fox Foundation for Parkinson's Research (J.E. and T.P.); Vetenskapsradet via support to the Linne Center for Developmental Biology and Regenerative Medicine, Vetenskapsradet (J.E. and T.P.); Goran Gustafssons Stiftelse; and Swedish Foundation for Strategic Research (J.E.).	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Du ZW, 2006, MOL CELL NEUROSCI, V33, P371, DOI 10.1016/j.mcn.2006.08.007; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hedlund E, 2009, J INTERN MED, V266, P358, DOI 10.1111/j.1365-2796.2009.02155.x; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Niederreither K, 2000, DEVELOPMENT, V127, P75; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WURST W, 1994, DEVELOPMENT, V120, P2065; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yin M, 2009, J NEUROSCI, V29, P5170, DOI 10.1523/JNEUROSCI.5569-08.2009; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	45	48	48	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					663	675		10.1016/j.stem.2011.04.001	http://dx.doi.org/10.1016/j.stem.2011.04.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624811	Bronze			2022-12-25	WOS:000291844100014
J	Takahashi, H; Katayama, K; Sohya, K; Miyamoto, H; Prasad, T; Matsumoto, Y; Ota, M; Yasuda, H; Tsumoto, T; Aruga, J; Craig, AM				Takahashi, Hideto; Katayama, Kei-ichi; Sohya, Kazuhiro; Miyamoto, Hiroyuki; Prasad, Tuhina; Matsumoto, Yoshifumi; Ota, Maya; Yasuda, Hiroki; Tsumoto, Tadaharu; Aruga, Jun; Craig, Ann Marie			Selective control of inhibitory synapse development by Slitrk3-PTP delta trans-synaptic interaction	NATURE NEUROSCIENCE			English	Article							PTP-DELTA; TYROSINE PHOSPHATASES; PROTEIN FAMILY; NEUREXINS; ADHESION; AUTISM; GABA; LAR; DIFFERENTIATION; NEUROLIGIN-2	Balanced development of excitatory and inhibitory synapses is required for normal brain function, and an imbalance in this development may underlie the pathogenesis of many neuropsychiatric disorders. Compared with the many identified trans-synaptic adhesion complexes that organize excitatory synapses, little is known about the organizers that are specific for inhibitory synapses. We found that Slit and NTRK-like family member 3 (Slitrk3) acts as a postsynaptic adhesion molecule that selectively regulates inhibitory synapse development via trans-interaction with axonal tyrosine phosphatase receptor PTP delta. When expressed in fibroblasts, Slitrk3 triggered only inhibitory presynaptic differentiation in contacting axons of co-cultured rat hippocampal neurons. Recombinant Slitrk3 preferentially localized to inhibitory postsynaptic sites. Slitrk3-deficient mice exhibited decreases in inhibitory, but not excitatory, synapse number and function in hippocampal CA1 neurons and exhibited increased seizure susceptibility and spontaneous epileptiform activity. Slitrk3 required trans-interaction with axonal PTP delta to induce inhibitory presynaptic differentiation. These results identify Slitrk3-PTP delta as an inhibitory-specific trans-synaptic organizing complex that is required for normal functional GABAergic synapse development.	[Katayama, Kei-ichi; Matsumoto, Yoshifumi; Ota, Maya; Aruga, Jun] RIKEN Brain Sci Inst BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan; [Takahashi, Hideto; Prasad, Tuhina; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Takahashi, Hideto; Prasad, Tuhina; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Sohya, Kazuhiro; Tsumoto, Tadaharu] RIKEN BSI, Lab Cort Circuit Plast, Wako, Saitama, Japan; [Sohya, Kazuhiro; Miyamoto, Hiroyuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Miyamoto, Hiroyuki] RIKEN BSI, Lab Neurobiol Synapse, Wako, Saitama, Japan; [Yasuda, Hiroki] Gunma Univ, Grad Sch Med, Educat & Res Support Ctr, Maebashi, Gunma 371, Japan	RIKEN; University of British Columbia; University of British Columbia; RIKEN; Japan Science & Technology Agency (JST); RIKEN; Gunma University	Aruga, J (corresponding author), RIKEN Brain Sci Inst BSI, Lab Behav & Dev Disorders, Wako, Saitama, Japan.	jaruga@brain.riken.jp; acraig@mail.ubc.ca	Craig, Ann Marie/M-2054-2014; Aruga, Jun/H-5837-2011; Katayama, Kei-ichi/J-4699-2013; Takahashi, Hideto/T-2650-2018	Aruga, Jun/0000-0001-7936-1375; Katayama, Kei-ichi/0000-0003-0527-4644; Takahashi, Hideto/0000-0002-6473-5060; Yasuda, Hiroki/0000-0001-5911-609X	NeuroDevNet Canadian Network of Centre of Excellence; US National Institutes of Health [MH070860]; Canadian Institutes of Health Research [MOP-84241]; Canada Research Chair; Japan Society for the Promotion of Science; National Alliance for Research on Schizophrenia and Depression; RIKEN BSI; Ministry of Education, Culture, Sports, Science (Japan) [21240031]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23500461, 21200016] Funding Source: KAKEN	NeuroDevNet Canadian Network of Centre of Excellence; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Alliance for Research on Schizophrenia and Depression(NARSAD); RIKEN BSI; Ministry of Education, Culture, Sports, Science (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank X. Zhou (Brain Research Centre, University of British Columbia) for excellent preparation of neuron cultures, N. Takashima (Lab for Behavioral and Developmental Disorders, RIKEN BSI) for technical assistance with seizure experiments and C. Nishioka (Research Resource Center, RIKEN BSI) for help generating Slitrk3 knockout mice. This work was supported by a NeuroDevNet Canadian Network of Centre of Excellence Opportunities Initiative Award, US National Institutes of Health grant MH070860, Canadian Institutes of Health Research grant MOP-84241 and Canada Research Chair awards to A. M. C., a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and a National Alliance for Research on Schizophrenia and Depression (Brain and Behavior Research Fund) Young Investigator grant to H. T., and RIKEN BSI funds and a Ministry of Education, Culture, Sports, Science (Japan) Grant-in-Aid for Scientific Research (A) (21240031) to J.A.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Beaubien F, 2009, DEV DYNAM, V238, P3285, DOI 10.1002/dvdy.22160; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suzuki T, 2009, HUM MOL GENET, V18, P1099, DOI 10.1093/hmg/ddp006; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Valnegri P, 2011, HUM MOL GENET, V20, P4797, DOI 10.1093/hmg/ddr418; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	50	159	159	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					389	U214		10.1038/nn.3040	http://dx.doi.org/10.1038/nn.3040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286174	Green Accepted			2022-12-25	WOS:000300793100012
J	LeDoux, J				LeDoux, Joseph			Rethinking the Emotional Brain	NEURON			English	Review							DORSAL PREMAMMILLARY NUCLEUS; CENTRAL AMYGDALA LESIONS; LOCUS-COERULEUS NEURONS; NEURAL SYSTEMS; MOLECULAR-MECHANISMS; PERIAQUEDUCTAL GRAY; LIMBIC SYSTEM; JAMES-LANGE; CORE AFFECT; ELECTRICAL-STIMULATION	I propose a reconceptualization of key phenomena important in the study of emotion-those phenomena that reflect functions and circuits related to survival, and that are shared by humans and other animals. The approach shifts the focus from questions about whether emotions that humans consciously feel are also present in other animals, and toward questions about the extent to which circuits and corresponding functions that are present in other animals (survival circuits and functions) are also present in humans. Survival circuit functions are not causally related to emotional feelings but obviously contribute to these, at least indirectly. The survival circuit concept integrates ideas about emotion, motivation, reinforcement, and arousal in the effort to understand how organisms survive and thrive by detecting and responding to challenges and opportunities in daily life.	[LeDoux, Joseph] NYU, Ctr Neural Sci, New York, NY 10003 USA; [LeDoux, Joseph] NYU, Dept Psychol, New York, NY 10003 USA; [LeDoux, Joseph] NYU, Emot Brain Inst, Orangeburg, NY 10962 USA; [LeDoux, Joseph] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	New York University; New York University; New York University; Nathan Kline Institute for Psychiatric Research	LeDoux, J (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	jel1@nyu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, R01MH038774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029053] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ADELMANN PK, 1989, ANNU REV PSYCHOL, V40, P249, DOI 10.1146/annurev.ps.40.020189.001341; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Amaral DG, 2003, ANN NY ACAD SCI, V1000, P337, DOI 10.1196/annals.1280.015; [Anonymous], 1987, EUR J PERSONALITY, V1, P141, DOI DOI 10.1002/PER.2410010304; Antoniadis EA, 2007, J NEUROSCI, V27, P7386, DOI 10.1523/JNEUROSCI.5643-06.2007; Arnold M.B., 1960, EMOTION PERSONALITY; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Aston-Jones G, 2005, SLEEP MED, V6, pS3, DOI 10.1016/S1389-9457(05)80002-4; ASTONJONES G, 1981, J NEUROSCI, V1, P887; ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; Averill J, 1980, EXPLAINING EMOTIONS; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; BALLEINE B, 1994, BEHAV BRAIN RES, V65, P181, DOI 10.1016/0166-4328(94)90104-X; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Barrett LF, 2007, PERSPECT PSYCHOL SCI, V2, P297, DOI 10.1111/j.1745-6916.2007.00046.x; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bekoff M., 2007, EMOTIONAL LIVES ANIM; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Bendesky A, 2011, NAT REV GENET, V12, P809, DOI 10.1038/nrg3065; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bernard C., 1879, LECONS PHENOMENES VI, DOI 10.5962/bhl.title.1817; Berridge K.C, 1999, WELL BEING; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; BINDRA D, 1968, PSYCHOL REV, V75, P1, DOI 10.1037/h0025306; BINDRA D, 1969, ANN NY ACAD SCI, V159, P1071, DOI 10.1111/j.1749-6632.1969.tb12998.x; BLANCHARD DC, 1990, AGGRESSIVE BEHAV, V16, P165; Blanchard DC, 2003, NEUROSCI LETT, V345, P145, DOI 10.1016/S0304-3940(03)00415-4; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Blaustein JD, 2008, ANNU REV PSYCHOL, V59, P93, DOI 10.1146/annurev.psych.59.103006.093556; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BORDI F, 1992, J NEUROSCI, V12, P2493; BOWLBY J, 1969, ATTACHMENT LOSS, DOI DOI 10.1177/000306518403200125; BRAAK E, 1980, J HIRNFORSCH, V21, P437; Brown SM, 2006, COGN AFFECT BEHAV NE, V6, P44, DOI 10.3758/CABN.6.1.44; BRUCE LL, 1995, BRAIN BEHAV EVOLUT, V46, P224, DOI 10.1159/000113276; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; BUCK R, 1980, J PERS SOC PSYCHOL, V38, P811, DOI 10.1037/0022-3514.38.5.811; Butler A. B., 2005, COMP VERTEBRATE NEUR; Cain CK, 2007, J EXP PSYCHOL-ANIM B, V33, P451, DOI 10.1037/0097-7403.33.4.451; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Cannon W.B, 1915, BODILY CHANGES PAIN; Cannon WB, 1927, AM J PSYCHOL, V39, P106, DOI 10.2307/1415404; Cannon WB, 1931, PSYCHOL REV, V38, P281, DOI 10.1037/h0072957; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carew TJ, 2001, NAT NEUROSCI, V4, P769, DOI 10.1038/90458; Casey BJ, 2011, DEPRESS ANXIETY, V28, P18, DOI 10.1002/da.20783; CHI CC, 1971, SCIENCE, V171, P703, DOI 10.1126/science.171.3972.703; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Choi JS, 2003, J NEUROSCI, V23, P8713; Cofer C. N, 1972, MOTIVATION EMOTION; Cofer CN, 1964, MOTIVATION THEORY RE; Cohen D.H, 1974, LIMBIC AUTONOMIC NER, P223; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P559; COONS EE, 1977, ANN NY ACAD SCI, V290, P158, DOI 10.1111/j.1749-6632.1977.tb39725.x; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Crick FC, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1133; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Darwin C., 1872, P374; DAVIDSON RJ, 1993, COGNITION EMOTION, V7, P115, DOI 10.1080/02699939308409180; Davies DC, 2002, BRAIN RES BULL, V57, P537, DOI 10.1016/S0361-9230(01)00687-6; Davis FC, 2011, EMOTION, V11, P647, DOI 10.1037/a0021625; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 1992, P255; Davis M, 1997, PHILOS T ROY SOC B, V352, P1675, DOI 10.1098/rstb.1997.0149; De Oca BM, 2007, J GEN PSYCHOL, V134, P153, DOI 10.3200/GENP.134.2.153-172; De Oca BM, 2004, INTEGR PHYS BEH SCI, V39, P318, DOI 10.1007/BF02734170; De Oca BM, 1998, J NEUROSCI, V18, P3426; Dehaene S, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1145; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Dixon Beth, 2001, ETHICS ENV, V6, P22; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; Duffy E, 1934, PSYCHOL REV, V41, P184, DOI 10.1037/h0074603; Duffy E, 1941, J GEN PSYCHOL, V25, P283, DOI 10.1080/00221309.1941.10544400; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1984, APPROACHES EMOTION, V3, P344; Ekman P, 1980, EXPLAINING EMOTIONS; Ekman P, 1972, NEBR S MOT 1971, P207; Ekman P., 1999, HDB COGNITION EMOTIO, P45, DOI [10.1017/S0140525X0800349X, DOI 10.1002/0470013494.CH3, 10.1002/0470013494.ch3]; Ekman P, 1999, ANNOTATED UPDATE C D; Ekman Paul, 1994, NATURE EMOTION FUNDA; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; ELLSWORTH PC, 1994, PSYCHOL REV, V101, P222, DOI 10.1037/0033-295X.101.2.222; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Estes WK, 1941, J EXP PSYCHOL, V29, P390, DOI 10.1037/h0062283; Everitt Barry J, 2003, Ann N Y Acad Sci, V985, P233; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Ferris CF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-111; Fitzsimons J T, 1979, Monogr Physiol Soc, P1; FLYNN JOHN P., 1967, P40; FOOTE SL, 1991, PROG BRAIN RES, V88, P521; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Frijda, 1988, COGNITIVE PERSPECTIV, P89, DOI [DOI 10.1007/978-94-009-2792-6_4, 10.1007/978-94-009-2792-6_4]; Frijda N.H., 1986, EMOTIONS; Frith C, 1996, COGNITIVE BRAIN RES, V5, P175, DOI 10.1016/S0926-6410(96)00054-7; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Frith C.D, 2008, FRONTIERS CONSCIOUSN, P225; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Gallistel R, 1980, ORG ACTION NEW SYNTH; GARCIA J, 1968, SCIENCE, V160, P794, DOI 10.1126/science.160.3829.794; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Glanzman DL, 2010, CURR BIOL, V20, pR31, DOI 10.1016/j.cub.2009.10.023; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Glimcher PW, 2003, BRADFORD BOOKS, P1; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Gray Jeffrey Alan, 1987, PSYCHOL FEAR STRESS; GRAY TS, 1993, ANN NY ACAD SCI, V697, P53, DOI 10.1111/j.1749-6632.1993.tb49922.x; Graybiel A, 1976, INPUT OUTPUT ANATOMY; Griffiths P.E., 1997, WHAT EMOTIONS REALLY; Griffiths P. E., 2004, THINKING FEELING CON, P233; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Hammond L.J, 1970, PHYSL CORRELATES EMO; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; Hebb Donald O., 1949, ORG BEHAV; Hess W.R, 1954, FUNCTIONAL ORG DIENC; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; HOLLAND PC, 1975, J COMP PHYSIOL PSYCH, V88, P459, DOI 10.1037/h0076219; Hull C., 1943, PRINCIPLES BEHAV; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Izard CE, 2007, PERSPECT PSYCHOL SCI, V2, P260, DOI [10.1111/j.1745-6916.2007.00044.x, 10.1111/j.1745-6916.2007.00053.x]; IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561; JACOBS BL, 1990, NEUROPSYCHOPHARMACOL, V3, P473; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jarymowicz M, 2009, CLOSER TO EMOTIONS, P55; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johnson AK, 2007, MED SCI SPORT EXER, V39, P1388, DOI 10.1249/mss.0b013e3180686de8; Johnson AW, 2009, J NEUROSCI, V29, P696, DOI 10.1523/JNEUROSCI.3758-08.2009; Johnson-Laird PhilipN., 1989, COGNITION EMOTION, V3, P81, DOI [10.1080/02699938908408075, DOI 10.1080/02699938908408075]; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Jouvet M, 1999, NEUROPSYCHOPHARMACOL, V21, pS24, DOI 10.1038/sj.npp.1395333; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; Kagan J., 2007, WHAT IS EMOTION HIST; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; KAPP B S, 1992, P229; KAPP BS, 1994, BEHAV NEUROSCI, V108, P81, DOI 10.1037/0735-7044.108.1.81; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; KILLCROSS AS, 1993, PSYCHOPHARMACOLOGY, V110, P479, DOI 10.1007/BF02244656; Kitayama SE, 1994, EMOTION CULTURE EMPI; Koob GF, 2009, BRAIN RES, V1293, P61, DOI 10.1016/j.brainres.2009.03.038; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lakoff G., 1987, WOMEN FIRE DANGEROUS; Lamprecht R., 2000, AMYGDALA; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; LANG PJ, 1994, PSYCHOL REV, V101, P211, DOI 10.1037/0033-295X.101.2.211; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lange C, 1885, EMOTIONS; Lashley KS, 1938, PSYCHOL REV, V45, P445, DOI 10.1037/h0060183; Lazaro-Munoz G, 2010, BIOL PSYCHIAT, V67, P1120, DOI 10.1016/j.biopsych.2009.12.002; Lazarus R.S., 1991, EMOTION ADAPTATION; LAZARUS RS, 1991, AM PSYCHOL, V46, P352, DOI 10.1037/0003-066X.46.4.352; LAZARUS RS, 1981, AM PSYCHOL, V36, P222, DOI 10.1037/0003-066X.36.2.222; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; LEDOUX J E, 1992, P339; LeDoux J. E., 1996, EMOTIONAL BRAIN; LeDoux J. E, 2008, FRONTIERS CONSCIOUSN, P69, DOI [10.1093/ acprof: oso/ 978019 9233151.003.0003, DOI 10.1093/ACPR0F:0S0/978019]; LeDoux J.E., 2002, SYNAPTIC SELF OUR BR; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux JE, 2012, PROG BRAIN RES, V195, P431, DOI 10.1016/B978-0-444-53860-4.00021-0; Ledoux Joseph E., 1995, P125; Leventhal H., 1987, COGNITION EMOTION, V1, P3, DOI [DOI 10.1080/02699938708408361, 10.1080/02699938708408361]; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lindsley DB., 1951, HDB EXPT PSYCHOL, P473; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; LOEWY AD, 1991, PROG BRAIN RES, V87, P253; Lopez H S, 1992, Curr Opin Neurobiol, V2, P317, DOI 10.1016/0959-4388(92)90122-2; Lorenz K.Z, 1981, FDN ETHOLOGY PRINCIP; Lucy JA, 1997, ANNU REV ANTHROPOL, V26, P291, DOI 10.1146/annurev.anthro.26.1.291; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Lyons W., 1980, EMOTION; MACLEAN PD, 1952, ELECTROEN CLIN NEURO, V4, P407, DOI 10.1016/0013-4694(52)90073-4; MACLEAN PD, 1949, PSYCHOSOM MED, V11, P338, DOI 10.1097/00006842-194911000-00003; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Mandler G., 1975, MIND EMOTION; Manning A, 1967, INTRO ANIMAL BEHAV; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Markham CM, 2004, NEUROSCI LETT, V372, P22, DOI 10.1016/j.neulet.2004.09.006; Marks I, 1987, FEARS PHOBIAS RITUAL; Martinez-Garcia F, 2002, BRAIN RES BULL, V57, P463, DOI 10.1016/S0361-9230(01)00665-7; Masson J.M., 1996, WHEN ELEPHANTS WEEP; Maturana HR., 1987, TREE KNOWLEDGE BIOL; McClelland D. C., 1976, ACHIEVEMENT MOTIVE; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McEwen BS, 2009, NEUROIMAGE, V47, P911, DOI 10.1016/j.neuroimage.2009.05.071; McGaugh J. L., 2003, MEMORY EMOTION MAKIN; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; McNaughton N., 1989, BIOL AND EMOTION; Miller N. E., 1944, PERSONALITY BEHAV DI, V1, P431; Mineka S, 2002, BIOL PSYCHIAT, V52, P927, DOI 10.1016/S0006-3223(02)01669-4; Mobbs D, 2009, J NEUROSCI, V29, P12236, DOI 10.1523/JNEUROSCI.2378-09.2009; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Moscarello JM, 2009, BEHAV BRAIN RES, V197, P9, DOI 10.1016/j.bbr.2008.07.025; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Mowrer OH, 1960, LEARNING THEORY BEHA, DOI DOI 10.1037/10802-000; Moyer KE., 1976, PSYCHOBIOLOGY AGGRES; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nauta WJ, 1970, NEUROSCIENCES, P7; Nesse R M, 1990, Hum Nat, V1, P261, DOI 10.1007/BF02733986; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Nieuwenhuys R., 1985, CHEMOARCHITECTURE BR, VVolume 33; Nishino Seiji, 2011, Handb Clin Neurol, V99, P765, DOI 10.1016/B978-0-444-52007-4.00006-0; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OHMAN A, 1986, PSYCHOPHYSIOLOGY, V23, P123, DOI 10.1111/j.1469-8986.1986.tb00608.x; Ohman A, 2009, SCAND J PSYCHOL, V50, P543, DOI 10.1111/j.1467-9450.2009.00784.x; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Olds J., 1977, DRIVES REINFORCEMENT; ONO T, 1992, P167; OOMURA Y, 1988, BRAIN RES BULL, V20, P863, DOI 10.1016/0361-9230(88)90103-7; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pagani JH, 2009, BRAIN RES, V1286, P133, DOI 10.1016/j.brainres.2009.06.062; PANKSEPP J, 1982, BEHAV BRAIN SCI, V5, P407, DOI 10.1017/S0140525X00012759; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J., 2000, HDB EMOTIONS; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pavesi E, 2011, NEUROPSYCHOPHARMACOL, V36, P926, DOI 10.1038/npp.2010.231; Petrovich GD, 1996, J COMP NEUROL, V374, P387, DOI 10.1002/(SICI)1096-9861(19961021)374:3<387::AID-CNE6>3.0.CO;2-Y; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Petrovich GD, 2002, J NEUROSCI, V22, P8748; Petrovich GD, 2011, PHYSIOL BEHAV, V104, P582, DOI 10.1016/j.physbeh.2011.04.059; Pfaff D.W., 1999, DRIVE NEUROBIOLOGICA, DOI DOI 10.7551/MITPRESS/2502.001.0001; Pfaff D, 2008, ANN NY ACAD SCI, V1129, P11, DOI 10.1196/annals.1417.019; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pinker S., 1997, MIND WORKS; Pirri JK, 2012, CURR OPIN NEUROBIOL, V22, P187, DOI 10.1016/j.conb.2011.12.007; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Prinz J, 2004, EMOTION EVOLUTION RA, P69, DOI DOI 10.1093/ACPROF:OSO/9780198528975.003.0004; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; REEP R, 1984, BRAIN BEHAV EVOLUT, V25, P5, DOI 10.1159/000118849; REIS DJ, 1987, CIRCULATION, V76, P2; REISENZEIN R, 1995, COGNITION EMOTION, V9, P383, DOI 10.1080/02699939508408973; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Reyes BAS, 2011, EXP NEUROL, V230, P96, DOI 10.1016/j.expneurol.2011.04.001; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; Robbins TW, 1997, BIOL PSYCHOL, V45, P57, DOI 10.1016/S0301-0511(96)05222-2; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; ROLLS E T, 1992, P143; Rolls E. T., 2005, EMOTION EXPLAINED; ROLLS ET, 1999, BRAIN EMOTION; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rorty Amelie Oksenberg, 1980, EXPLAINING EMOTIONS; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rudrauf D, 2009, INT J PSYCHOPHYSIOL, V72, P13, DOI 10.1016/j.ijpsycho.2008.03.015; Russell J.A, 1991, PERSPECTIVES PERSONA; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Sander D, 2005, NEURAL NETWORKS, V18, P317, DOI 10.1016/j.neunet.2005.03.001; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Saper CB, 2006, PROG BRAIN RES, V153, P243, DOI 10.1016/S0079-6123(06)53014-6; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Scarantino A, 2009, PHILOS SCI, V76, P940, DOI 10.1086/605816; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schachter S, 1975, HDB PSYCHOBIOLOGY, P529; Scherer K. R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Scherer K. R., 1984, REV PERSONALITY SOCI, V5, P37; Scherer KlausR., 2000, EMOTION DEV SELF ORG, P70, DOI [10.1017/CBO9780511527883.005, DOI 10.1017/CBO9780511527883.005]; SCHILDKRAUT JJ, 1967, SCIENCE, V156, P21, DOI 10.1126/science.156.3771.21; Schiller D, 2010, TRENDS COGN SCI, V14, P268, DOI 10.1016/j.tics.2010.04.002; Schimitel FG, 2012, NEUROSCIENCE, V200, P59, DOI 10.1016/j.neuroscience.2011.10.032; SCHNEIRLA TC, 1959, NEBR SYM MOTIV, V7, P1; Schober J, 2011, HORM BEHAV, V59, P689, DOI 10.1016/j.yhbeh.2010.10.005; Schoenbaum G, 2003, J NEUROSCI, V23, P9833; Schulkin J, 2003, RETHINKING HOMEOSTAS; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sears RM, 2010, J NEUROSCI, V30, P8263, DOI 10.1523/JNEUROSCI.5858-09.2010; SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3; Semendeferi K, 2011, CEREB CORTEX, V21, P1485, DOI 10.1093/cercor/bhq191; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shallice T., 1988, CONSCIOUSNESS CONT S, P305; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; SHEFFIELD FD, 1950, J COMP PHYSIOL PSYCH, V43, P471, DOI 10.1037/h0061365; Shepherd G. M., 1988, NEUROBIOLOGY; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Siegel A., 1981, HDB HYPOTHALAMUS B, V3, P203; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; STELLAR E, 1954, PSYCHOL REV, V61, P5, DOI 10.1037/0033-295X.101.2.301; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Steriade M, 1995, ARCH ITAL BIOL, V134, P5; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Sutton R.S., 1987, P 9 ANN C COGN SCI S, P355; Swanson L.W., 2002, BRAIN ARCHITECTURE U; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Talarovicova Alzbeta, 2007, Endocr Regul, V41, P155; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; THOMPSON R, 1974, B PSYCHONOMIC SOC, V4, P78; Tinbergen, 1951, STUDY INSTINCT; Tolman E.C, 1932, PURPOSIVE BEHAV; Tomkins SS, 1962, AFFECT IMAGERY CONSC, V1; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; TROWILL JA, 1969, PSYCHOL REV, V76, P264, DOI 10.1037/h0027295; VONHOLST E, 1962, SCI AM, V206, P50, DOI 10.1038/scientificamerican0362-50; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Walker DL, 2002, PSYCHOPHARMACOLOGY, V159, P304, DOI 10.1007/s002130100913; Wallace KJ, 2000, BEHAV NEUROSCI, V114, P912, DOI 10.1037//0735-7044.114.5.912; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Weinberger Norman M., 1995, P1071; Whalen P.J., 2009, HUMAN AMYGDALA; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whorf Benjamin., 1956, LANGUAGE THOUGHT REA; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Wierzbicka A., 1994, EMOTION CULTURE EMPI, P133, DOI DOI 10.1037/10152-004; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; YOVELL Y, 1992, J NEUROCHEM, V59, P1736, DOI 10.1111/j.1471-4159.1992.tb11005.x; Zachar P, 2006, J THEOR PHILOS PSYCH, V26, P120, DOI 10.1037/h0091270; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zhang TY, 2004, ANN NY ACAD SCI, V1032, P85, DOI 10.1196/annals.1314.007	365	827	835	9	269	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					653	676		10.1016/j.neuron.2012.02.004	http://dx.doi.org/10.1016/j.neuron.2012.02.004			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	899KS	22365542	Green Accepted, Bronze			2022-12-25	WOS:000300815400007
J	Thompson-Peer, KL; Bai, JH; Hu, ZT; Kaplan, JM				Thompson-Peer, Katherine L.; Bai, Jihong; Hu, Zhitao; Kaplan, Joshua M.			HBL-1 Patterns Synaptic Remodeling in C-elegans	NEURON			English	Article							TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; COUP-TFI; NEURONAL DEVELOPMENT; NUCLEAR RECEPTORS; MICRORNA; LET-7; PLASTICITY; HUNCHBACK; HOMOLOG	During development, circuits are refined by the dynamic addition and removal of synapses; however, little is known about the molecular mechanisms that dictate where and when synaptic refinement occurs. Here we describe transcriptional mechanisms that pattern remodeling of C. elegans neuromuscular junctions (NMJs). The embryonic GABAergic DD motor neurons remodel their synapses, whereas the later born VD neurons do not. This specificity is mediated by differential expression of a transcription factor (HBL-1), which is expressed in DD neurons but is repressed in VDs by UNC-55/COUP-TF. DD remodeling is delayed in hbl-1 mutants whereas precocious remodeling is observed in mutants lacking the microRNA mir-84, which inhibits hbl-1 expression. Mutations increasing and decreasing circuit activity cause corresponding changes in hbl-1 expression, and corresponding shifts in the timing of DD plasticity. Thus, convergent regulation of hbl-1 expression defines a genetic mechanism that patterns activity-dependent synaptic remodeling across cell types and across developmental time.	[Thompson-Peer, Katherine L.; Bai, Jihong; Hu, Zhitao; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Thompson-Peer, Katherine L.; Bai, Jihong; Hu, Zhitao; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	Thompson-Peer, Katherine/AAC-1051-2020	Thompson-Peer, Katherine/0000-0002-4200-3870; Hu, Zhitao/0000-0002-2948-3339	NIH National Center for Research Resources [NCRR]; Jane Coffin Childs Memorial Fund for Medical Research; National Institutes of Health [NS32196, K99MH085039]; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH085039, K99MH085039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032196, R01NS032196] Funding Source: NIH RePORTER	NIH National Center for Research Resources [NCRR](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Jane Coffin Childs Memorial Fund for Medical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Kaplan lab for helpful discussions and comments; the Caenorhabditis Genetics Center (that is funded by the NIH National Center for Research Resources [NCRR]), G. Hayes, and S. Russell for strains; and the Wellcome Trust Sanger Institute for the hbl-1 cosmid. This work was supported by a graduate research fellowship from National Science Foundation (K.T.-P.), a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research (J.B.), and grants from the National Institutes of Health to J.M.K. (NS32196) and J.B. (K99MH085039). K.T.-P. is an Albert J. Ryan Foundation fellow.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Bosman LWJ, 2009, NEUROSCIENCE, V162, P612, DOI 10.1016/j.neuroscience.2009.01.032; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Fay DS, 1999, DEV BIOL, V205, P240, DOI 10.1006/dbio.1998.9096; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Jiang B, 2007, J NEUROSCI, V27, P9648, DOI 10.1523/JNEUROSCI.2655-07.2007; Jin YS, 1999, J NEUROSCI, V19, P539; Jorgensen E.M., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.14.1, DOI 10.1895/WORMBOOK.1.14.1]; Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Melkman T, 2005, DEVELOPMENT, V132, P1935, DOI 10.1242/dev.01788; Mettler U, 2006, DEVELOPMENT, V133, P429, DOI 10.1242/dev.02229; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Roush SF, 2009, DEV BIOL, V334, P523, DOI 10.1016/j.ydbio.2009.07.012; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shan G, 2005, DEV BIOL, V280, P494, DOI 10.1016/j.ydbio.2005.01.032; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; WALTHALL WW, 1990, J NEUROBIOL, V21, P1085, DOI 10.1002/neu.480210712; WALTHALL WW, 1995, J NEUROSCI, V15, P1035; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; ZELHOF AC, 1995, MOL CELL BIOL, V15, P6736; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601; Zhou HM, 1998, J NEUROSCI, V18, P10438	64	34	35	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					453	465		10.1016/j.neuron.2011.11.025	http://dx.doi.org/10.1016/j.neuron.2011.11.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325199	Bronze, Green Accepted			2022-12-25	WOS:000300140600008
J	Stoianov, I; Zorzi, M				Stoianov, Ivilin; Zorzi, Marco			Emergence of a 'visual number sense' in hierarchical generative models	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; NUMEROSITY; CORTEX	Numerosity estimation is phylogenetically ancient and foundational to human mathematical learning, but its computational bases remain controversial. Here we show that visual numerosity emerges as a statistical property of images in 'deep networks' that learn a hierarchical generative model of the sensory input. Emergent numerosity detectors had response profiles resembling those of monkey parietal neurons and supported numerosity estimation with the same behavioral signature shown by humans and animals.	[Stoianov, Ivilin; Zorzi, Marco] Univ Padua, Dipartimento Psicol Gen, I-35100 Padua, Italy; [Zorzi, Marco] Univ Padua, Ctr Cognit Sci, I-35100 Padua, Italy	University of Padua; University of Padua	Zorzi, M (corresponding author), Univ Padua, Dipartimento Psicol Gen, I-35100 Padua, Italy.	marco.zorzi@unipd.it	Stoianov, Ivilin/AAX-8528-2020; Zorzi, Marco/B-7863-2008; Stoianov, Ivilin/G-5904-2011	Zorzi, Marco/0000-0002-4651-6390; Stoianov, Ivilin/0000-0003-0642-259X	European Research Council [210922]	European Research Council(European Research Council (ERC)European Commission)	This study was supported by the European Research Council (grant no. 210922 to M.Z.)	ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Roitman JD, 2007, PLOS BIOL, V5, P1672, DOI 10.1371/journal.pbio.0050208; Santens S, 2010, CEREB CORTEX, V20, P77, DOI 10.1093/cercor/bhp080; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497	15	183	185	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					194	196		10.1038/nn.2996	http://dx.doi.org/10.1038/nn.2996			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22231428				2022-12-25	WOS:000299603500009
J	Lerner, TN; Kreitzer, AC				Lerner, Talia N.; Kreitzer, Anatol C.			RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits	NEURON			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; MEDIUM SPINY NEURONS; BASAL GANGLIA; SYNAPTIC PLASTICITY; CHOLINERGIC INTERNEURONS; POSTNATAL-DEVELOPMENT; CALCIUM-CHANNELS; PHOSPHOLIPASE-C; DORSAL STRIATUM	Plasticity of excitatory synapses onto striatal projection neurons (MSNs) has the potential to regulate motor function by setting the gain on signals driving both direct- and indirect-pathway basal ganglia circuits. Endocannabinoid-dependent long-term depression (eCB-LTD) is the best characterized form of striatal plasticity, but the mechanisms governing its normal regulation and pathological dysregulation are not well understood. We characterized two distinct signaling pathways mediating eCB production in striatal indirect-pathway MSNs and found that both pathways were modulated by dopamine D2 and adenosine A2A receptors, acting through cAMP/PKA. We identified regulator of G protein signaling 4 (RGS4) as a key link between D2/A2A signaling and eCB mobilization pathways. In contrast to wild-type mice, RGS4(-/-) mice exhibited normal eCB-LTD after dopamine depletion and were significantly less impaired in the 6-OHDA model of Parkinson's disease. Taken together, these results suggest that inhibition of RGS4 may be an effective nondopaminergic strategy for treating Parkinson's disease.	[Lerner, Talia N.; Kreitzer, Anatol C.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Lerner, Talia N.; Kreitzer, Anatol C.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	akreitzer@gladstone.ucsf.edu	Lerner, Talia/AGW-7812-2022; Lerner, Talia/AAB-5439-2020	Lerner, Talia/0000-0002-3875-0654; 	National Center for Research Resources [RR18928-01]; National Institutes of Health [R01 NS064984]; Pew Biomedical Scholars Program; W.M. Keck Foundation; McKnight Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984, P30NS065780] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Biomedical Scholars Program; W.M. Keck Foundation(W.M. Keck Foundation); McKnight Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Taussig, T. Golde, C. Ceballos, Y. Chen, B. Sabatini, S. Finkbeiner, E. LaDow, E. Korb, L. Shoenfeld, N. Hammack, A. Kravitz, G. Hang, and other members of the Kreitzer Lab for helpful advice on experiments, comments on the manuscript, technical assistance, and reagents. We also thank N. Devidze and B. Masatsugu of the Gladstone Institutes' Behavioral Core for help obtaining the behavioral data. The Gladstone Institutes received support from a National Center for Research Resources grant (RR18928-01). This work was supported by the National Institutes of Health (R01 NS064984), the Pew Biomedical Scholars Program, the W.M. Keck Foundation, and the McKnight Foundation.	Ade KK, 2007, J NEUROSCI, V27, P2403, DOI 10.1523/JNEUROSCI.2916-06.2007; Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Bence-Hanulec KK, 2000, NEURON, V27, P121, DOI 10.1016/S0896-6273(00)00014-3; Blazer LL, 2011, BIOCHEMISTRY-US, V50, P3181, DOI 10.1021/bi1019622; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; CALABRESI P, 1994, J NEUROSCI, V14, P4871; Calabresi P, 1997, J NEUROSCI, V17, P4536; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; FILION M, 1991, BRAIN RES, V547, P142; Fino E, 2010, J PHYSIOL-LONDON, V588, P3045, DOI 10.1113/jphysiol.2010.188466; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; Fuxe K, 2007, MOVEMENT DISORD, V22, P1990, DOI 10.1002/mds.21440; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Geurts M, 2003, BIOCHEM PHARMACOL, V66, P1163, DOI 10.1016/S0006-2952(03)00447-7; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gold SJ, 1997, J NEUROSCI, V17, P8024; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Henkels KM, 2010, MOL CELL BIOL, V30, P2251, DOI 10.1128/MCB.01239-09; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kitada T, 2009, J NEUROCHEM, V110, P613, DOI 10.1111/j.1471-4159.2009.06152.x; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Lerner TN, 2011, CURR OPIN NEUROBIOL, V21, P322, DOI 10.1016/j.conb.2011.01.005; Lerner TN, 2010, J NEUROSCI, V30, P2160, DOI 10.1523/JNEUROSCI.5844-09.2010; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Obeso JA, 2000, NEUROLOGY, V55, pS7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Peterson DA, 2010, NEUROBIOL DIS, V37, P558, DOI 10.1016/j.nbd.2009.12.003; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Saugstad JA, 1998, J NEUROSCI, V18, P905; Schwendt M, 2007, J PHARMACOL EXP THER, V323, P650, DOI 10.1124/jpet.107.128561; Schwendt M, 2007, NEUROREPORT, V18, P1261, DOI 10.1097/WNR.0b013e328240507a; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Taymans JM, 2004, EUR J NEUROSCI, V19, P2249, DOI 10.1111/j.0953-816X.2004.03336.x; Tozzi A, 2007, NEUROPHARMACOLOGY, V53, P783, DOI 10.1016/j.neuropharm.2007.08.006; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195	63	136	141	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 26	2012	73	2					347	359		10.1016/j.neuron.2011.11.015	http://dx.doi.org/10.1016/j.neuron.2011.11.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284188	Green Accepted, Bronze			2022-12-25	WOS:000299761600015
J	Kim, ME; Shrestha, BR; Blazeski, R; Mason, CA; Grueber, WB				Kim, Michelle E.; Shrestha, Brikha R.; Blazeski, Richard; Mason, Carol A.; Grueber, Wesley B.			Integrins Establish Dendrite-Substrate Relationships that Promote Dendritic Self-Avoidance and Patterning in Drosophila Sensory Neurons	NEURON			English	Article							MULTIDENDRITIC NEURONS; SIGNALING PATHWAY; PROTEIN; DSCAM; GENE; MECHANISMS; SUBUNIT; COMPLEX; ARBORS; MORPHOGENESIS	Dendrites achieve characteristic spacing patterns during development to ensure appropriate coverage of territories. Mechanisms of dendrite positioning via repulsive dendrite-dendrite interactions are beginning to be elucidated, but the control, and importance, of dendrite positioning relative to their substrate is poorly understood. We found that dendritic branches of Drosophila dendritic arborization sensory neurons can be positioned either at the basal surface of epidermal cells, or enclosed within epidermal invaginations. We show that integrins control dendrite positioning on or within the epidermis in a cell autonomous manner by promoting dendritic retention on the basal surface. Loss of integrin function in neurons resulted in excessive self-crossing and dendrite maintenance defects, the former indicating a role for substrate interactions in self-avoidance. In contrast to a contact-mediated mechanism, we find that integrins prevent crossings that are noncontacting between dendrites in different three-dimensional positions, revealing a requirement for combined dendrite-dendrite and dendrite-substrate interactions in self-avoidance.	[Kim, Michelle E.; Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Shrestha, Brikha R.; Mason, Carol A.; Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY 10032 USA; [Blazeski, Richard; Mason, Carol A.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Grueber, WB (corresponding author), Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, 630 W 168th St,P&S 12-403, New York, NY 10032 USA.	wg2135@columbia.edu		Grueber, Wesley/0000-0001-6751-256X; Shrestha, Brikha/0000-0002-8874-2484	NIH NINDS [R01 NS061908]; Searle Scholars Program; Klingenstein Foundation; McKnight Endowment Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061908] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Searle Scholars Program; Klingenstein Foundation(Klingenstein Philanthropies); McKnight Endowment Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr. Yuh-Nung Jan for discussion of results prior to publication. We thank Drs. Kendal Broadie, Lynn Cooley, John Fessler and Lisa Fessler, Cynthia Hughes, Mark Krasnow, Maria Martin-Bermudo, Ben Ohlstein, Emma Rushton, the Bloomington Stock Center, and Developmental Studies Hybridoma Bank for fly stocks and antibodies. We thank members of the Grueber lab for contributing to analysis of GFP trap lines and Rachel Kim and Payal Jain for work on establishing EM protocols. We thank Drs. Jane Dodd, Oliver Hobert, and members of the Grueber lab for comments on the manuscript, and Dr. Qais Al-Awqati for helpful discussion. This work was supported by NIH NINDS R01 NS061908, the Searle Scholars Program, the Klingenstein Foundation, and the McKnight Endowment Fund (W.B.G.).	Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emtage L, 2004, NEURON, V44, P795, DOI 10.1016/j.neuron.2004.11.010; FEHON RG, 1994, DEVELOPMENT, V120, P545; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Koike-Kumagai M, 2009, EMBO J, V28, P3879, DOI 10.1038/emboj.2009.312; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levi BP, 2006, DEVELOPMENT, V133, P2383, DOI 10.1242/dev.02404; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; MACKRELL AJ, 1988, P NATL ACAD SCI USA, V85, P2633, DOI 10.1073/pnas.85.8.2633; Marrs GS, 2006, MOL CELL NEUROSCI, V32, P230, DOI 10.1016/j.mcn.2006.04.005; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Millard SS, 2008, CURR OPIN NEUROBIOL, V18, P84, DOI 10.1016/j.conb.2008.05.005; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; OSBORNE MP, 1964, NATURE, V201, P526, DOI 10.1038/201526a0; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Roote CE, 1996, DEVELOPMENT, V122, P1985; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Sugimura K, 2003, J NEUROSCI, V23, P3752; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; YEE GH, 1993, DEVELOPMENT, V118, P845; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	47	83	84	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 12	2012	73	1					79	91		10.1016/j.neuron.2011.10.033	http://dx.doi.org/10.1016/j.neuron.2011.10.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243748	Green Accepted, Bronze			2022-12-25	WOS:000299446800009
J	Liu, OW; Shen, K				Liu, Oliver W.; Shen, Kang			The transmembrane LRR protein DMA-1 promotes dendrite branching and growth in C. elegans	NATURE NEUROSCIENCE			English	Article							STRUCTURAL INSIGHTS; SIGNALING PATHWAY; NERVOUS-SYSTEM; DROSOPHILA; EXPRESSION; GENE; MORPHOGENESIS; TRANSPORT; RECEPTOR; NEURONS	Dendrites often adopt complex branched structures. The development and organization of these arbors fundamentally determine the potential input and connectivity of a given neuron. The cell-surface receptors that control dendritic branching remain poorly understood. We found that, in Caenorhabditis elegans, a previously uncharacterized transmembrane protein containing extracellular leucine-rich repeat (LRR) domains, which we named DMA-1 (dendrite-morphogenesis-abnormal), promotes dendrite branching and growth. Sustained expression of dma-1 was found only in the elaborately branched sensory neurons PVD and FLP. Genetic analysis revealed that the loss of dma-1 resulted in much reduced dendritic arbors, whereas overexpression of dma-1 resulted in excessive branching. Forced expression of dma-1 in neurons with simple dendrites was sufficient to promote ectopic branching. Worms lacking dma-1 were defective in sensing harsh touch. DMA-1 is the first transmembrane LRR protein to be implicated in dendritic branching and expands the breadth of roles of LRR receptors in nervous system development.	[Liu, Oliver W.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu			Howard Hughes Medical Institute; US National Institutes of Health; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Gao and Y. Fu for technical assistance, C. Chen, K. Mizumoto, P. Chia and A. Hellman for critical reading of the manuscript, and the members of the Shen laboratory for helpful discussion. We would also like to thank the members of the Hobert and the Jorgensen laboratories for sharing plasmids and expertise regarding fosmid recombineering and MosDel. This work was supported by grants from the Howard Hughes Medical Institute and the US National Institutes of Health to K. S., and a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund to O.W.L.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Caldwell JC, 2007, FLY, V1, P146, DOI 10.4161/fly.4562; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Hutter H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-529; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Mello C, 1995, METHOD CELL BIOL, V48, P451; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Wang GJ, 2010, NAT NEUROSCI, V13, P1489, DOI 10.1038/nn.2667; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	45	65	67	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					57	U74		10.1038/nn.2978	http://dx.doi.org/10.1038/nn.2978			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138642	Green Accepted			2022-12-25	WOS:000298414400014
J	Mao, TY; Kusefoglu, D; Hooks, BM; Huber, D; Petreanu, L; Svoboda, K				Mao, Tianyi; Kusefoglu, Deniz; Hooks, Bryan M.; Huber, Daniel; Petreanu, Leopoldo; Svoboda, Karel			Long-Range Neuronal Circuits Underlying the Interaction between Sensory and Motor Cortex	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; RAT BARREL CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; 5 PYRAMIDAL NEURONS; SENSORIMOTOR INTEGRATION; CORTICAL CONNECTIONS; OBJECT LOCALIZATION; VISUAL-CORTEX; INTRACORTICAL MICROSTIMULATION; FUNCTIONAL-ORGANIZATION	In the rodent vibrissal system, active sensation and sensorimotor integration are mediated in part by connections between barrel cortex and vibrissal motor cortex. Little is known about how these structures interact at the level of neurons. We used Channelrhodopsin-2 (ChR2) expression, combined with anterograde and retrograde labeling, to map connections between barrel cortex and pyramidal neurons in mouse motor cortex. Barrel cortex axons preferentially targeted upper layer (L2/3, L5A) neurons in motor cortex; input to neurons projecting back to barrel cortex was particularly strong. Barrel cortex input to deeper layers (L5B, L6) of motor cortex, including neurons projecting to the brainstem, was weak, despite pronounced geometric overlap of dendrites with axons from barrel cortex. Neurons in different layers received barrel cortex input within stereotyped dendritic domains. The cortico-cortical neurons in superficial layers of motor cortex thus couple motor and sensory signals and might mediate sensorimotor integration and motor learning.	[Mao, Tianyi; Kusefoglu, Deniz; Hooks, Bryan M.; Huber, Daniel; Petreanu, Leopoldo; Svoboda, Karel] HHMI, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), HHMI, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Petreanu, Leopoldo/0000-0003-1434-4691; Mao, Tianyi/0000-0002-3532-8319	Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Howard Hughes Medical Institute. We thank Gordon Shepherd for advice and extensive discussions; Asaf Keller for advice on electrical microstimulation in vM1; Tim O'Connor for programming; Brenda Shields, Amy Hu, Alma Arnold, and Kevin McGowan for technical support; Takashi Sato and Haining Zhong for help with experiments and analysis; Stefanie Kaech Petrie for help with the blind retrograde beads counting; and Diego Gutnisky and Zengcai Guo for comments on the manuscript.	Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Alloway KD, 2009, J COMP NEUROL, V515, P548, DOI 10.1002/cne.22073; Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Callaway EM, 2002, J NEUROCYTOL, V31, P231, DOI 10.1023/A:1024165824469; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Da Costa NM, 2009, J COMP NEUROL, V516, P264, DOI 10.1002/cne.22133; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hoffer ZS, 2005, J COMP NEUROL, V488, P82, DOI 10.1002/cne.20579; Hoffer ZS, 2003, J COMP NEUROL, V466, P525, DOI 10.1002/cne.10895; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lalazar H, 2008, CURR OPIN NEUROBIOL, V18, P573, DOI 10.1016/j.conb.2008.11.003; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; NUDO RJ, 1990, J COMP NEUROL, V296, P559, DOI 10.1002/cne.902960405; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; O'Connor SM, 2002, J NEUROPHYSIOL, V87, P2137, DOI 10.1152/jn.00229.2001; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Schubert D, 2003, J NEUROSCI, V23, P2961; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; SVOBODA K, 2010, HDB BRAIN MICROCIRCU; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; VOGT BA, 1978, J COMP NEUROL, V177, P179, DOI 10.1002/cne.901770202; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; WHITE EL, 1977, J COMP NEUROL, V175, P455, DOI 10.1002/cne.901750405; White EL, 2002, J NEUROCYTOL, V31, P195, DOI 10.1023/A:1024109606722; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	99	294	296	3	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					111	123		10.1016/j.neuron.2011.07.029	http://dx.doi.org/10.1016/j.neuron.2011.07.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982373	Green Accepted, Bronze			2022-12-25	WOS:000295856300012
J	Alexander, WH; Brown, JW				Alexander, William H.; Brown, Joshua W.			Medial prefrontal cortex as an action-outcome predictor	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; SUPPLEMENTARY EYE FIELD; TIME-ESTIMATION TASK; ERROR LIKELIHOOD; NEURONAL-ACTIVITY; COGNITIVE CONTROL; DECISION-MAKING; CONFLICT; PERFORMANCE; REWARD	The medial prefrontal cortex (mPFC) and especially anterior cingulate cortex is central to higher cognitive function and many clinical disorders, yet its basic function remains in dispute. Various competing theories of mPFC have treated effects of errors, conflict, error likelihood, volatility and reward, using findings from neuroimaging and neurophysiology in humans and monkeys. No single theory has been able to reconcile and account for the variety of findings. Here we show that a simple model based on standard learning rules can simulate and unify an unprecedented range of known effects in mPFC. The model reinterprets many known effects and suggests a new view of mPFC, as a region concerned with learning and predicting the likely outcomes of actions, whether good or bad. Cognitive control at the neural level is then seen as a result of evaluating the probable and actual outcomes of one's actions.	[Alexander, William H.; Brown, Joshua W.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brown, JW (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jwmbrown@indiana.edu	Brown, Joshua/G-2867-2011		Air Force Office of Scientific Research [FA9550-07-1-0454, R03 DA023462, R01 DA026457]; NARSAD; Sidney R. Baer Jr. Foundation; Department of the Interior (DOI) [D10PC20023]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023462, R01DA026457] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NARSAD(NARSAD); Sidney R. Baer Jr. Foundation; Department of the Interior (DOI); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Pessoa, S. Padmala, T. Braver, V. Stuphorn, A. Krawitz, D. Nee and the J. Schall laboratory for critical feedback. Supported in part by Air Force Office of Scientific Research FA9550-07-1-0454 (J. W. B.), R03 DA023462 (J. W. B.), R01 DA026457 (J. W. B.), a NARSAD Young Investigator Award (J. W. B.) and the Sidney R. Baer Jr. Foundation (J. W. B.). Supported by the Intelligence Advanced Research Projects Activity (IARPA) through Department of the Interior (DOI) contract D10PC20023. The US Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DOI or the US Government.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2009, PSYCHOL RES-PSYCH FO, V73, P744, DOI 10.1007/s00426-008-0198-7; Brown JW, 2009, NEUROIMAGE, V47, P334, DOI 10.1016/j.neuroimage.2009.04.034; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Cole MW, 2009, TRENDS NEUROSCI, V32, P566, DOI 10.1016/j.tins.2009.07.001; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; GEHRING WJ, 1990, PSYCHOPHYSIOLOGY, V27, P34; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Holroyd CB, 2005, J EXP PSYCHOL GEN, V134, P163, DOI 10.1037/0096-3445.134.2.163; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2007, PSYCHOPHYSIOLOGY, V44, P913, DOI 10.1111/j.1469-8986.2007.00561.x; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Nee DE, 2011, NEUROIMAGE, V54, P528, DOI 10.1016/j.neuroimage.2010.08.027; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Olson CR, 2002, PHYSIOL BEHAV, V77, P663, DOI 10.1016/S0031-9384(02)00945-9; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Singh SP, 1996, MACH LEARN, V22, P123, DOI 10.1007/BF00114726; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Yeung N, 2009, J NEUROSCI, V29, P14506, DOI 10.1523/JNEUROSCI.3615-09.2009; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	638	644	5	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1338	U163		10.1038/nn.2921	http://dx.doi.org/10.1038/nn.2921			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21926982	Green Accepted			2022-12-25	WOS:000295254200024
J	Chen, LZ; Wang, ZP; Ghosh-Roy, A; Hubert, T; Yan, D; O'Rourke, S; Bowerman, B; Wu, ZL; Jin, YS; Chisholm, AD				Chen, Lizhen; Wang, Zhiping; Ghosh-Roy, Anindya; Hubert, Thomas; Yan, Dong; O'Rourke, Sean; Bowerman, Bruce; Wu, Zilu; Jin, Yishi; Chisholm, Andrew D.			Axon Regeneration Pathways Identified by Systematic Genetic Screening in C. elegans	NEURON			English	Article							CAENORHABDITIS-ELEGANS; MICROTUBULE GROWTH; MOLECULAR-MECHANISMS; MAP KINASE; NOGO-A; GUIDANCE; PROTEIN; EXPRESSION; SUBUNIT; FAMILY	The mechanisms underlying the ability of axons to regrow after injury remain poorly explored at the molecular genetic level. We used a laser injury model in Caenorhabditis elegans mechanosensory neurons to screen 654 conserved genes for regulators of axonal regrowth. We uncover several functional clusters of genes that promote or repress regrowth, including genes classically known to affect axon guidance, membrane excitability, neurotransmission, and synaptic vesicle endocytosis. The conserved Art Guanine nucleotide Exchange Factor (GEF), EFA-6, acts as an intrinsic inhibitor of regrowth. By combining genetics and in vivo imaging, we show that EFA-6 inhibits regrowth via microtubule dynamics, independent of its Art GEF activity. Among newly identified regrowth inhibitors, only loss of function in EFA-6 partially bypasses the requirement for DLK-1 kinase. Identification of these pathways significantly expands our understanding of the genetic basis of axonal injury responses and repair.	[Chen, Lizhen; Wang, Zhiping; Ghosh-Roy, Anindya; Hubert, Thomas; Yan, Dong; Wu, Zilu; Jin, Yishi; Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Yan, Dong; Wu, Zilu; Jin, Yishi] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [O'Rourke, Sean; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Jin, Yishi] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Oregon; University of Oregon; University of California System; University of California San Diego	Jin, YS (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	yijin@ucsd.edu; chisholm@ucsd.edu	Chen, Lizhen/C-1800-2012; Yan, Dong/AAA-6559-2020	Yan, Dong/0000-0002-7542-1251; Jin, Yishi/0000-0002-9371-9860; Chisholm, Andrew/0000-0001-5091-0537; Ghosh-Roy, Anindya/0000-0002-3428-4588	NIH [R01 GM049859, GM058017, R01 NS035546, R01 NS057317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058017, R01GM049869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057317, R01NS035546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Alison Hughes, Niousha Saghafi, Amanda Rajapaksa, Sunny Sun, Peg Scott, Caroline Yu, Laura Toy, and other members of our labs for strain construction. We thank Johann Gagnon-Bartsch and Terry Speed for advice on statistical analysis; Cori Bargmann, Gian Garriga, and Erik Jorgensen for reagents; Chris Fang-Yen for the bead immobilization protocol; and Emily Troemel for comments on the manuscript. We thank the C. elegans Gene Knockout Consortium and the Japanese National Bioresource Project for deletion mutations, and the Caenorhabditis Genetics Center for strains. L.C., A.D.C., and Y.J. designed the screen. Z. Wu performed axotomy, imaging, and technical development. L.C. constructed strains and analyzed efa-6; Z. Wang analyzed slt-1/sax-3 signaling. A.G.-R. designed and performed MT imaging and analysis. L.C., Z. Wang, T.H., A.G.-R. and D.Y. contributed to the screen and analyzed the results. S.O'R. and B.B. provided reagents and unpublished data for efa-6. L.C., Z. Wang, Y.J., and A.D.C. wrote the manuscript. Z. Wang is a Fellow of the Jane Coffin Childs Memorial Fund. Z. Wu is an Associate and Y.J. is an Investigator of the Howard Hughes Medical Institute. Supported by grants from the NIH to B.B. (R01 GM049859 and GM058017), Y.J. (R01 NS035546), and A.D.C. (R01 NS057317).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Ambron RT, 1996, J NEUROSCI, V16, P7469; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BRENNER S, 1974, GENETICS, V77, P71; Brushart TM, 2002, J NEUROSCI, V22, P6631; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Doi M, 2008, MOL CELL NEUROSCI, V38, P548, DOI 10.1016/j.mcn.2008.05.003; Enes J, 2010, CURR BIOL, V20, P1154, DOI 10.1016/j.cub.2010.05.055; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; Ghosh-Roy A, 2010, DEV DYNAM, V239, P1460, DOI 10.1002/dvdy.22253; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Itoh A, 2009, BIOCHEM BIOPH RES CO, V383, P258, DOI 10.1016/j.bbrc.2009.04.009; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Li HC, 2008, J NEUROSCI, V28, P3595, DOI 10.1523/JNEUROSCI.5536-07.2008; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; Manning Gerard, 2005, WormBook, P1; Massaro CM, 2009, J CELL BIOL, V187, P101, DOI 10.1083/jcb.200903166; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nakano S, 2010, DEVELOPMENT, V137, P4017, DOI 10.1242/dev.058834; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; O'Rourke SM, 2010, NAT CELL BIOL, V12, P1235, DOI 10.1038/ncb2128; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SCHWARZ V, 2009, AM J PHYSIOL-CELL PH, V287, pC468; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Shim S, 2010, EXP NEUROL, V223, P38, DOI 10.1016/j.expneurol.2009.10.001; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Song S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001056; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; Tuck Elizabeth, 2010, Commun Integr Biol, V3, P209; Wang ZP, 2011, CURR OPIN NEUROBIOL, V21, P189, DOI 10.1016/j.conb.2010.08.010; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Woo WM, 2008, DEVELOPMENT, V135, P2747, DOI 10.1242/dev.015289; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Xie YM, 2001, J NEUROSCI, V21, P5130, DOI 10.1523/JNEUROSCI.21-14-05130.2001; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Yang Y, 2006, BRAIN RES, V1075, P1, DOI 10.1016/j.brainres.2005.12.060; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	82	137	142	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1043	1057		10.1016/j.neuron.2011.07.009	http://dx.doi.org/10.1016/j.neuron.2011.07.009			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943602	Green Accepted, Bronze			2022-12-25	WOS:000295556500010
J	Belgard, TG; Marques, AC; Oliver, PL; Abaan, HO; Sirey, TM; Hoerder-Suabedissen, A; Garcia-Moreno, F; Molnar, Z; Margulies, EH; Ponting, CP				Belgard, T. Grant; Marques, Ana C.; Oliver, Peter L.; Abaan, Hatice Ozel; Sirey, Tamara M.; Hoerder-Suabedissen, Anna; Garcia-Moreno, Fernando; Molnar, Zoltan; Margulies, Elliott H.; Ponting, Chris P.			A Transcriptomic Atlas of Mouse Neocortical Layers	NEURON			English	Article							LONG NONCODING RNAS; GENE-EXPRESSION; NMDA RECEPTORS; NEURONS; LOCALIZATION; EVOLUTION; RESOURCE; DATABASE; SUBPOPULATIONS; CONSERVATION	In the mammalian cortex, neurons and glia form a patterned structure across six layers whose complex cytoarchitectonic arrangement is likely to contribute to cognition. We sequenced transcriptomes from layers 1-6b of different areas (primary and secondary) of the adult (postnatal day 56) mouse somatosensory cortex to understand the transcriptional levels and functional repertoires of coding and noncoding loci for cells constituting these layers. A total of 5,835 protein-coding genes and 66 noncoding RNA loci are differentially expressed ("patterned") across the layers, on the basis of a machine-learning model (naive Bayes) approach. Layers 2-6b are each associated with specific functional and disease annotations that provide insights into their biological roles. This new resource (http://genserv.anat.ox.ac.uk/layers) greatly extends currently available resources, such as the Allen Mouse Brain Atlas and microarray data sets, by providing quantitative expression levels, by being genome-wide, by including novel loci, and by identifying candidate alternatively spliced transcripts that are differentially expressed across layers.	[Belgard, T. Grant; Sirey, Tamara M.; Hoerder-Suabedissen, Anna; Garcia-Moreno, Fernando; Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Belgard, T. Grant; Marques, Ana C.; Oliver, Peter L.; Sirey, Tamara M.; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Belgard, T. Grant; Abaan, Hatice Ozel; Margulies, Elliott H.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Molnar, Z (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England.	zoltan.molnar@dpag.ox.ac.uk; emargulies@illumina.com; chris.ponting@dpag.ox.ac.uk	Oliver, Peter/AAS-4022-2020; Molnar, Zoltan/J-7281-2012; Marques, Ana/GRR-9117-2022; Ponting, Chris/AAV-2621-2021; Hoerder-Suabedissen, Anna/G-7053-2011	Molnar, Zoltan/0000-0002-6852-6004; Belgard, Tildon/0000-0002-6962-7894; Oliver, Peter/0000-0003-3347-2461; Garcia-Moreno, Fernando/0000-0001-9048-4237; Hoerder-Suabedissen, Anna/0000-0003-1953-7871; Ponting, Chris/0000-0003-0202-7816; Marques, Ana Claudia/0000-0001-5174-8092	Marshall Scholarship; New College, Oxford; NIH-Oxford-Cambridge; Marie Curie Fellowship; National Human Genome Research Institute; MRC; BBSRC; MAC; Wellcome Trust; St. John's College, Oxford; ERC; Medical Research Council [G0900901, MC_U137761446] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200341] Funding Source: NIH RePORTER; MRC [MC_U137761446, G0900901] Funding Source: UKRI	Marshall Scholarship; New College, Oxford; NIH-Oxford-Cambridge(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Fellowship(European Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MAC; Wellcome Trust(Wellcome TrustEuropean Commission); St. John's College, Oxford; ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank W.Z. Wang, A.F. Cheung, and the NIH Intramural Sequencing Center for technical assistance; R.A. Chodroff, E.D. Green, A. Heger, L. Goodstadt, M. Goodson, C. Webber and J. Becker for helpful discussions. T.G.B. was supported by a Marshall Scholarship; New College, Oxford; and the NIH-Oxford-Cambridge Scholars Program. A.C.M. was supported by a Marie Curie Fellowship. E.H.M. and H.O.A. were supported by the Intramural Research Program of the National Human Genome Research Institute. A.H-S. was supported by a MRC Programme Grant to ZM. T.M.S. was supported by a BBSRC Project Grant to ZM and C.P.P. Z.M. was supported by MAC, BBSRC, Wellcome Trust and St. John's College, Oxford. P.L.O. was supported by the MRC and C.P.P. was supported by the MRC, BBSRC and ERC.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEEN MS, 2006, NEUROLOGY, V66, P1399; BELGARD TG, 2011, TRANSCRIPTOMIC ATLAS; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brodmann, 1909, VERGLEICHENDE LOKALI; Burbulla LF, 2010, EUR J CLIN INVEST, V40, P1048, DOI 10.1111/j.1365-2362.2010.02354.x; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Conti F, 1997, MOL NEUROBIOL, V14, P1, DOI 10.1007/BF02740618; Cucchiarini M, 2003, GENE THER, V10, P657, DOI 10.1038/sj.gt.3301925; CURRIE SN, 1994, BRAIN RES, V662, P103, DOI 10.1016/0006-8993(94)90801-X; Demsar J, 2004, LECT NOTES ARTIF INT, V3202, P537; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Hasan MR, 2006, FEBS LETT, V580, P3505, DOI 10.1016/j.febslet.2006.05.028; Hawrylycz M, 2010, METHODS, V50, P113, DOI 10.1016/j.ymeth.2009.09.005; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hoerder-Suabedissen A, 2009, CEREB CORTEX, V19, P1738, DOI 10.1093/cercor/bhn195; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Jones EG, 2010, CEREB CORTEX, V20, P2261, DOI 10.1093/cercor/bhq127; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Kaas JH, 2008, BRAIN RES BULL, V75, P384, DOI 10.1016/j.brainresbull.2007.10.009; Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lorente De No R., 1938, PHYSL NERVOUS SYST, P288; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Maruyama T, 2008, DEV NEUROBIOL, V68, P317, DOI 10.1002/dneu.20592; Melot T, 2001, EUR J BIOCHEM, V268, P3483, DOI 10.1046/j.1432-1327.2001.02251.x; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Ng L, 2010, METHODS, V50, P55, DOI 10.1016/j.ymeth.2009.10.001; Oeschger FM, 2012, CEREB CORTEX, V22, P1343, DOI 10.1093/cercor/bhr197; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; PETERS A, 1993, CEREB CORTEX, V3, P49, DOI 10.1093/cercor/3.1.49; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ray M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r148; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rowell JJ, 2010, J COMP NEUROL, V518, P3272, DOI 10.1002/cne.22399; Santos M, 2009, BRAIN RES REV, V62, P19, DOI 10.1016/j.brainresrev.2009.08.003; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Tan SS, 2009, GLIA, V57, P1024, DOI 10.1002/glia.20826; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; TOHYAMA M, 1974, BRAIN RES, V79, P139, DOI 10.1016/0006-8993(74)90573-3; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Uziel D, 2006, ANAT REC PART A, V288A, P135, DOI 10.1002/ar.a.20286; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; YAMAMOTO N, 2007, NOVART FDN SYMP, V288, P208; YAMAMOTO N, 2007, NOVART FDN SYMP, V288, P276; Yamamoto Nobuhiko, 2007, Novartis Found Symp, V288, P199; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	76	203	207	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					605	616		10.1016/j.neuron.2011.06.039	http://dx.doi.org/10.1016/j.neuron.2011.06.039			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867878	Green Published, hybrid			2022-12-25	WOS:000294521600007
J	Covington, HE; Maze, I; Sun, HS; Bomze, HM; DeMaio, KD; Wu, EY; Dietz, DM; Lobo, MK; Ghose, S; Mouzon, E; Neve, RL; Tamminga, CA; Nestler, EJ				Covington, Herbert E., III; Maze, Ian; Sun, HaoSheng; Bomze, Howard M.; DeMaio, Kristine D.; Wu, Emma Y.; Dietz, David M.; Lobo, Mary Kay; Ghose, Subroto; Mouzon, Ezekiel; Neve, Rachael L.; Tamminga, Carol A.; Nestler, Eric J.			A Role for Repressive Histone Methylation in Cocaine-Induced Vulnerability to Stress	NEURON			English	Article							MESOLIMBIC DOPAMINE SYSTEM; SOCIAL DEFEAT STRESS; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; CHROMATIN REGULATION; NEUROTROPHIC FACTOR; DEACETYLASE INHIBITORS; METHYLTRANSFERASE G9A; PSYCHIATRIC-DISORDERS; EPIGENETIC REGULATION	Substance abuse increases an individual's vulnerability to stress-related illnesses, which is presumably mediated by drug-induced neural adaptations that alter subsequent responses to stress. Here, we identify repressive histone methylation in nucleus accumbens (NAc), an important brain reward region, as a key mechanism linking cocaine exposure to increased stress vulnerability. Repeated cocaine administration prior to subchronic social defeat stress potentiated depressive-like behaviors in mice through decreased levels of histone H3 lysine 9 dimethylation in NAc. Cre-mediated reduction of the histone methyltransferase, G9a, in NAc promoted increased susceptibility to social stress, similar to that observed with repeated cocaine. Conversely, G9a overexpression in NAc after repeated cocaine protected mice from the consequences of subsequent stress. This resilience was mediated, in part, through repression of BDNF-TrkB-CREB signaling, which was induced after repeated cocaine or stress. Identifying such common regulatory mechanisms may aid in the development of new therapies for addiction and depression.	[Covington, Herbert E., III; Maze, Ian; Sun, HaoSheng; Dietz, David M.; Lobo, Mary Kay; Mouzon, Ezekiel; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Bomze, Howard M.; DeMaio, Kristine D.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Wu, Emma Y.; Ghose, Subroto; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Covington, Herbert E., III; Maze, Ian; Sun, HaoSheng; Dietz, David M.; Lobo, Mary Kay; Mouzon, Ezekiel; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Icahn School of Medicine at Mount Sinai	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, 1 Gustave L Levy Pl,Box 1065, New York, NY 10029 USA.	eric.nestler@mssm.edu	Ghose, Subroto/J-6732-2016; Lobo, Mary Kay/K-7734-2015; Maze, Ian/P-8077-2018; Dietz, David/J-9458-2015; Dietz, David/AAW-4574-2021	Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Sun, Haosheng/0000-0003-3919-559X; Maze, Ian/0000-0003-1490-7781; Dowd, Emma Wu/0000-0003-0219-8527	NIMH; NIDA; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172, R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014133, P01DA008227] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from NIMH and NIDA (to E.J.N.) and NARSAD (to H.E.C.).	Akbarian S, 2005, ARCH GEN PSYCHIAT, V62, P829, DOI 10.1001/archpsyc.62.8.829; Bahi A, 2008, PSYCHOPHARMACOLOGY, V199, P169, DOI 10.1007/s00213-008-1164-1; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Berglind WJ, 2009, J NEUROSCI, V29, P3715, DOI 10.1523/JNEUROSCI.5457-08.2009; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cleck JN, 2008, PSYCHOPHARMACOLOGY, V201, P15, DOI 10.1007/s00213-008-1243-3; Covington HE, 2005, NEUROPSYCHOPHARMACOL, V30, P310, DOI 10.1038/sj.npp.1300587; Covington HE, 2010, NEUROPHARMACOLOGY, V58, P683, DOI 10.1016/j.neuropharm.2009.12.004; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Der-Avakian A, 2010, BEHAV PHARMACOL, V21, P359, DOI 10.1097/FBP.0b013e32833c7cc8; Di Ciano P, 2008, NEUROPSYCHOPHARMACOL, V33, P1413, DOI 10.1038/sj.npp.1301522; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Ferguson SM, 2006, NEUROPSYCHOPHARMACOL, V31, P2660, DOI 10.1038/sj.npp.1301014; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Ford JD, 2009, DRUG ALCOHOL DEPEN, V99, P193, DOI 10.1016/j.drugalcdep.2008.07.004; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Grayson DR, 2010, MOL PHARMACOL, V77, P126, DOI 10.1124/mol.109.061333; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Grimm JW, 2003, J NEUROSCI, V23, P742; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Horger BA, 1999, J NEUROSCI, V19, P4110; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Meitzen J, 2011, J NEUROCHEM, V116, P984, DOI 10.1111/j.1471-4159.2010.07137.x; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Prasad BM, 1998, PSYCHOPHARMACOLOGY, V136, P24, DOI 10.1007/s002130050535; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Saka E, 2004, J NEUROSCI, V24, P7557, DOI 10.1523/JNEUROSCI.1072-04.2004; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schindler AG, 2010, NEUROPSYCHOPHARMACOL, V35, P1932, DOI 10.1038/npp.2010.67; Schroeder FA, 2008, NEUROPSYCHOPHARMACOL, V33, P2981, DOI 10.1038/npp.2008.15; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; SORG BA, 1991, BRAIN RES, V559, P29, DOI 10.1016/0006-8993(91)90283-2; Sun J, 2008, NEUROSCI LETT, V441, P72, DOI 10.1016/j.neulet.2008.05.010; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tidey JW, 1997, PSYCHOPHARMACOLOGY, V130, P203, DOI 10.1007/s002130050230; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Valjent E, 2000, J NEUROSCI, V20, P8701; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Zhang GC, 2007, NEUROSCI LETT, V427, P117, DOI 10.1016/j.neulet.2007.09.010	65	197	204	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 25	2011	71	4					656	670		10.1016/j.neuron.2011.06.007	http://dx.doi.org/10.1016/j.neuron.2011.06.007			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867882	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000294521600011
J	Phillips, MA; Colonnese, MT; Goldberg, J; Lewis, LD; Brown, EN; Constantine-Paton, M				Phillips, Marnie A.; Colonnese, Matthew T.; Goldberg, Julie; Lewis, Laura D.; Brown, Emery N.; Constantine-Paton, Martha			A Synaptic Strategy for Consolidation of Convergent Visuotopic Maps	NEURON			English	Article							RAT SUPERIOR COLLICULUS; CAT VISUAL-CORTEX; NMDA RECEPTOR; PYRAMIDAL NEURONS; IN-VIVO; SENSORY EXPERIENCE; NEURAL MAP; PLASTICITY; MICE; COMPETITION	The mechanisms by which experience guides refinement of converging afferent pathways are poorly understood. We describe a vision-driven refinement of corticocollicular inputs that determines the consolidation of retinal and visual cortical (VC) synapses on individual neurons in the superficial superior colliculus (sSC). Highly refined corticocollicular terminals form 1-2 days after eye-opening (EO), accompanied by VC-dependent filopodia sprouting on proximal dendrites, and PSD-95 and VC-dependent quadrupling of functional synapses. Delayed EO eliminates synapses, corticocollicular terminals, and spines on VC-recipient dendrites. Awake recordings after EO show that VC and retina cooperate to activate sSC neurons, and VC light responses precede sSC responses within intervals promoting potentiation. Eyelid closure is associated with more protracted cortical visual responses, causing the majority of VC spikes to follow those of the colliculus. These data implicate spike-timing plasticity as a mechanism for cortical input survival, and support a cooperative strategy for retinal and cortical coinnervation of the sSC.	[Phillips, Marnie A.; Constantine-Paton, Martha] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Phillips, Marnie A.; Goldberg, Julie; Lewis, Laura D.; Brown, Emery N.; Constantine-Paton, Martha] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Constantine-Paton, Martha] MIT, Dept Biol, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Colonnese, Matthew T.] Aix Marseille Univ, INSERM, U901, INMED,Fac Sci, F-13273 Marseille, France; [Brown, Emery N.] Massachusetts Gen Hosp, Neurosci Stat Res Lab, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Massachusetts General Hospital	Phillips, MA (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	marnie.a.phillips@gmail.com		Colonnese, Matthew/0000-0002-2480-1270; Lewis, Laura/0000-0002-4003-0277	NIH [EY006039]; Agence Nationale de Recherche, France; NATIONAL EYE INSTITUTE [R37EY006039, R01EY006039, R01EY014074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherche, France(French National Research Agency (ANR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank R. Desimone for helpful comments, C. Yee and A. Birdsey-Benton for technical assistance, W. Lee for transferring mutant mice, and C. Tunca for biochemistry advice. This work was supported by NIH grant EY006039 to M.C.-P. M.T.C. was supported by a grant to Rustem Khazipov (INSERM, France) from the Agence Nationale de Recherche, France.	BAKKUM BW, 1991, J NEUROSCI RES, V28, P65, DOI 10.1002/jnr.490280107; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Colonnese MT, 2001, J NEUROSCI, V21, P1557, DOI 10.1523/JNEUROSCI.21-05-01557.2001; Colonnese MT, 2006, J COMP NEUROL, V494, P738, DOI 10.1002/cne.20841; Colonnese MT, 2005, J NEUROSCI, V25, P1291, DOI 10.1523/JNEUROSCI.4063-04.2005; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; Held R, 2011, NAT NEUROSCI, V14, P551, DOI 10.1038/nn.2795; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; INOUE K, 1992, Okajimas Folia Anatomica Japonica, V68, P319; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Khachab MY, 1999, DEV BRAIN RES, V114, P179, DOI 10.1016/S0165-3806(99)00020-6; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Kruse W, 1996, P NATL ACAD SCI USA, V93, P6112, DOI 10.1073/pnas.93.12.6112; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; LUND RD, 1971, SCIENCE, V171, P804, DOI 10.1126/science.171.3973.804; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Maurer D, 2005, TRENDS COGN SCI, V9, P144, DOI 10.1016/j.tics.2005.01.006; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Ostrovsky Y, 2006, PSYCHOL SCI, V17, P1009, DOI 10.1111/j.1467-9280.2006.01827.x; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; SCHILLER PH, 2011, COMPR PHYSL S, P457; Shi J, 1997, J NEUROSCI, V17, P6264; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; THONG IG, 1986, DEV BRAIN RES, V25, P227, DOI 10.1016/0165-3806(86)90212-9; TOKUNAGA A, 1976, EXP NEUROL, V52, P189, DOI 10.1016/0014-4886(76)90164-3; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Vickers CA, 2006, BRAIN RES, V1090, P89, DOI 10.1016/j.brainres.2006.03.075; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; WARTON SS, 1989, SYNAPSE, V3, P136, DOI 10.1002/syn.890030205; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Yu LP, 2010, J NEUROSCI, V30, P4904, DOI 10.1523/JNEUROSCI.5575-09.2010; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	58	21	21	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					710	724		10.1016/j.neuron.2011.06.023	http://dx.doi.org/10.1016/j.neuron.2011.06.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867886	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000294521600015
J	Pomp, O; Dreesen, O; Leong, DFM; Meller-Pomp, O; Tan, TT; Zhou, F; Colman, A				Pomp, Oz; Dreesen, Oliver; Leong, Denise Fong Mei; Meller-Pomp, Orit; Tan, Thong Teck; Zhou, Fan; Colman, Alan			Unexpected X Chromosome Skewing during Culture and Reprogramming of Human Somatic Cells Can Be Alleviated by Exogenous Telomerase	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; BLOOD-CELLS; INACTIVATION; GENE; FEMALES; CANCER	Somatic tissues in female eutherian mammals are mosaic due to random X inactivation. In contrast to mice, X chromosome reactivation does not occur during the reprogramming of human female somatic cells to induced pluripotent stem cells (iPSCs), although this view is contested. Using balanced populations of female Rett patient and control fibroblasts, we confirm that all cells in iPSC colonies contain an inactive X, and additionally find that all colonies made from the same donor fibroblasts contain the same inactive X chromosome. Notably, this extreme "skewing" toward a particular dominant, active X is also a general feature of primary female fibroblasts during proliferation, and the skewing seen in reprogramming and fibroblast culture can be alleviated by overexpression of telomerase. These results have important implications for in vitro modeling of X-linked diseases and the interpretation of long-term culture studies in cancer and senescence using primary female fibroblast cell lines.	[Pomp, Oz; Dreesen, Oliver; Leong, Denise Fong Mei; Meller-Pomp, Orit; Tan, Thong Teck; Zhou, Fan; Colman, Alan] Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Colman, A (corresponding author), Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	alan.colman@imb.a-staredu.sg	Dreesen, Oliver/AAJ-2132-2020					Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bolduc V, 2008, J CLIN INVEST, V118, P333, DOI 10.1172/JCI33166; Bretherick K, 2005, CYTOGENET GENOME RES, V111, P260, DOI 10.1159/000086898; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Knudsen PS, 2007, CYTOGENET GENOME RES, V116, P24, DOI 10.1159/000097414; Kubota T, 1999, AM J MED GENET, V87, P258, DOI 10.1002/(SICI)1096-8628(19991126)87:3<258::AID-AJMG12>3.0.CO;2-Q; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li G, 2006, ONCOL REP, V16, P859; Lose F, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn345; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Minks J, 2008, J CLIN INVEST, V118, P20, DOI 10.1172/JCI34470; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	36	69	71	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					156	165		10.1016/j.stem.2011.06.004	http://dx.doi.org/10.1016/j.stem.2011.06.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816366	Bronze			2022-12-25	WOS:000293990900012
J	Hofer, SB; Ko, H; Pichler, B; Vogelstein, J; Ros, H; Zeng, HK; Lein, E; Lesica, NA; Mrsic-Flogel, TD				Hofer, Sonja B.; Ko, Ho; Pichler, Bruno; Vogelstein, Joshua; Ros, Hana; Zeng, Hongkui; Lein, Ed; Lesica, Nicholas A.; Mrsic-Flogel, Thomas D.			Differential connectivity and response dynamics of excitatory and inhibitory neurons in visual cortex	NATURE NEUROSCIENCE			English	Article							IN-VIVO; CORTICAL-NEURONS; FUNCTIONAL CONNECTIVITY; GABAERGIC NEURONS; TRANSGENIC MICE; STRIATE CORTEX; BEHAVING MICE; BARREL CORTEX; SIMPLE CELLS; NETWORKS	Neuronal responses during sensory processing are influenced by both the organization of intracortical connections and the statistical features of sensory stimuli. How these intrinsic and extrinsic factors govern the activity of excitatory and inhibitory populations is unclear. Using two-photon calcium imaging in vivo and intracellular recordings in vitro, we investigated the dependencies between synaptic connectivity, feature selectivity and network activity in pyramidal cells and fast-spiking parvalbumin-expressing (PV) interneurons in mouse visual cortex. In pyramidal cell populations, patterns of neuronal correlations were largely stimulus-dependent, indicating that their responses were not strongly dominated by functionally biased recurrent connectivity. By contrast, visual stimulation only weakly modified co-activation patterns of fast-spiking PV cells, consistent with the observation that these broadly tuned interneurons received very dense and strong synaptic input from nearby pyramidal cells with diverse feature selectivities. Therefore, feedforward and recurrent network influences determine the activity of excitatory and inhibitory ensembles in fundamentally different ways.	[Hofer, Sonja B.; Ko, Ho; Pichler, Bruno; Ros, Hana; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Vogelstein, Joshua] Johns Hopkins Univ, Baltimore, MD USA; [Zeng, Hongkui; Lein, Ed] Allen Inst Brain Sci, Seattle, WA USA; [Lesica, Nicholas A.] UCL, Ear Inst, London, England	University of London; University College London; Johns Hopkins University; Allen Institute for Brain Science; University of London; University College London	Mrsic-Flogel, TD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	t.mrsic-flogel@ucl.ac.uk	Ko, Ho/I-7513-2016; Vogelstein, Joshua/AAG-5489-2019; Ko, Ho/AAH-2755-2020	Ko, Ho/0000-0002-0254-3274; Vogelstein, Joshua/0000-0003-2487-6237; Ko, Ho/0000-0002-0254-3274; Lesica, Nicholas/0000-0001-5238-4462; Mrsic-Flogel, Tom/0000-0002-8947-408X; Hofer, Sonja/0000-0003-4921-8521	Wellcome Trust; European Research Council; European Molecular Biology Organization; Humboldt Foundation; European Community [FP2007-2013, 223326]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Humboldt Foundation(Alexander von Humboldt Foundation); European Community(European Commission)	We thank T. Margrie, A. Arenz and E. Rancz for help with in vivo electrophysiology, J. Sjostrom and K. Buchanan for help with in vitro electrophysiology, J. Rothman for NeuroMatic software, and M. Hubener and M. Sahani for comments on an earlier version of this manuscript. This work was supported by the Wellcome Trust (T.D.M.-F.), the European Research Council (T.D.M.-F.), the European Molecular Biology Organization (S.B.H.) and the Humboldt Foundation (S.B.H.). We also received funding from the European Community's Seventh Framework Programme (FP2007-2013) under grant agreement no. 223326 (T.D.M.-F.).	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Ch'ng YH, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00020; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oswald AMM, 2009, J NEUROSCI, V29, P10321, DOI 10.1523/JNEUROSCI.1703-09.2009; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	298	298	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1045	U146		10.1038/nn.2876	http://dx.doi.org/10.1038/nn.2876			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765421	Green Accepted			2022-12-25	WOS:000293123700019
J	Gu, ZL; Yakel, JL				Gu, Zhenglin; Yakel, Jerrel L.			Timing-Dependent Septal Cholinergic Induction of Dynamic Hippocampal Synaptic Plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PEPTIDE; ALPHA-7-CONTAINING NICOTINIC RECEPTORS; ALZHEIMERS-DISEASE; ACETYLCHOLINE-RECEPTORS; PYRAMIDAL CELLS; SK CHANNELS; MEMORY; INHIBITION	Cholinergic modulation of hippocampal synaptic plasticity has been studied extensively by applying receptor agonists or blockers; however, the effect of rapid physiological cholinergic stimuli on plasticity is largely unknown. Here, we report that septal cholinergic input, activated either by electrical stimulation or via an optogenetic approach, induced different types of hippocampal Schaffer collateral (SC) to CA1 synaptic plasticity, depending on the timing of cholinergic input relative to the SC input. When the cholinergic input was activated 100 or 10 ms prior to SC stimulation, it resulted in alpha 7 nAChR-dependent long-term potentiation (LTP) or short-term depression, respectively. When the cholinergic stimulation was delayed until 10 ms after the SC stimulation, a muscarinic AChR-dependent LTP was induced. Moreover, these various forms of plasticity were disrupted by A beta exposure. These results have revealed the remarkable temporal precision of cholinergic functions, providing a novel mechanism for information processing in cholinergic-dependent higher cognitive functions.	[Gu, Zhenglin; Yakel, Jerrel L.] NIEHS, Neurobiol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Yakel, JL (corresponding author), NIEHS, Neurobiol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA.	yakel@niehs.nih.gov		Yakel, Jerrel/0000-0001-5463-674X	NIH, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102506, ZIAES090089] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Patricia Lamb for animal genotyping and plasmid preparation, Drs. Negin Martin and Charles Romeo for virus packaging, Dr. James M. Wilson at University of Pennsylvania for providing the AAV serotype 9 helper plasmid, and Charles J. Tucker and Agnus Janoshazi for assistance with fluorescent microscopy. We also thank Drs. Serena Dudek, David Armstrong, Patricia Jensen, and Lutz Birnbaumer for discussions and critical reading of the manuscript. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences.	BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Cobb SR, 2005, J PHYSIOL-LONDON, V562, P81, DOI 10.1113/jphysiol.2004.076539; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; COLE AE, 1984, J PHYSIOL-LONDON, V352, P173, DOI 10.1113/jphysiol.1984.sp015285; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Ge SY, 2005, J NEUROSCI, V25, P6084, DOI 10.1523/JNEUROSCI.0542-05.2005; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jerusalinsky D, 1997, NEUROCHEM RES, V22, P507, DOI 10.1023/A:1027376230898; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Johnstone TB, 2011, J PHARMACOL EXP THER, V336, P908, DOI 10.1124/jpet.110.176255; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Leung LS, 2003, J NEUROSCI, V23, P9297; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mann EO, 2003, J PHYSIOL-LONDON, V551, P539, DOI 10.1113/jphysiol.2003.045492; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Maylie J, 2010, NEURON, V68, P809, DOI 10.1016/j.neuron.2010.11.037; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Power AE, 2003, NEUROBIOL LEARN MEM, V80, P178, DOI 10.1016/S1074-7427(03)00086-8; Reis HJ, 2009, CURR MED CHEM, V16, P796, DOI 10.2174/092986709787549271; Seeger T, 2004, J NEUROSCI, V24, P10117, DOI 10.1523/JNEUROSCI.3581-04.2004; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tu B, 2009, J NEUROSCI, V29, P10436, DOI 10.1523/JNEUROSCI.2580-09.2009; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wanaverbecq N, 2007, J NEUROSCI, V27, P5683, DOI 10.1523/JNEUROSCI.1732-07.2007; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Welsby PJ, 2007, NEUROPHARMACOLOGY, V53, P188, DOI 10.1016/j.neuropharm.2007.05.013; Welsby P, 2006, EUR J NEUROSCI, V24, P3109, DOI 10.1111/j.1460-9568.2006.05187.x; Widmer H, 2006, HIPPOCAMPUS, V16, P617, DOI 10.1002/hipo.20191; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; YASUDA R, 2004, SCI STKE; Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	55	201	205	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 14	2011	71	1					155	165		10.1016/j.neuron.2011.04.026	http://dx.doi.org/10.1016/j.neuron.2011.04.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745645	Green Accepted, Bronze			2022-12-25	WOS:000292806200014
J	Hayden, BY; Pearson, JM; Platt, ML				Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.			Neuronal basis of sequential foraging decisions in a patchy environment	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; REWARD SIGNALS; PREDICTION ERRORS; UNCERTAINTY; DOPAMINE; STRATEGY; CHOICE; BRAIN; DELAY; AREA	Deciding when to leave a depleting resource to exploit another is a fundamental problem for all decision makers. The neuronal mechanisms mediating patch-leaving decisions remain unknown. We found that neurons in primate (Macaca mulatta) dorsal anterior cingulate cortex, an area that is linked to reward monitoring and executive control, encode a decision variable signaling the relative value of leaving a depleting resource for a new one. Neurons fired during each sequential decision to stay in a patch and, for each travel time, these responses reached a fixed threshold for patch-leaving. Longer travel times reduced the gain of neural responses for choosing to stay in a patch and increased the firing rate threshold mandating patch-leaving. These modulations more closely matched behavioral decisions than any single task variable. These findings portend an understanding of the neural basis of foraging decisions and endorse the unification of theoretical and experimental work in ecology and neuroscience.	[Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Duke University; Duke University; Duke University	Hayden, BY (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	benhayden@gmail.com	Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281; Pearson, John/0000-0002-9876-7837	US National Institutes of Health [R01EY013496, K99 DA027718-01]; Tourette Syndrome Association; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA027718] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tourette Syndrome Association; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Heilbronner for comments on design, analysis and writing. This research was supported by US National Institutes of Health grant R01EY013496 (M. L. P.), a Fellowship from the Tourette Syndrome Association (B.Y.H.) and US National Institutes of Health grant K99 DA027718-01 (B.Y.H.).	Agetsuma N, 1998, J ETHOL, V16, P49, DOI 10.1007/BF02769282; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carpenter RHS, 1988, MOVEMENTS EYES; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Evans TA, 2007, J GEN PSYCHOL, V134, P199, DOI 10.3200/GENP.134.2.199-216; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Latty T, 2009, BEHAV ECOL, V20, P1160, DOI 10.1093/beheco/arp111; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Marr D., 1982, VISION COMPUTATIONAL; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5; McNickle GG, 2009, P NATL ACAD SCI USA, V106, P4747, DOI 10.1073/pnas.0807971106; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Smith E.A., 1992, EVOL ECOL; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Stephens DW, 2001, BEHAV ECOL, V12, P330, DOI 10.1093/beheco/12.3.330; Stern E, 2000, ARCH GEN PSYCHIAT, V57, P741, DOI 10.1001/archpsyc.57.8.741; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wilson E. O., 1998, CONSILIENCE UNITY KN; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	269	271	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					933	U165		10.1038/nn.2856	http://dx.doi.org/10.1038/nn.2856			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642973	Green Accepted			2022-12-25	WOS:000292081700023
J	Liu, WW; Liang, XH; Gong, JX; Yang, Z; Zhang, YH; Zhang, JX; Rao, Y				Liu, Weiwei; Liang, Xinhua; Gong, Jianxian; Yang, Zhen; Zhang, Yao-Hua; Zhang, Jian-Xu; Rao, Yi			Social regulation of aggression by pheromonal activation of Or65a olfactory neurons in Drosophila	NATURE NEUROSCIENCE			English	Article							ANTENNAL LOBE; CAENORHABDITIS-ELEGANS; MELANOGASTER; BEHAVIOR; EXPERIENCE; CIRCUIT; SYSTEM; REPRESENTATION; STIMULATION; ADAPTATION	When two socially naive Drosophila males meet, they will fight. However, prior social grouping of males reduces their aggression. We found olfactory communication to be important for modulating Drosophila aggression. Although acute exposure to the male-specific pheromone 11-cis-vaccenyl acetate (cVA) elicited aggression through Or67d olfactory receptor neurons (ORNs), chronic cVA exposure reduced aggression through Or65a ORNs. Or65a ORNs were not acutely involved in aggression, but blockade of synaptic transmission of Or65a ORNs during social grouping or prior chronic cVA exposure eliminated social modulation of aggression. Artificial activation of Or65a ORNs by ectopic expression of the Drosophila gene TrpA1 was sufficient to reduce aggression. Social suppression of aggression requires subsets of local interneurons in the antennal lobe. Our results indicate that activation of Or65a ORNs is important for social modulation of male aggression, demonstrate that the acute and chronic effects of a single pheromone are mediated by two distinct types of ORNs, reveal a behaviorally important role for interneurons and suggest a chemical method to reduce aggression in animals.	[Liu, Weiwei; Liang, Xinhua; Rao, Yi] Natl Inst Biol Sci, Beijing, Peoples R China; [Liang, Xinhua] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Liang, Xinhua] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Liu, Weiwei] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Gong, Jianxian; Yang, Zhen] Peking Univ, Sch Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhang, Yao-Hua; Zhang, Jian-Xu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Rao, Yi] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Normal University; Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University	Rao, Y (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	yrao@pku.edu.cn	Yang, Zhen/J-6306-2015; Gong, Jianxian/J-5946-2015	Yang, Zhen/0000-0001-8036-934X; Rao, Yi/0000-0002-0405-5426; Gong, Jianxian/0000-0001-8285-1420; Zhang, Yao-Hua/0000-0002-6318-413X; Liu, Weiwei/0000-0001-5082-9114	Ministry of Science and Technology [2010CB833900]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We are grateful to B. Dickson (Research Institute of Molecular Pathology), P. Garrity (Brandeis University), T. Lee (Janelia Farm Research Campus), L. Luo (Stanford University), P. Shen (University of Georgia) and L. Vosshall (Rockefeller University) for providing stocks, W. Guo, C. Zhou and other members of the Rao laboratory for helpful discussions and technical assistance, and J. Tan and M. Luo for help with electrophysiology. This work was supported by the Ministry of Science and Technology (973 program No. 2010CB833900).	AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; GETCHELL TV, 1978, J PHYSIOL-LONDON, V282, P541, DOI 10.1113/jphysiol.1978.sp012480; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han DD, 2000, DEVELOPMENT, V127, P573; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Lieber T, 2011, NEURON, V69, P468, DOI 10.1016/j.neuron.2010.12.015; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Rai S, 2007, DEV NEUROBIOL, V67, P1443, DOI 10.1002/dneu.20522; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Rose JK, 2005, J NEUROSCI, V25, P7159, DOI 10.1523/JNEUROSCI.1833-05.2005; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Valzelli L, 1978, Ann Ist Super Sanita, V14, P173; VALZELLI L, 1973, PSYCHOPHARMACOLOGIA, V31, P305, DOI 10.1007/BF00421275; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	49	98	103	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					896	U119		10.1038/nn.2836	http://dx.doi.org/10.1038/nn.2836			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685916				2022-12-25	WOS:000292081700018
J	Adelson, JD; Barreto, GE; Xu, LJ; Kim, T; Brott, BK; Ouyang, YB; Naserke, T; Djurisic, M; Xiong, XX; Shatz, CJ; Giffard, RG				Adelson, Jaimie D.; Barreto, George E.; Xu, Lijun; Kim, Taeho; Brott, Barbara K.; Ouyang, Yi-Bing; Naserke, Thorsten; Djurisic, Maja; Xiong, Xiaoxing; Shatz, Carla J.; Giffard, Rona G.			Neuroprotection from Stroke in the Absence of MHCI or PirB	NEURON			English	Article							OCULAR-DOMINANCE PLASTICITY; FIBRILLARY ACIDIC PROTEIN; CLASS-I MHC; VISUAL-CORTEX; FUNCTIONAL RECOVERY; AXONAL PLASTICITY; T-CELLS; SENSORIMOTOR CORTEX; CEREBRAL-ISCHEMIA; DENDRITIC SPINES	Recovery from stroke engages mechanisms of neural plasticity. Here we examine a role for MHC class I (MHCI) H2-Kb and H2-Db, as well as PirB receptor. These molecules restrict synaptic plasticity and motor learning in the healthy brain. Stroke elevates neuronal expression not only of H2-Kb and H2-Db, but also of PirB and downstream signaling. KbDb knockout (KO) or PirB KO mice have smaller infarcts and enhanced motor recovery. KO hippocampal organotypic slices, which lack an intact peripheral immune response, have less cell death after in vitro ischemia. In PirB KO mice, corticospinal projections from the motor cortex are enhanced, and the reactive astrocytic response is dampened after MCAO. Thus, molecules that function in the immune system act not only to limit synaptic plasticity in healthy neurons, but also to exacerbate brain injury. after ischemia. These results suggest therapies for stroke by targeting MHCI and PirB.	[Adelson, Jaimie D.; Kim, Taeho; Brott, Barbara K.; Naserke, Thorsten; Djurisic, Maja; Shatz, Carla J.] Stanford Univ, Dept Biol & Neurobiol, Stanford, CA 94305 USA; [Barreto, George E.; Xu, Lijun; Ouyang, Yi-Bing; Xiong, Xiaoxing; Giffard, Rona G.] Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Shatz, CJ (corresponding author), Stanford Univ, Dept Biol & Neurobiol, Stanford, CA 94305 USA.	cshatz@stanford.edu; rona.giffard@stanford.edu	Barreto, George E./AAD-7420-2020; Barreto, George E./B-5747-2014	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Xiong, Xiaoxing/0000-0001-6983-8547; Steinmetz, Jaimie/0000-0003-2397-4070; Giffard, Rona/0000-0003-2173-4436	NIH [MH07166, EY02858, RO1 GM49831, NS 053898]; Mathers Charitible Foundation; Ellison Foundation; National Defense Science and Engineering Graduate Fellowship; National Science Foundation; NATIONAL EYE INSTITUTE [R37EY002858, R01EY002858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Charitible Foundation; Ellison Foundation(Lawrence Ellison Foundation); National Defense Science and Engineering Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Sotelo and P. Kemper for help with laboratory logistics and mice breeding, Dr. H. Lee and Y. Kim for additional troubleshooting for qPCR reactions, and S. Cheng for genotyping assistance. The PirB mutant mice were generated by Dr. J. Syken in the Shatz laboratory. Thanks also to Dr. H. Ploegh, MIT, for KbDb KO mice. This work was supported by NIH grants MH07166 and EY02858, the Mathers Charitible Foundation, and the Ellison Foundation to C.J.S., a National Defense Science and Engineering Graduate Fellowship and National Science Foundation Graduate Research Fellowship to J.D.A., and NIH grants RO1 GM49831 and NS 053898 to R.G.G.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fournier AE, 2002, PROG BRAIN RES, V137, P361; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Matsushita H, 2011, J BIOL CHEM, V286, P25739, DOI 10.1074/jbc.M110.157859; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Nakamura Y, 2011, J BIOL CHEM, V286, P1876, DOI 10.1074/jbc.M110.163493; NAUS C, 1985, EXP BRAIN RES, V59, P365; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Netz J, 1997, BRAIN, V120, P1579, DOI 10.1093/brain/120.9.1579; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Piehl F, 2001, IMMUNOL REV, V184, P212, DOI 10.1034/j.1600-065x.2001.1840119.x; ROUILLER EM, 1991, EXP NEUROL, V114, P53, DOI 10.1016/0014-4886(91)90084-P; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Sopala M, 2000, NEUROSCI LETT, V281, P143, DOI 10.1016/S0304-3940(00)00829-6; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; Thams S, 2008, BRAIN RES REV, V57, P265, DOI 10.1016/j.brainresrev.2007.06.016; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; Washburn LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018439; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wu ZP, 2011, IMMUNOL LETT, V135, P118, DOI 10.1016/j.imlet.2010.10.011; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	56	97	103	3	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1100	1107		10.1016/j.neuron.2012.01.020	http://dx.doi.org/10.1016/j.neuron.2012.01.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445338	Green Accepted, Bronze			2022-12-25	WOS:000301998700008
J	Benz, C; Copley, MR; Kent, DG; Wohrer, S; Cortes, A; Aghaeepour, N; Ma, E; Mader, H; Rowe, K; Day, C; Treloar, D; Brinkman, RR; Eaves, CJ				Benz, Claudia; Copley, Michael R.; Kent, David G.; Wohrer, Stefan; Cortes, Adrian; Aghaeepour, Nima; Ma, Elaine; Mader, Heidi; Rowe, Keegan; Day, Christopher; Treloar, David; Brinkman, Ryan R.; Eaves, Connie J.			Hematopoietic Stem Cell Subtypes Expand Differentially during Development and Display Distinct Lymphopoietic Programs	CELL STEM CELL			English	Article							LIMITING DILUTION ANALYSIS; IN-VIVO; B-LYMPHOPOIESIS; CLONAL ANALYSIS; AGED MICE; TERM; POPULATIONS; COMPARTMENT; HETEROGENEITY; REPOPULATION	Adult hematopoietic stem cells (HSCs) with serially transplantable activity comprise two subtypes. One shows a balanced output of mature lymphoid and myeloid cells; the other appears selectively lymphoid deficient. We now show that both of these HSC subtypes are present in the fetal liver (at a 1:10 ratio) with the rarer, lymphoid-deficient HSCs immediately gaining an increased representation in the fetal bone marrow, suggesting that the marrow niche plays a key role in regulating their ensuing preferential amplification. Clonal analysis of HSC expansion posttransplant showed that both subtypes display an extensive but variable self-renewal activity with occasional interconversion. Clonal analysis of their differentiation programs demonstrated functional and molecular as well as quantitative HSC subtype-specific differences in the lymphoid progenitors they generate but an indistinguishable production of multipotent and myeloid-restricted progenitors. These findings establish a level of heterogeneity in HSC differentiation and expansion control that may have relevance to stem cell populations in other hierarchically organized tissues.	[Benz, Claudia; Copley, Michael R.; Kent, David G.; Wohrer, Stefan; Cortes, Adrian; Aghaeepour, Nima; Ma, Elaine; Mader, Heidi; Rowe, Keegan; Day, Christopher; Treloar, David; Brinkman, Ryan R.; Eaves, Connie J.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Brinkman, Ryan R.; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada	British Columbia Cancer Agency; University of British Columbia	Eaves, CJ (corresponding author), BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca	Kent, David/F-1084-2013; Kent, David/AAZ-4916-2021; Brinkman, Ryan/B-1108-2008	Kent, David/0000-0001-7871-8811; Brinkman, Ryan/0000-0002-9765-2990; Day, Christopher/0000-0001-8737-2322; Eaves, Connie/0000-0002-3452-1926	National Cancer Institute of Canada (NCIC, Toronto, ON); Terry Fox Foundation; Canadian Institutes of Health Research (CIHR, Toronto, ON); Canadian Cancer Society [700374]; Terry Fox Research Institute; Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany); Michael Smith Foundation for Health Research (MSFHR); CIHR; MSFHR; Austrian Science Fund (Vienna, Austria	National Cancer Institute of Canada (NCIC, Toronto, ON); Terry Fox Foundation; Canadian Institutes of Health Research (CIHR, Toronto, ON)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Research Institute; Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany)(German Research Foundation (DFG)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research); Austrian Science Fund (Vienna, Austria(Austrian Science Fund (FWF))	We thank the Flow Cytometry Facility of the Terry Fox Laboratory, the Animal Resource Centre of the BC Cancer Agency, and A. Cheung, M. Kardel, I. Sloma, and B. Dykstra for helpful comments. This work was supported by grants from the National Cancer Institute of Canada (NCIC, Toronto, ON, with funds from the Terry Fox Foundation), the Canadian Institutes of Health Research (CIHR, Toronto, ON), the Canadian Cancer Society (grant 700374), the Terry Fox Research Institute, and the Terry Fox Foundation. C.B. received a fellowship from the Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany); M.R.C. received a studentship from the Michael Smith Foundation for Health Research (MSFHR), Vanier Canada Graduate Scholarship from CIHR, and an MD/PhD Graduate Training Award from CIHR; D.G.K. received studentships from CIHR and MSFHR; S.W. received an Erwin Schroedinger Auslands Fellowship from the Austrian Science Fund (Vienna, Austria); and R.R.B. held a MSFHR Scholar Award.	Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Dzierzak E, 2005, CURR OPIN HEMATOL, V12, P197, DOI 10.1097/01.moh.0000160736.44726.0e; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; Kent D, 2007, CURR PROTOC STEM CEL; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Labrie JE, 2004, J EXP MED, V200, P411, DOI 10.1084/jem.20040845; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lescale C, 2010, AGING CELL, V9, P410, DOI 10.1111/j.1474-9726.2010.00566.x; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Miller JP, 2005, SEMIN IMMUNOL, V17, P321, DOI 10.1016/j.smim.2005.05.003; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Muller-Sieburg CE, 2006, CURR OPIN HEMATOL, V13, P243, DOI 10.1097/01.moh.0000231421.00407.65; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Northrup DL, 2008, IMMUNOL RES, V42, P106, DOI 10.1007/s12026-008-8043-z; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Szilvassy SJ, 2003, EXP HEMATOL, V31, P331, DOI 10.1016/S0301-472X(03)00005-5; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Zhong RK, 1996, J IMMUNOL, V157, P138	47	208	210	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					273	283		10.1016/j.stem.2012.02.007	http://dx.doi.org/10.1016/j.stem.2012.02.007			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385655	Bronze			2022-12-25	WOS:000301466500009
J	Unoki, T; Matsuda, S; Kakegawa, W; Ngo, TBV; Kohda, K; Suzuki, A; Funakoshi, Y; Hasegawa, H; Yuzaki, M; Kanaho, Y				Unoki, Takamitsu; Matsuda, Shinji; Kakegawa, Wataru; Ngo Thai Bich Van; Kohda, Kazuhisa; Suzuki, Atsushi; Funakoshi, Yuji; Hasegawa, Hiroshi; Yuzaki, Michisuke; Kanaho, Yasunori			NMDA Receptor-Mediated PIP5K Activation to Produce PI(4,5)P-2 Is Essential for AMPA Receptor Endocytosis during LTD	NEURON			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; LONG-TERM DEPRESSION; IONOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC VESICLE ENDOCYTOSIS; CLATHRIN-COATED PITS; I-GAMMA; HIPPOCAMPAL LTD; PROTEIN PHOSPHATASE-1; DEPENDENT ENDOCYTOSIS; PLASMA-MEMBRANE	NMDA receptor activation leads to clathrin-dependent endocytosis of postsynaptic AMPA receptors. Although this process controls long-term depression (LTD) induction in the hippocampus, how it is regulated by neuronal activities is not completely clear. Here, we show that Ca2+ influx through the NMDA receptor activates calcineurin and protein phosphatase 1 to dephosphorylate phosphatidylinositol 4-phosphate 5-kinase gamma 661 (PIP5K gamma 661), the major phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2)-producing enzyme in the brain. Bimolecular fluorescence complementation analysis revealed that the dephosphorylated PIP5K gamma 661 became associated with the clathrin adaptor protein complex AP-2 at postsynapses in situ. NMDA-induced AMPA receptor endocytosis and low-frequency stimulation-induced LTD were completely blocked by inhibiting the association between dephosphorylated PIP5K gamma 661 and AP-2 and by overexpression of a kinase-dead PIP5K gamma 661 mutant in hippocampal neurons. Furthermore, knockdown of PIP5K gamma 661 inhibited the NMDA-induced AMPA receptor endocytosis. Therefore, NMDA receptor activation controls AMPA receptor endocytosis during hippocampal LTD by regulating PIP5K gamma 661 activity at postsynapses.	[Matsuda, Shinji; Kakegawa, Wataru; Kohda, Kazuhisa; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Unoki, Takamitsu; Ngo Thai Bich Van; Suzuki, Atsushi; Funakoshi, Yuji; Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Physiol Chem, Tsukuba, Ibaraki 3058571, Japan; [Unoki, Takamitsu; Ngo Thai Bich Van; Suzuki, Atsushi; Funakoshi, Yuji; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058571, Japan; [Matsuda, Shinji; Kakegawa, Wataru; Kohda, Kazuhisa; Yuzaki, Michisuke] Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan; [Hasegawa, Hiroshi] Univ Tsukuba, Lab Dev Neurosci, Initiat Promot Young Scientists Independent Res, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan	Keio University; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	myuzaki@a5.keio.jp; ykanaho@md.tsukuba.ac.jp	Matsuda, Shinji/L-4727-2013; Matsuda, Shinji/GRR-5226-2022; UNOKI, Takamitsu/AAS-5650-2020; Kohda, Kazuhisa/L-4731-2013; Yuzaki, Michisuke/K-5328-2013; Kakegawa, Wataru/L-4900-2013; Kakegawa, Wataru/G-5569-2016	UNOKI, Takamitsu/0000-0002-2067-3734; Yuzaki, Michisuke/0000-0002-5750-3544; Ngo Thai Bich, Van/0000-0003-2693-4090	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science; MEXT [20247010, 22700343, 23240053, 23689012]; Mitsubishi Research Foundation; Grants-in-Aid for Scientific Research [23689012, 22700343] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Miyazaki (Osaka University), K. Nakayama (Kyoto University), M.A. Frohman (Stony Brook University), and J.G. Donaldson (National Institutes of Health) for providing the pCAGGS expression vector, human 132 adaptin cDNA, pVenus (1-173) N-1 and pVenus (155-238) C-1 vectors, and the anti-ARF6 antibody, respectively, and S. Narumi for technical assistance. This work was supported by Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and/or Japan Society for the Promotion of Science, Grant in Aid for Scientific Research to Y.K. (20247010), S.M. (22700343), W.K. (23240053), and M.Y. (23689012), by Core Research for Evolutional Science and Technology to MY., and by Special Coordination Funds for Promoting Science and Technology to H.H. from MEXT and the Mitsubishi Research Foundation.	Akiba Yosuke, 2002, Brain Res Gene Expr Patterns, V1, P123; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BORITZKI TJ, 1988, BIOCHEM PHARMACOL, V37, P4063, DOI 10.1016/0006-2952(88)90096-2; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHERNEVSKAYA NI, 1991, NATURE, V349, P418, DOI 10.1038/349418a0; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; DAYANITHI G, 1995, NEUROENDOCRINOLOGY, V61, P243, DOI 10.1159/000126846; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Gong LW, 2008, P NATL ACAD SCI USA, V105, P17561, DOI 10.1073/pnas.0809221105; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Harris SL, 2004, NEUROSCI LETT, V372, P132, DOI 10.1016/j.neulet.2004.09.019; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Matsuda K, 2003, J NEUROSCI, V23, P10064; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Morgan JR, 2004, J CELL BIOL, V167, P43, DOI 10.1083/jcb.200406020; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Rappoport JZ, 2009, J CELL SCI, V122, P1301, DOI 10.1242/jcs.040030; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Schnabel R, 2001, BRIT J PHARMACOL, V132, P1095, DOI 10.1038/sj.bjp.0703905; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; Semerdjieva S, 2008, J CELL BIOL, V183, P499, DOI 10.1083/jcb.200806016; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	71	51	53	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 12	2012	73	1					135	148		10.1016/j.neuron.2011.09.034	http://dx.doi.org/10.1016/j.neuron.2011.09.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243752	Bronze			2022-12-25	WOS:000299446800013
J	Oshimori, N; Fuchs, E				Oshimori, Naoki; Fuchs, Elaine			Paracrine TGF-beta Signaling Counterbalances BMP-Mediated Repression in Hair Follicle Stem Cell Activation	CELL STEM CELL			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN; SELF-RENEWAL; SKIN; REGENERATION; INDUCTION; NICHE; DIFFERENTIATION; PROLIFERATION; HOMEOSTASIS	Hair follicle (HF) regeneration begins when communication between quiescent epithelial stem cells (SCs) and underlying mesenchymal dermal papillae (DP) generates sufficient activating cues to overcome repressive BMP signals from surrounding niche cells. Here, we uncover a hitherto unrecognized DP transmitter, TGF-beta 2, which activates Smad2/3 transiently in HFSCs concomitant with entry into tissue regeneration. This signaling is critical: HFSCs that cannot sense TGF-beta exhibit significant delays in HF regeneration, whereas exogenous TGF-beta 2 stimulates HFSCs in vivo and in vitro. By engineering TGF-beta- and BMP-reporter mice, we show that TGF-beta 2 signaling antagonizes BMP signaling in HFSCs but not through competition for limiting Smad4-coactivator. Rather, our microarray, molecular, and genetic studies unveil Tmeff1 as a direct TGF-beta 2/Smad2/3 target gene, expressed by activated HFSCs and physiologically relevant in restricting and lowering BMP thresholds in the niche. Connecting BMP activity to an SC's response to TGF-beta s may explain why these signaling factors wield such diverse cellular effects.	[Oshimori, Naoki; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		International Human Frontier Science Program Organization; Japan Society for the Promotion of Science; National Institutes of Health [R01-AR050452]; Emerald Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR031737] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Karlsson for floxed-T beta RII mice; D. Padua and S. Tavazoie for information about pSmad2 antibodies; N. Stokes and D. Oristian for in utero lentiviral injections and assistance in the mouse facility; S. Beronja and Y.C. Hsu for critical reading of the manuscript; and S. Williams, M. Schober, T. Chen, M. Kadaja, and other E.F. laboratory members for discussions. We appreciate the assistance of S. Mazel in the RU Flow Cytometry Resource Center, the Comparative Bioscience Center (an American Association of Accreditation of Laboratory Animal Care facility) for expert handling and care of the mice, and Memorial Sloan Kettering Genomics Core Facility for RNA and microarray processing. N.O. was supported by International Human Frontier Science Program Organization and is currently supported by the Japan Society for the Promotion of Science. E.F. is an investigator of the Howard Hughes Medical Institute. This work was supported by grants to E.F. from National Institutes of Health (R01-AR050452) and Emerald Foundation.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; MASSAGUE J, 1992, MOL REPROD DEV, V32, P99, DOI 10.1002/mrd.1080320204; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yew KH, 2005, J BIOL CHEM, V280, P32209, DOI 10.1074/jbc.M505465200; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544	49	244	260	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					63	75		10.1016/j.stem.2011.11.005	http://dx.doi.org/10.1016/j.stem.2011.11.005			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226356	Green Accepted, Bronze			2022-12-25	WOS:000299449500011
J	Hama, H; Kurokawa, H; Kawano, H; Ando, R; Shimogori, T; Noda, H; Fukami, K; Sakaue-Sawano, A; Miyawaki, A				Hama, Hiroshi; Kurokawa, Hiroshi; Kawano, Hiroyuki; Ando, Ryoko; Shimogori, Tomomi; Noda, Hisayori; Fukami, Kiyoko; Sakaue-Sawano, Asako; Miyawaki, Atsushi			Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain	NATURE NEUROSCIENCE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; VASCULAR NICHE; TOOL; VISUALIZATION; PROTEINS; DEEP	Optical methods for viewing neuronal populations and projections in the intact mammalian brain are needed, but light scattering prevents imaging deep into brain structures. We imaged fixed brain tissue using Scale, an aqueous reagent that renders biological samples optically transparent but completely preserves fluorescent signals in the clarified structures. In Scale-treated mouse brain, neurons labeled with genetically encoded fluorescent proteins were visualized at an unprecedented depth in millimeter-scale networks and at subcellular resolution. The improved depth and scale of imaging permitted comprehensive three-dimensional reconstructions of cortical, callosal and hippocampal projections whose extent was limited only by the working distance of the objective lenses. In the intact neurogenic niche of the dentate gyrus, Scale allowed the quantitation of distances of neural stem cells to blood vessels. Our findings suggest that the Scale method will be useful for light microscopy-based connectomics of cellular networks in brain and other tissues.	[Hama, Hiroshi; Kurokawa, Hiroshi; Kawano, Hiroyuki; Ando, Ryoko; Shimogori, Tomomi; Noda, Hisayori; Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Kurokawa, Hiroshi; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan; [Kawano, Hiroyuki; Sakaue-Sawano, Asako; Miyawaki, Atsushi] Japan Sci & Technol Agcy, Wako, Saitama, Japan; [Noda, Hisayori] Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan	RIKEN; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	matsushi@brain.riken.jp	Shimogori, Tomomi/L-2893-2013; Tuluc, Petronel/C-2527-2011; Miyawaki, Atsushi/K-3569-2014	Shimogori, Tomomi/0000-0002-6931-5401; Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	Japan Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program; Grants-in-Aid for Scientific Research [10J08371] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sakurai, H. Otsuka and M. Hirano for general assistance, F. Ishidate, B. Zimmermann, R. Wolleschensky, Y. Watanabe, E. Nakasho, H. Kimura, T. Tajima and S. Horie for help with acquiring and analyzing images, RIKEN BSI-Olympus Collaboration Center for technical support, Y. Yoshihara (RIKEN), M. Yamaguchi and K. Mori (The University of Tokyo) for the Nestin promoter-GFP transgenic mice, J.R. Sanes (Harvard) for the YFP-H and GFP-M lines, E. Takahashi (RIKEN) for helpful advice on transgenic mice, S. J. Smith (Stanford) and J. W. Lichtman (Harvard) for helpful advice on tissue clearing, and D. Mou (Harvard), A. Govindarajan, K. Rockland and S. Tonegawa (Massachusetts Institute of Technology), A. Moore and C. Yokoyama (RIKEN) for critical comments. This work was partly supported by grants from Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Priority Areas and the Human Frontier Science Program.	Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk Winfried, 1995, P445; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; KELLER HE, 2001, CURR PROTOC CYTOM; Lichtman JW, 2008, NEURON, V60, P441, DOI 10.1016/j.neuron.2008.10.040; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liu YC, 2003, METHODS, V30, P86, DOI 10.1016/S1046-2023(03)00010-0; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parra SG, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3454391; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shimogori T, 2008, DEV GROWTH DIFFER, V50, P499, DOI [10.1111/j.1440-169x.2008.01045.x, 10.1111/j.1440-169X.2008.01045.x]; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zacharakis G, 2005, P NATL ACAD SCI USA, V102, P18252, DOI 10.1073/pnas.0504628102; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	42	796	837	5	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1481	U166		10.1038/nn.2928	http://dx.doi.org/10.1038/nn.2928			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21878933				2022-12-25	WOS:000296518600026
J	Mormann, F; Dubois, J; Kornblith, S; Milosavljevic, M; Cerf, M; Ison, M; Tsuchiya, N; Kraskov, A; Quiroga, RQ; Adolphs, R; Fried, I; Koch, C				Mormann, Florian; Dubois, Julien; Kornblith, Simon; Milosavljevic, Milica; Cerf, Moran; Ison, Matias; Tsuchiya, Naotsugu; Kraskov, Alexander; Quiroga, Rodrigo Quian; Adolphs, Ralph; Fried, Itzhak; Koch, Christof			A category-specific response to animals in the right human amygdala	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; SINGLE NEURONS; MONKEY; EMOTION	The amygdala is important in emotion, but it remains unknown whether it is specialized for certain stimulus categories. We analyzed responses recorded from 489 single neurons in the amygdalae of 41 neurosurgical patients and found a categorical selectivity for pictures of animals in the right amygdala. This selectivity appeared to be independent of emotional valence or arousal and may reflect the importance that animals held throughout our evolutionary past.	[Mormann, Florian; Dubois, Julien; Kornblith, Simon; Milosavljevic, Milica; Cerf, Moran; Tsuchiya, Naotsugu; Kraskov, Alexander; Quiroga, Rodrigo Quian; Adolphs, Ralph; Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mormann, Florian; Cerf, Moran; Ison, Matias; Fried, Itzhak] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Mormann, Florian; Cerf, Moran; Ison, Matias; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Mormann, Florian] Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany; [Ison, Matias; Quiroga, Rodrigo Quian] Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England; [Kraskov, Alexander] UCL, Inst Neurol, London, England; [Fried, Itzhak] Tel Aviv Med Ctr & Sch Med, Funct Neurosurg Unit, Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Koch, Christof] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	California Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Bonn; University of Leicester; University of London; University College London; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Korea University	Mormann, F (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	fmormann@yahoo.de	Kraskov, Alexander/J-7964-2012; Mormann, Florian/K-1582-2014; Mormann, Milica/GSN-2988-2022; Tsuchiya, Naotsugu/N-8153-2014	Kraskov, Alexander/0000-0002-3576-4719; Mormann, Florian/0000-0003-1305-8028; Ison, Matias/0000-0003-2937-8069; Tsuchiya, Naotsugu/0000-0003-4216-8701; Kornblith, Simon/0000-0002-9088-2443; Dubois, Julien/0000-0002-3029-173X; Koch, Christof/0000-0001-6482-8067	European Commission [OIF 040445]; World Class University through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-10008]; US National Institute of Neurological Disorders and Stroke; G. Harold and Leila Y. Mathers Foundation; Gimbel Discovery Fund; Dana Foundation; MRC [G0701038] Funding Source: UKRI; Medical Research Council [G0701038] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); G. Harold and Leila Y. Mathers Foundation; Gimbel Discovery Fund; Dana Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of our subjects for their participation, E. Behnke, T. Fields, E. Ho, V. Isiaka, E. Isham, K. Laird, N. Parikshak and A. Postolova for technical assistance with the electrophysiological recordings, and D. Tsao, I. Riedel-Kruse, U. Rutishauser and K. Fliessbach for useful discussion and comments on the manuscript. This research was supported by grants from the European Commission (Marie Curie OIF 040445, to F. M.), World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008, to C. K.), the US National Institute of Neurological Disorders and Stroke, the G. Harold and Leila Y. Mathers Foundation, the Gimbel Discovery Fund, and the Dana Foundation.	Bar M, 2007, NEUROPSYCHOLOGIA, V45, P2191, DOI 10.1016/j.neuropsychologia.2007.03.008; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Whalen P.J., 2009, HUMAN AMYGDALA	15	101	101	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1247	1249		10.1038/nn.2899	http://dx.doi.org/10.1038/nn.2899			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874014	Green Accepted			2022-12-25	WOS:000295254200011
J	Pratt, KG; Zimmerman, EC; Cook, DG; Sullivan, JM				Pratt, Kara G.; Zimmerman, Eric C.; Cook, David G.; Sullivan, Jane M.			Presenilin 1 regulates homeostatic synaptic scaling through Akt signaling	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; ACTIVATION; SYNAPSES	Neurons adapt to long-lasting changes in network activity, both in vivo and in vitro, by adjusting their synaptic strengths to stabilize firing rates. We found that homeostatic scaling of excitatory synapses was impaired in hippocampal neurons derived from mice lacking presenilin 1 (Psen1(-/-) mice) or expressing a familial Alzheimer's disease-linked Psen1 mutation (Psen1(M146V)). These findings suggest that deficits in synaptic homeostasis may contribute to brain dysfunction in Alzheimer's disease.	[Pratt, Kara G.; Zimmerman, Eric C.; Sullivan, Jane M.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Cook, David G.] Geriatr Res Educ & Clin Ctr, Vet Affairs Med Ctr, Seattle, WA USA; [Cook, David G.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sullivan, JM (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	jmsull@u.washington.edu			American Health Assistance Foundation; US National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS55804]; Veteran's Affairs Office of Research and Development Medical Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055804] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veteran's Affairs Office of Research and Development Medical Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. M. Ahlquist and N. Li for excellent technical assistance and R.L. Neve for generously providing the viral constructs. This work was supported by the American Health Assistance Foundation and the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS55804, J.M.S.), and the Veteran's Affairs Office of Research and Development Medical Research Service (D.G.C.).	Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hyman BT, 2011, NAT NEUROSCI, V14, P5, DOI 10.1038/nn0111-5; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008	15	55	55	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1112	1114		10.1038/nn.2893	http://dx.doi.org/10.1038/nn.2893			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841774	Green Accepted			2022-12-25	WOS:000294284900008
J	Yizhar, O; Fenno, LE; Davidson, TJ; Mogri, M; Deisseroth, K				Yizhar, Ofer; Fenno, Lief E.; Davidson, Thomas J.; Mogri, Murtaza; Deisseroth, Karl			Optogenetics in Neural Systems	NEURON			English	Editorial Material							ADENOASSOCIATED VIRUS VECTORS; CENTRAL SEROTONERGIC NEURONS; RESTORES VISUAL RESPONSES; WIDESPREAD GENE DELIVERY; IN-VIVO CONTROL; OPTICAL CONTROL; REMOTE-CONTROL; CORTICAL-NEURONS; ION CHANNELS; MILLISECOND-TIMESCALE	Both observational and perturbational technologies are essential for advancing the understanding of brain function and dysfunction. But while observational techniques have greatly advanced in the last century, techniques for perturbation that are matched to the speed and heterogeneity of neural systems have lagged behind. The technology of optogenetics represents a step toward addressing this disparity. Reliable and targetable single-component tools (which encompass both light sensation and effector function within a single protein) have enabled versatile new classes of investigation in the study of neural systems. Here we provide a primer on the application of optogenetics in neuroscience, focusing on the single-component tools and highlighting important problems, challenges, and technical considerations.	[Yizhar, Ofer; Fenno, Lief E.; Davidson, Thomas J.; Mogri, Murtaza; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	YIZHAR, OFER/AAV-8497-2021; Fenno, Lief/AAF-9638-2019; Fenno, Lief/AAK-2924-2020	Davidson, Thomas/0000-0003-0836-6333; Yizhar, Ofer/0000-0003-4228-1448	NIDA NIH HHS [R01 DA020794] Funding Source: Medline; NIH HHS [DP1 OD000616] Funding Source: Medline; NIMH NIH HHS [R01 MH086373, R01 MH075957] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R01MH086373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Benzekhroufa K, 2009, GENE THER, V16, P681, DOI 10.1038/gt.2009.7; Benzekhroufa K, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-23; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bernstein JG, 2008, PROC SPIE, V6854, DOI 10.1117/12.768798; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Blomer U, 1997, J VIROL, V71, P6641; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Deisseroth K, 2010, SCI AM, V303, P48, DOI 10.1038/scientificamerican1110-48; Depuy SD, 2011, J NEUROSCI, V31, P1981, DOI 10.1523/JNEUROSCI.4639-10.2011; Desai M, 2011, J NEUROPHYSIOL, V105, P1393, DOI 10.1152/jn.00828.2010; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Dreosti E, 2011, EXP PHYSIOL, V96, P4, DOI 10.1113/expphysiol.2009.051953; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Elwassif Maged M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3580; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Farah N, 2007, P ANN INT IEEE EMBS, P6369; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Fink DJ, 1996, ANNU REV NEUROSCI, V19, P265; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Grossman N, 2011, IEEE T BIO-MED ENG, V58, P1742, DOI 10.1109/TBME.2011.2114883; Grossman N, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016004; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Hull C, 2009, J NEUROSCI, V29, P8991, DOI 10.1523/JNEUROSCI.5717-08.2009; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Iwai Y, 2011, NEUROSCI RES, V70, P124, DOI 10.1016/j.neures.2011.01.007; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Kato S, 2007, HUM GENE THER, V18, P1141, DOI 10.1089/hum.2007.082; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Kramer RH, 2005, NAT CHEM BIOL, V1, P360, DOI 10.1038/nchembio750; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; LANYI JK, 1982, J BIOL CHEM, V257, P2674; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Leopold DA, 2010, NATURE, V465, P700, DOI 10.1038/465700a; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lewis TL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001021; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li N, 2011, P NATL ACAD SCI USA, V108, P8838, DOI 10.1073/pnas.1100815108; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lilley CE, 2001, J VIROL, V75, P4343, DOI 10.1128/JVI.75.9.4343-4356.2001; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lundby A, 2010, EUR BIOPHYS J BIOPHY, V39, P1625, DOI 10.1007/s00249-010-0620-0; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; MADISEN L, 2010, SOC NEUR M SAN DIEG; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markakis EA, 2010, MOL THER, V18, P588, DOI 10.1038/mt.2009.286; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; MICHEL H, 1976, FEBS LETT, V65, P175, DOI 10.1016/0014-5793(76)80473-5; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Monahan PE, 2000, MOL MED TODAY, V6, P433, DOI 10.1016/S1357-4310(00)01810-4; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Nathanson JL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.019.2009; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Paterna JC, 2004, J VIROL, V78, P6808, DOI 10.1128/JVI.78.13.6808-6817.2004; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; RACKER E, 1974, J BIOL CHEM, V249, P662; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; Sato M, 2005, BIOCHEMISTRY-US, V44, P4775, DOI 10.1021/bi047500f; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; SCHARF B, 1994, BIOCHEMISTRY-US, V33, P6387, DOI 10.1021/bi00187a002; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Shoham S, 2010, NAT METHODS, V7, P798, DOI 10.1038/nmeth1010-798; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Stroh A, 2011, STEM CELLS, V29, P78, DOI 10.1002/stem.558; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tan WB, 2010, J COMP NEUROL, V518, P1862, DOI 10.1002/cne.22308; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tonnesen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017560; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Vo-Dinh T, 2014, BIOMED PHOTONICS, DOI 10.1201/9780203008997-38; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Watson BO, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.006.2009; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; YIZHAR O, 2011, NATURE UNPUB; Yizhar O., 2011, COLD SPRING HARB PRO; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F., 2008, COLD SPRING HARB LAB; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007; Zhang JH, 2009, J MATER SCI, V44, P2046, DOI 10.1007/s10853-009-3283-4; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; ZHAO S, 2010, 2010 NEUR M PLANN ON; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7; Zimmermann D, 2008, BIOCHEM BIOPH RES CO, V369, P1022, DOI 10.1016/j.bbrc.2008.02.153	204	1209	1293	14	524	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 14	2011	71	1					9	34		10.1016/j.neuron.2011.06.004	http://dx.doi.org/10.1016/j.neuron.2011.06.004			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745635	Bronze			2022-12-25	WOS:000292806200004
J	Raingo, J; Khvotchev, M; Liu, P; Darios, F; Li, YC; Ramirez, DMO; Adachi, M; Lemieux, P; Toth, K; Davletov, B; Kavalali, ET				Raingo, Jesica; Khvotchev, Mikhail; Liu, Pei; Darios, Frederic; Li, Ying C.; Ramirez, Denise M. O.; Adachi, Megumi; Lemieux, Philippe; Toth, Katalin; Davletov, Bazbek; Kavalali, Ege T.			VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; MEMBRANE-FUSION; CA2+ SENSOR; FLUORESCENT PROTEINS; RECYCLING PATHWAYS; CENTRAL SYNAPSES; SYNAPTOTAGMIN-I; SNARE; INHIBITION; TRANSMISSION	Synaptic vesicles in the brain harbor several soluble N-ethylmaleimide-sensitive-factor attachment protein receptor (SNARE) proteins. With the exception of synaptobrevin2, or VAMP2 (syb2), which is directly involved in vesicle fusion, the role of these SNAREs in neurotransmission is unclear. Here we show that in mice syb2 drives rapid Ca2+-dependent synchronous neurotransmission, whereas the structurally homologous SNARE protein VAMP4 selectively maintains bulk Ca2+-dependent asynchronous release. At inhibitory nerve terminals, up- or downregulation of VAMP4 causes a correlated change in asynchronous release. Biochemically, VAMP4 forms a stable complex with SNAREs syntaxin-1 and SNAP-25 that does not interact with complexins or synaptotagmin-1, proteins essential for synchronous neurotransmission. Optical imaging of individual synapses indicates that trafficking of VAMP4 and syb2 show minimal overlap. Taken together, these findings suggest that VAMP4 and syb2 diverge functionally, traffic independently and support distinct forms of neurotransmission. These results provide molecular insight into how synapses diversify their release properties by taking advantage of distinct synaptic vesicle associated SNAREs.	[Raingo, Jesica; Khvotchev, Mikhail; Liu, Pei; Li, Ying C.; Ramirez, Denise M. O.; Kavalali, Ege T.] Univ Texas UT SW Med Ctr, Dept Neurosci, Dallas, TX USA; [Raingo, Jesica] Multidisciplinary Inst Cellular Biol, Electrophysiol Lab, Buenos Aires, DF, Argentina; [Darios, Frederic; Davletov, Bazbek] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Adachi, Megumi] UT SW Med Ctr, Dept Psychiat, Dallas, TX USA; [Lemieux, Philippe; Toth, Katalin] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ, Canada; [Kavalali, Ege T.] UT SW Med Ctr, Dept Physiol, Dallas, TX USA	MRC Laboratory Molecular Biology; University of Texas System; University of Texas Southwestern Medical Center Dallas; Laval University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kavalali, ET (corresponding author), Univ Texas UT SW Med Ctr, Dept Neurosci, Dallas, TX USA.	ege.kavalali@utsouthwestern.edu	Khvotchev, Mikhail/G-5411-2013; Davletov, Bazbek/ABA-8569-2021; Adachi, Megumi/M-7746-2017	Khvotchev, Mikhail/0000-0001-9328-8549; Adachi, Megumi/0000-0003-3404-6640; Li, Ying/0000-0003-4216-6183; Darios, Frederic/0000-0001-9800-5990; Davletov, Bazbek/0000-0003-4658-3275; Ramirez, Denise/0000-0003-4090-033X	US National Institute of Mental Health [MH066198]; MRC [MC_U105178791] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH093109, R01MH068437, R01MH066198] Funding Source: NIH RePORTER; Medical Research Council [MC_U105178791] Funding Source: researchfish	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Leitz for technical assistance and H. Kramer, L. Monteggia, E. Nelson and E. Nosyreva for advice and discussions. We also thank T.C. Sudhof (Stanford University) for the gift of synaptobrevin2 knockout mice and M.C. Wilson (University of New Mexico) for the gift of SNAP-25 knockout mice. This work was supported by grants from the US National Institute of Mental Health to E.T.K. (MH066198). E.T.K. is an established investigator of the American Heart Association.	Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Chung CH, 2008, J NEUROPHYSIOL, V100, P2089, DOI 10.1152/jn.90404.2008; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Iremonger KJ, 2007, J NEUROSCI, V27, P6684, DOI 10.1523/JNEUROSCI.0934-07.2007; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Ramirez DMO, 2011, CURR OPIN NEUROBIOL, V21, P275, DOI 10.1016/j.conb.2011.01.007; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	45	110	113	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					738	745		10.1038/nn.3067	http://dx.doi.org/10.1038/nn.3067			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406549	Green Accepted			2022-12-25	WOS:000303270200018
J	Ozuysal, Y; Baccus, SA				Ozuysal, Yusuf; Baccus, Stephen A.			Linking the Computational Structure of Variance Adaptation to Biophysical Mechanisms	NEURON			English	Article							RETINAL GANGLION-CELLS; CONTRAST GAIN-CONTROL; BIPOLAR CELLS; TEMPORAL CONTRAST; SYNAPTIC DEPRESSION; VISUAL-ADAPTATION; CALCIUM CURRENT; OBJECT MOTION; RESPONSES; NEURONS	In multiple sensory systems, adaptation to the variance of a sensory input changes the sensitivity, kinetics, and average response over timescales ranging from < 100 ms to tens of seconds. Here, we present a simple, biophysically relevant model of retinal contrast adaptation that accurately captures both the membrane potential response and all adaptive properties. The adaptive component of this model is a first-order kinetic process of the type used to describe ion channel gating and synaptic transmission. From the model, we conclude that all adaptive dynamics can be accounted for by depletion of a signaling mechanism, and that variance adaptation can be explained as adaptation to the mean of a rectified signal. The model parameters show strong similarity to known properties of bipolar cell synaptic vesicle pools. Diverse types of adaptive properties that implement theoretical principles of efficient coding can be generated by a single type of molecule or synapse with just a few microscopic states.	[Baccus, Stephen A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Ozuysal, Yusuf] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Baccus, SA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	baccus@stanford.edu			NEI; Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Karl Kirchgessner Foundation; Alfred P. Sloan Foundation; E. Matilda Ziegler Foundation; NATIONAL EYE INSTITUTE [R01EY016842, R01EY022933] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pew Charitable Trusts; McKnight Endowment Fund for Neuroscience; Karl Kirchgessner Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); E. Matilda Ziegler Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Kastner and M. Manu for technical assistance. This work was supported by grants from the NEI, Pew Charitable Trusts, McKnight Endowment Fund for Neuroscience, the Karl Kirchgessner Foundation, the Alfred P. Sloan Foundation and the E. Matilda Ziegler Foundation (S.A.B.).	Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; Baccus SA, 2006, NEURON, V51, P682, DOI 10.1016/j.neuron.2006.09.007; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Bonin V, 2006, J NEUROSCI, V26, P6346, DOI 10.1523/JNEUROSCI.0284-06.2006; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Burkhardt DA, 2007, VISUAL NEUROSCI, V24, P765, DOI 10.1017/S0952523807070630; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Fairhall AL, 2006, J NEUROPHYSIOL, V96, P2724, DOI 10.1152/jn.00995.2005; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Friedlander T, 2009, P NATL ACAD SCI USA, V106, P22558, DOI 10.1073/pnas.0902146106; Gaudry KS, 2007, J NEUROPHYSIOL, V98, P1287, DOI 10.1152/jn.00618.2006; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Gomis A, 1999, J NEUROSCI, V19, P6309; He YJ, 2002, J NEUROPHYSIOL, V87, P925, DOI 10.1152/jn.00225.2001; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Jolivet R, 2004, J NEUROPHYSIOL, V92, P959, DOI 10.1152/jn.00190.2004; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Olveczky BP, 2007, NEURON, V56, P689, DOI 10.1016/j.neuron.2007.09.030; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Rabl K, 2006, J NEUROSCI, V26, P2555, DOI 10.1523/JNEUROSCI.3667-05.2006; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rudd ME, 1997, NEURAL COMPUT, V9, P1047, DOI 10.1162/neco.1997.9.5.1047; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	57	70	71	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					1002	1015		10.1016/j.neuron.2011.12.029	http://dx.doi.org/10.1016/j.neuron.2011.12.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405209	Green Accepted, Bronze			2022-12-25	WOS:000301558600014
J	Cheng, LZ; Hansen, NF; Zhao, L; Du, YT; Zou, CL; Donovan, FX; Chou, BK; Zhou, GY; Li, SJ; Dowey, SN; Ye, ZH; Chandrasekharappa, SC; Yang, HM; Mullikin, JC; Liu, PP				Cheng, Linzhao; Hansen, Nancy F.; Zhao, Ling; Du, Yutao; Zou, Chunlin; Donovan, Frank X.; Chou, Bin-Kuan; Zhou, Guangyu; Li, Shijie; Dowey, Sarah N.; Ye, Zhaohui; Chandrasekharappa, Settara C.; Yang, Huanming; Mullikin, James C.; Liu, P. Paul		NISC Comparative Sequencing Progra	Low Incidence of DNA Sequence Variation in Human Induced Pluripotent Stem Cells Generated by Nonintegrating Plasmid Expression	CELL STEM CELL			English	Article							COPY NUMBER VARIATION; MUTATIONS; ACCURATE; DERIVATION; SPECTRUM	The utility of induced pluripotent stem cells (iPSCs) as models to study diseases and as sources for cell therapy depends on the integrity of their genomes. Despite recent publications of DNA sequence variations in the iPSCs, the true scope of such changes for the entire genome is not clear. Here we report the whole-genome sequencing of three human iPSC lines derived from two cell types of an adult donor by episomal vectors. The vector sequence was undetectable in the deeply sequenced iPSC lines. We identified 1,058-1,808 heterozygous single-nucleotide variants (SNVs), but no copy-number variants, in each iPSC line. Six to twelve of these SNVs were within coding regions in each iPSC line, but 50% of them are synonymous changes and the remaining are not selectively enriched for known genes associated with cancers. Our data thus suggest that episome-mediated reprogramming is not inherently mutagenic during integration-free iPSC induction.	[Cheng, Linzhao; Zou, Chunlin; Chou, Bin-Kuan; Dowey, Sarah N.; Ye, Zhaohui] Johns Hopkins Univ, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Cheng, Linzhao; Zou, Chunlin; Chou, Bin-Kuan; Dowey, Sarah N.; Ye, Zhaohui] Johns Hopkins Univ, Div Hematol, Baltimore, MD 21205 USA; [Hansen, Nancy F.; Mullikin, James C.] NHGRI, Comparat Genom Unit, NIH, Bethesda, MD 20892 USA; [Zhao, Ling; Liu, P. Paul] NHGRI, Oncogenesis & Dev Sect, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr NISC, NIH, Bethesda, MD 20892 USA; [Du, Yutao; Zhou, Guangyu; Li, Shijie; Yang, Huanming] Beijing Genom Inst BGI Shenzhen, Shenzhen 518000, Peoples R China	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Beijing Genomics Institute (BGI)	Cheng, LZ (corresponding author), Johns Hopkins Univ, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA.	lcheng@welch.jhu.edu; pliu@mail.nih.gov	Liu, Paul/A-7976-2012	Liu, Paul/0000-0002-6779-025X; Donovan, Frank X./0000-0002-7712-2335; Ye, Zhaohui/0000-0001-5272-9168; ZOU, CHUNLIN/0000-0002-3308-5544	Johns Hopkins University; NIH [RC2 HL101582, U01 HL099775, R01 HL073781]; NIH Center for Regenerative Medicine (NCRM); National Human Genome Research Institute at NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775, RC2HL101582, R01HL073781] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200346, ZIAHG200330, ZIAHG000030, ZIBHG000196, ZIAHG000029] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Regenerative Medicine (NCRM); National Human Genome Research Institute at NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Raman Sood and Blake Carrington for PCR and Sanger sequencing for confirming mutations and Xianmin Zeng in The Buck Institute in California for providing DNA from neural progenitor cells derived from BC1 iPSCs. This study was supported in part by Johns Hopkins University and NIH grants (RC2 HL101582, U01 HL099775, and R01 HL073781), an award from the NIH Center for Regenerative Medicine (NCRM), and The Intramural Research Program of The National Human Genome Research Institute at NIH.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	25	188	200	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 2	2012	10	3					337	344		10.1016/j.stem.2012.01.005	http://dx.doi.org/10.1016/j.stem.2012.01.005			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	908BX	22385660	Green Accepted, Bronze			2022-12-25	WOS:000301466500014
J	Miyata, S; Komatsu, Y; Yoshimura, Y; Taya, C; Kitagawa, H				Miyata, Shinji; Komatsu, Yukio; Yoshimura, Yumiko; Taya, Choji; Kitagawa, Hiroshi			Persistent cortical plasticity by upregulation of chondroitin 6-sulfation	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; RAT FRONTAL-CORTEX; PERINEURONAL NETS; CRITICAL PERIOD; INHIBITORY NEURONS; SULFATE; PARVALBUMIN	Cortical plasticity is most evident during a critical period in early life, but the mechanisms that restrict plasticity after the critical period are poorly understood. We found that a developmental increase in the 4- sulfation/6-sulfation (4S/6S) ratio of chondroitin sulfate proteoglycans (CSPGs), which are components of the brain extracellular matrix, leads to the termination of the critical period for ocular dominance plasticity in the mouse visual cortex. Condensation of CSPGs into perineuronal nets that enwrapped synaptic contacts on parvalbumin-expressing interneurons was prevented by cell-autonomous overexpression of chondroitin 6-sulfation, which maintains a low 4S/6S ratio. Furthermore, the increase in the 4S/6S ratio was required for the accumulation of Otx2, a homeoprotein that activates the development of parvalbumin-expressing interneurons, and for functional maturation of the electrophysiological properties of these cells. Our results indicate that the critical period for cortical plasticity is regulated by the 4S/6S ratio of CSPGs, which determines the maturation of parvalbumin-expressing interneurons.	[Miyata, Shinji; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan; [Miyata, Shinji; Kitagawa, Hiroshi] Kobe Univ, Global Ctr Excellence, Program Signal Transduct Med, Grad Sch Med,Chuo Ku, Kobe, Hyogo 657, Japan; [Komatsu, Yukio] Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 464, Japan; [Yoshimura, Yumiko] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Dev Neurophysiol, Okazaki, Aichi 4448787, Japan; [Taya, Choji] Tokyo Metropolitan Inst Med Sci, Lab Transgen Technol, Tokyo 113, Japan	Kobe Pharmaceutical University; Kobe University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Tokyo Metropolitan Institute of Medical Science	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan.	kitagawa@kobepharma-u.ac.jp	Miyata, Shinji/S-6000-2019; Kitagawa, Hiroshi/AAJ-1344-2020	Miyata, Shinji/0000-0001-6635-1645; Kitagawa, Hiroshi/0000-0002-9307-7079; Yoshimura, Yumiko/0000-0002-7526-4153	Ministry of Education, Culture, Sports, Science & Technology, Japan [21390025, 23110003, 23110004, 21890286]	Ministry of Education, Culture, Sports, Science & Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Maruyama and F. Murakami for technical advises on the VEP recordings and in utero electroporation, respectively. This work was funded by a Grant-in-Aid for Scientific Research-B 21390025 (to H. K.), grants from the Scientific Research on Innovative Areas (23110003 and 23110004 to H.K. and Y.K.), and a Young Scientists grant (21890286 to S.M.) from Ministry of Education, Culture, Sports, Science & Technology, Japan.	Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Erisir A, 2005, J COMP NEUROL, V485, P11, DOI 10.1002/cne.20507; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg EM, 2011, CEREB CORTEX, V21, P666, DOI 10.1093/cercor/bhq138; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; HARTIG W, 1992, NEUROREPORT, V3, P869; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Jiang B, 2005, BRAIN RES REV, V50, P126, DOI 10.1016/j.brainresrev.2005.05.007; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Lander C, 1998, J NEUROSCI, V18, P174; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Matthews RT, 2002, J NEUROSCI, V22, P7536; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Miyata S, 2005, NEUROSCIENCE, V136, P95, DOI 10.1016/j.neuroscience.2005.07.031; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x	49	230	236	3	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					414	U100		10.1038/nn.3023	http://dx.doi.org/10.1038/nn.3023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246436				2022-12-25	WOS:000300793100015
J	Brookes, E; de Santiago, I; Hebenstreit, D; Morris, KJ; Carroll, T; Xie, SQ; Stock, JK; Heidemann, M; Eick, D; Nozaki, N; Kimura, H; Ragoussis, J; Teichmann, SA; Pombo, A				Brookes, Emily; de Santiago, Ines; Hebenstreit, Daniel; Morris, Kelly J.; Carroll, Tom; Xie, Sheila Q.; Stock, Julie K.; Heidemann, Martin; Eick, Dirk; Nozaki, Naohito; Kimura, Hiroshi; Ragoussis, Jiannis; Teichmann, Sarah A.; Pombo, Ana			Polycomb Associates Genome-wide with a Specific RNA Polymerase II Variant, and Regulates Metabolic Genes in ESCs	CELL STEM CELL			English	Article							STEM-CELLS; BIVALENT GENES; SELF-RENEWAL; PLURIPOTENT; MARKS; HETEROGENEITY; CIRCUITRY; NETWORKS; NANOG	Polycomb repressor complexes (PRCs) are important chromatin modifiers fundamentally implicated in pluripotency and cancer. Polycomb silencing in embryonic stem cells (ESCs) can be accompanied by active chromatin and primed RNA polymerase II (RNAPII), but the relationship between PRCs and RNAPII remains unclear genome-wide. We mapped PRC repression markers and four RNAPII states in ESCs using ChIP-seq, and found that PRC targets exhibit a range of RNAPII variants. First, developmental PAC targets are bound by unproductive RNAPII (S5p(+)S7p(-)S2p(-)) genonne-wide. Sequential ChIP, Ring1B depletion, and genome-wide correlations show that PRCs and RNAPII-S5p physically bind to the same chromatin and functionally synergize. Second, we identify a cohort of genes marked by PRC and elongating RNAPII (S5p(+)S7p(+)S2p(+); they produce mRNA and protein, and their expression increases upon PRC1 knockdown. We show that this group of PRC targets switches between active and PRC-repressed states within the ESC population, and that many have roles in metabolism.	[Brookes, Emily; de Santiago, Ines; Morris, Kelly J.; Carroll, Tom; Xie, Sheila Q.; Stock, Julie K.; Pombo, Ana] Univ London Imperial Coll Sci Technol & Med, Sch Med, Ctr Clin Sci, MRC,Genome Funct Grp, London W12 0NN, England; [de Santiago, Ines] Gulbenkian Inst Sci, P-62780 Oeiras, Portugal; [Hebenstreit, Daniel; Teichmann, Sarah A.] MRC, Mol Biol Lab, Computat Genom Grp, Cambridge CB2 2QH, England; [Heidemann, Martin; Eick, Dirk] Ctr Integrated Prot Sci, Helmholtz Ctr Munich, Dept Mol Epigenet, D-81377 Munich, Germany; [Nozaki, Naohito] Tokyo Inst Technol, Biofrontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Ragoussis, Jiannis] Wellcome Trust Ctr Human Genet, Genom Res Grp, Oxford OX3 7BN, England	Imperial College London; MRC Laboratory Molecular Biology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Tokyo Institute of Technology; Osaka University; University of Oxford; Wellcome Centre for Human Genetics	Pombo, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Ctr Clin Sci, MRC,Genome Funct Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	ana.pombo@csc.mrc.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; hebenstreit, daniel/GWZ-2082-2022; Pombo, Ana/A-1045-2010; de Santiago, Ines/AAP-5859-2020; Kimura, Hiroshi/B-9524-2015	hebenstreit, daniel/0000-0003-0144-6728; Pombo, Ana/0000-0002-7493-6288; de Santiago, Ines/0000-0002-8172-1322; Kimura, Hiroshi/0000-0003-0854-083X; Ragoussis, Ioannis/0000-0002-8515-0934; Teichmann, Sarah/0000-0002-6294-6366; Brookes, Emily/0000-0003-2175-4349	InteGeR FP7 Marie Curie Initial Training Network [PITN-GA-2007-214902]; Medical Research Council (UK); Fundacao para a Ciencia e a Tecnologia [SFRH/BD/33205/2007]; MEXT of Japan; Deutsche Forschungsgemeinschaft [SFBTR5]; Wellcome Trust [075491/Z/04]; Children's Hospital Boston; Medical Research Council [MC_U105161047, MC_U120061476] Funding Source: researchfish; MRC [MC_U105161047, MC_U120061476] Funding Source: UKRI	InteGeR FP7 Marie Curie Initial Training Network; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); Children's Hospital Boston; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Lorne Lonie, Lorna Gregory, and Carme Camps (WTCHG, UK) for genome-wide libraries; Wendy Bickmore (MRC-HGU, UK) for ES-OS25 cells; Haruhiko Koseki (RIKEN, Japan) for Ring1B antibody; Haruhiko Koseki and Miguel Vidal (CSIC, Spain) for ES-ERT2 cells; Sanofi Aventis and the National Cancer Institute (NIH) for flavopiridol; Zoe Webster (CSC) for ESC culture assistance; Gopuraja Dharmalingam for next generation sequencing data processing; Niall Dillon and the Pombo laboratory (CSC) for critical reading of the manuscript; Madan Babu (MRC-LMB, UK) and Boris Lenhard (MRC-CSC) for helpful discussions; and the Medical Research Council (UK) and InteGeR FP7 Marie Curie Initial Training Network (project number PITN-GA-2007-214902) for support. I.d.S. was supported by Fundacao para a Ciencia e a Tecnologia (grant SFRH/BD/33205/2007; Portugal); H.K., by grants-in-aid from the MEXT of Japan; D.E., by Deutsche Forschungsgemeinschaft (SFBTR5); and J.R., by The Wellcome Trust (grant 075491/Z/04). E.B. thanks Yang Shi (Children's Hospital Boston) for support during the review process of this manuscript. E.B., K.J.M., J.K.S., S.X., M.H., D.E., N.N., H.K., J.R., and A.P. designed and/or performed laboratory experiments; I.d.S., D.H., T.C., SAT., and A.P. designed and/or performed bioinformatic analyses; E.B., I.d.S., D.H., S.A.T., and A.P. analyzed the data; and E.B., I.d.S., and A.P. designed the project and wrote the manuscript. N.N. is a founder of MAB Institute Inc.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Alder O, 2010, DEVELOPMENT, V137, P2483, DOI 10.1242/dev.048363; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; De Gobbi M, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-9; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Ferrai C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000270; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Richly H, 2010, BIOESSAYS, V32, P669, DOI 10.1002/bies.201000016; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sharov AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-102; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	49	213	216	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					157	170		10.1016/j.stem.2011.12.017	http://dx.doi.org/10.1016/j.stem.2011.12.017			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305566	hybrid, Green Published			2022-12-25	WOS:000300272100009
J	Morey, L; Pascual, G; Cozzuto, L; Roma, G; Wutz, A; Benitah, SA; Di Croce, L				Morey, Lluis; Pascual, Gloria; Cozzuto, Luca; Roma, Guglielmo; Wutz, Anton; Aznar Benitah, Salvador; Di Croce, Luciano			Nonoverlapping Functions of the Polycomb Group Cbx Family of Proteins in Embryonic Stem Cells	CELL STEM CELL			English	Article							METHYLATED HISTONE H3; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; X-INACTIVATION; RING1B; PRC1; UBIQUITYLATION; PROLIFERATION; GASTRULATION; MAINTENANCE	Polycomb group proteins are essential regulators of cell fate decisions during embryogenesis. In mammals, at least five different Cbx proteins (Cbx2, Cbx4, Cbx6, Cbx7, and Cbx8) are known to associate with the core Polycomb repressive complex 1 (PRC1). Here we show that pluripotency and differentiation of mouse embryonic stem cells (ESCs) is regulated by different Cbx-associated PRC1 complexes with unique functions. Maintenance of pluripotency primarily depends on Cbx7, while lineage commitment is orchestrated by Cbx2 and Cbx4. At the molecular level, we have uncovered a Polycomb autoregulatory loop in which Cbx7 represses the expression of prodifferentiation Cbx proteins, thereby maintaining the pluripotent state. We additionally show that the occupancy of Cbx7 on promoters is completely dependent on PRC2 activity but only partially dependent on a functional PRC1 complex. Thus, Cbx proteins confer distinct target selectivity to the PRC1 complex, achieving a balance between the self-renewal and the differentiation of ESCs.	[Morey, Lluis; Pascual, Gloria; Cozzuto, Luca; Roma, Guglielmo; Aznar Benitah, Salvador; Di Croce, Luciano] CRG, Barcelona 08003, Spain; [Morey, Lluis; Pascual, Gloria; Cozzuto, Luca; Roma, Guglielmo; Aznar Benitah, Salvador; Di Croce, Luciano] UPF, Barcelona 08003, Spain; [Wutz, Anton] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Cambridge	Di Croce, L (corresponding author), CRG, Dr Aiguader 88, Barcelona 08003, Spain.	luciano.dicroce@crg.es	Cozzuto, Luca/K-5385-2015; Di Croce, Luciano/E-7759-2015; Angulo, Gloria Pascual/AAA-7668-2019; Aznar-Benitah, Salvador/F-4761-2016	Cozzuto, Luca/0000-0003-3194-8892; Di Croce, Luciano/0000-0003-3488-6228; Angulo, Gloria Pascual/0000-0003-3810-6647; Aznar-Benitah, Salvador/0000-0002-9059-5049; Morey, Lluis/0000-0001-9851-4066	Spanish "Ministerio de Educacion y Ciencia" [BFU2010-18692]; AGAUR; CRG-Novartis; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); CRG-Novartis; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to V.A. Raker for help in preparing the manuscript, J. Walfridsson and M. Morey for critical reading of the manuscript, members of the Di Croce laboratory for discussions, and the CRG Genomic Unit. This work was supported by grants from the Spanish "Ministerio de Educacion y Ciencia" (CONSOLIDER and BFU2010-18692), from AGAUR to L.D.C. L.M. was supported by a postdoctoral CRG-Novartis fellowship. L.M designed the study and conducted all the experiments, except for the teratoma experiments performed by G.P. L.C. and G.R. performed the ChIP-seq peak calling and gene identification, and L.D.C. supervisec the experiments and provided intellectual support toward design and interpretation of the results. L.M, S.A.B, A.W., and L.C.D wrote the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Aloia L, 2010, J BIOL CHEM, V285, P7776, DOI 10.1074/jbc.M109.077156; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Bel S, 1998, DEVELOPMENT, V125, P3543; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Core N, 1997, DEVELOPMENT, V124, P721; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Piunti A, 2011, FUTURE ONCOL, V7, P57, DOI 10.2217/FON.10.157; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang RJ, 2008, BIOCHEMISTRY-US, V47, P8007, DOI 10.1021/bi800857f; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	42	238	250	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					47	62		10.1016/j.stem.2011.12.006	http://dx.doi.org/10.1016/j.stem.2011.12.006			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226355	Bronze			2022-12-25	WOS:000299449500010
J	Baudet, ML; Zivraj, KH; Abreu-Goodger, C; Muldal, A; Armisen, J; Blenkiron, C; Goldstein, LD; Miska, EA; Holt, CE				Baudet, Marie-Laure; Zivraj, Krishna H.; Abreu-Goodger, Cei; Muldal, Alistair; Armisen, Javier; Blenkiron, Cherie; Goldstein, Leonard D.; Miska, Eric A.; Holt, Christine E.			miR-124 acts through CoREST to control onset of Sema3A sensitivity in navigating retinal growth cones	NATURE NEUROSCIENCE			English	Article							AXON GUIDANCE; CAENORHABDITIS-ELEGANS; INTERMEDIATE TARGET; DEVELOPMENTAL TIME; MESSENGER-RNAS; SEMAPHORIN 3A; EMBRYONIC CNS; C-ELEGANS; MICRORNAS; EXPRESSION	During axon pathfinding, growth cones commonly show changes in sensitivity to guidance cues that follow a cell-intrinsic timetable. The cellular timer mechanisms that regulate such changes are, however, poorly understood. Here we have investigated microRNAs (miRNAs) in the timing control of sensitivity to the semaphorin Sema3A in Xenopus laevis retinal ganglion cell (RGC) growth cones. A developmental profiling screen identified miR-124 as a candidate timer. Loss of miR-124 delayed the onset of Sema3A sensitivity and concomitant neuropilin-1 (NRP1) receptor expression and caused cell-autonomous pathfinding errors. CoREST, a cofactor of a NRP1 repressor, was newly identified as a target and mediator of miR-124 for this highly specific temporal aspect of RGC growth cone responsiveness. Our findings indicate that miR-124 is important in regulating the intrinsic temporal changes in RGC growth cone sensitivity and suggest that miRNAs may act broadly as linear timers in vertebrate neuronal development.	[Baudet, Marie-Laure; Zivraj, Krishna H.; Muldal, Alistair; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Abreu-Goodger, Cei] CINVESTAV, Natl Lab Genom Biodivers Langebio, Guanajuato, Mexico; [Armisen, Javier; Blenkiron, Cherie; Goldstein, Leonard D.; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England	University of Cambridge; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	ceh@mole.bio.cam.ac.uk	Baudet, Marie-Laure/H-6343-2019; Blenkiron, Cherie/H-8468-2019; Baudet, Marie-Laure/B-1437-2015; Abreu-Goodger, Cei/A-1268-2010	Baudet, Marie-Laure/0000-0001-8957-5545; Blenkiron, Cherie/0000-0002-0217-3808; Baudet, Marie-Laure/0000-0001-8957-5545; Abreu-Goodger, Cei/0000-0001-8302-9893; Miska, Eric/0000-0002-4450-576X; Holt, Christine Elizabeth/0000-0003-2829-121X; Muldal, Alistair/0000-0002-0387-135X	National Research Council of Canada; Alberta Heritage Foundation for Medical Research; Wellcome Trust; UK Medical Research Council; SIROCCO; Cancer Research UK [11832] Funding Source: researchfish	National Research Council of Canada; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SIROCCO; Cancer Research UK(Cancer Research UK)	The authors wish to thank J. Woolford for her contribution to the analysis of high-throughput sequencing data, H. Lynn for help on cloning and M. Wood for participation in collapse analysis. We also thank A. Dwivedy, L. Strochlic, J. Falk, K. Leung, M. Agathocleous, A. Lin, S. McFarlane and A. Almeida for technical assistance. We thank W. Harris, A. C. Lee, J. Yoon and M. Agathocleous for critically reading the manuscript, as well as all the members of the Harris/Holt laboratory for their input. This work was supported by postdoctoral fellowships from the National Research Council of Canada (M.-L. B.) and Alberta Heritage Foundation for Medical Research (M.-L. B.), by Wellcome Trust Programme and UK Medical Research Council grants (C. E. H.) and by a European Framework 6 grant (SIROCCO) (E. A. M.).	Atkinson-Leadbeater K, 2010, J NEUROSCI, V30, P685, DOI 10.1523/JNEUROSCI.4165-09.2010; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Clark AM, 2010, NUCLEIC ACIDS RES, V38, P3780, DOI 10.1093/nar/gkq083; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Diefenbach TJ, 2000, J NEUROSCI, V20, P1484; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hocking JC, 2010, MECH DEVELOP, V127, P36, DOI 10.1016/j.mod.2009.11.002; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1984, J NEUROSCI, V4, P1130; Johnson MH, 2000, BIOESSAYS, V22, P57, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;57::AID-BIES10&gt;3.0.CO;2-L; Jung H, 2011, CURR OPIN GENET DEV, V21, P458, DOI 10.1016/j.gde.2011.04.004; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Mann F, 2004, INT J DEV BIOL, V48, P957, DOI 10.1387/ijdb.041899fm; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	50	88	94	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					29	U213		10.1038/nn.2979	http://dx.doi.org/10.1038/nn.2979			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22138647	Green Accepted			2022-12-25	WOS:000298414400011
J	Poldrack, RA				Poldrack, Russell A.			Inferring Mental States from Neuroimaging Data: From Reverse Inference to Large-Scale Decoding	NEURON			English	Article							HUMAN BRAIN ACTIVITY; NATURAL IMAGES; INTENTIONS; ACTIVATION; PATTERNS; MACHINE	A common goal of neuroimaging research is to use imaging data to identify the mental processes that are engaged when a subject performs a mental task. The use of reasoning from activation to mental functions, known as "reverse inference," has been previously criticized on the basis that it does not take into account how selectively the area is activated by the mental process in question. In this Perspective, I outline the critique of informal reverse inference and describe a number of new developments that provide the ability to more formally test the predictive power of neuroimaging data.	[Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Psychol, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Neurobiol, Austin, TX 78759 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Poldrack, RA (corresponding author), Univ Texas Austin, Imaging Res Ctr, 3925-BW Braker Lane, Austin, TX 78759 USA.	poldrack@mail.utexas.edu		Poldrack, Russell/0000-0001-6755-0259	National Institutes of Health [RO1MH082795]; National Science Foundation [OCI-1131441]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health grant RO1MH082795 and the National Science Foundation grant OCI-1131441. Thanks to Tyler Davis, Steve Hanson, Rajeev Raizada, Rebecca Saxe, Tom Schonberg, Gael Varoquax, Corey White, and Tal Yarkoni for helpful comments on a draft of this paper.	Aguirre G.K., 2003, BEHAV NEUROLOGY COGN, P85; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Carroll MK, 2009, NEUROIMAGE, V44, P112, DOI 10.1016/j.neuroimage.2008.08.020; Cohen JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00047; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Hanson SJ, 2008, NEURAL COMPUT, V20, P486, DOI 10.1162/neco.2007.09-06-340; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; IACOBONI M, 2007, NY TIMES        1111; Jimura K., 2011, NEUROPSYCHO IN PRESS; Kahneman D, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P523, DOI 10.1016/B978-0-12-374176-9.00033-6; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Lenartowicz A, 2010, TOP COGN SCI, V2, P678, DOI 10.1111/j.1756-8765.2010.01100.x; Lindstrom M., 2011, NY TIMES, pA21; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Pereira F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00072; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Pierce C.S., 1998, ESSENTIAL PIERCE, V2, p[1893, 331]; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Sarter M, 1996, AM PSYCHOL, V51, P13, DOI 10.1037/0003-066X.51.1.13; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/nmeth.1635, 10.1038/NMETH.1635]; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137	36	413	415	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					692	697		10.1016/j.neuron.2011.11.001	http://dx.doi.org/10.1016/j.neuron.2011.11.001			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	860TR	22153367	Green Accepted, Bronze			2022-12-25	WOS:000297971100005
J	Li, J; Schiller, D; Schoenbaum, G; Phelps, EA; Daw, ND				Li, Jian; Schiller, Daniela; Schoenbaum, Geoffrey; Phelps, Elizabeth A.; Daw, Nathaniel D.			Differential roles of human striatum and amygdala in associative learning	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; REWARD; PREDICTION; STIMULI; WORLD	Although the human amygdala and striatum have both been implicated in associative learning, only the striatum's contribution has been consistently computationally characterized. Using a reversal learning task, we found that amygdala blood oxygen level-dependent activity tracked associability as estimated by a computational model, and dissociated it from the striatal representation of reinforcement prediction error. These results extend the computational learning approach from striatum to amygdala, demonstrating their complementary roles in aversive learning.	[Li, Jian; Phelps, Elizabeth A.; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Li, Jian; Phelps, Elizabeth A.; Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Schiller, Daniela] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Schiller, Daniela] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Schiller, Daniela] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA	New York University; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Li, J (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lijian@nyu.edu	Schiller, Daniela/Q-2431-2018	Schiller, Daniela/0000-0002-0357-7724	McKnight Foundation; Human Frontiers Science Program [RGP0036/2009-C]; US National Institutes of Health (NIH) [MH087882]; James S. McDonnell Foundation; NIH [MH080756, DA015718, AG027097]; Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080756, R01MH087882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587, R01DA015718] Funding Source: NIH RePORTER	McKnight Foundation; Human Frontiers Science Program(Human Frontier Science Program); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Glimcher, R. Rutledge and E. DeWitt for discussions and comments. This research was supported by a McKnight Foundation Scholar Award, Human Frontiers Science Program grant RGP0036/2009-C, US National Institutes of Health (NIH) grant MH087882 (part of the CRCNS program, to N.D.D.), a James S. McDonnell Foundation grant and NIH grant MH080756 to E. A. P., and NIH grants DA015718 and AG027097 to G. S. This work was also supported by a Seaver Foundation grant to the Center for Brain Imaging.	Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Phelps, 2009, HUMAN AMYGDALA, P204; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593	15	218	220	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1250	1252		10.1038/nn.2904	http://dx.doi.org/10.1038/nn.2904			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21909088	Green Accepted			2022-12-25	WOS:000295254200012
J	Gray, JA; Shi, Y; Usui, H; During, MJ; Sakimura, K; Nicoll, RA				Gray, John A.; Shi, Yun; Usui, Hiroshi; During, Matthew J.; Sakimura, Kenji; Nicoll, Roger A.			Distinct Modes of AMPA Receptor Suppression at Developing Synapses by GluN2A and GluN2B: Single-Cell NMDA Receptor Subunit Deletion In Vivo	NEURON			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; SILENT SYNAPSES; SYNAPTIC PLASTICITY; FUNCTIONAL-PROPERTIES; REGIONAL EXPRESSION; NEURONAL PATTERNS; CRITICAL PERIOD; HIPPOCAMPAL; NR2B	During development there is an activity-dependent switch in synaptic N-Methyl-D-aspartate (NMDA) receptor subunit composition from predominantly GluN2B to GluN2A, though the precise role of this switch remains unknown. By deleting GluN2 subunits in single neurons during synaptogenesis, we find that both GluN2B and GluN2A suppress AMPA receptor expression, albeit by distinct means. Similar to GluN1, GluN2B deletion increases the number of functional synapses, while GluN2A deletion increases the strength of unitary connections without affecting the number of functional synapses. We propose a model of excitatory synapse maturation in which baseline activation of GluN2B-containing receptors prevents premature synapse maturation until correlated activity allows induction of functional synapses. This activity also triggers the switch to GluN2A, which dampens further potentiation. Furthermore, we analyze the subunit composition of synaptic NMDA receptors in CA1 pyramidal cells, provide electrophysiological evidence for a large population of synaptic triheteromeric receptors, and estimate the subunit-dependent open probability.	[Gray, John A.; Shi, Yun; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Usui, Hiroshi; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; [During, Matthew J.] Ohio State Univ, Dept Mol Virol, Columbus, OH 43210 USA; [During, Matthew J.] Ohio State Univ, Dept Immunol, Columbus, OH 43210 USA; [During, Matthew J.] Ohio State Univ, Dept Med Genet, Columbus, OH 43210 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Niigata University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	roger.nicoll@ucsf.edu	Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009; During, Matthew/E-3003-2011; During, Matthew/AAC-1388-2020; Gray, John Alan/Y-5730-2019	Shi, Yun/0000-0002-8842-9818; During, Matthew/0000-0002-3797-5026; Gray, John/0000-0002-7287-0748	NARSAD; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482, R01MH080379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044576] Funding Source: NIH RePORTER	NARSAD(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Susumu Tonegawa (Massachusetts Institute of Technology) for the Grin1<SUP>fl/fl</SUP> mice. We acknowledge Kirsten Bjorgan and Manual Cerpas for their genotyping assistance and all members of the Nicoll laboratory for their support. J.A.G. is funded by a NARSAD Young Investigator Award and is the NARSAD Hammerschlag Family Investigator. R.A.N. is funded by grants from the National Institute of Mental Health.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chazot PL, 1997, J NEUROCHEM, V69, P2138; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Colonnese MT, 2005, J NEUROSCI, V25, P1291, DOI 10.1523/JNEUROSCI.4063-04.2005; Colonnese MT, 2003, J NEUROPHYSIOL, V89, P57, DOI 10.1152/jn.00049.2002; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Ewald RC, 2008, J NEUROSCI, V28, P850, DOI 10.1523/JNEUROSCI.5078-07.2008; Flint AC, 1997, J NEUROSCI, V17, P2469; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Ito I, 1997, J PHYSIOL-LONDON, V500, P401, DOI 10.1113/jphysiol.1997.sp022030; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kew JNC, 1996, J PHYSIOL-LONDON, V497, P761, DOI 10.1113/jphysiol.1996.sp021807; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirson ED, 1999, J PHYSIOL-LONDON, V521, P99, DOI 10.1111/j.1469-7793.1999.00099.x; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; KONNERTH A, 1990, EXP BRAIN RES, V81, P209; Kumar SS, 2003, J NEUROSCI, V23, P10074; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792; Lu W, 2011, J NEUROPHYSIOL, V105, P923, DOI 10.1152/jn.00725.2010; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Momiyama A, 2000, J PHYSIOL-LONDON, V523, P621, DOI 10.1111/j.1469-7793.2000.t01-1-00621.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Thompson CL, 2002, MOL BRAIN RES, V102, P55, DOI 10.1016/S0169-328X(02)00183-3; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; ZHONG J, 1995, J NEUROCHEM, V64, P531	91	196	198	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1085	1101		10.1016/j.neuron.2011.08.007	http://dx.doi.org/10.1016/j.neuron.2011.08.007			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943605	Bronze, Green Accepted			2022-12-25	WOS:000295556500013
J	Talpalar, AE; Endo, T; Low, P; Borgius, L; Hagglund, M; Dougherty, KJ; Ryge, J; Hnasko, TS; Kiehn, O				Talpalar, Adolfo E.; Endo, Toshiaki; Low, Peter; Borgius, Lotta; Hagglund, Martin; Dougherty, Kimberly J.; Ryge, Jesper; Hnasko, Thomas S.; Kiehn, Ole			Identification of Minimal Neuronal Networks Involved in Flexor-Extensor Alternation in the Mammalian Spinal Cord	NEURON			English	Article							RECIPROCAL IA INHIBITION; MOTOR AXON COLLATERALS; PATTERN GENERATION; RHYTHMIC ACTIVITY; NEONATAL MOUSE; IN-VITRO; VOLTAGE OSCILLATIONS; RECURRENT INHIBITION; LOCOMOTOR CIRCUITS; FICTIVE LOCOMOTION	Neural networks in the spinal cord control two basic features of locomotor movements: rhythm generation and pattern generation. Rhythm generation is generally considered to be dependent on glutamatergic excitatory neurons. Pattern generation involves neural circuits controlling left-right alternation, which has been described in great detail, and flexor-extensor alternation, which remains poorly understood. Here, we use a mouse model in which glutamatergic neurotransmission has been ablated in the locomotor region of the spinal cord. The isolated in vitro spinal cord from these mice produces locomotor-like activity-when stimulated with neuroactive substances-with prominent flexor-extensor alternation. Under these conditions, unlike in control mice, networks of inhibitory interneurons generate the rhythmic activity. In the absence of glutamatergic synaptic transmission, the flexor-extensor alternation appears to be generated by la inhibitory interneurons, which mediate reciprocal inhibition from muscle proprioceptors to antagonist motor neurons. Our study defines a minimal inhibitory network that is needed to produce flexor-extensor alternation during locomotion.	[Talpalar, Adolfo E.; Endo, Toshiaki; Low, Peter; Borgius, Lotta; Hagglund, Martin; Dougherty, Kimberly J.; Ryge, Jesper; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; [Hnasko, Thomas S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	Karolinska Institutet; University of California System; University of California San Francisco	Kiehn, O (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden.	o.kiehn@ki.se	kiehn, ole/AAB-1262-2019; kiehn, ole/AAT-7881-2021; Talpalar, Adolfo/H-3996-2019	Talpalar, Adolfo/0000-0001-9056-6021; Ryge, Jesper/0000-0003-1992-7298; Hnasko, Thomas/0000-0001-6176-8513; Hagglund, Martin/0000-0003-1921-8563; Dougherty, Kimberly/0000-0002-0807-574X; Kiehn, Ole/0000-0002-5954-469X	Soderberg Foundation; Swedish Medical Research Council; Karolinska Institutet; StratNeuro; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504] Funding Source: NIH RePORTER	Soderberg Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet); StratNeuro; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by The Soderberg Foundation, Swedish Medical Research Council, friends of the Karolinska Institutet, and StratNeuro. We would like to thank Drs. Hans Hultborn and Elzbieta Jankowska for invaluable discussion of the data presented here, Dr. Richard Palmiter for the use of his laboratory in which the conditional Vglut2 mouse line was generated, and Ann-Charlotte Westerdahl for technical assistance.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bonnot A, 2009, J NEUROPHYSIOL, V101, P2995, DOI 10.1152/jn.90740.2008; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Geertsen SS, 2011, J PHYSIOL-LONDON, V589, P119, DOI 10.1113/jphysiol.2010.199125; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Hinckley C, 2005, NEUROSCIENCE, V131, P745, DOI 10.1016/j.neuroscience.2004.11.034; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; Hughes DI, 2004, BRAIN RES, V1017, P69, DOI 10.1016/j.brainres.2004.05.054; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P591, DOI 10.1113/jphysiol.1971.sp009487; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P613, DOI 10.1113/jphysiol.1971.sp009488; Hultborn H, 1998, ANN NY ACAD SCI, V860, P70, DOI 10.1111/j.1749-6632.1998.tb09039.x; HULTBORN H, 1976, ACTA PHYSIOL SCAND, V96, P193, DOI 10.1111/j.1748-1716.1976.tb10188.x; JANKOWSKA E, 1978, J PHYSIOL-LONDON, V285, P425, DOI 10.1113/jphysiol.1978.sp012580; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; Jean-Xavier C, 2007, P NATL ACAD SCI USA, V104, P11477, DOI 10.1073/pnas.0704832104; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; JORDAN LM, 1983, SYM SOC EXP BIOL, P423; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kjaerulff O, 1997, J NEUROSCI, V17, P9433; Lev-Tov A, 2000, J NEUROPHYSIOL, V83, P888, DOI 10.1152/jn.2000.83.2.888; Marchetti C, 2001, J PHYSIOL-LONDON, V530, P105, DOI 10.1111/j.1469-7793.2001.0105m.x; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; MILLER S, 1977, EXP BRAIN RES, V30, P387; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Nishimaru H, 2006, J NEUROSCI, V26, P5320, DOI 10.1523/JNEUROSCI.5127-05.2006; NOGA BR, 1987, EXP BRAIN RES, V66, P99; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; PRATT CA, 1987, J NEUROPHYSIOL, V57, P56, DOI 10.1152/jn.1987.57.1.56; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030; Talpalar AE, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00019; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; Zaporozhets E, 2004, J NEUROSCI METH, V139, P33, DOI 10.1016/j.jneumeth.2004.04.009; Zhang WQ, 1996, J COMP NEUROL, V374, P278, DOI 10.1002/(SICI)1096-9861(19961014)374:2<278::AID-CNE9>3.0.CO;2-#; Ziskind-Conhaim L, 2008, J NEUROPHYSIOL, V100, P2254, DOI 10.1152/jn.90437.2008	54	66	66	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1071	1084		10.1016/j.neuron.2011.07.011	http://dx.doi.org/10.1016/j.neuron.2011.07.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943604	Bronze			2022-12-25	WOS:000295556500012
J	Gregory, FD; Bryan, KE; Pangrsic, T; Calin-Jageman, IE; Moser, T; Lee, A				Gregory, Frederick D.; Bryan, Keith E.; Pangrsic, Tina; Calin-Jageman, Irina E.; Moser, Tobias; Lee, Amy			Harmonin inhibits presynaptic Ca(v)1.3 Ca2+ channels in mouse inner hair cells	NATURE NEUROSCIENCE			English	Article							MUTATIONS; COMPLEXES; DOMAIN	Harmonin is a scaffolding protein that is required for normal mechanosensory function in hair cells. We found a presynaptic association of harmonin and Ca(v)1.3 Ca2+ channels at the mouse inner hair cell synapse, which limits channel availability through a ubiquitin-dependent pathway.	[Gregory, Frederick D.; Bryan, Keith E.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Gregory, Frederick D.; Bryan, Keith E.; Lee, Amy] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Gregory, Frederick D.; Bryan, Keith E.; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Gregory, Frederick D.; Calin-Jageman, Irina E.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Gregory, Frederick D.; Calin-Jageman, Irina E.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Pangrsic, Tina; Moser, Tobias] Univ Gottingen, Dept Otolaryngol, InnerEarLab, Gottingen, Germany; [Pangrsic, Tina; Moser, Tobias] Univ Gottingen, Ctr Mol Physiol Brain, Bernstein Ctr Computat Neurosci, Gottingen, Germany	University of Iowa; University of Iowa; University of Iowa; Emory University; Emory University; University of Gottingen; University of Gottingen	Lee, A (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu	889, CRC/L-1607-2018; Moser, Tobias/L-5068-2014	889, CRC/0000-0002-6678-3138; Moser, Tobias/0000-0001-7145-0533; Lee, Amy/0000-0001-8021-0443; Calin-Jageman, Irina/0000-0002-2529-4223	US National Institutes of Health [DC009433, HL087120, DC010362, DC008417, DA015040, K12/GM000680]; Deafness Research Foundation; German Research Foundation (Collaborative Research Center) [889, A5]; German Research Foundation (Center for Molecular Physiology of the Brain) [FZT-103]; German Federal Ministry for Research and Technology (Bernstein Center for Computational Neuroscience Goettingen) [01GQ1005A]; Alexander von Humboldt fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008417, R01DC009433, P30DC010362, R55DC009433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA015040] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deafness Research Foundation; German Research Foundation (Collaborative Research Center)(German Research Foundation (DFG)); German Research Foundation (Center for Molecular Physiology of the Brain)(German Research Foundation (DFG)); German Federal Ministry for Research and Technology (Bernstein Center for Computational Neuroscience Goettingen); Alexander von Humboldt fellowship(Alexander von Humboldt Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank J. Striessnig for Cacna1d<SUP>-/-</SUP> mice, U. Mueller and U. Wolfrum for cDNAs and antibodies, Q. Zheng for Ush1c<SUP>-/-</SUP> tissue, H. Couchoux and A. Inagaki for contributing data, B. Fritzsch, C. Harata, M. Stamnes and R. Piper for advice and discussion, and J. Diamond for comments on the manuscript. This work was supported by the US National Institutes of Health (DC009433, HL087120 and DC010362 to A. L., DC008417 to I.E.C.-J., and DA015040 and K12/GM000680 to F. D. G.), the Deafness Research Foundation (A. L. and I.E.C.-J.), the German Research Foundation (Collaborative Research Center 889, project A5, Center for Molecular Physiology of the Brain, FZT-103, T. M.), the German Federal Ministry for Research and Technology (Bernstein Center for Computational Neuroscience Goettingen, 01GQ1005A, T. M.), and an Alexander von Humboldt fellowship to T.P.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909	15	61	63	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1109	1111		10.1038/nn.2895	http://dx.doi.org/10.1038/nn.2895			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21822269	Green Accepted			2022-12-25	WOS:000294284900007
J	Picardo, MA; Guigue, P; Bonifazi, P; Batista-Brito, R; Allene, C; Ribas, A; Fishell, G; Baude, A; Cossart, R				Picardo, Michel Aime; Guigue, Philippe; Bonifazi, Paolo; Batista-Brito, Renata; Allene, Camille; Ribas, Alain; Fishell, Gord; Baude, Agnes; Cossart, Rosa			Pioneer GABA Cells Comprise a Subpopulation of Hub Neurons in the Developing Hippocampus	NEURON			English	Article							CORTICAL INTERNEURONS; CA1 INTERNEURONS; SUBPLATE NEURONS; CONNECTIONS; ORIGINS; LONG; PROJECTION; DIVERSITY; NETWORKS; REGION	Connectivity in the developing hippocampus displays a functional organization particularly effective in supporting network synchronization, as it includes superconnected hub neurons. We have previously shown that hub network function is supported by a subpopulation of GABA neurons. However, it is unclear whether hub cells are only transiently present or later develop into distinctive subclasses of inter-neurons. These questions are difficult to assess given the heterogeneity of the GABA neurons and the poor early expression of markers. To circumvent this conundrum, we used "genetic fate mapping" that allows for the selective labeling of GABA neurons based on their place and time of origin. We show that early-generated GABA cells form a subpopulation of hub neurons, characterized by an exceptionally widespread axonal arborization and the ability to single-handedly impact network dynamics when stimulated. Pioneer hub neurons remain into adulthood, when they acquire the classical markers of long-range projecting GABA neurons.	[Picardo, Michel Aime; Guigue, Philippe; Bonifazi, Paolo; Allene, Camille; Ribas, Alain; Baude, Agnes; Cossart, Rosa] INSERM, U901, F-13009 Marseille, France; [Picardo, Michel Aime; Guigue, Philippe; Bonifazi, Paolo; Allene, Camille; Ribas, Alain; Baude, Agnes; Cossart, Rosa] Univ Mediterranee, UMR Aix Marseille 2 S901, F-13009 Marseille, France; [Picardo, Michel Aime; Guigue, Philippe; Bonifazi, Paolo; Allene, Camille; Ribas, Alain; Baude, Agnes; Cossart, Rosa] INMED, F-13009 Marseille, France; [Bonifazi, Paolo] Tel Aviv Univ, Beverly & Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Batista-Brito, Renata; Fishell, Gord] NYU Langone Med Ctr, Smilow Neurosci Program, New York, NY 10016 USA; [Batista-Brito, Renata; Fishell, Gord] NYU Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Batista-Brito, Renata; Fishell, Gord] NYU Langone Med Ctr, Dept Neural Sci, New York, NY 10016 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Tel Aviv University; NYU Langone Medical Center; NYU Langone Medical Center; NYU Langone Medical Center	Cossart, R (corresponding author), INSERM, U901, F-13009 Marseille, France.	cossart@inmed.univ-mrs.fr	Bonifazi, Paolo/N-9737-2018; Baude, Agnès/M-7356-2016; Cossart, Rosa/AAT-7934-2020; Cossart, Rosa/E-7674-2014; Bonifazi, Paolo/AAA-8035-2020	Bonifazi, Paolo/0000-0001-6374-8997; Baude, Agnès/0000-0002-7025-364X; Cossart, Rosa/0000-0003-2111-6638; Cossart, Rosa/0000-0003-2111-6638; Bonifazi, Paolo/0000-0001-6374-8997; Fishell, Gordon/0000-0002-9640-9278; Batista-Brito, Renata/0000-0003-1214-045X; picardo, michel/0000-0003-1198-3930	European Research Council [242852]; Fondation pour la Recherche Medicale; Fondation Bettencourt Schueller; INSERM; Ville de Marseille and Region PACA; FRC; CNRS; National Institutes of Health [RO1MH071679, R01NS039007]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039007] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Bettencourt Schueller; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ville de Marseille and Region PACA(Region Provence-Alpes-Cote d'Azur); FRC; CNRS(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. R. Machold for generating the DIx1/2-creER allele and Dr. J. Johnston for providing the Mash1<SUP>CreERTM</SUP> mouse. We thank Drs. Y. Ben-Ani and S. Feldt for critical comments. We thank Dr. M. Esclapez for providing occasional access to her Neurolucida system. Research in the Cossart group was supported by grants from the European Research Council (ERC FP7 Young Investigators 242852), the Fondation pour la Recherche Medicale (Equipe FRM 2008), the Fondation Bettencourt Schueller, INSERM, the Ville de Marseille and Region PACA and the FRC. Drs. R. Cossart and A. Baude are funded by the CNRS. Research in the Fishell laboratory is supported by the National Institutes of Health (R01 grants RO1MH071679 and R01NS039007).	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Arias MS, 2002, DEV BRAIN RES, V139, P331, DOI 10.1016/S0165-3806(02)00582-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Ceranik K, 1997, J NEUROSCI, V17, P5380; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Crepel V, 2007, NEURON, V54, P105, DOI 10.1016/j.neuron.2007.03.007; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; de la Prida LM, 1998, EUR J NEUROSCI, V10, P899, DOI 10.1046/j.1460-9568.1998.00097.x; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Ferraguti F, 2004, HIPPOCAMPUS, V14, P193, DOI 10.1002/hipo.10163; Fuentealba P, 2008, J NEUROSCI, V28, P10017, DOI 10.1523/JNEUROSCI.2052-08.2008; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Gozlan H, 2003, CEREB CORTEX, V13, P684, DOI 10.1093/cercor/13.6.684; Gulyas AI, 2003, EUR J NEUROSCI, V17, P1861, DOI 10.1046/j.1460-9568.2003.02630.x; Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x; Hirsch S, 2008, NEUROSCIENCE, V153, P1092, DOI 10.1016/j.neuroscience.2008.01.068; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Jinno S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.013.2009; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Leinekugel X, 1998, J NEUROSCI, V18, P6349; LINKE R, 1995, J COMP NEUROL, V351, P602, DOI 10.1002/cne.903510409; Long J.E., 2009, CEREB CORTEX, V19, pi96, DOI [10.1093/cercor/bhp045, DOI 10.1093/CERCOR/BHP045]; Luhmann HJ, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.019.2009; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Meyer G, 1998, J COMP NEUROL, V397, P493; Miyashita T, 2007, EUR J NEUROSCI, V26, P1193, DOI 10.1111/j.1460-9568.2007.05745.x; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Price DJ, 1997, J COMP NEUROL, V377, P414; SIK A, 1994, SCIENCE, V265, P1722, DOI 10.1126/science.8085161; SIK A, 1995, J NEUROSCI, V15, P6651; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Super H, 1998, J NEUROSCI, V18, P4616; Takacs VT, 2008, EUR J NEUROSCI, V28, P148, DOI 10.1111/j.1460-9568.2008.06319.x; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Voigt T, 2001, J NEUROSCI, V21, P8895, DOI 10.1523/JNEUROSCI.21-22-08895.2001	58	103	104	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					695	709		10.1016/j.neuron.2011.06.018	http://dx.doi.org/10.1016/j.neuron.2011.06.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867885	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000294521600014
J	Ho, GPH; Selvakumar, B; Mukai, J; Hester, LD; Wang, YX; Gogos, JA; Snyder, SH				Ho, Gary P. H.; Selvakumar, Balakrishnan; Mukai, Jun; Hester, Lynda D.; Wang, Yuxuan; Gogos, Joseph A.; Snyder, Solomon H.			S-Nitrosylation and S-Palmitoylation Reciprocally Regulate Synaptic Targeting of PSD-95	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; DENSITY PROTEIN PSD-95; LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY; AMPA RECEPTORS; NEURONAL DEVELOPMENT; BRAIN; ACETYLATION; ENDOCYTOSIS; TRAFFICKING	PSD-95, a principal scaffolding component of the postsynaptic density, is targeted to synapses by palmitoylation, where it couples NMDA receptor stimulation to production of nitric oxide (NO) by neuronal nitric oxide synthase (nNOS). Here, we show that PSD-95 is physiologically S-nitrosylated. We identify cysteines 3 and 5, which are palmitoylated, as sites of nitrosylation, suggesting a competition between these two modifications. In support of this hypothesis, physiologically produced NO inhibits PSD-95 palmitoylation in granule cells of the cerebellum, decreasing the number of PSD-95 clusters at synaptic sites. Further, decreased palmitoylation, as seen in heterologous cells treated with 2-bromopalmitate or in ZDHHC8 knockout mice deficient in a PSD-95 palmitoyltransferase, results in increased PSD-95 nitrosylation. These data support a model in which NMDA-mediated production of NO regulates targeting of PSD-95 to synapses via mutually competitive cysteine modifications. Thus, differential modification of cysteines may represent a general paradigm in signal transduction.	[Ho, Gary P. H.; Selvakumar, Balakrishnan; Hester, Lynda D.; Wang, Yuxuan; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Mukai, Jun; Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Columbia University; Columbia University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu		Mukai, Jun/0000-0003-2065-4784; Ho, Gary/0000-0001-7004-8630	US Public Health Service [MH18501]; Research Scientist Award [DA-00074]; National Institutes of Health [MH67068]; Simons Foundation; NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501, R01MH067068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Michael Koldobskiy for helpful discussions and Masoumeh Saleh for maintaining and genotyping the nNOS knockout mice. This work was supported by US Public Health Service Grant MH18501 and Research Scientist Award DA-00074 (to S.H.S.), National Institutes of Health grant MH67068 (to J.A.G.), a Simons Foundation grant (to J.A.G.), and a NARSAD Young Investigator Award (to J.M.).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Huang PL, 1996, J MOL MED-JMM, V74, P415, DOI 10.1007/s001090050043; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAFFREY SR, 2001, SCI STKE; Kang BN, 2010, J NEUROSCI, V30, P93, DOI 10.1523/JNEUROSCI.3974-09.2010; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Li B, 2003, J NEUROSCI, V23, P11244; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Selvakumar B, 2009, P NATL ACAD SCI USA, V106, P16440, DOI 10.1073/pnas.0908949106; Stein V, 2003, J NEUROSCI, V23, P5503; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635	50	109	109	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 14	2011	71	1					131	141		10.1016/j.neuron.2011.05.033	http://dx.doi.org/10.1016/j.neuron.2011.05.033			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745643	Green Accepted, Bronze			2022-12-25	WOS:000292806200012
J	Plotkin, JL; Day, M; Surmeier, DJ				Plotkin, Joshua L.; Day, Michelle; Surmeier, D. James			Synaptically driven state transitions in distal dendrites of striatal spiny neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; IN-VIVO; BASAL GANGLIA; INTRACELLULAR-RECORDINGS; DOPAMINERGIC CONTROL; RECEPTOR ACTIVATION; NEOSTRIATAL NEURONS; PROJECTION NEURONS; CALCIUM-CHANNELS	Striatal spiny neurons (SPNs) associate a diverse array of cortically processed information to regulate action selection. But how this is done by SPNs is poorly understood. A key step in this process is the transition of SPNs from a hyperpolarized 'down state' to a sustained, depolarized 'up state'. These transitions are thought to reflect a sustained synaptic barrage, involving the coordination of hundreds of pyramidal neurons. Indeed, in mice, simulation of cortical input by glutamate uncaging on proximal dendritic spines produced potential changes in SPNs that tracked input time course. However, brief glutamate uncaging at spines on distal dendrites evoked somatic up states lasting hundreds of milliseconds. These regenerative events depended upon both NMDA receptors and voltage-dependent Ca(2+) channels. Moreover, they were bidirectionally regulated by dopamine receptor signaling. This capacity not only changes our model of how up states are generated in SPNs, it also has fundamental implications for the associative process underlying action selection.	[Plotkin, Joshua L.; Day, Michelle; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Plotkin, Joshua/AAJ-5043-2021	Plotkin, Joshua/0000-0001-6232-7613	US National Institutes of Health [NS 034696, MH074866]; Picower Foundation; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866, P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034696, R01NS034696] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The US National Institutes of Health (NS 034696, MH074866), the Picower Foundation and CHDI Foundation supported this work. We thank J. Dempster, K. Saporito, N. Schwarz, S. Ulrich and D. Wokosin for technical assistance.	BARGAS J, 1991, BRAIN RES, V539, P159, DOI 10.1016/0006-8993(91)90700-6; BARGAS J, 1994, J NEUROSCI, V14, P6667; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; Czubayko U, 2002, P NATL ACAD SCI USA, V99, P15764, DOI 10.1073/pnas.242428599; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Galarraga E, 1997, NEUROREPORT, V8, P2183, DOI 10.1097/00001756-199707070-00019; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holthoff K, 2006, CELL TISSUE RES, V326, P369, DOI 10.1007/s00441-006-0263-8; Kaczorowski CC, 2007, J PHYSIOL-LONDON, V578, P799, DOI 10.1113/jphysiol.2006.124586; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Kasanetz F, 2006, J PHYSIOL-LONDON, V577, P97, DOI 10.1113/jphysiol.2006.113050; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Mahon S, 2003, J PHYSIOL-PARIS, V97, P557, DOI 10.1016/j.jphysparis.2004.01.013; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pidoux M, 2011, J PHYSIOL-LONDON, V589, P263, DOI 10.1113/jphysiol.2010.199646; Plenz D, 1998, J NEUROSCI, V18, P266; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 2010, PROG BRAIN RES, V183, P149, DOI 10.1016/S0079-6123(10)83008-0; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Wilson C. J., 1992, SINGLE NEURON COMPUT, P141, DOI [10.1016/B978-0-12-484815-3.50012-8, DOI 10.1016/B978-0-12-484815-3.50012-8]; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	50	96	97	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					881	U101		10.1038/nn.2848	http://dx.doi.org/10.1038/nn.2848			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666674	Green Accepted			2022-12-25	WOS:000292081700016
J	Erskine, L; Reijntjes, S; Pratt, T; Denti, L; Schwarz, Q; Vieira, JM; Alakakone, B; Shewan, D; Ruhrberg, C				Erskine, Lynda; Reijntjes, Susan; Pratt, Thomas; Denti, Laura; Schwarz, Quenten; Vieira, Joaquim M.; Alakakone, Bennett; Shewan, Derryck; Ruhrberg, Christiana			VEGF Signaling through Neuropilin 1 Guides Commissural Axon Crossing at the Optic Chiasm	NEURON			English	Article							ENDOTHELIAL GROWTH-FACTOR; GANGLION-CELL AXONS; CENTRAL-NERVOUS-SYSTEM; RETINAL AXONS; TUMOR-CELLS; GUIDANCE; MIDLINE; EXPRESSION; SEMAPHORIN; NEURONS	During development, the axons of retinal ganglion cell (RGC) neurons must decide whether to cross or avoid the midline at the optic chiasm to project to targets on both sides of the brain. By combining genetic analyses with in vitro assays, we show that neuropilin 1 (NRP1) promotes contralateral RGC projection in mammals. Unexpectedly, the NRP1 ligand involved is not an axon guidance cue of the class 3 semaphorin family, but VEGF164, the neuropilin-binding isoform of the classical vascular growth factor VEGF-A. VEGF164 is expressed at the chiasm midline and is required for normal contralateral growth in vivo. In outgrowth and growth cone turning assays, VEGF164 acts directly on NRP1-expressing contralateral RGCs to provide growth-promoting and chemoattractive signals. These findings have identified a permissive midline signal for axons at the chiasm midline and provide in vivo evidence that VEGF-A is an essential axon guidance cue.	[Erskine, Lynda; Reijntjes, Susan; Shewan, Derryck] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Pratt, Thomas] Univ Edinburgh, Genes & Dev Grp, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Pratt, Thomas] Univ Edinburgh, Genes & Dev Grp, Neurosci Res Ctr, Edinburgh EH8 9XD, Midlothian, Scotland; [Denti, Laura; Schwarz, Quenten; Vieira, Joaquim M.; Alakakone, Bennett; Ruhrberg, Christiana] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England	University of Aberdeen; University of Edinburgh; University of Edinburgh; University of London; University College London	Erskine, L (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland.	l.erskine@abdn.ac.uk; c.ruhrberg@ucl.ac.uk	Erskine, Lynda/AAE-9281-2020; Ruhrberg, Christiana/C-6404-2009; Schwarz, Quenten/AAE-7513-2021; Schwarz, Quenten/AAC-3726-2019	Ruhrberg, Christiana/0000-0002-3212-9381; Schwarz, Quenten/0000-0002-5958-4181; Erskine, Lynda/0000-0001-6538-9406; Pratt, Thomas/0000-0002-7105-3527; Vieira, Joaquim/0000-0003-2023-6304; Denti, Laura/0000-0002-6000-5765	Wellcome Trust [085476]; University of London [AR/CRF/B]; MRC [G0701460] Funding Source: UKRI; Medical Research Council [G0701460] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); University of London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Drs. A.L. Kolodkin, D.D. Ginty, C. Gu, H. Fujisawa, J. Rossant, G.H. Fong, and M. Taniguchi for mouse strains; the staff of the Biological Resources Unit at the UCL Institute of Ophthalmology for help with mouse husbandry; the Institute of Medical Sciences Microscopy and Imaging Facility for help with confocal microscopy; and Kathryn Davidson, Heather Walker, and Andrew Peace for technical assistance. This research was funded by a Wellcome Trust Project Grant to L.E. and C.R. (reference 085476) and a Central Research Fund grant from the University of London to C.R. (reference AR/CRF/B).	ADAMS RH, 2010, PERSPECT BIOL, V2; Bocker-Meffert S, 2002, INVEST OPHTH VIS SCI, V43, P2021; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Claudepierre T, 2008, DEV DYNAM, V237, P3394, DOI 10.1002/dvdy.21759; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Deiner MS, 1999, J NEUROSCI, V19, P9900; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Gariano RF, 2006, GENE EXPR PATTERNS, V6, P187, DOI 10.1016/j.modgep.2005.06.008; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; GODEMENT P, 1994, J NEUROSCI, V14, P7024; GODEMENT P, 1987, DEVELOPMENT, V101, P697; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hashimoto T, 2006, DEVELOPMENT, V133, P2201, DOI 10.1242/dev.02385; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Marcus RC, 1999, J COMP NEUROL, V403, P346; MARCUS RC, 1995, J NEUROSCI, V15, P3716; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Mason CA, 1997, J NEUROSCI, V17, P1086; Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; Schwarz Q, 2004, GENE DEV, V18, P2822, DOI 10.1101/gad.322904; Schwarz Q, 2010, CELL ADHES MIGR, V4, P61, DOI 10.4161/cam.4.1.10207; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; SRETAVAN DW, 1995, SCIENCE, V269, P98, DOI 10.1126/science.7541558; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; Thompson H, 2006, DEV BIOL, V296, P476, DOI 10.1016/j.ydbio.2006.06.017; Tian NM, 2008, DEVELOPMENT, V135, P4081, DOI 10.1242/dev.023572; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; Trousse F, 2001, DEVELOPMENT, V128, P3927; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	60	119	121	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 9	2011	70	5					951	965		10.1016/j.neuron.2011.02.052	http://dx.doi.org/10.1016/j.neuron.2011.02.052			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658587	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000291843500014
J	Miyoshi, N; Ishii, H; Nagano, H; Haraguchi, N; Dewi, DL; Kano, Y; Nishikawa, S; Tanemura, M; Mimori, K; Tanaka, F; Saito, T; Nishimura, J; Takemasa, I; Mizushima, T; Ikeda, M; Yamamoto, H; Sekimoto, M; Doki, Y; Mori, M				Miyoshi, Norikatsu; Ishii, Hideshi; Nagano, Hiroaki; Haraguchi, Naotsugu; Dewi, Dyah Laksmi; Kano, Yoshihiro; Nishikawa, Shinpei; Tanemura, Masahiro; Mimori, Koshi; Tanaka, Fumiaki; Saito, Toshiyuki; Nishimura, Junichi; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Doki, Yuichiro; Mori, Masaki			Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DEFINED FACTORS; GENERATION; INDUCTION; FIBROBLASTS; RNA	Induced pluripotent stem cells (iPSCs) can be generated from differentiated human and mouse somatic cells using transcription factors such as Oct4, Sox2, Klf4, and c-Myc. It is possible to augment the reprogramming process with chemical compounds, but issues related to low reprogramming efficiencies and, with a number of protocols, residual vector sequences, remain to be resolved. We show here that it is possible to reprogram mouse and human cells to pluripotency by direct transfection of mature double-stranded microRNAs (miRNAs). Our approaches use a combination of mir-200c plus mir-302 s and mir-369 s family miRNAs. Because this reprogramming method does not require vector-based gene transfer, it holds significant potential for biomedical research and regenerative medicine.	[Ishii, Hideshi; Mimori, Koshi; Tanaka, Fumiaki; Mori, Masaki] Kyushu Univ, Med Inst Bioregulat, Div Mol & Surg Oncol, Dept Mol & Cellular Biol, Beppu, Oita 8740838, Japan; [Miyoshi, Norikatsu; Ishii, Hideshi; Nagano, Hiroaki; Haraguchi, Naotsugu; Dewi, Dyah Laksmi; Kano, Yoshihiro; Nishikawa, Shinpei; Tanemura, Masahiro; Nishimura, Junichi; Takemasa, Ichiro; Mizushima, Tsunekazu; Ikeda, Masataka; Yamamoto, Hirofumi; Sekimoto, Mitsugu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Saito, Toshiyuki] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Transcriptome Profiling Grp, Chiba 2638555, Japan	Kyushu University; Osaka University; National Institutes for Quantum Science & Technology	Ishii, H (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Surg Oncol, Dept Mol & Cellular Biol, Tsurumihara 4546, Beppu, Oita 8740838, Japan.	hishii@gesurg.med.osaka-u.ac.jp; mmori@gesurg.med.osaka-u.ac.jp	Ishii, Hideshi/AAV-5317-2020; Sekimoto, Mitsugu/T-2217-2019; Sekimoto, MItsugu/AAE-5878-2019; Nishimura, Junichi/K-8390-2015; Mizushima, Tsunekazu/AAS-7245-2020; Dewi, Dyah Laksmi/GOP-2412-2022	Nishimura, Junichi/0000-0001-8220-3423; Mizushima, Tsunekazu/0000-0002-0825-6823; Dewi, Dyah Laksmi/0000-0001-7937-4221; Mimori, Koshi/0000-0003-3897-9974	Core Research for Evolutional Science and Technology (CREST); Ministry of Education, Culture, Sports, Science, and Technology [S: 21229015]; Ministry of Health, Labour and Welfare; Funding Program for Next Generation World-Leading Researchers, Japan [LS094]; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research [21591644] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Funding Program for Next Generation World-Leading Researchers, Japan; Tokyo Biochemical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank Dr. S. Yamanaka (Kyoto University) for fruitful discussions. We thank Drs. J.H. Moon, S. Miyazaki, H. Hoshnino, and Y. Omura for fruitful discussions and K. Kitagawa and S. Yamane for special technical assistance. This work was partly supported by a grant from Core Research for Evolutional Science and Technology (CREST) (M.M. and K.M.), a Grant-in-Aid for Scientific Research on Innovative Areas (M.M.), Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (S: 21229015) (M.M.), Grants-in-Aid for the 3rd Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare (M.M., H.I.), the Funding Program for Next Generation World-Leading Researchers, Japan (LS094) (K.M.), and a Grant-in-Aid from the Tokyo Biochemical Research Foundation (M.M.). The authors declare no competing financial interests.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	29	549	590	0	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					633	638		10.1016/j.stem.2011.05.001	http://dx.doi.org/10.1016/j.stem.2011.05.001			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21620789	Bronze			2022-12-25	WOS:000291844100011
J	Rock, JR; Gao, X; Xue, Y; Randell, SH; Kong, YY; Hogan, BLM				Rock, Jason R.; Gao, Xia; Xue, Yan; Randell, Scott H.; Kong, Young-Yun; Hogan, Brigid L. M.			Notch-Dependent Differentiation of Adult Airway Basal Stem Cells	CELL STEM CELL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SIGNALING CONTROLS; UBIQUITIN LIGASE; PROGENITOR CELLS; LUNG DEVELOPMENT; CLARA CELLS; MIND BOMB; EPITHELIUM; MAINTENANCE; FATES	The epithelium lining the airways of the adult human lung is composed of ciliated and secretory cells together with undifferentiated basal cells (BCs). The composition and organization of this epithelium is severely disrupted in many respiratory diseases. However, little is known about the mechanisms controlling airway homeostasis and repair after epithelial damage. Here, we exploit the mouse tracheobronchial epithelium, in which BCs function as resident stem cells, as a genetically tractable model of human small airways. Using a reporter allele we show that the low level of Notch signaling at steady state is greatly enhanced during repair and the generation of lumina! progenitors. Loss-of-function experiments show that Notch signaling is required for the differentiation, but not self-renewal, of BCs. Moreover, sustained Notch activation in BCs promotes their luminal differentiation, primarily toward secretory lineages. We also provide evidence that this function of Notch signaling is conserved in BCs from human airways.	[Rock, Jason R.; Gao, Xia; Xue, Yan; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Kong, Young-Yun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Chem, Seoul 151747, South Korea; [Randell, Scott H.] Univ N Carolina, CF Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU); University of North Carolina; University of North Carolina Chapel Hill	Hogan, BLM (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	b.hogan@cellbio.duke.edu			CFF [HL071303, F32-HL102920, R026-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL102920, T32HL007538, R01HL071303, R37HL071303] Funding Source: NIH RePORTER	CFF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript is dedicated to the memory of our friend and colleague Dr. Tim Oliver. The work was supported, in part, by NIH grants HL071303 (B.L.M.H.), F32-HL102920 (J.R.R.) and R026-CR07 from the CFF (S.H.R.). We thank Ryoichiro Kageyama, Nadean Brown, Jeffrey Whitsett, Chay Kuo, Terry Lechler, Emma Rawlins, Tannishtha Reya, Blanche Capel, and their lab members for advice and reagents.	Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Ito T, 2000, DEVELOPMENT, V127, P3913; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kauffman S L, 1980, Int Rev Exp Pathol, V22, P131; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakajima M, 1998, PATHOL INT, V48, P944; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Randell Scott H, 2006, Proc Am Thorac Soc, V3, P718, DOI 10.1513/pats.200605-117SF; RANDELL SH, 1991, AM J RESP CELL MOL, V4, P544, DOI 10.1165/ajrcmb/4.6.544; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Sakamoto M, 2003, J BIOL CHEM, V278, P44808, DOI 10.1074/jbc.M300448200; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Voynow JA, 2005, AM J RESP CRIT CARE, V172, P1013, DOI 10.1164/rccm.200410-1398OC; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Xu KL, 2010, AM J PHYSIOL-LUNG C, V298, pL45, DOI 10.1152/ajplung.90550.2008; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	40	290	293	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					639	648		10.1016/j.stem.2011.04.003	http://dx.doi.org/10.1016/j.stem.2011.04.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624809	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000291844100012
J	Cappello, S; Bohringer, CRJ; Bergami, M; Conzelmann, KK; Ghanem, A; Tomassy, GS; Arlotta, P; Mainardi, M; Allegra, M; Caleo, M; van Hengel, J; Brakebusch, C; Gotz, M				Cappello, Silvia; Boehringer, Christian R. J.; Bergami, Matteo; Conzelmann, Karl-Klaus; Ghanem, Alexander; Tomassy, Giulio Srubek; Arlotta, Paola; Mainardi, Marco; Allegra, Manuela; Caleo, Matteo; van Hengel, Jolanda; Brakebusch, Cord; Goetz, Magdalena			A Radial Glia-Specific Role of RhoA in Double Cortex Formation	NEURON			English	Article							ABNORMAL NEURONAL MIGRATION; OUTER SUBVENTRICULAR ZONE; SERUM RESPONSE FACTOR; CEREBRAL-CORTEX; CELL-MIGRATION; VISUAL-CORTEX; PYRAMIDAL NEURONS; PROGENITOR CELLS; CRE RECOMBINASE; IN-VIVO	The positioning of neurons in the cerebral cortex is of crucial importance for its function as highlighted by the severe consequences of migrational disorders in patients. Here we show that genetic deletion of the small GTPase RhoA in the developing cerebral cortex results in two migrational disorders: subcortical band heterotopia (SBH), a heterotopic cortex underlying the normotopic cortex, and cobblestone lissencephaly, in which neurons protrude beyond layer I at the pial surface of the brain. Surprisingly, Rhoyft(-/-) neurons migrated normally when transplanted into wild-type cerebral cortex, whereas the converse was not the case. Alterations in the radial glia scaffold are demonstrated to cause these migrational defects through destabilization of both the actin and the microtubules cytoskeleton. These data not only demonstrate that RhoA is largely dispensable for migration in neurons but also showed that defects in radial glial cells, rather than neurons, can be sufficient to produce SBH.	[Cappello, Silvia; Boehringer, Christian R. J.; Goetz, Magdalena] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Conzelmann, Karl-Klaus; Ghanem, Alexander] Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; [Conzelmann, Karl-Klaus; Ghanem, Alexander] Univ Munich, Gene Ctr, D-80336 Munich, Germany; [Tomassy, Giulio Srubek; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mainardi, Marco; Allegra, Manuela; Caleo, Matteo] CNR, Inst Neurosci, I-56100 Pisa, Italy; [van Hengel, Jolanda] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [van Hengel, Jolanda] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Brakebusch, Cord] Univ Copenhagen, Fac Hlth Sci, Inst Mol Pathol, DK-2200 Copenhagen, Denmark	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Harvard University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Copenhagen	Gotz, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany.	magdalena.goetz@helmholtz-muenchen.de	Cappello, Silvia/AAQ-4590-2021; Ghanem, Alexander/AAL-9902-2020; Bergami, Matteo/AAI-9972-2020; Mainardi, Marco/AAY-4025-2020; Allegra, Manuela/AAG-2680-2022; Allegra, Manuela/AFK-3908-2022; Conzelmann, Karl-Klaus/L-7239-2013	Cappello, Silvia/0000-0003-1553-6775; Allegra, Manuela/0000-0001-5152-8225; Allegra, Manuela/0000-0001-5152-8225; Boehringer-Shahidi, Christian/0000-0002-5606-6960; Bergami, Matteo/0000-0001-5525-5025; CALEO, MATTEO/0000-0002-4333-6378; Conzelmann, Karl-Klaus/0000-0002-8614-3656; Brakebusch, Cord/0000-0002-9342-1634	LMU; Deutsche Forschungsgemeinschaft; Leibniz Award; SFB 870; Bundesministerium fur Bildung und Forschung; European Union; Helmholtz Association	LMU; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Award; SFB 870; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Helmholtz Association(Helmholtz Association)	We would like to thank Stephen Robertson for excellent discussion and comments on the manuscript. We are particularly grateful to Guido Posern, Jeffrey Macklis, Carol Schuurmans, and Michele Studer for antibodies, plasmids, and probes; Gregor Pilz and Sven Falk for help in imaging brain slices; and Detlef Franzen, Timucin ozturk, Angelika Waiser, Andrea Steiner-Mezzadri, Luise Jennen, Nadin Hagendorf, and Saida Zoubaa for excellent technical help. M.B. has a LMU research fellowship. This work was supported by the Deutsche Forschungsgemeinschaft, including the Leibniz Award and SFB 870, Bundesministerium fur Bildung und Forschung, European Union, and the Helmholtz Association.	Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Berger J, 2004, GENESIS, V40, P195, DOI 10.1002/gene.20081; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bilasy SE, 2009, EUR J NEUROSCI, V29, P1994, DOI 10.1111/j.1460-9568.2009.06754.x; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Coleman JE, 2010, J NEUROSCI, V30, P9670, DOI 10.1523/JNEUROSCI.1248-10.2010; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Croquelois A, 2009, CEREB CORTEX, V19, P563, DOI 10.1093/cercor/bhn106; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fitzgerald MP, 2011, NEUROSCIENCE, V176, P455, DOI 10.1016/j.neuroscience.2010.12.003; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gotz M, 2003, NAT NEUROSCI, V6, P1245, DOI 10.1038/nn1203-1245; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Heng JIT, 2010, TRENDS NEUROSCI, V33, P38, DOI 10.1016/j.tins.2009.09.003; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kronenberg G, 2010, J NEUROSCI, V30, P3419, DOI 10.1523/JNEUROSCI.4231-09.2010; Lee KS, 1997, J NEUROSCI, V17, P6236; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Leone DP, 2010, DEV NEUROBIOL, V70, P659, DOI 10.1002/dneu.20804; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lodato S, 2011, NEURON, V69, P763, DOI 10.1016/j.neuron.2011.01.015; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Moers A, 2008, MOL CELL BIOL, V28, P1480, DOI 10.1128/MCB.00651-07; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Pinheiro EM, 2011, NAT CELL BIOL, V13, P989, DOI 10.1038/ncb2292; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Robertson SP, 2004, CLIN DYSMORPHOL, V13, P123, DOI 10.1097/01.mcd.0000130235.95356.40; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012	74	121	121	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					911	924		10.1016/j.neuron.2011.12.030	http://dx.doi.org/10.1016/j.neuron.2011.12.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405202	Bronze			2022-12-25	WOS:000301558600007
J	Shi, YC; Kirwan, P; Smith, J; Robinson, HPC; Livesey, FJ				Shi, Yichen; Kirwan, Peter; Smith, James; Robinson, Hugh P. C.; Livesey, Frederick J.			Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL NEURONOGENESIS; SUBVENTRICULAR ZONE; HUMAN ES; NEURONS; SPECIFICATION; SUBTYPE; DIFFERENTIATION; NEUROGENESIS; EVOLUTION; MODEL	Efforts to study the development and function of the human cerebral cortex in health and disease have been limited by the availability of model systems. Extrapolating from our understanding of rodent cortical development, we have developed a robust, multistep process for human cortical development from pluripotent stem cells: directed differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells to cortical stem and progenitor cells, followed by an extended period of cortical neurogenesis, neuronal terminal differentiation to acquire mature electrophysiological properties, and functional excitatory synaptic network formation. We found that induction of cortical neuroepithelial stem cells from human ES cells and human iPS cells was dependent on retinoid signaling. Furthermore, human ES cell and iPS cell differentiation to cerebral cortex recapitulated in vivo development to generate all classes of cortical projection neurons in a fixed temporal order. This system enables functional studies of human cerebral cortex development and the generation of individual-specific cortical networks ex vivo for disease modeling and therapeutic purposes.	[Shi, Yichen; Kirwan, Peter; Smith, James; Livesey, Frederick J.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Shi, Yichen; Kirwan, Peter; Smith, James; Livesey, Frederick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Robinson, Hugh P. C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Livesey, FJ (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	rick@gurdon.cam.ac.uk		Smith, James/0000-0001-9131-5849; Livesey, Rick/0000-0001-6128-3372; Robinson, Hugh/0000-0002-5048-9954; Kirwan, Peter/0000-0003-1446-7544	Biotechnology and Biological Sciences Research Council; University of Cambridge/Wellcome Trust; Wellcome Trust; Alzheimer's Research UK; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge/Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Vallier (Cambridge) and Y. Takashima for kindly providing human iPS cell lines and J. Nichols (Cambridge Centre for Stem Cell Research, Cambridge) for providing the Edi2 human ES cell line. We also thank the members of the Livesey laboratory for their contributions, comments and input to this research. Y. S. was supported by a Biotechnology and Biological Sciences Research Council Dorothy Hodgkin Studentship. P. K. was supported by the University of Cambridge/Wellcome Trust PhD Programme in Developmental Biology. This research benefits from core support to the Gurdon Institute from the Wellcome Trust and Cancer Research UK and grants to F. J. L. from the Wellcome Trust and Alzheimer's Research UK.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Au E, 2008, CELL STEM CELL, V3, P472, DOI 10.1016/j.stem.2008.10.013; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle V. B., 1998, CEREBRAL CORTEX; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; POLLEUX F, 2002, SCI STKE, V136, pPL9; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Takahashi T, 1996, J NEUROSCI, V16, P6183; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	46	534	552	10	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					477	U180		10.1038/nn.3041	http://dx.doi.org/10.1038/nn.3041			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22306606	Green Accepted			2022-12-25	WOS:000300793100023
J	Yao, J; Kwon, SE; Gaffaney, JD; Dunning, FM; Chapman, ER				Yao, Jun; Kwon, Sung E.; Gaffaney, Jon D.; Dunning, F. Mark; Chapman, Edwin R.			Uncoupling the roles of synaptotagmin I during endo- and exocytosis of synaptic vesicles	NATURE NEUROSCIENCE			English	Article							ENDOCYTIC SORTING ADAPTER; ADRENAL CHROMAFFIN CELLS; NEUROTRANSMITTER RELEASE; NERVE-TERMINALS; TRANSMITTER RELEASE; C2B DOMAIN; HIPPOCAMPAL-NEURONS; RAPID ENDOCYTOSIS; MEMBRANE-FUSION; CA2+ SENSOR	Synaptotagmin I (syt1) is required for normal rates of synaptic vesicle endo- and exocytosis. However, whether the kinetic defects observed during endocytosis in Syt1 knockout neurons are secondary to defective exocytosis or whether syt1 directly regulates the rate of vesicle retrieval remains unknown. To address this question, we sought to dissociate these two activities. We uncoupled the function of syt1 in exo- and endocytosis in mouse neurons either by re-targeting the protein or via mutagenesis of its tandem C2 domains. The effect of these manipulations on exo- and endocytosis were analyzed using electrophysiology, in conjunction with optical imaging of the vesicle cycle. Our results indicate that syt1 is directly involved in endocytosis. Notably, either of the C2 domains of syt1, C2A or C2B, was able to function as a Ca2+ sensor for endocytosis. Thus, syt1 functions as a dual Ca2+ sensor for both endo- and exocytosis, potentially coupling these two components of the vesicle cycle.	[Yao, Jun; Kwon, Sung E.; Gaffaney, Jon D.; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53715 USA; [Yao, Jun; Kwon, Sung E.; Gaffaney, Jon D.; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Madison, WI USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53715 USA.	chapman@wisc.edu		Chapman, Edwin/0000-0001-9787-8140; Yao, Jun/0000-0002-4916-3412	US National Institutes of Health [MH 61876]; American Heart Association [11POST5720016]; Epilepsy Foundation [09PRE2060819]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Hui for providing constructs used for the electrophysiology experiments shown in Figure 3. We also thank M.B. Jackson, X. Lou and members of the Chapman laboratory for their comments on this manuscript. This study was supported by a grant from the US National Institutes of Health (MH 61876). J.Y. is supported by an American Heart Association postdoctoral fellowship (11POST5720016). S.E.K. was supported by an Epilepsy Foundation predoctoral fellowship (09PRE2060819). E.R.C. is an Investigator of the Howard Hughes Medical Institute.	Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Clayton EL, 2007, J PHYSIOL-LONDON, V585, P687, DOI 10.1113/jphysiol.2007.137539; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kuromi H, 1997, NEUROSCI RES, V27, P101, DOI 10.1016/S0168-0102(96)01132-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	47	85	86	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					243	249		10.1038/nn.3013	http://dx.doi.org/10.1038/nn.3013			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22197832	Green Accepted			2022-12-25	WOS:000299603500015
J	Shigetomi, E; Tong, XP; Kwan, KY; Corey, DP; Khakh, BS				Shigetomi, Eiji; Tong, Xiaoping; Kwan, Kelvin Y.; Corey, David P.; Khakh, Baljit S.			TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3	NATURE NEUROSCIENCE			English	Article							GABA TRANSPORTERS; NEURAL ACTIVITY; GLIAL-CELLS; CA2+ ENTRY; ACTIVATION; RELEASE; MICE; CONTRIBUTES; EXCITATION; INDICATORS	Astrocytes contribute to the formation and function of synapses and are found throughout the brain, where they show intracellular store-mediated Ca(2+) signals. Here, using a membrane-tethered, genetically encoded calcium indicator (Lck-GCaMP3), we report the serendipitous discovery of a new type of Ca(2+) signal in rat hippocampal astrocyte-neuron cocultures. We found that Ca(2+) fluxes mediated by transient receptor potential A1 (TRPA1) channels gave rise to frequent and highly localized 'spotty' Ca(2+) microdomains near the membrane that contributed appreciably to resting Ca(2+) in astrocytes. Mechanistic evaluations in brain slices showed that decreases in astrocyte resting Ca(2+) concentrations mediated by TRPA1 channels decreased interneuron inhibitory synapse efficacy by reducing GABA transport by GAT-3, thus elevating extracellular GABA. Our data show how a transmembrane Ca(2+) source (TRPA1) targets a transporter (GAT-3) in astrocytes to regulate inhibitory synapses.	[Shigetomi, Eiji; Tong, Xiaoping; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Kwan, Kelvin Y.; Corey, David P.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu	SHIGETOMI, EIJI/I-2372-2012	Corey, David/0000-0003-4497-6016; Tong, Xiaoping/0000-0002-0908-8091; Kwan, Kelvin/0000-0002-8617-5543; Shigetomi, Eiji/0000-0002-5267-6155	US National Institutes of Health National Institute of Neurological Disorders and Stroke [NS060677]; Whitehall Foundation [NS071292, NS063186]; Stein-Oppenheimer Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071292, R01NS060677, R21NS063186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Whitehall Foundation; Stein-Oppenheimer Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors are indebted to T.J. O'Dell and M. V. Sofroniew for discussions during the course of these experiments. The authors are grateful to E. Toulme for assistance with western blots, to M. Hamby for tips on astrocyte-enriched cultures and to S. Kracun for molecular biology help and discussions. Thanks to M. Nedergaard for discussions during the early stages of this project. Special thanks to members of the Astrocyte Biology and Biophysics Affinity Group at UCLA for discussions. Thanks to A. Patapoutian (mouse TRPA1; The Scripps Research Institute), D. Julius (rat TRPA1; University of California San Francisco) and Y. Gwack (mCherry; University of California Los Angeles) for sharing plasmids. Thanks to N. Brecha (University of California Los Angeles) for GAT-1 and GAT-3 antibodies. Our work was supported mainly by US National Institutes of Health National Institute of Neurological Disorders and Stroke grant NS060677 and partly by grants NS071292 and NS063186, the Whitehall Foundation and a Stein-Oppenheimer Endowment Award (to B. S. K.).	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bomben VC, 2011, J CELL PHYSIOL, V226, P1879, DOI 10.1002/jcp.22518; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chiu CS, 2002, J NEUROSCI, V22, P10251; Clapham D. E., 2009, ENCY NEUROSCIENCE, P1109; Deken SL, 2003, J NEUROSCI, V23, P1563; Everaerts W, 2011, CURR BIOL, V21, P316, DOI 10.1016/j.cub.2011.01.031; Garcia-Anoveros J., 2007, V179, P347; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hill K, 2009, CELL CALCIUM, V45, P155, DOI 10.1016/j.ceca.2008.08.001; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moss FJ, 2009, J GEN PHYSIOL, V134, P489, DOI 10.1085/jgp.200910314; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Overstreet LS, 2000, J NEUROSCI, V20, P7914; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Shigetomi E, 2009, J VIS EXP, V26, P1142; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shirakawa H, 2010, J NEUROSCI, V30, P13116, DOI 10.1523/JNEUROSCI.1890-10.2010; Soeller C, 2004, PROG BIOPHYS MOL BIO, V85, P141, DOI 10.1016/j.pbiomolbio.2003.12.006; Song IS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1377; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	308	317	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					70	U215		10.1038/nn.3000	http://dx.doi.org/10.1038/nn.3000			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22158513	Green Accepted			2022-12-25	WOS:000298414400016
J	Sumioka, A; Brown, TE; Kato, AS; Bredt, DS; Kauer, JA; Tomita, S				Sumioka, Akio; Brown, Travis E.; Kato, Akihiko S.; Bredt, David S.; Kauer, Julie A.; Tomita, Susumu			PDZ binding of TARP gamma-8 controls synaptic transmission but not synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; TARP GAMMA-8; HIPPOCAMPAL; STARGAZIN; SURFACE; PSD-95	The reduction in synaptic transmission and plasticity in mice lacking the hippocampus-enriched AMPA receptor (AMPAR) auxiliary subunit TARP gamma-8 could be a result of a reduction in AMPAR expression or of the direct action of gamma-8. We generated TARP gamma-8 Delta 4 knock-in mice lacking the C-terminal PDZ ligand. We found that synaptic transmission and AMPARs were reduced in the mutant mice, but extrasynaptic AMPAR expression and long-term potentiation (LTP) were unaltered. Our findings suggest that there are distinct TARP-dependent mechanisms for synaptic transmission and LTP.	[Sumioka, Akio; Tomita, Susumu] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Sumioka, Akio; Tomita, Susumu] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Brown, Travis E.; Kauer, Julie A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Kato, Akihiko S.; Bredt, David S.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Yale University; Yale University; Brown University; Eli Lilly	Tomita, S (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA.	julie_kauer@brown.edu; susumu.tomita@yale.edu		Kauer, Julie/0000-0002-3362-1642	National Institute of Mental Health [MH077939]; US National Institutes of Health [NS050570, NS065251]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077939, R56MH077939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050570, R01NS065251] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Nicoll (University of California, San Francisco) for providing the gamma-8<SUP>-/-</SUP> mouse. The monoclonal antibody to SynDIG1 was developed by and/or obtained from the UC Davis/US National Institutes of Health NeuroMab. This work is supported by grants from the National Institute of Mental Health (MH077939 to S. T.) and from the US National Institutes of Health (NS050570 and NS065251 to J.A.K.).	Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Inamura M, 2006, NEUROSCI RES, V55, P45, DOI 10.1016/j.neures.2006.01.004; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Milstein AD, 2009, P NATL ACAD SCI USA, V106, P11348, DOI 10.1073/pnas.0905570106; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Stein V, 2003, J NEUROSCI, V23, P5503; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	14	51	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1410	1412		10.1038/nn.2952	http://dx.doi.org/10.1038/nn.2952			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22002768	Green Accepted			2022-12-25	WOS:000296518600014
J	Winkler, EA; Bell, RD; Zlokovic, BV				Winkler, Ethan A.; Bell, Robert D.; Zlokovic, Berislav V.			Central nervous system pericytes in health and disease	NATURE NEUROSCIENCE			English	Review							BLOOD-BRAIN-BARRIER; SMOOTH-MUSCLE-CELLS; PDGF BETA-RECEPTOR; ALZHEIMERS-DISEASE; DIABETIC-RETINOPATHY; TGF-BETA; BONE-MARROW; N-CADHERIN; ENDOTHELIAL SURVIVAL; FUNCTIONAL HYPEREMIA	Pericytes are uniquely positioned within the neurovascular unit to serve as vital integrators, coordinators and effectors of many neurovascular functions, including angiogenesis, blood-brain barrier (BBB) formation and maintenance, vascular stability and angioarchitecture, regulation of capillary blood flow and clearance of toxic cellular byproducts necessary for proper CNS homeostasis and neuronal function. New studies have revealed that pericyte deficiency in the CNS leads to BBB breakdown and brain hypoperfusion resulting in secondary neurodegenerative changes. Here we review recent progress in understanding the biology of CNS pericytes and their role in health and disease.	[Winkler, Ethan A.; Bell, Robert D.; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurol & Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA	University of Rochester	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Dept Neurol & Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu			US National Institutes of Health [R37 AG023084, R37 NS34467, HL63290]; Zilkha family; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zilkha family; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the US National Institutes of Health (grants R37 AG023084, R37 NS34467 and HL63290) and the Zilkha family for the research support.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Chen B, 2010, STROKE, V41, P2348, DOI 10.1161/STROKEAHA.110.584920; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; FLORES LD, 2009, HISTOL HISTOPATHOL, V24, P909; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kamouchi M, 2004, MOL BRAIN RES, V126, P114, DOI 10.1016/j.molbrainres.2004.03.008; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Kurz H, 2009, CELL ADHES MIGR, V3, P205, DOI 10.4161/cam.3.2.7855; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; Piquer-Gil M, 2009, J CEREBR BLOOD F MET, V29, P480, DOI 10.1038/jcbfm.2008.150; Quaegebeur A, 2010, NEURON, V68, P321, DOI 10.1016/j.neuron.2010.10.024; Regan JN, 2009, CIRC RES, V104, P419, DOI 10.1161/CIRCRESAHA.109.194233; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Sieczkiewicz GJ, 2003, MICROVASC RES, V66, P190, DOI 10.1016/S0026-2862(03)00055-4; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stenzel D, 2009, BLOOD, V114, P915, DOI 10.1182/blood-2008-10-186239; Stewart KS, 2011, BLOOD, V117, P719, DOI 10.1182/blood-2010-05-284869; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Van Geest RJ, 2010, INVEST OPHTH VIS SCI, V51, P1857, DOI 10.1167/iovs.09-4181; VERBEEK MM, 1995, J IMMUNOL, V154, P5876; VINTERS HV, 1994, ULTRASTRUCT PATHOL, V18, P333, DOI 10.3109/01913129409023202; Vinukonda G, 2010, STROKE, V41, P1766, DOI 10.1161/STROKEAHA.110.588400; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Wakui S, 2006, LAB INVEST, V86, P1172, DOI 10.1038/labinvest.3700476; Walshe TE, 2011, INVEST OPHTH VIS SCI, V52, P4472, DOI 10.1167/iovs.10-7061; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Winkler EA, 2011, DEV CELL, V20, P279, DOI 10.1016/j.devcel.2011.03.002; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	100	621	646	6	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1398	1405		10.1038/nn.2946	http://dx.doi.org/10.1038/nn.2946			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030551	Green Accepted			2022-12-25	WOS:000296518600012
J	Xu, NJ; Sun, SY; Gibson, JR; Henkemeyer, M				Xu, Nan-Jie; Sun, Suya; Gibson, Jay R.; Henkemeyer, Mark			A dual shaping mechanism for postsynaptic ephrin-B3 as a receptor that sculpts dendrites and synapses	NATURE NEUROSCIENCE			English	Article							REVERSE; EPHB; BINDING; SYNTENIN; SPINES; PICK1; GRB4; PHOSPHORYLATION; TRAFFICKING; MODULATION	As the neural network becomes wired, postsynaptic signaling molecules are thought to control the growth of dendrites and synapses. However, how these molecules are coordinated to sculpt postsynaptic structures is less well understood. We find that ephrin-B3, a transmembrane ligand for Eph receptors, functions postsynaptically as a receptor to transduce reverse signals into developing dendrites of mouse hippocampal neurons. Both tyrosine phosphorylation-dependent GRB4 SH2/SH3 adaptor-mediated signals and PSD-95-discs large-zona occludens-1 (PDZ) domain-dependent signals are required for inhibition of dendrite branching, whereas only PDZ interactions are necessary for spine formation and excitatory synaptic function. PICK1 and syntenin, two PDZ domain proteins, participate with ephrin-B3 in these postsynaptic activities. PICK1 has a specific role in spine and synapse formation, and syntenin promotes both dendrite pruning and synapse formation to build postsynaptic structures that are essential for neural circuits. The study thus dissects ephrin-B reverse signaling into three distinct intracellular pathways and protein-protein interactions that mediate the maturation of postsynaptic neurons.	[Xu, Nan-Jie; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Xu, Nan-Jie; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; [Sun, Suya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Gibson, Jay R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Henkemeyer, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	Mark.Henkemeyer@UTSouthwestern.edu	XU, Nan-Jie/AAJ-4363-2020; Xu, Nan-Jie/N-3391-2016	XU, Nan-Jie/0000-0003-2147-3352; Xu, Nan-Jie/0000-0003-2147-3352; Henkemeyer, Mark/0000-0002-7525-1061	US National Institutes of Health [R01 MH66332]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Sanes (Harvard University) for Thy1-GFP-M transgenic mice, G. Chenaux (University of Texas Southwestern Medical Center) for Efnb2<SUP>6F Delta V</SUP> mice, H. Zeng (Allen Institute for Brain Science) for CAGG-tdTomato transgenic mice, A. McMahon (Harvard University) for CAGG-Cre-ER (TM) transgenic mice, A. Bergemann (Mount Sinai Medical Center) for eB3 cDNA pEXPRmELF3, I. M. Ethell (University of California, Riverside) for HA-syndecan-2 plasmid, I. Bezprozvanny, B. Miller and A. Patel (University of Texas Southwestern) for electrophysiological recording setups and assistance with electrophysiology, and F. Sprouse (University of Texas Southwestern Medical Center) for genotyping. This research was supported by a US National Institutes of Health grant (R01 MH66332) to M. H.	Antion MD, 2010, MOL CELL NEUROSCI, V45, P378, DOI 10.1016/j.mcn.2010.07.011; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Bouzioukh F, 2007, J NEUROSCI, V27, P11279, DOI 10.1523/JNEUROSCI.3393-07.2007; Bush JO, 2009, GENE DEV, V23, P1586, DOI 10.1101/gad.1807209; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hirbec H, 2005, MOL CELL NEUROSCI, V28, P737, DOI 10.1016/j.mcn.2004.12.005; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McClelland AC, 2010, P NATL ACAD SCI USA, V107, P8830, DOI 10.1073/pnas.0910644107; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	50	56	61	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1421	U92		10.1038/nn.2931	http://dx.doi.org/10.1038/nn.2931			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21964490	Green Accepted			2022-12-25	WOS:000296518600018
J	Tian, XL; Li, J; Valakh, V; DiAntonio, A; Wu, CL				Tian, Xiaolin; Li, Jing; Valakh, Vera; DiAntonio, Aaron; Wu, Chunlai			Drosophila Rae1 controls the abundance of the ubiquitin ligase Highwire in post-mitotic neurons	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA STABILITY; MAP KINASE PATHWAY; C-ELEGANS RPM-1; SYNAPTIC GROWTH; WALLENDA/DLK KINASE; AXON REGENERATION; FORMATION REVEALS; MYC PAM; PROTEIN; COMPLEX	The evolutionarily conserved Highwire (Hiw)/Drosophila Fsn E3 ubiquitin ligase complex is required for normal synaptic morphology during development and axonal regeneration after injury. However, little is known about the molecular mechanisms that regulate the Hiw E3 ligase complex. Using tandem affinity purification techniques, we identified Drosophila Rae1 as a previously unknown component of the Hiw/Fsn complex. Loss of Rae1 function in neurons results in morphological defects at the neuromuscular junction that are similar to those seen in hiw mutants. We found that Rae1 physically and genetically interacts with Hiw and restrains synaptic terminal growth by regulating the MAP kinase kinase kinase Wallenda. Moreover, we found that the Rae1 is both necessary and sufficient to promote Hiw protein abundance, and it does so by binding to Hiw and protecting Hiw from autophagy-mediated degradation. These results describe a previously unknown mechanism that selectively controls Hiw protein abundance during synaptic development.	[Tian, Xiaolin; Li, Jing; Wu, Chunlai] Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA; [Valakh, Vera; DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Washington University (WUSTL)	Wu, CL (corresponding author), Louisiana State Univ, Neurosci Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA.	cwu@lsuhsc.edu		DiAntonio, Aaron/0000-0002-7262-0968	US National Institutes of Health [NS070962, DA020812]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are particularly grateful to D. Sitterlin for providing the antibody to Rae1. We would like to thank the A.J. Siteman Cancer Center at the Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, and the Department of Physiology at the Louisiana State University Health Sciences Center in New Orleans for the use of their proteomic core facilities. We are grateful to T. Neufeld and the Bloomington Stock Center for fly stocks, and the Developmental Studies Hybridoma Bank for antibodies. We also thank B. Grill and Y. Jin for helpful comments. This work is supported by grants from the US National Institutes of Health (NS070962 to C. W. and DA020812 to A.D.).	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Culican SM, 2009, MOL CELL NEUROSCI, V41, P304, DOI 10.1016/j.mcn.2009.04.001; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Garbarini N, 2008, CELL PHYSIOL BIOCHEM, V22, P31, DOI 10.1159/000149781; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kraemer D, 2001, EUR J CELL BIOL, V80, P733, DOI 10.1078/0171-9335-00216; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Sitterlin D, 2004, GENE, V326, P107, DOI 10.1016/j.gene.2003.10.024; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Uthaman SB, 2008, J NEUROSCI, V28, P8615, DOI 10.1523/JNEUROSCI.2990-08.2008; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	46	33	37	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1267	U193		10.1038/nn.2922	http://dx.doi.org/10.1038/nn.2922			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874015	Green Accepted			2022-12-25	WOS:000295254200015
J	Rosen, EY; Wexler, EM; Versano, R; Coppola, G; Gao, FY; Winden, KD; Oldham, MC; Martens, LH; Zhou, P; Farese, RV; Geschwind, DH				Rosen, Ezra Y.; Wexler, Eric M.; Versano, Revital; Coppola, Giovanni; Gao, Fuying; Winden, Kellen D.; Oldham, Michael C.; Martens, Lauren Herl; Zhou, Ping; Farese, Robert V., Jr.; Geschwind, Daniel H.			Functional Genomic Analyses Identify Pathways Dysregulated by Progranulin Deficiency, Implicating Wnt Signaling	NEURON			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GENE-EXPRESSION; PROTEIN; MUTATIONS; APOPTOSIS; DISEASE; TRANSCRIPTOME; ORGANIZATION; DYSFUNCTION; MODULATION	Progranulin (GRN) mutations cause frontotemporal dementia (FTD), but GRN's function in the CNS remains largely unknown. To identify the pathways downstream of GRN, we used weighted gene coexpression network analysis (WGCNA) to develop a systems-level view of transcriptional alterations in a human neural progenitor model of GRN-deficiency. This highlighted key pathways such as apoptosis and ubiquitination in GRN deficient human neurons, while revealing an unexpected major role for the Wnt signaling pathway, which was confirmed by analysis of gene expression data from postmortem FTD brain. Furthermore, we observed that the Wnt receptor Fzd2 was one of only a few genes upregulated at 6 weeks in a GRN knockout mouse, and that FZD2 reduction caused increased apoptosis, while its upregulation promoted neuronal survival in vitro. Together, these in vitro and in vivo data point to an adaptive role for altered Wnt signaling in GRN deficiency-mediated FTD, representing a potential therapeutic target.	[Rosen, Ezra Y.; Winden, Kellen D.; Geschwind, Daniel H.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Rosen, Ezra Y.; Wexler, Eric M.; Coppola, Giovanni; Winden, Kellen D.; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Rosen, Ezra Y.; Versano, Revital; Coppola, Giovanni; Gao, Fuying; Winden, Kellen D.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Wexler, Eric M.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Oldham, Michael C.] Univ Calif San Francisco, Dept Neurol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94158 USA; [Martens, Lauren Herl; Zhou, Ping; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94158 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA.	dhg@ucla.edu			Consortium for Frontotemporal Dementia (CFR); NIA [5R01AG026938]; NIH/NINDS [5T32NS048004-05]; John Douglas French Alzheimer's Foundation; NIMH [K08MH74362]; NIH [AG034793]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH074362, T32MH073526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026938, F31AG034793] Funding Source: NIH RePORTER	Consortium for Frontotemporal Dementia (CFR); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John Douglas French Alzheimer's Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Consortium for Frontotemporal Dementia (CFR). This work was supported by NIA 5R01AG026938 (D.H.G.), by NIH/NINDS Neurobehavioral Genetics Training Grant 5T32NS048004-05 (E.Y.R.), the John Douglas French Alzheimer's Foundation and NIMH K08MH74362 (E.M.W.), and by NIH AG034793 (L.H.M.). We are also grateful to Jeremy Miller for critical reading of this manuscript and we would like to thank Lauren Kawaguchi for her expertise as laboratory manager.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Behrens MI, 2009, CURR ALZHEIMER RES, V6, P196, DOI 10.2174/156720509788486608; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Chow TW, 1999, ARCH NEUROL-CHICAGO, V56, P817, DOI 10.1001/archneur.56.7.817; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Geschwind DH, 2001, AM J MED GENET, V101, P370; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guerra RR, 2007, GROWTH FACTORS, V25, P280, DOI 10.1080/08977190701781222; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V392, P495, DOI 10.1016/j.bbrc.2010.01.049; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Karsten SL, 2006, NEURON, V51, P549, DOI 10.1016/j.neuron.2006.07.019; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; MIMICS K, 2004, NAT NEUROSCI, V7, P434; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001136; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pickford F, 2011, AM J PATHOL, V178, P284, DOI 10.1016/j.ajpath.2010.11.002; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Rawal N, 2009, BIOCHEM BIOPH RES CO, V388, P473, DOI 10.1016/j.bbrc.2009.07.014; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	71	99	101	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1030	1042		10.1016/j.neuron.2011.07.021	http://dx.doi.org/10.1016/j.neuron.2011.07.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943601	Bronze, Green Accepted			2022-12-25	WOS:000295556500009
J	Kummer, MP; Hermes, M; Delekarte, A; Hammerschmidt, T; Kumar, S; Terwel, D; Walter, J; Pape, HC; Konig, S; Roeber, S; Jessen, F; Klockgether, T; Korte, M; Heneka, MT				Kummer, Markus P.; Hermes, Michael; Delekarte, Andrea; Hammerschmidt, Thea; Kumar, Sathish; Terwel, Dick; Walter, Jochen; Pape, Hans-Christian; Koenig, Simone; Roeber, Sigrun; Jessen, Frank; Klockgether, Thomas; Korte, Martin; Heneka, Michael T.			Nitration of Tyrosine 10 Critically Enhances Amyloid beta Aggregation and Plaque Formation	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; SELECTIVE INHIBITOR; RAT HIPPOCAMPUS; TRANSGENIC MICE; MOUSE MODEL; PROTEIN; BRAIN	Part of the inflammatory response in Alzheimer's disease (AD) is the upregulation of the inducible nitric oxide synthase (NOS2) resulting in increased NO production. NO contributes to cell signaling by inducing posttranslational protein modifications. Under pathological conditions there is a shift from the signal transducing actions to the formation of protein tyrosine nitration by secondary products like peroxynitrite and nitrogen dioxide. We identified amyloid beta (A beta) as an NO target, which is nitrated at tyrosine 10 (3NTyr(10)-A beta). Nitration of A beta accelerated its aggregation and was detected in the core of A beta plaques of APP/PS1 mice and AD brains. NOS2 deficiency or oral treatment with the NOS2 inhibitor L-NIL strongly decreased 3NTyr(10)-A beta, overall A beta deposition and cognitive dysfunction in APP/PS1 mice. Further, injection of 3NTyr(10)-A beta into the brain of young APP/PS1 mice induced beta-amyloidosis. This suggests a disease modifying role for NOS2 in AD and therefore represents a potential therapeutic target.	[Kummer, Markus P.; Hermes, Michael; Hammerschmidt, Thea; Terwel, Dick; Klockgether, Thomas; Heneka, Michael T.] Univ Bonn, Clin Neurosci Unit, Dept Neurol, D-53127 Bonn, Germany; [Delekarte, Andrea; Korte, Martin] TU Braunschweig, Div Cellular Neurobiol, Inst Zool, D-38106 Braunschweig, Germany; [Hammerschmidt, Thea; Pape, Hans-Christian] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Mol Neurol Grp, Dept Neurol, D-53127 Bonn, Germany; [Koenig, Simone] Interdisciplinary Ctr Clin Res Munster, D-48149 Munster, Germany; [Roeber, Sigrun] Univ Munich, Inst Neuropathol, D-81377 Munich, Germany; [Jessen, Frank] Univ Bonn, Dept Psychiat, D-53127 Bonn, Germany; [Jessen, Frank; Klockgether, Thomas; Heneka, Michael T.] German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany	University of Bonn; Braunschweig University of Technology; University of Munster; University of Bonn; University of Munster; University of Munich; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Heneka, MT (corresponding author), Univ Bonn, Clin Neurosci Unit, Dept Neurol, Siegmund Freud Str 25, D-53127 Bonn, Germany.	michael.heneka@ukb.uni-bonn.de	Kumar, Sathish/L-1367-2019; Walter, Jochen/B-3677-2014; Jessen, Frank/E-7655-2012; Jessen, Frank/AAK-6170-2020; Wang, Caihong/T-5837-2019; Heneka, Michael/AAE-8011-2019; König, Simone/B-6504-2008; Heneka, Michael/E-8072-2015	Wang, Caihong/0000-0002-6808-3709; König, Simone/0000-0003-0672-7246; Kummer, Markus P./0000-0002-0993-2918; Kumar, Sathish/0000-0002-2792-7047; Walter, Jochen/0000-0002-4678-2912; Heneka, Michael/0000-0003-4996-1630	Deutsche Forschungsgemeinschaft [HE 3350/4-1, HE 3350 4-2, KFO177, TP4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Drs. Mathias Jucker and Gary Landreth for critically reading the manuscript. We are grateful to Drs. Sascha Weggen and Claus Pietrzik for providing antibody IC16, Dr. Yoji Kato for providing antibody IC3, and to Claudia Hulsmann, Daisy Axt, Ana Viera-Saecker, and Anna-Maria Mehlich for excellent technical assistance. The E7 antibody developed by M. Klymkowsky was obtained from the Developmental Studies Hybridoma Bank. This study was supported by the Deutsche Forschungsgemeinschaft (HE 3350/4-1 und HE 3350 4-2; KFO177, TP4) to M.T.H. M.P.K. and M.T.H. conceived the experiments. M.P.K., M.H., M.T.H., A.D., T.H., S. Kumar, and S. Konig carried out experiments. M.P.K., M.H., A.D., S. Kumar, S. Konig, M.K., and M.T.H. designed and carried out data analysis. S.R. and F.J. provided and characterized human samples. M.P.K., S. Kumar, S. Konig, D.T., J.W., T.K., M.K., and M.T.H. cowrote the paper. All authors participated in the discussion.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Chen GQ, 1999, J NEUROSCI, V19, P7983; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; Colton CA, 2008, J ALZHEIMERS DIS, V15, P571; Combs CK, 2001, J NEUROSCI, V21, P1179; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Ferger B, 2001, J NEUROCHEM, V78, P509, DOI 10.1046/j.1471-4159.2001.00429.x; Fernandez-Vizarra P, 2004, NEUROBIOL DIS, V15, P287, DOI 10.1016/j.nbd.2003.10.010; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Heneka MT, 2001, J NEUROPATH EXP NEUR, V60, P906, DOI 10.1093/jnen/60.9.906; Hensley K, 1998, J NEUROSCI, V18, P8126; Horiguchi T, 2003, AM J PATHOL, V163, P1021, DOI 10.1016/S0002-9440(10)63462-1; Inestrosa NC, 2005, NEUROBIOL AGING, V26, P1023, DOI 10.1016/j.neurobiolaging.2004.09.016; Ishii K, 2000, FASEB J, V14, P1485, DOI 10.1096/fj.14.11.1485; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Jardanhazi-Kurutz D, 2010, NEUROCHEM INT, V57, P375, DOI 10.1016/j.neuint.2010.02.001; Kato Y, 2000, BIOCHEM BIOPH RES CO, V275, P11, DOI 10.1006/bbrc.2000.3265; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10686; Lee J, 2002, NEUROMOL MED, V2, P29; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Luth HJ, 2002, BRAIN RES, V953, P135, DOI 10.1016/S0006-8993(02)03280-8; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Nakamura T, 2009, APOPTOSIS, V14, P455, DOI 10.1007/s10495-008-0301-y; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; OLTON DS, 1987, PHYSIOL BEHAV, V40, P793, DOI 10.1016/0031-9384(87)90286-1; Petersson AS, 2001, J MASS SPECTROM, V36, P616, DOI 10.1002/jms.161; Poderoso JJ, 2009, ARCH BIOCHEM BIOPHYS, V484, P214, DOI 10.1016/j.abb.2008.12.020; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rebello S, 2002, AAPS PHARMSCI S1, V4; Rodrigo J, 2004, NEUROSCIENCE, V128, P73, DOI 10.1016/j.neuroscience.2004.06.030; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; Smith MA, 1997, J NEUROSCI, V17, P2653; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Tran MH, 2001, FASEB J, V15, P1407, DOI 10.1096/fj.00-0719fje; Vodovotz Y, 1996, J EXP MED, V184, P1425, DOI 10.1084/jem.184.4.1425; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008	57	224	228	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 8	2011	71	5					833	844		10.1016/j.neuron.2011.07.001	http://dx.doi.org/10.1016/j.neuron.2011.07.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903077	Bronze			2022-12-25	WOS:000294877900009
J	Gu, Y; Liu, S; Fetsch, CR; Yang, Y; Fok, S; Sunkara, A; DeAngelis, GC; Angelaki, DE				Gu, Yong; Liu, Sheng; Fetsch, Christopher R.; Yang, Yun; Fok, Sam; Sunkara, Adhira; DeAngelis, Gregory C.; Angelaki, Dora E.			Perceptual Learning Reduces Interneuronal Correlations in Macaque Visual Cortex	NEURON			English	Article							SUPERIOR TEMPORAL AREA; SELF-MOTION PERCEPTION; PURSUIT EYE-MOVEMENTS; ADULT OWL MONKEYS; HEADING PERCEPTION; CORTICAL AREA; NEURONAL CORRELATION; NOISE CORRELATIONS; POPULATION CODE; ATTENTION	Responses of neurons in early visual cortex change little with training and appear insufficient to account for perceptual learning. Behavioral performance, however, relies on population activity, and the accuracy of a population code is constrained by correlated noise among neurons. We tested whether training changes interneuronal correlations in the dorsal medial superior temporal area, which is involved in multisensory heading perception. Pairs of single units were recorded simultaneously in two groups of subjects: animals trained extensively in a heading discrimination task, and "naive" animals that performed a passive fixation task. Correlated noise was significantly weaker in trained versus naive animals, which might be expected to improve coding efficiency. However, we show that the observed uniform reduction in noise correlations leads to little change in population coding efficiency when all neurons are decoded. Thus, global changes in correlated noise among sensory neurons may be insufficient to account for perceptual learning.	[Gu, Yong; Liu, Sheng; Fetsch, Christopher R.; Yang, Yun; Fok, Sam; Sunkara, Adhira; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Washington University (WUSTL); University of Rochester	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu		Liu, Sheng/0000-0002-2497-8666; DeAngelis, Gregory/0000-0002-1635-1273	National Institutes of Health [EY019087, EY016178]; NATIONAL EYE INSTITUTE [R01EY016178, R01EY019087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from National Institutes of Health (EY019087 to D.E.A., and EY016178 to G.C.D.).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BACH M, 1986, EXP BRAIN RES, V61, P451; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bejjanki VR, 2011, NAT NEUROSCI, V14, P642, DOI 10.1038/nn.2796; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Chowdhury SA, 2008, NEURON, V60, P367, DOI 10.1016/j.neuron.2008.08.023; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; GU Y, 2008, SOC NEUR ABSTR; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Lee D, 1998, J NEUROSCI, V18, P1161; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; Wilke SD, 2002, NEURAL COMPUT, V14, P155, DOI 10.1162/089976602753284482; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Zhang T, 2011, J NEUROSCI, V31, P2569, DOI 10.1523/JNEUROSCI.5520-10.2011; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	64	143	145	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 25	2011	71	4					750	761		10.1016/j.neuron.2011.06.015	http://dx.doi.org/10.1016/j.neuron.2011.06.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867889	Bronze, Green Accepted			2022-12-25	WOS:000294521600018
J	Liu, BH; Li, YT; Ma, WP; Pan, CJ; Zhang, LI; Tao, HW				Liu, Bao-hua; Li, Ya-tang; Ma, Wen-pei; Pan, Chen-jie; Zhang, Li I.; Tao, Huizhong Whit			Broad Inhibition Sharpens Orientation Selectivity by Expanding Input Dynamic Range in Mouse Simple Cells	NEURON			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELD PROPERTIES; PRIMARY AUDITORY-CORTEX; CORTICAL SIMPLE CELLS; IN-VIVO; DIRECTION SELECTIVITY; SHUNTING INHIBITION; SYNAPTIC INTEGRATION; BALANCED INHIBITION; STRIATE CORTEX	Orientation selectivity (OS) is an emergent property in the primary visual cortex (V1). How OS arises from synaptic circuits remains unsolved. Here, in vivo whole-cell recordings in the mouse V1 revealed that simple cells received broadly tuned excitation and even more broadly tuned inhibition. Excitation and inhibition shared a similar orientation preference and temporally overlapped substantially. Neuron modeling and dynamic-clamp recording further revealed that excitatory inputs alone would result in membrane potential responses with significantly attenuated selectivity, due to a saturating input-output function of the membrane filtering. Inhibition ameliorated the attenuation of excitatory selectivity by expanding the input dynamic range and caused additional sharpening of output responses beyond unselectively suppressing responses at all orientations. This "blur-sharpening" effect allows selectivity conveyed by excitatory inputs to be better expressed, which may be a general mechanism underlying the generation of feature-selective responses in the face of strong excitatory inputs that are weakly biased.	[Liu, Bao-hua; Li, Ya-tang; Ma, Wen-pei; Pan, Chen-jie; Zhang, Li I.; Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Liu, Bao-hua; Li, Ya-tang; Pan, Chen-jie] Univ So Calif, Keck Sch Med, Grad Programs, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Tao, HW (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	htao@usc.edu	MA, WENPEI/M-7374-2013; Li, Ya-tang/AAF-2573-2020; Li, Ya-tang/A-9583-2011; Tao, Huizhong W/HDM-9767-2022	Li, Ya-tang/0000-0003-2763-1534; 	US National Institutes of Health [EY018718, EY019049]; National Institute of Health [DC008983, DC008588]; NATIONAL EYE INSTITUTE [R01EY019049, R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983, R21DC008588] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants to H.W.T. from the US National Institutes of Health (EY018718 and EY019049). L.I.Z. is a Searle Scholar and Packard Fellow and was also supported by the National Institute of Health (DC008983, DC008588).	Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2006, CURR OPIN NEUROBIOL, V16, P377, DOI 10.1016/j.conb.2006.06.014; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Murphy BK, 2003, J NEUROSCI, V23, P10040; Nagtegaal AP, 2010, J NEUROPHYSIOL, V104, P940, DOI 10.1152/jn.00264.2010; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2003, J NEUROPHYSIOL, V90, P342, DOI 10.1152/jn.01018.2002; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; Van Hooser SD, 2006, J NEUROSCI, V26, P7680, DOI 10.1523/JNEUROSCI.0108-06.2006; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	65	121	121	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 11	2011	71	3					542	554		10.1016/j.neuron.2011.06.017	http://dx.doi.org/10.1016/j.neuron.2011.06.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835349	Bronze, Green Accepted			2022-12-25	WOS:000293991700016
J	Saito, T; Suemoto, T; Brouwers, N; Sleegers, K; Funamoto, S; Mihira, N; Matsuba, Y; Yamada, K; Nilsson, P; Takano, J; Nishimura, M; Iwata, N; Van Broeckhoven, C; Ihara, Y; Saido, TC				Saito, Takashi; Suemoto, Takahiro; Brouwers, Nathalie; Sleegers, Kristel; Funamoto, Satoru; Mihira, Naomi; Matsuba, Yukio; Yamada, Kazuyuki; Nilsson, Per; Takano, Jiro; Nishimura, Masaki; Iwata, Nobuhisa; Van Broeckhoven, Christine; Ihara, Yasuo; Saido, Takaomi C.			Potent amyloidogenicity and pathogenicity of A beta 43	NATURE NEUROSCIENCE			English	Article							AMYLOID-BETA-PROTEIN; GAMMA-SECRETASE ACTIVITY; DISEASE-LIKE PATHOLOGY; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; SENILE PLAQUES; IN-VIVO; PRESENILIN MUTATIONS; TERMINAL FRAGMENT	The amyloid-beta peptide A beta 42 is known to be a primary amyloidogenic and pathogenic agent in Alzheimer's disease. However, the role of A beta 43, which is found just as frequently in the brains of affected individuals, remains unresolved. We generated knock-in mice containing a pathogenic presenilin-1 R278I mutation that causes overproduction of A beta 43. Homozygosity was embryonic lethal, indicating that the mutation involves a loss of function. Crossing amyloid precursor protein transgenic mice with heterozygous mutant mice resulted in elevated A beta 43, impairment of short-term memory and acceleration of amyloid-b pathology, which accompanied pronounced accumulation of A beta 43 in plaque cores similar in biochemical composition to those observed in the brains of affected individuals. Consistently, A beta 43 showed a higher propensity to aggregate and was more neurotoxic than A beta 42. Other pathogenic presenilin mutations also caused overproduction of A beta 43 in a manner correlating with A beta 42 and with the age of disease onset. These findings indicate that A beta 43, an overlooked species, is potently amyloidogenic, neurotoxic and abundant in vivo.	[Saito, Takashi; Suemoto, Takahiro; Mihira, Naomi; Matsuba, Yukio; Nilsson, Per; Takano, Jiro; Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan; [Brouwers, Nathalie; Sleegers, Kristel; Van Broeckhoven, Christine] Flanders Interunivers Inst Biotechnol, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [Brouwers, Nathalie; Sleegers, Kristel; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, B-2020 Antwerp, Belgium; [Funamoto, Satoru; Ihara, Yasuo] Doshisha Univ, Fac Life Sci, Kyoto 602, Japan; [Yamada, Kazuyuki] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Dept Mol Med Sci, Div Biotechnol, Grad Sch Biomed Sci, Nagasaki 852, Japan	RIKEN; University of Antwerp; Doshisha University; RIKEN; Shiga University of Medical Science; Nagasaki University	Saido, TC (corresponding author), RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saito, Takashi/G-2563-2015; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Saido, Takaomi C/N-5472-2015; Brouwers, Nathalie/L-2089-2014	Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Saido, Takaomi C/0000-0003-1970-6903; Brouwers, Nathalie/0000-0002-9808-9394	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan; TAKEDA Science Foundation; Fund for Scientific Research - Flanders (FWO-V); Belgian Federal Science Policy Office [P6/43]; Flemish Government; Grants-in-Aid for Scientific Research [22700379] Funding Source: KAKEN	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); TAKEDA Science Foundation(Takeda Science Foundation (TSF)); Fund for Scientific Research - Flanders (FWO-V)(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Flemish Government(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M.N. Rossor (University College London) for sharing clinical information about the R278I mutation carriers, J.Q. Trojanowski and V.M.-Y. Lee (University of Pennsylvania) for providing postmortem brain tissues, R. Kopan (Washington University) for providing Myc-tagged Delta Notch1 plasmid, A. Takashima (RIKEN Brain Science Institute) for providing antibody to Aph-1, and J. Hardy (University College London) for valuable discussions. This work was supported by research grants from RIKEN Brain Science Institute, the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare of Japan, the TAKEDA Science Foundation, the Fund for Scientific Research - Flanders (FWO-V), the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office and a Methusalem Excellence Grant of the Flemish Government to C.V.B. N.B receives a FWO-V postdoctoral fellowship.	Arango D, 2001, AM J MED GENET, V103, P138, DOI 10.1002/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Godbolt AK, 2004, NEUROLOGY, V63, P1702, DOI 10.1212/01.WNL.0000143060.98164.1A; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; IIZUKA T, 1995, BRAIN RES, V702, P275, DOI 10.1016/0006-8993(95)01163-2; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kaneko H, 2007, J NEUROSCI, V27, P13092, DOI 10.1523/JNEUROSCI.4244-07.2007; Keller L, 2010, EUR J HUM GENET, V18, P1202, DOI 10.1038/ejhg.2010.107; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kimura N, 2001, EXP ANIM TOKYO, V50, P77, DOI 10.1538/expanim.50.77; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Parvathy S, 2001, ARCH NEUROL-CHICAGO, V58, P2025, DOI 10.1001/archneur.58.12.2025; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Van Vickle GD, 2007, BIOCHEMISTRY-US, V46, P10317, DOI 10.1021/bi700951u; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	50	200	204	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1023	U120		10.1038/nn.2858	http://dx.doi.org/10.1038/nn.2858			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725313	Green Submitted			2022-12-25	WOS:000293123700016
J	Boyer, SW; Schroeder, AV; Smith-Berdan, S; Forsberg, EC				Boyer, Scott W.; Schroeder, Aaron V.; Smith-Berdan, Stephanie; Forsberg, E. Camilla			All Hematopoietic Cells Develop from Hematopoietic Stem Cells through Flk2/Flt3-Positive Progenitor Cells	CELL STEM CELL			English	Article							COMMON LYMPHOID PROGENITORS; MULTIPOTENT PROGENITORS; DENDRITIC CELLS; FLT3 LIGAND; HETEROGENEITY; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; PRECURSORS; STAGE	While it is clear that a single hematopoietic stem cell (HSC) is capable of giving rise to all other hematopoietic cell types, the differentiation paths beyond HSC remain controversial. Contradictory reports on the lineage potential of progenitor populations have questioned their physiological contribution of progenitor populations to multilineage differentiation. Here, we established a lineage tracing mouse model that enabled direct assessment of differentiation pathways in vivo. We provide definitive evidence that differentiation into all hematopoietic lineages, including megakaryocyte/erythroid cell types, involves Flk2-expressing non-self-renewing progenitors. A Flk2+ stage was used during steady-state hematopoiesis, after irradiation-induced stress and upon HSC transplantation. In contrast, HSC origin and maintenance do not include a Flk2+ stage. These data demonstrate that HSC specification and maintenance are Flk2 independent, and that hematopoietic lineage separation occurs downstream of Flk2 upregulation.	[Boyer, Scott W.; Forsberg, E. Camilla] Univ Calif Santa Cruz, Program Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Schroeder, Aaron V.; Smith-Berdan, Stephanie; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Forsberg, EC (corresponding author), Univ Calif Santa Cruz, Program Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	cforsber@ucsc.edu			California Institute for Regenerative Medicine (CIRM); CIRM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Bleul and Boehm for providing the Flk2-Cre mice. We thank Daniel Carlin, Joshua Stuart, and Abel Rodriguez for expert advice on statistical analyses, Holger Karsunky and Hanno Hock for comments on the manuscript, and Matthew Zimmer for animal care. This work was supported by a California Institute for Regenerative Medicine (CIRM) New Faculty Award to E.C.F and a CIRM Shared Stem Cell Facility award to UCSC. The authors declare no conflicts of interest.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Akashi K, 2009, ANN NY ACAD SCI, V1176, P18, DOI 10.1111/j.1749-6632.2009.04570.x; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Boiers C, 2010, BLOOD, V115, P5061, DOI 10.1182/blood-2009-12-258756; Ceredig R, 2009, NAT REV IMMUNOL, V9, P293, DOI 10.1038/nri2525; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Hock H, 2005, NATURE, V435, P573, DOI 10.1038/435573a; Hock H, 2010, J EXP MED, V207, P1127, DOI 10.1084/jem.20100950; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807	37	141	141	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					64	73		10.1016/j.stem.2011.04.021	http://dx.doi.org/10.1016/j.stem.2011.04.021			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726834	Green Accepted, Bronze			2022-12-25	WOS:000293157000010
J	Xu, HP; Furman, M; Mineur, YS; Chen, H; King, SL; Zenisek, D; Zhou, ZJ; Butts, DA; Tian, N; Picciotto, MR; Crair, MC				Xu, Hong-ping; Furman, Moran; Mineur, Yann S.; Chen, Hui; King, Sarah L.; Zenisek, David; Zhou, Z. Jimmy; Butts, Daniel A.; Tian, Ning; Picciotto, Marina R.; Crair, Michael C.			An Instructive Role for Patterned Spontaneous Retinal Activity in Mouse Visual Map Development	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; OCULAR DOMINANCE COLUMNS; EYE-SPECIFIC SEGREGATION; ACTIVITY-DEPENDENT REFINEMENT; LATERAL GENICULATE-NUCLEUS; MICE LACKING; BETA-2 SUBUNIT; RETINOGENICULATE PROJECTIONS; RETINOTOPIC MAP; SUPERIOR COLLICULUS	Complex neural circuits in the mammalian brain develop through a combination of genetic instruction and activity-dependent refinement. The relative role of these factors and the form of neuronal activity responsible for circuit development is a matter of significant debate. In the mammalian visual system, retinal ganglion cell projections to the brain are mapped with respect to retinotopic location and eye of origin. We manipulated the pattern of spontaneous retinal waves present during development without changing overall activity levels through the transgenic expression of beta 2-nicotinic acetylcholine receptors in retinal ganglion cells of mice. We used this manipulation to demonstrate that spontaneous retinal activity is not just permissive, but instructive in the emergence of eye-specific segregation and retinotopic refinement in the mouse visual system. This suggests that specific patterns of spontaneous activity throughout the developing brain are essential in the emergence of specific and distinct patterns of neuronal connectivity.	[Xu, Hong-ping; Furman, Moran; Tian, Ning; Picciotto, Marina R.; Crair, Michael C.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Mineur, Yann S.; King, Sarah L.; Picciotto, Marina R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Chen, Hui; Zenisek, David; Zhou, Z. Jimmy; Tian, Ning; Crair, Michael C.] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Zenisek, David; Zhou, Z. Jimmy] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Butts, Daniel A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Butts, Daniel A.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA	Yale University; Yale University; Yale University; Yale University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Xu, HP (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	hong-ping.xu@yale.edu; michael.crair@yale.edu	Zenisek, David/C-6555-2011; Picciotto, Marina R./F-8747-2012; Butts, Daniel A/B-8346-2008; Mineur, Yann/E-2487-2018; Chen, Hui/J-5907-2013	Picciotto, Marina R./0000-0002-4404-1280; Butts, Daniel A/0000-0002-0158-5317; Mineur, Yann/0000-0002-8030-6776; Chen, Hui/0000-0002-1560-8540; King, Sarah/0000-0002-7412-9558	NIH [P30 EY000785, R01 EY015788, R01 EY012345, R01 EY014990, R01 EY010894, EY017353]; RPB [R01 DA14241, DA10455]; family of William Ziegler III; NATIONAL EYE INSTITUTE [P30EY000785, R01EY014990, R01EY017353, R01EY012345, P30EY014800, R01EY015788, R01EY010894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014241, R01DA010455, R29DA010455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB(Research to Prevent Blindness (RPB)); family of William Ziegler III; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank members of the Crair lab for valuable comments on the manuscript, particularly Onkar Dhande and James Ackman, and Yueyi Zhang for technical help. This work was supported by NIH grant P30 EY000785 to M.C.C., D.Z., N.T., and Z.J.Z.; R01 EY015788 to M.C.C.; R01 EY012345 to N.T.; R01 EY014990 to D.Z.; R01 EY010894 and EY017353 to Z.J.Z.; an RPB Challenge Grant to the Department of Ophthalmology and Visual Science and R01 DA14241 and DA10455 to M.R.P. M.C.C. also thanks the family of William Ziegler III for their support.	Bansal A, 2000, J NEUROSCI, V20, P7672; BEKOFF A, 1975, P NATL ACAD SCI USA, V72, P1245, DOI 10.1073/pnas.72.4.1245; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Butts DA, 1999, J NEUROSCI, V19, P3580; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Carrillo RA, 2010, NEURON, V68, P32, DOI 10.1016/j.neuron.2010.09.005; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Cline H, 2003, TRENDS NEUROSCI, V26, P655, DOI 10.1016/j.tins.2003.10.005; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; King SL, 2003, J NEUROSCI, V23, P3837; Kumado T, 2009, DEV BIOL, V326, P237, DOI 10.1016/j.ydbio.2008.11.012; LUND RD, 1974, J COMP NEUROL, V158, P383, DOI 10.1002/cne.901580403; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Mukhin AG, 2000, MOL PHARMACOL, V57, P642, DOI 10.1124/mol.57.3.642; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Plas DT, 2005, J COMP NEUROL, V491, P305, DOI 10.1002/cne.20694; Rebsam A, 2009, J NEUROSCI, V29, P14855, DOI 10.1523/JNEUROSCI.3462-09.2009; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang LP, 2009, J NEUROSCI, V29, P12909, DOI 10.1523/JNEUROSCI.2128-09.2009; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Xu HP, 2010, NEURON, V65, P503, DOI 10.1016/j.neuron.2010.01.035; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644	62	129	130	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1115	1127		10.1016/j.neuron.2011.04.028	http://dx.doi.org/10.1016/j.neuron.2011.04.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689598	Green Accepted, Bronze			2022-12-25	WOS:000292410700010
J	Min, R; Nevian, T				Min, Rogier; Nevian, Thomas			Astrocyte signaling controls spike timing-dependent depression at neocortical synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT SOMATOSENSORY CORTEX; SYNAPTIC-TRANSMISSION; D-SERINE; NEUROTRANSMITTER RELEASE; INHIBITORY SYNAPSES; PRESYNAPTIC NMDA; PYRAMIDAL CELLS; GLIAL-CELLS; PLASTICITY	Endocannabinoid mediated spike timing dependent depression (t-LTD) is crucially involved in the development of the sensory neocortex. t-LTD at excitatory synapses in the developing rat barrel cortex requires cannabinoid CBI receptor (CB1R) activation, as well as activation of NMDA receptors located on the presynaptic terminal, but the exact signaling cascade leading to t-LTD remains unclear. We found that astrocytes are critically involved in t-LTD. Astrocytes gradually increased their Ca2+ signaling specifically during the induction of t-LTD in a CB1R-dependent manner. In this way, astrocytes might act as a memory buffer for previous coincident neuronal activity. Following activation, astrocytes released glutamate, which activated presynaptic NMDA receptors to induce t-LTD. Astrocyte stimulation coincident with afferent activity resulted in long-term depression, indicating that astrocyte activation is sufficient for the induction of synaptic depression. Taken together, our findings describe the retrograde signaling cascade underlying neocortical t-LTD. The critical involvement of astrocytes in this process highlights their importance for experience-dependent sensory remodeling.	[Min, Rogier; Nevian, Thomas] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland	University of Bern	Nevian, T (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	nevian@pyl.unibe.ch	Min, Rogier/C-7137-2012	Min, Rogier/0000-0002-3574-7599; Nevian, Thomas/0000-0001-9804-608X	Swiss National Science Foundation [3100A0-118395]; Berne University Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Berne University Research Foundation	We thank A. Volterra, H.D. Mansvelder, H.-R. Luscher, M. Santello, L.M. Palmer and E. Perez-Garci for their comments on the manuscript. This work was supported by the Swiss National Science Foundation (T.N., grant 3100A0-118395) and an Equipment grant of the Berne University Research Foundation.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heifets BD, 2008, P NATL ACAD SCI USA, V105, P10250, DOI 10.1073/pnas.0711880105; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kakegawa W, 2011, NAT NEUROSCI, V14, P603, DOI 10.1038/nn.2791; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Li L, 2009, NEURON, V64, P537, DOI 10.1016/j.neuron.2009.10.005; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Tsetsenis T, 2011, P NATL ACAD SCI USA, V108, P14300, DOI 10.1073/pnas.1112237108; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Zilberter M, 2009, CEREB CORTEX, V19, P2308, DOI 10.1093/cercor/bhn247	50	235	236	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					746	753		10.1038/nn.3075	http://dx.doi.org/10.1038/nn.3075			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446881				2022-12-25	WOS:000303270200019
J	Ronesi, JA; Collins, KA; Hays, SA; Tsai, NP; Guo, WR; Birnbaum, SG; Hu, JH; Worley, PF; Gibson, JR; Huber, KM				Ronesi, Jennifer A.; Collins, Katie A.; Hays, Seth A.; Tsai, Nien-Pei; Guo, Weirui; Birnbaum, Shari G.; Hu, Jia-Hua; Worley, Paul F.; Gibson, Jay R.; Huber, Kimberly M.			Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; PROTEIN-SYNTHESIS; SELECT BEHAVIORS; MESSENGER-RNAS; TRANSLATION; PHOSPHORYLATION; ACTIVATION; INHIBITION; MECHANISMS	Enhanced metabotropic glutamate receptor subunit 5 (mGluR5) function is causally associated with the pathophysiology of fragile X syndrome, a leading inherited cause of intellectual disability and autism. Here we provide evidence that altered mGluR5-Homer scaffolds contribute to mGluR5 dysfunction and phenotypes in the fragile X syndrome mouse model, Fmr1 knockout (Fmr1(-/y)). In Fmr1(-/y) mice, mGluR5 was less associated with long Homer isoforms but more associated with the short Homer1a. Genetic deletion of Homer1a restored mGluR5-long Homer scaffolds and corrected several phenotypes in Fmr1(-/y) mice, including altered mGluR5 signaling, neocortical circuit dysfunction and behavior. Acute, peptide-mediated disruption of mGluR5-Homer scaffolds in wild-type mice mimicked many Fmr1(-/y) phenotypes. In contrast, Homer1a deletion did not rescue altered mGluR-dependent long-term synaptic depression or translational control of target mRNAs of fragile X mental retardation protein, the gene product of Fmr1. Our findings reveal new functions for mGluR5-Homer interactions in the brain and delineate distinct mechanisms of mGluR5 dysfunction in a mouse model of cognitive dysfunction and autism.	[Ronesi, Jennifer A.; Collins, Katie A.; Hays, Seth A.; Tsai, Nien-Pei; Guo, Weirui; Gibson, Jay R.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Birnbaum, Shari G.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Hu, Jia-Hua; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Guo, Weirui/G-2868-2015; Huber, Kimberly/X-5534-2019; Hays, Seth/U-4701-2019	Hays, Seth/0000-0003-4225-241X	US National Institutes of Health [NS045711, HD052731, HD056370, GM008203]; Autism Speaks; FRAXA Research Foundation; The Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731, R01HD056370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; FRAXA Research Foundation; The Hartwell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank L. Ormazabal and N. Cabalo for technical assistance. This research was supported by the grants from the US National Institutes of Health NS045711, HD052731 (K.M.H.), HD056370 (J.R.G.), GM008203 (S.A.H.), Autism Speaks (K.M.H.), FRAXA Research Foundation and The Hartwell Foundation (J.A.R.).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; BAKKER CE, 1994, CELL, V78, P23; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Liu ZH, 2009, NEUROSCI LETT, V454, P62, DOI 10.1016/j.neulet.2009.02.066; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mackiewicz M, 2008, PHYSIOL GENOMICS, V33, P91, DOI 10.1152/physiolgenomics.00189.2007; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Orlando LR, 2009, J NEUROCHEM, V110, P557, DOI 10.1111/j.1471-4159.2009.06139.x; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Potschka H, 2002, EUR J NEUROSCI, V16, P2157, DOI 10.1046/j.1460-9568.2002.02265.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Ronesi JA, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.15pe6; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Thomas AM, 2012, PSYCHOPHARMACOLOGY, V219, P47, DOI 10.1007/s00213-011-2375-4; Thomas AM, 2011, BEHAV BRAIN RES, V223, P310, DOI 10.1016/j.bbr.2011.04.049; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	50	188	189	6	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					431	U122		10.1038/nn.3033	http://dx.doi.org/10.1038/nn.3033			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267161	Green Accepted			2022-12-25	WOS:000300793100017
J	Weng, QJ; Chen, Y; Wang, HB; Xu, XM; Yang, B; He, QJ; Shou, WN; Chen, Y; Higashi, Y; van den Berghe, V; Seuntjens, E; Kernie, SG; Bukshpun, P; Sherr, EH; Huylebroeck, D; Lu, QR				Weng, Qinjie; Chen, Ying; Wang, Haibo; Xu, Xiaomei; Yang, Bo; He, Qiaojun; Shou, Weinian; Chen, Yan; Higashi, Yujiro; van den Berghe, Veronique; Seuntjens, Eve; Kernie, Steven G.; Bukshpun, Polina; Sherr, Elliott H.; Huylebroeck, Danny; Lu, Q. Richard			Dual-Mode Modulation of Smad Signaling by Smad-Interacting Protein Sip1 Is Required for Myelination in the Central Nervous System	NEURON			English	Article							BONE MORPHOGENETIC PROTEIN; MOWAT-WILSON-SYNDROME; OLIGODENDROCYTE PRECURSOR CELLS; MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTORS; BETA-CATENIN; DEMYELINATED LESIONS; CNS MYELINATION; IN-VITRO; DIFFERENTIATION	Myelination by oligodendrocytes in the central nervous system (CNS) is essential for proper brain function, yet the molecular determinants that control this process remain poorly understood. The basic helix-loop-helix transcription factors Olig1 and Olig2 promote myelination, whereas bone morphogenetic protein (BMP) and Wnt/beta-catenin signaling inhibit myelination. Here we show that these opposing regulators of myelination are functionally linked by the Olig1/2 common target Smad-interacting protein-1 (Sip1). We demonstrate that Sip1 is an essential modulator of CNS myelination. Sip1 represses differentiation inhibitory signals by antagonizing BMP receptor-activated Smad activity while activating crucial oligodendrocyte-promoting factors. Importantly, a key Sip1-activated target, Smad7, is required for oligodendrocyte differentiation and partially rescues differentiation defects caused by Sip1 loss. Smad7 promotes myelination by blocking the BMP-and beta-catenin-negative regulatory pathways. Thus, our findings reveal that Sip1-mediated antagonism of inhibitory signaling is critical for promoting CNS myelination and point to new mediators for myelin repair.	[Weng, Qinjie; Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Weng, Qinjie; Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Weng, Qinjie; Yang, Bo; He, Qiaojun] Zhejiang Univ, Lab Tumor & Endocrine Pharmacol, Inst Pharmacol & Toxicol & Biochem Pharmaceut, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Shou, Weinian] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Chen, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Higashi, Yujiro] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi 4800392, Japan; [van den Berghe, Veronique; Seuntjens, Eve; Huylebroeck, Danny] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Biol Celgen, B-3000 Louvain, Belgium; [van den Berghe, Veronique; Seuntjens, Eve; Huylebroeck, Danny] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bukshpun, Polina; Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Zhejiang University; Indiana University System; Indiana University Bloomington; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; KU Leuven; Flanders Institute for Biotechnology (VIB); Columbia University; Columbia University; University of California System; University of California San Francisco	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	Seuntjens, Eve/AAM-2478-2021; Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Seuntjens, Eve/0000-0002-0126-461X; van den Berghe, Veronique/0000-0001-8787-4365; Huylebroeck, Danny/0000-0003-4862-1079	National Institutes of Health [R01NS072427]; National Multiple Sclerosis Society [RG3978]; Research Council of Katholieke Universiteit Leuven [OT-09/053, GOA-11/012]; FWO-V [G.0954.11N]; Queen Elisabeth Medical Foundation [GSKE 1113]; Interuniversity Attraction Poles (IUAP) [6/20]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Research Council of Katholieke Universiteit Leuven(KU Leuven); FWO-V(FWO); Queen Elisabeth Medical Foundation; Interuniversity Attraction Poles (IUAP)(Belgian Federal Science Policy Office); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Y. Yu, A. Nishiyama, B. Kim, W. Liu, L. Liu, C. Shen, Melinda K. Duncan, and A. Francis and A. Conidi for technical support. We thank C. Stiles, J. Svaren, S. Yoon, E. Olson, J. Johnson, J. Li, E. Hurlock, N. Ma, and O. Barca-Mayo for critical comments and suggestions. This study was funded in part by grants from the National Institutes of Health (R01NS072427) and the National Multiple Sclerosis Society (RG3978) (to Q.R.L.) and the Research Council of Katholieke Universiteit Leuven (OT-09/053 and GOA-11/012), FWO-V (G.0954.11N to D.H. and E.S.), the Queen Elisabeth Medical Foundation (GSKE 1113) and Interuniversity Attraction Poles (IUAP 6/20), and the type 3 large-infrastructure support InfraMouse by the Hercules Foundation (to D.H.).	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; Garavelli L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-42; Goossens S, 2011, BLOOD, V117, P5620, DOI 10.1182/blood-2010-08-300236; Hall AK, 2004, J NEUROSCI RES, V76, P1, DOI 10.1002/jnr.20019; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Howng SYB, 2010, GENE DEV, V24, P301, DOI 10.1101/gad.1864510; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kadi L, 2006, J NEUROIMMUNOL, V174, P133, DOI 10.1016/j.jneuroim.2006.01.011; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mar S, 2010, PEDIATR NEUROL, V42, P239, DOI 10.1016/j.pediatrneurol.2009.08.011; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Millar SE, 2006, DEV CELL, V11, P274, DOI 10.1016/j.devcel.2006.08.008; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Moal FDL, 2007, HUM MUTAT, V28, P313, DOI 10.1002/humu.20452; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; Ogata T, 2011, NEUROSCIENCE, V176, P132, DOI 10.1016/j.neuroscience.2010.12.015; Pearson KL, 1999, BBA-GENE STRUCT EXPR, V1489, P354, DOI 10.1016/S0167-4781(99)00166-9; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Sabo JK, 2011, J NEUROSCI, V31, P4504, DOI 10.1523/JNEUROSCI.5859-10.2011; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Samanta J, 2007, J NEUROSCI, V27, P7397, DOI 10.1523/JNEUROSCI.1434-07.2007; Schell-Apacik CC, 2008, AM J MED GENET A, V146A, P2501, DOI 10.1002/ajmg.a.32476; See J, 2004, MOL CELL NEUROSCI, V26, P481, DOI 10.1016/j.mcn.2004.04.004; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Sztriha L, 2003, NEUROPEDIATRICS, V34, P322; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van Grunsven LA, 2007, DEV BIOL, V306, P34, DOI 10.1016/j.ydbio.2007.02.045; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Verstappen G, 2008, HUM MOL GENET, V17, P1175, DOI 10.1093/hmg/ddn007; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; Wu YY, 2003, DEV DYNAM, V226, P675, DOI 10.1002/dvdy.10278; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zalc B, 2000, SCIENCE, V288, P271; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zweier C, 2005, EUR J MED GENET, V48, P97, DOI 10.1016/j.ejmg.2005.01.003	63	130	136	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					713	728		10.1016/j.neuron.2011.12.021	http://dx.doi.org/10.1016/j.neuron.2011.12.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365546	Green Accepted, Bronze			2022-12-25	WOS:000300815400011
J	Heidenreich, M; Lechner, SG; Vardanyan, V; Wetzel, C; Cremers, CW; De Leenheer, EM; Aranguez, G; Moreno-Pelayo, MA; Jentsch, TJ; Lewin, GR				Heidenreich, Matthias; Lechner, Stefan G.; Vardanyan, Vitya; Wetzel, Christiane; Cremers, Cor W.; De Leenheer, Els M.; Aranguez, Gracia; Angel Moreno-Pelayo, Miguel; Jentsch, Thomas J.; Lewin, Gary R.			KCNQ4 K+ channels tune mechanoreceptors for normal touch sensation in mouse and man	NATURE NEUROSCIENCE			English	Article							RAPIDLY ADAPTING MECHANORECEPTORS; STIMULUS-RESPONSE FUNCTIONS; GLABROUS SKIN AREA; OUTER HAIR-CELLS; SENSORY NEURONS; POTASSIUM CHANNELS; DOMINANT DEAFNESS; MAMMALIAN-CELLS; AFFERENTS; CURRENTS	Mutations inactivating the potassium channel KCNQ4 (K(v)7.4) lead to deafness in humans and mice. In addition to its expression in mechanosensitive hair cells of the inner ear, KCNQ4 is found in the auditory pathway and in trigeminal nuclei that convey somatosensory information. We have now detected KCNQ4 in the peripheral nerve endings of cutaneous rapidly adapting hair follicle and Meissner corpuscle mechanoreceptors from mice and humans. Electrophysiological recordings from single afferents from Kcnq4(-/-) mice and mice carrying a KCNQ4 mutation found in DFNA2-type monogenic dominant human hearing loss showed elevated mechanosensitivity and altered frequency response of rapidly adapting, but not of slowly adapting nor of D-hair, mechanoreceptor neurons. Human subjects from independent DFNA2 pedigrees outperformed age-matched control subjects when tested for vibrotactile acuity at low frequencies. This work describes a gene mutation that modulates touch sensitivity in mice and humans and establishes KCNQ4 as a specific molecular marker for rapidly adapting Meissner and a subset of hair follicle afferents.	[Heidenreich, Matthias; Vardanyan, Vitya; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Heidenreich, Matthias; Lechner, Stefan G.; Vardanyan, Vitya; Wetzel, Christiane; Jentsch, Thomas J.; Lewin, Gary R.] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Cremers, Cor W.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [De Leenheer, Els M.] Ghent Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ghent, Belgium; [De Leenheer, Els M.] Univ Ghent, B-9000 Ghent, Belgium; [Aranguez, Gracia] Hosp Gen Univ Gregorio Maranon, Serv Otorrinolaringol, Madrid, Spain; [Angel Moreno-Pelayo, Miguel] Hosp Ramon & Cajal, IRYCIS, CIBERER, Unidad Genet Mol, E-28034 Madrid, Spain; [Jentsch, Thomas J.; Lewin, Gary R.] Charite, D-13353 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Radboud University Nijmegen; Ghent University; Ghent University Hospital; Ghent University; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Ramon y Cajal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	jentsch@fmp-berlin.de; glewin@mdc-berlin.de	De Leenheer, Els/AGB-3503-2022; Lewin, Gary R/B-8028-2011; Cremers, C.W.R.J./L-4254-2015	De Leenheer, Els/0000-0002-2789-3529; Jentsch, Thomas/0000-0002-3509-2553; Lewin, Gary/0000-0002-2890-6352; Lechner, Stefan/0000-0001-9402-9127; Wetzel, Christiane/0000-0003-0587-8018; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098	Leibniz Gemeinschaft; Prix Louis-Jeantet de Medecine; Ernst-Jung Preis fur Medizin; Deutsche Forschungsgemeinschaft (DFG) [SFB665]; DFG [Exc 257 NeuroCure]	Leibniz Gemeinschaft; Prix Louis-Jeantet de Medecine; Ernst-Jung Preis fur Medizin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank P. Seidler and H. Thraenhardt for technical assistance, the DFNA2 families for their collaboration, C. Birchmeier (MDC Berlin) for the MafA antibody, M. Maurer (Charite Berlin) for human skin biopsies and B. Purfuerst for electron microscopy. Supported by an SAW (Senatsausschuss Wettbewerb) grant of the Leibniz Gemeinschaft to T.J.J. and G. R. L., the Prix Louis-Jeantet de Medecine and the Ernst-Jung Preis fur Medizin to T.J.J. and grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB665) to G. R. L.; additional funding (T.J.J. and G. R. L.) was provided by the DFG (Exc 257 NeuroCure).	Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Bensmaia SJ, 2008, J NEUROSCI, V28, P776, DOI 10.1523/JNEUROSCI.4162-07.2008; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blake DT, 1997, J NEUROSCI, V17, P7480; BOLANOWSKI SJ, 1984, J NEUROPHYSIOL, V51, P793, DOI 10.1152/jn.1984.51.4.793; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; DARIANSMITH I, 1980, J PHYSIOL-LONDON, V309, P135, DOI 10.1113/jphysiol.1980.sp013499; De Leenheer EMR, 2002, ANN OTO RHINOL LARYN, V111, P267, DOI 10.1177/000348940211100312; French AS, 2004, CAN J PHYSIOL PHARM, V82, P541, DOI 10.1139/Y04-031; Hammami S, 2009, J PHYSIOL-LONDON, V587, P2225, DOI 10.1113/jphysiol.2008.163550; Hu J, 2010, EMBO J, V29, P855, DOI 10.1038/emboj.2009.398; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; KNIBESTO.M, 1973, J PHYSIOL-LONDON, V232, P427, DOI 10.1113/jphysiol.1973.sp010279; KNIBESTOL M, 1975, J PHYSIOL-LONDON, V245, P63, DOI 10.1113/jphysiol.1975.sp010835; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lechner SG, 2003, J PHYSIOL-LONDON, V553, P789, DOI 10.1113/jphysiol.2003.052449; Lechner SG, 2009, J PHYSIOL-LONDON, V587, P3493, DOI 10.1113/jphysiol.2009.175059; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; LOEWENSTEIN WR, 1958, J GEN PHYSIOL, V41, P1245, DOI 10.1085/jgp.41.6.1245; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Milenkovic N, 2008, J NEUROPHYSIOL, V100, P2771, DOI 10.1152/jn.90799.2008; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Sogaard R, 2001, AM J PHYSIOL-CELL PH, V280, pC859; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Trulsson M, 2010, J NEUROPHYSIOL, V103, P1741, DOI 10.1152/jn.01146.2009; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; VALLBO AB, 1995, J PHYSIOL-LONDON, V483, P783, DOI 10.1113/jphysiol.1995.sp020622; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284	50	73	77	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					138	U217		10.1038/nn.2985	http://dx.doi.org/10.1038/nn.2985			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101641				2022-12-25	WOS:000298414400024
J	Croxson, PL; Kyriazis, DA; Baxter, MG				Croxson, Paula L.; Kyriazis, Diana A.; Baxter, Mark G.			Cholinergic modulation of a specific memory function of prefrontal cortex	NATURE NEUROSCIENCE			English	Article							PERSISTENT ACTIVITY; ALZHEIMERS-DISEASE; ATTENTION; LESIONS	Deficits in prefrontal cholinergic function are implicated in cognitive impairment in many neuropsychiatric diseases, but acetylcholine's specific role remains elusive. Rhesus monkeys with selective lesions of cholinergic input to prefrontal cortex (PFC) were unimpaired in tests of decision making and episodic memory that require intact PFC, but were severely impaired on a spatial working memory task. These observations are consistent with a specific role for prefrontal acetylcholine in working memory.	[Croxson, Paula L.; Baxter, Mark G.] Mt Sinai Sch Med, Dept Neurosci, Glickenhaus Lab Neuropsychol, New York, NY 10029 USA; [Croxson, Paula L.; Baxter, Mark G.] Mt Sinai Sch Med, Dept Neurosci, Friedman Brain Inst, New York, NY USA; [Croxson, Paula L.; Kyriazis, Diana A.; Baxter, Mark G.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford	Baxter, MG (corresponding author), Mt Sinai Sch Med, Dept Neurosci, Glickenhaus Lab Neuropsychol, New York, NY 10029 USA.	mark.baxter@mssm.edu		Croxson, Paula/0000-0002-4649-980X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank D. Gaffan for advice and support, and C. Bergmann, G. Daubney, C. Rae and K. Murphy for technical assistance. This research was supported by a grant from the Wellcome Trust (M.G.B.).	BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; Bartus RT, 2009, PSYCHOPHARMACOLOGY, V202, P15, DOI 10.1007/s00213-008-1365-7; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; Baxter MG, 1996, BEHAV NEUROSCI, V110, P898, DOI 10.1037/0735-7044.110.5.898; BIERER LM, 1995, J NEUROCHEM, V64, P749; Browning PGF, 2010, CEREB CORTEX, V20, P282, DOI 10.1093/cercor/bhp097; Chudasama Y, 2004, LEARN MEMORY, V11, P78, DOI 10.1101/lm.70904; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Johnson JK, 1999, ARCH NEUROL-CHICAGO, V56, P1233, DOI 10.1001/archneur.56.10.1233; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Schon K, 2005, J NEUROSCI, V25, P9112, DOI 10.1523/JNEUROSCI.1982-05.2005; Turchi J, 2005, P NATL ACAD SCI USA, V102, P2158, DOI 10.1073/pnas.0409708102; Wilson CRE, 2010, TRENDS NEUROSCI, V33, P533, DOI 10.1016/j.tins.2010.08.001	15	101	104	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1510	1512		10.1038/nn.2971	http://dx.doi.org/10.1038/nn.2971			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057191	Green Accepted			2022-12-25	WOS:000297546300008
J	DeJesus-Hernandez, M; Mackenzie, IR; Boeve, BF; Boxer, AL; Baker, M; Rutherford, NJ; Nicholson, AM; Finch, NA; Flynn, H; Adamson, J; Kouri, N; Wojtas, A; Sengdy, P; Hsiung, GYR; Karydas, A; Seeley, WW; Josephs, KA; Coppola, G; Geschwind, DH; Wszolek, ZK; Feldman, H; Knopman, DS; Petersen, RC; Miller, BL; Dickson, DW; Boylan, KB; Graff-Radford, NR; Rademakers, R				DeJesus-Hernandez, Mariely; Mackenzie, Ian R.; Boeve, Bradley F.; Boxer, Adam L.; Baker, Matt; Rutherford, Nicola J.; Nicholson, Alexandra M.; Finch, NiCole A.; Flynn, Heather; Adamson, Jennifer; Kouri, Naomi; Wojtas, Aleksandra; Sengdy, Pheth; Hsiung, Ging-Yuek R.; Karydas, Anna; Seeley, William W.; Josephs, Keith A.; Coppola, Giovanni; Geschwind, Daniel H.; Wszolek, Zbigniew K.; Feldman, Howard; Knopman, David S.; Petersen, Ronald C.; Miller, Bruce L.; Dickson, Dennis W.; Boylan, Kevin B.; Graff-Radford, Neill R.; Rademakers, Rosa			Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; EXONIC SPLICING ENHANCERS; MOTOR-NEURON DISEASE; MYOTONIC-DYSTROPHY; COGNITIVE IMPAIRMENT; CTG REPEAT; DEMENTIA; MUTATIONS; TDP-43	Several families have been reported with autosomal-dominant frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), genetically linked to chromosome 9p21. Here, we report an expansion of a noncoding GGGGCC hexanucleotide repeat in the gene C9ORF72 that is strongly associated with disease in a large FTD/ALS kindred, previously reported to be conclusively linked to chromosome 9p. This same repeat expansion was identified in the majority of our families with a combined FTD/ALS phenotype and TDP-43-based pathology. Analysis of extended clinical series found the C9ORF72 repeat expansion to be the most common genetic abnormality in both familial FTD (11.7%) and familial ALS (23.5%). The repeat expansion leads to the loss of one alternatively spliced C9ORF72 transcript and to formation of nuclear RNA foci, suggesting multiple disease mechanisms. Our findings indicate that repeat expansion in C9ORF72 is a major cause of both FTD and ALS.	[Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5C 1M9, Canada; [DeJesus-Hernandez, Mariely; Baker, Matt; Rutherford, Nicola J.; Nicholson, Alexandra M.; Finch, NiCole A.; Adamson, Jennifer; Kouri, Naomi; Wojtas, Aleksandra; Dickson, Dennis W.; Rademakers, Rosa] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA; [Boeve, Bradley F.; Josephs, Keith A.; Knopman, David S.; Petersen, Ronald C.] Mayo Clin Rochester, Dept Neurol, Rochester, MN 55905 USA; [Boxer, Adam L.; Karydas, Anna; Seeley, William W.; Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Sengdy, Pheth; Hsiung, Ging-Yuek R.; Feldman, Howard] Univ British Columbia, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Wszolek, Zbigniew K.; Boylan, Kevin B.; Graff-Radford, Neill R.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL 32224 USA; [Feldman, Howard] Bristol Myers Squibb, Neurosci Global Clin Res, Wallingford, CT 06492 USA	University of British Columbia; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Mayo Clinic; Bristol-Myers Squibb	Mackenzie, IR (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5C 1M9, Canada.	ian.mackenzie@vch.ca; rademakers.rosa@mayo.edu	Hsiung, Robin/AAT-1661-2021; Kouri, Naomi/G-6695-2013; Wszolek, Zbigniew K./AAB-1431-2019	Hsiung, Robin/0000-0002-8017-0856; Kouri, N/0000-0002-6841-9882; Feldman, Howard/0000-0002-9258-4538; Dickson, Dennis W/0000-0001-7189-7917	National Institute on Aging [P50 AG016574, U01 AG006786]; ALS Association; Mayo Foundation; MCF ALS Center; NIH [R01 NS065782, R01 AG026251, R01 AG037491]; NIH/NINDS [1RC2NS070276, NS057567, P50NS072187]; Mayo Clinic Florida (MCF) Research Committee [90052030]; Dystonia Medical Research Foundation; Susan Bass Bolch (MCF) [90052031, 90052]; Canadian Institutes of Health Research (CIHR) [179009, 74580]; Pacific Alzheimer's Research Foundation (PARF) Center [C06-01]; John Douglas French Foundation; Hellman Family Foundation; Tau Research Consortium; Larry Hillblom Foundation; State of CA;  [R01AG038791];  [R01AG031278];  [P50AG023501];  [P01AG019724];  [P50 AG1657303]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057567, R01NS065782, RC2NS070276, P50NS072187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019724, R01AG031278, P50AG016574, R01AG037491, R01AG038791, R01AG026251, U01AG006786, P50AG023501, P50AG016573] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ALS Association; Mayo Foundation; MCF ALS Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Florida (MCF) Research Committee; Dystonia Medical Research Foundation; Susan Bass Bolch (MCF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pacific Alzheimer's Research Foundation (PARF) Center; John Douglas French Foundation; Hellman Family Foundation; Tau Research Consortium; Larry Hillblom Foundation; State of CA; ; ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to all patients, family members, and caregivers who participated in this study. The expert technical assistance of Pamela Desaro, Amelia Johnston, and Thomas Kryston in the collection of DNA and postmortem tissue in the Mayo Clinic Florida ALS Center and of Margaret Luk in performing immunohistochemistry at UBC is also acknowledged. We also thank Richard Crook, Jennifer Gass, and Ashley Cannon for technical assistance with the genetic and expression analyses. This research was funded as part of the Mayo Clinic ADRC grant from the National Institute on Aging (P50 AG016574), and members of one family were participants in the Mayo Clinic Alzheimer's Disease Patient Registry (ADPR) from the National Institute on Aging (U01 AG006786). Research was further funded by the ALS Association (P.R.), Mayo Foundation and MCF ALS Center donor funds (K.B.B.). R.R. is also funded by NIH grants R01 NS065782 and R01 AG026251. Some TDP-43 analysis was funded by NIH grant R01 AG037491 (K.A.J.). Z.K.W. is partially supported by the NIH/NINDS 1RC2NS070276, NS057567, P50NS072187, Mayo Clinic Florida (MCF) Research Committee CR program (MCF #90052030), Dystonia Medical Research Foundation, and the gift from Carl Edward Bolch, Jr., and Susan Bass Bolch (MCF #90052031/PAU #90052). The UBC studies were funded by the Canadian Institutes of Health Research (CIHR) Operating Grants #179009 and #74580 and by the Pacific Alzheimer's Research Foundation (PARF) Center Grant C06-01. G-YRH is supported by a Clinical Genetics Investigatorship award from the CIHR. A.L.B. is funded by R01AG038791, R01AG031278, the John Douglas French Foundation, the Hellman Family Foundation, and the Tau Research Consortium. B.L.M. is funded by P50AG023501, P01AG019724, the Larry Hillblom Foundation, and the State of CA and P50 AG1657303 to B.L.M. and W.W.S.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baumer D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001523; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Galloway JN, 2009, FUTUR NEUROL, V4, P785, DOI 10.2217/FNL.09.44; Gijselinck I, 2010, ARCH NEUROL-CHICAGO, V67, P606, DOI 10.1001/archneurol.2010.82; Giordana MT, 2011, NEUROL SCI, V32, P9, DOI 10.1007/s10072-010-0439-6; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Hantash FM, 2010, GENET MED, V12, P162, DOI 10.1097/GIM.0b013e3181d0d40e; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Le Ber I, 2009, NEUROLOGY, V72, P1669, DOI 10.1212/WNL.0b013e3181a55f1c; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Luty AA, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-32; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; MOK K, 2011, NEUROBIOL A IN PRESS, DOI DOI 10.1016/J.NEUR0BIOLAGING.2011.08.005; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pearson JP, 2011, J NEUROL, V258, P647, DOI 10.1007/s00415-010-5815-x; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; RENTON AE, 2011, NEURON IN PRESS, V72, DOI DOI 10.1016/J.NEURON.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Valdmanis PN, 2007, ARCH NEUROL-CHICAGO, V64, P240, DOI 10.1001/archneur.64.2.240; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	54	3199	3286	6	336	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 20	2011	72	2					245	256		10.1016/j.neuron.2011.09.011	http://dx.doi.org/10.1016/j.neuron.2011.09.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	21944778	Bronze, Green Accepted			2022-12-25	WOS:000296224000008
J	Maier, N; Tejero-Cantero, A; Dorrn, AL; Winterer, J; Beed, PS; Morris, G; Kempter, R; Poulet, JFA; Leibold, C; Schmitz, D				Maier, Nikolaus; Tejero-Cantero, Alvaro; Dorrn, Anja L.; Winterer, Jochen; Beed, Prateep S.; Morris, Genela; Kempter, Richard; Poulet, James F. A.; Leibold, Christian; Schmitz, Dietmar			Coherent Phasic Excitation during Hippocampal Ripples	NEURON			English	Article							WHOLE-CELL RECORDINGS; SHARP WAVES; INTRACELLULAR BLOCKADE; NETWORK PATTERNS; PYRAMIDAL CELLS; BARREL CORTEX; MEMORY; REACTIVATION; STATE; OSCILLATIONS	High-frequency hippocampal network oscillations, or "ripples," are thought to be involved in episodic memory. According to current theories, memory traces are represented by assemblies of principal neurons that are activated during ripple-associated network states. Here we performed in vivo and in vitro experiments to investigate the synaptic mechanisms during ripples. We discovered postsynaptic currents that are phase-locked to ripples and coherent among even distant CA1 pyramidal neurons. These fast currents are consistent with excitatory postsynaptic currents (EPSCs) as they are observed at the equilibrium potential of Cl-, and they display kinetics characteristic of EPSCs. Furthermore, they survived after intracellular blockade of GABAergic transmission and are effective to regulate the timing of action potentials. In addition, our data show a progressive synchronization of phasic excitation and inhibition during the course of ripples. Together, our results demonstrate the presence of phasic excitation during ripples reflecting an exquisite temporal coordination of assemblies of active pyramidal cells.	[Maier, Nikolaus; Dorrn, Anja L.; Winterer, Jochen; Beed, Prateep S.; Morris, Genela; Poulet, James F. A.; Schmitz, Dietmar] Charite, Neurowissensch Forschungszentrum, D-10117 Berlin, Germany; [Tejero-Cantero, Alvaro; Leibold, Christian] Univ Munich, Div Neurobiol, D-82152 Planegg, Germany; [Tejero-Cantero, Alvaro] Grad Sch Syst Neurosci, D-82152 Planegg, Germany; [Dorrn, Anja L.; Poulet, James F. A.; Schmitz, Dietmar] Max Delbruck Ctr Mol Med MDC, Dept Neurosci, D-13092 Berlin, Germany; [Morris, Genela; Kempter, Richard; Schmitz, Dietmar] Bernstein Ctr Computat Neurosci Berlin, D-10115 Berlin, Germany; [Morris, Genela] Univ Haifa, Fac Sci & Sci Educ, Dept Neurobiol & Ethol, IL-31905 Haifa, Israel; [Kempter, Richard] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Leibold, Christian] Bernstein Ctr Computat Neurosci Munich, D-82152 Planegg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Haifa; Humboldt University of Berlin	Schmitz, D (corresponding author), Charite, Neurowissensch Forschungszentrum, D-10117 Berlin, Germany.	dietmar.schmitz@charite.de	Leibold, Christian/AAT-8895-2021; Maier, Nikolaus/CAH-9008-2022; Maier, Nikolaus/CAF-2990-2022	Leibold, Christian/0000-0002-4859-8000; Maier, Nikolaus/0000-0001-5203-0736; Morris, Genela/0000-0002-5417-8977; Schmitz, Dietmar/0000-0003-2741-5241; Poulet, James/0000-0003-0296-5415; Dorrn, Anja L./0000-0002-4215-3609	DFG [Exc 257, SFB 618, Le-2250/2-1]; BMBF (BCCN) [01GQ0440, 01GQ0410]; ERC [260590]	DFG(German Research Foundation (DFG)); BMBF (BCCN)(Federal Ministry of Education & Research (BMBF)); ERC(European Research Council (ERC)European Commission)	We wish to thank Sarah Shoichet, Anja Gundlfinger, Alexey Ponomarenko, Christian Wozny, Jose R. Donoso, Nikolai Axmacher, and Robert Schmidt for constructive comments on earlier versions of the manuscript; Peter Barry (UNSW) for advice on estimation of LJPs; Roger D. Traub for valuable discussions; as well as Serena Dudek and Robert J. Bridges for help on establishing recordings with DNDS. We highly appreciate the technical assistance of Susanne Rieckmann and Anke Schonherr. This study has been supported by grants from the DFG (Exc 257, SFB 618, and Le-2250/2-1) and the BMBF (BCCN, grant numbers 01GQ0440 and 01GQ0410) and the ERC starting grant (260590).	Axmacher N, 2008, BRAIN, V131, P1806, DOI 10.1093/brain/awn103; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/S0306-4522(96)00251-5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Leibold C, 2006, NEURAL COMPUT, V18, P904, DOI 10.1162/089976606775774714; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Maier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006925; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Nimmrich V, 2005, J PHYSIOL-LONDON, V563, P663, DOI 10.1113/jphysiol.2004.079558; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sullivan D, 2011, J NEUROSCI, V31, P8605, DOI 10.1523/JNEUROSCI.0294-11.2011; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; Traub RD, 2000, J NEUROSCI, V20, P2086; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Wang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010253; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, J NEUROSCI, V15, P30	57	85	87	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 6	2011	72	1					137	152		10.1016/j.neuron.2011.08.016	http://dx.doi.org/10.1016/j.neuron.2011.08.016			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982375	Bronze			2022-12-25	WOS:000295856300014
J	Wannig, A; Stanisor, L; Roelfsema, PR				Wannig, Aurel; Stanisor, Liviu; Roelfsema, Pieter R.			Automatic spread of attentional response modulation along Gestalt criteria in primary visual cortex	NATURE NEUROSCIENCE			English	Article							OBJECT-BASED ATTENTION	Visual attention can select spatial locations, features and objects. Theories of object-based attention claim that attention enhances the representation of all parts of an object, even parts that are not task relevant. We recorded neuronal activity in area V1 of macaque monkeys and observed an automatic spread of attention to image elements outside of the attentional focus when they were bound to an attended stimulus by Gestalt criteria.	[Wannig, Aurel; Stanisor, Liviu; Roelfsema, Pieter R.] Royal Netherlands Acad Arts & Sci, Dept Vis & Cognit, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam	Roelfsema, PR (corresponding author), Royal Netherlands Acad Arts & Sci, Dept Vis & Cognit, Netherlands Inst Neurosci, Amsterdam, Netherlands.	p.roelfsema@nin.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034	NWO-ALW [816.02.018]; NWO-VICI [016.075.608]	NWO-ALW(Netherlands Organization for Scientific Research (NWO)); NWO-VICI(Netherlands Organization for Scientific Research (NWO))	We thank J. Poort, B. Dagnino, B. van Vugt and J. Fecteau for additional data collection, and K. Brandsma and D. Vleesenbeek for biotechnical support. This work was supported by NWO-ALW grant 816.02.018 and by an NWO-VICI grant 016.075.608 awarded to P.R.R.	Conner CE, 1997, J NEUROSCI, V17, P3201; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Lamy D, 2002, PERCEPT PSYCHOPHYS, V64, P52, DOI 10.3758/BF03194557; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Richard AM, 2008, J EXP PSYCHOL HUMAN, V34, P842, DOI 10.1037/0096-1523.34.4.842; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Shomstein S, 2002, PERCEPT PSYCHOPHYS, V64, P41, DOI 10.3758/BF03194556; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wannig A, 2007, NEURON, V54, P639, DOI 10.1016/j.neuron.2007.05.001; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640	15	79	81	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1243	1244		10.1038/nn.2910	http://dx.doi.org/10.1038/nn.2910			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21926984				2022-12-25	WOS:000295254200009
J	Osterhout, JA; Josten, N; Yamada, J; Pan, F; Wu, SW; Nguyen, PL; Panagiotakos, G; Inoue, YU; Egusa, SF; Volgyi, B; Inoue, T; Bloomfield, SA; Barres, BA; Berson, DM; Feldheim, DA; Huberman, AD				Osterhout, Jessica A.; Josten, Nicko; Yamada, Jena; Pan, Feng; Wu, Shaw-wen; Nguyen, Phong L.; Panagiotakos, Georgia; Inoue, Yukiko U.; Egusa, Saki F.; Volgyi, Bela; Inoue, Takayoshi; Bloomfield, Stewart A.; Barres, Ben A.; Berson, David M.; Feldheim, David A.; Huberman, Andrew D.			Cadherin-6 Mediates Axon-Target Matching in a Non-Image-Forming Visual Circuit	NEURON			English	Article							GANGLION-CELL SUBTYPES; DIFFERENTIAL EXPRESSION; N-CADHERIN; POSTNATAL MOUSE; RETINA; PROJECTIONS; PATTERNS; SYSTEM; BRAIN; CONNECTIVITY	Neural circuits consist of highly precise connections among specific types of neurons that serve a common functional goal. How neurons distinguish among different synaptic targets to form functionally precise circuits remains largely unknown. Here, we show that during development, the adhesion molecule cadherin-6 (Cdh6) is expressed by a subset of retinal ganglion cells (RGCs) and also by their targets in the brain. All of the Cdh6-expressing retinorecipient nuclei mediate non-image-forming visual functions. A screen of mice expressing GFP in specific subsets of RGCs revealed that Cdh3-RGCs which also express Cdh6 selectively innervate Cdh6-expressing retinorecipient targets. Moreover, in Cdh6-deficient mice, the axons of Cdh3-RGCs fail to properly innervate their targets and instead project to other visual nuclei. These findings provide functional evidence that classical cadherins promote mammalian CNS circuit development by ensuring that axons of specific cell types connect to their appropriate synaptic targets.	[Osterhout, Jessica A.; Wu, Shaw-wen; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Osterhout, Jessica A.; Wu, Shaw-wen; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Josten, Nicko; Panagiotakos, Georgia; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Yamada, Jena; Feldheim, David A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Pan, Feng; Volgyi, Bela; Bloomfield, Stewart A.] NYU, Dept Physiol & Neurosci & Ophthalmol, New York, NY 10016 USA; [Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Inoue, Yukiko U.; Egusa, Saki F.; Inoue, Takayoshi] Natl Inst Neurosci, Tokyo 1878502, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University; University of California System; University of California Santa Cruz; New York University; Brown University; National Center for Neurology & Psychiatry - Japan	Huberman, AD (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.	ahuberman@ucsd.edu	Volgyi, Bela/B-1016-2011; Inoue-Ueno, Yukiko/AAQ-1601-2020; Volgyi, Bela/A-9079-2013	Inoue-Ueno, Yukiko/0000-0002-4105-9127; Volgyi, Bela/0000-0001-7481-390X; Inoue, Takayoshi/0000-0001-7155-2150; PAN, Feng/0000-0002-5256-4380; PANAGIOTAKOS, GEORGIA/0000-0001-9444-2480	NIH [R01 EY014689, R01 EY07360, EY17832, R21 EY018320, R01 EY11310, R01 EY12793]; E. Matilda Ziegler Foundation for the Blind; NATIONAL EYE INSTITUTE [R01EY012793, R21EY018320, R01EY022157, R01EY014689, R01EY017832, R01EY011310, R01EY007360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); E. Matilda Ziegler Foundation for the Blind; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Gregory Dressler for the cadherin-6 antibody and Tom Clandinin and Maureen Estevez for their helpful suggestions. This work was supported by NIH R01 EY014689 (D.A.F.), NIH R01 EY07360 (S.B.), NIH EY17832 to (B.V.), NIH R21 EY018320 and NIH R01 EY11310 (B.A.B), and NIH R01 EY12793 (D.M.B.) and the E. Matilda Ziegler Foundation for the Blind (A.D.H.).	Berson D., 2008, SENSES COMPREHENSIVE, P491, DOI DOI 10.1016/B978-012370880-9.00280-2; BOWLING DB, 1980, NATURE, V286, P899, DOI 10.1038/286899a0; Clandinin TR, 2009, CURR OPIN NEUROBIOL, V19, P174, DOI 10.1016/j.conb.2009.04.011; Dahl U, 2002, MOL CELL BIOL, V22, P1474, DOI 10.1128/MCB.22.5.1474-1487.2002; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Ellsworth CA, 2005, J COMP NEUROL, V488, P140, DOI 10.1002/cne.20602; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Hertel N, 2008, J COMP NEUROL, V508, P511, DOI 10.1002/cne.21696; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P546; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Inoue YU, 2009, NEUROSCI RES, V63, P2, DOI 10.1016/j.neures.2008.09.005; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Mah SP, 2000, DEV BIOL, V223, P38, DOI 10.1006/dbio.2000.9738; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Prichard JR, 2002, NEUROSCIENCE, V114, P781, DOI 10.1016/S0306-4522(02)00293-2; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; SCALIA F, 1972, J COMP NEUROL, V145, P223, DOI 10.1002/cne.901450208; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; TAMAMAKI N, 1995, J COMP NEUROL, V354, P583, DOI 10.1002/cne.903540408; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037	36	111	114	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 25	2011	71	4					632	639		10.1016/j.neuron.2011.07.006	http://dx.doi.org/10.1016/j.neuron.2011.07.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867880	Green Accepted, Bronze			2022-12-25	WOS:000294521600009
J	Sopher, BL; Ladd, PD; Pineda, VV; Libby, RT; Sunkin, SM; Hurley, JB; Thienes, CP; Gaasterland, T; Filippova, GN; La Spada, AR				Sopher, Bryce L.; Ladd, Paula D.; Pineda, Victor V.; Libby, Randell T.; Sunkin, Susan M.; Hurley, James B.; Thienes, Cortlandt P.; Gaasterland, Terry; Filippova, Galina N.; La Spada, Albert R.			CTCF Regulates Ataxin-7 Expression through Promotion of a Convergently Transcribed, Antisense Noncoding RNA	NEURON			English	Article							DOMINANT CEREBELLAR ATAXIAS; CCCTC-BINDING FACTOR; NEURODEGENERATIVE DISEASES; POLYGLUTAMINE EXPANSION; RETINAL DEGENERATION; REPEAT INSTABILITY; TRANSGENIC MICE; CAG REPEAT; GENE; REGION	Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder caused by CAG/polyglutamine repeat expansions in the ataxin-7 gene. Ataxin-7 is a component of two different transcription coactivator complexes, and recent work indicates that disease protein normal function is altered in polyglutamine neurodegeneration. Given this, we studied how ataxin-7 gene expression is regulated. The ataxin-7 repeat and translation start site are flanked by binding sites for CTCF, a highly conserved multifunctional transcription regulator. When we analyzed this region, we discovered an adjacent alternative promoter and a convergently transcribed antisense noncoding RNA, SCAANT1. To understand how CTCF regulates ataxin-7 gene expression, we introduced ataxin-7 mini-genes into mice, and found that CTCF is required for SCAANT1 expression. Loss of SCAANT1 derepressed ataxin-7 sense transcription in a cis-dependent fashion and was accompanied by chromatin remodeling. Discovery of this pathway underscores the importance of altered epigenetic regulation for disease pathology at repeat loci exhibiting bidirectional transcription.	[La Spada, Albert R.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Sopher, Bryce L.; Pineda, Victor V.; Libby, Randell T.; Thienes, Cortlandt P.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ladd, Paula D.; La Spada, Albert R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [La Spada, Albert R.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Gaasterland, Terry] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Gaasterland, Terry; La Spada, Albert R.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [La Spada, Albert R.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Sunkin, Susan M.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Filippova, Galina N.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Allen Institute for Brain Science; Fred Hutchinson Cancer Center	La Spada, AR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	alaspada@ucsd.edu	La Spada, Albert/AAG-8809-2020	Thienes, Cortlandt/0000-0002-1715-7835	NIH [GM59356, EY14061, GM59356-09-S1, EY01730]; Allen Institute for Brain Science; NATIONAL EYE INSTITUTE [P30EY001730, R01EY014061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Institute for Brain Science; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank A. Smith, S. Baccam, K. Takushi, J. Huang, and D. Possin for outstanding technical assistance, and B. Ren for critical reading of the manuscript. This work was supported by funding from the NIH (GM59356, EY14061, and ARRA award GM59356-09-S1 to A.R.L., and EY01730 [Vision Research Core] to UWMC). S.M.S. is supported by the Allen Institute for Brain Science, founded by Paul G. Allen and Jody Patton.	Ahn JK, 2005, AM J OPHTHALMOL, V139, P923, DOI 10.1016/j.ajo.2004.10.055; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen SM, 2004, HUM MOL GENET, V13, P53, DOI 10.1093/hmg/ddh005; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; LaSpada AR, 1997, BRAIN PATHOL, V7, P943; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Stevanin G, 2000, EUR J HUM GENET, V8, P4, DOI 10.1038/sj.ejhg.5200403; TO KW, 1993, OPHTHALMOLOGY, V100, P15; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Wang YH, 1996, J MOL BIOL, V263, P511, DOI 10.1006/jmbi.1996.0593; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	49	94	97	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1071	1084		10.1016/j.neuron.2011.05.027	http://dx.doi.org/10.1016/j.neuron.2011.05.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689595	Green Accepted, Bronze			2022-12-25	WOS:000292410700007
J	Lammel, S; Ion, DI; Roeper, J; Malenka, RC				Lammel, Stephan; Ion, Daniela I.; Roeper, Jochen; Malenka, Robert C.			Projection-Specific Modulation of Dopamine Neuron Synapses by Aversive and Rewarding Stimuli	NEURON			English	Article							VENTRAL TEGMENTAL AREA; COCAINE-INDUCED POTENTIATION; NUCLEUS-ACCUMBENS SHELL; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; IN-VIVO; DRUG-ADDICTION; MIDBRAIN; STRENGTH; SIGNALS	Midbrain dopamine (DA) neurons are not homogeneous but differ in their molecular properties and responses to external stimuli. We examined whether the modulation of excitatory synapses on DA neurons by rewarding or aversive stimuli depends on the brain area to which these DA neurons project. We identified DA neuron subpopulations in slices after injection of "Retrobeads" into single target areas of adult mice and found differences in basal synaptic properties. Administration of cocaine selectively modified excitatory synapses on DA cells projecting to nucleus accumbens (NAG) medial shell while an aversive stimulus selectively modified synapses on DA cells projecting to medial prefrontal cortex. In contrast, synapses on DA neurons projecting to NAc lateral shell were modified by both rewarding and aversive stimuli, which presumably reflects saliency. These results suggest that the mesocorticolimbic DA system may be comprised of three anatomically distinct circuits, each modified by distinct aspects of motivationally relevant stimuli.	[Lammel, Stephan; Ion, Daniela I.; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Roeper, Jochen] Goethe Univ Frankfurt, Ctr Neurosci, Inst Neurophysiol, D-60528 Frankfurt, Germany	Stanford University; Goethe University Frankfurt	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Lokey Stem Cell Res Bldg,265 Campus Dr,Room G1021, Stanford, CA 94305 USA.	malenka@stanford.edu	Lammel, Stephan/O-8295-2018	Lammel, Stephan/0000-0002-3350-3208; Roeper, Jochen/0000-0003-2145-8742	National Institute on Drug Abuse; German Academy of Sciences Leopoldina; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); German Academy of Sciences Leopoldina; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse and by a fellowship from the German Academy of Sciences Leopoldina (to S.L.). Retrograde tracing and immunohistochemistry were by S.L. and D.I.I. Electrophysiology was by S.L. The study was designed and results were analyzed and interpreted by S.L., J.R., and R.C.M. The manuscript was written by S.L., J.R., and R.C.M.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chen BT, 2010, ANN NY ACAD SCI, V1187, P129, DOI 10.1111/j.1749-6632.2009.05154.x; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Haber SN, 2000, J NEUROSCI, V20, P2369; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; MA QP, 1993, PEPTIDES, V14, P561, DOI 10.1016/0196-9781(93)90145-7; Malenka Robert C., 2002, Neuron, V36, P29, DOI 10.1016/S0896-6273(02)00938-8; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Ungless MA, 2010, NEUROSCI BIOBEHAV R, V35, P151, DOI 10.1016/j.neubiorev.2010.04.006; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Young AMJ, 2004, J NEUROSCI METH, V138, P57, DOI 10.1016/j.jneumeth.2004.03.003; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang TA, 2010, NEUROPHARMACOLOGY, V59, P431, DOI 10.1016/j.neuropharm.2010.06.004	61	488	495	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					855	862		10.1016/j.neuron.2011.03.025	http://dx.doi.org/10.1016/j.neuron.2011.03.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658580	Green Accepted, Bronze			2022-12-25	WOS:000291843500007
J	Smith, LL; Yeung, J; Zeisig, BB; Popov, N; Huijbers, I; Barnes, J; Wilson, AJ; Taskesen, E; Delwel, R; Gil, J; Van Lohuizen, M; So, CWE				Smith, Lan-Lan; Yeung, Jenny; Zeisig, Bernd B.; Popov, Nikolay; Huijbers, Ivo; Barnes, Josephine; Wilson, Amanda J.; Taskesen, Erdogan; Delwel, Ruud; Gil, Jesus; Van Lohuizen, Maarten; So, Chi Wai Eric			Functional Crosstalk between Bmi1 and MLL/Hoxa9 Axis in Establishment of Normal Hematopoietic and Leukemic Stem Cells	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; PROLIFERATIVE CAPACITY; CHILDHOOD LEUKEMIA; HSC ACTIVITY; BONE-MARROW; CBF-BETA; TRANSFORMATION; EXPRESSION; POLYCOMB; MLL	Bmi1 is required for efficient self-renewal of hematopoietic stem cells (HSCs) and leukemic stem cells (LSCs). In this study, we investigated whether leukemia-associated fusion proteins, which differ in their ability to activate Hox expression, could initiate leukemia in the absence of Bmi1. AML1-ETO and PLZF-RAR alpha, which do not activate Hox, triggered senescence in Bmi1(-/-) cells. In contrast, MLL-AF9, which drives expression of Hoxa7 and Hoxa9, readily transformed Bmi1(-/-) cells. MLL-AF9 could not initiate leukemia in Bmi1(-/-)Hoxa9(-/-) mice, which have further compromised HSC functions. But either gene could restore the ability of MLL-AF9 to establish LSCs in the double null background. As reported for Bmi1, Hoxa9 regulates expression of p16(ink4a)/p19(ARF) locus and could overcome senescence induced by AML1-ETO. Together, these results reveal an important functional interplay between MLL/Hox and Bmi1 in regulating cellular senescence for LSC development, suggesting that a synergistic targeting of both molecules is required to eradicate a broader spectrum of LSCs.	[Smith, Lan-Lan; Yeung, Jenny; Zeisig, Bernd B.; Barnes, Josephine; Wilson, Amanda J.; So, Chi Wai Eric] Kings Coll London, Dept Haematol Med, Leukaemia & Stem Cell Biol Lab, London SE5 9NU, England; [Popov, Nikolay; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England; [Huijbers, Ivo; Van Lohuizen, Maarten] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Huijbers, Ivo; Van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Taskesen, Erdogan; Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [So, Chi Wai Eric] Inst Canc Res, Haematooncol Sect, Greater London SM5 2NG, England	University of London; King's College London; Imperial College London; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; University of London; Institute of Cancer Research - UK	So, CWE (corresponding author), Kings Coll London, Dept Haematol Med, Leukaemia & Stem Cell Biol Lab, London SE5 9NU, England.	eric.so@kcl.ac.uk	Taskesen, Erdogan/N-4983-2015; Gil, Jesus/C-7739-2012; Huijbers, Ivo/I-3229-2019	Taskesen, Erdogan/0000-0002-3430-9618; Gil, Jesus/0000-0002-4303-6260; Yeung, Jenny/0000-0002-1452-1056; Wilson, Amanda/0000-0001-5681-9611; Barnes, Josephine/0000-0001-9938-3176	MRC; CRUK; LLR; Medical Research Council [G0800892, MC_U120085810] Funding Source: researchfish; MRC [MC_U120085810, G0800892] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); LLR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Cleary for his help and constructive advice in the early phase of the project in particular; M. Greaves for critical discussion; J. Licht and K. Rice for providing clinical data and bioinformatic support on the t(11; 17) cases; N. Cheung, E. Amin, W. Vetharoy, C. Kwok, A. Thornhill, C. Foley, I. Titley, and G. Vijayaraghavan for technical assistance; D.E. Zhang, R. Slany, and C.V. Dang for provision of useful reagents; G. Dickson, A. Thompson, and T. Lappin for initial help in Hox qPCR analysis; and P. Tse for professional graphic assistance. J.G. and N.P. are funded by the MRC. C.-W.-E.S. is an AICR fellow and EMBO young investigator. This work is supported by CRUK and in part by LLR.	Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bach C, 2010, BLOOD, V115, P2910, DOI 10.1182/blood-2009-04-216606; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cheung N, 2011, FEBS LETT, V585, P2100, DOI 10.1016/j.febslet.2011.03.068; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Faubert A, 2008, COLD SH Q B, V73, P555, DOI 10.1101/sqb.2008.73.030; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Irelan JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005067; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Kwok C, 2006, CANCER CELL, V9, P95, DOI 10.1016/j.ccr.2006.01.005; Kwok C, 2010, BLOOD, V115, P3176, DOI 10.1182/blood-2009-12-260570; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liedtke M, 2009, BLOOD, V113, P6061, DOI 10.1182/blood-2008-12-197061; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rice KL, 2009, BLOOD, V114, P5499, DOI 10.1182/blood-2009-03-206524; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yeung J, 2010, CANCER CELL, V18, P606, DOI 10.1016/j.ccr.2010.10.032; Yeung Jenny, 2009, V538, P301, DOI 10.1007/978-1-59745-418-6_15; Zeisig BB, 2008, CANCER CELL, V14, P345, DOI 10.1016/j.ccr.2008.10.008; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zeisig Bernd B., 2009, V538, P207, DOI 10.1007/978-1-59745-418-6_10	55	97	102	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					649	662		10.1016/j.stem.2011.05.004	http://dx.doi.org/10.1016/j.stem.2011.05.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624810	Bronze			2022-12-25	WOS:000291844100013
J	Sagi, Y; Tavor, I; Hofstetter, S; Tzur-Moryosef, S; Blumenfeld-Katzir, T; Assaf, Y				Sagi, Yaniv; Tavor, Ido; Hofstetter, Shir; Tzur-Moryosef, Shimrit; Blumenfeld-Katzir, Tamar; Assaf, Yaniv			Learning in the Fast Lane: New Insights into Neuroplasticity	NEURON			English	Article							LONG-TERM POTENTIATION; WHITE-MATTER; RAT-BRAIN; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; GENDER-DIFFERENCES; WORKING-MEMORY; DIFFUSION; WATER; STIMULATION	The timescale of structural remodeling that accompanies functional neuroplasticity is largely unknown. Although structural remodeling of human brain tissue is known to occur following long-term (weeks) acquisition of a new skill, little is known as to what happens structurally when the brain needs to adopt new sequences of procedural rules or memorize a cascade of events within minutes or hours. Using diffusion tensor imaging (DTI), an MRI-based framework, we examined subjects before and after a spatial learning and memory task. Microstructural changes (as reflected by DTI measures) of limbic system structures (hippocampus and parahippocampus) were significant after only 2 hr of training. This observation was also found in a supporting rat study. We conclude that cellular rearrangement of neural tissue can be detected by DTI, and that this modality may allow neuroplasticity to be localized over short timescales.	[Sagi, Yaniv; Tavor, Ido; Hofstetter, Shir; Tzur-Moryosef, Shimrit; Blumenfeld-Katzir, Tamar; Assaf, Yaniv] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Assaf, Y (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	assafyan@post.tau.ac.il	Tavor, Ido/AAB-1345-2019; Jovicich, Jorge/D-2293-2010	Tavor, Ido/0000-0002-9117-4449; Assaf, Yaniv/0000-0001-6828-7595; Hofstetter, Shir/0000-0002-7137-4830	European Commission [238292]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors wish to thank the Raymond and Beverly Sackler Insitute for Biophysics, the Israel Science Foundation, and the Strauss Center for Computational Neuroimaging of Tel Aviv University for the purchase and maintenance of the 7T MRI system. Y.A. wishes to thank the Israel Science Foundation (ISF grant 994/08), and Future and Emerging Technologies (FET) Programme within the Seventh Framework Programme for Research of the European Commission (FET-Open, "CONNECT" project), grant 238292.	Assaf Y, 2008, BIOESSAYS, V30, P1235, DOI 10.1002/bies.20851; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LATOUR LL, 1994, MAGNET RESON MED, V32, P189, DOI 10.1002/mrm.1910320207; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; Lee B, 2010, NEUROIMAGE, V52, P9, DOI 10.1016/j.neuroimage.2010.04.014; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Moseley M, 2002, BRAIN COGNITION, V50, P396, DOI 10.1016/S0278-2626(02)00524-9; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Sasson E, 2010, NEUROIMAGE, V50, P1231, DOI 10.1016/j.neuroimage.2009.12.079; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schweinsburg AD, 2005, J INT NEUROPSYCH SOC, V11, P631, DOI 10.1017/S1355617705050757; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; vanderToorn A, 1996, MAGN RESON MED, V36, P52, DOI 10.1002/mrm.1910360110; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	39	315	318	4	190	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1195	1203		10.1016/j.neuron.2012.01.025	http://dx.doi.org/10.1016/j.neuron.2012.01.025			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445346	Bronze			2022-12-25	WOS:000301998700016
J	van Zessen, R; Phillips, JL; Budygin, EA; Stuber, GD				van Zessen, Ruud; Phillips, Jana L.; Budygin, Evgeny A.; Stuber, Garret D.			Activation of VTA GABA Neurons Disrupts Reward Consumption	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE NEURONS; METHYL-D-ASPARTATE; NUCLEUS-ACCUMBENS; GABAERGIC NEURONS; SUBSTANTIA-NIGRA; SEEKING BEHAVIOR; AVERSIVE STIMULI; FIRING PATTERN; FOOD-SEEKING	The activity of ventral tegmental area (VTA) dopamine (DA) neurons promotes behavioral responses to rewards and environmental stimuli that predict them. VTA GABA inputs synapse directly onto DA neurons and may regulate DA neuronal activity to alter reward-related behaviors; however, the functional consequences of selective activation of VTA GABA neurons remains unknown. Here, we show that in vivo optogenetic activation of VTA GABA neurons disrupts reward consummatory behavior but not conditioned anticipatory behavior in response to reward-predictive cues. In addition, direct activation of VTA GABA projections to the nucleus accumbens (NAc) resulted in detectable GABA release but did not alter reward consumption. Furthermore, optogenetic stimulation of VTA GABA neurons directly suppressed the activity and excitability of neighboring DA neurons as well as the release of DA in the NAc, suggesting that the dynamic interplay between VTA DA and GABA neurons can control the initiation and termination of reward-related behaviors.	[van Zessen, Ruud; Phillips, Jana L.; Stuber, Garret D.] Univ N Carolina, Dept Psychiat, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [van Zessen, Ruud; Phillips, Jana L.; Stuber, Garret D.] Univ N Carolina, Dept Cellular & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [van Zessen, Ruud] Univ Med Ctr Utrecht, Masterprogram Neurosci & Cognit, Rudolf Magnus Inst, Dept Neurosci & Pharmacol, NL-3584 CX Utrecht, Netherlands; [Budygin, Evgeny A.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Utrecht University; Utrecht University Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	Chee, Melissa/G-4150-2014; Budygin, Evgeny/ABD-1899-2021; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Stuber, Garret/E-1160-2011	Chee, Melissa/0000-0003-3815-9095; Stuber, Garret/0000-0003-1730-4855	NARSAD; Whitehall Foundation; Foundation of Hope; NIDA [DA029325, DA032750]; Department of Psychiatry at UNC Chapel Hill; Hendrik Muller Fonds; Fundatie van de Vrijvrouwe van Renswoude; David de Wied Stichting; Vreedefonds;  [DA021634]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA032750, K01DA021634, R01DA032750, R21DA029325] Funding Source: NIH RePORTER	NARSAD(NARSAD); Whitehall Foundation; Foundation of Hope; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Department of Psychiatry at UNC Chapel Hill; Hendrik Muller Fonds; Fundatie van de Vrijvrouwe van Renswoude; David de Wied Stichting; Vreedefonds; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Bradford Lowell and Linh Vong for providing the VGat-ires-Cre mice and Dr. Karl Deisseroth for AAV-DIO-ChR2-eYFP, and AAV-DIO-GFP constructs. We also thank Randall Ung and Dr. Vladimir Gukassyan and the UNC Neuroscience Center Microscopy Core Facility for assistance. This study was supported by funds from NARSAD, The Whitehall Foundation, The Foundation of Hope, NIDA (DA029325 and DA032750), and startup funds provided by the Department of Psychiatry at UNC Chapel Hill (G.D.S.) and DA021634 (E.A.B.). R.v.Z. was supported by the Hendrik Muller Fonds, Fundatie van de Vrijvrouwe van Renswoude, David de Wied Stichting, and Vreedefonds. R.v.Z. and G.D.S. conceived and designed all experiments. R.v.Z., J.P., E.A.B., and G.D.S. performed experiments and analyzed the data. R.v.Z. and G.D.S. wrote the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Bonci A, 1997, J NEUROSCI, V17, P796; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; COUSINS MS, 1993, PHARMACOL BIOCHEM BE, V46, P943, DOI 10.1016/0091-3057(93)90226-J; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Deister CA, 2009, J NEUROSCI, V29, P15888, DOI 10.1523/JNEUROSCI.4053-09.2009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Hanlon EC, 2004, PSYCHOPHARMACOLOGY, V172, P241, DOI 10.1007/s00213-003-1654-0; Ikemoto S, 1996, BEHAV NEUROSCI, V110, P331, DOI 10.1037/0735-7044.110.2.331; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Lobb CJ, 2010, J NEUROPHYSIOL, V104, P403, DOI 10.1152/jn.00204.2010; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Madhavan A, 2010, J NEUROSCI, V30, P14029, DOI 10.1523/JNEUROSCI.3366-10.2010; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mileykovskiy B, 2011, J NEUROSCI, V31, P7471, DOI 10.1523/JNEUROSCI.5731-10.2011; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nowend KL, 2001, PHARMACOL BIOCHEM BE, V69, P373, DOI 10.1016/S0091-3057(01)00524-X; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; OVERTON P, 1992, SYNAPSE, V10, P131, DOI 10.1002/syn.890100208; Paladini CA, 1999, SYNAPSE, V32, P165, DOI 10.1002/(SICI)1098-2396(19990601)32:3<165::AID-SYN3>3.0.CO;2-N; Paladini CA, 1999, BRAIN RES, V832, P145, DOI 10.1016/S0006-8993(99)01484-5; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; SALAMONE JD, 1990, NEUROSCIENCE, V39, P17, DOI 10.1016/0306-4522(90)90218-S; Salamone JD, 2001, NEUROSCIENCE, V105, P863, DOI 10.1016/S0306-4522(01)00249-4; SALAMONE JD, 1993, PHARMACOL BIOCHEM BE, V44, P605, DOI 10.1016/0091-3057(93)90174-R; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; Ungless MA, 2010, NEUROSCI BIOBEHAV R, V35, P151, DOI 10.1016/j.neubiorev.2010.04.006; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	63	386	388	3	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 22	2012	73	6					1184	1194		10.1016/j.neuron.2012.02.016	http://dx.doi.org/10.1016/j.neuron.2012.02.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445345	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000301998700015
J	Goffin, D; Allen, M; Zhang, L; Amorim, M; Wang, ITJ; Reyes, ARS; Mercado-Berton, A; Ong, C; Cohen, S; Hu, LD; Blendy, JA; Carlson, GC; Siegel, SJ; Greenberg, ME; Zhou, ZL				Goffin, Darren; Allen, Megan; Zhang, Le; Amorim, Maria; Wang, I-Ting Judy; Reyes, Arith-Ruth S.; Mercado-Berton, Amy; Ong, Caroline; Cohen, Sonia; Hu, Linda; Blendy, Julie A.; Carlson, Gregory C.; Siegel, Steve J.; Greenberg, Michael E.; Zhou, Zhaolan			Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses	NATURE NEUROSCIENCE			English	Article							MOUSE MODEL; HISTONE DEACETYLASE; PYRAMIDAL NEURONS; OSCILLATIONS; DEFICIENCY; AUTISM; MICE	Mutations in the MECP2 gene cause the autism spectrum disorder Rett syndrome (RTT). One of the most common MeCP2 mutations associated with RTT occurs at threonine 158, converting it to methionine (T158M) or alanine (T158A). To understand the role of T158 mutations in the pathogenesis of RTT, we generated knockin mice that recapitulate the MeCP2 T158A mutation. We found a causal role for T158A mutation in the development of RTT-like phenotypes, including developmental regression, motor dysfunction, and learning and memory deficits. These phenotypes resemble those present in Mecp2 null mice and manifest through a reduction in MeCP2 binding to methylated DNA and a decrease in MeCP2 protein stability. The age-dependent development of event-related neuronal responses was disrupted by MeCP2 mutation, suggesting that impaired neuronal circuitry underlies the pathogenesis of RTT and that assessment of event-related potentials (ERPs) may serve as a biomarker for RTT and treatment evaluation.	[Goffin, Darren; Allen, Megan; Zhang, Le; Amorim, Maria; Wang, I-Ting Judy; Reyes, Arith-Ruth S.; Zhou, Zhaolan] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Mercado-Berton, Amy; Blendy, Julie A.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Ong, Caroline; Cohen, Sonia; Hu, Linda; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Carlson, Gregory C.; Siegel, Steve J.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; University of Pennsylvania	Zhou, ZL (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	zhaolan@mail.med.upenn.edu	de Amorim, Maria Galli/K-8259-2016	de Amorim, Maria Galli/0000-0002-1910-8770; Siegel, Steven/0000-0001-8058-9713; Goffin, Darren/0000-0001-6284-1452; Zhang, Le/0000-0002-4860-831X	US National Institutes of Health [R00 NS058391, P30 HD026979]; Philadelphia Foundation; International Rett Syndrome Foundation; Alavi-Dabiri Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS058391] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation; International Rett Syndrome Foundation; Alavi-Dabiri Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is dedicated to the memory of Dr. Tom Kadesch, an inspirational colleague and mentor. We thank A. West, D. Epstein and members of the Zhou laboratory for critical readings of the manuscript, and the Intellectual and Developmental Disability Research Center Gene Manipulation Core (P30 HD18655) at the Children's Hospital Boston for generation of knockin mice (M. Thompson, Y. Zhou and H. Ye). This work was supported by grants from the US National Institutes of Health (R00 NS058391 and P30 HD026979), the Philadelphia Foundation and International Rett Syndrome Foundation to Z.Z. D.G. acknowledges the generous support of the Alavi-Dabiri Postdoctoral Fellowship. Z.Z. is a Pew Scholar in Biomedical Science.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; BADER GG, 1989, BRAIN DEV-JPN, V11, P110, DOI 10.1016/S0387-7604(89)80078-6; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; D'Cruz JA, 2010, NEUROBIOL DIS, V38, P8, DOI 10.1016/j.nbd.2009.12.018; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Gandal MJ, 2011, NEUROPHARMACOLOGY; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kerr B, 2008, HUM MOL GENET, V17, P1707, DOI 10.1093/hmg/ddn061; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Schanen C, 2004, AM J MED GENET A, V126A, P129, DOI 10.1002/ajmg.a.20571; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stauder JEA, 2006, BRAIN DEV-JPN, V28, P487, DOI 10.1016/j.braindev.2006.02.011; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vacca M, 2001, BRAIN DEV-JPN, V23, pS246, DOI 10.1016/S0387-7604(01)00343-6; Winterer G, 2000, CLIN NEUROPHYSIOL, V111, P837, DOI 10.1016/S1388-2457(99)00322-3; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009	44	151	153	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					274	283		10.1038/nn.2997	http://dx.doi.org/10.1038/nn.2997			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22119903	Green Accepted			2022-12-25	WOS:000299603500019
J	Ross, SE; McCord, AE; Jung, C; Atan, D; Mok, SI; Hemberg, M; Kim, TK; Salogiannis, J; Hu, LD; Cohen, S; Lin, YX; Harrar, D; McInnes, RR; Greenberg, ME				Ross, Sarah E.; McCord, Alejandra E.; Jung, Cynthia; Atan, Denize; Mok, Stephanie I.; Hemberg, Martin; Kim, Tae-Kyung; Salogiannis, John; Hu, Linda; Cohen, Sonia; Lin, Yingxi; Harrar, Dana; McInnes, Roderick R.; Greenberg, Michael E.			Bhlhb5 and Prdm8 Form a Repressor Complex Involved in Neuronal Circuit Assembly	NEURON			English	Article							LOOP-HELIX PROTEIN; DEVELOPING MOUSE-BRAIN; TRANSCRIPTION FACTOR; HISTONE METHYLTRANSFERASE; RECOMBINATION HOTSPOTS; AXONAL OUTGROWTH; PRADER-WILLI; SPINAL-CORD; EXPRESSION; SPECIFICATION	Although transcription factors that repress gene expression play critical roles in nervous system development, their mechanism of action remains to be understood. Here, we report that the Olig-related transcription factor Bhlhb5 (also known as Bhlhe22) forms a repressor complex with the PR/SET domain protein, Prdm8. We find that Bhlhb5 binds to sequence-specific DNA elements and then recruits Prdm8, which mediates the repression of target genes. This interaction is critical for repressor function since mice lacking either Bhlhb5 or Prdm8 have strikingly similar cellular and behavioral phenotypes, including axonal mistargeting by neurons of the dorsal telencephalon and abnormal itch-like behavior. We provide evidence that Cadherin-11 functions as target of the Prdm8/Bhlhb5 repressor complex that must be repressed for proper neural circuit formation to occur. These findings suggest that Prdm8 is an obligate partner of Bhlhb5, forming a repressor complex that directs neural circuit assembly in part through the precise regulation of Cadherin-11.	[Ross, Sarah E.; McCord, Alejandra E.; Mok, Stephanie I.; Kim, Tae-Kyung; Salogiannis, John; Hu, Linda; Cohen, Sonia; Lin, Yingxi; Harrar, Dana; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Jung, Cynthia; Atan, Denize; McInnes, Roderick R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Jung, Cynthia; Atan, Denize; McInnes, Roderick R.] Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; [Hemberg, Martin] Harvard Univ, Childrens Hosp Boston, Dept Ophthalmol, Ctr Brain Sci, Boston, MA 02115 USA; [Hemberg, Martin] Harvard Univ, Swartz Ctr Theoret Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; Harvard University	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Salogiannis, John/AAX-3128-2021; Kim, Tae-Kyung/AAX-4230-2020; Atan, Denize/B-5536-2019	Salogiannis, John/0000-0002-1988-7284; Kim, Tae-Kyung/0000-0001-5161-9864; Atan, Denize/0000-0003-1217-4852; /0000-0002-7002-1275; Harrar, Dana/0000-0001-6382-8479	Jane Coffin Childs Fellowship; Dystonia Medical Research Foundation; NIH [NS028829]; Developmental Disabilities Mental Retardation Research Center [NIH-P30-HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER	Jane Coffin Childs Fellowship; Dystonia Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Developmental Disabilities Mental Retardation Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Takeichi for supplying the Cdh11 mutant mice; A. Cano for supplying the HA-tagged E2-2B expression vector; E.C. Griffith for critical readings of the manuscript; D. Harmin for help with statistical analysis; P. Zhang for assistance with mouse colony management; the Intellectual and Developmental Disabilities Research Center (IDDRC) Gene Manipulation Core (M. Thompson, Y. Zhou, and H. Ye); the Harvard Medical School Rodent Histopathology Core (R.T. Bronson), and the IDDRC Molecular Genetics Core. This work was supported by a Jane Coffin Childs Fellowship and a Dystonia Medical Research Foundation Fellowship to S.E.R., NIH grant NS028829 to M.E.G., and the Developmental Disabilities Mental Retardation Research Center grant NIH-P30-HD-18655.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bramblett DE, 2004, NEURON, V43, P779, DOI 10.1016/j.neuron.2004.08.032; Bramblett DE, 2002, GENOMICS, V79, P402, DOI 10.1006/geno.2002.6708; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Farah MH, 2000, DEVELOPMENT, V127, P693; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Finger JH, 2002, J NEUROSCI, V22, P10346; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kim KC, 2003, CANCER RES, V63, P7619; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kimura Y, 1996, DEV DYNAM, V206, P455, DOI 10.1002/(SICI)1097-0177(199608)206:4<455::AID-AJA11>3.0.CO;2-W; KIMURA Y, 1995, DEV BIOL, V169, P347, DOI 10.1006/dbio.1995.1149; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Ledent Valerie, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0030; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Li HL, 2011, NEURON, V69, P918, DOI 10.1016/j.neuron.2011.01.030; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Marthiens W, 2005, MOL CELL NEUROSCI, V28, P715, DOI 10.1016/j.mcn.2004.12.001; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Peyton M, 1996, MOL CELL BIOL, V16, P626; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stevens JD, 2008, DIFFERENTIATION, V76, P1006, DOI 10.1111/j.1432-0436.2008.00285.x; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xu ZP, 2002, GENOMICS, V80, P311, DOI 10.1006/geno.2002.6833; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	52	80	82	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					292	303		10.1016/j.neuron.2011.09.035	http://dx.doi.org/10.1016/j.neuron.2011.09.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284184	Green Published, Green Accepted, Bronze			2022-12-25	WOS:000299761600011
J	Han, C; Wang, DN; Soba, P; Zhu, SJ; Lin, XH; Jan, LY; Jan, YN				Han, Chun; Wang, Denan; Soba, Peter; Zhu, Sijun; Lin, Xinhua; Jan, Lily Yeh; Jan, Yuh-Nung			Integrins Regulate Repulsion-Mediated Dendritic Patterning of Drosophila Sensory Neurons by Restricting Dendrites in a 2D Space	NEURON			English	Article							SELF-AVOIDANCE; SIGNALING PATHWAY; GENETIC-ANALYSIS; NERVOUS-SYSTEM; CELL-ADHESION; REQUIRE DSCAM; PS INTEGRINS; MOUSE RETINA; MORPHOGENESIS; PROTEIN	Dendrites of the same neuron usually avoid each other. Some neurons also repel similar neurons through dendrite-dendrite interaction to tile the receptive field. Nonoverlapping coverage based on such contact-dependent repulsion requires dendrites to compete for limited space. Here we show that Drosophila class IV dendritic arborization (da) neurons, which tile the larval body wall, grow their dendrites mainly in a 2D space on the extracellular matrix (ECM) secreted by the epidermis. Removing neuronal integrins or blocking epidermal laminin production causes dendrites to grow into the epidermis, suggesting that integrin-laminin interaction attaches dendrites to the ECM. We further show that some of the previously identified tiling mutants fail to confine dendrites in a 2D plane. Expansion of these mutant dendrites in three dimensions results in overlap of dendritic fields. Moreover, overexpression of integrins in these mutant neurons effectively reduces dendritic crossing and restores tiling, revealing an additional mechanism for tiling.	[Han, Chun; Wang, Denan; Soba, Peter; Zhu, Sijun; Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA; [Han, Chun; Wang, Denan; Soba, Peter; Zhu, Sijun; Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94158 USA; [Han, Chun; Wang, Denan; Soba, Peter; Zhu, Sijun; Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94158 USA; [Lin, Xinhua] Chinese Acad Sci, State Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China; [Lin, Xinhua] Chinese Acad Sci, Key Lab Stem Cell & Dev Biol, Inst Zool, Beijing 100101, Peoples R China; [Lin, Xinhua] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Cincinnati Children's Hospital Medical Center	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu	Soba, Peter/AAC-8143-2020; Soba, Peter/AAK-1134-2021	Soba, Peter/0000-0002-6163-4686; Soba, Peter/0000-0002-6163-4686; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Han, Chun/0000-0001-7319-8095	Jane Coffin Childs Memorial Fund; California Institute for Regenerative Medicine (CIRM); NIH [2R01 GM063891, 2R37NS040929]; American Cancer Society [RSG-07-051]; Chinese Academy of Sciences [KSCX2-YW-R-263]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Wes Gruber for communicating results prior to publication. We thank members of the Jan lab for discussion; Chung-hui Yang for help in cloning and making transgenic lines; Yang Xiang for testing of electrophysiological experiments; Sandra Barbel for help in dendrite tracing; Mark Krasnow, Frieder Schoeck, Jian Wang, Bloomington Stock Center, VDRC, and FlyTrap for fly stocks; DSHB for antibodies This work was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund to C.H., a California Institute for Regenerative Medicine (CIRM) grant to S.Z., NIH grant (2R01 GM063891), American Cancer Society (RSG-07-051), and the Knowledge Innovation Program of the Chinese Academy of Sciences KSCX2-YW-R-263 to X.L., and by NIH grant (2R37NS040929) to Y.N.J. L.Y.J. and Y.N.J. are investigators of Howard Hughes Medical Institute.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWER DL, 1995, DEVELOPMENT, V121, P1311; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; BUNCH TA, 1992, GENETICS, V132, P519; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Cong JL, 2001, DEVELOPMENT, V128, P2793; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; Denda S, 2007, METHOD ENZYMOL, V426, P203, DOI 10.1016/S0076-6879(07)26010-0; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Geng W, 2000, GENETICS, V156, P1817; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Halfon MS, 2002, GENESIS, V34, P135, DOI 10.1002/gene.10136; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; HENCHCLIFFE C, 1993, DEVELOPMENT, V118, P325; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Huckfeldt RM, 2009, NAT NEUROSCI, V12, P35, DOI 10.1038/nn.2236; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Kapfhammer Josef P., 1992, Current Opinion in Cell Biology, V4, P863, DOI 10.1016/0955-0674(92)90112-P; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Koike-Kumagai M, 2009, EMBO J, V28, P3879, DOI 10.1038/emboj.2009.312; KOLB H, 1992, J COMP NEUROL, V318, P147, DOI 10.1002/cne.903180204; KRAMER AP, 1985, J NEUROSCI, V5, P768; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; Lunde K, 1998, DEVELOPMENT, V125, P4145; MARIANI AP, 1990, J COMP NEUROL, V301, P382, DOI 10.1002/cne.903010305; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nakamoto T, 2004, CURR BIOL, V14, pR121, DOI 10.1016/j.cub.2004.01.020; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Sdrulla AD, 2006, CEREBELLUM, V5, P105, DOI 10.1080/14734220600620908; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Stevens A, 2002, J NEUROSCI, V22, P4448, DOI 10.1523/JNEUROSCI.22-11-04448.2002; Sugimura K, 2003, J NEUROSCI, V23, P3752; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2010, J NEUROSCI, V30, P3579, DOI 10.1523/JNEUROSCI.6319-09.2010; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	65	112	113	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 12	2012	73	1					64	78		10.1016/j.neuron.2011.10.036	http://dx.doi.org/10.1016/j.neuron.2011.10.036			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243747	Green Accepted, Bronze			2022-12-25	WOS:000299446800008
J	Oesch, NW; Diamond, JS				Oesch, Nicholas W.; Diamond, Jeffrey S.			Ribbon synapses compute temporal contrast and encode luminance in retinal rod bipolar cells	NATURE NEUROSCIENCE			English	Article							AII AMACRINE CELLS; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; SYNAPTIC DEPRESSION; VISUAL-ADAPTATION; MAMMALIAN RETINA; MOUSE RETINA; LIGHT RESPONSES; CALCIUM CURRENT; FAST EXOCYTOSIS	Contrast is computed throughout the nervous system to encode changing inputs efficiently. The retina encodes luminance and contrast over a wide range of visual conditions and must adapt its responses to maintain sensitivity and to avoid saturation. We examined the means by which one type of adaptation allows individual synapses to compute contrast and encode luminance in biphasic responses to step changes in light levels. Light-evoked depletion of the readily releasable vesicle pool (RRP) at rod bipolar cell ribbon synapses in rat retina limited the dynamic range available to encode transient, but not sustained, responses, thereby allowing the transient and sustained components of release to compute temporal contrast and encode mean light levels, respectively. A release/replenishment model revealed that a single, homogeneous pool of synaptic vesicles is sufficient to generate this behavior and that a partial depletion of the RRP is the dominant mechanism for shaping the biphasic contrast/luminance response.	[Oesch, Nicholas W.; Diamond, Jeffrey S.] Natl Inst Neurol Disorders & Stroke, Synapt Physiol Sect, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Diamond, JS (corresponding author), Natl Inst Neurol Disorders & Stroke, Synapt Physiol Sect, US Natl Inst Hlth, Bethesda, MD USA.	diamondj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629; Oesch, Nicholas/0000-0001-6972-0741	National Institute of Neurological Disorders and Stroke [NS002986]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003039] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Murphy for helpful discussions, and W.W. Kothmann, A. Poleg-Polsky and A. Scimemi for comments on the manuscript. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program (NS002986).	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADELSON EH, 1982, VISION RES, V22, P1299, DOI 10.1016/0042-6989(82)90143-2; Atluri PP, 1998, J NEUROSCI, V18, P8214; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; Berntson A, 2004, VISUAL NEUROSCI, V21, P913, DOI 10.1017/S095252380421611X; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Dunn FA, 2008, NEURON, V57, P894, DOI 10.1016/j.neuron.2008.01.031; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GREEN DG, 1986, VISION RES, V26, P1417, DOI 10.1016/0042-6989(86)90165-3; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Jarsky T, 2011, J NEUROSCI, V31, P11003, DOI 10.1523/JNEUROSCI.2631-11.2011; Jarsky T, 2010, J NEUROSCI, V30, P11885, DOI 10.1523/JNEUROSCI.1415-10.2010; Keen EC, 2006, P NATL ACAD SCI USA, V103, P5537, DOI 10.1073/pnas.0601103103; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; QUASTEL DMJ, 1992, NEUROSCIENCE, V51, P657, DOI 10.1016/0306-4522(92)90305-L; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; Snellman J, 2009, J PHYSIOL-LONDON, V587, P2443, DOI 10.1113/jphysiol.2008.165241; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tian M, 2010, J NEUROSCI, V30, P4650, DOI 10.1523/JNEUROSCI.4212-09.2010; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; WERNER G, 1965, J NEUROPHYSIOL, V28, P359, DOI 10.1152/jn.1965.28.2.359; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058	49	80	81	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1555	U84		10.1038/nn.2945	http://dx.doi.org/10.1038/nn.2945			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22019730	Green Accepted			2022-12-25	WOS:000297546300015
J	Arnold, K; Sarkar, A; Yram, MA; Polo, JM; Bronson, R; Sengupta, S; Seandel, M; Geijsen, N; Hochedlinger, K				Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Bronson, Rod; Sengupta, Sumitra; Seandel, Marco; Geijsen, Niels; Hochedlinger, Konrad			Sox2(+) Adult Stem and Progenitor Cells Are Important for Tissue Regeneration and Survival of Mice	CELL STEM CELL			English	Article							SELF-RENEWAL; IN-VITRO; EXPRESSION; MARKER; DIFFERENTIATION; INDUCTION; SPERMATOGENESIS; IDENTIFICATION; PLURIPOTENCY; MULTIPOTENT	The transcription factor Sox2 maintains the pluripotency of early embryonic cells and regulates the formation of several epithelia during fetal development. Whether Sox2 continues to play a role in adult tissues remains largely unknown. We show here that Sox2 marks adult cells in several epithelial tissues where its expression has not previously been characterized, including the stomach, cervix, anus, testes, lens, and multiple glands. Genetic lineage tracing and transplantation experiments demonstrate that Sox2-expressing cells continuously give rise to mature cell types within these tissues, documenting their self-renewal and differentiation potentials. Consistent with these findings, ablation of Sox2(+) cells in mice results in a disruption of epithelial tissue homeostasis and lethality. Developmental fate mapping reveals that Sox2(+) adult stem cells originate from fetal Sox2(+) tissue progenitors. Thus, our results identify Sox2 expression in numerous adult endodermal and ectodermal stem cell compartments, which are critical for normal tissue regeneration and survival.	[Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Geijsen, Niels; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Geijsen, Niels; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Arnold, Katrin; Sarkar, Abby; Yram, Mary Anna; Polo, Jose M.; Geijsen, Niels; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bronson, Rod] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Sengupta, Sumitra; Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Cornell University	Hochedlinger, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	khochedlinger@helix.mgh.harvard.edu	Sengupta, Sumitra/G-1814-2017	Sengupta, Sumitra/0000-0003-2861-5608; Sarkar, Abby/0000-0001-6101-1721; Polo, Jose M/0000-0002-2531-778X	Harvard Stem Cell Institute; NIH [R01HD058013-01A1]; Kimmel Foundation for Cancer Research; V Foundation for Cancer Research; MGH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Foundation for Cancer Research; V Foundation for Cancer Research; MGH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Laura Prickett-Rice and Kat Folz-Donahoe for assistance with FACS, and Markus Schober, Nimet Maherali, and Matthias Stadtfeld for helpful discussions and critical reading of the manuscript. K.A. and K.H. were supported by a Seed Grant from the Harvard Stem Cell Institute. Additional support to K.H. was from the NIH Director's Innovator Award R01HD058013-01A1, the Kimmel and V Foundations for Cancer Research, and MGH startup funds.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lombaert IMA, 2010, FRONT ORAL BIOL, V14, P90, DOI 10.1159/000313709; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tian H., 2011, NATURE IN PRESS, DOI [10.1038/nature10408, DOI 10.1038/NATURE10408]; Yamada S, 2006, ENDOCR J, V53, P789, DOI 10.1507/endocrj.K06-116; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	46	494	515	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					317	329		10.1016/j.stem.2011.09.001	http://dx.doi.org/10.1016/j.stem.2011.09.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982232	Green Accepted, Bronze			2022-12-25	WOS:000296041200010
J	Luis, TC; Naber, BAE; Roozen, PPC; Brugman, MH; de Haas, EFE; Ghazvini, M; Fibbe, WE; van Dongen, JJM; Fodde, R; Staal, FJT				Luis, Tiago C.; Naber, Brigitta A. E.; Roozen, Paul P. C.; Brugman, Martijn H.; de Haas, Edwin F. E.; Ghazvini, Mehrnaz; Fibbe, Willem E.; van Dongen, Jacques J. M.; Fodde, Riccardo; Staal, Frank J. T.			Canonical Wnt Signaling Regulates Hematopoiesis in a Dosage-Dependent Fashion	CELL STEM CELL			English	Article							STEM-CELL FUNCTION; BETA-CATENIN IMPAIRS; SELF-RENEWAL; MOUSE DEVELOPMENT; APC; DIFFERENTIATION; MODEL; TRANSCRIPTION; EXPRESSION; ACTIVATION	Canonical Wnt signaling has been implicated in the regulation of hematopoiesis. By employing a Wnt-reporter mouse, we observed that Wnt signaling is differentially activated during hematopoiesis, suggesting an important regulatory role for specific Wnt signaling levels. To investigate whether canonical Wnt signaling regulates hematopoiesis in a dosage-dependent fashion, we analyzed the effect of different mutations in the Adenomatous polyposis coli gene (Apc), a negative modulator of the canonical Wnt pathway. By combining different targeted hypomorphic alleles and a conditional deletion allele of Apc, a gradient of five different Wnt signaling levels was obtained in vivo. We here show that different, lineage-specific Wnt dosages regulate hematopoietic stem cells (HSCs), myeloid precursors, and T lymphoid precursors during hematopoiesis. Differential, lineage-specific optimal Wnt dosages provide a unifying concept that explains the differences reported among inducible gain-of-function approaches, leading to either HSC expansion or depletion of the HSC pool.	[Luis, Tiago C.; Naber, Brigitta A. E.; de Haas, Edwin F. E.; van Dongen, Jacques J. M.; Staal, Frank J. T.] Erasmus Univ, Erasmus MC, Dept Immunol, Med Ctr, NL-3015 CE Rotterdam, Netherlands; [Luis, Tiago C.; Naber, Brigitta A. E.; Roozen, Paul P. C.; Brugman, Martijn H.; Fibbe, Willem E.; Staal, Frank J. T.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Ghazvini, Mehrnaz; Fodde, Riccardo] Erasmus Univ, Med Ctr, Erasmus MC, Dept Pathol,Josephine Nefkens Inst, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Staal, FJT (corresponding author), Erasmus Univ, Erasmus MC, Dept Immunol, Med Ctr, NL-3015 CE Rotterdam, Netherlands.	f.j.t.staal@lumc.nl	van Dongen, Jacques J.M./F-8537-2015; Fodde, Riccardo/AAW-9394-2021; Brugman, Martijn/F-3389-2011	van Dongen, Jacques J.M./0000-0001-7686-0021; Fodde, Riccardo/0000-0001-9839-4324; Brugman, Martijn/0000-0003-2675-2705; van Dongen, Jacques J.M./0000-0002-3650-7087; Ghazvini, Mehrnaz/0000-0001-7859-6930; Cunha Luis, Tiago/0000-0002-6305-1257; Naber, Brigitta/0000-0002-0031-6086	Fundacao para a Ciencia e a Tecnologia, Portugal; Association of International Cancer Research (AICR); The Netherlands Organization for Health Research and Development [ZonMW 40-00812-98-09050]; Dutch Cancer Society; Dutch Government [03038]; EU; TuMIC	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Association of International Cancer Research (AICR); The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Cancer Society(KWF Kankerbestrijding); Dutch Government; EU(European Commission); TuMIC	We acknowledge Prof. Dr. L. Parreira (Lisbon, Portugal) for continuous support and discussions and Dr. Bjorn Claussen for help with the Ctnb1<SUP>Delta ex3</SUP> mouse experiments. T.C.L. is supported by "Fundacao para a Ciencia e a Tecnologia, Portugal." F.J.T.S. is supported in part by the Association of International Cancer Research (AICR) and a TOP-Grant from The Netherlands Organization for Health Research and Development (ZonMW 40-00812-98-09050). R.F. is supported by the Dutch Cancer Society, the BSIK program of the Dutch Government (Grant No. 03038; http://www.stemcells.nl), the EU FP6 and FP7 consortia Migrating Cancer Stem Cells program (MCSCs; http://www.mcscs.eu), and TuMIC (integrated concept of tumor metastasis; http://itgmv1.fzk.de/www/tumic/tumic_main.htm).	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Currier N, 2010, GENESIS, V48, P183, DOI 10.1002/dvg.20604; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dervovic D, 2010, SEMIN IMMUNOL, V22, P276, DOI 10.1016/j.smim.2010.04.014; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fodde R, 2003, NAT CELL BIOL, V5, P190, DOI 10.1038/ncb0303-190; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Lane SW, 2010, BLOOD, V115, P3489, DOI 10.1182/blood-2009-11-251728; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Robanus-Maandag EC, 2010, CARCINOGENESIS, V31, P946, DOI 10.1093/carcin/bgq046; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; STAAL FJ, 2008, CELL, V132, P729; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Trowbridge JJ, 2006, NAT IMMUNOL, V7, P1021, DOI 10.1038/ni1006-1021; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Weerkamp F, 2006, P NATL ACAD SCI USA, V103, P3322, DOI 10.1073/pnas.0511299103; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu Q, 2007, J IMMUNOL, V178, P5028, DOI 10.4049/jimmunol.178.8.5028; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	68	222	230	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					345	356		10.1016/j.stem.2011.07.017	http://dx.doi.org/10.1016/j.stem.2011.07.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982234	Bronze			2022-12-25	WOS:000296041200012
J	Zelano, C; Mohanty, A; Gottfried, JA				Zelano, Christina; Mohanty, Aprajita; Gottfried, Jay A.			Olfactory Predictive Codes and Stimulus Templates in Piriform Cortex	NEURON			English	Article							HUMAN VISUAL-CORTEX; SELECTIVE ATTENTION; NEURONAL CIRCUITRY; PREFRONTAL CORTEX; NEURAL MECHANISMS; ODOR PERCEPTION; EVOKED ACTIVITY; IMAGERY MIMICS; HUMAN BRAIN; MODULATION	Neuroscientific models of sensory perception suggest that the brain utilizes predictive codes in advance of a stimulus encounter, enabling organisms to infer forthcoming sensory events. However, it is poorly understood how such mechanisms are implemented in the olfactory system. Combining high-resolution functional magnetic resonance imaging with multivariate (pattern-based) analyses, we examined the spatiotemporal evolution of odor perception in the human brain during an olfactory search task. Ensemble activity patterns in anterior piriform cortex (APC) and orbitofrontal cortex (OFC) reflected the attended odor target both before and after stimulus onset. In contrast, prestimulus ensemble representations of the odor target in posterior piriform cortex (PPC) gave way to poststimulus representations of the odor itself. Critically, the robustness of target-related patterns in PPC predicted subsequent behavioral performance. Our findings directly show that the brain generates predictive templates or "search images" in PPC, with physical correspondence to odor-specific pattern representations, to augment olfactory perception.	[Zelano, Christina; Gottfried, Jay A.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Mohanty, Aprajita] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA	Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zelano, C (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	c-zelano@northwestern.edu			National Institute on Deafness and Other Communication Disorders [1R01DC010014, K08DC007653, F32DC010530-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010014, F32DC010530, K08DC007653] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Katherina Hauner, Joel Mainland, and M.-Marsel Mesulam for helpful comments and Katie Phillips for assistance in collecting data. This work is supported by the National Institute on Deafness and Other Communication Disorders grants 1R01DC010014 and K08DC007653 (to J.A.G.) and F32DC010530-01A1 (to C.Z).	Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Bensafi M, 2007, J NEUROPHYSIOL, V98, P3254, DOI 10.1152/jn.00349.2007; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; Djordjevic J, 2005, NEUROIMAGE, V24, P791, DOI 10.1016/j.neuroimage.2004.09.035; Djordjevic J, 2004, PSYCHOL SCI, V15, P143, DOI 10.1111/j.0956-7976.2004.01503001.x; Esterman M, 2010, CEREB CORTEX, V20, P1245, DOI 10.1093/cercor/bhp188; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; FREEMAN WJ, 1981, PERSPECT BIOL MED, V24, P561; FREEMAN WJ, 1983, BIOL PSYCHIAT, V18, P1107; FREEMAN WJ, 1979, BIOL CYBERN, V35, P221, DOI 10.1007/BF00344205; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; Friston KJ, 2005, ANNU REV PSYCHOL, V56, P57, DOI 10.1146/annurev.psych.56.091103.070311; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Good KP, 2010, SCHIZOPHR RES, V124, P60, DOI 10.1016/j.schres.2010.07.010; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HABERLY LB, 1985, CHEM SENSES, V10, P219, DOI 10.1093/chemse/10.2.219; HASSELMO ME, 1990, COLD SPRING HARB SYM, V55, P599; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Johnson BN, 2007, J NEUROSCI METH, V160, P231, DOI 10.1016/j.jneumeth.2006.09.008; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; KUMAR S, 2011, J COGN NEUROSCI; LAING DG, 1992, PHYSIOL BEHAV, V52, P1047, DOI 10.1016/0031-9384(92)90458-E; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Linster C, 2007, NEUROBIOL LEARN MEM, V87, P352, DOI 10.1016/j.nlm.2006.09.011; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mai J.K., 1997, ATLAS HUMAN BRAIN; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Martin C, 2004, J PHYSIOLOGY-PARIS, V98, P467, DOI 10.1016/j.jphysparis.2005.09.003; McMains SA, 2007, J NEUROPHYSIOL, V98, P2110, DOI 10.1152/jn.00538.2007; Mesulam M, 2008, ANN NEUROL, V64, P367, DOI 10.1002/ana.21534; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Plailly J, 2008, J NEUROSCI, V28, P5257, DOI 10.1523/JNEUROSCI.5607-07.2008; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; RAY JP, 1992, J COMP NEUROL, V323, P167, DOI 10.1002/cne.903230204; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Sabri M, 2005, NEUROIMAGE, V25, P969, DOI 10.1016/j.neuroimage.2004.12.033; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Sela L, 2010, EXP BRAIN RES, V205, P13, DOI 10.1007/s00221-010-2348-6; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stevenson RJ, 2007, PERCEPTION, V36, P1821, DOI 10.1068/p5563; Stevenson RJ, 2011, PSYCHIAT RES, V185, P321, DOI 10.1016/j.psychres.2010.07.032; Stokes M, 2009, P NATL ACAD SCI USA, V106, P19569, DOI 10.1073/pnas.0905306106; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Sylvester CM, 2009, J NEUROSCI, V29, P10671, DOI 10.1523/JNEUROSCI.1141-09.2009; Takiguchi N, 2008, CHEM SENSES, V33, P283, DOI 10.1093/chemse/bjm086; Veldhuizen MG, 2007, CHEM SENSES, V32, P569, DOI 10.1093/chemse/bjm025; WALD A, 1949, P NATL ACAD SCI USA, V35, P99, DOI 10.1073/pnas.35.2.99; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Zelano C, 2007, J NEUROPHYSIOL, V97, P1969, DOI 10.1152/jn.01122.2006; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; Zelano C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004965	68	112	115	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					178	187		10.1016/j.neuron.2011.08.010	http://dx.doi.org/10.1016/j.neuron.2011.08.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	833BH	21982378	Green Accepted, Bronze			2022-12-25	WOS:000295856300017
J	Kopp-Scheinpflug, C; Tozer, AJB; Robinson, SW; Tempel, BL; Hennig, MH; Forsythe, ID				Kopp-Scheinpflug, Cornelia; Tozer, Adam J. B.; Robinson, Susan W.; Tempel, Bruce L.; Hennig, Matthias H.; Forsythe, Ian D.			The Sound of Silence: Ionic Mechanisms Encoding Sound Termination	NEURON			English	Article							SUPERIOR PARAOLIVARY NUCLEUS; RAT MEDIAL NUCLEUS; CURRENT I-H; TRAPEZOID BODY; INFERIOR COLLICULUS; RESPONSE PROPERTIES; COCHLEAR NUCLEUS; PRINCIPAL CELLS; AUDITORY-SYSTEM; OLIVARY COMPLEX	Offset responses upon termination of a stimulus are crucial for perceptual grouping and gap detection. These gaps are key features of vocal communication, but an ionic mechanism capable of generating fast offsets from auditory stimuli has proven elusive. Offset firing arises in the brainstem superior paraolivary nucleus (SPN), which receives powerful inhibition during sound and converts this into precise action potential (AP) firing upon sound termination. Whole-cell patch recording in vitro showed that offset firing was triggered by IPSPs rather than EPSPs. We show that AP firing can emerge from inhibition through integration of large IPSPs, driven by an extremely negative chloride reversal potential (E-Cl), combined with a large hyperpolarization-activated nonspecific cationic current (I-H), with a secondary contribution from a T-type calcium conductance (I-TCa). On activation by the IPSP, I-H potently accelerates the membrane time constant, so when the sound ceases, a rapid repolarization triggers multiple offset APs that match onset timing accuracy.	[Kopp-Scheinpflug, Cornelia; Tozer, Adam J. B.; Robinson, Susan W.; Forsythe, Ian D.] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England; [Tempel, Bruce L.] Univ Washington, VM Bloedel Hearing Res Ctr, Seattle, WA 98195 USA; [Tempel, Bruce L.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA; [Hennig, Matthias H.] Univ Edinburgh, Inst Adapt & Neural Computat, Sch Informat, Edinburgh EH8 9AB, Midlothian, Scotland; [Hennig, Matthias H.] Ctr Syst Biol Edinburgh, Edinburgh EH9 3JD, Midlothian, Scotland	University of Leicester; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Edinburgh	Forsythe, ID (corresponding author), Univ Leicester, MRC Toxicol Unit, Hodgkin Bldg, Leicester LE1 9HN, Leics, England.	idf@le.ac.uk	; Steinert, Joern R/A-6678-2008	Forsythe, Ian/0000-0001-8216-0419; Kopp-Scheinpflug, Conny/0000-0002-8083-6232; Hennig, Matthias/0000-0001-7270-5817; Steinert, Joern R/0000-0003-1640-0845	Medical Research Council(MRC), UK [G0900425]; NIH [DC002793]; MRC [MC_U132681855, G0900425] Funding Source: UKRI; Medical Research Council [G0900425, MC_U132681855] Funding Source: researchfish	Medical Research Council(MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK, MRC Fellowship G0900425 (M.H.), and NIH DC002793 (B.T.). We are grateful to Matt Nolan and Derrick Garden for providing the HCN1 knockout mice and thank Sarah J. Griffin for initial implementation of our Neuron models. Author contributions: C.K.-S., conducted experiments, analyzed and interpreted data, and jointly wrote the manuscript; A.J.B.T. conducted calcium current experiments; S.W.R. conducted immunohistochemistry; B.L.T. supported and advised on in vivo experiments; M.H.H. developed the computational model in consultation with I.D.F. and C.K.-S.; and I.D.F. conceived of the project jointly with C.K.-S., designed experiments, interpreted data, and jointly wrote the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Alvina K, 2008, NAT NEUROSCI, V11, P1256, DOI 10.1038/nn.2195; Aman TK, 2007, BIOPHYS J, V92, P1938, DOI 10.1529/biophysj.106.093500; Aubie B, 2009, J NEUROSCI, V29, P9255, DOI 10.1523/JNEUROSCI.1085-09.2009; Bal R, 2000, J NEUROPHYSIOL, V84, P806, DOI 10.1152/jn.2000.84.2.806; BANKS MI, 1992, J NEUROSCI, V12, P2819; Barnes-Davies M, 2004, EUR J NEUROSCI, V19, P325, DOI 10.1111/j.0953-816X.2003.03133.x; Behrend O, 2002, J NEUROPHYSIOL, V87, P2915, DOI 10.1152/jn.2002.87.6.2915; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Bottjer SW, 2005, NEURON, V46, P4, DOI 10.1016/j.neuron.2005.03.020; BRUDZYNSKI SM, 1993, PHYSIOL BEHAV, V54, P215, DOI 10.1016/0031-9384(93)90102-L; Cooper AJ, 2000, J PHYSIOL-LONDON, V527, P291, DOI 10.1111/j.1469-7793.2000.t01-1-00291.x; Covey E, 1999, ANNU REV PHYSIOL, V61, P457, DOI 10.1146/annurev.physiol.61.1.457; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; Dehmel S, 2002, HEARING RES, V172, P18, DOI 10.1016/S0378-5955(02)00353-2; Grothe B, 2000, MICROSC RES TECHNIQ, V51, P382, DOI 10.1002/1097-0029(20001115)51:4<382::AID-JEMT7>3.0.CO;2-7; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Holmstrom LA, 2010, J NEUROSCI, V30, P802, DOI 10.1523/JNEUROSCI.1964-09.2010; Hooper SL, 2002, NAT NEUROSCI, V5, P552, DOI 10.1038/nn838; Johnston J, 2008, J PHYSIOL-LONDON, V586, P3493, DOI 10.1113/jphysiol.2008.153734; Kadner A, 2008, NEUROSCIENCE, V151, P868, DOI 10.1016/j.neuroscience.2007.11.008; Kadner A, 2006, J NEUROPHYSIOL, V95, P1499, DOI 10.1152/jn.00902.2005; Kaila K, 1997, J NEUROSCI, V17, P7662; Koch U, 2003, J NEUROPHYSIOL, V90, P3679, DOI 10.1152/jn.00375.2003; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Kopp-Scheinpflug C, 2003, J NEUROSCI, V23, P9199, DOI 10.1523/jneurosci.23-27-09199.2003; Kulesza RJ, 2008, HEARING RES, V241, P52, DOI 10.1016/j.heares.2008.04.010; Kulesza RJ, 2003, J NEUROPHYSIOL, V89, P2299, DOI 10.1152/jn.00547.2002; KUWABARA N, 1991, J COMP NEUROL, V314, P684, DOI 10.1002/cne.903140405; KUWABARA N, 1991, J COMP NEUROL, V314, P707, DOI 10.1002/cne.903140406; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P215, DOI 10.1113/jphysiol.1988.sp017287; Lohrke S, 2005, EUR J NEUROSCI, V22, P2708, DOI 10.1111/j.1460-9568.2005.04465.x; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Oertel D, 2008, NEUROSCIENCE, V154, P77, DOI 10.1016/j.neuroscience.2008.01.085; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Plack CJ, 2000, J ACOUST SOC AM, V108, P1162, DOI 10.1121/1.1287022; Pollak GD, 2011, HEARING RES, V273, P134, DOI 10.1016/j.heares.2010.03.083; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; Rudolph M, 2005, NEURAL COMPUT, V17, P2301, DOI 10.1162/0899766054796932; Saldana E, 2000, ANAT EMBRYOL, V202, P265, DOI 10.1007/s004290000109; Saldana E, 2009, NEUROSCIENCE, V163, P372, DOI 10.1016/j.neuroscience.2009.06.030; SCHOFIELD BR, 1995, J COMP NEUROL, V360, P135, DOI 10.1002/cne.903600110; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Snell KB, 2000, J ACOUST SOC AM, V107, P1615, DOI 10.1121/1.428446; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; SOMMER I, 1993, EXP BRAIN RES, V95, P223; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Walton JP, 2010, HEARING RES, V264, P63, DOI 10.1016/j.heares.2010.03.002; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Xie R, 2007, J NEUROSCI, V27, P9469, DOI 10.1523/JNEUROSCI.2865-07.2007; ZOOK JM, 1982, J COMP NEUROL, V207, P1, DOI 10.1002/cne.902070102	59	79	83	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 8	2011	71	5					911	925		10.1016/j.neuron.2011.06.028	http://dx.doi.org/10.1016/j.neuron.2011.06.028			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	820AM	21903083	Bronze			2022-12-25	WOS:000294877900015
J	Freeman, J; Simoncelli, EP				Freeman, Jeremy; Simoncelli, Eero P.			Metamers of the ventral stream	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; OBJECT RECOGNITION; AREA V2; NEURONS; SELECTIVITY; MODEL; REPRESENTATION; INTEGRATION; ATTENTION; MASKING	The human capacity to recognize complex visual patterns emerges in a sequence of brain areas known as the ventral stream, beginning with primary visual cortex (V1). We developed a population model for mid-ventral processing, in which nonlinear combinations of V1 responses are averaged in receptive fields that grow with eccentricity. To test the model, we generated novel forms of visual metamers, stimuli that differ physically but look the same. We developed a behavioral protocol that uses metameric stimuli to estimate the receptive field sizes in which the model features are represented. Because receptive field sizes change along the ventral stream, our behavioral results can identify the visual area corresponding to the representation. Measurements in human observers implicate visual area V2, providing a new functional account of neurons in this area. The model also explains deficits of peripheral vision known as crowding, and provides a quantitative framework for assessing the capabilities and limitations of everyday vision.	[Freeman, Jeremy; Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University	Freeman, J (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	freeman@cns.nyu.edu		Simoncelli, Eero/0000-0002-1206-527X	National Science Foundation; Howard Hughes Medical Institute	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We would like to thank R. Rosenholtz for early inspiration and discussions regarding the relationship between texture and crowding, N. Rust for discussions about the nature of information represented in the ventral stream, C. Anderson for discussions about the scaling of receptive fields with eccentricity, M. Landy, A. Girshick and R. Goris for advice on experimental design, C. Ekanadham and U. Rajashaker for advice on the model and analysis, and D. Ganguli, D. Heeger, J. McDermott, E. Merriam and C. Ziemba for comments on the initial manuscript. This work was supported by a National Science Foundation Graduate Student Fellowship to J. F. and a Howard Hughes Medical Institute Investigatorship to E.P.S.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Balas B, 2008, PATTERN RECOGN, V41, P972, DOI 10.1016/j.patcog.2007.08.007; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Chung STL, 2007, VISION RES, V47, P3150, DOI 10.1016/j.visres.2007.08.017; David SV, 2006, J NEUROPHYSIOL, V96, P3492, DOI 10.1152/jn.00575.2006; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GEIGER G, 1992, COGNITIVE BRAIN RES, V1, P39, DOI 10.1016/0926-6410(92)90004-B; Graham N.V.S, 1989, VISUAL PATTERN ANAL; GRANLUND GH, 1978, COMPUT VISION GRAPH, V8, P155, DOI 10.1016/0146-664X(78)90047-3; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Julesz B., 1962, IRE T INFORM THEOR, V8, P84, DOI [10.1109/TIT.1962.1057698, DOI 10.1109/TIT.1962.1057698]; Koenderink J. J., 1997, Algebraic Frames for the Perception-Action Cycle. International Workshop, AFPAC'97. Proceedings, P66, DOI 10.1007/BFb0017861; Kovesi P, 2000, PSYCHOL RES-PSYCH FO, V64, P136, DOI 10.1007/s004260000024; LeCun Y., 1989, ADV NEURAL INFORM PR, V2, DOI DOI 10.1111/DSU.12130; Lettvin JY, 1976, SCIENCES, V16, P10, DOI [10.1002/j.2326-1951.1976.tb01231.x, DOI 10.1002/J.2326-1951.1976.TB01231.X]; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; MACMILLAN NA, 1977, PSYCHOL REV, V84, P452, DOI 10.1037/0033-295X.84.5.452; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rodionova EI, 2004, EXP BRAIN RES, V158, P373, DOI 10.1007/s00221-004-1967-1; Rolls E. T., 2009, OBJECT CATEGORIZATIO, P257, DOI [10.1017/CBO9780511635465.015, DOI 10.1017/CB09780511635465.015]; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; Schmid AM, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.015.2009; Scolari M, 2007, J VISION, V7, DOI 10.1167/7.2.7; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V10, P375, DOI 10.3758/BF03207464; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wandell B.A., 1995, FDN VISION; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Zoccolan D, 2007, J NEUROSCI, V27, P12292, DOI 10.1523/JNEUROSCI.1897-07.2007	50	345	349	2	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1195	U130		10.1038/nn.2889	http://dx.doi.org/10.1038/nn.2889			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841776	Green Accepted			2022-12-25	WOS:000294284900021
J	Dawlaty, MM; Ganz, K; Powell, BE; Hu, YC; Markoulaki, S; Cheng, AW; Gao, Q; Kim, J; Choi, SW; Page, DC; Jaenisch, R				Dawlaty, Meelad M.; Ganz, Kibibi; Powell, Benjamin E.; Hu, Yueh-Chiang; Markoulaki, Styliani; Cheng, Albert W.; Gao, Qing; Kim, Jongpil; Choi, Sang-Woon; Page, David C.; Jaenisch, Rudolf			Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal Development	CELL STEM CELL			English	Article							ACTIVE DNA DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; CELLS; MICE; COMPLEMENTATION; SPECIFICATION; CONVERSION; GENOME; BRAIN	The Tet family of enzymes (Tet1/2/3) converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). Mouse embryonic stem cells (mESCs) highly express Tet1 and have an elevated level of 5hmC. Tet1 has been implicated in ESC maintenance and lineage specification in vitro but its precise function in development is not well defined. To establish the role of Tet1 in pluripotency and development, we have generated Tet1 mutant mESCs and mice. Tet1(-/-) ESCs have reduced levels of 5hmC and subtle changes in global gene expression, and are pluripotent and support development of live-born mice in tetraploid complementation assay, but display skewed differentiation toward trophectoderm in vitro. Tet1 mutant mice are viable, fertile, and grossly normal, though some mutant mice have a slightly smaller body size at birth. Our data suggest that Tet1 loss leading to a partial reduction in 5hmC levels does not affect pluripotency in ESCs and is compatible with embryonic and postnatal development.	[Dawlaty, Meelad M.; Ganz, Kibibi; Powell, Benjamin E.; Hu, Yueh-Chiang; Markoulaki, Styliani; Cheng, Albert W.; Gao, Qing; Kim, Jongpil; Page, David C.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.; Page, David C.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA; [Cheng, Albert W.] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA; [Choi, Sang-Woon] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Page, David C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts University; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hu, Yueh-Chiang/AAX-2370-2020	Powell, Benjamin/0000-0003-2533-8262; Hu, Yueh-Chiang/0000-0002-7992-0525; Cheng, Albert/0000-0003-2653-5743	Boehringer Ingelheim; Croucher; NIH [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R01CA087869, R37CA084198] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); Croucher; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.M.D is a Damon Runyon Fellow. B.E.P is supported by a Ph.D. fellowship from the Boehringer Ingelheim Fonds. A.W.C. is supported by a Croucher scholarship. D.C.P is an HHMI investigator. R.J. is funded by NIH grants 5-RO1-HDO45022, 5-R37-CA084198, and 5-RO1-CA087869. R.J. is an adviser to Stemgent and cofounder of Fate Therapeutics.	Dawlaty MM, 2006, METHODS, V39, P370, DOI 10.1016/j.ymeth.2006.06.009; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	21	369	382	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					166	175		10.1016/j.stem.2011.07.010	http://dx.doi.org/10.1016/j.stem.2011.07.010			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816367	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000293990900013
J	Abe, K; Watanabe, D				Abe, Kentaro; Watanabe, Dai			Songbirds possess the spontaneous ability to discriminate syntactic rules	NATURE NEUROSCIENCE			English	Article							MALE ZEBRA FINCHES; LANGUAGE-ACQUISITION; SONG-DISCRIMINATION; NEURAL MECHANISMS; CONSPECIFIC SONG; BIRDSONG; SPEECH; LESIONS; NEUROBIOLOGY; ORGANIZATION	Whether the computational systems in language perception involve specific abilities in humans is debated. The vocalizations of songbirds share many features with human speech, but whether songbirds possess a similar computational ability to process auditory information as humans is unknown. We analyzed their spontaneous discrimination of auditory stimuli and found that the Bengalese finch (Lonchura striata var. domestica) can use the syntactical information processing of syllables to discriminate songs). These finches were also able to acquire artificial grammatical rules from synthesized syllable strings and to discriminate novel auditory information according to them. We found that a specific brain region was involved in such discrimination and that this ability was acquired postnatally through the encounter with various conspecific songs. Our results indicate that passerine songbirds spontaneously acquire the ability to process hierarchical structures, an ability that was previously supposed to be specific to humans.	[Abe, Kentaro; Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan; [Abe, Kentaro] Japan Sci & Technol Agcy, Saitama, Japan; [Watanabe, Dai] Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Abe, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan.	k.abe.789@gmail.com	Abe, Kentaro/T-2247-2019	Abe, Kentaro/0000-0002-3923-6323	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Science and Technology Agency; Sumitomo Foundation; Inamori Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sumitomo Foundation; Inamori Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank N. Yokoi, M. Wajima and F. Ageta for maintenance of animals, as well as members of Watanabe laboratory for various suggestions and K. Fujita for critical reading of the initial manuscript. This work was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (K.A.) and of the Ministry of Education, Culture, Sports, Science and Technology in Japan (D.W.), the Precursory Research for Embryonic Science and Technology program of Japan Science and Technology Agency (K.A.) and scientific research grants from the Sumitomo Foundation (K.A.), the Inamori Foundation (K.A.) and Takeda Science Foundation (D.W.).	Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2004, TRENDS COGN SCI, V8, P245, DOI 10.1016/S1364-6613(04)00116-0; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Hauser MD, 2007, LANG LEARN DEV, V3, P101, DOI 10.1080/15475440701225394; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; MARLER P, 1970, AM SCI, V58, P669; MARLER P, 1985, ANIM BEHAV, V33, P57, DOI 10.1016/S0003-3472(85)80120-2; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Pinker Steven, 1994, LANGUAGE INSTINCT; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Stripling R, 1997, J NEUROSCI, V17, P3883; van Heijningen CAA, 2009, P NATL ACAD SCI USA, V106, P20538, DOI 10.1073/pnas.0908113106; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; Wahl M, 2008, NEURON, V59, P695, DOI 10.1016/j.neuron.2008.07.011	50	125	129	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1067	U173		10.1038/nn.2869	http://dx.doi.org/10.1038/nn.2869			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706017				2022-12-25	WOS:000293123700022
J	Chiang, LY; Poole, K; Oliveira, BE; Duarte, N; Sierra, YAB; Bruckner-Tuderman, L; Koch, M; Hu, J; Lewin, GR				Chiang, Li-Yang; Poole, Kate; Oliveira, Beatriz E.; Duarte, Neuza; Sierra, Yinth Andrea Bernal; Bruckner-Tuderman, Leena; Koch, Manuel; Hu, Jing; Lewin, Gary R.			Laminin-332 coordinates mechanotransduction and growth cone bifurcation in sensory neurons	NATURE NEUROSCIENCE			English	Article							MECHANOSENSITIVE ION CHANNELS; DORSAL-ROOT GANGLION; EPIDERMOLYSIS-BULLOSA; NEURITE OUTGROWTH; EXPRESSION; CELLS; SKIN; CLASSIFICATION; INNERVATION; SUBTYPES	Laminin-332 is a major component of the dermo-epidermal skin basement membrane and maintains skin integrity. The transduction of mechanical force into electrical signals by sensory endings in the skin requires mechanosensitive channels. We found that mouse epidermal keratinocytes produce a matrix that is inhibitory for sensory mechanotransduction and that the active molecular component is laminin-332. Substrate-bound laminin-332 specifically suppressed one type of mechanosensitive current ( rapidly adapting) independently of integrin-receptor activation. This mechanotransduction suppression could be exerted locally and was mediated by preventing the formation of protein tethers necessary for current activation. We also found that laminin-332 could locally control sensory axon branching behavior. Loss of laminin-332 in humans led to increased sensory terminal branching and may lead to a de-repression of mechanosensitive currents. These previously unknown functions for this matrix molecule may explain some of the extreme pain experienced by individuals with epidermolysis bullosa who are deficient in laminin-332.	[Chiang, Li-Yang; Poole, Kate; Duarte, Neuza; Sierra, Yinth Andrea Bernal; Hu, Jing; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Chiang, Li-Yang; Poole, Kate; Duarte, Neuza; Sierra, Yinth Andrea Bernal; Hu, Jing; Lewin, Gary R.] Charite, D-13353 Berlin, Germany; [Oliveira, Beatriz E.; Koch, Manuel] Univ Cologne, Inst Oral & Musculoskeletal Biol, Ctr Biochem, Dept Dermatol, Cologne, Germany; [Oliveira, Beatriz E.; Koch, Manuel] Univ Cologne, Ctr Mol Med Cologne, Fac Med, Cologne, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, Dept Dermatol, Freiburg, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, Freiburg Inst Adv Studies, Sch Life Sci LifeNet, Freiburg, Germany; [Hu, Jing] Ctr Integrat Neurosci, Tubingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Cologne; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany.	jing.hu@cin.uni-tuebingen.de; glewin@mdc-berlin.de	Lewin, Gary R/B-8028-2011; Hu, Jing/G-2092-2011; Poole, Kate/G-1830-2011; Koch, Manuel/AAG-9914-2021	Poole, Kate/0000-0003-0879-6093; Koch, Manuel/0000-0002-2962-7814; Duarte, Neuza/0000-0001-5695-0775; Lewin, Gary/0000-0002-2890-6352	Deutsche Forschungsgemeinschaft; Federal Ministry of Education and Research (BMBF); von Humboldt fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); von Humboldt fellowship	We thank members of the Lewin laboratory for advice and comments on the manuscript. H. Thranhardt and A. Wegner provided excellent technical support. We thank R. Bonsch for performing the western blot for laminin-332. We also thank M. Bastmeyer and A. von Philipsborn for their help in establishing the micro-contact printing method in the laboratory. We are grateful to B. Erdmann for help and advice with the TEM experiments. This work was supported by grants from the Deutsche Forschungsgemeinschaft (G.R.L. and M.K.), a Network Epidermolysis Bullosa grant from the Federal Ministry of Education and Research (BMBF, L.B.-T.) and a von Humboldt fellowship (J.H.).	Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Aumailley M, 2003, MATRIX BIOL, V22, P49, DOI 10.1016/S0945-053X(03)00013-1; Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; BRUCKERTUDERMAN L, 2003, DERMATOLOGY, P1483; Culley B, 2001, NEUROSCI LETT, V301, P83, DOI 10.1016/S0304-3940(01)01615-9; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-1; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Fine JD, 2004, CLIN EXP DERMATOL, V29, P122, DOI 10.1111/j.1365-2230.2004.01428.x; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Halata Z., 1975, MECHANORECEPTORS MAM; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Herod J, 2002, PAEDIATR ANAESTH, V12, P388, DOI 10.1046/j.1460-9592.2002.00768.x; Hu J, 2010, EMBO J, V29, P855, DOI 10.1038/emboj.2009.398; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Jensen KB, 2003, MOL CELL PROTEOMICS, V2, P61, DOI 10.1074/mcp.M200049-MCP200; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; KRUGER L, 1989, J COMP NEUROL, V280, P291, DOI 10.1002/cne.902800210; Lechner SG, 2009, J PHYSIOL-LONDON, V587, P3493, DOI 10.1113/jphysiol.2009.175059; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; LEWIN GR, 1991, J NEUROPHYSIOL, V66, P1205, DOI 10.1152/jn.1991.66.4.1205; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Masunaga T, 1996, J HISTOCHEM CYTOCHEM, V44, P1223, DOI 10.1177/44.11.8918896; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Plopper G, 1996, J CELL SCI, V109, P1965; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Sann SB, 2008, J NEUROSCI, V28, P2366, DOI 10.1523/JNEUROSCI.3828-07.2008; Simone DA, 1998, J NEUROSCI, V18, P8947; Sinclair D., 1981, MECH CUTANEOUS SENSA; TOMASELLI KJ, 1993, J NEUROSCI, V13, P4880; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; Uitto J, 2004, AM J MED GENET C, V131C, P61, DOI 10.1002/ajmg.c.30035; VERRANDO P, 1994, LAB INVEST, V71, P567; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251; von Philipsborn AC, 2006, DEVELOPMENT, V133, P2487, DOI 10.1242/dev.02412; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Xia YP, 1996, J CELL BIOL, V132, P727, DOI 10.1083/jcb.132.4.727; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	45	46	46	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					993	U79		10.1038/nn.2873	http://dx.doi.org/10.1038/nn.2873			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21725315				2022-12-25	WOS:000293123700012
J	Fournier, J; Monier, C; Pananceau, M; Fregnac, Y				Fournier, Julien; Monier, Cyril; Pananceau, Marc; Fregnac, Yves			Adaptation of the simple or complex nature of V1 receptive fields to visual statistics	NATURE NEUROSCIENCE			English	Article							CATS STRIATE CORTEX; UNDERLYING CONTRAST ADAPTATION; INFORMATION-TRANSMISSION; RESPONSE MODULATION; INHIBITORY NEURONS; STIMULUS CONTRAST; SPATIAL SUMMATION; SIMPLE CELLS; CONNECTIVITY; SYSTEM	Receptive fields in primary visual cortex (V1) are categorized as simple or complex, depending on their spatial selectivity to stimulus contrast polarity. We studied the dependence of this classification on visual context by comparing, in the same cell, the synaptic responses to three classical receptive field mapping protocols: sparse noise, ternary dense noise and flashed Gabor noise. Intracellular recordings revealed that the relative weights of simple-like and complex-like receptive field components were scaled so as to make the same receptive field more simple-like with dense noise stimulation and more complex-like with sparse or Gabor noise stimulations. However, once these context-dependent receptive fields were convolved with the corresponding stimulus, the balance between simple-like and complex-like contributions to the synaptic responses appeared to be invariant across input statistics. This normalization of the linear/nonlinear input ratio suggests a previously unknown form of homeostatic control of V1 functional properties, optimizing the network nonlinearities to the statistical structure of the visual input.	[Fournier, Julien; Monier, Cyril; Pananceau, Marc; Fregnac, Yves] CNRS, Unite Neurosci Informat & Complexite, UPR 3293, Gif Sur Yvette, France; [Pananceau, Marc] Univ Paris 11, Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Fournier, J (corresponding author), CNRS, Unite Neurosci Informat & Complexite, UPR 3293, Gif Sur Yvette, France.	Fournier@unic.cnrs-gif.fr; fregnac@unic.cnrs-gif.fr		Fournier, Julien/0000-0001-7167-8132	CNRS; Agence Nationale de la Recherche; European community [FP6-2004-IST-FETPI 15879, FP7-2009-ICT-FET 243914]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); European community(European Commission)	We are thankful to G. Sadoc for his invaluable technical assistance in developing the stimulation software and kernel analysis library tools. We thank A. Davison for comments and suggestions on the manuscript. We are thankful to Z. Kisvarday and K. Sari for their help in the biocytin labeling protocol. We acknowledge the financial support of CNRS, the Agence Nationale de la Recherche (Natstats and V1-Complex), European community contracts Facets (FP6-2004-IST-FETPI 15879) and Brain-i-nets (FP7-2009-ICT-FET 243914).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Crowder NA, 2007, J NEUROPHYSIOL, V98, P1155, DOI 10.1152/jn.00433.2007; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Higley MJ, 2007, J NEUROPHYSIOL, V97, P3819, DOI 10.1152/jn.00098.2007; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SO YT, 1981, J NEUROPHYSIOL, V45, P107, DOI 10.1152/jn.1981.45.1.107; STRYKER M, 1972, VISION RES, V12, P2005, DOI 10.1016/0042-6989(72)90054-5; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Troyer TW, 1998, J NEUROSCI, V18, P5908; Victor JD, 2006, J NEUROPHYSIOL, V95, P379, DOI 10.1152/jn.00498.2005; Victor JD, 2009, J NEUROPHYSIOL, V102, P3414, DOI 10.1152/jn.00086.2009; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Westwick D. T., 2003, IDENTIFICATION NONLI; Yeh CI, 2009, P NATL ACAD SCI USA, V106, P14652, DOI 10.1073/pnas.0907406106	49	43	43	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1053	U156		10.1038/nn.2861	http://dx.doi.org/10.1038/nn.2861			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21765424	Green Submitted			2022-12-25	WOS:000293123700020
J	Hu, ZT; Pym, ECG; Babu, K; Murray, ABV; Kaplan, JM				Hu, Zhitao; Pym, Edward C. G.; Babu, Kavita; Murray, Amy B. Vashlishan; Kaplan, Joshua M.			A Neuropeptide-Mediated Stretch Response Links Muscle Contraction to Changes in Neurotransmitter Release	NEURON			English	Article							DENSE-CORE VESICLE; CAENORHABDITIS-ELEGANS LACKING; SYNAPTIC-TRANSMISSION; MASS-SPECTROMETRY; C. ELEGANS; SYNAPTOBREVIN; DROSOPHILA; RECEPTOR; MUTANTS; PDF	Although Caenorhabditis elegans has been utilized extensively to study synapse formation and function, relatively little is known about synaptic plasticity in C. elegans. We show that a brief treatment with the cholinesterase inhibitor aldicarb induces a form of presynaptic potentiation whereby ACh release at neuromuscular junctions (NMJs) is doubled. Aldicarb-induced potentiation was eliminated by mutations that block processing of proneuropeptides, by mutations inactivating a single proneuropeptide (NLP-12), and by those inactivating an NLP-12 receptor (CKR-2). NLP-12 expression is limited to a single stretch-activated neuron, DVA. Analysis of a YFP-tagged NLP-12 suggests that aldicarb stimulates DVA secretion of NLP-12. Mutations disrupting the DVA mechanoreceptor (TRP-4) decreased aldicarb-induced NLP-12 secretion and blocked aldicarb-induced synaptic potentiation. Mutants lacking NLP-12 or CKR-2 have decreased locomotion rates. Collectively, these results suggest that NLP-12 mediates a mechanosensory feedback loop that couples muscle contraction to changes in presynaptic release, thereby providing a mechanism for proprioceptive control of locomotion.	[Hu, Zhitao; Pym, Edward C. G.; Babu, Kavita; Murray, Amy B. Vashlishan; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hu, Zhitao; Pym, Edward C. G.; Babu, Kavita; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Murray, Amy B. Vashlishan] Emerson Coll, Dept Commun Sci & Disorders, Boston, MA 02116 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	Babu, Kavita/O-1913-2017; hu, zhitao/H-5626-2011	Babu, Kavita/0000-0002-7527-3666; Hu, Zhitao/0000-0002-2948-3339	NIH [DK80215]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following for strains and reagents: Liliane Schoofs, Tom Janssen, Shawn Xu, and the C. elegans Genetics Stock Center. We thank members of the Kaplan laboratory for critical comments on the manuscript. This work was supported by an NIH research grant to J.M.K. (DK80215).	BRENNER S, 1974, GENETICS, V77, P71; Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Dittman JS, 2008, J NEUROSCI, V28, P7104, DOI 10.1523/JNEUROSCI.0378-08.2008; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Husson SJ, 2007, FEBS LETT, V581, P4288, DOI 10.1016/j.febslet.2007.08.003; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Jacob TC, 2003, J NEUROSCI, V23, P2122; Janssen T, 2008, ENDOCRINOLOGY, V149, P2826, DOI 10.1210/en.2007-1772; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; McVeigh P, 2006, INT J PARASITOL, V36, P633, DOI 10.1016/j.ijpara.2006.01.009; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nonet ML, 1998, J NEUROSCI, V18, P70; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wicks SR, 1996, J NEUROSCI, V16, P4017	38	53	56	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 14	2011	71	1					92	102		10.1016/j.neuron.2011.04.021	http://dx.doi.org/10.1016/j.neuron.2011.04.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745640	Green Accepted, Bronze			2022-12-25	WOS:000292806200009
J	La Marca, R; Cerri, F; Horiuchi, K; Bachi, A; Feltri, ML; Wrabetz, L; Blobel, CP; Quattrini, A; Salzer, JL; Taveggia, C				La Marca, Rosa; Cerri, Federica; Horiuchi, Keisuke; Bachi, Angela; Feltri, M. Laura; Wrabetz, Lawrence; Blobel, Carl P.; Quattrini, Angelo; Salzer, James L.; Taveggia, Carla			TACE (ADAM17) inhibits Schwann cell myelination	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); PERIPHERAL-NERVE MYELINATION; AMYLOID PRECURSOR PROTEIN; CONVERTING-ENZYME; ALPHA-SECRETASE; LIPID RAFTS; NEUREGULIN-1; BACE1; REMYELINATION; EXPRESSION	Tumor necrosis factor-alpha-converting enzyme (TACE; also known as ADAM17) is a proteolytic sheddase that is responsible for the cleavage of several membrane-bound molecules. We report that TACE cleaves neuregulin-1 (NRG1) type III in the epidermal growth factor domain, probably inactivating it (as assessed by deficient activation of the phosphatidylinositol-3-OH kinase pathway), and thereby negatively regulating peripheral nervous system (PNS) myelination. Lentivirus-mediated knockdown of TACE in vitro in dorsal root ganglia neurons accelerates the onset of myelination and results in hypermyelination. In agreement, motor neurons of conditional knockout mice lacking TACE specifically in these cells are significantly hypermyelinated, and small-caliber fibers are aberrantly myelinated. Further, reduced TACE activity rescues hypomyelination in NRG1 type III haploinsufficient mice in vivo. We also show that the inhibitory effect of TACE is neuron-autonomous, as Schwann cells lacking TACE elaborate myelin of normal thickness. Thus, TACE is a modulator of NRG1 type III activity and is a negative regulator of myelination in the PNS.	[La Marca, Rosa; Cerri, Federica; Quattrini, Angelo; Taveggia, Carla] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [La Marca, Rosa; Cerri, Federica; Quattrini, Angelo; Taveggia, Carla] Ist Sci San Raffaele, Inst Expt Neurol, I-20132 Milan, Italy; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Bachi, Angela; Feltri, M. Laura; Wrabetz, Lawrence] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Blobel, Carl P.] Cornell Univ, Hosp Special Surg, Weill Med Coll, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Salzer, James L.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Salzer, James L.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Salzer, James L.] NYU, Sch Med, Smilow Neurosci Program, New York, NY USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Keio University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Cornell University; New York University; New York University; New York University	Taveggia, C (corresponding author), Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy.	taveggia.carla@hsr.it	Horiuchi, Keisuke/L-2277-2013; Cerri, Federica/AAO-1670-2020; Messier, Claude/A-2322-2008; Feltri, Maria Laura/J-5286-2018; bachi, angela/B-3527-2015; Taveggia, Carla/AAN-4784-2020; Quattrini, Angelo/J-8373-2018	Horiuchi, Keisuke/0000-0001-7063-9609; Messier, Claude/0000-0002-4791-1763; bachi, angela/0000-0003-4842-6556; Quattrini, Angelo/0000-0002-8226-8320; La Marca, Rosa/0000-0002-9478-5296; Salzer, James/0000-0001-9126-7197	Federazione Italiana Sclerosi Multipla (FISM) [2007/PC/01]; Compagnia di San Paolo; US National Institute of Health [R01-NS045630, R01-NS055256, R01-GM64750, RO1-NS26001]; Telethon Italia [GGP08021, GGP071100, GPP10007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055256, R01NS026001, R01NS045630] Funding Source: NIH RePORTER	Federazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Compagnia di San Paolo(Compagnia di San Paolo); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon Italia(Fondazione Telethon); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Arber (University of Basel) for providing the HB9-cre transgenic line, M. Filbin (Hunter College) for antibodies, P. Podini for assistance with electron microscopy, G. Dina and A. Cattaneo for technical support and Y. Poitelon for artwork. This study was supported by the Federazione Italiana Sclerosi Multipla (FISM) (grant 2007/PC/01) and the Compagnia di San Paolo (C. T.); by the US National Institute of Health (grants R01-NS045630 (M. L. F.), R01-NS055256 (L. W.), R01-GM64750 (C. P. B.) and RO1-NS26001 (J.L.S.)); by Telethon Italia (grants GGP08021 (M. L. F.), GGP071100 (L. W.) and GPP10007 (C. T., L. W. and M. L. F.)). C. T. is a recipient of a FISM Transition Career Award.	Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; BURGESS TL, 1995, J BIOL CHEM, V270, P19188, DOI 10.1074/jbc.270.32.19188; Buser AM, 2009, EUR J NEUROSCI, V29, P2276, DOI 10.1111/j.1460-9568.2009.06785.x; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; DONALD D, 1934, J COMP NEUROL, V60, P437; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; Frenzel KE, 2001, J NEUROCHEM, V77, P1; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Fricker FR, 2009, J NEUROSCI, V29, P7667, DOI 10.1523/JNEUROSCI.6053-08.2009; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; KOO EH, 1994, J BIOL CHEM, V269, P17386; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Meyer D, 1997, DEVELOPMENT, V124, P3575; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Ozkaynak E, 2010, J NEUROSCI, V30, P3857, DOI 10.1523/JNEUROSCI.6287-09.2010; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita K, 2007, GLIA, V55, P1199, DOI 10.1002/glia.20533; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wakatsuki S, 2009, J BIOL CHEM, V284, P2957, DOI 10.1074/jbc.M803191200; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Wrabetz L, 1998, J NEUROBIOL, V34, P10, DOI 10.1002/(SICI)1097-4695(199801)34:1<10::AID-NEU2>3.0.CO;2-F; Yang HC, 2004, J NEUROCHEM, V91, P1249, DOI 10.1111/j.1471-4159.2004.02764.x; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	50	105	106	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					857	U73		10.1038/nn.2849	http://dx.doi.org/10.1038/nn.2849			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21666671	Green Accepted			2022-12-25	WOS:000292081700013
J	Renna, JM; Weng, SJ; Berson, DM				Renna, Jordan M.; Weng, Shijun; Berson, David M.			Light acts through melanopsin to alter retinal waves and segregation of retinogeniculate afferents	NATURE NEUROSCIENCE			English	Article							GANGLION-CELLS; PHOTORECEPTORS; NETWORK	Waves of correlated activity sweeping across the early postnatal mouse retina promote the segregation and refinement of retinofugal projections. This process has been thought to be spontaneous and unaffected by visual experience. We found, however, that light prolongs spiking during the waves and enhances the segregation of retinogeniculate afferents, and that it did so by activating melanopsin-expressing, intrinsically photosensitive retinal ganglion cells.	[Renna, Jordan M.; Weng, Shijun; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Renna, JM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	jordan_renna@brown.edu			US National Institutes of Health [EY012793, EY017137, EY020108]; NATIONAL EYE INSTITUTE [F32EY020108, R01EY012793, R01EY017137] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Hattar for sharing his Opn4<SUP>Cre</SUP> mouse line, J. Gandy for assistance with data processing and D. Boghossian for technical assistance. In addition, we would like to thank M. Crair and O. Dhande for advice on ocular injection techniques. This work was supported by US National Institutes of Health R01 grants EY012793 and EY017137, and F32 grant EY020108.	Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Rich KA, 1997, J COMP NEUROL, V388, P47; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644	15	52	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					827	829		10.1038/nn.2845	http://dx.doi.org/10.1038/nn.2845			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21642974	Green Accepted			2022-12-25	WOS:000292081700008
J	Fischer, E; Bulthoff, HH; Logothetis, NK; Bartels, A				Fischer, Elvira; Buelthoff, Heinrich H.; Logothetis, Nikos K.; Bartels, Andreas			Human Areas V3A and V6 Compensate for Self-Induced Planar Visual Motion	NEURON			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; POSTERIOR PARIETAL CORTEX; EYE-MOVEMENTS; MACAQUE MONKEY; CORTICAL AREA; HUMAN BRAIN; PERCEPTUAL STABILITY; MST NEURONS; OPTIC FLOW; FMRI	Little is known about mechanisms mediating a stable perception of the world during pursuit eye movements. Here, we used fMRI to determine to what extent human motion-responsive areas integrate planar retinal motion with nonretinal eye movement signals in order to discard self-induced planar retinal motion and to respond to objective ("real") motion. In contrast to other areas, V3A lacked responses to self-induced planar retinal motion but responded strongly to head-centered motion, even when retinally canceled by pursuit. This indicates a near-complete multimodal integration of visual with non-visual planar motion signals in V3A. V3A could be mapped selectively and robustly in every single subject on this basis. V6 also reported head-centered planar motion, even when 3D flow was added to it, but was suppressed by retinal planar motion. These findings suggest a dominant contribution of human areas V3A and V6 to head-centered motion perception and to perceptual stability during eye movements.	[Fischer, Elvira; Bartels, Andreas] Univ Tubingen, Vis & Cognit Lab, Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Fischer, Elvira; Buelthoff, Heinrich H.; Logothetis, Nikos K.; Bartels, Andreas] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea; [Logothetis, Nikos K.] Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M13 9PT, Lancs, England	Eberhard Karls University of Tubingen; Max Planck Society; Korea University; University of Manchester	Bartels, A (corresponding author), Univ Tubingen, Vis & Cognit Lab, Ctr Integrat Neurosci, D-72076 Tubingen, Germany.	andreas.bartels@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Bartels, Andreas/A-9446-2014; Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bartels, Andreas/0000-0002-4939-7817; Bülthoff, Heinrich H/0000-0003-2568-0607; 	Centre of Integrative Neuroscience, Tubingen; Max Planck Society, Germany; WCU (World Class University); Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10008]	Centre of Integrative Neuroscience, Tubingen; Max Planck Society, Germany(Max Planck Society); WCU (World Class University); Ministry of Education, Science and Technology through the National Research Foundation of Korea	This research was supported by the Centre of Integrative Neuroscience, Tubingen, by the Max Planck Society, Germany, and also received support by the WCU (World Class University) program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10008).	Anderson JC, 2005, J COMP NEUROL, V488, P320, DOI 10.1002/cne.20580; Arnoldussen DM, 2011, P NATL ACAD SCI USA, V108, P11668, DOI 10.1073/pnas.1102984108; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Cardin V, 2011, J NEUROPHYSIOL, V106, P1240, DOI 10.1152/jn.01120.2010; Cardin V, 2010, CEREB CORTEX, V20, P1964, DOI 10.1093/cercor/bhp268; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Chukoskie L, 2009, J NEUROPHYSIOL, V102, P3225, DOI 10.1152/jn.90692.2008; Crespi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021661; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; Dicke PW, 2008, EUR J NEUROSCI, V27, P991, DOI 10.1111/j.1460-9568.2008.06054.x; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; ERICKSON RG, 1991, EXP BRAIN RES, V86, P608; Fischer E., 2011, CEREB CORTE IN PRESS; GALLETTI C, 1990, EXP BRAIN RES, V82, P67; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; GIBSON JJ, 1954, PSYCHOL REV, V61, P304, DOI 10.1037/h0061885; GIRARD P, 1991, J NEUROPHYSIOL, V66, P1493, DOI 10.1152/jn.1991.66.5.1493; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Huk AC, 2002, J NEUROSCI, V22, P7195; Ilg UJ, 2004, NEURON, V43, P145, DOI 10.1016/j.neuron.2004.06.006; Lindner A, 2006, J COGNITIVE NEUROSCI, V18, P1899, DOI 10.1162/jocn.2006.18.11.1899; McKeefry DJ, 2008, J NEUROSCI, V28, P6848, DOI 10.1523/JNEUROSCI.1287-08.2008; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Peuskens H, 2001, J NEUROSCI, V21, P2451, DOI 10.1523/JNEUROSCI.21-07-02451.2001; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Royden CS, 2004, NEUROREPORT, V15, P1013, DOI 10.1097/00001756-200404290-00016; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Smith A.T., 2011, CEREB CORTE IN PRESS; Stanton GB, 2005, EXP BRAIN RES, V165, P179, DOI 10.1007/s00221-005-2292-z; Tikhonov A, 2004, NEUROIMAGE, V21, P593, DOI 10.1016/j.neuroimage.2003.09.045; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Trenner MU, 2008, HUM BRAIN MAPP, V29, P300, DOI 10.1002/hbm.20387; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; Zhang T, 2004, NEURON, V42, P993, DOI 10.1016/j.neuron.2004.06.008	48	47	48	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 22	2012	73	6					1228	1240		10.1016/j.neuron.2012.01.022	http://dx.doi.org/10.1016/j.neuron.2012.01.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445349	Bronze			2022-12-25	WOS:000301998700019
J	Xu, W; Morishita, W; Buckmaster, PS; Pang, ZP; Malenka, RC; Sudhof, TC				Xu, Wei; Morishita, Wade; Buckmaster, Paul S.; Pang, Zhiping P.; Malenka, Robert C.; Suedhof, Thomas C.			Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure of Fast Synchronous Synaptic Transmission	NEURON			English	Article							TIMING-DEPENDENT PLASTICITY; PATTERN SEPARATION; PREFRONTAL CORTEX; DENTATE GYRUS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; NEURAL INFORMATION; THETA OSCILLATIONS; REMOTE MEMORIES; HIPPOCAMPUS	Neurons encode information by firing spikes in isolation or bursts and propagate information by spike-triggered neurotransmitter release that initiates synaptic transmission. Isolated spikes trigger neurotransmitter release unreliably but with high temporal precision. In contrast, bursts of spikes trigger neurotransmission reliably (i.e., boost transmission fidelity), but the resulting synaptic responses are temporally imprecise. However, the relative physiological importance of different spike-firing modes remains unclear. Here, we show that knockdown of synaptotagmin-1, the major Ca2+ sensor for neurotransmitter release, abrogated neurotransmission evoked by isolated spikes but only delayed, without abolishing, neurotransmission evoked by bursts of spikes. Nevertheless, knockdown of synaptotagmin-1 in the hippocampal CA1 region did not impede acquisition of recent contextual fear memories, although it did impair the precision of such memories. In contrast, knockdown of synaptotagmin-1 in the prefrontal cortex impaired all remote fear memories. These results indicate that different brain circuits and types of memory employ distinct spike-coding schemes to encode and transmit information.	[Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Xu, Wei; Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Morishita, Wade; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Buckmaster, Paul S.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	tcs1@stanford.edu	Pang, Zhiping/AAF-5757-2020	xu, wei/0000-0003-0987-2481; Pang, Zhiping/0000-0002-6183-1233	NIMH Conte Center [5 P50 MH086403-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH099153, P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER	NIMH Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Mark Kay (Stanford University) and Dr. Eric J. Nestler (Mount Sinai Medical School) for AAV vectors and AAV preparation protocols. This work was supported by NIMH Conte Center project number 5 P50 MH086403-03.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Borst JGG, 2010, TRENDS NEUROSCI, V33, P259, DOI 10.1016/j.tins.2010.03.003; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Britton JC, 2011, DEPRESS ANXIETY, V28, P5, DOI 10.1002/da.20733; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fowler SC, 2003, PSYCHOPHARMACOLOGY, V170, P167, DOI 10.1007/s00213-003-1528-5; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Polsky A, 2009, J NEUROSCI, V29, P11891, DOI 10.1523/JNEUROSCI.5250-08.2009; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rudy JW, 2005, LEARN MEMORY, V12, P445, DOI 10.1101/lm.97905; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Sheffield MEJ, 2011, NAT NEUROSCI, V14, P200, DOI 10.1038/nn.2728; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Varshney LR, 2006, NEURON, V52, P409, DOI 10.1016/j.neuron.2006.10.017; Walker AG, 2008, J NEUROSCI, V28, P8973, DOI 10.1523/JNEUROSCI.2804-08.2008; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	49	117	122	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 8	2012	73	5					990	1001		10.1016/j.neuron.2011.12.036	http://dx.doi.org/10.1016/j.neuron.2011.12.036			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909IQ	22405208	Green Accepted, Bronze			2022-12-25	WOS:000301558600013
J	Dean, HL; Hagan, MA; Pesaran, B				Dean, Heather L.; Hagan, Maureen A.; Pesaran, Bijan			Only Coherent Spiking in Posterior Parietal Cortex Coordinates Looking and Reaching	NEURON			English	Article							EYE-HAND COORDINATION; LOCAL-FIELD POTENTIALS; MOTOR CORTEX; VOLUNTARY MOVEMENT; DECISION-MAKING; CEREBRAL-CORTEX; NEURAL-CONTROL; VISUAL-CORTEX; ARM MOVEMENTS; OSCILLATIONS	Here, we report that temporally patterned, coherent spiking activity in the posterior parietal cortex (PPC) coordinates the timing of looking and reaching. Using a spike-field approach, we identify a population of parietal area LIP neurons that fire spikes coherently with 15 Hz beta-frequency LFP activity. The firing rate of coherently active neurons predicts the reaction times (RTs) of coordinated reach-saccade movements but not of saccades when made alone. Area LIP neurons that do not fire coherently do not predict RT of either movement type. Similar beta-band LFP activity is present in the parietal reach region but not nearby visual area V3d. This suggests that coherent spiking activity in PPC can control reaches and saccades together. We propose that the neural mechanism of coordination involves a shared representation that acts to slow or speed movements together.	[Dean, Heather L.; Hagan, Maureen A.; Pesaran, Bijan] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Pesaran, B (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	bijan@nyu.edu	Hagan, Maureen/O-1005-2019	Hagan, Maureen/0000-0003-4965-2731; Pesaran, Bijan/0000-0003-4116-0038	CRCNS [R01 MH-087882]; NSF CAREER [BCS-0955701]; Patterson Trust; NIH [T32 MN-19524, T32 EY-007136]; Burroughs Wellcome Fund; NYSTAR; McKnight Scholar Award; Sloan Research Fellowship; NATIONAL EYE INSTITUTE [T32EY007136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019524, R01MH087882] Funding Source: NIH RePORTER	CRCNS; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Patterson Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NYSTAR; McKnight Scholar Award; Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Eva Tsui for assistance with animal training, Gerardo Moreno for surgical assistance, Roch Comeau, Stephen Frey and Brian Hynes for customizations to the Brainsight system and Bob Shapley for comments on the manuscript. This work was supported, in part, by CRCNS Program award R01 MH-087882, NSF CAREER Award BCS-0955701, a Fellowship in Brain Circuitry from the Patterson Trust (HLD), NIH Training grant T32 MN-19524 (HLD), NIH Training grant T32 EY-007136 (MAH), a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (BP), a Watson Investigator Program Award from NYSTAR (BP), a McKnight Scholar Award (BP), and a Sloan Research Fellowship (BP).	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 1998, NOVART FDN SYMP, V218, P109; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Barry RJ, 2005, J PSYCHOPHYSIOL, V19, P91, DOI 10.1027/0269-8803.19.2.91; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Boucher L, 2007, PERCEPT PSYCHOPHYS, V69, P785, DOI 10.3758/BF03193779; BOUYER JJ, 1987, NEUROSCIENCE, V22, P863, DOI 10.1016/0306-4522(87)92965-4; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Broadbent D. E., 1971, DECISION STRESS; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carey DP, 2002, PROG BRAIN RES, V140, P311; Chen XM, 2010, J NEUROSCI, V30, P14657, DOI 10.1523/JNEUROSCI.2669-10.2010; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; Dean HL, 2011, J NEUROSCI, V31, P2399, DOI 10.1523/JNEUROSCI.4591-10.2011; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Gaveau V, 2008, NEUROPSYCHOLOGIA, V46, P475, DOI 10.1016/j.neuropsychologia.2007.08.028; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kuhn AA, 2004, BRAIN, V127, P735, DOI 10.1093/brain/awh106; Lee J, 2010, J NEUROPHYSIOL, V104, P2556, DOI 10.1152/jn.01040.2009; Lunenburger L, 2000, EUR J NEUROSCI, V12, P4107, DOI 10.1046/j.1460-9568.2000.00298.x; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Miall RC, 2002, BRAIN COGNITION, V48, P212, DOI 10.1006/brcg.2001.1314; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Neggers SFW, 2002, HUM MOVEMENT SCI, V21, P349, DOI 10.1016/S0167-9457(02)00120-3; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Pesaran B, 2010, CURR OPIN NEUROBIOL, V20, P166, DOI 10.1016/j.conb.2010.03.003; Pesaran B, 2009, NEURON, V61, P1, DOI 10.1016/j.neuron.2008.12.019; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Prablanc C, 2003, PROG BRAIN RES, V142, P155; Prevosto V, 2010, CEREB CORTEX, V20, P214, DOI 10.1093/cercor/bhp091; Reimer J, 2010, J NEUROSCI, V30, P11506, DOI 10.1523/JNEUROSCI.5947-09.2010; REQUIN J, 1995, ACTA PSYCHOL, V90, P81, DOI 10.1016/0001-6918(95)00039-W; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; ROUGEUL A, 1979, ELECTROEN CLIN NEURO, V46, P310, DOI 10.1016/0013-4694(79)90205-0; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Sailer U, 2000, EXP BRAIN RES, V134, P163, DOI 10.1007/s002210000457; Saleh M, 2010, NEURON, V65, P461, DOI 10.1016/j.neuron.2010.02.001; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Song JH, 2009, J NEUROPHYSIOL, V102, P2681, DOI 10.1152/jn.91352.2008; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Zanos T.P., 2010, J NEUROPHYSIOL; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	59	68	71	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 23	2012	73	4					829	841		10.1016/j.neuron.2011.12.035	http://dx.doi.org/10.1016/j.neuron.2011.12.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365554	Green Accepted, Bronze			2022-12-25	WOS:000300815400019
J	Kondo, M; Takei, Y; Hirokawa, N				Kondo, Makoto; Takei, Yosuke; Hirokawa, Nobutaka			Motor Protein KIF1A Is Essential for Hippocampal Synaptogeness and Learning Enhancement in an Enriched Environment	NEURON			English	Article							AMPA RECEPTOR PROPERTIES; NEUROTROPHIC FACTOR; DENTATE GYRUS; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; SPATIAL MEMORY; ADULT MICE; BRAIN; NEUROGENESIS; NEURONS	Environmental enrichment causes a variety of effects on brain structure and function. Brain-derived neurotrophic factor (BDNF) plays an important role in enrichment-induced neuronal changes; however, the precise mechanism underlying these effects remains uncertain. In this study, a specific upregulation of kinesin superfamily motor protein 1A (KIF1A) was observed in the hippocampi of mice kept in an enriched environment and, in hippocampal neurons in vitro, BDNF increased the levels of KIF1A and of KIF1A-mediated cargo transport. Analysis of Bdnf(+/-) and Kif1a(+/-) mice revealed that a lack of KIF1A upregulation resulted in a loss of enrichment-induced hippocampal synaptogenesis and learning enhancement. Meanwhile, KIF1A overexpression promoted synaptogenesis via the formation of presynaptic boutons. These findings demonstrate that KIF1A is indispensable for BDNF-mediated hippocampal synaptogenesis and learning enhancement induced by enrichment. This is a new molecular motor-mediated presynaptic mechanism underlying experience-dependent neuroplasticity.	[Kondo, Makoto; Takei, Yosuke; Hirokawa, Nobutaka] Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Tokyo 1130033, Japan; [Hirokawa, Nobutaka] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia	University of Tokyo; King Abdulaziz University	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Takei, Yosuke/I-1828-2015	Takei, Yosuke/0000-0002-5026-8027	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Sato, H. Fukuda, N. Onouchi, T. Akamatsu, T. Aizawa, and all other members of the Hirokawa laboratory for technical assistance and discussions. This work was supported by a grant-in-aid for specially promoted research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N.H.).	Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Crawley J.N, 2007, WHATS WRONG MY MOUSE, P115; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Fukaya M, 2000, J COMP NEUROL, V426, P572; Gagne J, 1998, BRAIN RES, V799, P16, DOI 10.1016/S0006-8993(98)00451-X; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Naka F, 2005, BRAIN DEV-JPN, V27, P275, DOI 10.1016/j.braindev.2004.07.006; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Sztainberg Y, 2010, NAT PROTOC, V5, P1535, DOI 10.1038/nprot.2010.114; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	50	93	95	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					743	757		10.1016/j.neuron.2011.12.020	http://dx.doi.org/10.1016/j.neuron.2011.12.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365548	Bronze			2022-12-25	WOS:000300815400013
J	Tan, GH; Liu, YY; Hu, XL; Yin, DM; Mei, L; Xiong, ZQ				Tan, Guo-He; Liu, Yuan-Yuan; Hu, Xiao-Ling; Yin, Dong-Min; Mei, Lin; Xiong, Zhi-Qi			Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons	NATURE NEUROSCIENCE			English	Article							SCHIZOPHRENIA-LIKE PSYCHOSIS; NMDA RECEPTORS; EPILEPSY; SEIZURES; MODEL; NRG1; TRKB	Epilepsy is a common and refractory neurological disorder, but the neuronal regulatory mechanisms of epileptogenesis remain largely unclear. Activity-dependent transcription of genes for neurotrophins such as brain-derived neurotrophic factor (BDNF) has been shown to promote epileptogenesis; however, little is known about factors that may act as intrinsic, homeostatic or counterbalancing mechanisms. Using rodent models, here we show that limbic seizure activity upregulated NRG1-ErbB4 signaling and that epileptogenesis was inhibited by infusing NRG1 intracerebrally but exacerbated by neutralizing endogenous NRG1 with soluble ErbB4 extracellular domain, by inhibiting ErbB4 activation or by deleting the Erbb4 gene. Furthermore, specific depletion of ErbB4 in parvalbumin-expressing interneurons abolished NRG1-mediated inhibition of epileptogenesis and promoted kindling progression, resulting in increased spontaneous seizures and exuberant mossy fiber sprouting. In contrast, depleting ErbB4 in CaMKII alpha-positive pyramidal neurons had no effect. Thus, NRG1-induced activation of ErbB4 in parvalbumin-expressing inhibitory interneurons may serve as a critical endogenous negative-feedback mechanism to suppress limbic epileptogenesis.	[Yin, Dong-Min; Mei, Lin] Georgias Hlth Sci Univ, Program Dev Neurobiol, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Yin, Dong-Min; Mei, Lin] Georgias Hlth Sci Univ, Dept Neurol, Inst Mol Med & Genet, Augusta, GA USA; [Tan, Guo-He; Liu, Yuan-Yuan; Hu, Xiao-Ling; Xiong, Zhi-Qi] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Tan, Guo-He; Liu, Yuan-Yuan; Hu, Xiao-Ling; Xiong, Zhi-Qi] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Mei, L (corresponding author), Georgias Hlth Sci Univ, Program Dev Neurobiol, Inst Mol Med & Genet, Augusta, GA 30912 USA.	lmei@georgiahealth.edu; xiongzhiqi@ion.ac.cn	Mei, Lin/G-8755-2012		973 Program [2011CBA00407]; National Natural Science Foundation of China [30925016, 31021063]; Chinese Academy of Sciences [XDA01020305]; US National Institutes of Health	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Gassmann (University of Basel) for kindly supplying us with heart-rescued Erbb4<SUP>-/-</SUP> mice, C. Lai (Indiana University) for Erbb4<SUP>loxP/loxP</SUP> mice, S. Arbor (University of Basel) for Pvalb-cre mice and G. Schutz (German Cancer Research Center) for Camk2a-iCre and Camk2a-CreER mice. We also thank T.-m. Gao (Southern Medical University) for help concerning transgenic mice and M. Sliwkowski (Genentech) for NRG1 We are grateful to J.O. McNamara and M.-M. Poo for their comments on this work. We also thank Y.-J. Xin, X.-Y. Feng, L. Huang, B. Lu and Y. Shen for their help on genotyping, animal models and histological experiments. This work was supported in part by grants from the 973 Program (2011CBA00407), National Natural Science Foundation of China (30925016; 31021063) and Chinese Academy of Sciences (XDA01020305) to Z.Q.X. and from the US National Institutes of Health to L.M.	Backx L, 2009, EUR J HUM GENET, V17, P378, DOI 10.1038/ejhg.2008.180; BERTRAM EH, 1993, BRAIN RES, V625, P295, DOI 10.1016/0006-8993(93)91071-Y; Binder DK, 1999, J NEUROSCI, V19, P1424; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Bob P, 2010, PROG NEURO-PSYCHOPH, V34, P143, DOI 10.1016/j.pnpbp.2009.10.015; BRUTON CJ, 1994, NEUROLOGY, V44, P34, DOI 10.1212/WNL.44.1.34; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; Chen Y., P NATL ACAD SCI US; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Delorenzo RJ, 1999, NEUROSCIENTIST, V5, P86, DOI 10.1177/107385849900500213; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Iyengar SS, 2008, BRAIN RES, V1208, P67, DOI 10.1016/j.brainres.2008.02.045; KIDO H, 1989, JPN J PSYCHIAT NEUR, V43, P433; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pitcher G.M, NAT MED; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rice AC, 1998, ADV BEHAV BIOL, V48, P267; Roysommuti S, 2003, NEUROSCIENCE, V121, P779, DOI 10.1016/S0306-4522(03)00503-7; Sachdev P, 1998, AM J PSYCHIAT, V155, P325, DOI 10.1176/ajp.155.3.325; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; STEVENS JR, 1988, SCHIZOPHR RES, V1, P79, DOI 10.1016/0920-9964(88)90044-8; Stoll SW, 2001, NEOPLASIA, V3, P339, DOI 10.1038/sj.neo.7900170; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009	46	78	83	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					258	266		10.1038/nn.3005	http://dx.doi.org/10.1038/nn.3005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22158510				2022-12-25	WOS:000299603500017
J	Kern, A; Albarran-Zeckler, R; Walsh, HE; Smith, RG				Kern, Andras; Albarran-Zeckler, Rosie; Walsh, Heidi E.; Smith, Roy G.			Apo-Ghrelin Receptor Forms Heteromers with DRD2 in Hypothalamic Neurons and Is Essential for Anorexigenic Effects of DRD2 Agonism	NEURON			English	Article							HORMONE SECRETAGOGUE RECEPTOR; TIME-RESOLVED FRET; FOOD-INTAKE; CONSTITUTIVE ACTIVITY; CROSS-TALK; DOPAMINE; OBESE; EXPRESSION; KINASE; DIMERIZATION	We identified subsets of neurons in the brain that coexpress the dopamine receptor subtype-2 (DRD2) and the ghrelin receptor (GHSR1a). Combination of FRET confocal microscopy and Tr-FRET established the presence of GHSR1a:DRD2 heteromers in hypothalamic neurons. To interrogate function, mice were treated with the selective DRD2 agonist cabergoline, which produced anorexia in wild-type and ghrelin(-/-) mice; intriguingly, ghsr(-/-) mice were refractory illustrating dependence on GHSR1a, but not ghrelin. Elucidation of mechanism showed that formation of GHSR1a:DRD2 heteromers allosterically modifies canonical DRD2 dopamine signaling resulting in G beta gamma subunit-dependent mobilization of [Ca2+](i) independent of GHSR1a basal activity. By targeting the interaction between GHSR1a and DRD2 in wild-type mice with a highly selective GHSR1a antagonist (JMV2959) cabergoline-induced anorexia was blocked. Inhibiting dopamine signaling in subsets of neurons with a GHSR1a antagonist has profound therapeutic implications by providing enhanced selectivity because neurons expressing DRD2 alone would be unaffected.	[Kern, Andras; Albarran-Zeckler, Rosie; Walsh, Heidi E.; Smith, Roy G.] Scripps Florida, Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Smith, RG (corresponding author), Scripps Florida, Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA.	rgsmith@scripps.edu	Kern, Andras/F-2823-2014		US National Institutes of Health [R01AG019230]; NATIONAL INSTITUTE ON AGING [R01AG019230] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors gratefully thank Bryan Wharram for assistance with the food-intake experiments. The drd2<SUP>-/-</SUP> mouse brain was a gift from Emiliana Borelli (Department of Microbiology and Molecular Genetics, University of California Irvine). This work was supported by the grant from the US National Institutes of Health (R01AG019230 to R.G.S.).	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; BUTTON D, 1993, CELL CALCIUM, V14, P663, DOI 10.1016/0143-4160(93)90091-J; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Comings DE, 1996, MOL PSYCHIATR, V1, P325; Costantini VJA, 2011, NEUROENDOCRINOLOGY, V94, P158, DOI 10.1159/000328968; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Feighner SD, 1999, SCIENCE, V284, P2184, DOI 10.1126/science.284.5423.2184; Feighner SD, 1998, MOL ENDOCRINOL, V12, P137, DOI 10.1210/mend.12.1.0051; Fetissov SO, 2002, AM J PHYSIOL-REG I, V283, pR905, DOI 10.1152/ajpregu.00092.2002; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Grouselle D, 2008, J NEUROENDOCRINOL, V20, P1138, DOI 10.1111/j.1365-2826.2008.01770.x; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kern A, 2007, ENDOCRINOLOGY, V148, P1181, DOI 10.1210/en.2006-1086; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Korner J, 2003, OBES RES, V11, P311, DOI 10.1038/oby.2003.46; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; PATCHETT AA, 1995, P NATL ACAD SCI USA, V92, P7001, DOI 10.1073/pnas.92.15.7001; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Pijl H, 2003, EUR J PHARMACOL, V480, P125, DOI 10.1016/j.ejphar.2003.08.100; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Smith RG, 1996, RECENT PROG HORM RES, V51, P261; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992	53	218	224	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					317	332		10.1016/j.neuron.2011.10.038	http://dx.doi.org/10.1016/j.neuron.2011.10.038			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284186	Green Accepted, Bronze			2022-12-25	WOS:000299761600013
J	He, M; Liu, Y; Wang, XW; Zhang, MQ; Hannon, GJ; Huang, ZJ				He, Miao; Liu, Yu; Wang, Xiaowo; Zhang, Michael Q.; Hannon, Gregory J.; Huang, Z. Josh			Cell-Type-Based Analysis of MicroRNA Profiles in the Mouse Brain	NEURON			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CEREBRAL-CORTEX; MESSENGER-RNA; SYSTEMATIC IDENTIFICATION; GABAERGIC NEURONS; ADAR DEAMINASES; IN-VIVO; TARGETS; INTERNEURONS; MIRNAS	MicroRNAs (miRNA) are implicated in brain development and function but the underlying mechanisms have been difficult to study in part due to the cellular heterogeneity in neural circuits. To systematically analyze miRNA expression in neurons, we have established a miRNA tagging and affinity-purification (miRAP) method that is targeted to cell types through the Cre-loxP binary system in mice. Our studies of the neocortex and cerebellum reveal the expression of a large fraction of known miRNAs with distinct profiles in glutamatergic and GABAergic neurons and subtypes of GABAergic neurons. We further detected putative novel miRNAs, tissue or cell type-specific strand selection of miRNAs, and miRNA editing. Our method thus will facilitate a systematic analysis of miRNA expression and regulation in specific neuron types in the context of neuronal development, physiology, plasticity, pathology, and disease models, and is generally applicable to other cell types and tissues.	[He, Miao; Hannon, Gregory J.; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [He, Miao] SUNY Stony Brook, Genet Program, Stony Brook, NY 11790 USA; [Liu, Yu; Wang, Xiaowo; Zhang, Michael Q.] Tsinghua Univ, MOE Key Lab Bioinformat, TNLIST, Dept Automat, Beijing 100084, Peoples R China; [Liu, Yu; Wang, Xiaowo; Zhang, Michael Q.] Tsinghua Univ, Bioinformat Div, TNLIST, Dept Automat, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Dallas, TX 75080 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Tsinghua University; Tsinghua University; University of Texas System; University of Texas Dallas	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu	He, Miao/AAQ-1044-2020; Wang, Xiaowo/K-4886-2012; Hannon, Gregory/AAB-3568-2019	He, Miao/0000-0003-0731-6801; Wang, Xiaowo/0000-0003-2965-8036; Huang, Z. Josh/0000-0003-0592-028X	NIH [MH088661, RC1 MH088661]; CSHL; National Natural Science Foundation of China [60905013, 91019016, 31061160497]; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088661] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSHL; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Ingrid Ibarra, Astrid Desiree Haase, and Assaf Gordon for help with small RNA library preparation and deep sequencing processing, Benjamin Czech and Bing Zhang for help with miRNA northern blotting, Keerthi Krishnan for help with FAGS sorting protocol optimization, and Sang Yong Kim for help with generation of knockin mice. This work was supported in part by NIH MH088661 to M.Q.Z., RC1 MH088661 to Z.J.H., Roberston Neuroscience Fund of CSHL to Z.J.H., and National Natural Science Foundation of China (60905013, 91019016, 31061160497) to X.W., M.Q.Z, and Y.L.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Benjamini Y, 1995, CONTROLLING FALSE DI, DOI [10.1176/ajp.156.6, DOI 10.1176/AJP.156.6]; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Brennicke A, 1999, FEMS MICROBIOL REV, V23, P297, DOI 10.1111/j.1574-6976.1999.tb00401.x; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hobert O, 2010, TRENDS NEUROSCI, V33, P435, DOI 10.1016/j.tins.2010.05.006; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leung WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S3; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Meguro R, 2004, J NEUROCHEM, V91, P144, DOI 10.1111/j.1471-4159.2004.02701.x; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Poole RJ, 2006, CURR BIOL, V16, P2279, DOI 10.1016/j.cub.2006.09.041; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Spierings DC, 2011, BLOOD, V117, P5340, DOI 10.1182/blood-2010-10-316034; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tai HC, 2006, CURR BIOL, V16, pR121, DOI 10.1016/j.cub.2006.02.006; Tang FC, 2008, BIOCHEM BIOPH RES CO, V372, P24, DOI 10.1016/j.bbrc.2008.04.137; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	72	198	201	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 12	2012	73	1					35	48		10.1016/j.neuron.2011.11.010	http://dx.doi.org/10.1016/j.neuron.2011.11.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880YP	22243745	Green Accepted, Bronze			2022-12-25	WOS:000299446800006
J	House, DRC; EIstrott, J; Koh, E; Chung, J; Feldman, DE				House, David R. C.; EIstrott, Justin; Koh, Eileen; Chung, Jason; Feldman, Daniel E.			Parallel Regulation of Feedforward Inhibition and Excitation during Whisker Map Plasticity	NEURON			English	Article							RAT SOMATOSENSORY CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; BARREL CORTEX; CORTICAL INHIBITION; VISUAL-CORTEX; IN-VIVO; STIMULUS SELECTIVITY; SYNAPTIC MECHANISMS; PYRAMIDAL NEURONS	Sensory experience drives robust plasticity of sensory maps in cerebral cortex, but the role of inhibitory circuits in this process is not fully understood. We show that classical deprivation-induced whisker map plasticity in layer 2/3 (L2/3) of rat somatosensory (Si) cortex involves robust weakening of L4-L2/3 feedforward inhibition. This weakening was caused by reduced L4 excitation onto L2/3 fast-spiking (FS) interneurons, which mediate sensitive feedforward inhibition and was partially offset by strengthening of unitary FS to L2/3 pyramidal cell synapses. Weakening of feedforward inhibition paralleled the known weakening of feedforward excitation. As a result, mean excitation-inhibition balance and timing onto L2/3 pyramidal cells were preserved. Thus, reduced feedforward inhibition is a covert compensatory process that can maintain excitatory-inhibitory balance during classical deprivation-induced Hebbian map plasticity.	[House, David R. C.; EIstrott, Justin; Koh, Eileen; Chung, Jason; Feldman, Daniel E.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [House, David R. C.; EIstrott, Justin; Koh, Eileen; Chung, Jason; Feldman, Daniel E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [House, David R. C.] Univ Calif San Diego, Neurosci PhD Program, La Jolla, CA 92093 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego	Feldman, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, 142 LSA 3200, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu		Elstrott, Justin/0000-0001-6694-5929	National Institutes of Health [2R01 NS046652, 1R01 NS073912]; Elizabeth Rennie Endowment for Epilepsy at University of California, Berkeley; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046652, R01NS073912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Rennie Endowment for Epilepsy at University of California, Berkeley; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Massimo Scanziani for experiment suggestions, Chloe Thomas and Luke Bogart for histology assistance, and Kevin Bender for pyramidal cell reconstruction. Supported by National Institutes of Health 2R01 NS046652 and 1R01 NS073912, and the Mary Elizabeth Rennie Endowment for Epilepsy at University of California, Berkeley.	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Bender KJ, 2003, J NEUROSCI, V23, P8759; Broser P, 2008, CEREB CORTEX, V18, P1588, DOI 10.1093/cercor/bhm189; Bruno RM, 2002, J NEUROSCI, V22, P10966; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Cheetham CEJ, 2007, J NEUROSCI, V27, P3456, DOI 10.1523/JNEUROSCI.5143-06.2007; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Drew PJ, 2009, CEREB CORTEX, V19, P331, DOI 10.1093/cercor/bhn085; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Foeller E, 2005, J NEUROPHYSIOL, V94, P4387, DOI 10.1152/jn.00553.2005; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fuchs JL, 1998, J COMP NEUROL, V395, P209; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Helmstaedter M, 2008, J NEUROSCI, V28, P8273, DOI 10.1523/JNEUROSCI.5701-07.2008; Holmgren CD, 2001, J NEUROSCI, V21, P8270; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Hull C, 2009, J NEUROSCI, V29, P9127, DOI 10.1523/JNEUROSCI.5971-08.2009; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Maffei A, 2010, J NEUROSCI, V30, P3304, DOI 10.1523/JNEUROSCI.5340-09.2010; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Poleg-Polsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019463; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	67	75	75	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					819	831		10.1016/j.neuron.2011.09.008	http://dx.doi.org/10.1016/j.neuron.2011.09.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153377	Green Accepted, Bronze			2022-12-25	WOS:000297971100015
J	Iadecola, C; Anrather, J				Iadecola, Costantino; Anrather, Josef			Stroke research at a crossroad: asking the brain for directions	NATURE NEUROSCIENCE			English	Article							ISCHEMIC TOLERANCE; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; NITRIC-OXIDE; EXERCISE; MECHANISMS; PROTECTION; NEUROPROTECTION; INJURY; NEUROBIOLOGY	Ischemic stroke remains a vexing public health problem. Although progress has been made in prevention and supportive care, efforts to protect the brain from ischemic cell death have failed. Thus, no new treatment has made it from bench to bedside since tissue plasminogen activator was introduced in 1996. The brain has a remarkable capacity for self-preservation, illustrated by the protective responses induced by ischemia, preconditioning and exercise. Here we describe the mechanisms underlying brain self-protection, with the goal of identifying features that could provide insight into stroke therapy. Unlike traditional therapeutic approaches based on counteracting selected pathways of the ischemic cascade, endogenous neuroprotection relies on coordinated neurovascular programs that support cerebral perfusion, mitigate the harmful effects of cerebral ischemia and promote tissue restoration. Learning how the brain triggers and implements these protective measures may advance our quest to treat stroke.	[Iadecola, Costantino; Anrather, Josef] Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA	Cornell University	Iadecola, C (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY USA.	coi2001@med.cornell.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	US National Institutes of Health [R37-NS34179, NS35806]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034179, R01NS035806] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants R37-NS34179 and NS35806.	Andjelkovic AV, 2003, J CEREBR BLOOD F MET, V23, P1348, DOI 10.1097/01.WCB.0000091762.61714.FE; Bath PMW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub3; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Digicaylioglu M, 2010, EXPERT OPIN BIOL TH, V10, P937, DOI 10.1517/14712598.2010.481435; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dreixler JC, 2011, EXP EYE RES, V92, P521, DOI 10.1016/j.exer.2011.03.015; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Fagan SC, 2011, TRANSL STROKE RES, V2, P202, DOI 10.1007/s12975-011-0072-6; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Gesuete R, 2011, STROKE, V42, P1445, DOI 10.1161/STROKEAHA.110.603266; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Greenberg David A, 2006, NeuroRx, V3, P458, DOI 10.1016/j.nurx.2006.08.003; Hachinski V, 2010, STROKE, V41, P1084, DOI 10.1161/STROKEAHA.110.586156; Hardingham GE, 2011, ANTIOXID REDOX SIGN, V14, P1421, DOI 10.1089/ars.2010.3573; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Huang SS, 2006, CIRC J, V70, P1070, DOI 10.1253/circj.70.1070; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Johansson A, 2000, J INTERN MED, V247, P179, DOI 10.1046/j.1365-2796.2000.00600.x; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koch S, 2011, STROKE, V42, P1387, DOI 10.1161/STROKEAHA.110.605840; Kunz A., 2008, HDB CLIN NEUROL, V92, P283, DOI 10.1016/S0072-9752(08)01914-3; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Liebeskind DS, 2010, CURR OPIN NEUROL, V23, P36, DOI 10.1097/WCO.0b013e328334da32; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Morris KC, 2011, J CEREBR BLOOD F MET, V31, P1003, DOI 10.1038/jcbfm.2010.229; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P773, DOI 10.1097/01.WCB.0000075009.47474.F9; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen CM, 2011, J THROMB HAEMOST, V9, P404, DOI 10.1111/j.1538-7836.2010.04142.x; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saxena P, 2010, J CARDIAC SURG, V25, P127, DOI 10.1111/j.1540-8191.2009.00820.x; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Stapels M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000502; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Zaheer A, 2006, NEUROCHEM RES, V31, P579, DOI 10.1007/s11064-006-9049-3; Zhang F, 2011, NEUROSCIENCE, V177, P170, DOI 10.1016/j.neuroscience.2011.01.018; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	50	281	294	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1363	1368		10.1038/nn.2953	http://dx.doi.org/10.1038/nn.2953			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030546	Green Accepted			2022-12-25	WOS:000296518600007
J	Maret, S; Faraguna, U; Nelson, AB; Cirelli, C; Tononi, G				Maret, Stephanie; Faraguna, Ugo; Nelson, Aaron B.; Cirelli, Chiara; Tononi, Giulio			Sleep and waking modulate spine turnover in the adolescent mouse cortex	NATURE NEUROSCIENCE			English	Article							SYNAPTIC HOMEOSTASIS; PLASTICITY; INCREASES; WAKE	Cortical development involves synaptic formation and elimination. Although synaptogenesis predominates in the early stages and pruning in the later stages, the two processes are thought to happen concurrently. In adults, synaptic strength is modulated by behavioral state, and we asked whether synaptic remodeling may be affected by sleep and waking states. Using two-photon microscopy in adolescent mice, we found that waking results in a net increase in cortical spines, whereas sleep is associated with net spine loss.	[Maret, Stephanie; Faraguna, Ugo; Nelson, Aaron B.; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Nelson, Aaron B.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.	ccirelli@wisc.edu; gtononi@wisc.edu	Faraguna, Ugo/J-6805-2012	Faraguna, Ugo/0000-0002-4814-7218	US National Institutes of Health; National Institute of Mental Health [1R01MH091326]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091326] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a US National Institutes of Health Director's Pioneer award (to G. T.) and the National Institute of Mental Health (1R01MH091326 to G. T. and C. C.).	Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cirelli C, 2006, J NEUROCHEM, V98, P1632, DOI 10.1111/j.1471-4159.2006.04058.x; DASH MB, 2009, NEUROSCIENCE, V29, P620; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Nikonova EV, 2010, SLEEP, V33, P889, DOI 10.1093/sleep/33.7.889; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010	15	188	189	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1418	1420		10.1038/nn.2934	http://dx.doi.org/10.1038/nn.2934			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21983682	Green Accepted			2022-12-25	WOS:000296518600017
J	Ambasudhan, R; Talantova, M; Coleman, R; Yuan, X; Zhu, SY; Lipton, SA; Ding, S				Ambasudhan, Rajesh; Talantova, Maria; Coleman, Ronald; Yuan, Xu; Zhu, Saiyong; Lipton, Stuart A.; Ding, Sheng			Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions	CELL STEM CELL			English	Article							DIRECT CONVERSION; SOMATIC-CELLS; STEM-CELLS; MIR-124; DIFFERENTIATION; HYBRIDIZATION; EXPRESSION; MICRORNAS	Human induced pluripotent stem cells (hiPSCs) have been generated by reprogramming a number of different somatic cell types using a variety of approaches. In addition, direct reprogramming of mature cells from one lineage to another has emerged recently as an alternative strategy for generating cell types of interest. Here we show that a combination of a microRNA (miR-124) and two transcription factors (MYT1L and BRN2) is sufficient to directly reprogram postnatal and adult human primary dermal fibroblasts (mesoderm) to functional neurons (ectoderm) under precisely defined conditions. These human induced neurons (hiNs) exhibit typical neuronal morphology and marker gene expression, fire action potentials, and produce functional synapses between each other. Our findings have major implications for cell-replacement strategies in neurodegenerative diseases, disease modeling, and neural developmental studies.	[Ambasudhan, Rajesh; Talantova, Maria; Lipton, Stuart A.] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Ambasudhan, Rajesh; Coleman, Ronald; Yuan, Xu; Zhu, Saiyong; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Zhu, Saiyong; Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lipton, SA (corresponding author), Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@sanfordburnham.org; sheng.ding@gladstone.ucsf.edu		Lipton, Stuart/0000-0002-3490-1259	NIH [P01 HD29587, P01 ES016738, P30 NS057096, R01 EY05477]; California Institute for Regenerative Medicine; NICHD; NICHD, NHLBI; NEI; NIMH/NIH; Prostate Cancer Foundation; Fate Therapeutics; Gladstone Institutes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Prostate Cancer Foundation; Fate Therapeutics; Gladstone Institutes(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Marius Wernig (Stanford University) for the generous gift of pBrn2-TetO-FUW and pMyt1I-TetO-FUW plasmids. We thank all members of the Ding lab for helpful discussions, and Wenlin Li and Jem Efe for critical reading of the manuscript. M.T. and S.A.L. were supported in part by NIH grants P01 HD29587, P01 ES016738, P30 NS057096, and R01 EY05477, and by the California Institute for Regenerative Medicine. S.D. was supported by funding from NICHD, NHLBI, NEI, and NIMH/NIH, California Institute for Regenerative Medicine, Prostate Cancer Foundation, Fate Therapeutics, and the Gladstone Institutes. R.A. conceived the study. R.A., MT., SAL., and S.D. designed experiments. R.A. performed viral infections, generated hiN cells, conducted cellular and molecular characterization, and interpreted the results. R.C. assisted in constructing viral vectors. X.Y. assisted in qPCR analysis and the cell culture. X.Y. and R.C. contributed equally to this work. S.Z. assisted in the cell culture. M.T. and SAL. designed, performed, and/or analyzed the electrophysiological assays. R.A. and M.T. produced the figures. R.A., SAL., and S.D. wrote and/or edited the manuscript.	Caiazzo M, 2011, NATURE; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Pang Z.P., 2011, NATURE; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	26	358	396	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					113	118		10.1016/j.stem.2011.07.002	http://dx.doi.org/10.1016/j.stem.2011.07.002			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21802386	Green Accepted, Bronze			2022-12-25	WOS:000293990900008
J	Fancy, SPJ; Harrington, EP; Yuen, TJ; Silbereis, JC; Zhao, C; Baranzini, SE; Bruce, CC; Otero, JJ; Huang, EJ; Nusse, R; Franklin, RJM; Rowitch, DH				Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Zhao, Chao; Baranzini, Sergio E.; Bruce, Charlotte C.; Otero, Jose J.; Huang, Eric J.; Nusse, Roel; Franklin, Robin J. M.; Rowitch, David H.			Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER INJURY; BETA-CATENIN; MULTIPLE-SCLEROSIS; CNS REMYELINATION; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; SIGNALING PATHWAY; DIFFERENTIATION; TRANSCRIPTION; MYELINATION	Permanent damage to white matter tracts, comprising axons and myelinating oligodendrocytes, is an important component of brain injuries of the newborn that cause cerebral palsy and cognitive disabilities, as well as multiple sclerosis in adults. However, regulatory factors relevant in human developmental myelin disorders and in myelin regeneration are unclear. We found that AXIN2 was expressed in immature oligodendrocyte progenitor cells (OLPs) in white matter lesions of human newborns with neonatal hypoxic-ischemic and gliotic brain damage, as well as in active multiple sclerosis lesions in adults. Axin2 is a target of Wnt transcriptional activation that negatively feeds back on the pathway, promoting beta-catenin degradation. We found that Axin2 function was essential for normal kinetics of remyelination. The small molecule inhibitor XAV939, which targets the enzymatic activity of tankyrase, acted to stabilize Axin2 levels in OLPs from brain and spinal cord and accelerated their differentiation and myelination after hypoxic and demyelinating injury. Together, these findings indicate that Axin2 is an essential regulator of remyelination and that it might serve as a pharmacological checkpoint in this process.	[Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, San Francisco, CA USA; [Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Otero, Jose J.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Harrington, Emily P.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Zhao, Chao; Bruce, Charlotte C.; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge, England; [Zhao, Chao; Bruce, Charlotte C.; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Baranzini, Sergio E.] Univ Cambridge, Dept Neurol, Cambridge, England; [Otero, Jose J.; Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Nusse, Roel] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Rowitch, David H.] Univ Calif San Francisco, Div Neonatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Cambridge; University of Cambridge; University of Cambridge; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu	Huang, Eric J./AAH-7997-2019; Otero, Jose/AAI-4891-2020; Baranzini, Sergio/A-9422-2013; Otero, Jose Javier/B-8955-2013	Huang, Eric J./0000-0002-5381-3801; Otero, Jose/0000-0003-0680-4520; Baranzini, Sergio/0000-0003-0067-194X; Harrington, Emily P/0000-0001-6352-8687; Franklin, Robin/0000-0001-6522-2104; Rowitch, David/0000-0002-0079-0060; Yuen, Tracy/0000-0002-3451-9279	National Multiple Sclerosis Society; United Kingdom Multiple Sclerosis Society; US National Institutes of Health [NS040511, NS047572]; University of California, San Francisco; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572, R01NS040511] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); United Kingdom Multiple Sclerosis Society; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Birchmeier for Axin2-lacZ mice. This work was supported by a Promise 2010 grant from the National Multiple Sclerosis Society (to R.J.M.F. and D.H.R.), the United Kingdom Multiple Sclerosis Society (to R.J.M.F.), the US National Institutes of Health (NS040511 and NS047572 to D.H.R.) and the Medical Scientist Training Program at the University of California, San Francisco (to E.P.H.). S.E.B. is a Harry Weaver Neuroscience Scholar of the National Multiple Sclerosis Society. R.N. and D.H.R. are Howard Hughes Medical Institute Investigators.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dao DY, 2010, J ORTHOP RES, V28, P89, DOI 10.1002/jor.20954; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Feigenson K, 2009, MOL CELL NEUROSCI, V42, P255, DOI 10.1016/j.mcn.2009.07.010; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106	37	255	271	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1009	U99		10.1038/nn.2855	http://dx.doi.org/10.1038/nn.2855			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706018	Green Submitted, Green Accepted			2022-12-25	WOS:000293123700014
J	Brockmann, MD; Poschel, B; Cichon, N; Hanganu-Opatz, IL				Brockmann, Marco D.; Poeschel, Beatrice; Cichon, Nicole; Hanganu-Opatz, Ileana L.			Coupled Oscillations Mediate Directed Interactions between Prefrontal Cortex and Hippocampus of the Neonatal Rat	NEURON			English	Article							THETA-RHYTHM; SPINDLE BURSTS; VISUAL-CORTEX; RETINAL WAVES; IN-VIVO; SLEEP; MODEL; SCHIZOPHRENIA; SYNCHRONY; NETWORKS	The coactivation of prefrontal and hippocampal networks in oscillatory rhythms is critical for precise information flow in mnemonic and executive tasks, yet the mechanisms governing its development are still unknown. Here, we demonstrate that already in neonatal rats, patterns of discontinuous oscillatory activity precisely entrain the firing of prefrontal neurons and have distinct spatial and temporal organization over cingulate and prelimbic cortices. Moreover, we show that hippocampal theta bursts drive the generation of neonatal prefrontal oscillations by phase-locking the neuronal firing via axonal pathways. Consequently, functional impairment of the hippocampus reduces the prefrontal activity. With ongoing maturation continuous theta-gamma oscillations emerge and mutually entrain the prejuvenile prefrontal-hippocampal networks. Thus, theta-modulated communication within developing prefrontal-hippocampal networks may be relevant for circuitry refinement and maturation of functional units underlying information storage at adulthood.	[Brockmann, Marco D.; Poeschel, Beatrice; Cichon, Nicole; Hanganu-Opatz, Ileana L.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20251 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hanganu-Opatz, IL (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20251 Hamburg, Germany.	hangop@zmnh.uni-hamburg.de			German Research Foundation [Ha4466/3-1]; German Federal Ministry of Education and Research [01GQ0809]	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank Drs. M. Denker, T. Siapas, A. Sirota, and M. Ding for valuable discussions, Drs. A. Draguhn, S. Grun, and W. Kilb for helpful suggestions and comments on the manuscript, and Dr. G. Schneider and G. Meckenhauser for assistance on statistics. I.L.H.-O. acknowledges support by the Emmy Noether-Program of German Research Foundation (Ha4466/3-1) and the German Federal Ministry of Education and Research (01GQ0809).	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; ANGEVINE JB, 1975, HIPPOCAMPUS, V1, P61; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bertrand JB, 2010, HIPPOCAMPUS, V20, P264, DOI 10.1002/hipo.20628; BOLLES RC, 1964, ANIM BEHAV, V12, P427, DOI 10.1016/0003-3472(64)90062-4; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G., 2006, RHYTHMS BRAIN; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Deller T, 1996, CELL TISSUE RES, V286, P293, DOI 10.1007/s004410050699; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; DREYFUS-BRISAC C, 1962, World Neurol, V3, P5; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Hanganu-Opatz IL, 2010, BRAIN RES REV, V64, P160, DOI 10.1016/j.brainresrev.2010.03.005; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lahtinen H, 2002, J NEUROPHYSIOL, V88, P1469, DOI 10.1152/jn.2002.88.3.1469; Leipsic P. F. O., 1901, LANCET, V158, P1027, DOI [10.1016/S0140-6736(01)01429-5, DOI 10.1016/S0140-6736(01)01429-5]; LEUNG LWS, 1987, BRAIN RES, V407, P68, DOI 10.1016/0006-8993(87)91220-0; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Loveland KA, 2008, NEUROPSYCHOLOGIA, V46, P49, DOI 10.1016/j.neuropsychologia.2007.08.017; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; Mohns EJ, 2008, J NEUROSCI, V28, P10134, DOI 10.1523/JNEUROSCI.1967-08.2008; Mohns EJ, 2010, J NEUROSCI, V30, P3438, DOI 10.1523/JNEUROSCI.4832-09.2010; Moran RJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00200; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; PANG KC, 2010, HIPPOCAMPUS, V17; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Soteropoulos DS, 2006, J NEUROPHYSIOL, V95, P1194, DOI 10.1152/jn.00935.2005; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; SWANSON LW, 1981, BRAIN RES, V217, P150, DOI 10.1016/0006-8993(81)90192-X; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Traub RD, 2000, J NEUROSCI, V20, P2086; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Van Quyen ML, 2008, J NEUROSCI, V28, P6104, DOI 10.1523/JNEUROSCI.0437-08.2008; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P471, DOI 10.1016/j.siny.2006.07.008; Vecchierini MF, 2007, NEUROPHYSIOL CLIN, V37, P311, DOI 10.1016/j.neucli.2007.10.008; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	61	132	132	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 28	2011	71	2					332	347		10.1016/j.neuron.2011.05.041	http://dx.doi.org/10.1016/j.neuron.2011.05.041			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	801JF	21791291	Bronze			2022-12-25	WOS:000293433900016
J	Kao, TJ; Kania, A				Kao, Tzu-Jen; Kania, Artur			Ephrin-Mediated cis-Attenuation of Eph Receptor Signaling Is Essential for Spinal Motor Axon Guidance	NEURON			English	Article							MAMMALIAN VISUAL-SYSTEM; GANGLION-CELL AXONS; TYROSINE KINASE; TRANSMEMBRANE LIGANDS; PATHWAY SELECTION; IN-VITRO; LIMB; EXPRESSION; PHOSPHORYLATION; NEURONS	Axon guidance receptors guide neuronal growth cones by binding in trans to axon guidance ligands in the developing nervous system. Some ligands are coexpressed in cis with their receptors, raising the question of the relative contribution of cis and trans interactions to axon guidance. Spinal motor axons use Eph receptors to select a limb trajectory in response to trans ephrins, while expressing ephrins in cis. We show that changes in motor neuron ephrin expression result in trajectory selection defects mirrored by changes in growth cone sensitivity to ephrins in vitro, arguing for ephrin cis-attenuation of Eph function. Furthermore, the relative contribution of trans-signaling and cis-attenuation is influenced by the subcellular distribution of ephrins to membrane patches containing Eph receptors. Thus, growth cone ephrins are essential for axon guidance in vivo and the balance between cis and trans modes of axon guidance ligand-receptor interaction contributes to the diversity of axon guidance signaling responses.	[Kao, Tzu-Jen; Kania, Artur] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Kania, Artur] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Kania, Artur] McGill Univ, Dept Biol, Div Expt Med, Montreal, PQ H3A 2B2, Canada; [Kania, Artur] McGill Univ, Dept Anat & Cell Biol, Div Expt Med, Montreal, PQ H3A 2B2, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; McGill University	Kania, A (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	artur.kania@ircm.qc.ca		Kania, Artur/0000-0002-5209-2520	Canadian Institutes of Health Research; EJLB foundation [MOP-77556, IG-74068]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EJLB foundation	We thank Uwe Drescher for the ephrin-A5E129K:GFP expression construct, Elena Pasquale for the ephrin-B2DC:GFP expression construct, and Keith Murai for the ephrin-A5 antibody. We also thank Michel Cayouette, Frederic Charron, Chris Law, and Keith Mural for comments on this manuscript, Julie Cardin and Meirong Liang for technical assistance, and Lise Delorme for secretarial assistance. This work was supported by a grant from the Canadian Institutes of Health Research and the EJLB foundation to A.K. (MOP-77556 and IG-74068).	Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; HAMBURGER V, 1951, J MORPHOL, V88, P195; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Imondi R, 2000, DEVELOPMENT, V127, P1397; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kao TJ, 2009, J NEUROSCI, V29, P5690, DOI 10.1523/JNEUROSCI.0265-09.2009; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; KOLODKIN AL, 2011, BIOL, V3; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Moret F, 2007, DEVELOPMENT, V134, P4491, DOI 10.1242/dev.011452; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Nakanishi H, 2007, P NATL ACAD SCI USA, V104, P14442, DOI 10.1073/pnas.0703211104; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	65	98	100	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 14	2011	71	1					76	91		10.1016/j.neuron.2011.05.031	http://dx.doi.org/10.1016/j.neuron.2011.05.031			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745639	Bronze			2022-12-25	WOS:000292806200008
J	Weick, M; Demb, JB				Weick, Michael; Demb, Jonathan B.			Delayed-Rectifier K Channels Contribute to Contrast Adaptation in Mammalian Retinal Ganglion Cells	NEURON			English	Article							PYRAMIDAL NEURONS; BIPOLAR CELLS; POTASSIUM CHANNELS; TEMPORAL CONTRAST; GAIN-CONTROL; INTRINSIC DYNAMICS; VISUAL-ADAPTATION; IN-VIVO; CAT; SALAMANDER	Retinal ganglion cells adapt by reducing their sensitivity during periods of high contrast. Contrast adaptation in the firing response depends on both presynaptic and intrinsic mechanisms. Here, we investigated intrinsic mechanisms for contrast adaptation in OFF Alpha ganglion cells in the in vitro guinea pig retina. Using either visual stimulation or current injection, we show that brief depolarization evoked spiking and suppressed firing during subsequent depolarization. The suppression could be explained by Na channel inactivation, as shown in salamander cells. However, brief hyperpolarization in the physiological range (5-10 mV) also suppressed firing during subsequent depolarization. This suppression was selectively sensitive to blockers of delayed-rectifier K channels (K-DR). In somatic membrane patches, we observed tetraethylammonium-sensitive K-DR currents that activated near -25 mV. Recovery from inactivation occurred at potentials hyperpolarized to V-rest. Brief periods of hyperpolarization apparently remove K-DR inactivation and thereby increase the channel pool available to suppress excitability during subsequent depolarization.	[Weick, Michael; Demb, Jonathan B.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Demb, Jonathan B.] Univ Michigan, Kellogg Eye Ctr, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Demb, JB (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 300 George St,Suite 8100, New Haven, CT 06511 USA.	jonathan.demb@yale.edu		Demb, Jonathan/0000-0003-2227-9041	Research to Prevent Blindness Career Development award; Alfred P. Sloan Foundation; National Institutes of Health [EY14454, EY14454-S1, EY07003]; NATIONAL EYE INSTITUTE [R01EY014454, P30EY007003] Funding Source: NIH RePORTER	Research to Prevent Blindness Career Development award(Research to Prevent Blindness (RPB)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Mania Kupershtok for technical assistance and Dr. Josh Singer for comments on the manuscript. Supported by a Research to Prevent Blindness Career Development award, an Alfred P. Sloan Foundation fellowship and the National Institutes of Health (EY14454; EY14454-S1; core grant EY07003).	Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Baranauskas G, 2007, MOL NEUROBIOL, V35, P129, DOI 10.1007/s12035-007-8001-0; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chouabe C, 1998, MOL PHARMACOL, V54, P695; Colbert CM, 1997, J NEUROSCI, V17, P6512; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Eller P, 2000, BRIT J PHARMACOL, V130, P669, DOI 10.1038/sj.bjp.0703352; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Fukami H, 2005, J NEUROPHYSIOL, V93, P678, DOI 10.1152/jn.00277.2004; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Gaudry KS, 2007, J NEUROPHYSIOL, V98, P1287, DOI 10.1152/jn.00618.2006; Gaudry KS, 2007, J NEUROSCI, V27, P8071, DOI 10.1523/JNEUROSCI.1093-07.2007; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Guan D, 2007, J NEUROPHYSIOL, V97, P1931, DOI 10.1152/jn.00933.2006; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; Holtje M, 2007, J NEUROSCI RES, V85, P19, DOI 10.1002/jnr.21105; Ishida A T, 2000, Arch Soc Esp Oftalmol, V75, P69; KANEDA M, 1991, NEUROSCI RES, V11, P261, DOI 10.1016/0168-0102(91)90009-N; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Lee SC, 2007, J NEUROPHYSIOL, V97, P3790, DOI 10.1152/jn.01241.2006; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Liang ZY, 2010, J NEUROSCI, V30, P5533, DOI 10.1523/JNEUROSCI.4733-09.2010; Mahon S, 2000, J PHYSIOL-LONDON, V527, P345, DOI 10.1111/j.1469-7793.2000.t01-1-00345.x; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Mao BQ, 2002, J COMPUT NEUROSCI, V12, P147, DOI 10.1023/A:1016563028021; Mao BQ, 1998, VISUAL NEUROSCI, V15, P425; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; MAYER ML, 1988, J PHYSIOL-LONDON, V396, P417, DOI 10.1113/jphysiol.1988.sp016970; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; NISTRI A, 1992, J PHYSIOL-LONDON, V457, P575, DOI 10.1113/jphysiol.1992.sp019395; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Perchenet L, 2000, J PHARMACOL EXP THER, V295, P771; Pinto LH, 1998, PROG RETIN EYE RES, V17, P207; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; SPAIN WJ, 1991, J PHYSIOL-LONDON, V434, P609, DOI 10.1113/jphysiol.1991.sp018489; STORM JF, 1993, SEMIN NEUROSCI, V5, P79; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Werblin FS, 2010, VISUAL NEUROSCI, V27, P1, DOI 10.1017/S0952523810000076; YOO Y, 2008, PFLUGERS ARCH, V456, P549; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	59	23	24	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 14	2011	71	1					166	179		10.1016/j.neuron.2011.04.033	http://dx.doi.org/10.1016/j.neuron.2011.04.033			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745646	Green Accepted, Bronze			2022-12-25	WOS:000292806200015
J	Bar-Nur, O; Russ, HA; Efrat, S; Benvenisty, N				Bar-Nur, Ori; Russ, Holger A.; Efrat, Shimon; Benvenisty, Nissim			Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION; SOMATIC-CELLS; IN-VITRO; GENERATION; METHYLATION	Human induced pluripotent stem cells (HiPSCs) appear to be highly similar to human embryonic stem cells (HESCs). Using two genetic lineage-tracing systems, we demonstrate the generation of iPSC lines from human pancreatic islet beta cells. These reprogrammed cells acquired markers of pluripotent cells and differentiated into the three embryonic germ layers. However, the beta cell-derived iPSCs (BiPSCs) maintained open chromatin structure at key beta-cell genes, together with a unique DNA methylation signature that distinguishes them from other PSCs. BiPSCs also demonstrated an increased ability to differentiate into insulin-producing cells both in vitro and in vivo, compared with ESCs and isogenic non-beta iPSCs. Our results suggest that the epigenetic memory may predispose BiPSCs to differentiate more readily into insulin producing cells. These findings demonstrate that HiPSC phenotype may be influenced by their cells of origin, and suggest that their skewed differentiation potential may be advantageous for cell replacement therapy.	[Russ, Holger A.; Efrat, Shimon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Bar-Nur, Ori; Benvenisty, Nissim] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, Stem Cell Unit, IL-91904 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Efrat, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il; nissimb@cc.huji.ac.il	Bar-Nur, Ori/GWQ-5917-2022	Efrat, Shimon/0000-0001-5987-232X	JDRF [31-2008-413]; Integrated Islet Distribution Program; Juvenile Diabetes Research Foundation; Israeli Science Foundation	JDRF(Juvenile Diabetes Research Foundation); Integrated Islet Distribution Program; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israeli Science Foundation(Israel Science Foundation)	Human islets were provided through the JDRF award 31-2008-413 (ECIT Islets for Basic Research Program) and the Integrated Islet Distribution Program. We thank Leeat Anker-Kitai, Sarah Knoller, Galina Weingarten, Adva Maimon, and Inbal Caspi for technical assistance. We thank Ran Elkon for assistance with the statistical analysis. This research was partially supported by the Juvenile Diabetes Research Foundation and the Israeli Science Foundation. This work was performed in partial fulfillment of the requirements for a Ph.D. degree of O.B.-N. and H.A.R. O.B.-N. is a Clore fellow. O.B.N., H.A.R., S.E., and N.B. conceived and designed the study, analyzed the data, and wrote the paper. O.B.N. and H.A.R. preformed the experimental work.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Gao SR, 2003, BIOL REPROD, V69, P48, DOI 10.1095/biolreprod.102.014522; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; RUSS HA, CELL TRANSP IN PRESS; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	439	468	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					17	23		10.1016/j.stem.2011.06.007	http://dx.doi.org/10.1016/j.stem.2011.06.007			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726830	Bronze			2022-12-25	WOS:000293157000006
J	Wunderlich, K; Dayan, P; Dolan, RJ				Wunderlich, Klaus; Dayan, Peter; Dolan, Raymond J.			Mapping value based planning and extensively trained choice in the human brain	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; TEMPORAL DIFFERENCE MODELS; ORBITOFRONTAL CORTEX; BASAL GANGLIA; DECISION-MAKING; PREDICTION ERRORS; STRIATUM; REWARD; REPRESENTATION; COMPUTATIONS	Investigations of the underlying mechanisms of choice in humans have focused on learning from prediction errors, leaving the computational structure of value based planning comparatively underexplored. Using behavioral and neuroimaging analyses of a minimax decision task, we found that the computational processes underlying forward planning are expressed in the anterior caudate nucleus as values of individual branching steps in a decision tree. In contrast, values represented in the putamen pertain solely to values learned during extensive training. During actual choice, both striatal areas showed a functional coupling to ventromedial prefrontal cortex, consistent with this region acting as a value comparator. Our findings point toward an architecture of choice in which segregated value systems operate in parallel in the striatum for planning and extensively trained choices, with medial prefrontal cortex integrating their outputs.	[Wunderlich, Klaus; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England	University of London; University College London; University of London; University College London	Wunderlich, K (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	kwunder@gmail.com		Dolan, Ray/0000-0001-9356-761X; Dayan, Peter/0000-0003-3476-1839	Wellcome Trust [091593/Z/10/Z]; Max Planck Award; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Award(Max Planck Society); Gatsby Charitable Foundation	We thank W. Yoshida and J. Oberg for help with data acquisition, and N. Daw and M. Guitart Masip for their valuable and insightful comments on the manuscript. This study was supported by a Wellcome Trust Program Grant and Max Planck Award (RID. and KM.) and the Gatsby Charitable Foundation (P.D.). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z).	Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; FitzGerald THB, 2010, CURR BIOL, V20, P1823, DOI 10.1016/j.cub.2010.08.048; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1990, NEURAL NETWORKS CONT, P179; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	43	198	200	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					786	791		10.1038/nn.3068	http://dx.doi.org/10.1038/nn.3068			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406551	Green Accepted, Green Published			2022-12-25	WOS:000303270200024
J	de Calignon, A; Polydoro, M; Suarez-Calvet, M; William, C; Adamowicz, DH; Kopeikina, KJ; Pitstick, R; Sahara, N; Ashe, KH; Carlson, GA; Spires-Jones, TL; Hyman, BT				de Calignon, Alix; Polydoro, Manuela; Suarez-Calvet, Marc; William, Christopher; Adamowicz, David H.; Kopeikina, Kathy J.; Pitstick, Rose; Sahara, Naruhiko; Ashe, Karen H.; Carlson, George A.; Spires-Jones, Tara L.; Hyman, Bradley T.			Propagation of Tau Pathology in a Model of Early Alzheimer's Disease	NEURON			English	Article							ENTORHINAL CORTEX; DENTATE GYRUS; SYNAPSE LOSS; PATHOGENETIC IMPLICATIONS; PROTEIN IMMUNOREACTIVITY; HIPPOCAMPAL-FORMATION; ELECTRON-MICROSCOPY; CEREBROSPINAL-FLUID; PERFORANT PATH; NEURONAL LOSS	Neurofibrillary tangles advance from layer II of the entorhinal cortex (EC-II) toward limbic and association cortices as Alzheimer's disease evolves. However, the mechanism involved in this hierarchical pattern of disease progression is unknown. We describe a transgenic mouse model in which overexpression of human tau P301L is restricted to EC-II. Tau pathology progresses from EC transgene-expressing neurons to neurons without detectable transgene expression, first to EC neighboring cells, followed by propagation to neurons downstream in the synaptic circuit such as the dentate gyrus, CA fields of the hippocampus, and cingulate cortex. Human tau protein spreads to these regions and coaggregates with endogenous mouse tau. With age, synaptic degeneration occurs in the entorhinal target zone and EC neurons are lost. These data suggest that a sequence of progressive misfolding of tau proteins, circuit-based transfer to new cell populations, and deafferentation induced degeneration are part of a process of tau-induced neurodegeneration.	[de Calignon, Alix; Polydoro, Manuela; Suarez-Calvet, Marc; William, Christopher; Adamowicz, David H.; Kopeikina, Kathy J.; Spires-Jones, Tara L.; Hyman, Bradley T.] Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis,Dept Neurol, Massachusetts Gen Hosp,Alzheimers Dis Res Lab, Charlestown, MA 02129 USA; [de Calignon, Alix] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Suarez-Calvet, Marc] Univ Autonoma Barcelona, Dept Neurol, Hosp Santa Creu & St Pau, Barcelona 08025, Spain; [Kopeikina, Kathy J.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Pitstick, Rose; Carlson, George A.] McLaughlin Res Inst, Great Falls, MT 59405 USA; [Sahara, Naruhiko] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Carlson, George A.] Univ Minnesota, Dept Neurol, Sch Med, Minneapolis, MN 55455 USA	Harvard University; Massachusetts General Hospital; University of Oxford; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Boston University; McLaughlin Research Institute for Biomedical Sciences, Inc.; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities	Hyman, BT (corresponding author), Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis,Dept Neurol, Massachusetts Gen Hosp,Alzheimers Dis Res Lab, Charlestown, MA 02129 USA.	bhyman@partners.org	Suárez-Calvet, Marc/W-8633-2019; Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598; Suarez-Calvet, Marc/0000-0002-2993-569X	Alzheimer's Association; National Institutes of Health [AG08487, AG026249, K08NS069811, K99AG33670, R21AG038835-01A1, R21 NS067127]; American Health Assistance Foundation [A2011086]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067127, K08NS069811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG008487, K99AG033670, R01AG008487, R21AG038835, P50AG005134, R00AG033670, R01AG026249] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by an Alzheimer's Association Zenith award; National Institutes of Health grants AG08487, AG026249, K08NS069811, K99AG33670, R21AG038835-01A1, and R21 NS067127; and American Health Assistance Foundation grant A2011086. We thank Mark Mayford for providing neuropsin-tTA mice, Peter Davies for providing tau antibodies, and Zhanyun Fan, Taylor Friedman, Charles Vanderburg, Ozge Cagsal-Getkin, and Meredith Banigan for technical assistance.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Chin SSM, 1996, J NEUROPATH EXP NEUR, V55, P499; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Franklin K., 2007, MOUSE BRAIN STEREOTA; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; GEINISMAN Y, 1979, BRAIN RES, V168, P485, DOI 10.1016/0006-8993(79)90304-4; GEINISMAN Y, 1977, BRAIN RES, V134, P541, DOI 10.1016/0006-8993(77)90828-9; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; HYMAN BT, 1987, ANN NEUROL, V21, P259, DOI 10.1002/ana.410210307; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; HYMAN BT, 1988, BRAIN RES, V450, P392, DOI 10.1016/0006-8993(88)91582-X; Hyman BT, 1998, J NEUROPATH EXP NEUR, V57, P305, DOI 10.1097/00005072-199804000-00001; HYMAN BT, 1990, NEUROLOGY, V40, P1721, DOI 10.1212/WNL.40.11.1721; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Iliev AI, 2006, J BIOL CHEM, V281, P37195, DOI 10.1074/jbc.M604863200; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; NAKANO I, 1992, ACTA NEUROPATHOL, V83, P228, DOI 10.1007/BF00296783; NISHIMURA M, 1995, AM J PATHOL, V146, P1052; PAPASOZOMENOS SC, 1989, LAB INVEST, V60, P123; PAPASOZOMENOS SC, 1989, LAB INVEST, V60, P375; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; van Groen T, 2001, HIPPOCAMPUS, V11, P397, DOI 10.1002/hipo.1054; VANHOESEN GW, 1975, BRAIN RES, V95, P1, DOI 10.1016/0006-8993(75)90204-8; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; WITTER MP, 1988, NEUROSCI LETT, V85, P193, DOI 10.1016/0304-3940(88)90350-3; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	50	965	980	4	189	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 23	2012	73	4					685	697		10.1016/j.neuron.2011.11.033	http://dx.doi.org/10.1016/j.neuron.2011.11.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365544	Green Accepted, Bronze			2022-12-25	WOS:000300815400009
J	Yang, Y; Shu, XG; Liu, D; Shang, Y; Wu, Y; Pei, L; Xu, X; Tian, Q; Zhang, J; Qian, K; Wang, YX; Petralia, RS; Tu, WH; Zhu, LQ; Wang, JZ; Lu, YM				Yang, Ying; Shu, Xiaogang; Liu, Dan; Shang, You; Wu, Yan; Pei, Lei; Xu, Xin; Tian, Qing; Zhang, Jian; Qian, Kun; Wang, Ya-Xian; Petralia, Ronald S.; Tu, Weihong; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming			EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; RAP1 ACTIVATION; GENE-EXPRESSION; EXCHANGE FACTOR; CELL-DEATH; MICRORNAS; MEMORY; PROTEINS; REVEALS	EPAC proteins are the guanine nucleotide exchange factors that act as the intracellular receptors for cyclic AMP. Two variants of EPAC genes including EPAC1 and EPAC2 are cloned and are widely expressed throughout the brain. But, their functions in the brain remain unknown. Here, we genetically delete EPAC1 (EPAC1(-/-)) EPAC2 (EPAC2(-/-)), or both EPAC1 and EPAC2 genes (EPAC(-/-)) in the fore-brain of mice. We show that EPAC null mutation impairs long-term potentiation (LTP) and that this impairment is paralleled with the severe deficits in spatial learning and social interactions and is mediated in a direct manner by miR-124 transcription and Zif268 translation. Knockdown of miR-124 restores Zif268 and hence reverses all aspects of the EPAC(-/-) phenotypes, whereas expression of miR-124 or knockdown of Zif268 reproduces the effects of EPAC null mutation. Thus, EPAC proteins control miR-124 transcription in the brain for processing spatial learning and social interactions.	[Yang, Ying; Liu, Dan; Pei, Lei; Tian, Qing; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ China, Key Lab Neurol Dis, Wuhan 430030, Peoples R China; [Yang, Ying; Liu, Dan; Pei, Lei; Tian, Qing; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming] Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Shu, Xiaogang; Shang, You; Wu, Yan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Shu, Xiaogang; Shang, You; Wu, Yan; Xu, Xin; Zhang, Jian; Qian, Kun; Tu, Weihong; Lu, Youming] Louisiana State Univ, Sch Med, Dept Neurol, New Orleans, LA 70112 USA; [Shu, Xiaogang; Shang, You; Wu, Yan; Xu, Xin; Zhang, Jian; Qian, Kun; Tu, Weihong; Lu, Youming] Louisiana State Univ, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Wang, Ya-Xian; Petralia, Ronald S.] Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Huazhong University of Science & Technology; Ministry of Education, China; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Louisiana State University System; Louisiana State University System; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Zhu, LQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ China, Key Lab Neurol Dis, Wuhan 430030, Peoples R China.	zhulq@mail.hust.du.cn; wangjz@mail.hust.edu.cn; lym@mail.hust.edu.cn	Yang, Ying/J-3901-2016	zhu, lingqiang/0000-0001-9964-9229; shang, you/0000-0003-4097-6131	National Natural Science Foundation of China [81130079]; National Institute of Health (NIH/NINDS) [R01NS5051383]; NIH/NIA [R01AG033282]; New Century Excellent Talents in University (NCET [10-0421]; NIH/NIDCD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, ZICDC000081] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Century Excellent Talents in University (NCET(Program for New Century Excellent Talents in University (NCET)); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Natural Science Foundation of China (Grant 81130079 YL), National Institute of Health (NIH/NINDS, R01NS5051383Y.L and NIH/NIA R01AG033282Y.L), the New Century Excellent Talents in University (NCET-10-0421, L.-Q.Z.), and the NIH/NIDCD Intramural Program (R.S.P. and Y.-X.W.).	Arvanitis DN, 2010, MOL CELL BIOL, V30, P2508, DOI 10.1128/MCB.01620-09; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Clark AM, 2010, NUCLEIC ACIDS RES, V38, P3780, DOI 10.1093/nar/gkq083; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; FARNSWORTH CL, 1991, CELL, V64, P625, DOI 10.1016/0092-8674(91)90246-U; Fischbach SJ, 2009, NEURON, V63, P714, DOI 10.1016/j.neuron.2009.09.007; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ouyang M, 2008, P NATL ACAD SCI USA, V105, P11993, DOI 10.1073/pnas.0804172105; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Renaudineau S, 2009, P NATL ACAD SCI USA, V106, P11771, DOI 10.1073/pnas.0900484106; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	58	138	139	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 23	2012	73	4					774	788		10.1016/j.neuron.2012.02.003	http://dx.doi.org/10.1016/j.neuron.2012.02.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899KS	22365550	Green Accepted, Bronze			2022-12-25	WOS:000300815400015
J	Amir-Zilberstein, L; Blechman, J; Sztainberg, Y; Norton, WNJ; Reuveny, A; Borodovsky, N; Tahor, M; Bonkowsky, JL; Bally-Cuif, L; Chen, A; Levkowitz, G				Amir-Zilberstein, Liat; Blechman, Janna; Sztainberg, Yehezkel; Norton, William N. J.; Reuveny, Adriana; Borodovsky, Nataliya; Tahor, Maayan; Bonkowsky, Joshua L.; Bally-Cuif, Laure; Chen, Alon; Levkowitz, Gil			Homeodomain Protein Otp and Activity-Dependent Splicing Modulate Neuronal Adaptation to Stress	NEURON			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-INTERRENAL AXIS; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; GENE-TRANSCRIPTION; MESSENGER-RNA; CELL LINEAGES; RECEPTOR; EXPRESSION	Regulation of corticotropin-releasing hormone (CRH) activity is critical for the animal's adaptation to stressful challenges, and its dysregulation is associated with psychiatric disorders in humans. However, the molecular mechanism underlying this transcriptional response to stress is not well understood. Using various stress paradigms in mouse and zebrafish, we show that the hypothalamic transcription factor Orthopedia modulates the expression of CRH as well as the splicing factor Ataxin 2-Binding Protein-1 (A2BP1/Rbfox-1). We further show that the G protein coupled receptor PAC1, which is a known A2BP1/Rbfox-1 splicing target and an important mediator of CRH activity, is alternatively spliced in response to a stressful challenge. The generation of PAC1-hop messenger RNA isoform by alternative splicing is required for termination of CRH transcription, normal activation of the hypothalamic-pituitary-adrenal axis and adaptive anxiety-like behavior. Our study identifies an evolutionarily conserved biochemical pathway that modulates the neuronal adaptation to stress through transcriptional activation and alternative splicing.	[Amir-Zilberstein, Liat; Blechman, Janna; Reuveny, Adriana; Borodovsky, Nataliya; Tahor, Maayan; Levkowitz, Gil] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Sztainberg, Yehezkel; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sztainberg, Yehezkel] Bar Ilan Univ, Gonda Brain Res Ctr, IL-52900 Ramat Gan, Israel; [Norton, William N. J.; Bally-Cuif, Laure] Inst Neurobiol Alfred Fessard, Lab Neurobiol & Dev, F-91198 Gif Sur Yvette, France; [Bonkowsky, Joshua L.] Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA; [Bonkowsky, Joshua L.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Weizmann Institute of Science; Weizmann Institute of Science; Bar Ilan University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Levkowitz, G (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, POB 26, IL-76100 Rehovot, Israel.	gil.levkowitz@weizmann.ac.il	Norton, William/E-9924-2012; Levkowitz, Gil/AAB-9441-2019	Levkowitz, Gil/0000-0002-3896-1881; Chen, Alon/0000-0003-3625-8233; Bally-Cuif, Laure/0000-0001-6611-6274	German-Israeli Foundation; Israel Science Foundation; Kirk Center for Childhood Cancer and Immunological Disorders; Irvin Green Alzheimer's Research Fund; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA024753] Funding Source: NIH RePORTER	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Kirk Center for Childhood Cancer and Immunological Disorders; Irvin Green Alzheimer's Research Fund; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Thanks are due to Shifra Ben Dor and Dena Leshkowitz for sequence, phylogenetic, and genomic analyses; Raya Eilam for assisting with the immunohistochemistry of Otp; Limor Ziv and Berta Levavi-Sivan for help with the cortisol measurements; Wolfgang Driever and Soojin Ryu for kindly providing the otpa<SUP>m866</SUP> mutant line; Amos Gutnick for graphic illustrations; Chi-Bin Chien for the Tol2kit plasmid vectors; Giselbert Hauptmann for the crh probe; and Mike Fainzilber, Elior Peles, Marnie Halpern, Avraham Yaron, and Amos Gutnick for comments on this manuscript. The research in the Levkowitz laboratory is supported by the German-Israeli Foundation, Israel Science Foundation, Kirk Center for Childhood Cancer and Immunological Disorders, and Irvin Green Alzheimer's Research Fund. G.L. is an incumbent of the Tauro Career Development Chair in Biomedical Research. L.A.-Z designed and performed most of the experiments and collected and analyzed the data. J.B. performed the coimmunoprecipitation and cortisol measurements and participated in PAC1 gain-of-function experiments. A.R., N.B., and M.T. performed the in situ hybridization and immunostaining. J.L.B. generated the transgenic otpb:Gal4 transgenic line. Y.S., A.R., and G.L. performed the novelty stress assay in fish. W.H.J.N. and L.B.-C. designed, performed, and analyzed the larval anxiety-like behavior. Y.S. and A.C. performed stress challenges and PVN dissection procedures in mice. G.L. initiated and headed the project and prepared the figures and the manuscript. All authors discussed the results and contributed to the data interpretation.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Agarwal A, 2005, MOL BRAIN RES, V138, P45, DOI 10.1016/j.molbrainres.2005.03.016; Aguilera G, 1998, TRENDS ENDOCRIN MET, V9, P329, DOI 10.1016/S1043-2760(98)00079-4; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Bardet SM, 2008, BRAIN RES BULL, V75, P231, DOI 10.1016/j.brainresbull.2007.10.037; BARRY TP, 1995, GEN COMP ENDOCR, V97, P57, DOI 10.1006/gcen.1995.1006; Bencan Z, 2008, PHYSIOL BEHAV, V95, P408, DOI 10.1016/j.physbeh.2008.07.009; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Bernier NJ, 2009, FISH PHYSIOL, V28, P235, DOI 10.1016/S1546-5098(09)28006-X; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; Blechman J, 2011, J NEUROSCI, V31, P14835, DOI 10.1523/JNEUROSCI.1798-11.2011; Brunson KL, 2001, MOL PSYCHIATR, V6, P647, DOI 10.1038/sj.mp.4000942; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Fujimoto E, 2011, DEV BIOL, V352, P393, DOI 10.1016/j.ydbio.2011.01.023; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Garcia-Moreno F, 2010, NAT NEUROSCI, V13, P680, DOI 10.1038/nn.2556; Hamshere ML, 2009, BRIT J PSYCHIAT, V195, P23, DOI 10.1192/bjp.bp.108.061424; Hashimoto H, 1996, J COMP NEUROL, V371, P567; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; HERMAN JP, 1989, BRAIN RES, V501, P235, DOI 10.1016/0006-8993(89)90641-0; HERMAN JP, 1992, MOL ENDOCRINOL, V6, P1061, DOI 10.1210/me.6.7.1061; Ishiguro H, 2001, J NEURAL TRANSM, V108, P849, DOI 10.1007/s007020170034; Ishihama T, 2010, BEHAV BRAIN RES, V209, P274, DOI 10.1016/j.bbr.2010.02.009; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kageyama K, 2007, J ENDOCRINOL, V195, P199, DOI 10.1677/JOE-07-0125; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Liu Y, 2008, ENDOCRINOLOGY, V149, P3512, DOI 10.1210/en.2008-0052; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Lyu RM, 2000, J BIOL CHEM, V275, P36134, DOI 10.1074/jbc.M004612200; Ma XM, 1997, J ENDOCRINOL, V152, P81, DOI 10.1677/joe.0.1520081; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Mustafa T, 2007, J BIOL CHEM, V282, P8079, DOI 10.1074/jbc.M609638200; Mustafa T, 2010, CELL SIGNAL, V22, P1420, DOI 10.1016/j.cellsig.2010.05.005; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Peter J, 2002, FRONT NEUROENDOCRIN, V23, P342, DOI 10.1016/S0091-3022(02)00005-5; Pisegna JR, 1996, J BIOL CHEM, V271, P17267, DOI 10.1074/jbc.271.29.17267; Regev L, 2011, MOL PSYCHIATR, V16, P714, DOI 10.1038/mp.2010.64; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; Stouthart AJHX, 1998, J ENDOCRINOL, V157, P127, DOI 10.1677/joe.0.1570127; Stroth N, 2010, NEUROSCIENCE, V165, P1025, DOI 10.1016/j.neuroscience.2009.11.023; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Wolfl S, 1999, MOL ENDOCRINOL, V13, P659, DOI 10.1210/me.13.5.659; WOLMAN M, 2011, DEV NEUROBI IN PRESS; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Yao M, 2007, GEN COMP ENDOCR, V153, P200, DOI 10.1016/j.ygcen.2007.01.046; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	72	41	44	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					279	291		10.1016/j.neuron.2011.11.019	http://dx.doi.org/10.1016/j.neuron.2011.11.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284183	Green Accepted, Bronze			2022-12-25	WOS:000299761600010
J	El Bejjani, R; Hammarlund, M				El Bejjani, Rachid; Hammarlund, Marc			Notch Signaling Inhibits Axon Regeneration	NEURON			English	Article							GAMMA-SECRETASE INHIBITORS; CAENORHABDITIS-ELEGANS; C-ELEGANS; IN-VIVO; MYELIN INHIBITORS; CELL-INTERACTIONS; NERVOUS-SYSTEM; LIN-12 GENE; RECEPTOR; GLP-1	Many neurons have limited capacity to regenerate their axons after injury. Neurons in the mammalian central nervous system do not regenerate, and even neurons in the peripheral nervous system often fail to regenerate to their former targets. This failure is likely due in part to pathways that actively restrict regeneration; however, only a few factors that limit regeneration are known. Here, using single-neuron analysis of regeneration in vivo, we show that Notch/lin-12 signaling inhibits the regeneration of mature C. elegans neurons. Notch signaling suppresses regeneration by acting autonomously in the injured cell to prevent growth cone formation. The metalloprotease and gamma-secretase cleavage events that lead to Notch activation during development are also required for its activity in regeneration. Furthermore, blocking Notch activation immediately after injury improves regeneration. Our results define a postdevelopmental role for the Notch pathway as a repressor of axon regeneration in vivo.	[El Bejjani, Rachid; Hammarlund, Marc] Yale Univ, Sch Med, Dept Genet, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University	Hammarlund, M (corresponding author), Yale Univ, Sch Med, Dept Genet, Program Cellular Neurosci Neurodegenerat & Repair, 295 Congress Ave, New Haven, CT 06510 USA.	marc.hammarlund@yale.edu		El Bejjani, Rachid/0000-0003-2328-0773	Beckman Foundation; Ellison Medical Foundation; National Institutes of Health [R01NS066082]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066082] Funding Source: NIH RePORTER	Beckman Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Iva Greenwald, Anne Hart, and Yishi Jin for helpful discussions and reagents and Daniel Colon-Ramos, Antonio Giraldez, and Mike Hurwitz for comments on the manuscript. Work in the Hammarlund laboratory is supported by the Beckman Foundation, the Ellison Medical Foundation, and National Institutes of Health grant R01NS066082 to M.H. Experiments were designed by Rachid El Bejjani and Marc Hammarlund and were executed by Rachid El Bejjani.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; AUSTIN J, 1989, CELL, V58, P565, DOI 10.1016/0092-8674(89)90437-6; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Chao MY, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-45; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Filbin MT, 2008, NEURON, V60, P740, DOI 10.1016/j.neuron.2008.12.001; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Green Iain, 2005, P1; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Jarriault S, 2005, DEV BIOL, V287, P1, DOI 10.1016/j.ydbio.2005.08.014; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; LAMBIE EJ, 1991, DEVELOPMENT, V112, P231; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Li XJ, 1997, P NATL ACAD SCI USA, V94, P12204, DOI 10.1073/pnas.94.22.12204; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Ouellet J, 2008, DEVELOPMENT, V135, P2583, DOI 10.1242/dev.012435; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Priess James R, 2005, WormBook, P1; QIAO L, 1995, GENETICS, V141, P551; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Singh K, 2011, CURR BIOL, V21, P825, DOI 10.1016/j.cub.2011.04.010; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Solomon A, 2008, DEV BIOL, V316, P191, DOI 10.1016/j.ydbio.2007.12.046; Stiernagle Theresa, 2006, WormBook, P1; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tax FE, 1997, GENETICS, V147, P1675; Wen CH, 1997, DEVELOPMENT, V124, P4759; Wittenburg N, 2000, NATURE, V406, P306, DOI 10.1038/35018575; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	55	63	78	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 26	2012	73	2					268	278		10.1016/j.neuron.2011.11.017	http://dx.doi.org/10.1016/j.neuron.2011.11.017			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EP	22284182	Bronze, Green Accepted			2022-12-25	WOS:000299761600009
J	Lin, Q; Wei, W; Coelho, CM; Li, X; Baker-Andresen, D; Dudley, K; Ratnu, VS; Boskovic, Z; Kobor, MS; Sun, YE; Bredy, TW				Lin, Quan; Wei, Wei; Coelho, Carlos M.; Li, Xiang; Baker-Andresen, Danay; Dudley, Kevin; Ratnu, Vikram S.; Boskovic, Zoran; Kobor, Michael S.; Sun, Yi E.; Bredy, Timothy W.			The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory	NATURE NEUROSCIENCE			English	Article							CALCINEURIN; PLASTICITY; RECEPTORS; CREB; RNAS	MicroRNAs are small non-coding RNAs that mediate post-transcriptional gene silencing. Fear-extinction learning in C57/Bl6J mice led to increased expression of the brain-specific microRNA miR-128b, which disrupted stability of several plasticity-related target genes and regulated formation of fear-extinction memory. Increased miR-128b activity may therefore facilitate the transition from retrieval of the original fear memory toward the formation of a new fear-extinction memory.	[Wei, Wei; Coelho, Carlos M.; Li, Xiang; Baker-Andresen, Danay; Dudley, Kevin; Ratnu, Vikram S.; Boskovic, Zoran; Bredy, Timothy W.] Univ Queensland, Psychiat Epigenom Lab, Queensland Brain Inst, Brisbane, Qld, Australia; [Lin, Quan; Sun, Yi E.] Univ Calif Los Angeles, David Geffen Sch Med, Intellectual Dev & Disabil Res Ctr, Los Angeles, CA 90095 USA; [Kobor, Michael S.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada	University of Queensland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia	Bredy, TW (corresponding author), Univ Queensland, Psychiat Epigenom Lab, Queensland Brain Inst, Brisbane, Qld, Australia.	t.bredy@uq.edu.au	Wei, Wei/C-3471-2016; Coelho, Carlos/A-5065-2010; Boskovic, Zoran/Y-2764-2018	Wei, Wei/0000-0001-5768-7729; Coelho, Carlos/0000-0002-2320-7931; Boskovic, Zoran/0000-0002-9867-1827; Kobor, Michael/0000-0003-4140-1743; Dudley, Kevin/0000-0001-5762-1068; Bredy, Timothy/0000-0003-3280-126X	Michael Smith Foundation for Health Research; US National Institutes of Health [R01 MH084095]; Canadian Institutes of Health Research; National Institute on Drug Abuse [K99DA026503-01]; Australian Research Council [DP1096148]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA026503] Funding Source: NIH RePORTER	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Greengard and A. Nairn for their comments and the generous gift of RCS antibody, G. Quirk and C. Stevenson for suggestions, and R. Tweedale for editing the manuscript. This work was supported by a scholar award from the Michael Smith Foundation for Health Research (M. S. K.), a US National Institutes of Health EUREKA grant (R01 MH084095, Y.E.S.), and previous grants from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the National Institute on Drug Abuse (K99DA026503-01), and a current grant from the Australian Research Council (DP1096148, T.W.B.).	Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lauzon NM, 2009, J NEUROSCI, V29, P4836, DOI 10.1523/JNEUROSCI.0178-09.2009; Lin CH, 2003, J NEUROSCI, V23, P1574; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Mueller D, 2010, BIOL PSYCHIAT, V68, P1055, DOI 10.1016/j.biopsych.2010.08.014; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451	15	133	136	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1115	1117		10.1038/nn.2891	http://dx.doi.org/10.1038/nn.2891			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841775	Green Submitted			2022-12-25	WOS:000294284900009
J	Trenholm, S; Johnson, K; Li, X; Smith, RG; Awatramani, GB				Trenholm, Stuart; Johnson, Kyle; Li, Xiao; Smith, Robert G.; Awatramani, Gautam B.			Parallel Mechanisms Encode Direction in the Retina	NEURON			English	Article							SELECTIVE GANGLION-CELLS; DENDRITIC STRUCTURE; SOLE ASYMMETRY; INPUT; GABA; IDENTIFICATION; INHIBITION; SYNAPSE; MOTION	In the retina, presynaptic inhibitory mechanisms that shape directionally selective (DS) responses in output ganglion cells are well established. However, the nature of inhibition-independent forms of directional selectivity remains poorly defined. Here, we describe a genetically specified set of ON-OFF DS ganglion cells (DSGCs) that code anterior motion. This entire population of DSGCs exhibits asymmetric dendritic arborizations that orientate toward the preferred direction. We demonstrate that morphological asymmetries along with nonlinear dendritic conductances generate a centrifugal (soma-to-dendrite) preference that does not critically depend upon, but works in parallel with the GABAergic circuitry. We also show that in symmetrical DSGCs, such dendritic DS mechanisms are aligned with, or are in opposition to, the inhibitory DS circuitry in distinct dendritic subfields where they differentially interact to promote or weaken directional preferences. Thus, pre- and postsynaptic DS mechanisms interact uniquely in distinct ganglion cell populations, enabling efficient DS coding under diverse conditions.	[Trenholm, Stuart; Johnson, Kyle; Awatramani, Gautam B.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 1X5, Canada; [Li, Xiao; Smith, Robert G.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	Dalhousie University; University of Pennsylvania	Awatramani, GB (corresponding author), Dalhousie Univ, Dept Anat & Neurobiol, 5850 Coll St, Halifax, NS B3H 1X5, Canada.	gba@dal.ca		Trenholm, Stuart/0000-0001-5792-0957	National Eye Institute [EY016607]; Natural Sciences and Engineering Research Council of Canada [342202-2007]; NATIONAL EYE INSTITUTE [R01EY016607] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Drs. W. Baldridge and S. Barnes for useful discussions and for their helpful comments on this manuscript, Dr. R. Brownstone for providing us with the Hb9::eGFP<SUP>+</SUP> transgenic mouse line, and Dr. J. Boyd for his help in writing custom software for two-photon imaging. We also thank Alexander Goroshkov, Priyanka Singh, and Belinda Dunn for providing technical support and Neasa Bheilbigh and Marika Forsythe for help in morphological reconstructions. This work was supported by the National Eye Institute (EY016607) awarded to R.G.S. and by the Natural Sciences and Engineering Research Council of Canada (grant 342202-2007) awarded to G.B.A.	Ackert JM, 2009, J PHYSIOL-LONDON, V587, P4481, DOI 10.1113/jphysiol.2009.173344; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; BULTHOFF H, 1987, BRAIN RES, V407, P152, DOI 10.1016/0006-8993(87)91230-3; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; EGELHAAF M, 1990, BRAIN RES, V509, P156, DOI 10.1016/0006-8993(90)90325-6; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; He SG, 1999, J NEUROSCI, V19, P8049; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Ogmen H, 1991, NEURAL COMPUT, V3, P333, DOI 10.1162/neco.1991.3.3.333; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; RALL W, 1964, NEURAL THEORY MODELI, P72; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Smith RD, 1996, VISUAL NEUROSCI, V13, P423, DOI 10.1017/S0952523800008105; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; VANEY DI, 1994, J NEUROSCI, V14, P6301; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; YANG G, 1994, J NEUROSCI, V14, P5267; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	44	93	95	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					683	694		10.1016/j.neuron.2011.06.020	http://dx.doi.org/10.1016/j.neuron.2011.06.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867884	Green Accepted, Bronze			2022-12-25	WOS:000294521600013
J	Kay, JN; Voinescu, PE; Chu, MW; Sanes, JR				Kay, Jeremy N.; Voinescu, P. Emanuela; Chu, Monica W.; Sanes, Joshua R.			Neurod6 expression defines new retinal amacrine cell subtypes and regulates their fate	NATURE NEUROSCIENCE			English	Article							HORIZONTAL CELLS; MOUSE RETINA; SPECIFICATION; DIVERSITY; PTF1A; INTERNEURONS; INTEGRATION; INHIBITION; SUBSETS; BIASES	Most regions of the CNS contain many subtypes of inhibitory interneurons with specialized roles in circuit function. In the mammalian retina, the similar to 30 subtypes of inhibitory interneurons called amacrine cells (ACs) are generally divided into two groups: wide/medium-field GABAergic ACs and narrow-field glycinergic ACs, which mediate lateral and vertical interactions, respectively, within the inner plexiform layer. We used expression profiling and mouse transgenic lines to identify and characterize two closely related narrow-field AC subtypes. Both arise postnatally and one is neither glycinergic nor GABAergic (nGnG). Two transcription factors selectively expressed by these subtypes, Neurod6 and special AT-rich-sequence-binding protein 2 (Satb2), regulate a postmitotic cell fate choice between these subtypes. Satb2 induces Neurod6, which persists in nGnG ACs and promotes their fate but is downregulated in the related glycinergic AC subtype. Our results support the view that cell fate decisions made in progenitors and their progeny act together to diversify ACs.	[Kay, Jeremy N.; Voinescu, P. Emanuela; Chu, Monica W.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Kay, Jeremy N.; Voinescu, P. Emanuela; Chu, Monica W.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Kay, Jeremy/G-9309-2011		Life Sciences Research Foundation; US National Institutes of Health; Howard Hughes Medical Institute [43667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029169] Funding Source: NIH RePORTER	Life Sciences Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Reed (Johns Hopkins University) for providing anti-Ebf, D. Pow (University of Queensland) for anti-glycine, L. Reichardt (University of California San Francisco) and K. Nave (Max Planck Institute, Gottingen) for Neurod6<SUP>cre</SUP> mice, T. Misgeld and J. Lichtman (Harvard University) for MP mice, R. Born and V. Berezovskii (Harvard University) for macaque retinal tissue and X. Duan for advice and assistance with the retrovirus. J.N.K. was supported by a Life Sciences Research Foundation postdoctoral fellowship. This work was supported by a grant from the US National Institutes of Health to J.R.S. and by Collaborative Innovation Award number 43667 from the Howard Hughes Medical Institute.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Apostolova G, 2010, J NEUROSCI, V30, P16356, DOI 10.1523/JNEUROSCI.3502-10.2010; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Cossart R, 2011, CURR OPIN NEUROBIOL, V21, P160, DOI 10.1016/j.conb.2010.10.003; Davis JA, 1996, J NEUROSCI, V16, P5082; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heinze L, 2007, J COMP NEUROL, V500, P693, DOI 10.1002/cne.21201; Hsueh HA, 2008, J NEUROPHYSIOL, V100, P2077, DOI 10.1152/jn.90417.2008; Inoue T, 2002, DEVELOPMENT, V129, P831; Jiang HS, 2009, J NEUROSCI, V29, P10449, DOI 10.1523/JNEUROSCI.3048-09.2009; Jin KX, 2010, J NEUROSCI, V30, P11902, DOI 10.1523/JNEUROSCI.2187-10.2010; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Li C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-231; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Pow DV, 1999, VISUAL NEUROSCI, V16, P231, DOI 10.1017/S0952523899162047; Schubert T, 2008, J NEUROPHYSIOL, V100, P304, DOI 10.1152/jn.90202.2008; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Strettoi E, 1996, P NATL ACAD SCI USA, V93, P14906, DOI 10.1073/pnas.93.25.14906; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	49	86	87	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					965	U45		10.1038/nn.2859	http://dx.doi.org/10.1038/nn.2859			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743471	Green Accepted			2022-12-25	WOS:000293123700009
J	Mittmann, W; Wallace, DJ; Czubayko, U; Herb, JT; Schaefer, AT; Looger, LL; Denk, W; Kerr, JND				Mittmann, Wolfgang; Wallace, Damian J.; Czubayko, Uwe; Herb, Jan T.; Schaefer, Andreas T.; Looger, Loren L.; Denk, Winfried; Kerr, Jason N. D.			Two-photon calcium imaging of evoked activity from L5 somatosensory neurons in vivo	NATURE NEUROSCIENCE			English	Article							CELLULAR RESOLUTION; PYRAMIDAL NEURONS; VISUAL-CORTEX; NEURAL ACTIVITY; MICROSCOPY; DENDRITES; BRAIN; AWAKE; MICE; ORGANIZATION	Multiphoton imaging (MPI) is widely used for recording activity simultaneously from many neurons in superficial cortical layers in vivo. We combined regenerative amplification multiphoton microscopy (RAMM) with genetically encoded calcium indicators to extend MPI of neuronal population activity into layer 5 (L5) of adult mouse somatosensory cortex. We found that this approach could be used to record and quantify spontaneous and sensory-evoked activity in populations of L5 neuronal somata located as much as 800. m below the pia. In addition, we found that RAMM could be used to simultaneously image activity from large (similar to 80) populations of apical dendrites and follow these dendrites down to their somata of origin.	[Mittmann, Wolfgang; Wallace, Damian J.; Czubayko, Uwe; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, Tubingen, Germany; [Mittmann, Wolfgang; Denk, Winfried] Max Planck Inst Med Res, Dept Biomed Opt, Heidelberg, Germany; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA USA	Max Planck Society; Max Planck Society; Howard Hughes Medical Institute	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Tubingen, Germany.	jason@tuebingen.mpg.de	denk, winfried/I-6627-2012	Schaefer, Andreas/0000-0002-4677-8788; Kerr, Jason/0000-0001-9459-883X	Max Planck Society	Max Planck Society(Max Planck Society)	We would like to thank P. Theer for technical help with the RegA, J. Sawinski for help with detection system fabrication and D. S. Greenberg for dendrite morphology analysis. This work was supported by the Max Planck Society.	de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 2001, Patent No. 6249379; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; THEER P, 2004, COMBINED FACULTIES N, V100; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai PS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2804014; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	38	135	139	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1089	U195		10.1038/nn.2879	http://dx.doi.org/10.1038/nn.2879			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743473				2022-12-25	WOS:000293123700025
J	Yasuda, M; Johnson-Venkatesh, EM; Zhang, HL; Parent, JM; Sutton, MA; Umemori, H				Yasuda, Masahiro; Johnson-Venkatesh, Erin M.; Zhang, Helen; Parent, Jack M.; Sutton, Michael A.; Umemori, Hisashi			Multiple Forms of Activity-Dependent Competition Refine Hippocampal Circuits In Vivo	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; DENTATE GRANULE CELLS; ADULT NEUROGENESIS; ENTORHINAL CORTEX; SYNAPSE ELIMINATION; FUNCTIONAL-SIGNIFICANCE; MAMMALIAN BRAIN; NMDA RECEPTORS; MOSSY FIBERS; NEURONS	Efficient memory formation relies on the establishment of functional hippocampal circuits. It has been proposed that synaptic connections are refined by neural activity to form functional brain circuitry. However, it is not known whether and how hippocampal connections are refined by neural activity in vivo. Using a mouse genetic system in which restricted populations of neurons in the hippocampal circuit are inactivated, we show that inactive axons are eliminated after they develop through a competition with active axons. Remarkably, in the dentate gyrus, which undergoes neurogenesis throughout life, axon refinement is achieved by a competition between mature and young neurons. These results demonstrate that activity-dependent competition plays multiple roles in the establishment of functional memory circuits in vivo.	[Yasuda, Masahiro; Johnson-Venkatesh, Erin M.; Sutton, Michael A.; Umemori, Hisashi] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Zhang, Helen; Parent, Jack M.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Sutton, Michael A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Umemori, Hisashi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Umemori, H (corresponding author), Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	umemoh@umich.edu		Umemori, Hisashi/0000-0001-7198-2062; Sutton, Michael/0000-0002-0692-6459	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr. Foundation; March of Dimes Foundation; Whitehall Foundation; NIH [MH091429, NS070005]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070005] Funding Source: NIH RePORTER	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr. Foundation; March of Dimes Foundation(March of Dimes); Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Nakafuku and J.R. Sanes for critical comments on the manuscript; M. Mayford for tTA-EC, tetO-nls-lacZ, and tetO-tau-lacZ lines; J. Gogos for the tetO-TeTxLC-tau-lacZ line; M. Zhang and C. Kanki for technical assistance; and W. Filipiak, G. Gavrilina, M. Van Keuren, and the Transgenic Animal Model Core of the University of Michigan for preparation of transgenic mice. Core support was provided by the University of Michigan Center for Organogenesis. This work was supported by the Ester A. & Joseph Klingenstein Fund, the Edward Mallinckrodt Jr. Foundation, the March of Dimes Foundation, the Whitehall Foundation, and NIH grants MH091429 and NS070005 (H.U.).	Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Comu S, 1997, J NEUROSCI, V17, P8702; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; deToledo-Morrell L, 2004, NEUROBIOL AGING, V25, P1197, DOI 10.1016/j.neurobiolaging.2003.12.007; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Elmer GI, 2004, PSYCHOPHARMACOLOGY, V174, P177, DOI 10.1007/s00213-003-1757-7; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Lorenzetto E, 2009, P NATL ACAD SCI USA, V106, P16475, DOI 10.1073/pnas.0907298106; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Singer BH, 2009, J COMP NEUROL, V514, P567, DOI 10.1002/cne.22052; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	66	68	70	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 23	2011	70	6					1128	1142		10.1016/j.neuron.2011.04.027	http://dx.doi.org/10.1016/j.neuron.2011.04.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787XT	21689599	Bronze, Green Accepted			2022-12-25	WOS:000292410700011
J	Gilman, SR; Iossifov, I; Levy, D; Ronemus, M; Wigler, M; Vitkup, D				Gilman, Sarah R.; Iossifov, Ivan; Levy, Dan; Ronemus, Michael; Wigler, Michael; Vitkup, Dennis			Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses	NEURON			English	Article							CORTICAL PYRAMIDAL NEURONS; DENDRITIC SPINE DENSITY; COPY-NUMBER VARIATION; GENOMEWIDE ASSOCIATION; COMPLEX; DISORDERS; PATHOLOGY; MTOR; WNT; EXPRESSION	Identification of complex molecular networks underlying common human phenotypes is a major challenge of modern genetics. In this study, we develop a method for network-based analysis of genetic associations (NETBAG). We use NETBAG to identify a large biological network of genes affected by rare de novo CNVs in autism. The genes forming the network are primarily related to synapse development, axon targeting, and neuron motility. The identified network is strongly related to genes previously implicated in autism and intellectual disability phenotypes. Our results are also consistent with the hypothesis that significantly stronger functional perturbations are required to trigger the autistic phenotype in females compared to males. Overall, the presented analysis of de novo variants supports the hypothesis that perturbed synaptogenesis is at the heart of autism. More generally, our study provides proof of the principle that networks underlying complex human phenotypes can be identified by a network-based functional analysis of rare genetic variants.	[Gilman, Sarah R.; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Gilman, Sarah R.; Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Iossifov, Ivan; Levy, Dan; Ronemus, Michael; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Columbia University; Columbia University; Cold Spring Harbor Laboratory	Iossifov, I (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, 1130 St Nicolas Ave, New York, NY 10032 USA.	iossifov@cshl.edu; dv2121@columbia.edu		Ronemus, Michael/0000-0003-0237-3540; Wigler, Michael/0000-0003-4396-1971	Simons Foundation [SF51]; National Centers for Biomedical Computing (MAGNet) [U54CA121852]; Simons Foundation Autism Research Initiative;  [T32 GM082797]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797, R01GM079759] Funding Source: NIH RePORTER	Simons Foundation; National Centers for Biomedical Computing (MAGNet); Simons Foundation Autism Research Initiative; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the Simons Foundation (SFARI award number SF51 to M.W.), the National Centers for Biomedical Computing (MAGNet) grant U54CA121852 to Columbia University. S.R.G. was supported by the training grant T32 GM082797. We are grateful to all of the families at the participating SFARI Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, B. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, E. Wijsman).; We would also like to sincerely thank Simons Foundation Autism Research Initiative for generous financial support, Linda Van Aelst, Thomas Jessell, Gerald Fischbach, Marian Carlson, Alan Packer, Barry Honig, Itsik Pe'er, Lauren DeMaria, and Stephen Johnson for helpful discussions.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Iossifov I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000559; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reiner O, 2005, MOL NEUROBIOL, V31, P117, DOI 10.1385/MN:31:1-3:117; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; SALINAS PC, 1994, DEVELOPMENT, V120, P1277; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang K, 2010, CELL, V142, P351, DOI 10.1016/j.cell.2010.07.025; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	67	484	496	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 9	2011	70	5					898	907		10.1016/j.neuron.2011.05.021	http://dx.doi.org/10.1016/j.neuron.2011.05.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	780GW	21658583	Green Accepted, Bronze			2022-12-25	WOS:000291843500010
J	Karimi, MM; Goyal, P; Maksakova, IA; Bilenky, M; Leung, D; Tang, JX; Shinkai, Y; Mager, DL; Jones, S; Hirst, M; Lorincz, MC				Karimi, Mohammad M.; Goyal, Preeti; Maksakova, Irina A.; Bilenky, Misha; Leung, Danny; Tang, Jie Xin; Shinkai, Yoichi; Mager, Dixie L.; Jones, Steven; Hirst, Martin; Lorincz, Matthew C.			DNA Methylation and SETDB1/H3K9me3 Regulate Predominantly Distinct Sets of Genes, Retroelements, and Chimeric Transcripts in mESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; ENDOGENOUS RETROVIRUSES; TRANSPOSABLE ELEMENTS; HISTONE H3; RNA-SEQ; CHROMATIN; GENOME; PARALLEL; COMPLEX; RETROTRANSPOSON	DNA methylation and histone H3 lysine 9 trimethylation (H3K9me3) play important roles in silencing of genes and retroelements. However, a comprehensive comparison of genes and repetitive elements repressed by these pathways has not been reported. Here we show that in mouse embryonic stem cells (mESCs), the genes upregulated after deletion of the H3K9 methyltransferase Setdb1 are distinct from those derepressed in mESC deficient in the DNA methyltransferases Dnmt1, Dnmt3a, and Dnmt3b, with the exception of a small number of primarily germline-specific genes. Numerous endogenous retroviruses (ERVs) lose H3K9me3 and are concomitantly derepressed exclusively in SETDB1 knockout mESCs. Strikingly, similar to 15% of upregulated genes are induced in association with derepression of promoter-proximal ERVs, half in the context of "chimeric" transcripts that initiate within these retroelements and splice to genic exons. Thus, SETDB1 plays a previously unappreciated yet critical role in inhibiting aberrant gene transcription by suppressing the expression of proximal ERVs.	[Karimi, Mohammad M.; Goyal, Preeti; Maksakova, Irina A.; Leung, Danny; Tang, Jie Xin; Mager, Dixie L.; Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Bilenky, Misha; Jones, Steven; Hirst, Martin] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Sakyo Ku, Expt Res Ctr Infect Dis, Kawara, Kyoto 6068507, Japan; [Shinkai, Yoichi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kawara, Kyoto 6068507, Japan; [Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of British Columbia; British Columbia Cancer Agency; Kyoto University; Kyoto University; British Columbia Cancer Agency	Lorincz, MC (corresponding author), Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	mlorincz@interchange.ubc.ca	Jones, Steven J/C-3621-2009; Shinkai, Yoichi/N-3909-2014; Hirst, Martin/B-7684-2016	Jones, Steven J/0000-0003-3394-2208; Shinkai, Yoichi/0000-0002-6051-2484; Karimi, Mohammad Mahdi/0000-0001-5017-1252; Leung, Danny Chi Yeu/0000-0002-2472-894X; Lorincz, Matthew/0000-0003-0885-0467; Mager, Dixie/0000-0002-5955-2550	MEXT of Japan; CIHR [77805, 92093]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CIHR(Canadian Institutes of Health Research (CIHR))	We thank M. Okano for Dnmt TKO mESCs and T. Jenuwein for Suv39h DKO mESCs. We are also grateful to Jim Bone, Bryeanna Villani, Nina Thiessen, and to members of the GSC Functional Genomics and Sequence Production groups and M.C.L. lab for technical support. We thank Keji Zhao, Ting Wang, Irina Stancheva, and Dirk Schubeler for helpful discussions. This work was supported by grants from the Genome Network Project from MEXT of Japan to Y.S. and CIHR grants 77805 to M.C.L. and 92093 to M.C.L. and M.H. M.C.L. is an MSFHR Scholar and a CIHR New Investigator.	Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Dunn CA, 2005, GENE, V364, P2, DOI 10.1016/j.gene.2005.05.045; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Hutnick LK, 2010, J BIOL CHEM, V285, P21082, DOI 10.1074/jbc.M110.125674; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JS, 1999, J VIROL, V73, P5166, DOI 10.1128/JVI.73.6.5166-5171.1999; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sugino H, 2004, GENE, V337, P91, DOI 10.1016/j.gene.2004.04.011; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Vasicek TJ, 1997, GENETICS, V147, P777; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	54	310	313	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					676	687		10.1016/j.stem.2011.04.004	http://dx.doi.org/10.1016/j.stem.2011.04.004			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21624812	Bronze, Green Accepted			2022-12-25	WOS:000291844100015
J	Han, DW; Tapia, N; Hermann, A; Hemmer, K; Hoing, S; Arauzo-Bravo, MJ; Zaehres, H; Wu, GM; Frank, S; Moritz, S; Greber, B; Yang, JH; Lee, HT; Schwamborn, JC; Storch, A; Scholer, HR				Han, Dong Wook; Tapia, Natalia; Hermann, Andreas; Hemmer, Kathrin; Hoeing, Susanne; Arauzo-Bravo, Marcos J.; Zaehres, Holm; Wu, Guangming; Frank, Stefan; Moritz, Soeren; Greber, Boris; Yang, Ji Hun; Lee, Hoon Taek; Schwamborn, Jens C.; Storch, Alexander; Schoeler, Hans R.			Direct Reprogramming of Fibroblasts into Neural Stem Cells by Defined Factors	CELL STEM CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; DIRECT CONVERSION; MOUSE FIBROBLASTS; DOPAMINERGIC-NEURONS; FUNCTIONAL-NEURONS; HOMEOBOX GENES; GENERATION; EXPRESSION; BRAIN; PLURIPOTENCY	Recent studies have shown that defined sets of transcription factors can directly reprogram differentiated somatic cells to a different differentiated cell type without passing through a pluripotent state, but the restricted proliferative and lineage potential of the resulting cells limits the scope of their potential applications. Here we show that a combination of transcription factors (Brn4/Pou3f4, Sox2, Klf4, c-Myc, plus E47/Tcf3) induces mouse fibroblasts to directly acquire a neural stem cell identity which we term as induced neural stem cells (iNSCs). Direct reprogramming of fibroblasts into iNSCs is a gradual process in which the donor transcriptional program is silenced over time. iNSCs exhibit cell morphology, gene expression, epigenetic features, differentiation potential, and self-renewing capacity, as well as in vitro and in vivo functionality similar to those of wild-type NSCs. We conclude that differentiated cells can be reprogrammed directly into specific somatic stem cell types by defined sets of specific transcription factors.	[Han, Dong Wook; Tapia, Natalia; Hoeing, Susanne; Arauzo-Bravo, Marcos J.; Zaehres, Holm; Wu, Guangming; Frank, Stefan; Moritz, Soeren; Greber, Boris; Yang, Ji Hun; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Han, Dong Wook; Lee, Hoon Taek] Konkuk Univ, SMART Inst Adv Biomed Sci, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea; [Hermann, Andreas; Storch, Alexander] Tech Univ Dresden, Dept Neurol, Div Neurodegenerat Dis, D-01307 Dresden, Germany; [Hermann, Andreas; Storch, Alexander] Tech Univ Dresden, CRTD, D-01307 Dresden, Germany; [Hermann, Andreas; Storch, Alexander] German Ctr Neurodegenerat Dis DZNE, D-01307 Dresden, Germany; [Hemmer, Kathrin; Schwamborn, Jens C.] Univ Munster, ZMBE, Inst Cell Biol, Stem Cell Biol & Regenerat Grp, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Konkuk University; Konkuk University Medical Center; Technische Universitat Dresden; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; University of Munster; University of Munster	Han, DW (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	dwhan@konkuk.ac.kr; office@mpi-muenster.mpg.de	Hermann, Andreas/D-4213-2017; , HS/AAB-4434-2019; Schwamborn, Jens C/F-9395-2011; Marcos, Arauzo-Bravo/A-1706-2011; Tapia, Natalia/H-5500-2012	Hermann, Andreas/0000-0002-7364-7791; , HS/0000-0003-2643-5136; Schwamborn, Jens C/0000-0003-4496-0559; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Greber, Boris/0000-0002-9404-7293; Wu, Guangming/0000-0003-1923-7609; Tapia, Natalia/0000-0003-0226-1952	Max Planck Society; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0013885]; National Research Foundation (NRF); Korean government (MEST) [2011-0019490]	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation (NRF); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by the Max Planck Society; the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0013885); and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (2011-0019490). We are grateful to Areti Malapetsas for editing the manuscript. D.W.H. and H.R.S. designed the experiments. D.W.H., A.H., NT., K.H., S.H., H.Z., S.F., B.G., S.M., and J.H.Y. performed the experiments. D.W.H., A.H., N.T., S.H., M.J.A.-B., S.F., S.M., H.T.L., J.C.S., and A.S. analyzed the data. D.W.H., NT., and H.R.S. wrote the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; GIAMPAOLO A, 1989, DIFFERENTIATION, V40, P191, DOI 10.1111/j.1432-0436.1989.tb00598.x; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Poh A, 2002, INT J DEV BIOL, V46, P597; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	38	395	426	1	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					465	472		10.1016/j.stem.2012.02.021	http://dx.doi.org/10.1016/j.stem.2012.02.021			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22445517	Bronze			2022-12-25	WOS:000303079400014
J	Abrahamsson, T; Cathala, L; Matsui, K; Shigemoto, R; DiGregorio, DA				Abrahamsson, Therese; Cathala, Laurence; Matsui, Ko; Shigemoto, Ryuichi; DiGregorio, David A.			Thin Dendrites of Cerebellar Interneurons Confer Sublinear Synaptic Integration and a Gradient of Short-Term Plasticity	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; MOLECULAR LAYER INTERNEURONS; LATERAL GENICULATE-NUCLEUS; PERMEABLE AMPA RECEPTORS; PURKINJE-CELLS; STELLATE CELLS; GRANULE CELLS; POSTSYNAPTIC POTENTIALS; COINCIDENCE DETECTION; HIPPOCAMPAL-NEURONS	Interneurons are critical for neuronal circuit function, but how their dendritic morphologies and membrane properties influence information flow within neuronal circuits is largely unknown. We studied the spatiotemporal profile of synaptic integration and short-term plasticity in dendrites of mature cerebellar stellate cells by combining two-photon guided electrical stimulation, glutamate uncaging, electron microscopy, and modeling. Synaptic activation within thin (0.4 mu m) dendrites produced somatic responses that became smaller and slower with increasing distance from the soma, sublinear subthreshold input-output relationships, and a somatodendritic gradient of short-term plasticity. Unlike most studies showing that neurons employ active dendritic mechanisms, we found that passive cable properties of thin dendrites determine the sublinear integration and plasticity gradient, which both result from large dendritic depolarizations that reduce synaptic driving force. These integrative properties allow stellate cells to act as spatiotemporal filters of synaptic input patterns, thereby biasing their output in favor of sparse presynaptic activity.	[Abrahamsson, Therese; DiGregorio, David A.] Inst Pasteur, Unit Dynam Neuronal Imaging, F-75724 Paris 15, France; [Abrahamsson, Therese; DiGregorio, David A.] Inst Pasteur, CNRS, URA 2182, F-75724 Paris 15, France; [Cathala, Laurence] Sorbonne Univ, CNRS, UMR 7102, Univ Paris 06, F-75005 Paris, France; [Abrahamsson, Therese; Cathala, Laurence; DiGregorio, David A.] Univ Paris 05, CNRS, UMR 8118, F-75006 Paris, France; [Matsui, Ko; Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	DiGregorio, DA (corresponding author), Inst Pasteur, Unit Dynam Neuronal Imaging, 25 Rue Dr Roux, F-75724 Paris 15, France.	david.digregorio@pasteur.fr	Shigemoto, Ryuichi/E-3628-2013; Matsui, Ko/AAE-3687-2019	Shigemoto, Ryuichi/0000-0001-8761-9444; Matsui, Ko/0000-0003-1068-9705	Centre National de la Recherche Scientifique; Fondation Fyssen; Fondation pour la Recherche Medicale; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (Neuroscience and Blanc); European Commision [LSHM-CT-2007-037765]; Fondation pour la Recherche Medicate; Swedish Research Council	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation Fyssen; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (Neuroscience and Blanc)(French National Research Agency (ANR)); European Commision; Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Centre National de la Recherche Scientifique through the Actions Thematiques et Incitatives sur Programme, Fondation Fyssen, Fondation pour la Recherche Medicale, Federation pour la Recherche sur le Cerveau, Agence Nationale de la Recherche (Neuroscience and Blanc), and the European Commision FP6 Specific Targeted Project for Photolysis (LSHM-CT-2007-037765) to D.A.D., Fondation pour la Recherche Medicate and the Swedish Research Council to T.A. We thank Emilienne Repak for assistance in installing the 405 nm diode laser, Elek Molnar for AMPA receptor antibody, Sachiko Yamada for the EM reconstruction, and Christophe Mulle for the gift of GYKI. We thank Jeremy Dittman, Boris Barbour, Marla Feller, Lyle Graham, Tom Otis, Angus Silver, and Jack Waters for comments on the manuscript.	Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bagnall MW, 2011, NEURON, V71, P180, DOI 10.1016/j.neuron.2011.05.032; Bao J, 2010, J NEUROSCI, V30, P8171, DOI 10.1523/JNEUROSCI.0276-10.2010; Bender VA, 2009, J NEUROSCI, V29, P10974, DOI 10.1523/JNEUROSCI.2123-09.2009; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; BLOOMFIELD SA, 1987, J PHYSIOL-LONDON, V383, P653; Bower JM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00027; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Cohen D, 2000, PROG BRAIN RES, V124, P107; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; DiGregorio DA, 2007, J NEUROSCI, V27, P8344, DOI 10.1523/JNEUROSCI.2399-07.2007; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dizon MJ, 2011, J NEUROSCI, V31, P10463, DOI 10.1523/JNEUROSCI.1350-11.2011; Eccles J.C., 1967, CEREBELLUM COMPUTATI; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Emri ZS, 2001, NEUROSCIENCE, V104, P1013, DOI 10.1016/S0306-4522(01)00136-1; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Gao WC, 2003, J NEUROSCI, V23, P1859; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Isope P, 2002, J NEUROSCI, V22, P9668; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Katona G, 2011, P NATL ACAD SCI USA, V108, P2148, DOI 10.1073/pnas.1009270108; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LLANO I, 1991, NEURON, V7, P577, DOI 10.1016/0896-6273(91)90370-F; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mejia-Gervacio S, 2007, NEURON, V53, P843, DOI 10.1016/j.neuron.2007.02.023; Mittmann W, 2004, CURR BIOL, V14, pR837, DOI 10.1016/j.cub.2004.09.036; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; Myoga MH, 2009, J NEUROSCI, V29, P7803, DOI 10.1523/JNEUROSCI.0030-09.2009; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Norenberg A, 2010, P NATL ACAD SCI USA, V107, P894, DOI 10.1073/pnas.0910716107; Palay SL, 1974, CEREBELLAR CORTEX CO; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Ruigrok TJH, 2011, CEREBELLUM, V10, P464, DOI 10.1007/s12311-010-0164-y; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Sultan F, 1998, J COMP NEUROL, V393, P353; SZENTAGOTHAI J, 1965, Prog Brain Res, V14, P1; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; THURBON D, 1994, J NEUROPHYSIOL, V71, P1948, DOI 10.1152/jn.1994.71.5.1948; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137	87	70	71	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 22	2012	73	6					1159	1172		10.1016/j.neuron.2012.01.027	http://dx.doi.org/10.1016/j.neuron.2012.01.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	915BU	22445343	Bronze			2022-12-25	WOS:000301998700013
J	Gibbs, KD; Jager, A; Crespo, O; Goltsev, Y; Trejo, A; Richard, CE; Nolan, GP				Gibbs, Kenneth D., Jr.; Jager, Astraea; Crespo, Oliver; Goltsev, Yury; Trejo, Angelica; Richard, Chase E.; Nolan, Garry P.			Decoupling of Tumor-Initiating Activity from Stable Immunophenotype in HoxA9-Meis1-Driven AML	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER STEM-CELLS; EVOLUTION; HIERARCHY; CYTOMETRY; GENE; RARE	Increasing evidence suggests tumors are maintained by cancer stem cells; however, their nature remains controversial. In a HoxA9-Meis1 (H9M) model of acute myeloid leukemia (AML), we found that tumor-initiating activity existed in three, immunophenotypically distinct compartments, corresponding to disparate lineages on the normal hematopoietic hierarchy-stem/progenitor cells (Lin(-)kit(+)) and committed progenitors of the myeloid (Gr1(+)kit(+)) and lymphoid lineages (Lym(+)kit(+)). These distinct tumor-initiating cells (TICs) clonally recapitulated the immunophenotypic spectrum of the original tumor in vivo (including cells with a less-differentiated immunophenotype) and shared signaling networks, such that in vivo pharmacologic targeting of conserved TIC survival pathways (DNA methyltransferase and MEK phosphorylation) significantly increased survival. Collectively, H9M AML is organized as an atypical hierarchy that defies the strict lineage marker boundaries and unidirectional differentiation of normal hematopoiesis. Moreover, this suggests that in certain malignancies tumor-initiation activity (or "cancer stemness") can represent a cellular state that exists independently of distinct immunophenotypic definition.	[Gibbs, Kenneth D., Jr.; Jager, Astraea; Crespo, Oliver; Goltsev, Yury; Trejo, Angelica; Richard, Chase E.; Nolan, Garry P.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Gibbs, Kenneth D., Jr.; Crespo, Oliver] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Gibbs, Kenneth/0000-0002-3532-5396	NSF GRFP; Stanford DARE Fellowship; NIH/NCI [1R01CA130826, U54CA149145, 5U54CA143907]; CIRM [DR1-01477]; NATIONAL CANCER INSTITUTE [R01CA130826, U54CA143907, U54CA149145] Funding Source: NIH RePORTER	NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford DARE Fellowship; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Simonds, G. Behbehani, and W. Fantl for critical review of the manuscript and S. Bendall, E. Zunder, A. Deshpande, and R. Majeti for helpful conversations. K.G. was funded by NSF GRFP and Stanford DARE Fellowship. This work was supported by NIH/NCI grants 1R01CA130826, U54CA149145, and 5U54CA143907, as well as CIRM grant DR1-01477. G.P.N. is the Rachford and Carlotta A. Harris Endowed Professor, is a member of the scientific advisory board at DVS Sciences, and is a paid consultant for BD Biosciences and Nodality, Inc. K.G. designed the study, performed experiments, analyzed results, and wrote the manuscript. A.J., O.C., Y.G., A.T., and C.E.R. performed experiments. G.P.N. designed experiments and wrote the manuscript.	Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gibbs KD, 2011, BLOOD, V117, P4226, DOI 10.1182/blood-2010-07-298232; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624	29	46	47	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 3	2012	10	2					210	217		10.1016/j.stem.2012.01.004	http://dx.doi.org/10.1016/j.stem.2012.01.004			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	892FM	22305570	Bronze, Green Accepted			2022-12-25	WOS:000300272100013
J	Kennerley, SW; Behrens, TEJ; Wallis, JD				Kennerley, Steven W.; Behrens, Timothy E. J.; Wallis, Jonathan D.			Double dissociation of value computations in orbitofrontal and anterior cingulate neurons	NATURE NEUROSCIENCE			English	Article							TEMPORALLY DISCOUNTED VALUES; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINE NEURONS; ECONOMIC VALUE; INTERTEMPORAL CHOICE; REWARD PREFERENCE; SINGLE NEURONS; DISTINCT ROLES; PERFORMANCE	Damage to prefrontal cortex (PFC) impairs decision-making, but the underlying value computations that might cause such impairments remain unclear. Here we report that value computations are doubly dissociable among PFC neurons. Although many PFC neurons encoded chosen value, they used opponent encoding schemes such that averaging the neuronal population extinguished value coding. However, a special population of neurons in anterior cingulate cortex (ACC), but not in orbitofrontal cortex (OFC), multiplexed chosen value across decision parameters using a unified encoding scheme and encoded reward prediction errors. In contrast, neurons in OFC, but not ACC, encoded chosen value relative to the recent history of choice values. Together, these results suggest complementary valuation processes across PFC areas: OFC neurons dynamically evaluate current choices relative to recent choice values, whereas ACC neurons encode choice predictions and prediction errors using a common valuation currency reflecting the integration of multiple decision parameters.	[Kennerley, Steven W.; Behrens, Timothy E. J.] UCL, Inst Neurol, London, England; [Kennerley, Steven W.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of London; University College London; University of California System; University of California Berkeley; University of Oxford; University of California System; University of California Berkeley	Kennerley, SW (corresponding author), UCL, Inst Neurol, London, England.	s.kennerley@ucl.ac.uk	Kennerley, Steven W/E-3330-2018	Kennerley, Steven W/0000-0002-5696-7507; Wallis, Joni/0000-0001-7262-7417; Behrens, Timothy/0000-0003-0048-1177	US National Institute on Drug Abuse [R01DA19028]; US National Institute of Neurological Disorders and Stroke [P01NS040813]; US National Institute on Mental Health [F32MH081521]; Wellcome Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH081521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute on Mental Health; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was funded by US National Institute on Drug Abuse grant R01DA19028, US National Institute of Neurological Disorders and Stroke grant P01NS040813 to J.W. and US National Institute on Mental Health training grant F32MH081521 to S.W.K. T.E.J.B. and S.W.K. are supported by the Wellcome Trust.	Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kobayashi S, 2010, J NEUROSCI, V30, P534, DOI 10.1523/JNEUROSCI.4009-09.2010; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2009, J NEUROSCI, V29, P14004, DOI 10.1523/JNEUROSCI.3751-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prevost C, 2010, J NEUROSCI, V30, P14080, DOI 10.1523/JNEUROSCI.2752-10.2010; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354	50	299	303	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1581	U119		10.1038/nn.2961	http://dx.doi.org/10.1038/nn.2961			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037498	Green Accepted			2022-12-25	WOS:000297546300019
J	Hatsopoulos, NG; Suminski, AJ				Hatsopoulos, Nicholas G.; Suminski, Aaron J.			Sensing with the Motor Cortex	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; OPTIMAL FEEDBACK-CONTROL; PYRAMIDAL TRACT NEURONS; REACHING MOVEMENTS; CORTICAL-NEURONS; PRECENTRAL CORTEX; ISOMETRIC-FORCE; CEREBRAL-CORTEX; NEURAL ACTIVITY; ARM MOVEMENTS	The primary motor cortex is a critical node in the network of brain regions responsible for voluntary motor behavior. It has been less appreciated, however, that the motor cortex exhibits sensory responses in a variety of modalities including vision and somatosensation. We review current work that emphasizes the heterogeneity in sensorimotor responses in the motor cortex and focus on its implications for cortical control of movement as well as for brain-machine interface development.	[Hatsopoulos, Nicholas G.] Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA; [Hatsopoulos, Nicholas G.; Suminski, Aaron J.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Hatsopoulos, NG (corresponding author), Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA.	nicho@uchicago.edu		Suminski, Aaron/0000-0002-8793-5049	NINDS NIH HHS [R01 NS048845-07, R01 NS048845, R01 NS045853, R01 NS045853-08] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048845, R01NS045853] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott A, 2006, NATURE, V442, P125, DOI 10.1038/442125a; ALBEFESS.D, 1966, EXP BRAIN RES, V1, P127; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Cabel DW, 2001, J NEUROPHYSIOL, V86, P2102, DOI 10.1152/jn.2001.86.4.2102; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Cheng YW, 2007, CEREB CORTEX, V17, P1979, DOI 10.1093/cercor/bhl107; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Cover TM, 1991, ELEMENTS INFORM THEO; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; Fitzsimmons NA, 2007, J NEUROSCI, V27, P5593, DOI 10.1523/JNEUROSCI.5297-06.2007; FLAMENT D, 1988, J NEUROPHYSIOL, V60, P1268, DOI 10.1152/jn.1988.60.4.1268; FLANAGAN JR, 1993, J MOTOR BEHAV, V25, P140, DOI 10.1080/00222895.1993.9942045; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; FROMM C, 1984, EXP BRAIN RES, V54, P177; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GEORGOPOULOS AP, 1984, EXP BRAIN RES, V54, P446; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GHEZ C, 1995, CAN J PHYSIOL PHARM, V73, P273, DOI 10.1139/y95-038; GIELEN CCAM, 1988, J PHYSIOL-LONDON, V407, P275, DOI 10.1113/jphysiol.1988.sp017415; Gilja V, 2011, IEEE T BIO-MED ENG, V58, P1891, DOI 10.1109/TBME.2011.2107553; GOLDRING S, 1972, SCIENCE, V175, P1493, DOI 10.1126/science.175.4029.1493; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; HEPPREYMOND MC, 1978, J PHYSIOL-PARIS, V74, P287; Herter TM, 2009, J NEUROPHYSIOL, V101, P150, DOI 10.1152/jn.90230.2008; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kandel E., 2000, PRINCIPLES NEURAL SC; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P341, DOI 10.1098/rspb.1976.0083; Leuthardt EC, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0979; LUCIER GE, 1975, J PHYSIOL-LONDON, V251, P833, DOI 10.1113/jphysiol.1975.sp011125; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mason CR, 1998, NEUROREPORT, V9, P989, DOI 10.1097/00001756-199804200-00007; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Moran D, 2010, CURR OPIN NEUROBIOL, V20, P741, DOI 10.1016/j.conb.2010.09.010; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Naito E, 2011, NEUROCASE, V17, P133, DOI 10.1080/13554794.2010.498428; Nelson RJ, 1996, CURR OPIN NEUROBIOL, V6, P801, DOI 10.1016/S0959-4388(96)80031-6; Nii Y, 1996, NEUROLOGY, V46, P360, DOI 10.1212/WNL.46.2.360; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; O'Doherty J.E., 2011, NATURE IN PRESS; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; PHILLIPS CG, 1969, PROC R SOC SER B-BIO, V173, P141, DOI 10.1098/rspb.1969.0044; Porter R, 1993, CORTICOSPINAL FUNCTI; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; Pruszynski JA, 2011, J NEUROPHYSIOL, V106, P449, DOI 10.1152/jn.01052.2010; Pruszynski JA, 2010, J NEUROPHYSIOL, V103, P564, DOI 10.1152/jn.00791.2009; Raos V, 2007, J NEUROSCI, V27, P12675, DOI 10.1523/JNEUROSCI.2988-07.2007; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; Saleh M, 2010, J NEUROSCI, V30, P17079, DOI 10.1523/JNEUROSCI.2558-10.2010; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; SMITH AM, 1975, EXP BRAIN RES, V23, P315; Stark E, 2007, EUR J NEUROSCI, V26, P1055, DOI 10.1111/j.1460-9568.2007.05711.x; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Suminski AJ, 2009, NEURAL NETWORKS, V22, P1224, DOI 10.1016/j.neunet.2009.05.006; Taira M, 1996, EXP BRAIN RES, V109, P367; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tkach D, 2007, J NEUROSCI, V27, P13241, DOI 10.1523/JNEUROSCI.2895-07.2007; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wahnoun R, 2006, J NEURAL ENG, V3, P162, DOI 10.1088/1741-2560/3/2/010; Wiesendanger M, 1975, Can J Neurol Sci, V2, P295; WISE SP, 1981, J NEUROPHYSIOL, V45, P482, DOI 10.1152/jn.1981.45.3.482; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; WONG YC, 1978, J NEUROPHYSIOL, V41, P1107, DOI 10.1152/jn.1978.41.5.1107; WOOLSEY CN, 1979, J NEUROSURG, V51, P476, DOI 10.3171/jns.1979.51.4.0476; Wu W, 2006, EXP BRAIN RES, V175, P197, DOI 10.1007/s00221-006-0556-x	101	98	98	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 3	2011	72	3					477	487		10.1016/j.neuron.2011.10.020	http://dx.doi.org/10.1016/j.neuron.2011.10.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	845ME	22078507	Green Accepted, Bronze			2022-12-25	WOS:000296826000006
J	Markwardt, SJ; Dieni, CV; Wadiche, JI; Overstreet-Wadiche, L				Markwardt, Sean J.; Dieni, Cristina V.; Wadiche, Jacques I.; Overstreet-Wadiche, Linda			Ivy/neurogliaform interneurons coordinate activity in the neurogenic niche	NATURE NEUROSCIENCE			English	Article							NEUROGLIAFORM CELLS; NEURONS; HIPPOCAMPUS; INHIBITION; NETWORK; IVY	Depolarization by the neurotransmitter GABA regulates adult neurogenesis. We found interneurons of the neurogliaform cell family to be a primary source of GABA for newborn neurons in mouse dentate gyrus. GABAergic depolarization occurred in concert with reduced synaptic inhibition of mature neurons, suggesting that the local circuitry coordinates the activation of new and pre-existing cells.	[Markwardt, Sean J.; Dieni, Cristina V.; Wadiche, Jacques I.; Overstreet-Wadiche, Linda] Univ Alabama, McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Overstreet-Wadiche, L (corresponding author), Univ Alabama, McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA.	lwadiche@uab.edu	DIENI, Cristina Vittoria/J-7998-2019	DIENI, Cristina Vittoria/0000-0003-1632-5590; Wadiche, Linda/0000-0001-7367-5998; Wadiche, Jacques/0000-0001-8180-2061	US National Institutes of Health [5T32GM008111, 5R01NS064025, 2P30NS047466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, R01NS064025] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Wadiche laboratory and A. Tzingounis for helpful comments, and A. Margolies and C. Zhao for technical assistance. This work was supported by grants from the US National Institutes of Health (5T32GM008111, 5R01NS064025 and 2P30NS047466).	Armstrong C, 2011, J COMP NEUROL, V519, P1476, DOI 10.1002/cne.22577; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Karayannis T, 2010, J NEUROSCI, V30, P9898, DOI 10.1523/JNEUROSCI.5883-09.2010; Markwardt SJ, 2009, J NEUROSCI, V29, P15063, DOI 10.1523/JNEUROSCI.2727-09.2009; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Olah S, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/004.2007, 10.3389/neuro.04.004.2007]; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010	15	61	63	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1407	1409		10.1038/nn.2935	http://dx.doi.org/10.1038/nn.2935			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21983681	Green Accepted			2022-12-25	WOS:000296518600013
J	Dieter, SM; Ball, CR; Hoffmann, CM; Nowrouzi, A; Herbst, F; Zavidij, O; Abel, U; Arens, A; Weichert, W; Brand, K; Koch, M; Weitz, J; Schmidt, M; von Kalle, C; Glimm, H				Dieter, Sebastian M.; Ball, Claudia R.; Hoffmann, Christopher M.; Nowrouzi, Ali; Herbst, Friederike; Zavidij, Oksana; Abel, Ulrich; Arens, Anne; Weichert, Wilko; Brand, Karsten; Koch, Moritz; Weitz, Juergen; Schmidt, Manfred; von Kalle, Christof; Glimm, Hanno			Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases	CELL STEM CELL			English	Article							INTESTINAL STEM-CELL; GENE-THERAPY; COLORECTAL-CANCER; PANCREATIC-CANCER; PHENOTYPIC CHARACTERIZATION; PROGNOSTIC-SIGNIFICANCE; REPOPULATING ACTIVITY; MELANOMA-CELLS; BONE-MARROW; VECTOR	Human colon cancer harbors a small subfraction of tumor-initiating cells (TICs) that is assumed to be a functionally homogeneous stem-cell-like population driving tumor maintenance and metastasis formation. We found unexpected cellular heterogeneity within the TIC compartment, which contains three types of TICs. Extensively self-renewing long-term TICs (LT-TICs) maintained tumor formation in serial xenotransplants. Tumor transient amplifying cells (T-TACs) with limited or no self-renewal capacity contributed to tumor formation only in primary mice. Rare delayed contributing TICs (DC-TICs) were exclusively active in secondary or tertiary mice. Bone marrow was identified as an important reservoir of LT-TICs. Metastasis formation was almost exclusively driven by self-renewing LT-TICs. Our results demonstrate that tumor initiation, self-renewal, and metastasis formation are limited to particular subpopulations of TICs in primary human colon cancer. We identify LT-TICs as a quantifiable target for therapies aimed toward eradication of self-renewing tumorigenic and metastatic colon cancer cells.	[Dieter, Sebastian M.; Ball, Claudia R.; Hoffmann, Christopher M.; Nowrouzi, Ali; Herbst, Friederike; Zavidij, Oksana; Abel, Ulrich; Arens, Anne; Schmidt, Manfred; von Kalle, Christof; Glimm, Hanno] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, D-69120 Heidelberg, Germany; [Dieter, Sebastian M.; Ball, Claudia R.; Hoffmann, Christopher M.; Nowrouzi, Ali; Herbst, Friederike; Zavidij, Oksana; Abel, Ulrich; Arens, Anne; Schmidt, Manfred; von Kalle, Christof; Glimm, Hanno] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Weichert, Wilko; Brand, Karsten] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany; [Koch, Moritz; Weitz, Juergen] Heidelberg Univ, Dept Surg, D-69120 Heidelberg, Germany; [Abel, Ulrich] Heidelberg Univ, Dept Med Biometry, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	von Kalle, C (corresponding author), Natl Ctr Tumor Dis NCT, Dept Translat Oncol, D-69120 Heidelberg, Germany.	christof.kalle@nct-heidelberg.de; hanno.glimm@nct-heidelberg.de	Weitz, Juergen/L-7136-2018	Ball, Claudia/0000-0002-1749-3791; Dieter, Sebastian/0000-0003-1324-7638	DKFZ Light Microscopy Facility; Deutsche Forschungsgemeinschaft [KFO 227]; Baden-Wurttemberg Stiftung; Konrad Adenauer Foundation	DKFZ Light Microscopy Facility; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung; Konrad Adenauer Foundation	We gratefully acknowledge Manfred Jugold (Division of Medical Physics in Radiology, DKFZ) for small animal MRT imaging, Steffen Schmitt (Core facility flow cytometry, DKFZ) for cell sorting, Brigitte Engelhardt (AG Foto, DKFZ) for assistance in image preparation, and the support by the DKFZ Light Microscopy Facility. We thank Norma Howells and Silke Hamzaoui-Nord for animal care and Sylvia Fessler, Nadine Krenzer, and Stefanie Dietz for technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KFO 227) and the Baden-Wurttemberg Stiftung. S.M.D. was supported by a scholarship of the Konrad Adenauer Foundation.	Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eisterer W, 2005, LEUKEMIA, V19, P435, DOI 10.1038/sj.leu.2403649; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Glimm H, 2005, BLOOD, V106, P893, DOI 10.1182/blood-2004-07-2859; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LINDEMANN F, 1992, LANCET, V340, P685, DOI 10.1016/0140-6736(92)92230-D; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2009, J MOL MED, V87, P1097, DOI 10.1007/s00109-009-0518-4; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; SCHLIMOK G, 1990, J CLIN ONCOL, V8, P831, DOI 10.1200/JCO.1990.8.5.831; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	36	222	232	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 7	2011	9	4					357	365		10.1016/j.stem.2011.08.010	http://dx.doi.org/10.1016/j.stem.2011.08.010			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	835MT	21982235	Bronze			2022-12-25	WOS:000296041200013
J	Daquinag, AC; Zhang, Y; Amaya-Manzanares, F; Simmons, PJ; Kolonin, MG				Daquinag, Alexes C.; Zhang, Yan; Amaya-Manzanares, Felipe; Simmons, Paul J.; Kolonin, Mikhail G.			An Isoform of Decorin Is a Resistin Receptor on the Surface of Adipose Progenitor Cells	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-BETA; STROMAL CELLS; IN-VIVO; ENDOTHELIAL-CELLS; COLLAGEN FIBRILLOGENESIS; PHAGE DISPLAY; BONE-MARROW; TISSUE; PROLIFERATION	Adipose stromal cells (ASCs) serve as mesenchymal progenitors in white adipose tissue (WAT). Intercellular interactions involving ASCs have remained obscure. By merging phage display technology with fluorescence-activated cell sorting (FACS), we screened a combinatorial library for peptides that target mouse ASCs in vivo. We isolated peptide CSWKYWFGEC that specifically homes to ASCs, used it as bait to purify the corresponding ASC surface receptor, and identified it as a previously unreported cleavage product of decorin (DCN) lacking the glycanation site (termed Delta DCN). We demonstrate that Delta DCN is differentially expressed on ASC surface. In a screen for Delta DCN-binding proteins, we identified resistin, an adipokine for which the receptor has been unknown. Expression of Delta DCN in 3T3-L1 cells promoted proliferation and migration but suppressed lipid accumulation upon adipogenesis induction, which was resistin dependent. We conclude that Delta DCN serves as a functional receptor of resistin in adipocyte progenitors and may regulate WAT expansion.	[Daquinag, Alexes C.; Zhang, Yan; Amaya-Manzanares, Felipe; Simmons, Paul J.; Kolonin, Mikhail G.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Kolonin, MG (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA.	mikhail.g.kolonin@uth.tmc.edu		Kolonin, Mikhail/0000-0002-3743-7869	Komen for the Cure Award [KG080782]; American Heart Association [0835434N]; Cancer Prevention and Research Institute of Texas [RP100400]	Komen for the Cure Award(Susan G. Komen Breast Cancer Foundation); American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas	We are grateful to Erkki Koivunen, Renata Pasqualini, Wadih Arap, and Keith L. March for providing reagents. We thank Magnus Hook, Philipp Scherer, and Mitchell Lazar for insightful discussions. This work was supported by Komen for the Cure Award KG080782, the American Heart Association Grant 0835434N, and the Cancer Prevention and Research Institute of Texas Award RP100400 to M.G.K.	Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; BELLOWS CF, 2011, OBESITY IN PRESS, DOI DOI 10.1038/OBY.2010.347; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Copland I, 2008, EXP HEMATOL, V36, P93, DOI 10.1016/j.exphem.2007.08.032; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Daquinag AC, 2011, TRENDS PHARMACOL SCI, V32, P300, DOI 10.1016/j.tips.2011.01.004; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; FRIEDENSTEIN AJ, 1980, BLOOD, V25, P19; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5472.CAN-05-2748; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kolonin MG, 2002, P NATL ACAD SCI USA, V99, P13055, DOI 10.1073/pnas.162468499; Kolonin MG, 2006, FASEB J, V20, P979, DOI 10.1096/fj.05-5186fje; Kolonin MG, 2009, NAT BIOTECHNOL, V27, P252, DOI 10.1038/nbt0309-252; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Mu H, 2006, CARDIOVASC RES, V70, P146, DOI 10.1016/j.cardiores.2006.01.015; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Nelimarkka L, 2001, AM J PATHOL, V158, P345, DOI 10.1016/S0002-9440(10)63975-2; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Roughley PJ, 1996, BIOCHEM J, V318, P779, DOI 10.1042/bj3180779; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; SIMMONS PJ, 1991, BLOOD, V78, P55; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Villena JA, 2002, HORM METAB RES, V34, P664, DOI 10.1055/s-2002-38244; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	60	147	151	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					74	86		10.1016/j.stem.2011.05.017	http://dx.doi.org/10.1016/j.stem.2011.05.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21683670	Bronze			2022-12-25	WOS:000293157000011
J	Lee, DA; Bedont, JL; Pak, T; Wang, H; Song, J; Miranda-Angulo, A; Takiar, V; Charubhumi, V; Balordi, F; Takebayashi, H; Aja, S; Ford, E; Fishell, G; Blackshaw, S				Lee, Daniel A.; Bedont, Joseph L.; Pak, Thomas; Wang, Hong; Song, Juan; Miranda-Angulo, Ana; Takiar, Vani; Charubhumi, Vanessa; Balordi, Francesca; Takebayashi, Hirohide; Aja, Susan; Ford, Eric; Fishell, Gordon; Blackshaw, Seth			Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche	NATURE NEUROSCIENCE			English	Article							ENERGY-BALANCE; BRAIN; 3RD-VENTRICLE; CELLS; RAT	Adult hypothalamic neurogenesis has recently been reported, but the cell of origin and the function of these newborn neurons are unknown. Using genetic fate mapping, we found that median eminence tanycytes generate newborn neurons. Blocking this neurogenesis altered the weight and metabolic activity of adult mice. These findings reveal a previously unreported neurogenic niche in the mammalian hypothalamus with important implications for metabolism.	[Lee, Daniel A.; Bedont, Joseph L.; Pak, Thomas; Wang, Hong; Miranda-Angulo, Ana; Takiar, Vani; Charubhumi, Vanessa; Aja, Susan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Lee, Daniel A.; Song, Juan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Song, Juan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Miranda-Angulo, Ana] Univ Antioquia, Medellin, Colombia; [Balordi, Francesca; Fishell, Gordon] NYU, Sch Med, Smilow Res Ctr, Neurosci Program, New York, NY USA; [Balordi, Francesca; Fishell, Gordon] NYU, Sch Med, Smilow Res Ctr, Dept Cell Biol, New York, NY USA; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD USA; [Ford, Eric] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidad de Antioquia; New York University; New York University; Niigata University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	sblack@jhmi.edu	Takebayashi, Hirohide/AAO-1693-2020	Miranda-Angulo, Ana L./0000-0003-4938-3033; Lee, Daniel/0000-0001-7411-2740; Pak, Thomas/0000-0003-2716-1210; Fishell, Gordon/0000-0002-9640-9278	US National Institutes of Health [F31 NS063550]; NSF; Basil O'Connor Starter Scholar Award; Klingenstein Fund; NARSAD; NATIONAL EYE INSTITUTE [T32EY007143, T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063550] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Basil O'Connor Starter Scholar Award; Klingenstein Fund(Klingenstein Philanthropies); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Nathans, S. Hattar, N. Gaiano, P. Achanta, C. Montojo, D. McClellan, T Shimogori, T. Moran, E. Newman, M. Taylor and W. Yap for comments on the manuscript. We also thank M. Bonaguidi, C. Montojo, J. Reyes, M. Armour, E. Velarde, N. Forbes-McBean, WE Han and the Johns Hopkins School of Medicine Microscope Facility for technical advice and assistance. This work was supported by US National Institutes of Health grant F31 NS063550 and an NSF Graduate Fellowship (to D.A.L.), a Basil O'Connor Starter Scholar Award and grants from the Klingenstein Fund and NARSAD (to S.B.). S.B. is a W.M. Keck Distinguished Young Scholar in Medical Research.	Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DAVELLA D, 1994, J NEUROSURG, V81, P774, DOI 10.3171/jns.1994.81.5.0774; Ford EC, 2011, RADIAT RES, V175, P774, DOI 10.1667/RR2214.1; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mathew TC, 2008, ANAT HISTOL EMBRYOL, V37, P9, DOI 10.1111/j.1439-0264.2007.00786.x; Matinfar M, 2007, LECT NOTES COMPUT SC, V4792, P926; Miller I, 2004, NEUROREPORT, V15, P925, DOI 10.1097/00001756-200404090-00038; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Simerly RB, 2008, PHYSIOL BEHAV, V94, P79, DOI 10.1016/j.physbeh.2007.11.023; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	15	322	331	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					700	702		10.1038/nn.3079	http://dx.doi.org/10.1038/nn.3079			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446882	Green Accepted			2022-12-25	WOS:000303270200013
J	Ma, LX; Hu, BY; Liu, Y; Vermilyea, SC; Liu, HS; Gao, L; Sun, Y; Zhang, XQ; Zhang, SC				Ma, Lixiang; Hu, Baoyang; Liu, Yan; Vermilyea, Scott Christopher; Liu, Huisheng; Gao, Lu; Sun, Yan; Zhang, Xiaoqing; Zhang, Su-Chun			Human Embryonic Stem Cell-Derived GABA Neurons Correct Locomotion Deficits in Quinolinic Acid-Lesioned Mice	CELL STEM CELL			English	Article							FETAL STRIATAL TRANSPLANTATION; HUNTINGTONS-DISEASE; NEURAL DIFFERENTIATION; ANIMAL-MODELS; AXON GROWTH; IN-VITRO; TELENCEPHALON; PROGENITORS; EXPRESSION; GENES	Degeneration of medium spiny GABA neurons in the basal ganglia underlies motor' dysfunction in Huntington's disease (HD), which presently lacks effective therapy. In this study, we have successfully directed human embryonic stem cells (hESCs) to enriched populations of DARPP32-expressing forebrain GABA neurons. Transplantation of these human forebrain GABA neurons and their progenitors, but not spinal GABA cells, into the striatum of quinolinic acid-lesioned mice results in generation of large populations of DARPP32(+) GABA neurons, which project to the substantia nigra as well as receiving glutamatergic and dopaminergic inputs, corresponding to correction of motor deficits. This finding raises hopes for cell therapy for HD.	[Ma, Lixiang; Liu, Yan; Gao, Lu; Sun, Yan; Zhang, Su-Chun] Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200032, Peoples R China; [Zhang, Su-Chun] Fudan Univ, Inst Biomed Sci, Inst Stem Cell & Regenerat Med, Shanghai 200032, Peoples R China; [Hu, Baoyang] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Liu, Yan; Vermilyea, Scott Christopher; Liu, Huisheng; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA; [Zhang, Xiaoqing] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Tongji University	Zhang, SC (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai 200032, Peoples R China.	zhang@waisman.wisc.edu	Zhang, Xiaoqing/O-3424-2017; Hu, Baoyang/R-8374-2016	Zhang, Xiaoqing/0000-0002-7405-1893; Hu, Baoyang/0000-0003-3993-4014; ma, lixiang/0000-0001-9399-155X	NIH-NINDS [NS045926]; NICHD [P30 HD03352]; Ministry of Science and Technology, China [2006CB94700, 2006AA02A101]; Shanghai Municipality [06dj14001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064578, R01NS045926] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Shanghai Municipality; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the NIH-NINDS (NS045926), the NICHD (P30 HD03352), Ministry of Science and Technology, China (2006CB94700, 2006AA02A101), and Shanghai Municipality (06dj14001).	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Bachoud-Levi AC, 2006, LANCET NEUROL, V5, P303, DOI 10.1016/S1474-4422(06)70381-7; Bachoud-Levi AC, 2000, EXP NEUROL, V161, P194, DOI 10.1006/exnr.1999.7239; Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; CAMPBELL K, 1993, NEUROSCIENCE, V53, P403, DOI 10.1016/0306-4522(93)90204-S; Clelland CD, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E8; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Dobrossy M, 2006, EXP NEUROL, V199, P373, DOI 10.1016/j.expneurol.2005.12.033; Dunnett SB, 2007, BRAIN RES BULL, V72, P132, DOI 10.1016/j.brainresbull.2006.10.019; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fode C, 2000, GENE DEV, V14, P67; Gallina P, 2010, EXP NEUROL, V222, P30, DOI 10.1016/j.expneurol.2009.12.005; GERFEN CR, 1988, J ELECTRON MICR TECH, V10, P265, DOI 10.1002/jemt.1060100305; Goto S, 1997, EXP NEUROL, V147, P503, DOI 10.1006/exnr.1997.6628; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hauser RA, 2002, NEUROLOGY, V58, P687, DOI 10.1212/WNL.58.5.687; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Johnson CD, 2010, HUM MOL GENET, V19, pR98, DOI 10.1093/hmg/ddq148; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KOLLER WC, 1985, NEUROLOGY, V35, P1450, DOI 10.1212/WNL.35.10.1450; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Mazzocchi-Jones D, 2011, NEUROREHAB NEURAL RE, V25, P548, DOI 10.1177/1545968311402090; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Nakao N, 2000, PROG NEUROBIOL, V61, P313, DOI 10.1016/S0301-0082(99)00058-1; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OUIMET CC, 1984, J NEUROSCI, V4, P111; Palfi S, 1998, NAT MED, V4, P963, DOI 10.1038/nm0898-963; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; PEARLMAN S, 1993, BRAIN RES, V613, P203, DOI 10.1016/0006-8993(93)90900-8; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Pfeifer K, 2004, EUR J NEUROSCI, V20, P1695, DOI 10.1111/j.1460-9568.2004.03657.x; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Reuter I, 2008, J NEUROL NEUROSUR PS, V79, P948, DOI 10.1136/jnnp.2007.142380; Rosser AE, 2002, J NEUROL NEUROSUR PS, V73, P678, DOI 10.1136/jnnp.73.6.678; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sanberg P R, 1989, J Neural Transplant, V1, P23; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toresson H, 2000, MECH DEVELOP, V94, P183, DOI 10.1016/S0925-4773(00)00324-5; Toresson H, 2001, DEVELOPMENT, V128, P4769; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Wichterle H, 2001, DEVELOPMENT, V128, P3759; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; WICTORIN K, 1992, PROG NEUROBIOL, V38, P611, DOI 10.1016/0301-0082(92)90044-F; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yun K, 2001, DEVELOPMENT, V128, P193; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	58	210	220	2	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 6	2012	10	4					455	464		10.1016/j.stem.2012.01.021	http://dx.doi.org/10.1016/j.stem.2012.01.021			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	929QA	22424902	Bronze, Green Accepted			2022-12-25	WOS:000303079400013
J	Giraud, AL; Poeppel, D				Giraud, Anne-Lise; Poeppel, David			Cortical oscillations and speech processing: emerging computational principles and operations	NATURE NEUROSCIENCE			English	Article							TIME-COMPRESSED SPEECH; AUDITORY-CORTEX; TEMPORAL ENVELOPE; PERCEPTION; SENSITIVITY; PATTERNS; RHYTHMS; SPECIALIZATION; COMPREHENSION	Neuronal oscillations are ubiquitous in the brain and may contribute to cognition in several ways: for example, by segregating information and organizing spike timing. Recent data show that delta, theta and gamma oscillations are specifically engaged by the multi-timescale, quasi-rhythmic properties of speech and can track its dynamics. We argue that they are foundational in speech and language processing, 'packaging' incoming information into units of the appropriate temporal granularity. Such stimulus-brain alignment arguably results from auditory and motor tuning throughout the evolution of speech and language and constitutes a natural model system allowing auditory research to make a unique contribution to the issue of how neural oscillatory activity affects human cognition.	[Giraud, Anne-Lise] Ecole Normale Super, INSERM, U960, Dept Etud Cognit, F-75231 Paris, France; [Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); New York University	Giraud, AL (corresponding author), Ecole Normale Super, INSERM, U960, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	annelise.giraud@gmail.com			Centre National de la Recherche Scientifique of France; European Research Council; US National Institutes of Health [2R01 DC05660]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique of France(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are deeply grateful to C. Liegeois-Chauvel for providing stereotactic EEG data and C.-G. Benar for related methodological support. In A.-L.G.'s team we thank Y. Beigneux, B. Morillon and L. Arnal, who analyzed these data; A. Hyafil, C. Kapdebon and L. Fontolan, who carried out the computational modeling work; and K. Lehongre and D. Roussillon, who conducted the experiments in human subjects. In D.P.'s team, we thank H. Luo, M. Howard and G. Cogan for pioneering work and many discussions of these issues. We also thank our colleagues O. Ghitza, S. Greenberg, B. Gutkin, V. Wyart, C. Lorenzi, F. Ramus and C. Schroeder for motivating and discussing various aspects of this research. This work is supported by the Centre National de la Recherche Scientifique of France and the European Research Council (A.-L.G.), and US National Institutes of Health grant 2R01 DC05660 (D.P.).	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Adank P, 2009, J ACOUST SOC AM, V126, P2649, DOI 10.1121/1.3216914; Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chandrasekaran C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002165; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Ding N, 2009, J NEUROPHYSIOL, V102, P2731, DOI 10.1152/jn.00523.2009; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Ghitza O, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00130; Ghitza O, 2009, PHONETICA, V66, P113, DOI 10.1159/000208934; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Heimbauer LA, 2011, CURR BIOL, V21, P1210, DOI 10.1016/j.cub.2011.06.007; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Jamison HL, 2006, CEREB CORTEX, V16, P1266, DOI 10.1093/cercor/bhj068; Kayser C, 2010, P NATL ACAD SCI USA, V107, P16976, DOI 10.1073/pnas.1012656107; Kopell N, 2011, HIPPOCAMPAL MICROCIR; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shamir M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000370; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang Y, 2011, NEUROSCIENCE, V190, P398, DOI 10.1016/j.neuroscience.2011.06.010; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	50	956	966	8	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					511	517		10.1038/nn.3063	http://dx.doi.org/10.1038/nn.3063			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22426255	Green Accepted, Green Published			2022-12-25	WOS:000302114500008
J	Lovett-Barron, M; Turi, GF; Kaifosh, P; Lee, PH; Bolze, F; Sun, XH; Nicoud, JF; Zemelman, BV; Sternson, SM; Losonczy, A				Lovett-Barron, Matthew; Turi, Gergely F.; Kaifosh, Patrick; Lee, Peter H.; Bolze, Frederic; Sun, Xiao-Hua; Nicoud, Jean-Francois; Zemelman, Boris V.; Sternson, Scott M.; Losonczy, Attila			Regulation of neuronal input transformations by tunable dendritic inhibition	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; HIPPOCAMPAL INTERNEURONS; RAT HIPPOCAMPUS; GABAERGIC INTERNEURONS; PLACE CELLS; IN-VIVO; NETWORK; PLASTICITY; OSCILLATIONS; POTENTIALS	Transforming synaptic input into action potential output is a fundamental function of neurons. The pattern of action potential output from principal cells of the mammalian hippocampus encodes spatial and nonspatial information, but the cellular and circuit mechanisms by which neurons transform their synaptic input into a given output are unknown. Using a combination of optical activation and cell type-specific pharmacogenetic silencing in vitro, we found that dendritic inhibition is the primary regulator of input-output transformations in mouse hippocampal CA1 pyramidal cells, and acts by gating the dendritic electrogenesis driving burst spiking. Dendrite-targeting interneurons are themselves modulated by interneurons targeting pyramidal cell somata, providing a synaptic substrate for tuning pyramidal cell output through interactions in the local inhibitory network. These results provide evidence for a division of labor in cortical circuits, where distinct computational functions are implemented by subtypes of local inhibitory neurons.	[Lovett-Barron, Matthew; Turi, Gergely F.; Kaifosh, Patrick; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Lee, Peter H.; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA USA; [Bolze, Frederic; Sun, Xiao-Hua; Nicoud, Jean-Francois] Univ Strasbourg, Lab Biophoton & Pharmacol, Ctr Natl Rech Sci, UMR 7213, Strasbourg, France; [Zemelman, Boris V.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	Columbia University; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Austin	Losonczy, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	al2856@columbia.edu	Turi, Gergely/E-7631-2013; Bolze, Frederic/AAX-9871-2021; Turi, Gergely/G-5054-2019	Turi, Gergely/0000-0001-5651-9459; Lee, Peter H/0000-0003-4177-4099; Sternson, Scott/0000-0002-0835-444X; Zemelman, Boris/0000-0003-2463-4887; Kaifosh, Patrick/0000-0002-1470-5701; Lovett-Barron, Matthew/0000-0003-1425-5277	Natural Sciences and Engineering Research Council of Canada; Searle Scholar Program; Gatsby Foundation; Kavli Institute at Columbia University; Howard Hughes Medical Institute; Agence Nationale pour la Recherche (France) [ANR PCV 07 10035]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Searle Scholar Program; Gatsby Foundation; Kavli Institute at Columbia University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agence Nationale pour la Recherche (France)(French National Research Agency (ANR))	We thank R. Nyilas, R. Field, A. Qureshi, J.K. Baruni and A. Villacis for help with histology. We thank J.C. Magee, L. F. Abbott, G. Buzsaki, S. A. Siegelbaum and T. M. Jessell for discussions and comments on a previous version of the manuscript. This work was supported by Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships (M.L.-B. and P. K.), the Searle Scholar Program, the Gatsby Foundation and Kavli Institute at Columbia University (A. L.) and the Howard Hughes Medical Institute (S. M. S.). F. B. thanks the Agence Nationale pour la Recherche (France) for financial support (ANR PCV 07 10035).	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cobb SR, 1997, NEUROSCIENCE, V79, P629, DOI 10.1016/S0306-4522(97)00055-9; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Collingridge G.L., 1988, J PHYSIOL-LONDON, V399, P282; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Katona I, 1999, J NEUROSCI, V19, P4544; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x; KNOWLES WD, 1981, J NEUROSCI, V1, P1236; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MULLIGAN KA, 1988, J COMP NEUROL, V270, P86, DOI 10.1002/cne.902700108; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903	50	268	268	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					423	U111		10.1038/nn.3024	http://dx.doi.org/10.1038/nn.3024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246433				2022-12-25	WOS:000300793100016
J	Weber, F; Machens, CK; Borst, A				Weber, Franz; Machens, Christian K.; Borst, Alexander			Disentangling the functional consequences of the connectivity between optic-flow processing neurons	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; MOTION-SENSITIVE NEURONS; PRIMARY VISUAL-CORTEX; SPIKING NEURONS; POPULATION; SYSTEM; FLY; INTERNEURONS; PERFORMANCE; DEPENDENCE	Typically, neurons in sensory areas are highly interconnected. Coupling two neurons can synchronize their activity and affect a variety of single-cell properties, such as their stimulus tuning, firing rate or gain. All of these factors must be considered to understand how two neurons should be coupled to optimally process stimuli. We quantified the functional effect of an interaction between two optic-flow processing neurons (Vi and H1) in the fly (Lucilia sericata). Using a generative model, we estimated a uni-directional coupling from H1 to Vi. Especially at a low signal-to-noise ratio (SNR), the coupling strongly improved the information about optic-flow in Vi. We identified two constraints confining the strength of the interaction. First, for weak couplings, Vi benefited from inputs by H1 without a concomitant shift of its stimulus tuning. Second, at both low and high SNR, the coupling strength lay in a range in which the information carried by single spikes is optimal.	[Weber, Franz; Borst, Alexander] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany; [Weber, Franz] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany; [Machens, Christian K.] Ecole Normale Super, Grp Neural Theory, Dept Etud Cognit, INSERM,U960, F-75231 Paris, France	Max Planck Society; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Weber, F (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany.	weberf@neuro.mpg.de		Machens, Christian/0000-0003-1717-1562	Deutsche Forschungsgemeinschaft (DFG) [1091]; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank E. Schneidman and G. Tkacik for important discussions during the Methods in Computational Neuroscience course in Woods Hole, Massachusetts. We thank M. Walter for improving the functionality of the LED arena, F. Schwarz for help with the experiments and H. Eichner for critically reading the manuscript. F. W. is supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, Research Training Group 1091) and the Max Planck Society. C. K. M. is funded through the Emmy-Noether program of the DFG and a "Chaire d'excellence" of the Agence National de la Recherche.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BEERSMA DGM, 1977, J COMP PHYSIOL, V119, P207, DOI 10.1007/BF00656634; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Borst A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016303; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Gerwinn S, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00012; GILBERT CD, 1985, VISION RES, V25, P365, DOI 10.1016/0042-6989(85)90061-6; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2007, FRONT NEUROSCI-SWITZ, V1, P111, DOI 10.3389/neuro.01.1.1.008.2007; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; Reichardt W., 1961, S PRINC SENS COMM, P303; Rieke F., 1999, SPIKES; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Weber F, 2010, NEURON, V67, P629, DOI 10.1016/j.neuron.2010.07.017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	48	7	7	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					441	U132		10.1038/nn.3044	http://dx.doi.org/10.1038/nn.3044			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22327473				2022-12-25	WOS:000300793100018
J	Nazzaro, C; Greco, B; Cerovic, M; Baxter, P; Rubino, T; Trusel, M; Parolaro, D; Tkatch, T; Benfenati, F; Pedarzani, P; Tonini, R				Nazzaro, Cristiano; Greco, Barbara; Cerovic, Milica; Baxter, Paul; Rubino, Tiziana; Trusel, Massimo; Parolaro, Daniela; Tkatch, Tatiana; Benfenati, Fabio; Pedarzani, Paola; Tonini, Raffaella			SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; MEDIUM SPINY NEURONS; SYNAPTIC PLASTICITY; ENDOCANNABINOID RELEASE; DOPAMINERGIC CONTROL; INDUCED DYSKINESIA; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; RECEPTORS; EXPOSURE	Endocannabinoids (eCBs) regulate neuronal activity in the dorso-lateral striatum (DLS), a brain region that is involved in habitual behaviors. How synaptic eCB signaling contributes to habitual behaviors under physiological and pathological conditions remains unclear. Using a mouse model of cannabinoid tolerance, we found that persistent activation of the eCB pathway impaired eCB-mediated long-term depression (LTD) and synaptic depotentiation in the DLS. The loss of eCB LTD, occurring preferentially at cortical connections to striatopallidal neurons, was associated with a shift in behavioral control from goal-directed action to habitual responding. eCB LTD and behavioral alterations were rescued by in vivo modulation of small-conductance calcium activated potassium channel (SK channel) activity in the DLS, which potentiates eCB signaling. Our results reveal a direct relationship between drug tolerance and changes in control of instrumental performance by establishing a central role for eCB LTD in habit expression. In addition, SK channels emerge as molecular targets to fine tune the eCB pathway under pathological conditions.	[Nazzaro, Cristiano; Greco, Barbara; Trusel, Massimo; Tkatch, Tatiana; Benfenati, Fabio; Tonini, Raffaella] IIT, Dept Neurosci & Brain Technol, Genoa, Italy; [Cerovic, Milica] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Baxter, Paul; Pedarzani, Paola] UCL, Res Dept Neurosci Physiol & Pharmacol, London, England; [Rubino, Tiziana; Parolaro, Daniela] Univ Insubria, DBSF, Busto Arsizio, VA, Italy	Istituto Italiano di Tecnologia - IIT; Cardiff University; University of London; University College London; University of Insubria	Tonini, R (corresponding author), IIT, Dept Neurosci & Brain Technol, Genoa, Italy.	raffaella.tonini@iit.it	Rubino, Tiziana/AAC-8210-2020; Tonini, Raffaella/J-2960-2012	Cerovic, Milica/0000-0002-8417-0503; Trusel, Massimo/0000-0001-6208-2476; TONINI, Raffaella/0000-0003-1652-4709; Tkatch, Tatiana/0000-0001-6626-7435; RUBINO, Tiziana/0000-0002-3128-6377; Baxter, Paul/0000-0003-2142-1085	Istituto Italiano di Tecnologia; Medical Research Council [CEG G0100066]; MRC [G0100066] Funding Source: UKRI; Medical Research Council [G0100066] Funding Source: researchfish	Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to V. Di Marzo, L. Gasparini and F. Papaleo for critical reading of the manuscript, and D. Piomelli for helpful discussion of the results. This research was supported by the Istituto Italiano di Tecnologia. P.P. acknowledges support from the Medical Research Council (CEG G0100066).	Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Centonze D, 2006, BIOL PSYCHIAT, V60, P436, DOI 10.1016/j.biopsych.2005.11.018; Chaperon F, 1999, CRIT REV NEUROBIOL, V13, P243, DOI 10.1615/CritRevNeurobiol.v13.i3.20; DeRusso AL, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00017; Fino E, 2010, J PHYSIOL-LONDON, V588, P3045, DOI 10.1113/jphysiol.2010.188466; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Hilario MRF, 2008, FRONT NEUROSCI-SWITZ, V2, P208, DOI 10.3389/neuro.01.030.2008; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Hoffman AF, 2003, J NEUROSCI, V23, P4815; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; Maldonado R, 2003, J NEURAL TRANSM-SUPP, P1; Maldonado R, 2002, J NEUROSCI, V22, P3326; Martin BR, 2004, TRENDS PHARMACOL SCI, V25, P325, DOI 10.1016/j.tips.2004.04.005; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Picconi B, 2011, BRAIN, V134, P375, DOI 10.1093/brain/awq342; Quinn JJ, 2007, NAT NEUROSCI, V10, P1398, DOI 10.1038/nn1994; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Rubino T, 2005, J NEUROCHEM, V93, P984, DOI 10.1111/j.1471-4159.2005.03101.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Tonini R, 2006, J NEUROSCI, V26, P5810, DOI 10.1523/JNEUROSCI.5469-05.2006; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	46	81	81	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					284	293		10.1038/nn.3022	http://dx.doi.org/10.1038/nn.3022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22231426				2022-12-25	WOS:000299603500020
J	Ruckh, JM; Zhao, JW; Shadrach, JL; van Wijngaarden, P; Rao, TN; Wagers, AJ; Franklin, RJM				Ruckh, Julia M.; Zhao, Jing-Wei; Shadrach, Jennifer L.; van Wijngaarden, Peter; Rao, Tata Nageswara; Wagers, Amy J.; Franklin, Robin J. M.			Rejuvenation of Regeneration in the Aging Central Nervous System	CELL STEM CELL			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; REMYELINATION EFFICIENCY; CHEMOKINE RECEPTOR; MULTIPLE-SCLEROSIS; HEMATOPOIETIC STEM; CNS REMYELINATION; PROGENITOR CELLS; DIFFERENTIATION; REPAIR; MICE	Remyelination is a regenerative process in the central nervous system (CNS) that produces new myelin sheaths from adult stem cells. The decline in remyelination that occurs with advancing age poses a significant barrier to therapy in the CNS, particularly for long-term demyelinating diseases such as multiple sclerosis (MS). Here we show that remyelination of experimentally induced demyelination is enhanced in old mice exposed to a youthful systemic milieu through heterochronic parabiosis. Restored remyelination in old animals involves recruitment to the repairing lesions of blood-derived monocytes from the young parabiotic partner, and preventing this recruitment partially inhibits rejuvenation of remyelination. These data suggest that enhanced remyelinating activity requires both youthful monocytes and other factors, and that remyelination-enhancing therapies targeting endogenous cells can be effective throughout life.	[Shadrach, Jennifer L.; Rao, Tata Nageswara; Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, Cambridge, MA 02215 USA; [Ruckh, Julia M.; Zhao, Jing-Wei; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge CB3 0ES, England; [Ruckh, Julia M.; Zhao, Jing-Wei; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB3 0ES, England; [Ruckh, Julia M.; Zhao, Jing-Wei; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Shadrach, Jennifer L.; Rao, Tata Nageswara; Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02215 USA; [Shadrach, Jennifer L.; Rao, Tata Nageswara; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA 02215 USA	Harvard University; Howard Hughes Medical Institute; University of Cambridge; University of Cambridge; University of Cambridge; Harvard University; Harvard University; Joslin Diabetes Center, Inc.	Wagers, AJ (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, 7 Divin Ave, Cambridge, MA 02215 USA.	amy.wagers@joslin.harvard.edu; rjf1000@cam.ac.uk	Zhao, Jing-Wei/A-6887-2012; Zhao, Jing-Wei/L-9964-2014	Zhao, Jing-Wei/0000-0002-1135-9743; Franklin, Robin/0000-0001-6522-2104; Tata, Nageswara Rao/0000-0002-9928-5944; van Wijngaarden, Peter/0000-0002-8800-7834	European Leukodystrophy Association (ELA); Research into Ageing; UK Multiple Sclerosis Society; National Multiple Sclerosis Society; Burroughs-Wellcome Fund; Harvard Stem Cell Institute; British Consulate General Science and Innovation Network; National Institutes of Health [1 DP2 OD004345-01]; National Health and Medical Research Council of Australia; Medical Research Council, UK; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; Rosetrees Trust [M144] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	European Leukodystrophy Association (ELA); Research into Ageing; UK Multiple Sclerosis Society; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Harvard Stem Cell Institute; British Consulate General Science and Innovation Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Buruzula and J. LaVecchio at Joslin's HSCl/DERC Flow Cytometry Core (NIH P30 DK036836) for their excellent technical support. This work was supported in part by grants from the European Leukodystrophy Association (ELA) (to R.J.M.F. and A.J.W), Research into Ageing, the UK Multiple Sclerosis Society and National Multiple Sclerosis Society (to R.J.M.F.), the Burroughs-Wellcome Fund, the Harvard Stem Cell Institute, the British Consulate General Science and Innovation Network, and National Institutes of Health 1 DP2 OD004345-01 (to A.J.W.). P.v.W. was supported by the National Health and Medical Research Council of Australia. J.M.R. was supported by a Ph.D. studentship from the Medical Research Council, UK.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; CONNOR JR, 1986, BRAIN RES, V368, P319, DOI 10.1016/0006-8993(86)90576-7; DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Hinks GL, 2000, MOL CELL NEUROSCI, V16, P542, DOI 10.1006/mcne.2000.0897; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Mason JL, 2003, J NEUROSCI, V23, P7710; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Vana AC, 2007, J NEUROPATH EXP NEUR, V66, P975, DOI 10.1097/NEN.0b013e3181587d46; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	30	436	459	2	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 6	2012	10	1					96	103		10.1016/j.stem.2011.11.019	http://dx.doi.org/10.1016/j.stem.2011.11.019			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880ZQ	22226359	Green Accepted, Bronze			2022-12-25	WOS:000299449500014
J	Raznahan, A; Lerch, JP; Lee, N; Greenstein, D; Wallace, GL; Stockman, M; Clasen, L; Shaw, PW; Giedd, JN				Raznahan, Armin; Lerch, Jason P.; Lee, Nancy; Greenstein, Dede; Wallace, Gregory L.; Stockman, Michael; Clasen, Liv; Shaw, Phillip W.; Giedd, Jay N.			Patterns of Coordinated Anatomical Change in Human Cortical Development: A Longitudinal Neuroimaging Study of Maturational Coupling	NEURON			English	Article							DEFAULT MODE NETWORK; INTRINSIC FUNCTIONAL ARCHITECTURE; AUTOMATED 3-D EXTRACTION; RESTING-STATE NETWORKS; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; PREFRONTAL CORTEX; CEREBRAL-CORTEX; THICKNESS; SEX	Understanding of human structural brain development has rapidly advanced in recent years, but remains fundamentally "localizational" in nature. Here, we use 376 longitudinally acquired structural brain scans from 108 typically developing adolescents to conduct the first study of coordinated anatomical change within the developing cortex. Correlation in rates of anatomical change was regionally heterogeneous, with fronto-temporal association cortices showing the strongest and most widespread maturational coupling with other cortical areas, and lower-order sensory cortices showing the least. Canonical cortical systems with rich structural and functional interconnectivity showed significantly elevated maturational coupling. Evidence for sexually dimorphic maturational coupling was found within a frontopolar-centered prefrontal system involved in complex decision-making. By providing the first link between cortical connectivity and the coordination of cortical development, we reveal a hitherto unseen property of healthy brain maturation, which may represent a target for neurodeveloprnental disease processes, and a substrate for sexually dimorphic behavior in adolescence.	[Raznahan, Armin; Lee, Nancy; Greenstein, Dede; Wallace, Gregory L.; Stockman, Michael; Clasen, Liv; Shaw, Phillip W.; Giedd, Jay N.] NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA; [Lerch, Jason P.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Lerch, Jason P.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Raznahan, A (corresponding author), NIMH, Child Psychiat Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	raznahana@mail.nih.gov	Lee, Nancy/M-7492-2016; Shaw, Philip/A-1129-2008; Giedd, Jay N/B-7302-2012; Wallace, Gregory/H-2158-2018; Raznahan, Armin/F-4534-2012; Giedd, Jay/J-9644-2015; Giedd, Jay N./A-3080-2008	Lee, Nancy/0000-0002-6663-0713; Shaw, Philip/0000-0002-1313-2526; Giedd, Jay N/0000-0003-0827-3460; Wallace, Gregory/0000-0003-0329-5054; Raznahan, Armin/0000-0002-5622-1190; Giedd, Jay/0000-0003-2002-8978; 	Intramural NIH HHS [Z99 MH999999] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002794] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burman KJ, 2011, CEREB CORTEX, V21, P1712, DOI 10.1093/cercor/bhq239; Cauda F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013107; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Christakou A, 2009, NEUROIMAGE, V48, P223, DOI 10.1016/j.neuroimage.2009.06.070; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; GORDON CT, 1994, SCHIZOPHRENIA BULL, V20, P697, DOI 10.1093/schbul/20.4.697; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Home Office, 2001, CRIM STAT; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Lyons R A, 1999, Inj Prev, V5, P129; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; MASSIE DL, 1995, ACCIDENT ANAL PREV, V27, P73, DOI 10.1016/0001-4575(94)00050-V; McQuillan R, 2006, PUBLIC HEALTH, V120, P732, DOI 10.1016/j.puhe.2006.02.011; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Mesulam M, 2000, PRINCIPLES BEHAV COG; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schmitt JE, 2009, NEUROIMAGE, V47, P56, DOI 10.1016/j.neuroimage.2008.06.039; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; YORKE CH, 1975, J COMP NEUROL, V164, P233, DOI 10.1002/cne.901640206; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	76	215	215	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					873	884		10.1016/j.neuron.2011.09.028	http://dx.doi.org/10.1016/j.neuron.2011.09.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153381	Green Accepted, Bronze			2022-12-25	WOS:000297971100019
J	Li, SX; Huang, S; Bren, N; Noridomi, K; Dellisanti, CD; Sine, SM; Chen, L				Li, Shu-Xing; Huang, Sun; Bren, Nina; Noridomi, Kaori; Dellisanti, Cosma D.; Sine, Steven M.; Chen, Lin			Ligand-binding domain of an alpha(7)-nicotinic receptor chimera and its complex with agonist	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; CURARIFORM ANTAGONISTS; CRYSTAL-STRUCTURE; PROTEIN REVEALS; ALPHA-7 SUBUNIT; LOOP; MUTAGENESIS; PERMEATION	The alpha(7) acetylcholine receptor (AChR) mediates pre- and postsynaptic neurotransmission in the central nervous system and is a potential therapeutic target in neurodegenerative, neuropsychiatric and inflammatory disorders. We determined the crystal structure of the extracellular domain of a receptor chimera constructed from the human alpha(7) AChR and Lymnaea stagnalis acetylcholine binding protein (AChBP), which shares 64% sequence identity and 71% similarity with native alpha(7). We also determined the structure with bound epibatidine, a potent AChR agonist. Comparison of the structures revealed molecular rearrangements and interactions that mediate agonist recognition and early steps in signal transduction in alpha(7) AChRs. The structures further revealed a ring of negative charge within the central vestibule, poised to contribute to cation selectivity. Structure-guided mutational studies disclosed distinctive contributions to agonist recognition and signal transduction in alpha(7) AChRs. The structures provide a realistic template for structure-aided drug design and for defining structure-function relationships of alpha(7) AChRs.	[Li, Shu-Xing; Noridomi, Kaori; Dellisanti, Cosma D.; Chen, Lin] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Shu-Xing; Noridomi, Kaori; Dellisanti, Cosma D.; Chen, Lin] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Huang, Sun; Bren, Nina; Sine, Steven M.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN USA; [Sine, Steven M.] Mayo Clin, Dept Neurol, Coll Med, Rochester, MN USA; [Chen, Lin] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Mayo Clinic; Mayo Clinic; University of Southern California	Chen, L (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	sine@mayo.edu; linchen@usc.edu	Li, Shu-Xing/C-5370-2011; chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; Noridomi, Kaori/0000-0002-4303-7511	US National Institutes of Health [NS031744, HL076334, GM064642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Advanced Light Source Berkeley Center for Structural Biology staff members C. Ralston, P. Zwart, C. Bertoldo, A. Rozales and K. Royal for help with data collection, N. Chelyapov and University of Southern California NanoBiophysics Core Facility for help with multi-angle light scattering analyses and P. Taylor for providing cDNA encoding AChBP. This work is supported by US National Institutes of Health grants NS031744 to S. M. S. and HL076334 and GM064642 to L.C.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grosman C, 2000, J GEN PHYSIOL, V115, P637, DOI 10.1085/jgp.115.5.637; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; JONES DH, 1992, BIOTECHNIQUES, V12, P528; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SEGUELA P, 1993, J NEUROSCI, V13, P596; SINE SM, 1994, J BIOL CHEM, V269, P8808; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	38	158	165	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1253	U173		10.1038/nn.2908	http://dx.doi.org/10.1038/nn.2908			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909087	Green Accepted			2022-12-25	WOS:000295254200013
J	Valnegri, P; Khelfaoui, M; Dorseuil, O; Bassani, S; Lagneaux, C; Gianfelice, A; Benfante, R; Chelly, J; Billuart, P; Sala, C; Passafaro, M				Valnegri, Pamela; Khelfaoui, Malik; Dorseuil, Olivier; Bassani, Silvia; Lagneaux, Celine; Gianfelice, Antonella; Benfante, Roberta; Chelly, Jamel; Billuart, Pierre; Sala, Carlo; Passafaro, Maria			A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erb alpha	NATURE NEUROSCIENCE			English	Article							LINKED MENTAL-RETARDATION; KAINIC ACID NEUROTOXICITY; CEREBELLAR HYPOPLASIA; RESPONSE ELEMENT; ORPHAN RECEPTOR; GENE-EXPRESSION; INTELLECTUAL DISABILITY; VENTRICULAR ENLARGEMENT; SUPRACHIASMATIC NUCLEUS; PROTEIN OLIGOPHRENIN-1	Oligophrenin-1 regulates dendritic spine morphology in the brain. Mutations in the oligophrenin-1 gene (OPHN1) cause intellectual disability. We discovered a previously unknown partner of oligophrenin-1, Rev-erb alpha, a nuclear receptor that represses the transcription of circadian oscillators. We found that oligophrenin-1 interacts with Rev-erb alpha in the mouse brain, causing it to locate to dendrites, reducing its repressor activity and protecting it from degradation. Our results indicate the presence of a circadian oscillator in the hippocampus, involving the clock gene Bmal1 (also known as Arntl), that is modulated by Rev-erb alpha and requires oligophrenin-1 for normal oscillation. We also found that synaptic activity induced Rev-erb alpha localization to dendrites and spines, a process that is mediated by AMPA receptor activation and requires oligophrenin-1. Our data reveal new interactions between synaptic activity and circadian oscillators, and delineate a new means of communication between nucleus and synapse that may provide insight into normal plasticity and the etiology of intellectual disability.	[Valnegri, Pamela; Bassani, Silvia; Gianfelice, Antonella; Benfante, Roberta; Sala, Carlo; Passafaro, Maria] Univ Milan, Dept Pharmacol, CNR, Inst Neurosci, Milan, Italy; [Valnegri, Pamela; Bassani, Silvia; Passafaro, Maria] Dulbecco Telethon Inst, Milan, Italy; [Khelfaoui, Malik; Dorseuil, Olivier; Lagneaux, Celine; Chelly, Jamel; Billuart, Pierre] INSERM, U1016, Inst Cochin, Paris, France; [Khelfaoui, Malik; Dorseuil, Olivier; Lagneaux, Celine; Chelly, Jamel; Billuart, Pierre] CNRS, UMR8104, Paris, France; [Khelfaoui, Malik; Dorseuil, Olivier; Lagneaux, Celine; Chelly, Jamel; Billuart, Pierre] Univ Paris 05, Paris, France; [Sala, Carlo] Neurol Inst, Milan, Italy; [Sala, Carlo] Fdn Carlo Besta, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; IRCCS Istituto Neurologico Besta	Passafaro, M (corresponding author), Univ Milan, Dept Pharmacol, CNR, Inst Neurosci, Milan, Italy.	m.passafaro@in.cnr.it	Billuart, Pierre/K-3832-2017; Sala, Carlo/A-2493-2009; Chelly, Jamel/J-7528-2015; Bassani, Silvia/A-7241-2012; Benfante, Roberta/C-1513-2015	Billuart, Pierre/0000-0003-1913-1687; Sala, Carlo/0000-0003-0662-9523; Chelly, Jamel/0000-0002-0939-8719; Bassani, Silvia/0000-0003-0553-7168; Benfante, Roberta/0000-0001-5396-5429	Telethon Italy [S01014TELU, GGP09196]; Fondazione Cariplo [2008-2318, 2009.264]; Fondazione Mariani; Project TerDisMental [16983 - Rif.SAL-50]; Ricerca Scientifica a Tema Libero (RSTL) Consiglio Nazionale delle Ricerche (CNR); Regione Lombardia [SAL-50-16983]; Italian Institute of Technology; French National Research Agency [ANR-06-Neuro-003-02, ANR-08-MNPS-037-04]; European Union [241995]; Fondation Jerome Lejeune; INSERM; Fondation pour La Recherche Medicale	Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Fondazione Mariani; Project TerDisMental; Ricerca Scientifica a Tema Libero (RSTL) Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Regione Lombardia(Regione Lombardia); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); French National Research Agency(French National Research Agency (ANR)); European Union(European Commission); Fondation Jerome Lejeune; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour La Recherche Medicale(Fondation pour la Recherche Medicale)	The authors thank D. Ward for assisting with the manuscript. The authors thank E. Challet, D. Ciocca and S. Reibel-Foisset for advice with the circadian experiments. M. P. was supported by Telethon Italy (S01014TELU), Fondazione Cariplo (2008-2318), Fondazione Mariani, Project TerDisMental, ID 16983 - Rif.SAL-50. C. S. was supported by Telethon-Italy grant GGP09196, Fondazione CARIPLO project no. 2009.264, Ricerca Scientifica a Tema Libero (RSTL) Consiglio Nazionale delle Ricerche (CNR), Regione Lombardia Project no. SAL-50-16983 TERDISMENTAL and an Italian Institute of Technology Seed Grant. P. B., O.D. and J.C. are supported by the French National Research Agency (ANR-06-Neuro-003-02, ANR-08-MNPS-037-04), European Union (Gencodys, FP7 241995), Fondation Jerome Lejeune and INSERM. C. L. was supported by the "Fondation pour La Recherche Medicale".	Abe H, 2001, EUR J NEUROSCI, V14, P1121, DOI 10.1046/j.0953-816x.2001.01732.x; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Battaglioli E, 1998, J NEUROCHEM, V71, P1261; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chaudhury D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-63; Chomez P, 2000, DEVELOPMENT, V127, P1489; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; FERKANY JW, 1984, NATURE, V308, P561, DOI 10.1038/308561a0; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Nakano-Kobayashi A, 2009, CURR BIOL, V19, P1133, DOI 10.1016/j.cub.2009.05.022; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Tentler D, 1999, EUR J HUM GENET, V7, P541, DOI 10.1038/sj.ejhg.5200320; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; ZACZEK R, 1981, NEUROPHARMACOLOGY, V20, P183, DOI 10.1016/0028-3908(81)90202-1	46	47	52	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1293	U108		10.1038/nn.2911	http://dx.doi.org/10.1038/nn.2911			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874017				2022-12-25	WOS:000295254200018
J	Pan, EH; Zhang, XA; Huang, Z; Krezel, A; Zhao, M; Tinberg, CE; Lippard, SJ; McNamara, JO				Pan, Enhui; Zhang, Xiao-an; Huang, Zhen; Krezel, Artur; Zhao, Min; Tinberg, Christine E.; Lippard, Stephen J.; McNamara, James O.			Vesicular Zinc Promotes Presynaptic and Inhibits Postsynaptic Long-Term Potentiation of Mossy Fiber-CA3 Synapse	NEURON			English	Article							NMDA RECEPTORS; HIPPOCAMPAL; RELEASE; MEMORY; NEUROTROPHINS; DISRUPTION; COMPONENTS; TERMINALS; VESICLES; BRAIN	The presence of zinc in glutamatergic synaptic vesicles of excitatory neurons of mammalian cerebral cortex suggests that zinc might regulate plasticity of synapses formed by these neurons. Long-term potentiation (LTP) is a form of synaptic plasticity that may underlie learning and memory. We tested the hypothesis that zinc within vesicles of mossy fibers (mf) contributes to mf-LTP, a classical form of presynaptic LTP. We synthesized an extracellular zinc chelator with selectivity and kinetic properties suitable for study of the large transient of zinc in the synaptic cleft induced by mf stimulation. We found that vesicular zinc is required for presynaptic mf-LTP. Unexpectedly, vesicular zinc also inhibits a form of postsynaptic mf-LTP. Because the mf-CA3 synapse provides a major source of excitatory input to the hippocampus, regulating its efficacy by these dual actions, vesicular zinc is critical to proper function of hippocampal circuitry in health and disease.	[Zhang, Xiao-an; Huang, Zhen; Zhao, Min; Tinberg, Christine E.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Pan, Enhui; McNamara, James O.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA; [Krezel, Artur] Univ Wroclaw, Lab Prot Engn, PL-50137 Wroclaw, Poland	Massachusetts Institute of Technology (MIT); Duke University; Duke University; Duke University; University of Wroclaw	Lippard, SJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lippard@mit.edu; jmc@neuro.duke.edu	Krezel, Artur/AAG-8729-2021; Huang, Zhen/N-1894-2013; Krezel, Artur/E-7047-2011; Zhang, Xiao-an/E-4458-2016	Krezel, Artur/0000-0001-9252-5784; Zhang, Xiao-an/0000-0001-9417-4228	National Institute of General Medical Sciences [GM065519]; National Institute of Neurological Disease and Stroke [NS56217]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institute of General Medical Sciences (GM065519 to S.J.L.) and from the National Institute of Neurological Disease and Stroke (NS56217 to J.O.M.). The authors thank Drs. Daniela Buccella, Nicole Calakos, Danny Jones, and Richard Mooney for valuable discussions and Wei-Hua Qian for support of mouse husbandry and genotyping.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Alder J, 2005, J NEUROSCI, V25, P3080, DOI 10.1523/JNEUROSCI.2970-04.2005; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Breustedt J, 2003, P NATL ACAD SCI USA, V100, P12450, DOI 10.1073/pnas.2035117100; Budde T, 1997, NEUROSCIENCE, V79, P347, DOI 10.1016/S0306-4522(96)00695-1; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chang C. J., 2006, METAL IONS LIFE SCI, V1, P321; Chang CJ, 2004, CHEM BIOL, V11, P203, DOI 10.1016/j.chembiol.2004.01.017; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cole TB, 2001, BRAIN RES, V891, P253, DOI 10.1016/S0006-8993(00)03220-0; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; HAUG FMS, 1967, HISTOCHEMISTRY, V8, P355, DOI 10.1007/BF00401978; He XP, 2010, J NEUROSCI, V30, P6188, DOI 10.1523/JNEUROSCI.5821-09.2010; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kamiya H, 2002, J NEUROSCI, V22, P10524; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; Li Y, 2010, J NEUROPHYSIOL, V103, P2846, DOI 10.1152/jn.01140.2009; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MASKE H, 1955, NATURWISSENSCHAFTEN, V42, P424, DOI 10.1007/BF00601955; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nolan EM, 2005, J AM CHEM SOC, V127, P16812, DOI 10.1021/ja052184t; Paoletti P, 1997, J NEUROSCI, V17, P5711; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Quinta-Ferreira ME, 2004, BRAIN RES, V1004, P52, DOI 10.1016/j.brainres.2004.01.013; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Regehr WG, 2001, SYNAPSES, P135; Reid CA, 2004, J NEUROSCI, V24, P3618, DOI 10.1523/JNEUROSCI.3567-03.2004; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Stoltenberg M, 2004, J MOL HISTOL, V35, P141; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Tyler WJ, 2002, NEUROSCIENTIST, V8, P524, DOI 10.1177/1073858402238511; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhang XA, 2007, P NATL ACAD SCI USA, V104, P10780, DOI 10.1073/pnas.0702393104	46	134	135	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 22	2011	71	6					1116	1126		10.1016/j.neuron.2011.07.019	http://dx.doi.org/10.1016/j.neuron.2011.07.019			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DM	21943607	Green Accepted, Green Published, Bronze			2022-12-25	WOS:000295556500015
J	Osakada, F; Mori, T; Cetin, AH; Marshel, JH; Virgen, B; Callaway, EM				Osakada, Fumitaka; Mori, Takuma; Cetin, Ali H.; Marshel, James H.; Virgen, Beatriz; Callaway, Edward M.			New Rabies Virus Variants for Monitoring and Manipulating Activity and Gene Expression in Defined Neural Circuits	NEURON			English	Article							IN-VIVO; TRANSGENIC MICE; NEURONS; SINGLE; RECOMBINANT; SUBTYPES; NETWORKS; SPECIFICITY; PHYSIOLOGY; DISSECTION	Glycoprotein-deleted (Delta G) rabies virus is a powerful tool for studies of neural circuit structure. Here, we describe the development and demonstrate the utility of new resources that allow experiments directly investigating relationships between the structure and function of neural circuits. New methods and reagents allowed efficient production of 12 novel Delta G rabies variants from plasmid DNA. These new rabies viruses express useful neuroscience tools, including the Ca2+ indicator GCaMP3 for monitoring activity; Channelrhodopsin-2 for photoactivation; allatostatin receptor for inactivation by ligand application; and rtTA, ER(T2)CreER(T2), or FLPo, for control of gene expression. These new tools allow neurons targeted on the basis of their connectivity to have their function assayed or their activity or gene expression manipulated. Combining these tools with in vivo imaging and optogenetic methods and/or inducible gene expression in transgenic mice will facilitate experiments investigating neural circuit development, plasticity, and function that have not been possible with existing reagents.	[Osakada, Fumitaka; Mori, Takuma; Cetin, Ali H.; Marshel, James H.; Virgen, Beatriz; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA.	callaway@salk.edu	Marshel, James/W-2792-2019; Mori, Takuma/AFS-0267-2022; Mori, Takuma/GMX-3581-2022; Callaway, Edward/D-4336-2011	Marshel, James/0000-0003-3517-8493; Mori, Takuma/0000-0002-4195-2804; Mori, Takuma/0000-0002-4195-2804; Callaway, Edward/0000-0002-6366-5267; Osakada, Fumitaka/0000-0002-9078-1458	National Institutes of Health [MH063912, NS069464, EY010742]; Kavli Institute for Brain and Mind at University of California San Diego; Japan Society for the Promotion of Science; Kanae Foundation for the Promotion of Medical Science; Uehara Memorial Foundation; Naito Foundation; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Brain and Mind at University of California San Diego; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation for the Promotion of Medical Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I.R. Wickersham and J. Choi for helpful discussions; K.D. Roby, M. De La Parra, and K. von Bochmann for technical assistance; members of the Callaway laboratory for stimulating discussions; K.K. Conzelmann for the BSR T7/5 cell line; O. Britz and M. Goulding for the He La cells expressing frt-STOP-frt-nLacZ; I.M. Verma for HIV lentivirus packaging plasmids; X. Wu for the pNLST7; R. Tsien for the mCherry plasmid; K. Deisseroth for the ChR2-mCherry plasmid; L.L. Looger for the GCaMP3 plasmid; and C.L. Cepko for the pCAG-ER<SUP>T2</SUP>CreER<SUP>T2</SUP> and pCALNL-DsRed. F.O. is thankful to N. Osakada for constant encouragement and support. We are grateful for support from the National Institutes of Health (MH063912, NS069464, and EY010742: E.M.C.), the Kavli Institute for Brain and Mind at University of California San Diego (E.M.C.), the Japan Society for the Promotion of Science (F.O.), the Kanae Foundation for the Promotion of Medical Science (F.O.), the Uehara Memorial Foundation (F.O.), and the Naito Foundation (F.O.).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/NMETH.1292, 10.1038/nmeth.1292]; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Card J P, 2001, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0105s09; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Choi J, 2010, P NATL ACAD SCI USA, V107, P16703, DOI 10.1073/pnas.1006233107; COULON P, 1982, J GEN VIROL, V61, P97, DOI 10.1099/0022-1317-61-1-97; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Diez-Garcia J, 2007, NEUROIMAGE, V34, P859, DOI 10.1016/j.neuroimage.2006.10.021; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Le Mercier P, 2002, J VIROL, V76, P2024, DOI 10.1128/JVI.76.4.2024-2027.2002; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McGettigan JP, 2003, J VIROL, V77, P10889, DOI 10.1128/JVI.77.20.10889-10899.2003; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nassi JJ, 2007, NEURON, V55, P799, DOI 10.1016/j.neuron.2007.07.037; Ohara S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.001.2009; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schnell MJ, 2000, P NATL ACAD SCI USA, V97, P3544, DOI 10.1073/pnas.050589197; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; SYMONS RH, 1992, ANNU REV BIOCHEM, V61, P641; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Weible AP, 2010, J NEUROSCI, V30, P16509, DOI 10.1523/JNEUROSCI.2442-10.2010; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wu XF, 2008, VIRUS RES, V131, P95, DOI 10.1016/j.virusres.2007.07.018; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; ZHU XD, 1995, J BIOL CHEM, V270, P23044, DOI 10.1074/jbc.270.39.23044	70	214	231	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 25	2011	71	4					617	631		10.1016/j.neuron.2011.07.005	http://dx.doi.org/10.1016/j.neuron.2011.07.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	815JJ	21867879	Green Accepted, Bronze			2022-12-25	WOS:000294521600008
J	Zheng, JK; Umikawa, M; Zhang, SC; Huynh, H; Silvany, R; Chen, BPC; Chen, LP; Zhang, CC				Zheng, Junke; Umikawa, Masato; Zhang, Shichuan; Huynh, HoangDinh; Silvany, Robert; Chen, Benjamin P. C.; Chen, Lieping; Zhang, Cheng Cheng			Ex Vivo Expanded Hematopoietic Stem Cells Overcome the MHC Barrier in Allogeneic Transplantation	CELL STEM CELL			English	Article							STROMAL CELLS; GROWTH-FACTOR; EXPANSION; POPULATION; MICE; RECONSTITUTION; PROGENITORS; ENGRAFTMENT; FACILITATE; SUPPORTS	The lack of understanding of the interplay between hematopoietic stem cells (HSCs) and the immune system has severely hampered the stem cell research and practice of transplantation. Major problems for allogeneic transplantation include low levels of donor engraftment and high risks of graft-versus-host disease (GVHD). Transplantation of purified allogeneic HSCs diminishes the risk of GVHD but results in decreased engraftment. Here we show that ex vivo expanded mouse HSCs efficiently overcame the major histocompatibility complex barrier and repopulated allogeneic-recipient mice. An 8-day expansion culture led to a 40-fold increase of the allograft ability of HSCs. Both increased numbers of HSCs and culture-induced elevation of expression of the immune inhibitor CD274 (B7-H1 or PD-L1) on the surface of HSCs contributed to the enhancement. Our study indicates the great potential of utilizing ex vivo expanded HSCs for allogeneic transplantation and suggests that the immune privilege of HSCs can be modulated.	[Zheng, Junke; Umikawa, Masato; Huynh, HoangDinh; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zheng, Junke; Umikawa, Masato; Huynh, HoangDinh; Silvany, Robert; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Zhang, Shichuan; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University	Zhang, CC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	alec.zhang@utsouthwestern.edu	Zhang, Cheng/GRS-8698-2022	Chen, Lieping/0000-0002-6825-3069	NIH [K01 CA 120099, R01 CA50519]; American Society of Hematology; DOD [PR093256]; CPRIT [RP100402]; Gabrielle's Angel Foundation; AHA [09BGIA2230372]; NATIONAL CANCER INSTITUTE [R01CA050519, K01CA120099] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; DOD(United States Department of Defense); CPRIT; Gabrielle's Angel Foundation; AHA(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support to C.C.Z. was from NIH grant K01 CA 120099, American Society of Hematology Junior Faculty Award, AHA 09BGIA2230372, DOD PR093256, CPRIT RP100402, and the Gabrielle's Angel Foundation. Support to B.P.C.C. was from NIH grant R01 CA50519.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Bridenbaugh S, 2008, BLOOD, V111, P1735, DOI 10.1182/blood-2007-02-076000; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chou S, 2010, P NATL ACAD SCI USA, V107, P7799, DOI 10.1073/pnas.1003586107; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Drake AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018382; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gandy KL, 1999, IMMUNITY, V11, P579, DOI 10.1016/S1074-7613(00)80133-8; Gyurkocza B, 2010, EXPERT REV HEMATOL, V3, P285, DOI 10.1586/EHM.10.21; Heckl D, 2011, BLOOD, V117, P3737, DOI 10.1182/blood-2010-09-308262; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; KAUFMAN CL, 1994, BLOOD, V84, P2436; Khoury M, 2011, STEM CELLS DEV, V20, P1371, DOI 10.1089/scd.2010.0456; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Noda S, 2008, STEM CELLS, V26, P646, DOI 10.1634/stemcells.2007-0623; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Taylor KN, 2008, CELL IMMUNOL, V251, P43, DOI 10.1016/j.cellimm.2008.03.003; Wang BY, 1997, P NATL ACAD SCI USA, V94, P14632, DOI 10.1073/pnas.94.26.14632; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zheng JK, 2011, BLOOD, V117, P470, DOI 10.1182/blood-2010-06-291716; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	36	52	61	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 5	2011	9	2					119	130		10.1016/j.stem.2011.06.003	http://dx.doi.org/10.1016/j.stem.2011.06.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	808PM	21816363	Bronze, Green Accepted			2022-12-25	WOS:000293990900009
J	Bagnall, MW; Hull, C; Bushong, EA; Ellisman, MH; Scanziani, M				Bagnall, Martha W.; Hull, Court; Bushong, Eric A.; Ellisman, Mark H.; Scanziani, Massimo			Multiple Clusters of Release Sites Formed by Individual Thalamic Afferents onto Cortical Interneurons Ensure Reliable Transmission	NEURON			English	Article							THALAMOCORTICAL FEEDFORWARD INHIBITION; SPINY STELLATE CELLS; MOUSE SMI CORTEX; BARREL CORTEX; SOMATOSENSORY CORTEX; MULTIVESICULAR RELEASE; EXCITATORY SYNAPSES; PYRAMIDAL CELLS; VISUAL-CORTEX; LAYER-IV	Thalamic afferents supply the cortex with sensory information by contacting both excitatory neurons and inhibitory interneurons. Interestingly, thalamic contacts with interneurons constitute such a powerful synapse that even one afferent can fire interneurons, thereby driving feedforward inhibition. However, the spatial representation of this potent synapse on interneuron dendrites is poorly understood. Using Ca imaging and electron microscopy we show that an individual thalamic afferent forms multiple contacts with the interneuronal proximal dendritic arbor, preferentially near branch points. More contacts are correlated with larger amplitude synaptic responses. Each contact, consisting of a single bouton, can release up to seven vesicles simultaneously, resulting in graded and reliable Ca transients. Computational modeling indicates that the release of multiple vesicles at each contact minimally reduces the efficiency of the thalamic afferent in exciting the interneuron. This strategy preserves the spatial representation of thalamocortical inputs across the dendritic arbor over a wide range of release conditions.	[Bagnall, Martha W.; Hull, Court; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Bagnall, Martha W.; Hull, Court; Scanziani, Massimo] Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Bagnall, Martha W.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Bagnall, MW (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	mbagnall@northwestern.edu; massimo@biomail.ucsd.edu		Bagnall, Martha/0000-0003-2102-6165; Hull, Court/0000-0002-0360-8367	postdoctoral National Research Service [NS060585]; National Center for Research Resources [5P41RR004050]; NIH [MH070058]; Gatsby Charitable Foundation; Howard Hughes Medical Institute;  [NS007220]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS060585] Funding Source: NIH RePORTER	postdoctoral National Research Service; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to J. Isaacson, the members of the Scanziani and Isaacson laboratories, and D. DiGregorio for discussion of this work, to P. Abelkop for histological help, to R. Malinow and H. Makino for use of the two-photon microscope, and to J. Evora for mouse colony support. A. Gartland contributed code for simulation of conductance injection in the NEURON modeling environment. This work was supported by a training grant to M.W.B. (NS007220), a postdoctoral National Research Service Award fellowship to C.H. (NS060585), National Center for Research Resources grant 5P41RR004050 to M.H.E., NIH grant MH070058 to M.S., the Gatsby Charitable Foundation, and the Howard Hughes Medical Institute.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ahmed B, 1997, J COMP NEUROL, V380, P230; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; Bruno RM, 2002, J NEUROSCI, V22, P10966; Carnevale NT, 2006, NEURON BOOK; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fontanez DE, 2006, NEUROSCIENCE, V137, P1177, DOI 10.1016/j.neuroscience.2005.10.022; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Hull C, 2009, J NEUROSCI, V29, P9127, DOI 10.1523/JNEUROSCI.5971-08.2009; Hur EE, 2005, J COMP NEUROL, V483, P351, DOI 10.1002/cne.20444; Inoue T, 2006, J NEUROPHYSIOL, V96, P1746, DOI 10.1152/jn.00301.2006; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; KHARAZIA VN, 1994, J NEUROSCI, V14, P6021; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; McBride TJ, 2008, J NEUROSCI, V28, P6960, DOI 10.1523/JNEUROSCI.1352-08.2008; Miles R, 1996, CURR OPIN NEUROBIOL, V6, P387, DOI 10.1016/S0959-4388(96)80124-3; Nahmani M, 2005, J COMP NEUROL, V484, P458, DOI 10.1002/cne.20505; Norenberg A, 2010, P NATL ACAD SCI USA, V107, P894, DOI 10.1073/pnas.0910716107; Peron SP, 2009, NEURON, V63, P830, DOI 10.1016/j.neuron.2009.09.010; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; RAIL W, 1970, EXCITATORY SYNAPTIC, P175; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; Tan ZJ, 2008, P NATL ACAD SCI USA, V105, P2187, DOI 10.1073/pnas.0710628105; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITE EL, 1984, J COMP NEUROL, V229, P311, DOI 10.1002/cne.902290303; WHITE EL, 1981, J COMP NEUROL, V195, P265, DOI 10.1002/cne.901950207; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Zhou M, 1995, J NEUROSCI METH, V62, P149, DOI 10.1016/0165-0270(95)00069-0	73	55	55	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 14	2011	71	1					180	194		10.1016/j.neuron.2011.05.032	http://dx.doi.org/10.1016/j.neuron.2011.05.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	793FQ	21745647	Green Accepted, Bronze			2022-12-25	WOS:000292806200016
J	Rao, MS				Rao, Mahendra S.			Funding Translational Work in Cell-Based Therapy	CELL STEM CELL			English	Editorial Material							STEM; PRODUCTS; MEDICINE	The cell therapy branch of the regenerative medicine field has been innovative in developing new models of delivery and development and identifying alternative sources of funding. We discuss the implications of these changes for pharmaceutical companies and the opportunities they offer to a new entrepreneur.	Life Technol, Frederick, MD 21704 USA	Thermo Fisher Scientific	Rao, MS (corresponding author), Life Technol, 7335 Execut Way, Frederick, MD 21704 USA.	mahendra.rao@lifetech.com			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041192] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Brown N, 2006, TECHNOL ANAL STRATEG, V18, P313, DOI 10.1080/09537320600777044; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Freeman SN, 2010, CELL STEM CELL, V7, P283, DOI 10.1016/j.stem.2010.08.003; Harvey O, 2009, POLITICS POLICY, V37, P51, DOI 10.1111/j.1747-1346.2008.00161.x; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Salter B, 2006, REGEN MED, V1, P671, DOI 10.2217/17460751.1.5.671; Salter B, 2007, REGEN MED, V2, P75, DOI 10.2217/17460751.2.1.75	12	22	22	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 8	2011	9	1					7	10		10.1016/j.stem.2011.06.009	http://dx.doi.org/10.1016/j.stem.2011.06.009			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	797VA	21726828	Bronze			2022-12-25	WOS:000293157000004
J	Johnson, SL; Eckrich, T; Kuhn, S; Zampini, V; Franz, C; Ranatunga, KM; Roberts, TP; Masetto, S; Knipper, M; Kros, CJ; Marcotti, W				Johnson, Stuart L.; Eckrich, Tobias; Kuhn, Stephanie; Zampini, Valeria; Franz, Christoph; Ranatunga, Kishani M.; Roberts, Terri P.; Masetto, Sergio; Knipper, Marlies; Kros, Corne J.; Marcotti, Walter			Position-dependent patterning of spontaneous action potentials in immature cochlear inner hair cells	NATURE NEUROSCIENCE			English	Article							SPONTANEOUS DISCHARGE PATTERNS; SPIRAL GANGLION-CELLS; NEUROTRANSMITTER RELEASE; DEVELOPMENTAL REGULATION; MAMMALIAN COCHLEA; RIBBON SYNAPSES; AUDITORY-SYSTEM; HEARING; EXPRESSION; CHANNELS	Spontaneous action potential activity is crucial for mammalian sensory system development. In the auditory system, patterned firing activity has been observed in immature spiral ganglion and brain-stem neurons and is likely to depend on cochlear inner hair cell (IHC) action potentials. It remains uncertain whether spiking activity is intrinsic to developing IHCs and whether it shows patterning. We found that action potentials were intrinsically generated by immature IHCs of altricial rodents and that apical IHCs showed bursting activity as opposed to more sustained firing in basal cells. We show that the efferent neurotransmitter acetylcholine fine-tunes the IHC's resting membrane potential (V(m)), and as such is crucial for the bursting pattern in apical cells. Endogenous extracellular ATP also contributes to the V(m) of apical and basal IHCs by triggering small-conductance Ca(2+)-activated K(+) (SK2) channels. We propose that the difference in firing pattern along the cochlea instructs the tonotopic differentiation of IHCs and auditory pathway.	[Johnson, Stuart L.; Eckrich, Tobias; Kuhn, Stephanie; Zampini, Valeria; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Zampini, Valeria; Masetto, Sergio] Univ Pavia, Dept Physiol, I-27100 Pavia, Italy; [Franz, Christoph; Knipper, Marlies] Univ Tubingen, Lab Mol Physiol Hearing, Dept Otolaryngol, Tubingen Hearing Res Ctr, Tubingen, Germany; [Ranatunga, Kishani M.; Roberts, Terri P.; Kros, Corne J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Sheffield; University of Pavia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Sussex	Marcotti, W (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	c.j.kros@sussex.ac.uk; w.marcotti@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478	Wellcome Trust [088719]; Royal National Institute for Deaf People [G41]; Deafness Research UK; Medical Research Council [G0100798]; MRC [G0100798] Funding Source: UKRI; RNID [G41] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal National Institute for Deaf People; Deafness Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RNID	This work was supported by project grants from the Wellcome Trust (088719), the Royal National Institute for Deaf People (G41) and Deafness Research UK to W.M. and a Medical Research Council Programme Grant (G0100798) to C.J.K. SK2-knockout mice were obtained from J.P. Adelman. W.M. is a Royal Society University Research Fellow.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Evans MG, 1996, J PHYSIOL-LONDON, V491, P563, DOI 10.1113/jphysiol.1996.sp021240; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Goutman JD, 2005, J PHYSIOL-LONDON, V566, P49, DOI 10.1113/jphysiol.2005.087460; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Housley GD, 2006, J MEMBRANE BIOL, V209, P89, DOI 10.1007/s00232-005-0835-7; Huang LC, 2006, HISTOCHEM CELL BIOL, V125, P681, DOI 10.1007/s00418-005-0119-4; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Johnson SL, 2007, J PHYSIOL-LONDON, V583, P631, DOI 10.1113/jphysiol.2007.136630; Johnson SL, 2009, J PHYSIOL-LONDON, V587, P1715, DOI 10.1113/jphysiol.2009.168542; Jones TA, 2000, J NEUROPHYSIOL, V83, P1452, DOI 10.1152/jn.2000.83.3.1452; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koppl C, 2007, J NEUROPHYSIOL, V98, P1843, DOI 10.1152/jn.00844.2007; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kros CJ, 2007, HEARING RES, V227, P3, DOI 10.1016/j.heares.2006.12.005; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lippe WR, 1995, BRAIN RES, V703, P205, DOI 10.1016/0006-8993(95)01096-3; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maison SF, 2002, J NEUROSCI, V22, P10838; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; PUJOL R, 1998, DEV AUDITORY SYSTEM, P146; SOBKOWICZ HM, 1992, DEV AUDITORY VESTIBU, V2, P59; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Sugasawa M, 1996, J PHYSIOL-LONDON, V491, P707, DOI 10.1113/jphysiol.1996.sp021251; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Walsh Edward J., 1992, P161; Wangemann P., 1996, COCHLEA, P130, DOI [10.1007/978-1-4612-0757-3_3, DOI 10.1007/978-1-4612-0757-3_3]; Zampini V, 2010, J PHYSIOL-LONDON, V588, P187, DOI 10.1113/jphysiol.2009.181917; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	50	112	112	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					711	U386		10.1038/nn.2803	http://dx.doi.org/10.1038/nn.2803			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21572434	Green Accepted			2022-12-25	WOS:000290958000013
J	Leventhal, DK; Gage, GJ; Schmidt, R; Pettibone, JR; Case, AC; Berke, JD				Leventhal, Daniel K.; Gage, Gregory J.; Schmidt, Robert; Pettibone, Jeffrey R.; Case, Alaina C.; Berke, Joshua D.			Basal Ganglia Beta Oscillations Accompany Cue Utilization	NEURON			English	Article							SUBTHALAMIC NUCLEUS OSCILLATIONS; EXTERNAL GLOBUS-PALLIDUS; REACTION-TIME-TASK; PARKINSONS-DISEASE; MOTOR CORTEX; SYNCHRONOUS OSCILLATIONS; SENSORIMOTOR CORTEX; BAND OSCILLATIONS; STRIATAL NEURONS; WORKING-MEMORY	Beta oscillations in cortical-basal ganglia (BG) circuits have been implicated in normal movement suppression and motor impairment in Parkinson's disease. To dissect the functional correlates of these rhythms we compared neural activity during four distinct variants of a cued choice task in rats. Brief beta (similar to 20 Hz) oscillations occurred simultaneously throughout the cortical-BG network, both spontaneously and at precise moments of task performance. Beta phase was rapidly reset in response to salient cues, yet increases in beta power were not rigidly linked to cues, movements, or movement suppression. Rather, beta power was enhanced after cues were used to determine motor output. We suggest that beta oscillations reflect a postdecision stabilized state of cortical-BG networks, which normally reduces interference from alternative potential actions. The abnormally strong beta seen in Parkinson's Disease may reflect overstabilization of these networks, producing pathological persistence of the current motor state.	[Gage, Gregory J.; Schmidt, Robert; Pettibone, Jeffrey R.; Case, Alaina C.; Berke, Joshua D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Leventhal, Daniel K.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Berke, JD (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jdberke@umich.edu	Schmidt, Robert/H-6125-2017	Schmidt, Robert/0000-0002-2474-3744; Leventhal, Daniel/0000-0001-8174-5933	National Institute on Drug Abuse; Whitehall Foundation; University of Michigan; National Institutes on Neurological Disorders and Stroke [NS007222]; National Institutes on Aging [AG024824]; DFG [SCHM 2745/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007222, R01NS078435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014318, R21DA032259] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Whitehall Foundation; University of Michigan(University of Michigan System); National Institutes on Neurological Disorders and Stroke; National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank members of the Berke laboratory for assistance with experiments and Roger Albin, Nicolas Mallet, and Daniel Weissman for their useful comments. This work was supported by the National Institute on Drug Abuse, the Whitehall Foundation, and the University of Michigan. D.K.L. was supported by National Institutes on Neurological Disorders and Stroke training grant NS007222 and National Institutes on Aging grant AG024824. R.S. was supported by DFG-grant SCHM 2745/1-1.	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Alegre M, 2005, EUR J NEUROSCI, V22, P2315, DOI 10.1111/j.1460-9568.2005.04409.x; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Barch DM, 2009, SCHIZOPHRENIA BULL, V35, P115, DOI 10.1093/schbul/sbn154; Baufreton J, 2005, J NEUROSCI, V25, P8505, DOI 10.1523/JNEUROSCI.1163-05.2005; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke J.D., 2005, BASAL GANGLIA; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; Berke JD, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00045; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brown P, 1998, J NEUROPHYSIOL, V80, P2911, DOI 10.1152/jn.1998.80.6.2911; Burkhardt JM, 2007, EUR J NEUROSCI, V26, P1912, DOI 10.1111/j.1460-9568.2007.05813.x; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Canolty RT, 2007, FRONT NEUROSCI-SWITZ, V1, P185, DOI 10.3389/neuro.01.1.1.014.2007; Castle M, 2005, J COMP NEUROL, V483, P143, DOI 10.1002/cne.20421; Chen CC, 2007, EXP NEUROL, V205, P214, DOI 10.1016/j.expneurol.2007.01.027; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Courtemanche R, 2003, J NEUROSCI, V23, P11741; Degos B, 2009, CEREB CORTEX, V19, P1616, DOI 10.1093/cercor/bhn199; Dejean C, 2011, J NEUROSCI, V31, P6098, DOI 10.1523/JNEUROSCI.3311-09.2011; Deschenes M, 1996, EUR J NEUROSCI, V8, P329, DOI 10.1111/j.1460-9568.1996.tb01217.x; Dodla R, 2010, BIOPHYS J, V98, pL5, DOI 10.1016/j.bpj.2009.11.003; Dowd E, 2007, BIOCHEM SOC T, V35, P428, DOI 10.1042/BST0350428; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Feola TW, 2000, BEHAV NEUROSCI, V114, P838, DOI 10.1037/0735-7044.114.4.838; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Holgado AJN, 2010, J NEUROSCI, V30, P12340, DOI 10.1523/JNEUROSCI.0817-10.2010; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jasper H., 1949, ARCH PSYCHIAT NERVEN, V183, P163, DOI [DOI 10.1007/BF01062488, 10.1007/BF01062488]; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kita H, 2007, PROG BRAIN RES, V160, P111, DOI 10.1016/S0079-6123(06)60007-1; Klostermann F, 2007, EUR J NEUROSCI, V25, P1604, DOI 10.1111/j.1460-9568.2007.05417.x; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2005, EXP NEUROL, V194, P212, DOI 10.1016/j.expneurol.2005.02.010; Kuhn AA, 2004, BRAIN, V127, P735, DOI 10.1093/brain/awh106; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lalo E, 2007, EXP BRAIN RES, V177, P137, DOI 10.1007/s00221-006-0655-8; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luce RD, 1986, RESPONSE TIMES THEIR; MacKay WA, 1995, BRAIN RES, V704, P167, DOI 10.1016/0006-8993(95)01109-9; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; Moustafa AA, 2008, NEUROPSYCHOLOGIA, V46, P3144, DOI 10.1016/j.neuropsychologia.2008.07.011; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; NINI A, 1995, J NEUROPHYSIOL, V74, P1800, DOI 10.1152/jn.1995.74.4.1800; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Ralph-Williams RJ, 2002, J NEUROSCI, V22, P9604; Reimer J, 2010, J NEUROSCI, V30, P11506, DOI 10.1523/JNEUROSCI.5947-09.2010; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sochurkova D, 2003, EXP BRAIN RES, V149, P401, DOI 10.1007/s00221-003-1371-2; Stoffers D, 2001, NEUROLOGY, V57, P2111, DOI 10.1212/WNL.57.11.2111; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Swann N, 2011, J NEUROSCI, V31, P5721, DOI 10.1523/JNEUROSCI.6135-10.2011; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Weinberger M, 2006, J NEUROPHYSIOL, V96, P3248, DOI 10.1152/jn.00697.2006; Weinberger M, 2009, EXP NEUROL, V219, P58, DOI 10.1016/j.expneurol.2009.05.014; Williams D, 2005, EUR J NEUROSCI, V21, P249, DOI 10.1111/j.1460-9568.2004.03817.x; Williams D, 2003, BRAIN, V126, P1975, DOI 10.1093/brain/awg194; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	88	191	191	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 9	2012	73	3					523	536		10.1016/j.neuron.2011.11.032	http://dx.doi.org/10.1016/j.neuron.2011.11.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	890JJ	22325204	Bronze, Green Accepted			2022-12-25	WOS:000300140600013
J	Fletcher, RB; Prasol, MS; Estrada, J; Baudhuin, A; Vranizan, K; Choi, YG; Ngai, J				Fletcher, Russell B.; Prasol, Melanie S.; Estrada, Jose; Baudhuin, Ariane; Vranizan, Karen; Choi, Yoon Gi; Ngai, John			p63 Regulates Olfactory Stem Cell Self-Renewal and Differentiation	NEURON			English	Article							GLOBOSE BASAL-CELLS; MULTIPOTENT PROGENITORS; P53 HOMOLOG; EPITHELIUM; PROLIFERATION; NORMALIZATION; INACTIVATION; REGENERATION; SUMMARIES; DYNAMICS	The olfactory epithelium is a sensory neuroepithelium that supports adult neurogenesis and tissue regeneration following injury, making it an excellent model for investigating neural stem cell regulation in vivo. Previous studies have identified the horizontal basal cell (HBC) as the neural stem cell of the postnatal olfactory epithelium. However, the molecules and pathways regulating HBC self-renewal and differentiation are unknown. In the present study, we demonstrate that the transcription factor p63, a member of the p53 tumor suppressor gene family known to regulate stem cell dynamics in other epithelia, is highly enriched in HBCs. We show that p63 is required cell autonomously for olfactory stem cell renewal and further demonstrate that p63 functions to repress HBC differentiation. These results provide critical insight into the genetic regulation of the olfactory stem cell in vivo and more generally provide an entree toward understanding the coordination of stem cell self-renewal and differentiation.	[Fletcher, Russell B.; Prasol, Melanie S.; Estrada, Jose; Baudhuin, Ariane; Vranizan, Karen; Choi, Yoon Gi; Ngai, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Fletcher, Russell B.; Prasol, Melanie S.; Estrada, Jose; Baudhuin, Ariane; Vranizan, Karen; Choi, Yoon Gi; Ngai, John] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ngai, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	jngai@socrates.berkeley.edu	Pillay, Nischalan/F-9536-2012		National Institute on Deafness; University of California, Berkeley Siebel Stem Cell Institute; California Institute of Regenerative Medicine; National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007235, F32DC009552] Funding Source: NIH RePORTER	National Institute on Deafness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); University of California, Berkeley Siebel Stem Cell Institute(University of California System); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Roop, R. Behringer, and N. lwai for providing Krt5-crePR mice, P. Chambon and R. Reed for providing Krt5-creER(T2) mice, A. Mills for providing p63<SUP>loxl</SUP> mice, and Hector Nolla for his invaluable help with FACS. This work was supported by grants from the National Institute on Deafness and Other Communication Disorders (R.B.F. and J.N.) and the University of California, Berkeley Siebel Stem Cell Institute (J.N.), a training grant from the California Institute of Regenerative Medicine (R.B.F. and M.S.P.), and a predoctoral fellowship from the National Science Foundation (J.E.). This paper is dedicated to Karen Vranizan (1954-2009), cherished friend and colleague-we will forever miss you.	Blanpain C, 2007, NAT CELL BIOL, V9, P731, DOI 10.1038/ncb0707-731; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BURD GD, 1993, MICROSC RES TECHNIQ, V24, P195, DOI 10.1002/jemt.1070240302; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 1997, DEVELOPMENT, V124, P1611; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Dugani CB, 2009, J NEUROSCI, V29, P6710, DOI 10.1523/JNEUROSCI.5878-08.2009; Duggan CD, 2008, J NEUROSCI, V28, P5229, DOI 10.1523/JNEUROSCI.1134-08.2008; Duggan CD, 2007, NAT NEUROSCI, V10, P673, DOI 10.1038/nn0607-673; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Huard JMT, 1998, J COMP NEUROL, V400, P469; HUARD JMT, 1995, DEV DYNAM, V203, P17, DOI 10.1002/aja.1002030103; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwai N, 2008, STEM CELLS, V26, P1298, DOI 10.1634/stemcells.2007-0891; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; King KE, 2006, CARCINOGENESIS, V27, P53, DOI 10.1093/carcin/bgi200; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Manglapus GL, 2004, J COMP NEUROL, V479, P216, DOI 10.1002/cne.20316; MATULIONIS DH, 1976, AM J ANAT, V145, P79, DOI 10.1002/aja.1001450106; MATULIONIS DH, 1975, AM J ANAT, V142, P67, DOI 10.1002/aja.1001420106; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2002, GENESIS, V32, P138, DOI 10.1002/gene.10067; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Packard A, 2011, J NEUROSCI, V31, P8748, DOI 10.1523/JNEUROSCI.0681-11.2011; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; SMART IHM, 1971, J ANAT, V109, P243; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou ZJ, 2002, GENESIS, V32, P191, DOI 10.1002/gene.10064	58	85	90	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					748	759		10.1016/j.neuron.2011.09.009	http://dx.doi.org/10.1016/j.neuron.2011.09.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153372	Green Accepted, Bronze			2022-12-25	WOS:000297971100010
J	Vargas, E; Bezanilla, F; Roux, B				Vargas, Ernesto; Bezanilla, Francisco; Roux, Benoit			In Search of a Consensus Model of the Resting State of a Voltage-Sensing Domain	NEURON			English	Article							SHAKER K+-CHANNEL; FOCUSED ELECTRIC-FIELD; CHARGE-TRANSFER CENTER; GATED ION CHANNELS; A-GO-GO; POTASSIUM CHANNEL; GATING-CHARGE; MOLECULAR-DYNAMICS; S4 SEGMENT; ATOMIC CONSTRAINTS	Voltage-sensing domains (VSDs) undergo conformational changes in response to the membrane potential and are the critical structural modules responsible for the activation of voltage-gated channels. Structural information about the key conformational states underlying voltage activation is currently incomplete. Through the use of experimentally determined residue-residue interactions as structural constraints, we determine and refine a model of the Kv channel VSD in the resting conformation. The resulting structural model is in broad agreement with results that originate from various labs using different techniques, indicating the emergence of a consensus for the structural basis of voltage sensing.	[Vargas, Ernesto; Bezanilla, Francisco; Roux, Benoit] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Roux, B (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	roux@uchicago.edu	Vargas, Ernesto/F-7433-2015		National Institutes of Health [GM062342, GM030376, GM007183-35]; University of Chicago (National Institutes of Health [T32 EB009412]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM030376, R37GM030376, R01GM062342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago (National Institutes of Health(University of ChicagoUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Luca Maragliano for valuable discussions, Fatemeh Khalili-Araghi for providing the refined initial models, and Amelia Ran-dich for helpful manuscript revisions. This work was supported by the National Institutes of Health via grant GM062342 (BR.), grant GM030376 (F.B.), and training grant GM007183-35 (E.V.). Ernesto Vargas was supported by the Graduate Program in Biophysical Sciences at the University of Chicago (National Institutes of Health grant T32 EB009412).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Broomand A, 2008, NEURON, V59, P770, DOI 10.1016/j.neuron.2008.07.008; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; CLORE GM, 1993, J MOL BIOL, V231, P82, DOI 10.1006/jmbi.1993.1259; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; Delemotte L, 2010, BIOPHYS J, V99, pL72, DOI 10.1016/j.bpj.2010.08.069; Freites JA, 2006, BIOPHYS J, V91, pL90, DOI 10.1529/biophysj.106.096065; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lewis A, 2008, J GEN PHYSIOL, V131, P549, DOI 10.1085/jgp.200809962; Lin MCA, 2011, J GEN PHYSIOL, V138, P155, DOI 10.1085/jgp.201110642; Lin MCA, 2010, J GEN PHYSIOL, V135, P415, DOI 10.1085/jgp.200910320; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips LR, 2010, J GEN PHYSIOL, V136, P629, DOI 10.1085/jgp.201010517; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rodriguez BM, 1996, NEUROPHARMACOLOGY, V35, P775, DOI 10.1016/0028-3908(96)00111-6; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Schow EV, 2010, BIOPHYS J, V98, P2857, DOI 10.1016/j.bpj.2010.03.031; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tang CY, 2000, J GEN PHYSIOL, V115, P319, DOI 10.1085/jgp.115.3.319; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Vieira-Pires RS, 2010, J GEN PHYSIOL, V136, P585, DOI 10.1085/jgp.201010508; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Xu YP, 2010, CELL, V142, P580, DOI 10.1016/j.cell.2010.07.013; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	57	79	79	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 8	2011	72	5					713	720		10.1016/j.neuron.2011.09.024	http://dx.doi.org/10.1016/j.neuron.2011.09.024			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153369	Bronze, Green Accepted			2022-12-25	WOS:000297971100007
J	Witten, IB; Steinberg, EE; Lee, SY; Davidson, TJ; Zalocusky, KA; Brodsky, M; Yizhar, O; Cho, SL; Gong, SC; Ramakrishnan, C; Stuber, GD; Tye, KM; Janak, PH; Deisseroth, K				Witten, Ilana B.; Steinberg, Elizabeth E.; Lee, Soo Yeun; Davidson, Thomas J.; Zalocusky, Kelly A.; Brodsky, Matthew; Yizhar, Ofer; Cho, Saemi L.; Gong, Shiaoching; Ramakrishnan, Charu; Stuber, Garret D.; Tye, Kay M.; Janak, Patricia H.; Deisseroth, Karl			Recombinase-Driver Rat Lines: Tools, Techniques, and Optogenetic Application to Dopamine-Mediated Reinforcement	NEURON			English	Article							VENTRAL TEGMENTAL AREA; INTRACRANIAL SELF-STIMULATION; POSITIVE REINFORCEMENT; NUCLEUS-ACCUMBENS; FOREBRAIN-BUNDLE; WORKING-MEMORY; NEURONS; REWARD; BRAIN; MODULATION	Currently there is no general approach for achieving specific optogenetic control of genetically defined cell types in rats, which provide a powerful experimental system for numerous established neurophysiological and behavioral paradigms. To overcome this challenge we have generated genetically restricted recombinase-driver rat lines suitable for driving gene expression in specific cell types, expressing Cre recombinase under the control of large genomic regulatory regions (200-300 kb). Multiple tyrosine hydroxylase (Th)::Cre and choline acetyltransferase (Chat)::Cre lines were produced that exhibited specific opsin expression in targeted cell types. We additionally developed methods for utilizing optogenetic tools in freely moving rats and leveraged these technologies to clarify the causal relationship between dopamine (DA) neuron firing and positive reinforcement, observing that optical stimulation of DA neurons in the ventral tegmental area (VTA) of Th::Cre rats is sufficient to support vigorous intracranial self-stimulation (ICSS). These studies complement existing targeting approaches by extending the generalizability of optogenetics to traditionally non-genetically-tractable but vital animal models.	[Witten, Ilana B.; Lee, Soo Yeun; Davidson, Thomas J.; Zalocusky, Kelly A.; Brodsky, Matthew; Yizhar, Ofer; Ramakrishnan, Charu; Tye, Kay M.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Witten, Ilana B.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Witten, Ilana B.] Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Steinberg, Elizabeth E.; Cho, Saemi L.; Janak, Patricia H.] UCSF, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Steinberg, Elizabeth E.; Janak, Patricia H.] UCSF, Grad Program Neurosci, San Francisco, CA 94158 USA; [Lee, Soo Yeun; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Brodsky, Matthew] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gong, Shiaoching] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA; [Stuber, Garret D.] Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] HHMI, Stanford, CA 94305 USA; [Zalocusky, Kelly A.; Deisseroth, Karl] Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA	Stanford University; Princeton University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Stanford University; University of Washington; University of Washington Seattle; Weizmann Institute of Science; Rockefeller University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Massachusetts Institute of Technology (MIT); Northwell Health; Stanford University; Howard Hughes Medical Institute; Stanford University	Witten, IB (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	iwitten@princeton.edu; pjanak@gallo.ucsf.edu; deissero@stanford.edu	Stuber, Garret/E-1160-2011; YIZHAR, OFER/AAV-8497-2021; Tye, Kay/J-6158-2013	Tye, Kay/0000-0002-2435-0182; Yizhar, Ofer/0000-0003-4228-1448; Janak, Patricia/0000-0002-3333-9049; Davidson, Thomas/0000-0003-0836-6333; Stuber, Garret/0000-0003-1730-4855; Ramakrishnan, Charu/0000-0002-3474-6332	Helen Hay Whitney Foundation; NSF; Berry postdoctoral fellowship; NRSA [F32 MH880102]; PILM (MIT); State of California for medical research on alcohol and substance abuse through UCSF; Keck, Snyder, Woo, Yu; McKnight Foundations,; CIRM; DARPA REPAIR; Gatsby Charitable Foundation; National Institute of Mental Health,; National Institute on Drug Abuse;  [P50 AA017072];  [R01 DA015096]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096, DP2DA035149, R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NSF(National Science Foundation (NSF)); Berry postdoctoral fellowship; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PILM (MIT); State of California for medical research on alcohol and substance abuse through UCSF; Keck, Snyder, Woo, Yu; McKnight Foundations,; CIRM(California Institute for Regenerative Medicine); DARPA REPAIR; Gatsby Charitable Foundation; National Institute of Mental Health,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank lnbal Goshen and Ramesh Ramakrishnan for advice and experimental assistance, as well as Stephan Lammel and Elyssa Margolis for advice on the in vitro VTA recordings. I.B.W. is supported by the Helen Hay Whitney Foundation; E.E.S and K.A.Z. are supported by an NSF Graduate Research Fellowship; T.J.D. is supported by a Berry postdoctoral fellowship; K.M.T is supported by NRSA fellowship F32 MH880102 and PILM (MIT). P.H.J. is supported by P50 AA017072 and R01 DA015096, and funds from the State of California for medical research on alcohol and substance abuse through UCSF. Full funding support for K.D. is listed at www.optogenetics. org/funding, and includes the Keck, Snyder, Woo, Yu, and McKnight Foundations, as well as CIRM, the DARPA REPAIR program, the Gatsby Charitable Foundation, the National Institute of Mental Health, and the National Institute on Drug Abuse.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Berke JD, 2009, J NEUROPHYSIOL, V101, P1575, DOI 10.1152/jn.91106.2008; BIELAJEW C, 1986, J NEUROSCI, V6, P919; BROBECK JR, 1963, SCIENCE, V140, P218, DOI 10.1126/science.140.3563.218; BUZSAKI G, 1989, J NEUROSCI METH, V28, P209, DOI 10.1016/0165-0270(89)90038-1; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chudasama Y, 2004, NEUROPSYCHOPHARMACOL, V29, P1628, DOI 10.1038/sj.npp.1300490; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; CORBETT D, 1980, BRAIN RES, V185, P1, DOI 10.1016/0006-8993(80)90666-6; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Filipiak WE, 2006, TRANSGENIC RES, V15, P673, DOI 10.1007/s11248-006-9002-x; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; GALLISTEL CR, 1985, J NEUROSCI, V5, P1246; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERMAN DC, 1974, BRAIN RES, V73, P381, DOI 10.1016/0006-8993(74)90666-0; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gutierrez R, 2010, J NEUROSCI, V30, P287, DOI 10.1523/JNEUROSCI.0855-09.2010; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; MOGENSON GJ, 1979, BRAIN RES, V171, P247, DOI 10.1016/0006-8993(79)90331-7; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Nathanson JL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.019.2009; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; OLDS ME, 1963, INT J NEUROPHARMACOL, V2, P309, DOI 10.1016/0028-3908(63)90007-8; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Owesson-White CA, 2008, P NATL ACAD SCI USA, V105, P11957, DOI 10.1073/pnas.0803896105; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Pontecorvo MJ, 1996, COGNITIVE BRAIN RES, V3, P205, DOI 10.1016/0926-6410(96)00007-9; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Wang YM, 1999, HUM GENE THER, V10, P1763, DOI 10.1089/10430349950017446; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011	61	442	452	0	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 8	2011	72	5					721	733		10.1016/j.neuron.2011.10.028	http://dx.doi.org/10.1016/j.neuron.2011.10.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	860TR	22153370	Green Submitted, Green Accepted, Bronze			2022-12-25	WOS:000297971100008
J	Haxby, JV; Guntupalli, JS; Connolly, AC; Halchenko, YO; Conroy, BR; Gobbini, MI; Hanke, M; Ramadge, PJ				Haxby, James V.; Guntupalli, J. Swaroop; Connolly, Andrew C.; Halchenko, Yaroslav O.; Conroy, Bryan R.; Gobbini, M. Ida; Hanke, Michael; Ramadge, Peter J.			A Common, High-Dimensional Model of the Representational Space in Human Ventral Temporal Cortex	NEURON			English	Article							HUMAN BRAIN ACTIVITY; OBJECT RECOGNITION; NATURAL IMAGES; VISUAL-CORTEX; FACE AREA; FMRI; SELECTIVITY; ARCHITECTURE; SPECIFICITY; PERCEPTION	We present a high-dimensional model of the representational space in human ventral temporal (VT) cortex in which dimensions are response-tuning functions that are common across individuals and patterns of response are modeled as weighted sums of basis patterns associated with these response tunings. We map response-pattern vectors, measured with fMRI, from individual subjects' voxel spaces into this common model space using a new method, "hyperalignment." Hyperalignment parameters based on responses during one experiment-movie viewing-identified 35 common response-tuning functions that captured fine-grained distinctions among a wide range of stimuli in the movie and in two category perception experiments. Between-subject classification (BSC, multivariate pattern classification based on other subjects' data) of response-pattern vectors in common model space greatly exceeded BSC of anatomically aligned responses and matched within-subject classification. Results indicate that population codes for complex visual stimuli in VT cortex are based on response-tuning functions that are common across individuals.	[Haxby, James V.; Guntupalli, J. Swaroop; Connolly, Andrew C.; Halchenko, Yaroslav O.; Gobbini, M. Ida; Hanke, Michael] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Haxby, James V.] Univ Trento, Ctr Mind Brain Sci, I-38068 Rovereto, Italy; [Conroy, Bryan R.; Ramadge, Peter J.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Gobbini, M. Ida] Univ Bologna, Dipartimento Psicol, I-40127 Bologna, Italy	Dartmouth College; University of Trento; Princeton University; University of Bologna	Haxby, JV (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	james.v.haxby@dartmouth.edu	Hanke, Michael/F-1382-2013; Hanke, Michael/A-7726-2013	Hanke, Michael/0000-0001-6398-6370; Hanke, Michael/0000-0001-6398-6370; Connolly, Andrew C./0000-0003-4366-8230; Halchenko, Yaroslav/0000-0003-3456-2493; Guntupalli, J. Swaroop/0000-0002-0677-5590	National Institutes of Mental Health [F32MH085433-01A1, 5R01MH075706]; Neukom Institute for Computational Sciences at Dartmouth; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075706, F32MH085433] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Neukom Institute for Computational Sciences at Dartmouth; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Jason Gors for assistance with data collection and Courtney Rogers for administrative support. Funding was provided by National Institutes of Mental Health grants, F32MH085433-01A1 (Connolly) and 5R01MH075706 (Haxby), and by a graduate fellowship from the Neukom Institute for Computational Sciences at Dartmouth (Guntupalli).	Abdi H, 2009, NEUROIMAGE, V45, P89, DOI 10.1016/j.neuroimage.2008.11.008; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Brants M, 2011, NEUROIMAGE, V56, P1372, DOI 10.1016/j.neuroimage.2011.02.079; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Connolly A.C., UNDERSTANDI IN PRESS; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Freiwald WA, 2009, NAT NEUROSCI, V12, P1187, DOI 10.1038/nn.2363; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lashkari D, 2010, NEUROIMAGE, V50, P1085, DOI 10.1016/j.neuroimage.2009.12.106; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Toole AJ, 2005, J COGNITIVE NEUROSCI, V17, P580, DOI 10.1162/0898929053467550; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Reddy L, 2007, CURR BIOL, V17, P2067, DOI 10.1016/j.cub.2007.10.043; Sabuncu MR, 2010, CEREB CORTEX, V20, P130, DOI 10.1093/cercor/bhp085; SCHONEMA.PH, 1966, PSYCHOMETRIKA, V31, P1, DOI 10.1007/BF02289451; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409	46	341	342	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 20	2011	72	2					404	416		10.1016/j.neuron.2011.08.026	http://dx.doi.org/10.1016/j.neuron.2011.08.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837SR	22017997	Green Accepted, Bronze			2022-12-25	WOS:000296224000020
J	Koulakov, AA; Rinberg, D				Koulakov, Alexei A.; Rinberg, Dmitry			Sparse Incomplete Representations: A Potential Role of Olfactory Granule Cells	NEURON			English	Article							BULB; INHIBITION; NETWORKS; ODOR; ORGANIZATION; SYSTEM; COMPUTATION; MODULATION; GLOMERULI; NEURONS	Mitral/tufted cells of the olfactory bulb receive odorant information from receptor neurons and transmit this information to the cortex. Studies in awake behaving animals have found that sustained responses of mitral cells to odorants are rare, suggesting sparse combinatorial representation of the odorants. Careful alignment of mitral cell firing with the phase of the respiration cycle revealed brief transient activity in the larger population of mitral cells, which respond to odorants during a small fraction of the respiration cycle. Responses of these cells are therefore temporally sparse. Here, we propose a mathematical model for the olfactory bulb network that can reproduce both combinatorially and temporally sparse mitral cell codes. We argue that sparse codes emerge as a result of the balance between mitral cells' excitatory inputs and inhibition provided by the granule cells. Our model suggests functional significance for the dendrodendritic synapses mediating interactions between mitral and granule cells.	[Koulakov, Alexei A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Koulakov, AA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	akula@cshl.edu			Aspen Center for Physics; NIH [R01EY018068]; NATIONAL EYE INSTITUTE [R01EY018068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092928] Funding Source: NIH RePORTER	Aspen Center for Physics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dmitry Chklovskii, Venkerakesh Murty, Barak Pearlmutter, Sebastian Seung, and Anthony Zador for useful discussions; Henry Greenside and Joshua Dudman for comments on the manuscript; and Aspen Center for Physics for support. A.A.K. was supported by NIH R01EY018068.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Assisi C, 2011, NEURON, V69, P373, DOI 10.1016/j.neuron.2010.12.019; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; DAVIS BJ, 1981, J COMP NEUROL, V203, P475, DOI 10.1002/cne.902030310; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Firestein Stuart, 2004, Sci STKE, V2004, ppe15; Fuentes RA, 2008, J NEUROPHYSIOL, V100, P422, DOI 10.1152/jn.00095.2008; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; Lee DD, 1997, ADV NEUR IN, V9, P515; Linster C, 1997, BEHAV BRAIN RES, V84, P117, DOI 10.1016/S0166-4328(97)83331-1; Linster C, 2001, BEHAV NEUROSCI, V115, P826, DOI 10.1037//0735-7044.115.4.826; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; MOULTON DG, 1963, OLFACTION TASTE, V1, P71; MUMFORD D, 1994, LARGE SCALE NEURONAL, P125; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rozell CJ, 2008, NEURAL COMPUT, V20, P2526, DOI 10.1162/neco.2008.03-07-486; Seung HS, 1998, ADV NEUR IN, V10, P329; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Ukhanov K, 2010, J NEUROPHYSIOL, V103, P1114, DOI 10.1152/jn.00980.2009; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wick SD, 2010, J COMPUT NEUROSCI, V28, P29, DOI 10.1007/s10827-009-0183-1	39	61	61	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 6	2011	72	1					124	136		10.1016/j.neuron.2011.07.031	http://dx.doi.org/10.1016/j.neuron.2011.07.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	833BH	21982374	Bronze, Green Accepted			2022-12-25	WOS:000295856300013
J	Di Castro, MA; Chuquet, J; Liaudet, N; Bhaukaurally, K; Santello, M; Bouvier, D; Tiret, P; Volterra, A				Di Castro, Maria Amalia; Chuquet, Julien; Liaudet, Nicolas; Bhaukaurally, Khaleel; Santello, Mirko; Bouvier, David; Tiret, Pascale; Volterra, Andrea			Local Ca2+ detection and modulation of synaptic release by astrocytes	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IN-SITU; HIPPOCAMPAL ASTROCYTES; POSTSYNAPTIC CURRENTS; GLUTAMATE EXOCYTOSIS; DENDRITIC SPINES; GRANULE CELLS; PLASTICITY; STIMULATION; TRANSMISSION	Astrocytes communicate with synapses by means of intracellular calcium ([Ca2+](i)) elevations, but local calcium dynamics in astrocytic processes have never been thoroughly investigated. By taking advantage of high-resolution two-photon microscopy, we identify the characteristics of local astrocyte calcium activity in the adult mouse hippocampus. Astrocytic processes showed intense activity, triggered by physiological transmission at neighboring synapses. They encoded synchronous synaptic events generated by sparse action potentials into robust regional (similar to 12 mu m) [Ca2+](i) elevations. Unexpectedly, they also sensed spontaneous synaptic events, producing highly confined (similar to 4 mu m), fast (millisecond-scale) miniature Ca2+ responses. This Ca2+ activity in astrocytic processes is generated through GTP- and inositol-1,4,5-trisphosphate-dependent signaling and is relevant for basal synaptic function. Thus, buffering astrocyte [Ca2+](i) or blocking a receptor mediating local astrocyte Ca2+ signals decreased synaptic transmission reliability in minimal stimulation experiments. These data provide direct evidence that astrocytes are integrated in local synaptic functioning in adult brain.	[Di Castro, Maria Amalia; Chuquet, Julien; Liaudet, Nicolas; Bhaukaurally, Khaleel; Santello, Mirko; Bouvier, David; Tiret, Pascale; Volterra, Andrea] Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland	University of Lausanne	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Lausanne, Switzerland.	andrea.volterra@unil.ch	Santello, Mirko/F-9007-2014; Di Castro, Maria Amalia/AGY-9938-2022; Chuquet, Julien/AAH-1615-2021; Bouvier, David S./E-3999-2014	Santello, Mirko/0000-0002-7709-4127; Di Castro, Maria Amalia/0000-0001-7480-1087; Bouvier, David S./0000-0002-8630-1044; Volterra, Andrea/0000-0003-1069-1602; Liaudet, Nicolas/0000-0002-0749-5857	Swiss National Science Foundation [3100A0-100850, 3100A0-120398]; MBF Foundation, Triesen; LI/Synapsis Foundation, Zurich; Swiss National Science Foundation National Center of Competence in Research; University of Lausanne Faculty of Biology and Medicine	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MBF Foundation, Triesen; LI/Synapsis Foundation, Zurich; Swiss National Science Foundation National Center of Competence in Research; University of Lausanne Faculty of Biology and Medicine	We thank P. Bezzi for experiments in cultured astrocytes and critical comments, K. D. McCarthy (University of North Carolina, Chapel Hill) and P. G. Haydon (Tufts University) for providing Itpr2<SUP>-/-</SUP> mice, H. Kettenmann (Max Delbruck Center) for providing GFAP-EGFP mice, V. Crunelli, R. Schneggenburger and F. Helmchen for suggestions, and T. Oertner for critical reading of a previous manuscript version. This work was supported by grants from Swiss National Science Foundation (3100A0-100850 and 3100A0-120398) to A. V.; J.C. received a postdoctoral fellowship from MBF Foundation, Triesen, LI/Synapsis Foundation, Zurich; P. T., from Swiss National Science Foundation National Center of Competence in Research 'Synapsy'. M. S. received a University of Lausanne Faculty of Biology and Medicine PhD fellowship.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; BERGERSEN LH, CEREB CORTE IN PRESS; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Chao TI, 2002, TRIPARTITE SYNAPSE G, P3; Colonnese MT, 2005, J NEUROSCI, V25, P1291, DOI 10.1523/JNEUROSCI.4063-04.2005; Doengi M, 2009, P NATL ACAD SCI USA, V106, P17570, DOI 10.1073/pnas.0809513106; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P2945, DOI 10.1073/pnas.0811017106; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matyash V, 2001, MOL CELL NEUROSCI, V18, P664, DOI 10.1006/mcne.2001.1047; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nolte C, 2001, GLIA, V33, P72; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Pankratov Y, 2007, J GEN PHYSIOL, V129, P257, DOI 10.1085/jgp.200609693; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Trommald M, 1997, J COMP NEUROL, V377, P15, DOI 10.1002/(SICI)1096-9861(19970106)377:1<15::AID-CNE3>3.0.CO;2-M; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; YASUDA R, 2004, SCI STKE, V219, P15, DOI DOI 10.1126/STKE.2192004P15; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	339	339	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1276	U87		10.1038/nn.2929	http://dx.doi.org/10.1038/nn.2929			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909085				2022-12-25	WOS:000295254200016
J	Hua, ZL; Leal-Ortiz, S; Foss, SM; Waites, CL; Garner, CC; Voglmaier, SM; Edwards, RH				Hua, Zhaolin; Leal-Ortiz, Sergio; Foss, Sarah M.; Waites, Clarissa L.; Garner, Craig C.; Voglmaier, Susan M.; Edwards, Robert H.			v-SNARE Composition Distinguishes Synaptic Vesicle Pools	NEURON			English	Article							SPONTANEOUS NEUROTRANSMITTER RELEASE; FROG NEUROMUSCULAR-JUNCTION; MOSSY FIBER SYNAPSES; VESICULAR MONOAMINE; MEMBRANE COMPARTMENT; FLUORESCENT PROTEINS; TRANSMITTER RELEASE; ENDOCYTIC PATHWAYS; RECYCLING PATHWAYS; ADAPTER PROTEIN-3	Synaptic vesicles belong to two distinct pools, a recycling pool responsible for the evoked release of neurotransmitter and a resting pool unresponsive to stimulation. The uniform appearance of synaptic vesicles has suggested that differences in location or cytoskeletal association account for these differences in function. We now find that the v-SNARE tetanus toxin-insensitive vesicle-associated membrane protein (VAMP7) differs from other synaptic vesicle proteins in its distribution to the two pools, providing evidence that they differ in molecular composition. We also find that both resting and recycling pools undergo spontaneous release, and when activated by deletion of the longin domain, VAMP7 influences the properties of release. Further, the endocytosis that follows evoked and spontaneous release differs in mechanism, and specific sequences confer targeting to the different vesicle pools. The results suggest that different endocytic mechanisms generate synaptic vesicles with different proteins that can endow the vesicles with distinct properties.	[Hua, Zhaolin; Foss, Sarah M.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Hua, Zhaolin; Foss, Sarah M.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; [Foss, Sarah M.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Grad Program Cell Biol, San Francisco, CA 94143 USA; [Voglmaier, Susan M.] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Leal-Ortiz, Sergio; Waites, Clarissa L.; Garner, Craig C.] Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu		Hua, Zhaolin/0000-0001-9242-1387; Garner, Craig/0000-0003-1970-5417	American Heart Association; NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083691, R01MH050712, R37MH050712, K08MH071626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Peden, V. Faundez, and R. Kelly for antibodies to VAMP7 and SV2, J. Rothman for helpful suggestions, and T.A. Ryan and the members of the Edwards lab for discussion. This work was supported by a fellowship from the American Heart Association (to Z.H.) and a grant from NIMH (to R.H.E.).	Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Alberts P, 2003, MOL BIOL CELL, V14, P4207, DOI 10.1091/mbc.e03-03-0147; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Blumstein J, 2001, J NEUROSCI, V21, P8034, DOI 10.1523/JNEUROSCI.21-20-08034.2001; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; Coco S, 1999, J NEUROSCI, V19, P9803; De Gois S, 2006, CELL MOL NEUROBIOL, V26, P679, DOI 10.1007/s10571-006-9054-8; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fernandez-Alfonso T, 2008, BRAIN CELL BIOL, V36, P87, DOI 10.1007/s11068-008-9030-y; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Hua YF, 2010, NAT NEUROSCI, V13, P1451, DOI 10.1038/nn.2695; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mitchell SJ, 2004, J NEUROSCI, V24, P4884, DOI 10.1523/JNEUROSCI.0174-04.2004; Muzerelle A, 2003, NEUROSCIENCE, V122, P59, DOI 10.1016/S0306-4522(03)00567-0; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Voglmaier SM, 2007, CURR OPIN NEUROBIOL, V17, P374, DOI 10.1016/j.conb.2007.04.002; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wasser CR, 2009, NEUROSCIENCE, V158, P177, DOI 10.1016/j.neuroscience.2008.03.028; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Wilhelm BG, 2010, NAT NEUROSCI, V13, P1454, DOI 10.1038/nn.2690; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	76	122	123	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 11	2011	71	3					474	487		10.1016/j.neuron.2011.06.010	http://dx.doi.org/10.1016/j.neuron.2011.06.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835344	Green Accepted, Bronze			2022-12-25	WOS:000293991700011
J	Krueppel, R; Remy, S; Beck, H				Krueppel, Roland; Remy, Stefan; Beck, Heinz			Dendritic Integration in Hippocampal Dentate Granule Cells	NEURON			English	Article							ACTION-POTENTIAL INITIATION; SYNAPTIC-TRANSMISSION; ACTIVE PROPAGATION; OBLIQUE DENDRITES; PYRAMIDAL NEURONS; BASAL DENDRITES; GYRUS; PLASTICITY; BACKPROPAGATION; INACTIVATION	Hippocampal granule cells are important relay stations that transfer information from the entorhinal cortex into the hippocampus proper. This process is critically determined by the integrative properties of granule cell dendrites. However, their small diameter has so far hampered efforts to examine their properties directly. Using a combination of dual somatodendritic patch-clamp recordings and multiphoton glutamate uncaging, we now show that the integrative properties of granule cell dendrites differ substantially from other principal neurons. Due to a very strong dendritic voltage attenuation, the impact of individual synapses on granule cell output is low. At the same time, integration is linearized by voltage-dependent boosting mechanisms, only weakly affected by input synchrony, and independent of input location. These experiments establish that dentate granule cell dendritic properties are optimized for linear integration and strong attenuation of synaptic input from the entorhinal cortex, which may contribute to the sparse activity of granule cells in vivo.	[Krueppel, Roland; Beck, Heinz] Univ Bonn, Dept Epileptol, Lab Cognit Res & Expt Epileptol, D-53105 Bonn, Germany; [Remy, Stefan] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, D-53175 Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Beck, H (corresponding author), Univ Bonn, Dept Epileptol, Lab Cognit Res & Expt Epileptol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	heinz.beck@ukb.uni-bonn.de		Kruppel, Roland/0000-0002-6173-0002	Deutsche Forschungsgemeinschaft [SFB TR3]; Nationales Genomforschungsnetzwerk NGFN<SUP>plus</SUP> EmiNet; EPICURE; ERANET Neuron 'EpiNet'; Ministry for Innovation, Research, Science, Research, and Technology NRW; University of Bonn Medical Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nationales Genomforschungsnetzwerk NGFN<SUP>plus</SUP> EmiNet; EPICURE; ERANET Neuron 'EpiNet'; Ministry for Innovation, Research, Science, Research, and Technology NRW; University of Bonn Medical Center	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TR3), Nationales Genomforschungsnetzwerk NGFN<SUP>plus</SUP> EmiNet, EPICURE, ERANET Neuron 'EpiNet', Ministry for Innovation, Research, Science, Research, and Technology NRW, and the BONFOR program of the University of Bonn Medical Center. We thank J.C. Magee and D. Dietrich for suggestions on the manuscript, T. Nevian for technical help with the dendritic recordings, and F. Helmchen for support.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ariav G, 2003, J NEUROSCI, V23, P7750; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Colbert CM, 1997, J NEUROSCI, V17, P6512; DESMOND NL, 1984, J COMP NEUROL, V227, P589, DOI 10.1002/cne.902270410; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998, DOI 10.1152/jn.2001.86.6.2998; HAMA K, 1989, J ELECTRON MICR TECH, V12, P80, DOI 10.1002/jemt.1060120203; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; JEFFERYS JGR, 1979, J PHYSIOL-LONDON, V289, P375, DOI 10.1113/jphysiol.1979.sp012742; Jung HY, 1997, J NEUROSCI, V17, P6639; KELLER BU, 1991, J PHYSIOL-LONDON, V435, P275, DOI 10.1113/jphysiol.1991.sp018510; Kress GJ, 2008, J NEUROPHYSIOL, V100, P281, DOI 10.1152/jn.90295.2008; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LAMBERT JDC, 1990, J NEUROPHYSIOL, V64, P119, DOI 10.1152/jn.1990.64.1.119; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Makara JK, 2009, NAT NEUROSCI, V12, P1485, DOI 10.1038/nn.2428; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; PATTON PE, 1995, HIPPOCAMPUS, V5, P245, DOI 10.1002/hipo.450050402; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Remy S, 2009, NEURON, V61, P906, DOI 10.1016/j.neuron.2009.01.032; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073	44	125	126	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 11	2011	71	3					512	528		10.1016/j.neuron.2011.05.043	http://dx.doi.org/10.1016/j.neuron.2011.05.043			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	808PU	21835347	Bronze			2022-12-25	WOS:000293991700014
J	Liu, GH; Suzuki, K; Qu, J; Sancho-Martinez, I; Yi, F; Li, M; Kumar, S; Nivet, E; Kim, J; Soligalla, RD; Dubova, I; Goebl, A; Plongthongkum, N; Fung, HL; Zhang, K; Loring, JF; Laurent, LC; Belmonte, JCI				Liu, Guang-Hui; Suzuki, Keiichiro; Qu, Jing; Sancho-Martinez, Ignacio; Yi, Fei; Li, Mo; Kumar, Sachin; Nivet, Emmanuel; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Goebl, April; Plongthongkum, Nongluk; Fung, Ho-Lim; Zhang, Kun; Loring, Jeanne F.; Laurent, Louise C.; Izpisua Belmonte, Juan Carlos			Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DEPENDENT ADENOVIRAL VECTORS; GILFORD-PROGERIA-SYNDROME; ZINC-FINGER NUCLEASES; HOMOLOGOUS RECOMBINATION; HUMAN ESCS; COPY NUMBER; DISEASE; PLURIPOTENCY; THERAPY	Combination of stem cell-based approaches with gene-editing technologies represents an attractive strategy for studying human disease and developing therapies. However, gene-editing methodologies described to date for human cells suffer from technical limitations including limited target gene size, low targeting efficiency at transcriptionally inactive loci, and off-target genetic effects that could hamper broad clinical application. To address these limitations, and as a proof of principle, we focused on homologous recombination-based gene correction of multiple mutations on lamin A (LMNA), which are associated with various degenerative diseases. We show that helper-dependent adenoviral vectors (HDAdVs) provide a highly efficient and safe method for correcting mutations in large genomic regions in human induced pluripotent stem cells and can also be effective in adult human mesenchymal stem cells. This type of approach could be used to generate genotype-matched cell lines for disease modeling and drug discovery and potentially also in therapeutics.	[Liu, Guang-Hui; Suzuki, Keiichiro; Qu, Jing; Sancho-Martinez, Ignacio; Yi, Fei; Li, Mo; Kumar, Sachin; Nivet, Emmanuel; Kim, Jessica; Soligalla, Rupa Devi; Dubova, Ilir; Goebl, April; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Plongthongkum, Nongluk; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Loring, Jeanne F.; Laurent, Louise C.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Zhang, Kun/ABE-6349-2020; Li, Mo/J-2090-2014; Loring, Jeanne F/A-1620-2011; Li, Mo/AAM-8266-2021; Qu, Jing/ABB-9088-2020; Nivet, Emmanuel/C-2729-2014	Zhang, Kun/0000-0002-7596-5224; Loring, Jeanne F/0000-0001-6226-9767; Li, Mo/0000-0003-0827-8907; Nivet, Emmanuel/0000-0001-7903-4059; Liu, Guang-Hui/0000-0001-9289-8177; qu, jing/0000-0002-3988-5067; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Plongthongkum, Nongluk/0000-0002-1305-285X; Suzuki, Keiichiro/0000-0001-5603-9105; Laurent, Louise/0000-0002-2095-7534	CIRM [TG2-01158, TR1-01250]; AFAR/Ellison Medical Foundation; F.M. Kirby Foundation; NIH [K12HD001259-11]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Ellison Medical Foundation; Helmsley Foundation; MICINN; Fundacion Cellex;  [DA025779]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); F.M. Kirby Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Foundation; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex(Foundation CELLEX); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank K. Mitani, P. Ng, and A. Lieber for kindly providing experimental materials, J. Karlseder, L. Gerace, M. Hetzer, and C. Rodriguez Esteban for helpful discussions, C. Lynch for running SNP genotyping arrays, M.C. Llach for karyotyping, M. Marti for teratoma analysis, Y. Xia and S.-L. Yang for technical help, and M. Schwarz for administrative help. G.-H.L. was partially supported by a CIRM grant (TG2-01158), and J.Q. was partially supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship. E.N. was partially supported by a F.M. Kirby Foundation postdoctoral fellowship. L.C.L. is supported by NIH K12HD001259-11. The work by L.C.L. and J.F.L. was supported by CIRM TR1-01250. This study was supported by grants from DA025779 (K.Z.), the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Ellison Medical Foundation, Helmsley Foundation, MICINN, and Fundacion Cellex (J.C.I.B.).	Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Burke B, 2001, TRAFFIC, V2, P675, DOI 10.1034/j.1600-0854.2001.21001.x; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Khan IF, 2010, MOL THER, V18, P1192, DOI 10.1038/mt.2010.55; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mitsui K, 2009, BIOCHEM BIOPH RES CO, V388, P711, DOI 10.1016/j.bbrc.2009.08.075; Nieminen M, 2010, EXP CELL RES, V316, P2578, DOI 10.1016/j.yexcr.2010.06.004; Palmer DJ, 2004, MOL THER, V10, P792, DOI 10.1016/j.ymthe.2004.06.1013; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sancho-Martinez I, 2011, CLIN PHARMACOL THER, V89, P746, DOI 10.1038/clpt.2010.341; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shayakhmetov DM, 2004, J VIROL, V78, P10009, DOI 10.1128/JVI.78.18.10009-10022.2004; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Zaremba-Czogalla M, 2011, CELL MOL BIOL LETT, V16, P114, DOI 10.2478/s11658-010-0038-9; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	39	185	196	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 3	2011	8	6					688	694		10.1016/j.stem.2011.04.019	http://dx.doi.org/10.1016/j.stem.2011.04.019			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	780HC	21596650	Green Accepted, Bronze			2022-12-25	WOS:000291844100016
J	Chen, FY; Zha, DJ; Fridberger, A; Zheng, JF; Choudhury, N; Jacques, SL; Wang, RK; Shi, XR; Nuttall, AL				Chen, Fangyi; Zha, Dingjun; Fridberger, Anders; Zheng, Jiefu; Choudhury, Niloy; Jacques, Steven L.; Wang, Ruikang K.; Shi, Xiaorui; Nuttall, Alfred L.			A differentially amplified motion in the ear for near-threshold sound detection	NATURE NEUROSCIENCE			English	Article							BASILAR-MEMBRANE MOTION; HAIR-CELLS; MECHANOELECTRICAL TRANSDUCTION; REVERSE TRANSDUCTION; TECTORIAL MEMBRANE; ORGAN; COCHLEA; AMPLIFICATION; SENSITIVITY; POTENTIALS	The ear is a remarkably sensitive pressure fluctuation detector. In guinea pigs, behavioral measurements indicate a minimum detectable sound pressure of similar to 20 mu Pa at 16 kHz. Such faint sounds produce 0.1-nm basilar membrane displacements, a distance smaller than conformational transitions in ion channels. It seems that noise within the auditory system would swamp such tiny motions, making weak sounds imperceptible. Here we propose a new mechanism contributing to a resolution of this problem and validate it through direct measurement. We hypothesized that vibration at the apical side of hair cells is enhanced compared with that at the commonly measured basilar membrane side. Using in vivo optical coherence tomography, we demonstrated that apical-side vibrations peaked at a higher frequency, had different timing and were enhanced compared with those at the basilar membrane. These effects depend nonlinearly on the stimulus sound pressure level. The timing difference and enhancement of vibrations are important for explaining how the noise problem is circumvented.	[Chen, Fangyi; Zha, Dingjun; Fridberger, Anders; Zheng, Jiefu; Shi, Xiaorui; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Zha, Dingjun] Fourth Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Xijing Hosp, Xian, Peoples R China; [Fridberger, Anders] Karolinska Inst, Dept Clin Sci Intervent & Technol, Ctr Hearing & Commun Res, Stockholm, Sweden; [Choudhury, Niloy; Jacques, Steven L.; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Jacques, Steven L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Shi, Xiaorui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Xiaorui] Chinese Acad Med Sci, Inst Microcirculat, Beijing 100037, Peoples R China; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; Air Force Military Medical University; Karolinska Institutet; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; University of Michigan System; University of Michigan	Nuttall, AL (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	nuttall@ohsu.edu	Wang, Ruikang/L-3889-2019; Fridberger, Anders/E-8977-2010; Chen, Fangyi/I-3497-2018	Wang, Ruikang/0000-0001-5169-8822; Fridberger, Anders/0000-0002-7960-1559; Chen, Fangyi/0000-0002-5024-6215	US National Institutes of Health, National Institute on Deafness and Other Communication Disorders [DC00141, DC010399, DC010201]; Swedish Research Council [K2008-63X-14061-08-3]; Tysta Skolan Foundation; Horselskadades Riksforbund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010399, R01DC010201, R01DC010844] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tysta Skolan Foundation; Horselskadades Riksforbund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank E. de Boer, T. Ren, A. Magnusson and P. Gillespie for critical discussions and reading of the manuscript. This work was supported by US National Institutes of Health, National Institute on Deafness and Other Communication Disorders grants DC00141 (A.L.N.), DC010399 (A.L.N.) and DC010201 (R.K.W.); and Swedish Research Council grant K2008-63X-14061-08-3, the Tysta Skolan Foundation and Horselskadades Riksforbund (A.F.).	ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; BADENKRISTENSEN K, 1983, J PHYSIOL-LONDON, V335, P699, DOI 10.1113/jphysiol.1983.sp014559; Barral J, 2010, P NATL ACAD SCI USA, V107, P8079, DOI 10.1073/pnas.0913657107; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chen FY, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717134; Choudhury N, 2006, HEARING RES, V220, P1, DOI 10.1016/j.heares.2006.06.006; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Dallos P, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P97, DOI 10.1142/9789812704931_0013; de Boer E, 2000, J ACOUST SOC AM, V107, P1497, DOI 10.1121/1.428436; DENK W, 1989, PHYS REV LETT, V63, P207, DOI 10.1103/PhysRevLett.63.207; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; FLOCK A, 1965, COLD SPRING HARB SYM, V30, P133, DOI 10.1101/SQB.1965.030.01.016; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; Fridberger A, 2003, NAT NEUROSCI, V6, P446, DOI 10.1038/nn1047; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HEFFNER R, 1971, J ACOUST SOC AM, V49, P1888, DOI 10.1121/1.1912596; HOOD LJ, 1991, HEARING RES, V55, P109, DOI 10.1016/0378-5955(91)90097-S; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Jaramillo F, 1998, NAT NEUROSCI, V1, P384, DOI 10.1038/1597; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Khanna SM, 2000, HEARING RES, V149, P55, DOI 10.1016/S0378-5955(00)00162-3; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; Kolston PJ, 1999, P NATL ACAD SCI USA, V96, P3676, DOI 10.1073/pnas.96.7.3676; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; Nuttall AL, 1995, HEARING RES, V92, P170, DOI 10.1016/0378-5955(95)00216-2; OLSON ES, 1991, J ACOUST SOC AM, V89, P1262, DOI 10.1121/1.400535; Pickles J. O, 1988, INTRO PHYSL HEARING; PROSEN CA, 1978, J ACOUST SOC AM, V63, P559, DOI 10.1121/1.381754; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 2005, P NATL ACAD SCI USA, V102, P18614, DOI 10.1073/pnas.0509323102; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Tomo I, 2007, BIOPHYS J, V93, P3279, DOI 10.1529/biophysj.107.105072; van Netten SM, 2003, P NATL ACAD SCI USA, V100, P15510, DOI 10.1073/pnas.2632626100; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671	45	149	152	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					770	U366		10.1038/nn.2827	http://dx.doi.org/10.1038/nn.2827			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21602821	Green Accepted			2022-12-25	WOS:000290958000021
J	Lindvall, O				Lindvall, Olle			Why Is It Taking So Long to Develop Clinically Competitive Stem Cell Therapies for CNS Disorders?	CELL STEM CELL			English	Editorial Material							PARKINSONS-DISEASE; DOPAMINE NEURONS; TRANSPLANTATION	The remarkable advancements in basic stem cell research with implications for several central nervous system disorders have so far not been translated into clinically effective therapies. Here I discuss some of the underlying problems and how they could be overcome.	Univ Lund Hosp, Lund Stem Cell Ctr, SE-22184 Lund, Sweden	Lund University; Skane University Hospital	Lindvall, O (corresponding author), Univ Lund Hosp, Lund Stem Cell Ctr, SE-22184 Lund, Sweden.	olle.lindvall@med.lu.se		Barker, Roger Alistair/0000-0001-8843-7730; Isacson, Ole/0000-0001-8091-8302	Medical Research Council [G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784] Funding Source: Medline; NINDS NIH HHS [P01 NS057778, P50 NS039793] Funding Source: Medline; Wellcome Trust [079249] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust)		BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; Cicchetti F, 2009, P NATL ACAD SCI USA, V106, P12483, DOI 10.1073/pnas.0904239106; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lindvall O, 2012, CELL STEM CELL, V10, P660, DOI [10.1016/j.stem.2012.04.004, 10.1016/j.stem.2012.01.009]; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649	9	83	86	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 14	2012	10	6					660	662		10.1016/j.stem.2012.04.004	http://dx.doi.org/10.1016/j.stem.2012.04.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	965LD	22704504	Bronze			2022-12-25	WOS:000305768400010
